"","pmid","doi","title","abstract","year","month","day","jabbrv","journal","keywords","lastname","firstname","address","email"
"1","34252085","10.1371/journal.pcbi.1009162","Detecting behavioural changes in human movement to inform the spatial scale of interventions against COVID-19.","On March 23 2020, the UK enacted an intensive, nationwide lockdown to mitigate transmission of COVID-19. As restrictions began to ease, more localized interventions were used to target resurgences in transmission. Understanding the spatial scale of networks of human interaction, and how these networks change over time, is critical to targeting interventions at the most at-risk areas without unnecessarily restricting areas at low risk of resurgence. We use detailed human mobility data aggregated ","2021","07","23","PLoS Comput Biol","PLoS computational biology",NA,"Gibbs","Hamish","Department of Infectious Disease Epidemiology, London School of Hygiene &amp",NA
"2","34252085","10.1371/journal.pcbi.1009162","Detecting behavioural changes in human movement to inform the spatial scale of interventions against COVID-19.","On March 23 2020, the UK enacted an intensive, nationwide lockdown to mitigate transmission of COVID-19. As restrictions began to ease, more localized interventions were used to target resurgences in transmission. Understanding the spatial scale of networks of human interaction, and how these networks change over time, is critical to targeting interventions at the most at-risk areas without unnecessarily restricting areas at low risk of resurgence. We use detailed human mobility data aggregated ","2021","07","23","PLoS Comput Biol","PLoS computational biology",NA,"Nightingale","Emily","Department of Global Health and Development, London School of Hygiene &amp",NA
"3","34252085","10.1371/journal.pcbi.1009162","Detecting behavioural changes in human movement to inform the spatial scale of interventions against COVID-19.","On March 23 2020, the UK enacted an intensive, nationwide lockdown to mitigate transmission of COVID-19. As restrictions began to ease, more localized interventions were used to target resurgences in transmission. Understanding the spatial scale of networks of human interaction, and how these networks change over time, is critical to targeting interventions at the most at-risk areas without unnecessarily restricting areas at low risk of resurgence. We use detailed human mobility data aggregated ","2021","07","23","PLoS Comput Biol","PLoS computational biology",NA,"Liu","Yang","Department of Infectious Disease Epidemiology, London School of Hygiene &amp",NA
"4","34252085","10.1371/journal.pcbi.1009162","Detecting behavioural changes in human movement to inform the spatial scale of interventions against COVID-19.","On March 23 2020, the UK enacted an intensive, nationwide lockdown to mitigate transmission of COVID-19. As restrictions began to ease, more localized interventions were used to target resurgences in transmission. Understanding the spatial scale of networks of human interaction, and how these networks change over time, is critical to targeting interventions at the most at-risk areas without unnecessarily restricting areas at low risk of resurgence. We use detailed human mobility data aggregated ","2021","07","23","PLoS Comput Biol","PLoS computational biology",NA,"Cheshire","James","Department of Geography, University College London, London, United Kingdom",NA
"5","34252085","10.1371/journal.pcbi.1009162","Detecting behavioural changes in human movement to inform the spatial scale of interventions against COVID-19.","On March 23 2020, the UK enacted an intensive, nationwide lockdown to mitigate transmission of COVID-19. As restrictions began to ease, more localized interventions were used to target resurgences in transmission. Understanding the spatial scale of networks of human interaction, and how these networks change over time, is critical to targeting interventions at the most at-risk areas without unnecessarily restricting areas at low risk of resurgence. We use detailed human mobility data aggregated ","2021","07","23","PLoS Comput Biol","PLoS computational biology",NA,"Danon","Leon","Department of Engineering Mathematics, University of Bristol, Bristol, United Kingdom",NA
"6","34252085","10.1371/journal.pcbi.1009162","Detecting behavioural changes in human movement to inform the spatial scale of interventions against COVID-19.","On March 23 2020, the UK enacted an intensive, nationwide lockdown to mitigate transmission of COVID-19. As restrictions began to ease, more localized interventions were used to target resurgences in transmission. Understanding the spatial scale of networks of human interaction, and how these networks change over time, is critical to targeting interventions at the most at-risk areas without unnecessarily restricting areas at low risk of resurgence. We use detailed human mobility data aggregated ","2021","07","23","PLoS Comput Biol","PLoS computational biology",NA,"Smeeth","Liam","Faculty of Epidemiology and Population Health, London School of Hygiene &amp",NA
"7","34252085","10.1371/journal.pcbi.1009162","Detecting behavioural changes in human movement to inform the spatial scale of interventions against COVID-19.","On March 23 2020, the UK enacted an intensive, nationwide lockdown to mitigate transmission of COVID-19. As restrictions began to ease, more localized interventions were used to target resurgences in transmission. Understanding the spatial scale of networks of human interaction, and how these networks change over time, is critical to targeting interventions at the most at-risk areas without unnecessarily restricting areas at low risk of resurgence. We use detailed human mobility data aggregated ","2021","07","23","PLoS Comput Biol","PLoS computational biology",NA,"Pearson","Carl A B","Department of Infectious Disease Epidemiology, London School of Hygiene &amp",NA
"8","34252085","10.1371/journal.pcbi.1009162","Detecting behavioural changes in human movement to inform the spatial scale of interventions against COVID-19.","On March 23 2020, the UK enacted an intensive, nationwide lockdown to mitigate transmission of COVID-19. As restrictions began to ease, more localized interventions were used to target resurgences in transmission. Understanding the spatial scale of networks of human interaction, and how these networks change over time, is critical to targeting interventions at the most at-risk areas without unnecessarily restricting areas at low risk of resurgence. We use detailed human mobility data aggregated ","2021","07","23","PLoS Comput Biol","PLoS computational biology",NA,"Grundy","Chris","Department of Infectious Disease Epidemiology, London School of Hygiene &amp",NA
"9","34252085","10.1371/journal.pcbi.1009162","Detecting behavioural changes in human movement to inform the spatial scale of interventions against COVID-19.","On March 23 2020, the UK enacted an intensive, nationwide lockdown to mitigate transmission of COVID-19. As restrictions began to ease, more localized interventions were used to target resurgences in transmission. Understanding the spatial scale of networks of human interaction, and how these networks change over time, is critical to targeting interventions at the most at-risk areas without unnecessarily restricting areas at low risk of resurgence. We use detailed human mobility data aggregated ","2021","07","23","PLoS Comput Biol","PLoS computational biology",NA,"Kucharski","Adam J","Department of Infectious Disease Epidemiology, London School of Hygiene &amp",NA
"10","34252085","10.1371/journal.pcbi.1009162","Detecting behavioural changes in human movement to inform the spatial scale of interventions against COVID-19.","On March 23 2020, the UK enacted an intensive, nationwide lockdown to mitigate transmission of COVID-19. As restrictions began to ease, more localized interventions were used to target resurgences in transmission. Understanding the spatial scale of networks of human interaction, and how these networks change over time, is critical to targeting interventions at the most at-risk areas without unnecessarily restricting areas at low risk of resurgence. We use detailed human mobility data aggregated ","2021","07","23","PLoS Comput Biol","PLoS computational biology",NA,"Eggo","Rosalind M","Department of Infectious Disease Epidemiology, London School of Hygiene &amp",NA
"11","34252083","10.1371/journal.pcbi.1009146","OpenABM-Covid19-An agent-based model for non-pharmaceutical interventions against COVID-19 including contact tracing.","SARS-CoV-2 has spread across the world, causing high mortality and unprecedented restrictions on social and economic activity. Policymakers are assessing how best to navigate through the ongoing epidemic, with computational models being used to predict the spread of infection and assess the impact of public health measures. Here, we present OpenABM-Covid19: an agent-based simulation of the epidemic including detailed age-stratification and realistic social networks. By default the model is param","2021","07","12","PLoS Comput Biol","PLoS computational biology",NA,"Hinch","Robert","Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom",NA
"12","34252083","10.1371/journal.pcbi.1009146","OpenABM-Covid19-An agent-based model for non-pharmaceutical interventions against COVID-19 including contact tracing.","SARS-CoV-2 has spread across the world, causing high mortality and unprecedented restrictions on social and economic activity. Policymakers are assessing how best to navigate through the ongoing epidemic, with computational models being used to predict the spread of infection and assess the impact of public health measures. Here, we present OpenABM-Covid19: an agent-based simulation of the epidemic including detailed age-stratification and realistic social networks. By default the model is param","2021","07","12","PLoS Comput Biol","PLoS computational biology",NA,"Probert","William J M","Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom",NA
"13","34252083","10.1371/journal.pcbi.1009146","OpenABM-Covid19-An agent-based model for non-pharmaceutical interventions against COVID-19 including contact tracing.","SARS-CoV-2 has spread across the world, causing high mortality and unprecedented restrictions on social and economic activity. Policymakers are assessing how best to navigate through the ongoing epidemic, with computational models being used to predict the spread of infection and assess the impact of public health measures. Here, we present OpenABM-Covid19: an agent-based simulation of the epidemic including detailed age-stratification and realistic social networks. By default the model is param","2021","07","12","PLoS Comput Biol","PLoS computational biology",NA,"Nurtay","Anel","Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom",NA
"14","34252083","10.1371/journal.pcbi.1009146","OpenABM-Covid19-An agent-based model for non-pharmaceutical interventions against COVID-19 including contact tracing.","SARS-CoV-2 has spread across the world, causing high mortality and unprecedented restrictions on social and economic activity. Policymakers are assessing how best to navigate through the ongoing epidemic, with computational models being used to predict the spread of infection and assess the impact of public health measures. Here, we present OpenABM-Covid19: an agent-based simulation of the epidemic including detailed age-stratification and realistic social networks. By default the model is param","2021","07","12","PLoS Comput Biol","PLoS computational biology",NA,"Kendall","Michelle","Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom",NA
"15","34252083","10.1371/journal.pcbi.1009146","OpenABM-Covid19-An agent-based model for non-pharmaceutical interventions against COVID-19 including contact tracing.","SARS-CoV-2 has spread across the world, causing high mortality and unprecedented restrictions on social and economic activity. Policymakers are assessing how best to navigate through the ongoing epidemic, with computational models being used to predict the spread of infection and assess the impact of public health measures. Here, we present OpenABM-Covid19: an agent-based simulation of the epidemic including detailed age-stratification and realistic social networks. By default the model is param","2021","07","12","PLoS Comput Biol","PLoS computational biology",NA,"Wymant","Chris","Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom",NA
"16","34252083","10.1371/journal.pcbi.1009146","OpenABM-Covid19-An agent-based model for non-pharmaceutical interventions against COVID-19 including contact tracing.","SARS-CoV-2 has spread across the world, causing high mortality and unprecedented restrictions on social and economic activity. Policymakers are assessing how best to navigate through the ongoing epidemic, with computational models being used to predict the spread of infection and assess the impact of public health measures. Here, we present OpenABM-Covid19: an agent-based simulation of the epidemic including detailed age-stratification and realistic social networks. By default the model is param","2021","07","12","PLoS Comput Biol","PLoS computational biology",NA,"Hall","Matthew","Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom",NA
"17","34252083","10.1371/journal.pcbi.1009146","OpenABM-Covid19-An agent-based model for non-pharmaceutical interventions against COVID-19 including contact tracing.","SARS-CoV-2 has spread across the world, causing high mortality and unprecedented restrictions on social and economic activity. Policymakers are assessing how best to navigate through the ongoing epidemic, with computational models being used to predict the spread of infection and assess the impact of public health measures. Here, we present OpenABM-Covid19: an agent-based simulation of the epidemic including detailed age-stratification and realistic social networks. By default the model is param","2021","07","12","PLoS Comput Biol","PLoS computational biology",NA,"Lythgoe","Katrina","Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom",NA
"18","34252083","10.1371/journal.pcbi.1009146","OpenABM-Covid19-An agent-based model for non-pharmaceutical interventions against COVID-19 including contact tracing.","SARS-CoV-2 has spread across the world, causing high mortality and unprecedented restrictions on social and economic activity. Policymakers are assessing how best to navigate through the ongoing epidemic, with computational models being used to predict the spread of infection and assess the impact of public health measures. Here, we present OpenABM-Covid19: an agent-based simulation of the epidemic including detailed age-stratification and realistic social networks. By default the model is param","2021","07","12","PLoS Comput Biol","PLoS computational biology",NA,"Bulas Cruz","Ana","Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom",NA
"19","34252083","10.1371/journal.pcbi.1009146","OpenABM-Covid19-An agent-based model for non-pharmaceutical interventions against COVID-19 including contact tracing.","SARS-CoV-2 has spread across the world, causing high mortality and unprecedented restrictions on social and economic activity. Policymakers are assessing how best to navigate through the ongoing epidemic, with computational models being used to predict the spread of infection and assess the impact of public health measures. Here, we present OpenABM-Covid19: an agent-based simulation of the epidemic including detailed age-stratification and realistic social networks. By default the model is param","2021","07","12","PLoS Comput Biol","PLoS computational biology",NA,"Zhao","Lele","Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom",NA
"20","34252083","10.1371/journal.pcbi.1009146","OpenABM-Covid19-An agent-based model for non-pharmaceutical interventions against COVID-19 including contact tracing.","SARS-CoV-2 has spread across the world, causing high mortality and unprecedented restrictions on social and economic activity. Policymakers are assessing how best to navigate through the ongoing epidemic, with computational models being used to predict the spread of infection and assess the impact of public health measures. Here, we present OpenABM-Covid19: an agent-based simulation of the epidemic including detailed age-stratification and realistic social networks. By default the model is param","2021","07","12","PLoS Comput Biol","PLoS computational biology",NA,"Stewart","Andrea","Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom",NA
"21","34252083","10.1371/journal.pcbi.1009146","OpenABM-Covid19-An agent-based model for non-pharmaceutical interventions against COVID-19 including contact tracing.","SARS-CoV-2 has spread across the world, causing high mortality and unprecedented restrictions on social and economic activity. Policymakers are assessing how best to navigate through the ongoing epidemic, with computational models being used to predict the spread of infection and assess the impact of public health measures. Here, we present OpenABM-Covid19: an agent-based simulation of the epidemic including detailed age-stratification and realistic social networks. By default the model is param","2021","07","12","PLoS Comput Biol","PLoS computational biology",NA,"Ferretti","Luca","Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom",NA
"22","34252083","10.1371/journal.pcbi.1009146","OpenABM-Covid19-An agent-based model for non-pharmaceutical interventions against COVID-19 including contact tracing.","SARS-CoV-2 has spread across the world, causing high mortality and unprecedented restrictions on social and economic activity. Policymakers are assessing how best to navigate through the ongoing epidemic, with computational models being used to predict the spread of infection and assess the impact of public health measures. Here, we present OpenABM-Covid19: an agent-based simulation of the epidemic including detailed age-stratification and realistic social networks. By default the model is param","2021","07","12","PLoS Comput Biol","PLoS computational biology",NA,"Montero","Daniel","IBM United Kingdom, Portsmouth, United Kingdom",NA
"23","34252083","10.1371/journal.pcbi.1009146","OpenABM-Covid19-An agent-based model for non-pharmaceutical interventions against COVID-19 including contact tracing.","SARS-CoV-2 has spread across the world, causing high mortality and unprecedented restrictions on social and economic activity. Policymakers are assessing how best to navigate through the ongoing epidemic, with computational models being used to predict the spread of infection and assess the impact of public health measures. Here, we present OpenABM-Covid19: an agent-based simulation of the epidemic including detailed age-stratification and realistic social networks. By default the model is param","2021","07","12","PLoS Comput Biol","PLoS computational biology",NA,"Warren","James","IBM United Kingdom, Portsmouth, United Kingdom",NA
"24","34252083","10.1371/journal.pcbi.1009146","OpenABM-Covid19-An agent-based model for non-pharmaceutical interventions against COVID-19 including contact tracing.","SARS-CoV-2 has spread across the world, causing high mortality and unprecedented restrictions on social and economic activity. Policymakers are assessing how best to navigate through the ongoing epidemic, with computational models being used to predict the spread of infection and assess the impact of public health measures. Here, we present OpenABM-Covid19: an agent-based simulation of the epidemic including detailed age-stratification and realistic social networks. By default the model is param","2021","07","12","PLoS Comput Biol","PLoS computational biology",NA,"Mather","Nicole","IBM United Kingdom, Portsmouth, United Kingdom",NA
"25","34252083","10.1371/journal.pcbi.1009146","OpenABM-Covid19-An agent-based model for non-pharmaceutical interventions against COVID-19 including contact tracing.","SARS-CoV-2 has spread across the world, causing high mortality and unprecedented restrictions on social and economic activity. Policymakers are assessing how best to navigate through the ongoing epidemic, with computational models being used to predict the spread of infection and assess the impact of public health measures. Here, we present OpenABM-Covid19: an agent-based simulation of the epidemic including detailed age-stratification and realistic social networks. By default the model is param","2021","07","12","PLoS Comput Biol","PLoS computational biology",NA,"Abueg","Matthew","Google Research, Mountain View, California, United States of America",NA
"26","34252083","10.1371/journal.pcbi.1009146","OpenABM-Covid19-An agent-based model for non-pharmaceutical interventions against COVID-19 including contact tracing.","SARS-CoV-2 has spread across the world, causing high mortality and unprecedented restrictions on social and economic activity. Policymakers are assessing how best to navigate through the ongoing epidemic, with computational models being used to predict the spread of infection and assess the impact of public health measures. Here, we present OpenABM-Covid19: an agent-based simulation of the epidemic including detailed age-stratification and realistic social networks. By default the model is param","2021","07","12","PLoS Comput Biol","PLoS computational biology",NA,"Wu","Neo","Google Research, Mountain View, California, United States of America",NA
"27","34252083","10.1371/journal.pcbi.1009146","OpenABM-Covid19-An agent-based model for non-pharmaceutical interventions against COVID-19 including contact tracing.","SARS-CoV-2 has spread across the world, causing high mortality and unprecedented restrictions on social and economic activity. Policymakers are assessing how best to navigate through the ongoing epidemic, with computational models being used to predict the spread of infection and assess the impact of public health measures. Here, we present OpenABM-Covid19: an agent-based simulation of the epidemic including detailed age-stratification and realistic social networks. By default the model is param","2021","07","12","PLoS Comput Biol","PLoS computational biology",NA,"Legat","Olivier","Google Research, Mountain View, California, United States of America",NA
"28","34252083","10.1371/journal.pcbi.1009146","OpenABM-Covid19-An agent-based model for non-pharmaceutical interventions against COVID-19 including contact tracing.","SARS-CoV-2 has spread across the world, causing high mortality and unprecedented restrictions on social and economic activity. Policymakers are assessing how best to navigate through the ongoing epidemic, with computational models being used to predict the spread of infection and assess the impact of public health measures. Here, we present OpenABM-Covid19: an agent-based simulation of the epidemic including detailed age-stratification and realistic social networks. By default the model is param","2021","07","12","PLoS Comput Biol","PLoS computational biology",NA,"Bentley","Katie","The Francis Crick Institute, London, United Kingdom",NA
"29","34252083","10.1371/journal.pcbi.1009146","OpenABM-Covid19-An agent-based model for non-pharmaceutical interventions against COVID-19 including contact tracing.","SARS-CoV-2 has spread across the world, causing high mortality and unprecedented restrictions on social and economic activity. Policymakers are assessing how best to navigate through the ongoing epidemic, with computational models being used to predict the spread of infection and assess the impact of public health measures. Here, we present OpenABM-Covid19: an agent-based simulation of the epidemic including detailed age-stratification and realistic social networks. By default the model is param","2021","07","12","PLoS Comput Biol","PLoS computational biology",NA,"Mead","Thomas","The Francis Crick Institute, London, United Kingdom",NA
"30","34252083","10.1371/journal.pcbi.1009146","OpenABM-Covid19-An agent-based model for non-pharmaceutical interventions against COVID-19 including contact tracing.","SARS-CoV-2 has spread across the world, causing high mortality and unprecedented restrictions on social and economic activity. Policymakers are assessing how best to navigate through the ongoing epidemic, with computational models being used to predict the spread of infection and assess the impact of public health measures. Here, we present OpenABM-Covid19: an agent-based simulation of the epidemic including detailed age-stratification and realistic social networks. By default the model is param","2021","07","12","PLoS Comput Biol","PLoS computational biology",NA,"Van-Vuuren","Kelvin","The Francis Crick Institute, London, United Kingdom",NA
"31","34252083","10.1371/journal.pcbi.1009146","OpenABM-Covid19-An agent-based model for non-pharmaceutical interventions against COVID-19 including contact tracing.","SARS-CoV-2 has spread across the world, causing high mortality and unprecedented restrictions on social and economic activity. Policymakers are assessing how best to navigate through the ongoing epidemic, with computational models being used to predict the spread of infection and assess the impact of public health measures. Here, we present OpenABM-Covid19: an agent-based simulation of the epidemic including detailed age-stratification and realistic social networks. By default the model is param","2021","07","12","PLoS Comput Biol","PLoS computational biology",NA,"Feldner-Busztin","Dylan","The Francis Crick Institute, London, United Kingdom",NA
"32","34252083","10.1371/journal.pcbi.1009146","OpenABM-Covid19-An agent-based model for non-pharmaceutical interventions against COVID-19 including contact tracing.","SARS-CoV-2 has spread across the world, causing high mortality and unprecedented restrictions on social and economic activity. Policymakers are assessing how best to navigate through the ongoing epidemic, with computational models being used to predict the spread of infection and assess the impact of public health measures. Here, we present OpenABM-Covid19: an agent-based simulation of the epidemic including detailed age-stratification and realistic social networks. By default the model is param","2021","07","12","PLoS Comput Biol","PLoS computational biology",NA,"Ristori","Tommaso","Department of Biomedical Engineering, Boston University, Boston, Massachusetts, United States of America",NA
"33","34252083","10.1371/journal.pcbi.1009146","OpenABM-Covid19-An agent-based model for non-pharmaceutical interventions against COVID-19 including contact tracing.","SARS-CoV-2 has spread across the world, causing high mortality and unprecedented restrictions on social and economic activity. Policymakers are assessing how best to navigate through the ongoing epidemic, with computational models being used to predict the spread of infection and assess the impact of public health measures. Here, we present OpenABM-Covid19: an agent-based simulation of the epidemic including detailed age-stratification and realistic social networks. By default the model is param","2021","07","12","PLoS Comput Biol","PLoS computational biology",NA,"Finkelstein","Anthony","Department of Computer Science, University College London, London, United Kingdom",NA
"34","34252083","10.1371/journal.pcbi.1009146","OpenABM-Covid19-An agent-based model for non-pharmaceutical interventions against COVID-19 including contact tracing.","SARS-CoV-2 has spread across the world, causing high mortality and unprecedented restrictions on social and economic activity. Policymakers are assessing how best to navigate through the ongoing epidemic, with computational models being used to predict the spread of infection and assess the impact of public health measures. Here, we present OpenABM-Covid19: an agent-based simulation of the epidemic including detailed age-stratification and realistic social networks. By default the model is param","2021","07","12","PLoS Comput Biol","PLoS computational biology",NA,"Bonsall","David G","Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom",NA
"35","34252083","10.1371/journal.pcbi.1009146","OpenABM-Covid19-An agent-based model for non-pharmaceutical interventions against COVID-19 including contact tracing.","SARS-CoV-2 has spread across the world, causing high mortality and unprecedented restrictions on social and economic activity. Policymakers are assessing how best to navigate through the ongoing epidemic, with computational models being used to predict the spread of infection and assess the impact of public health measures. Here, we present OpenABM-Covid19: an agent-based simulation of the epidemic including detailed age-stratification and realistic social networks. By default the model is param","2021","07","12","PLoS Comput Biol","PLoS computational biology",NA,"Abeler-Dörner","Lucie","Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom",NA
"36","34252083","10.1371/journal.pcbi.1009146","OpenABM-Covid19-An agent-based model for non-pharmaceutical interventions against COVID-19 including contact tracing.","SARS-CoV-2 has spread across the world, causing high mortality and unprecedented restrictions on social and economic activity. Policymakers are assessing how best to navigate through the ongoing epidemic, with computational models being used to predict the spread of infection and assess the impact of public health measures. Here, we present OpenABM-Covid19: an agent-based simulation of the epidemic including detailed age-stratification and realistic social networks. By default the model is param","2021","07","12","PLoS Comput Biol","PLoS computational biology",NA,"Fraser","Christophe","Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom",NA
"37","34252080","10.1371/journal.pbio.3001333","Viral dynamics of acute SARS-CoV-2 infection and applications to diagnostic and public health strategies.","SARS-CoV-2 infections are characterized by viral proliferation and clearance phases and can be followed by low-level persistent viral RNA shedding. The dynamics of viral RNA concentration, particularly in the early stages of infection, can inform clinical measures and interventions such as test-based screening. We used prospective longitudinal quantitative reverse transcription PCR testing to measure the viral RNA trajectories for 68 individuals during the resumption of the 2019-2020 National Ba","2021","07","23","PLoS Biol","PLoS biology",NA,"Kissler","Stephen M","Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America",NA
"38","34252080","10.1371/journal.pbio.3001333","Viral dynamics of acute SARS-CoV-2 infection and applications to diagnostic and public health strategies.","SARS-CoV-2 infections are characterized by viral proliferation and clearance phases and can be followed by low-level persistent viral RNA shedding. The dynamics of viral RNA concentration, particularly in the early stages of infection, can inform clinical measures and interventions such as test-based screening. We used prospective longitudinal quantitative reverse transcription PCR testing to measure the viral RNA trajectories for 68 individuals during the resumption of the 2019-2020 National Ba","2021","07","23","PLoS Biol","PLoS biology",NA,"Fauver","Joseph R","Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut, United States of America",NA
"39","34252080","10.1371/journal.pbio.3001333","Viral dynamics of acute SARS-CoV-2 infection and applications to diagnostic and public health strategies.","SARS-CoV-2 infections are characterized by viral proliferation and clearance phases and can be followed by low-level persistent viral RNA shedding. The dynamics of viral RNA concentration, particularly in the early stages of infection, can inform clinical measures and interventions such as test-based screening. We used prospective longitudinal quantitative reverse transcription PCR testing to measure the viral RNA trajectories for 68 individuals during the resumption of the 2019-2020 National Ba","2021","07","23","PLoS Biol","PLoS biology",NA,"Mack","Christina","Real World Solutions, IQVIA, Durham, North Carolina, United States of America",NA
"40","34252080","10.1371/journal.pbio.3001333","Viral dynamics of acute SARS-CoV-2 infection and applications to diagnostic and public health strategies.","SARS-CoV-2 infections are characterized by viral proliferation and clearance phases and can be followed by low-level persistent viral RNA shedding. The dynamics of viral RNA concentration, particularly in the early stages of infection, can inform clinical measures and interventions such as test-based screening. We used prospective longitudinal quantitative reverse transcription PCR testing to measure the viral RNA trajectories for 68 individuals during the resumption of the 2019-2020 National Ba","2021","07","23","PLoS Biol","PLoS biology",NA,"Olesen","Scott W","Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America",NA
"41","34252080","10.1371/journal.pbio.3001333","Viral dynamics of acute SARS-CoV-2 infection and applications to diagnostic and public health strategies.","SARS-CoV-2 infections are characterized by viral proliferation and clearance phases and can be followed by low-level persistent viral RNA shedding. The dynamics of viral RNA concentration, particularly in the early stages of infection, can inform clinical measures and interventions such as test-based screening. We used prospective longitudinal quantitative reverse transcription PCR testing to measure the viral RNA trajectories for 68 individuals during the resumption of the 2019-2020 National Ba","2021","07","23","PLoS Biol","PLoS biology",NA,"Tai","Caroline","Real World Solutions, IQVIA, Durham, North Carolina, United States of America",NA
"42","34252080","10.1371/journal.pbio.3001333","Viral dynamics of acute SARS-CoV-2 infection and applications to diagnostic and public health strategies.","SARS-CoV-2 infections are characterized by viral proliferation and clearance phases and can be followed by low-level persistent viral RNA shedding. The dynamics of viral RNA concentration, particularly in the early stages of infection, can inform clinical measures and interventions such as test-based screening. We used prospective longitudinal quantitative reverse transcription PCR testing to measure the viral RNA trajectories for 68 individuals during the resumption of the 2019-2020 National Ba","2021","07","23","PLoS Biol","PLoS biology",NA,"Shiue","Kristin Y","Real World Solutions, IQVIA, Durham, North Carolina, United States of America",NA
"43","34252080","10.1371/journal.pbio.3001333","Viral dynamics of acute SARS-CoV-2 infection and applications to diagnostic and public health strategies.","SARS-CoV-2 infections are characterized by viral proliferation and clearance phases and can be followed by low-level persistent viral RNA shedding. The dynamics of viral RNA concentration, particularly in the early stages of infection, can inform clinical measures and interventions such as test-based screening. We used prospective longitudinal quantitative reverse transcription PCR testing to measure the viral RNA trajectories for 68 individuals during the resumption of the 2019-2020 National Ba","2021","07","23","PLoS Biol","PLoS biology",NA,"Kalinich","Chaney C","Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut, United States of America",NA
"44","34252080","10.1371/journal.pbio.3001333","Viral dynamics of acute SARS-CoV-2 infection and applications to diagnostic and public health strategies.","SARS-CoV-2 infections are characterized by viral proliferation and clearance phases and can be followed by low-level persistent viral RNA shedding. The dynamics of viral RNA concentration, particularly in the early stages of infection, can inform clinical measures and interventions such as test-based screening. We used prospective longitudinal quantitative reverse transcription PCR testing to measure the viral RNA trajectories for 68 individuals during the resumption of the 2019-2020 National Ba","2021","07","23","PLoS Biol","PLoS biology",NA,"Jednak","Sarah","Department of Health Management and Policy, University of Michigan School of Public Health, Ann Arbor, Michigan, United States of America",NA
"45","34252080","10.1371/journal.pbio.3001333","Viral dynamics of acute SARS-CoV-2 infection and applications to diagnostic and public health strategies.","SARS-CoV-2 infections are characterized by viral proliferation and clearance phases and can be followed by low-level persistent viral RNA shedding. The dynamics of viral RNA concentration, particularly in the early stages of infection, can inform clinical measures and interventions such as test-based screening. We used prospective longitudinal quantitative reverse transcription PCR testing to measure the viral RNA trajectories for 68 individuals during the resumption of the 2019-2020 National Ba","2021","07","23","PLoS Biol","PLoS biology",NA,"Ott","Isabel M","Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut, United States of America",NA
"46","34252080","10.1371/journal.pbio.3001333","Viral dynamics of acute SARS-CoV-2 infection and applications to diagnostic and public health strategies.","SARS-CoV-2 infections are characterized by viral proliferation and clearance phases and can be followed by low-level persistent viral RNA shedding. The dynamics of viral RNA concentration, particularly in the early stages of infection, can inform clinical measures and interventions such as test-based screening. We used prospective longitudinal quantitative reverse transcription PCR testing to measure the viral RNA trajectories for 68 individuals during the resumption of the 2019-2020 National Ba","2021","07","23","PLoS Biol","PLoS biology",NA,"Vogels","Chantal B F","Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut, United States of America",NA
"47","34252080","10.1371/journal.pbio.3001333","Viral dynamics of acute SARS-CoV-2 infection and applications to diagnostic and public health strategies.","SARS-CoV-2 infections are characterized by viral proliferation and clearance phases and can be followed by low-level persistent viral RNA shedding. The dynamics of viral RNA concentration, particularly in the early stages of infection, can inform clinical measures and interventions such as test-based screening. We used prospective longitudinal quantitative reverse transcription PCR testing to measure the viral RNA trajectories for 68 individuals during the resumption of the 2019-2020 National Ba","2021","07","23","PLoS Biol","PLoS biology",NA,"Wohlgemuth","Jay","Quest Diagnostics, San Juan Capistrano, California, United States of America",NA
"48","34252080","10.1371/journal.pbio.3001333","Viral dynamics of acute SARS-CoV-2 infection and applications to diagnostic and public health strategies.","SARS-CoV-2 infections are characterized by viral proliferation and clearance phases and can be followed by low-level persistent viral RNA shedding. The dynamics of viral RNA concentration, particularly in the early stages of infection, can inform clinical measures and interventions such as test-based screening. We used prospective longitudinal quantitative reverse transcription PCR testing to measure the viral RNA trajectories for 68 individuals during the resumption of the 2019-2020 National Ba","2021","07","23","PLoS Biol","PLoS biology",NA,"Weisberger","James","Bioreference Laboratories, Elmwood Park, New Jersey, United States of America",NA
"49","34252080","10.1371/journal.pbio.3001333","Viral dynamics of acute SARS-CoV-2 infection and applications to diagnostic and public health strategies.","SARS-CoV-2 infections are characterized by viral proliferation and clearance phases and can be followed by low-level persistent viral RNA shedding. The dynamics of viral RNA concentration, particularly in the early stages of infection, can inform clinical measures and interventions such as test-based screening. We used prospective longitudinal quantitative reverse transcription PCR testing to measure the viral RNA trajectories for 68 individuals during the resumption of the 2019-2020 National Ba","2021","07","23","PLoS Biol","PLoS biology",NA,"DiFiori","John","Hospital for Special Surgery, New York, New York, United States of America",NA
"50","34252080","10.1371/journal.pbio.3001333","Viral dynamics of acute SARS-CoV-2 infection and applications to diagnostic and public health strategies.","SARS-CoV-2 infections are characterized by viral proliferation and clearance phases and can be followed by low-level persistent viral RNA shedding. The dynamics of viral RNA concentration, particularly in the early stages of infection, can inform clinical measures and interventions such as test-based screening. We used prospective longitudinal quantitative reverse transcription PCR testing to measure the viral RNA trajectories for 68 individuals during the resumption of the 2019-2020 National Ba","2021","07","23","PLoS Biol","PLoS biology",NA,"Anderson","Deverick J","Duke Center for Antimicrobial Stewardship and Infection Prevention, Durham, North Carolina, United States of America",NA
"51","34252080","10.1371/journal.pbio.3001333","Viral dynamics of acute SARS-CoV-2 infection and applications to diagnostic and public health strategies.","SARS-CoV-2 infections are characterized by viral proliferation and clearance phases and can be followed by low-level persistent viral RNA shedding. The dynamics of viral RNA concentration, particularly in the early stages of infection, can inform clinical measures and interventions such as test-based screening. We used prospective longitudinal quantitative reverse transcription PCR testing to measure the viral RNA trajectories for 68 individuals during the resumption of the 2019-2020 National Ba","2021","07","23","PLoS Biol","PLoS biology",NA,"Mancell","Jimmie","Department of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee, United States of America",NA
"52","34252080","10.1371/journal.pbio.3001333","Viral dynamics of acute SARS-CoV-2 infection and applications to diagnostic and public health strategies.","SARS-CoV-2 infections are characterized by viral proliferation and clearance phases and can be followed by low-level persistent viral RNA shedding. The dynamics of viral RNA concentration, particularly in the early stages of infection, can inform clinical measures and interventions such as test-based screening. We used prospective longitudinal quantitative reverse transcription PCR testing to measure the viral RNA trajectories for 68 individuals during the resumption of the 2019-2020 National Ba","2021","07","23","PLoS Biol","PLoS biology",NA,"Ho","David D","Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons, New York, New York, United States of America",NA
"53","34252080","10.1371/journal.pbio.3001333","Viral dynamics of acute SARS-CoV-2 infection and applications to diagnostic and public health strategies.","SARS-CoV-2 infections are characterized by viral proliferation and clearance phases and can be followed by low-level persistent viral RNA shedding. The dynamics of viral RNA concentration, particularly in the early stages of infection, can inform clinical measures and interventions such as test-based screening. We used prospective longitudinal quantitative reverse transcription PCR testing to measure the viral RNA trajectories for 68 individuals during the resumption of the 2019-2020 National Ba","2021","07","23","PLoS Biol","PLoS biology",NA,"Grubaugh","Nathan D","Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut, United States of America",NA
"54","34252080","10.1371/journal.pbio.3001333","Viral dynamics of acute SARS-CoV-2 infection and applications to diagnostic and public health strategies.","SARS-CoV-2 infections are characterized by viral proliferation and clearance phases and can be followed by low-level persistent viral RNA shedding. The dynamics of viral RNA concentration, particularly in the early stages of infection, can inform clinical measures and interventions such as test-based screening. We used prospective longitudinal quantitative reverse transcription PCR testing to measure the viral RNA trajectories for 68 individuals during the resumption of the 2019-2020 National Ba","2021","07","23","PLoS Biol","PLoS biology",NA,"Grad","Yonatan H","Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America",NA
"55","34252078","10.1371/journal.pcbi.1009210","Bayesian back-calculation and nowcasting for line list data during the COVID-19 pandemic.","Surveillance is critical to mounting an appropriate and effective response to pandemics. However, aggregated case report data suffers from reporting delays and can lead to misleading inferences. Different from aggregated case report data, line list data is a table contains individual features such as dates of symptom onset and reporting for each reported case and a good source for modeling delays. Current methods for modeling reporting delays are not particularly appropriate for line list data, ","2021","07","23","PLoS Comput Biol","PLoS computational biology",NA,"Li","Tenglong","Department of Biostatistics, School of Public Health, Boston University, Boston, Massachusetts, United States of America",NA
"56","34252078","10.1371/journal.pcbi.1009210","Bayesian back-calculation and nowcasting for line list data during the COVID-19 pandemic.","Surveillance is critical to mounting an appropriate and effective response to pandemics. However, aggregated case report data suffers from reporting delays and can lead to misleading inferences. Different from aggregated case report data, line list data is a table contains individual features such as dates of symptom onset and reporting for each reported case and a good source for modeling delays. Current methods for modeling reporting delays are not particularly appropriate for line list data, ","2021","07","23","PLoS Comput Biol","PLoS computational biology",NA,"White","Laura F","Department of Biostatistics, School of Public Health, Boston University, Boston, Massachusetts, United States of America",NA
"57","34252054","10.1172/jci.insight.148920","HIV infection drives interferon signalling within intestinal SARS-CoV-2 target cells.","Severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) infects epithelial cells of the human gastrointestinal (GI) tract and causes related symptoms. HIV infection impairs gut homeostasis and is associated with an increased risk of COVID-19 fatality. To investigate the potential link between these observations, we analysed single cell transcriptional profiles and SARS-CoV-2 entry receptor expression across lymphoid and mucosal human tissue from chronically HIV infected individuals and uni","2021","07","12","JCI Insight","JCI insight","AIDS/HIV; COVID-19; Innate immunity","Fardoos","Rabiah","Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark",NA
"58","34252054","10.1172/jci.insight.148920","HIV infection drives interferon signalling within intestinal SARS-CoV-2 target cells.","Severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) infects epithelial cells of the human gastrointestinal (GI) tract and causes related symptoms. HIV infection impairs gut homeostasis and is associated with an increased risk of COVID-19 fatality. To investigate the potential link between these observations, we analysed single cell transcriptional profiles and SARS-CoV-2 entry receptor expression across lymphoid and mucosal human tissue from chronically HIV infected individuals and uni","2021","07","12","JCI Insight","JCI insight","AIDS/HIV; COVID-19; Innate immunity","Asowata","Osaretin E","AHRI, Africa Health Research Institute, Durban, South Africa",NA
"59","34252054","10.1172/jci.insight.148920","HIV infection drives interferon signalling within intestinal SARS-CoV-2 target cells.","Severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) infects epithelial cells of the human gastrointestinal (GI) tract and causes related symptoms. HIV infection impairs gut homeostasis and is associated with an increased risk of COVID-19 fatality. To investigate the potential link between these observations, we analysed single cell transcriptional profiles and SARS-CoV-2 entry receptor expression across lymphoid and mucosal human tissue from chronically HIV infected individuals and uni","2021","07","12","JCI Insight","JCI insight","AIDS/HIV; COVID-19; Innate immunity","Herbert","Nicholas","AHRI, Africa Health Research Institute, Durban, South Africa",NA
"60","34252054","10.1172/jci.insight.148920","HIV infection drives interferon signalling within intestinal SARS-CoV-2 target cells.","Severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) infects epithelial cells of the human gastrointestinal (GI) tract and causes related symptoms. HIV infection impairs gut homeostasis and is associated with an increased risk of COVID-19 fatality. To investigate the potential link between these observations, we analysed single cell transcriptional profiles and SARS-CoV-2 entry receptor expression across lymphoid and mucosal human tissue from chronically HIV infected individuals and uni","2021","07","12","JCI Insight","JCI insight","AIDS/HIV; COVID-19; Innate immunity","Nyquist","Sarah K","Department of Chemistry, Massachusetts Institute of Technology (MIT), Cambridge, United States of America",NA
"61","34252054","10.1172/jci.insight.148920","HIV infection drives interferon signalling within intestinal SARS-CoV-2 target cells.","Severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) infects epithelial cells of the human gastrointestinal (GI) tract and causes related symptoms. HIV infection impairs gut homeostasis and is associated with an increased risk of COVID-19 fatality. To investigate the potential link between these observations, we analysed single cell transcriptional profiles and SARS-CoV-2 entry receptor expression across lymphoid and mucosal human tissue from chronically HIV infected individuals and uni","2021","07","12","JCI Insight","JCI insight","AIDS/HIV; COVID-19; Innate immunity","Zungu","Yenzekile","AHRI, Africa Health Research Institute, Durban, South Africa",NA
"62","34252054","10.1172/jci.insight.148920","HIV infection drives interferon signalling within intestinal SARS-CoV-2 target cells.","Severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) infects epithelial cells of the human gastrointestinal (GI) tract and causes related symptoms. HIV infection impairs gut homeostasis and is associated with an increased risk of COVID-19 fatality. To investigate the potential link between these observations, we analysed single cell transcriptional profiles and SARS-CoV-2 entry receptor expression across lymphoid and mucosal human tissue from chronically HIV infected individuals and uni","2021","07","12","JCI Insight","JCI insight","AIDS/HIV; COVID-19; Innate immunity","Singh","Alveera","AHRI, Africa Health Research Institute, Durban, South Africa",NA
"63","34252054","10.1172/jci.insight.148920","HIV infection drives interferon signalling within intestinal SARS-CoV-2 target cells.","Severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) infects epithelial cells of the human gastrointestinal (GI) tract and causes related symptoms. HIV infection impairs gut homeostasis and is associated with an increased risk of COVID-19 fatality. To investigate the potential link between these observations, we analysed single cell transcriptional profiles and SARS-CoV-2 entry receptor expression across lymphoid and mucosal human tissue from chronically HIV infected individuals and uni","2021","07","12","JCI Insight","JCI insight","AIDS/HIV; COVID-19; Innate immunity","Ngoepe","Abigail","AHRI, Africa Health Research Institute, Durban, South Africa",NA
"64","34252054","10.1172/jci.insight.148920","HIV infection drives interferon signalling within intestinal SARS-CoV-2 target cells.","Severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) infects epithelial cells of the human gastrointestinal (GI) tract and causes related symptoms. HIV infection impairs gut homeostasis and is associated with an increased risk of COVID-19 fatality. To investigate the potential link between these observations, we analysed single cell transcriptional profiles and SARS-CoV-2 entry receptor expression across lymphoid and mucosal human tissue from chronically HIV infected individuals and uni","2021","07","12","JCI Insight","JCI insight","AIDS/HIV; COVID-19; Innate immunity","Mbano","Ian M","School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa",NA
"65","34252054","10.1172/jci.insight.148920","HIV infection drives interferon signalling within intestinal SARS-CoV-2 target cells.","Severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) infects epithelial cells of the human gastrointestinal (GI) tract and causes related symptoms. HIV infection impairs gut homeostasis and is associated with an increased risk of COVID-19 fatality. To investigate the potential link between these observations, we analysed single cell transcriptional profiles and SARS-CoV-2 entry receptor expression across lymphoid and mucosal human tissue from chronically HIV infected individuals and uni","2021","07","12","JCI Insight","JCI insight","AIDS/HIV; COVID-19; Innate immunity","Mthabela","Ntombifuthi","AHRI, Africa Health Research Institute, Durban, South Africa",NA
"66","34252054","10.1172/jci.insight.148920","HIV infection drives interferon signalling within intestinal SARS-CoV-2 target cells.","Severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) infects epithelial cells of the human gastrointestinal (GI) tract and causes related symptoms. HIV infection impairs gut homeostasis and is associated with an increased risk of COVID-19 fatality. To investigate the potential link between these observations, we analysed single cell transcriptional profiles and SARS-CoV-2 entry receptor expression across lymphoid and mucosal human tissue from chronically HIV infected individuals and uni","2021","07","12","JCI Insight","JCI insight","AIDS/HIV; COVID-19; Innate immunity","Ramjit","Dirhona","AHRI, Africa Health Research Institute, Durban, South Africa",NA
"67","34252054","10.1172/jci.insight.148920","HIV infection drives interferon signalling within intestinal SARS-CoV-2 target cells.","Severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) infects epithelial cells of the human gastrointestinal (GI) tract and causes related symptoms. HIV infection impairs gut homeostasis and is associated with an increased risk of COVID-19 fatality. To investigate the potential link between these observations, we analysed single cell transcriptional profiles and SARS-CoV-2 entry receptor expression across lymphoid and mucosal human tissue from chronically HIV infected individuals and uni","2021","07","12","JCI Insight","JCI insight","AIDS/HIV; COVID-19; Innate immunity","Karim","Farina","AHRI, Africa Health Research Institute, Durban, South Africa",NA
"68","34252054","10.1172/jci.insight.148920","HIV infection drives interferon signalling within intestinal SARS-CoV-2 target cells.","Severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) infects epithelial cells of the human gastrointestinal (GI) tract and causes related symptoms. HIV infection impairs gut homeostasis and is associated with an increased risk of COVID-19 fatality. To investigate the potential link between these observations, we analysed single cell transcriptional profiles and SARS-CoV-2 entry receptor expression across lymphoid and mucosal human tissue from chronically HIV infected individuals and uni","2021","07","12","JCI Insight","JCI insight","AIDS/HIV; COVID-19; Innate immunity","Kuhn","Warren","Department General Justice Gizenga Mpanza Regional Hospital, University of KwaZulu-Natal, Durban, South Africa",NA
"69","34252054","10.1172/jci.insight.148920","HIV infection drives interferon signalling within intestinal SARS-CoV-2 target cells.","Severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) infects epithelial cells of the human gastrointestinal (GI) tract and causes related symptoms. HIV infection impairs gut homeostasis and is associated with an increased risk of COVID-19 fatality. To investigate the potential link between these observations, we analysed single cell transcriptional profiles and SARS-CoV-2 entry receptor expression across lymphoid and mucosal human tissue from chronically HIV infected individuals and uni","2021","07","12","JCI Insight","JCI insight","AIDS/HIV; COVID-19; Innate immunity","Madela","Fusi G","Discipline General Surgery, Inkosi Albert Luthuli Central Hospital, University of KwaZulu-Nata, Durban, South Africa",NA
"70","34252054","10.1172/jci.insight.148920","HIV infection drives interferon signalling within intestinal SARS-CoV-2 target cells.","Severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) infects epithelial cells of the human gastrointestinal (GI) tract and causes related symptoms. HIV infection impairs gut homeostasis and is associated with an increased risk of COVID-19 fatality. To investigate the potential link between these observations, we analysed single cell transcriptional profiles and SARS-CoV-2 entry receptor expression across lymphoid and mucosal human tissue from chronically HIV infected individuals and uni","2021","07","12","JCI Insight","JCI insight","AIDS/HIV; COVID-19; Innate immunity","Manzini","Vukani T","Discipline General Surgery, Inkosi Albert Luthuli Central Hospital, University of KwaZulu-Nata, Durban, South Africa",NA
"71","34252054","10.1172/jci.insight.148920","HIV infection drives interferon signalling within intestinal SARS-CoV-2 target cells.","Severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) infects epithelial cells of the human gastrointestinal (GI) tract and causes related symptoms. HIV infection impairs gut homeostasis and is associated with an increased risk of COVID-19 fatality. To investigate the potential link between these observations, we analysed single cell transcriptional profiles and SARS-CoV-2 entry receptor expression across lymphoid and mucosal human tissue from chronically HIV infected individuals and uni","2021","07","12","JCI Insight","JCI insight","AIDS/HIV; COVID-19; Innate immunity","Anderson","Frank","Discipline General Surgery, Inkosi Albert Luthuli Central Hospital, University of KwaZulu-Nata, Durban, South Africa",NA
"72","34252054","10.1172/jci.insight.148920","HIV infection drives interferon signalling within intestinal SARS-CoV-2 target cells.","Severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) infects epithelial cells of the human gastrointestinal (GI) tract and causes related symptoms. HIV infection impairs gut homeostasis and is associated with an increased risk of COVID-19 fatality. To investigate the potential link between these observations, we analysed single cell transcriptional profiles and SARS-CoV-2 entry receptor expression across lymphoid and mucosal human tissue from chronically HIV infected individuals and uni","2021","07","12","JCI Insight","JCI insight","AIDS/HIV; COVID-19; Innate immunity","Berger","Bonnie","Computer Science &amp",NA
"73","34252054","10.1172/jci.insight.148920","HIV infection drives interferon signalling within intestinal SARS-CoV-2 target cells.","Severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) infects epithelial cells of the human gastrointestinal (GI) tract and causes related symptoms. HIV infection impairs gut homeostasis and is associated with an increased risk of COVID-19 fatality. To investigate the potential link between these observations, we analysed single cell transcriptional profiles and SARS-CoV-2 entry receptor expression across lymphoid and mucosal human tissue from chronically HIV infected individuals and uni","2021","07","12","JCI Insight","JCI insight","AIDS/HIV; COVID-19; Innate immunity","Pers","Tune H","Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Copenhagen, Denmark",NA
"74","34252054","10.1172/jci.insight.148920","HIV infection drives interferon signalling within intestinal SARS-CoV-2 target cells.","Severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) infects epithelial cells of the human gastrointestinal (GI) tract and causes related symptoms. HIV infection impairs gut homeostasis and is associated with an increased risk of COVID-19 fatality. To investigate the potential link between these observations, we analysed single cell transcriptional profiles and SARS-CoV-2 entry receptor expression across lymphoid and mucosal human tissue from chronically HIV infected individuals and uni","2021","07","12","JCI Insight","JCI insight","AIDS/HIV; COVID-19; Innate immunity","Shalek","Alex K","Department of Chemistry, Massachusetts Institute of Technology (MIT), Cambridge, United States of America",NA
"75","34252054","10.1172/jci.insight.148920","HIV infection drives interferon signalling within intestinal SARS-CoV-2 target cells.","Severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) infects epithelial cells of the human gastrointestinal (GI) tract and causes related symptoms. HIV infection impairs gut homeostasis and is associated with an increased risk of COVID-19 fatality. To investigate the potential link between these observations, we analysed single cell transcriptional profiles and SARS-CoV-2 entry receptor expression across lymphoid and mucosal human tissue from chronically HIV infected individuals and uni","2021","07","12","JCI Insight","JCI insight","AIDS/HIV; COVID-19; Innate immunity","Leslie","Alasdair","School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa",NA
"76","34252054","10.1172/jci.insight.148920","HIV infection drives interferon signalling within intestinal SARS-CoV-2 target cells.","Severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) infects epithelial cells of the human gastrointestinal (GI) tract and causes related symptoms. HIV infection impairs gut homeostasis and is associated with an increased risk of COVID-19 fatality. To investigate the potential link between these observations, we analysed single cell transcriptional profiles and SARS-CoV-2 entry receptor expression across lymphoid and mucosal human tissue from chronically HIV infected individuals and uni","2021","07","12","JCI Insight","JCI insight","AIDS/HIV; COVID-19; Innate immunity","Kløverpris","Henrik","AHRI, Africa Health Research Institute, Durban, South Africa",NA
"77","34252053","10.4269/ajtmh.21-0058","The Pediatric Eye Health Challenge Beyond 2020.","Evidence suggests that improved eye health offers the potential to progress toward achieving United Nations Sustainable Development Goals (SDGs). With Vision 2020: Right to Sight Initiative coming to an end and the emergence of the coronavirus pandemic, it is necessary to revisit the priority of pediatric eye health. Considering the profound impact of childhood blindness and visual impairment, it is important to draw the attention of public health leaders, policymakers, organizations, and govern","2021","07","12","Am J Trop Med Hyg","The American journal of tropical medicine and hygiene",NA,"Sharma","Indra Prasad","Gyalyum Kesang Choeden Wangchuck National Eye Center, Jigme Dorji Wangchuck National Referral Hospital, Thimphu, Bhutan",NA
"78","34251994","10.1080/00224545.2021.1918620","The onset of COVID-19, common identity, and intergroup prejudice.","The research presented here examined the relationship between the onset of the COVID-19 pandemic, social group identity, intergroup contact, and prejudice. Utilizing a common ingroup identity approach, two datasets, which were composed of data from university students collected via online questionnaires before and after the onset of COVID-19, were combined (N = 511). Participants identified as either one of two subordinate student identities: domestic (i.e. U.S. citizen or permanent resident) or","2021","07","12","J Soc Psychol","The Journal of social psychology","COVID-19; intergroup bias; intergroup contact; prejudice; social identity","Toprakkiran","Selin","University of Rochester",NA
"79","34251994","10.1080/00224545.2021.1918620","The onset of COVID-19, common identity, and intergroup prejudice.","The research presented here examined the relationship between the onset of the COVID-19 pandemic, social group identity, intergroup contact, and prejudice. Utilizing a common ingroup identity approach, two datasets, which were composed of data from university students collected via online questionnaires before and after the onset of COVID-19, were combined (N = 511). Participants identified as either one of two subordinate student identities: domestic (i.e. U.S. citizen or permanent resident) or","2021","07","12","J Soc Psychol","The Journal of social psychology","COVID-19; intergroup bias; intergroup contact; prejudice; social identity","Gordils","Jonathan","University of Hartford",NA
"80","34251990","10.1080/00185868.2021.1948375","The Impact of Embarrassment to Product Purchase and Brand Influence on the Perceived Benefits and Availability of Ayurveda Products in the COVID-19 Era: an Investigation by SEM Approach.","Ayurveda as alternative medicine is widely popular across the globe. Moreover, after the onset of COVID-19, it has been looked at as a preferred option to boost immunity to prevent the infection of COVID-19. However, in developing countries, the misconceptions associated with Ayurveda lead to post-purchase embarrassment. This study proposes a model of perceived increased Availability of Ayurveda products in the market, with dependent variables such as brand influence, perceived immunity against ","2021","07","12","Hosp Top","Hospital topics","Ayurveda; COVID-19; brand influence; customer ethnocentrism; embarrassment related to product purchase","Mhatre","Krupa","Symbiosis Institute of Health Sciences, A Constituent of Symbiosis International, Deemed University, Pune, Maharashtra, India",NA
"81","34251990","10.1080/00185868.2021.1948375","The Impact of Embarrassment to Product Purchase and Brand Influence on the Perceived Benefits and Availability of Ayurveda Products in the COVID-19 Era: an Investigation by SEM Approach.","Ayurveda as alternative medicine is widely popular across the globe. Moreover, after the onset of COVID-19, it has been looked at as a preferred option to boost immunity to prevent the infection of COVID-19. However, in developing countries, the misconceptions associated with Ayurveda lead to post-purchase embarrassment. This study proposes a model of perceived increased Availability of Ayurveda products in the market, with dependent variables such as brand influence, perceived immunity against ","2021","07","12","Hosp Top","Hospital topics","Ayurveda; COVID-19; brand influence; customer ethnocentrism; embarrassment related to product purchase","Singh","Ankit","Symbiosis Institute of Health Sciences, A Constituent of Symbiosis International, Deemed University, Pune, Maharashtra, India",NA
"82","34251989","10.1080/21505594.2021.1929800","The journey of SARS-CoV-2 in human hosts: a review of immune responses, immunosuppression, and their consequences.","Coronavirus disease 2019 (COVID-19) is a highly infectious viral disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Laboratory findings from a significant number of patients with COVID-19 indicate the occurrence of leukocytopenia, specifically lymphocytopenia. Moreover, infected patients can experience contrasting outcomes depending on lymphocytopenia status. Patients with resolved lymphocytopenia are more likely to recover, whereas critically ill patients with signs","2021","07","23","Virulence","Virulence","COVID-19; SARS-CoV-2; coronavirus; cytokine storm; immunosuppression; leukocytopenia; lymphocytopenia; severe acute respiratory syndrome coronavirus 2; COVID-19; Cell Death; Cytokine Release Syndrome; Cytokines; Humans; Immune Tolerance; Immunity; Lymphopenia; SARS-CoV-2; Virus Replication","Alshammary","Amal F","Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Saud University, Riyadh, Saudi Arabia",NA
"83","34251989","10.1080/21505594.2021.1929800","The journey of SARS-CoV-2 in human hosts: a review of immune responses, immunosuppression, and their consequences.","Coronavirus disease 2019 (COVID-19) is a highly infectious viral disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Laboratory findings from a significant number of patients with COVID-19 indicate the occurrence of leukocytopenia, specifically lymphocytopenia. Moreover, infected patients can experience contrasting outcomes depending on lymphocytopenia status. Patients with resolved lymphocytopenia are more likely to recover, whereas critically ill patients with signs","2021","07","23","Virulence","Virulence","COVID-19; SARS-CoV-2; coronavirus; cytokine storm; immunosuppression; leukocytopenia; lymphocytopenia; severe acute respiratory syndrome coronavirus 2; COVID-19; Cell Death; Cytokine Release Syndrome; Cytokines; Humans; Immune Tolerance; Immunity; Lymphopenia; SARS-CoV-2; Virus Replication","Al-Sulaiman","Abdulrahman M","Department of Medical and Molecular Virology, Prince Sultan Military Medical City, Riyadh, Saudi Arabia",NA
"84","34251972","10.1080/08830185.2021.1939696","Adverse rare events to vaccines for COVID-19: From hypersensitivity reactions to thrombosis and thrombocytopenia.","Vaccines for the prevention of coronavirus disease 2019 (COVID-19) started to be developed since the initiation of the COVID-19 pandemic. Up to now, four vaccines have been authorized by international agencies such as European Medicines Agency (EMA). Two are DNA vaccines (ChAdOx1 nCov-19 and Ad26.COV2.S) and two mRNA vaccines (BNT162b2 and mRNA-1273). The administration of the vaccines has been associated with a strong decrease in the infections by SARS-CoV-2 and deaths associated with it. Howev","2021","07","22","Int Rev Immunol","International reviews of immunology","Allergy; COVID-19; hypersensitivity; thrombosis; vaccines","Novak","Natalija","Department of Dermatology and Allergy, University Hospital, Bonn, Germany",NA
"85","34251972","10.1080/08830185.2021.1939696","Adverse rare events to vaccines for COVID-19: From hypersensitivity reactions to thrombosis and thrombocytopenia.","Vaccines for the prevention of coronavirus disease 2019 (COVID-19) started to be developed since the initiation of the COVID-19 pandemic. Up to now, four vaccines have been authorized by international agencies such as European Medicines Agency (EMA). Two are DNA vaccines (ChAdOx1 nCov-19 and Ad26.COV2.S) and two mRNA vaccines (BNT162b2 and mRNA-1273). The administration of the vaccines has been associated with a strong decrease in the infections by SARS-CoV-2 and deaths associated with it. Howev","2021","07","22","Int Rev Immunol","International reviews of immunology","Allergy; COVID-19; hypersensitivity; thrombosis; vaccines","Tordesillas","Leticia","Department of Tumor Biology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA",NA
"86","34251972","10.1080/08830185.2021.1939696","Adverse rare events to vaccines for COVID-19: From hypersensitivity reactions to thrombosis and thrombocytopenia.","Vaccines for the prevention of coronavirus disease 2019 (COVID-19) started to be developed since the initiation of the COVID-19 pandemic. Up to now, four vaccines have been authorized by international agencies such as European Medicines Agency (EMA). Two are DNA vaccines (ChAdOx1 nCov-19 and Ad26.COV2.S) and two mRNA vaccines (BNT162b2 and mRNA-1273). The administration of the vaccines has been associated with a strong decrease in the infections by SARS-CoV-2 and deaths associated with it. Howev","2021","07","22","Int Rev Immunol","International reviews of immunology","Allergy; COVID-19; hypersensitivity; thrombosis; vaccines","Cabanillas","Beatriz","Department of Allergy, Research Institute Hospital 12 de Octubre, Madrid, Spain",NA
"87","34251964","10.1080/09286586.2021.1943457","Dry Eye and Visual Display Terminal-Related Symptoms among University Students during the Coronavirus Disease Pandemic.","Purpose: To evaluate dry eye (DE) and subjective visual display terminal (VDT)-related symptoms in university students who moved their classes online due to the COVID-19 pandemic.Methods: Cross-sectional study of students who were taking online classes. In May 2020, the participants completed a Dry Eye Questionnaire (DEQ-5) and a self-report survey, which included demographics, medical history, information on the use of VDT and presence of VDT-related symptoms. Partic","2021","07","12","Ophthalmic Epidemiol","Ophthalmic epidemiology","COVID-19; Dry eye disease; students; visual display terminal","Cartes","Cristian","Unidad de Lágrima y Superficie Ocular (ULSO), Santiago, Chile",NA
"88","34251964","10.1080/09286586.2021.1943457","Dry Eye and Visual Display Terminal-Related Symptoms among University Students during the Coronavirus Disease Pandemic.","Purpose: To evaluate dry eye (DE) and subjective visual display terminal (VDT)-related symptoms in university students who moved their classes online due to the COVID-19 pandemic.Methods: Cross-sectional study of students who were taking online classes. In May 2020, the participants completed a Dry Eye Questionnaire (DEQ-5) and a self-report survey, which included demographics, medical history, information on the use of VDT and presence of VDT-related symptoms. Partic","2021","07","12","Ophthalmic Epidemiol","Ophthalmic epidemiology","COVID-19; Dry eye disease; students; visual display terminal","Segovia","Christian","Unidad de Lágrima y Superficie Ocular (ULSO), Santiago, Chile",NA
"89","34251964","10.1080/09286586.2021.1943457","Dry Eye and Visual Display Terminal-Related Symptoms among University Students during the Coronavirus Disease Pandemic.","Purpose: To evaluate dry eye (DE) and subjective visual display terminal (VDT)-related symptoms in university students who moved their classes online due to the COVID-19 pandemic.Methods: Cross-sectional study of students who were taking online classes. In May 2020, the participants completed a Dry Eye Questionnaire (DEQ-5) and a self-report survey, which included demographics, medical history, information on the use of VDT and presence of VDT-related symptoms. Partic","2021","07","12","Ophthalmic Epidemiol","Ophthalmic epidemiology","COVID-19; Dry eye disease; students; visual display terminal","Salinas-Toro","Daniela","Unidad de Lágrima y Superficie Ocular (ULSO), Santiago, Chile",NA
"90","34251964","10.1080/09286586.2021.1943457","Dry Eye and Visual Display Terminal-Related Symptoms among University Students during the Coronavirus Disease Pandemic.","Purpose: To evaluate dry eye (DE) and subjective visual display terminal (VDT)-related symptoms in university students who moved their classes online due to the COVID-19 pandemic.Methods: Cross-sectional study of students who were taking online classes. In May 2020, the participants completed a Dry Eye Questionnaire (DEQ-5) and a self-report survey, which included demographics, medical history, information on the use of VDT and presence of VDT-related symptoms. Partic","2021","07","12","Ophthalmic Epidemiol","Ophthalmic epidemiology","COVID-19; Dry eye disease; students; visual display terminal","Goya","Claudia","Unidad de Lágrima y Superficie Ocular (ULSO), Santiago, Chile",NA
"91","34251964","10.1080/09286586.2021.1943457","Dry Eye and Visual Display Terminal-Related Symptoms among University Students during the Coronavirus Disease Pandemic.","Purpose: To evaluate dry eye (DE) and subjective visual display terminal (VDT)-related symptoms in university students who moved their classes online due to the COVID-19 pandemic.Methods: Cross-sectional study of students who were taking online classes. In May 2020, the participants completed a Dry Eye Questionnaire (DEQ-5) and a self-report survey, which included demographics, medical history, information on the use of VDT and presence of VDT-related symptoms. Partic","2021","07","12","Ophthalmic Epidemiol","Ophthalmic epidemiology","COVID-19; Dry eye disease; students; visual display terminal","Alonso","Maria Jesus","Alumni Department, Universidad de los Andes, Santiago, Chile",NA
"92","34251964","10.1080/09286586.2021.1943457","Dry Eye and Visual Display Terminal-Related Symptoms among University Students during the Coronavirus Disease Pandemic.","Purpose: To evaluate dry eye (DE) and subjective visual display terminal (VDT)-related symptoms in university students who moved their classes online due to the COVID-19 pandemic.Methods: Cross-sectional study of students who were taking online classes. In May 2020, the participants completed a Dry Eye Questionnaire (DEQ-5) and a self-report survey, which included demographics, medical history, information on the use of VDT and presence of VDT-related symptoms. Partic","2021","07","12","Ophthalmic Epidemiol","Ophthalmic epidemiology","COVID-19; Dry eye disease; students; visual display terminal","Lopez-Solis","Remigio","Unidad de Lágrima y Superficie Ocular (ULSO), Santiago, Chile",NA
"93","34251964","10.1080/09286586.2021.1943457","Dry Eye and Visual Display Terminal-Related Symptoms among University Students during the Coronavirus Disease Pandemic.","Purpose: To evaluate dry eye (DE) and subjective visual display terminal (VDT)-related symptoms in university students who moved their classes online due to the COVID-19 pandemic.Methods: Cross-sectional study of students who were taking online classes. In May 2020, the participants completed a Dry Eye Questionnaire (DEQ-5) and a self-report survey, which included demographics, medical history, information on the use of VDT and presence of VDT-related symptoms. Partic","2021","07","12","Ophthalmic Epidemiol","Ophthalmic epidemiology","COVID-19; Dry eye disease; students; visual display terminal","Zapata","Claudia","Unidad de Lágrima y Superficie Ocular (ULSO), Santiago, Chile",NA
"94","34251964","10.1080/09286586.2021.1943457","Dry Eye and Visual Display Terminal-Related Symptoms among University Students during the Coronavirus Disease Pandemic.","Purpose: To evaluate dry eye (DE) and subjective visual display terminal (VDT)-related symptoms in university students who moved their classes online due to the COVID-19 pandemic.Methods: Cross-sectional study of students who were taking online classes. In May 2020, the participants completed a Dry Eye Questionnaire (DEQ-5) and a self-report survey, which included demographics, medical history, information on the use of VDT and presence of VDT-related symptoms. Partic","2021","07","12","Ophthalmic Epidemiol","Ophthalmic epidemiology","COVID-19; Dry eye disease; students; visual display terminal","Cabezas","Mauricio","Unidad de Lágrima y Superficie Ocular (ULSO), Santiago, Chile",NA
"95","34251964","10.1080/09286586.2021.1943457","Dry Eye and Visual Display Terminal-Related Symptoms among University Students during the Coronavirus Disease Pandemic.","Purpose: To evaluate dry eye (DE) and subjective visual display terminal (VDT)-related symptoms in university students who moved their classes online due to the COVID-19 pandemic.Methods: Cross-sectional study of students who were taking online classes. In May 2020, the participants completed a Dry Eye Questionnaire (DEQ-5) and a self-report survey, which included demographics, medical history, information on the use of VDT and presence of VDT-related symptoms. Partic","2021","07","12","Ophthalmic Epidemiol","Ophthalmic epidemiology","COVID-19; Dry eye disease; students; visual display terminal","Yañez","Patricio","Unidad de Lágrima y Superficie Ocular (ULSO), Santiago, Chile",NA
"96","34251964","10.1080/09286586.2021.1943457","Dry Eye and Visual Display Terminal-Related Symptoms among University Students during the Coronavirus Disease Pandemic.","Purpose: To evaluate dry eye (DE) and subjective visual display terminal (VDT)-related symptoms in university students who moved their classes online due to the COVID-19 pandemic.Methods: Cross-sectional study of students who were taking online classes. In May 2020, the participants completed a Dry Eye Questionnaire (DEQ-5) and a self-report survey, which included demographics, medical history, information on the use of VDT and presence of VDT-related symptoms. Partic","2021","07","12","Ophthalmic Epidemiol","Ophthalmic epidemiology","COVID-19; Dry eye disease; students; visual display terminal","Flores-Rodriguez","Patricia","Unidad de Lágrima y Superficie Ocular (ULSO), Santiago, Chile",NA
"97","34251964","10.1080/09286586.2021.1943457","Dry Eye and Visual Display Terminal-Related Symptoms among University Students during the Coronavirus Disease Pandemic.","Purpose: To evaluate dry eye (DE) and subjective visual display terminal (VDT)-related symptoms in university students who moved their classes online due to the COVID-19 pandemic.Methods: Cross-sectional study of students who were taking online classes. In May 2020, the participants completed a Dry Eye Questionnaire (DEQ-5) and a self-report survey, which included demographics, medical history, information on the use of VDT and presence of VDT-related symptoms. Partic","2021","07","12","Ophthalmic Epidemiol","Ophthalmic epidemiology","COVID-19; Dry eye disease; students; visual display terminal","Lopez","Daniela","Unidad de Lágrima y Superficie Ocular (ULSO), Santiago, Chile",NA
"98","34251964","10.1080/09286586.2021.1943457","Dry Eye and Visual Display Terminal-Related Symptoms among University Students during the Coronavirus Disease Pandemic.","Purpose: To evaluate dry eye (DE) and subjective visual display terminal (VDT)-related symptoms in university students who moved their classes online due to the COVID-19 pandemic.Methods: Cross-sectional study of students who were taking online classes. In May 2020, the participants completed a Dry Eye Questionnaire (DEQ-5) and a self-report survey, which included demographics, medical history, information on the use of VDT and presence of VDT-related symptoms. Partic","2021","07","12","Ophthalmic Epidemiol","Ophthalmic epidemiology","COVID-19; Dry eye disease; students; visual display terminal","Matus","Gonzalo","Unidad de Lágrima y Superficie Ocular (ULSO), Santiago, Chile",NA
"99","34251964","10.1080/09286586.2021.1943457","Dry Eye and Visual Display Terminal-Related Symptoms among University Students during the Coronavirus Disease Pandemic.","Purpose: To evaluate dry eye (DE) and subjective visual display terminal (VDT)-related symptoms in university students who moved their classes online due to the COVID-19 pandemic.Methods: Cross-sectional study of students who were taking online classes. In May 2020, the participants completed a Dry Eye Questionnaire (DEQ-5) and a self-report survey, which included demographics, medical history, information on the use of VDT and presence of VDT-related symptoms. Partic","2021","07","12","Ophthalmic Epidemiol","Ophthalmic epidemiology","COVID-19; Dry eye disease; students; visual display terminal","Traipe","Leonidas","Unidad de Lágrima y Superficie Ocular (ULSO), Santiago, Chile",NA
"100","34251932","10.3928/02793695-20210623-01","Adapting to COVID-19 Stressors: The Role of Nursing.","The coronavirus disease 2019 (COVID-19) pandemic has influenced daily life in many ways, with significant effects on mental health and coping. Psychiatric nurses can leverage their expertise in supporting adaptive coping among individuals affected by the stressors of the pandemic. Literature related to common mental health stressors of the COVID-19 pandemic can guide nurses seeking to support clients. The current article uses the Roy Adaptation Model and a review of the literature to provide a f","2021","07","12","J Psychosoc Nurs Ment Health Serv","Journal of psychosocial nursing and mental health services",NA,"Harding","Shari Lynn",NA,NA
"101","34251930","10.3928/02793695-20210527-03","Nurses' Grief Counseling for Bereaved Family Members of COVID-19 Patients in Wuhan, China: A Cross-Sectional Survey.","This is the first study to assess nurses' attitudes and skills regarding grief counseling for bereaved family members of patients who died from coronavirus disease 2019 (COVID-19) in Wuhan, China. Using a cross-sectional design, 412 nurses selected through convenience sampling completed a demographic characteristics survey, Attitudes of Grief Counseling Scale, (AGCS) and Skills of Grief Counseling Scale (SGCS). Average AGCS score was 32.89 (SD = 9.46), with an overall percentage rate scor","2021","07","12","J Psychosoc Nurs Ment Health Serv","Journal of psychosocial nursing and mental health services",NA,"Kong","Chan",NA,NA
"102","34251930","10.3928/02793695-20210527-03","Nurses' Grief Counseling for Bereaved Family Members of COVID-19 Patients in Wuhan, China: A Cross-Sectional Survey.","This is the first study to assess nurses' attitudes and skills regarding grief counseling for bereaved family members of patients who died from coronavirus disease 2019 (COVID-19) in Wuhan, China. Using a cross-sectional design, 412 nurses selected through convenience sampling completed a demographic characteristics survey, Attitudes of Grief Counseling Scale, (AGCS) and Skills of Grief Counseling Scale (SGCS). Average AGCS score was 32.89 (SD = 9.46), with an overall percentage rate scor","2021","07","12","J Psychosoc Nurs Ment Health Serv","Journal of psychosocial nursing and mental health services",NA,"Tan","Lingling",NA,NA
"103","34251930","10.3928/02793695-20210527-03","Nurses' Grief Counseling for Bereaved Family Members of COVID-19 Patients in Wuhan, China: A Cross-Sectional Survey.","This is the first study to assess nurses' attitudes and skills regarding grief counseling for bereaved family members of patients who died from coronavirus disease 2019 (COVID-19) in Wuhan, China. Using a cross-sectional design, 412 nurses selected through convenience sampling completed a demographic characteristics survey, Attitudes of Grief Counseling Scale, (AGCS) and Skills of Grief Counseling Scale (SGCS). Average AGCS score was 32.89 (SD = 9.46), with an overall percentage rate scor","2021","07","12","J Psychosoc Nurs Ment Health Serv","Journal of psychosocial nursing and mental health services",NA,"Gao","Xudong",NA,NA
"104","34251930","10.3928/02793695-20210527-03","Nurses' Grief Counseling for Bereaved Family Members of COVID-19 Patients in Wuhan, China: A Cross-Sectional Survey.","This is the first study to assess nurses' attitudes and skills regarding grief counseling for bereaved family members of patients who died from coronavirus disease 2019 (COVID-19) in Wuhan, China. Using a cross-sectional design, 412 nurses selected through convenience sampling completed a demographic characteristics survey, Attitudes of Grief Counseling Scale, (AGCS) and Skills of Grief Counseling Scale (SGCS). Average AGCS score was 32.89 (SD = 9.46), with an overall percentage rate scor","2021","07","12","J Psychosoc Nurs Ment Health Serv","Journal of psychosocial nursing and mental health services",NA,"Fan","Hongru",NA,NA
"105","34251930","10.3928/02793695-20210527-03","Nurses' Grief Counseling for Bereaved Family Members of COVID-19 Patients in Wuhan, China: A Cross-Sectional Survey.","This is the first study to assess nurses' attitudes and skills regarding grief counseling for bereaved family members of patients who died from coronavirus disease 2019 (COVID-19) in Wuhan, China. Using a cross-sectional design, 412 nurses selected through convenience sampling completed a demographic characteristics survey, Attitudes of Grief Counseling Scale, (AGCS) and Skills of Grief Counseling Scale (SGCS). Average AGCS score was 32.89 (SD = 9.46), with an overall percentage rate scor","2021","07","12","J Psychosoc Nurs Ment Health Serv","Journal of psychosocial nursing and mental health services",NA,"Zhang","Juan",NA,NA
"106","34251930","10.3928/02793695-20210527-03","Nurses' Grief Counseling for Bereaved Family Members of COVID-19 Patients in Wuhan, China: A Cross-Sectional Survey.","This is the first study to assess nurses' attitudes and skills regarding grief counseling for bereaved family members of patients who died from coronavirus disease 2019 (COVID-19) in Wuhan, China. Using a cross-sectional design, 412 nurses selected through convenience sampling completed a demographic characteristics survey, Attitudes of Grief Counseling Scale, (AGCS) and Skills of Grief Counseling Scale (SGCS). Average AGCS score was 32.89 (SD = 9.46), with an overall percentage rate scor","2021","07","12","J Psychosoc Nurs Ment Health Serv","Journal of psychosocial nursing and mental health services",NA,"Wang","Zhimin",NA,NA
"107","34251930","10.3928/02793695-20210527-03","Nurses' Grief Counseling for Bereaved Family Members of COVID-19 Patients in Wuhan, China: A Cross-Sectional Survey.","This is the first study to assess nurses' attitudes and skills regarding grief counseling for bereaved family members of patients who died from coronavirus disease 2019 (COVID-19) in Wuhan, China. Using a cross-sectional design, 412 nurses selected through convenience sampling completed a demographic characteristics survey, Attitudes of Grief Counseling Scale, (AGCS) and Skills of Grief Counseling Scale (SGCS). Average AGCS score was 32.89 (SD = 9.46), with an overall percentage rate scor","2021","07","12","J Psychosoc Nurs Ment Health Serv","Journal of psychosocial nursing and mental health services",NA,"Wang","Jing",NA,NA
"108","34251929","10.3928/02793695-20210623-03","Stressors Among Chinese Frontline Health Care Workers Exposed to COVID-19 and Associated Mental Health Outcomes.","The current study aimed to identify the main stressors inherent to caring for patients with coronavirus disease 2019 (COVID-19) and associated mental health outcomes among frontline health care workers. Data were collected via an online questionnaire from 651 frontline health care workers providing direct medical services for patients with suspected or confirmed COVID-19. Participants reported the stressors inherent to caring for patients with COVID-19, including depression, anxiety, and insomni","2021","07","12","J Psychosoc Nurs Ment Health Serv","Journal of psychosocial nursing and mental health services",NA,"Zhang","Xuan",NA,NA
"109","34251929","10.3928/02793695-20210623-03","Stressors Among Chinese Frontline Health Care Workers Exposed to COVID-19 and Associated Mental Health Outcomes.","The current study aimed to identify the main stressors inherent to caring for patients with coronavirus disease 2019 (COVID-19) and associated mental health outcomes among frontline health care workers. Data were collected via an online questionnaire from 651 frontline health care workers providing direct medical services for patients with suspected or confirmed COVID-19. Participants reported the stressors inherent to caring for patients with COVID-19, including depression, anxiety, and insomni","2021","07","12","J Psychosoc Nurs Ment Health Serv","Journal of psychosocial nursing and mental health services",NA,"Sun","Jiwei",NA,NA
"110","34251929","10.3928/02793695-20210623-03","Stressors Among Chinese Frontline Health Care Workers Exposed to COVID-19 and Associated Mental Health Outcomes.","The current study aimed to identify the main stressors inherent to caring for patients with coronavirus disease 2019 (COVID-19) and associated mental health outcomes among frontline health care workers. Data were collected via an online questionnaire from 651 frontline health care workers providing direct medical services for patients with suspected or confirmed COVID-19. Participants reported the stressors inherent to caring for patients with COVID-19, including depression, anxiety, and insomni","2021","07","12","J Psychosoc Nurs Ment Health Serv","Journal of psychosocial nursing and mental health services",NA,"Sun","Meng",NA,NA
"111","34251929","10.3928/02793695-20210623-03","Stressors Among Chinese Frontline Health Care Workers Exposed to COVID-19 and Associated Mental Health Outcomes.","The current study aimed to identify the main stressors inherent to caring for patients with coronavirus disease 2019 (COVID-19) and associated mental health outcomes among frontline health care workers. Data were collected via an online questionnaire from 651 frontline health care workers providing direct medical services for patients with suspected or confirmed COVID-19. Participants reported the stressors inherent to caring for patients with COVID-19, including depression, anxiety, and insomni","2021","07","12","J Psychosoc Nurs Ment Health Serv","Journal of psychosocial nursing and mental health services",NA,"Wang","Juan",NA,NA
"112","34251929","10.3928/02793695-20210623-03","Stressors Among Chinese Frontline Health Care Workers Exposed to COVID-19 and Associated Mental Health Outcomes.","The current study aimed to identify the main stressors inherent to caring for patients with coronavirus disease 2019 (COVID-19) and associated mental health outcomes among frontline health care workers. Data were collected via an online questionnaire from 651 frontline health care workers providing direct medical services for patients with suspected or confirmed COVID-19. Participants reported the stressors inherent to caring for patients with COVID-19, including depression, anxiety, and insomni","2021","07","12","J Psychosoc Nurs Ment Health Serv","Journal of psychosocial nursing and mental health services",NA,"Li","Yanyan",NA,NA
"113","34251929","10.3928/02793695-20210623-03","Stressors Among Chinese Frontline Health Care Workers Exposed to COVID-19 and Associated Mental Health Outcomes.","The current study aimed to identify the main stressors inherent to caring for patients with coronavirus disease 2019 (COVID-19) and associated mental health outcomes among frontline health care workers. Data were collected via an online questionnaire from 651 frontline health care workers providing direct medical services for patients with suspected or confirmed COVID-19. Participants reported the stressors inherent to caring for patients with COVID-19, including depression, anxiety, and insomni","2021","07","12","J Psychosoc Nurs Ment Health Serv","Journal of psychosocial nursing and mental health services",NA,"Wu","Liuliu",NA,NA
"114","34251929","10.3928/02793695-20210623-03","Stressors Among Chinese Frontline Health Care Workers Exposed to COVID-19 and Associated Mental Health Outcomes.","The current study aimed to identify the main stressors inherent to caring for patients with coronavirus disease 2019 (COVID-19) and associated mental health outcomes among frontline health care workers. Data were collected via an online questionnaire from 651 frontline health care workers providing direct medical services for patients with suspected or confirmed COVID-19. Participants reported the stressors inherent to caring for patients with COVID-19, including depression, anxiety, and insomni","2021","07","12","J Psychosoc Nurs Ment Health Serv","Journal of psychosocial nursing and mental health services",NA,"Mao","Fangxiang",NA,NA
"115","34251929","10.3928/02793695-20210623-03","Stressors Among Chinese Frontline Health Care Workers Exposed to COVID-19 and Associated Mental Health Outcomes.","The current study aimed to identify the main stressors inherent to caring for patients with coronavirus disease 2019 (COVID-19) and associated mental health outcomes among frontline health care workers. Data were collected via an online questionnaire from 651 frontline health care workers providing direct medical services for patients with suspected or confirmed COVID-19. Participants reported the stressors inherent to caring for patients with COVID-19, including depression, anxiety, and insomni","2021","07","12","J Psychosoc Nurs Ment Health Serv","Journal of psychosocial nursing and mental health services",NA,"Cao","Fenglin",NA,NA
"116","34251929","10.3928/02793695-20210623-03","Stressors Among Chinese Frontline Health Care Workers Exposed to COVID-19 and Associated Mental Health Outcomes.","The current study aimed to identify the main stressors inherent to caring for patients with coronavirus disease 2019 (COVID-19) and associated mental health outcomes among frontline health care workers. Data were collected via an online questionnaire from 651 frontline health care workers providing direct medical services for patients with suspected or confirmed COVID-19. Participants reported the stressors inherent to caring for patients with COVID-19, including depression, anxiety, and insomni","2021","07","12","J Psychosoc Nurs Ment Health Serv","Journal of psychosocial nursing and mental health services",NA,"Luan","Xiaorong",NA,NA
"117","34251915","10.1080/10410236.2021.1950297","Promoting the Ambiguity of a Public Health Crisis Can Facilitate Adjustment: The Joint Influence of an Ambiguous Message Focus and Implicit Self-Theories.","In the early stage of a novel public health crisis, such as an infectious disease, there is often uncertainty about whether the crisis will be permanent. We find that emphasizing the potential permanency of the situation surrounding the crisis can backfire, depending on the implicit self-theory held by people. Data collected during the COVID-19 outbreak showed that when the crisis situation was communicated as potentially being permanent in nature, entity theorists, who view personal qualities a","2021","07","12","Health Commun","Health communication",NA,"Park","Ji Kyung","Marketing, Department of Business Administration, University of Delaware",NA
"118","34251915","10.1080/10410236.2021.1950297","Promoting the Ambiguity of a Public Health Crisis Can Facilitate Adjustment: The Joint Influence of an Ambiguous Message Focus and Implicit Self-Theories.","In the early stage of a novel public health crisis, such as an infectious disease, there is often uncertainty about whether the crisis will be permanent. We find that emphasizing the potential permanency of the situation surrounding the crisis can backfire, depending on the implicit self-theory held by people. Data collected during the COVID-19 outbreak showed that when the crisis situation was communicated as potentially being permanent in nature, entity theorists, who view personal qualities a","2021","07","12","Health Commun","Health communication",NA,"Shapiro","Stewart","Marketing, Department of Business Administration, University of Delaware",NA
"119","34251905","10.7326/M21-2366","The Case for Mandating COVID-19 Vaccines for Health Care Workers.",NA,"2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Klompas","Michael","Harvard Medical School, Harvard Pilgrim Health Care Institute, and Brigham and Women's Hospital, Boston, Massachusetts (M",NA
"120","34251905","10.7326/M21-2366","The Case for Mandating COVID-19 Vaccines for Health Care Workers.",NA,"2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Pearson","Madelyn","Brigham and Women's Hospital, Boston, Massachusetts (M.P., C",NA
"121","34251905","10.7326/M21-2366","The Case for Mandating COVID-19 Vaccines for Health Care Workers.",NA,"2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Morris","Charles","Brigham and Women's Hospital, Boston, Massachusetts (M.P., C",NA
"122","34251904","10.7326/L21-0389","Update Alert: Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2).",NA,"2021","07","24","Ann Intern Med","Annals of internal medicine",NA,"Qaseem","Amir","American College of Physicians, Philadelphia, Pennsylvania (A.Q., I",NA
"123","34251904","10.7326/L21-0389","Update Alert: Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2).",NA,"2021","07","24","Ann Intern Med","Annals of internal medicine",NA,"Yost","Jennifer","Villanova University, Villanova, Pennsylvania (J",NA
"124","34251904","10.7326/L21-0389","Update Alert: Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2).",NA,"2021","07","24","Ann Intern Med","Annals of internal medicine",NA,"Etxeandia-Ikobaltzeta","Itziar","American College of Physicians, Philadelphia, Pennsylvania (A.Q., I",NA
"125","34251904","10.7326/L21-0389","Update Alert: Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2).",NA,"2021","07","24","Ann Intern Med","Annals of internal medicine",NA,"Abraham","George M","Saint Vincent Hospital-Worcester Medical Center, Worcester, Massachusetts (G.M",NA
"126","34251904","10.7326/L21-0389","Update Alert: Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2).",NA,"2021","07","24","Ann Intern Med","Annals of internal medicine",NA,"Jokela","Janet A","University of Illinois College of Medicine at Urbana-Champaign, Champaign, Illinois (J.A",NA
"127","34251904","10.7326/L21-0389","Update Alert: Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2).",NA,"2021","07","24","Ann Intern Med","Annals of internal medicine",NA,"Miller","Matthew C","Penn Medicine Radnor, Radnor, Pennsylvania (M.C",NA
"128","34251904","10.7326/L21-0389","Update Alert: Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2).",NA,"2021","07","24","Ann Intern Med","Annals of internal medicine",NA,"Forciea","Mary Ann","Penn Medicine, Philadelphia, Pennsylvania (M.A",NA
"129","34251904","10.7326/L21-0389","Update Alert: Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2).",NA,"2021","07","24","Ann Intern Med","Annals of internal medicine",NA,"Humphrey","Linda L","Portland Veterans Affairs Medical Center and Oregon Health &amp",NA
"130","34251903","10.7326/M21-0653","Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 : A Randomized Trial.","New treatment modalities are urgently needed for patients with COVID-19. The World Health Organization (WHO) Solidarity trial showed no effect of remdesivir or hydroxychloroquine (HCQ) on mortality, but the antiviral effects of these drugs are not known. To evaluate the effects of remdesivir and HCQ on all-cause, in-hospital mortality; the degree of respiratory failure and inflammation; and viral clearance in the oropharynx. NOR-Solidarity is an independent, add-on, randomized controlled trial t","2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Barratt-Due","Andreas","Oslo University Hospital, Oslo, Norway (A.B., I.C.O., T.K., T.T., C",NA
"131","34251903","10.7326/M21-0653","Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 : A Randomized Trial.","New treatment modalities are urgently needed for patients with COVID-19. The World Health Organization (WHO) Solidarity trial showed no effect of remdesivir or hydroxychloroquine (HCQ) on mortality, but the antiviral effects of these drugs are not known. To evaluate the effects of remdesivir and HCQ on all-cause, in-hospital mortality; the degree of respiratory failure and inflammation; and viral clearance in the oropharynx. NOR-Solidarity is an independent, add-on, randomized controlled trial t","2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Olsen","Inge Christoffer","Oslo University Hospital, Oslo, Norway (A.B., I.C.O., T.K., T.T., C",NA
"132","34251903","10.7326/M21-0653","Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 : A Randomized Trial.","New treatment modalities are urgently needed for patients with COVID-19. The World Health Organization (WHO) Solidarity trial showed no effect of remdesivir or hydroxychloroquine (HCQ) on mortality, but the antiviral effects of these drugs are not known. To evaluate the effects of remdesivir and HCQ on all-cause, in-hospital mortality; the degree of respiratory failure and inflammation; and viral clearance in the oropharynx. NOR-Solidarity is an independent, add-on, randomized controlled trial t","2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Nezvalova-Henriksen","Katerina","Oslo University Hospital and Hospital Pharmacies, South-Eastern Norway Enterprise, Oslo, Norway (K",NA
"133","34251903","10.7326/M21-0653","Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 : A Randomized Trial.","New treatment modalities are urgently needed for patients with COVID-19. The World Health Organization (WHO) Solidarity trial showed no effect of remdesivir or hydroxychloroquine (HCQ) on mortality, but the antiviral effects of these drugs are not known. To evaluate the effects of remdesivir and HCQ on all-cause, in-hospital mortality; the degree of respiratory failure and inflammation; and viral clearance in the oropharynx. NOR-Solidarity is an independent, add-on, randomized controlled trial t","2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Kåsine","Trine","Oslo University Hospital, Oslo, Norway (A.B., I.C.O., T.K., T.T., C",NA
"134","34251903","10.7326/M21-0653","Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 : A Randomized Trial.","New treatment modalities are urgently needed for patients with COVID-19. The World Health Organization (WHO) Solidarity trial showed no effect of remdesivir or hydroxychloroquine (HCQ) on mortality, but the antiviral effects of these drugs are not known. To evaluate the effects of remdesivir and HCQ on all-cause, in-hospital mortality; the degree of respiratory failure and inflammation; and viral clearance in the oropharynx. NOR-Solidarity is an independent, add-on, randomized controlled trial t","2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Lund-Johansen","Fridtjof","Oslo University Hospital and ImmunoLingo Convergence Centre, University of Oslo, Oslo, Norway (F",NA
"135","34251903","10.7326/M21-0653","Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 : A Randomized Trial.","New treatment modalities are urgently needed for patients with COVID-19. The World Health Organization (WHO) Solidarity trial showed no effect of remdesivir or hydroxychloroquine (HCQ) on mortality, but the antiviral effects of these drugs are not known. To evaluate the effects of remdesivir and HCQ on all-cause, in-hospital mortality; the degree of respiratory failure and inflammation; and viral clearance in the oropharynx. NOR-Solidarity is an independent, add-on, randomized controlled trial t","2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Hoel","Hedda","Institute of Clinical Medicine and Research Institute of Internal Medicine, Oslo University Hospital, and Lovisenberg Diaconal Hospital, Oslo, Norway (H",NA
"136","34251903","10.7326/M21-0653","Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 : A Randomized Trial.","New treatment modalities are urgently needed for patients with COVID-19. The World Health Organization (WHO) Solidarity trial showed no effect of remdesivir or hydroxychloroquine (HCQ) on mortality, but the antiviral effects of these drugs are not known. To evaluate the effects of remdesivir and HCQ on all-cause, in-hospital mortality; the degree of respiratory failure and inflammation; and viral clearance in the oropharynx. NOR-Solidarity is an independent, add-on, randomized controlled trial t","2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Holten","Aleksander Rygh","Institute of Clinical Medicine, Oslo University Hospital, Oslo, Norway (A.R.H., S.D., J.T.A., K.T., A.S., F.M., A.M.D., M",NA
"137","34251903","10.7326/M21-0653","Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 : A Randomized Trial.","New treatment modalities are urgently needed for patients with COVID-19. The World Health Organization (WHO) Solidarity trial showed no effect of remdesivir or hydroxychloroquine (HCQ) on mortality, but the antiviral effects of these drugs are not known. To evaluate the effects of remdesivir and HCQ on all-cause, in-hospital mortality; the degree of respiratory failure and inflammation; and viral clearance in the oropharynx. NOR-Solidarity is an independent, add-on, randomized controlled trial t","2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Tveita","Anders","Bærum Hospital, Vestre Viken Hospital Trust, Drammen, Norway (A",NA
"138","34251903","10.7326/M21-0653","Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 : A Randomized Trial.","New treatment modalities are urgently needed for patients with COVID-19. The World Health Organization (WHO) Solidarity trial showed no effect of remdesivir or hydroxychloroquine (HCQ) on mortality, but the antiviral effects of these drugs are not known. To evaluate the effects of remdesivir and HCQ on all-cause, in-hospital mortality; the degree of respiratory failure and inflammation; and viral clearance in the oropharynx. NOR-Solidarity is an independent, add-on, randomized controlled trial t","2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Mathiessen","Alexander","Diakonhjemmet Hospital, Oslo, Norway (A",NA
"139","34251903","10.7326/M21-0653","Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 : A Randomized Trial.","New treatment modalities are urgently needed for patients with COVID-19. The World Health Organization (WHO) Solidarity trial showed no effect of remdesivir or hydroxychloroquine (HCQ) on mortality, but the antiviral effects of these drugs are not known. To evaluate the effects of remdesivir and HCQ on all-cause, in-hospital mortality; the degree of respiratory failure and inflammation; and viral clearance in the oropharynx. NOR-Solidarity is an independent, add-on, randomized controlled trial t","2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Haugli","Mette","Sørlandet Hospital SSK, Kristiansand, Norway (M",NA
"140","34251903","10.7326/M21-0653","Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 : A Randomized Trial.","New treatment modalities are urgently needed for patients with COVID-19. The World Health Organization (WHO) Solidarity trial showed no effect of remdesivir or hydroxychloroquine (HCQ) on mortality, but the antiviral effects of these drugs are not known. To evaluate the effects of remdesivir and HCQ on all-cause, in-hospital mortality; the degree of respiratory failure and inflammation; and viral clearance in the oropharynx. NOR-Solidarity is an independent, add-on, randomized controlled trial t","2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Eiken","Ragnhild","Innlandet Hospital Trust, Lillehammer, Norway (R",NA
"141","34251903","10.7326/M21-0653","Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 : A Randomized Trial.","New treatment modalities are urgently needed for patients with COVID-19. The World Health Organization (WHO) Solidarity trial showed no effect of remdesivir or hydroxychloroquine (HCQ) on mortality, but the antiviral effects of these drugs are not known. To evaluate the effects of remdesivir and HCQ on all-cause, in-hospital mortality; the degree of respiratory failure and inflammation; and viral clearance in the oropharynx. NOR-Solidarity is an independent, add-on, randomized controlled trial t","2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Kildal","Anders Benjamin","University Hospital of North Norway, Tromsø, Norway (A.B",NA
"142","34251903","10.7326/M21-0653","Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 : A Randomized Trial.","New treatment modalities are urgently needed for patients with COVID-19. The World Health Organization (WHO) Solidarity trial showed no effect of remdesivir or hydroxychloroquine (HCQ) on mortality, but the antiviral effects of these drugs are not known. To evaluate the effects of remdesivir and HCQ on all-cause, in-hospital mortality; the degree of respiratory failure and inflammation; and viral clearance in the oropharynx. NOR-Solidarity is an independent, add-on, randomized controlled trial t","2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Berg","Åse","Stavanger University Hospital, Stavanger, Norway (Å",NA
"143","34251903","10.7326/M21-0653","Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 : A Randomized Trial.","New treatment modalities are urgently needed for patients with COVID-19. The World Health Organization (WHO) Solidarity trial showed no effect of remdesivir or hydroxychloroquine (HCQ) on mortality, but the antiviral effects of these drugs are not known. To evaluate the effects of remdesivir and HCQ on all-cause, in-hospital mortality; the degree of respiratory failure and inflammation; and viral clearance in the oropharynx. NOR-Solidarity is an independent, add-on, randomized controlled trial t","2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Johannessen","Asgeir","Institute of Clinical Medicine, Oslo University Hospital, Oslo, and Vestfold Hospital Trust, Tønsberg, Norway (A",NA
"144","34251903","10.7326/M21-0653","Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 : A Randomized Trial.","New treatment modalities are urgently needed for patients with COVID-19. The World Health Organization (WHO) Solidarity trial showed no effect of remdesivir or hydroxychloroquine (HCQ) on mortality, but the antiviral effects of these drugs are not known. To evaluate the effects of remdesivir and HCQ on all-cause, in-hospital mortality; the degree of respiratory failure and inflammation; and viral clearance in the oropharynx. NOR-Solidarity is an independent, add-on, randomized controlled trial t","2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Heggelund","Lars","Drammen Hospital, Vestre Viken Hospital Trust, Drammen, and University of Bergen, Bergen, Norway (L",NA
"145","34251903","10.7326/M21-0653","Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 : A Randomized Trial.","New treatment modalities are urgently needed for patients with COVID-19. The World Health Organization (WHO) Solidarity trial showed no effect of remdesivir or hydroxychloroquine (HCQ) on mortality, but the antiviral effects of these drugs are not known. To evaluate the effects of remdesivir and HCQ on all-cause, in-hospital mortality; the degree of respiratory failure and inflammation; and viral clearance in the oropharynx. NOR-Solidarity is an independent, add-on, randomized controlled trial t","2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Dahl","Tuva Børresdatter","Research Institute of Internal Medicine, Oslo University Hospital, Oslo, Norway (T.B.D., K.H",NA
"146","34251903","10.7326/M21-0653","Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 : A Randomized Trial.","New treatment modalities are urgently needed for patients with COVID-19. The World Health Organization (WHO) Solidarity trial showed no effect of remdesivir or hydroxychloroquine (HCQ) on mortality, but the antiviral effects of these drugs are not known. To evaluate the effects of remdesivir and HCQ on all-cause, in-hospital mortality; the degree of respiratory failure and inflammation; and viral clearance in the oropharynx. NOR-Solidarity is an independent, add-on, randomized controlled trial t","2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Skåra","Karoline Hansen","Research Institute of Internal Medicine, Oslo University Hospital, Oslo, Norway (T.B.D., K.H",NA
"147","34251903","10.7326/M21-0653","Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 : A Randomized Trial.","New treatment modalities are urgently needed for patients with COVID-19. The World Health Organization (WHO) Solidarity trial showed no effect of remdesivir or hydroxychloroquine (HCQ) on mortality, but the antiviral effects of these drugs are not known. To evaluate the effects of remdesivir and HCQ on all-cause, in-hospital mortality; the degree of respiratory failure and inflammation; and viral clearance in the oropharynx. NOR-Solidarity is an independent, add-on, randomized controlled trial t","2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Mielnik","Pawel","Førde Central Hospital, Førde, Norway (P",NA
"148","34251903","10.7326/M21-0653","Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 : A Randomized Trial.","New treatment modalities are urgently needed for patients with COVID-19. The World Health Organization (WHO) Solidarity trial showed no effect of remdesivir or hydroxychloroquine (HCQ) on mortality, but the antiviral effects of these drugs are not known. To evaluate the effects of remdesivir and HCQ on all-cause, in-hospital mortality; the degree of respiratory failure and inflammation; and viral clearance in the oropharynx. NOR-Solidarity is an independent, add-on, randomized controlled trial t","2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Kieu Le","Lan Ai","Haugesund Hospital, Haugesund, Norway (L.A",NA
"149","34251903","10.7326/M21-0653","Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 : A Randomized Trial.","New treatment modalities are urgently needed for patients with COVID-19. The World Health Organization (WHO) Solidarity trial showed no effect of remdesivir or hydroxychloroquine (HCQ) on mortality, but the antiviral effects of these drugs are not known. To evaluate the effects of remdesivir and HCQ on all-cause, in-hospital mortality; the degree of respiratory failure and inflammation; and viral clearance in the oropharynx. NOR-Solidarity is an independent, add-on, randomized controlled trial t","2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Thoresen","Lars","Ringerike Hospital, Vestre Viken Hospital Trust, Ringerike, Norway (L",NA
"150","34251903","10.7326/M21-0653","Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 : A Randomized Trial.","New treatment modalities are urgently needed for patients with COVID-19. The World Health Organization (WHO) Solidarity trial showed no effect of remdesivir or hydroxychloroquine (HCQ) on mortality, but the antiviral effects of these drugs are not known. To evaluate the effects of remdesivir and HCQ on all-cause, in-hospital mortality; the degree of respiratory failure and inflammation; and viral clearance in the oropharynx. NOR-Solidarity is an independent, add-on, randomized controlled trial t","2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Ernst","Gernot","Kongsberg Hospital, Vestre Viken Hospital Trust, Drammen, Norway (G",NA
"151","34251903","10.7326/M21-0653","Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 : A Randomized Trial.","New treatment modalities are urgently needed for patients with COVID-19. The World Health Organization (WHO) Solidarity trial showed no effect of remdesivir or hydroxychloroquine (HCQ) on mortality, but the antiviral effects of these drugs are not known. To evaluate the effects of remdesivir and HCQ on all-cause, in-hospital mortality; the degree of respiratory failure and inflammation; and viral clearance in the oropharynx. NOR-Solidarity is an independent, add-on, randomized controlled trial t","2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Lihaug Hoff","Dag Arne","Ålesund Hospital, Møre and Romsdal Hospital Trust, Ålesund, Norway (D.A",NA
"152","34251903","10.7326/M21-0653","Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 : A Randomized Trial.","New treatment modalities are urgently needed for patients with COVID-19. The World Health Organization (WHO) Solidarity trial showed no effect of remdesivir or hydroxychloroquine (HCQ) on mortality, but the antiviral effects of these drugs are not known. To evaluate the effects of remdesivir and HCQ on all-cause, in-hospital mortality; the degree of respiratory failure and inflammation; and viral clearance in the oropharynx. NOR-Solidarity is an independent, add-on, randomized controlled trial t","2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Skudal","Hilde","Telemark Hospital Trust, Skien, Norway (H",NA
"153","34251903","10.7326/M21-0653","Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 : A Randomized Trial.","New treatment modalities are urgently needed for patients with COVID-19. The World Health Organization (WHO) Solidarity trial showed no effect of remdesivir or hydroxychloroquine (HCQ) on mortality, but the antiviral effects of these drugs are not known. To evaluate the effects of remdesivir and HCQ on all-cause, in-hospital mortality; the degree of respiratory failure and inflammation; and viral clearance in the oropharynx. NOR-Solidarity is an independent, add-on, randomized controlled trial t","2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Kittang","Bård Reiakvam","Haraldsplass Deaconess Hospital, Bergen, Norway (B.R",NA
"154","34251903","10.7326/M21-0653","Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 : A Randomized Trial.","New treatment modalities are urgently needed for patients with COVID-19. The World Health Organization (WHO) Solidarity trial showed no effect of remdesivir or hydroxychloroquine (HCQ) on mortality, but the antiviral effects of these drugs are not known. To evaluate the effects of remdesivir and HCQ on all-cause, in-hospital mortality; the degree of respiratory failure and inflammation; and viral clearance in the oropharynx. NOR-Solidarity is an independent, add-on, randomized controlled trial t","2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Olsen","Roy Bjørkholt","Sorlandet Hospital, Arendal, Norway (R.B",NA
"155","34251903","10.7326/M21-0653","Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 : A Randomized Trial.","New treatment modalities are urgently needed for patients with COVID-19. The World Health Organization (WHO) Solidarity trial showed no effect of remdesivir or hydroxychloroquine (HCQ) on mortality, but the antiviral effects of these drugs are not known. To evaluate the effects of remdesivir and HCQ on all-cause, in-hospital mortality; the degree of respiratory failure and inflammation; and viral clearance in the oropharynx. NOR-Solidarity is an independent, add-on, randomized controlled trial t","2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Tholin","Birgitte","Molde Hospital, Møre and Romsdal Hospital Trust, Molde, Norway (B",NA
"156","34251903","10.7326/M21-0653","Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 : A Randomized Trial.","New treatment modalities are urgently needed for patients with COVID-19. The World Health Organization (WHO) Solidarity trial showed no effect of remdesivir or hydroxychloroquine (HCQ) on mortality, but the antiviral effects of these drugs are not known. To evaluate the effects of remdesivir and HCQ on all-cause, in-hospital mortality; the degree of respiratory failure and inflammation; and viral clearance in the oropharynx. NOR-Solidarity is an independent, add-on, randomized controlled trial t","2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Ystrøm","Carl Magnus","Innlandet Hospital Trust, Elverum, Norway (C.M",NA
"157","34251903","10.7326/M21-0653","Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 : A Randomized Trial.","New treatment modalities are urgently needed for patients with COVID-19. The World Health Organization (WHO) Solidarity trial showed no effect of remdesivir or hydroxychloroquine (HCQ) on mortality, but the antiviral effects of these drugs are not known. To evaluate the effects of remdesivir and HCQ on all-cause, in-hospital mortality; the degree of respiratory failure and inflammation; and viral clearance in the oropharynx. NOR-Solidarity is an independent, add-on, randomized controlled trial t","2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Skei","Nina Vibeche","Levanger Hospital, Nord-Trøndelag Hospital Trust, Levanger, Norway (N.V",NA
"158","34251903","10.7326/M21-0653","Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 : A Randomized Trial.","New treatment modalities are urgently needed for patients with COVID-19. The World Health Organization (WHO) Solidarity trial showed no effect of remdesivir or hydroxychloroquine (HCQ) on mortality, but the antiviral effects of these drugs are not known. To evaluate the effects of remdesivir and HCQ on all-cause, in-hospital mortality; the degree of respiratory failure and inflammation; and viral clearance in the oropharynx. NOR-Solidarity is an independent, add-on, randomized controlled trial t","2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Tran","Trung","Oslo University Hospital, Oslo, Norway (A.B., I.C.O., T.K., T.T., C",NA
"159","34251903","10.7326/M21-0653","Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 : A Randomized Trial.","New treatment modalities are urgently needed for patients with COVID-19. The World Health Organization (WHO) Solidarity trial showed no effect of remdesivir or hydroxychloroquine (HCQ) on mortality, but the antiviral effects of these drugs are not known. To evaluate the effects of remdesivir and HCQ on all-cause, in-hospital mortality; the degree of respiratory failure and inflammation; and viral clearance in the oropharynx. NOR-Solidarity is an independent, add-on, randomized controlled trial t","2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Dudman","Susanne","Institute of Clinical Medicine, Oslo University Hospital, Oslo, Norway (A.R.H., S.D., J.T.A., K.T., A.S., F.M., A.M.D., M",NA
"160","34251903","10.7326/M21-0653","Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 : A Randomized Trial.","New treatment modalities are urgently needed for patients with COVID-19. The World Health Organization (WHO) Solidarity trial showed no effect of remdesivir or hydroxychloroquine (HCQ) on mortality, but the antiviral effects of these drugs are not known. To evaluate the effects of remdesivir and HCQ on all-cause, in-hospital mortality; the degree of respiratory failure and inflammation; and viral clearance in the oropharynx. NOR-Solidarity is an independent, add-on, randomized controlled trial t","2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Andersen","Jan Terje","Institute of Clinical Medicine, Oslo University Hospital, Oslo, Norway (A.R.H., S.D., J.T.A., K.T., A.S., F.M., A.M.D., M",NA
"161","34251903","10.7326/M21-0653","Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 : A Randomized Trial.","New treatment modalities are urgently needed for patients with COVID-19. The World Health Organization (WHO) Solidarity trial showed no effect of remdesivir or hydroxychloroquine (HCQ) on mortality, but the antiviral effects of these drugs are not known. To evaluate the effects of remdesivir and HCQ on all-cause, in-hospital mortality; the degree of respiratory failure and inflammation; and viral clearance in the oropharynx. NOR-Solidarity is an independent, add-on, randomized controlled trial t","2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Hannula","Raisa","Trondheim University Hospital, Trondheim, Norway (R",NA
"162","34251903","10.7326/M21-0653","Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 : A Randomized Trial.","New treatment modalities are urgently needed for patients with COVID-19. The World Health Organization (WHO) Solidarity trial showed no effect of remdesivir or hydroxychloroquine (HCQ) on mortality, but the antiviral effects of these drugs are not known. To evaluate the effects of remdesivir and HCQ on all-cause, in-hospital mortality; the degree of respiratory failure and inflammation; and viral clearance in the oropharynx. NOR-Solidarity is an independent, add-on, randomized controlled trial t","2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Dalgard","Olav","Institute of Clinical Medicine, Oslo University Hospital, Oslo, and Akershus University Hospital, Lørenskog, Norway (O",NA
"163","34251903","10.7326/M21-0653","Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 : A Randomized Trial.","New treatment modalities are urgently needed for patients with COVID-19. The World Health Organization (WHO) Solidarity trial showed no effect of remdesivir or hydroxychloroquine (HCQ) on mortality, but the antiviral effects of these drugs are not known. To evaluate the effects of remdesivir and HCQ on all-cause, in-hospital mortality; the degree of respiratory failure and inflammation; and viral clearance in the oropharynx. NOR-Solidarity is an independent, add-on, randomized controlled trial t","2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Finbråten","Ane-Kristine","Unger-Vetlesen Institute, Lovisenberg Diaconal Hospital, Oslo, Norway (A",NA
"164","34251903","10.7326/M21-0653","Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 : A Randomized Trial.","New treatment modalities are urgently needed for patients with COVID-19. The World Health Organization (WHO) Solidarity trial showed no effect of remdesivir or hydroxychloroquine (HCQ) on mortality, but the antiviral effects of these drugs are not known. To evaluate the effects of remdesivir and HCQ on all-cause, in-hospital mortality; the degree of respiratory failure and inflammation; and viral clearance in the oropharynx. NOR-Solidarity is an independent, add-on, randomized controlled trial t","2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Tonby","Kristian","Institute of Clinical Medicine, Oslo University Hospital, Oslo, Norway (A.R.H., S.D., J.T.A., K.T., A.S., F.M., A.M.D., M",NA
"165","34251903","10.7326/M21-0653","Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 : A Randomized Trial.","New treatment modalities are urgently needed for patients with COVID-19. The World Health Organization (WHO) Solidarity trial showed no effect of remdesivir or hydroxychloroquine (HCQ) on mortality, but the antiviral effects of these drugs are not known. To evaluate the effects of remdesivir and HCQ on all-cause, in-hospital mortality; the degree of respiratory failure and inflammation; and viral clearance in the oropharynx. NOR-Solidarity is an independent, add-on, randomized controlled trial t","2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Blomberg","Bjorn","Haukeland University Hospital and University of Bergen, Bergen, Norway (B",NA
"166","34251903","10.7326/M21-0653","Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 : A Randomized Trial.","New treatment modalities are urgently needed for patients with COVID-19. The World Health Organization (WHO) Solidarity trial showed no effect of remdesivir or hydroxychloroquine (HCQ) on mortality, but the antiviral effects of these drugs are not known. To evaluate the effects of remdesivir and HCQ on all-cause, in-hospital mortality; the degree of respiratory failure and inflammation; and viral clearance in the oropharynx. NOR-Solidarity is an independent, add-on, randomized controlled trial t","2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Aballi","Saad","Østfold Hospital Kalnes, Grålum, Norway (S",NA
"167","34251903","10.7326/M21-0653","Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 : A Randomized Trial.","New treatment modalities are urgently needed for patients with COVID-19. The World Health Organization (WHO) Solidarity trial showed no effect of remdesivir or hydroxychloroquine (HCQ) on mortality, but the antiviral effects of these drugs are not known. To evaluate the effects of remdesivir and HCQ on all-cause, in-hospital mortality; the degree of respiratory failure and inflammation; and viral clearance in the oropharynx. NOR-Solidarity is an independent, add-on, randomized controlled trial t","2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Fladeby","Cathrine","Oslo University Hospital, Oslo, Norway (A.B., I.C.O., T.K., T.T., C",NA
"168","34251903","10.7326/M21-0653","Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 : A Randomized Trial.","New treatment modalities are urgently needed for patients with COVID-19. The World Health Organization (WHO) Solidarity trial showed no effect of remdesivir or hydroxychloroquine (HCQ) on mortality, but the antiviral effects of these drugs are not known. To evaluate the effects of remdesivir and HCQ on all-cause, in-hospital mortality; the degree of respiratory failure and inflammation; and viral clearance in the oropharynx. NOR-Solidarity is an independent, add-on, randomized controlled trial t","2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Steffensen","Anne","Institute of Clinical Medicine, Oslo University Hospital, Oslo, Norway (A.R.H., S.D., J.T.A., K.T., A.S., F.M., A.M.D., M",NA
"169","34251903","10.7326/M21-0653","Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 : A Randomized Trial.","New treatment modalities are urgently needed for patients with COVID-19. The World Health Organization (WHO) Solidarity trial showed no effect of remdesivir or hydroxychloroquine (HCQ) on mortality, but the antiviral effects of these drugs are not known. To evaluate the effects of remdesivir and HCQ on all-cause, in-hospital mortality; the degree of respiratory failure and inflammation; and viral clearance in the oropharynx. NOR-Solidarity is an independent, add-on, randomized controlled trial t","2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Müller","Fredrik","Institute of Clinical Medicine, Oslo University Hospital, Oslo, Norway (A.R.H., S.D., J.T.A., K.T., A.S., F.M., A.M.D., M",NA
"170","34251903","10.7326/M21-0653","Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 : A Randomized Trial.","New treatment modalities are urgently needed for patients with COVID-19. The World Health Organization (WHO) Solidarity trial showed no effect of remdesivir or hydroxychloroquine (HCQ) on mortality, but the antiviral effects of these drugs are not known. To evaluate the effects of remdesivir and HCQ on all-cause, in-hospital mortality; the degree of respiratory failure and inflammation; and viral clearance in the oropharynx. NOR-Solidarity is an independent, add-on, randomized controlled trial t","2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Dyrhol-Riise","Anne Ma","Institute of Clinical Medicine, Oslo University Hospital, Oslo, Norway (A.R.H., S.D., J.T.A., K.T., A.S., F.M., A.M.D., M",NA
"171","34251903","10.7326/M21-0653","Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 : A Randomized Trial.","New treatment modalities are urgently needed for patients with COVID-19. The World Health Organization (WHO) Solidarity trial showed no effect of remdesivir or hydroxychloroquine (HCQ) on mortality, but the antiviral effects of these drugs are not known. To evaluate the effects of remdesivir and HCQ on all-cause, in-hospital mortality; the degree of respiratory failure and inflammation; and viral clearance in the oropharynx. NOR-Solidarity is an independent, add-on, randomized controlled trial t","2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Trøseid","Marius","Institute of Clinical Medicine, Oslo University Hospital, Oslo, Norway (A.R.H., S.D., J.T.A., K.T., A.S., F.M., A.M.D., M",NA
"172","34251903","10.7326/M21-0653","Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 : A Randomized Trial.","New treatment modalities are urgently needed for patients with COVID-19. The World Health Organization (WHO) Solidarity trial showed no effect of remdesivir or hydroxychloroquine (HCQ) on mortality, but the antiviral effects of these drugs are not known. To evaluate the effects of remdesivir and HCQ on all-cause, in-hospital mortality; the degree of respiratory failure and inflammation; and viral clearance in the oropharynx. NOR-Solidarity is an independent, add-on, randomized controlled trial t","2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Aukrust","Pål","Institute of Clinical Medicine and Research Institute of Internal Medicine, Oslo University Hospital, Oslo, Norway (P",NA
"173","34251900","10.7326/L21-0393","Update Alert 6: Masks for Prevention of Respiratory Virus Infections, Including SARS-CoV-2, in Health Care and Community Settings.",NA,"2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Chou","Roger","Pacific Northwest Evidence-based Practice Center and Oregon Health &amp",NA
"174","34251900","10.7326/L21-0393","Update Alert 6: Masks for Prevention of Respiratory Virus Infections, Including SARS-CoV-2, in Health Care and Community Settings.",NA,"2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Dana","Tracy","Pacific Northwest Evidence-based Practice Center and Oregon Health &amp",NA
"175","34251900","10.7326/L21-0393","Update Alert 6: Masks for Prevention of Respiratory Virus Infections, Including SARS-CoV-2, in Health Care and Community Settings.",NA,"2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Jungbauer","Rebecca","Pacific Northwest Evidence-based Practice Center and Oregon Health &amp",NA
"176","34251899","10.7326/W21-0001","Annals Story Slam - Future I.M. Experience: Resilience During COVID-19.",NA,"2021","07","12","Ann Intern Med","Annals of internal medicine",NA,"Fountaine","Carlee","University of Washington Boise Internal Medicine Residency, Boise, Idaho (C",NA
"177","34251899","10.7326/W21-0001","Annals Story Slam - Future I.M. Experience: Resilience During COVID-19.",NA,"2021","07","12","Ann Intern Med","Annals of internal medicine",NA,"Kalu","Vivian","American University of Antigua College of Medicine, Coolidge, Antigua (V",NA
"178","34251899","10.7326/W21-0001","Annals Story Slam - Future I.M. Experience: Resilience During COVID-19.",NA,"2021","07","12","Ann Intern Med","Annals of internal medicine",NA,"Upadhyay","Naman","Thomas Jefferson University Hospital, Philadelphia, Pennsylvania (N",NA
"179","34251899","10.7326/W21-0001","Annals Story Slam - Future I.M. Experience: Resilience During COVID-19.",NA,"2021","07","12","Ann Intern Med","Annals of internal medicine",NA,"Frankel","Lexi","Nova Southeastern University Dr. Kiran C. Patel College of Osteopathic Medicine, Fort Lauderdale, Florida (L",NA
"180","34251899","10.7326/W21-0001","Annals Story Slam - Future I.M. Experience: Resilience During COVID-19.",NA,"2021","07","12","Ann Intern Med","Annals of internal medicine",NA,"Kozar","Victoria","University of Connecticut School of Medicine, Farmington, Connecticut (V",NA
"181","34251899","10.7326/W21-0001","Annals Story Slam - Future I.M. Experience: Resilience During COVID-19.",NA,"2021","07","12","Ann Intern Med","Annals of internal medicine",NA,"Valentin","Christopher","Far Eastern University - Nicanor Reyes Medical Foundation, Quezon City, Philippines (C",NA
"182","34251899","10.7326/W21-0001","Annals Story Slam - Future I.M. Experience: Resilience During COVID-19.",NA,"2021","07","12","Ann Intern Med","Annals of internal medicine",NA,"Abraham","Kristy","University of Illinois at Chicago, Chicago, Illinois (K",NA
"183","34251899","10.7326/W21-0001","Annals Story Slam - Future I.M. Experience: Resilience During COVID-19.",NA,"2021","07","12","Ann Intern Med","Annals of internal medicine",NA,"Mahesh","Amrita","University of New Mexico, Albuquerque, New Mexico (A",NA
"184","34251899","10.7326/W21-0001","Annals Story Slam - Future I.M. Experience: Resilience During COVID-19.",NA,"2021","07","12","Ann Intern Med","Annals of internal medicine",NA,"Panchagnula","Neha","Texas Tech University Health Sciences Center Permian Basin, Odessa, Texas (N",NA
"185","34251899","10.7326/W21-0001","Annals Story Slam - Future I.M. Experience: Resilience During COVID-19.",NA,"2021","07","12","Ann Intern Med","Annals of internal medicine",NA,"Liu","Joy","Kaiser Permanente, Oakland Medical Center, Oakland, California (J",NA
"186","34251899","10.7326/W21-0001","Annals Story Slam - Future I.M. Experience: Resilience During COVID-19.",NA,"2021","07","12","Ann Intern Med","Annals of internal medicine",NA,"Phyo","Zaw","Johns Hopkins University School of Medicine, Baltimore, Maryland (Z",NA
"187","34251899","10.7326/W21-0001","Annals Story Slam - Future I.M. Experience: Resilience During COVID-19.",NA,"2021","07","12","Ann Intern Med","Annals of internal medicine",NA,"Boozalis","Jaclyn","University of Texas at Austin Dell Medical School, Austin, Texas (J",NA
"188","34251897","10.1200/OP.21.00402","Implications of Evolving Guidelines for Coagulopathy and Thrombosis Management in COVID-19.",NA,"2021","07","12","JCO Oncol Pract","JCO oncology practice",NA,"Joshi","Himanshu","Institute for Healthcare Delivery Science, Department of Population Health Science &amp",NA
"189","34251853","10.12968/bjon.2021.30.13.S19","Developing and piloting a simulated placement experience for students.","COVID-19 and rising student numbers are affecting healthcare education, particularly access to clinical placements. As healthcare education is increasingly supported by technology and non-traditional teaching methods, educational experiences gained through clinical placement also require new approaches. This article explores and discusses the use of a simulated clinical placement for a dietetic student cohort. During this virtual placement, students were able to explore and experience a virtual ","2021","07","23","Br J Nurs","British journal of nursing (Mark Allen Publishing)","Dietetics; Education; Healthcare; Nursing; Simulation; COVID-19; Education, Distance; Education, Nursing, Baccalaureate; Humans; Learning; Nursing Education Research; Nursing Evaluation Research; Pilot Projects; Simulation Training; Students, Nursing; United Kingdom","Taylor","Natasha","Associate Professor, School of Nursing, Midwifery and Health, Coventry University",NA
"190","34251853","10.12968/bjon.2021.30.13.S19","Developing and piloting a simulated placement experience for students.","COVID-19 and rising student numbers are affecting healthcare education, particularly access to clinical placements. As healthcare education is increasingly supported by technology and non-traditional teaching methods, educational experiences gained through clinical placement also require new approaches. This article explores and discusses the use of a simulated clinical placement for a dietetic student cohort. During this virtual placement, students were able to explore and experience a virtual ","2021","07","23","Br J Nurs","British journal of nursing (Mark Allen Publishing)","Dietetics; Education; Healthcare; Nursing; Simulation; COVID-19; Education, Distance; Education, Nursing, Baccalaureate; Humans; Learning; Nursing Education Research; Nursing Evaluation Research; Pilot Projects; Simulation Training; Students, Nursing; United Kingdom","Wyres","Martyn","Associate Professor, School of Nursing, Midwifery and Health, Coventry University",NA
"191","34251853","10.12968/bjon.2021.30.13.S19","Developing and piloting a simulated placement experience for students.","COVID-19 and rising student numbers are affecting healthcare education, particularly access to clinical placements. As healthcare education is increasingly supported by technology and non-traditional teaching methods, educational experiences gained through clinical placement also require new approaches. This article explores and discusses the use of a simulated clinical placement for a dietetic student cohort. During this virtual placement, students were able to explore and experience a virtual ","2021","07","23","Br J Nurs","British journal of nursing (Mark Allen Publishing)","Dietetics; Education; Healthcare; Nursing; Simulation; COVID-19; Education, Distance; Education, Nursing, Baccalaureate; Humans; Learning; Nursing Education Research; Nursing Evaluation Research; Pilot Projects; Simulation Training; Students, Nursing; United Kingdom","Green","Abbie","Associate Professor, School of Nursing, Midwifery and Health, Coventry University",NA
"192","34251853","10.12968/bjon.2021.30.13.S19","Developing and piloting a simulated placement experience for students.","COVID-19 and rising student numbers are affecting healthcare education, particularly access to clinical placements. As healthcare education is increasingly supported by technology and non-traditional teaching methods, educational experiences gained through clinical placement also require new approaches. This article explores and discusses the use of a simulated clinical placement for a dietetic student cohort. During this virtual placement, students were able to explore and experience a virtual ","2021","07","23","Br J Nurs","British journal of nursing (Mark Allen Publishing)","Dietetics; Education; Healthcare; Nursing; Simulation; COVID-19; Education, Distance; Education, Nursing, Baccalaureate; Humans; Learning; Nursing Education Research; Nursing Evaluation Research; Pilot Projects; Simulation Training; Students, Nursing; United Kingdom","Hennessy-Priest","Kathleen","Assistant Professor, School of Nursing, Midwifery and Health, Coventry University",NA
"193","34251853","10.12968/bjon.2021.30.13.S19","Developing and piloting a simulated placement experience for students.","COVID-19 and rising student numbers are affecting healthcare education, particularly access to clinical placements. As healthcare education is increasingly supported by technology and non-traditional teaching methods, educational experiences gained through clinical placement also require new approaches. This article explores and discusses the use of a simulated clinical placement for a dietetic student cohort. During this virtual placement, students were able to explore and experience a virtual ","2021","07","23","Br J Nurs","British journal of nursing (Mark Allen Publishing)","Dietetics; Education; Healthcare; Nursing; Simulation; COVID-19; Education, Distance; Education, Nursing, Baccalaureate; Humans; Learning; Nursing Education Research; Nursing Evaluation Research; Pilot Projects; Simulation Training; Students, Nursing; United Kingdom","Phillips","Carla","Associate Professor, School of Nursing, Midwifery and Health, Coventry University",NA
"194","34251853","10.12968/bjon.2021.30.13.S19","Developing and piloting a simulated placement experience for students.","COVID-19 and rising student numbers are affecting healthcare education, particularly access to clinical placements. As healthcare education is increasingly supported by technology and non-traditional teaching methods, educational experiences gained through clinical placement also require new approaches. This article explores and discusses the use of a simulated clinical placement for a dietetic student cohort. During this virtual placement, students were able to explore and experience a virtual ","2021","07","23","Br J Nurs","British journal of nursing (Mark Allen Publishing)","Dietetics; Education; Healthcare; Nursing; Simulation; COVID-19; Education, Distance; Education, Nursing, Baccalaureate; Humans; Learning; Nursing Education Research; Nursing Evaluation Research; Pilot Projects; Simulation Training; Students, Nursing; United Kingdom","Daymond","Emily","Physiotherapist, Torbay and South Devon NHS Foundation Trust",NA
"195","34251853","10.12968/bjon.2021.30.13.S19","Developing and piloting a simulated placement experience for students.","COVID-19 and rising student numbers are affecting healthcare education, particularly access to clinical placements. As healthcare education is increasingly supported by technology and non-traditional teaching methods, educational experiences gained through clinical placement also require new approaches. This article explores and discusses the use of a simulated clinical placement for a dietetic student cohort. During this virtual placement, students were able to explore and experience a virtual ","2021","07","23","Br J Nurs","British journal of nursing (Mark Allen Publishing)","Dietetics; Education; Healthcare; Nursing; Simulation; COVID-19; Education, Distance; Education, Nursing, Baccalaureate; Humans; Learning; Nursing Education Research; Nursing Evaluation Research; Pilot Projects; Simulation Training; Students, Nursing; United Kingdom","Love","Rachel","Senior Lecturer, Faculty of Health, Education and Society, University of Northampton",NA
"196","34251853","10.12968/bjon.2021.30.13.S19","Developing and piloting a simulated placement experience for students.","COVID-19 and rising student numbers are affecting healthcare education, particularly access to clinical placements. As healthcare education is increasingly supported by technology and non-traditional teaching methods, educational experiences gained through clinical placement also require new approaches. This article explores and discusses the use of a simulated clinical placement for a dietetic student cohort. During this virtual placement, students were able to explore and experience a virtual ","2021","07","23","Br J Nurs","British journal of nursing (Mark Allen Publishing)","Dietetics; Education; Healthcare; Nursing; Simulation; COVID-19; Education, Distance; Education, Nursing, Baccalaureate; Humans; Learning; Nursing Education Research; Nursing Evaluation Research; Pilot Projects; Simulation Training; Students, Nursing; United Kingdom","Johnson","Rebecca","Associate Professor, School of Nursing, Midwifery and Health, Coventry University",NA
"197","34251853","10.12968/bjon.2021.30.13.S19","Developing and piloting a simulated placement experience for students.","COVID-19 and rising student numbers are affecting healthcare education, particularly access to clinical placements. As healthcare education is increasingly supported by technology and non-traditional teaching methods, educational experiences gained through clinical placement also require new approaches. This article explores and discusses the use of a simulated clinical placement for a dietetic student cohort. During this virtual placement, students were able to explore and experience a virtual ","2021","07","23","Br J Nurs","British journal of nursing (Mark Allen Publishing)","Dietetics; Education; Healthcare; Nursing; Simulation; COVID-19; Education, Distance; Education, Nursing, Baccalaureate; Humans; Learning; Nursing Education Research; Nursing Evaluation Research; Pilot Projects; Simulation Training; Students, Nursing; United Kingdom","Wright","Jane","Lecturer, School of Nursing, Midwifery and Health, Coventry University",NA
"198","34251852","10.12968/bjon.2021.30.13.828","Should SARS-CoV-2 vaccination for all frontline healthcare staff be compulsory?","Emeritus Professor Alan Glasper, from the University of Southampton, discusses the issues raised by the recent government decision to make vaccination against the virus causing COVID-19 mandatory for care home staff.","2021","07","23","Br J Nurs","British journal of nursing (Mark Allen Publishing)","COVID-19; COVID-19 Vaccines; Health Personnel; Humans; Mandatory Programs; State Medicine; United Kingdom; Vaccination","Glasper","Alan","Emeritus Professor, University of Southampton",NA
"199","34251845","10.12968/bjon.2021.30.13.822","The impact of Brexit and COVID-19 on nursing in the UK.",NA,"2021","07","16","Br J Nurs","British journal of nursing (Mark Allen Publishing)","COVID-19; European Union; Humans; Nursing; United Kingdom","Carvalho","Filipe","Advanced Nurse Practitioner in Colorectal Surgery/Lead Nurse for RIG &amp",NA
"200","34251833","10.1021/acs.jproteome.1c00458","Integrative Modeling of Plasma Metabolic and Lipoprotein Biomarkers of SARS-CoV-2 Infection in Spanish and Australian COVID-19 Patient Cohorts.","Quantitative plasma lipoprotein and metabolite profiles were measured on an autonomous community of the Basque Country (Spain) cohort consisting of hospitalized COVID-19 patients (n = 72) and a matched control group (n = 75) and a Western Australian (WA) cohort consisting of (n = 17) SARS-CoV-2 positives and (n = 20) healthy controls using 600 MHz <sup>1</sup>H nuclear magnetic resonance (NMR) spectroscopy. Spanish samples were measured in two laboratories using one-d","2021","07","12","J Proteome Res","Journal of proteome research","COVID-19; NMR spectroscopy; SARS-CoV-2; diagnostic modeling; lipoproteins; metabolic phenotyping; phenoconversion; plasma IVDr; population cross-validation","Masuda","Reika","Australian National Phenome Centre, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, WA 6150, Australia",NA
"201","34251833","10.1021/acs.jproteome.1c00458","Integrative Modeling of Plasma Metabolic and Lipoprotein Biomarkers of SARS-CoV-2 Infection in Spanish and Australian COVID-19 Patient Cohorts.","Quantitative plasma lipoprotein and metabolite profiles were measured on an autonomous community of the Basque Country (Spain) cohort consisting of hospitalized COVID-19 patients (n = 72) and a matched control group (n = 75) and a Western Australian (WA) cohort consisting of (n = 17) SARS-CoV-2 positives and (n = 20) healthy controls using 600 MHz <sup>1</sup>H nuclear magnetic resonance (NMR) spectroscopy. Spanish samples were measured in two laboratories using one-d","2021","07","12","J Proteome Res","Journal of proteome research","COVID-19; NMR spectroscopy; SARS-CoV-2; diagnostic modeling; lipoproteins; metabolic phenotyping; phenoconversion; plasma IVDr; population cross-validation","Lodge","Samantha","Australian National Phenome Centre, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, WA 6150, Australia",NA
"202","34251833","10.1021/acs.jproteome.1c00458","Integrative Modeling of Plasma Metabolic and Lipoprotein Biomarkers of SARS-CoV-2 Infection in Spanish and Australian COVID-19 Patient Cohorts.","Quantitative plasma lipoprotein and metabolite profiles were measured on an autonomous community of the Basque Country (Spain) cohort consisting of hospitalized COVID-19 patients (n = 72) and a matched control group (n = 75) and a Western Australian (WA) cohort consisting of (n = 17) SARS-CoV-2 positives and (n = 20) healthy controls using 600 MHz <sup>1</sup>H nuclear magnetic resonance (NMR) spectroscopy. Spanish samples were measured in two laboratories using one-d","2021","07","12","J Proteome Res","Journal of proteome research","COVID-19; NMR spectroscopy; SARS-CoV-2; diagnostic modeling; lipoproteins; metabolic phenotyping; phenoconversion; plasma IVDr; population cross-validation","Nitschke","Philipp","Australian National Phenome Centre, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, WA 6150, Australia",NA
"203","34251833","10.1021/acs.jproteome.1c00458","Integrative Modeling of Plasma Metabolic and Lipoprotein Biomarkers of SARS-CoV-2 Infection in Spanish and Australian COVID-19 Patient Cohorts.","Quantitative plasma lipoprotein and metabolite profiles were measured on an autonomous community of the Basque Country (Spain) cohort consisting of hospitalized COVID-19 patients (n = 72) and a matched control group (n = 75) and a Western Australian (WA) cohort consisting of (n = 17) SARS-CoV-2 positives and (n = 20) healthy controls using 600 MHz <sup>1</sup>H nuclear magnetic resonance (NMR) spectroscopy. Spanish samples were measured in two laboratories using one-d","2021","07","12","J Proteome Res","Journal of proteome research","COVID-19; NMR spectroscopy; SARS-CoV-2; diagnostic modeling; lipoproteins; metabolic phenotyping; phenoconversion; plasma IVDr; population cross-validation","Spraul","Manfred","Bruker Biospin GmbH, Silberstreifen, Ettlingen 76275, Germany",NA
"204","34251833","10.1021/acs.jproteome.1c00458","Integrative Modeling of Plasma Metabolic and Lipoprotein Biomarkers of SARS-CoV-2 Infection in Spanish and Australian COVID-19 Patient Cohorts.","Quantitative plasma lipoprotein and metabolite profiles were measured on an autonomous community of the Basque Country (Spain) cohort consisting of hospitalized COVID-19 patients (n = 72) and a matched control group (n = 75) and a Western Australian (WA) cohort consisting of (n = 17) SARS-CoV-2 positives and (n = 20) healthy controls using 600 MHz <sup>1</sup>H nuclear magnetic resonance (NMR) spectroscopy. Spanish samples were measured in two laboratories using one-d","2021","07","12","J Proteome Res","Journal of proteome research","COVID-19; NMR spectroscopy; SARS-CoV-2; diagnostic modeling; lipoproteins; metabolic phenotyping; phenoconversion; plasma IVDr; population cross-validation","Schaefer","Hartmut","Bruker Biospin GmbH, Silberstreifen, Ettlingen 76275, Germany",NA
"205","34251833","10.1021/acs.jproteome.1c00458","Integrative Modeling of Plasma Metabolic and Lipoprotein Biomarkers of SARS-CoV-2 Infection in Spanish and Australian COVID-19 Patient Cohorts.","Quantitative plasma lipoprotein and metabolite profiles were measured on an autonomous community of the Basque Country (Spain) cohort consisting of hospitalized COVID-19 patients (n = 72) and a matched control group (n = 75) and a Western Australian (WA) cohort consisting of (n = 17) SARS-CoV-2 positives and (n = 20) healthy controls using 600 MHz <sup>1</sup>H nuclear magnetic resonance (NMR) spectroscopy. Spanish samples were measured in two laboratories using one-d","2021","07","12","J Proteome Res","Journal of proteome research","COVID-19; NMR spectroscopy; SARS-CoV-2; diagnostic modeling; lipoproteins; metabolic phenotyping; phenoconversion; plasma IVDr; population cross-validation","Bong","Sze-How","Australian National Phenome Centre, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, WA 6150, Australia",NA
"206","34251833","10.1021/acs.jproteome.1c00458","Integrative Modeling of Plasma Metabolic and Lipoprotein Biomarkers of SARS-CoV-2 Infection in Spanish and Australian COVID-19 Patient Cohorts.","Quantitative plasma lipoprotein and metabolite profiles were measured on an autonomous community of the Basque Country (Spain) cohort consisting of hospitalized COVID-19 patients (n = 72) and a matched control group (n = 75) and a Western Australian (WA) cohort consisting of (n = 17) SARS-CoV-2 positives and (n = 20) healthy controls using 600 MHz <sup>1</sup>H nuclear magnetic resonance (NMR) spectroscopy. Spanish samples were measured in two laboratories using one-d","2021","07","12","J Proteome Res","Journal of proteome research","COVID-19; NMR spectroscopy; SARS-CoV-2; diagnostic modeling; lipoproteins; metabolic phenotyping; phenoconversion; plasma IVDr; population cross-validation","Kimhofer","Torben","Australian National Phenome Centre, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, WA 6150, Australia",NA
"207","34251833","10.1021/acs.jproteome.1c00458","Integrative Modeling of Plasma Metabolic and Lipoprotein Biomarkers of SARS-CoV-2 Infection in Spanish and Australian COVID-19 Patient Cohorts.","Quantitative plasma lipoprotein and metabolite profiles were measured on an autonomous community of the Basque Country (Spain) cohort consisting of hospitalized COVID-19 patients (n = 72) and a matched control group (n = 75) and a Western Australian (WA) cohort consisting of (n = 17) SARS-CoV-2 positives and (n = 20) healthy controls using 600 MHz <sup>1</sup>H nuclear magnetic resonance (NMR) spectroscopy. Spanish samples were measured in two laboratories using one-d","2021","07","12","J Proteome Res","Journal of proteome research","COVID-19; NMR spectroscopy; SARS-CoV-2; diagnostic modeling; lipoproteins; metabolic phenotyping; phenoconversion; plasma IVDr; population cross-validation","Hall","Drew","Australian National Phenome Centre, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, WA 6150, Australia",NA
"208","34251833","10.1021/acs.jproteome.1c00458","Integrative Modeling of Plasma Metabolic and Lipoprotein Biomarkers of SARS-CoV-2 Infection in Spanish and Australian COVID-19 Patient Cohorts.","Quantitative plasma lipoprotein and metabolite profiles were measured on an autonomous community of the Basque Country (Spain) cohort consisting of hospitalized COVID-19 patients (n = 72) and a matched control group (n = 75) and a Western Australian (WA) cohort consisting of (n = 17) SARS-CoV-2 positives and (n = 20) healthy controls using 600 MHz <sup>1</sup>H nuclear magnetic resonance (NMR) spectroscopy. Spanish samples were measured in two laboratories using one-d","2021","07","12","J Proteome Res","Journal of proteome research","COVID-19; NMR spectroscopy; SARS-CoV-2; diagnostic modeling; lipoproteins; metabolic phenotyping; phenoconversion; plasma IVDr; population cross-validation","Loo","Ruey Leng","Australian National Phenome Centre, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, WA 6150, Australia",NA
"209","34251833","10.1021/acs.jproteome.1c00458","Integrative Modeling of Plasma Metabolic and Lipoprotein Biomarkers of SARS-CoV-2 Infection in Spanish and Australian COVID-19 Patient Cohorts.","Quantitative plasma lipoprotein and metabolite profiles were measured on an autonomous community of the Basque Country (Spain) cohort consisting of hospitalized COVID-19 patients (n = 72) and a matched control group (n = 75) and a Western Australian (WA) cohort consisting of (n = 17) SARS-CoV-2 positives and (n = 20) healthy controls using 600 MHz <sup>1</sup>H nuclear magnetic resonance (NMR) spectroscopy. Spanish samples were measured in two laboratories using one-d","2021","07","12","J Proteome Res","Journal of proteome research","COVID-19; NMR spectroscopy; SARS-CoV-2; diagnostic modeling; lipoproteins; metabolic phenotyping; phenoconversion; plasma IVDr; population cross-validation","Bizkarguenaga","Maider","CIC bioGUNE, Asociación Centro de Investigación Cooperativa en Biociencias, Bizkaia Science and Technology Park, Building 800, 48160 Derio, Bizkaia, Spain",NA
"210","34251833","10.1021/acs.jproteome.1c00458","Integrative Modeling of Plasma Metabolic and Lipoprotein Biomarkers of SARS-CoV-2 Infection in Spanish and Australian COVID-19 Patient Cohorts.","Quantitative plasma lipoprotein and metabolite profiles were measured on an autonomous community of the Basque Country (Spain) cohort consisting of hospitalized COVID-19 patients (n = 72) and a matched control group (n = 75) and a Western Australian (WA) cohort consisting of (n = 17) SARS-CoV-2 positives and (n = 20) healthy controls using 600 MHz <sup>1</sup>H nuclear magnetic resonance (NMR) spectroscopy. Spanish samples were measured in two laboratories using one-d","2021","07","12","J Proteome Res","Journal of proteome research","COVID-19; NMR spectroscopy; SARS-CoV-2; diagnostic modeling; lipoproteins; metabolic phenotyping; phenoconversion; plasma IVDr; population cross-validation","Bruzzone","Chiara","CIC bioGUNE, Asociación Centro de Investigación Cooperativa en Biociencias, Bizkaia Science and Technology Park, Building 800, 48160 Derio, Bizkaia, Spain",NA
"211","34251833","10.1021/acs.jproteome.1c00458","Integrative Modeling of Plasma Metabolic and Lipoprotein Biomarkers of SARS-CoV-2 Infection in Spanish and Australian COVID-19 Patient Cohorts.","Quantitative plasma lipoprotein and metabolite profiles were measured on an autonomous community of the Basque Country (Spain) cohort consisting of hospitalized COVID-19 patients (n = 72) and a matched control group (n = 75) and a Western Australian (WA) cohort consisting of (n = 17) SARS-CoV-2 positives and (n = 20) healthy controls using 600 MHz <sup>1</sup>H nuclear magnetic resonance (NMR) spectroscopy. Spanish samples were measured in two laboratories using one-d","2021","07","12","J Proteome Res","Journal of proteome research","COVID-19; NMR spectroscopy; SARS-CoV-2; diagnostic modeling; lipoproteins; metabolic phenotyping; phenoconversion; plasma IVDr; population cross-validation","Gil-Redondo","Rubén","CIC bioGUNE, Asociación Centro de Investigación Cooperativa en Biociencias, Bizkaia Science and Technology Park, Building 800, 48160 Derio, Bizkaia, Spain",NA
"212","34251833","10.1021/acs.jproteome.1c00458","Integrative Modeling of Plasma Metabolic and Lipoprotein Biomarkers of SARS-CoV-2 Infection in Spanish and Australian COVID-19 Patient Cohorts.","Quantitative plasma lipoprotein and metabolite profiles were measured on an autonomous community of the Basque Country (Spain) cohort consisting of hospitalized COVID-19 patients (n = 72) and a matched control group (n = 75) and a Western Australian (WA) cohort consisting of (n = 17) SARS-CoV-2 positives and (n = 20) healthy controls using 600 MHz <sup>1</sup>H nuclear magnetic resonance (NMR) spectroscopy. Spanish samples were measured in two laboratories using one-d","2021","07","12","J Proteome Res","Journal of proteome research","COVID-19; NMR spectroscopy; SARS-CoV-2; diagnostic modeling; lipoproteins; metabolic phenotyping; phenoconversion; plasma IVDr; population cross-validation","Embade","Nieves","CIC bioGUNE, Asociación Centro de Investigación Cooperativa en Biociencias, Bizkaia Science and Technology Park, Building 800, 48160 Derio, Bizkaia, Spain",NA
"213","34251833","10.1021/acs.jproteome.1c00458","Integrative Modeling of Plasma Metabolic and Lipoprotein Biomarkers of SARS-CoV-2 Infection in Spanish and Australian COVID-19 Patient Cohorts.","Quantitative plasma lipoprotein and metabolite profiles were measured on an autonomous community of the Basque Country (Spain) cohort consisting of hospitalized COVID-19 patients (n = 72) and a matched control group (n = 75) and a Western Australian (WA) cohort consisting of (n = 17) SARS-CoV-2 positives and (n = 20) healthy controls using 600 MHz <sup>1</sup>H nuclear magnetic resonance (NMR) spectroscopy. Spanish samples were measured in two laboratories using one-d","2021","07","12","J Proteome Res","Journal of proteome research","COVID-19; NMR spectroscopy; SARS-CoV-2; diagnostic modeling; lipoproteins; metabolic phenotyping; phenoconversion; plasma IVDr; population cross-validation","Mato","José M","CIC bioGUNE, Asociación Centro de Investigación Cooperativa en Biociencias, Bizkaia Science and Technology Park, Building 800, 48160 Derio, Bizkaia, Spain",NA
"214","34251833","10.1021/acs.jproteome.1c00458","Integrative Modeling of Plasma Metabolic and Lipoprotein Biomarkers of SARS-CoV-2 Infection in Spanish and Australian COVID-19 Patient Cohorts.","Quantitative plasma lipoprotein and metabolite profiles were measured on an autonomous community of the Basque Country (Spain) cohort consisting of hospitalized COVID-19 patients (n = 72) and a matched control group (n = 75) and a Western Australian (WA) cohort consisting of (n = 17) SARS-CoV-2 positives and (n = 20) healthy controls using 600 MHz <sup>1</sup>H nuclear magnetic resonance (NMR) spectroscopy. Spanish samples were measured in two laboratories using one-d","2021","07","12","J Proteome Res","Journal of proteome research","COVID-19; NMR spectroscopy; SARS-CoV-2; diagnostic modeling; lipoproteins; metabolic phenotyping; phenoconversion; plasma IVDr; population cross-validation","Holmes","Elaine","Australian National Phenome Centre, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, WA 6150, Australia",NA
"215","34251833","10.1021/acs.jproteome.1c00458","Integrative Modeling of Plasma Metabolic and Lipoprotein Biomarkers of SARS-CoV-2 Infection in Spanish and Australian COVID-19 Patient Cohorts.","Quantitative plasma lipoprotein and metabolite profiles were measured on an autonomous community of the Basque Country (Spain) cohort consisting of hospitalized COVID-19 patients (n = 72) and a matched control group (n = 75) and a Western Australian (WA) cohort consisting of (n = 17) SARS-CoV-2 positives and (n = 20) healthy controls using 600 MHz <sup>1</sup>H nuclear magnetic resonance (NMR) spectroscopy. Spanish samples were measured in two laboratories using one-d","2021","07","12","J Proteome Res","Journal of proteome research","COVID-19; NMR spectroscopy; SARS-CoV-2; diagnostic modeling; lipoproteins; metabolic phenotyping; phenoconversion; plasma IVDr; population cross-validation","Wist","Julien","Australian National Phenome Centre, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, WA 6150, Australia",NA
"216","34251833","10.1021/acs.jproteome.1c00458","Integrative Modeling of Plasma Metabolic and Lipoprotein Biomarkers of SARS-CoV-2 Infection in Spanish and Australian COVID-19 Patient Cohorts.","Quantitative plasma lipoprotein and metabolite profiles were measured on an autonomous community of the Basque Country (Spain) cohort consisting of hospitalized COVID-19 patients (n = 72) and a matched control group (n = 75) and a Western Australian (WA) cohort consisting of (n = 17) SARS-CoV-2 positives and (n = 20) healthy controls using 600 MHz <sup>1</sup>H nuclear magnetic resonance (NMR) spectroscopy. Spanish samples were measured in two laboratories using one-d","2021","07","12","J Proteome Res","Journal of proteome research","COVID-19; NMR spectroscopy; SARS-CoV-2; diagnostic modeling; lipoproteins; metabolic phenotyping; phenoconversion; plasma IVDr; population cross-validation","Millet","Oscar","CIC bioGUNE, Asociación Centro de Investigación Cooperativa en Biociencias, Bizkaia Science and Technology Park, Building 800, 48160 Derio, Bizkaia, Spain",NA
"217","34251833","10.1021/acs.jproteome.1c00458","Integrative Modeling of Plasma Metabolic and Lipoprotein Biomarkers of SARS-CoV-2 Infection in Spanish and Australian COVID-19 Patient Cohorts.","Quantitative plasma lipoprotein and metabolite profiles were measured on an autonomous community of the Basque Country (Spain) cohort consisting of hospitalized COVID-19 patients (n = 72) and a matched control group (n = 75) and a Western Australian (WA) cohort consisting of (n = 17) SARS-CoV-2 positives and (n = 20) healthy controls using 600 MHz <sup>1</sup>H nuclear magnetic resonance (NMR) spectroscopy. Spanish samples were measured in two laboratories using one-d","2021","07","12","J Proteome Res","Journal of proteome research","COVID-19; NMR spectroscopy; SARS-CoV-2; diagnostic modeling; lipoproteins; metabolic phenotyping; phenoconversion; plasma IVDr; population cross-validation","Nicholson","Jeremy K","Australian National Phenome Centre, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, WA 6150, Australia",NA
"218","34251748","10.1111/tbed.14234","A computational study of the interface interaction between SARS-CoV-2 RBD and ACE2 from human, cat, dog, and ferret.","The total impact of the worldwide COVID-19 pandemic is still emerging, changing all relationships as a result, including those with pet animals. In the infection process, the use of angiotensin-converting enzyme 2 (ACE2) as a cellular receptor to the spike protein of the new coronavirus is a fundamental step. In this sense, understanding which residue plays what role in the interaction between SARS-CoV-2 spike glycoprotein and ACE2 from cats, dogs, and ferrets is an important guide for helping t","2021","07","22","Transbound Emerg Dis","Transboundary and emerging diseases","Severe acute respiratory syndrome coronavirus 2; angiotensin-converting enzyme 2; molecular dynamics; receptor binding domain","Soté","William O","Chemistry Institute, Federal University of Uberlandia, Minas Gerais, Brazil",NA
"219","34251748","10.1111/tbed.14234","A computational study of the interface interaction between SARS-CoV-2 RBD and ACE2 from human, cat, dog, and ferret.","The total impact of the worldwide COVID-19 pandemic is still emerging, changing all relationships as a result, including those with pet animals. In the infection process, the use of angiotensin-converting enzyme 2 (ACE2) as a cellular receptor to the spike protein of the new coronavirus is a fundamental step. In this sense, understanding which residue plays what role in the interaction between SARS-CoV-2 spike glycoprotein and ACE2 from cats, dogs, and ferrets is an important guide for helping t","2021","07","22","Transbound Emerg Dis","Transboundary and emerging diseases","Severe acute respiratory syndrome coronavirus 2; angiotensin-converting enzyme 2; molecular dynamics; receptor binding domain","Franca","Eduardo F","Chemistry Institute, Federal University of Uberlandia, Minas Gerais, Brazil",NA
"220","34251748","10.1111/tbed.14234","A computational study of the interface interaction between SARS-CoV-2 RBD and ACE2 from human, cat, dog, and ferret.","The total impact of the worldwide COVID-19 pandemic is still emerging, changing all relationships as a result, including those with pet animals. In the infection process, the use of angiotensin-converting enzyme 2 (ACE2) as a cellular receptor to the spike protein of the new coronavirus is a fundamental step. In this sense, understanding which residue plays what role in the interaction between SARS-CoV-2 spike glycoprotein and ACE2 from cats, dogs, and ferrets is an important guide for helping t","2021","07","22","Transbound Emerg Dis","Transboundary and emerging diseases","Severe acute respiratory syndrome coronavirus 2; angiotensin-converting enzyme 2; molecular dynamics; receptor binding domain","Hora","Aline S","School of Veterinary Medicine, Federal University of Uberlandia, Minas Gerais, Brazil",NA
"221","34251748","10.1111/tbed.14234","A computational study of the interface interaction between SARS-CoV-2 RBD and ACE2 from human, cat, dog, and ferret.","The total impact of the worldwide COVID-19 pandemic is still emerging, changing all relationships as a result, including those with pet animals. In the infection process, the use of angiotensin-converting enzyme 2 (ACE2) as a cellular receptor to the spike protein of the new coronavirus is a fundamental step. In this sense, understanding which residue plays what role in the interaction between SARS-CoV-2 spike glycoprotein and ACE2 from cats, dogs, and ferrets is an important guide for helping t","2021","07","22","Transbound Emerg Dis","Transboundary and emerging diseases","Severe acute respiratory syndrome coronavirus 2; angiotensin-converting enzyme 2; molecular dynamics; receptor binding domain","Comar","Moacyr","Chemistry Institute, Federal University of Uberlandia, Minas Gerais, Brazil",NA
"222","34251735","10.1111/ans.17066","Advocacy for COVID-19 vaccination at perioperative consultations: An opportunity for protection.",NA,"2021","07","12","ANZ J Surg","ANZ journal of surgery",NA,"Douglas","Ned","Department of Anaesthesia and Pain Management, Royal Melbourne Hospital, Melbourne, Victoria, Australia",NA
"223","34251735","10.1111/ans.17066","Advocacy for COVID-19 vaccination at perioperative consultations: An opportunity for protection.",NA,"2021","07","12","ANZ J Surg","ANZ journal of surgery",NA,"Gregorevic","Katherine","Proactive care of Older People having Surgery at the Royal Melbourne Hospital (POPS - RMH), Melbourne, Victoria, Australia",NA
"224","34251735","10.1111/ans.17066","Advocacy for COVID-19 vaccination at perioperative consultations: An opportunity for protection.",NA,"2021","07","12","ANZ J Surg","ANZ journal of surgery",NA,"Law","Mandy","COVID-19 Vaccination Service, Royal Melbourne Hospital, Melbourne, Victoria, Australia",NA
"225","34251735","10.1111/ans.17066","Advocacy for COVID-19 vaccination at perioperative consultations: An opportunity for protection.",NA,"2021","07","12","ANZ J Surg","ANZ journal of surgery",NA,"Thomson","Benjamin N J","Department of General Surgical Specialties, Royal Melbourne Hospital, Melbourne, Victoria, Australia",NA
"226","34251735","10.1111/ans.17066","Advocacy for COVID-19 vaccination at perioperative consultations: An opportunity for protection.",NA,"2021","07","12","ANZ J Surg","ANZ journal of surgery",NA,"Johnson","Douglas F","Department of General Medicine, Royal Melbourne Hospital, Melbourne, Victoria, Australia",NA
"227","34251732","10.1111/1753-6405.13132","COVID-19 as a context in suicide: early insights from Victoria, Australia.","To examine how the coronavirus (COVID-19) pandemic and its consequences may have influenced suicide in Victoria, Australia. A mixed methods study of consecutive Victorian suicide cases spanning 1 January 2015 to 31 January 2021. Interrupted time series analysis examined whether suicide frequency changed following the pandemic onset. Thematic analysis was undertaken of police reports in suicides linked with COVID-19 to try to understand how COVID-19 acted as a stressor. The frequency of Victorian","2021","07","12","Aust N Z J Public Health","Australian and New Zealand journal of public health","COVID-19; mixed-methods; suicide","Dwyer","Justin","Psychosocial Cancer Care, St Vincent's Hospital Melbourne, Victoria",NA
"228","34251732","10.1111/1753-6405.13132","COVID-19 as a context in suicide: early insights from Victoria, Australia.","To examine how the coronavirus (COVID-19) pandemic and its consequences may have influenced suicide in Victoria, Australia. A mixed methods study of consecutive Victorian suicide cases spanning 1 January 2015 to 31 January 2021. Interrupted time series analysis examined whether suicide frequency changed following the pandemic onset. Thematic analysis was undertaken of police reports in suicides linked with COVID-19 to try to understand how COVID-19 acted as a stressor. The frequency of Victorian","2021","07","12","Aust N Z J Public Health","Australian and New Zealand journal of public health","COVID-19; mixed-methods; suicide","Dwyer","Jeremy","Coroners Court of Victoria",NA
"229","34251732","10.1111/1753-6405.13132","COVID-19 as a context in suicide: early insights from Victoria, Australia.","To examine how the coronavirus (COVID-19) pandemic and its consequences may have influenced suicide in Victoria, Australia. A mixed methods study of consecutive Victorian suicide cases spanning 1 January 2015 to 31 January 2021. Interrupted time series analysis examined whether suicide frequency changed following the pandemic onset. Thematic analysis was undertaken of police reports in suicides linked with COVID-19 to try to understand how COVID-19 acted as a stressor. The frequency of Victorian","2021","07","12","Aust N Z J Public Health","Australian and New Zealand journal of public health","COVID-19; mixed-methods; suicide","Hiscock","Richard","Translational Obstetrics Group, Department of Obstetrics and Gynaecology, The University of Melbourne, Victoria",NA
"230","34251732","10.1111/1753-6405.13132","COVID-19 as a context in suicide: early insights from Victoria, Australia.","To examine how the coronavirus (COVID-19) pandemic and its consequences may have influenced suicide in Victoria, Australia. A mixed methods study of consecutive Victorian suicide cases spanning 1 January 2015 to 31 January 2021. Interrupted time series analysis examined whether suicide frequency changed following the pandemic onset. Thematic analysis was undertaken of police reports in suicides linked with COVID-19 to try to understand how COVID-19 acted as a stressor. The frequency of Victorian","2021","07","12","Aust N Z J Public Health","Australian and New Zealand journal of public health","COVID-19; mixed-methods; suicide","O'Callaghan","Clare","Psychosocial Cancer Care, St Vincent's Hospital Melbourne, Victoria",NA
"231","34251732","10.1111/1753-6405.13132","COVID-19 as a context in suicide: early insights from Victoria, Australia.","To examine how the coronavirus (COVID-19) pandemic and its consequences may have influenced suicide in Victoria, Australia. A mixed methods study of consecutive Victorian suicide cases spanning 1 January 2015 to 31 January 2021. Interrupted time series analysis examined whether suicide frequency changed following the pandemic onset. Thematic analysis was undertaken of police reports in suicides linked with COVID-19 to try to understand how COVID-19 acted as a stressor. The frequency of Victorian","2021","07","12","Aust N Z J Public Health","Australian and New Zealand journal of public health","COVID-19; mixed-methods; suicide","Taylor","Keryn","Psychosocial Cancer Care, St Vincent's Hospital Melbourne, Victoria",NA
"232","34251732","10.1111/1753-6405.13132","COVID-19 as a context in suicide: early insights from Victoria, Australia.","To examine how the coronavirus (COVID-19) pandemic and its consequences may have influenced suicide in Victoria, Australia. A mixed methods study of consecutive Victorian suicide cases spanning 1 January 2015 to 31 January 2021. Interrupted time series analysis examined whether suicide frequency changed following the pandemic onset. Thematic analysis was undertaken of police reports in suicides linked with COVID-19 to try to understand how COVID-19 acted as a stressor. The frequency of Victorian","2021","07","12","Aust N Z J Public Health","Australian and New Zealand journal of public health","COVID-19; mixed-methods; suicide","Millar","Ciara","Coroners Court of Victoria",NA
"233","34251732","10.1111/1753-6405.13132","COVID-19 as a context in suicide: early insights from Victoria, Australia.","To examine how the coronavirus (COVID-19) pandemic and its consequences may have influenced suicide in Victoria, Australia. A mixed methods study of consecutive Victorian suicide cases spanning 1 January 2015 to 31 January 2021. Interrupted time series analysis examined whether suicide frequency changed following the pandemic onset. Thematic analysis was undertaken of police reports in suicides linked with COVID-19 to try to understand how COVID-19 acted as a stressor. The frequency of Victorian","2021","07","12","Aust N Z J Public Health","Australian and New Zealand journal of public health","COVID-19; mixed-methods; suicide","Lamb","Ashne","Coroners Court of Victoria",NA
"234","34251732","10.1111/1753-6405.13132","COVID-19 as a context in suicide: early insights from Victoria, Australia.","To examine how the coronavirus (COVID-19) pandemic and its consequences may have influenced suicide in Victoria, Australia. A mixed methods study of consecutive Victorian suicide cases spanning 1 January 2015 to 31 January 2021. Interrupted time series analysis examined whether suicide frequency changed following the pandemic onset. Thematic analysis was undertaken of police reports in suicides linked with COVID-19 to try to understand how COVID-19 acted as a stressor. The frequency of Victorian","2021","07","12","Aust N Z J Public Health","Australian and New Zealand journal of public health","COVID-19; mixed-methods; suicide","Bugeja","Lyndal","Department of Forensic Medicine, Monash University, Victoria",NA
"235","34251730","10.1111/ijcp.14624","Assessment of severity and mortality of COVID-19 with anti-A1 and B IgM isohemagglutinins, a reflection of the innate immune status.","The relationship between the innate immune system that creates the polysaccharide antibody response and COVID-19 is not fully understood. In this study, it was aimed to determine the predictive values of isohemagglutinins in COVID-19 severity/mortality. Approximately 15440 patients diagnosed with COVID-19 were examined, and a total of 286 patients with anti-B and anti-A1 IgM isohemagglutinins test results were randomly enrolled in the study. These patients were stratified into two groups accordi","2021","07","12","Int J Clin Pract","International journal of clinical practice","COVID-19; anti-A1 IgM; anti-B IgM; isohemagglutinins; mortality","Ozcelik","Fatih","University of Health Sciences Turkey, Sultan 2. Abdulhamid Han Training and Research Hospital, Department of Medical Biochemistry, Istanbul, Turkey",NA
"236","34251730","10.1111/ijcp.14624","Assessment of severity and mortality of COVID-19 with anti-A1 and B IgM isohemagglutinins, a reflection of the innate immune status.","The relationship between the innate immune system that creates the polysaccharide antibody response and COVID-19 is not fully understood. In this study, it was aimed to determine the predictive values of isohemagglutinins in COVID-19 severity/mortality. Approximately 15440 patients diagnosed with COVID-19 were examined, and a total of 286 patients with anti-B and anti-A1 IgM isohemagglutinins test results were randomly enrolled in the study. These patients were stratified into two groups accordi","2021","07","12","Int J Clin Pract","International journal of clinical practice","COVID-19; anti-A1 IgM; anti-B IgM; isohemagglutinins; mortality","Tanoglu","Alpaslan","University of Health Sciences Turkey, Sancaktepe Sehit Prof Dr Ilhan Varank Training and Research Hospital, Department of Gastroenterology, Istanbul, Turkey",NA
"237","34251730","10.1111/ijcp.14624","Assessment of severity and mortality of COVID-19 with anti-A1 and B IgM isohemagglutinins, a reflection of the innate immune status.","The relationship between the innate immune system that creates the polysaccharide antibody response and COVID-19 is not fully understood. In this study, it was aimed to determine the predictive values of isohemagglutinins in COVID-19 severity/mortality. Approximately 15440 patients diagnosed with COVID-19 were examined, and a total of 286 patients with anti-B and anti-A1 IgM isohemagglutinins test results were randomly enrolled in the study. These patients were stratified into two groups accordi","2021","07","12","Int J Clin Pract","International journal of clinical practice","COVID-19; anti-A1 IgM; anti-B IgM; isohemagglutinins; mortality","Guven","Bulent Baris","University of Health Sciences Turkey, Sultan 2. Abdulhamid Han Training and Research Hospital, Department of Anesthesia and Reanimation, Istanbul, Turkey",NA
"238","34251730","10.1111/ijcp.14624","Assessment of severity and mortality of COVID-19 with anti-A1 and B IgM isohemagglutinins, a reflection of the innate immune status.","The relationship between the innate immune system that creates the polysaccharide antibody response and COVID-19 is not fully understood. In this study, it was aimed to determine the predictive values of isohemagglutinins in COVID-19 severity/mortality. Approximately 15440 patients diagnosed with COVID-19 were examined, and a total of 286 patients with anti-B and anti-A1 IgM isohemagglutinins test results were randomly enrolled in the study. These patients were stratified into two groups accordi","2021","07","12","Int J Clin Pract","International journal of clinical practice","COVID-19; anti-A1 IgM; anti-B IgM; isohemagglutinins; mortality","Keskin","Umran","University of Health Sciences Turkey, Haydarpasa Numune Training and Research Hospital, Department of Internal Medicine, Istanbul, Turkey",NA
"239","34251730","10.1111/ijcp.14624","Assessment of severity and mortality of COVID-19 with anti-A1 and B IgM isohemagglutinins, a reflection of the innate immune status.","The relationship between the innate immune system that creates the polysaccharide antibody response and COVID-19 is not fully understood. In this study, it was aimed to determine the predictive values of isohemagglutinins in COVID-19 severity/mortality. Approximately 15440 patients diagnosed with COVID-19 were examined, and a total of 286 patients with anti-B and anti-A1 IgM isohemagglutinins test results were randomly enrolled in the study. These patients were stratified into two groups accordi","2021","07","12","Int J Clin Pract","International journal of clinical practice","COVID-19; anti-A1 IgM; anti-B IgM; isohemagglutinins; mortality","Kaplan","Mustafa","University of Health Sciences Turkey, Sultan 2. Abdulhamid Han Training and Research Hospital, Department of Internal Medicine, Istanbul, Turkey",NA
"240","34251685","10.1111/anae.15540","Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study.",NA,"2021","07","12","Anaesthesia","Anaesthesia",NA,"Lobo","D","Groupe hospitalier Diaconesses, Croix Saint-Simon, Paris, France",NA
"241","34251685","10.1111/anae.15540","Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study.",NA,"2021","07","12","Anaesthesia","Anaesthesia",NA,"Devys","J M","Groupe hospitalier Diaconesses, Croix Saint-Simon, Paris, France",NA
"242","34251683","10.1002/jmv.27192","Relapse of microscopic polyangiitis after vaccination against COVID-19: A case report.",NA,"2021","07","21","J Med Virol","Journal of medical virology",NA,"Conticini","Edoardo","Department of Medicine, Surgery, and Neurosciences, Rheumatology Unit, University of Siena, Siena, Italy",NA
"243","34251683","10.1002/jmv.27192","Relapse of microscopic polyangiitis after vaccination against COVID-19: A case report.",NA,"2021","07","21","J Med Virol","Journal of medical virology",NA,"d'Alessandro","Miriana","Department of Medicine, Surgery, and Neurosciences, Respiratory Diseases and Lung Transplantation Unit, University of Siena, Siena, Italy",NA
"244","34251683","10.1002/jmv.27192","Relapse of microscopic polyangiitis after vaccination against COVID-19: A case report.",NA,"2021","07","21","J Med Virol","Journal of medical virology",NA,"Bergantini","Laura","Department of Medicine, Surgery, and Neurosciences, Respiratory Diseases and Lung Transplantation Unit, University of Siena, Siena, Italy",NA
"245","34251683","10.1002/jmv.27192","Relapse of microscopic polyangiitis after vaccination against COVID-19: A case report.",NA,"2021","07","21","J Med Virol","Journal of medical virology",NA,"Bargagli","Elena","Department of Medicine, Surgery, and Neurosciences, Respiratory Diseases and Lung Transplantation Unit, University of Siena, Siena, Italy",NA
"246","34251683","10.1002/jmv.27192","Relapse of microscopic polyangiitis after vaccination against COVID-19: A case report.",NA,"2021","07","21","J Med Virol","Journal of medical virology",NA,"Gentili","Francesco","Department of Radiological Sciences, Diagnostic Imaging Unit, Azienda Ospedaliero-Universitaria Senese, Siena, Italy",NA
"247","34251683","10.1002/jmv.27192","Relapse of microscopic polyangiitis after vaccination against COVID-19: A case report.",NA,"2021","07","21","J Med Virol","Journal of medical virology",NA,"Mazzei","Maria Antonietta","Department of Radiological Sciences, Diagnostic Imaging Unit, Azienda Ospedaliero-Universitaria Senese, Siena, Italy",NA
"248","34251683","10.1002/jmv.27192","Relapse of microscopic polyangiitis after vaccination against COVID-19: A case report.",NA,"2021","07","21","J Med Virol","Journal of medical virology",NA,"Cantarini","Luca","Department of Medicine, Surgery, and Neurosciences, Rheumatology Unit, University of Siena, Siena, Italy",NA
"249","34251683","10.1002/jmv.27192","Relapse of microscopic polyangiitis after vaccination against COVID-19: A case report.",NA,"2021","07","21","J Med Virol","Journal of medical virology",NA,"Frediani","Bruno","Department of Medicine, Surgery, and Neurosciences, Rheumatology Unit, University of Siena, Siena, Italy",NA
"250","34251655","10.1007/s40121-021-00478-8","COVID-19: Zinc and Angiotensin-Converting Enzyme 2 (ACE2) Deficiencies as Determinants of Risk and Severity of Disease: A Narrative Review.","A growing body of evidence supports the premise that deficiencies of zinc and angiotensin-converting enzyme 2 (ACE2, a zinc enzyme) determine severity of coronavirus disease 2019 (COVID-19). ACE2 is part of the renin-angiotensin system (RAS) and acts as a feedback control system moderating blood pressure, keeping blood pressure within normal limits. For a virus to infect a person, the virus has to get inside the person's cells. The virus that causes COVID-19 uses ACE2 to get into the cell. Think","2021","07","15","Infect Dis Ther","Infectious diseases and therapy","Angiotensin-converting enzyme 2 (ACE2); COVID-19; Future treatments; Narrative review; Pathophysiology; Reninangiotensin system (RAS); SARS-CoV-2; Zinc; Zinc deficiency","Salgo","Miklos P",", Hillsborough, CA, USA. miklossalgo@aol","miklossalgo@aol.com"
"251","34251647","10.1007/s13679-021-00449-7","COVID-19 Self-quarantine and Weight Gain Risk Factors in Adults.","The COVID-19 pandemic is associated with weight gain in certain individuals. This review highlights the risk factors for weight gain during COVID-19 self-quarantine in adults. Among those who have gained weight during COVID-19 self-quarantine, self-reported body weight has increased between .5 and 1.8 kg (± 2.8 kg) after just 2 months of quarantine. Identified risk factors for weight gain during COVID-19 self-quarantine are the following: increased sedentary behaviors, decreased physical activit","2021","07","15","Curr Obes Rep","Current obesity reports","COVID-19; Pandemic; Self-quarantine; Weight gain","Zeigler","Zachary","College of Science Engineering and Technology, Grand Canyon University, 19013 W Solano Dr. Litchfield Park, Phoenix, AZ, 85340, USA. Zachary.zeigler@gcu","Zachary.zeigler@gcu.edu"
"252","34251644","10.1007/978-3-030-74180-8_10","Role of L-Arginine in Nitric Oxide Synthesis and Health in Humans.","As a functional amino acid (AA), L-arginine (Arg) serves not only as a building block of protein but also as an essential substrate for the synthesis of nitric oxide (NO), creatine, polyamines, homoarginine, and agmatine in mammals (including humans). NO (a major vasodilator) increases blood flow to tissues. Arg and its metabolites play important roles in metabolism and physiology. Arg is required to maintain the urea cycle in the active state to detoxify ammonia. This AA also activates cellular","2021","07","14","Adv Exp Med Biol","Advances in experimental medicine and biology","Arginine; Blood flow; Disease; Health; Metabolism; Nitric oxide; Skeletal muscle; Animals; Arginine; COVID-19; Female; Humans; Male; Nitric Oxide; Pregnancy; Protein Biosynthesis; SARS-CoV-2","Wu","Guoyao","Departments of Animal Science, Texas A&amp",NA
"253","34251644","10.1007/978-3-030-74180-8_10","Role of L-Arginine in Nitric Oxide Synthesis and Health in Humans.","As a functional amino acid (AA), L-arginine (Arg) serves not only as a building block of protein but also as an essential substrate for the synthesis of nitric oxide (NO), creatine, polyamines, homoarginine, and agmatine in mammals (including humans). NO (a major vasodilator) increases blood flow to tissues. Arg and its metabolites play important roles in metabolism and physiology. Arg is required to maintain the urea cycle in the active state to detoxify ammonia. This AA also activates cellular","2021","07","14","Adv Exp Med Biol","Advances in experimental medicine and biology","Arginine; Blood flow; Disease; Health; Metabolism; Nitric oxide; Skeletal muscle; Animals; Arginine; COVID-19; Female; Humans; Male; Nitric Oxide; Pregnancy; Protein Biosynthesis; SARS-CoV-2","Meininger","Cynthia J","Medical Physiology, Texas A&amp",NA
"254","34251644","10.1007/978-3-030-74180-8_10","Role of L-Arginine in Nitric Oxide Synthesis and Health in Humans.","As a functional amino acid (AA), L-arginine (Arg) serves not only as a building block of protein but also as an essential substrate for the synthesis of nitric oxide (NO), creatine, polyamines, homoarginine, and agmatine in mammals (including humans). NO (a major vasodilator) increases blood flow to tissues. Arg and its metabolites play important roles in metabolism and physiology. Arg is required to maintain the urea cycle in the active state to detoxify ammonia. This AA also activates cellular","2021","07","14","Adv Exp Med Biol","Advances in experimental medicine and biology","Arginine; Blood flow; Disease; Health; Metabolism; Nitric oxide; Skeletal muscle; Animals; Arginine; COVID-19; Female; Humans; Male; Nitric Oxide; Pregnancy; Protein Biosynthesis; SARS-CoV-2","McNeal","Catherine J","Department of Internal Medicine, Baylor Scott &amp",NA
"255","34251644","10.1007/978-3-030-74180-8_10","Role of L-Arginine in Nitric Oxide Synthesis and Health in Humans.","As a functional amino acid (AA), L-arginine (Arg) serves not only as a building block of protein but also as an essential substrate for the synthesis of nitric oxide (NO), creatine, polyamines, homoarginine, and agmatine in mammals (including humans). NO (a major vasodilator) increases blood flow to tissues. Arg and its metabolites play important roles in metabolism and physiology. Arg is required to maintain the urea cycle in the active state to detoxify ammonia. This AA also activates cellular","2021","07","14","Adv Exp Med Biol","Advances in experimental medicine and biology","Arginine; Blood flow; Disease; Health; Metabolism; Nitric oxide; Skeletal muscle; Animals; Arginine; COVID-19; Female; Humans; Male; Nitric Oxide; Pregnancy; Protein Biosynthesis; SARS-CoV-2","Bazer","Fuller W","Departments of Animal Science, Texas A&amp",NA
"256","34251644","10.1007/978-3-030-74180-8_10","Role of L-Arginine in Nitric Oxide Synthesis and Health in Humans.","As a functional amino acid (AA), L-arginine (Arg) serves not only as a building block of protein but also as an essential substrate for the synthesis of nitric oxide (NO), creatine, polyamines, homoarginine, and agmatine in mammals (including humans). NO (a major vasodilator) increases blood flow to tissues. Arg and its metabolites play important roles in metabolism and physiology. Arg is required to maintain the urea cycle in the active state to detoxify ammonia. This AA also activates cellular","2021","07","14","Adv Exp Med Biol","Advances in experimental medicine and biology","Arginine; Blood flow; Disease; Health; Metabolism; Nitric oxide; Skeletal muscle; Animals; Arginine; COVID-19; Female; Humans; Male; Nitric Oxide; Pregnancy; Protein Biosynthesis; SARS-CoV-2","Rhoads","J Marc","Department of Pediatrics and Division of Gastroenterology, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, 77030, USA",NA
"257","34251600","10.1007/s12574-021-00537-6","A simple complementary approach to reduce risk of contamination with COVID-19 during transesophageal echocardiography.",NA,"2021","07","15","J Echocardiogr","Journal of echocardiography",NA,"Behjati","Mohaddeseh","Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Valiasr Ave Niayesh Intersection, Tehran, Iran. behjatimohaddeseh@gmail","behjatimohaddeseh@gmail.com"
"258","34251592","10.1007/s11262-021-01860-x","Temporal landscape of mutational frequencies in SARS-CoV-2 genomes of Bangladesh: possible implications from the ongoing outbreak in Bangladesh.","Along with intrinsic evolution, adaptation to selective pressure in new environments might have resulted in the circulatory SARS-CoV-2 strains in response to the geoenvironmental conditions of a country and the demographic profile of its population. With this target, the current study traced the evolutionary route and mutational frequency of 198 Bangladesh-originated SARS-CoV-2 genomic sequences available in the GISAID platform over a period of 13 weeks as of 14 July 2020. The analyses were perf","2021","07","15","Virus Genes","Virus genes","Bangladesh; Frequency; Molecular phylogeny; Mutation; Protein structure; SARS-CoV-2","Saha","Otun","Department of Microbiology, University of Dhaka, Dhaka, 1000, Bangladesh",NA
"259","34251592","10.1007/s11262-021-01860-x","Temporal landscape of mutational frequencies in SARS-CoV-2 genomes of Bangladesh: possible implications from the ongoing outbreak in Bangladesh.","Along with intrinsic evolution, adaptation to selective pressure in new environments might have resulted in the circulatory SARS-CoV-2 strains in response to the geoenvironmental conditions of a country and the demographic profile of its population. With this target, the current study traced the evolutionary route and mutational frequency of 198 Bangladesh-originated SARS-CoV-2 genomic sequences available in the GISAID platform over a period of 13 weeks as of 14 July 2020. The analyses were perf","2021","07","15","Virus Genes","Virus genes","Bangladesh; Frequency; Molecular phylogeny; Mutation; Protein structure; SARS-CoV-2","Islam","Israt","Department of Microbiology, University of Dhaka, Dhaka, 1000, Bangladesh",NA
"260","34251592","10.1007/s11262-021-01860-x","Temporal landscape of mutational frequencies in SARS-CoV-2 genomes of Bangladesh: possible implications from the ongoing outbreak in Bangladesh.","Along with intrinsic evolution, adaptation to selective pressure in new environments might have resulted in the circulatory SARS-CoV-2 strains in response to the geoenvironmental conditions of a country and the demographic profile of its population. With this target, the current study traced the evolutionary route and mutational frequency of 198 Bangladesh-originated SARS-CoV-2 genomic sequences available in the GISAID platform over a period of 13 weeks as of 14 July 2020. The analyses were perf","2021","07","15","Virus Genes","Virus genes","Bangladesh; Frequency; Molecular phylogeny; Mutation; Protein structure; SARS-CoV-2","Shatadru","Rokaiya Nurani","Department of Microbiology, University of Dhaka, Dhaka, 1000, Bangladesh",NA
"261","34251592","10.1007/s11262-021-01860-x","Temporal landscape of mutational frequencies in SARS-CoV-2 genomes of Bangladesh: possible implications from the ongoing outbreak in Bangladesh.","Along with intrinsic evolution, adaptation to selective pressure in new environments might have resulted in the circulatory SARS-CoV-2 strains in response to the geoenvironmental conditions of a country and the demographic profile of its population. With this target, the current study traced the evolutionary route and mutational frequency of 198 Bangladesh-originated SARS-CoV-2 genomic sequences available in the GISAID platform over a period of 13 weeks as of 14 July 2020. The analyses were perf","2021","07","15","Virus Genes","Virus genes","Bangladesh; Frequency; Molecular phylogeny; Mutation; Protein structure; SARS-CoV-2","Rakhi","Nadira Naznin","Department of Microbiology, University of Dhaka, Dhaka, 1000, Bangladesh",NA
"262","34251592","10.1007/s11262-021-01860-x","Temporal landscape of mutational frequencies in SARS-CoV-2 genomes of Bangladesh: possible implications from the ongoing outbreak in Bangladesh.","Along with intrinsic evolution, adaptation to selective pressure in new environments might have resulted in the circulatory SARS-CoV-2 strains in response to the geoenvironmental conditions of a country and the demographic profile of its population. With this target, the current study traced the evolutionary route and mutational frequency of 198 Bangladesh-originated SARS-CoV-2 genomic sequences available in the GISAID platform over a period of 13 weeks as of 14 July 2020. The analyses were perf","2021","07","15","Virus Genes","Virus genes","Bangladesh; Frequency; Molecular phylogeny; Mutation; Protein structure; SARS-CoV-2","Hossain","Md Shahadat","Department of Biotechnology and Genetic Engineering, Noakhali Science and Technology University, Noakhali, 3814, Bangladesh",NA
"263","34251592","10.1007/s11262-021-01860-x","Temporal landscape of mutational frequencies in SARS-CoV-2 genomes of Bangladesh: possible implications from the ongoing outbreak in Bangladesh.","Along with intrinsic evolution, adaptation to selective pressure in new environments might have resulted in the circulatory SARS-CoV-2 strains in response to the geoenvironmental conditions of a country and the demographic profile of its population. With this target, the current study traced the evolutionary route and mutational frequency of 198 Bangladesh-originated SARS-CoV-2 genomic sequences available in the GISAID platform over a period of 13 weeks as of 14 July 2020. The analyses were perf","2021","07","15","Virus Genes","Virus genes","Bangladesh; Frequency; Molecular phylogeny; Mutation; Protein structure; SARS-CoV-2","Rahaman","Md Mizanur","Department of Microbiology, University of Dhaka, Dhaka, 1000, Bangladesh. razu002@du.ac","razu002@du.ac.bd"
"264","34251585","10.1007/s11547-021-01390-4","Cross-sectional analysis of follow-up chest MRI and chest CT scans in patients previously affected by COVID-19.","The aim of the study was to prospectively evaluate the agreement between chest magnetic resonance imaging (MRI) and computed tomography (CT) and to assess the diagnostic performance of chest MRI relative to that of CT during the follow-up of patients recovered from coronavirus disease 2019. Fifty-two patients underwent both follow-up chest CT and MRI scans, evaluated for ground-glass opacities (GGOs), consolidation, interlobular septal thickening, fibrosis, pleural indentation, vessel enlargemen","2021","07","15","Radiol Med","La Radiologia medica","COVID-19; Chest computerized tomography; Chest magnetic resonance imaging; Pneumonia","Pecoraro","Martina","Department of Radiological Sciences, Oncology and Pathology, Sapienza/Policlinico Umberto I, Viale Regina Elena 324, 00161, Rome, Italy",NA
"265","34251585","10.1007/s11547-021-01390-4","Cross-sectional analysis of follow-up chest MRI and chest CT scans in patients previously affected by COVID-19.","The aim of the study was to prospectively evaluate the agreement between chest magnetic resonance imaging (MRI) and computed tomography (CT) and to assess the diagnostic performance of chest MRI relative to that of CT during the follow-up of patients recovered from coronavirus disease 2019. Fifty-two patients underwent both follow-up chest CT and MRI scans, evaluated for ground-glass opacities (GGOs), consolidation, interlobular septal thickening, fibrosis, pleural indentation, vessel enlargemen","2021","07","15","Radiol Med","La Radiologia medica","COVID-19; Chest computerized tomography; Chest magnetic resonance imaging; Pneumonia","Cipollari","Stefano","Department of Radiological Sciences, Oncology and Pathology, Sapienza/Policlinico Umberto I, Viale Regina Elena 324, 00161, Rome, Italy",NA
"266","34251585","10.1007/s11547-021-01390-4","Cross-sectional analysis of follow-up chest MRI and chest CT scans in patients previously affected by COVID-19.","The aim of the study was to prospectively evaluate the agreement between chest magnetic resonance imaging (MRI) and computed tomography (CT) and to assess the diagnostic performance of chest MRI relative to that of CT during the follow-up of patients recovered from coronavirus disease 2019. Fifty-two patients underwent both follow-up chest CT and MRI scans, evaluated for ground-glass opacities (GGOs), consolidation, interlobular septal thickening, fibrosis, pleural indentation, vessel enlargemen","2021","07","15","Radiol Med","La Radiologia medica","COVID-19; Chest computerized tomography; Chest magnetic resonance imaging; Pneumonia","Marchitelli","Livia","Department of Radiological Sciences, Oncology and Pathology, Sapienza/Policlinico Umberto I, Viale Regina Elena 324, 00161, Rome, Italy",NA
"267","34251585","10.1007/s11547-021-01390-4","Cross-sectional analysis of follow-up chest MRI and chest CT scans in patients previously affected by COVID-19.","The aim of the study was to prospectively evaluate the agreement between chest magnetic resonance imaging (MRI) and computed tomography (CT) and to assess the diagnostic performance of chest MRI relative to that of CT during the follow-up of patients recovered from coronavirus disease 2019. Fifty-two patients underwent both follow-up chest CT and MRI scans, evaluated for ground-glass opacities (GGOs), consolidation, interlobular septal thickening, fibrosis, pleural indentation, vessel enlargemen","2021","07","15","Radiol Med","La Radiologia medica","COVID-19; Chest computerized tomography; Chest magnetic resonance imaging; Pneumonia","Messina","Emanuele","Department of Radiological Sciences, Oncology and Pathology, Sapienza/Policlinico Umberto I, Viale Regina Elena 324, 00161, Rome, Italy",NA
"268","34251585","10.1007/s11547-021-01390-4","Cross-sectional analysis of follow-up chest MRI and chest CT scans in patients previously affected by COVID-19.","The aim of the study was to prospectively evaluate the agreement between chest magnetic resonance imaging (MRI) and computed tomography (CT) and to assess the diagnostic performance of chest MRI relative to that of CT during the follow-up of patients recovered from coronavirus disease 2019. Fifty-two patients underwent both follow-up chest CT and MRI scans, evaluated for ground-glass opacities (GGOs), consolidation, interlobular septal thickening, fibrosis, pleural indentation, vessel enlargemen","2021","07","15","Radiol Med","La Radiologia medica","COVID-19; Chest computerized tomography; Chest magnetic resonance imaging; Pneumonia","Del Monte","Maurizio","Department of Radiological Sciences, Oncology and Pathology, Sapienza/Policlinico Umberto I, Viale Regina Elena 324, 00161, Rome, Italy",NA
"269","34251585","10.1007/s11547-021-01390-4","Cross-sectional analysis of follow-up chest MRI and chest CT scans in patients previously affected by COVID-19.","The aim of the study was to prospectively evaluate the agreement between chest magnetic resonance imaging (MRI) and computed tomography (CT) and to assess the diagnostic performance of chest MRI relative to that of CT during the follow-up of patients recovered from coronavirus disease 2019. Fifty-two patients underwent both follow-up chest CT and MRI scans, evaluated for ground-glass opacities (GGOs), consolidation, interlobular septal thickening, fibrosis, pleural indentation, vessel enlargemen","2021","07","15","Radiol Med","La Radiologia medica","COVID-19; Chest computerized tomography; Chest magnetic resonance imaging; Pneumonia","Galea","Nicola","Department of Radiological Sciences, Oncology and Pathology, Sapienza/Policlinico Umberto I, Viale Regina Elena 324, 00161, Rome, Italy",NA
"270","34251585","10.1007/s11547-021-01390-4","Cross-sectional analysis of follow-up chest MRI and chest CT scans in patients previously affected by COVID-19.","The aim of the study was to prospectively evaluate the agreement between chest magnetic resonance imaging (MRI) and computed tomography (CT) and to assess the diagnostic performance of chest MRI relative to that of CT during the follow-up of patients recovered from coronavirus disease 2019. Fifty-two patients underwent both follow-up chest CT and MRI scans, evaluated for ground-glass opacities (GGOs), consolidation, interlobular septal thickening, fibrosis, pleural indentation, vessel enlargemen","2021","07","15","Radiol Med","La Radiologia medica","COVID-19; Chest computerized tomography; Chest magnetic resonance imaging; Pneumonia","Ciardi","Maria Rosa","Department of Public Health and Infectious Disease, Sapienza/Policlinico Umberto I, Viale Regina Elena 324, 00161, Rome, Italy",NA
"271","34251585","10.1007/s11547-021-01390-4","Cross-sectional analysis of follow-up chest MRI and chest CT scans in patients previously affected by COVID-19.","The aim of the study was to prospectively evaluate the agreement between chest magnetic resonance imaging (MRI) and computed tomography (CT) and to assess the diagnostic performance of chest MRI relative to that of CT during the follow-up of patients recovered from coronavirus disease 2019. Fifty-two patients underwent both follow-up chest CT and MRI scans, evaluated for ground-glass opacities (GGOs), consolidation, interlobular septal thickening, fibrosis, pleural indentation, vessel enlargemen","2021","07","15","Radiol Med","La Radiologia medica","COVID-19; Chest computerized tomography; Chest magnetic resonance imaging; Pneumonia","Francone","Marco","Department of Radiological Sciences, Oncology and Pathology, Sapienza/Policlinico Umberto I, Viale Regina Elena 324, 00161, Rome, Italy",NA
"272","34251585","10.1007/s11547-021-01390-4","Cross-sectional analysis of follow-up chest MRI and chest CT scans in patients previously affected by COVID-19.","The aim of the study was to prospectively evaluate the agreement between chest magnetic resonance imaging (MRI) and computed tomography (CT) and to assess the diagnostic performance of chest MRI relative to that of CT during the follow-up of patients recovered from coronavirus disease 2019. Fifty-two patients underwent both follow-up chest CT and MRI scans, evaluated for ground-glass opacities (GGOs), consolidation, interlobular septal thickening, fibrosis, pleural indentation, vessel enlargemen","2021","07","15","Radiol Med","La Radiologia medica","COVID-19; Chest computerized tomography; Chest magnetic resonance imaging; Pneumonia","Catalano","Carlo","Department of Radiological Sciences, Oncology and Pathology, Sapienza/Policlinico Umberto I, Viale Regina Elena 324, 00161, Rome, Italy",NA
"273","34251585","10.1007/s11547-021-01390-4","Cross-sectional analysis of follow-up chest MRI and chest CT scans in patients previously affected by COVID-19.","The aim of the study was to prospectively evaluate the agreement between chest magnetic resonance imaging (MRI) and computed tomography (CT) and to assess the diagnostic performance of chest MRI relative to that of CT during the follow-up of patients recovered from coronavirus disease 2019. Fifty-two patients underwent both follow-up chest CT and MRI scans, evaluated for ground-glass opacities (GGOs), consolidation, interlobular septal thickening, fibrosis, pleural indentation, vessel enlargemen","2021","07","15","Radiol Med","La Radiologia medica","COVID-19; Chest computerized tomography; Chest magnetic resonance imaging; Pneumonia","Panebianco","Valeria","Department of Radiological Sciences, Oncology and Pathology, Sapienza/Policlinico Umberto I, Viale Regina Elena 324, 00161, Rome, Italy. valeria.panebianco@uniroma1","valeria.panebianco@uniroma1.it"
"274","34251568","10.1007/s00535-021-01807-x","Reply to: ""COVID-19-associated liver injury (COVALI): role of hepatologists"".",NA,"2021","07","15","J Gastroenterol","Journal of gastroenterology","COVID-19; Chronic liver disease; Liver injury; Liver transplant; SARS-CoV-2","Li","Dongxiao","Department of Gastroenterology, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou, 450004, Henan, China",NA
"275","34251568","10.1007/s00535-021-01807-x","Reply to: ""COVID-19-associated liver injury (COVALI): role of hepatologists"".",NA,"2021","07","15","J Gastroenterol","Journal of gastroenterology","COVID-19; Chronic liver disease; Liver injury; Liver transplant; SARS-CoV-2","Ding","Xiangming","Department of Gastroenterology, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou, 450004, Henan, China",NA
"276","34251568","10.1007/s00535-021-01807-x","Reply to: ""COVID-19-associated liver injury (COVALI): role of hepatologists"".",NA,"2021","07","15","J Gastroenterol","Journal of gastroenterology","COVID-19; Chronic liver disease; Liver injury; Liver transplant; SARS-CoV-2","Tian","Dean","Department of Gastroenterology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, Hubei, China",NA
"277","34251568","10.1007/s00535-021-01807-x","Reply to: ""COVID-19-associated liver injury (COVALI): role of hepatologists"".",NA,"2021","07","15","J Gastroenterol","Journal of gastroenterology","COVID-19; Chronic liver disease; Liver injury; Liver transplant; SARS-CoV-2","Xia","Limin","Department of Gastroenterology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, Hubei, China. xialimin@tjh.tjmu.edu","xialimin@tjh.tjmu.edu.cn"
"278","34251565","10.1007/s10730-021-09455-7","COVID-19 and the Authority of Science.","In an attempt to respond effectively to the COVID-19 pandemic, policy makers and scientific experts who advise them have aspired to present a unified front. Leveraging the authority of science, they have at times portrayed politically favored COVID interventions, such as lockdowns, as strongly grounded in scientific evidence-even to the point of claiming that enacting such interventions is simply a matter of ""following the science."" Strictly speaking, all such claims are false, since facts alone","2021","07","15","HEC Forum","HEC forum : an interdisciplinary journal on hospitals' ethical and legal issues","COVID-19; Consensus; Coronavirus; Media bias; Moral authority; Mortality rate; Science; Scientific authority; Scientific method","Trotter","Griffin","Emeritus Professor, Saint Louis University, 1234 Eagle Crest Drive, Oak Harbor, WA, 98277, USA. griffin.trotter@gmail","griffin.trotter@gmail.com"
"279","34251560","10.1007/s11259-021-09808-0","Porcine enteric coronaviruses: an updated overview of the pathogenesis, prevalence, and diagnosis.","The recent prevalence of coronavirus (CoV) poses a serious threat to animal and human health. Currently, porcine enteric coronaviruses (PECs), including the transmissible gastroenteritis virus (TGEV), the novel emerging swine acute diarrhoea syndrome coronavirus (SADS-CoV), porcine delta coronavirus (PDCoV), and re-emerging porcine epidemic diarrhoea virus (PEDV), which infect pigs of different ages, have caused more frequent occurrences of diarrhoea, vomiting, and dehydration with high morbidit","2021","07","15","Vet Res Commun","Veterinary research communications","Porcine delta coronavirus; Porcine enteric coronavirus; Porcine epidemic diarrhoea virus; Swine acute diarrhoea syndrome coronavirus; Transmissible gastroenteritis virus","Liu","Qiang","Nanchong Key Laboratory of Disease Prevention, Control and Detection in Livestock and Poultry, Nanchong Vocational and Technical College, Nanchong, 637131, China. liuqiang_yyy@163","yyy@163.com"
"280","34251560","10.1007/s11259-021-09808-0","Porcine enteric coronaviruses: an updated overview of the pathogenesis, prevalence, and diagnosis.","The recent prevalence of coronavirus (CoV) poses a serious threat to animal and human health. Currently, porcine enteric coronaviruses (PECs), including the transmissible gastroenteritis virus (TGEV), the novel emerging swine acute diarrhoea syndrome coronavirus (SADS-CoV), porcine delta coronavirus (PDCoV), and re-emerging porcine epidemic diarrhoea virus (PEDV), which infect pigs of different ages, have caused more frequent occurrences of diarrhoea, vomiting, and dehydration with high morbidit","2021","07","15","Vet Res Commun","Veterinary research communications","Porcine delta coronavirus; Porcine enteric coronavirus; Porcine epidemic diarrhoea virus; Swine acute diarrhoea syndrome coronavirus; Transmissible gastroenteritis virus","Wang","Huai-Yu","Nanchong Key Laboratory of Disease Prevention, Control and Detection in Livestock and Poultry, Nanchong Vocational and Technical College, Nanchong, 637131, China",NA
"281","34251551","10.1007/s10554-021-02340-x","Long term effects of mild severity COVID-19 on right ventricular functions.","Coronavirus disease 2019 (COVID-19) is a newly recognized infectious disease that has spread rapidly. COVID-19 has been associated with a number of cardiovascular involvements, including ventricular functions. The aim of our study was to evaluate the right ventricular functions of mild severity COVID-19 patients 3 months after, and compare them to the right ventricular functions of healthy volunteers. For this single-center study, data from 105 patients who were treated for mild severity COVID-1","2021","07","15","Int J Cardiovasc Imaging","The international journal of cardiovascular imaging","Coronavirus disease 2019; Right ventricular function; Speckle tracking echocardiography","Akkaya","Fatih","Department of Cardiology, Ordu University, Ordu, Turkey",NA
"282","34251551","10.1007/s10554-021-02340-x","Long term effects of mild severity COVID-19 on right ventricular functions.","Coronavirus disease 2019 (COVID-19) is a newly recognized infectious disease that has spread rapidly. COVID-19 has been associated with a number of cardiovascular involvements, including ventricular functions. The aim of our study was to evaluate the right ventricular functions of mild severity COVID-19 patients 3 months after, and compare them to the right ventricular functions of healthy volunteers. For this single-center study, data from 105 patients who were treated for mild severity COVID-1","2021","07","15","Int J Cardiovasc Imaging","The international journal of cardiovascular imaging","Coronavirus disease 2019; Right ventricular function; Speckle tracking echocardiography","Yenerçag","Feyza Nur Topçu","Provincial Health Directorate, Ordu, Turkey",NA
"283","34251551","10.1007/s10554-021-02340-x","Long term effects of mild severity COVID-19 on right ventricular functions.","Coronavirus disease 2019 (COVID-19) is a newly recognized infectious disease that has spread rapidly. COVID-19 has been associated with a number of cardiovascular involvements, including ventricular functions. The aim of our study was to evaluate the right ventricular functions of mild severity COVID-19 patients 3 months after, and compare them to the right ventricular functions of healthy volunteers. For this single-center study, data from 105 patients who were treated for mild severity COVID-1","2021","07","15","Int J Cardiovasc Imaging","The international journal of cardiovascular imaging","Coronavirus disease 2019; Right ventricular function; Speckle tracking echocardiography","Kaya","Ahmet","Department of Cardiology, Ordu University, Ordu, Turkey",NA
"284","34251551","10.1007/s10554-021-02340-x","Long term effects of mild severity COVID-19 on right ventricular functions.","Coronavirus disease 2019 (COVID-19) is a newly recognized infectious disease that has spread rapidly. COVID-19 has been associated with a number of cardiovascular involvements, including ventricular functions. The aim of our study was to evaluate the right ventricular functions of mild severity COVID-19 patients 3 months after, and compare them to the right ventricular functions of healthy volunteers. For this single-center study, data from 105 patients who were treated for mild severity COVID-1","2021","07","15","Int J Cardiovasc Imaging","The international journal of cardiovascular imaging","Coronavirus disease 2019; Right ventricular function; Speckle tracking echocardiography","Sener","Yusuf Ziya","Department of Cardiology, Beypazari State Hospital, Ankara, Turkey. yzsener@yahoo.com","yzsener@yahoo.com.tr"
"285","34251551","10.1007/s10554-021-02340-x","Long term effects of mild severity COVID-19 on right ventricular functions.","Coronavirus disease 2019 (COVID-19) is a newly recognized infectious disease that has spread rapidly. COVID-19 has been associated with a number of cardiovascular involvements, including ventricular functions. The aim of our study was to evaluate the right ventricular functions of mild severity COVID-19 patients 3 months after, and compare them to the right ventricular functions of healthy volunteers. For this single-center study, data from 105 patients who were treated for mild severity COVID-1","2021","07","15","Int J Cardiovasc Imaging","The international journal of cardiovascular imaging","Coronavirus disease 2019; Right ventricular function; Speckle tracking echocardiography","Bagci","Ali","Department of Cardiology, Suleyman Demirel University, Isparta, Turkey",NA
"286","34251549","10.1007/s00705-021-05149-0","ddPCR increases detection of SARS-CoV-2 RNA in patients with low viral loads.","RT-qPCR detection of SARS-CoV-2 RNA still represents the method of reference to diagnose and monitor COVID-19. From the onset of the pandemic, however, doubts have been expressed concerning the sensitivity of this molecular diagnosis method. Droplet digital PCR (ddPCR) is a third-generation PCR technique that is particularly adapted to detecting low-abundance targets. We developed two-color ddPCR assays for the detection of four different regions of SARS-CoV-2 RNA, including non-structural (IP4-","2021","07","15","Arch Virol","Archives of virology",NA,"Marchio","Agnès","Unité ""Organisation nucléaire et Oncogenèse"", INSERM U993, Institut Pasteur, 28, rue du Docteur Roux, 75724, Paris, Cedex 15, France. agnes.marchio@pasteur","agnes.marchio@pasteur.fr"
"287","34251549","10.1007/s00705-021-05149-0","ddPCR increases detection of SARS-CoV-2 RNA in patients with low viral loads.","RT-qPCR detection of SARS-CoV-2 RNA still represents the method of reference to diagnose and monitor COVID-19. From the onset of the pandemic, however, doubts have been expressed concerning the sensitivity of this molecular diagnosis method. Droplet digital PCR (ddPCR) is a third-generation PCR technique that is particularly adapted to detecting low-abundance targets. We developed two-color ddPCR assays for the detection of four different regions of SARS-CoV-2 RNA, including non-structural (IP4-","2021","07","15","Arch Virol","Archives of virology",NA,"Batejat","Christophe","Cellule d'Intervention Biologique d'Urgence, Institut Pasteur, Paris, France",NA
"288","34251549","10.1007/s00705-021-05149-0","ddPCR increases detection of SARS-CoV-2 RNA in patients with low viral loads.","RT-qPCR detection of SARS-CoV-2 RNA still represents the method of reference to diagnose and monitor COVID-19. From the onset of the pandemic, however, doubts have been expressed concerning the sensitivity of this molecular diagnosis method. Droplet digital PCR (ddPCR) is a third-generation PCR technique that is particularly adapted to detecting low-abundance targets. We developed two-color ddPCR assays for the detection of four different regions of SARS-CoV-2 RNA, including non-structural (IP4-","2021","07","15","Arch Virol","Archives of virology",NA,"Vanhomwegen","Jessica","Cellule d'Intervention Biologique d'Urgence, Institut Pasteur, Paris, France",NA
"289","34251549","10.1007/s00705-021-05149-0","ddPCR increases detection of SARS-CoV-2 RNA in patients with low viral loads.","RT-qPCR detection of SARS-CoV-2 RNA still represents the method of reference to diagnose and monitor COVID-19. From the onset of the pandemic, however, doubts have been expressed concerning the sensitivity of this molecular diagnosis method. Droplet digital PCR (ddPCR) is a third-generation PCR technique that is particularly adapted to detecting low-abundance targets. We developed two-color ddPCR assays for the detection of four different regions of SARS-CoV-2 RNA, including non-structural (IP4-","2021","07","15","Arch Virol","Archives of virology",NA,"Feher","Maxence","Cellule d'Intervention Biologique d'Urgence, Institut Pasteur, Paris, France",NA
"290","34251549","10.1007/s00705-021-05149-0","ddPCR increases detection of SARS-CoV-2 RNA in patients with low viral loads.","RT-qPCR detection of SARS-CoV-2 RNA still represents the method of reference to diagnose and monitor COVID-19. From the onset of the pandemic, however, doubts have been expressed concerning the sensitivity of this molecular diagnosis method. Droplet digital PCR (ddPCR) is a third-generation PCR technique that is particularly adapted to detecting low-abundance targets. We developed two-color ddPCR assays for the detection of four different regions of SARS-CoV-2 RNA, including non-structural (IP4-","2021","07","15","Arch Virol","Archives of virology",NA,"Grassin","Quentin","Cellule d'Intervention Biologique d'Urgence, Institut Pasteur, Paris, France",NA
"291","34251549","10.1007/s00705-021-05149-0","ddPCR increases detection of SARS-CoV-2 RNA in patients with low viral loads.","RT-qPCR detection of SARS-CoV-2 RNA still represents the method of reference to diagnose and monitor COVID-19. From the onset of the pandemic, however, doubts have been expressed concerning the sensitivity of this molecular diagnosis method. Droplet digital PCR (ddPCR) is a third-generation PCR technique that is particularly adapted to detecting low-abundance targets. We developed two-color ddPCR assays for the detection of four different regions of SARS-CoV-2 RNA, including non-structural (IP4-","2021","07","15","Arch Virol","Archives of virology",NA,"Chazal","Maxime","Département de Virologie, Centre National de la Recherche Scientifique (CNRS) Unité Mixte de Recherche (UMR) 3569, Institut Pasteur, Paris, France",NA
"292","34251549","10.1007/s00705-021-05149-0","ddPCR increases detection of SARS-CoV-2 RNA in patients with low viral loads.","RT-qPCR detection of SARS-CoV-2 RNA still represents the method of reference to diagnose and monitor COVID-19. From the onset of the pandemic, however, doubts have been expressed concerning the sensitivity of this molecular diagnosis method. Droplet digital PCR (ddPCR) is a third-generation PCR technique that is particularly adapted to detecting low-abundance targets. We developed two-color ddPCR assays for the detection of four different regions of SARS-CoV-2 RNA, including non-structural (IP4-","2021","07","15","Arch Virol","Archives of virology",NA,"Raulin","Olivia","Laboratoire de Biologie Médicale, Centre Hospitalier Compiègne-Noyon, Compiègne, France",NA
"293","34251549","10.1007/s00705-021-05149-0","ddPCR increases detection of SARS-CoV-2 RNA in patients with low viral loads.","RT-qPCR detection of SARS-CoV-2 RNA still represents the method of reference to diagnose and monitor COVID-19. From the onset of the pandemic, however, doubts have been expressed concerning the sensitivity of this molecular diagnosis method. Droplet digital PCR (ddPCR) is a third-generation PCR technique that is particularly adapted to detecting low-abundance targets. We developed two-color ddPCR assays for the detection of four different regions of SARS-CoV-2 RNA, including non-structural (IP4-","2021","07","15","Arch Virol","Archives of virology",NA,"Farges-Berth","Anne","Laboratoire de Biologie Médicale, Groupe Hospitalier Nord-Essonne, Site de Longjumeau, Longjumeau, France",NA
"294","34251549","10.1007/s00705-021-05149-0","ddPCR increases detection of SARS-CoV-2 RNA in patients with low viral loads.","RT-qPCR detection of SARS-CoV-2 RNA still represents the method of reference to diagnose and monitor COVID-19. From the onset of the pandemic, however, doubts have been expressed concerning the sensitivity of this molecular diagnosis method. Droplet digital PCR (ddPCR) is a third-generation PCR technique that is particularly adapted to detecting low-abundance targets. We developed two-color ddPCR assays for the detection of four different regions of SARS-CoV-2 RNA, including non-structural (IP4-","2021","07","15","Arch Virol","Archives of virology",NA,"Reibel","Florence","Laboratoire de Biologie Médicale, Groupe Hospitalier Nord-Essonne, Site d'Orsay, Orsay, France",NA
"295","34251549","10.1007/s00705-021-05149-0","ddPCR increases detection of SARS-CoV-2 RNA in patients with low viral loads.","RT-qPCR detection of SARS-CoV-2 RNA still represents the method of reference to diagnose and monitor COVID-19. From the onset of the pandemic, however, doubts have been expressed concerning the sensitivity of this molecular diagnosis method. Droplet digital PCR (ddPCR) is a third-generation PCR technique that is particularly adapted to detecting low-abundance targets. We developed two-color ddPCR assays for the detection of four different regions of SARS-CoV-2 RNA, including non-structural (IP4-","2021","07","15","Arch Virol","Archives of virology",NA,"Estève","Vincent","Laboratoire de Biologie Médicale, Groupe Hospitalier Nord-Essonne, Site de Longjumeau, Longjumeau, France",NA
"296","34251549","10.1007/s00705-021-05149-0","ddPCR increases detection of SARS-CoV-2 RNA in patients with low viral loads.","RT-qPCR detection of SARS-CoV-2 RNA still represents the method of reference to diagnose and monitor COVID-19. From the onset of the pandemic, however, doubts have been expressed concerning the sensitivity of this molecular diagnosis method. Droplet digital PCR (ddPCR) is a third-generation PCR technique that is particularly adapted to detecting low-abundance targets. We developed two-color ddPCR assays for the detection of four different regions of SARS-CoV-2 RNA, including non-structural (IP4-","2021","07","15","Arch Virol","Archives of virology",NA,"Dejean","Anne","Unité ""Organisation nucléaire et Oncogenèse"", INSERM U993, Institut Pasteur, 28, rue du Docteur Roux, 75724, Paris, Cedex 15, France",NA
"297","34251549","10.1007/s00705-021-05149-0","ddPCR increases detection of SARS-CoV-2 RNA in patients with low viral loads.","RT-qPCR detection of SARS-CoV-2 RNA still represents the method of reference to diagnose and monitor COVID-19. From the onset of the pandemic, however, doubts have been expressed concerning the sensitivity of this molecular diagnosis method. Droplet digital PCR (ddPCR) is a third-generation PCR technique that is particularly adapted to detecting low-abundance targets. We developed two-color ddPCR assays for the detection of four different regions of SARS-CoV-2 RNA, including non-structural (IP4-","2021","07","15","Arch Virol","Archives of virology",NA,"Jouvenet","Nolwenn","Département de Virologie, Centre National de la Recherche Scientifique (CNRS) Unité Mixte de Recherche (UMR) 3569, Institut Pasteur, Paris, France",NA
"298","34251549","10.1007/s00705-021-05149-0","ddPCR increases detection of SARS-CoV-2 RNA in patients with low viral loads.","RT-qPCR detection of SARS-CoV-2 RNA still represents the method of reference to diagnose and monitor COVID-19. From the onset of the pandemic, however, doubts have been expressed concerning the sensitivity of this molecular diagnosis method. Droplet digital PCR (ddPCR) is a third-generation PCR technique that is particularly adapted to detecting low-abundance targets. We developed two-color ddPCR assays for the detection of four different regions of SARS-CoV-2 RNA, including non-structural (IP4-","2021","07","15","Arch Virol","Archives of virology",NA,"Manuguerra","Jean-Claude","Cellule d'Intervention Biologique d'Urgence, Institut Pasteur, Paris, France",NA
"299","34251549","10.1007/s00705-021-05149-0","ddPCR increases detection of SARS-CoV-2 RNA in patients with low viral loads.","RT-qPCR detection of SARS-CoV-2 RNA still represents the method of reference to diagnose and monitor COVID-19. From the onset of the pandemic, however, doubts have been expressed concerning the sensitivity of this molecular diagnosis method. Droplet digital PCR (ddPCR) is a third-generation PCR technique that is particularly adapted to detecting low-abundance targets. We developed two-color ddPCR assays for the detection of four different regions of SARS-CoV-2 RNA, including non-structural (IP4-","2021","07","15","Arch Virol","Archives of virology",NA,"Pineau","Pascal","Unité ""Organisation nucléaire et Oncogenèse"", INSERM U993, Institut Pasteur, 28, rue du Docteur Roux, 75724, Paris, Cedex 15, France. pascal.pineau@pasteur","pascal.pineau@pasteur.fr"
"300","34251506","10.1007/s00134-021-06448-5","Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.","To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill patients with coronavirus disease 2019 (COVID-19). Critically ill adults with COVID-19 were randomized to receive lopinavir-ritonavir, hydroxychloroquine, combination therapy of lopinavir-ritonavir and hydroxychloroquine or no antiviral therapy (control). The primary endpoint was an ordinal scale of organ support-free days. Analyses used a Bayesian cumulative logistic model and expressed treatment effects as an","2021","07","15","Intensive Care Med","Intensive care medicine","Adaptive platform trial; COVID-19; Hydroxychloroquine; Intensive care; Lopinavir-ritonavir; Pandemic; Pneumonia","Arabi","Yaseen M","Intensive Care Department, Ministry of the National Guard-Health Affairs, ICU 1425, P.O. Box 22490, Riyadh, 11426, Kingdom of Saudi Arabia. arabi@ngha.med","arabi@ngha.med.sa"
"301","34251506","10.1007/s00134-021-06448-5","Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.","To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill patients with coronavirus disease 2019 (COVID-19). Critically ill adults with COVID-19 were randomized to receive lopinavir-ritonavir, hydroxychloroquine, combination therapy of lopinavir-ritonavir and hydroxychloroquine or no antiviral therapy (control). The primary endpoint was an ordinal scale of organ support-free days. Analyses used a Bayesian cumulative logistic model and expressed treatment effects as an","2021","07","15","Intensive Care Med","Intensive care medicine","Adaptive platform trial; COVID-19; Hydroxychloroquine; Intensive care; Lopinavir-ritonavir; Pandemic; Pneumonia","Gordon","Anthony C","Division of Anaesthetics, Pain Medicine and Intensive Care, Imperial College London, London, UK",NA
"302","34251506","10.1007/s00134-021-06448-5","Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.","To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill patients with coronavirus disease 2019 (COVID-19). Critically ill adults with COVID-19 were randomized to receive lopinavir-ritonavir, hydroxychloroquine, combination therapy of lopinavir-ritonavir and hydroxychloroquine or no antiviral therapy (control). The primary endpoint was an ordinal scale of organ support-free days. Analyses used a Bayesian cumulative logistic model and expressed treatment effects as an","2021","07","15","Intensive Care Med","Intensive care medicine","Adaptive platform trial; COVID-19; Hydroxychloroquine; Intensive care; Lopinavir-ritonavir; Pandemic; Pneumonia","Derde","Lennie P G","Intensive Care Center, University Medical Center Utrecht, Utrecht, The Netherlands",NA
"303","34251506","10.1007/s00134-021-06448-5","Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.","To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill patients with coronavirus disease 2019 (COVID-19). Critically ill adults with COVID-19 were randomized to receive lopinavir-ritonavir, hydroxychloroquine, combination therapy of lopinavir-ritonavir and hydroxychloroquine or no antiviral therapy (control). The primary endpoint was an ordinal scale of organ support-free days. Analyses used a Bayesian cumulative logistic model and expressed treatment effects as an","2021","07","15","Intensive Care Med","Intensive care medicine","Adaptive platform trial; COVID-19; Hydroxychloroquine; Intensive care; Lopinavir-ritonavir; Pandemic; Pneumonia","Nichol","Alistair D","University College Dublin Clinical Research Centre At St Vincents University Hospital, Dublin, Ireland",NA
"304","34251506","10.1007/s00134-021-06448-5","Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.","To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill patients with coronavirus disease 2019 (COVID-19). Critically ill adults with COVID-19 were randomized to receive lopinavir-ritonavir, hydroxychloroquine, combination therapy of lopinavir-ritonavir and hydroxychloroquine or no antiviral therapy (control). The primary endpoint was an ordinal scale of organ support-free days. Analyses used a Bayesian cumulative logistic model and expressed treatment effects as an","2021","07","15","Intensive Care Med","Intensive care medicine","Adaptive platform trial; COVID-19; Hydroxychloroquine; Intensive care; Lopinavir-ritonavir; Pandemic; Pneumonia","Murthy","Srinivas","Department of Pediatrics, University of British Columbia, Vancouver, Canada",NA
"305","34251506","10.1007/s00134-021-06448-5","Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.","To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill patients with coronavirus disease 2019 (COVID-19). Critically ill adults with COVID-19 were randomized to receive lopinavir-ritonavir, hydroxychloroquine, combination therapy of lopinavir-ritonavir and hydroxychloroquine or no antiviral therapy (control). The primary endpoint was an ordinal scale of organ support-free days. Analyses used a Bayesian cumulative logistic model and expressed treatment effects as an","2021","07","15","Intensive Care Med","Intensive care medicine","Adaptive platform trial; COVID-19; Hydroxychloroquine; Intensive care; Lopinavir-ritonavir; Pandemic; Pneumonia","Beidh","Farah Al","Division of Anaesthetics, Pain Medicine and Intensive Care, Imperial College London, London, UK",NA
"306","34251506","10.1007/s00134-021-06448-5","Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.","To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill patients with coronavirus disease 2019 (COVID-19). Critically ill adults with COVID-19 were randomized to receive lopinavir-ritonavir, hydroxychloroquine, combination therapy of lopinavir-ritonavir and hydroxychloroquine or no antiviral therapy (control). The primary endpoint was an ordinal scale of organ support-free days. Analyses used a Bayesian cumulative logistic model and expressed treatment effects as an","2021","07","15","Intensive Care Med","Intensive care medicine","Adaptive platform trial; COVID-19; Hydroxychloroquine; Intensive care; Lopinavir-ritonavir; Pandemic; Pneumonia","Annane","Djillali","Department of Intensive Care, Hôpital Raymond Poincaré (APHP), 92380, Garches, France",NA
"307","34251506","10.1007/s00134-021-06448-5","Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.","To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill patients with coronavirus disease 2019 (COVID-19). Critically ill adults with COVID-19 were randomized to receive lopinavir-ritonavir, hydroxychloroquine, combination therapy of lopinavir-ritonavir and hydroxychloroquine or no antiviral therapy (control). The primary endpoint was an ordinal scale of organ support-free days. Analyses used a Bayesian cumulative logistic model and expressed treatment effects as an","2021","07","15","Intensive Care Med","Intensive care medicine","Adaptive platform trial; COVID-19; Hydroxychloroquine; Intensive care; Lopinavir-ritonavir; Pandemic; Pneumonia","Swaidan","Lolowa Al","King Abdullah International Medical Research Center, Riyadh, Kingdom of Saudi Arabia",NA
"308","34251506","10.1007/s00134-021-06448-5","Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.","To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill patients with coronavirus disease 2019 (COVID-19). Critically ill adults with COVID-19 were randomized to receive lopinavir-ritonavir, hydroxychloroquine, combination therapy of lopinavir-ritonavir and hydroxychloroquine or no antiviral therapy (control). The primary endpoint was an ordinal scale of organ support-free days. Analyses used a Bayesian cumulative logistic model and expressed treatment effects as an","2021","07","15","Intensive Care Med","Intensive care medicine","Adaptive platform trial; COVID-19; Hydroxychloroquine; Intensive care; Lopinavir-ritonavir; Pandemic; Pneumonia","Beane","Abi","Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK",NA
"309","34251506","10.1007/s00134-021-06448-5","Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.","To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill patients with coronavirus disease 2019 (COVID-19). Critically ill adults with COVID-19 were randomized to receive lopinavir-ritonavir, hydroxychloroquine, combination therapy of lopinavir-ritonavir and hydroxychloroquine or no antiviral therapy (control). The primary endpoint was an ordinal scale of organ support-free days. Analyses used a Bayesian cumulative logistic model and expressed treatment effects as an","2021","07","15","Intensive Care Med","Intensive care medicine","Adaptive platform trial; COVID-19; Hydroxychloroquine; Intensive care; Lopinavir-ritonavir; Pandemic; Pneumonia","Beasley","Richard","Medical Research Institute of New Zealand, Wellington, New Zealand",NA
"310","34251506","10.1007/s00134-021-06448-5","Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.","To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill patients with coronavirus disease 2019 (COVID-19). Critically ill adults with COVID-19 were randomized to receive lopinavir-ritonavir, hydroxychloroquine, combination therapy of lopinavir-ritonavir and hydroxychloroquine or no antiviral therapy (control). The primary endpoint was an ordinal scale of organ support-free days. Analyses used a Bayesian cumulative logistic model and expressed treatment effects as an","2021","07","15","Intensive Care Med","Intensive care medicine","Adaptive platform trial; COVID-19; Hydroxychloroquine; Intensive care; Lopinavir-ritonavir; Pandemic; Pneumonia","Berry","Lindsay R","Berry Consultants, Austin, TX, USA",NA
"311","34251506","10.1007/s00134-021-06448-5","Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.","To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill patients with coronavirus disease 2019 (COVID-19). Critically ill adults with COVID-19 were randomized to receive lopinavir-ritonavir, hydroxychloroquine, combination therapy of lopinavir-ritonavir and hydroxychloroquine or no antiviral therapy (control). The primary endpoint was an ordinal scale of organ support-free days. Analyses used a Bayesian cumulative logistic model and expressed treatment effects as an","2021","07","15","Intensive Care Med","Intensive care medicine","Adaptive platform trial; COVID-19; Hydroxychloroquine; Intensive care; Lopinavir-ritonavir; Pandemic; Pneumonia","Bhimani","Zahra","St. Michael's Hospital Unity Health Toronto, Toronto, Canada",NA
"312","34251506","10.1007/s00134-021-06448-5","Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.","To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill patients with coronavirus disease 2019 (COVID-19). Critically ill adults with COVID-19 were randomized to receive lopinavir-ritonavir, hydroxychloroquine, combination therapy of lopinavir-ritonavir and hydroxychloroquine or no antiviral therapy (control). The primary endpoint was an ordinal scale of organ support-free days. Analyses used a Bayesian cumulative logistic model and expressed treatment effects as an","2021","07","15","Intensive Care Med","Intensive care medicine","Adaptive platform trial; COVID-19; Hydroxychloroquine; Intensive care; Lopinavir-ritonavir; Pandemic; Pneumonia","Bonten","Marc J M","Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands",NA
"313","34251506","10.1007/s00134-021-06448-5","Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.","To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill patients with coronavirus disease 2019 (COVID-19). Critically ill adults with COVID-19 were randomized to receive lopinavir-ritonavir, hydroxychloroquine, combination therapy of lopinavir-ritonavir and hydroxychloroquine or no antiviral therapy (control). The primary endpoint was an ordinal scale of organ support-free days. Analyses used a Bayesian cumulative logistic model and expressed treatment effects as an","2021","07","15","Intensive Care Med","Intensive care medicine","Adaptive platform trial; COVID-19; Hydroxychloroquine; Intensive care; Lopinavir-ritonavir; Pandemic; Pneumonia","Bradbury","Charlotte A","Faculty of Health Sciences, University of Bristol, Bristol, UK",NA
"314","34251506","10.1007/s00134-021-06448-5","Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.","To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill patients with coronavirus disease 2019 (COVID-19). Critically ill adults with COVID-19 were randomized to receive lopinavir-ritonavir, hydroxychloroquine, combination therapy of lopinavir-ritonavir and hydroxychloroquine or no antiviral therapy (control). The primary endpoint was an ordinal scale of organ support-free days. Analyses used a Bayesian cumulative logistic model and expressed treatment effects as an","2021","07","15","Intensive Care Med","Intensive care medicine","Adaptive platform trial; COVID-19; Hydroxychloroquine; Intensive care; Lopinavir-ritonavir; Pandemic; Pneumonia","Brunkhorst","Frank M","Anesthesiology and Intensive Care Medicine, Jena University Hospital, Jena, Germany",NA
"315","34251506","10.1007/s00134-021-06448-5","Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.","To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill patients with coronavirus disease 2019 (COVID-19). Critically ill adults with COVID-19 were randomized to receive lopinavir-ritonavir, hydroxychloroquine, combination therapy of lopinavir-ritonavir and hydroxychloroquine or no antiviral therapy (control). The primary endpoint was an ordinal scale of organ support-free days. Analyses used a Bayesian cumulative logistic model and expressed treatment effects as an","2021","07","15","Intensive Care Med","Intensive care medicine","Adaptive platform trial; COVID-19; Hydroxychloroquine; Intensive care; Lopinavir-ritonavir; Pandemic; Pneumonia","Buxton","Meredith","Global Coalition for Adaptive Research, San Francisco, CA, USA",NA
"316","34251506","10.1007/s00134-021-06448-5","Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.","To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill patients with coronavirus disease 2019 (COVID-19). Critically ill adults with COVID-19 were randomized to receive lopinavir-ritonavir, hydroxychloroquine, combination therapy of lopinavir-ritonavir and hydroxychloroquine or no antiviral therapy (control). The primary endpoint was an ordinal scale of organ support-free days. Analyses used a Bayesian cumulative logistic model and expressed treatment effects as an","2021","07","15","Intensive Care Med","Intensive care medicine","Adaptive platform trial; COVID-19; Hydroxychloroquine; Intensive care; Lopinavir-ritonavir; Pandemic; Pneumonia","Buzgau","Adrian","Monash University, Melbourne, Australia",NA
"317","34251506","10.1007/s00134-021-06448-5","Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.","To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill patients with coronavirus disease 2019 (COVID-19). Critically ill adults with COVID-19 were randomized to receive lopinavir-ritonavir, hydroxychloroquine, combination therapy of lopinavir-ritonavir and hydroxychloroquine or no antiviral therapy (control). The primary endpoint was an ordinal scale of organ support-free days. Analyses used a Bayesian cumulative logistic model and expressed treatment effects as an","2021","07","15","Intensive Care Med","Intensive care medicine","Adaptive platform trial; COVID-19; Hydroxychloroquine; Intensive care; Lopinavir-ritonavir; Pandemic; Pneumonia","Cheng","Allen","Monash University, Melbourne, Australia",NA
"318","34251506","10.1007/s00134-021-06448-5","Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.","To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill patients with coronavirus disease 2019 (COVID-19). Critically ill adults with COVID-19 were randomized to receive lopinavir-ritonavir, hydroxychloroquine, combination therapy of lopinavir-ritonavir and hydroxychloroquine or no antiviral therapy (control). The primary endpoint was an ordinal scale of organ support-free days. Analyses used a Bayesian cumulative logistic model and expressed treatment effects as an","2021","07","15","Intensive Care Med","Intensive care medicine","Adaptive platform trial; COVID-19; Hydroxychloroquine; Intensive care; Lopinavir-ritonavir; Pandemic; Pneumonia","De Jong","Menno","Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Centers, Amsterdam, The Netherlands",NA
"319","34251506","10.1007/s00134-021-06448-5","Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.","To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill patients with coronavirus disease 2019 (COVID-19). Critically ill adults with COVID-19 were randomized to receive lopinavir-ritonavir, hydroxychloroquine, combination therapy of lopinavir-ritonavir and hydroxychloroquine or no antiviral therapy (control). The primary endpoint was an ordinal scale of organ support-free days. Analyses used a Bayesian cumulative logistic model and expressed treatment effects as an","2021","07","15","Intensive Care Med","Intensive care medicine","Adaptive platform trial; COVID-19; Hydroxychloroquine; Intensive care; Lopinavir-ritonavir; Pandemic; Pneumonia","Detry","Michelle A","Berry Consultants, Austin, TX, USA",NA
"320","34251506","10.1007/s00134-021-06448-5","Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.","To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill patients with coronavirus disease 2019 (COVID-19). Critically ill adults with COVID-19 were randomized to receive lopinavir-ritonavir, hydroxychloroquine, combination therapy of lopinavir-ritonavir and hydroxychloroquine or no antiviral therapy (control). The primary endpoint was an ordinal scale of organ support-free days. Analyses used a Bayesian cumulative logistic model and expressed treatment effects as an","2021","07","15","Intensive Care Med","Intensive care medicine","Adaptive platform trial; COVID-19; Hydroxychloroquine; Intensive care; Lopinavir-ritonavir; Pandemic; Pneumonia","Duffy","Eamon J","Infectious Disease, Auckland City Hospital, Auckland, New Zealand",NA
"321","34251506","10.1007/s00134-021-06448-5","Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.","To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill patients with coronavirus disease 2019 (COVID-19). Critically ill adults with COVID-19 were randomized to receive lopinavir-ritonavir, hydroxychloroquine, combination therapy of lopinavir-ritonavir and hydroxychloroquine or no antiviral therapy (control). The primary endpoint was an ordinal scale of organ support-free days. Analyses used a Bayesian cumulative logistic model and expressed treatment effects as an","2021","07","15","Intensive Care Med","Intensive care medicine","Adaptive platform trial; COVID-19; Hydroxychloroquine; Intensive care; Lopinavir-ritonavir; Pandemic; Pneumonia","Estcourt","Lise J","NHS Blood and Transplant, Oxford, UK",NA
"322","34251506","10.1007/s00134-021-06448-5","Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.","To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill patients with coronavirus disease 2019 (COVID-19). Critically ill adults with COVID-19 were randomized to receive lopinavir-ritonavir, hydroxychloroquine, combination therapy of lopinavir-ritonavir and hydroxychloroquine or no antiviral therapy (control). The primary endpoint was an ordinal scale of organ support-free days. Analyses used a Bayesian cumulative logistic model and expressed treatment effects as an","2021","07","15","Intensive Care Med","Intensive care medicine","Adaptive platform trial; COVID-19; Hydroxychloroquine; Intensive care; Lopinavir-ritonavir; Pandemic; Pneumonia","Fitzgerald","Mark","Berry Consultants, Austin, TX, USA",NA
"323","34251506","10.1007/s00134-021-06448-5","Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.","To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill patients with coronavirus disease 2019 (COVID-19). Critically ill adults with COVID-19 were randomized to receive lopinavir-ritonavir, hydroxychloroquine, combination therapy of lopinavir-ritonavir and hydroxychloroquine or no antiviral therapy (control). The primary endpoint was an ordinal scale of organ support-free days. Analyses used a Bayesian cumulative logistic model and expressed treatment effects as an","2021","07","15","Intensive Care Med","Intensive care medicine","Adaptive platform trial; COVID-19; Hydroxychloroquine; Intensive care; Lopinavir-ritonavir; Pandemic; Pneumonia","Fowler","Rob","University of Toronto, Toronto, ON, Canada",NA
"324","34251506","10.1007/s00134-021-06448-5","Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.","To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill patients with coronavirus disease 2019 (COVID-19). Critically ill adults with COVID-19 were randomized to receive lopinavir-ritonavir, hydroxychloroquine, combination therapy of lopinavir-ritonavir and hydroxychloroquine or no antiviral therapy (control). The primary endpoint was an ordinal scale of organ support-free days. Analyses used a Bayesian cumulative logistic model and expressed treatment effects as an","2021","07","15","Intensive Care Med","Intensive care medicine","Adaptive platform trial; COVID-19; Hydroxychloroquine; Intensive care; Lopinavir-ritonavir; Pandemic; Pneumonia","Girard","Timothy D","UPMC Health System, Pittsburgh, PA, USA",NA
"325","34251506","10.1007/s00134-021-06448-5","Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.","To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill patients with coronavirus disease 2019 (COVID-19). Critically ill adults with COVID-19 were randomized to receive lopinavir-ritonavir, hydroxychloroquine, combination therapy of lopinavir-ritonavir and hydroxychloroquine or no antiviral therapy (control). The primary endpoint was an ordinal scale of organ support-free days. Analyses used a Bayesian cumulative logistic model and expressed treatment effects as an","2021","07","15","Intensive Care Med","Intensive care medicine","Adaptive platform trial; COVID-19; Hydroxychloroquine; Intensive care; Lopinavir-ritonavir; Pandemic; Pneumonia","Goligher","Ewan C","Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, Canada",NA
"326","34251506","10.1007/s00134-021-06448-5","Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.","To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill patients with coronavirus disease 2019 (COVID-19). Critically ill adults with COVID-19 were randomized to receive lopinavir-ritonavir, hydroxychloroquine, combination therapy of lopinavir-ritonavir and hydroxychloroquine or no antiviral therapy (control). The primary endpoint was an ordinal scale of organ support-free days. Analyses used a Bayesian cumulative logistic model and expressed treatment effects as an","2021","07","15","Intensive Care Med","Intensive care medicine","Adaptive platform trial; COVID-19; Hydroxychloroquine; Intensive care; Lopinavir-ritonavir; Pandemic; Pneumonia","Goossens","Herman","University of Antwerp, Wilrijk, Belgium",NA
"327","34251506","10.1007/s00134-021-06448-5","Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.","To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill patients with coronavirus disease 2019 (COVID-19). Critically ill adults with COVID-19 were randomized to receive lopinavir-ritonavir, hydroxychloroquine, combination therapy of lopinavir-ritonavir and hydroxychloroquine or no antiviral therapy (control). The primary endpoint was an ordinal scale of organ support-free days. Analyses used a Bayesian cumulative logistic model and expressed treatment effects as an","2021","07","15","Intensive Care Med","Intensive care medicine","Adaptive platform trial; COVID-19; Hydroxychloroquine; Intensive care; Lopinavir-ritonavir; Pandemic; Pneumonia","Haniffa","Rashan","National Intensive Care Surveillance-Mahidol Oxford Research Unit, Colombo, Sri Lanka",NA
"328","34251506","10.1007/s00134-021-06448-5","Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.","To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill patients with coronavirus disease 2019 (COVID-19). Critically ill adults with COVID-19 were randomized to receive lopinavir-ritonavir, hydroxychloroquine, combination therapy of lopinavir-ritonavir and hydroxychloroquine or no antiviral therapy (control). The primary endpoint was an ordinal scale of organ support-free days. Analyses used a Bayesian cumulative logistic model and expressed treatment effects as an","2021","07","15","Intensive Care Med","Intensive care medicine","Adaptive platform trial; COVID-19; Hydroxychloroquine; Intensive care; Lopinavir-ritonavir; Pandemic; Pneumonia","Higgins","Alisa M","The Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, Australia",NA
"329","34251506","10.1007/s00134-021-06448-5","Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.","To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill patients with coronavirus disease 2019 (COVID-19). Critically ill adults with COVID-19 were randomized to receive lopinavir-ritonavir, hydroxychloroquine, combination therapy of lopinavir-ritonavir and hydroxychloroquine or no antiviral therapy (control). The primary endpoint was an ordinal scale of organ support-free days. Analyses used a Bayesian cumulative logistic model and expressed treatment effects as an","2021","07","15","Intensive Care Med","Intensive care medicine","Adaptive platform trial; COVID-19; Hydroxychloroquine; Intensive care; Lopinavir-ritonavir; Pandemic; Pneumonia","Hills","Thomas E","Medical Research Institute of New Zealand, Wellington, New Zealand",NA
"330","34251506","10.1007/s00134-021-06448-5","Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.","To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill patients with coronavirus disease 2019 (COVID-19). Critically ill adults with COVID-19 were randomized to receive lopinavir-ritonavir, hydroxychloroquine, combination therapy of lopinavir-ritonavir and hydroxychloroquine or no antiviral therapy (control). The primary endpoint was an ordinal scale of organ support-free days. Analyses used a Bayesian cumulative logistic model and expressed treatment effects as an","2021","07","15","Intensive Care Med","Intensive care medicine","Adaptive platform trial; COVID-19; Hydroxychloroquine; Intensive care; Lopinavir-ritonavir; Pandemic; Pneumonia","Horvat","Christopher M","UPMC Health System, Pittsburgh, PA, USA",NA
"331","34251506","10.1007/s00134-021-06448-5","Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.","To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill patients with coronavirus disease 2019 (COVID-19). Critically ill adults with COVID-19 were randomized to receive lopinavir-ritonavir, hydroxychloroquine, combination therapy of lopinavir-ritonavir and hydroxychloroquine or no antiviral therapy (control). The primary endpoint was an ordinal scale of organ support-free days. Analyses used a Bayesian cumulative logistic model and expressed treatment effects as an","2021","07","15","Intensive Care Med","Intensive care medicine","Adaptive platform trial; COVID-19; Hydroxychloroquine; Intensive care; Lopinavir-ritonavir; Pandemic; Pneumonia","Huang","David T","UPMC Health System, Pittsburgh, PA, USA",NA
"332","34251506","10.1007/s00134-021-06448-5","Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.","To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill patients with coronavirus disease 2019 (COVID-19). Critically ill adults with COVID-19 were randomized to receive lopinavir-ritonavir, hydroxychloroquine, combination therapy of lopinavir-ritonavir and hydroxychloroquine or no antiviral therapy (control). The primary endpoint was an ordinal scale of organ support-free days. Analyses used a Bayesian cumulative logistic model and expressed treatment effects as an","2021","07","15","Intensive Care Med","Intensive care medicine","Adaptive platform trial; COVID-19; Hydroxychloroquine; Intensive care; Lopinavir-ritonavir; Pandemic; Pneumonia","King","Andrew J","University of Pittsburgh School of Medicine, Pittsburgh, PA, USA",NA
"333","34251506","10.1007/s00134-021-06448-5","Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.","To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill patients with coronavirus disease 2019 (COVID-19). Critically ill adults with COVID-19 were randomized to receive lopinavir-ritonavir, hydroxychloroquine, combination therapy of lopinavir-ritonavir and hydroxychloroquine or no antiviral therapy (control). The primary endpoint was an ordinal scale of organ support-free days. Analyses used a Bayesian cumulative logistic model and expressed treatment effects as an","2021","07","15","Intensive Care Med","Intensive care medicine","Adaptive platform trial; COVID-19; Hydroxychloroquine; Intensive care; Lopinavir-ritonavir; Pandemic; Pneumonia","Lamontagne","Francois","Université de Sherbrooke, Sherbrooke, Canada",NA
"334","34251506","10.1007/s00134-021-06448-5","Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.","To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill patients with coronavirus disease 2019 (COVID-19). Critically ill adults with COVID-19 were randomized to receive lopinavir-ritonavir, hydroxychloroquine, combination therapy of lopinavir-ritonavir and hydroxychloroquine or no antiviral therapy (control). The primary endpoint was an ordinal scale of organ support-free days. Analyses used a Bayesian cumulative logistic model and expressed treatment effects as an","2021","07","15","Intensive Care Med","Intensive care medicine","Adaptive platform trial; COVID-19; Hydroxychloroquine; Intensive care; Lopinavir-ritonavir; Pandemic; Pneumonia","Lawler","Patrick R","University of Toronto, Toronto, ON, Canada",NA
"335","34251506","10.1007/s00134-021-06448-5","Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.","To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill patients with coronavirus disease 2019 (COVID-19). Critically ill adults with COVID-19 were randomized to receive lopinavir-ritonavir, hydroxychloroquine, combination therapy of lopinavir-ritonavir and hydroxychloroquine or no antiviral therapy (control). The primary endpoint was an ordinal scale of organ support-free days. Analyses used a Bayesian cumulative logistic model and expressed treatment effects as an","2021","07","15","Intensive Care Med","Intensive care medicine","Adaptive platform trial; COVID-19; Hydroxychloroquine; Intensive care; Lopinavir-ritonavir; Pandemic; Pneumonia","Lewis","Roger","Berry Consultants, Austin, TX, USA",NA
"336","34251506","10.1007/s00134-021-06448-5","Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.","To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill patients with coronavirus disease 2019 (COVID-19). Critically ill adults with COVID-19 were randomized to receive lopinavir-ritonavir, hydroxychloroquine, combination therapy of lopinavir-ritonavir and hydroxychloroquine or no antiviral therapy (control). The primary endpoint was an ordinal scale of organ support-free days. Analyses used a Bayesian cumulative logistic model and expressed treatment effects as an","2021","07","15","Intensive Care Med","Intensive care medicine","Adaptive platform trial; COVID-19; Hydroxychloroquine; Intensive care; Lopinavir-ritonavir; Pandemic; Pneumonia","Linstrum","Kelsey","UPMC Health System, Pittsburgh, PA, USA",NA
"337","34251506","10.1007/s00134-021-06448-5","Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.","To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill patients with coronavirus disease 2019 (COVID-19). Critically ill adults with COVID-19 were randomized to receive lopinavir-ritonavir, hydroxychloroquine, combination therapy of lopinavir-ritonavir and hydroxychloroquine or no antiviral therapy (control). The primary endpoint was an ordinal scale of organ support-free days. Analyses used a Bayesian cumulative logistic model and expressed treatment effects as an","2021","07","15","Intensive Care Med","Intensive care medicine","Adaptive platform trial; COVID-19; Hydroxychloroquine; Intensive care; Lopinavir-ritonavir; Pandemic; Pneumonia","Litton","Edward","Intensive Care Unit, Fiona Stanley Hospital, Perth, Australia",NA
"338","34251506","10.1007/s00134-021-06448-5","Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.","To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill patients with coronavirus disease 2019 (COVID-19). Critically ill adults with COVID-19 were randomized to receive lopinavir-ritonavir, hydroxychloroquine, combination therapy of lopinavir-ritonavir and hydroxychloroquine or no antiviral therapy (control). The primary endpoint was an ordinal scale of organ support-free days. Analyses used a Bayesian cumulative logistic model and expressed treatment effects as an","2021","07","15","Intensive Care Med","Intensive care medicine","Adaptive platform trial; COVID-19; Hydroxychloroquine; Intensive care; Lopinavir-ritonavir; Pandemic; Pneumonia","Lorenzi","Elizabeth","Berry Consultants, Austin, TX, USA",NA
"339","34251506","10.1007/s00134-021-06448-5","Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.","To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill patients with coronavirus disease 2019 (COVID-19). Critically ill adults with COVID-19 were randomized to receive lopinavir-ritonavir, hydroxychloroquine, combination therapy of lopinavir-ritonavir and hydroxychloroquine or no antiviral therapy (control). The primary endpoint was an ordinal scale of organ support-free days. Analyses used a Bayesian cumulative logistic model and expressed treatment effects as an","2021","07","15","Intensive Care Med","Intensive care medicine","Adaptive platform trial; COVID-19; Hydroxychloroquine; Intensive care; Lopinavir-ritonavir; Pandemic; Pneumonia","Malakouti","Salim","Computer Science, University of Pittsburgh, Pittsburgh, PA, USA",NA
"340","34251506","10.1007/s00134-021-06448-5","Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.","To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill patients with coronavirus disease 2019 (COVID-19). Critically ill adults with COVID-19 were randomized to receive lopinavir-ritonavir, hydroxychloroquine, combination therapy of lopinavir-ritonavir and hydroxychloroquine or no antiviral therapy (control). The primary endpoint was an ordinal scale of organ support-free days. Analyses used a Bayesian cumulative logistic model and expressed treatment effects as an","2021","07","15","Intensive Care Med","Intensive care medicine","Adaptive platform trial; COVID-19; Hydroxychloroquine; Intensive care; Lopinavir-ritonavir; Pandemic; Pneumonia","McAuley","Daniel F","Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast, Northern Ireland, UK",NA
"341","34251506","10.1007/s00134-021-06448-5","Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.","To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill patients with coronavirus disease 2019 (COVID-19). Critically ill adults with COVID-19 were randomized to receive lopinavir-ritonavir, hydroxychloroquine, combination therapy of lopinavir-ritonavir and hydroxychloroquine or no antiviral therapy (control). The primary endpoint was an ordinal scale of organ support-free days. Analyses used a Bayesian cumulative logistic model and expressed treatment effects as an","2021","07","15","Intensive Care Med","Intensive care medicine","Adaptive platform trial; COVID-19; Hydroxychloroquine; Intensive care; Lopinavir-ritonavir; Pandemic; Pneumonia","McGlothlin","Anna","Berry Consultants, Austin, TX, USA",NA
"342","34251506","10.1007/s00134-021-06448-5","Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.","To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill patients with coronavirus disease 2019 (COVID-19). Critically ill adults with COVID-19 were randomized to receive lopinavir-ritonavir, hydroxychloroquine, combination therapy of lopinavir-ritonavir and hydroxychloroquine or no antiviral therapy (control). The primary endpoint was an ordinal scale of organ support-free days. Analyses used a Bayesian cumulative logistic model and expressed treatment effects as an","2021","07","15","Intensive Care Med","Intensive care medicine","Adaptive platform trial; COVID-19; Hydroxychloroquine; Intensive care; Lopinavir-ritonavir; Pandemic; Pneumonia","Mcguinness","Shay","Medical Research Institute of New Zealand, Wellington, New Zealand",NA
"343","34251506","10.1007/s00134-021-06448-5","Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.","To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill patients with coronavirus disease 2019 (COVID-19). Critically ill adults with COVID-19 were randomized to receive lopinavir-ritonavir, hydroxychloroquine, combination therapy of lopinavir-ritonavir and hydroxychloroquine or no antiviral therapy (control). The primary endpoint was an ordinal scale of organ support-free days. Analyses used a Bayesian cumulative logistic model and expressed treatment effects as an","2021","07","15","Intensive Care Med","Intensive care medicine","Adaptive platform trial; COVID-19; Hydroxychloroquine; Intensive care; Lopinavir-ritonavir; Pandemic; Pneumonia","McVerry","Bryan J","UPMC Health System, Pittsburgh, PA, USA",NA
"344","34251506","10.1007/s00134-021-06448-5","Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.","To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill patients with coronavirus disease 2019 (COVID-19). Critically ill adults with COVID-19 were randomized to receive lopinavir-ritonavir, hydroxychloroquine, combination therapy of lopinavir-ritonavir and hydroxychloroquine or no antiviral therapy (control). The primary endpoint was an ordinal scale of organ support-free days. Analyses used a Bayesian cumulative logistic model and expressed treatment effects as an","2021","07","15","Intensive Care Med","Intensive care medicine","Adaptive platform trial; COVID-19; Hydroxychloroquine; Intensive care; Lopinavir-ritonavir; Pandemic; Pneumonia","Montgomery","Stephanie K","UPMC Health System, Pittsburgh, PA, USA",NA
"345","34251506","10.1007/s00134-021-06448-5","Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.","To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill patients with coronavirus disease 2019 (COVID-19). Critically ill adults with COVID-19 were randomized to receive lopinavir-ritonavir, hydroxychloroquine, combination therapy of lopinavir-ritonavir and hydroxychloroquine or no antiviral therapy (control). The primary endpoint was an ordinal scale of organ support-free days. Analyses used a Bayesian cumulative logistic model and expressed treatment effects as an","2021","07","15","Intensive Care Med","Intensive care medicine","Adaptive platform trial; COVID-19; Hydroxychloroquine; Intensive care; Lopinavir-ritonavir; Pandemic; Pneumonia","Morpeth","Susan C","Microbiology Laboratory, Middlemore Hospital, Auckland, New Zealand",NA
"346","34251506","10.1007/s00134-021-06448-5","Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.","To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill patients with coronavirus disease 2019 (COVID-19). Critically ill adults with COVID-19 were randomized to receive lopinavir-ritonavir, hydroxychloroquine, combination therapy of lopinavir-ritonavir and hydroxychloroquine or no antiviral therapy (control). The primary endpoint was an ordinal scale of organ support-free days. Analyses used a Bayesian cumulative logistic model and expressed treatment effects as an","2021","07","15","Intensive Care Med","Intensive care medicine","Adaptive platform trial; COVID-19; Hydroxychloroquine; Intensive care; Lopinavir-ritonavir; Pandemic; Pneumonia","Mouncey","Paul R","Clinical Trials Unit, Intensive Care National Audit and Research Centre, London, UK",NA
"347","34251506","10.1007/s00134-021-06448-5","Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.","To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill patients with coronavirus disease 2019 (COVID-19). Critically ill adults with COVID-19 were randomized to receive lopinavir-ritonavir, hydroxychloroquine, combination therapy of lopinavir-ritonavir and hydroxychloroquine or no antiviral therapy (control). The primary endpoint was an ordinal scale of organ support-free days. Analyses used a Bayesian cumulative logistic model and expressed treatment effects as an","2021","07","15","Intensive Care Med","Intensive care medicine","Adaptive platform trial; COVID-19; Hydroxychloroquine; Intensive care; Lopinavir-ritonavir; Pandemic; Pneumonia","Orr","Katrina","Pharmacy Department, Fiona Stanley Hospital, Perth, Australia",NA
"348","34251506","10.1007/s00134-021-06448-5","Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.","To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill patients with coronavirus disease 2019 (COVID-19). Critically ill adults with COVID-19 were randomized to receive lopinavir-ritonavir, hydroxychloroquine, combination therapy of lopinavir-ritonavir and hydroxychloroquine or no antiviral therapy (control). The primary endpoint was an ordinal scale of organ support-free days. Analyses used a Bayesian cumulative logistic model and expressed treatment effects as an","2021","07","15","Intensive Care Med","Intensive care medicine","Adaptive platform trial; COVID-19; Hydroxychloroquine; Intensive care; Lopinavir-ritonavir; Pandemic; Pneumonia","Parke","Rachael","Medical Research Institute of New Zealand, Wellington, New Zealand",NA
"349","34251506","10.1007/s00134-021-06448-5","Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.","To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill patients with coronavirus disease 2019 (COVID-19). Critically ill adults with COVID-19 were randomized to receive lopinavir-ritonavir, hydroxychloroquine, combination therapy of lopinavir-ritonavir and hydroxychloroquine or no antiviral therapy (control). The primary endpoint was an ordinal scale of organ support-free days. Analyses used a Bayesian cumulative logistic model and expressed treatment effects as an","2021","07","15","Intensive Care Med","Intensive care medicine","Adaptive platform trial; COVID-19; Hydroxychloroquine; Intensive care; Lopinavir-ritonavir; Pandemic; Pneumonia","Parker","Jane C","The Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, Australia",NA
"350","34251506","10.1007/s00134-021-06448-5","Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.","To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill patients with coronavirus disease 2019 (COVID-19). Critically ill adults with COVID-19 were randomized to receive lopinavir-ritonavir, hydroxychloroquine, combination therapy of lopinavir-ritonavir and hydroxychloroquine or no antiviral therapy (control). The primary endpoint was an ordinal scale of organ support-free days. Analyses used a Bayesian cumulative logistic model and expressed treatment effects as an","2021","07","15","Intensive Care Med","Intensive care medicine","Adaptive platform trial; COVID-19; Hydroxychloroquine; Intensive care; Lopinavir-ritonavir; Pandemic; Pneumonia","Patanwala","Asad E","School of Pharmacy, University of Sydney, Sydney, Australia",NA
"351","34251506","10.1007/s00134-021-06448-5","Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.","To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill patients with coronavirus disease 2019 (COVID-19). Critically ill adults with COVID-19 were randomized to receive lopinavir-ritonavir, hydroxychloroquine, combination therapy of lopinavir-ritonavir and hydroxychloroquine or no antiviral therapy (control). The primary endpoint was an ordinal scale of organ support-free days. Analyses used a Bayesian cumulative logistic model and expressed treatment effects as an","2021","07","15","Intensive Care Med","Intensive care medicine","Adaptive platform trial; COVID-19; Hydroxychloroquine; Intensive care; Lopinavir-ritonavir; Pandemic; Pneumonia","Rowan","Kathryn M","Intensive Care National Audit and Research Centre (ICNARC), London, UK",NA
"352","34251506","10.1007/s00134-021-06448-5","Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.","To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill patients with coronavirus disease 2019 (COVID-19). Critically ill adults with COVID-19 were randomized to receive lopinavir-ritonavir, hydroxychloroquine, combination therapy of lopinavir-ritonavir and hydroxychloroquine or no antiviral therapy (control). The primary endpoint was an ordinal scale of organ support-free days. Analyses used a Bayesian cumulative logistic model and expressed treatment effects as an","2021","07","15","Intensive Care Med","Intensive care medicine","Adaptive platform trial; COVID-19; Hydroxychloroquine; Intensive care; Lopinavir-ritonavir; Pandemic; Pneumonia","Santos","Marlene S","St. Michael's Hospital Unity Health Toronto, Toronto, Canada",NA
"353","34251506","10.1007/s00134-021-06448-5","Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.","To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill patients with coronavirus disease 2019 (COVID-19). Critically ill adults with COVID-19 were randomized to receive lopinavir-ritonavir, hydroxychloroquine, combination therapy of lopinavir-ritonavir and hydroxychloroquine or no antiviral therapy (control). The primary endpoint was an ordinal scale of organ support-free days. Analyses used a Bayesian cumulative logistic model and expressed treatment effects as an","2021","07","15","Intensive Care Med","Intensive care medicine","Adaptive platform trial; COVID-19; Hydroxychloroquine; Intensive care; Lopinavir-ritonavir; Pandemic; Pneumonia","Saunders","Christina T","Berry Consultants, Austin, TX, USA",NA
"354","34251506","10.1007/s00134-021-06448-5","Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.","To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill patients with coronavirus disease 2019 (COVID-19). Critically ill adults with COVID-19 were randomized to receive lopinavir-ritonavir, hydroxychloroquine, combination therapy of lopinavir-ritonavir and hydroxychloroquine or no antiviral therapy (control). The primary endpoint was an ordinal scale of organ support-free days. Analyses used a Bayesian cumulative logistic model and expressed treatment effects as an","2021","07","15","Intensive Care Med","Intensive care medicine","Adaptive platform trial; COVID-19; Hydroxychloroquine; Intensive care; Lopinavir-ritonavir; Pandemic; Pneumonia","Seymour","Christopher W","UPMC Health System, Pittsburgh, PA, USA",NA
"355","34251506","10.1007/s00134-021-06448-5","Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.","To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill patients with coronavirus disease 2019 (COVID-19). Critically ill adults with COVID-19 were randomized to receive lopinavir-ritonavir, hydroxychloroquine, combination therapy of lopinavir-ritonavir and hydroxychloroquine or no antiviral therapy (control). The primary endpoint was an ordinal scale of organ support-free days. Analyses used a Bayesian cumulative logistic model and expressed treatment effects as an","2021","07","15","Intensive Care Med","Intensive care medicine","Adaptive platform trial; COVID-19; Hydroxychloroquine; Intensive care; Lopinavir-ritonavir; Pandemic; Pneumonia","Shankar-Hari","Manu","Critical Care Medicine, Guy's and St Thomas' NHS Foundation Trust, London, UK",NA
"356","34251506","10.1007/s00134-021-06448-5","Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.","To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill patients with coronavirus disease 2019 (COVID-19). Critically ill adults with COVID-19 were randomized to receive lopinavir-ritonavir, hydroxychloroquine, combination therapy of lopinavir-ritonavir and hydroxychloroquine or no antiviral therapy (control). The primary endpoint was an ordinal scale of organ support-free days. Analyses used a Bayesian cumulative logistic model and expressed treatment effects as an","2021","07","15","Intensive Care Med","Intensive care medicine","Adaptive platform trial; COVID-19; Hydroxychloroquine; Intensive care; Lopinavir-ritonavir; Pandemic; Pneumonia","Tong","Steven Y C","Victorian Infectious Diseases Service, The Royal Melbourne Hospital, Peter Doherty Institute for Infection and Immunity, Melbourne, Australia",NA
"357","34251506","10.1007/s00134-021-06448-5","Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.","To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill patients with coronavirus disease 2019 (COVID-19). Critically ill adults with COVID-19 were randomized to receive lopinavir-ritonavir, hydroxychloroquine, combination therapy of lopinavir-ritonavir and hydroxychloroquine or no antiviral therapy (control). The primary endpoint was an ordinal scale of organ support-free days. Analyses used a Bayesian cumulative logistic model and expressed treatment effects as an","2021","07","15","Intensive Care Med","Intensive care medicine","Adaptive platform trial; COVID-19; Hydroxychloroquine; Intensive care; Lopinavir-ritonavir; Pandemic; Pneumonia","Turgeon","Alexis F","Division of Critical Care Medicine, Department of Anesthesiology and Critical Care Medicine, Laval University, Quebec City, QC, Canada",NA
"358","34251506","10.1007/s00134-021-06448-5","Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.","To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill patients with coronavirus disease 2019 (COVID-19). Critically ill adults with COVID-19 were randomized to receive lopinavir-ritonavir, hydroxychloroquine, combination therapy of lopinavir-ritonavir and hydroxychloroquine or no antiviral therapy (control). The primary endpoint was an ordinal scale of organ support-free days. Analyses used a Bayesian cumulative logistic model and expressed treatment effects as an","2021","07","15","Intensive Care Med","Intensive care medicine","Adaptive platform trial; COVID-19; Hydroxychloroquine; Intensive care; Lopinavir-ritonavir; Pandemic; Pneumonia","Turner","Anne M","Medical Research Institute of New Zealand, Wellington, New Zealand",NA
"359","34251506","10.1007/s00134-021-06448-5","Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.","To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill patients with coronavirus disease 2019 (COVID-19). Critically ill adults with COVID-19 were randomized to receive lopinavir-ritonavir, hydroxychloroquine, combination therapy of lopinavir-ritonavir and hydroxychloroquine or no antiviral therapy (control). The primary endpoint was an ordinal scale of organ support-free days. Analyses used a Bayesian cumulative logistic model and expressed treatment effects as an","2021","07","15","Intensive Care Med","Intensive care medicine","Adaptive platform trial; COVID-19; Hydroxychloroquine; Intensive care; Lopinavir-ritonavir; Pandemic; Pneumonia","Van de Veerdonk","Frank Leo","Department of Internal Medicine, Radboudumc, Nijmegen, The Netherlands",NA
"360","34251506","10.1007/s00134-021-06448-5","Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.","To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill patients with coronavirus disease 2019 (COVID-19). Critically ill adults with COVID-19 were randomized to receive lopinavir-ritonavir, hydroxychloroquine, combination therapy of lopinavir-ritonavir and hydroxychloroquine or no antiviral therapy (control). The primary endpoint was an ordinal scale of organ support-free days. Analyses used a Bayesian cumulative logistic model and expressed treatment effects as an","2021","07","15","Intensive Care Med","Intensive care medicine","Adaptive platform trial; COVID-19; Hydroxychloroquine; Intensive care; Lopinavir-ritonavir; Pandemic; Pneumonia","Zarychanski","Ryan","Critical Care Department, University of Manitoba, Winnipeg, Canada",NA
"361","34251506","10.1007/s00134-021-06448-5","Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.","To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill patients with coronavirus disease 2019 (COVID-19). Critically ill adults with COVID-19 were randomized to receive lopinavir-ritonavir, hydroxychloroquine, combination therapy of lopinavir-ritonavir and hydroxychloroquine or no antiviral therapy (control). The primary endpoint was an ordinal scale of organ support-free days. Analyses used a Bayesian cumulative logistic model and expressed treatment effects as an","2021","07","15","Intensive Care Med","Intensive care medicine","Adaptive platform trial; COVID-19; Hydroxychloroquine; Intensive care; Lopinavir-ritonavir; Pandemic; Pneumonia","Green","Cameron","The Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, Australia",NA
"362","34251506","10.1007/s00134-021-06448-5","Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.","To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill patients with coronavirus disease 2019 (COVID-19). Critically ill adults with COVID-19 were randomized to receive lopinavir-ritonavir, hydroxychloroquine, combination therapy of lopinavir-ritonavir and hydroxychloroquine or no antiviral therapy (control). The primary endpoint was an ordinal scale of organ support-free days. Analyses used a Bayesian cumulative logistic model and expressed treatment effects as an","2021","07","15","Intensive Care Med","Intensive care medicine","Adaptive platform trial; COVID-19; Hydroxychloroquine; Intensive care; Lopinavir-ritonavir; Pandemic; Pneumonia","Berry","Scott","Berry Consultants, Austin, TX, USA",NA
"363","34251506","10.1007/s00134-021-06448-5","Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.","To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill patients with coronavirus disease 2019 (COVID-19). Critically ill adults with COVID-19 were randomized to receive lopinavir-ritonavir, hydroxychloroquine, combination therapy of lopinavir-ritonavir and hydroxychloroquine or no antiviral therapy (control). The primary endpoint was an ordinal scale of organ support-free days. Analyses used a Bayesian cumulative logistic model and expressed treatment effects as an","2021","07","15","Intensive Care Med","Intensive care medicine","Adaptive platform trial; COVID-19; Hydroxychloroquine; Intensive care; Lopinavir-ritonavir; Pandemic; Pneumonia","Marshall","John C","St. Michael's Hospital Unity Health Toronto, Toronto, Canada",NA
"364","34251506","10.1007/s00134-021-06448-5","Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.","To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill patients with coronavirus disease 2019 (COVID-19). Critically ill adults with COVID-19 were randomized to receive lopinavir-ritonavir, hydroxychloroquine, combination therapy of lopinavir-ritonavir and hydroxychloroquine or no antiviral therapy (control). The primary endpoint was an ordinal scale of organ support-free days. Analyses used a Bayesian cumulative logistic model and expressed treatment effects as an","2021","07","15","Intensive Care Med","Intensive care medicine","Adaptive platform trial; COVID-19; Hydroxychloroquine; Intensive care; Lopinavir-ritonavir; Pandemic; Pneumonia","McArthur","Colin","Department of Critical Care Medicine, Auckland City Hospital, Auckland, New Zealand",NA
"365","34251506","10.1007/s00134-021-06448-5","Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.","To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill patients with coronavirus disease 2019 (COVID-19). Critically ill adults with COVID-19 were randomized to receive lopinavir-ritonavir, hydroxychloroquine, combination therapy of lopinavir-ritonavir and hydroxychloroquine or no antiviral therapy (control). The primary endpoint was an ordinal scale of organ support-free days. Analyses used a Bayesian cumulative logistic model and expressed treatment effects as an","2021","07","15","Intensive Care Med","Intensive care medicine","Adaptive platform trial; COVID-19; Hydroxychloroquine; Intensive care; Lopinavir-ritonavir; Pandemic; Pneumonia","Angus","Derek C","UPMC Health System, Pittsburgh, PA, USA",NA
"366","34251506","10.1007/s00134-021-06448-5","Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.","To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill patients with coronavirus disease 2019 (COVID-19). Critically ill adults with COVID-19 were randomized to receive lopinavir-ritonavir, hydroxychloroquine, combination therapy of lopinavir-ritonavir and hydroxychloroquine or no antiviral therapy (control). The primary endpoint was an ordinal scale of organ support-free days. Analyses used a Bayesian cumulative logistic model and expressed treatment effects as an","2021","07","15","Intensive Care Med","Intensive care medicine","Adaptive platform trial; COVID-19; Hydroxychloroquine; Intensive care; Lopinavir-ritonavir; Pandemic; Pneumonia","Webb","Steven A","The Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, Australia",NA
"367","34251472","10.1007/s00192-021-04908-6","Translation and validation of the Persian ICIQ bladder diary.","The objective was to translate the International Consultation of Incontinence Questionnaire (ICIQ) bladder diary into Persian and validate it among the Iranian population with lower urinary tract symptoms. After obtaining permission from the ICIQ group to translate the ICIQ bladder diary into Persian, we translated, back-translated it, and developed a Persian ICIQ bladder diary. Then, we evaluated its reliability and validity virtually via social media owing to some limitations caused by the COV","2021","07","15","Int Urogynecol J","International urogynecology journal","Bladder diary; International Consultation on Incontinence; Lower urinary tract symptoms; Translation; Validation","Tayebi","Sona","Urology Department, Faculty of Medicine, Tabriz University of Medical Sciences, Azadi Street, Golgasht Avenue, Tabriz, East Azarbaijan, 5166/15731, Iran",NA
"368","34251472","10.1007/s00192-021-04908-6","Translation and validation of the Persian ICIQ bladder diary.","The objective was to translate the International Consultation of Incontinence Questionnaire (ICIQ) bladder diary into Persian and validate it among the Iranian population with lower urinary tract symptoms. After obtaining permission from the ICIQ group to translate the ICIQ bladder diary into Persian, we translated, back-translated it, and developed a Persian ICIQ bladder diary. Then, we evaluated its reliability and validity virtually via social media owing to some limitations caused by the COV","2021","07","15","Int Urogynecol J","International urogynecology journal","Bladder diary; International Consultation on Incontinence; Lower urinary tract symptoms; Translation; Validation","Salehi-Pourmehr","Hanieh","Research Center for Evidence-based medicine, Iranian EBM Centre: A Joanna Briggs Institute (JBI) Center of Excellence, Tabriz University of Medical Sciences, Azadi Street, Golgasht Avenue, Tabriz, East Azarbaijan, 5166/15731, Iran",NA
"369","34251472","10.1007/s00192-021-04908-6","Translation and validation of the Persian ICIQ bladder diary.","The objective was to translate the International Consultation of Incontinence Questionnaire (ICIQ) bladder diary into Persian and validate it among the Iranian population with lower urinary tract symptoms. After obtaining permission from the ICIQ group to translate the ICIQ bladder diary into Persian, we translated, back-translated it, and developed a Persian ICIQ bladder diary. Then, we evaluated its reliability and validity virtually via social media owing to some limitations caused by the COV","2021","07","15","Int Urogynecol J","International urogynecology journal","Bladder diary; International Consultation on Incontinence; Lower urinary tract symptoms; Translation; Validation","Hajebrahimi","Sakineh","Urology Department, Faculty of Medicine, Tabriz University of Medical Sciences, Azadi Street, Golgasht Avenue, Tabriz, East Azarbaijan, 5166/15731, Iran. hajebrahimis@gmail","hajebrahimis@gmail.com"
"370","34251472","10.1007/s00192-021-04908-6","Translation and validation of the Persian ICIQ bladder diary.","The objective was to translate the International Consultation of Incontinence Questionnaire (ICIQ) bladder diary into Persian and validate it among the Iranian population with lower urinary tract symptoms. After obtaining permission from the ICIQ group to translate the ICIQ bladder diary into Persian, we translated, back-translated it, and developed a Persian ICIQ bladder diary. Then, we evaluated its reliability and validity virtually via social media owing to some limitations caused by the COV","2021","07","15","Int Urogynecol J","International urogynecology journal","Bladder diary; International Consultation on Incontinence; Lower urinary tract symptoms; Translation; Validation","Hashim","Hashim","Bristol Urological Institute, Southmead Hospital, North Bristol NHS Trust, Bristol, UK",NA
"371","34251465","10.1007/s00103-021-03381-2","[""From Crisis to Health in All Policies."" Conference report from the Poverty and Health 2021 Congress].","The annual Poverty and Health congress, which has been organized by Gesundheit Berlin-Brandenburg e. V. since 1995, has become one of the biggest public health events in Germany. It offers an exchange platform for science, practice, and politics. This year's congress topic was ""From Crisis to Health in All Policies,"" which aimed to address the SARS-CoV-2 pandemic's impact on society in general and public health in particular. Overall, 80 panels were organized with close to 500 experts discussing","2021","07","15","Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz","Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz","COVID-19; Health equity; Health in all policies; Health inequality; Health prevention; Poverty","Amler","Marion","Gesundheit Berlin-Brandenburg e. V., Friedrichstraße 231, 10969, Berlin, Deutschland",NA
"372","34251465","10.1007/s00103-021-03381-2","[""From Crisis to Health in All Policies."" Conference report from the Poverty and Health 2021 Congress].","The annual Poverty and Health congress, which has been organized by Gesundheit Berlin-Brandenburg e. V. since 1995, has become one of the biggest public health events in Germany. It offers an exchange platform for science, practice, and politics. This year's congress topic was ""From Crisis to Health in All Policies,"" which aimed to address the SARS-CoV-2 pandemic's impact on society in general and public health in particular. Overall, 80 panels were organized with close to 500 experts discussing","2021","07","15","Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz","Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz","COVID-19; Health equity; Health in all policies; Health inequality; Health prevention; Poverty","Bollmann","Julian","Gesundheit Berlin-Brandenburg e. V., Friedrichstraße 231, 10969, Berlin, Deutschland",NA
"373","34251465","10.1007/s00103-021-03381-2","[""From Crisis to Health in All Policies."" Conference report from the Poverty and Health 2021 Congress].","The annual Poverty and Health congress, which has been organized by Gesundheit Berlin-Brandenburg e. V. since 1995, has become one of the biggest public health events in Germany. It offers an exchange platform for science, practice, and politics. This year's congress topic was ""From Crisis to Health in All Policies,"" which aimed to address the SARS-CoV-2 pandemic's impact on society in general and public health in particular. Overall, 80 panels were organized with close to 500 experts discussing","2021","07","15","Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz","Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz","COVID-19; Health equity; Health in all policies; Health inequality; Health prevention; Poverty","Waldhauer","Julia","Abteilung für Epidemiologie und Gesundheitsmonitoring, Robert Koch-Institut, Berlin, Deutschland",NA
"374","34251465","10.1007/s00103-021-03381-2","[""From Crisis to Health in All Policies."" Conference report from the Poverty and Health 2021 Congress].","The annual Poverty and Health congress, which has been organized by Gesundheit Berlin-Brandenburg e. V. since 1995, has become one of the biggest public health events in Germany. It offers an exchange platform for science, practice, and politics. This year's congress topic was ""From Crisis to Health in All Policies,"" which aimed to address the SARS-CoV-2 pandemic's impact on society in general and public health in particular. Overall, 80 panels were organized with close to 500 experts discussing","2021","07","15","Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz","Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz","COVID-19; Health equity; Health in all policies; Health inequality; Health prevention; Poverty","Janella","Maren","Gesundheit Berlin-Brandenburg e. V., Friedrichstraße 231, 10969, Berlin, Deutschland. janella@gesundheitbb","janella@gesundheitbb.de"
"375","34251451","10.1093/gerona/glab199","Associations between recently diagnosed conditions and hospitalization due to COVID-19 in patients aged 50 years and older- A SHARE-based analysis.","Only a few studies have been carried out with a large sample size on the relationship between chronic conditions and hospitalization for COVID-19, and there is no research examining recently diagnosed conditions. Our purpose was to evaluate this association in a large sample including the older population from Europe and Israel. Data from the SHARE COVID-19 Survey, a representative survey of individuals aged 50 or over residing in 27 European countries and Israel, were retrieved. Associations be","2021","07","12","J Gerontol A Biol Sci Med Sci","The journals of gerontology. Series A, Biological sciences and medical sciences","SARS-CoV-2; diabetes; hypertension; lung disease; multimorbidity","López-Bueno","Rubén","Department of Physical Medicine and Nursing, University of Zaragoza, Zaragoza, Spain",NA
"376","34251451","10.1093/gerona/glab199","Associations between recently diagnosed conditions and hospitalization due to COVID-19 in patients aged 50 years and older- A SHARE-based analysis.","Only a few studies have been carried out with a large sample size on the relationship between chronic conditions and hospitalization for COVID-19, and there is no research examining recently diagnosed conditions. Our purpose was to evaluate this association in a large sample including the older population from Europe and Israel. Data from the SHARE COVID-19 Survey, a representative survey of individuals aged 50 or over residing in 27 European countries and Israel, were retrieved. Associations be","2021","07","12","J Gerontol A Biol Sci Med Sci","The journals of gerontology. Series A, Biological sciences and medical sciences","SARS-CoV-2; diabetes; hypertension; lung disease; multimorbidity","Torres-Castro","Rodrigo","Department of Physical Therapy, Faculty of Medicine, University of Chile, Santiago, Chile",NA
"377","34251451","10.1093/gerona/glab199","Associations between recently diagnosed conditions and hospitalization due to COVID-19 in patients aged 50 years and older- A SHARE-based analysis.","Only a few studies have been carried out with a large sample size on the relationship between chronic conditions and hospitalization for COVID-19, and there is no research examining recently diagnosed conditions. Our purpose was to evaluate this association in a large sample including the older population from Europe and Israel. Data from the SHARE COVID-19 Survey, a representative survey of individuals aged 50 or over residing in 27 European countries and Israel, were retrieved. Associations be","2021","07","12","J Gerontol A Biol Sci Med Sci","The journals of gerontology. Series A, Biological sciences and medical sciences","SARS-CoV-2; diabetes; hypertension; lung disease; multimorbidity","Koyanagi","Ai","Research and Development Unit, Parc Sanitari Sant Joan de Déu, Barcelona, Spain",NA
"378","34251451","10.1093/gerona/glab199","Associations between recently diagnosed conditions and hospitalization due to COVID-19 in patients aged 50 years and older- A SHARE-based analysis.","Only a few studies have been carried out with a large sample size on the relationship between chronic conditions and hospitalization for COVID-19, and there is no research examining recently diagnosed conditions. Our purpose was to evaluate this association in a large sample including the older population from Europe and Israel. Data from the SHARE COVID-19 Survey, a representative survey of individuals aged 50 or over residing in 27 European countries and Israel, were retrieved. Associations be","2021","07","12","J Gerontol A Biol Sci Med Sci","The journals of gerontology. Series A, Biological sciences and medical sciences","SARS-CoV-2; diabetes; hypertension; lung disease; multimorbidity","Smith","Lee","Cambridge Centre for Sport and Exercise Science, Anglia Ruskin University, Cambridge, United Kingdom",NA
"379","34251451","10.1093/gerona/glab199","Associations between recently diagnosed conditions and hospitalization due to COVID-19 in patients aged 50 years and older- A SHARE-based analysis.","Only a few studies have been carried out with a large sample size on the relationship between chronic conditions and hospitalization for COVID-19, and there is no research examining recently diagnosed conditions. Our purpose was to evaluate this association in a large sample including the older population from Europe and Israel. Data from the SHARE COVID-19 Survey, a representative survey of individuals aged 50 or over residing in 27 European countries and Israel, were retrieved. Associations be","2021","07","12","J Gerontol A Biol Sci Med Sci","The journals of gerontology. Series A, Biological sciences and medical sciences","SARS-CoV-2; diabetes; hypertension; lung disease; multimorbidity","Soysal","Pinar","Department of Geriatric Medicine, Faculty of Medicine, Bezmialem Vakif University, Istanbul, Turkey",NA
"380","34251451","10.1093/gerona/glab199","Associations between recently diagnosed conditions and hospitalization due to COVID-19 in patients aged 50 years and older- A SHARE-based analysis.","Only a few studies have been carried out with a large sample size on the relationship between chronic conditions and hospitalization for COVID-19, and there is no research examining recently diagnosed conditions. Our purpose was to evaluate this association in a large sample including the older population from Europe and Israel. Data from the SHARE COVID-19 Survey, a representative survey of individuals aged 50 or over residing in 27 European countries and Israel, were retrieved. Associations be","2021","07","12","J Gerontol A Biol Sci Med Sci","The journals of gerontology. Series A, Biological sciences and medical sciences","SARS-CoV-2; diabetes; hypertension; lung disease; multimorbidity","Calatayud","Joaquín","National Research Centre for the Working Environment, Copenhagen, Denmark",NA
"381","34251441","10.1001/jamanetworkopen.2021.16572","Estimated SARS-CoV-2 Seroprevalence in US Patients Receiving Dialysis 1 Year After the Beginning of the COVID-19 Pandemic.","Seroprevalence studies complement data on detected cases and attributed deaths in assessing the cumulative spread of the SARS-CoV-2 virus. To estimate seroprevalence of SARS-CoV-2 antibodies in patients receiving dialysis and adults in the US in January 2021 before the widespread introduction of COVID-19 vaccines. This cross-sectional study used data from the third largest US dialysis organization (US Renal Care), which has facilities located nationwide, to estimate SARS-CoV-2 seroprevalence amo","2021","07","19","JAMA Netw Open","JAMA network open","Aged; Aged, 80 and over; COVID-19; Cross-Sectional Studies; Dialysis; Female; Humans; Male; Middle Aged; Plasma; SARS-CoV-2; Seroepidemiologic Studies; Surveys and Questionnaires; United States","Anand","Shuchi","Division of Nephrology, Department of Medicine, Stanford University, Palo Alto, California",NA
"382","34251441","10.1001/jamanetworkopen.2021.16572","Estimated SARS-CoV-2 Seroprevalence in US Patients Receiving Dialysis 1 Year After the Beginning of the COVID-19 Pandemic.","Seroprevalence studies complement data on detected cases and attributed deaths in assessing the cumulative spread of the SARS-CoV-2 virus. To estimate seroprevalence of SARS-CoV-2 antibodies in patients receiving dialysis and adults in the US in January 2021 before the widespread introduction of COVID-19 vaccines. This cross-sectional study used data from the third largest US dialysis organization (US Renal Care), which has facilities located nationwide, to estimate SARS-CoV-2 seroprevalence amo","2021","07","19","JAMA Netw Open","JAMA network open","Aged; Aged, 80 and over; COVID-19; Cross-Sectional Studies; Dialysis; Female; Humans; Male; Middle Aged; Plasma; SARS-CoV-2; Seroepidemiologic Studies; Surveys and Questionnaires; United States","Montez-Rath","Maria","Division of Nephrology, Department of Medicine, Stanford University, Palo Alto, California",NA
"383","34251441","10.1001/jamanetworkopen.2021.16572","Estimated SARS-CoV-2 Seroprevalence in US Patients Receiving Dialysis 1 Year After the Beginning of the COVID-19 Pandemic.","Seroprevalence studies complement data on detected cases and attributed deaths in assessing the cumulative spread of the SARS-CoV-2 virus. To estimate seroprevalence of SARS-CoV-2 antibodies in patients receiving dialysis and adults in the US in January 2021 before the widespread introduction of COVID-19 vaccines. This cross-sectional study used data from the third largest US dialysis organization (US Renal Care), which has facilities located nationwide, to estimate SARS-CoV-2 seroprevalence amo","2021","07","19","JAMA Netw Open","JAMA network open","Aged; Aged, 80 and over; COVID-19; Cross-Sectional Studies; Dialysis; Female; Humans; Male; Middle Aged; Plasma; SARS-CoV-2; Seroepidemiologic Studies; Surveys and Questionnaires; United States","Han","Jialin","Division of Nephrology, Department of Medicine, Stanford University, Palo Alto, California",NA
"384","34251441","10.1001/jamanetworkopen.2021.16572","Estimated SARS-CoV-2 Seroprevalence in US Patients Receiving Dialysis 1 Year After the Beginning of the COVID-19 Pandemic.","Seroprevalence studies complement data on detected cases and attributed deaths in assessing the cumulative spread of the SARS-CoV-2 virus. To estimate seroprevalence of SARS-CoV-2 antibodies in patients receiving dialysis and adults in the US in January 2021 before the widespread introduction of COVID-19 vaccines. This cross-sectional study used data from the third largest US dialysis organization (US Renal Care), which has facilities located nationwide, to estimate SARS-CoV-2 seroprevalence amo","2021","07","19","JAMA Netw Open","JAMA network open","Aged; Aged, 80 and over; COVID-19; Cross-Sectional Studies; Dialysis; Female; Humans; Male; Middle Aged; Plasma; SARS-CoV-2; Seroepidemiologic Studies; Surveys and Questionnaires; United States","Cadden","LinaCel","Ascend Clinical Laboratory, Redwood City, California",NA
"385","34251441","10.1001/jamanetworkopen.2021.16572","Estimated SARS-CoV-2 Seroprevalence in US Patients Receiving Dialysis 1 Year After the Beginning of the COVID-19 Pandemic.","Seroprevalence studies complement data on detected cases and attributed deaths in assessing the cumulative spread of the SARS-CoV-2 virus. To estimate seroprevalence of SARS-CoV-2 antibodies in patients receiving dialysis and adults in the US in January 2021 before the widespread introduction of COVID-19 vaccines. This cross-sectional study used data from the third largest US dialysis organization (US Renal Care), which has facilities located nationwide, to estimate SARS-CoV-2 seroprevalence amo","2021","07","19","JAMA Netw Open","JAMA network open","Aged; Aged, 80 and over; COVID-19; Cross-Sectional Studies; Dialysis; Female; Humans; Male; Middle Aged; Plasma; SARS-CoV-2; Seroepidemiologic Studies; Surveys and Questionnaires; United States","Hunsader","Patti","Ascend Clinical Laboratory, Redwood City, California",NA
"386","34251441","10.1001/jamanetworkopen.2021.16572","Estimated SARS-CoV-2 Seroprevalence in US Patients Receiving Dialysis 1 Year After the Beginning of the COVID-19 Pandemic.","Seroprevalence studies complement data on detected cases and attributed deaths in assessing the cumulative spread of the SARS-CoV-2 virus. To estimate seroprevalence of SARS-CoV-2 antibodies in patients receiving dialysis and adults in the US in January 2021 before the widespread introduction of COVID-19 vaccines. This cross-sectional study used data from the third largest US dialysis organization (US Renal Care), which has facilities located nationwide, to estimate SARS-CoV-2 seroprevalence amo","2021","07","19","JAMA Netw Open","JAMA network open","Aged; Aged, 80 and over; COVID-19; Cross-Sectional Studies; Dialysis; Female; Humans; Male; Middle Aged; Plasma; SARS-CoV-2; Seroepidemiologic Studies; Surveys and Questionnaires; United States","Kerschmann","Russell","Ascend Clinical Laboratory, Redwood City, California",NA
"387","34251441","10.1001/jamanetworkopen.2021.16572","Estimated SARS-CoV-2 Seroprevalence in US Patients Receiving Dialysis 1 Year After the Beginning of the COVID-19 Pandemic.","Seroprevalence studies complement data on detected cases and attributed deaths in assessing the cumulative spread of the SARS-CoV-2 virus. To estimate seroprevalence of SARS-CoV-2 antibodies in patients receiving dialysis and adults in the US in January 2021 before the widespread introduction of COVID-19 vaccines. This cross-sectional study used data from the third largest US dialysis organization (US Renal Care), which has facilities located nationwide, to estimate SARS-CoV-2 seroprevalence amo","2021","07","19","JAMA Netw Open","JAMA network open","Aged; Aged, 80 and over; COVID-19; Cross-Sectional Studies; Dialysis; Female; Humans; Male; Middle Aged; Plasma; SARS-CoV-2; Seroepidemiologic Studies; Surveys and Questionnaires; United States","Beyer","Paul","Ascend Clinical Laboratory, Redwood City, California",NA
"388","34251441","10.1001/jamanetworkopen.2021.16572","Estimated SARS-CoV-2 Seroprevalence in US Patients Receiving Dialysis 1 Year After the Beginning of the COVID-19 Pandemic.","Seroprevalence studies complement data on detected cases and attributed deaths in assessing the cumulative spread of the SARS-CoV-2 virus. To estimate seroprevalence of SARS-CoV-2 antibodies in patients receiving dialysis and adults in the US in January 2021 before the widespread introduction of COVID-19 vaccines. This cross-sectional study used data from the third largest US dialysis organization (US Renal Care), which has facilities located nationwide, to estimate SARS-CoV-2 seroprevalence amo","2021","07","19","JAMA Netw Open","JAMA network open","Aged; Aged, 80 and over; COVID-19; Cross-Sectional Studies; Dialysis; Female; Humans; Male; Middle Aged; Plasma; SARS-CoV-2; Seroepidemiologic Studies; Surveys and Questionnaires; United States","Boyd","Scott D","Department of Pathology, Stanford University, Palo Alto, California",NA
"389","34251441","10.1001/jamanetworkopen.2021.16572","Estimated SARS-CoV-2 Seroprevalence in US Patients Receiving Dialysis 1 Year After the Beginning of the COVID-19 Pandemic.","Seroprevalence studies complement data on detected cases and attributed deaths in assessing the cumulative spread of the SARS-CoV-2 virus. To estimate seroprevalence of SARS-CoV-2 antibodies in patients receiving dialysis and adults in the US in January 2021 before the widespread introduction of COVID-19 vaccines. This cross-sectional study used data from the third largest US dialysis organization (US Renal Care), which has facilities located nationwide, to estimate SARS-CoV-2 seroprevalence amo","2021","07","19","JAMA Netw Open","JAMA network open","Aged; Aged, 80 and over; COVID-19; Cross-Sectional Studies; Dialysis; Female; Humans; Male; Middle Aged; Plasma; SARS-CoV-2; Seroepidemiologic Studies; Surveys and Questionnaires; United States","Garcia","Pablo","Division of Nephrology, Department of Medicine, Stanford University, Palo Alto, California",NA
"390","34251441","10.1001/jamanetworkopen.2021.16572","Estimated SARS-CoV-2 Seroprevalence in US Patients Receiving Dialysis 1 Year After the Beginning of the COVID-19 Pandemic.","Seroprevalence studies complement data on detected cases and attributed deaths in assessing the cumulative spread of the SARS-CoV-2 virus. To estimate seroprevalence of SARS-CoV-2 antibodies in patients receiving dialysis and adults in the US in January 2021 before the widespread introduction of COVID-19 vaccines. This cross-sectional study used data from the third largest US dialysis organization (US Renal Care), which has facilities located nationwide, to estimate SARS-CoV-2 seroprevalence amo","2021","07","19","JAMA Netw Open","JAMA network open","Aged; Aged, 80 and over; COVID-19; Cross-Sectional Studies; Dialysis; Female; Humans; Male; Middle Aged; Plasma; SARS-CoV-2; Seroepidemiologic Studies; Surveys and Questionnaires; United States","Dittrich","Mary","US Renal Care, Plano, Texas",NA
"391","34251441","10.1001/jamanetworkopen.2021.16572","Estimated SARS-CoV-2 Seroprevalence in US Patients Receiving Dialysis 1 Year After the Beginning of the COVID-19 Pandemic.","Seroprevalence studies complement data on detected cases and attributed deaths in assessing the cumulative spread of the SARS-CoV-2 virus. To estimate seroprevalence of SARS-CoV-2 antibodies in patients receiving dialysis and adults in the US in January 2021 before the widespread introduction of COVID-19 vaccines. This cross-sectional study used data from the third largest US dialysis organization (US Renal Care), which has facilities located nationwide, to estimate SARS-CoV-2 seroprevalence amo","2021","07","19","JAMA Netw Open","JAMA network open","Aged; Aged, 80 and over; COVID-19; Cross-Sectional Studies; Dialysis; Female; Humans; Male; Middle Aged; Plasma; SARS-CoV-2; Seroepidemiologic Studies; Surveys and Questionnaires; United States","Block","Geoffrey A","US Renal Care, Plano, Texas",NA
"392","34251441","10.1001/jamanetworkopen.2021.16572","Estimated SARS-CoV-2 Seroprevalence in US Patients Receiving Dialysis 1 Year After the Beginning of the COVID-19 Pandemic.","Seroprevalence studies complement data on detected cases and attributed deaths in assessing the cumulative spread of the SARS-CoV-2 virus. To estimate seroprevalence of SARS-CoV-2 antibodies in patients receiving dialysis and adults in the US in January 2021 before the widespread introduction of COVID-19 vaccines. This cross-sectional study used data from the third largest US dialysis organization (US Renal Care), which has facilities located nationwide, to estimate SARS-CoV-2 seroprevalence amo","2021","07","19","JAMA Netw Open","JAMA network open","Aged; Aged, 80 and over; COVID-19; Cross-Sectional Studies; Dialysis; Female; Humans; Male; Middle Aged; Plasma; SARS-CoV-2; Seroepidemiologic Studies; Surveys and Questionnaires; United States","Parsonnet","Julie","Division of Infectious Diseases &amp",NA
"393","34251441","10.1001/jamanetworkopen.2021.16572","Estimated SARS-CoV-2 Seroprevalence in US Patients Receiving Dialysis 1 Year After the Beginning of the COVID-19 Pandemic.","Seroprevalence studies complement data on detected cases and attributed deaths in assessing the cumulative spread of the SARS-CoV-2 virus. To estimate seroprevalence of SARS-CoV-2 antibodies in patients receiving dialysis and adults in the US in January 2021 before the widespread introduction of COVID-19 vaccines. This cross-sectional study used data from the third largest US dialysis organization (US Renal Care), which has facilities located nationwide, to estimate SARS-CoV-2 seroprevalence amo","2021","07","19","JAMA Netw Open","JAMA network open","Aged; Aged, 80 and over; COVID-19; Cross-Sectional Studies; Dialysis; Female; Humans; Male; Middle Aged; Plasma; SARS-CoV-2; Seroepidemiologic Studies; Surveys and Questionnaires; United States","Chertow","Glenn M","Division of Nephrology, Department of Medicine, Stanford University, Palo Alto, California",NA
"394","34251432","10.1093/infdis/jiab362","Letter to the Editor in Response to Zhou et al.",NA,"2021","07","13","J Infect Dis","The Journal of infectious diseases","Antiviral; COVID-19; Molnupiravir; SARS-CoV-2","Troth","Sean","Merck &amp",NA
"395","34251432","10.1093/infdis/jiab362","Letter to the Editor in Response to Zhou et al.",NA,"2021","07","13","J Infect Dis","The Journal of infectious diseases","Antiviral; COVID-19; Molnupiravir; SARS-CoV-2","Butterton","Joan","Merck &amp",NA
"396","34251432","10.1093/infdis/jiab362","Letter to the Editor in Response to Zhou et al.",NA,"2021","07","13","J Infect Dis","The Journal of infectious diseases","Antiviral; COVID-19; Molnupiravir; SARS-CoV-2","DeAnda","Carisa Stadlman","Merck &amp",NA
"397","34251432","10.1093/infdis/jiab362","Letter to the Editor in Response to Zhou et al.",NA,"2021","07","13","J Infect Dis","The Journal of infectious diseases","Antiviral; COVID-19; Molnupiravir; SARS-CoV-2","Escobar","Patricia","Merck &amp",NA
"398","34251432","10.1093/infdis/jiab362","Letter to the Editor in Response to Zhou et al.",NA,"2021","07","13","J Infect Dis","The Journal of infectious diseases","Antiviral; COVID-19; Molnupiravir; SARS-CoV-2","Grobler","Jay","Merck &amp",NA
"399","34251432","10.1093/infdis/jiab362","Letter to the Editor in Response to Zhou et al.",NA,"2021","07","13","J Infect Dis","The Journal of infectious diseases","Antiviral; COVID-19; Molnupiravir; SARS-CoV-2","Hazuda","Daria","Merck &amp",NA
"400","34251432","10.1093/infdis/jiab362","Letter to the Editor in Response to Zhou et al.",NA,"2021","07","13","J Infect Dis","The Journal of infectious diseases","Antiviral; COVID-19; Molnupiravir; SARS-CoV-2","Painter","George","Emory Institute of Drug Development (EIDD), Emory University, Atlanta, GA, USA",NA
"401","34251417","10.1001/jama.2021.11035","Association Between BNT162b2 Vaccination and Incidence of SARS-CoV-2 Infection in Pregnant Women.","Data on BNT162b2 messenger RNA (mRNA) vaccine (Pfizer-BioNTech) effectiveness and safety in pregnancy are currently lacking because pregnant women were excluded from the phase 3 trial. To assess the association between receipt of BNT162b2 mRNA vaccine and risk of SARS-CoV-2 infection among pregnant women. This was a retrospective cohort study within the pregnancy registry of a large state-mandated health care organization in Israel. Pregnant women vaccinated with a first dose from December 19, 2","2021","07","20","JAMA","JAMA",NA,"Goldshtein","Inbal","Maccabitech Institute for Research and Innovation, Maccabi Healthcare Services, Tel Aviv, Israel",NA
"402","34251417","10.1001/jama.2021.11035","Association Between BNT162b2 Vaccination and Incidence of SARS-CoV-2 Infection in Pregnant Women.","Data on BNT162b2 messenger RNA (mRNA) vaccine (Pfizer-BioNTech) effectiveness and safety in pregnancy are currently lacking because pregnant women were excluded from the phase 3 trial. To assess the association between receipt of BNT162b2 mRNA vaccine and risk of SARS-CoV-2 infection among pregnant women. This was a retrospective cohort study within the pregnancy registry of a large state-mandated health care organization in Israel. Pregnant women vaccinated with a first dose from December 19, 2","2021","07","20","JAMA","JAMA",NA,"Nevo","Daniel","Department of Statistics and Operations Research, Tel Aviv University, Tel Aviv, Israel",NA
"403","34251417","10.1001/jama.2021.11035","Association Between BNT162b2 Vaccination and Incidence of SARS-CoV-2 Infection in Pregnant Women.","Data on BNT162b2 messenger RNA (mRNA) vaccine (Pfizer-BioNTech) effectiveness and safety in pregnancy are currently lacking because pregnant women were excluded from the phase 3 trial. To assess the association between receipt of BNT162b2 mRNA vaccine and risk of SARS-CoV-2 infection among pregnant women. This was a retrospective cohort study within the pregnancy registry of a large state-mandated health care organization in Israel. Pregnant women vaccinated with a first dose from December 19, 2","2021","07","20","JAMA","JAMA",NA,"Steinberg","David M","Department of Statistics and Operations Research, Tel Aviv University, Tel Aviv, Israel",NA
"404","34251417","10.1001/jama.2021.11035","Association Between BNT162b2 Vaccination and Incidence of SARS-CoV-2 Infection in Pregnant Women.","Data on BNT162b2 messenger RNA (mRNA) vaccine (Pfizer-BioNTech) effectiveness and safety in pregnancy are currently lacking because pregnant women were excluded from the phase 3 trial. To assess the association between receipt of BNT162b2 mRNA vaccine and risk of SARS-CoV-2 infection among pregnant women. This was a retrospective cohort study within the pregnancy registry of a large state-mandated health care organization in Israel. Pregnant women vaccinated with a first dose from December 19, 2","2021","07","20","JAMA","JAMA",NA,"Rotem","Ran S","Maccabitech Institute for Research and Innovation, Maccabi Healthcare Services, Tel Aviv, Israel",NA
"405","34251417","10.1001/jama.2021.11035","Association Between BNT162b2 Vaccination and Incidence of SARS-CoV-2 Infection in Pregnant Women.","Data on BNT162b2 messenger RNA (mRNA) vaccine (Pfizer-BioNTech) effectiveness and safety in pregnancy are currently lacking because pregnant women were excluded from the phase 3 trial. To assess the association between receipt of BNT162b2 mRNA vaccine and risk of SARS-CoV-2 infection among pregnant women. This was a retrospective cohort study within the pregnancy registry of a large state-mandated health care organization in Israel. Pregnant women vaccinated with a first dose from December 19, 2","2021","07","20","JAMA","JAMA",NA,"Gorfine","Malka","Department of Statistics and Operations Research, Tel Aviv University, Tel Aviv, Israel",NA
"406","34251417","10.1001/jama.2021.11035","Association Between BNT162b2 Vaccination and Incidence of SARS-CoV-2 Infection in Pregnant Women.","Data on BNT162b2 messenger RNA (mRNA) vaccine (Pfizer-BioNTech) effectiveness and safety in pregnancy are currently lacking because pregnant women were excluded from the phase 3 trial. To assess the association between receipt of BNT162b2 mRNA vaccine and risk of SARS-CoV-2 infection among pregnant women. This was a retrospective cohort study within the pregnancy registry of a large state-mandated health care organization in Israel. Pregnant women vaccinated with a first dose from December 19, 2","2021","07","20","JAMA","JAMA",NA,"Chodick","Gabriel","Maccabitech Institute for Research and Innovation, Maccabi Healthcare Services, Tel Aviv, Israel",NA
"407","34251417","10.1001/jama.2021.11035","Association Between BNT162b2 Vaccination and Incidence of SARS-CoV-2 Infection in Pregnant Women.","Data on BNT162b2 messenger RNA (mRNA) vaccine (Pfizer-BioNTech) effectiveness and safety in pregnancy are currently lacking because pregnant women were excluded from the phase 3 trial. To assess the association between receipt of BNT162b2 mRNA vaccine and risk of SARS-CoV-2 infection among pregnant women. This was a retrospective cohort study within the pregnancy registry of a large state-mandated health care organization in Israel. Pregnant women vaccinated with a first dose from December 19, 2","2021","07","20","JAMA","JAMA",NA,"Segal","Yaakov","Primary Health Division, Maccabi Healthcare Services, Tel Aviv, Israel",NA
"408","34251411","10.1001/jamapediatrics.2021.1855","COVID-19 Vaccination of Minors Without Parental Consent: Respecting Emerging Autonomy and Advancing Public Health.",NA,"2021","07","12","JAMA Pediatr","JAMA pediatrics",NA,"Morgan","Larissa","University of Pennsylvania Carey Law School, Philadelphia",NA
"409","34251411","10.1001/jamapediatrics.2021.1855","COVID-19 Vaccination of Minors Without Parental Consent: Respecting Emerging Autonomy and Advancing Public Health.",NA,"2021","07","12","JAMA Pediatr","JAMA pediatrics",NA,"Schwartz","Jason L","Department of Health Policy and Management, School of Public Health, Yale University, New Haven, Connecticut",NA
"410","34251411","10.1001/jamapediatrics.2021.1855","COVID-19 Vaccination of Minors Without Parental Consent: Respecting Emerging Autonomy and Advancing Public Health.",NA,"2021","07","12","JAMA Pediatr","JAMA pediatrics",NA,"Sisti","Dominic A","Department of Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania, Philadelphia",NA
"411","34251356","10.1172/jci.insight.150012","Simultaneous evaluation of antibodies that inhibit SARS-CoV-2 variants via multiplex assay.","The SARS-CoV-2 Receptor Binding Domain (RBD) is both the principal target of neutralizing antibodies, and one of the most rapidly evolving domains, which can result in the emergence of immune escape mutations limiting the effectiveness of vaccines and antibody therapeutics. To facilitate surveillance, we developed a rapid, high-throughput, multiplex assay able to assess the inhibitory response of antibodies to 24 RBD natural variants simultaneously. We demonstrate how this assay can be implement","2021","07","12","JCI Insight","JCI insight","COVID-19; Immunoglobulins","Lopez","Ester","Department of Microbiology and Immunology, The University of Melbourne, Melbourne, Australia",NA
"412","34251356","10.1172/jci.insight.150012","Simultaneous evaluation of antibodies that inhibit SARS-CoV-2 variants via multiplex assay.","The SARS-CoV-2 Receptor Binding Domain (RBD) is both the principal target of neutralizing antibodies, and one of the most rapidly evolving domains, which can result in the emergence of immune escape mutations limiting the effectiveness of vaccines and antibody therapeutics. To facilitate surveillance, we developed a rapid, high-throughput, multiplex assay able to assess the inhibitory response of antibodies to 24 RBD natural variants simultaneously. We demonstrate how this assay can be implement","2021","07","12","JCI Insight","JCI insight","COVID-19; Immunoglobulins","Haycroft","Ebene R","Department of Microbiology and Immunology, The University of Melbourne, Melbourne, Australia",NA
"413","34251356","10.1172/jci.insight.150012","Simultaneous evaluation of antibodies that inhibit SARS-CoV-2 variants via multiplex assay.","The SARS-CoV-2 Receptor Binding Domain (RBD) is both the principal target of neutralizing antibodies, and one of the most rapidly evolving domains, which can result in the emergence of immune escape mutations limiting the effectiveness of vaccines and antibody therapeutics. To facilitate surveillance, we developed a rapid, high-throughput, multiplex assay able to assess the inhibitory response of antibodies to 24 RBD natural variants simultaneously. We demonstrate how this assay can be implement","2021","07","12","JCI Insight","JCI insight","COVID-19; Immunoglobulins","Adair","Amy","Infectious Diseases and Immune Defense Division, The Walter and Eliza Hall Institute, Melbourne, Australia",NA
"414","34251356","10.1172/jci.insight.150012","Simultaneous evaluation of antibodies that inhibit SARS-CoV-2 variants via multiplex assay.","The SARS-CoV-2 Receptor Binding Domain (RBD) is both the principal target of neutralizing antibodies, and one of the most rapidly evolving domains, which can result in the emergence of immune escape mutations limiting the effectiveness of vaccines and antibody therapeutics. To facilitate surveillance, we developed a rapid, high-throughput, multiplex assay able to assess the inhibitory response of antibodies to 24 RBD natural variants simultaneously. We demonstrate how this assay can be implement","2021","07","12","JCI Insight","JCI insight","COVID-19; Immunoglobulins","Mordant","Francesca L","Department of Microbiology and Immunology, The University of Melbourne, Melbourne, Australia",NA
"415","34251356","10.1172/jci.insight.150012","Simultaneous evaluation of antibodies that inhibit SARS-CoV-2 variants via multiplex assay.","The SARS-CoV-2 Receptor Binding Domain (RBD) is both the principal target of neutralizing antibodies, and one of the most rapidly evolving domains, which can result in the emergence of immune escape mutations limiting the effectiveness of vaccines and antibody therapeutics. To facilitate surveillance, we developed a rapid, high-throughput, multiplex assay able to assess the inhibitory response of antibodies to 24 RBD natural variants simultaneously. We demonstrate how this assay can be implement","2021","07","12","JCI Insight","JCI insight","COVID-19; Immunoglobulins","O'Neill","Matthew T","Infectious Diseases and Immune Defense Division, The Walter and Eliza Hall Institute, Melbourne, Australia",NA
"416","34251356","10.1172/jci.insight.150012","Simultaneous evaluation of antibodies that inhibit SARS-CoV-2 variants via multiplex assay.","The SARS-CoV-2 Receptor Binding Domain (RBD) is both the principal target of neutralizing antibodies, and one of the most rapidly evolving domains, which can result in the emergence of immune escape mutations limiting the effectiveness of vaccines and antibody therapeutics. To facilitate surveillance, we developed a rapid, high-throughput, multiplex assay able to assess the inhibitory response of antibodies to 24 RBD natural variants simultaneously. We demonstrate how this assay can be implement","2021","07","12","JCI Insight","JCI insight","COVID-19; Immunoglobulins","Pymm","Phillip","Infectious Diseases and Immune Defense Division, The Walter and Eliza Hall Institute, Melbourne, Australia",NA
"417","34251356","10.1172/jci.insight.150012","Simultaneous evaluation of antibodies that inhibit SARS-CoV-2 variants via multiplex assay.","The SARS-CoV-2 Receptor Binding Domain (RBD) is both the principal target of neutralizing antibodies, and one of the most rapidly evolving domains, which can result in the emergence of immune escape mutations limiting the effectiveness of vaccines and antibody therapeutics. To facilitate surveillance, we developed a rapid, high-throughput, multiplex assay able to assess the inhibitory response of antibodies to 24 RBD natural variants simultaneously. We demonstrate how this assay can be implement","2021","07","12","JCI Insight","JCI insight","COVID-19; Immunoglobulins","Redmond","Samuel J","Department of Microbiology and Immunology, The University of Melbourne, Melbourne, Australia",NA
"418","34251356","10.1172/jci.insight.150012","Simultaneous evaluation of antibodies that inhibit SARS-CoV-2 variants via multiplex assay.","The SARS-CoV-2 Receptor Binding Domain (RBD) is both the principal target of neutralizing antibodies, and one of the most rapidly evolving domains, which can result in the emergence of immune escape mutations limiting the effectiveness of vaccines and antibody therapeutics. To facilitate surveillance, we developed a rapid, high-throughput, multiplex assay able to assess the inhibitory response of antibodies to 24 RBD natural variants simultaneously. We demonstrate how this assay can be implement","2021","07","12","JCI Insight","JCI insight","COVID-19; Immunoglobulins","Lee","Wen Shi","Department of Microbiology and Immunology, The University of Melbourne, Melbourne, Australia",NA
"419","34251356","10.1172/jci.insight.150012","Simultaneous evaluation of antibodies that inhibit SARS-CoV-2 variants via multiplex assay.","The SARS-CoV-2 Receptor Binding Domain (RBD) is both the principal target of neutralizing antibodies, and one of the most rapidly evolving domains, which can result in the emergence of immune escape mutations limiting the effectiveness of vaccines and antibody therapeutics. To facilitate surveillance, we developed a rapid, high-throughput, multiplex assay able to assess the inhibitory response of antibodies to 24 RBD natural variants simultaneously. We demonstrate how this assay can be implement","2021","07","12","JCI Insight","JCI insight","COVID-19; Immunoglobulins","Gherardin","Nicholas A","Department of Microbiology and Immunology, The University of Melbourne, Melbourne, Australia",NA
"420","34251356","10.1172/jci.insight.150012","Simultaneous evaluation of antibodies that inhibit SARS-CoV-2 variants via multiplex assay.","The SARS-CoV-2 Receptor Binding Domain (RBD) is both the principal target of neutralizing antibodies, and one of the most rapidly evolving domains, which can result in the emergence of immune escape mutations limiting the effectiveness of vaccines and antibody therapeutics. To facilitate surveillance, we developed a rapid, high-throughput, multiplex assay able to assess the inhibitory response of antibodies to 24 RBD natural variants simultaneously. We demonstrate how this assay can be implement","2021","07","12","JCI Insight","JCI insight","COVID-19; Immunoglobulins","Wheatley","Adam K","Department of Microbiology and Immunology, The University of Melbourne, Melbourne, Australia",NA
"421","34251356","10.1172/jci.insight.150012","Simultaneous evaluation of antibodies that inhibit SARS-CoV-2 variants via multiplex assay.","The SARS-CoV-2 Receptor Binding Domain (RBD) is both the principal target of neutralizing antibodies, and one of the most rapidly evolving domains, which can result in the emergence of immune escape mutations limiting the effectiveness of vaccines and antibody therapeutics. To facilitate surveillance, we developed a rapid, high-throughput, multiplex assay able to assess the inhibitory response of antibodies to 24 RBD natural variants simultaneously. We demonstrate how this assay can be implement","2021","07","12","JCI Insight","JCI insight","COVID-19; Immunoglobulins","Juno","Jennifer A","Department of Microbiology and Immunology, The University of Melbourne, Melbourne, Australia",NA
"422","34251356","10.1172/jci.insight.150012","Simultaneous evaluation of antibodies that inhibit SARS-CoV-2 variants via multiplex assay.","The SARS-CoV-2 Receptor Binding Domain (RBD) is both the principal target of neutralizing antibodies, and one of the most rapidly evolving domains, which can result in the emergence of immune escape mutations limiting the effectiveness of vaccines and antibody therapeutics. To facilitate surveillance, we developed a rapid, high-throughput, multiplex assay able to assess the inhibitory response of antibodies to 24 RBD natural variants simultaneously. We demonstrate how this assay can be implement","2021","07","12","JCI Insight","JCI insight","COVID-19; Immunoglobulins","Selva","Kevin John","Department of Microbiology and Immunology, The University of Melbourne, Melbourne, Australia",NA
"423","34251356","10.1172/jci.insight.150012","Simultaneous evaluation of antibodies that inhibit SARS-CoV-2 variants via multiplex assay.","The SARS-CoV-2 Receptor Binding Domain (RBD) is both the principal target of neutralizing antibodies, and one of the most rapidly evolving domains, which can result in the emergence of immune escape mutations limiting the effectiveness of vaccines and antibody therapeutics. To facilitate surveillance, we developed a rapid, high-throughput, multiplex assay able to assess the inhibitory response of antibodies to 24 RBD natural variants simultaneously. We demonstrate how this assay can be implement","2021","07","12","JCI Insight","JCI insight","COVID-19; Immunoglobulins","Davis","Samantha K","Department of Microbiology and Immunology, The University of Melbourne, Melbourne, Australia",NA
"424","34251356","10.1172/jci.insight.150012","Simultaneous evaluation of antibodies that inhibit SARS-CoV-2 variants via multiplex assay.","The SARS-CoV-2 Receptor Binding Domain (RBD) is both the principal target of neutralizing antibodies, and one of the most rapidly evolving domains, which can result in the emergence of immune escape mutations limiting the effectiveness of vaccines and antibody therapeutics. To facilitate surveillance, we developed a rapid, high-throughput, multiplex assay able to assess the inhibitory response of antibodies to 24 RBD natural variants simultaneously. We demonstrate how this assay can be implement","2021","07","12","JCI Insight","JCI insight","COVID-19; Immunoglobulins","Grimley","Samantha L","Department of Microbiology and Immunology, The University of Melbourne, Melbourne, Australia",NA
"425","34251356","10.1172/jci.insight.150012","Simultaneous evaluation of antibodies that inhibit SARS-CoV-2 variants via multiplex assay.","The SARS-CoV-2 Receptor Binding Domain (RBD) is both the principal target of neutralizing antibodies, and one of the most rapidly evolving domains, which can result in the emergence of immune escape mutations limiting the effectiveness of vaccines and antibody therapeutics. To facilitate surveillance, we developed a rapid, high-throughput, multiplex assay able to assess the inhibitory response of antibodies to 24 RBD natural variants simultaneously. We demonstrate how this assay can be implement","2021","07","12","JCI Insight","JCI insight","COVID-19; Immunoglobulins","Harty","Leigh","Department of Microbiology and Immunology, The University of Melbourne, Melbourne, Australia",NA
"426","34251356","10.1172/jci.insight.150012","Simultaneous evaluation of antibodies that inhibit SARS-CoV-2 variants via multiplex assay.","The SARS-CoV-2 Receptor Binding Domain (RBD) is both the principal target of neutralizing antibodies, and one of the most rapidly evolving domains, which can result in the emergence of immune escape mutations limiting the effectiveness of vaccines and antibody therapeutics. To facilitate surveillance, we developed a rapid, high-throughput, multiplex assay able to assess the inhibitory response of antibodies to 24 RBD natural variants simultaneously. We demonstrate how this assay can be implement","2021","07","12","JCI Insight","JCI insight","COVID-19; Immunoglobulins","Purcell","Damian Fj","Department of Microbiology and Immunology, The University of Melbourne, Melbourne, Australia",NA
"427","34251356","10.1172/jci.insight.150012","Simultaneous evaluation of antibodies that inhibit SARS-CoV-2 variants via multiplex assay.","The SARS-CoV-2 Receptor Binding Domain (RBD) is both the principal target of neutralizing antibodies, and one of the most rapidly evolving domains, which can result in the emergence of immune escape mutations limiting the effectiveness of vaccines and antibody therapeutics. To facilitate surveillance, we developed a rapid, high-throughput, multiplex assay able to assess the inhibitory response of antibodies to 24 RBD natural variants simultaneously. We demonstrate how this assay can be implement","2021","07","12","JCI Insight","JCI insight","COVID-19; Immunoglobulins","Subbarao","Kanta","WHO Collaborating Centre for Reference and Research on Influenza, The University of Melbourne, Melbourne, Australia",NA
"428","34251356","10.1172/jci.insight.150012","Simultaneous evaluation of antibodies that inhibit SARS-CoV-2 variants via multiplex assay.","The SARS-CoV-2 Receptor Binding Domain (RBD) is both the principal target of neutralizing antibodies, and one of the most rapidly evolving domains, which can result in the emergence of immune escape mutations limiting the effectiveness of vaccines and antibody therapeutics. To facilitate surveillance, we developed a rapid, high-throughput, multiplex assay able to assess the inhibitory response of antibodies to 24 RBD natural variants simultaneously. We demonstrate how this assay can be implement","2021","07","12","JCI Insight","JCI insight","COVID-19; Immunoglobulins","Godfrey","Dale I","Department of Microbiology and Immunology, The University of Melbourne, Melbourne, Australia",NA
"429","34251356","10.1172/jci.insight.150012","Simultaneous evaluation of antibodies that inhibit SARS-CoV-2 variants via multiplex assay.","The SARS-CoV-2 Receptor Binding Domain (RBD) is both the principal target of neutralizing antibodies, and one of the most rapidly evolving domains, which can result in the emergence of immune escape mutations limiting the effectiveness of vaccines and antibody therapeutics. To facilitate surveillance, we developed a rapid, high-throughput, multiplex assay able to assess the inhibitory response of antibodies to 24 RBD natural variants simultaneously. We demonstrate how this assay can be implement","2021","07","12","JCI Insight","JCI insight","COVID-19; Immunoglobulins","Kent","Stephen J","Department of Microbiology and Immunology, The University of Melbourne, Melbourne, Australia",NA
"430","34251356","10.1172/jci.insight.150012","Simultaneous evaluation of antibodies that inhibit SARS-CoV-2 variants via multiplex assay.","The SARS-CoV-2 Receptor Binding Domain (RBD) is both the principal target of neutralizing antibodies, and one of the most rapidly evolving domains, which can result in the emergence of immune escape mutations limiting the effectiveness of vaccines and antibody therapeutics. To facilitate surveillance, we developed a rapid, high-throughput, multiplex assay able to assess the inhibitory response of antibodies to 24 RBD natural variants simultaneously. We demonstrate how this assay can be implement","2021","07","12","JCI Insight","JCI insight","COVID-19; Immunoglobulins","Tham","Wai-Hong","Infectious Diseases and Immune Defense Division, The Walter and Eliza Hall Institute, Melbourne, Australia",NA
"431","34251356","10.1172/jci.insight.150012","Simultaneous evaluation of antibodies that inhibit SARS-CoV-2 variants via multiplex assay.","The SARS-CoV-2 Receptor Binding Domain (RBD) is both the principal target of neutralizing antibodies, and one of the most rapidly evolving domains, which can result in the emergence of immune escape mutations limiting the effectiveness of vaccines and antibody therapeutics. To facilitate surveillance, we developed a rapid, high-throughput, multiplex assay able to assess the inhibitory response of antibodies to 24 RBD natural variants simultaneously. We demonstrate how this assay can be implement","2021","07","12","JCI Insight","JCI insight","COVID-19; Immunoglobulins","Chung","Amy W","Department of Microbiology and Immunology, The University of Melbourne, Melbourne, Australia",NA
"432","34251354","","The Management of Pulmonary Fibrosis in COVID-19.","Pulmonary fibrosis due to COVID-19 is recognized as sequel of ARDS characterized by failed alveolar re-epithelization, fibroblast activation, excessive collagen deposition and other extracellular matrix components that disrupt the normal lung architecture. There are risk factor for pulmonary fibrosis namely advanced age, severe ARDS infection, mechanical ventilation due to ventilator-induced lung injury, smoking and chronic alcoholism. Diagnosis of post-COVID pulmonary fibrosis can be made by cl","2021","07","15","Acta Med Indones","Acta medica Indonesiana","COVID-19; pulmonary fibrosis; COVID-19; Combined Modality Therapy; Humans; Pneumonia, Viral; Pulmonary Fibrosis; Risk Factors; SARS-CoV-2; Tomography, X-Ray Computed","Rumende","Cleopas Martin","Division of Respirology and Critical Care, Department of Internal Medicine, Cipto Mangunkusumo Hospital, Jakarta. rumende_martin@yahoo","martin@yahoo.com"
"433","34251354","","The Management of Pulmonary Fibrosis in COVID-19.","Pulmonary fibrosis due to COVID-19 is recognized as sequel of ARDS characterized by failed alveolar re-epithelization, fibroblast activation, excessive collagen deposition and other extracellular matrix components that disrupt the normal lung architecture. There are risk factor for pulmonary fibrosis namely advanced age, severe ARDS infection, mechanical ventilation due to ventilator-induced lung injury, smoking and chronic alcoholism. Diagnosis of post-COVID pulmonary fibrosis can be made by cl","2021","07","15","Acta Med Indones","Acta medica Indonesiana","COVID-19; pulmonary fibrosis; COVID-19; Combined Modality Therapy; Humans; Pneumonia, Viral; Pulmonary Fibrosis; Risk Factors; SARS-CoV-2; Tomography, X-Ray Computed","Susanto","Erwin C","Division of Respirology and Critical Care, Department of Internal Medicine, Cipto Mangunkusumo Hospital, Jakarta. rumende_martin@yahoo",NA
"434","34251354","","The Management of Pulmonary Fibrosis in COVID-19.","Pulmonary fibrosis due to COVID-19 is recognized as sequel of ARDS characterized by failed alveolar re-epithelization, fibroblast activation, excessive collagen deposition and other extracellular matrix components that disrupt the normal lung architecture. There are risk factor for pulmonary fibrosis namely advanced age, severe ARDS infection, mechanical ventilation due to ventilator-induced lung injury, smoking and chronic alcoholism. Diagnosis of post-COVID pulmonary fibrosis can be made by cl","2021","07","15","Acta Med Indones","Acta medica Indonesiana","COVID-19; pulmonary fibrosis; COVID-19; Combined Modality Therapy; Humans; Pneumonia, Viral; Pulmonary Fibrosis; Risk Factors; SARS-CoV-2; Tomography, X-Ray Computed","Sitorus","Truely P","Division of Respirology and Critical Care, Department of Internal Medicine, Cipto Mangunkusumo Hospital, Jakarta. rumende_martin@yahoo",NA
"435","34251353","","Psychotherapy for Healthcare Provider During COVID-19 Pandemic: An Evidence Based Clinical Review.","health workers are one of the groups affected physically as well as psychologically from the pandemic. Recent studies showed many of the health workers reported experiencing anxiety, depression, and insomnia. This study aims to identify psychotherapy as a psychological health intervention, for healthcare workers during the COVID-19 pandemic. an evidence based clinical review of psychotherapy as a psychological health intervention, reported in the literature, which is developed for healthcare wor","2021","07","15","Acta Med Indones","Acta medica Indonesiana","COVID-19; healthcare workers; internal medicine; medical journal; psychosomatic; psychotherapy; COVID-19; Evidence-Based Medicine; Health Personnel; Humans; Pandemics; Psychotherapy; SARS-CoV-2","Shatri","Hamzah",". Division of Psychosomatic and Palliative, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia - Cipto Mangunkusumo Hospital Jakarta, Indonesia. 2. Clinical Epidemiology Unit, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia - Cipto Mangunkusumo Hospital, Jakarta, Indonesia.. hshatri@yahoo","hshatri@yahoo.com"
"436","34251353","","Psychotherapy for Healthcare Provider During COVID-19 Pandemic: An Evidence Based Clinical Review.","health workers are one of the groups affected physically as well as psychologically from the pandemic. Recent studies showed many of the health workers reported experiencing anxiety, depression, and insomnia. This study aims to identify psychotherapy as a psychological health intervention, for healthcare workers during the COVID-19 pandemic. an evidence based clinical review of psychotherapy as a psychological health intervention, reported in the literature, which is developed for healthcare wor","2021","07","15","Acta Med Indones","Acta medica Indonesiana","COVID-19; healthcare workers; internal medicine; medical journal; psychosomatic; psychotherapy; COVID-19; Evidence-Based Medicine; Health Personnel; Humans; Pandemics; Psychotherapy; SARS-CoV-2","Putranto","Rudi",". Division of Psychosomatic and Palliative, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia - Cipto Mangunkusumo Hospital Jakarta, Indonesia. 2. Clinical Epidemiology Unit, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia - Cipto Mangunkusumo Hospital, Jakarta, Indonesia.. hshatri@yahoo",NA
"437","34251353","","Psychotherapy for Healthcare Provider During COVID-19 Pandemic: An Evidence Based Clinical Review.","health workers are one of the groups affected physically as well as psychologically from the pandemic. Recent studies showed many of the health workers reported experiencing anxiety, depression, and insomnia. This study aims to identify psychotherapy as a psychological health intervention, for healthcare workers during the COVID-19 pandemic. an evidence based clinical review of psychotherapy as a psychological health intervention, reported in the literature, which is developed for healthcare wor","2021","07","15","Acta Med Indones","Acta medica Indonesiana","COVID-19; healthcare workers; internal medicine; medical journal; psychosomatic; psychotherapy; COVID-19; Evidence-Based Medicine; Health Personnel; Humans; Pandemics; Psychotherapy; SARS-CoV-2","Faisal","Edward",". Division of Psychosomatic and Palliative, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia - Cipto Mangunkusumo Hospital Jakarta, Indonesia. 2. Clinical Epidemiology Unit, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia - Cipto Mangunkusumo Hospital, Jakarta, Indonesia.. hshatri@yahoo",NA
"438","34251353","","Psychotherapy for Healthcare Provider During COVID-19 Pandemic: An Evidence Based Clinical Review.","health workers are one of the groups affected physically as well as psychologically from the pandemic. Recent studies showed many of the health workers reported experiencing anxiety, depression, and insomnia. This study aims to identify psychotherapy as a psychological health intervention, for healthcare workers during the COVID-19 pandemic. an evidence based clinical review of psychotherapy as a psychological health intervention, reported in the literature, which is developed for healthcare wor","2021","07","15","Acta Med Indones","Acta medica Indonesiana","COVID-19; healthcare workers; internal medicine; medical journal; psychosomatic; psychotherapy; COVID-19; Evidence-Based Medicine; Health Personnel; Humans; Pandemics; Psychotherapy; SARS-CoV-2","Fitrianti","Fita",". Division of Psychosomatic and Palliative, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia - Cipto Mangunkusumo Hospital Jakarta, Indonesia. 2. Clinical Epidemiology Unit, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia - Cipto Mangunkusumo Hospital, Jakarta, Indonesia.. hshatri@yahoo",NA
"439","34251353","","Psychotherapy for Healthcare Provider During COVID-19 Pandemic: An Evidence Based Clinical Review.","health workers are one of the groups affected physically as well as psychologically from the pandemic. Recent studies showed many of the health workers reported experiencing anxiety, depression, and insomnia. This study aims to identify psychotherapy as a psychological health intervention, for healthcare workers during the COVID-19 pandemic. an evidence based clinical review of psychotherapy as a psychological health intervention, reported in the literature, which is developed for healthcare wor","2021","07","15","Acta Med Indones","Acta medica Indonesiana","COVID-19; healthcare workers; internal medicine; medical journal; psychosomatic; psychotherapy; COVID-19; Evidence-Based Medicine; Health Personnel; Humans; Pandemics; Psychotherapy; SARS-CoV-2","Adhiatma","Kresna",". Division of Psychosomatic and Palliative, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia - Cipto Mangunkusumo Hospital Jakarta, Indonesia. 2. Clinical Epidemiology Unit, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia - Cipto Mangunkusumo Hospital, Jakarta, Indonesia.. hshatri@yahoo",NA
"440","34251353","","Psychotherapy for Healthcare Provider During COVID-19 Pandemic: An Evidence Based Clinical Review.","health workers are one of the groups affected physically as well as psychologically from the pandemic. Recent studies showed many of the health workers reported experiencing anxiety, depression, and insomnia. This study aims to identify psychotherapy as a psychological health intervention, for healthcare workers during the COVID-19 pandemic. an evidence based clinical review of psychotherapy as a psychological health intervention, reported in the literature, which is developed for healthcare wor","2021","07","15","Acta Med Indones","Acta medica Indonesiana","COVID-19; healthcare workers; internal medicine; medical journal; psychosomatic; psychotherapy; COVID-19; Evidence-Based Medicine; Health Personnel; Humans; Pandemics; Psychotherapy; SARS-CoV-2","Zulmiyusrini","Putri",". Division of Psychosomatic and Palliative, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia - Cipto Mangunkusumo Hospital Jakarta, Indonesia. 2. Clinical Epidemiology Unit, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia - Cipto Mangunkusumo Hospital, Jakarta, Indonesia.. hshatri@yahoo",NA
"441","34251353","","Psychotherapy for Healthcare Provider During COVID-19 Pandemic: An Evidence Based Clinical Review.","health workers are one of the groups affected physically as well as psychologically from the pandemic. Recent studies showed many of the health workers reported experiencing anxiety, depression, and insomnia. This study aims to identify psychotherapy as a psychological health intervention, for healthcare workers during the COVID-19 pandemic. an evidence based clinical review of psychotherapy as a psychological health intervention, reported in the literature, which is developed for healthcare wor","2021","07","15","Acta Med Indones","Acta medica Indonesiana","COVID-19; healthcare workers; internal medicine; medical journal; psychosomatic; psychotherapy; COVID-19; Evidence-Based Medicine; Health Personnel; Humans; Pandemics; Psychotherapy; SARS-CoV-2","Diba","Sonya Farah",". Division of Psychosomatic and Palliative, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia - Cipto Mangunkusumo Hospital Jakarta, Indonesia. 2. Clinical Epidemiology Unit, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia - Cipto Mangunkusumo Hospital, Jakarta, Indonesia.. hshatri@yahoo",NA
"442","34251353","","Psychotherapy for Healthcare Provider During COVID-19 Pandemic: An Evidence Based Clinical Review.","health workers are one of the groups affected physically as well as psychologically from the pandemic. Recent studies showed many of the health workers reported experiencing anxiety, depression, and insomnia. This study aims to identify psychotherapy as a psychological health intervention, for healthcare workers during the COVID-19 pandemic. an evidence based clinical review of psychotherapy as a psychological health intervention, reported in the literature, which is developed for healthcare wor","2021","07","15","Acta Med Indones","Acta medica Indonesiana","COVID-19; healthcare workers; internal medicine; medical journal; psychosomatic; psychotherapy; COVID-19; Evidence-Based Medicine; Health Personnel; Humans; Pandemics; Psychotherapy; SARS-CoV-2","Lukman","Petrin R",". Division of Psychosomatic and Palliative, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia - Cipto Mangunkusumo Hospital Jakarta, Indonesia. 2. Clinical Epidemiology Unit, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia - Cipto Mangunkusumo Hospital, Jakarta, Indonesia.. hshatri@yahoo",NA
"443","34251348","","Tocilizumab as a Treatment for 'Cytokine Storm Syndrome' in COVID-19: A Case Report.","Coronavirus disease 19 (COVID-19) which is caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), has been a problem worldwide, particularly due to the high rate of transmission and wide range of clinical manifestations. Acute respiratory distress syndrome (ARDS) and multiorgan failure are the most common events observed in severe cases and can be fatal. Cytokine storm syndrome emerges as one of the possibilities for the development of ARDS and multiorgan failure in severe cases","2021","07","15","Acta Med Indones","Acta medica Indonesiana","COVID-19; SARS-CoV-2; Tocilizumab; acute respiratory distress syndrome (ARDS); Antibodies, Monoclonal, Humanized; Biomarkers; COVID-19; Cytokine Release Syndrome; Humans; Interleukin-6; Male; Middle Aged; SARS-CoV-2","Syam","Ari Fahrial","Fellow of the American College of Physicians","syam@hotmail.com"
"444","34251348","","Tocilizumab as a Treatment for 'Cytokine Storm Syndrome' in COVID-19: A Case Report.","Coronavirus disease 19 (COVID-19) which is caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), has been a problem worldwide, particularly due to the high rate of transmission and wide range of clinical manifestations. Acute respiratory distress syndrome (ARDS) and multiorgan failure are the most common events observed in severe cases and can be fatal. Cytokine storm syndrome emerges as one of the possibilities for the development of ARDS and multiorgan failure in severe cases","2021","07","15","Acta Med Indones","Acta medica Indonesiana","COVID-19; SARS-CoV-2; Tocilizumab; acute respiratory distress syndrome (ARDS); Antibodies, Monoclonal, Humanized; Biomarkers; COVID-19; Cytokine Release Syndrome; Humans; Interleukin-6; Male; Middle Aged; SARS-CoV-2","Pitoyo","Ceva W","Fellow of the American College of Physicians",NA
"445","34251348","","Tocilizumab as a Treatment for 'Cytokine Storm Syndrome' in COVID-19: A Case Report.","Coronavirus disease 19 (COVID-19) which is caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), has been a problem worldwide, particularly due to the high rate of transmission and wide range of clinical manifestations. Acute respiratory distress syndrome (ARDS) and multiorgan failure are the most common events observed in severe cases and can be fatal. Cytokine storm syndrome emerges as one of the possibilities for the development of ARDS and multiorgan failure in severe cases","2021","07","15","Acta Med Indones","Acta medica Indonesiana","COVID-19; SARS-CoV-2; Tocilizumab; acute respiratory distress syndrome (ARDS); Antibodies, Monoclonal, Humanized; Biomarkers; COVID-19; Cytokine Release Syndrome; Humans; Interleukin-6; Male; Middle Aged; SARS-CoV-2","Suhendro","Suhendro","Fellow of the American College of Physicians",NA
"446","34251348","","Tocilizumab as a Treatment for 'Cytokine Storm Syndrome' in COVID-19: A Case Report.","Coronavirus disease 19 (COVID-19) which is caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), has been a problem worldwide, particularly due to the high rate of transmission and wide range of clinical manifestations. Acute respiratory distress syndrome (ARDS) and multiorgan failure are the most common events observed in severe cases and can be fatal. Cytokine storm syndrome emerges as one of the possibilities for the development of ARDS and multiorgan failure in severe cases","2021","07","15","Acta Med Indones","Acta medica Indonesiana","COVID-19; SARS-CoV-2; Tocilizumab; acute respiratory distress syndrome (ARDS); Antibodies, Monoclonal, Humanized; Biomarkers; COVID-19; Cytokine Release Syndrome; Humans; Interleukin-6; Male; Middle Aged; SARS-CoV-2","Zulkarnain","Benny","Fellow of the American College of Physicians",NA
"447","34251348","","Tocilizumab as a Treatment for 'Cytokine Storm Syndrome' in COVID-19: A Case Report.","Coronavirus disease 19 (COVID-19) which is caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), has been a problem worldwide, particularly due to the high rate of transmission and wide range of clinical manifestations. Acute respiratory distress syndrome (ARDS) and multiorgan failure are the most common events observed in severe cases and can be fatal. Cytokine storm syndrome emerges as one of the possibilities for the development of ARDS and multiorgan failure in severe cases","2021","07","15","Acta Med Indones","Acta medica Indonesiana","COVID-19; SARS-CoV-2; Tocilizumab; acute respiratory distress syndrome (ARDS); Antibodies, Monoclonal, Humanized; Biomarkers; COVID-19; Cytokine Release Syndrome; Humans; Interleukin-6; Male; Middle Aged; SARS-CoV-2","Indrasari","Nuri D","Fellow of the American College of Physicians",NA
"448","34251348","","Tocilizumab as a Treatment for 'Cytokine Storm Syndrome' in COVID-19: A Case Report.","Coronavirus disease 19 (COVID-19) which is caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), has been a problem worldwide, particularly due to the high rate of transmission and wide range of clinical manifestations. Acute respiratory distress syndrome (ARDS) and multiorgan failure are the most common events observed in severe cases and can be fatal. Cytokine storm syndrome emerges as one of the possibilities for the development of ARDS and multiorgan failure in severe cases","2021","07","15","Acta Med Indones","Acta medica Indonesiana","COVID-19; SARS-CoV-2; Tocilizumab; acute respiratory distress syndrome (ARDS); Antibodies, Monoclonal, Humanized; Biomarkers; COVID-19; Cytokine Release Syndrome; Humans; Interleukin-6; Male; Middle Aged; SARS-CoV-2","Aditianingsih","Dita","Fellow of the American College of Physicians",NA
"449","34251348","","Tocilizumab as a Treatment for 'Cytokine Storm Syndrome' in COVID-19: A Case Report.","Coronavirus disease 19 (COVID-19) which is caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), has been a problem worldwide, particularly due to the high rate of transmission and wide range of clinical manifestations. Acute respiratory distress syndrome (ARDS) and multiorgan failure are the most common events observed in severe cases and can be fatal. Cytokine storm syndrome emerges as one of the possibilities for the development of ARDS and multiorgan failure in severe cases","2021","07","15","Acta Med Indones","Acta medica Indonesiana","COVID-19; SARS-CoV-2; Tocilizumab; acute respiratory distress syndrome (ARDS); Antibodies, Monoclonal, Humanized; Biomarkers; COVID-19; Cytokine Release Syndrome; Humans; Interleukin-6; Male; Middle Aged; SARS-CoV-2","Irawan","Cosphiadi","Fellow of the American College of Physicians",NA
"450","34251348","","Tocilizumab as a Treatment for 'Cytokine Storm Syndrome' in COVID-19: A Case Report.","Coronavirus disease 19 (COVID-19) which is caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), has been a problem worldwide, particularly due to the high rate of transmission and wide range of clinical manifestations. Acute respiratory distress syndrome (ARDS) and multiorgan failure are the most common events observed in severe cases and can be fatal. Cytokine storm syndrome emerges as one of the possibilities for the development of ARDS and multiorgan failure in severe cases","2021","07","15","Acta Med Indones","Acta medica Indonesiana","COVID-19; SARS-CoV-2; Tocilizumab; acute respiratory distress syndrome (ARDS); Antibodies, Monoclonal, Humanized; Biomarkers; COVID-19; Cytokine Release Syndrome; Humans; Interleukin-6; Male; Middle Aged; SARS-CoV-2","Susilo","Adityo","Fellow of the American College of Physicians",NA
"451","34251348","","Tocilizumab as a Treatment for 'Cytokine Storm Syndrome' in COVID-19: A Case Report.","Coronavirus disease 19 (COVID-19) which is caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), has been a problem worldwide, particularly due to the high rate of transmission and wide range of clinical manifestations. Acute respiratory distress syndrome (ARDS) and multiorgan failure are the most common events observed in severe cases and can be fatal. Cytokine storm syndrome emerges as one of the possibilities for the development of ARDS and multiorgan failure in severe cases","2021","07","15","Acta Med Indones","Acta medica Indonesiana","COVID-19; SARS-CoV-2; Tocilizumab; acute respiratory distress syndrome (ARDS); Antibodies, Monoclonal, Humanized; Biomarkers; COVID-19; Cytokine Release Syndrome; Humans; Interleukin-6; Male; Middle Aged; SARS-CoV-2","Rumende","Cleopas M","Fellow of the American College of Physicians",NA
"452","34251348","","Tocilizumab as a Treatment for 'Cytokine Storm Syndrome' in COVID-19: A Case Report.","Coronavirus disease 19 (COVID-19) which is caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), has been a problem worldwide, particularly due to the high rate of transmission and wide range of clinical manifestations. Acute respiratory distress syndrome (ARDS) and multiorgan failure are the most common events observed in severe cases and can be fatal. Cytokine storm syndrome emerges as one of the possibilities for the development of ARDS and multiorgan failure in severe cases","2021","07","15","Acta Med Indones","Acta medica Indonesiana","COVID-19; SARS-CoV-2; Tocilizumab; acute respiratory distress syndrome (ARDS); Antibodies, Monoclonal, Humanized; Biomarkers; COVID-19; Cytokine Release Syndrome; Humans; Interleukin-6; Male; Middle Aged; SARS-CoV-2","Wijaya","Ika P","Fellow of the American College of Physicians",NA
"453","34251348","","Tocilizumab as a Treatment for 'Cytokine Storm Syndrome' in COVID-19: A Case Report.","Coronavirus disease 19 (COVID-19) which is caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), has been a problem worldwide, particularly due to the high rate of transmission and wide range of clinical manifestations. Acute respiratory distress syndrome (ARDS) and multiorgan failure are the most common events observed in severe cases and can be fatal. Cytokine storm syndrome emerges as one of the possibilities for the development of ARDS and multiorgan failure in severe cases","2021","07","15","Acta Med Indones","Acta medica Indonesiana","COVID-19; SARS-CoV-2; Tocilizumab; acute respiratory distress syndrome (ARDS); Antibodies, Monoclonal, Humanized; Biomarkers; COVID-19; Cytokine Release Syndrome; Humans; Interleukin-6; Male; Middle Aged; SARS-CoV-2","Ibrahim","Fera","Fellow of the American College of Physicians",NA
"454","34251348","","Tocilizumab as a Treatment for 'Cytokine Storm Syndrome' in COVID-19: A Case Report.","Coronavirus disease 19 (COVID-19) which is caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), has been a problem worldwide, particularly due to the high rate of transmission and wide range of clinical manifestations. Acute respiratory distress syndrome (ARDS) and multiorgan failure are the most common events observed in severe cases and can be fatal. Cytokine storm syndrome emerges as one of the possibilities for the development of ARDS and multiorgan failure in severe cases","2021","07","15","Acta Med Indones","Acta medica Indonesiana","COVID-19; SARS-CoV-2; Tocilizumab; acute respiratory distress syndrome (ARDS); Antibodies, Monoclonal, Humanized; Biomarkers; COVID-19; Cytokine Release Syndrome; Humans; Interleukin-6; Male; Middle Aged; SARS-CoV-2","Rasmin","Menaldi","Fellow of the American College of Physicians",NA
"455","34251348","","Tocilizumab as a Treatment for 'Cytokine Storm Syndrome' in COVID-19: A Case Report.","Coronavirus disease 19 (COVID-19) which is caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), has been a problem worldwide, particularly due to the high rate of transmission and wide range of clinical manifestations. Acute respiratory distress syndrome (ARDS) and multiorgan failure are the most common events observed in severe cases and can be fatal. Cytokine storm syndrome emerges as one of the possibilities for the development of ARDS and multiorgan failure in severe cases","2021","07","15","Acta Med Indones","Acta medica Indonesiana","COVID-19; SARS-CoV-2; Tocilizumab; acute respiratory distress syndrome (ARDS); Antibodies, Monoclonal, Humanized; Biomarkers; COVID-19; Cytokine Release Syndrome; Humans; Interleukin-6; Male; Middle Aged; SARS-CoV-2","Alwi","Idrus","Fellow of the American College of Physicians",NA
"456","34251348","","Tocilizumab as a Treatment for 'Cytokine Storm Syndrome' in COVID-19: A Case Report.","Coronavirus disease 19 (COVID-19) which is caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), has been a problem worldwide, particularly due to the high rate of transmission and wide range of clinical manifestations. Acute respiratory distress syndrome (ARDS) and multiorgan failure are the most common events observed in severe cases and can be fatal. Cytokine storm syndrome emerges as one of the possibilities for the development of ARDS and multiorgan failure in severe cases","2021","07","15","Acta Med Indones","Acta medica Indonesiana","COVID-19; SARS-CoV-2; Tocilizumab; acute respiratory distress syndrome (ARDS); Antibodies, Monoclonal, Humanized; Biomarkers; COVID-19; Cytokine Release Syndrome; Humans; Interleukin-6; Male; Middle Aged; SARS-CoV-2","Makmun","Dadang","Fellow of the American College of Physicians",NA
"457","34251340","","Pulmonary Fibrosis Caused by Severe COVID-19 Infection: Discharge May Not Be The End of Treatment.","Since December 2019, COVID-19 caused by SARS-CoV-2 infection has been spread rapidly in the world. Beside acute respiratory distress syndrome found in acute phase of infection, there is also pulmonary fibrosis as a chronic complication due to COVID-19. With the global pandemic of COVID-19, more and more autopsy and puncture histopathological results have been published.Until now there is no specific therapy to handle post-inflammatory pulmonary fibrosis due to COVID-19 infection. Several studies","2021","07","15","Acta Med Indones","Acta medica Indonesiana","COVID-19; Indonesia; pulmonary fibrosis; COVID-19; Humans; Pandemics; Patient Discharge; Pneumonia, Viral; Pulmonary Fibrosis; SARS-CoV-2","Rumende","Cleopas Martin","Division of Respirology and Clinical Care, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia - Cipto Mangunkusumo Hospital, Jakarta, Indonesia. rumende_martin@yahoo","martin@yahoo.com"
"458","34251325","","Virtual teaching for medical students during SARS-CoV-2 pandemic.",NA,"2021","07","12","Clin Exp Rheumatol","Clinical and experimental rheumatology",NA,"Pfeil","Alexander","Department of Internal Medicine III, Jena University Hospital - Friedrich Schiller University Jena, Germany. alexander.pfeil@med.uni-jena","alexander.pfeil@med.uni"
"459","34251325","","Virtual teaching for medical students during SARS-CoV-2 pandemic.",NA,"2021","07","12","Clin Exp Rheumatol","Clinical and experimental rheumatology",NA,"Franz","Marcus","Department of Internal Medicine I, Jena University Hospital - Friedrich Schiller University Jena, Germany",NA
"460","34251325","","Virtual teaching for medical students during SARS-CoV-2 pandemic.",NA,"2021","07","12","Clin Exp Rheumatol","Clinical and experimental rheumatology",NA,"Hoffmann","Tobias","Department of Internal Medicine III, Jena University Hospital - Friedrich Schiller University Jena, Germany",NA
"461","34251325","","Virtual teaching for medical students during SARS-CoV-2 pandemic.",NA,"2021","07","12","Clin Exp Rheumatol","Clinical and experimental rheumatology",NA,"Klemm","Philipp","Department of Rheumatology, Immunology, Osteology and Physical Medicine, Campus Kerckhoff, Justus-Liebig University Gießen, Bad Nauheim, Germany",NA
"462","34251325","","Virtual teaching for medical students during SARS-CoV-2 pandemic.",NA,"2021","07","12","Clin Exp Rheumatol","Clinical and experimental rheumatology",NA,"Oelzner","Peter","Department of Internal Medicine III, Jena University Hospital - Friedrich Schiller University Jena, Germany",NA
"463","34251325","","Virtual teaching for medical students during SARS-CoV-2 pandemic.",NA,"2021","07","12","Clin Exp Rheumatol","Clinical and experimental rheumatology",NA,"Müller-Ladner","Ulf","Department of Rheumatology, Immunology, Osteology and Physical Medicine, Campus Kerckhoff, Justus-Liebig University Gießen, Bad Nauheim, Germany",NA
"464","34251325","","Virtual teaching for medical students during SARS-CoV-2 pandemic.",NA,"2021","07","12","Clin Exp Rheumatol","Clinical and experimental rheumatology",NA,"Hueber","Axel J","Section Rheumatology, Sozialstiftung Bamberg, and Department of Internal Medicine 3, Rheumatology and Immunology, University Hospital Erlangen, Germany",NA
"465","34251325","","Virtual teaching for medical students during SARS-CoV-2 pandemic.",NA,"2021","07","12","Clin Exp Rheumatol","Clinical and experimental rheumatology",NA,"Lange","Uwe","Department of Rheumatology, Immunology, Osteology and Physical Medicine, Campus Kerckhoff, Justus-Liebig University Gießen, Bad Nauheim, Germany",NA
"466","34251325","","Virtual teaching for medical students during SARS-CoV-2 pandemic.",NA,"2021","07","12","Clin Exp Rheumatol","Clinical and experimental rheumatology",NA,"Wolf","Gunter","Department of Internal Medicine III, Jena University Hospital - Friedrich Schiller University Jena, Germany",NA
"467","34251325","","Virtual teaching for medical students during SARS-CoV-2 pandemic.",NA,"2021","07","12","Clin Exp Rheumatol","Clinical and experimental rheumatology",NA,"Schett","Georg","Department of Internal Medicine 3, Rheumatology and Immunology, and German Center Immune Therapy, University Hospital Erlangen, Germany",NA
"468","34251325","","Virtual teaching for medical students during SARS-CoV-2 pandemic.",NA,"2021","07","12","Clin Exp Rheumatol","Clinical and experimental rheumatology",NA,"Simon","David","Department of Internal Medicine 3, Rheumatology and Immunology, and German Center Immune Therapy, University Hospital Erlangen, Germany",NA
"469","34251325","","Virtual teaching for medical students during SARS-CoV-2 pandemic.",NA,"2021","07","12","Clin Exp Rheumatol","Clinical and experimental rheumatology",NA,"Kleyer","Arnd","Department of Internal Medicine 3, Rheumatology and Immunology, and German Center Immune Therapy, University Hospital Erlangen, Germany",NA
"470","34251316","","SARS-CoV-2 infection may not be a prerequisite for developing multisystem inflammatory syndrome in children.",NA,"2021","07","12","Clin Exp Rheumatol","Clinical and experimental rheumatology",NA,"Kwak","Ji Hee","Department of Paediatrics, Kangbuk Samsung Hospital, Sungkyunkwan University, Seoul, Republic of Korea",NA
"471","34251316","","SARS-CoV-2 infection may not be a prerequisite for developing multisystem inflammatory syndrome in children.",NA,"2021","07","12","Clin Exp Rheumatol","Clinical and experimental rheumatology",NA,"Choi","Jong-Woon","Department of Paediatrics, Bundang Jesaeng Hospital, Daejin Medical Centre, Seongnam, Republic of Korea",NA
"472","34251316","","SARS-CoV-2 infection may not be a prerequisite for developing multisystem inflammatory syndrome in children.",NA,"2021","07","12","Clin Exp Rheumatol","Clinical and experimental rheumatology",NA,"Lee","Soo-Young","Department of Paediatrics, St. Mary's Hospital, The Catholic University of Korea, Seoul, Republic of Korea. sylee@catholic.ac","sylee@catholic.ac.kr"
"473","34251312","","Incidence and risk factors for moderate/severe COVID-19 in rheumatic diseases patients on hydroxychloroquine: a 24-week prospective cohort.","To evaluate the incidence of COVID-19 and its main outcomes in rheumatic disease (RD) patients on hydroxychloroquine (HCQ) compared to household cohabitants (HC). This is a 24-week nationwide prospective multi-centre cohort with a control group without RD and not using HCQ. All participants were monitored through scheduled phone interviews performed by health professionals. Details regarding COVID-19 symptoms, and epidemiological, clinical, and demographic data were recorded on a specific web-ba","2021","07","12","Clin Exp Rheumatol","Clinical and experimental rheumatology",NA,"Pinheiro","Marcelo M","Hospital São Paulo da Universidade Federal de São Paulo, Escola Paulista de Medicina (Unifesp/EPM), São Paulo-SP, Brazil. mpinheiro@uol.com","mpinheiro@uol.com.br"
"474","34251312","","Incidence and risk factors for moderate/severe COVID-19 in rheumatic diseases patients on hydroxychloroquine: a 24-week prospective cohort.","To evaluate the incidence of COVID-19 and its main outcomes in rheumatic disease (RD) patients on hydroxychloroquine (HCQ) compared to household cohabitants (HC). This is a 24-week nationwide prospective multi-centre cohort with a control group without RD and not using HCQ. All participants were monitored through scheduled phone interviews performed by health professionals. Details regarding COVID-19 symptoms, and epidemiological, clinical, and demographic data were recorded on a specific web-ba","2021","07","12","Clin Exp Rheumatol","Clinical and experimental rheumatology",NA,"Pileggi","Gecilmara S","Hospital São Paulo da Universidade Federal de São Paulo, Escola Paulista de Medicina (Unifesp/EPM), São Paulo-SP, Brazil",NA
"475","34251312","","Incidence and risk factors for moderate/severe COVID-19 in rheumatic diseases patients on hydroxychloroquine: a 24-week prospective cohort.","To evaluate the incidence of COVID-19 and its main outcomes in rheumatic disease (RD) patients on hydroxychloroquine (HCQ) compared to household cohabitants (HC). This is a 24-week nationwide prospective multi-centre cohort with a control group without RD and not using HCQ. All participants were monitored through scheduled phone interviews performed by health professionals. Details regarding COVID-19 symptoms, and epidemiological, clinical, and demographic data were recorded on a specific web-ba","2021","07","12","Clin Exp Rheumatol","Clinical and experimental rheumatology",NA,"Kakehasi","Adriana M","Hospital das Clínicas, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte-MG, Brazil",NA
"476","34251312","","Incidence and risk factors for moderate/severe COVID-19 in rheumatic diseases patients on hydroxychloroquine: a 24-week prospective cohort.","To evaluate the incidence of COVID-19 and its main outcomes in rheumatic disease (RD) patients on hydroxychloroquine (HCQ) compared to household cohabitants (HC). This is a 24-week nationwide prospective multi-centre cohort with a control group without RD and not using HCQ. All participants were monitored through scheduled phone interviews performed by health professionals. Details regarding COVID-19 symptoms, and epidemiological, clinical, and demographic data were recorded on a specific web-ba","2021","07","12","Clin Exp Rheumatol","Clinical and experimental rheumatology",NA,"Gomides Reis","Ana Paula M","Hospital Universitário de Brasília da Universidade de Brasília, EBSERH (HUB-UnB), Brasília-DF, Brazil",NA
"477","34251312","","Incidence and risk factors for moderate/severe COVID-19 in rheumatic diseases patients on hydroxychloroquine: a 24-week prospective cohort.","To evaluate the incidence of COVID-19 and its main outcomes in rheumatic disease (RD) patients on hydroxychloroquine (HCQ) compared to household cohabitants (HC). This is a 24-week nationwide prospective multi-centre cohort with a control group without RD and not using HCQ. All participants were monitored through scheduled phone interviews performed by health professionals. Details regarding COVID-19 symptoms, and epidemiological, clinical, and demographic data were recorded on a specific web-ba","2021","07","12","Clin Exp Rheumatol","Clinical and experimental rheumatology",NA,"Reis-Neto","Edgard Torres","Hospital São Paulo da Universidade Federal de São Paulo, Escola Paulista de Medicina (Unifesp/EPM), São Paulo-SP, Brazil",NA
"478","34251312","","Incidence and risk factors for moderate/severe COVID-19 in rheumatic diseases patients on hydroxychloroquine: a 24-week prospective cohort.","To evaluate the incidence of COVID-19 and its main outcomes in rheumatic disease (RD) patients on hydroxychloroquine (HCQ) compared to household cohabitants (HC). This is a 24-week nationwide prospective multi-centre cohort with a control group without RD and not using HCQ. All participants were monitored through scheduled phone interviews performed by health professionals. Details regarding COVID-19 symptoms, and epidemiological, clinical, and demographic data were recorded on a specific web-ba","2021","07","12","Clin Exp Rheumatol","Clinical and experimental rheumatology",NA,"Abreu","Mirhelen M","Hospital Universitário Clementino Fraga Filho, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro-RJ, Brazil",NA
"479","34251312","","Incidence and risk factors for moderate/severe COVID-19 in rheumatic diseases patients on hydroxychloroquine: a 24-week prospective cohort.","To evaluate the incidence of COVID-19 and its main outcomes in rheumatic disease (RD) patients on hydroxychloroquine (HCQ) compared to household cohabitants (HC). This is a 24-week nationwide prospective multi-centre cohort with a control group without RD and not using HCQ. All participants were monitored through scheduled phone interviews performed by health professionals. Details regarding COVID-19 symptoms, and epidemiological, clinical, and demographic data were recorded on a specific web-ba","2021","07","12","Clin Exp Rheumatol","Clinical and experimental rheumatology",NA,"Albuquerque","Cleandro P","Hospital Universitário de Brasília da Universidade de Brasília, EBSERH (HUB-UnB), Brasília-DF, Brazil",NA
"480","34251312","","Incidence and risk factors for moderate/severe COVID-19 in rheumatic diseases patients on hydroxychloroquine: a 24-week prospective cohort.","To evaluate the incidence of COVID-19 and its main outcomes in rheumatic disease (RD) patients on hydroxychloroquine (HCQ) compared to household cohabitants (HC). This is a 24-week nationwide prospective multi-centre cohort with a control group without RD and not using HCQ. All participants were monitored through scheduled phone interviews performed by health professionals. Details regarding COVID-19 symptoms, and epidemiological, clinical, and demographic data were recorded on a specific web-ba","2021","07","12","Clin Exp Rheumatol","Clinical and experimental rheumatology",NA,"Araújo","Nafice C","Hospital do Servidor Público Estadual, Instituto de Assistência Médica ao Servidor Público Estadual (IAMSPE), São Paulo-SP, Brazil",NA
"481","34251312","","Incidence and risk factors for moderate/severe COVID-19 in rheumatic diseases patients on hydroxychloroquine: a 24-week prospective cohort.","To evaluate the incidence of COVID-19 and its main outcomes in rheumatic disease (RD) patients on hydroxychloroquine (HCQ) compared to household cohabitants (HC). This is a 24-week nationwide prospective multi-centre cohort with a control group without RD and not using HCQ. All participants were monitored through scheduled phone interviews performed by health professionals. Details regarding COVID-19 symptoms, and epidemiological, clinical, and demographic data were recorded on a specific web-ba","2021","07","12","Clin Exp Rheumatol","Clinical and experimental rheumatology",NA,"Bacchiega","Ana Beatriz","Faculdade de Medicina de Barretos (FACISB), Education &amp",NA
"482","34251312","","Incidence and risk factors for moderate/severe COVID-19 in rheumatic diseases patients on hydroxychloroquine: a 24-week prospective cohort.","To evaluate the incidence of COVID-19 and its main outcomes in rheumatic disease (RD) patients on hydroxychloroquine (HCQ) compared to household cohabitants (HC). This is a 24-week nationwide prospective multi-centre cohort with a control group without RD and not using HCQ. All participants were monitored through scheduled phone interviews performed by health professionals. Details regarding COVID-19 symptoms, and epidemiological, clinical, and demographic data were recorded on a specific web-ba","2021","07","12","Clin Exp Rheumatol","Clinical and experimental rheumatology",NA,"Bianchi","Dante V","Santa Casa de Misericórdia do Rio de Janeiro (HGSCMRJ), Rio de Janeiro-RJ, Brazil",NA
"483","34251312","","Incidence and risk factors for moderate/severe COVID-19 in rheumatic diseases patients on hydroxychloroquine: a 24-week prospective cohort.","To evaluate the incidence of COVID-19 and its main outcomes in rheumatic disease (RD) patients on hydroxychloroquine (HCQ) compared to household cohabitants (HC). This is a 24-week nationwide prospective multi-centre cohort with a control group without RD and not using HCQ. All participants were monitored through scheduled phone interviews performed by health professionals. Details regarding COVID-19 symptoms, and epidemiological, clinical, and demographic data were recorded on a specific web-ba","2021","07","12","Clin Exp Rheumatol","Clinical and experimental rheumatology",NA,"Bica","Blanca","Hospital São Paulo da Universidade Federal de São Paulo, Escola Paulista de Medicina (Unifesp/EPM), São Paulo-SP, Brazil",NA
"484","34251312","","Incidence and risk factors for moderate/severe COVID-19 in rheumatic diseases patients on hydroxychloroquine: a 24-week prospective cohort.","To evaluate the incidence of COVID-19 and its main outcomes in rheumatic disease (RD) patients on hydroxychloroquine (HCQ) compared to household cohabitants (HC). This is a 24-week nationwide prospective multi-centre cohort with a control group without RD and not using HCQ. All participants were monitored through scheduled phone interviews performed by health professionals. Details regarding COVID-19 symptoms, and epidemiological, clinical, and demographic data were recorded on a specific web-ba","2021","07","12","Clin Exp Rheumatol","Clinical and experimental rheumatology",NA,"Bonfa","Eloisa","Rheumatology Division, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo-SP, Brazil",NA
"485","34251312","","Incidence and risk factors for moderate/severe COVID-19 in rheumatic diseases patients on hydroxychloroquine: a 24-week prospective cohort.","To evaluate the incidence of COVID-19 and its main outcomes in rheumatic disease (RD) patients on hydroxychloroquine (HCQ) compared to household cohabitants (HC). This is a 24-week nationwide prospective multi-centre cohort with a control group without RD and not using HCQ. All participants were monitored through scheduled phone interviews performed by health professionals. Details regarding COVID-19 symptoms, and epidemiological, clinical, and demographic data were recorded on a specific web-ba","2021","07","12","Clin Exp Rheumatol","Clinical and experimental rheumatology",NA,"Borba","Eduardo F","Rheumatology Division, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo-SP, Brazil",NA
"486","34251312","","Incidence and risk factors for moderate/severe COVID-19 in rheumatic diseases patients on hydroxychloroquine: a 24-week prospective cohort.","To evaluate the incidence of COVID-19 and its main outcomes in rheumatic disease (RD) patients on hydroxychloroquine (HCQ) compared to household cohabitants (HC). This is a 24-week nationwide prospective multi-centre cohort with a control group without RD and not using HCQ. All participants were monitored through scheduled phone interviews performed by health professionals. Details regarding COVID-19 symptoms, and epidemiological, clinical, and demographic data were recorded on a specific web-ba","2021","07","12","Clin Exp Rheumatol","Clinical and experimental rheumatology",NA,"Egypto Brito","Danielle C S","Hospital Universit rio Lauro Wanderley, Universidade Federal da Para ba (UFPB), Jo o Pessoa-PB, Brazil",NA
"487","34251312","","Incidence and risk factors for moderate/severe COVID-19 in rheumatic diseases patients on hydroxychloroquine: a 24-week prospective cohort.","To evaluate the incidence of COVID-19 and its main outcomes in rheumatic disease (RD) patients on hydroxychloroquine (HCQ) compared to household cohabitants (HC). This is a 24-week nationwide prospective multi-centre cohort with a control group without RD and not using HCQ. All participants were monitored through scheduled phone interviews performed by health professionals. Details regarding COVID-19 symptoms, and epidemiological, clinical, and demographic data were recorded on a specific web-ba","2021","07","12","Clin Exp Rheumatol","Clinical and experimental rheumatology",NA,"Calderaro","Debora C","Hospital das Clínicas, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte-MG, Brazil",NA
"488","34251312","","Incidence and risk factors for moderate/severe COVID-19 in rheumatic diseases patients on hydroxychloroquine: a 24-week prospective cohort.","To evaluate the incidence of COVID-19 and its main outcomes in rheumatic disease (RD) patients on hydroxychloroquine (HCQ) compared to household cohabitants (HC). This is a 24-week nationwide prospective multi-centre cohort with a control group without RD and not using HCQ. All participants were monitored through scheduled phone interviews performed by health professionals. Details regarding COVID-19 symptoms, and epidemiological, clinical, and demographic data were recorded on a specific web-ba","2021","07","12","Clin Exp Rheumatol","Clinical and experimental rheumatology",NA,"Pinto Duarte","Ângela L B","Hospital das Clínicas da Universidade Federal de Pernambuco (UFPE), Recife-PE, Brazil",NA
"489","34251312","","Incidence and risk factors for moderate/severe COVID-19 in rheumatic diseases patients on hydroxychloroquine: a 24-week prospective cohort.","To evaluate the incidence of COVID-19 and its main outcomes in rheumatic disease (RD) patients on hydroxychloroquine (HCQ) compared to household cohabitants (HC). This is a 24-week nationwide prospective multi-centre cohort with a control group without RD and not using HCQ. All participants were monitored through scheduled phone interviews performed by health professionals. Details regarding COVID-19 symptoms, and epidemiological, clinical, and demographic data were recorded on a specific web-ba","2021","07","12","Clin Exp Rheumatol","Clinical and experimental rheumatology",NA,"Espírito Santo","Rafaela C","Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre-RS, Brazil",NA
"490","34251312","","Incidence and risk factors for moderate/severe COVID-19 in rheumatic diseases patients on hydroxychloroquine: a 24-week prospective cohort.","To evaluate the incidence of COVID-19 and its main outcomes in rheumatic disease (RD) patients on hydroxychloroquine (HCQ) compared to household cohabitants (HC). This is a 24-week nationwide prospective multi-centre cohort with a control group without RD and not using HCQ. All participants were monitored through scheduled phone interviews performed by health professionals. Details regarding COVID-19 symptoms, and epidemiological, clinical, and demographic data were recorded on a specific web-ba","2021","07","12","Clin Exp Rheumatol","Clinical and experimental rheumatology",NA,"Fernandes","Paula R","Hospital Universitário da Universidade Federal de Juiz de Fora (UFJF), Juiz de Fora-MG, Brazil",NA
"491","34251312","","Incidence and risk factors for moderate/severe COVID-19 in rheumatic diseases patients on hydroxychloroquine: a 24-week prospective cohort.","To evaluate the incidence of COVID-19 and its main outcomes in rheumatic disease (RD) patients on hydroxychloroquine (HCQ) compared to household cohabitants (HC). This is a 24-week nationwide prospective multi-centre cohort with a control group without RD and not using HCQ. All participants were monitored through scheduled phone interviews performed by health professionals. Details regarding COVID-19 symptoms, and epidemiological, clinical, and demographic data were recorded on a specific web-ba","2021","07","12","Clin Exp Rheumatol","Clinical and experimental rheumatology",NA,"Guimarães","Mariana P","Santa Casa de Misericórdia de Belo Horizonte, Belo Horizonte-MG, Brazil",NA
"492","34251312","","Incidence and risk factors for moderate/severe COVID-19 in rheumatic diseases patients on hydroxychloroquine: a 24-week prospective cohort.","To evaluate the incidence of COVID-19 and its main outcomes in rheumatic disease (RD) patients on hydroxychloroquine (HCQ) compared to household cohabitants (HC). This is a 24-week nationwide prospective multi-centre cohort with a control group without RD and not using HCQ. All participants were monitored through scheduled phone interviews performed by health professionals. Details regarding COVID-19 symptoms, and epidemiological, clinical, and demographic data were recorded on a specific web-ba","2021","07","12","Clin Exp Rheumatol","Clinical and experimental rheumatology",NA,"Poti Gomes","Kirla W","Hospital Geral de Fortaleza (HGF), Fortaleza-CE, Brazil",NA
"493","34251312","","Incidence and risk factors for moderate/severe COVID-19 in rheumatic diseases patients on hydroxychloroquine: a 24-week prospective cohort.","To evaluate the incidence of COVID-19 and its main outcomes in rheumatic disease (RD) patients on hydroxychloroquine (HCQ) compared to household cohabitants (HC). This is a 24-week nationwide prospective multi-centre cohort with a control group without RD and not using HCQ. All participants were monitored through scheduled phone interviews performed by health professionals. Details regarding COVID-19 symptoms, and epidemiological, clinical, and demographic data were recorded on a specific web-ba","2021","07","12","Clin Exp Rheumatol","Clinical and experimental rheumatology",NA,"Faustino Ilana","Gabriela G","Centro Avançado de Pesquisa, Estudos e Diagnóstico (CAPED), Centro Médico Ribeirão shopping, Ribeirão Preto-SP, Brazil",NA
"494","34251312","","Incidence and risk factors for moderate/severe COVID-19 in rheumatic diseases patients on hydroxychloroquine: a 24-week prospective cohort.","To evaluate the incidence of COVID-19 and its main outcomes in rheumatic disease (RD) patients on hydroxychloroquine (HCQ) compared to household cohabitants (HC). This is a 24-week nationwide prospective multi-centre cohort with a control group without RD and not using HCQ. All participants were monitored through scheduled phone interviews performed by health professionals. Details regarding COVID-19 symptoms, and epidemiological, clinical, and demographic data were recorded on a specific web-ba","2021","07","12","Clin Exp Rheumatol","Clinical and experimental rheumatology",NA,"Klumb","Evandro M","Hospital Universitário Pedro Ernesto, Universidade do Estado do Rio de Janeiro (UERJ), Rio de Janeiro-RJ, Brazil",NA
"495","34251312","","Incidence and risk factors for moderate/severe COVID-19 in rheumatic diseases patients on hydroxychloroquine: a 24-week prospective cohort.","To evaluate the incidence of COVID-19 and its main outcomes in rheumatic disease (RD) patients on hydroxychloroquine (HCQ) compared to household cohabitants (HC). This is a 24-week nationwide prospective multi-centre cohort with a control group without RD and not using HCQ. All participants were monitored through scheduled phone interviews performed by health professionals. Details regarding COVID-19 symptoms, and epidemiological, clinical, and demographic data were recorded on a specific web-ba","2021","07","12","Clin Exp Rheumatol","Clinical and experimental rheumatology",NA,"Marques","Claudia D L","Hospital das Clínicas da Universidade Federal de Pernambuco (UFPE), Recife-PE, Brazil",NA
"496","34251312","","Incidence and risk factors for moderate/severe COVID-19 in rheumatic diseases patients on hydroxychloroquine: a 24-week prospective cohort.","To evaluate the incidence of COVID-19 and its main outcomes in rheumatic disease (RD) patients on hydroxychloroquine (HCQ) compared to household cohabitants (HC). This is a 24-week nationwide prospective multi-centre cohort with a control group without RD and not using HCQ. All participants were monitored through scheduled phone interviews performed by health professionals. Details regarding COVID-19 symptoms, and epidemiological, clinical, and demographic data were recorded on a specific web-ba","2021","07","12","Clin Exp Rheumatol","Clinical and experimental rheumatology",NA,"Guedes de Melo","Ana Karla","Hospital Universitário Lauro Wanderley, Universidade Federal da Paraíba (UFPB), João Pessoa-PB, Brazil",NA
"497","34251312","","Incidence and risk factors for moderate/severe COVID-19 in rheumatic diseases patients on hydroxychloroquine: a 24-week prospective cohort.","To evaluate the incidence of COVID-19 and its main outcomes in rheumatic disease (RD) patients on hydroxychloroquine (HCQ) compared to household cohabitants (HC). This is a 24-week nationwide prospective multi-centre cohort with a control group without RD and not using HCQ. All participants were monitored through scheduled phone interviews performed by health professionals. Details regarding COVID-19 symptoms, and epidemiological, clinical, and demographic data were recorded on a specific web-ba","2021","07","12","Clin Exp Rheumatol","Clinical and experimental rheumatology",NA,"Monticielo","Odirlei A","Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre-RS, Brazil",NA
"498","34251312","","Incidence and risk factors for moderate/severe COVID-19 in rheumatic diseases patients on hydroxychloroquine: a 24-week prospective cohort.","To evaluate the incidence of COVID-19 and its main outcomes in rheumatic disease (RD) patients on hydroxychloroquine (HCQ) compared to household cohabitants (HC). This is a 24-week nationwide prospective multi-centre cohort with a control group without RD and not using HCQ. All participants were monitored through scheduled phone interviews performed by health professionals. Details regarding COVID-19 symptoms, and epidemiological, clinical, and demographic data were recorded on a specific web-ba","2021","07","12","Clin Exp Rheumatol","Clinical and experimental rheumatology",NA,"Mota","Licia M H","Hospital Universitário de Brasília da Universidade de Brasília, EBSERH (HUB-UnB), Brasília-DF, Brazil",NA
"499","34251312","","Incidence and risk factors for moderate/severe COVID-19 in rheumatic diseases patients on hydroxychloroquine: a 24-week prospective cohort.","To evaluate the incidence of COVID-19 and its main outcomes in rheumatic disease (RD) patients on hydroxychloroquine (HCQ) compared to household cohabitants (HC). This is a 24-week nationwide prospective multi-centre cohort with a control group without RD and not using HCQ. All participants were monitored through scheduled phone interviews performed by health professionals. Details regarding COVID-19 symptoms, and epidemiological, clinical, and demographic data were recorded on a specific web-ba","2021","07","12","Clin Exp Rheumatol","Clinical and experimental rheumatology",NA,"Munhoz","Gabriela A","Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), São Paulo-SP, Brazil",NA
"500","34251312","","Incidence and risk factors for moderate/severe COVID-19 in rheumatic diseases patients on hydroxychloroquine: a 24-week prospective cohort.","To evaluate the incidence of COVID-19 and its main outcomes in rheumatic disease (RD) patients on hydroxychloroquine (HCQ) compared to household cohabitants (HC). This is a 24-week nationwide prospective multi-centre cohort with a control group without RD and not using HCQ. All participants were monitored through scheduled phone interviews performed by health professionals. Details regarding COVID-19 symptoms, and epidemiological, clinical, and demographic data were recorded on a specific web-ba","2021","07","12","Clin Exp Rheumatol","Clinical and experimental rheumatology",NA,"Paiva","Eduardo S","Universidade Federal do Paraná (UFPR), Curitiba-PR, Brazil",NA
"501","34251312","","Incidence and risk factors for moderate/severe COVID-19 in rheumatic diseases patients on hydroxychloroquine: a 24-week prospective cohort.","To evaluate the incidence of COVID-19 and its main outcomes in rheumatic disease (RD) patients on hydroxychloroquine (HCQ) compared to household cohabitants (HC). This is a 24-week nationwide prospective multi-centre cohort with a control group without RD and not using HCQ. All participants were monitored through scheduled phone interviews performed by health professionals. Details regarding COVID-19 symptoms, and epidemiological, clinical, and demographic data were recorded on a specific web-ba","2021","07","12","Clin Exp Rheumatol","Clinical and experimental rheumatology",NA,"Pereira","Helena L Alves","Hospital Universitário Getúlio Vargas Universidade Federal do Amazonas, Manaus-AM, Brazil",NA
"502","34251312","","Incidence and risk factors for moderate/severe COVID-19 in rheumatic diseases patients on hydroxychloroquine: a 24-week prospective cohort.","To evaluate the incidence of COVID-19 and its main outcomes in rheumatic disease (RD) patients on hydroxychloroquine (HCQ) compared to household cohabitants (HC). This is a 24-week nationwide prospective multi-centre cohort with a control group without RD and not using HCQ. All participants were monitored through scheduled phone interviews performed by health professionals. Details regarding COVID-19 symptoms, and epidemiological, clinical, and demographic data were recorded on a specific web-ba","2021","07","12","Clin Exp Rheumatol","Clinical and experimental rheumatology",NA,"Provenza","José Roberto","Pontifícia Universidade Católica de Campinas (PUC-CAMP), Campinas-SP, Brazil",NA
"503","34251312","","Incidence and risk factors for moderate/severe COVID-19 in rheumatic diseases patients on hydroxychloroquine: a 24-week prospective cohort.","To evaluate the incidence of COVID-19 and its main outcomes in rheumatic disease (RD) patients on hydroxychloroquine (HCQ) compared to household cohabitants (HC). This is a 24-week nationwide prospective multi-centre cohort with a control group without RD and not using HCQ. All participants were monitored through scheduled phone interviews performed by health professionals. Details regarding COVID-19 symptoms, and epidemiological, clinical, and demographic data were recorded on a specific web-ba","2021","07","12","Clin Exp Rheumatol","Clinical and experimental rheumatology",NA,"Ribeiro","Sandra L Euzébio","Hospital Universitário Getúlio Vargas Universidade Federal do Amazonas, Manaus-AM, Brazil",NA
"504","34251312","","Incidence and risk factors for moderate/severe COVID-19 in rheumatic diseases patients on hydroxychloroquine: a 24-week prospective cohort.","To evaluate the incidence of COVID-19 and its main outcomes in rheumatic disease (RD) patients on hydroxychloroquine (HCQ) compared to household cohabitants (HC). This is a 24-week nationwide prospective multi-centre cohort with a control group without RD and not using HCQ. All participants were monitored through scheduled phone interviews performed by health professionals. Details regarding COVID-19 symptoms, and epidemiological, clinical, and demographic data were recorded on a specific web-ba","2021","07","12","Clin Exp Rheumatol","Clinical and experimental rheumatology",NA,"Rocha","Laurindo F","Instituto de Medicina Integral Professor Fernando Figueira (IMIP/PE), Recife-PE, Brazil",NA
"505","34251312","","Incidence and risk factors for moderate/severe COVID-19 in rheumatic diseases patients on hydroxychloroquine: a 24-week prospective cohort.","To evaluate the incidence of COVID-19 and its main outcomes in rheumatic disease (RD) patients on hydroxychloroquine (HCQ) compared to household cohabitants (HC). This is a 24-week nationwide prospective multi-centre cohort with a control group without RD and not using HCQ. All participants were monitored through scheduled phone interviews performed by health professionals. Details regarding COVID-19 symptoms, and epidemiological, clinical, and demographic data were recorded on a specific web-ba","2021","07","12","Clin Exp Rheumatol","Clinical and experimental rheumatology",NA,"Sato","Emilia I","Hospital São Paulo da Universidade Federal de São Paulo, Escola Paulista de Medicina (Unifesp/EPM), São Paulo-SP, Brazil",NA
"506","34251312","","Incidence and risk factors for moderate/severe COVID-19 in rheumatic diseases patients on hydroxychloroquine: a 24-week prospective cohort.","To evaluate the incidence of COVID-19 and its main outcomes in rheumatic disease (RD) patients on hydroxychloroquine (HCQ) compared to household cohabitants (HC). This is a 24-week nationwide prospective multi-centre cohort with a control group without RD and not using HCQ. All participants were monitored through scheduled phone interviews performed by health professionals. Details regarding COVID-19 symptoms, and epidemiological, clinical, and demographic data were recorded on a specific web-ba","2021","07","12","Clin Exp Rheumatol","Clinical and experimental rheumatology",NA,"Skare","Telma","Hospital Universitário Evangélico Mackenzie (HUEM), Curitiba-PR, Brazil",NA
"507","34251312","","Incidence and risk factors for moderate/severe COVID-19 in rheumatic diseases patients on hydroxychloroquine: a 24-week prospective cohort.","To evaluate the incidence of COVID-19 and its main outcomes in rheumatic disease (RD) patients on hydroxychloroquine (HCQ) compared to household cohabitants (HC). This is a 24-week nationwide prospective multi-centre cohort with a control group without RD and not using HCQ. All participants were monitored through scheduled phone interviews performed by health professionals. Details regarding COVID-19 symptoms, and epidemiological, clinical, and demographic data were recorded on a specific web-ba","2021","07","12","Clin Exp Rheumatol","Clinical and experimental rheumatology",NA,"de Souza","Viviane A","Hospital Universitário da Universidade Federal de Juiz de Fora (UFJF), Juiz de Fora-MG, Brazil",NA
"508","34251312","","Incidence and risk factors for moderate/severe COVID-19 in rheumatic diseases patients on hydroxychloroquine: a 24-week prospective cohort.","To evaluate the incidence of COVID-19 and its main outcomes in rheumatic disease (RD) patients on hydroxychloroquine (HCQ) compared to household cohabitants (HC). This is a 24-week nationwide prospective multi-centre cohort with a control group without RD and not using HCQ. All participants were monitored through scheduled phone interviews performed by health professionals. Details regarding COVID-19 symptoms, and epidemiological, clinical, and demographic data were recorded on a specific web-ba","2021","07","12","Clin Exp Rheumatol","Clinical and experimental rheumatology",NA,"Valim","Valeria","Hospital Universitário Cassiano Antonio de Moraes, Universidade Federal do Espírito Santo, Vitória-ES, Brazil",NA
"509","34251312","","Incidence and risk factors for moderate/severe COVID-19 in rheumatic diseases patients on hydroxychloroquine: a 24-week prospective cohort.","To evaluate the incidence of COVID-19 and its main outcomes in rheumatic disease (RD) patients on hydroxychloroquine (HCQ) compared to household cohabitants (HC). This is a 24-week nationwide prospective multi-centre cohort with a control group without RD and not using HCQ. All participants were monitored through scheduled phone interviews performed by health professionals. Details regarding COVID-19 symptoms, and epidemiological, clinical, and demographic data were recorded on a specific web-ba","2021","07","12","Clin Exp Rheumatol","Clinical and experimental rheumatology",NA,"Lacerda","Marcus V G","Instituto Leônidas &amp",NA
"510","34251312","","Incidence and risk factors for moderate/severe COVID-19 in rheumatic diseases patients on hydroxychloroquine: a 24-week prospective cohort.","To evaluate the incidence of COVID-19 and its main outcomes in rheumatic disease (RD) patients on hydroxychloroquine (HCQ) compared to household cohabitants (HC). This is a 24-week nationwide prospective multi-centre cohort with a control group without RD and not using HCQ. All participants were monitored through scheduled phone interviews performed by health professionals. Details regarding COVID-19 symptoms, and epidemiological, clinical, and demographic data were recorded on a specific web-ba","2021","07","12","Clin Exp Rheumatol","Clinical and experimental rheumatology",NA,"Xavier","Ricardo M","Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre-RS, Brazil",NA
"511","34251312","","Incidence and risk factors for moderate/severe COVID-19 in rheumatic diseases patients on hydroxychloroquine: a 24-week prospective cohort.","To evaluate the incidence of COVID-19 and its main outcomes in rheumatic disease (RD) patients on hydroxychloroquine (HCQ) compared to household cohabitants (HC). This is a 24-week nationwide prospective multi-centre cohort with a control group without RD and not using HCQ. All participants were monitored through scheduled phone interviews performed by health professionals. Details regarding COVID-19 symptoms, and epidemiological, clinical, and demographic data were recorded on a specific web-ba","2021","07","12","Clin Exp Rheumatol","Clinical and experimental rheumatology",NA,"Ferreira","Gilda A","Hospital das Clínicas, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte-MG, Brazil",NA
"512","34251307","","Efficacy and safety of tocilizumab in the management of COVID-19: a systematic review and meta-analysis of observational studies.","This systematic review and meta-analysis was aimed to evaluate the efficacy and safety of tocilizumab (TCZ) in treating severe coronavirus disease 2019 (COVID-19). The electronic search was made using PubMed, Scopus, CENTRAL, and Google scholar to identify the retrospective observational reports. The studies published from 01 January 2020 to 30th October 2020. Participants were hospitalised COVID-19 patients. Interventions included tocilizumab versus placebo/standard of care. The comparison will","2021","07","12","Clin Exp Rheumatol","Clinical and experimental rheumatology",NA,"Viswanatha","Gollapalle L","Independent Researcher and Consultant, Kengeri, Bangalore, Karnataka, India. glv_000@yahoo","000@yahoo.com"
"513","34251307","","Efficacy and safety of tocilizumab in the management of COVID-19: a systematic review and meta-analysis of observational studies.","This systematic review and meta-analysis was aimed to evaluate the efficacy and safety of tocilizumab (TCZ) in treating severe coronavirus disease 2019 (COVID-19). The electronic search was made using PubMed, Scopus, CENTRAL, and Google scholar to identify the retrospective observational reports. The studies published from 01 January 2020 to 30th October 2020. Participants were hospitalised COVID-19 patients. Interventions included tocilizumab versus placebo/standard of care. The comparison will","2021","07","12","Clin Exp Rheumatol","Clinical and experimental rheumatology",NA,"Anjana Male","Ch K V L S N","Department of Pharmaceutical Chemistry and Phytochemistry, Nirmala College of Pharmacy, Mangalagiri, Andhra Pradesh, India",NA
"514","34251307","","Efficacy and safety of tocilizumab in the management of COVID-19: a systematic review and meta-analysis of observational studies.","This systematic review and meta-analysis was aimed to evaluate the efficacy and safety of tocilizumab (TCZ) in treating severe coronavirus disease 2019 (COVID-19). The electronic search was made using PubMed, Scopus, CENTRAL, and Google scholar to identify the retrospective observational reports. The studies published from 01 January 2020 to 30th October 2020. Participants were hospitalised COVID-19 patients. Interventions included tocilizumab versus placebo/standard of care. The comparison will","2021","07","12","Clin Exp Rheumatol","Clinical and experimental rheumatology",NA,"Shylaja","Hanumanthappa","Independent Researcher, Kengeri, Bangalore, Karnataka, India",NA
"515","34251248","10.1063/5.0050887","Interrupting vaccination policies can greatly spread SARS-CoV-2 and enhance mortality from COVID-19 disease: The AstraZeneca case for France and Italy.","Several European countries have suspended the inoculation of the AstraZeneca vaccine out of suspicion that it causes deep vein thrombosis. In this letter, we report some Fermi estimates performed using a stochastic model aimed at making a risk-benefit analysis of the interruption of the delivery of the AstraZeneca vaccine in France and Italy. Our results clearly show that excess deaths due to the interruption of the vaccination campaign injections largely overrun those due to thrombosis even in ","2021","07","13","Chaos","Chaos (Woodbury, N.Y.)",NA,"Faranda","Davide","Laboratoire des Sciences du Climat et de l'Environnement, CEA Saclay l'Orme des Merisiers, UMR 8212 CEA-CNRS-UVSQ, Université Paris-Saclay &amp",NA
"516","34251248","10.1063/5.0050887","Interrupting vaccination policies can greatly spread SARS-CoV-2 and enhance mortality from COVID-19 disease: The AstraZeneca case for France and Italy.","Several European countries have suspended the inoculation of the AstraZeneca vaccine out of suspicion that it causes deep vein thrombosis. In this letter, we report some Fermi estimates performed using a stochastic model aimed at making a risk-benefit analysis of the interruption of the delivery of the AstraZeneca vaccine in France and Italy. Our results clearly show that excess deaths due to the interruption of the vaccination campaign injections largely overrun those due to thrombosis even in ","2021","07","13","Chaos","Chaos (Woodbury, N.Y.)",NA,"Alberti","Tommaso","National Institute for Astrophysics-Institute for Space Astrophysics and Planetology (INAF-IAPS), via del Fosso del Cavaliere 100, 00133 Rome, Italy",NA
"517","34251248","10.1063/5.0050887","Interrupting vaccination policies can greatly spread SARS-CoV-2 and enhance mortality from COVID-19 disease: The AstraZeneca case for France and Italy.","Several European countries have suspended the inoculation of the AstraZeneca vaccine out of suspicion that it causes deep vein thrombosis. In this letter, we report some Fermi estimates performed using a stochastic model aimed at making a risk-benefit analysis of the interruption of the delivery of the AstraZeneca vaccine in France and Italy. Our results clearly show that excess deaths due to the interruption of the vaccination campaign injections largely overrun those due to thrombosis even in ","2021","07","13","Chaos","Chaos (Woodbury, N.Y.)",NA,"Arutkin","Maxence","UMR CNRS 7083 Gulliver, ESPCI Paris, 10 rue Vauquelin, 75005 Paris, France",NA
"518","34251248","10.1063/5.0050887","Interrupting vaccination policies can greatly spread SARS-CoV-2 and enhance mortality from COVID-19 disease: The AstraZeneca case for France and Italy.","Several European countries have suspended the inoculation of the AstraZeneca vaccine out of suspicion that it causes deep vein thrombosis. In this letter, we report some Fermi estimates performed using a stochastic model aimed at making a risk-benefit analysis of the interruption of the delivery of the AstraZeneca vaccine in France and Italy. Our results clearly show that excess deaths due to the interruption of the vaccination campaign injections largely overrun those due to thrombosis even in ","2021","07","13","Chaos","Chaos (Woodbury, N.Y.)",NA,"Lembo","Valerio","National Research Council of Italy, Institute of Atmospheric Sciences and Climate (CNR-ISAC), 40129 Bologna, Italy",NA
"519","34251248","10.1063/5.0050887","Interrupting vaccination policies can greatly spread SARS-CoV-2 and enhance mortality from COVID-19 disease: The AstraZeneca case for France and Italy.","Several European countries have suspended the inoculation of the AstraZeneca vaccine out of suspicion that it causes deep vein thrombosis. In this letter, we report some Fermi estimates performed using a stochastic model aimed at making a risk-benefit analysis of the interruption of the delivery of the AstraZeneca vaccine in France and Italy. Our results clearly show that excess deaths due to the interruption of the vaccination campaign injections largely overrun those due to thrombosis even in ","2021","07","13","Chaos","Chaos (Woodbury, N.Y.)",NA,"Lucarini","Valerio","Department of Mathematics and Statistics, University of Reading, Reading, United Kingdom and Centre for the Mathematics of Planet Earth, University of Reading, RG6 6AX Reading, United Kingdom",NA
"520","34251243","10.1063/5.0046772","Criticality in epidemic spread: An application in the case of COVID19 infected population.","Recently, it has been successfully shown that the temporal evolution of the fraction of COVID-19 infected people possesses the same dynamics as the ones demonstrated by a self-organizing diffusion model over a lattice, in the frame of universality. In this brief, the relevant emerging dynamics are further investigated. Evidence that this nonlinear model demonstrates critical dynamics is scrutinized within the frame of the physics of critical phenomena. Additionally, the concept of criticality ov","2021","07","13","Chaos","Chaos (Woodbury, N.Y.)",NA,"Contoyiannis","Y","Department of Electrical and Electronics Engineering, University of West Attica, Ancient Olive Grove Campus, 250 Thivon and P. Ralli, Aigaleo, Athens GR-12244, Greece",NA
"521","34251243","10.1063/5.0046772","Criticality in epidemic spread: An application in the case of COVID19 infected population.","Recently, it has been successfully shown that the temporal evolution of the fraction of COVID-19 infected people possesses the same dynamics as the ones demonstrated by a self-organizing diffusion model over a lattice, in the frame of universality. In this brief, the relevant emerging dynamics are further investigated. Evidence that this nonlinear model demonstrates critical dynamics is scrutinized within the frame of the physics of critical phenomena. Additionally, the concept of criticality ov","2021","07","13","Chaos","Chaos (Woodbury, N.Y.)",NA,"Stavrinides","S G","School of Science and Technology, International Hellenic University, Thermi Campus, 57001 Thessaloniki, Greece",NA
"522","34251243","10.1063/5.0046772","Criticality in epidemic spread: An application in the case of COVID19 infected population.","Recently, it has been successfully shown that the temporal evolution of the fraction of COVID-19 infected people possesses the same dynamics as the ones demonstrated by a self-organizing diffusion model over a lattice, in the frame of universality. In this brief, the relevant emerging dynamics are further investigated. Evidence that this nonlinear model demonstrates critical dynamics is scrutinized within the frame of the physics of critical phenomena. Additionally, the concept of criticality ov","2021","07","13","Chaos","Chaos (Woodbury, N.Y.)",NA,"Hanias","M P","Physics Department, International Hellenic University, St Lucas, 65404 Kavala, Greece",NA
"523","34251243","10.1063/5.0046772","Criticality in epidemic spread: An application in the case of COVID19 infected population.","Recently, it has been successfully shown that the temporal evolution of the fraction of COVID-19 infected people possesses the same dynamics as the ones demonstrated by a self-organizing diffusion model over a lattice, in the frame of universality. In this brief, the relevant emerging dynamics are further investigated. Evidence that this nonlinear model demonstrates critical dynamics is scrutinized within the frame of the physics of critical phenomena. Additionally, the concept of criticality ov","2021","07","13","Chaos","Chaos (Woodbury, N.Y.)",NA,"Kampitakis","M","Major Network Installations Department, Hellenic Electricity Distribution Network Operator S.A., 18547 Athens, Greece",NA
"524","34251243","10.1063/5.0046772","Criticality in epidemic spread: An application in the case of COVID19 infected population.","Recently, it has been successfully shown that the temporal evolution of the fraction of COVID-19 infected people possesses the same dynamics as the ones demonstrated by a self-organizing diffusion model over a lattice, in the frame of universality. In this brief, the relevant emerging dynamics are further investigated. Evidence that this nonlinear model demonstrates critical dynamics is scrutinized within the frame of the physics of critical phenomena. Additionally, the concept of criticality ov","2021","07","13","Chaos","Chaos (Woodbury, N.Y.)",NA,"Papadopoulos","P","Department of Electrical and Electronics Engineering, University of West Attica, Ancient Olive Grove Campus, 250 Thivon and P. Ralli, Aigaleo, Athens GR-12244, Greece",NA
"525","34251243","10.1063/5.0046772","Criticality in epidemic spread: An application in the case of COVID19 infected population.","Recently, it has been successfully shown that the temporal evolution of the fraction of COVID-19 infected people possesses the same dynamics as the ones demonstrated by a self-organizing diffusion model over a lattice, in the frame of universality. In this brief, the relevant emerging dynamics are further investigated. Evidence that this nonlinear model demonstrates critical dynamics is scrutinized within the frame of the physics of critical phenomena. Additionally, the concept of criticality ov","2021","07","13","Chaos","Chaos (Woodbury, N.Y.)",NA,"Picos","R","Department of Industrial Engineering and Construction, University of Balearic Islands, 07122 Palma, Spain",NA
"526","34251243","10.1063/5.0046772","Criticality in epidemic spread: An application in the case of COVID19 infected population.","Recently, it has been successfully shown that the temporal evolution of the fraction of COVID-19 infected people possesses the same dynamics as the ones demonstrated by a self-organizing diffusion model over a lattice, in the frame of universality. In this brief, the relevant emerging dynamics are further investigated. Evidence that this nonlinear model demonstrates critical dynamics is scrutinized within the frame of the physics of critical phenomena. Additionally, the concept of criticality ov","2021","07","13","Chaos","Chaos (Woodbury, N.Y.)",NA,"Potirakis","S M","Department of Industrial Engineering and Construction, University of Balearic Islands, 07122 Palma, Spain",NA
"527","34251243","10.1063/5.0046772","Criticality in epidemic spread: An application in the case of COVID19 infected population.","Recently, it has been successfully shown that the temporal evolution of the fraction of COVID-19 infected people possesses the same dynamics as the ones demonstrated by a self-organizing diffusion model over a lattice, in the frame of universality. In this brief, the relevant emerging dynamics are further investigated. Evidence that this nonlinear model demonstrates critical dynamics is scrutinized within the frame of the physics of critical phenomena. Additionally, the concept of criticality ov","2021","07","13","Chaos","Chaos (Woodbury, N.Y.)",NA,"Kosmidis","E K","Laboratory of Physiology, Department of Medicine, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece",NA
"528","34251238","10.1063/5.0041993","How adherence to public health measures shapes epidemic spreading: A temporal network model.","The COVID-19 pandemic has laid bare the importance of non-pharmaceutical interventions in the containment of airborne infectious diseases. Social distancing and mask-wearing have been found to contain COVID-19 spreading across a number of observational studies, but a precise understanding of their combined effectiveness is lacking. An underdeveloped area of research entails the quantification of the specific role of each of these measures when they are differentially adopted by the population. P","2021","07","13","Chaos","Chaos (Woodbury, N.Y.)",NA,"Behring","Brandon M","Department of Mechanical and Aerospace Engineering, Tandon School of Engineering, New York University, Six MetroTech Center, Brooklyn, New York 11201, USA",NA
"529","34251238","10.1063/5.0041993","How adherence to public health measures shapes epidemic spreading: A temporal network model.","The COVID-19 pandemic has laid bare the importance of non-pharmaceutical interventions in the containment of airborne infectious diseases. Social distancing and mask-wearing have been found to contain COVID-19 spreading across a number of observational studies, but a precise understanding of their combined effectiveness is lacking. An underdeveloped area of research entails the quantification of the specific role of each of these measures when they are differentially adopted by the population. P","2021","07","13","Chaos","Chaos (Woodbury, N.Y.)",NA,"Rizzo","Alessandro","Department of Electronics and Telecommunications, Politecnico di Torino, 10128 Torino, Italy",NA
"530","34251238","10.1063/5.0041993","How adherence to public health measures shapes epidemic spreading: A temporal network model.","The COVID-19 pandemic has laid bare the importance of non-pharmaceutical interventions in the containment of airborne infectious diseases. Social distancing and mask-wearing have been found to contain COVID-19 spreading across a number of observational studies, but a precise understanding of their combined effectiveness is lacking. An underdeveloped area of research entails the quantification of the specific role of each of these measures when they are differentially adopted by the population. P","2021","07","13","Chaos","Chaos (Woodbury, N.Y.)",NA,"Porfiri","Maurizio","Department of Mechanical and Aerospace Engineering, Tandon School of Engineering, New York University, Six MetroTech Center, Brooklyn, New York 11201, USA",NA
"531","34251226","10.1063/5.0021108","Stochastic analysis of COVID-19 by a SEIR model with Lévy noise.","We propose a Lévy noise-driven susceptible-exposed-infected-recovered model incorporating media coverage to analyze the outbreak of COVID-19. We conduct a theoretical analysis of the stochastic model by the suitable Lyapunov function, including the existence and uniqueness of the positive solution, the dynamic properties around the disease-free equilibrium and the endemic equilibrium; we deduce a stochastic basic reproduction number R0 <sup>s</sup> for the extinction of disease, that ","2021","07","13","Chaos","Chaos (Woodbury, N.Y.)",NA,"Ding","Yamin","School of Mathematics and Statistics, Xi'an Jiaotong University, Xi'an 710049, China",NA
"532","34251226","10.1063/5.0021108","Stochastic analysis of COVID-19 by a SEIR model with Lévy noise.","We propose a Lévy noise-driven susceptible-exposed-infected-recovered model incorporating media coverage to analyze the outbreak of COVID-19. We conduct a theoretical analysis of the stochastic model by the suitable Lyapunov function, including the existence and uniqueness of the positive solution, the dynamic properties around the disease-free equilibrium and the endemic equilibrium; we deduce a stochastic basic reproduction number R0 <sup>s</sup> for the extinction of disease, that ","2021","07","13","Chaos","Chaos (Woodbury, N.Y.)",NA,"Fu","Yuxuan","School of Mathematics and Statistics, Xi'an Jiaotong University, Xi'an 710049, China",NA
"533","34251226","10.1063/5.0021108","Stochastic analysis of COVID-19 by a SEIR model with Lévy noise.","We propose a Lévy noise-driven susceptible-exposed-infected-recovered model incorporating media coverage to analyze the outbreak of COVID-19. We conduct a theoretical analysis of the stochastic model by the suitable Lyapunov function, including the existence and uniqueness of the positive solution, the dynamic properties around the disease-free equilibrium and the endemic equilibrium; we deduce a stochastic basic reproduction number R0 <sup>s</sup> for the extinction of disease, that ","2021","07","13","Chaos","Chaos (Woodbury, N.Y.)",NA,"Kang","Yanmei","School of Mathematics and Statistics, Xi'an Jiaotong University, Xi'an 710049, China",NA
"534","34251153","","Cardiopulmonary resuscitation in prone position: usefulness in patients with SARS-CoV-2 infection.",NA,"2021","07","15","Emergencias","Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias","COVID-19; Cardiopulmonary Resuscitation; Heart Arrest; Humans; Patient Positioning; Prone Position","Añez de Molina","Anna","Universidad de Barcelona, Barcelona, España",NA
"535","34251153","","Cardiopulmonary resuscitation in prone position: usefulness in patients with SARS-CoV-2 infection.",NA,"2021","07","15","Emergencias","Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias","COVID-19; Cardiopulmonary Resuscitation; Heart Arrest; Humans; Patient Positioning; Prone Position","D'Annuzio","Ángela","Universidad de Barcelona, Barcelona, España",NA
"536","34251153","","Cardiopulmonary resuscitation in prone position: usefulness in patients with SARS-CoV-2 infection.",NA,"2021","07","15","Emergencias","Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias","COVID-19; Cardiopulmonary Resuscitation; Heart Arrest; Humans; Patient Positioning; Prone Position","Saval Segura","Cristina","Hospital Sagrat Cor, Barcelona, España",NA
"537","34251141","","Risk models for predicting in-hospital mortality from COVID-19 pneumonia in the elderly.","To compare the prognostic value of 3 severity scales: the Pneumonia Severity Index (PSI), the CURB-65 pneumonia severity score, and the Severity Community-Acquired Pneumonia (SCAP) score. To build a new predictive model for in-hospital mortality in patients over the age of 75 years admitted with pneumonia due to the coronavirus disease 2019 (COVID-19). Retrospective study of patients older than 75 years admitted from the emergency department for COVID-19 pneumonia between March 12 and April 27, ","2021","07","15","Emergencias","Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias","COVID-19; Escalas de gravedad; Modelo predictivo; Mortalidad; Mortality; Predictive model; Prognosis; Pronóstico; Severity scales; Aged; Aged, 80 and over; Area Under Curve; COVID-19; Female; Hospital Mortality; Humans; Male; Models, Theoretical; ROC Curve; Retrospective Studies; Severity of Illness Index","López-Izquierdo","Raúl","Servicio de Urgencias, Hospital Universitario Río Hortega, Valladolid, España. Departamento de Cirugía, Oftalmología, Otorrinolaringología y Fisioterapia, Facultad de Medicina, Universidad de Valladolid, España",NA
"538","34251141","","Risk models for predicting in-hospital mortality from COVID-19 pneumonia in the elderly.","To compare the prognostic value of 3 severity scales: the Pneumonia Severity Index (PSI), the CURB-65 pneumonia severity score, and the Severity Community-Acquired Pneumonia (SCAP) score. To build a new predictive model for in-hospital mortality in patients over the age of 75 years admitted with pneumonia due to the coronavirus disease 2019 (COVID-19). Retrospective study of patients older than 75 years admitted from the emergency department for COVID-19 pneumonia between March 12 and April 27, ","2021","07","15","Emergencias","Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias","COVID-19; Escalas de gravedad; Modelo predictivo; Mortalidad; Mortality; Predictive model; Prognosis; Pronóstico; Severity scales; Aged; Aged, 80 and over; Area Under Curve; COVID-19; Female; Hospital Mortality; Humans; Male; Models, Theoretical; ROC Curve; Retrospective Studies; Severity of Illness Index","Ruiz Albi","Tomás","Servicio de Neumología, Hospital Universitario Río Hortega, Valladolid, España",NA
"539","34251141","","Risk models for predicting in-hospital mortality from COVID-19 pneumonia in the elderly.","To compare the prognostic value of 3 severity scales: the Pneumonia Severity Index (PSI), the CURB-65 pneumonia severity score, and the Severity Community-Acquired Pneumonia (SCAP) score. To build a new predictive model for in-hospital mortality in patients over the age of 75 years admitted with pneumonia due to the coronavirus disease 2019 (COVID-19). Retrospective study of patients older than 75 years admitted from the emergency department for COVID-19 pneumonia between March 12 and April 27, ","2021","07","15","Emergencias","Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias","COVID-19; Escalas de gravedad; Modelo predictivo; Mortalidad; Mortality; Predictive model; Prognosis; Pronóstico; Severity scales; Aged; Aged, 80 and over; Area Under Curve; COVID-19; Female; Hospital Mortality; Humans; Male; Models, Theoretical; ROC Curve; Retrospective Studies; Severity of Illness Index","Bermejo-Martín","Jesús Francisco","Grupo de Investigación Biomédica en Infección Respiratoria y Sepsis (Biosepsis) (IBSAL), España. Centro de Investigación Biomédica en Red en Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, España",NA
"540","34251141","","Risk models for predicting in-hospital mortality from COVID-19 pneumonia in the elderly.","To compare the prognostic value of 3 severity scales: the Pneumonia Severity Index (PSI), the CURB-65 pneumonia severity score, and the Severity Community-Acquired Pneumonia (SCAP) score. To build a new predictive model for in-hospital mortality in patients over the age of 75 years admitted with pneumonia due to the coronavirus disease 2019 (COVID-19). Retrospective study of patients older than 75 years admitted from the emergency department for COVID-19 pneumonia between March 12 and April 27, ","2021","07","15","Emergencias","Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias","COVID-19; Escalas de gravedad; Modelo predictivo; Mortalidad; Mortality; Predictive model; Prognosis; Pronóstico; Severity scales; Aged; Aged, 80 and over; Area Under Curve; COVID-19; Female; Hospital Mortality; Humans; Male; Models, Theoretical; ROC Curve; Retrospective Studies; Severity of Illness Index","Almansa","Raquel","Grupo de Investigación Biomédica en Infección Respiratoria y Sepsis (Biosepsis) (IBSAL), España. Centro de Investigación Biomédica en Red en Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, España",NA
"541","34251141","","Risk models for predicting in-hospital mortality from COVID-19 pneumonia in the elderly.","To compare the prognostic value of 3 severity scales: the Pneumonia Severity Index (PSI), the CURB-65 pneumonia severity score, and the Severity Community-Acquired Pneumonia (SCAP) score. To build a new predictive model for in-hospital mortality in patients over the age of 75 years admitted with pneumonia due to the coronavirus disease 2019 (COVID-19). Retrospective study of patients older than 75 years admitted from the emergency department for COVID-19 pneumonia between March 12 and April 27, ","2021","07","15","Emergencias","Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias","COVID-19; Escalas de gravedad; Modelo predictivo; Mortalidad; Mortality; Predictive model; Prognosis; Pronóstico; Severity scales; Aged; Aged, 80 and over; Area Under Curve; COVID-19; Female; Hospital Mortality; Humans; Male; Models, Theoretical; ROC Curve; Retrospective Studies; Severity of Illness Index","Villafañe Sanz","Fátima Victoria","Servicio de Urgencias, Hospital Universitario Río Hortega, Valladolid, España",NA
"542","34251141","","Risk models for predicting in-hospital mortality from COVID-19 pneumonia in the elderly.","To compare the prognostic value of 3 severity scales: the Pneumonia Severity Index (PSI), the CURB-65 pneumonia severity score, and the Severity Community-Acquired Pneumonia (SCAP) score. To build a new predictive model for in-hospital mortality in patients over the age of 75 years admitted with pneumonia due to the coronavirus disease 2019 (COVID-19). Retrospective study of patients older than 75 years admitted from the emergency department for COVID-19 pneumonia between March 12 and April 27, ","2021","07","15","Emergencias","Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias","COVID-19; Escalas de gravedad; Modelo predictivo; Mortalidad; Mortality; Predictive model; Prognosis; Pronóstico; Severity scales; Aged; Aged, 80 and over; Area Under Curve; COVID-19; Female; Hospital Mortality; Humans; Male; Models, Theoretical; ROC Curve; Retrospective Studies; Severity of Illness Index","Arroyo Olmedo","Lucia","Servicio de Neumología, Hospital Universitario Río Hortega, Valladolid, España",NA
"543","34251141","","Risk models for predicting in-hospital mortality from COVID-19 pneumonia in the elderly.","To compare the prognostic value of 3 severity scales: the Pneumonia Severity Index (PSI), the CURB-65 pneumonia severity score, and the Severity Community-Acquired Pneumonia (SCAP) score. To build a new predictive model for in-hospital mortality in patients over the age of 75 years admitted with pneumonia due to the coronavirus disease 2019 (COVID-19). Retrospective study of patients older than 75 years admitted from the emergency department for COVID-19 pneumonia between March 12 and April 27, ","2021","07","15","Emergencias","Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias","COVID-19; Escalas de gravedad; Modelo predictivo; Mortalidad; Mortality; Predictive model; Prognosis; Pronóstico; Severity scales; Aged; Aged, 80 and over; Area Under Curve; COVID-19; Female; Hospital Mortality; Humans; Male; Models, Theoretical; ROC Curve; Retrospective Studies; Severity of Illness Index","Urbina Carrera","Carolina Andrea","Servicio de Neumología, Hospital Universitario Río Hortega, Valladolid, España",NA
"544","34251141","","Risk models for predicting in-hospital mortality from COVID-19 pneumonia in the elderly.","To compare the prognostic value of 3 severity scales: the Pneumonia Severity Index (PSI), the CURB-65 pneumonia severity score, and the Severity Community-Acquired Pneumonia (SCAP) score. To build a new predictive model for in-hospital mortality in patients over the age of 75 years admitted with pneumonia due to the coronavirus disease 2019 (COVID-19). Retrospective study of patients older than 75 years admitted from the emergency department for COVID-19 pneumonia between March 12 and April 27, ","2021","07","15","Emergencias","Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias","COVID-19; Escalas de gravedad; Modelo predictivo; Mortalidad; Mortality; Predictive model; Prognosis; Pronóstico; Severity scales; Aged; Aged, 80 and over; Area Under Curve; COVID-19; Female; Hospital Mortality; Humans; Male; Models, Theoretical; ROC Curve; Retrospective Studies; Severity of Illness Index","Sánchez Ramón","Susana","Servicio de Urgencias, Hospital Universitario Río Hortega, Valladolid, España. Departamento de Medicina, Dermatología y Toxicología, Facultad de Medicina, Universidad de Valladolid, España",NA
"545","34251141","","Risk models for predicting in-hospital mortality from COVID-19 pneumonia in the elderly.","To compare the prognostic value of 3 severity scales: the Pneumonia Severity Index (PSI), the CURB-65 pneumonia severity score, and the Severity Community-Acquired Pneumonia (SCAP) score. To build a new predictive model for in-hospital mortality in patients over the age of 75 years admitted with pneumonia due to the coronavirus disease 2019 (COVID-19). Retrospective study of patients older than 75 years admitted from the emergency department for COVID-19 pneumonia between March 12 and April 27, ","2021","07","15","Emergencias","Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias","COVID-19; Escalas de gravedad; Modelo predictivo; Mortalidad; Mortality; Predictive model; Prognosis; Pronóstico; Severity scales; Aged; Aged, 80 and over; Area Under Curve; COVID-19; Female; Hospital Mortality; Humans; Male; Models, Theoretical; ROC Curve; Retrospective Studies; Severity of Illness Index","Martín-Rodríguez","Francisco","Unidad Móvil de Emergencias, Gerencia de Emergencias Sanitarias de Castilla y León (SACYL), España. Centro de Simulación Clínica Avanzada, Facultad de Medicina, Universidad de Valladolid, Valladolid, España",NA
"546","34251141","","Risk models for predicting in-hospital mortality from COVID-19 pneumonia in the elderly.","To compare the prognostic value of 3 severity scales: the Pneumonia Severity Index (PSI), the CURB-65 pneumonia severity score, and the Severity Community-Acquired Pneumonia (SCAP) score. To build a new predictive model for in-hospital mortality in patients over the age of 75 years admitted with pneumonia due to the coronavirus disease 2019 (COVID-19). Retrospective study of patients older than 75 years admitted from the emergency department for COVID-19 pneumonia between March 12 and April 27, ","2021","07","15","Emergencias","Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias","COVID-19; Escalas de gravedad; Modelo predictivo; Mortalidad; Mortality; Predictive model; Prognosis; Pronóstico; Severity scales; Aged; Aged, 80 and over; Area Under Curve; COVID-19; Female; Hospital Mortality; Humans; Male; Models, Theoretical; ROC Curve; Retrospective Studies; Severity of Illness Index","Moreno Torrero","Fernando","Servicio de Neumología, Hospital Universitario Río Hortega, Valladolid, España",NA
"547","34251141","","Risk models for predicting in-hospital mortality from COVID-19 pneumonia in the elderly.","To compare the prognostic value of 3 severity scales: the Pneumonia Severity Index (PSI), the CURB-65 pneumonia severity score, and the Severity Community-Acquired Pneumonia (SCAP) score. To build a new predictive model for in-hospital mortality in patients over the age of 75 years admitted with pneumonia due to the coronavirus disease 2019 (COVID-19). Retrospective study of patients older than 75 years admitted from the emergency department for COVID-19 pneumonia between March 12 and April 27, ","2021","07","15","Emergencias","Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias","COVID-19; Escalas de gravedad; Modelo predictivo; Mortalidad; Mortality; Predictive model; Prognosis; Pronóstico; Severity scales; Aged; Aged, 80 and over; Area Under Curve; COVID-19; Female; Hospital Mortality; Humans; Male; Models, Theoretical; ROC Curve; Retrospective Studies; Severity of Illness Index","Álvarez","Daniel","Servicio de Neumología, Hospital Universitario Río Hortega, Valladolid, España. Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Instituto de Salud Carlos III, Madrid, España. Grupo de Ingeniería Biomédica (GIB), Universidad de Valladolid, Valladolid, España",NA
"548","34251141","","Risk models for predicting in-hospital mortality from COVID-19 pneumonia in the elderly.","To compare the prognostic value of 3 severity scales: the Pneumonia Severity Index (PSI), the CURB-65 pneumonia severity score, and the Severity Community-Acquired Pneumonia (SCAP) score. To build a new predictive model for in-hospital mortality in patients over the age of 75 years admitted with pneumonia due to the coronavirus disease 2019 (COVID-19). Retrospective study of patients older than 75 years admitted from the emergency department for COVID-19 pneumonia between March 12 and April 27, ","2021","07","15","Emergencias","Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias","COVID-19; Escalas de gravedad; Modelo predictivo; Mortalidad; Mortality; Predictive model; Prognosis; Pronóstico; Severity scales; Aged; Aged, 80 and over; Area Under Curve; COVID-19; Female; Hospital Mortality; Humans; Male; Models, Theoretical; ROC Curve; Retrospective Studies; Severity of Illness Index","Del Campo Matía","Félix","Servicio de Neumología, Hospital Universitario Río Hortega, Valladolid, España. Departamento de Medicina, Dermatología y Toxicología, Facultad de Medicina, Universidad de Valladolid, España. Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Instituto de Salud Carlos III, Madrid, España",NA
"549","34251140","","Mortality in patients treated for COVID-19 in the emergency department of a tertiary care hospital during the first phase of the pandemic: Derivation of a risk model for emergency departments.","To develop a risk model to predict 30-day mortality after emergency department treatment for COVID-19. Observational retrospective cohort study including 2511 patients with COVID-19 who came to our emergency department between March 1 and April 30, 2020. We analyzed variables with Kaplan Meier survival and Cox regression analyses. All-cause mortality was 8% at 30 days. Independent variables associated with higher risk of mortality were age over 50 years, a Barthel index score less than 90, alter","2021","07","15","Emergencias","Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias","COVID-19; Emergency department; Indicador de mortalidad; Infección SARS-CoV-2; Mortality; Risk factors; SARS-CoV-2 infection; Urgencias; C-Reactive Protein; COVID-19; Emergency Service, Hospital; Glomerular Filtration Rate; Humans; Kaplan-Meier Estimate; Lung; Middle Aged; Models, Theoretical; Retrospective Studies; Risk Factors; Tertiary Care Centers","García-Martínez","Ana","Área de Urgencias, Hospital Clinic, Barcelona, España. Universitat de Barcelona, España",NA
"550","34251140","","Mortality in patients treated for COVID-19 in the emergency department of a tertiary care hospital during the first phase of the pandemic: Derivation of a risk model for emergency departments.","To develop a risk model to predict 30-day mortality after emergency department treatment for COVID-19. Observational retrospective cohort study including 2511 patients with COVID-19 who came to our emergency department between March 1 and April 30, 2020. We analyzed variables with Kaplan Meier survival and Cox regression analyses. All-cause mortality was 8% at 30 days. Independent variables associated with higher risk of mortality were age over 50 years, a Barthel index score less than 90, alter","2021","07","15","Emergencias","Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias","COVID-19; Emergency department; Indicador de mortalidad; Infección SARS-CoV-2; Mortality; Risk factors; SARS-CoV-2 infection; Urgencias; C-Reactive Protein; COVID-19; Emergency Service, Hospital; Glomerular Filtration Rate; Humans; Kaplan-Meier Estimate; Lung; Middle Aged; Models, Theoretical; Retrospective Studies; Risk Factors; Tertiary Care Centers","López-Barbeito","Beatriz","Área de Urgencias, Hospital Clinic, Barcelona, España. Universitat de Barcelona, España",NA
"551","34251140","","Mortality in patients treated for COVID-19 in the emergency department of a tertiary care hospital during the first phase of the pandemic: Derivation of a risk model for emergency departments.","To develop a risk model to predict 30-day mortality after emergency department treatment for COVID-19. Observational retrospective cohort study including 2511 patients with COVID-19 who came to our emergency department between March 1 and April 30, 2020. We analyzed variables with Kaplan Meier survival and Cox regression analyses. All-cause mortality was 8% at 30 days. Independent variables associated with higher risk of mortality were age over 50 years, a Barthel index score less than 90, alter","2021","07","15","Emergencias","Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias","COVID-19; Emergency department; Indicador de mortalidad; Infección SARS-CoV-2; Mortality; Risk factors; SARS-CoV-2 infection; Urgencias; C-Reactive Protein; COVID-19; Emergency Service, Hospital; Glomerular Filtration Rate; Humans; Kaplan-Meier Estimate; Lung; Middle Aged; Models, Theoretical; Retrospective Studies; Risk Factors; Tertiary Care Centers","Coll-Vinent","Blanca","Área de Urgencias, Hospital Clinic, Barcelona, España. Universitat de Barcelona, España",NA
"552","34251140","","Mortality in patients treated for COVID-19 in the emergency department of a tertiary care hospital during the first phase of the pandemic: Derivation of a risk model for emergency departments.","To develop a risk model to predict 30-day mortality after emergency department treatment for COVID-19. Observational retrospective cohort study including 2511 patients with COVID-19 who came to our emergency department between March 1 and April 30, 2020. We analyzed variables with Kaplan Meier survival and Cox regression analyses. All-cause mortality was 8% at 30 days. Independent variables associated with higher risk of mortality were age over 50 years, a Barthel index score less than 90, alter","2021","07","15","Emergencias","Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias","COVID-19; Emergency department; Indicador de mortalidad; Infección SARS-CoV-2; Mortality; Risk factors; SARS-CoV-2 infection; Urgencias; C-Reactive Protein; COVID-19; Emergency Service, Hospital; Glomerular Filtration Rate; Humans; Kaplan-Meier Estimate; Lung; Middle Aged; Models, Theoretical; Retrospective Studies; Risk Factors; Tertiary Care Centers","Placer","Arrate","Área de Urgencias, Hospital Clinic, Barcelona, España. Universitat de Barcelona, España",NA
"553","34251140","","Mortality in patients treated for COVID-19 in the emergency department of a tertiary care hospital during the first phase of the pandemic: Derivation of a risk model for emergency departments.","To develop a risk model to predict 30-day mortality after emergency department treatment for COVID-19. Observational retrospective cohort study including 2511 patients with COVID-19 who came to our emergency department between March 1 and April 30, 2020. We analyzed variables with Kaplan Meier survival and Cox regression analyses. All-cause mortality was 8% at 30 days. Independent variables associated with higher risk of mortality were age over 50 years, a Barthel index score less than 90, alter","2021","07","15","Emergencias","Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias","COVID-19; Emergency department; Indicador de mortalidad; Infección SARS-CoV-2; Mortality; Risk factors; SARS-CoV-2 infection; Urgencias; C-Reactive Protein; COVID-19; Emergency Service, Hospital; Glomerular Filtration Rate; Humans; Kaplan-Meier Estimate; Lung; Middle Aged; Models, Theoretical; Retrospective Studies; Risk Factors; Tertiary Care Centers","Font","Carme","Área de Urgencias, Hospital Clinic, Barcelona, España. Universitat de Barcelona, España",NA
"554","34251140","","Mortality in patients treated for COVID-19 in the emergency department of a tertiary care hospital during the first phase of the pandemic: Derivation of a risk model for emergency departments.","To develop a risk model to predict 30-day mortality after emergency department treatment for COVID-19. Observational retrospective cohort study including 2511 patients with COVID-19 who came to our emergency department between March 1 and April 30, 2020. We analyzed variables with Kaplan Meier survival and Cox regression analyses. All-cause mortality was 8% at 30 days. Independent variables associated with higher risk of mortality were age over 50 years, a Barthel index score less than 90, alter","2021","07","15","Emergencias","Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias","COVID-19; Emergency department; Indicador de mortalidad; Infección SARS-CoV-2; Mortality; Risk factors; SARS-CoV-2 infection; Urgencias; C-Reactive Protein; COVID-19; Emergency Service, Hospital; Glomerular Filtration Rate; Humans; Kaplan-Meier Estimate; Lung; Middle Aged; Models, Theoretical; Retrospective Studies; Risk Factors; Tertiary Care Centers","Rosa Vargas","Carmen","Área de Urgencias, Hospital Clinic, Barcelona, España. Universitat de Barcelona, España",NA
"555","34251140","","Mortality in patients treated for COVID-19 in the emergency department of a tertiary care hospital during the first phase of the pandemic: Derivation of a risk model for emergency departments.","To develop a risk model to predict 30-day mortality after emergency department treatment for COVID-19. Observational retrospective cohort study including 2511 patients with COVID-19 who came to our emergency department between March 1 and April 30, 2020. We analyzed variables with Kaplan Meier survival and Cox regression analyses. All-cause mortality was 8% at 30 days. Independent variables associated with higher risk of mortality were age over 50 years, a Barthel index score less than 90, alter","2021","07","15","Emergencias","Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias","COVID-19; Emergency department; Indicador de mortalidad; Infección SARS-CoV-2; Mortality; Risk factors; SARS-CoV-2 infection; Urgencias; C-Reactive Protein; COVID-19; Emergency Service, Hospital; Glomerular Filtration Rate; Humans; Kaplan-Meier Estimate; Lung; Middle Aged; Models, Theoretical; Retrospective Studies; Risk Factors; Tertiary Care Centers","Sánchez","Carolina","Área de Urgencias, Hospital Clinic, Barcelona, España. Universitat de Barcelona, España",NA
"556","34251140","","Mortality in patients treated for COVID-19 in the emergency department of a tertiary care hospital during the first phase of the pandemic: Derivation of a risk model for emergency departments.","To develop a risk model to predict 30-day mortality after emergency department treatment for COVID-19. Observational retrospective cohort study including 2511 patients with COVID-19 who came to our emergency department between March 1 and April 30, 2020. We analyzed variables with Kaplan Meier survival and Cox regression analyses. All-cause mortality was 8% at 30 days. Independent variables associated with higher risk of mortality were age over 50 years, a Barthel index score less than 90, alter","2021","07","15","Emergencias","Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias","COVID-19; Emergency department; Indicador de mortalidad; Infección SARS-CoV-2; Mortality; Risk factors; SARS-CoV-2 infection; Urgencias; C-Reactive Protein; COVID-19; Emergency Service, Hospital; Glomerular Filtration Rate; Humans; Kaplan-Meier Estimate; Lung; Middle Aged; Models, Theoretical; Retrospective Studies; Risk Factors; Tertiary Care Centers","Piñango","Daniela","Área de Urgencias, Hospital Clinic, Barcelona, España. Universitat de Barcelona, España",NA
"557","34251140","","Mortality in patients treated for COVID-19 in the emergency department of a tertiary care hospital during the first phase of the pandemic: Derivation of a risk model for emergency departments.","To develop a risk model to predict 30-day mortality after emergency department treatment for COVID-19. Observational retrospective cohort study including 2511 patients with COVID-19 who came to our emergency department between March 1 and April 30, 2020. We analyzed variables with Kaplan Meier survival and Cox regression analyses. All-cause mortality was 8% at 30 days. Independent variables associated with higher risk of mortality were age over 50 years, a Barthel index score less than 90, alter","2021","07","15","Emergencias","Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias","COVID-19; Emergency department; Indicador de mortalidad; Infección SARS-CoV-2; Mortality; Risk factors; SARS-CoV-2 infection; Urgencias; C-Reactive Protein; COVID-19; Emergency Service, Hospital; Glomerular Filtration Rate; Humans; Kaplan-Meier Estimate; Lung; Middle Aged; Models, Theoretical; Retrospective Studies; Risk Factors; Tertiary Care Centers","Gómez-Angelats","Elisenda","Área de Urgencias, Hospital Clinic, Barcelona, España. Universitat de Barcelona, España",NA
"558","34251140","","Mortality in patients treated for COVID-19 in the emergency department of a tertiary care hospital during the first phase of the pandemic: Derivation of a risk model for emergency departments.","To develop a risk model to predict 30-day mortality after emergency department treatment for COVID-19. Observational retrospective cohort study including 2511 patients with COVID-19 who came to our emergency department between March 1 and April 30, 2020. We analyzed variables with Kaplan Meier survival and Cox regression analyses. All-cause mortality was 8% at 30 days. Independent variables associated with higher risk of mortality were age over 50 years, a Barthel index score less than 90, alter","2021","07","15","Emergencias","Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias","COVID-19; Emergency department; Indicador de mortalidad; Infección SARS-CoV-2; Mortality; Risk factors; SARS-CoV-2 infection; Urgencias; C-Reactive Protein; COVID-19; Emergency Service, Hospital; Glomerular Filtration Rate; Humans; Kaplan-Meier Estimate; Lung; Middle Aged; Models, Theoretical; Retrospective Studies; Risk Factors; Tertiary Care Centers","Curtelin","David","Área de Urgencias, Hospital Clinic, Barcelona, España. Universitat de Barcelona, España",NA
"559","34251140","","Mortality in patients treated for COVID-19 in the emergency department of a tertiary care hospital during the first phase of the pandemic: Derivation of a risk model for emergency departments.","To develop a risk model to predict 30-day mortality after emergency department treatment for COVID-19. Observational retrospective cohort study including 2511 patients with COVID-19 who came to our emergency department between March 1 and April 30, 2020. We analyzed variables with Kaplan Meier survival and Cox regression analyses. All-cause mortality was 8% at 30 days. Independent variables associated with higher risk of mortality were age over 50 years, a Barthel index score less than 90, alter","2021","07","15","Emergencias","Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias","COVID-19; Emergency department; Indicador de mortalidad; Infección SARS-CoV-2; Mortality; Risk factors; SARS-CoV-2 infection; Urgencias; C-Reactive Protein; COVID-19; Emergency Service, Hospital; Glomerular Filtration Rate; Humans; Kaplan-Meier Estimate; Lung; Middle Aged; Models, Theoretical; Retrospective Studies; Risk Factors; Tertiary Care Centers","Salgado","Emilio","Área de Urgencias, Hospital Clinic, Barcelona, España. Universitat de Barcelona, España",NA
"560","34251140","","Mortality in patients treated for COVID-19 in the emergency department of a tertiary care hospital during the first phase of the pandemic: Derivation of a risk model for emergency departments.","To develop a risk model to predict 30-day mortality after emergency department treatment for COVID-19. Observational retrospective cohort study including 2511 patients with COVID-19 who came to our emergency department between March 1 and April 30, 2020. We analyzed variables with Kaplan Meier survival and Cox regression analyses. All-cause mortality was 8% at 30 days. Independent variables associated with higher risk of mortality were age over 50 years, a Barthel index score less than 90, alter","2021","07","15","Emergencias","Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias","COVID-19; Emergency department; Indicador de mortalidad; Infección SARS-CoV-2; Mortality; Risk factors; SARS-CoV-2 infection; Urgencias; C-Reactive Protein; COVID-19; Emergency Service, Hospital; Glomerular Filtration Rate; Humans; Kaplan-Meier Estimate; Lung; Middle Aged; Models, Theoretical; Retrospective Studies; Risk Factors; Tertiary Care Centers","Aya","Francisco","Área de Urgencias, Hospital Clinic, Barcelona, España. Universitat de Barcelona, España",NA
"561","34251140","","Mortality in patients treated for COVID-19 in the emergency department of a tertiary care hospital during the first phase of the pandemic: Derivation of a risk model for emergency departments.","To develop a risk model to predict 30-day mortality after emergency department treatment for COVID-19. Observational retrospective cohort study including 2511 patients with COVID-19 who came to our emergency department between March 1 and April 30, 2020. We analyzed variables with Kaplan Meier survival and Cox regression analyses. All-cause mortality was 8% at 30 days. Independent variables associated with higher risk of mortality were age over 50 years, a Barthel index score less than 90, alter","2021","07","15","Emergencias","Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias","COVID-19; Emergency department; Indicador de mortalidad; Infección SARS-CoV-2; Mortality; Risk factors; SARS-CoV-2 infection; Urgencias; C-Reactive Protein; COVID-19; Emergency Service, Hospital; Glomerular Filtration Rate; Humans; Kaplan-Meier Estimate; Lung; Middle Aged; Models, Theoretical; Retrospective Studies; Risk Factors; Tertiary Care Centers","Martínez-Nadal","Gemma","Área de Urgencias, Hospital Clinic, Barcelona, España. Universitat de Barcelona, España",NA
"562","34251140","","Mortality in patients treated for COVID-19 in the emergency department of a tertiary care hospital during the first phase of the pandemic: Derivation of a risk model for emergency departments.","To develop a risk model to predict 30-day mortality after emergency department treatment for COVID-19. Observational retrospective cohort study including 2511 patients with COVID-19 who came to our emergency department between March 1 and April 30, 2020. We analyzed variables with Kaplan Meier survival and Cox regression analyses. All-cause mortality was 8% at 30 days. Independent variables associated with higher risk of mortality were age over 50 years, a Barthel index score less than 90, alter","2021","07","15","Emergencias","Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias","COVID-19; Emergency department; Indicador de mortalidad; Infección SARS-CoV-2; Mortality; Risk factors; SARS-CoV-2 infection; Urgencias; C-Reactive Protein; COVID-19; Emergency Service, Hospital; Glomerular Filtration Rate; Humans; Kaplan-Meier Estimate; Lung; Middle Aged; Models, Theoretical; Retrospective Studies; Risk Factors; Tertiary Care Centers","Alonso","José Ramón","Área de Urgencias, Hospital Clinic, Barcelona, España. Universitat de Barcelona, España",NA
"563","34251140","","Mortality in patients treated for COVID-19 in the emergency department of a tertiary care hospital during the first phase of the pandemic: Derivation of a risk model for emergency departments.","To develop a risk model to predict 30-day mortality after emergency department treatment for COVID-19. Observational retrospective cohort study including 2511 patients with COVID-19 who came to our emergency department between March 1 and April 30, 2020. We analyzed variables with Kaplan Meier survival and Cox regression analyses. All-cause mortality was 8% at 30 days. Independent variables associated with higher risk of mortality were age over 50 years, a Barthel index score less than 90, alter","2021","07","15","Emergencias","Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias","COVID-19; Emergency department; Indicador de mortalidad; Infección SARS-CoV-2; Mortality; Risk factors; SARS-CoV-2 infection; Urgencias; C-Reactive Protein; COVID-19; Emergency Service, Hospital; Glomerular Filtration Rate; Humans; Kaplan-Meier Estimate; Lung; Middle Aged; Models, Theoretical; Retrospective Studies; Risk Factors; Tertiary Care Centers","García-Gozalbes","Julia","Área de Urgencias, Hospital Clinic, Barcelona, España. Universitat de Barcelona, España",NA
"564","34251140","","Mortality in patients treated for COVID-19 in the emergency department of a tertiary care hospital during the first phase of the pandemic: Derivation of a risk model for emergency departments.","To develop a risk model to predict 30-day mortality after emergency department treatment for COVID-19. Observational retrospective cohort study including 2511 patients with COVID-19 who came to our emergency department between March 1 and April 30, 2020. We analyzed variables with Kaplan Meier survival and Cox regression analyses. All-cause mortality was 8% at 30 days. Independent variables associated with higher risk of mortality were age over 50 years, a Barthel index score less than 90, alter","2021","07","15","Emergencias","Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias","COVID-19; Emergency department; Indicador de mortalidad; Infección SARS-CoV-2; Mortality; Risk factors; SARS-CoV-2 infection; Urgencias; C-Reactive Protein; COVID-19; Emergency Service, Hospital; Glomerular Filtration Rate; Humans; Kaplan-Meier Estimate; Lung; Middle Aged; Models, Theoretical; Retrospective Studies; Risk Factors; Tertiary Care Centers","Fresco","Leticia","Área de Urgencias, Hospital Clinic, Barcelona, España. Universitat de Barcelona, España",NA
"565","34251140","","Mortality in patients treated for COVID-19 in the emergency department of a tertiary care hospital during the first phase of the pandemic: Derivation of a risk model for emergency departments.","To develop a risk model to predict 30-day mortality after emergency department treatment for COVID-19. Observational retrospective cohort study including 2511 patients with COVID-19 who came to our emergency department between March 1 and April 30, 2020. We analyzed variables with Kaplan Meier survival and Cox regression analyses. All-cause mortality was 8% at 30 days. Independent variables associated with higher risk of mortality were age over 50 years, a Barthel index score less than 90, alter","2021","07","15","Emergencias","Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias","COVID-19; Emergency department; Indicador de mortalidad; Infección SARS-CoV-2; Mortality; Risk factors; SARS-CoV-2 infection; Urgencias; C-Reactive Protein; COVID-19; Emergency Service, Hospital; Glomerular Filtration Rate; Humans; Kaplan-Meier Estimate; Lung; Middle Aged; Models, Theoretical; Retrospective Studies; Risk Factors; Tertiary Care Centers","Galicia","Miguel","Área de Urgencias, Hospital Clinic, Barcelona, España. Universitat de Barcelona, España",NA
"566","34251140","","Mortality in patients treated for COVID-19 in the emergency department of a tertiary care hospital during the first phase of the pandemic: Derivation of a risk model for emergency departments.","To develop a risk model to predict 30-day mortality after emergency department treatment for COVID-19. Observational retrospective cohort study including 2511 patients with COVID-19 who came to our emergency department between March 1 and April 30, 2020. We analyzed variables with Kaplan Meier survival and Cox regression analyses. All-cause mortality was 8% at 30 days. Independent variables associated with higher risk of mortality were age over 50 years, a Barthel index score less than 90, alter","2021","07","15","Emergencias","Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias","COVID-19; Emergency department; Indicador de mortalidad; Infección SARS-CoV-2; Mortality; Risk factors; SARS-CoV-2 infection; Urgencias; C-Reactive Protein; COVID-19; Emergency Service, Hospital; Glomerular Filtration Rate; Humans; Kaplan-Meier Estimate; Lung; Middle Aged; Models, Theoretical; Retrospective Studies; Risk Factors; Tertiary Care Centers","Perea","Milagrosa","Área de Urgencias, Hospital Clinic, Barcelona, España. Universitat de Barcelona, España",NA
"567","34251140","","Mortality in patients treated for COVID-19 in the emergency department of a tertiary care hospital during the first phase of the pandemic: Derivation of a risk model for emergency departments.","To develop a risk model to predict 30-day mortality after emergency department treatment for COVID-19. Observational retrospective cohort study including 2511 patients with COVID-19 who came to our emergency department between March 1 and April 30, 2020. We analyzed variables with Kaplan Meier survival and Cox regression analyses. All-cause mortality was 8% at 30 days. Independent variables associated with higher risk of mortality were age over 50 years, a Barthel index score less than 90, alter","2021","07","15","Emergencias","Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias","COVID-19; Emergency department; Indicador de mortalidad; Infección SARS-CoV-2; Mortality; Risk factors; SARS-CoV-2 infection; Urgencias; C-Reactive Protein; COVID-19; Emergency Service, Hospital; Glomerular Filtration Rate; Humans; Kaplan-Meier Estimate; Lung; Middle Aged; Models, Theoretical; Retrospective Studies; Risk Factors; Tertiary Care Centers","Carbó","Miriam","Área de Urgencias, Hospital Clinic, Barcelona, España. Universitat de Barcelona, España",NA
"568","34251140","","Mortality in patients treated for COVID-19 in the emergency department of a tertiary care hospital during the first phase of the pandemic: Derivation of a risk model for emergency departments.","To develop a risk model to predict 30-day mortality after emergency department treatment for COVID-19. Observational retrospective cohort study including 2511 patients with COVID-19 who came to our emergency department between March 1 and April 30, 2020. We analyzed variables with Kaplan Meier survival and Cox regression analyses. All-cause mortality was 8% at 30 days. Independent variables associated with higher risk of mortality were age over 50 years, a Barthel index score less than 90, alter","2021","07","15","Emergencias","Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias","COVID-19; Emergency department; Indicador de mortalidad; Infección SARS-CoV-2; Mortality; Risk factors; SARS-CoV-2 infection; Urgencias; C-Reactive Protein; COVID-19; Emergency Service, Hospital; Glomerular Filtration Rate; Humans; Kaplan-Meier Estimate; Lung; Middle Aged; Models, Theoretical; Retrospective Studies; Risk Factors; Tertiary Care Centers","Iniesta","Nerea","Área de Urgencias, Hospital Clinic, Barcelona, España. Universitat de Barcelona, España",NA
"569","34251140","","Mortality in patients treated for COVID-19 in the emergency department of a tertiary care hospital during the first phase of the pandemic: Derivation of a risk model for emergency departments.","To develop a risk model to predict 30-day mortality after emergency department treatment for COVID-19. Observational retrospective cohort study including 2511 patients with COVID-19 who came to our emergency department between March 1 and April 30, 2020. We analyzed variables with Kaplan Meier survival and Cox regression analyses. All-cause mortality was 8% at 30 days. Independent variables associated with higher risk of mortality were age over 50 years, a Barthel index score less than 90, alter","2021","07","15","Emergencias","Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias","COVID-19; Emergency department; Indicador de mortalidad; Infección SARS-CoV-2; Mortality; Risk factors; SARS-CoV-2 infection; Urgencias; C-Reactive Protein; COVID-19; Emergency Service, Hospital; Glomerular Filtration Rate; Humans; Kaplan-Meier Estimate; Lung; Middle Aged; Models, Theoretical; Retrospective Studies; Risk Factors; Tertiary Care Centers","Escoda","Ona","Área de Urgencias, Hospital Clinic, Barcelona, España. Universitat de Barcelona, España",NA
"570","34251140","","Mortality in patients treated for COVID-19 in the emergency department of a tertiary care hospital during the first phase of the pandemic: Derivation of a risk model for emergency departments.","To develop a risk model to predict 30-day mortality after emergency department treatment for COVID-19. Observational retrospective cohort study including 2511 patients with COVID-19 who came to our emergency department between March 1 and April 30, 2020. We analyzed variables with Kaplan Meier survival and Cox regression analyses. All-cause mortality was 8% at 30 days. Independent variables associated with higher risk of mortality were age over 50 years, a Barthel index score less than 90, alter","2021","07","15","Emergencias","Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias","COVID-19; Emergency department; Indicador de mortalidad; Infección SARS-CoV-2; Mortality; Risk factors; SARS-CoV-2 infection; Urgencias; C-Reactive Protein; COVID-19; Emergency Service, Hospital; Glomerular Filtration Rate; Humans; Kaplan-Meier Estimate; Lung; Middle Aged; Models, Theoretical; Retrospective Studies; Risk Factors; Tertiary Care Centers","Perelló","Rafael","Área de Urgencias, Hospital Clinic, Barcelona, España. Universitat de Barcelona, España",NA
"571","34251140","","Mortality in patients treated for COVID-19 in the emergency department of a tertiary care hospital during the first phase of the pandemic: Derivation of a risk model for emergency departments.","To develop a risk model to predict 30-day mortality after emergency department treatment for COVID-19. Observational retrospective cohort study including 2511 patients with COVID-19 who came to our emergency department between March 1 and April 30, 2020. We analyzed variables with Kaplan Meier survival and Cox regression analyses. All-cause mortality was 8% at 30 days. Independent variables associated with higher risk of mortality were age over 50 years, a Barthel index score less than 90, alter","2021","07","15","Emergencias","Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias","COVID-19; Emergency department; Indicador de mortalidad; Infección SARS-CoV-2; Mortality; Risk factors; SARS-CoV-2 infection; Urgencias; C-Reactive Protein; COVID-19; Emergency Service, Hospital; Glomerular Filtration Rate; Humans; Kaplan-Meier Estimate; Lung; Middle Aged; Models, Theoretical; Retrospective Studies; Risk Factors; Tertiary Care Centers","Cuerpo","Sandra","Área de Urgencias, Hospital Clinic, Barcelona, España. Universitat de Barcelona, España",NA
"572","34251140","","Mortality in patients treated for COVID-19 in the emergency department of a tertiary care hospital during the first phase of the pandemic: Derivation of a risk model for emergency departments.","To develop a risk model to predict 30-day mortality after emergency department treatment for COVID-19. Observational retrospective cohort study including 2511 patients with COVID-19 who came to our emergency department between March 1 and April 30, 2020. We analyzed variables with Kaplan Meier survival and Cox regression analyses. All-cause mortality was 8% at 30 days. Independent variables associated with higher risk of mortality were age over 50 years, a Barthel index score less than 90, alter","2021","07","15","Emergencias","Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias","COVID-19; Emergency department; Indicador de mortalidad; Infección SARS-CoV-2; Mortality; Risk factors; SARS-CoV-2 infection; Urgencias; C-Reactive Protein; COVID-19; Emergency Service, Hospital; Glomerular Filtration Rate; Humans; Kaplan-Meier Estimate; Lung; Middle Aged; Models, Theoretical; Retrospective Studies; Risk Factors; Tertiary Care Centers","Flores","Vanesa","Área de Urgencias, Hospital Clinic, Barcelona, España. Universitat de Barcelona, España",NA
"573","34251140","","Mortality in patients treated for COVID-19 in the emergency department of a tertiary care hospital during the first phase of the pandemic: Derivation of a risk model for emergency departments.","To develop a risk model to predict 30-day mortality after emergency department treatment for COVID-19. Observational retrospective cohort study including 2511 patients with COVID-19 who came to our emergency department between March 1 and April 30, 2020. We analyzed variables with Kaplan Meier survival and Cox regression analyses. All-cause mortality was 8% at 30 days. Independent variables associated with higher risk of mortality were age over 50 years, a Barthel index score less than 90, alter","2021","07","15","Emergencias","Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias","COVID-19; Emergency department; Indicador de mortalidad; Infección SARS-CoV-2; Mortality; Risk factors; SARS-CoV-2 infection; Urgencias; C-Reactive Protein; COVID-19; Emergency Service, Hospital; Glomerular Filtration Rate; Humans; Kaplan-Meier Estimate; Lung; Middle Aged; Models, Theoretical; Retrospective Studies; Risk Factors; Tertiary Care Centers","Alemany","Xavier","Área de Urgencias, Hospital Clinic, Barcelona, España. Universitat de Barcelona, España",NA
"574","34251140","","Mortality in patients treated for COVID-19 in the emergency department of a tertiary care hospital during the first phase of the pandemic: Derivation of a risk model for emergency departments.","To develop a risk model to predict 30-day mortality after emergency department treatment for COVID-19. Observational retrospective cohort study including 2511 patients with COVID-19 who came to our emergency department between March 1 and April 30, 2020. We analyzed variables with Kaplan Meier survival and Cox regression analyses. All-cause mortality was 8% at 30 days. Independent variables associated with higher risk of mortality were age over 50 years, a Barthel index score less than 90, alter","2021","07","15","Emergencias","Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias","COVID-19; Emergency department; Indicador de mortalidad; Infección SARS-CoV-2; Mortality; Risk factors; SARS-CoV-2 infection; Urgencias; C-Reactive Protein; COVID-19; Emergency Service, Hospital; Glomerular Filtration Rate; Humans; Kaplan-Meier Estimate; Lung; Middle Aged; Models, Theoretical; Retrospective Studies; Risk Factors; Tertiary Care Centers","Miró","Òscar","Área de Urgencias, Hospital Clinic, Barcelona, España. Universitat de Barcelona, España",NA
"575","34251140","","Mortality in patients treated for COVID-19 in the emergency department of a tertiary care hospital during the first phase of the pandemic: Derivation of a risk model for emergency departments.","To develop a risk model to predict 30-day mortality after emergency department treatment for COVID-19. Observational retrospective cohort study including 2511 patients with COVID-19 who came to our emergency department between March 1 and April 30, 2020. We analyzed variables with Kaplan Meier survival and Cox regression analyses. All-cause mortality was 8% at 30 days. Independent variables associated with higher risk of mortality were age over 50 years, a Barthel index score less than 90, alter","2021","07","15","Emergencias","Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias","COVID-19; Emergency department; Indicador de mortalidad; Infección SARS-CoV-2; Mortality; Risk factors; SARS-CoV-2 infection; Urgencias; C-Reactive Protein; COVID-19; Emergency Service, Hospital; Glomerular Filtration Rate; Humans; Kaplan-Meier Estimate; Lung; Middle Aged; Models, Theoretical; Retrospective Studies; Risk Factors; Tertiary Care Centers","Ortega Romero","Mª Del Mar","Área de Urgencias, Hospital Clinic, Barcelona, España. Universitat de Barcelona, España",NA
"576","34251139","","Mortality risk model for patients with suspected COVID-19 based on information available from an emergency dispatch center.","To develop and validate a scale to stratify risk of 2-day mortality based on data collected during calls to an emergency dispatch center from patients with suspected coronavirus disease 2019 (COVID-19). Retrospective multicenter study of consecutive patients over the age of 18 years with suspected COVID-19 who were transported from home over the course of 3 months after telephone interviews with dispatchers. We analyzed clinical and epidemiologic variables and comorbidities in relation to death ","2021","07","15","Emergencias","Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias","COVID-19; Early-warning scores; Emergency health services; Escalas de alerta temprana; Medical dispatch; Prognosis; Pronóstico; Regulación médica; Servicios de emergencias médicos; Aged; COVID-19; Comorbidity; Emergency Medical Dispatch; Female; Hospitalization; Humans; Logistic Models; Male; ROC Curve; Retrospective Studies","Martín-Rodríguez","Francisco","Gerencia de Emergencias Sanitarias, Gerencia Regional de Salud de Castilla y León (SACYL), España. Facultad de Medicina, Universidad de Valladolid, Valladolid, España",NA
"577","34251139","","Mortality risk model for patients with suspected COVID-19 based on information available from an emergency dispatch center.","To develop and validate a scale to stratify risk of 2-day mortality based on data collected during calls to an emergency dispatch center from patients with suspected coronavirus disease 2019 (COVID-19). Retrospective multicenter study of consecutive patients over the age of 18 years with suspected COVID-19 who were transported from home over the course of 3 months after telephone interviews with dispatchers. We analyzed clinical and epidemiologic variables and comorbidities in relation to death ","2021","07","15","Emergencias","Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias","COVID-19; Early-warning scores; Emergency health services; Escalas de alerta temprana; Medical dispatch; Prognosis; Pronóstico; Regulación médica; Servicios de emergencias médicos; Aged; COVID-19; Comorbidity; Emergency Medical Dispatch; Female; Hospitalization; Humans; Logistic Models; Male; ROC Curve; Retrospective Studies","Sanz-García","Ancor","Hospital de la Princesa, Madrid, España",NA
"578","34251139","","Mortality risk model for patients with suspected COVID-19 based on information available from an emergency dispatch center.","To develop and validate a scale to stratify risk of 2-day mortality based on data collected during calls to an emergency dispatch center from patients with suspected coronavirus disease 2019 (COVID-19). Retrospective multicenter study of consecutive patients over the age of 18 years with suspected COVID-19 who were transported from home over the course of 3 months after telephone interviews with dispatchers. We analyzed clinical and epidemiologic variables and comorbidities in relation to death ","2021","07","15","Emergencias","Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias","COVID-19; Early-warning scores; Emergency health services; Escalas de alerta temprana; Medical dispatch; Prognosis; Pronóstico; Regulación médica; Servicios de emergencias médicos; Aged; COVID-19; Comorbidity; Emergency Medical Dispatch; Female; Hospitalization; Humans; Logistic Models; Male; ROC Curve; Retrospective Studies","Alberdi Iglesias","Ana","Hospital Clínico Universitario de Valladolid, Gerencia Regional de Salud de Castilla y León (SACYL), España",NA
"579","34251139","","Mortality risk model for patients with suspected COVID-19 based on information available from an emergency dispatch center.","To develop and validate a scale to stratify risk of 2-day mortality based on data collected during calls to an emergency dispatch center from patients with suspected coronavirus disease 2019 (COVID-19). Retrospective multicenter study of consecutive patients over the age of 18 years with suspected COVID-19 who were transported from home over the course of 3 months after telephone interviews with dispatchers. We analyzed clinical and epidemiologic variables and comorbidities in relation to death ","2021","07","15","Emergencias","Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias","COVID-19; Early-warning scores; Emergency health services; Escalas de alerta temprana; Medical dispatch; Prognosis; Pronóstico; Regulación médica; Servicios de emergencias médicos; Aged; COVID-19; Comorbidity; Emergency Medical Dispatch; Female; Hospitalization; Humans; Logistic Models; Male; ROC Curve; Retrospective Studies","Ortega Rabbione","Guillermo","Hospital de la Princesa, Madrid, España",NA
"580","34251139","","Mortality risk model for patients with suspected COVID-19 based on information available from an emergency dispatch center.","To develop and validate a scale to stratify risk of 2-day mortality based on data collected during calls to an emergency dispatch center from patients with suspected coronavirus disease 2019 (COVID-19). Retrospective multicenter study of consecutive patients over the age of 18 years with suspected COVID-19 who were transported from home over the course of 3 months after telephone interviews with dispatchers. We analyzed clinical and epidemiologic variables and comorbidities in relation to death ","2021","07","15","Emergencias","Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias","COVID-19; Early-warning scores; Emergency health services; Escalas de alerta temprana; Medical dispatch; Prognosis; Pronóstico; Regulación médica; Servicios de emergencias médicos; Aged; COVID-19; Comorbidity; Emergency Medical Dispatch; Female; Hospitalization; Humans; Logistic Models; Male; ROC Curve; Retrospective Studies","Del Pozo Vegas","Carlos","Hospital Clínico Universitario de Valladolid, Gerencia Regional de Salud de Castilla y León (SACYL), España",NA
"581","34251139","","Mortality risk model for patients with suspected COVID-19 based on information available from an emergency dispatch center.","To develop and validate a scale to stratify risk of 2-day mortality based on data collected during calls to an emergency dispatch center from patients with suspected coronavirus disease 2019 (COVID-19). Retrospective multicenter study of consecutive patients over the age of 18 years with suspected COVID-19 who were transported from home over the course of 3 months after telephone interviews with dispatchers. We analyzed clinical and epidemiologic variables and comorbidities in relation to death ","2021","07","15","Emergencias","Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias","COVID-19; Early-warning scores; Emergency health services; Escalas de alerta temprana; Medical dispatch; Prognosis; Pronóstico; Regulación médica; Servicios de emergencias médicos; Aged; COVID-19; Comorbidity; Emergency Medical Dispatch; Female; Hospitalization; Humans; Logistic Models; Male; ROC Curve; Retrospective Studies","de la Torre-Díez","Isabel","Escuela Técnica Superior de Ingenieros de Telecomunicación, Universidad de Valladolid, Valladolid, España",NA
"582","34251139","","Mortality risk model for patients with suspected COVID-19 based on information available from an emergency dispatch center.","To develop and validate a scale to stratify risk of 2-day mortality based on data collected during calls to an emergency dispatch center from patients with suspected coronavirus disease 2019 (COVID-19). Retrospective multicenter study of consecutive patients over the age of 18 years with suspected COVID-19 who were transported from home over the course of 3 months after telephone interviews with dispatchers. We analyzed clinical and epidemiologic variables and comorbidities in relation to death ","2021","07","15","Emergencias","Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias","COVID-19; Early-warning scores; Emergency health services; Escalas de alerta temprana; Medical dispatch; Prognosis; Pronóstico; Regulación médica; Servicios de emergencias médicos; Aged; COVID-19; Comorbidity; Emergency Medical Dispatch; Female; Hospitalization; Humans; Logistic Models; Male; ROC Curve; Retrospective Studies","Fernández Bayón","Germán","Hospital de Medina del Campo, Gerencia Regional de Salud de Castilla y León (SACYL), España",NA
"583","34251139","","Mortality risk model for patients with suspected COVID-19 based on information available from an emergency dispatch center.","To develop and validate a scale to stratify risk of 2-day mortality based on data collected during calls to an emergency dispatch center from patients with suspected coronavirus disease 2019 (COVID-19). Retrospective multicenter study of consecutive patients over the age of 18 years with suspected COVID-19 who were transported from home over the course of 3 months after telephone interviews with dispatchers. We analyzed clinical and epidemiologic variables and comorbidities in relation to death ","2021","07","15","Emergencias","Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias","COVID-19; Early-warning scores; Emergency health services; Escalas de alerta temprana; Medical dispatch; Prognosis; Pronóstico; Regulación médica; Servicios de emergencias médicos; Aged; COVID-19; Comorbidity; Emergency Medical Dispatch; Female; Hospitalization; Humans; Logistic Models; Male; ROC Curve; Retrospective Studies","Delgado Benito","Juan Francisco","Gerencia de Emergencias Sanitarias, Gerencia Regional de Salud de Castilla y León (SACYL), España",NA
"584","34251139","","Mortality risk model for patients with suspected COVID-19 based on information available from an emergency dispatch center.","To develop and validate a scale to stratify risk of 2-day mortality based on data collected during calls to an emergency dispatch center from patients with suspected coronavirus disease 2019 (COVID-19). Retrospective multicenter study of consecutive patients over the age of 18 years with suspected COVID-19 who were transported from home over the course of 3 months after telephone interviews with dispatchers. We analyzed clinical and epidemiologic variables and comorbidities in relation to death ","2021","07","15","Emergencias","Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias","COVID-19; Early-warning scores; Emergency health services; Escalas de alerta temprana; Medical dispatch; Prognosis; Pronóstico; Regulación médica; Servicios de emergencias médicos; Aged; COVID-19; Comorbidity; Emergency Medical Dispatch; Female; Hospitalization; Humans; Logistic Models; Male; ROC Curve; Retrospective Studies","Gómez-Escolar Pérez","Marta","Gerencia de Emergencias Sanitarias, Gerencia Regional de Salud de Castilla y León (SACYL), España",NA
"585","34251139","","Mortality risk model for patients with suspected COVID-19 based on information available from an emergency dispatch center.","To develop and validate a scale to stratify risk of 2-day mortality based on data collected during calls to an emergency dispatch center from patients with suspected coronavirus disease 2019 (COVID-19). Retrospective multicenter study of consecutive patients over the age of 18 years with suspected COVID-19 who were transported from home over the course of 3 months after telephone interviews with dispatchers. We analyzed clinical and epidemiologic variables and comorbidities in relation to death ","2021","07","15","Emergencias","Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias","COVID-19; Early-warning scores; Emergency health services; Escalas de alerta temprana; Medical dispatch; Prognosis; Pronóstico; Regulación médica; Servicios de emergencias médicos; Aged; COVID-19; Comorbidity; Emergency Medical Dispatch; Female; Hospitalization; Humans; Logistic Models; Male; ROC Curve; Retrospective Studies","García Cortés","José Javier","Gerencia de Emergencias Sanitarias, Gerencia Regional de Salud de Castilla y León (SACYL), España",NA
"586","34251139","","Mortality risk model for patients with suspected COVID-19 based on information available from an emergency dispatch center.","To develop and validate a scale to stratify risk of 2-day mortality based on data collected during calls to an emergency dispatch center from patients with suspected coronavirus disease 2019 (COVID-19). Retrospective multicenter study of consecutive patients over the age of 18 years with suspected COVID-19 who were transported from home over the course of 3 months after telephone interviews with dispatchers. We analyzed clinical and epidemiologic variables and comorbidities in relation to death ","2021","07","15","Emergencias","Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias","COVID-19; Early-warning scores; Emergency health services; Escalas de alerta temprana; Medical dispatch; Prognosis; Pronóstico; Regulación médica; Servicios de emergencias médicos; Aged; COVID-19; Comorbidity; Emergency Medical Dispatch; Female; Hospitalization; Humans; Logistic Models; Male; ROC Curve; Retrospective Studies","López-Izquierdo","Raúl","Hospital Universitario Río Hortega de Valladolid, Gerencia Regional de Salud de Castilla y León (SACYL)",NA
"587","34251137","","Keys to interpreting predictive models for the patient with COVID-19.",NA,"2021","07","15","Emergencias","Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias","COVID-19; Humans; Models, Theoretical","González Del Castillo","Juan","Servicio de Urgencias, IdISSC. Hospital Clínico San Carlos, Madrid, España",NA
"588","34251135","","Utility of open remote access medical advice in the COVID-19 pandemic among liver pre- and post-transplant patients.",NA,"2021","07","19","Isr Med Assoc J","The Israel Medical Association journal : IMAJ","COVID-19; Female; Health Services Accessibility; Hotlines; Humans; Infection Control; Israel; Liver Diseases; Liver Transplantation; Male; Middle Aged; Organizational Innovation; Patient Acceptance of Health Care; Perioperative Medicine; Remote Consultation; SARS-CoV-2","Milgrom","Yael","Department of Gastroenterology and Liver Diseases, Hadassah Medical Organization and Faculty of Medicine, Hebrew University of Jerusalem, Israel",NA
"589","34251135","","Utility of open remote access medical advice in the COVID-19 pandemic among liver pre- and post-transplant patients.",NA,"2021","07","19","Isr Med Assoc J","The Israel Medical Association journal : IMAJ","COVID-19; Female; Health Services Accessibility; Hotlines; Humans; Infection Control; Israel; Liver Diseases; Liver Transplantation; Male; Middle Aged; Organizational Innovation; Patient Acceptance of Health Care; Perioperative Medicine; Remote Consultation; SARS-CoV-2","Safadi","Rifaat","Department of Gastroenterology and Liver Diseases, Hadassah Medical Organization and Faculty of Medicine, Hebrew University of Jerusalem, Israelletter",NA
"590","34251129","","Distance Learning in the Field of Medicine: Hope or Hype?",NA,"2021","07","22","Isr Med Assoc J","The Israel Medical Association journal : IMAJ","COVID-19; Curriculum; Education, Distance; Education, Medical; Humans; Israel; Psychology, Educational; SARS-CoV-2; Teaching; Telemedicine","Tsur","Avishai M","Israel Defense Forces, Medical Corps, Tel Hashomer, Israel",NA
"591","34251129","","Distance Learning in the Field of Medicine: Hope or Hype?",NA,"2021","07","22","Isr Med Assoc J","The Israel Medical Association journal : IMAJ","COVID-19; Curriculum; Education, Distance; Education, Medical; Humans; Israel; Psychology, Educational; SARS-CoV-2; Teaching; Telemedicine","Ziv","Amitai","Israel Center for Medical Simulation, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel",NA
"592","34251129","","Distance Learning in the Field of Medicine: Hope or Hype?",NA,"2021","07","22","Isr Med Assoc J","The Israel Medical Association journal : IMAJ","COVID-19; Curriculum; Education, Distance; Education, Medical; Humans; Israel; Psychology, Educational; SARS-CoV-2; Teaching; Telemedicine","Amital","Howard","Department of Medicine B, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel",NA
"593","34251121","","A Retrospective Investigation of Neuraxial Anesthesia Rates for Elective Cesarean Delivery Before and During the SARS-CoV-2 Pandemic.","Our hospital used to perform cesarean delivery under general anesthesia rather than neuraxial anesthesia, mostly because of patient refusal of members of the conservative Bedouin society. According to recommendations implemented by the Israeli Obstetric Anesthesia Society, which were implemented due to the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic, we increased the rate of neuraxial anesthesia among deliveries. To compare the rates of neuraxial anesthesia in our cesar","2021","07","19","Isr Med Assoc J","The Israel Medical Association journal : IMAJ","Adult; Anesthesia, Conduction; Anesthesia, General; Anesthesia, Obstetrical; Arabs; COVID-19; Cesarean Section; Delivery Rooms; Elective Surgical Procedures; Female; Humans; Infection Control; Israel; Organizational Innovation; Pregnancy; Procedures and Techniques Utilization; Retrospective Studies; Treatment Refusal","Binyamin","Yair","Department of Anesthesiology, Soroka Medical Center, and Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel",NA
"594","34251121","","A Retrospective Investigation of Neuraxial Anesthesia Rates for Elective Cesarean Delivery Before and During the SARS-CoV-2 Pandemic.","Our hospital used to perform cesarean delivery under general anesthesia rather than neuraxial anesthesia, mostly because of patient refusal of members of the conservative Bedouin society. According to recommendations implemented by the Israeli Obstetric Anesthesia Society, which were implemented due to the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic, we increased the rate of neuraxial anesthesia among deliveries. To compare the rates of neuraxial anesthesia in our cesar","2021","07","19","Isr Med Assoc J","The Israel Medical Association journal : IMAJ","Adult; Anesthesia, Conduction; Anesthesia, General; Anesthesia, Obstetrical; Arabs; COVID-19; Cesarean Section; Delivery Rooms; Elective Surgical Procedures; Female; Humans; Infection Control; Israel; Organizational Innovation; Pregnancy; Procedures and Techniques Utilization; Retrospective Studies; Treatment Refusal","Heesen","Phillip","Faculty of Medicine, University of Zurich, Zurich, Switzerland",NA
"595","34251121","","A Retrospective Investigation of Neuraxial Anesthesia Rates for Elective Cesarean Delivery Before and During the SARS-CoV-2 Pandemic.","Our hospital used to perform cesarean delivery under general anesthesia rather than neuraxial anesthesia, mostly because of patient refusal of members of the conservative Bedouin society. According to recommendations implemented by the Israeli Obstetric Anesthesia Society, which were implemented due to the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic, we increased the rate of neuraxial anesthesia among deliveries. To compare the rates of neuraxial anesthesia in our cesar","2021","07","19","Isr Med Assoc J","The Israel Medical Association journal : IMAJ","Adult; Anesthesia, Conduction; Anesthesia, General; Anesthesia, Obstetrical; Arabs; COVID-19; Cesarean Section; Delivery Rooms; Elective Surgical Procedures; Female; Humans; Infection Control; Israel; Organizational Innovation; Pregnancy; Procedures and Techniques Utilization; Retrospective Studies; Treatment Refusal","Gruzman","Igor","Department of Anesthesiology, Soroka Medical Center, and Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel",NA
"596","34251121","","A Retrospective Investigation of Neuraxial Anesthesia Rates for Elective Cesarean Delivery Before and During the SARS-CoV-2 Pandemic.","Our hospital used to perform cesarean delivery under general anesthesia rather than neuraxial anesthesia, mostly because of patient refusal of members of the conservative Bedouin society. According to recommendations implemented by the Israeli Obstetric Anesthesia Society, which were implemented due to the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic, we increased the rate of neuraxial anesthesia among deliveries. To compare the rates of neuraxial anesthesia in our cesar","2021","07","19","Isr Med Assoc J","The Israel Medical Association journal : IMAJ","Adult; Anesthesia, Conduction; Anesthesia, General; Anesthesia, Obstetrical; Arabs; COVID-19; Cesarean Section; Delivery Rooms; Elective Surgical Procedures; Female; Humans; Infection Control; Israel; Organizational Innovation; Pregnancy; Procedures and Techniques Utilization; Retrospective Studies; Treatment Refusal","Zlotnik","Alexander","Department of Anesthesiology, Soroka Medical Center, and Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel",NA
"597","34251121","","A Retrospective Investigation of Neuraxial Anesthesia Rates for Elective Cesarean Delivery Before and During the SARS-CoV-2 Pandemic.","Our hospital used to perform cesarean delivery under general anesthesia rather than neuraxial anesthesia, mostly because of patient refusal of members of the conservative Bedouin society. According to recommendations implemented by the Israeli Obstetric Anesthesia Society, which were implemented due to the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic, we increased the rate of neuraxial anesthesia among deliveries. To compare the rates of neuraxial anesthesia in our cesar","2021","07","19","Isr Med Assoc J","The Israel Medical Association journal : IMAJ","Adult; Anesthesia, Conduction; Anesthesia, General; Anesthesia, Obstetrical; Arabs; COVID-19; Cesarean Section; Delivery Rooms; Elective Surgical Procedures; Female; Humans; Infection Control; Israel; Organizational Innovation; Pregnancy; Procedures and Techniques Utilization; Retrospective Studies; Treatment Refusal","Ioscovich","Alexander","Department of Anesthesiology, Shaare Zedek Medical Center, Jerusalem, Israel",NA
"598","34251121","","A Retrospective Investigation of Neuraxial Anesthesia Rates for Elective Cesarean Delivery Before and During the SARS-CoV-2 Pandemic.","Our hospital used to perform cesarean delivery under general anesthesia rather than neuraxial anesthesia, mostly because of patient refusal of members of the conservative Bedouin society. According to recommendations implemented by the Israeli Obstetric Anesthesia Society, which were implemented due to the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic, we increased the rate of neuraxial anesthesia among deliveries. To compare the rates of neuraxial anesthesia in our cesar","2021","07","19","Isr Med Assoc J","The Israel Medical Association journal : IMAJ","Adult; Anesthesia, Conduction; Anesthesia, General; Anesthesia, Obstetrical; Arabs; COVID-19; Cesarean Section; Delivery Rooms; Elective Surgical Procedures; Female; Humans; Infection Control; Israel; Organizational Innovation; Pregnancy; Procedures and Techniques Utilization; Retrospective Studies; Treatment Refusal","Ronen","Ariel","Department of Anesthesiology, Rabin Medical Center (Beilinson Campus), Petah Tikva, Israel",NA
"599","34251121","","A Retrospective Investigation of Neuraxial Anesthesia Rates for Elective Cesarean Delivery Before and During the SARS-CoV-2 Pandemic.","Our hospital used to perform cesarean delivery under general anesthesia rather than neuraxial anesthesia, mostly because of patient refusal of members of the conservative Bedouin society. According to recommendations implemented by the Israeli Obstetric Anesthesia Society, which were implemented due to the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic, we increased the rate of neuraxial anesthesia among deliveries. To compare the rates of neuraxial anesthesia in our cesar","2021","07","19","Isr Med Assoc J","The Israel Medical Association journal : IMAJ","Adult; Anesthesia, Conduction; Anesthesia, General; Anesthesia, Obstetrical; Arabs; COVID-19; Cesarean Section; Delivery Rooms; Elective Surgical Procedures; Female; Humans; Infection Control; Israel; Organizational Innovation; Pregnancy; Procedures and Techniques Utilization; Retrospective Studies; Treatment Refusal","Weiniger","Carolyn F","Division of Anesthesia, Critical Care and Pain, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel",NA
"600","34251121","","A Retrospective Investigation of Neuraxial Anesthesia Rates for Elective Cesarean Delivery Before and During the SARS-CoV-2 Pandemic.","Our hospital used to perform cesarean delivery under general anesthesia rather than neuraxial anesthesia, mostly because of patient refusal of members of the conservative Bedouin society. According to recommendations implemented by the Israeli Obstetric Anesthesia Society, which were implemented due to the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic, we increased the rate of neuraxial anesthesia among deliveries. To compare the rates of neuraxial anesthesia in our cesar","2021","07","19","Isr Med Assoc J","The Israel Medical Association journal : IMAJ","Adult; Anesthesia, Conduction; Anesthesia, General; Anesthesia, Obstetrical; Arabs; COVID-19; Cesarean Section; Delivery Rooms; Elective Surgical Procedures; Female; Humans; Infection Control; Israel; Organizational Innovation; Pregnancy; Procedures and Techniques Utilization; Retrospective Studies; Treatment Refusal","Frank","Dmitry","Department of Anesthesiology, Soroka Medical Center, and Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel",NA
"601","34251121","","A Retrospective Investigation of Neuraxial Anesthesia Rates for Elective Cesarean Delivery Before and During the SARS-CoV-2 Pandemic.","Our hospital used to perform cesarean delivery under general anesthesia rather than neuraxial anesthesia, mostly because of patient refusal of members of the conservative Bedouin society. According to recommendations implemented by the Israeli Obstetric Anesthesia Society, which were implemented due to the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic, we increased the rate of neuraxial anesthesia among deliveries. To compare the rates of neuraxial anesthesia in our cesar","2021","07","19","Isr Med Assoc J","The Israel Medical Association journal : IMAJ","Adult; Anesthesia, Conduction; Anesthesia, General; Anesthesia, Obstetrical; Arabs; COVID-19; Cesarean Section; Delivery Rooms; Elective Surgical Procedures; Female; Humans; Infection Control; Israel; Organizational Innovation; Pregnancy; Procedures and Techniques Utilization; Retrospective Studies; Treatment Refusal","Sheiner","Eyal","Obstetrics and Gynecology, Soroka Medical Center, and Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel",NA
"602","34251121","","A Retrospective Investigation of Neuraxial Anesthesia Rates for Elective Cesarean Delivery Before and During the SARS-CoV-2 Pandemic.","Our hospital used to perform cesarean delivery under general anesthesia rather than neuraxial anesthesia, mostly because of patient refusal of members of the conservative Bedouin society. According to recommendations implemented by the Israeli Obstetric Anesthesia Society, which were implemented due to the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic, we increased the rate of neuraxial anesthesia among deliveries. To compare the rates of neuraxial anesthesia in our cesar","2021","07","19","Isr Med Assoc J","The Israel Medical Association journal : IMAJ","Adult; Anesthesia, Conduction; Anesthesia, General; Anesthesia, Obstetrical; Arabs; COVID-19; Cesarean Section; Delivery Rooms; Elective Surgical Procedures; Female; Humans; Infection Control; Israel; Organizational Innovation; Pregnancy; Procedures and Techniques Utilization; Retrospective Studies; Treatment Refusal","Orbach-Zinger","Sharon","Department of Anesthesiology, Rabin Medical Center (Beilinson Campus), Petah Tikva, Israel",NA
"603","34251120","","Teaching During the COVID-19 Pandemic: The Experience of the Faculty of Medicine at the Technion-Israel Institute of Technology.","The coronavirus disease-2019 (COVID-19) pandemic forced drastic changes in all layers of life. Social distancing and lockdown drove the educational system to uncharted territories at an accelerated pace, leaving educators little time to adjust. To describe changes in teaching during the first phase of the COVID-19 pandemic. We described the steps implemented at the Technion-Israel Institute of Technology Faculty of Medicine during the initial 4 months of the COVID-19 pandemic to preserve teachin","2021","07","19","Isr Med Assoc J","The Israel Medical Association journal : IMAJ","COVID-19; Communicable Disease Control; Education, Distance; Education, Medical; Humans; Needs Assessment; Organizational Innovation; Outcome Assessment, Health Care; Physical Distancing; SARS-CoV-2; Schools, Medical; Teaching","Flugelman","Moshe Y","Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel",NA
"604","34251120","","Teaching During the COVID-19 Pandemic: The Experience of the Faculty of Medicine at the Technion-Israel Institute of Technology.","The coronavirus disease-2019 (COVID-19) pandemic forced drastic changes in all layers of life. Social distancing and lockdown drove the educational system to uncharted territories at an accelerated pace, leaving educators little time to adjust. To describe changes in teaching during the first phase of the COVID-19 pandemic. We described the steps implemented at the Technion-Israel Institute of Technology Faculty of Medicine during the initial 4 months of the COVID-19 pandemic to preserve teachin","2021","07","19","Isr Med Assoc J","The Israel Medical Association journal : IMAJ","COVID-19; Communicable Disease Control; Education, Distance; Education, Medical; Humans; Needs Assessment; Organizational Innovation; Outcome Assessment, Health Care; Physical Distancing; SARS-CoV-2; Schools, Medical; Teaching","Margalit","Ruth","Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel",NA
"605","34251120","","Teaching During the COVID-19 Pandemic: The Experience of the Faculty of Medicine at the Technion-Israel Institute of Technology.","The coronavirus disease-2019 (COVID-19) pandemic forced drastic changes in all layers of life. Social distancing and lockdown drove the educational system to uncharted territories at an accelerated pace, leaving educators little time to adjust. To describe changes in teaching during the first phase of the COVID-19 pandemic. We described the steps implemented at the Technion-Israel Institute of Technology Faculty of Medicine during the initial 4 months of the COVID-19 pandemic to preserve teachin","2021","07","19","Isr Med Assoc J","The Israel Medical Association journal : IMAJ","COVID-19; Communicable Disease Control; Education, Distance; Education, Medical; Humans; Needs Assessment; Organizational Innovation; Outcome Assessment, Health Care; Physical Distancing; SARS-CoV-2; Schools, Medical; Teaching","Aronheim","Ami","Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel",NA
"606","34251120","","Teaching During the COVID-19 Pandemic: The Experience of the Faculty of Medicine at the Technion-Israel Institute of Technology.","The coronavirus disease-2019 (COVID-19) pandemic forced drastic changes in all layers of life. Social distancing and lockdown drove the educational system to uncharted territories at an accelerated pace, leaving educators little time to adjust. To describe changes in teaching during the first phase of the COVID-19 pandemic. We described the steps implemented at the Technion-Israel Institute of Technology Faculty of Medicine during the initial 4 months of the COVID-19 pandemic to preserve teachin","2021","07","19","Isr Med Assoc J","The Israel Medical Association journal : IMAJ","COVID-19; Communicable Disease Control; Education, Distance; Education, Medical; Humans; Needs Assessment; Organizational Innovation; Outcome Assessment, Health Care; Physical Distancing; SARS-CoV-2; Schools, Medical; Teaching","Barak","Omri","Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel",NA
"607","34251120","","Teaching During the COVID-19 Pandemic: The Experience of the Faculty of Medicine at the Technion-Israel Institute of Technology.","The coronavirus disease-2019 (COVID-19) pandemic forced drastic changes in all layers of life. Social distancing and lockdown drove the educational system to uncharted territories at an accelerated pace, leaving educators little time to adjust. To describe changes in teaching during the first phase of the COVID-19 pandemic. We described the steps implemented at the Technion-Israel Institute of Technology Faculty of Medicine during the initial 4 months of the COVID-19 pandemic to preserve teachin","2021","07","19","Isr Med Assoc J","The Israel Medical Association journal : IMAJ","COVID-19; Communicable Disease Control; Education, Distance; Education, Medical; Humans; Needs Assessment; Organizational Innovation; Outcome Assessment, Health Care; Physical Distancing; SARS-CoV-2; Schools, Medical; Teaching","Marom","Assaf","Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel",NA
"608","34251120","","Teaching During the COVID-19 Pandemic: The Experience of the Faculty of Medicine at the Technion-Israel Institute of Technology.","The coronavirus disease-2019 (COVID-19) pandemic forced drastic changes in all layers of life. Social distancing and lockdown drove the educational system to uncharted territories at an accelerated pace, leaving educators little time to adjust. To describe changes in teaching during the first phase of the COVID-19 pandemic. We described the steps implemented at the Technion-Israel Institute of Technology Faculty of Medicine during the initial 4 months of the COVID-19 pandemic to preserve teachin","2021","07","19","Isr Med Assoc J","The Israel Medical Association journal : IMAJ","COVID-19; Communicable Disease Control; Education, Distance; Education, Medical; Humans; Needs Assessment; Organizational Innovation; Outcome Assessment, Health Care; Physical Distancing; SARS-CoV-2; Schools, Medical; Teaching","Dolnikov","Katya","Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel",NA
"609","34251120","","Teaching During the COVID-19 Pandemic: The Experience of the Faculty of Medicine at the Technion-Israel Institute of Technology.","The coronavirus disease-2019 (COVID-19) pandemic forced drastic changes in all layers of life. Social distancing and lockdown drove the educational system to uncharted territories at an accelerated pace, leaving educators little time to adjust. To describe changes in teaching during the first phase of the COVID-19 pandemic. We described the steps implemented at the Technion-Israel Institute of Technology Faculty of Medicine during the initial 4 months of the COVID-19 pandemic to preserve teachin","2021","07","19","Isr Med Assoc J","The Israel Medical Association journal : IMAJ","COVID-19; Communicable Disease Control; Education, Distance; Education, Medical; Humans; Needs Assessment; Organizational Innovation; Outcome Assessment, Health Care; Physical Distancing; SARS-CoV-2; Schools, Medical; Teaching","Braun","Eyal","Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel",NA
"610","34251120","","Teaching During the COVID-19 Pandemic: The Experience of the Faculty of Medicine at the Technion-Israel Institute of Technology.","The coronavirus disease-2019 (COVID-19) pandemic forced drastic changes in all layers of life. Social distancing and lockdown drove the educational system to uncharted territories at an accelerated pace, leaving educators little time to adjust. To describe changes in teaching during the first phase of the COVID-19 pandemic. We described the steps implemented at the Technion-Israel Institute of Technology Faculty of Medicine during the initial 4 months of the COVID-19 pandemic to preserve teachin","2021","07","19","Isr Med Assoc J","The Israel Medical Association journal : IMAJ","COVID-19; Communicable Disease Control; Education, Distance; Education, Medical; Humans; Needs Assessment; Organizational Innovation; Outcome Assessment, Health Care; Physical Distancing; SARS-CoV-2; Schools, Medical; Teaching","Raz-Pasteur","Ayelet","Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel",NA
"611","34251120","","Teaching During the COVID-19 Pandemic: The Experience of the Faculty of Medicine at the Technion-Israel Institute of Technology.","The coronavirus disease-2019 (COVID-19) pandemic forced drastic changes in all layers of life. Social distancing and lockdown drove the educational system to uncharted territories at an accelerated pace, leaving educators little time to adjust. To describe changes in teaching during the first phase of the COVID-19 pandemic. We described the steps implemented at the Technion-Israel Institute of Technology Faculty of Medicine during the initial 4 months of the COVID-19 pandemic to preserve teachin","2021","07","19","Isr Med Assoc J","The Israel Medical Association journal : IMAJ","COVID-19; Communicable Disease Control; Education, Distance; Education, Medical; Humans; Needs Assessment; Organizational Innovation; Outcome Assessment, Health Care; Physical Distancing; SARS-CoV-2; Schools, Medical; Teaching","Azzam","Zaher S","Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel",NA
"612","34251120","","Teaching During the COVID-19 Pandemic: The Experience of the Faculty of Medicine at the Technion-Israel Institute of Technology.","The coronavirus disease-2019 (COVID-19) pandemic forced drastic changes in all layers of life. Social distancing and lockdown drove the educational system to uncharted territories at an accelerated pace, leaving educators little time to adjust. To describe changes in teaching during the first phase of the COVID-19 pandemic. We described the steps implemented at the Technion-Israel Institute of Technology Faculty of Medicine during the initial 4 months of the COVID-19 pandemic to preserve teachin","2021","07","19","Isr Med Assoc J","The Israel Medical Association journal : IMAJ","COVID-19; Communicable Disease Control; Education, Distance; Education, Medical; Humans; Needs Assessment; Organizational Innovation; Outcome Assessment, Health Care; Physical Distancing; SARS-CoV-2; Schools, Medical; Teaching","Hochstein","David","Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel",NA
"613","34251120","","Teaching During the COVID-19 Pandemic: The Experience of the Faculty of Medicine at the Technion-Israel Institute of Technology.","The coronavirus disease-2019 (COVID-19) pandemic forced drastic changes in all layers of life. Social distancing and lockdown drove the educational system to uncharted territories at an accelerated pace, leaving educators little time to adjust. To describe changes in teaching during the first phase of the COVID-19 pandemic. We described the steps implemented at the Technion-Israel Institute of Technology Faculty of Medicine during the initial 4 months of the COVID-19 pandemic to preserve teachin","2021","07","19","Isr Med Assoc J","The Israel Medical Association journal : IMAJ","COVID-19; Communicable Disease Control; Education, Distance; Education, Medical; Humans; Needs Assessment; Organizational Innovation; Outcome Assessment, Health Care; Physical Distancing; SARS-CoV-2; Schools, Medical; Teaching","Haddad","Riad","Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel",NA
"614","34251120","","Teaching During the COVID-19 Pandemic: The Experience of the Faculty of Medicine at the Technion-Israel Institute of Technology.","The coronavirus disease-2019 (COVID-19) pandemic forced drastic changes in all layers of life. Social distancing and lockdown drove the educational system to uncharted territories at an accelerated pace, leaving educators little time to adjust. To describe changes in teaching during the first phase of the COVID-19 pandemic. We described the steps implemented at the Technion-Israel Institute of Technology Faculty of Medicine during the initial 4 months of the COVID-19 pandemic to preserve teachin","2021","07","19","Isr Med Assoc J","The Israel Medical Association journal : IMAJ","COVID-19; Communicable Disease Control; Education, Distance; Education, Medical; Humans; Needs Assessment; Organizational Innovation; Outcome Assessment, Health Care; Physical Distancing; SARS-CoV-2; Schools, Medical; Teaching","Nave","Rachel","Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel",NA
"615","34251120","","Teaching During the COVID-19 Pandemic: The Experience of the Faculty of Medicine at the Technion-Israel Institute of Technology.","The coronavirus disease-2019 (COVID-19) pandemic forced drastic changes in all layers of life. Social distancing and lockdown drove the educational system to uncharted territories at an accelerated pace, leaving educators little time to adjust. To describe changes in teaching during the first phase of the COVID-19 pandemic. We described the steps implemented at the Technion-Israel Institute of Technology Faculty of Medicine during the initial 4 months of the COVID-19 pandemic to preserve teachin","2021","07","19","Isr Med Assoc J","The Israel Medical Association journal : IMAJ","COVID-19; Communicable Disease Control; Education, Distance; Education, Medical; Humans; Needs Assessment; Organizational Innovation; Outcome Assessment, Health Care; Physical Distancing; SARS-CoV-2; Schools, Medical; Teaching","Riskin","Arieh","Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel",NA
"616","34251120","","Teaching During the COVID-19 Pandemic: The Experience of the Faculty of Medicine at the Technion-Israel Institute of Technology.","The coronavirus disease-2019 (COVID-19) pandemic forced drastic changes in all layers of life. Social distancing and lockdown drove the educational system to uncharted territories at an accelerated pace, leaving educators little time to adjust. To describe changes in teaching during the first phase of the COVID-19 pandemic. We described the steps implemented at the Technion-Israel Institute of Technology Faculty of Medicine during the initial 4 months of the COVID-19 pandemic to preserve teachin","2021","07","19","Isr Med Assoc J","The Israel Medical Association journal : IMAJ","COVID-19; Communicable Disease Control; Education, Distance; Education, Medical; Humans; Needs Assessment; Organizational Innovation; Outcome Assessment, Health Care; Physical Distancing; SARS-CoV-2; Schools, Medical; Teaching","Waisman","Dan","Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel",NA
"617","34251120","","Teaching During the COVID-19 Pandemic: The Experience of the Faculty of Medicine at the Technion-Israel Institute of Technology.","The coronavirus disease-2019 (COVID-19) pandemic forced drastic changes in all layers of life. Social distancing and lockdown drove the educational system to uncharted territories at an accelerated pace, leaving educators little time to adjust. To describe changes in teaching during the first phase of the COVID-19 pandemic. We described the steps implemented at the Technion-Israel Institute of Technology Faculty of Medicine during the initial 4 months of the COVID-19 pandemic to preserve teachin","2021","07","19","Isr Med Assoc J","The Israel Medical Association journal : IMAJ","COVID-19; Communicable Disease Control; Education, Distance; Education, Medical; Humans; Needs Assessment; Organizational Innovation; Outcome Assessment, Health Care; Physical Distancing; SARS-CoV-2; Schools, Medical; Teaching","Glueck","Robert","Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel",NA
"618","34251120","","Teaching During the COVID-19 Pandemic: The Experience of the Faculty of Medicine at the Technion-Israel Institute of Technology.","The coronavirus disease-2019 (COVID-19) pandemic forced drastic changes in all layers of life. Social distancing and lockdown drove the educational system to uncharted territories at an accelerated pace, leaving educators little time to adjust. To describe changes in teaching during the first phase of the COVID-19 pandemic. We described the steps implemented at the Technion-Israel Institute of Technology Faculty of Medicine during the initial 4 months of the COVID-19 pandemic to preserve teachin","2021","07","19","Isr Med Assoc J","The Israel Medical Association journal : IMAJ","COVID-19; Communicable Disease Control; Education, Distance; Education, Medical; Humans; Needs Assessment; Organizational Innovation; Outcome Assessment, Health Care; Physical Distancing; SARS-CoV-2; Schools, Medical; Teaching","Mekel","Michal","Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel",NA
"619","34251120","","Teaching During the COVID-19 Pandemic: The Experience of the Faculty of Medicine at the Technion-Israel Institute of Technology.","The coronavirus disease-2019 (COVID-19) pandemic forced drastic changes in all layers of life. Social distancing and lockdown drove the educational system to uncharted territories at an accelerated pace, leaving educators little time to adjust. To describe changes in teaching during the first phase of the COVID-19 pandemic. We described the steps implemented at the Technion-Israel Institute of Technology Faculty of Medicine during the initial 4 months of the COVID-19 pandemic to preserve teachin","2021","07","19","Isr Med Assoc J","The Israel Medical Association journal : IMAJ","COVID-19; Communicable Disease Control; Education, Distance; Education, Medical; Humans; Needs Assessment; Organizational Innovation; Outcome Assessment, Health Care; Physical Distancing; SARS-CoV-2; Schools, Medical; Teaching","Avraham","Yael","Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel",NA
"620","34251120","","Teaching During the COVID-19 Pandemic: The Experience of the Faculty of Medicine at the Technion-Israel Institute of Technology.","The coronavirus disease-2019 (COVID-19) pandemic forced drastic changes in all layers of life. Social distancing and lockdown drove the educational system to uncharted territories at an accelerated pace, leaving educators little time to adjust. To describe changes in teaching during the first phase of the COVID-19 pandemic. We described the steps implemented at the Technion-Israel Institute of Technology Faculty of Medicine during the initial 4 months of the COVID-19 pandemic to preserve teachin","2021","07","19","Isr Med Assoc J","The Israel Medical Association journal : IMAJ","COVID-19; Communicable Disease Control; Education, Distance; Education, Medical; Humans; Needs Assessment; Organizational Innovation; Outcome Assessment, Health Care; Physical Distancing; SARS-CoV-2; Schools, Medical; Teaching","Bar-Peled","Uval","Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel",NA
"621","34251120","","Teaching During the COVID-19 Pandemic: The Experience of the Faculty of Medicine at the Technion-Israel Institute of Technology.","The coronavirus disease-2019 (COVID-19) pandemic forced drastic changes in all layers of life. Social distancing and lockdown drove the educational system to uncharted territories at an accelerated pace, leaving educators little time to adjust. To describe changes in teaching during the first phase of the COVID-19 pandemic. We described the steps implemented at the Technion-Israel Institute of Technology Faculty of Medicine during the initial 4 months of the COVID-19 pandemic to preserve teachin","2021","07","19","Isr Med Assoc J","The Israel Medical Association journal : IMAJ","COVID-19; Communicable Disease Control; Education, Distance; Education, Medical; Humans; Needs Assessment; Organizational Innovation; Outcome Assessment, Health Care; Physical Distancing; SARS-CoV-2; Schools, Medical; Teaching","Kacev","Ronit","Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel",NA
"622","34251120","","Teaching During the COVID-19 Pandemic: The Experience of the Faculty of Medicine at the Technion-Israel Institute of Technology.","The coronavirus disease-2019 (COVID-19) pandemic forced drastic changes in all layers of life. Social distancing and lockdown drove the educational system to uncharted territories at an accelerated pace, leaving educators little time to adjust. To describe changes in teaching during the first phase of the COVID-19 pandemic. We described the steps implemented at the Technion-Israel Institute of Technology Faculty of Medicine during the initial 4 months of the COVID-19 pandemic to preserve teachin","2021","07","19","Isr Med Assoc J","The Israel Medical Association journal : IMAJ","COVID-19; Communicable Disease Control; Education, Distance; Education, Medical; Humans; Needs Assessment; Organizational Innovation; Outcome Assessment, Health Care; Physical Distancing; SARS-CoV-2; Schools, Medical; Teaching","Keren","Michal","Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel",NA
"623","34251120","","Teaching During the COVID-19 Pandemic: The Experience of the Faculty of Medicine at the Technion-Israel Institute of Technology.","The coronavirus disease-2019 (COVID-19) pandemic forced drastic changes in all layers of life. Social distancing and lockdown drove the educational system to uncharted territories at an accelerated pace, leaving educators little time to adjust. To describe changes in teaching during the first phase of the COVID-19 pandemic. We described the steps implemented at the Technion-Israel Institute of Technology Faculty of Medicine during the initial 4 months of the COVID-19 pandemic to preserve teachin","2021","07","19","Isr Med Assoc J","The Israel Medical Association journal : IMAJ","COVID-19; Communicable Disease Control; Education, Distance; Education, Medical; Humans; Needs Assessment; Organizational Innovation; Outcome Assessment, Health Care; Physical Distancing; SARS-CoV-2; Schools, Medical; Teaching","Karban","Amir","Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel",NA
"624","34251120","","Teaching During the COVID-19 Pandemic: The Experience of the Faculty of Medicine at the Technion-Israel Institute of Technology.","The coronavirus disease-2019 (COVID-19) pandemic forced drastic changes in all layers of life. Social distancing and lockdown drove the educational system to uncharted territories at an accelerated pace, leaving educators little time to adjust. To describe changes in teaching during the first phase of the COVID-19 pandemic. We described the steps implemented at the Technion-Israel Institute of Technology Faculty of Medicine during the initial 4 months of the COVID-19 pandemic to preserve teachin","2021","07","19","Isr Med Assoc J","The Israel Medical Association journal : IMAJ","COVID-19; Communicable Disease Control; Education, Distance; Education, Medical; Humans; Needs Assessment; Organizational Innovation; Outcome Assessment, Health Care; Physical Distancing; SARS-CoV-2; Schools, Medical; Teaching","Eisenberg","Elon","Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel",NA
"625","34251092","10.1002/pbc.29194","Leukaemia and lockdown: The delayed infection model of childhood acute lymphoblastic leukaemia and the COVID-19 pandemic.","Acute lymphoblastic leukaemia (ALL) is the most common type of leukaemia diagnosed in children. The prevailing hypothesis regarding pathogenesis of childhood ALL was developed by Greaves, and states that ALL is caused by an abnormal immune response to a common infection. The response arises either due to naivety of the immune system caused by a lack of common childhood infections, or genetic susceptibility due to specific alleles. The former explanation is known as the delayed infection hypothes","2021","07","12","Pediatr Blood Cancer","Pediatric blood &amp; cancer","ALL; COVID-19; delayed infection hypothesis","Lillie","Katy","University of Oxford, Medical Sciences Division, Oxford, UK",NA
"626","34251081","10.1111/tid.13685","Convalescent plasma treatment for early post-kidney transplant acquired COVID-19.",NA,"2021","07","21","Transpl Infect Dis","Transplant infectious disease : an official journal of the Transplantation Society",NA,"Kluger","Malte A","III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany",NA
"627","34251081","10.1111/tid.13685","Convalescent plasma treatment for early post-kidney transplant acquired COVID-19.",NA,"2021","07","21","Transpl Infect Dis","Transplant infectious disease : an official journal of the Transplantation Society",NA,"Czogalla","Jan","III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany",NA
"628","34251081","10.1111/tid.13685","Convalescent plasma treatment for early post-kidney transplant acquired COVID-19.",NA,"2021","07","21","Transpl Infect Dis","Transplant infectious disease : an official journal of the Transplantation Society",NA,"Schmidt-Lauber","Christian","III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany",NA
"629","34251081","10.1111/tid.13685","Convalescent plasma treatment for early post-kidney transplant acquired COVID-19.",NA,"2021","07","21","Transpl Infect Dis","Transplant infectious disease : an official journal of the Transplantation Society",NA,"Peine","Sven","Institute for Transfusion Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany",NA
"630","34251081","10.1111/tid.13685","Convalescent plasma treatment for early post-kidney transplant acquired COVID-19.",NA,"2021","07","21","Transpl Infect Dis","Transplant infectious disease : an official journal of the Transplantation Society",NA,"Schmiedel","Stefan","I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany",NA
"631","34251081","10.1111/tid.13685","Convalescent plasma treatment for early post-kidney transplant acquired COVID-19.",NA,"2021","07","21","Transpl Infect Dis","Transplant infectious disease : an official journal of the Transplantation Society",NA,"Bangert","Katrin","Department of Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany",NA
"632","34251081","10.1111/tid.13685","Convalescent plasma treatment for early post-kidney transplant acquired COVID-19.",NA,"2021","07","21","Transpl Infect Dis","Transplant infectious disease : an official journal of the Transplantation Society",NA,"Kluge","Stefan","Department of Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany",NA
"633","34251081","10.1111/tid.13685","Convalescent plasma treatment for early post-kidney transplant acquired COVID-19.",NA,"2021","07","21","Transpl Infect Dis","Transplant infectious disease : an official journal of the Transplantation Society",NA,"Huber","Samuel","I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany",NA
"634","34251081","10.1111/tid.13685","Convalescent plasma treatment for early post-kidney transplant acquired COVID-19.",NA,"2021","07","21","Transpl Infect Dis","Transplant infectious disease : an official journal of the Transplantation Society",NA,"Puelles","Victor G","III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany",NA
"635","34251081","10.1111/tid.13685","Convalescent plasma treatment for early post-kidney transplant acquired COVID-19.",NA,"2021","07","21","Transpl Infect Dis","Transplant infectious disease : an official journal of the Transplantation Society",NA,"Fischer","Lutz","University Transplant Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany",NA
"636","34251081","10.1111/tid.13685","Convalescent plasma treatment for early post-kidney transplant acquired COVID-19.",NA,"2021","07","21","Transpl Infect Dis","Transplant infectious disease : an official journal of the Transplantation Society",NA,"Huber","Tobias B","III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany",NA
"637","34251081","10.1111/tid.13685","Convalescent plasma treatment for early post-kidney transplant acquired COVID-19.",NA,"2021","07","21","Transpl Infect Dis","Transplant infectious disease : an official journal of the Transplantation Society",NA,"Grahammer","Florian","III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany",NA
"638","34251057","10.1002/gps.5602","Evaluation of the mental health of care home staff in the Covid-19 era. What price did care home workers pay for standing by their patients?","The characteristics of this pandemic increase the potential psychological impact on care homes workers (CHWs). The aims of this study were to analyse the mental health and health-related quality of life (HRQoL) of a broad sample of CHWs in Spain and to identify potential factors that have a significant effect on their mental health and HRQoL. This descriptive study comprised 210 CHWs who completed the Generalized Anxiety Disorder 7-item Scale, the Patient Health Questionnaire-9, the Impact Event","2021","07","22","Int J Geriatr Psychiatry","International journal of geriatric psychiatry","anxiety; care home workers; depression; health-related quality of life; stress","Martín","Josune","Research Unit, Galdakao-Usansolo Hospital, Galdakao, Spain",NA
"639","34251057","10.1002/gps.5602","Evaluation of the mental health of care home staff in the Covid-19 era. What price did care home workers pay for standing by their patients?","The characteristics of this pandemic increase the potential psychological impact on care homes workers (CHWs). The aims of this study were to analyse the mental health and health-related quality of life (HRQoL) of a broad sample of CHWs in Spain and to identify potential factors that have a significant effect on their mental health and HRQoL. This descriptive study comprised 210 CHWs who completed the Generalized Anxiety Disorder 7-item Scale, the Patient Health Questionnaire-9, the Impact Event","2021","07","22","Int J Geriatr Psychiatry","International journal of geriatric psychiatry","anxiety; care home workers; depression; health-related quality of life; stress","Padierna","Ángel","Department of Psychiatry, Galdakao-Usansolo Hospital, Galdakao, Spain",NA
"640","34251057","10.1002/gps.5602","Evaluation of the mental health of care home staff in the Covid-19 era. What price did care home workers pay for standing by their patients?","The characteristics of this pandemic increase the potential psychological impact on care homes workers (CHWs). The aims of this study were to analyse the mental health and health-related quality of life (HRQoL) of a broad sample of CHWs in Spain and to identify potential factors that have a significant effect on their mental health and HRQoL. This descriptive study comprised 210 CHWs who completed the Generalized Anxiety Disorder 7-item Scale, the Patient Health Questionnaire-9, the Impact Event","2021","07","22","Int J Geriatr Psychiatry","International journal of geriatric psychiatry","anxiety; care home workers; depression; health-related quality of life; stress","Villanueva","Ane","Research Unit, Galdakao-Usansolo Hospital, Galdakao, Spain",NA
"641","34251057","10.1002/gps.5602","Evaluation of the mental health of care home staff in the Covid-19 era. What price did care home workers pay for standing by their patients?","The characteristics of this pandemic increase the potential psychological impact on care homes workers (CHWs). The aims of this study were to analyse the mental health and health-related quality of life (HRQoL) of a broad sample of CHWs in Spain and to identify potential factors that have a significant effect on their mental health and HRQoL. This descriptive study comprised 210 CHWs who completed the Generalized Anxiety Disorder 7-item Scale, the Patient Health Questionnaire-9, the Impact Event","2021","07","22","Int J Geriatr Psychiatry","International journal of geriatric psychiatry","anxiety; care home workers; depression; health-related quality of life; stress","Quintana","José M","Research Unit, Galdakao-Usansolo Hospital, Galdakao, Spain",NA
"642","34251047","10.1002/jcla.23906","Diagnostic performance of the Elecsys SARS-CoV-2 antigen assay in the clinical routine of a tertiary care hospital: Preliminary results from a single-center evaluation.","This report describes a manufacturer-independent evaluation of the diagnostic accuracy of the Elecsys SARS-CoV-2 antigen assay from Roche Diagnostics in a tertiary care setting. In this single-center study, we used nasopharyngeal swabs from 403 cases from the emergency department and intensive care unit of our hospital. The reference standard for detecting SARS-CoV-2 was the reverse-transcription polymerase chain reaction (RT-PCR) assay. Cycle threshold (Ct) values were recorded for positive RT-","2021","07","12","J Clin Lab Anal","Journal of clinical laboratory analysis","Antigen; COVID-19; SARS-CoV-2; diagnostic test; immunoassay; laboratory medicine; polymerase chain reaction; virology","Mueller","Thomas","Department of Clinical Pathology, Hospital of Bolzano, Bolzano, Italy",NA
"643","34251047","10.1002/jcla.23906","Diagnostic performance of the Elecsys SARS-CoV-2 antigen assay in the clinical routine of a tertiary care hospital: Preliminary results from a single-center evaluation.","This report describes a manufacturer-independent evaluation of the diagnostic accuracy of the Elecsys SARS-CoV-2 antigen assay from Roche Diagnostics in a tertiary care setting. In this single-center study, we used nasopharyngeal swabs from 403 cases from the emergency department and intensive care unit of our hospital. The reference standard for detecting SARS-CoV-2 was the reverse-transcription polymerase chain reaction (RT-PCR) assay. Cycle threshold (Ct) values were recorded for positive RT-","2021","07","12","J Clin Lab Anal","Journal of clinical laboratory analysis","Antigen; COVID-19; SARS-CoV-2; diagnostic test; immunoassay; laboratory medicine; polymerase chain reaction; virology","Kompatscher","Julia","Department of Anesthesiology and Intensive Care Medicine, Hospital of Bolzano, Bolzano, Italy",NA
"644","34251047","10.1002/jcla.23906","Diagnostic performance of the Elecsys SARS-CoV-2 antigen assay in the clinical routine of a tertiary care hospital: Preliminary results from a single-center evaluation.","This report describes a manufacturer-independent evaluation of the diagnostic accuracy of the Elecsys SARS-CoV-2 antigen assay from Roche Diagnostics in a tertiary care setting. In this single-center study, we used nasopharyngeal swabs from 403 cases from the emergency department and intensive care unit of our hospital. The reference standard for detecting SARS-CoV-2 was the reverse-transcription polymerase chain reaction (RT-PCR) assay. Cycle threshold (Ct) values were recorded for positive RT-","2021","07","12","J Clin Lab Anal","Journal of clinical laboratory analysis","Antigen; COVID-19; SARS-CoV-2; diagnostic test; immunoassay; laboratory medicine; polymerase chain reaction; virology","La Guardia","Mario","Department of Emergency Medicine, Bolzano Hospital, Bolzano, Italy",NA
"645","34251026","10.1111/ijd.15779","COVID-19 vaccination: possible short-term exacerbations of oral mucosal diseases.",NA,"2021","07","12","Int J Dermatol","International journal of dermatology",NA,"Kulkarni","Roopali","Department of Oral Medicine, University of Pennsylvania School of Dental Medicine, Philadelphia, PA, USA",NA
"646","34251026","10.1111/ijd.15779","COVID-19 vaccination: possible short-term exacerbations of oral mucosal diseases.",NA,"2021","07","12","Int J Dermatol","International journal of dermatology",NA,"Sollecito","Thomas P","Department of Oral Medicine, University of Pennsylvania School of Dental Medicine, Philadelphia, PA, USA",NA
"647","34250979","10.1097/INF.0000000000003195","The Indirect Impact of the SARS-CoV-2 Pandemic on Invasive Group a Streptococcus, Streptococcus Pneumoniae and Staphylococcus Aureus Infections in Houston Area Children.","Masking and social distancing have been adopted to mitigate the severe acute respiratory syndrome coronavirus 2 pandemic. We evaluated the indirect impact of severe acute respiratory syndrome coronavirus 2 prevention strategies on invasive Staphylococcus aureus, Streptococcus pneumoniae (pneumococcus) and Group A Streptococcus in Houston area children. We observed a decline in invasive pneumococcal disease and invasive Group A Streptococcus temporally associated with social distancing/masking/sc","2021","07","21","Pediatr Infect Dis J","The Pediatric infectious disease journal","COVID-19; Child; Coinfection; Hospitalization; Humans; Pandemics; Pneumococcal Infections; Prospective Studies; SARS-CoV-2; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus pneumoniae; Streptococcus pyogenes","McNeil","J Chase","From the Section of Infectious Diseases, Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas",NA
"648","34250979","10.1097/INF.0000000000003195","The Indirect Impact of the SARS-CoV-2 Pandemic on Invasive Group a Streptococcus, Streptococcus Pneumoniae and Staphylococcus Aureus Infections in Houston Area Children.","Masking and social distancing have been adopted to mitigate the severe acute respiratory syndrome coronavirus 2 pandemic. We evaluated the indirect impact of severe acute respiratory syndrome coronavirus 2 prevention strategies on invasive Staphylococcus aureus, Streptococcus pneumoniae (pneumococcus) and Group A Streptococcus in Houston area children. We observed a decline in invasive pneumococcal disease and invasive Group A Streptococcus temporally associated with social distancing/masking/sc","2021","07","21","Pediatr Infect Dis J","The Pediatric infectious disease journal","COVID-19; Child; Coinfection; Hospitalization; Humans; Pandemics; Pneumococcal Infections; Prospective Studies; SARS-CoV-2; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus pneumoniae; Streptococcus pyogenes","Flores","Anthony R","Division of Infectious Diseases, Department of Pediatrics, University of Texas Health Science Center, Houston, Texas",NA
"649","34250979","10.1097/INF.0000000000003195","The Indirect Impact of the SARS-CoV-2 Pandemic on Invasive Group a Streptococcus, Streptococcus Pneumoniae and Staphylococcus Aureus Infections in Houston Area Children.","Masking and social distancing have been adopted to mitigate the severe acute respiratory syndrome coronavirus 2 pandemic. We evaluated the indirect impact of severe acute respiratory syndrome coronavirus 2 prevention strategies on invasive Staphylococcus aureus, Streptococcus pneumoniae (pneumococcus) and Group A Streptococcus in Houston area children. We observed a decline in invasive pneumococcal disease and invasive Group A Streptococcus temporally associated with social distancing/masking/sc","2021","07","21","Pediatr Infect Dis J","The Pediatric infectious disease journal","COVID-19; Child; Coinfection; Hospitalization; Humans; Pandemics; Pneumococcal Infections; Prospective Studies; SARS-CoV-2; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus pneumoniae; Streptococcus pyogenes","Kaplan","Sheldon L","From the Section of Infectious Diseases, Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas",NA
"650","34250979","10.1097/INF.0000000000003195","The Indirect Impact of the SARS-CoV-2 Pandemic on Invasive Group a Streptococcus, Streptococcus Pneumoniae and Staphylococcus Aureus Infections in Houston Area Children.","Masking and social distancing have been adopted to mitigate the severe acute respiratory syndrome coronavirus 2 pandemic. We evaluated the indirect impact of severe acute respiratory syndrome coronavirus 2 prevention strategies on invasive Staphylococcus aureus, Streptococcus pneumoniae (pneumococcus) and Group A Streptococcus in Houston area children. We observed a decline in invasive pneumococcal disease and invasive Group A Streptococcus temporally associated with social distancing/masking/sc","2021","07","21","Pediatr Infect Dis J","The Pediatric infectious disease journal","COVID-19; Child; Coinfection; Hospitalization; Humans; Pandemics; Pneumococcal Infections; Prospective Studies; SARS-CoV-2; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus pneumoniae; Streptococcus pyogenes","Hulten","Kristina G","From the Section of Infectious Diseases, Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas",NA
"651","34250969","10.1097/INF.0000000000003198","Performance of RT-PCR on Saliva Specimens Compared With Nasopharyngeal Swabs for the Detection of SARS-CoV-2 in Children: A Prospective Comparative Clinical Trial.","Saliva reverse transcriptase-Polymerase chain reaction (RT-PCR) is an attractive alternative for the detection of severe acute respiratory syndrome coronavirus 2 in adults with less known in children. Children with coronavirus disease 2019 symptoms were prospectively enrolled in a 1-month comparative clinical trial of saliva and nasopharyngeal (NP) RT-PCR. Detection rates and sensitivities of saliva and NP RT-PCR were compared as well as discordant NP and saliva RT-PCR findings including viral l","2021","07","21","Pediatr Infect Dis J","The Pediatric infectious disease journal","COVID-19; COVID-19 Testing; Child; Child, Preschool; Diagnostic Tests, Routine; Female; Humans; Infant; Infant, Newborn; Male; Nasopharynx; Prospective Studies; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Saliva; Sensitivity and Specificity; Specimen Handling; Viral Load","Fougère","Yves","From the Pediatric Infectious Diseases and Vaccinology Unit, Department Women-Mother-Child, Lausanne University Hospital, Lausanne, Switzerland",NA
"652","34250969","10.1097/INF.0000000000003198","Performance of RT-PCR on Saliva Specimens Compared With Nasopharyngeal Swabs for the Detection of SARS-CoV-2 in Children: A Prospective Comparative Clinical Trial.","Saliva reverse transcriptase-Polymerase chain reaction (RT-PCR) is an attractive alternative for the detection of severe acute respiratory syndrome coronavirus 2 in adults with less known in children. Children with coronavirus disease 2019 symptoms were prospectively enrolled in a 1-month comparative clinical trial of saliva and nasopharyngeal (NP) RT-PCR. Detection rates and sensitivities of saliva and NP RT-PCR were compared as well as discordant NP and saliva RT-PCR findings including viral l","2021","07","21","Pediatr Infect Dis J","The Pediatric infectious disease journal","COVID-19; COVID-19 Testing; Child; Child, Preschool; Diagnostic Tests, Routine; Female; Humans; Infant; Infant, Newborn; Male; Nasopharynx; Prospective Studies; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Saliva; Sensitivity and Specificity; Specimen Handling; Viral Load","Schwob","Jean Marc","Department of Formation, Research and Innovation, Tropical and Travel Medicine Unit, Center for Primary Care and Public Health (Unisanté), Lausanne, Switzerland",NA
"653","34250969","10.1097/INF.0000000000003198","Performance of RT-PCR on Saliva Specimens Compared With Nasopharyngeal Swabs for the Detection of SARS-CoV-2 in Children: A Prospective Comparative Clinical Trial.","Saliva reverse transcriptase-Polymerase chain reaction (RT-PCR) is an attractive alternative for the detection of severe acute respiratory syndrome coronavirus 2 in adults with less known in children. Children with coronavirus disease 2019 symptoms were prospectively enrolled in a 1-month comparative clinical trial of saliva and nasopharyngeal (NP) RT-PCR. Detection rates and sensitivities of saliva and NP RT-PCR were compared as well as discordant NP and saliva RT-PCR findings including viral l","2021","07","21","Pediatr Infect Dis J","The Pediatric infectious disease journal","COVID-19; COVID-19 Testing; Child; Child, Preschool; Diagnostic Tests, Routine; Female; Humans; Infant; Infant, Newborn; Male; Nasopharynx; Prospective Studies; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Saliva; Sensitivity and Specificity; Specimen Handling; Viral Load","Miauton","Alix","Department of Formation, Research and Innovation, Tropical and Travel Medicine Unit, Center for Primary Care and Public Health (Unisanté), Lausanne, Switzerland",NA
"654","34250969","10.1097/INF.0000000000003198","Performance of RT-PCR on Saliva Specimens Compared With Nasopharyngeal Swabs for the Detection of SARS-CoV-2 in Children: A Prospective Comparative Clinical Trial.","Saliva reverse transcriptase-Polymerase chain reaction (RT-PCR) is an attractive alternative for the detection of severe acute respiratory syndrome coronavirus 2 in adults with less known in children. Children with coronavirus disease 2019 symptoms were prospectively enrolled in a 1-month comparative clinical trial of saliva and nasopharyngeal (NP) RT-PCR. Detection rates and sensitivities of saliva and NP RT-PCR were compared as well as discordant NP and saliva RT-PCR findings including viral l","2021","07","21","Pediatr Infect Dis J","The Pediatric infectious disease journal","COVID-19; COVID-19 Testing; Child; Child, Preschool; Diagnostic Tests, Routine; Female; Humans; Infant; Infant, Newborn; Male; Nasopharynx; Prospective Studies; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Saliva; Sensitivity and Specificity; Specimen Handling; Viral Load","Hoegger","Francesca","Service of Pediatrics, Department Women-Mother-Child, Lausanne University Hospital, Lausanne, Switzerland",NA
"655","34250969","10.1097/INF.0000000000003198","Performance of RT-PCR on Saliva Specimens Compared With Nasopharyngeal Swabs for the Detection of SARS-CoV-2 in Children: A Prospective Comparative Clinical Trial.","Saliva reverse transcriptase-Polymerase chain reaction (RT-PCR) is an attractive alternative for the detection of severe acute respiratory syndrome coronavirus 2 in adults with less known in children. Children with coronavirus disease 2019 symptoms were prospectively enrolled in a 1-month comparative clinical trial of saliva and nasopharyngeal (NP) RT-PCR. Detection rates and sensitivities of saliva and NP RT-PCR were compared as well as discordant NP and saliva RT-PCR findings including viral l","2021","07","21","Pediatr Infect Dis J","The Pediatric infectious disease journal","COVID-19; COVID-19 Testing; Child; Child, Preschool; Diagnostic Tests, Routine; Female; Humans; Infant; Infant, Newborn; Male; Nasopharynx; Prospective Studies; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Saliva; Sensitivity and Specificity; Specimen Handling; Viral Load","Opota","Onya","Department of Laboratory, Institute of Microbiology, Lausanne University Hospital, Lausanne, Switzerland",NA
"656","34250969","10.1097/INF.0000000000003198","Performance of RT-PCR on Saliva Specimens Compared With Nasopharyngeal Swabs for the Detection of SARS-CoV-2 in Children: A Prospective Comparative Clinical Trial.","Saliva reverse transcriptase-Polymerase chain reaction (RT-PCR) is an attractive alternative for the detection of severe acute respiratory syndrome coronavirus 2 in adults with less known in children. Children with coronavirus disease 2019 symptoms were prospectively enrolled in a 1-month comparative clinical trial of saliva and nasopharyngeal (NP) RT-PCR. Detection rates and sensitivities of saliva and NP RT-PCR were compared as well as discordant NP and saliva RT-PCR findings including viral l","2021","07","21","Pediatr Infect Dis J","The Pediatric infectious disease journal","COVID-19; COVID-19 Testing; Child; Child, Preschool; Diagnostic Tests, Routine; Female; Humans; Infant; Infant, Newborn; Male; Nasopharynx; Prospective Studies; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Saliva; Sensitivity and Specificity; Specimen Handling; Viral Load","Jaton","Katia","Department of Laboratory, Institute of Microbiology, Lausanne University Hospital, Lausanne, Switzerland",NA
"657","34250969","10.1097/INF.0000000000003198","Performance of RT-PCR on Saliva Specimens Compared With Nasopharyngeal Swabs for the Detection of SARS-CoV-2 in Children: A Prospective Comparative Clinical Trial.","Saliva reverse transcriptase-Polymerase chain reaction (RT-PCR) is an attractive alternative for the detection of severe acute respiratory syndrome coronavirus 2 in adults with less known in children. Children with coronavirus disease 2019 symptoms were prospectively enrolled in a 1-month comparative clinical trial of saliva and nasopharyngeal (NP) RT-PCR. Detection rates and sensitivities of saliva and NP RT-PCR were compared as well as discordant NP and saliva RT-PCR findings including viral l","2021","07","21","Pediatr Infect Dis J","The Pediatric infectious disease journal","COVID-19; COVID-19 Testing; Child; Child, Preschool; Diagnostic Tests, Routine; Female; Humans; Infant; Infant, Newborn; Male; Nasopharynx; Prospective Studies; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Saliva; Sensitivity and Specificity; Specimen Handling; Viral Load","Brouillet","Rene","Department of Laboratory, Institute of Microbiology, Lausanne University Hospital, Lausanne, Switzerland",NA
"658","34250969","10.1097/INF.0000000000003198","Performance of RT-PCR on Saliva Specimens Compared With Nasopharyngeal Swabs for the Detection of SARS-CoV-2 in Children: A Prospective Comparative Clinical Trial.","Saliva reverse transcriptase-Polymerase chain reaction (RT-PCR) is an attractive alternative for the detection of severe acute respiratory syndrome coronavirus 2 in adults with less known in children. Children with coronavirus disease 2019 symptoms were prospectively enrolled in a 1-month comparative clinical trial of saliva and nasopharyngeal (NP) RT-PCR. Detection rates and sensitivities of saliva and NP RT-PCR were compared as well as discordant NP and saliva RT-PCR findings including viral l","2021","07","21","Pediatr Infect Dis J","The Pediatric infectious disease journal","COVID-19; COVID-19 Testing; Child; Child, Preschool; Diagnostic Tests, Routine; Female; Humans; Infant; Infant, Newborn; Male; Nasopharynx; Prospective Studies; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Saliva; Sensitivity and Specificity; Specimen Handling; Viral Load","Greub","Gilbert","Department of Laboratory, Institute of Microbiology, Lausanne University Hospital, Lausanne, Switzerland",NA
"659","34250969","10.1097/INF.0000000000003198","Performance of RT-PCR on Saliva Specimens Compared With Nasopharyngeal Swabs for the Detection of SARS-CoV-2 in Children: A Prospective Comparative Clinical Trial.","Saliva reverse transcriptase-Polymerase chain reaction (RT-PCR) is an attractive alternative for the detection of severe acute respiratory syndrome coronavirus 2 in adults with less known in children. Children with coronavirus disease 2019 symptoms were prospectively enrolled in a 1-month comparative clinical trial of saliva and nasopharyngeal (NP) RT-PCR. Detection rates and sensitivities of saliva and NP RT-PCR were compared as well as discordant NP and saliva RT-PCR findings including viral l","2021","07","21","Pediatr Infect Dis J","The Pediatric infectious disease journal","COVID-19; COVID-19 Testing; Child; Child, Preschool; Diagnostic Tests, Routine; Female; Humans; Infant; Infant, Newborn; Male; Nasopharynx; Prospective Studies; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Saliva; Sensitivity and Specificity; Specimen Handling; Viral Load","Genton","Blaise","Department of Formation, Research and Innovation, Tropical and Travel Medicine Unit, Center for Primary Care and Public Health (Unisanté), Lausanne, Switzerland",NA
"660","34250969","10.1097/INF.0000000000003198","Performance of RT-PCR on Saliva Specimens Compared With Nasopharyngeal Swabs for the Detection of SARS-CoV-2 in Children: A Prospective Comparative Clinical Trial.","Saliva reverse transcriptase-Polymerase chain reaction (RT-PCR) is an attractive alternative for the detection of severe acute respiratory syndrome coronavirus 2 in adults with less known in children. Children with coronavirus disease 2019 symptoms were prospectively enrolled in a 1-month comparative clinical trial of saliva and nasopharyngeal (NP) RT-PCR. Detection rates and sensitivities of saliva and NP RT-PCR were compared as well as discordant NP and saliva RT-PCR findings including viral l","2021","07","21","Pediatr Infect Dis J","The Pediatric infectious disease journal","COVID-19; COVID-19 Testing; Child; Child, Preschool; Diagnostic Tests, Routine; Female; Humans; Infant; Infant, Newborn; Male; Nasopharynx; Prospective Studies; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Saliva; Sensitivity and Specificity; Specimen Handling; Viral Load","Gehri","Mario","Service of Pediatrics, Department Women-Mother-Child, Lausanne University Hospital, Lausanne, Switzerland",NA
"661","34250969","10.1097/INF.0000000000003198","Performance of RT-PCR on Saliva Specimens Compared With Nasopharyngeal Swabs for the Detection of SARS-CoV-2 in Children: A Prospective Comparative Clinical Trial.","Saliva reverse transcriptase-Polymerase chain reaction (RT-PCR) is an attractive alternative for the detection of severe acute respiratory syndrome coronavirus 2 in adults with less known in children. Children with coronavirus disease 2019 symptoms were prospectively enrolled in a 1-month comparative clinical trial of saliva and nasopharyngeal (NP) RT-PCR. Detection rates and sensitivities of saliva and NP RT-PCR were compared as well as discordant NP and saliva RT-PCR findings including viral l","2021","07","21","Pediatr Infect Dis J","The Pediatric infectious disease journal","COVID-19; COVID-19 Testing; Child; Child, Preschool; Diagnostic Tests, Routine; Female; Humans; Infant; Infant, Newborn; Male; Nasopharynx; Prospective Studies; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Saliva; Sensitivity and Specificity; Specimen Handling; Viral Load","Taddeo","Ilaria","Pediatric Emergency Center, Vidy-Med, Lausanne, Switzerland",NA
"662","34250969","10.1097/INF.0000000000003198","Performance of RT-PCR on Saliva Specimens Compared With Nasopharyngeal Swabs for the Detection of SARS-CoV-2 in Children: A Prospective Comparative Clinical Trial.","Saliva reverse transcriptase-Polymerase chain reaction (RT-PCR) is an attractive alternative for the detection of severe acute respiratory syndrome coronavirus 2 in adults with less known in children. Children with coronavirus disease 2019 symptoms were prospectively enrolled in a 1-month comparative clinical trial of saliva and nasopharyngeal (NP) RT-PCR. Detection rates and sensitivities of saliva and NP RT-PCR were compared as well as discordant NP and saliva RT-PCR findings including viral l","2021","07","21","Pediatr Infect Dis J","The Pediatric infectious disease journal","COVID-19; COVID-19 Testing; Child; Child, Preschool; Diagnostic Tests, Routine; Female; Humans; Infant; Infant, Newborn; Male; Nasopharynx; Prospective Studies; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Saliva; Sensitivity and Specificity; Specimen Handling; Viral Load","D'Acremont","Valérie","Department of Formation, Research and Innovation, Tropical and Travel Medicine Unit, Center for Primary Care and Public Health (Unisanté), Lausanne, Switzerland",NA
"663","34250969","10.1097/INF.0000000000003198","Performance of RT-PCR on Saliva Specimens Compared With Nasopharyngeal Swabs for the Detection of SARS-CoV-2 in Children: A Prospective Comparative Clinical Trial.","Saliva reverse transcriptase-Polymerase chain reaction (RT-PCR) is an attractive alternative for the detection of severe acute respiratory syndrome coronavirus 2 in adults with less known in children. Children with coronavirus disease 2019 symptoms were prospectively enrolled in a 1-month comparative clinical trial of saliva and nasopharyngeal (NP) RT-PCR. Detection rates and sensitivities of saliva and NP RT-PCR were compared as well as discordant NP and saliva RT-PCR findings including viral l","2021","07","21","Pediatr Infect Dis J","The Pediatric infectious disease journal","COVID-19; COVID-19 Testing; Child; Child, Preschool; Diagnostic Tests, Routine; Female; Humans; Infant; Infant, Newborn; Male; Nasopharynx; Prospective Studies; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Saliva; Sensitivity and Specificity; Specimen Handling; Viral Load","Asner","Sandra A","From the Pediatric Infectious Diseases and Vaccinology Unit, Department Women-Mother-Child, Lausanne University Hospital, Lausanne, Switzerland",NA
"664","34250968","10.1097/INF.0000000000003199","Longitudinal Follow-up of Antibody Responses in Pediatric Patients With COVID-19 up to 9 Months After Infection.","Antibody response developed within 2-3 weeks after exposure to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been shown to decrease over time; however, there is limited data about antibody levels at 6 months or later postinfection, particularly in children. A prospective multicenter study was performed using 315 samples of 74 confirmed and 10 probable coronavirus disease 2019 pediatric cases. About 20% of these cases were classified as asymptomatic, 74% as mild/moderate and 6%","2021","07","21","Pediatr Infect Dis J","The Pediatric infectious disease journal","Adolescent; Antibodies, Viral; Antibody Formation; COVID-19; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Immunoglobulin A; Immunoglobulin G; Infant; Longitudinal Studies; Male; Prospective Studies; SARS-CoV-2","Oygar","Pembe Derin","From the Department of Pediatric Infectious Diseases, Hacettepe University Faculty of Medicine, Ankara, Turkey",NA
"665","34250968","10.1097/INF.0000000000003199","Longitudinal Follow-up of Antibody Responses in Pediatric Patients With COVID-19 up to 9 Months After Infection.","Antibody response developed within 2-3 weeks after exposure to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been shown to decrease over time; however, there is limited data about antibody levels at 6 months or later postinfection, particularly in children. A prospective multicenter study was performed using 315 samples of 74 confirmed and 10 probable coronavirus disease 2019 pediatric cases. About 20% of these cases were classified as asymptomatic, 74% as mild/moderate and 6%","2021","07","21","Pediatr Infect Dis J","The Pediatric infectious disease journal","Adolescent; Antibodies, Viral; Antibody Formation; COVID-19; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Immunoglobulin A; Immunoglobulin G; Infant; Longitudinal Studies; Male; Prospective Studies; SARS-CoV-2","Ozsurekci","Yasemin","From the Department of Pediatric Infectious Diseases, Hacettepe University Faculty of Medicine, Ankara, Turkey",NA
"666","34250968","10.1097/INF.0000000000003199","Longitudinal Follow-up of Antibody Responses in Pediatric Patients With COVID-19 up to 9 Months After Infection.","Antibody response developed within 2-3 weeks after exposure to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been shown to decrease over time; however, there is limited data about antibody levels at 6 months or later postinfection, particularly in children. A prospective multicenter study was performed using 315 samples of 74 confirmed and 10 probable coronavirus disease 2019 pediatric cases. About 20% of these cases were classified as asymptomatic, 74% as mild/moderate and 6%","2021","07","21","Pediatr Infect Dis J","The Pediatric infectious disease journal","Adolescent; Antibodies, Viral; Antibody Formation; COVID-19; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Immunoglobulin A; Immunoglobulin G; Infant; Longitudinal Studies; Male; Prospective Studies; SARS-CoV-2","Gurlevik","Sibel Lacinel","From the Department of Pediatric Infectious Diseases, Hacettepe University Faculty of Medicine, Ankara, Turkey",NA
"667","34250968","10.1097/INF.0000000000003199","Longitudinal Follow-up of Antibody Responses in Pediatric Patients With COVID-19 up to 9 Months After Infection.","Antibody response developed within 2-3 weeks after exposure to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been shown to decrease over time; however, there is limited data about antibody levels at 6 months or later postinfection, particularly in children. A prospective multicenter study was performed using 315 samples of 74 confirmed and 10 probable coronavirus disease 2019 pediatric cases. About 20% of these cases were classified as asymptomatic, 74% as mild/moderate and 6%","2021","07","21","Pediatr Infect Dis J","The Pediatric infectious disease journal","Adolescent; Antibodies, Viral; Antibody Formation; COVID-19; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Immunoglobulin A; Immunoglobulin G; Infant; Longitudinal Studies; Male; Prospective Studies; SARS-CoV-2","Aykac","Kubra","Department of Pediatrics, Ankara Health Sciences University Hospital Pediatric Infectious Diseases Unit, Ankara, Turkey",NA
"668","34250968","10.1097/INF.0000000000003199","Longitudinal Follow-up of Antibody Responses in Pediatric Patients With COVID-19 up to 9 Months After Infection.","Antibody response developed within 2-3 weeks after exposure to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been shown to decrease over time; however, there is limited data about antibody levels at 6 months or later postinfection, particularly in children. A prospective multicenter study was performed using 315 samples of 74 confirmed and 10 probable coronavirus disease 2019 pediatric cases. About 20% of these cases were classified as asymptomatic, 74% as mild/moderate and 6%","2021","07","21","Pediatr Infect Dis J","The Pediatric infectious disease journal","Adolescent; Antibodies, Viral; Antibody Formation; COVID-19; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Immunoglobulin A; Immunoglobulin G; Infant; Longitudinal Studies; Male; Prospective Studies; SARS-CoV-2","Kukul","Musa Gurel","From the Department of Pediatric Infectious Diseases, Hacettepe University Faculty of Medicine, Ankara, Turkey",NA
"669","34250968","10.1097/INF.0000000000003199","Longitudinal Follow-up of Antibody Responses in Pediatric Patients With COVID-19 up to 9 Months After Infection.","Antibody response developed within 2-3 weeks after exposure to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been shown to decrease over time; however, there is limited data about antibody levels at 6 months or later postinfection, particularly in children. A prospective multicenter study was performed using 315 samples of 74 confirmed and 10 probable coronavirus disease 2019 pediatric cases. About 20% of these cases were classified as asymptomatic, 74% as mild/moderate and 6%","2021","07","21","Pediatr Infect Dis J","The Pediatric infectious disease journal","Adolescent; Antibodies, Viral; Antibody Formation; COVID-19; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Immunoglobulin A; Immunoglobulin G; Infant; Longitudinal Studies; Male; Prospective Studies; SARS-CoV-2","Cura Yayla","Burcu Ceylan","Department of Pediatrics, Ankara Health Sciences University Hospital Pediatric Infectious Diseases Unit, Ankara, Turkey",NA
"670","34250968","10.1097/INF.0000000000003199","Longitudinal Follow-up of Antibody Responses in Pediatric Patients With COVID-19 up to 9 Months After Infection.","Antibody response developed within 2-3 weeks after exposure to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been shown to decrease over time; however, there is limited data about antibody levels at 6 months or later postinfection, particularly in children. A prospective multicenter study was performed using 315 samples of 74 confirmed and 10 probable coronavirus disease 2019 pediatric cases. About 20% of these cases were classified as asymptomatic, 74% as mild/moderate and 6%","2021","07","21","Pediatr Infect Dis J","The Pediatric infectious disease journal","Adolescent; Antibodies, Viral; Antibody Formation; COVID-19; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Immunoglobulin A; Immunoglobulin G; Infant; Longitudinal Studies; Male; Prospective Studies; SARS-CoV-2","Ilbay","Sare","From the Department of Pediatric Infectious Diseases, Hacettepe University Faculty of Medicine, Ankara, Turkey",NA
"671","34250968","10.1097/INF.0000000000003199","Longitudinal Follow-up of Antibody Responses in Pediatric Patients With COVID-19 up to 9 Months After Infection.","Antibody response developed within 2-3 weeks after exposure to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been shown to decrease over time; however, there is limited data about antibody levels at 6 months or later postinfection, particularly in children. A prospective multicenter study was performed using 315 samples of 74 confirmed and 10 probable coronavirus disease 2019 pediatric cases. About 20% of these cases were classified as asymptomatic, 74% as mild/moderate and 6%","2021","07","21","Pediatr Infect Dis J","The Pediatric infectious disease journal","Adolescent; Antibodies, Viral; Antibody Formation; COVID-19; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Immunoglobulin A; Immunoglobulin G; Infant; Longitudinal Studies; Male; Prospective Studies; SARS-CoV-2","Karakaya","Jale","Department of Biostatistics, Hacettepe University Faculty of Medicine, Ankara, Turkey",NA
"672","34250968","10.1097/INF.0000000000003199","Longitudinal Follow-up of Antibody Responses in Pediatric Patients With COVID-19 up to 9 Months After Infection.","Antibody response developed within 2-3 weeks after exposure to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been shown to decrease over time; however, there is limited data about antibody levels at 6 months or later postinfection, particularly in children. A prospective multicenter study was performed using 315 samples of 74 confirmed and 10 probable coronavirus disease 2019 pediatric cases. About 20% of these cases were classified as asymptomatic, 74% as mild/moderate and 6%","2021","07","21","Pediatr Infect Dis J","The Pediatric infectious disease journal","Adolescent; Antibodies, Viral; Antibody Formation; COVID-19; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Immunoglobulin A; Immunoglobulin G; Infant; Longitudinal Studies; Male; Prospective Studies; SARS-CoV-2","Teksam","Ozlem","Department of Pediatric Emergency Medicine, Hacettepe University Faculty of Medicine, Ankara, Turkey",NA
"673","34250968","10.1097/INF.0000000000003199","Longitudinal Follow-up of Antibody Responses in Pediatric Patients With COVID-19 up to 9 Months After Infection.","Antibody response developed within 2-3 weeks after exposure to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been shown to decrease over time; however, there is limited data about antibody levels at 6 months or later postinfection, particularly in children. A prospective multicenter study was performed using 315 samples of 74 confirmed and 10 probable coronavirus disease 2019 pediatric cases. About 20% of these cases were classified as asymptomatic, 74% as mild/moderate and 6%","2021","07","21","Pediatr Infect Dis J","The Pediatric infectious disease journal","Adolescent; Antibodies, Viral; Antibody Formation; COVID-19; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Immunoglobulin A; Immunoglobulin G; Infant; Longitudinal Studies; Male; Prospective Studies; SARS-CoV-2","Cengiz","Ali Bulent","From the Department of Pediatric Infectious Diseases, Hacettepe University Faculty of Medicine, Ankara, Turkey",NA
"674","34250968","10.1097/INF.0000000000003199","Longitudinal Follow-up of Antibody Responses in Pediatric Patients With COVID-19 up to 9 Months After Infection.","Antibody response developed within 2-3 weeks after exposure to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been shown to decrease over time; however, there is limited data about antibody levels at 6 months or later postinfection, particularly in children. A prospective multicenter study was performed using 315 samples of 74 confirmed and 10 probable coronavirus disease 2019 pediatric cases. About 20% of these cases were classified as asymptomatic, 74% as mild/moderate and 6%","2021","07","21","Pediatr Infect Dis J","The Pediatric infectious disease journal","Adolescent; Antibodies, Viral; Antibody Formation; COVID-19; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Immunoglobulin A; Immunoglobulin G; Infant; Longitudinal Studies; Male; Prospective Studies; SARS-CoV-2","Ceyhan","Mehmet","From the Department of Pediatric Infectious Diseases, Hacettepe University Faculty of Medicine, Ankara, Turkey",NA
"675","34250967","10.1097/INF.0000000000003204","A Bayesian Model to Predict COVID-19 Severity in Children.","We aimed to identify risk factors causing critical disease in hospitalized children with COVID-19 and to build a predictive model to anticipate the probability of need for critical care. We conducted a multicenter, prospective study of children with SARS-CoV-2 infection in 52 Spanish hospitals. The primary outcome was the need for critical care. We used a multivariable Bayesian model to estimate the probability of needing critical care. The study enrolled 350 children from March 12, 2020, to Jul","2021","07","21","Pediatr Infect Dis J","The Pediatric infectious disease journal","Adolescent; Bayes Theorem; COVID-19; Child; Child, Preschool; Comorbidity; Critical Care; Critical Illness; Female; Humans; Infant; Infant, Newborn; Male; Prospective Studies; Risk Factors; SARS-CoV-2; Severity of Illness Index; Systemic Inflammatory Response Syndrome","Domínguez-Rodríguez","Sara","From the Fundación de Investigación Biomédica Hospital 12 de Octubre, Instituto de Investigación 12 de Octubre (imas12), Madrid, Spain",NA
"676","34250967","10.1097/INF.0000000000003204","A Bayesian Model to Predict COVID-19 Severity in Children.","We aimed to identify risk factors causing critical disease in hospitalized children with COVID-19 and to build a predictive model to anticipate the probability of need for critical care. We conducted a multicenter, prospective study of children with SARS-CoV-2 infection in 52 Spanish hospitals. The primary outcome was the need for critical care. We used a multivariable Bayesian model to estimate the probability of needing critical care. The study enrolled 350 children from March 12, 2020, to Jul","2021","07","21","Pediatr Infect Dis J","The Pediatric infectious disease journal","Adolescent; Bayes Theorem; COVID-19; Child; Child, Preschool; Comorbidity; Critical Care; Critical Illness; Female; Humans; Infant; Infant, Newborn; Male; Prospective Studies; Risk Factors; SARS-CoV-2; Severity of Illness Index; Systemic Inflammatory Response Syndrome","Villaverde","Serena","From the Fundación de Investigación Biomédica Hospital 12 de Octubre, Instituto de Investigación 12 de Octubre (imas12), Madrid, Spain",NA
"677","34250967","10.1097/INF.0000000000003204","A Bayesian Model to Predict COVID-19 Severity in Children.","We aimed to identify risk factors causing critical disease in hospitalized children with COVID-19 and to build a predictive model to anticipate the probability of need for critical care. We conducted a multicenter, prospective study of children with SARS-CoV-2 infection in 52 Spanish hospitals. The primary outcome was the need for critical care. We used a multivariable Bayesian model to estimate the probability of needing critical care. The study enrolled 350 children from March 12, 2020, to Jul","2021","07","21","Pediatr Infect Dis J","The Pediatric infectious disease journal","Adolescent; Bayes Theorem; COVID-19; Child; Child, Preschool; Comorbidity; Critical Care; Critical Illness; Female; Humans; Infant; Infant, Newborn; Male; Prospective Studies; Risk Factors; SARS-CoV-2; Severity of Illness Index; Systemic Inflammatory Response Syndrome","Sanz-Santaeufemia","Francisco J","Hospital Universitario Niño Jesús, Madrid, Spain",NA
"678","34250967","10.1097/INF.0000000000003204","A Bayesian Model to Predict COVID-19 Severity in Children.","We aimed to identify risk factors causing critical disease in hospitalized children with COVID-19 and to build a predictive model to anticipate the probability of need for critical care. We conducted a multicenter, prospective study of children with SARS-CoV-2 infection in 52 Spanish hospitals. The primary outcome was the need for critical care. We used a multivariable Bayesian model to estimate the probability of needing critical care. The study enrolled 350 children from March 12, 2020, to Jul","2021","07","21","Pediatr Infect Dis J","The Pediatric infectious disease journal","Adolescent; Bayes Theorem; COVID-19; Child; Child, Preschool; Comorbidity; Critical Care; Critical Illness; Female; Humans; Infant; Infant, Newborn; Male; Prospective Studies; Risk Factors; SARS-CoV-2; Severity of Illness Index; Systemic Inflammatory Response Syndrome","Grasa","Carlos","RITIP (Translational Research Network in Paediatric Infectious Diseases), Madrid, Spain",NA
"679","34250967","10.1097/INF.0000000000003204","A Bayesian Model to Predict COVID-19 Severity in Children.","We aimed to identify risk factors causing critical disease in hospitalized children with COVID-19 and to build a predictive model to anticipate the probability of need for critical care. We conducted a multicenter, prospective study of children with SARS-CoV-2 infection in 52 Spanish hospitals. The primary outcome was the need for critical care. We used a multivariable Bayesian model to estimate the probability of needing critical care. The study enrolled 350 children from March 12, 2020, to Jul","2021","07","21","Pediatr Infect Dis J","The Pediatric infectious disease journal","Adolescent; Bayes Theorem; COVID-19; Child; Child, Preschool; Comorbidity; Critical Care; Critical Illness; Female; Humans; Infant; Infant, Newborn; Male; Prospective Studies; Risk Factors; SARS-CoV-2; Severity of Illness Index; Systemic Inflammatory Response Syndrome","Soriano-Arandes","Antoni","Pediatric Infectious Diseases and Immunodeficiencies Unit, Hospital Universitari Vall d'Hebron, Vall d'Hebron Research Institute, Barcelona, Catalonia, Spain",NA
"680","34250967","10.1097/INF.0000000000003204","A Bayesian Model to Predict COVID-19 Severity in Children.","We aimed to identify risk factors causing critical disease in hospitalized children with COVID-19 and to build a predictive model to anticipate the probability of need for critical care. We conducted a multicenter, prospective study of children with SARS-CoV-2 infection in 52 Spanish hospitals. The primary outcome was the need for critical care. We used a multivariable Bayesian model to estimate the probability of needing critical care. The study enrolled 350 children from March 12, 2020, to Jul","2021","07","21","Pediatr Infect Dis J","The Pediatric infectious disease journal","Adolescent; Bayes Theorem; COVID-19; Child; Child, Preschool; Comorbidity; Critical Care; Critical Illness; Female; Humans; Infant; Infant, Newborn; Male; Prospective Studies; Risk Factors; SARS-CoV-2; Severity of Illness Index; Systemic Inflammatory Response Syndrome","Saavedra-Lozano","Jesús","Paediatric Infectious Diseases Unit, Department of Paediatrics, Hospital Universitario Gregorio Marañón, Madrid, Spain",NA
"681","34250967","10.1097/INF.0000000000003204","A Bayesian Model to Predict COVID-19 Severity in Children.","We aimed to identify risk factors causing critical disease in hospitalized children with COVID-19 and to build a predictive model to anticipate the probability of need for critical care. We conducted a multicenter, prospective study of children with SARS-CoV-2 infection in 52 Spanish hospitals. The primary outcome was the need for critical care. We used a multivariable Bayesian model to estimate the probability of needing critical care. The study enrolled 350 children from March 12, 2020, to Jul","2021","07","21","Pediatr Infect Dis J","The Pediatric infectious disease journal","Adolescent; Bayes Theorem; COVID-19; Child; Child, Preschool; Comorbidity; Critical Care; Critical Illness; Female; Humans; Infant; Infant, Newborn; Male; Prospective Studies; Risk Factors; SARS-CoV-2; Severity of Illness Index; Systemic Inflammatory Response Syndrome","Fumadó","Victoria","Paediatric Infectious Diseases Unit, Department of Paediatrics, Hospital Universitario Sant Joan de Deu Barcelona, Barcelona, Spain",NA
"682","34250967","10.1097/INF.0000000000003204","A Bayesian Model to Predict COVID-19 Severity in Children.","We aimed to identify risk factors causing critical disease in hospitalized children with COVID-19 and to build a predictive model to anticipate the probability of need for critical care. We conducted a multicenter, prospective study of children with SARS-CoV-2 infection in 52 Spanish hospitals. The primary outcome was the need for critical care. We used a multivariable Bayesian model to estimate the probability of needing critical care. The study enrolled 350 children from March 12, 2020, to Jul","2021","07","21","Pediatr Infect Dis J","The Pediatric infectious disease journal","Adolescent; Bayes Theorem; COVID-19; Child; Child, Preschool; Comorbidity; Critical Care; Critical Illness; Female; Humans; Infant; Infant, Newborn; Male; Prospective Studies; Risk Factors; SARS-CoV-2; Severity of Illness Index; Systemic Inflammatory Response Syndrome","Epalza","Cristina","From the Fundación de Investigación Biomédica Hospital 12 de Octubre, Instituto de Investigación 12 de Octubre (imas12), Madrid, Spain",NA
"683","34250967","10.1097/INF.0000000000003204","A Bayesian Model to Predict COVID-19 Severity in Children.","We aimed to identify risk factors causing critical disease in hospitalized children with COVID-19 and to build a predictive model to anticipate the probability of need for critical care. We conducted a multicenter, prospective study of children with SARS-CoV-2 infection in 52 Spanish hospitals. The primary outcome was the need for critical care. We used a multivariable Bayesian model to estimate the probability of needing critical care. The study enrolled 350 children from March 12, 2020, to Jul","2021","07","21","Pediatr Infect Dis J","The Pediatric infectious disease journal","Adolescent; Bayes Theorem; COVID-19; Child; Child, Preschool; Comorbidity; Critical Care; Critical Illness; Female; Humans; Infant; Infant, Newborn; Male; Prospective Studies; Risk Factors; SARS-CoV-2; Severity of Illness Index; Systemic Inflammatory Response Syndrome","Serna-Pascual","Miquel","From the Fundación de Investigación Biomédica Hospital 12 de Octubre, Instituto de Investigación 12 de Octubre (imas12), Madrid, Spain",NA
"684","34250967","10.1097/INF.0000000000003204","A Bayesian Model to Predict COVID-19 Severity in Children.","We aimed to identify risk factors causing critical disease in hospitalized children with COVID-19 and to build a predictive model to anticipate the probability of need for critical care. We conducted a multicenter, prospective study of children with SARS-CoV-2 infection in 52 Spanish hospitals. The primary outcome was the need for critical care. We used a multivariable Bayesian model to estimate the probability of needing critical care. The study enrolled 350 children from March 12, 2020, to Jul","2021","07","21","Pediatr Infect Dis J","The Pediatric infectious disease journal","Adolescent; Bayes Theorem; COVID-19; Child; Child, Preschool; Comorbidity; Critical Care; Critical Illness; Female; Humans; Infant; Infant, Newborn; Male; Prospective Studies; Risk Factors; SARS-CoV-2; Severity of Illness Index; Systemic Inflammatory Response Syndrome","Alonso-Cadenas","José A","Hospital Universitario Niño Jesús, Madrid, Spain",NA
"685","34250967","10.1097/INF.0000000000003204","A Bayesian Model to Predict COVID-19 Severity in Children.","We aimed to identify risk factors causing critical disease in hospitalized children with COVID-19 and to build a predictive model to anticipate the probability of need for critical care. We conducted a multicenter, prospective study of children with SARS-CoV-2 infection in 52 Spanish hospitals. The primary outcome was the need for critical care. We used a multivariable Bayesian model to estimate the probability of needing critical care. The study enrolled 350 children from March 12, 2020, to Jul","2021","07","21","Pediatr Infect Dis J","The Pediatric infectious disease journal","Adolescent; Bayes Theorem; COVID-19; Child; Child, Preschool; Comorbidity; Critical Care; Critical Illness; Female; Humans; Infant; Infant, Newborn; Male; Prospective Studies; Risk Factors; SARS-CoV-2; Severity of Illness Index; Systemic Inflammatory Response Syndrome","Rodríguez-Molino","Paula","RITIP (Translational Research Network in Paediatric Infectious Diseases), Madrid, Spain",NA
"686","34250967","10.1097/INF.0000000000003204","A Bayesian Model to Predict COVID-19 Severity in Children.","We aimed to identify risk factors causing critical disease in hospitalized children with COVID-19 and to build a predictive model to anticipate the probability of need for critical care. We conducted a multicenter, prospective study of children with SARS-CoV-2 infection in 52 Spanish hospitals. The primary outcome was the need for critical care. We used a multivariable Bayesian model to estimate the probability of needing critical care. The study enrolled 350 children from March 12, 2020, to Jul","2021","07","21","Pediatr Infect Dis J","The Pediatric infectious disease journal","Adolescent; Bayes Theorem; COVID-19; Child; Child, Preschool; Comorbidity; Critical Care; Critical Illness; Female; Humans; Infant; Infant, Newborn; Male; Prospective Studies; Risk Factors; SARS-CoV-2; Severity of Illness Index; Systemic Inflammatory Response Syndrome","Pujol-Morro","Joan","Pediatric Infectious Diseases and Immunodeficiencies Unit, Hospital Universitari Vall d'Hebron, Vall d'Hebron Research Institute, Barcelona, Catalonia, Spain",NA
"687","34250967","10.1097/INF.0000000000003204","A Bayesian Model to Predict COVID-19 Severity in Children.","We aimed to identify risk factors causing critical disease in hospitalized children with COVID-19 and to build a predictive model to anticipate the probability of need for critical care. We conducted a multicenter, prospective study of children with SARS-CoV-2 infection in 52 Spanish hospitals. The primary outcome was the need for critical care. We used a multivariable Bayesian model to estimate the probability of needing critical care. The study enrolled 350 children from March 12, 2020, to Jul","2021","07","21","Pediatr Infect Dis J","The Pediatric infectious disease journal","Adolescent; Bayes Theorem; COVID-19; Child; Child, Preschool; Comorbidity; Critical Care; Critical Illness; Female; Humans; Infant; Infant, Newborn; Male; Prospective Studies; Risk Factors; SARS-CoV-2; Severity of Illness Index; Systemic Inflammatory Response Syndrome","Aguilera-Alonso","David","Paediatric Infectious Diseases Unit, Department of Paediatrics, Hospital Universitario Gregorio Marañón, Madrid, Spain",NA
"688","34250967","10.1097/INF.0000000000003204","A Bayesian Model to Predict COVID-19 Severity in Children.","We aimed to identify risk factors causing critical disease in hospitalized children with COVID-19 and to build a predictive model to anticipate the probability of need for critical care. We conducted a multicenter, prospective study of children with SARS-CoV-2 infection in 52 Spanish hospitals. The primary outcome was the need for critical care. We used a multivariable Bayesian model to estimate the probability of needing critical care. The study enrolled 350 children from March 12, 2020, to Jul","2021","07","21","Pediatr Infect Dis J","The Pediatric infectious disease journal","Adolescent; Bayes Theorem; COVID-19; Child; Child, Preschool; Comorbidity; Critical Care; Critical Illness; Female; Humans; Infant; Infant, Newborn; Male; Prospective Studies; Risk Factors; SARS-CoV-2; Severity of Illness Index; Systemic Inflammatory Response Syndrome","Simó","Silvia","Paediatric Infectious Diseases Unit, Department of Paediatrics, Hospital Universitario Sant Joan de Deu Barcelona, Barcelona, Spain",NA
"689","34250967","10.1097/INF.0000000000003204","A Bayesian Model to Predict COVID-19 Severity in Children.","We aimed to identify risk factors causing critical disease in hospitalized children with COVID-19 and to build a predictive model to anticipate the probability of need for critical care. We conducted a multicenter, prospective study of children with SARS-CoV-2 infection in 52 Spanish hospitals. The primary outcome was the need for critical care. We used a multivariable Bayesian model to estimate the probability of needing critical care. The study enrolled 350 children from March 12, 2020, to Jul","2021","07","21","Pediatr Infect Dis J","The Pediatric infectious disease journal","Adolescent; Bayes Theorem; COVID-19; Child; Child, Preschool; Comorbidity; Critical Care; Critical Illness; Female; Humans; Infant; Infant, Newborn; Male; Prospective Studies; Risk Factors; SARS-CoV-2; Severity of Illness Index; Systemic Inflammatory Response Syndrome","Villanueva-Medina","Sara","From the Fundación de Investigación Biomédica Hospital 12 de Octubre, Instituto de Investigación 12 de Octubre (imas12), Madrid, Spain",NA
"690","34250967","10.1097/INF.0000000000003204","A Bayesian Model to Predict COVID-19 Severity in Children.","We aimed to identify risk factors causing critical disease in hospitalized children with COVID-19 and to build a predictive model to anticipate the probability of need for critical care. We conducted a multicenter, prospective study of children with SARS-CoV-2 infection in 52 Spanish hospitals. The primary outcome was the need for critical care. We used a multivariable Bayesian model to estimate the probability of needing critical care. The study enrolled 350 children from March 12, 2020, to Jul","2021","07","21","Pediatr Infect Dis J","The Pediatric infectious disease journal","Adolescent; Bayes Theorem; COVID-19; Child; Child, Preschool; Comorbidity; Critical Care; Critical Illness; Female; Humans; Infant; Infant, Newborn; Male; Prospective Studies; Risk Factors; SARS-CoV-2; Severity of Illness Index; Systemic Inflammatory Response Syndrome","Iglesias-Bouzas","M Isabel","Paediatric Intensive Care Unit, Hospital Universitario Niño Jesús, Madrid, Spain",NA
"691","34250967","10.1097/INF.0000000000003204","A Bayesian Model to Predict COVID-19 Severity in Children.","We aimed to identify risk factors causing critical disease in hospitalized children with COVID-19 and to build a predictive model to anticipate the probability of need for critical care. We conducted a multicenter, prospective study of children with SARS-CoV-2 infection in 52 Spanish hospitals. The primary outcome was the need for critical care. We used a multivariable Bayesian model to estimate the probability of needing critical care. The study enrolled 350 children from March 12, 2020, to Jul","2021","07","21","Pediatr Infect Dis J","The Pediatric infectious disease journal","Adolescent; Bayes Theorem; COVID-19; Child; Child, Preschool; Comorbidity; Critical Care; Critical Illness; Female; Humans; Infant; Infant, Newborn; Male; Prospective Studies; Risk Factors; SARS-CoV-2; Severity of Illness Index; Systemic Inflammatory Response Syndrome","Mellado","M José","Hospital Universitario Niño Jesús, Madrid, Spain",NA
"692","34250967","10.1097/INF.0000000000003204","A Bayesian Model to Predict COVID-19 Severity in Children.","We aimed to identify risk factors causing critical disease in hospitalized children with COVID-19 and to build a predictive model to anticipate the probability of need for critical care. We conducted a multicenter, prospective study of children with SARS-CoV-2 infection in 52 Spanish hospitals. The primary outcome was the need for critical care. We used a multivariable Bayesian model to estimate the probability of needing critical care. The study enrolled 350 children from March 12, 2020, to Jul","2021","07","21","Pediatr Infect Dis J","The Pediatric infectious disease journal","Adolescent; Bayes Theorem; COVID-19; Child; Child, Preschool; Comorbidity; Critical Care; Critical Illness; Female; Humans; Infant; Infant, Newborn; Male; Prospective Studies; Risk Factors; SARS-CoV-2; Severity of Illness Index; Systemic Inflammatory Response Syndrome","Herrero","Blanca","Hospital Universitario Niño Jesús, Madrid, Spain",NA
"693","34250967","10.1097/INF.0000000000003204","A Bayesian Model to Predict COVID-19 Severity in Children.","We aimed to identify risk factors causing critical disease in hospitalized children with COVID-19 and to build a predictive model to anticipate the probability of need for critical care. We conducted a multicenter, prospective study of children with SARS-CoV-2 infection in 52 Spanish hospitals. The primary outcome was the need for critical care. We used a multivariable Bayesian model to estimate the probability of needing critical care. The study enrolled 350 children from March 12, 2020, to Jul","2021","07","21","Pediatr Infect Dis J","The Pediatric infectious disease journal","Adolescent; Bayes Theorem; COVID-19; Child; Child, Preschool; Comorbidity; Critical Care; Critical Illness; Female; Humans; Infant; Infant, Newborn; Male; Prospective Studies; Risk Factors; SARS-CoV-2; Severity of Illness Index; Systemic Inflammatory Response Syndrome","Melendo","Susana","Pediatric Infectious Diseases and Immunodeficiencies Unit, Hospital Universitari Vall d'Hebron, Vall d'Hebron Research Institute, Barcelona, Catalonia, Spain",NA
"694","34250967","10.1097/INF.0000000000003204","A Bayesian Model to Predict COVID-19 Severity in Children.","We aimed to identify risk factors causing critical disease in hospitalized children with COVID-19 and to build a predictive model to anticipate the probability of need for critical care. We conducted a multicenter, prospective study of children with SARS-CoV-2 infection in 52 Spanish hospitals. The primary outcome was the need for critical care. We used a multivariable Bayesian model to estimate the probability of needing critical care. The study enrolled 350 children from March 12, 2020, to Jul","2021","07","21","Pediatr Infect Dis J","The Pediatric infectious disease journal","Adolescent; Bayes Theorem; COVID-19; Child; Child, Preschool; Comorbidity; Critical Care; Critical Illness; Female; Humans; Infant; Infant, Newborn; Male; Prospective Studies; Risk Factors; SARS-CoV-2; Severity of Illness Index; Systemic Inflammatory Response Syndrome","De la Torre","Mercedes","Hospital Universitario Niño Jesús, Madrid, Spain",NA
"695","34250967","10.1097/INF.0000000000003204","A Bayesian Model to Predict COVID-19 Severity in Children.","We aimed to identify risk factors causing critical disease in hospitalized children with COVID-19 and to build a predictive model to anticipate the probability of need for critical care. We conducted a multicenter, prospective study of children with SARS-CoV-2 infection in 52 Spanish hospitals. The primary outcome was the need for critical care. We used a multivariable Bayesian model to estimate the probability of needing critical care. The study enrolled 350 children from March 12, 2020, to Jul","2021","07","21","Pediatr Infect Dis J","The Pediatric infectious disease journal","Adolescent; Bayes Theorem; COVID-19; Child; Child, Preschool; Comorbidity; Critical Care; Critical Illness; Female; Humans; Infant; Infant, Newborn; Male; Prospective Studies; Risk Factors; SARS-CoV-2; Severity of Illness Index; Systemic Inflammatory Response Syndrome","Del Rosal","Teresa","RITIP (Translational Research Network in Paediatric Infectious Diseases), Madrid, Spain",NA
"696","34250967","10.1097/INF.0000000000003204","A Bayesian Model to Predict COVID-19 Severity in Children.","We aimed to identify risk factors causing critical disease in hospitalized children with COVID-19 and to build a predictive model to anticipate the probability of need for critical care. We conducted a multicenter, prospective study of children with SARS-CoV-2 infection in 52 Spanish hospitals. The primary outcome was the need for critical care. We used a multivariable Bayesian model to estimate the probability of needing critical care. The study enrolled 350 children from March 12, 2020, to Jul","2021","07","21","Pediatr Infect Dis J","The Pediatric infectious disease journal","Adolescent; Bayes Theorem; COVID-19; Child; Child, Preschool; Comorbidity; Critical Care; Critical Illness; Female; Humans; Infant; Infant, Newborn; Male; Prospective Studies; Risk Factors; SARS-CoV-2; Severity of Illness Index; Systemic Inflammatory Response Syndrome","Soler-Palacin","Pere","Pediatric Infectious Diseases and Immunodeficiencies Unit, Hospital Universitari Vall d'Hebron, Vall d'Hebron Research Institute, Barcelona, Catalonia, Spain",NA
"697","34250967","10.1097/INF.0000000000003204","A Bayesian Model to Predict COVID-19 Severity in Children.","We aimed to identify risk factors causing critical disease in hospitalized children with COVID-19 and to build a predictive model to anticipate the probability of need for critical care. We conducted a multicenter, prospective study of children with SARS-CoV-2 infection in 52 Spanish hospitals. The primary outcome was the need for critical care. We used a multivariable Bayesian model to estimate the probability of needing critical care. The study enrolled 350 children from March 12, 2020, to Jul","2021","07","21","Pediatr Infect Dis J","The Pediatric infectious disease journal","Adolescent; Bayes Theorem; COVID-19; Child; Child, Preschool; Comorbidity; Critical Care; Critical Illness; Female; Humans; Infant; Infant, Newborn; Male; Prospective Studies; Risk Factors; SARS-CoV-2; Severity of Illness Index; Systemic Inflammatory Response Syndrome","Calvo","Cristina","Hospital Universitario Niño Jesús, Madrid, Spain",NA
"698","34250967","10.1097/INF.0000000000003204","A Bayesian Model to Predict COVID-19 Severity in Children.","We aimed to identify risk factors causing critical disease in hospitalized children with COVID-19 and to build a predictive model to anticipate the probability of need for critical care. We conducted a multicenter, prospective study of children with SARS-CoV-2 infection in 52 Spanish hospitals. The primary outcome was the need for critical care. We used a multivariable Bayesian model to estimate the probability of needing critical care. The study enrolled 350 children from March 12, 2020, to Jul","2021","07","21","Pediatr Infect Dis J","The Pediatric infectious disease journal","Adolescent; Bayes Theorem; COVID-19; Child; Child, Preschool; Comorbidity; Critical Care; Critical Illness; Female; Humans; Infant; Infant, Newborn; Male; Prospective Studies; Risk Factors; SARS-CoV-2; Severity of Illness Index; Systemic Inflammatory Response Syndrome","Urretavizcaya-Martínez","María","Paediatrics Department, Complejo Hospitalario de Navarra, Pamplona, Spain",NA
"699","34250967","10.1097/INF.0000000000003204","A Bayesian Model to Predict COVID-19 Severity in Children.","We aimed to identify risk factors causing critical disease in hospitalized children with COVID-19 and to build a predictive model to anticipate the probability of need for critical care. We conducted a multicenter, prospective study of children with SARS-CoV-2 infection in 52 Spanish hospitals. The primary outcome was the need for critical care. We used a multivariable Bayesian model to estimate the probability of needing critical care. The study enrolled 350 children from March 12, 2020, to Jul","2021","07","21","Pediatr Infect Dis J","The Pediatric infectious disease journal","Adolescent; Bayes Theorem; COVID-19; Child; Child, Preschool; Comorbidity; Critical Care; Critical Illness; Female; Humans; Infant; Infant, Newborn; Male; Prospective Studies; Risk Factors; SARS-CoV-2; Severity of Illness Index; Systemic Inflammatory Response Syndrome","Pareja","Marta","Paediatrics Department, Complejo Hospitalario Universitario de Albacete, Albacete, Spain",NA
"700","34250967","10.1097/INF.0000000000003204","A Bayesian Model to Predict COVID-19 Severity in Children.","We aimed to identify risk factors causing critical disease in hospitalized children with COVID-19 and to build a predictive model to anticipate the probability of need for critical care. We conducted a multicenter, prospective study of children with SARS-CoV-2 infection in 52 Spanish hospitals. The primary outcome was the need for critical care. We used a multivariable Bayesian model to estimate the probability of needing critical care. The study enrolled 350 children from March 12, 2020, to Jul","2021","07","21","Pediatr Infect Dis J","The Pediatric infectious disease journal","Adolescent; Bayes Theorem; COVID-19; Child; Child, Preschool; Comorbidity; Critical Care; Critical Illness; Female; Humans; Infant; Infant, Newborn; Male; Prospective Studies; Risk Factors; SARS-CoV-2; Severity of Illness Index; Systemic Inflammatory Response Syndrome","Ara-Montojo","Fátima","Paediatrics Department, Hospital Universitario Quironsalud Madrid, Madrid, Spain",NA
"701","34250967","10.1097/INF.0000000000003204","A Bayesian Model to Predict COVID-19 Severity in Children.","We aimed to identify risk factors causing critical disease in hospitalized children with COVID-19 and to build a predictive model to anticipate the probability of need for critical care. We conducted a multicenter, prospective study of children with SARS-CoV-2 infection in 52 Spanish hospitals. The primary outcome was the need for critical care. We used a multivariable Bayesian model to estimate the probability of needing critical care. The study enrolled 350 children from March 12, 2020, to Jul","2021","07","21","Pediatr Infect Dis J","The Pediatric infectious disease journal","Adolescent; Bayes Theorem; COVID-19; Child; Child, Preschool; Comorbidity; Critical Care; Critical Illness; Female; Humans; Infant; Infant, Newborn; Male; Prospective Studies; Risk Factors; SARS-CoV-2; Severity of Illness Index; Systemic Inflammatory Response Syndrome","Ruiz Del Prado","Yolanda","Paediatrics Department, Hospital San Pedro, Logroño, Spain",NA
"702","34250967","10.1097/INF.0000000000003204","A Bayesian Model to Predict COVID-19 Severity in Children.","We aimed to identify risk factors causing critical disease in hospitalized children with COVID-19 and to build a predictive model to anticipate the probability of need for critical care. We conducted a multicenter, prospective study of children with SARS-CoV-2 infection in 52 Spanish hospitals. The primary outcome was the need for critical care. We used a multivariable Bayesian model to estimate the probability of needing critical care. The study enrolled 350 children from March 12, 2020, to Jul","2021","07","21","Pediatr Infect Dis J","The Pediatric infectious disease journal","Adolescent; Bayes Theorem; COVID-19; Child; Child, Preschool; Comorbidity; Critical Care; Critical Illness; Female; Humans; Infant; Infant, Newborn; Male; Prospective Studies; Risk Factors; SARS-CoV-2; Severity of Illness Index; Systemic Inflammatory Response Syndrome","Gallego","Nerea","Paediatrics Department, Hospital Universitari Son Espases, Palma de Mallorca, Spain",NA
"703","34250967","10.1097/INF.0000000000003204","A Bayesian Model to Predict COVID-19 Severity in Children.","We aimed to identify risk factors causing critical disease in hospitalized children with COVID-19 and to build a predictive model to anticipate the probability of need for critical care. We conducted a multicenter, prospective study of children with SARS-CoV-2 infection in 52 Spanish hospitals. The primary outcome was the need for critical care. We used a multivariable Bayesian model to estimate the probability of needing critical care. The study enrolled 350 children from March 12, 2020, to Jul","2021","07","21","Pediatr Infect Dis J","The Pediatric infectious disease journal","Adolescent; Bayes Theorem; COVID-19; Child; Child, Preschool; Comorbidity; Critical Care; Critical Illness; Female; Humans; Infant; Infant, Newborn; Male; Prospective Studies; Risk Factors; SARS-CoV-2; Severity of Illness Index; Systemic Inflammatory Response Syndrome","Illán Ramos","Marta","Paediatrics Department, Hospital Universitario Clínico San Carlos, Madrid, Spain",NA
"704","34250967","10.1097/INF.0000000000003204","A Bayesian Model to Predict COVID-19 Severity in Children.","We aimed to identify risk factors causing critical disease in hospitalized children with COVID-19 and to build a predictive model to anticipate the probability of need for critical care. We conducted a multicenter, prospective study of children with SARS-CoV-2 infection in 52 Spanish hospitals. The primary outcome was the need for critical care. We used a multivariable Bayesian model to estimate the probability of needing critical care. The study enrolled 350 children from March 12, 2020, to Jul","2021","07","21","Pediatr Infect Dis J","The Pediatric infectious disease journal","Adolescent; Bayes Theorem; COVID-19; Child; Child, Preschool; Comorbidity; Critical Care; Critical Illness; Female; Humans; Infant; Infant, Newborn; Male; Prospective Studies; Risk Factors; SARS-CoV-2; Severity of Illness Index; Systemic Inflammatory Response Syndrome","Cobos","Elena","From the Fundación de Investigación Biomédica Hospital 12 de Octubre, Instituto de Investigación 12 de Octubre (imas12), Madrid, Spain",NA
"705","34250967","10.1097/INF.0000000000003204","A Bayesian Model to Predict COVID-19 Severity in Children.","We aimed to identify risk factors causing critical disease in hospitalized children with COVID-19 and to build a predictive model to anticipate the probability of need for critical care. We conducted a multicenter, prospective study of children with SARS-CoV-2 infection in 52 Spanish hospitals. The primary outcome was the need for critical care. We used a multivariable Bayesian model to estimate the probability of needing critical care. The study enrolled 350 children from March 12, 2020, to Jul","2021","07","21","Pediatr Infect Dis J","The Pediatric infectious disease journal","Adolescent; Bayes Theorem; COVID-19; Child; Child, Preschool; Comorbidity; Critical Care; Critical Illness; Female; Humans; Infant; Infant, Newborn; Male; Prospective Studies; Risk Factors; SARS-CoV-2; Severity of Illness Index; Systemic Inflammatory Response Syndrome","Tagarro","Alfredo","From the Fundación de Investigación Biomédica Hospital 12 de Octubre, Instituto de Investigación 12 de Octubre (imas12), Madrid, Spain",NA
"706","34250967","10.1097/INF.0000000000003204","A Bayesian Model to Predict COVID-19 Severity in Children.","We aimed to identify risk factors causing critical disease in hospitalized children with COVID-19 and to build a predictive model to anticipate the probability of need for critical care. We conducted a multicenter, prospective study of children with SARS-CoV-2 infection in 52 Spanish hospitals. The primary outcome was the need for critical care. We used a multivariable Bayesian model to estimate the probability of needing critical care. The study enrolled 350 children from March 12, 2020, to Jul","2021","07","21","Pediatr Infect Dis J","The Pediatric infectious disease journal","Adolescent; Bayes Theorem; COVID-19; Child; Child, Preschool; Comorbidity; Critical Care; Critical Illness; Female; Humans; Infant; Infant, Newborn; Male; Prospective Studies; Risk Factors; SARS-CoV-2; Severity of Illness Index; Systemic Inflammatory Response Syndrome","Moraleda","Cinta","From the Fundación de Investigación Biomédica Hospital 12 de Octubre, Instituto de Investigación 12 de Octubre (imas12), Madrid, Spain",NA
"707","34250939","10.3233/JAD-210287","Brain Stress Mapping in COVID-19 Survivors Using MR Spectroscopy: New Avenue of Mental Health Status Monitoring.","Coronavirus (COVID-19) has emerged as a human catastrophe worldwide, and it has impacted human life more detrimentally than the combined effect of World Wars I and II. Various research studies reported that the disease is not confined to the respiratory system but also leads to neurological and neuropsychiatric disorders suggesting that the virus is potent to affect the central nervous system (CNS). Moreover, the damage to CNS may continue to rise even after the COVID-19 infection subsides which","2021","07","12","J Alzheimers Dis","Journal of Alzheimer's disease : JAD","Brain; COVID-19; cognition; gamma-aminobutyric acid; glutathione; magnetic resonance spectroscopy; mental health; psychiatry","Samkaria","Avantika","Neuroimaging and Neurospectroscopy (NINS) Laboratory, National Brain Research Centre, Gurgaon, India",NA
"708","34250939","10.3233/JAD-210287","Brain Stress Mapping in COVID-19 Survivors Using MR Spectroscopy: New Avenue of Mental Health Status Monitoring.","Coronavirus (COVID-19) has emerged as a human catastrophe worldwide, and it has impacted human life more detrimentally than the combined effect of World Wars I and II. Various research studies reported that the disease is not confined to the respiratory system but also leads to neurological and neuropsychiatric disorders suggesting that the virus is potent to affect the central nervous system (CNS). Moreover, the damage to CNS may continue to rise even after the COVID-19 infection subsides which","2021","07","12","J Alzheimers Dis","Journal of Alzheimer's disease : JAD","Brain; COVID-19; cognition; gamma-aminobutyric acid; glutathione; magnetic resonance spectroscopy; mental health; psychiatry","Punjabi","Khushboo","Neuroimaging and Neurospectroscopy (NINS) Laboratory, National Brain Research Centre, Gurgaon, India",NA
"709","34250939","10.3233/JAD-210287","Brain Stress Mapping in COVID-19 Survivors Using MR Spectroscopy: New Avenue of Mental Health Status Monitoring.","Coronavirus (COVID-19) has emerged as a human catastrophe worldwide, and it has impacted human life more detrimentally than the combined effect of World Wars I and II. Various research studies reported that the disease is not confined to the respiratory system but also leads to neurological and neuropsychiatric disorders suggesting that the virus is potent to affect the central nervous system (CNS). Moreover, the damage to CNS may continue to rise even after the COVID-19 infection subsides which","2021","07","12","J Alzheimers Dis","Journal of Alzheimer's disease : JAD","Brain; COVID-19; cognition; gamma-aminobutyric acid; glutathione; magnetic resonance spectroscopy; mental health; psychiatry","Sharma","Shallu","Neuroimaging and Neurospectroscopy (NINS) Laboratory, National Brain Research Centre, Gurgaon, India",NA
"710","34250939","10.3233/JAD-210287","Brain Stress Mapping in COVID-19 Survivors Using MR Spectroscopy: New Avenue of Mental Health Status Monitoring.","Coronavirus (COVID-19) has emerged as a human catastrophe worldwide, and it has impacted human life more detrimentally than the combined effect of World Wars I and II. Various research studies reported that the disease is not confined to the respiratory system but also leads to neurological and neuropsychiatric disorders suggesting that the virus is potent to affect the central nervous system (CNS). Moreover, the damage to CNS may continue to rise even after the COVID-19 infection subsides which","2021","07","12","J Alzheimers Dis","Journal of Alzheimer's disease : JAD","Brain; COVID-19; cognition; gamma-aminobutyric acid; glutathione; magnetic resonance spectroscopy; mental health; psychiatry","Joon","Shallu","Neuroimaging and Neurospectroscopy (NINS) Laboratory, National Brain Research Centre, Gurgaon, India",NA
"711","34250939","10.3233/JAD-210287","Brain Stress Mapping in COVID-19 Survivors Using MR Spectroscopy: New Avenue of Mental Health Status Monitoring.","Coronavirus (COVID-19) has emerged as a human catastrophe worldwide, and it has impacted human life more detrimentally than the combined effect of World Wars I and II. Various research studies reported that the disease is not confined to the respiratory system but also leads to neurological and neuropsychiatric disorders suggesting that the virus is potent to affect the central nervous system (CNS). Moreover, the damage to CNS may continue to rise even after the COVID-19 infection subsides which","2021","07","12","J Alzheimers Dis","Journal of Alzheimer's disease : JAD","Brain; COVID-19; cognition; gamma-aminobutyric acid; glutathione; magnetic resonance spectroscopy; mental health; psychiatry","Sandal","Kanika","Neuroimaging and Neurospectroscopy (NINS) Laboratory, National Brain Research Centre, Gurgaon, India",NA
"712","34250939","10.3233/JAD-210287","Brain Stress Mapping in COVID-19 Survivors Using MR Spectroscopy: New Avenue of Mental Health Status Monitoring.","Coronavirus (COVID-19) has emerged as a human catastrophe worldwide, and it has impacted human life more detrimentally than the combined effect of World Wars I and II. Various research studies reported that the disease is not confined to the respiratory system but also leads to neurological and neuropsychiatric disorders suggesting that the virus is potent to affect the central nervous system (CNS). Moreover, the damage to CNS may continue to rise even after the COVID-19 infection subsides which","2021","07","12","J Alzheimers Dis","Journal of Alzheimer's disease : JAD","Brain; COVID-19; cognition; gamma-aminobutyric acid; glutathione; magnetic resonance spectroscopy; mental health; psychiatry","Dasgupta","Tirthankar","Moner Alo, Psychiatric Clinic, Kolkata, West Bengal, India",NA
"713","34250939","10.3233/JAD-210287","Brain Stress Mapping in COVID-19 Survivors Using MR Spectroscopy: New Avenue of Mental Health Status Monitoring.","Coronavirus (COVID-19) has emerged as a human catastrophe worldwide, and it has impacted human life more detrimentally than the combined effect of World Wars I and II. Various research studies reported that the disease is not confined to the respiratory system but also leads to neurological and neuropsychiatric disorders suggesting that the virus is potent to affect the central nervous system (CNS). Moreover, the damage to CNS may continue to rise even after the COVID-19 infection subsides which","2021","07","12","J Alzheimers Dis","Journal of Alzheimer's disease : JAD","Brain; COVID-19; cognition; gamma-aminobutyric acid; glutathione; magnetic resonance spectroscopy; mental health; psychiatry","Sharma","Pooja","Medanta Institute of Education and Research, Medicity, Gurgaon, India",NA
"714","34250939","10.3233/JAD-210287","Brain Stress Mapping in COVID-19 Survivors Using MR Spectroscopy: New Avenue of Mental Health Status Monitoring.","Coronavirus (COVID-19) has emerged as a human catastrophe worldwide, and it has impacted human life more detrimentally than the combined effect of World Wars I and II. Various research studies reported that the disease is not confined to the respiratory system but also leads to neurological and neuropsychiatric disorders suggesting that the virus is potent to affect the central nervous system (CNS). Moreover, the damage to CNS may continue to rise even after the COVID-19 infection subsides which","2021","07","12","J Alzheimers Dis","Journal of Alzheimer's disease : JAD","Brain; COVID-19; cognition; gamma-aminobutyric acid; glutathione; magnetic resonance spectroscopy; mental health; psychiatry","Mandal","Pravat K","Neuroimaging and Neurospectroscopy (NINS) Laboratory, National Brain Research Centre, Gurgaon, India",NA
"715","34250914","10.3233/THC-212921","Clinical characteristics and outcomes of COVID-19 long-term nucleic acid positive patients.","This study aimed to investigate the clinical characteristics and outcomes of coronavirus disease-19 (COVID-19) long-term nucleic acid positive patients (hereinafter referred to as CLTAPs). Patients were recruited from the Xiaogan Central Hospital between 16 January 2020 and 28 March 2020. Among the 562 cases of patients with laboratory-identified COVID-19 infection by real-time polymerase chain reaction (qtPCR), 19 cases of COVID-19 patients with more than 41 days from the first to the last time","2021","07","12","Technol Health Care","Technology and health care : official journal of the European Society for Engineering and Medicine","CLTAPs; COVID-19; CT characteristics; clinical features; coronavirus","Zhu","Xuan","Medical College of Wuhan University of Science and Technology, Wuhan, Hubei 430071, China",NA
"716","34250914","10.3233/THC-212921","Clinical characteristics and outcomes of COVID-19 long-term nucleic acid positive patients.","This study aimed to investigate the clinical characteristics and outcomes of coronavirus disease-19 (COVID-19) long-term nucleic acid positive patients (hereinafter referred to as CLTAPs). Patients were recruited from the Xiaogan Central Hospital between 16 January 2020 and 28 March 2020. Among the 562 cases of patients with laboratory-identified COVID-19 infection by real-time polymerase chain reaction (qtPCR), 19 cases of COVID-19 patients with more than 41 days from the first to the last time","2021","07","12","Technol Health Care","Technology and health care : official journal of the European Society for Engineering and Medicine","CLTAPs; COVID-19; CT characteristics; clinical features; coronavirus","Zhu","Xinxin","Medical College of Wuhan University of Science and Technology, Wuhan, Hubei 430071, China",NA
"717","34250914","10.3233/THC-212921","Clinical characteristics and outcomes of COVID-19 long-term nucleic acid positive patients.","This study aimed to investigate the clinical characteristics and outcomes of coronavirus disease-19 (COVID-19) long-term nucleic acid positive patients (hereinafter referred to as CLTAPs). Patients were recruited from the Xiaogan Central Hospital between 16 January 2020 and 28 March 2020. Among the 562 cases of patients with laboratory-identified COVID-19 infection by real-time polymerase chain reaction (qtPCR), 19 cases of COVID-19 patients with more than 41 days from the first to the last time","2021","07","12","Technol Health Care","Technology and health care : official journal of the European Society for Engineering and Medicine","CLTAPs; COVID-19; CT characteristics; clinical features; coronavirus","Wang","Min","Medical College of Wuhan University of Science and Technology, Wuhan, Hubei 430071, China",NA
"718","34250914","10.3233/THC-212921","Clinical characteristics and outcomes of COVID-19 long-term nucleic acid positive patients.","This study aimed to investigate the clinical characteristics and outcomes of coronavirus disease-19 (COVID-19) long-term nucleic acid positive patients (hereinafter referred to as CLTAPs). Patients were recruited from the Xiaogan Central Hospital between 16 January 2020 and 28 March 2020. Among the 562 cases of patients with laboratory-identified COVID-19 infection by real-time polymerase chain reaction (qtPCR), 19 cases of COVID-19 patients with more than 41 days from the first to the last time","2021","07","12","Technol Health Care","Technology and health care : official journal of the European Society for Engineering and Medicine","CLTAPs; COVID-19; CT characteristics; clinical features; coronavirus","Yang","Fang","Medical College of Wuhan University of Science and Technology, Wuhan, Hubei 430071, China",NA
"719","34250914","10.3233/THC-212921","Clinical characteristics and outcomes of COVID-19 long-term nucleic acid positive patients.","This study aimed to investigate the clinical characteristics and outcomes of coronavirus disease-19 (COVID-19) long-term nucleic acid positive patients (hereinafter referred to as CLTAPs). Patients were recruited from the Xiaogan Central Hospital between 16 January 2020 and 28 March 2020. Among the 562 cases of patients with laboratory-identified COVID-19 infection by real-time polymerase chain reaction (qtPCR), 19 cases of COVID-19 patients with more than 41 days from the first to the last time","2021","07","12","Technol Health Care","Technology and health care : official journal of the European Society for Engineering and Medicine","CLTAPs; COVID-19; CT characteristics; clinical features; coronavirus","Sun","Zhibing","Department of Internal Medicine, Xiaogan Hospital Affiliated to Wuhan University of Science and Technology, The Central Hospital of Xiaogan, Xiaogan, Hubei 432000, China",NA
"720","34250914","10.3233/THC-212921","Clinical characteristics and outcomes of COVID-19 long-term nucleic acid positive patients.","This study aimed to investigate the clinical characteristics and outcomes of coronavirus disease-19 (COVID-19) long-term nucleic acid positive patients (hereinafter referred to as CLTAPs). Patients were recruited from the Xiaogan Central Hospital between 16 January 2020 and 28 March 2020. Among the 562 cases of patients with laboratory-identified COVID-19 infection by real-time polymerase chain reaction (qtPCR), 19 cases of COVID-19 patients with more than 41 days from the first to the last time","2021","07","12","Technol Health Care","Technology and health care : official journal of the European Society for Engineering and Medicine","CLTAPs; COVID-19; CT characteristics; clinical features; coronavirus","Yang","Xiaohong","Department of Infectious Diseases, Xiaogan Hospital Affiliated to Wuhan University of Science and Technology, The Central Hospital of Xiaogan, Xiaogan, Hubei 432000, China",NA
"721","34250914","10.3233/THC-212921","Clinical characteristics and outcomes of COVID-19 long-term nucleic acid positive patients.","This study aimed to investigate the clinical characteristics and outcomes of coronavirus disease-19 (COVID-19) long-term nucleic acid positive patients (hereinafter referred to as CLTAPs). Patients were recruited from the Xiaogan Central Hospital between 16 January 2020 and 28 March 2020. Among the 562 cases of patients with laboratory-identified COVID-19 infection by real-time polymerase chain reaction (qtPCR), 19 cases of COVID-19 patients with more than 41 days from the first to the last time","2021","07","12","Technol Health Care","Technology and health care : official journal of the European Society for Engineering and Medicine","CLTAPs; COVID-19; CT characteristics; clinical features; coronavirus","Yan","Yimin","Medical College of Wuhan University of Science and Technology, Wuhan, Hubei 430071, China",NA
"722","34250907","10.7554/eLife.64683","Ct threshold values, a proxy for viral load in community SARS-CoV-2 cases, demonstrate wide variation across populations and over time.","Information on SARS-CoV-2 in representative community surveillance is limited, particularly cycle threshold (Ct) values (a proxy for viral load). We included all positive nose and throat swabs 26 April 2020 to 13 March 2021 from the UK's national COVID-19 Infection Survey, tested by RT-PCR for the N, S, and ORF1ab genes. We investigated predictors of median Ct value using quantile regression. Of 3,312,159 nose and throat swabs, 27,902 (0.83%) were RT-PCR-positive, 10,317 (37%), 11,012 (40%), and","2021","07","22","Elife","eLife","SARS-CoV-2; community; infectious disease; medicine; microbiology; symptoms; viral load; COVID-19; COVID-19 Testing; Humans; SARS-CoV-2; Viral Load","Walker","A Sarah","Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom",NA
"723","34250907","10.7554/eLife.64683","Ct threshold values, a proxy for viral load in community SARS-CoV-2 cases, demonstrate wide variation across populations and over time.","Information on SARS-CoV-2 in representative community surveillance is limited, particularly cycle threshold (Ct) values (a proxy for viral load). We included all positive nose and throat swabs 26 April 2020 to 13 March 2021 from the UK's national COVID-19 Infection Survey, tested by RT-PCR for the N, S, and ORF1ab genes. We investigated predictors of median Ct value using quantile regression. Of 3,312,159 nose and throat swabs, 27,902 (0.83%) were RT-PCR-positive, 10,317 (37%), 11,012 (40%), and","2021","07","22","Elife","eLife","SARS-CoV-2; community; infectious disease; medicine; microbiology; symptoms; viral load; COVID-19; COVID-19 Testing; Humans; SARS-CoV-2; Viral Load","Pritchard","Emma","Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom",NA
"724","34250907","10.7554/eLife.64683","Ct threshold values, a proxy for viral load in community SARS-CoV-2 cases, demonstrate wide variation across populations and over time.","Information on SARS-CoV-2 in representative community surveillance is limited, particularly cycle threshold (Ct) values (a proxy for viral load). We included all positive nose and throat swabs 26 April 2020 to 13 March 2021 from the UK's national COVID-19 Infection Survey, tested by RT-PCR for the N, S, and ORF1ab genes. We investigated predictors of median Ct value using quantile regression. Of 3,312,159 nose and throat swabs, 27,902 (0.83%) were RT-PCR-positive, 10,317 (37%), 11,012 (40%), and","2021","07","22","Elife","eLife","SARS-CoV-2; community; infectious disease; medicine; microbiology; symptoms; viral load; COVID-19; COVID-19 Testing; Humans; SARS-CoV-2; Viral Load","House","Thomas","Department of Mathematics, University of Manchester, Manchester, United Kingdom",NA
"725","34250907","10.7554/eLife.64683","Ct threshold values, a proxy for viral load in community SARS-CoV-2 cases, demonstrate wide variation across populations and over time.","Information on SARS-CoV-2 in representative community surveillance is limited, particularly cycle threshold (Ct) values (a proxy for viral load). We included all positive nose and throat swabs 26 April 2020 to 13 March 2021 from the UK's national COVID-19 Infection Survey, tested by RT-PCR for the N, S, and ORF1ab genes. We investigated predictors of median Ct value using quantile regression. Of 3,312,159 nose and throat swabs, 27,902 (0.83%) were RT-PCR-positive, 10,317 (37%), 11,012 (40%), and","2021","07","22","Elife","eLife","SARS-CoV-2; community; infectious disease; medicine; microbiology; symptoms; viral load; COVID-19; COVID-19 Testing; Humans; SARS-CoV-2; Viral Load","Robotham","Julie V","The National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford, Oxford, United Kingdom",NA
"726","34250907","10.7554/eLife.64683","Ct threshold values, a proxy for viral load in community SARS-CoV-2 cases, demonstrate wide variation across populations and over time.","Information on SARS-CoV-2 in representative community surveillance is limited, particularly cycle threshold (Ct) values (a proxy for viral load). We included all positive nose and throat swabs 26 April 2020 to 13 March 2021 from the UK's national COVID-19 Infection Survey, tested by RT-PCR for the N, S, and ORF1ab genes. We investigated predictors of median Ct value using quantile regression. Of 3,312,159 nose and throat swabs, 27,902 (0.83%) were RT-PCR-positive, 10,317 (37%), 11,012 (40%), and","2021","07","22","Elife","eLife","SARS-CoV-2; community; infectious disease; medicine; microbiology; symptoms; viral load; COVID-19; COVID-19 Testing; Humans; SARS-CoV-2; Viral Load","Birrell","Paul J","National Infection Service, Public Health England, London, United Kingdom",NA
"727","34250907","10.7554/eLife.64683","Ct threshold values, a proxy for viral load in community SARS-CoV-2 cases, demonstrate wide variation across populations and over time.","Information on SARS-CoV-2 in representative community surveillance is limited, particularly cycle threshold (Ct) values (a proxy for viral load). We included all positive nose and throat swabs 26 April 2020 to 13 March 2021 from the UK's national COVID-19 Infection Survey, tested by RT-PCR for the N, S, and ORF1ab genes. We investigated predictors of median Ct value using quantile regression. Of 3,312,159 nose and throat swabs, 27,902 (0.83%) were RT-PCR-positive, 10,317 (37%), 11,012 (40%), and","2021","07","22","Elife","eLife","SARS-CoV-2; community; infectious disease; medicine; microbiology; symptoms; viral load; COVID-19; COVID-19 Testing; Humans; SARS-CoV-2; Viral Load","Bell","Iain","Office for National Statistics, Newport, United Kingdom",NA
"728","34250907","10.7554/eLife.64683","Ct threshold values, a proxy for viral load in community SARS-CoV-2 cases, demonstrate wide variation across populations and over time.","Information on SARS-CoV-2 in representative community surveillance is limited, particularly cycle threshold (Ct) values (a proxy for viral load). We included all positive nose and throat swabs 26 April 2020 to 13 March 2021 from the UK's national COVID-19 Infection Survey, tested by RT-PCR for the N, S, and ORF1ab genes. We investigated predictors of median Ct value using quantile regression. Of 3,312,159 nose and throat swabs, 27,902 (0.83%) were RT-PCR-positive, 10,317 (37%), 11,012 (40%), and","2021","07","22","Elife","eLife","SARS-CoV-2; community; infectious disease; medicine; microbiology; symptoms; viral load; COVID-19; COVID-19 Testing; Humans; SARS-CoV-2; Viral Load","Bell","John I","Office of the Regius Professor of Medicine, University of Oxford, Oxford, United Kingdom",NA
"729","34250907","10.7554/eLife.64683","Ct threshold values, a proxy for viral load in community SARS-CoV-2 cases, demonstrate wide variation across populations and over time.","Information on SARS-CoV-2 in representative community surveillance is limited, particularly cycle threshold (Ct) values (a proxy for viral load). We included all positive nose and throat swabs 26 April 2020 to 13 March 2021 from the UK's national COVID-19 Infection Survey, tested by RT-PCR for the N, S, and ORF1ab genes. We investigated predictors of median Ct value using quantile regression. Of 3,312,159 nose and throat swabs, 27,902 (0.83%) were RT-PCR-positive, 10,317 (37%), 11,012 (40%), and","2021","07","22","Elife","eLife","SARS-CoV-2; community; infectious disease; medicine; microbiology; symptoms; viral load; COVID-19; COVID-19 Testing; Humans; SARS-CoV-2; Viral Load","Newton","John N","Health Improvement Directorate, Public Health England, London, United Kingdom",NA
"730","34250907","10.7554/eLife.64683","Ct threshold values, a proxy for viral load in community SARS-CoV-2 cases, demonstrate wide variation across populations and over time.","Information on SARS-CoV-2 in representative community surveillance is limited, particularly cycle threshold (Ct) values (a proxy for viral load). We included all positive nose and throat swabs 26 April 2020 to 13 March 2021 from the UK's national COVID-19 Infection Survey, tested by RT-PCR for the N, S, and ORF1ab genes. We investigated predictors of median Ct value using quantile regression. Of 3,312,159 nose and throat swabs, 27,902 (0.83%) were RT-PCR-positive, 10,317 (37%), 11,012 (40%), and","2021","07","22","Elife","eLife","SARS-CoV-2; community; infectious disease; medicine; microbiology; symptoms; viral load; COVID-19; COVID-19 Testing; Humans; SARS-CoV-2; Viral Load","Farrar","Jeremy","Wellcome Trust, London, United Kingdom",NA
"731","34250907","10.7554/eLife.64683","Ct threshold values, a proxy for viral load in community SARS-CoV-2 cases, demonstrate wide variation across populations and over time.","Information on SARS-CoV-2 in representative community surveillance is limited, particularly cycle threshold (Ct) values (a proxy for viral load). We included all positive nose and throat swabs 26 April 2020 to 13 March 2021 from the UK's national COVID-19 Infection Survey, tested by RT-PCR for the N, S, and ORF1ab genes. We investigated predictors of median Ct value using quantile regression. Of 3,312,159 nose and throat swabs, 27,902 (0.83%) were RT-PCR-positive, 10,317 (37%), 11,012 (40%), and","2021","07","22","Elife","eLife","SARS-CoV-2; community; infectious disease; medicine; microbiology; symptoms; viral load; COVID-19; COVID-19 Testing; Humans; SARS-CoV-2; Viral Load","Diamond","Ian","Office for National Statistics, Newport, United Kingdom",NA
"732","34250907","10.7554/eLife.64683","Ct threshold values, a proxy for viral load in community SARS-CoV-2 cases, demonstrate wide variation across populations and over time.","Information on SARS-CoV-2 in representative community surveillance is limited, particularly cycle threshold (Ct) values (a proxy for viral load). We included all positive nose and throat swabs 26 April 2020 to 13 March 2021 from the UK's national COVID-19 Infection Survey, tested by RT-PCR for the N, S, and ORF1ab genes. We investigated predictors of median Ct value using quantile regression. Of 3,312,159 nose and throat swabs, 27,902 (0.83%) were RT-PCR-positive, 10,317 (37%), 11,012 (40%), and","2021","07","22","Elife","eLife","SARS-CoV-2; community; infectious disease; medicine; microbiology; symptoms; viral load; COVID-19; COVID-19 Testing; Humans; SARS-CoV-2; Viral Load","Studley","Ruth","Office for National Statistics, Newport, United Kingdom",NA
"733","34250907","10.7554/eLife.64683","Ct threshold values, a proxy for viral load in community SARS-CoV-2 cases, demonstrate wide variation across populations and over time.","Information on SARS-CoV-2 in representative community surveillance is limited, particularly cycle threshold (Ct) values (a proxy for viral load). We included all positive nose and throat swabs 26 April 2020 to 13 March 2021 from the UK's national COVID-19 Infection Survey, tested by RT-PCR for the N, S, and ORF1ab genes. We investigated predictors of median Ct value using quantile regression. Of 3,312,159 nose and throat swabs, 27,902 (0.83%) were RT-PCR-positive, 10,317 (37%), 11,012 (40%), and","2021","07","22","Elife","eLife","SARS-CoV-2; community; infectious disease; medicine; microbiology; symptoms; viral load; COVID-19; COVID-19 Testing; Humans; SARS-CoV-2; Viral Load","Hay","Jodie","University of Glasgow, Glasgow, United Kingdom",NA
"734","34250907","10.7554/eLife.64683","Ct threshold values, a proxy for viral load in community SARS-CoV-2 cases, demonstrate wide variation across populations and over time.","Information on SARS-CoV-2 in representative community surveillance is limited, particularly cycle threshold (Ct) values (a proxy for viral load). We included all positive nose and throat swabs 26 April 2020 to 13 March 2021 from the UK's national COVID-19 Infection Survey, tested by RT-PCR for the N, S, and ORF1ab genes. We investigated predictors of median Ct value using quantile regression. Of 3,312,159 nose and throat swabs, 27,902 (0.83%) were RT-PCR-positive, 10,317 (37%), 11,012 (40%), and","2021","07","22","Elife","eLife","SARS-CoV-2; community; infectious disease; medicine; microbiology; symptoms; viral load; COVID-19; COVID-19 Testing; Humans; SARS-CoV-2; Viral Load","Vihta","Karina-Doris","Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom",NA
"735","34250907","10.7554/eLife.64683","Ct threshold values, a proxy for viral load in community SARS-CoV-2 cases, demonstrate wide variation across populations and over time.","Information on SARS-CoV-2 in representative community surveillance is limited, particularly cycle threshold (Ct) values (a proxy for viral load). We included all positive nose and throat swabs 26 April 2020 to 13 March 2021 from the UK's national COVID-19 Infection Survey, tested by RT-PCR for the N, S, and ORF1ab genes. We investigated predictors of median Ct value using quantile regression. Of 3,312,159 nose and throat swabs, 27,902 (0.83%) were RT-PCR-positive, 10,317 (37%), 11,012 (40%), and","2021","07","22","Elife","eLife","SARS-CoV-2; community; infectious disease; medicine; microbiology; symptoms; viral load; COVID-19; COVID-19 Testing; Humans; SARS-CoV-2; Viral Load","Peto","Timothy Ea","Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom",NA
"736","34250907","10.7554/eLife.64683","Ct threshold values, a proxy for viral load in community SARS-CoV-2 cases, demonstrate wide variation across populations and over time.","Information on SARS-CoV-2 in representative community surveillance is limited, particularly cycle threshold (Ct) values (a proxy for viral load). We included all positive nose and throat swabs 26 April 2020 to 13 March 2021 from the UK's national COVID-19 Infection Survey, tested by RT-PCR for the N, S, and ORF1ab genes. We investigated predictors of median Ct value using quantile regression. Of 3,312,159 nose and throat swabs, 27,902 (0.83%) were RT-PCR-positive, 10,317 (37%), 11,012 (40%), and","2021","07","22","Elife","eLife","SARS-CoV-2; community; infectious disease; medicine; microbiology; symptoms; viral load; COVID-19; COVID-19 Testing; Humans; SARS-CoV-2; Viral Load","Stoesser","Nicole","Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom",NA
"737","34250907","10.7554/eLife.64683","Ct threshold values, a proxy for viral load in community SARS-CoV-2 cases, demonstrate wide variation across populations and over time.","Information on SARS-CoV-2 in representative community surveillance is limited, particularly cycle threshold (Ct) values (a proxy for viral load). We included all positive nose and throat swabs 26 April 2020 to 13 March 2021 from the UK's national COVID-19 Infection Survey, tested by RT-PCR for the N, S, and ORF1ab genes. We investigated predictors of median Ct value using quantile regression. Of 3,312,159 nose and throat swabs, 27,902 (0.83%) were RT-PCR-positive, 10,317 (37%), 11,012 (40%), and","2021","07","22","Elife","eLife","SARS-CoV-2; community; infectious disease; medicine; microbiology; symptoms; viral load; COVID-19; COVID-19 Testing; Humans; SARS-CoV-2; Viral Load","Matthews","Philippa C","Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom",NA
"738","34250907","10.7554/eLife.64683","Ct threshold values, a proxy for viral load in community SARS-CoV-2 cases, demonstrate wide variation across populations and over time.","Information on SARS-CoV-2 in representative community surveillance is limited, particularly cycle threshold (Ct) values (a proxy for viral load). We included all positive nose and throat swabs 26 April 2020 to 13 March 2021 from the UK's national COVID-19 Infection Survey, tested by RT-PCR for the N, S, and ORF1ab genes. We investigated predictors of median Ct value using quantile regression. Of 3,312,159 nose and throat swabs, 27,902 (0.83%) were RT-PCR-positive, 10,317 (37%), 11,012 (40%), and","2021","07","22","Elife","eLife","SARS-CoV-2; community; infectious disease; medicine; microbiology; symptoms; viral load; COVID-19; COVID-19 Testing; Humans; SARS-CoV-2; Viral Load","Eyre","David W","Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom",NA
"739","34250907","10.7554/eLife.64683","Ct threshold values, a proxy for viral load in community SARS-CoV-2 cases, demonstrate wide variation across populations and over time.","Information on SARS-CoV-2 in representative community surveillance is limited, particularly cycle threshold (Ct) values (a proxy for viral load). We included all positive nose and throat swabs 26 April 2020 to 13 March 2021 from the UK's national COVID-19 Infection Survey, tested by RT-PCR for the N, S, and ORF1ab genes. We investigated predictors of median Ct value using quantile regression. Of 3,312,159 nose and throat swabs, 27,902 (0.83%) were RT-PCR-positive, 10,317 (37%), 11,012 (40%), and","2021","07","22","Elife","eLife","SARS-CoV-2; community; infectious disease; medicine; microbiology; symptoms; viral load; COVID-19; COVID-19 Testing; Humans; SARS-CoV-2; Viral Load","Pouwels","Koen B","Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom",NA
"740","34250894","10.3238/arztebl.m2021.0179","Oxygen Treatment In Covid-19.",NA,"2021","07","14","Dtsch Arztebl Int","Deutsches Arzteblatt international","COVID-19; Humans; Oxygen; Respiration, Artificial; SARS-CoV-2","Gottlieb","Jens",NA,NA
"741","34250894","10.3238/arztebl.m2021.0179","Oxygen Treatment In Covid-19.",NA,"2021","07","14","Dtsch Arztebl Int","Deutsches Arzteblatt international","COVID-19; Humans; Oxygen; Respiration, Artificial; SARS-CoV-2","Volk","Thomas",NA,NA
"742","34250894","10.3238/arztebl.m2021.0179","Oxygen Treatment In Covid-19.",NA,"2021","07","14","Dtsch Arztebl Int","Deutsches Arzteblatt international","COVID-19; Humans; Oxygen; Respiration, Artificial; SARS-CoV-2","Fühner","Thomas",NA,NA
"743","34250890","10.1017/dmp.2021.219","Rapid Assessment of COVID-19 Screening Program for Travelers in Iran: A Qualitative Study.","COVID-19 screening stations set up by Iranian Red Crescent Society have been available for seventeen days with the aim of identifying and treating people with coronavirus, reducing road trips, and sensitizing people to the problem. This study aims to investigate the challenges of the procedure. A qualitative study was used to find the challenges of the COVID-19 screening centers. Volunteers, branch managers, and headquarter managers of the Iranian Red Crescent Society participated in this study ","2021","07","12","Disaster Med Public Health Prep","Disaster medicine and public health preparedness","Ethics; Humanitarian response; Logistic; Mental health; Volunteering","Seddighi","Hamed","Student Research Committee, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran, Postal Address: Kodakyar Ave., Daneshjou Blvd., Thern, Email Address: hseddighi@gmail.com, Phone: +98 35 3821 35 99","hseddighi@gmail.com"
"744","34250890","10.1017/dmp.2021.219","Rapid Assessment of COVID-19 Screening Program for Travelers in Iran: A Qualitative Study.","COVID-19 screening stations set up by Iranian Red Crescent Society have been available for seventeen days with the aim of identifying and treating people with coronavirus, reducing road trips, and sensitizing people to the problem. This study aims to investigate the challenges of the procedure. A qualitative study was used to find the challenges of the COVID-19 screening centers. Volunteers, branch managers, and headquarter managers of the Iranian Red Crescent Society participated in this study ","2021","07","12","Disaster Med Public Health Prep","Disaster medicine and public health preparedness","Ethics; Humanitarian response; Logistic; Mental health; Volunteering","Salmani","Ibrahim","Department of Health in Disaster and Emergency, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran, e.salmani.n@gmail","e.salmani.n@gmail.com"
"745","34250890","10.1017/dmp.2021.219","Rapid Assessment of COVID-19 Screening Program for Travelers in Iran: A Qualitative Study.","COVID-19 screening stations set up by Iranian Red Crescent Society have been available for seventeen days with the aim of identifying and treating people with coronavirus, reducing road trips, and sensitizing people to the problem. This study aims to investigate the challenges of the procedure. A qualitative study was used to find the challenges of the COVID-19 screening centers. Volunteers, branch managers, and headquarter managers of the Iranian Red Crescent Society participated in this study ","2021","07","12","Disaster Med Public Health Prep","Disaster medicine and public health preparedness","Ethics; Humanitarian response; Logistic; Mental health; Volunteering","Baharmand","Hossein","Department of ICT, University of Agder, 4879 Grimstad, Norway, Email address: hossein.baharmand@uia","hossein.baharmand@uia.no"
"746","34250890","10.1017/dmp.2021.219","Rapid Assessment of COVID-19 Screening Program for Travelers in Iran: A Qualitative Study.","COVID-19 screening stations set up by Iranian Red Crescent Society have been available for seventeen days with the aim of identifying and treating people with coronavirus, reducing road trips, and sensitizing people to the problem. This study aims to investigate the challenges of the procedure. A qualitative study was used to find the challenges of the COVID-19 screening centers. Volunteers, branch managers, and headquarter managers of the Iranian Red Crescent Society participated in this study ","2021","07","12","Disaster Med Public Health Prep","Disaster medicine and public health preparedness","Ethics; Humanitarian response; Logistic; Mental health; Volunteering","Seddighi","Saeideh","Social Science Department, Tehran University, Tehran, Iran, Saeideh.seddighi@gmail","Saeideh.seddighi@gmail.com"
"747","34250890","10.1017/dmp.2021.219","Rapid Assessment of COVID-19 Screening Program for Travelers in Iran: A Qualitative Study.","COVID-19 screening stations set up by Iranian Red Crescent Society have been available for seventeen days with the aim of identifying and treating people with coronavirus, reducing road trips, and sensitizing people to the problem. This study aims to investigate the challenges of the procedure. A qualitative study was used to find the challenges of the COVID-19 screening centers. Volunteers, branch managers, and headquarter managers of the Iranian Red Crescent Society participated in this study ","2021","07","12","Disaster Med Public Health Prep","Disaster medicine and public health preparedness","Ethics; Humanitarian response; Logistic; Mental health; Volunteering","Sharifi Sedeh","Mehrab","School of Public Health, Tehran University of Medical Science (TUMS), Iranmehrabsharifi@gmail","Iranmehrabsharifi@gmail.com"
"748","34250888","10.1017/dmp.2021.218","Protection and Response of a Tertiary Hospital in Shenzhen, China to the COVID-19 Outbreak-the Practice of the Comprehensive Response Mode.","To evaluate the management mode for the prevention and control of coronavirus 2019 (COVID-19) transmission utilized at a general hospital in Shenzhen, China, with the aim to maintain the normal operation of the hospital. From January 2, 2020 to April 23, 2020, Hong Kong-Shenzhen Hospital, a tertiary hospital in Shenzhen, has operated a special response protocol named comprehensive pandemic prevention and control model, which mainly includes six aspects: 1) human resource management; 2) equipment","2021","07","12","Disaster Med Public Health Prep","Disaster medicine and public health preparedness","COVID-19; General hospital; Novel coronavirus pneumonia; Prevention and control measures","Hu","Benling","Breast Surgery, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China",NA
"749","34250888","10.1017/dmp.2021.218","Protection and Response of a Tertiary Hospital in Shenzhen, China to the COVID-19 Outbreak-the Practice of the Comprehensive Response Mode.","To evaluate the management mode for the prevention and control of coronavirus 2019 (COVID-19) transmission utilized at a general hospital in Shenzhen, China, with the aim to maintain the normal operation of the hospital. From January 2, 2020 to April 23, 2020, Hong Kong-Shenzhen Hospital, a tertiary hospital in Shenzhen, has operated a special response protocol named comprehensive pandemic prevention and control model, which mainly includes six aspects: 1) human resource management; 2) equipment","2021","07","12","Disaster Med Public Health Prep","Disaster medicine and public health preparedness","COVID-19; General hospital; Novel coronavirus pneumonia; Prevention and control measures","Yang","Le","Emergency Department, Shenzhen University General Hospital, Shenzhen, China",NA
"750","34250888","10.1017/dmp.2021.218","Protection and Response of a Tertiary Hospital in Shenzhen, China to the COVID-19 Outbreak-the Practice of the Comprehensive Response Mode.","To evaluate the management mode for the prevention and control of coronavirus 2019 (COVID-19) transmission utilized at a general hospital in Shenzhen, China, with the aim to maintain the normal operation of the hospital. From January 2, 2020 to April 23, 2020, Hong Kong-Shenzhen Hospital, a tertiary hospital in Shenzhen, has operated a special response protocol named comprehensive pandemic prevention and control model, which mainly includes six aspects: 1) human resource management; 2) equipment","2021","07","12","Disaster Med Public Health Prep","Disaster medicine and public health preparedness","COVID-19; General hospital; Novel coronavirus pneumonia; Prevention and control measures","Wei","Chan","Breast Surgery, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China",NA
"751","34250888","10.1017/dmp.2021.218","Protection and Response of a Tertiary Hospital in Shenzhen, China to the COVID-19 Outbreak-the Practice of the Comprehensive Response Mode.","To evaluate the management mode for the prevention and control of coronavirus 2019 (COVID-19) transmission utilized at a general hospital in Shenzhen, China, with the aim to maintain the normal operation of the hospital. From January 2, 2020 to April 23, 2020, Hong Kong-Shenzhen Hospital, a tertiary hospital in Shenzhen, has operated a special response protocol named comprehensive pandemic prevention and control model, which mainly includes six aspects: 1) human resource management; 2) equipment","2021","07","12","Disaster Med Public Health Prep","Disaster medicine and public health preparedness","COVID-19; General hospital; Novel coronavirus pneumonia; Prevention and control measures","Luo","Min","Breast Surgery, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China",NA
"752","34250882","10.1017/ice.2021.313","COVID-19 Incidence After Exposures in Shared Patient Rooms, Tertiary Care Center, Iowa, July 2020-May 2021.","The incidence of COVID-19 exposures in shared patient rooms was low at our institution: 1.8/1,000 shared room patient-days. However, the secondary attack rate (21.6%) was comparable to that reported in household exposures. Lengthier exposures were associated with COVID-19 conversion. Hospitals should implement measures to decrease shared room exposures.","2021","07","12","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology","COVID-19; healthcare-associated infection; shared patient rooms","Trannel","Alexandra","University of Iowa Hospitals &amp",NA
"753","34250882","10.1017/ice.2021.313","COVID-19 Incidence After Exposures in Shared Patient Rooms, Tertiary Care Center, Iowa, July 2020-May 2021.","The incidence of COVID-19 exposures in shared patient rooms was low at our institution: 1.8/1,000 shared room patient-days. However, the secondary attack rate (21.6%) was comparable to that reported in household exposures. Lengthier exposures were associated with COVID-19 conversion. Hospitals should implement measures to decrease shared room exposures.","2021","07","12","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology","COVID-19; healthcare-associated infection; shared patient rooms","Kobayashi","Takaaki","University of Iowa Hospitals &amp",NA
"754","34250882","10.1017/ice.2021.313","COVID-19 Incidence After Exposures in Shared Patient Rooms, Tertiary Care Center, Iowa, July 2020-May 2021.","The incidence of COVID-19 exposures in shared patient rooms was low at our institution: 1.8/1,000 shared room patient-days. However, the secondary attack rate (21.6%) was comparable to that reported in household exposures. Lengthier exposures were associated with COVID-19 conversion. Hospitals should implement measures to decrease shared room exposures.","2021","07","12","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology","COVID-19; healthcare-associated infection; shared patient rooms","Dains","Angelique","University of Iowa Hospitals &amp",NA
"755","34250882","10.1017/ice.2021.313","COVID-19 Incidence After Exposures in Shared Patient Rooms, Tertiary Care Center, Iowa, July 2020-May 2021.","The incidence of COVID-19 exposures in shared patient rooms was low at our institution: 1.8/1,000 shared room patient-days. However, the secondary attack rate (21.6%) was comparable to that reported in household exposures. Lengthier exposures were associated with COVID-19 conversion. Hospitals should implement measures to decrease shared room exposures.","2021","07","12","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology","COVID-19; healthcare-associated infection; shared patient rooms","Abosi","Oluchi J","University of Iowa Hospitals &amp",NA
"756","34250882","10.1017/ice.2021.313","COVID-19 Incidence After Exposures in Shared Patient Rooms, Tertiary Care Center, Iowa, July 2020-May 2021.","The incidence of COVID-19 exposures in shared patient rooms was low at our institution: 1.8/1,000 shared room patient-days. However, the secondary attack rate (21.6%) was comparable to that reported in household exposures. Lengthier exposures were associated with COVID-19 conversion. Hospitals should implement measures to decrease shared room exposures.","2021","07","12","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology","COVID-19; healthcare-associated infection; shared patient rooms","Jenn","Kyle E","University of Iowa Hospitals &amp",NA
"757","34250882","10.1017/ice.2021.313","COVID-19 Incidence After Exposures in Shared Patient Rooms, Tertiary Care Center, Iowa, July 2020-May 2021.","The incidence of COVID-19 exposures in shared patient rooms was low at our institution: 1.8/1,000 shared room patient-days. However, the secondary attack rate (21.6%) was comparable to that reported in household exposures. Lengthier exposures were associated with COVID-19 conversion. Hospitals should implement measures to decrease shared room exposures.","2021","07","12","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology","COVID-19; healthcare-associated infection; shared patient rooms","Meacham","Holly","University of Iowa Hospitals &amp",NA
"758","34250882","10.1017/ice.2021.313","COVID-19 Incidence After Exposures in Shared Patient Rooms, Tertiary Care Center, Iowa, July 2020-May 2021.","The incidence of COVID-19 exposures in shared patient rooms was low at our institution: 1.8/1,000 shared room patient-days. However, the secondary attack rate (21.6%) was comparable to that reported in household exposures. Lengthier exposures were associated with COVID-19 conversion. Hospitals should implement measures to decrease shared room exposures.","2021","07","12","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology","COVID-19; healthcare-associated infection; shared patient rooms","Sheeler","Lorinda L","University of Iowa Hospitals &amp",NA
"759","34250882","10.1017/ice.2021.313","COVID-19 Incidence After Exposures in Shared Patient Rooms, Tertiary Care Center, Iowa, July 2020-May 2021.","The incidence of COVID-19 exposures in shared patient rooms was low at our institution: 1.8/1,000 shared room patient-days. However, the secondary attack rate (21.6%) was comparable to that reported in household exposures. Lengthier exposures were associated with COVID-19 conversion. Hospitals should implement measures to decrease shared room exposures.","2021","07","12","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology","COVID-19; healthcare-associated infection; shared patient rooms","Etienne","William","University of Iowa Hospitals &amp",NA
"760","34250882","10.1017/ice.2021.313","COVID-19 Incidence After Exposures in Shared Patient Rooms, Tertiary Care Center, Iowa, July 2020-May 2021.","The incidence of COVID-19 exposures in shared patient rooms was low at our institution: 1.8/1,000 shared room patient-days. However, the secondary attack rate (21.6%) was comparable to that reported in household exposures. Lengthier exposures were associated with COVID-19 conversion. Hospitals should implement measures to decrease shared room exposures.","2021","07","12","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology","COVID-19; healthcare-associated infection; shared patient rooms","Kukla","Mary E","University of Iowa Hospitals &amp",NA
"761","34250882","10.1017/ice.2021.313","COVID-19 Incidence After Exposures in Shared Patient Rooms, Tertiary Care Center, Iowa, July 2020-May 2021.","The incidence of COVID-19 exposures in shared patient rooms was low at our institution: 1.8/1,000 shared room patient-days. However, the secondary attack rate (21.6%) was comparable to that reported in household exposures. Lengthier exposures were associated with COVID-19 conversion. Hospitals should implement measures to decrease shared room exposures.","2021","07","12","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology","COVID-19; healthcare-associated infection; shared patient rooms","Alsuhaibani","Mohammed","University of Iowa Hospitals &amp",NA
"762","34250882","10.1017/ice.2021.313","COVID-19 Incidence After Exposures in Shared Patient Rooms, Tertiary Care Center, Iowa, July 2020-May 2021.","The incidence of COVID-19 exposures in shared patient rooms was low at our institution: 1.8/1,000 shared room patient-days. However, the secondary attack rate (21.6%) was comparable to that reported in household exposures. Lengthier exposures were associated with COVID-19 conversion. Hospitals should implement measures to decrease shared room exposures.","2021","07","12","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology","COVID-19; healthcare-associated infection; shared patient rooms","Holley","Stephanie","University of Iowa Hospitals &amp",NA
"763","34250882","10.1017/ice.2021.313","COVID-19 Incidence After Exposures in Shared Patient Rooms, Tertiary Care Center, Iowa, July 2020-May 2021.","The incidence of COVID-19 exposures in shared patient rooms was low at our institution: 1.8/1,000 shared room patient-days. However, the secondary attack rate (21.6%) was comparable to that reported in household exposures. Lengthier exposures were associated with COVID-19 conversion. Hospitals should implement measures to decrease shared room exposures.","2021","07","12","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology","COVID-19; healthcare-associated infection; shared patient rooms","Strandberg","Kelsey","University of Iowa Hospitals &amp",NA
"764","34250882","10.1017/ice.2021.313","COVID-19 Incidence After Exposures in Shared Patient Rooms, Tertiary Care Center, Iowa, July 2020-May 2021.","The incidence of COVID-19 exposures in shared patient rooms was low at our institution: 1.8/1,000 shared room patient-days. However, the secondary attack rate (21.6%) was comparable to that reported in household exposures. Lengthier exposures were associated with COVID-19 conversion. Hospitals should implement measures to decrease shared room exposures.","2021","07","12","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology","COVID-19; healthcare-associated infection; shared patient rooms","Marra","Alexandre R","University of Iowa Hospitals &amp",NA
"765","34250882","10.1017/ice.2021.313","COVID-19 Incidence After Exposures in Shared Patient Rooms, Tertiary Care Center, Iowa, July 2020-May 2021.","The incidence of COVID-19 exposures in shared patient rooms was low at our institution: 1.8/1,000 shared room patient-days. However, the secondary attack rate (21.6%) was comparable to that reported in household exposures. Lengthier exposures were associated with COVID-19 conversion. Hospitals should implement measures to decrease shared room exposures.","2021","07","12","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology","COVID-19; healthcare-associated infection; shared patient rooms","Kritzman","Jeffrey","University of Iowa Hospitals &amp",NA
"766","34250882","10.1017/ice.2021.313","COVID-19 Incidence After Exposures in Shared Patient Rooms, Tertiary Care Center, Iowa, July 2020-May 2021.","The incidence of COVID-19 exposures in shared patient rooms was low at our institution: 1.8/1,000 shared room patient-days. However, the secondary attack rate (21.6%) was comparable to that reported in household exposures. Lengthier exposures were associated with COVID-19 conversion. Hospitals should implement measures to decrease shared room exposures.","2021","07","12","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology","COVID-19; healthcare-associated infection; shared patient rooms","Ford","Bradley","University of Iowa Hospitals &amp",NA
"767","34250882","10.1017/ice.2021.313","COVID-19 Incidence After Exposures in Shared Patient Rooms, Tertiary Care Center, Iowa, July 2020-May 2021.","The incidence of COVID-19 exposures in shared patient rooms was low at our institution: 1.8/1,000 shared room patient-days. However, the secondary attack rate (21.6%) was comparable to that reported in household exposures. Lengthier exposures were associated with COVID-19 conversion. Hospitals should implement measures to decrease shared room exposures.","2021","07","12","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology","COVID-19; healthcare-associated infection; shared patient rooms","Wellington","Melanie","University of Iowa Hospitals &amp",NA
"768","34250882","10.1017/ice.2021.313","COVID-19 Incidence After Exposures in Shared Patient Rooms, Tertiary Care Center, Iowa, July 2020-May 2021.","The incidence of COVID-19 exposures in shared patient rooms was low at our institution: 1.8/1,000 shared room patient-days. However, the secondary attack rate (21.6%) was comparable to that reported in household exposures. Lengthier exposures were associated with COVID-19 conversion. Hospitals should implement measures to decrease shared room exposures.","2021","07","12","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology","COVID-19; healthcare-associated infection; shared patient rooms","Diekema","Daniel J","University of Iowa Hospitals &amp",NA
"769","34250882","10.1017/ice.2021.313","COVID-19 Incidence After Exposures in Shared Patient Rooms, Tertiary Care Center, Iowa, July 2020-May 2021.","The incidence of COVID-19 exposures in shared patient rooms was low at our institution: 1.8/1,000 shared room patient-days. However, the secondary attack rate (21.6%) was comparable to that reported in household exposures. Lengthier exposures were associated with COVID-19 conversion. Hospitals should implement measures to decrease shared room exposures.","2021","07","12","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology","COVID-19; healthcare-associated infection; shared patient rooms","Salinas","Jorge L","University of Iowa Hospitals &amp",NA
"770","34250877","10.1017/ice.2021.318","Airborne transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): What is the implication of hospital infection control?",NA,"2021","07","23","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Wong","Shuk-Ching","Infection Control Team, Queen Mary Hospital, Hong Kong West Cluster, Hong Kong Special Administrative Region, China",NA
"771","34250877","10.1017/ice.2021.318","Airborne transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): What is the implication of hospital infection control?",NA,"2021","07","23","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Yuen","Lithia Lai-Ha","Infection Control Team, Queen Mary Hospital, Hong Kong West Cluster, Hong Kong Special Administrative Region, China",NA
"772","34250877","10.1017/ice.2021.318","Airborne transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): What is the implication of hospital infection control?",NA,"2021","07","23","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Chan","Veronica Wing-Man","Infection Control Team, Queen Mary Hospital, Hong Kong West Cluster, Hong Kong Special Administrative Region, China",NA
"773","34250877","10.1017/ice.2021.318","Airborne transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): What is the implication of hospital infection control?",NA,"2021","07","23","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Chen","Jonathan Hon-Kwan","Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China",NA
"774","34250877","10.1017/ice.2021.318","Airborne transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): What is the implication of hospital infection control?",NA,"2021","07","23","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"To","Kelvin Kai-Wang","Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China",NA
"775","34250877","10.1017/ice.2021.318","Airborne transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): What is the implication of hospital infection control?",NA,"2021","07","23","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Yuen","Kwok-Yung","Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China",NA
"776","34250877","10.1017/ice.2021.318","Airborne transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): What is the implication of hospital infection control?",NA,"2021","07","23","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Cheng","Vincent Chi-Chung","Infection Control Team, Queen Mary Hospital, Hong Kong West Cluster, Hong Kong Special Administrative Region, China",NA
"777","34250875","10.2174/1871530321666210709164925","Insulin therapy and outcome from coronavirus disease 2019 (COVID-19): A Systematic Review, Meta-Analysis, and Meta-Regression.","Currently, the relationship between insulin therapy and COVID-19 outcome is not yet established. Our study aims to evaluate the possible association between insulin and the poor composite development of COVID-19. We systematically searched the PubMed and Europe PMC database using specific keywords related to our aims until December 12th, 2020. All articles published on COVID-19 and insulin were retrieved. Statistical analysis was done using Review Manager 5.4 and Comprehensive Meta-Analysis vers","2021","07","12","Endocr Metab Immune Disord Drug Targets","Endocrine, metabolic &amp; immune disorders drug targets","COVID-19; SARS-CoV-2; coronavirus; diabetes; insulin; medications","Hariyanto","Timotius Ivan","Faculty of Medicine, Pelita Harapan University, Boulevard Jendral Sudirman street, Karawaci, Tangerang, Indonesia",NA
"778","34250875","10.2174/1871530321666210709164925","Insulin therapy and outcome from coronavirus disease 2019 (COVID-19): A Systematic Review, Meta-Analysis, and Meta-Regression.","Currently, the relationship between insulin therapy and COVID-19 outcome is not yet established. Our study aims to evaluate the possible association between insulin and the poor composite development of COVID-19. We systematically searched the PubMed and Europe PMC database using specific keywords related to our aims until December 12th, 2020. All articles published on COVID-19 and insulin were retrieved. Statistical analysis was done using Review Manager 5.4 and Comprehensive Meta-Analysis vers","2021","07","12","Endocr Metab Immune Disord Drug Targets","Endocrine, metabolic &amp; immune disorders drug targets","COVID-19; SARS-CoV-2; coronavirus; diabetes; insulin; medications","Lugito","Nata Pratama Hardjo","Department of Internal Medicine, Faculty of Medicine, Pelita Harapan University, Boulevard Jendral Sudirman street, Karawaci, Tangerang, Indonesia",NA
"779","34250875","10.2174/1871530321666210709164925","Insulin therapy and outcome from coronavirus disease 2019 (COVID-19): A Systematic Review, Meta-Analysis, and Meta-Regression.","Currently, the relationship between insulin therapy and COVID-19 outcome is not yet established. Our study aims to evaluate the possible association between insulin and the poor composite development of COVID-19. We systematically searched the PubMed and Europe PMC database using specific keywords related to our aims until December 12th, 2020. All articles published on COVID-19 and insulin were retrieved. Statistical analysis was done using Review Manager 5.4 and Comprehensive Meta-Analysis vers","2021","07","12","Endocr Metab Immune Disord Drug Targets","Endocrine, metabolic &amp; immune disorders drug targets","COVID-19; SARS-CoV-2; coronavirus; diabetes; insulin; medications","Yanto","Theo Audi","Department of Internal Medicine, Faculty of Medicine, Pelita Harapan University, Boulevard Jendral Sudirman street, Karawaci, Tangerang, Indonesia",NA
"780","34250875","10.2174/1871530321666210709164925","Insulin therapy and outcome from coronavirus disease 2019 (COVID-19): A Systematic Review, Meta-Analysis, and Meta-Regression.","Currently, the relationship between insulin therapy and COVID-19 outcome is not yet established. Our study aims to evaluate the possible association between insulin and the poor composite development of COVID-19. We systematically searched the PubMed and Europe PMC database using specific keywords related to our aims until December 12th, 2020. All articles published on COVID-19 and insulin were retrieved. Statistical analysis was done using Review Manager 5.4 and Comprehensive Meta-Analysis vers","2021","07","12","Endocr Metab Immune Disord Drug Targets","Endocrine, metabolic &amp; immune disorders drug targets","COVID-19; SARS-CoV-2; coronavirus; diabetes; insulin; medications","Siregar","Jeremia Immanuel","Department of Internal Medicine, Faculty of Medicine, Pelita Harapan University, Boulevard Jendral Sudirman street, Karawaci, Tangerang, Indonesia",NA
"781","34250875","10.2174/1871530321666210709164925","Insulin therapy and outcome from coronavirus disease 2019 (COVID-19): A Systematic Review, Meta-Analysis, and Meta-Regression.","Currently, the relationship between insulin therapy and COVID-19 outcome is not yet established. Our study aims to evaluate the possible association between insulin and the poor composite development of COVID-19. We systematically searched the PubMed and Europe PMC database using specific keywords related to our aims until December 12th, 2020. All articles published on COVID-19 and insulin were retrieved. Statistical analysis was done using Review Manager 5.4 and Comprehensive Meta-Analysis vers","2021","07","12","Endocr Metab Immune Disord Drug Targets","Endocrine, metabolic &amp; immune disorders drug targets","COVID-19; SARS-CoV-2; coronavirus; diabetes; insulin; medications","Kurniawan","Andree","Department of Internal Medicine, Faculty of Medicine, Pelita Harapan University, Boulevard Jendral Sudirman street, Karawaci, Tangerang, Indonesia",NA
"782","34250872","10.2174/1389201022666210709141320","Drug repurposing: an alternative strategy to treat COVID-19.","In order to curve the ongoing trend of the COVID-19 pandemic and save more lives, effective treatments against COVID-19 are urgently needed. Comparing to developing new drugs, which may take too much time, it's more efficient and cost-effective to repurpose existing drugs in the treatment of COVID-19. Fortunately, some of the shared features of COVID-19 and other well-known diseases make it possible to use old strategies to combat this new challenge. In this paper, we reviewed various possible s","2021","07","12","Curr Pharm Biotechnol","Current pharmaceutical biotechnology","Anti-viral agents; COVID-19; Immuno-regulation; Risk factor; SARS-CoV-2; Surfactants; pH","Han","Pengyu","The 980th Hospital of PLA Joint Logistics Force, Shijiazhuang, Shijiazhuang, 050082, China",NA
"783","34250872","10.2174/1389201022666210709141320","Drug repurposing: an alternative strategy to treat COVID-19.","In order to curve the ongoing trend of the COVID-19 pandemic and save more lives, effective treatments against COVID-19 are urgently needed. Comparing to developing new drugs, which may take too much time, it's more efficient and cost-effective to repurpose existing drugs in the treatment of COVID-19. Fortunately, some of the shared features of COVID-19 and other well-known diseases make it possible to use old strategies to combat this new challenge. In this paper, we reviewed various possible s","2021","07","12","Curr Pharm Biotechnol","Current pharmaceutical biotechnology","Anti-viral agents; COVID-19; Immuno-regulation; Risk factor; SARS-CoV-2; Surfactants; pH","Zheng","Huifang","The 980th Hospital of PLA Joint Logistics Force, Shijiazhuang, Shijiazhuang, 050082, China",NA
"784","34250872","10.2174/1389201022666210709141320","Drug repurposing: an alternative strategy to treat COVID-19.","In order to curve the ongoing trend of the COVID-19 pandemic and save more lives, effective treatments against COVID-19 are urgently needed. Comparing to developing new drugs, which may take too much time, it's more efficient and cost-effective to repurpose existing drugs in the treatment of COVID-19. Fortunately, some of the shared features of COVID-19 and other well-known diseases make it possible to use old strategies to combat this new challenge. In this paper, we reviewed various possible s","2021","07","12","Curr Pharm Biotechnol","Current pharmaceutical biotechnology","Anti-viral agents; COVID-19; Immuno-regulation; Risk factor; SARS-CoV-2; Surfactants; pH","Wen","Pingping","Dalian Customs District, Dalian, China",NA
"785","34250872","10.2174/1389201022666210709141320","Drug repurposing: an alternative strategy to treat COVID-19.","In order to curve the ongoing trend of the COVID-19 pandemic and save more lives, effective treatments against COVID-19 are urgently needed. Comparing to developing new drugs, which may take too much time, it's more efficient and cost-effective to repurpose existing drugs in the treatment of COVID-19. Fortunately, some of the shared features of COVID-19 and other well-known diseases make it possible to use old strategies to combat this new challenge. In this paper, we reviewed various possible s","2021","07","12","Curr Pharm Biotechnol","Current pharmaceutical biotechnology","Anti-viral agents; COVID-19; Immuno-regulation; Risk factor; SARS-CoV-2; Surfactants; pH","Pan","Li","Dalian Customs District, Dalian, China",NA
"786","34250872","10.2174/1389201022666210709141320","Drug repurposing: an alternative strategy to treat COVID-19.","In order to curve the ongoing trend of the COVID-19 pandemic and save more lives, effective treatments against COVID-19 are urgently needed. Comparing to developing new drugs, which may take too much time, it's more efficient and cost-effective to repurpose existing drugs in the treatment of COVID-19. Fortunately, some of the shared features of COVID-19 and other well-known diseases make it possible to use old strategies to combat this new challenge. In this paper, we reviewed various possible s","2021","07","12","Curr Pharm Biotechnol","Current pharmaceutical biotechnology","Anti-viral agents; COVID-19; Immuno-regulation; Risk factor; SARS-CoV-2; Surfactants; pH","Geng","Dan","Dalian Customs District, Dalian, China",NA
"787","34250872","10.2174/1389201022666210709141320","Drug repurposing: an alternative strategy to treat COVID-19.","In order to curve the ongoing trend of the COVID-19 pandemic and save more lives, effective treatments against COVID-19 are urgently needed. Comparing to developing new drugs, which may take too much time, it's more efficient and cost-effective to repurpose existing drugs in the treatment of COVID-19. Fortunately, some of the shared features of COVID-19 and other well-known diseases make it possible to use old strategies to combat this new challenge. In this paper, we reviewed various possible s","2021","07","12","Curr Pharm Biotechnol","Current pharmaceutical biotechnology","Anti-viral agents; COVID-19; Immuno-regulation; Risk factor; SARS-CoV-2; Surfactants; pH","Sun","Diangxing","The 980th Hospital of PLA Joint Logistics Force, Shijiazhuang, Shijiazhuang, 050082, China",NA
"788","34250868","10.1177/14604582211021470","Social media affordances and information abundance: Enabling fake news sharing during the COVID-19 health crisis.","This study modelled factors that predict fake news sharing during the COVID-19 health crisis using the perspective of the affordance and cognitive load theory. Data were drawn from 385 social media users in Nigeria, and Partial Least Squares (PLS) was used to analyse the data. We found that news-find-me perception, information overload, trust in online information, status seeking, self-expression and information sharing predicted fake news sharing related to COVID-19 pandemic among","2021","07","13","Health Informatics J","Health informatics journal","COVID-19; Nigeria; fake news; fake news sharing; social media users","Apuke","Oberiri Destiny","School of Communication, Universiti Sains Malaysia, Malaysia",NA
"789","34250868","10.1177/14604582211021470","Social media affordances and information abundance: Enabling fake news sharing during the COVID-19 health crisis.","This study modelled factors that predict fake news sharing during the COVID-19 health crisis using the perspective of the affordance and cognitive load theory. Data were drawn from 385 social media users in Nigeria, and Partial Least Squares (PLS) was used to analyse the data. We found that news-find-me perception, information overload, trust in online information, status seeking, self-expression and information sharing predicted fake news sharing related to COVID-19 pandemic among","2021","07","13","Health Informatics J","Health informatics journal","COVID-19; Nigeria; fake news; fake news sharing; social media users","Omar","Bahiyah","School of Communication, Universiti Sains Malaysia, Malaysia",NA
"790","34250865","10.1177/14034948211027817","How the Norwegian population was affected by non-pharmaceutical interventions during the first six weeks of the COVID-19 lockdown.","The aim of this study was to examine how the Norwegian general adult population was affected by non-pharmaceutical interventions during the first six weeks of the COVID-19 lockdown. We assessed quarantine, symptoms, social distancing, home office/school, work status, social contact and health-care contact through digital access and knowledge. A cross-sectional survey was performed of 29,535 adults (aged 18-99) in Norway after six weeks of non-pharmaceutical interventions in March/April 2020. Mos","2021","07","12","Scand J Public Health","Scandinavian journal of public health","COVID-19; Non-pharmaceutical interventions; health-care seeking; health-care service utilisation; mitigation; pandemic; public health; social distancing; social isolation; suppression","Mæland","Silje","Department of Global Public Health and Primary Care, Faculty of medicine, University of Bergen, Norway",NA
"791","34250865","10.1177/14034948211027817","How the Norwegian population was affected by non-pharmaceutical interventions during the first six weeks of the COVID-19 lockdown.","The aim of this study was to examine how the Norwegian general adult population was affected by non-pharmaceutical interventions during the first six weeks of the COVID-19 lockdown. We assessed quarantine, symptoms, social distancing, home office/school, work status, social contact and health-care contact through digital access and knowledge. A cross-sectional survey was performed of 29,535 adults (aged 18-99) in Norway after six weeks of non-pharmaceutical interventions in March/April 2020. Mos","2021","07","12","Scand J Public Health","Scandinavian journal of public health","COVID-19; Non-pharmaceutical interventions; health-care seeking; health-care service utilisation; mitigation; pandemic; public health; social distancing; social isolation; suppression","Bjørknes","Ragnhild","Department of health promotion and development, Faculty of psychology, University of Bergen, Norway",NA
"792","34250865","10.1177/14034948211027817","How the Norwegian population was affected by non-pharmaceutical interventions during the first six weeks of the COVID-19 lockdown.","The aim of this study was to examine how the Norwegian general adult population was affected by non-pharmaceutical interventions during the first six weeks of the COVID-19 lockdown. We assessed quarantine, symptoms, social distancing, home office/school, work status, social contact and health-care contact through digital access and knowledge. A cross-sectional survey was performed of 29,535 adults (aged 18-99) in Norway after six weeks of non-pharmaceutical interventions in March/April 2020. Mos","2021","07","12","Scand J Public Health","Scandinavian journal of public health","COVID-19; Non-pharmaceutical interventions; health-care seeking; health-care service utilisation; mitigation; pandemic; public health; social distancing; social isolation; suppression","Lehmann","Stine","Department of health promotion and development, Faculty of psychology, University of Bergen, Norway",NA
"793","34250865","10.1177/14034948211027817","How the Norwegian population was affected by non-pharmaceutical interventions during the first six weeks of the COVID-19 lockdown.","The aim of this study was to examine how the Norwegian general adult population was affected by non-pharmaceutical interventions during the first six weeks of the COVID-19 lockdown. We assessed quarantine, symptoms, social distancing, home office/school, work status, social contact and health-care contact through digital access and knowledge. A cross-sectional survey was performed of 29,535 adults (aged 18-99) in Norway after six weeks of non-pharmaceutical interventions in March/April 2020. Mos","2021","07","12","Scand J Public Health","Scandinavian journal of public health","COVID-19; Non-pharmaceutical interventions; health-care seeking; health-care service utilisation; mitigation; pandemic; public health; social distancing; social isolation; suppression","Sandal","Gro Mjeldheim","Department of Psychosocial Science, Faculty of psychology, University of Bergen, Norway",NA
"794","34250865","10.1177/14034948211027817","How the Norwegian population was affected by non-pharmaceutical interventions during the first six weeks of the COVID-19 lockdown.","The aim of this study was to examine how the Norwegian general adult population was affected by non-pharmaceutical interventions during the first six weeks of the COVID-19 lockdown. We assessed quarantine, symptoms, social distancing, home office/school, work status, social contact and health-care contact through digital access and knowledge. A cross-sectional survey was performed of 29,535 adults (aged 18-99) in Norway after six weeks of non-pharmaceutical interventions in March/April 2020. Mos","2021","07","12","Scand J Public Health","Scandinavian journal of public health","COVID-19; Non-pharmaceutical interventions; health-care seeking; health-care service utilisation; mitigation; pandemic; public health; social distancing; social isolation; suppression","Hazell","William","Bergen Municipality, Norway",NA
"795","34250865","10.1177/14034948211027817","How the Norwegian population was affected by non-pharmaceutical interventions during the first six weeks of the COVID-19 lockdown.","The aim of this study was to examine how the Norwegian general adult population was affected by non-pharmaceutical interventions during the first six weeks of the COVID-19 lockdown. We assessed quarantine, symptoms, social distancing, home office/school, work status, social contact and health-care contact through digital access and knowledge. A cross-sectional survey was performed of 29,535 adults (aged 18-99) in Norway after six weeks of non-pharmaceutical interventions in March/April 2020. Mos","2021","07","12","Scand J Public Health","Scandinavian journal of public health","COVID-19; Non-pharmaceutical interventions; health-care seeking; health-care service utilisation; mitigation; pandemic; public health; social distancing; social isolation; suppression","Rabben","Åsgeir Kjetland","Bergen Municipality, Norway",NA
"796","34250865","10.1177/14034948211027817","How the Norwegian population was affected by non-pharmaceutical interventions during the first six weeks of the COVID-19 lockdown.","The aim of this study was to examine how the Norwegian general adult population was affected by non-pharmaceutical interventions during the first six weeks of the COVID-19 lockdown. We assessed quarantine, symptoms, social distancing, home office/school, work status, social contact and health-care contact through digital access and knowledge. A cross-sectional survey was performed of 29,535 adults (aged 18-99) in Norway after six weeks of non-pharmaceutical interventions in March/April 2020. Mos","2021","07","12","Scand J Public Health","Scandinavian journal of public health","COVID-19; Non-pharmaceutical interventions; health-care seeking; health-care service utilisation; mitigation; pandemic; public health; social distancing; social isolation; suppression","Vedaa","Øystein","Department of Health Promotion, Norwegian Institute of Public Health, Norway",NA
"797","34250865","10.1177/14034948211027817","How the Norwegian population was affected by non-pharmaceutical interventions during the first six weeks of the COVID-19 lockdown.","The aim of this study was to examine how the Norwegian general adult population was affected by non-pharmaceutical interventions during the first six weeks of the COVID-19 lockdown. We assessed quarantine, symptoms, social distancing, home office/school, work status, social contact and health-care contact through digital access and knowledge. A cross-sectional survey was performed of 29,535 adults (aged 18-99) in Norway after six weeks of non-pharmaceutical interventions in March/April 2020. Mos","2021","07","12","Scand J Public Health","Scandinavian journal of public health","COVID-19; Non-pharmaceutical interventions; health-care seeking; health-care service utilisation; mitigation; pandemic; public health; social distancing; social isolation; suppression","Skogen","Jens Christoffer","Department of Health Promotion, Norwegian Institute of Public Health, Norway",NA
"798","34250865","10.1177/14034948211027817","How the Norwegian population was affected by non-pharmaceutical interventions during the first six weeks of the COVID-19 lockdown.","The aim of this study was to examine how the Norwegian general adult population was affected by non-pharmaceutical interventions during the first six weeks of the COVID-19 lockdown. We assessed quarantine, symptoms, social distancing, home office/school, work status, social contact and health-care contact through digital access and knowledge. A cross-sectional survey was performed of 29,535 adults (aged 18-99) in Norway after six weeks of non-pharmaceutical interventions in March/April 2020. Mos","2021","07","12","Scand J Public Health","Scandinavian journal of public health","COVID-19; Non-pharmaceutical interventions; health-care seeking; health-care service utilisation; mitigation; pandemic; public health; social distancing; social isolation; suppression","Fadnes","Lars Thore","Department of Global Public Health and Primary Care, Faculty of medicine, University of Bergen, Norway",NA
"799","34250864","10.1177/01410768211030835","The COVID-19 pandemic: the third wave?",NA,"2021","07","16","J R Soc Med","Journal of the Royal Society of Medicine","COVID-19; Humans; Mutation; Pandemics; SARS-CoV-2","Ashton","John","Independent Public Health Consultant, Liverpool L25 5JF, UK",NA
"800","34250834","10.1177/20587384211031763","The effectiveness of Colchicine as an anti-inflammatory drug in the treatment of coronavirus disease 2019: Meta-analysis.","A recently discovered coronavirus, SARS-CoV-2, caused a global respiratory disease pandemic called COVID-19. Many studies have shown the excessive activation of the innate immune response that leads to the adverse outcomes of COVID-19, and anti-inflammatory drugs are very useful in the treatment and management of this infection. The activities of Colchicine, one of the anti-inflammatory drugs, target several pathways related to excessive inflammation of COVID-19. This study aimed to evaluate the","2021","07","14","Int J Immunopathol Pharmacol","International journal of immunopathology and pharmacology","COVID-19; Colchicine; anti-inflammatory; hospitalization time; mortality rate; Anti-Inflammatory Agents; COVID-19; Colchicine; Hospital Mortality; Humans; Length of Stay; Time Factors; Treatment Outcome","Golpour","Monireh","Molecular and Cell Biology Research Center, Student Research Committee, Faculty of Medicine, Mazandaran University of Medical Science, Sari, Iran",NA
"801","34250834","10.1177/20587384211031763","The effectiveness of Colchicine as an anti-inflammatory drug in the treatment of coronavirus disease 2019: Meta-analysis.","A recently discovered coronavirus, SARS-CoV-2, caused a global respiratory disease pandemic called COVID-19. Many studies have shown the excessive activation of the innate immune response that leads to the adverse outcomes of COVID-19, and anti-inflammatory drugs are very useful in the treatment and management of this infection. The activities of Colchicine, one of the anti-inflammatory drugs, target several pathways related to excessive inflammation of COVID-19. This study aimed to evaluate the","2021","07","14","Int J Immunopathol Pharmacol","International journal of immunopathology and pharmacology","COVID-19; Colchicine; anti-inflammatory; hospitalization time; mortality rate; Anti-Inflammatory Agents; COVID-19; Colchicine; Hospital Mortality; Humans; Length of Stay; Time Factors; Treatment Outcome","Mousavi","Tahoora","Molecular and Cell Biology Research Center, Hemoglobinopathy Research Institute, Mazandaran University of Medical Sciences, Sari, Iran",NA
"802","34250834","10.1177/20587384211031763","The effectiveness of Colchicine as an anti-inflammatory drug in the treatment of coronavirus disease 2019: Meta-analysis.","A recently discovered coronavirus, SARS-CoV-2, caused a global respiratory disease pandemic called COVID-19. Many studies have shown the excessive activation of the innate immune response that leads to the adverse outcomes of COVID-19, and anti-inflammatory drugs are very useful in the treatment and management of this infection. The activities of Colchicine, one of the anti-inflammatory drugs, target several pathways related to excessive inflammation of COVID-19. This study aimed to evaluate the","2021","07","14","Int J Immunopathol Pharmacol","International journal of immunopathology and pharmacology","COVID-19; Colchicine; anti-inflammatory; hospitalization time; mortality rate; Anti-Inflammatory Agents; COVID-19; Colchicine; Hospital Mortality; Humans; Length of Stay; Time Factors; Treatment Outcome","Alimohammadi","Mina","Department of Immunology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran",NA
"803","34250834","10.1177/20587384211031763","The effectiveness of Colchicine as an anti-inflammatory drug in the treatment of coronavirus disease 2019: Meta-analysis.","A recently discovered coronavirus, SARS-CoV-2, caused a global respiratory disease pandemic called COVID-19. Many studies have shown the excessive activation of the innate immune response that leads to the adverse outcomes of COVID-19, and anti-inflammatory drugs are very useful in the treatment and management of this infection. The activities of Colchicine, one of the anti-inflammatory drugs, target several pathways related to excessive inflammation of COVID-19. This study aimed to evaluate the","2021","07","14","Int J Immunopathol Pharmacol","International journal of immunopathology and pharmacology","COVID-19; Colchicine; anti-inflammatory; hospitalization time; mortality rate; Anti-Inflammatory Agents; COVID-19; Colchicine; Hospital Mortality; Humans; Length of Stay; Time Factors; Treatment Outcome","Mosayebian","Ali","Department of Immunology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran",NA
"804","34250834","10.1177/20587384211031763","The effectiveness of Colchicine as an anti-inflammatory drug in the treatment of coronavirus disease 2019: Meta-analysis.","A recently discovered coronavirus, SARS-CoV-2, caused a global respiratory disease pandemic called COVID-19. Many studies have shown the excessive activation of the innate immune response that leads to the adverse outcomes of COVID-19, and anti-inflammatory drugs are very useful in the treatment and management of this infection. The activities of Colchicine, one of the anti-inflammatory drugs, target several pathways related to excessive inflammation of COVID-19. This study aimed to evaluate the","2021","07","14","Int J Immunopathol Pharmacol","International journal of immunopathology and pharmacology","COVID-19; Colchicine; anti-inflammatory; hospitalization time; mortality rate; Anti-Inflammatory Agents; COVID-19; Colchicine; Hospital Mortality; Humans; Length of Stay; Time Factors; Treatment Outcome","Shiran","Mohammadreza","Department of Physiology and Pharmacology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran",NA
"805","34250834","10.1177/20587384211031763","The effectiveness of Colchicine as an anti-inflammatory drug in the treatment of coronavirus disease 2019: Meta-analysis.","A recently discovered coronavirus, SARS-CoV-2, caused a global respiratory disease pandemic called COVID-19. Many studies have shown the excessive activation of the innate immune response that leads to the adverse outcomes of COVID-19, and anti-inflammatory drugs are very useful in the treatment and management of this infection. The activities of Colchicine, one of the anti-inflammatory drugs, target several pathways related to excessive inflammation of COVID-19. This study aimed to evaluate the","2021","07","14","Int J Immunopathol Pharmacol","International journal of immunopathology and pharmacology","COVID-19; Colchicine; anti-inflammatory; hospitalization time; mortality rate; Anti-Inflammatory Agents; COVID-19; Colchicine; Hospital Mortality; Humans; Length of Stay; Time Factors; Treatment Outcome","Alizadeh Navaei","Reza","Gastrointestinal Cancer Research Center, Non-Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran",NA
"806","34250834","10.1177/20587384211031763","The effectiveness of Colchicine as an anti-inflammatory drug in the treatment of coronavirus disease 2019: Meta-analysis.","A recently discovered coronavirus, SARS-CoV-2, caused a global respiratory disease pandemic called COVID-19. Many studies have shown the excessive activation of the innate immune response that leads to the adverse outcomes of COVID-19, and anti-inflammatory drugs are very useful in the treatment and management of this infection. The activities of Colchicine, one of the anti-inflammatory drugs, target several pathways related to excessive inflammation of COVID-19. This study aimed to evaluate the","2021","07","14","Int J Immunopathol Pharmacol","International journal of immunopathology and pharmacology","COVID-19; Colchicine; anti-inflammatory; hospitalization time; mortality rate; Anti-Inflammatory Agents; COVID-19; Colchicine; Hospital Mortality; Humans; Length of Stay; Time Factors; Treatment Outcome","Rafiei","Alireza","Department of Immunology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran",NA
"807","34250830","10.1177/00031348211031848","Increasing Social Media Presence for Graduate Medical Education Programs.","Virtual residency interviews during COVID-19 pandemic created a need for residency programs to use social media to increase their visibility and connect with potential applicants. This was, however, new and a road never travelled for many programs. This report describes how our General Surgery Residency Program increased its presence through social media by using various exposure methods and approaches, including diversifying presence and developing candid personalized content. Results suggest t","2021","07","12","Am Surg","The American surgeon","graduate medical education social media presence; resident education; social and electronic media; virtual residency interviews","Walk","Casey T","Department of Surgery, Boonshoft School of Medicine, Wright State University, Dayton, OH, USA",NA
"808","34250830","10.1177/00031348211031848","Increasing Social Media Presence for Graduate Medical Education Programs.","Virtual residency interviews during COVID-19 pandemic created a need for residency programs to use social media to increase their visibility and connect with potential applicants. This was, however, new and a road never travelled for many programs. This report describes how our General Surgery Residency Program increased its presence through social media by using various exposure methods and approaches, including diversifying presence and developing candid personalized content. Results suggest t","2021","07","12","Am Surg","The American surgeon","graduate medical education social media presence; resident education; social and electronic media; virtual residency interviews","Gerardo","Rodrigo","Department of Surgery, Boonshoft School of Medicine, Wright State University, Dayton, OH, USA",NA
"809","34250830","10.1177/00031348211031848","Increasing Social Media Presence for Graduate Medical Education Programs.","Virtual residency interviews during COVID-19 pandemic created a need for residency programs to use social media to increase their visibility and connect with potential applicants. This was, however, new and a road never travelled for many programs. This report describes how our General Surgery Residency Program increased its presence through social media by using various exposure methods and approaches, including diversifying presence and developing candid personalized content. Results suggest t","2021","07","12","Am Surg","The American surgeon","graduate medical education social media presence; resident education; social and electronic media; virtual residency interviews","Parikh","Priti P","Department of Surgery, Boonshoft School of Medicine, Wright State University, Dayton, OH, USA",NA
"810","34250826","10.1177/03000605211030124","Comparison of hemoglobin level and neutrophil to lymphocyte ratio as prognostic markers in patients with COVID-19.","Anemia can negatively affect the outcome of many diseases, including infections and inflammatory conditions. To compare the prognostic value of hemoglobin level and the neutrophil/lymphocyte ratio (NLR) for prediction of coronavirus disease 2019 (COVID-19) severity. In this retrospective cohort study, clinical data from patients with laboratory-confirmed COVID-19 were collected from hospital records from 10 April 2020 to 30 July 2020. The proportions of patients with mild, moderate, and severe C","2021","07","13","J Int Med Res","The Journal of international medical research","Coronavirus disease 2019; anemia; hemoglobin; hospital; intensive care unit; neutrophil/lymphocyte ratio; patient stratification; severity; COVID-19; Humans; Lymphocyte Count; Lymphocytes; Neutrophils; Prognosis; ROC Curve; Retrospective Studies; SARS-CoV-2","Fouad","Shaimaa Hani","Departments of Internal Medicine and Allergy and Clinical Immunology, Faculty of Medicine, Ain Shams University, Cairo, Egypt",NA
"811","34250826","10.1177/03000605211030124","Comparison of hemoglobin level and neutrophil to lymphocyte ratio as prognostic markers in patients with COVID-19.","Anemia can negatively affect the outcome of many diseases, including infections and inflammatory conditions. To compare the prognostic value of hemoglobin level and the neutrophil/lymphocyte ratio (NLR) for prediction of coronavirus disease 2019 (COVID-19) severity. In this retrospective cohort study, clinical data from patients with laboratory-confirmed COVID-19 were collected from hospital records from 10 April 2020 to 30 July 2020. The proportions of patients with mild, moderate, and severe C","2021","07","13","J Int Med Res","The Journal of international medical research","Coronavirus disease 2019; anemia; hemoglobin; hospital; intensive care unit; neutrophil/lymphocyte ratio; patient stratification; severity; COVID-19; Humans; Lymphocyte Count; Lymphocytes; Neutrophils; Prognosis; ROC Curve; Retrospective Studies; SARS-CoV-2","Allam","Mohamed Farouk","Department of Family Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt",NA
"812","34250826","10.1177/03000605211030124","Comparison of hemoglobin level and neutrophil to lymphocyte ratio as prognostic markers in patients with COVID-19.","Anemia can negatively affect the outcome of many diseases, including infections and inflammatory conditions. To compare the prognostic value of hemoglobin level and the neutrophil/lymphocyte ratio (NLR) for prediction of coronavirus disease 2019 (COVID-19) severity. In this retrospective cohort study, clinical data from patients with laboratory-confirmed COVID-19 were collected from hospital records from 10 April 2020 to 30 July 2020. The proportions of patients with mild, moderate, and severe C","2021","07","13","J Int Med Res","The Journal of international medical research","Coronavirus disease 2019; anemia; hemoglobin; hospital; intensive care unit; neutrophil/lymphocyte ratio; patient stratification; severity; COVID-19; Humans; Lymphocyte Count; Lymphocytes; Neutrophils; Prognosis; ROC Curve; Retrospective Studies; SARS-CoV-2","Taha","Sara Ibrahim","Department of Clinical Pathology, Faculty of Medicine, Ain Shams University, Cairo, Egypt",NA
"813","34250826","10.1177/03000605211030124","Comparison of hemoglobin level and neutrophil to lymphocyte ratio as prognostic markers in patients with COVID-19.","Anemia can negatively affect the outcome of many diseases, including infections and inflammatory conditions. To compare the prognostic value of hemoglobin level and the neutrophil/lymphocyte ratio (NLR) for prediction of coronavirus disease 2019 (COVID-19) severity. In this retrospective cohort study, clinical data from patients with laboratory-confirmed COVID-19 were collected from hospital records from 10 April 2020 to 30 July 2020. The proportions of patients with mild, moderate, and severe C","2021","07","13","J Int Med Res","The Journal of international medical research","Coronavirus disease 2019; anemia; hemoglobin; hospital; intensive care unit; neutrophil/lymphocyte ratio; patient stratification; severity; COVID-19; Humans; Lymphocyte Count; Lymphocytes; Neutrophils; Prognosis; ROC Curve; Retrospective Studies; SARS-CoV-2","Okba","Ahmed Ashraf","Department of Radiology, Faculty of Medicine, Ain Shams University, Cairo, Egypt",NA
"814","34250826","10.1177/03000605211030124","Comparison of hemoglobin level and neutrophil to lymphocyte ratio as prognostic markers in patients with COVID-19.","Anemia can negatively affect the outcome of many diseases, including infections and inflammatory conditions. To compare the prognostic value of hemoglobin level and the neutrophil/lymphocyte ratio (NLR) for prediction of coronavirus disease 2019 (COVID-19) severity. In this retrospective cohort study, clinical data from patients with laboratory-confirmed COVID-19 were collected from hospital records from 10 April 2020 to 30 July 2020. The proportions of patients with mild, moderate, and severe C","2021","07","13","J Int Med Res","The Journal of international medical research","Coronavirus disease 2019; anemia; hemoglobin; hospital; intensive care unit; neutrophil/lymphocyte ratio; patient stratification; severity; COVID-19; Humans; Lymphocyte Count; Lymphocytes; Neutrophils; Prognosis; ROC Curve; Retrospective Studies; SARS-CoV-2","Hosny","Amr","Department of Anesthesiology and Intensive Care, Faculty of Medicine, Ain Shams University, Cairo, Egypt",NA
"815","34250826","10.1177/03000605211030124","Comparison of hemoglobin level and neutrophil to lymphocyte ratio as prognostic markers in patients with COVID-19.","Anemia can negatively affect the outcome of many diseases, including infections and inflammatory conditions. To compare the prognostic value of hemoglobin level and the neutrophil/lymphocyte ratio (NLR) for prediction of coronavirus disease 2019 (COVID-19) severity. In this retrospective cohort study, clinical data from patients with laboratory-confirmed COVID-19 were collected from hospital records from 10 April 2020 to 30 July 2020. The proportions of patients with mild, moderate, and severe C","2021","07","13","J Int Med Res","The Journal of international medical research","Coronavirus disease 2019; anemia; hemoglobin; hospital; intensive care unit; neutrophil/lymphocyte ratio; patient stratification; severity; COVID-19; Humans; Lymphocyte Count; Lymphocytes; Neutrophils; Prognosis; ROC Curve; Retrospective Studies; SARS-CoV-2","Moneer","Mayada","Departments of Internal Medicine and Allergy and Clinical Immunology, Faculty of Medicine, Ain Shams University, Cairo, Egypt",NA
"816","34250826","10.1177/03000605211030124","Comparison of hemoglobin level and neutrophil to lymphocyte ratio as prognostic markers in patients with COVID-19.","Anemia can negatively affect the outcome of many diseases, including infections and inflammatory conditions. To compare the prognostic value of hemoglobin level and the neutrophil/lymphocyte ratio (NLR) for prediction of coronavirus disease 2019 (COVID-19) severity. In this retrospective cohort study, clinical data from patients with laboratory-confirmed COVID-19 were collected from hospital records from 10 April 2020 to 30 July 2020. The proportions of patients with mild, moderate, and severe C","2021","07","13","J Int Med Res","The Journal of international medical research","Coronavirus disease 2019; anemia; hemoglobin; hospital; intensive care unit; neutrophil/lymphocyte ratio; patient stratification; severity; COVID-19; Humans; Lymphocyte Count; Lymphocytes; Neutrophils; Prognosis; ROC Curve; Retrospective Studies; SARS-CoV-2","Roman","Sylvia Wefky","Departments of Internal Medicine and Allergy and Clinical Immunology, Faculty of Medicine, Ain Shams University, Cairo, Egypt",NA
"817","34250818","10.1177/11206721211030774","Telephone-based consultation in an acute eye clinic service: A patient satisfaction survey.","The coronavirus pandemic has forced healthcare staff across all medical specialties to adapt new and different ways of working. A new approach has been set up in the Acute Referral Clinic (ARC) at Musgrove Park Hospital and a survey has been conducted to measure the impact of the new method on patient and healthcare professionals' satisfaction with the new service. A telephone-based consultation was introduced in ARC at Musgrove Park Hospital in March 2020 and patients were instructed to fill ou","2021","07","12","Eur J Ophthalmol","European journal of ophthalmology","Telemedicine; examination techniques; practice management; preventive medicine/screening; socioeconomics and education in medicine/ophthalmology","Sieberer","Julia","Ophthalmology, Musgrove Park Hospital, Somerset NHS Foundation Trust, Taunton, Somerset, UK",NA
"818","34250818","10.1177/11206721211030774","Telephone-based consultation in an acute eye clinic service: A patient satisfaction survey.","The coronavirus pandemic has forced healthcare staff across all medical specialties to adapt new and different ways of working. A new approach has been set up in the Acute Referral Clinic (ARC) at Musgrove Park Hospital and a survey has been conducted to measure the impact of the new method on patient and healthcare professionals' satisfaction with the new service. A telephone-based consultation was introduced in ARC at Musgrove Park Hospital in March 2020 and patients were instructed to fill ou","2021","07","12","Eur J Ophthalmol","European journal of ophthalmology","Telemedicine; examination techniques; practice management; preventive medicine/screening; socioeconomics and education in medicine/ophthalmology","Hughes","Patrick","Ophthalmology, Musgrove Park Hospital, Somerset NHS Foundation Trust, Taunton, Somerset, UK",NA
"819","34250818","10.1177/11206721211030774","Telephone-based consultation in an acute eye clinic service: A patient satisfaction survey.","The coronavirus pandemic has forced healthcare staff across all medical specialties to adapt new and different ways of working. A new approach has been set up in the Acute Referral Clinic (ARC) at Musgrove Park Hospital and a survey has been conducted to measure the impact of the new method on patient and healthcare professionals' satisfaction with the new service. A telephone-based consultation was introduced in ARC at Musgrove Park Hospital in March 2020 and patients were instructed to fill ou","2021","07","12","Eur J Ophthalmol","European journal of ophthalmology","Telemedicine; examination techniques; practice management; preventive medicine/screening; socioeconomics and education in medicine/ophthalmology","Sian","Indy","Ophthalmology, Musgrove Park Hospital, Somerset NHS Foundation Trust, Taunton, Somerset, UK",NA
"820","34250805","10.1021/acs.molpharmaceut.1c00324","Favipiravir-Based Ionic Liquids as Potent Antiviral Drugs for Oral Delivery: Synthesis, Solubility, and Pharmacokinetic Evaluation.","Coronavirus disease 2019 (COVID-19) has spread across the world, and no specific antiviral drugs have yet been approved to combat this disease. Favipiravir (FAV) is an antiviral drug that is currently in clinical trials for use against COVID-19. However, the delivery of FAV is challenging because of its limited solubility, and its formulation is difficult with common organic solvents and water. To address these issues, four FAV ionic liquids (FAV-ILs) were synthesized as potent antiviral prodrug","2021","07","12","Mol Pharm","Molecular pharmaceutics","biodistribution; coronavirus disease; favipiravir; ionic liquid; oral absorption","Moshikur","Rahman Md","Department of Applied Chemistry, Graduate School of Engineering, Kyushu University, 744 Motooka, Nishi-ku, Fukuoka 819-0395, Japan",NA
"821","34250805","10.1021/acs.molpharmaceut.1c00324","Favipiravir-Based Ionic Liquids as Potent Antiviral Drugs for Oral Delivery: Synthesis, Solubility, and Pharmacokinetic Evaluation.","Coronavirus disease 2019 (COVID-19) has spread across the world, and no specific antiviral drugs have yet been approved to combat this disease. Favipiravir (FAV) is an antiviral drug that is currently in clinical trials for use against COVID-19. However, the delivery of FAV is challenging because of its limited solubility, and its formulation is difficult with common organic solvents and water. To address these issues, four FAV ionic liquids (FAV-ILs) were synthesized as potent antiviral prodrug","2021","07","12","Mol Pharm","Molecular pharmaceutics","biodistribution; coronavirus disease; favipiravir; ionic liquid; oral absorption","Ali","Md Korban","Department of Applied Chemistry, Graduate School of Engineering, Kyushu University, 744 Motooka, Nishi-ku, Fukuoka 819-0395, Japan",NA
"822","34250805","10.1021/acs.molpharmaceut.1c00324","Favipiravir-Based Ionic Liquids as Potent Antiviral Drugs for Oral Delivery: Synthesis, Solubility, and Pharmacokinetic Evaluation.","Coronavirus disease 2019 (COVID-19) has spread across the world, and no specific antiviral drugs have yet been approved to combat this disease. Favipiravir (FAV) is an antiviral drug that is currently in clinical trials for use against COVID-19. However, the delivery of FAV is challenging because of its limited solubility, and its formulation is difficult with common organic solvents and water. To address these issues, four FAV ionic liquids (FAV-ILs) were synthesized as potent antiviral prodrug","2021","07","12","Mol Pharm","Molecular pharmaceutics","biodistribution; coronavirus disease; favipiravir; ionic liquid; oral absorption","Wakabayashi","Rie","Department of Applied Chemistry, Graduate School of Engineering, Kyushu University, 744 Motooka, Nishi-ku, Fukuoka 819-0395, Japan",NA
"823","34250805","10.1021/acs.molpharmaceut.1c00324","Favipiravir-Based Ionic Liquids as Potent Antiviral Drugs for Oral Delivery: Synthesis, Solubility, and Pharmacokinetic Evaluation.","Coronavirus disease 2019 (COVID-19) has spread across the world, and no specific antiviral drugs have yet been approved to combat this disease. Favipiravir (FAV) is an antiviral drug that is currently in clinical trials for use against COVID-19. However, the delivery of FAV is challenging because of its limited solubility, and its formulation is difficult with common organic solvents and water. To address these issues, four FAV ionic liquids (FAV-ILs) were synthesized as potent antiviral prodrug","2021","07","12","Mol Pharm","Molecular pharmaceutics","biodistribution; coronavirus disease; favipiravir; ionic liquid; oral absorption","Moniruzzaman","Muhammad","Department of Chemical Engineering, Universiti Teknologi PETRONAS, 32610 Seri Iskandar, Perak, Malaysia",NA
"824","34250805","10.1021/acs.molpharmaceut.1c00324","Favipiravir-Based Ionic Liquids as Potent Antiviral Drugs for Oral Delivery: Synthesis, Solubility, and Pharmacokinetic Evaluation.","Coronavirus disease 2019 (COVID-19) has spread across the world, and no specific antiviral drugs have yet been approved to combat this disease. Favipiravir (FAV) is an antiviral drug that is currently in clinical trials for use against COVID-19. However, the delivery of FAV is challenging because of its limited solubility, and its formulation is difficult with common organic solvents and water. To address these issues, four FAV ionic liquids (FAV-ILs) were synthesized as potent antiviral prodrug","2021","07","12","Mol Pharm","Molecular pharmaceutics","biodistribution; coronavirus disease; favipiravir; ionic liquid; oral absorption","Goto","Masahiro","Department of Applied Chemistry, Graduate School of Engineering, Kyushu University, 744 Motooka, Nishi-ku, Fukuoka 819-0395, Japan",NA
"825","34250768","10.7748/ns.2021.e11645","Understanding the disproportionate effects of COVID-19 on nurses from ethnic minority backgrounds.","People from ethnic minority backgrounds in the UK have been disproportionately affected by coronavirus disease 2019 (COVID-19), with higher death rates and suboptimal health outcomes compared with those from white ethnic backgrounds. This trend is reflected in healthcare staff from ethnic minority backgrounds, including nurses, who are disproportionately affected by COVID-19 and have higher death rates from the disease. The theory of intersectionality contends that social categorisations such as","2021","07","12","Nurs Stand","Nursing standard (Royal College of Nursing (Great Britain) : 1987)","COVID-19; black and minority ethnic; coronavirus; culture; discrimination; diversity; ethnicity; professional; staff welfare; workforce","Qureshi","Irtiza","The Institute for Health Research, University of Bedfordshire, Luton, England",NA
"826","34250768","10.7748/ns.2021.e11645","Understanding the disproportionate effects of COVID-19 on nurses from ethnic minority backgrounds.","People from ethnic minority backgrounds in the UK have been disproportionately affected by coronavirus disease 2019 (COVID-19), with higher death rates and suboptimal health outcomes compared with those from white ethnic backgrounds. This trend is reflected in healthcare staff from ethnic minority backgrounds, including nurses, who are disproportionately affected by COVID-19 and have higher death rates from the disease. The theory of intersectionality contends that social categorisations such as","2021","07","12","Nurs Stand","Nursing standard (Royal College of Nursing (Great Britain) : 1987)","COVID-19; black and minority ethnic; coronavirus; culture; discrimination; diversity; ethnicity; professional; staff welfare; workforce","Garcia","Rebecca","School of Health, Wellbeing and Social Care, Faculty of Wellbeing, Education and Language Studies, The Open University, Milton Keynes, England",NA
"827","34250768","10.7748/ns.2021.e11645","Understanding the disproportionate effects of COVID-19 on nurses from ethnic minority backgrounds.","People from ethnic minority backgrounds in the UK have been disproportionately affected by coronavirus disease 2019 (COVID-19), with higher death rates and suboptimal health outcomes compared with those from white ethnic backgrounds. This trend is reflected in healthcare staff from ethnic minority backgrounds, including nurses, who are disproportionately affected by COVID-19 and have higher death rates from the disease. The theory of intersectionality contends that social categorisations such as","2021","07","12","Nurs Stand","Nursing standard (Royal College of Nursing (Great Britain) : 1987)","COVID-19; black and minority ethnic; coronavirus; culture; discrimination; diversity; ethnicity; professional; staff welfare; workforce","Ali","Nasreen","The Institute for Health Research, University of Bedfordshire, Luton, England",NA
"828","34250768","10.7748/ns.2021.e11645","Understanding the disproportionate effects of COVID-19 on nurses from ethnic minority backgrounds.","People from ethnic minority backgrounds in the UK have been disproportionately affected by coronavirus disease 2019 (COVID-19), with higher death rates and suboptimal health outcomes compared with those from white ethnic backgrounds. This trend is reflected in healthcare staff from ethnic minority backgrounds, including nurses, who are disproportionately affected by COVID-19 and have higher death rates from the disease. The theory of intersectionality contends that social categorisations such as","2021","07","12","Nurs Stand","Nursing standard (Royal College of Nursing (Great Britain) : 1987)","COVID-19; black and minority ethnic; coronavirus; culture; discrimination; diversity; ethnicity; professional; staff welfare; workforce","Randhawa","Gurch","The Institute for Health Research, University of Bedfordshire, Luton, England",NA
"829","34250766","10.14814/phy2.14802","Monitoring lung injury with particle flow rate in LPS- and COVID-19-induced ARDS.","In severe acute respiratory distress syndrome (ARDS), extracorporeal membrane oxygenation (ECMO) is a life-prolonging treatment, especially among COVID-19 patients. Evaluation of lung injury progression is challenging with current techniques. Diagnostic imaging or invasive diagnostics are risky given the difficulties of intra-hospital transportation, contraindication of biopsies, and the potential for the spread of infections, such as in COVID-19 patients. We have recently shown that particle fl","2021","07","21","Physiol Rep","Physiological reports","COVID-19; acute respiratory distress syndrome; extra corporal membrane oxygenation; lung injury diagnostics; Animals; Blood Gas Analysis; COVID-19; Extracorporeal Membrane Oxygenation; Lipopolysaccharides; Lung; Lung Injury; Particulate Matter; Respiration, Artificial; Respiratory Distress Syndrome; Swine","Stenlo","Martin","Department of Cardiothoracic Anaesthesia and Intensive Care and Cardiothoracic Surgery and Transplantation, Skåne University Hospital, Lund University, Sweden",NA
"830","34250766","10.14814/phy2.14802","Monitoring lung injury with particle flow rate in LPS- and COVID-19-induced ARDS.","In severe acute respiratory distress syndrome (ARDS), extracorporeal membrane oxygenation (ECMO) is a life-prolonging treatment, especially among COVID-19 patients. Evaluation of lung injury progression is challenging with current techniques. Diagnostic imaging or invasive diagnostics are risky given the difficulties of intra-hospital transportation, contraindication of biopsies, and the potential for the spread of infections, such as in COVID-19 patients. We have recently shown that particle fl","2021","07","21","Physiol Rep","Physiological reports","COVID-19; acute respiratory distress syndrome; extra corporal membrane oxygenation; lung injury diagnostics; Animals; Blood Gas Analysis; COVID-19; Extracorporeal Membrane Oxygenation; Lipopolysaccharides; Lung; Lung Injury; Particulate Matter; Respiration, Artificial; Respiratory Distress Syndrome; Swine","Silva","Iran A N","Department of Experimental Medical Sciences, Lung Bioengineering and Regeneration, Lund University, Sweden",NA
"831","34250766","10.14814/phy2.14802","Monitoring lung injury with particle flow rate in LPS- and COVID-19-induced ARDS.","In severe acute respiratory distress syndrome (ARDS), extracorporeal membrane oxygenation (ECMO) is a life-prolonging treatment, especially among COVID-19 patients. Evaluation of lung injury progression is challenging with current techniques. Diagnostic imaging or invasive diagnostics are risky given the difficulties of intra-hospital transportation, contraindication of biopsies, and the potential for the spread of infections, such as in COVID-19 patients. We have recently shown that particle fl","2021","07","21","Physiol Rep","Physiological reports","COVID-19; acute respiratory distress syndrome; extra corporal membrane oxygenation; lung injury diagnostics; Animals; Blood Gas Analysis; COVID-19; Extracorporeal Membrane Oxygenation; Lipopolysaccharides; Lung; Lung Injury; Particulate Matter; Respiration, Artificial; Respiratory Distress Syndrome; Swine","Hyllén","Snejana","Department of Cardiothoracic Anaesthesia and Intensive Care and Cardiothoracic Surgery and Transplantation, Skåne University Hospital, Lund University, Sweden",NA
"832","34250766","10.14814/phy2.14802","Monitoring lung injury with particle flow rate in LPS- and COVID-19-induced ARDS.","In severe acute respiratory distress syndrome (ARDS), extracorporeal membrane oxygenation (ECMO) is a life-prolonging treatment, especially among COVID-19 patients. Evaluation of lung injury progression is challenging with current techniques. Diagnostic imaging or invasive diagnostics are risky given the difficulties of intra-hospital transportation, contraindication of biopsies, and the potential for the spread of infections, such as in COVID-19 patients. We have recently shown that particle fl","2021","07","21","Physiol Rep","Physiological reports","COVID-19; acute respiratory distress syndrome; extra corporal membrane oxygenation; lung injury diagnostics; Animals; Blood Gas Analysis; COVID-19; Extracorporeal Membrane Oxygenation; Lipopolysaccharides; Lung; Lung Injury; Particulate Matter; Respiration, Artificial; Respiratory Distress Syndrome; Swine","Bölükbas","Deniz A","Department of Experimental Medical Sciences, Lung Bioengineering and Regeneration, Lund University, Sweden",NA
"833","34250766","10.14814/phy2.14802","Monitoring lung injury with particle flow rate in LPS- and COVID-19-induced ARDS.","In severe acute respiratory distress syndrome (ARDS), extracorporeal membrane oxygenation (ECMO) is a life-prolonging treatment, especially among COVID-19 patients. Evaluation of lung injury progression is challenging with current techniques. Diagnostic imaging or invasive diagnostics are risky given the difficulties of intra-hospital transportation, contraindication of biopsies, and the potential for the spread of infections, such as in COVID-19 patients. We have recently shown that particle fl","2021","07","21","Physiol Rep","Physiological reports","COVID-19; acute respiratory distress syndrome; extra corporal membrane oxygenation; lung injury diagnostics; Animals; Blood Gas Analysis; COVID-19; Extracorporeal Membrane Oxygenation; Lipopolysaccharides; Lung; Lung Injury; Particulate Matter; Respiration, Artificial; Respiratory Distress Syndrome; Swine","Niroomand","Anna","Department of Clinical Sciences, Lund University, Sweden",NA
"834","34250766","10.14814/phy2.14802","Monitoring lung injury with particle flow rate in LPS- and COVID-19-induced ARDS.","In severe acute respiratory distress syndrome (ARDS), extracorporeal membrane oxygenation (ECMO) is a life-prolonging treatment, especially among COVID-19 patients. Evaluation of lung injury progression is challenging with current techniques. Diagnostic imaging or invasive diagnostics are risky given the difficulties of intra-hospital transportation, contraindication of biopsies, and the potential for the spread of infections, such as in COVID-19 patients. We have recently shown that particle fl","2021","07","21","Physiol Rep","Physiological reports","COVID-19; acute respiratory distress syndrome; extra corporal membrane oxygenation; lung injury diagnostics; Animals; Blood Gas Analysis; COVID-19; Extracorporeal Membrane Oxygenation; Lipopolysaccharides; Lung; Lung Injury; Particulate Matter; Respiration, Artificial; Respiratory Distress Syndrome; Swine","Grins","Edgars","Department of Cardiothoracic Anaesthesia and Intensive Care and Cardiothoracic Surgery and Transplantation, Skåne University Hospital, Lund University, Sweden",NA
"835","34250766","10.14814/phy2.14802","Monitoring lung injury with particle flow rate in LPS- and COVID-19-induced ARDS.","In severe acute respiratory distress syndrome (ARDS), extracorporeal membrane oxygenation (ECMO) is a life-prolonging treatment, especially among COVID-19 patients. Evaluation of lung injury progression is challenging with current techniques. Diagnostic imaging or invasive diagnostics are risky given the difficulties of intra-hospital transportation, contraindication of biopsies, and the potential for the spread of infections, such as in COVID-19 patients. We have recently shown that particle fl","2021","07","21","Physiol Rep","Physiological reports","COVID-19; acute respiratory distress syndrome; extra corporal membrane oxygenation; lung injury diagnostics; Animals; Blood Gas Analysis; COVID-19; Extracorporeal Membrane Oxygenation; Lipopolysaccharides; Lung; Lung Injury; Particulate Matter; Respiration, Artificial; Respiratory Distress Syndrome; Swine","Ederoth","Per","Department of Cardiothoracic Anaesthesia and Intensive Care and Cardiothoracic Surgery and Transplantation, Skåne University Hospital, Lund University, Sweden",NA
"836","34250766","10.14814/phy2.14802","Monitoring lung injury with particle flow rate in LPS- and COVID-19-induced ARDS.","In severe acute respiratory distress syndrome (ARDS), extracorporeal membrane oxygenation (ECMO) is a life-prolonging treatment, especially among COVID-19 patients. Evaluation of lung injury progression is challenging with current techniques. Diagnostic imaging or invasive diagnostics are risky given the difficulties of intra-hospital transportation, contraindication of biopsies, and the potential for the spread of infections, such as in COVID-19 patients. We have recently shown that particle fl","2021","07","21","Physiol Rep","Physiological reports","COVID-19; acute respiratory distress syndrome; extra corporal membrane oxygenation; lung injury diagnostics; Animals; Blood Gas Analysis; COVID-19; Extracorporeal Membrane Oxygenation; Lipopolysaccharides; Lung; Lung Injury; Particulate Matter; Respiration, Artificial; Respiratory Distress Syndrome; Swine","Hallgren","Oskar","Wallenberg Center for Molecular Medicine, Lund University, Sweden",NA
"837","34250766","10.14814/phy2.14802","Monitoring lung injury with particle flow rate in LPS- and COVID-19-induced ARDS.","In severe acute respiratory distress syndrome (ARDS), extracorporeal membrane oxygenation (ECMO) is a life-prolonging treatment, especially among COVID-19 patients. Evaluation of lung injury progression is challenging with current techniques. Diagnostic imaging or invasive diagnostics are risky given the difficulties of intra-hospital transportation, contraindication of biopsies, and the potential for the spread of infections, such as in COVID-19 patients. We have recently shown that particle fl","2021","07","21","Physiol Rep","Physiological reports","COVID-19; acute respiratory distress syndrome; extra corporal membrane oxygenation; lung injury diagnostics; Animals; Blood Gas Analysis; COVID-19; Extracorporeal Membrane Oxygenation; Lipopolysaccharides; Lung; Lung Injury; Particulate Matter; Respiration, Artificial; Respiratory Distress Syndrome; Swine","Pierre","Leif","Department of Cardiothoracic Anaesthesia and Intensive Care and Cardiothoracic Surgery and Transplantation, Skåne University Hospital, Lund University, Sweden",NA
"838","34250766","10.14814/phy2.14802","Monitoring lung injury with particle flow rate in LPS- and COVID-19-induced ARDS.","In severe acute respiratory distress syndrome (ARDS), extracorporeal membrane oxygenation (ECMO) is a life-prolonging treatment, especially among COVID-19 patients. Evaluation of lung injury progression is challenging with current techniques. Diagnostic imaging or invasive diagnostics are risky given the difficulties of intra-hospital transportation, contraindication of biopsies, and the potential for the spread of infections, such as in COVID-19 patients. We have recently shown that particle fl","2021","07","21","Physiol Rep","Physiological reports","COVID-19; acute respiratory distress syndrome; extra corporal membrane oxygenation; lung injury diagnostics; Animals; Blood Gas Analysis; COVID-19; Extracorporeal Membrane Oxygenation; Lipopolysaccharides; Lung; Lung Injury; Particulate Matter; Respiration, Artificial; Respiratory Distress Syndrome; Swine","Wagner","Darcy E","Department of Experimental Medical Sciences, Lung Bioengineering and Regeneration, Lund University, Sweden",NA
"839","34250766","10.14814/phy2.14802","Monitoring lung injury with particle flow rate in LPS- and COVID-19-induced ARDS.","In severe acute respiratory distress syndrome (ARDS), extracorporeal membrane oxygenation (ECMO) is a life-prolonging treatment, especially among COVID-19 patients. Evaluation of lung injury progression is challenging with current techniques. Diagnostic imaging or invasive diagnostics are risky given the difficulties of intra-hospital transportation, contraindication of biopsies, and the potential for the spread of infections, such as in COVID-19 patients. We have recently shown that particle fl","2021","07","21","Physiol Rep","Physiological reports","COVID-19; acute respiratory distress syndrome; extra corporal membrane oxygenation; lung injury diagnostics; Animals; Blood Gas Analysis; COVID-19; Extracorporeal Membrane Oxygenation; Lipopolysaccharides; Lung; Lung Injury; Particulate Matter; Respiration, Artificial; Respiratory Distress Syndrome; Swine","Lindstedt","Sandra","Department of Cardiothoracic Anaesthesia and Intensive Care and Cardiothoracic Surgery and Transplantation, Skåne University Hospital, Lund University, Sweden",NA
"840","34250748","10.1111/iwj.13657","The legacy of the COVID-19 pandemic and potential impact on persons with wounds.",NA,"2021","07","15","Int Wound J","International wound journal",NA,"Queen","Douglas",NA,NA
"841","34250748","10.1111/iwj.13657","The legacy of the COVID-19 pandemic and potential impact on persons with wounds.",NA,"2021","07","15","Int Wound J","International wound journal",NA,"Harding","Keith",NA,NA
"842","34250694","10.1002/hec.4383","The ""Great Lockdown"": Inactive workers and mortality by Covid-19.","In response to the Covid-19 outbreak, the Italian Government imposed an economic lockdown on March 22, 2020, and ordered the closing of all non-essential economic activities. This paper estimates the causal effects of this measure on mortality by Covid-19 and on mobility patterns. The identification of the causal effects exploits the variation in the active population across municipalities induced by the economic lockdown. The difference-in-differences empirical design compares outcomes in munic","2021","07","12","Health Econ","Health economics","Covid-19; economic lockdown; excess deaths; mobility","Borri","Nicola","Luiss University, Rome, Italy",NA
"843","34250694","10.1002/hec.4383","The ""Great Lockdown"": Inactive workers and mortality by Covid-19.","In response to the Covid-19 outbreak, the Italian Government imposed an economic lockdown on March 22, 2020, and ordered the closing of all non-essential economic activities. This paper estimates the causal effects of this measure on mortality by Covid-19 and on mobility patterns. The identification of the causal effects exploits the variation in the active population across municipalities induced by the economic lockdown. The difference-in-differences empirical design compares outcomes in munic","2021","07","12","Health Econ","Health economics","Covid-19; economic lockdown; excess deaths; mobility","Drago","Francesco","University of Catania, Catania, Italy",NA
"844","34250694","10.1002/hec.4383","The ""Great Lockdown"": Inactive workers and mortality by Covid-19.","In response to the Covid-19 outbreak, the Italian Government imposed an economic lockdown on March 22, 2020, and ordered the closing of all non-essential economic activities. This paper estimates the causal effects of this measure on mortality by Covid-19 and on mobility patterns. The identification of the causal effects exploits the variation in the active population across municipalities induced by the economic lockdown. The difference-in-differences empirical design compares outcomes in munic","2021","07","12","Health Econ","Health economics","Covid-19; economic lockdown; excess deaths; mobility","Santantonio","Chiara","Luiss University, Rome, Italy",NA
"845","34250694","10.1002/hec.4383","The ""Great Lockdown"": Inactive workers and mortality by Covid-19.","In response to the Covid-19 outbreak, the Italian Government imposed an economic lockdown on March 22, 2020, and ordered the closing of all non-essential economic activities. This paper estimates the causal effects of this measure on mortality by Covid-19 and on mobility patterns. The identification of the causal effects exploits the variation in the active population across municipalities induced by the economic lockdown. The difference-in-differences empirical design compares outcomes in munic","2021","07","12","Health Econ","Health economics","Covid-19; economic lockdown; excess deaths; mobility","Sobbrio","Francesco","University of Rome Tor Vergata, Rome, Italy",NA
"846","34250684","10.1111/bjhp.12546","Efficacy information influences intention to take COVID-19 vaccine.","A successful response to the COVID-19 pandemic requires achieving high levels of vaccine uptake. We tested whether directly contrasting the high efficacy of COVID-19 vaccines with the lower efficacy of the annual flu vaccine would increase intentions to take a COVID-19 vaccine. A pre-registered online study of 481 participants compared four information conditions: (1) no information; (2) COVID-19 Vaccine Information Only; and COVID-19 Vaccine Information combined with flu vaccine information sug","2021","07","12","Br J Health Psychol","British journal of health psychology","COVID-19; efficacy; health communication; protection motivation theory; vaccines","Davis","Colin J","School of Psychological Science, University of Bristol",NA
"847","34250684","10.1111/bjhp.12546","Efficacy information influences intention to take COVID-19 vaccine.","A successful response to the COVID-19 pandemic requires achieving high levels of vaccine uptake. We tested whether directly contrasting the high efficacy of COVID-19 vaccines with the lower efficacy of the annual flu vaccine would increase intentions to take a COVID-19 vaccine. A pre-registered online study of 481 participants compared four information conditions: (1) no information; (2) COVID-19 Vaccine Information Only; and COVID-19 Vaccine Information combined with flu vaccine information sug","2021","07","12","Br J Health Psychol","British journal of health psychology","COVID-19; efficacy; health communication; protection motivation theory; vaccines","Golding","Matt","Rubber Republic, Bristol, UK",NA
"848","34250684","10.1111/bjhp.12546","Efficacy information influences intention to take COVID-19 vaccine.","A successful response to the COVID-19 pandemic requires achieving high levels of vaccine uptake. We tested whether directly contrasting the high efficacy of COVID-19 vaccines with the lower efficacy of the annual flu vaccine would increase intentions to take a COVID-19 vaccine. A pre-registered online study of 481 participants compared four information conditions: (1) no information; (2) COVID-19 Vaccine Information Only; and COVID-19 Vaccine Information combined with flu vaccine information sug","2021","07","12","Br J Health Psychol","British journal of health psychology","COVID-19; efficacy; health communication; protection motivation theory; vaccines","McKay","Ryan","Department of Psychology, Royal Holloway, University of London, UK",NA
"849","34250637","10.1111/fcp.12715","Efficacy of Covid-19 vaccines: several modes of expression should be presented in scientific publications.","Several vaccines are being developed as part of the Covid-19 pandemic. Results of clinical trials for these vaccines were published with efficacy values more than 90%, using mainly Relative Risk (RR). In this paper, we decided to reanalyse the data using the different validated methods of risk expression. Using main publications, Absolute Risks (AR), AR Reduction (ARR), Number Needed to Treat (NNT) were calculated for five Covid-19 vaccines (tozinameran Comirnaty®, Moderna, Vaxzevria®, Janssen, ","2021","07","12","Fundam Clin Pharmacol","Fundamental &amp; clinical pharmacology","Covid-19 vaccines; Janssen (Ad26.COV2.S) vaccine; Vaxzevria®; absolute risk; number needed to treat; tozinameran","Montastruc","Jean-Louis","Service de Pharmacologie Médicale et Clinique, CIC INSERM 1436, Centre Hospitalier Universitaire-Faculté de Médecine, Toulouse, France",NA
"850","34250637","10.1111/fcp.12715","Efficacy of Covid-19 vaccines: several modes of expression should be presented in scientific publications.","Several vaccines are being developed as part of the Covid-19 pandemic. Results of clinical trials for these vaccines were published with efficacy values more than 90%, using mainly Relative Risk (RR). In this paper, we decided to reanalyse the data using the different validated methods of risk expression. Using main publications, Absolute Risks (AR), AR Reduction (ARR), Number Needed to Treat (NNT) were calculated for five Covid-19 vaccines (tozinameran Comirnaty®, Moderna, Vaxzevria®, Janssen, ","2021","07","12","Fundam Clin Pharmacol","Fundamental &amp; clinical pharmacology","Covid-19 vaccines; Janssen (Ad26.COV2.S) vaccine; Vaxzevria®; absolute risk; number needed to treat; tozinameran","Biron","Pierre","Professeur Honoraire de Pharmacologie Médicale, Faculté de Médecine, Montréal, Canada",NA
"851","34250637","10.1111/fcp.12715","Efficacy of Covid-19 vaccines: several modes of expression should be presented in scientific publications.","Several vaccines are being developed as part of the Covid-19 pandemic. Results of clinical trials for these vaccines were published with efficacy values more than 90%, using mainly Relative Risk (RR). In this paper, we decided to reanalyse the data using the different validated methods of risk expression. Using main publications, Absolute Risks (AR), AR Reduction (ARR), Number Needed to Treat (NNT) were calculated for five Covid-19 vaccines (tozinameran Comirnaty®, Moderna, Vaxzevria®, Janssen, ","2021","07","12","Fundam Clin Pharmacol","Fundamental &amp; clinical pharmacology","Covid-19 vaccines; Janssen (Ad26.COV2.S) vaccine; Vaxzevria®; absolute risk; number needed to treat; tozinameran","Sommet","Agnès","Service de Pharmacologie Médicale et Clinique, CIC INSERM 1436, Centre Hospitalier Universitaire-Faculté de Médecine, Toulouse, France",NA
"852","34250540","10.1093/infdis/jiab198","Corrigendum to: SARS-CoV-2 Serologic Assays in Control and Unknown Populations Demonstrate the Necessity of Virus Neutralization Testing.",NA,"2021","07","12","J Infect Dis","The Journal of infectious diseases",NA,"Rathe","Jennifer A","Department of Immunology, Center for Innate Immunity and Immune Disease, University of Washington, Seattle, Washington, USA",NA
"853","34250540","10.1093/infdis/jiab198","Corrigendum to: SARS-CoV-2 Serologic Assays in Control and Unknown Populations Demonstrate the Necessity of Virus Neutralization Testing.",NA,"2021","07","12","J Infect Dis","The Journal of infectious diseases",NA,"Hemann","Emily A","Department of Immunology, Center for Innate Immunity and Immune Disease, University of Washington, Seattle, Washington, USA",NA
"854","34250540","10.1093/infdis/jiab198","Corrigendum to: SARS-CoV-2 Serologic Assays in Control and Unknown Populations Demonstrate the Necessity of Virus Neutralization Testing.",NA,"2021","07","12","J Infect Dis","The Journal of infectious diseases",NA,"Eggenberger","Julie","Department of Immunology, Center for Innate Immunity and Immune Disease, University of Washington, Seattle, Washington, USA",NA
"855","34250540","10.1093/infdis/jiab198","Corrigendum to: SARS-CoV-2 Serologic Assays in Control and Unknown Populations Demonstrate the Necessity of Virus Neutralization Testing.",NA,"2021","07","12","J Infect Dis","The Journal of infectious diseases",NA,"Li","Zhaoqi","Department of Statistics, University of Washington, Seattle, Washington, USA",NA
"856","34250540","10.1093/infdis/jiab198","Corrigendum to: SARS-CoV-2 Serologic Assays in Control and Unknown Populations Demonstrate the Necessity of Virus Neutralization Testing.",NA,"2021","07","12","J Infect Dis","The Journal of infectious diseases",NA,"Knoll","Megan L","Department of Immunology, Center for Innate Immunity and Immune Disease, University of Washington, Seattle, Washington, USA",NA
"857","34250540","10.1093/infdis/jiab198","Corrigendum to: SARS-CoV-2 Serologic Assays in Control and Unknown Populations Demonstrate the Necessity of Virus Neutralization Testing.",NA,"2021","07","12","J Infect Dis","The Journal of infectious diseases",NA,"Stokes","Caleb","Department of Immunology, Center for Innate Immunity and Immune Disease, University of Washington, Seattle, Washington, USA",NA
"858","34250540","10.1093/infdis/jiab198","Corrigendum to: SARS-CoV-2 Serologic Assays in Control and Unknown Populations Demonstrate the Necessity of Virus Neutralization Testing.",NA,"2021","07","12","J Infect Dis","The Journal of infectious diseases",NA,"Hsiang","Tien-Ying","Department of Immunology, Center for Innate Immunity and Immune Disease, University of Washington, Seattle, Washington, USA",NA
"859","34250540","10.1093/infdis/jiab198","Corrigendum to: SARS-CoV-2 Serologic Assays in Control and Unknown Populations Demonstrate the Necessity of Virus Neutralization Testing.",NA,"2021","07","12","J Infect Dis","The Journal of infectious diseases",NA,"Netland","Jason","Department of Immunology, Center for Innate Immunity and Immune Disease, University of Washington, Seattle, Washington, USA",NA
"860","34250540","10.1093/infdis/jiab198","Corrigendum to: SARS-CoV-2 Serologic Assays in Control and Unknown Populations Demonstrate the Necessity of Virus Neutralization Testing.",NA,"2021","07","12","J Infect Dis","The Journal of infectious diseases",NA,"Takehara","Kennidy K","Department of Immunology, Center for Innate Immunity and Immune Disease, University of Washington, Seattle, Washington, USA",NA
"861","34250540","10.1093/infdis/jiab198","Corrigendum to: SARS-CoV-2 Serologic Assays in Control and Unknown Populations Demonstrate the Necessity of Virus Neutralization Testing.",NA,"2021","07","12","J Infect Dis","The Journal of infectious diseases",NA,"Pepper","Marion","Department of Immunology, Center for Innate Immunity and Immune Disease, University of Washington, Seattle, Washington, USA",NA
"862","34250540","10.1093/infdis/jiab198","Corrigendum to: SARS-CoV-2 Serologic Assays in Control and Unknown Populations Demonstrate the Necessity of Virus Neutralization Testing.",NA,"2021","07","12","J Infect Dis","The Journal of infectious diseases",NA,"Gale","Michael","Department of Immunology, Center for Innate Immunity and Immune Disease, University of Washington, Seattle, Washington, USA",NA
"863","34250530","10.1039/d1an00893e","Cross-validation of ELISA and a portable surface plasmon resonance instrument for IgG antibody serology with SARS-CoV-2 positive individuals.","We report on the development of surface plasmon resonance (SPR) sensors and matching ELISAs for the detection of nucleocapsid and spike antibodies specific against the novel coronavirus 2019 (SARS-CoV-2) in human serum, plasma and dried blood spots (DBS). When exposed to SARS-CoV-2 or a vaccine against SARS-CoV-2, the immune system responds by expressing antibodies at levels that can be detected and monitored to identify the fraction of the population potentially immunized against SARS-CoV-2 and","2021","07","16","Analyst","The Analyst",NA,"Djaileb","Abdelhadi","Department of Chemistry, Department of Biochemistry and PROTEO, The Québec Network for Research on Protein Function, Engineering and Applications, Université de Montréal, CP 6128 Succ. Centre-Ville, Montreal, Québec H3C 3J7, Canada. joelle.pelletier@umontreal.ca and Affinité Instruments, 1250 rue Guy, Suite 600, Montréal, Québec H3H 2L3, Canada","joelle.pelletier@umontreal.ca"
"864","34250530","10.1039/d1an00893e","Cross-validation of ELISA and a portable surface plasmon resonance instrument for IgG antibody serology with SARS-CoV-2 positive individuals.","We report on the development of surface plasmon resonance (SPR) sensors and matching ELISAs for the detection of nucleocapsid and spike antibodies specific against the novel coronavirus 2019 (SARS-CoV-2) in human serum, plasma and dried blood spots (DBS). When exposed to SARS-CoV-2 or a vaccine against SARS-CoV-2, the immune system responds by expressing antibodies at levels that can be detected and monitored to identify the fraction of the population potentially immunized against SARS-CoV-2 and","2021","07","16","Analyst","The Analyst",NA,"Hojjat Jodaylami","Maryam","Department of Chemistry, Quebec Centre for Advanced Materials (QCAM), Regroupement Québécois sur les Matériaux de Pointe (RQMP), and Centre interdisciplinaire de recherche sur le cerveau et l'apprentissage (CIRCA), Université de Montréal, CP 6128 Succ. Centre-Ville, Montreal, Québec H3C 3J7, Canada. jf.masson@umontreal","jf.masson@umontreal.ca"
"865","34250530","10.1039/d1an00893e","Cross-validation of ELISA and a portable surface plasmon resonance instrument for IgG antibody serology with SARS-CoV-2 positive individuals.","We report on the development of surface plasmon resonance (SPR) sensors and matching ELISAs for the detection of nucleocapsid and spike antibodies specific against the novel coronavirus 2019 (SARS-CoV-2) in human serum, plasma and dried blood spots (DBS). When exposed to SARS-CoV-2 or a vaccine against SARS-CoV-2, the immune system responds by expressing antibodies at levels that can be detected and monitored to identify the fraction of the population potentially immunized against SARS-CoV-2 and","2021","07","16","Analyst","The Analyst",NA,"Coutu","Julien","Department of Chemistry, Quebec Centre for Advanced Materials (QCAM), Regroupement Québécois sur les Matériaux de Pointe (RQMP), and Centre interdisciplinaire de recherche sur le cerveau et l'apprentissage (CIRCA), Université de Montréal, CP 6128 Succ. Centre-Ville, Montreal, Québec H3C 3J7, Canada. jf.masson@umontreal","jf.masson@umontreal.ca"
"866","34250530","10.1039/d1an00893e","Cross-validation of ELISA and a portable surface plasmon resonance instrument for IgG antibody serology with SARS-CoV-2 positive individuals.","We report on the development of surface plasmon resonance (SPR) sensors and matching ELISAs for the detection of nucleocapsid and spike antibodies specific against the novel coronavirus 2019 (SARS-CoV-2) in human serum, plasma and dried blood spots (DBS). When exposed to SARS-CoV-2 or a vaccine against SARS-CoV-2, the immune system responds by expressing antibodies at levels that can be detected and monitored to identify the fraction of the population potentially immunized against SARS-CoV-2 and","2021","07","16","Analyst","The Analyst",NA,"Ricard","Pierre","Department of Chemistry, Quebec Centre for Advanced Materials (QCAM), Regroupement Québécois sur les Matériaux de Pointe (RQMP), and Centre interdisciplinaire de recherche sur le cerveau et l'apprentissage (CIRCA), Université de Montréal, CP 6128 Succ. Centre-Ville, Montreal, Québec H3C 3J7, Canada. jf.masson@umontreal","jf.masson@umontreal.ca"
"867","34250530","10.1039/d1an00893e","Cross-validation of ELISA and a portable surface plasmon resonance instrument for IgG antibody serology with SARS-CoV-2 positive individuals.","We report on the development of surface plasmon resonance (SPR) sensors and matching ELISAs for the detection of nucleocapsid and spike antibodies specific against the novel coronavirus 2019 (SARS-CoV-2) in human serum, plasma and dried blood spots (DBS). When exposed to SARS-CoV-2 or a vaccine against SARS-CoV-2, the immune system responds by expressing antibodies at levels that can be detected and monitored to identify the fraction of the population potentially immunized against SARS-CoV-2 and","2021","07","16","Analyst","The Analyst",NA,"Lamarre","Mathieu","Department of Chemistry and Centre for Optics, Photonics and Lasers (COPL), Université Laval, 1045, av. de la Médecine, Québec City, Québec G1V 0A6, Canada",NA
"868","34250530","10.1039/d1an00893e","Cross-validation of ELISA and a portable surface plasmon resonance instrument for IgG antibody serology with SARS-CoV-2 positive individuals.","We report on the development of surface plasmon resonance (SPR) sensors and matching ELISAs for the detection of nucleocapsid and spike antibodies specific against the novel coronavirus 2019 (SARS-CoV-2) in human serum, plasma and dried blood spots (DBS). When exposed to SARS-CoV-2 or a vaccine against SARS-CoV-2, the immune system responds by expressing antibodies at levels that can be detected and monitored to identify the fraction of the population potentially immunized against SARS-CoV-2 and","2021","07","16","Analyst","The Analyst",NA,"Rochet","Léa","Department of Chemistry, Department of Biochemistry and PROTEO, The Québec Network for Research on Protein Function, Engineering and Applications, Université de Montréal, CP 6128 Succ. Centre-Ville, Montreal, Québec H3C 3J7, Canada. joelle.pelletier@umontreal","joelle.pelletier@umontreal.ca"
"869","34250530","10.1039/d1an00893e","Cross-validation of ELISA and a portable surface plasmon resonance instrument for IgG antibody serology with SARS-CoV-2 positive individuals.","We report on the development of surface plasmon resonance (SPR) sensors and matching ELISAs for the detection of nucleocapsid and spike antibodies specific against the novel coronavirus 2019 (SARS-CoV-2) in human serum, plasma and dried blood spots (DBS). When exposed to SARS-CoV-2 or a vaccine against SARS-CoV-2, the immune system responds by expressing antibodies at levels that can be detected and monitored to identify the fraction of the population potentially immunized against SARS-CoV-2 and","2021","07","16","Analyst","The Analyst",NA,"Cellier-Goetghebeur","Stella","Department of Chemistry, Department of Biochemistry and PROTEO, The Québec Network for Research on Protein Function, Engineering and Applications, Université de Montréal, CP 6128 Succ. Centre-Ville, Montreal, Québec H3C 3J7, Canada. joelle.pelletier@umontreal","joelle.pelletier@umontreal.ca"
"870","34250530","10.1039/d1an00893e","Cross-validation of ELISA and a portable surface plasmon resonance instrument for IgG antibody serology with SARS-CoV-2 positive individuals.","We report on the development of surface plasmon resonance (SPR) sensors and matching ELISAs for the detection of nucleocapsid and spike antibodies specific against the novel coronavirus 2019 (SARS-CoV-2) in human serum, plasma and dried blood spots (DBS). When exposed to SARS-CoV-2 or a vaccine against SARS-CoV-2, the immune system responds by expressing antibodies at levels that can be detected and monitored to identify the fraction of the population potentially immunized against SARS-CoV-2 and","2021","07","16","Analyst","The Analyst",NA,"Macaulay","Devin","Department of Chemistry and Centre for Optics, Photonics and Lasers (COPL), Université Laval, 1045, av. de la Médecine, Québec City, Québec G1V 0A6, Canada",NA
"871","34250530","10.1039/d1an00893e","Cross-validation of ELISA and a portable surface plasmon resonance instrument for IgG antibody serology with SARS-CoV-2 positive individuals.","We report on the development of surface plasmon resonance (SPR) sensors and matching ELISAs for the detection of nucleocapsid and spike antibodies specific against the novel coronavirus 2019 (SARS-CoV-2) in human serum, plasma and dried blood spots (DBS). When exposed to SARS-CoV-2 or a vaccine against SARS-CoV-2, the immune system responds by expressing antibodies at levels that can be detected and monitored to identify the fraction of the population potentially immunized against SARS-CoV-2 and","2021","07","16","Analyst","The Analyst",NA,"Charron","Benjamin","Department of Chemistry, Quebec Centre for Advanced Materials (QCAM), Regroupement Québécois sur les Matériaux de Pointe (RQMP), and Centre interdisciplinaire de recherche sur le cerveau et l'apprentissage (CIRCA), Université de Montréal, CP 6128 Succ. Centre-Ville, Montreal, Québec H3C 3J7, Canada. jf.masson@umontreal","jf.masson@umontreal.ca"
"872","34250530","10.1039/d1an00893e","Cross-validation of ELISA and a portable surface plasmon resonance instrument for IgG antibody serology with SARS-CoV-2 positive individuals.","We report on the development of surface plasmon resonance (SPR) sensors and matching ELISAs for the detection of nucleocapsid and spike antibodies specific against the novel coronavirus 2019 (SARS-CoV-2) in human serum, plasma and dried blood spots (DBS). When exposed to SARS-CoV-2 or a vaccine against SARS-CoV-2, the immune system responds by expressing antibodies at levels that can be detected and monitored to identify the fraction of the population potentially immunized against SARS-CoV-2 and","2021","07","16","Analyst","The Analyst",NA,"Lavallée","Étienne","Department of Chemistry, Department of Biochemistry and PROTEO, The Québec Network for Research on Protein Function, Engineering and Applications, Université de Montréal, CP 6128 Succ. Centre-Ville, Montreal, Québec H3C 3J7, Canada. joelle.pelletier@umontreal","joelle.pelletier@umontreal.ca"
"873","34250530","10.1039/d1an00893e","Cross-validation of ELISA and a portable surface plasmon resonance instrument for IgG antibody serology with SARS-CoV-2 positive individuals.","We report on the development of surface plasmon resonance (SPR) sensors and matching ELISAs for the detection of nucleocapsid and spike antibodies specific against the novel coronavirus 2019 (SARS-CoV-2) in human serum, plasma and dried blood spots (DBS). When exposed to SARS-CoV-2 or a vaccine against SARS-CoV-2, the immune system responds by expressing antibodies at levels that can be detected and monitored to identify the fraction of the population potentially immunized against SARS-CoV-2 and","2021","07","16","Analyst","The Analyst",NA,"Thibault","Vincent","Department of Chemistry, Quebec Centre for Advanced Materials (QCAM), Regroupement Québécois sur les Matériaux de Pointe (RQMP), and Centre interdisciplinaire de recherche sur le cerveau et l'apprentissage (CIRCA), Université de Montréal, CP 6128 Succ. Centre-Ville, Montreal, Québec H3C 3J7, Canada. jf.masson@umontreal","jf.masson@umontreal.ca"
"874","34250530","10.1039/d1an00893e","Cross-validation of ELISA and a portable surface plasmon resonance instrument for IgG antibody serology with SARS-CoV-2 positive individuals.","We report on the development of surface plasmon resonance (SPR) sensors and matching ELISAs for the detection of nucleocapsid and spike antibodies specific against the novel coronavirus 2019 (SARS-CoV-2) in human serum, plasma and dried blood spots (DBS). When exposed to SARS-CoV-2 or a vaccine against SARS-CoV-2, the immune system responds by expressing antibodies at levels that can be detected and monitored to identify the fraction of the population potentially immunized against SARS-CoV-2 and","2021","07","16","Analyst","The Analyst",NA,"Stevenson","Keisean","Department of Chemistry, Quebec Centre for Advanced Materials (QCAM), Regroupement Québécois sur les Matériaux de Pointe (RQMP), and Centre interdisciplinaire de recherche sur le cerveau et l'apprentissage (CIRCA), Université de Montréal, CP 6128 Succ. Centre-Ville, Montreal, Québec H3C 3J7, Canada. jf.masson@umontreal","jf.masson@umontreal.ca"
"875","34250530","10.1039/d1an00893e","Cross-validation of ELISA and a portable surface plasmon resonance instrument for IgG antibody serology with SARS-CoV-2 positive individuals.","We report on the development of surface plasmon resonance (SPR) sensors and matching ELISAs for the detection of nucleocapsid and spike antibodies specific against the novel coronavirus 2019 (SARS-CoV-2) in human serum, plasma and dried blood spots (DBS). When exposed to SARS-CoV-2 or a vaccine against SARS-CoV-2, the immune system responds by expressing antibodies at levels that can be detected and monitored to identify the fraction of the population potentially immunized against SARS-CoV-2 and","2021","07","16","Analyst","The Analyst",NA,"Forest","Simon","Department of Chemistry, Quebec Centre for Advanced Materials (QCAM), Regroupement Québécois sur les Matériaux de Pointe (RQMP), and Centre interdisciplinaire de recherche sur le cerveau et l'apprentissage (CIRCA), Université de Montréal, CP 6128 Succ. Centre-Ville, Montreal, Québec H3C 3J7, Canada. jf.masson@umontreal","jf.masson@umontreal.ca"
"876","34250530","10.1039/d1an00893e","Cross-validation of ELISA and a portable surface plasmon resonance instrument for IgG antibody serology with SARS-CoV-2 positive individuals.","We report on the development of surface plasmon resonance (SPR) sensors and matching ELISAs for the detection of nucleocapsid and spike antibodies specific against the novel coronavirus 2019 (SARS-CoV-2) in human serum, plasma and dried blood spots (DBS). When exposed to SARS-CoV-2 or a vaccine against SARS-CoV-2, the immune system responds by expressing antibodies at levels that can be detected and monitored to identify the fraction of the population potentially immunized against SARS-CoV-2 and","2021","07","16","Analyst","The Analyst",NA,"Live","Ludovic S","Affinité Instruments, 1250 rue Guy, Suite 600, Montréal, Québec H3H 2L3, Canada",NA
"877","34250530","10.1039/d1an00893e","Cross-validation of ELISA and a portable surface plasmon resonance instrument for IgG antibody serology with SARS-CoV-2 positive individuals.","We report on the development of surface plasmon resonance (SPR) sensors and matching ELISAs for the detection of nucleocapsid and spike antibodies specific against the novel coronavirus 2019 (SARS-CoV-2) in human serum, plasma and dried blood spots (DBS). When exposed to SARS-CoV-2 or a vaccine against SARS-CoV-2, the immune system responds by expressing antibodies at levels that can be detected and monitored to identify the fraction of the population potentially immunized against SARS-CoV-2 and","2021","07","16","Analyst","The Analyst",NA,"Abonnenc","Nanouk","CNETE and PROTEO, The Québec Network for Research on Protein Function, Engineering and Applications, Cégep de Shawinigan, 2263 Avenue du Collège, Shawinigan, Québec G9N 6 V8, Canada",NA
"878","34250530","10.1039/d1an00893e","Cross-validation of ELISA and a portable surface plasmon resonance instrument for IgG antibody serology with SARS-CoV-2 positive individuals.","We report on the development of surface plasmon resonance (SPR) sensors and matching ELISAs for the detection of nucleocapsid and spike antibodies specific against the novel coronavirus 2019 (SARS-CoV-2) in human serum, plasma and dried blood spots (DBS). When exposed to SARS-CoV-2 or a vaccine against SARS-CoV-2, the immune system responds by expressing antibodies at levels that can be detected and monitored to identify the fraction of the population potentially immunized against SARS-CoV-2 and","2021","07","16","Analyst","The Analyst",NA,"Guedon","Anthony","CNETE and PROTEO, The Québec Network for Research on Protein Function, Engineering and Applications, Cégep de Shawinigan, 2263 Avenue du Collège, Shawinigan, Québec G9N 6 V8, Canada",NA
"879","34250530","10.1039/d1an00893e","Cross-validation of ELISA and a portable surface plasmon resonance instrument for IgG antibody serology with SARS-CoV-2 positive individuals.","We report on the development of surface plasmon resonance (SPR) sensors and matching ELISAs for the detection of nucleocapsid and spike antibodies specific against the novel coronavirus 2019 (SARS-CoV-2) in human serum, plasma and dried blood spots (DBS). When exposed to SARS-CoV-2 or a vaccine against SARS-CoV-2, the immune system responds by expressing antibodies at levels that can be detected and monitored to identify the fraction of the population potentially immunized against SARS-CoV-2 and","2021","07","16","Analyst","The Analyst",NA,"Quessy","Patrik","CNETE and PROTEO, The Québec Network for Research on Protein Function, Engineering and Applications, Cégep de Shawinigan, 2263 Avenue du Collège, Shawinigan, Québec G9N 6 V8, Canada",NA
"880","34250530","10.1039/d1an00893e","Cross-validation of ELISA and a portable surface plasmon resonance instrument for IgG antibody serology with SARS-CoV-2 positive individuals.","We report on the development of surface plasmon resonance (SPR) sensors and matching ELISAs for the detection of nucleocapsid and spike antibodies specific against the novel coronavirus 2019 (SARS-CoV-2) in human serum, plasma and dried blood spots (DBS). When exposed to SARS-CoV-2 or a vaccine against SARS-CoV-2, the immune system responds by expressing antibodies at levels that can be detected and monitored to identify the fraction of the population potentially immunized against SARS-CoV-2 and","2021","07","16","Analyst","The Analyst",NA,"Lemay","Jean-François","CNETE and PROTEO, The Québec Network for Research on Protein Function, Engineering and Applications, Cégep de Shawinigan, 2263 Avenue du Collège, Shawinigan, Québec G9N 6 V8, Canada",NA
"881","34250530","10.1039/d1an00893e","Cross-validation of ELISA and a portable surface plasmon resonance instrument for IgG antibody serology with SARS-CoV-2 positive individuals.","We report on the development of surface plasmon resonance (SPR) sensors and matching ELISAs for the detection of nucleocapsid and spike antibodies specific against the novel coronavirus 2019 (SARS-CoV-2) in human serum, plasma and dried blood spots (DBS). When exposed to SARS-CoV-2 or a vaccine against SARS-CoV-2, the immune system responds by expressing antibodies at levels that can be detected and monitored to identify the fraction of the population potentially immunized against SARS-CoV-2 and","2021","07","16","Analyst","The Analyst",NA,"Farnós","Omar","Department of Bioengineering, McGill University McConnell Engineering Building, 3480 University Street, Montreal, Québec H3A 0E9, Canada",NA
"882","34250530","10.1039/d1an00893e","Cross-validation of ELISA and a portable surface plasmon resonance instrument for IgG antibody serology with SARS-CoV-2 positive individuals.","We report on the development of surface plasmon resonance (SPR) sensors and matching ELISAs for the detection of nucleocapsid and spike antibodies specific against the novel coronavirus 2019 (SARS-CoV-2) in human serum, plasma and dried blood spots (DBS). When exposed to SARS-CoV-2 or a vaccine against SARS-CoV-2, the immune system responds by expressing antibodies at levels that can be detected and monitored to identify the fraction of the population potentially immunized against SARS-CoV-2 and","2021","07","16","Analyst","The Analyst",NA,"Kamen","Amine","Department of Bioengineering, McGill University McConnell Engineering Building, 3480 University Street, Montreal, Québec H3A 0E9, Canada",NA
"883","34250530","10.1039/d1an00893e","Cross-validation of ELISA and a portable surface plasmon resonance instrument for IgG antibody serology with SARS-CoV-2 positive individuals.","We report on the development of surface plasmon resonance (SPR) sensors and matching ELISAs for the detection of nucleocapsid and spike antibodies specific against the novel coronavirus 2019 (SARS-CoV-2) in human serum, plasma and dried blood spots (DBS). When exposed to SARS-CoV-2 or a vaccine against SARS-CoV-2, the immune system responds by expressing antibodies at levels that can be detected and monitored to identify the fraction of the population potentially immunized against SARS-CoV-2 and","2021","07","16","Analyst","The Analyst",NA,"Stuible","Matthew","Mammalian Cell Expression, Human Health Therapeutics Research Centre, National Research Council Canada, Montréal, Québec, Canada",NA
"884","34250530","10.1039/d1an00893e","Cross-validation of ELISA and a portable surface plasmon resonance instrument for IgG antibody serology with SARS-CoV-2 positive individuals.","We report on the development of surface plasmon resonance (SPR) sensors and matching ELISAs for the detection of nucleocapsid and spike antibodies specific against the novel coronavirus 2019 (SARS-CoV-2) in human serum, plasma and dried blood spots (DBS). When exposed to SARS-CoV-2 or a vaccine against SARS-CoV-2, the immune system responds by expressing antibodies at levels that can be detected and monitored to identify the fraction of the population potentially immunized against SARS-CoV-2 and","2021","07","16","Analyst","The Analyst",NA,"Gervais","Christian","Mammalian Cell Expression, Human Health Therapeutics Research Centre, National Research Council Canada, Montréal, Québec, Canada",NA
"885","34250530","10.1039/d1an00893e","Cross-validation of ELISA and a portable surface plasmon resonance instrument for IgG antibody serology with SARS-CoV-2 positive individuals.","We report on the development of surface plasmon resonance (SPR) sensors and matching ELISAs for the detection of nucleocapsid and spike antibodies specific against the novel coronavirus 2019 (SARS-CoV-2) in human serum, plasma and dried blood spots (DBS). When exposed to SARS-CoV-2 or a vaccine against SARS-CoV-2, the immune system responds by expressing antibodies at levels that can be detected and monitored to identify the fraction of the population potentially immunized against SARS-CoV-2 and","2021","07","16","Analyst","The Analyst",NA,"Durocher","Yves","Mammalian Cell Expression, Human Health Therapeutics Research Centre, National Research Council Canada, Montréal, Québec, Canada",NA
"886","34250530","10.1039/d1an00893e","Cross-validation of ELISA and a portable surface plasmon resonance instrument for IgG antibody serology with SARS-CoV-2 positive individuals.","We report on the development of surface plasmon resonance (SPR) sensors and matching ELISAs for the detection of nucleocapsid and spike antibodies specific against the novel coronavirus 2019 (SARS-CoV-2) in human serum, plasma and dried blood spots (DBS). When exposed to SARS-CoV-2 or a vaccine against SARS-CoV-2, the immune system responds by expressing antibodies at levels that can be detected and monitored to identify the fraction of the population potentially immunized against SARS-CoV-2 and","2021","07","16","Analyst","The Analyst",NA,"Cholette","François","National Laboratory for HIV Reference Services, National Microbiology Laboratory at the JC Wilt Infectious Diseases Research Centre, Public Health Agency of Canada, Winnipeg, Canada and Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Canada",NA
"887","34250530","10.1039/d1an00893e","Cross-validation of ELISA and a portable surface plasmon resonance instrument for IgG antibody serology with SARS-CoV-2 positive individuals.","We report on the development of surface plasmon resonance (SPR) sensors and matching ELISAs for the detection of nucleocapsid and spike antibodies specific against the novel coronavirus 2019 (SARS-CoV-2) in human serum, plasma and dried blood spots (DBS). When exposed to SARS-CoV-2 or a vaccine against SARS-CoV-2, the immune system responds by expressing antibodies at levels that can be detected and monitored to identify the fraction of the population potentially immunized against SARS-CoV-2 and","2021","07","16","Analyst","The Analyst",NA,"Mesa","Christine","National Laboratory for HIV Reference Services, National Microbiology Laboratory at the JC Wilt Infectious Diseases Research Centre, Public Health Agency of Canada, Winnipeg, Canada",NA
"888","34250530","10.1039/d1an00893e","Cross-validation of ELISA and a portable surface plasmon resonance instrument for IgG antibody serology with SARS-CoV-2 positive individuals.","We report on the development of surface plasmon resonance (SPR) sensors and matching ELISAs for the detection of nucleocapsid and spike antibodies specific against the novel coronavirus 2019 (SARS-CoV-2) in human serum, plasma and dried blood spots (DBS). When exposed to SARS-CoV-2 or a vaccine against SARS-CoV-2, the immune system responds by expressing antibodies at levels that can be detected and monitored to identify the fraction of the population potentially immunized against SARS-CoV-2 and","2021","07","16","Analyst","The Analyst",NA,"Kim","John","National Laboratory for HIV Reference Services, National Microbiology Laboratory at the JC Wilt Infectious Diseases Research Centre, Public Health Agency of Canada, Winnipeg, Canada",NA
"889","34250530","10.1039/d1an00893e","Cross-validation of ELISA and a portable surface plasmon resonance instrument for IgG antibody serology with SARS-CoV-2 positive individuals.","We report on the development of surface plasmon resonance (SPR) sensors and matching ELISAs for the detection of nucleocapsid and spike antibodies specific against the novel coronavirus 2019 (SARS-CoV-2) in human serum, plasma and dried blood spots (DBS). When exposed to SARS-CoV-2 or a vaccine against SARS-CoV-2, the immune system responds by expressing antibodies at levels that can be detected and monitored to identify the fraction of the population potentially immunized against SARS-CoV-2 and","2021","07","16","Analyst","The Analyst",NA,"Cayer","Marie-Pierre","Héma-Québec, Affaires médicales et innovation, 1070, avenue des Sciences-de-la-Vie, Québec City, G1V 5C3, Québec, Canada",NA
"890","34250530","10.1039/d1an00893e","Cross-validation of ELISA and a portable surface plasmon resonance instrument for IgG antibody serology with SARS-CoV-2 positive individuals.","We report on the development of surface plasmon resonance (SPR) sensors and matching ELISAs for the detection of nucleocapsid and spike antibodies specific against the novel coronavirus 2019 (SARS-CoV-2) in human serum, plasma and dried blood spots (DBS). When exposed to SARS-CoV-2 or a vaccine against SARS-CoV-2, the immune system responds by expressing antibodies at levels that can be detected and monitored to identify the fraction of the population potentially immunized against SARS-CoV-2 and","2021","07","16","Analyst","The Analyst",NA,"de Grandmont","Marie-Joëlle","Héma-Québec, Affaires médicales et innovation, 1070, avenue des Sciences-de-la-Vie, Québec City, G1V 5C3, Québec, Canada",NA
"891","34250530","10.1039/d1an00893e","Cross-validation of ELISA and a portable surface plasmon resonance instrument for IgG antibody serology with SARS-CoV-2 positive individuals.","We report on the development of surface plasmon resonance (SPR) sensors and matching ELISAs for the detection of nucleocapsid and spike antibodies specific against the novel coronavirus 2019 (SARS-CoV-2) in human serum, plasma and dried blood spots (DBS). When exposed to SARS-CoV-2 or a vaccine against SARS-CoV-2, the immune system responds by expressing antibodies at levels that can be detected and monitored to identify the fraction of the population potentially immunized against SARS-CoV-2 and","2021","07","16","Analyst","The Analyst",NA,"Brouard","Danny","Héma-Québec, Affaires médicales et innovation, 1070, avenue des Sciences-de-la-Vie, Québec City, G1V 5C3, Québec, Canada",NA
"892","34250530","10.1039/d1an00893e","Cross-validation of ELISA and a portable surface plasmon resonance instrument for IgG antibody serology with SARS-CoV-2 positive individuals.","We report on the development of surface plasmon resonance (SPR) sensors and matching ELISAs for the detection of nucleocapsid and spike antibodies specific against the novel coronavirus 2019 (SARS-CoV-2) in human serum, plasma and dried blood spots (DBS). When exposed to SARS-CoV-2 or a vaccine against SARS-CoV-2, the immune system responds by expressing antibodies at levels that can be detected and monitored to identify the fraction of the population potentially immunized against SARS-CoV-2 and","2021","07","16","Analyst","The Analyst",NA,"Trottier","Sylvie","Centre de recherche du Centre hospitalier universitaire de Québec and Département de microbiologie-infectiologie et d'immunologie, Université Laval 2705, boulevard Laurier, Québec City, Québec, Canada G1V 4G2",NA
"893","34250530","10.1039/d1an00893e","Cross-validation of ELISA and a portable surface plasmon resonance instrument for IgG antibody serology with SARS-CoV-2 positive individuals.","We report on the development of surface plasmon resonance (SPR) sensors and matching ELISAs for the detection of nucleocapsid and spike antibodies specific against the novel coronavirus 2019 (SARS-CoV-2) in human serum, plasma and dried blood spots (DBS). When exposed to SARS-CoV-2 or a vaccine against SARS-CoV-2, the immune system responds by expressing antibodies at levels that can be detected and monitored to identify the fraction of the population potentially immunized against SARS-CoV-2 and","2021","07","16","Analyst","The Analyst",NA,"Boudreau","Denis","Department of Chemistry and Centre for Optics, Photonics and Lasers (COPL), Université Laval, 1045, av. de la Médecine, Québec City, Québec G1V 0A6, Canada",NA
"894","34250530","10.1039/d1an00893e","Cross-validation of ELISA and a portable surface plasmon resonance instrument for IgG antibody serology with SARS-CoV-2 positive individuals.","We report on the development of surface plasmon resonance (SPR) sensors and matching ELISAs for the detection of nucleocapsid and spike antibodies specific against the novel coronavirus 2019 (SARS-CoV-2) in human serum, plasma and dried blood spots (DBS). When exposed to SARS-CoV-2 or a vaccine against SARS-CoV-2, the immune system responds by expressing antibodies at levels that can be detected and monitored to identify the fraction of the population potentially immunized against SARS-CoV-2 and","2021","07","16","Analyst","The Analyst",NA,"Pelletier","Joelle N","Department of Chemistry, Department of Biochemistry and PROTEO, The Québec Network for Research on Protein Function, Engineering and Applications, Université de Montréal, CP 6128 Succ. Centre-Ville, Montreal, Québec H3C 3J7, Canada. joelle.pelletier@umontreal","joelle.pelletier@umontreal.ca"
"895","34250530","10.1039/d1an00893e","Cross-validation of ELISA and a portable surface plasmon resonance instrument for IgG antibody serology with SARS-CoV-2 positive individuals.","We report on the development of surface plasmon resonance (SPR) sensors and matching ELISAs for the detection of nucleocapsid and spike antibodies specific against the novel coronavirus 2019 (SARS-CoV-2) in human serum, plasma and dried blood spots (DBS). When exposed to SARS-CoV-2 or a vaccine against SARS-CoV-2, the immune system responds by expressing antibodies at levels that can be detected and monitored to identify the fraction of the population potentially immunized against SARS-CoV-2 and","2021","07","16","Analyst","The Analyst",NA,"Masson","Jean-Francois","Department of Chemistry, Quebec Centre for Advanced Materials (QCAM), Regroupement Québécois sur les Matériaux de Pointe (RQMP), and Centre interdisciplinaire de recherche sur le cerveau et l'apprentissage (CIRCA), Université de Montréal, CP 6128 Succ. Centre-Ville, Montreal, Québec H3C 3J7, Canada. jf.masson@umontreal","jf.masson@umontreal.ca"
"896","34250523","10.1007/s11528-021-00626-4","Preparing Teachers to Teach in K-12 Blended Environments: A Systematic Mapping Review of Research Trends, Impact, and Themes.","Despite evidence concerning the widespread growth of K-12 blended teaching and the impact that emergency remote teaching during the COVID-19 pandemic has had on the spread of K-12 online and blended teaching, we could find no systematic reviews focused on preparing K-12 teachers for blended teaching. Previous literature reviews, such as those from Halverson et al. (2012) and Drysdale et al. (2013), have noted the lack of research focused on K-12 blended teaching contexts. This systematic mapping","2021","07","13","TechTrends","TechTrends : for leaders in education &amp; training","Blended learning; K-12; Literature review; Professional development; Teacher education","Short","Cecil R","Texas Tech University, Lubbock, TX USA",NA
"897","34250523","10.1007/s11528-021-00626-4","Preparing Teachers to Teach in K-12 Blended Environments: A Systematic Mapping Review of Research Trends, Impact, and Themes.","Despite evidence concerning the widespread growth of K-12 blended teaching and the impact that emergency remote teaching during the COVID-19 pandemic has had on the spread of K-12 online and blended teaching, we could find no systematic reviews focused on preparing K-12 teachers for blended teaching. Previous literature reviews, such as those from Halverson et al. (2012) and Drysdale et al. (2013), have noted the lack of research focused on K-12 blended teaching contexts. This systematic mapping","2021","07","13","TechTrends","TechTrends : for leaders in education &amp; training","Blended learning; K-12; Literature review; Professional development; Teacher education","Graham","Charles R","Brigham Young University, Provo, UT USA",NA
"898","34250523","10.1007/s11528-021-00626-4","Preparing Teachers to Teach in K-12 Blended Environments: A Systematic Mapping Review of Research Trends, Impact, and Themes.","Despite evidence concerning the widespread growth of K-12 blended teaching and the impact that emergency remote teaching during the COVID-19 pandemic has had on the spread of K-12 online and blended teaching, we could find no systematic reviews focused on preparing K-12 teachers for blended teaching. Previous literature reviews, such as those from Halverson et al. (2012) and Drysdale et al. (2013), have noted the lack of research focused on K-12 blended teaching contexts. This systematic mapping","2021","07","13","TechTrends","TechTrends : for leaders in education &amp; training","Blended learning; K-12; Literature review; Professional development; Teacher education","Holmes","Theresa","Brigham Young University, Provo, UT USA",NA
"899","34250523","10.1007/s11528-021-00626-4","Preparing Teachers to Teach in K-12 Blended Environments: A Systematic Mapping Review of Research Trends, Impact, and Themes.","Despite evidence concerning the widespread growth of K-12 blended teaching and the impact that emergency remote teaching during the COVID-19 pandemic has had on the spread of K-12 online and blended teaching, we could find no systematic reviews focused on preparing K-12 teachers for blended teaching. Previous literature reviews, such as those from Halverson et al. (2012) and Drysdale et al. (2013), have noted the lack of research focused on K-12 blended teaching contexts. This systematic mapping","2021","07","13","TechTrends","TechTrends : for leaders in education &amp; training","Blended learning; K-12; Literature review; Professional development; Teacher education","Oviatt","Laura","Brigham Young University, Provo, UT USA",NA
"900","34250523","10.1007/s11528-021-00626-4","Preparing Teachers to Teach in K-12 Blended Environments: A Systematic Mapping Review of Research Trends, Impact, and Themes.","Despite evidence concerning the widespread growth of K-12 blended teaching and the impact that emergency remote teaching during the COVID-19 pandemic has had on the spread of K-12 online and blended teaching, we could find no systematic reviews focused on preparing K-12 teachers for blended teaching. Previous literature reviews, such as those from Halverson et al. (2012) and Drysdale et al. (2013), have noted the lack of research focused on K-12 blended teaching contexts. This systematic mapping","2021","07","13","TechTrends","TechTrends : for leaders in education &amp; training","Blended learning; K-12; Literature review; Professional development; Teacher education","Bateman","Hannah","Brigham Young University, Provo, UT USA",NA
"901","34250522","10.1089/tmr.2021.0007","A Pilot Trial Using Telemedicine in Radiation Oncology: The Future of Health Care Is Virtual.","Background: Social determinants of health directly affect cancer survival. Driven by advances in technology and recent demands due to COVID-19, telemedicine has the ability to improve patient access to care, lower health care costs, and increase workflow efficiency. The role of telemedicine in radiation oncology is not established. Materials and Methods: We conducted an IRB-approved pilot trial using a telehealth platform for the first post-radiation visit in patients with any canc","2021","07","13","Telemed Rep","Telemedicine reports","e-health; patient satisfaction; provider satisfaction; radiation oncology; telemedicine","Miller","Ryan C","Department of Radiation Oncology, Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, USA",NA
"902","34250522","10.1089/tmr.2021.0007","A Pilot Trial Using Telemedicine in Radiation Oncology: The Future of Health Care Is Virtual.","Background: Social determinants of health directly affect cancer survival. Driven by advances in technology and recent demands due to COVID-19, telemedicine has the ability to improve patient access to care, lower health care costs, and increase workflow efficiency. The role of telemedicine in radiation oncology is not established. Materials and Methods: We conducted an IRB-approved pilot trial using a telehealth platform for the first post-radiation visit in patients with any canc","2021","07","13","Telemed Rep","Telemedicine reports","e-health; patient satisfaction; provider satisfaction; radiation oncology; telemedicine","Simone","Brittany A","Department of Radiation Oncology, Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, USA",NA
"903","34250522","10.1089/tmr.2021.0007","A Pilot Trial Using Telemedicine in Radiation Oncology: The Future of Health Care Is Virtual.","Background: Social determinants of health directly affect cancer survival. Driven by advances in technology and recent demands due to COVID-19, telemedicine has the ability to improve patient access to care, lower health care costs, and increase workflow efficiency. The role of telemedicine in radiation oncology is not established. Materials and Methods: We conducted an IRB-approved pilot trial using a telehealth platform for the first post-radiation visit in patients with any canc","2021","07","13","Telemed Rep","Telemedicine reports","e-health; patient satisfaction; provider satisfaction; radiation oncology; telemedicine","Lombardo","Joseph F","Department of Radiation Oncology, Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, USA",NA
"904","34250522","10.1089/tmr.2021.0007","A Pilot Trial Using Telemedicine in Radiation Oncology: The Future of Health Care Is Virtual.","Background: Social determinants of health directly affect cancer survival. Driven by advances in technology and recent demands due to COVID-19, telemedicine has the ability to improve patient access to care, lower health care costs, and increase workflow efficiency. The role of telemedicine in radiation oncology is not established. Materials and Methods: We conducted an IRB-approved pilot trial using a telehealth platform for the first post-radiation visit in patients with any canc","2021","07","13","Telemed Rep","Telemedicine reports","e-health; patient satisfaction; provider satisfaction; radiation oncology; telemedicine","Taylor","James","Department of Radiation Oncology, Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, USA",NA
"905","34250522","10.1089/tmr.2021.0007","A Pilot Trial Using Telemedicine in Radiation Oncology: The Future of Health Care Is Virtual.","Background: Social determinants of health directly affect cancer survival. Driven by advances in technology and recent demands due to COVID-19, telemedicine has the ability to improve patient access to care, lower health care costs, and increase workflow efficiency. The role of telemedicine in radiation oncology is not established. Materials and Methods: We conducted an IRB-approved pilot trial using a telehealth platform for the first post-radiation visit in patients with any canc","2021","07","13","Telemed Rep","Telemedicine reports","e-health; patient satisfaction; provider satisfaction; radiation oncology; telemedicine","Nowak-Choi","Kamila","Department of Radiation Oncology, Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, USA",NA
"906","34250522","10.1089/tmr.2021.0007","A Pilot Trial Using Telemedicine in Radiation Oncology: The Future of Health Care Is Virtual.","Background: Social determinants of health directly affect cancer survival. Driven by advances in technology and recent demands due to COVID-19, telemedicine has the ability to improve patient access to care, lower health care costs, and increase workflow efficiency. The role of telemedicine in radiation oncology is not established. Materials and Methods: We conducted an IRB-approved pilot trial using a telehealth platform for the first post-radiation visit in patients with any canc","2021","07","13","Telemed Rep","Telemedicine reports","e-health; patient satisfaction; provider satisfaction; radiation oncology; telemedicine","Ko","Kevin","Department of Radiation Oncology, Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, USA",NA
"907","34250522","10.1089/tmr.2021.0007","A Pilot Trial Using Telemedicine in Radiation Oncology: The Future of Health Care Is Virtual.","Background: Social determinants of health directly affect cancer survival. Driven by advances in technology and recent demands due to COVID-19, telemedicine has the ability to improve patient access to care, lower health care costs, and increase workflow efficiency. The role of telemedicine in radiation oncology is not established. Materials and Methods: We conducted an IRB-approved pilot trial using a telehealth platform for the first post-radiation visit in patients with any canc","2021","07","13","Telemed Rep","Telemedicine reports","e-health; patient satisfaction; provider satisfaction; radiation oncology; telemedicine","Ferguson","Linda","Department of Radiation Oncology, Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, USA",NA
"908","34250522","10.1089/tmr.2021.0007","A Pilot Trial Using Telemedicine in Radiation Oncology: The Future of Health Care Is Virtual.","Background: Social determinants of health directly affect cancer survival. Driven by advances in technology and recent demands due to COVID-19, telemedicine has the ability to improve patient access to care, lower health care costs, and increase workflow efficiency. The role of telemedicine in radiation oncology is not established. Materials and Methods: We conducted an IRB-approved pilot trial using a telehealth platform for the first post-radiation visit in patients with any canc","2021","07","13","Telemed Rep","Telemedicine reports","e-health; patient satisfaction; provider satisfaction; radiation oncology; telemedicine","Donnelly","Ann","Department of Radiation Oncology, Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, USA",NA
"909","34250522","10.1089/tmr.2021.0007","A Pilot Trial Using Telemedicine in Radiation Oncology: The Future of Health Care Is Virtual.","Background: Social determinants of health directly affect cancer survival. Driven by advances in technology and recent demands due to COVID-19, telemedicine has the ability to improve patient access to care, lower health care costs, and increase workflow efficiency. The role of telemedicine in radiation oncology is not established. Materials and Methods: We conducted an IRB-approved pilot trial using a telehealth platform for the first post-radiation visit in patients with any canc","2021","07","13","Telemed Rep","Telemedicine reports","e-health; patient satisfaction; provider satisfaction; radiation oncology; telemedicine","Ali","Ayesha S","Department of Radiation Oncology, Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, USA",NA
"910","34250522","10.1089/tmr.2021.0007","A Pilot Trial Using Telemedicine in Radiation Oncology: The Future of Health Care Is Virtual.","Background: Social determinants of health directly affect cancer survival. Driven by advances in technology and recent demands due to COVID-19, telemedicine has the ability to improve patient access to care, lower health care costs, and increase workflow efficiency. The role of telemedicine in radiation oncology is not established. Materials and Methods: We conducted an IRB-approved pilot trial using a telehealth platform for the first post-radiation visit in patients with any canc","2021","07","13","Telemed Rep","Telemedicine reports","e-health; patient satisfaction; provider satisfaction; radiation oncology; telemedicine","Shi","Wenyin","Department of Radiation Oncology, Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, USA",NA
"911","34250522","10.1089/tmr.2021.0007","A Pilot Trial Using Telemedicine in Radiation Oncology: The Future of Health Care Is Virtual.","Background: Social determinants of health directly affect cancer survival. Driven by advances in technology and recent demands due to COVID-19, telemedicine has the ability to improve patient access to care, lower health care costs, and increase workflow efficiency. The role of telemedicine in radiation oncology is not established. Materials and Methods: We conducted an IRB-approved pilot trial using a telehealth platform for the first post-radiation visit in patients with any canc","2021","07","13","Telemed Rep","Telemedicine reports","e-health; patient satisfaction; provider satisfaction; radiation oncology; telemedicine","Dicker","Adam P","Department of Radiation Oncology, Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, USA",NA
"912","34250522","10.1089/tmr.2021.0007","A Pilot Trial Using Telemedicine in Radiation Oncology: The Future of Health Care Is Virtual.","Background: Social determinants of health directly affect cancer survival. Driven by advances in technology and recent demands due to COVID-19, telemedicine has the ability to improve patient access to care, lower health care costs, and increase workflow efficiency. The role of telemedicine in radiation oncology is not established. Materials and Methods: We conducted an IRB-approved pilot trial using a telehealth platform for the first post-radiation visit in patients with any canc","2021","07","13","Telemed Rep","Telemedicine reports","e-health; patient satisfaction; provider satisfaction; radiation oncology; telemedicine","Simone","Nicole L","Department of Radiation Oncology, Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, USA",NA
"913","34250519","10.1016/j.lanepe.2021.100162","Anosmia as a predictor for post-COVID-19 fatigue syndrome.",NA,"2021","07","20","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Wostyn","Peter","Department of Psychiatry, PC Sint-Amandus, Reigerlostraat 10, 8730 Beernem, Belgium",NA
"914","34250518","10.1016/j.lanepe.2021.100150","Decreased infectivity following BNT162b2 vaccination: A prospective cohort study in Israel.","BNT162b2 was shown to be 92% effective in preventing COVID-19. Prioritizing vaccine rollout, and achievement of herd immunity depend on SARS-CoV-2 transmission reduction. The vaccine's effect on infectivity is thus a critical priority. Among all 9650 HCW of a large tertiary medical center in Israel, we calculated the prevalence of positive SARS-CoV-2 qRT-PCR cases with asymptomatic presentation, tested following known or presumed exposure and the infectious subset (N-gene-Ct-value&lt;30) of thes","2021","07","13","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Regev-Yochay","Gili","Infection Prevention &amp",NA
"915","34250518","10.1016/j.lanepe.2021.100150","Decreased infectivity following BNT162b2 vaccination: A prospective cohort study in Israel.","BNT162b2 was shown to be 92% effective in preventing COVID-19. Prioritizing vaccine rollout, and achievement of herd immunity depend on SARS-CoV-2 transmission reduction. The vaccine's effect on infectivity is thus a critical priority. Among all 9650 HCW of a large tertiary medical center in Israel, we calculated the prevalence of positive SARS-CoV-2 qRT-PCR cases with asymptomatic presentation, tested following known or presumed exposure and the infectious subset (N-gene-Ct-value&lt;30) of thes","2021","07","13","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Amit","Sharon","Clinical Microbiology, Sheba Medical Center, Ramat Gan, Israel",NA
"916","34250518","10.1016/j.lanepe.2021.100150","Decreased infectivity following BNT162b2 vaccination: A prospective cohort study in Israel.","BNT162b2 was shown to be 92% effective in preventing COVID-19. Prioritizing vaccine rollout, and achievement of herd immunity depend on SARS-CoV-2 transmission reduction. The vaccine's effect on infectivity is thus a critical priority. Among all 9650 HCW of a large tertiary medical center in Israel, we calculated the prevalence of positive SARS-CoV-2 qRT-PCR cases with asymptomatic presentation, tested following known or presumed exposure and the infectious subset (N-gene-Ct-value&lt;30) of thes","2021","07","13","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Bergwerk","Moriah","Infection Prevention &amp",NA
"917","34250518","10.1016/j.lanepe.2021.100150","Decreased infectivity following BNT162b2 vaccination: A prospective cohort study in Israel.","BNT162b2 was shown to be 92% effective in preventing COVID-19. Prioritizing vaccine rollout, and achievement of herd immunity depend on SARS-CoV-2 transmission reduction. The vaccine's effect on infectivity is thus a critical priority. Among all 9650 HCW of a large tertiary medical center in Israel, we calculated the prevalence of positive SARS-CoV-2 qRT-PCR cases with asymptomatic presentation, tested following known or presumed exposure and the infectious subset (N-gene-Ct-value&lt;30) of thes","2021","07","13","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Lipsitch","Marc","Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard Chan School of Public Health, Boston, MA",NA
"918","34250518","10.1016/j.lanepe.2021.100150","Decreased infectivity following BNT162b2 vaccination: A prospective cohort study in Israel.","BNT162b2 was shown to be 92% effective in preventing COVID-19. Prioritizing vaccine rollout, and achievement of herd immunity depend on SARS-CoV-2 transmission reduction. The vaccine's effect on infectivity is thus a critical priority. Among all 9650 HCW of a large tertiary medical center in Israel, we calculated the prevalence of positive SARS-CoV-2 qRT-PCR cases with asymptomatic presentation, tested following known or presumed exposure and the infectious subset (N-gene-Ct-value&lt;30) of thes","2021","07","13","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Leshem","Eyal","Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel",NA
"919","34250518","10.1016/j.lanepe.2021.100150","Decreased infectivity following BNT162b2 vaccination: A prospective cohort study in Israel.","BNT162b2 was shown to be 92% effective in preventing COVID-19. Prioritizing vaccine rollout, and achievement of herd immunity depend on SARS-CoV-2 transmission reduction. The vaccine's effect on infectivity is thus a critical priority. Among all 9650 HCW of a large tertiary medical center in Israel, we calculated the prevalence of positive SARS-CoV-2 qRT-PCR cases with asymptomatic presentation, tested following known or presumed exposure and the infectious subset (N-gene-Ct-value&lt;30) of thes","2021","07","13","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Kahn","Rebecca","Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard Chan School of Public Health, Boston, MA",NA
"920","34250518","10.1016/j.lanepe.2021.100150","Decreased infectivity following BNT162b2 vaccination: A prospective cohort study in Israel.","BNT162b2 was shown to be 92% effective in preventing COVID-19. Prioritizing vaccine rollout, and achievement of herd immunity depend on SARS-CoV-2 transmission reduction. The vaccine's effect on infectivity is thus a critical priority. Among all 9650 HCW of a large tertiary medical center in Israel, we calculated the prevalence of positive SARS-CoV-2 qRT-PCR cases with asymptomatic presentation, tested following known or presumed exposure and the infectious subset (N-gene-Ct-value&lt;30) of thes","2021","07","13","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Lustig","Yaniv","Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel",NA
"921","34250518","10.1016/j.lanepe.2021.100150","Decreased infectivity following BNT162b2 vaccination: A prospective cohort study in Israel.","BNT162b2 was shown to be 92% effective in preventing COVID-19. Prioritizing vaccine rollout, and achievement of herd immunity depend on SARS-CoV-2 transmission reduction. The vaccine's effect on infectivity is thus a critical priority. Among all 9650 HCW of a large tertiary medical center in Israel, we calculated the prevalence of positive SARS-CoV-2 qRT-PCR cases with asymptomatic presentation, tested following known or presumed exposure and the infectious subset (N-gene-Ct-value&lt;30) of thes","2021","07","13","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Cohen","Carmit","Infection Prevention &amp",NA
"922","34250518","10.1016/j.lanepe.2021.100150","Decreased infectivity following BNT162b2 vaccination: A prospective cohort study in Israel.","BNT162b2 was shown to be 92% effective in preventing COVID-19. Prioritizing vaccine rollout, and achievement of herd immunity depend on SARS-CoV-2 transmission reduction. The vaccine's effect on infectivity is thus a critical priority. Among all 9650 HCW of a large tertiary medical center in Israel, we calculated the prevalence of positive SARS-CoV-2 qRT-PCR cases with asymptomatic presentation, tested following known or presumed exposure and the infectious subset (N-gene-Ct-value&lt;30) of thes","2021","07","13","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Doolman","Ram","Central laboratory, Sheba Medical Center, Ramat Gan, Israel",NA
"923","34250518","10.1016/j.lanepe.2021.100150","Decreased infectivity following BNT162b2 vaccination: A prospective cohort study in Israel.","BNT162b2 was shown to be 92% effective in preventing COVID-19. Prioritizing vaccine rollout, and achievement of herd immunity depend on SARS-CoV-2 transmission reduction. The vaccine's effect on infectivity is thus a critical priority. Among all 9650 HCW of a large tertiary medical center in Israel, we calculated the prevalence of positive SARS-CoV-2 qRT-PCR cases with asymptomatic presentation, tested following known or presumed exposure and the infectious subset (N-gene-Ct-value&lt;30) of thes","2021","07","13","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Ziv","Arnona","Gertner Institute for Epidemiology &amp",NA
"924","34250518","10.1016/j.lanepe.2021.100150","Decreased infectivity following BNT162b2 vaccination: A prospective cohort study in Israel.","BNT162b2 was shown to be 92% effective in preventing COVID-19. Prioritizing vaccine rollout, and achievement of herd immunity depend on SARS-CoV-2 transmission reduction. The vaccine's effect on infectivity is thus a critical priority. Among all 9650 HCW of a large tertiary medical center in Israel, we calculated the prevalence of positive SARS-CoV-2 qRT-PCR cases with asymptomatic presentation, tested following known or presumed exposure and the infectious subset (N-gene-Ct-value&lt;30) of thes","2021","07","13","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Novikov","Ilya","Gertner Institute for Epidemiology &amp",NA
"925","34250518","10.1016/j.lanepe.2021.100150","Decreased infectivity following BNT162b2 vaccination: A prospective cohort study in Israel.","BNT162b2 was shown to be 92% effective in preventing COVID-19. Prioritizing vaccine rollout, and achievement of herd immunity depend on SARS-CoV-2 transmission reduction. The vaccine's effect on infectivity is thus a critical priority. Among all 9650 HCW of a large tertiary medical center in Israel, we calculated the prevalence of positive SARS-CoV-2 qRT-PCR cases with asymptomatic presentation, tested following known or presumed exposure and the infectious subset (N-gene-Ct-value&lt;30) of thes","2021","07","13","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Rubin","Carmit","Infection Prevention &amp",NA
"926","34250518","10.1016/j.lanepe.2021.100150","Decreased infectivity following BNT162b2 vaccination: A prospective cohort study in Israel.","BNT162b2 was shown to be 92% effective in preventing COVID-19. Prioritizing vaccine rollout, and achievement of herd immunity depend on SARS-CoV-2 transmission reduction. The vaccine's effect on infectivity is thus a critical priority. Among all 9650 HCW of a large tertiary medical center in Israel, we calculated the prevalence of positive SARS-CoV-2 qRT-PCR cases with asymptomatic presentation, tested following known or presumed exposure and the infectious subset (N-gene-Ct-value&lt;30) of thes","2021","07","13","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Gimpelevich","Irena","Gertner Institute for Epidemiology &amp",NA
"927","34250518","10.1016/j.lanepe.2021.100150","Decreased infectivity following BNT162b2 vaccination: A prospective cohort study in Israel.","BNT162b2 was shown to be 92% effective in preventing COVID-19. Prioritizing vaccine rollout, and achievement of herd immunity depend on SARS-CoV-2 transmission reduction. The vaccine's effect on infectivity is thus a critical priority. Among all 9650 HCW of a large tertiary medical center in Israel, we calculated the prevalence of positive SARS-CoV-2 qRT-PCR cases with asymptomatic presentation, tested following known or presumed exposure and the infectious subset (N-gene-Ct-value&lt;30) of thes","2021","07","13","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Huppert","Amit","Gertner Institute for Epidemiology &amp",NA
"928","34250518","10.1016/j.lanepe.2021.100150","Decreased infectivity following BNT162b2 vaccination: A prospective cohort study in Israel.","BNT162b2 was shown to be 92% effective in preventing COVID-19. Prioritizing vaccine rollout, and achievement of herd immunity depend on SARS-CoV-2 transmission reduction. The vaccine's effect on infectivity is thus a critical priority. Among all 9650 HCW of a large tertiary medical center in Israel, we calculated the prevalence of positive SARS-CoV-2 qRT-PCR cases with asymptomatic presentation, tested following known or presumed exposure and the infectious subset (N-gene-Ct-value&lt;30) of thes","2021","07","13","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Rahav","Galia","Infecious Disease Unit, Sheba Medical Center, Ramat Gan, Israel",NA
"929","34250518","10.1016/j.lanepe.2021.100150","Decreased infectivity following BNT162b2 vaccination: A prospective cohort study in Israel.","BNT162b2 was shown to be 92% effective in preventing COVID-19. Prioritizing vaccine rollout, and achievement of herd immunity depend on SARS-CoV-2 transmission reduction. The vaccine's effect on infectivity is thus a critical priority. Among all 9650 HCW of a large tertiary medical center in Israel, we calculated the prevalence of positive SARS-CoV-2 qRT-PCR cases with asymptomatic presentation, tested following known or presumed exposure and the infectious subset (N-gene-Ct-value&lt;30) of thes","2021","07","13","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Afek","Arnon","Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel",NA
"930","34250518","10.1016/j.lanepe.2021.100150","Decreased infectivity following BNT162b2 vaccination: A prospective cohort study in Israel.","BNT162b2 was shown to be 92% effective in preventing COVID-19. Prioritizing vaccine rollout, and achievement of herd immunity depend on SARS-CoV-2 transmission reduction. The vaccine's effect on infectivity is thus a critical priority. Among all 9650 HCW of a large tertiary medical center in Israel, we calculated the prevalence of positive SARS-CoV-2 qRT-PCR cases with asymptomatic presentation, tested following known or presumed exposure and the infectious subset (N-gene-Ct-value&lt;30) of thes","2021","07","13","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Kreiss","Yitshak","Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel",NA
"931","34250517","10.1016/j.lanwpc.2021.100208","Recovery after Covid-19.",NA,"2021","07","13","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific",NA,"van den Borst","Bram","Radboud University Medical Center, Department of Pulmonary Diseases, Nijmegen, The Netherlands",NA
"932","34250516","10.1016/j.lanwpc.2021.100155","Reduction of hospitalisations and increased mortality for acute coronary syndromes during covid-19 era: <i>Not all countries are equal</i>.",NA,"2021","07","13","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","Acute coronary syndromes; COVID-19; Myocardial infarction","Spaccarotella","Carmen","Division of Cardiology, Center fo Cardiovascular Research, University Magna Graecia, Catanzaro, Italy",NA
"933","34250516","10.1016/j.lanwpc.2021.100155","Reduction of hospitalisations and increased mortality for acute coronary syndromes during covid-19 era: <i>Not all countries are equal</i>.",NA,"2021","07","13","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","Acute coronary syndromes; COVID-19; Myocardial infarction","Sorrentino","Sabato","Division of Cardiology, Center fo Cardiovascular Research, University Magna Graecia, Catanzaro, Italy",NA
"934","34250516","10.1016/j.lanwpc.2021.100155","Reduction of hospitalisations and increased mortality for acute coronary syndromes during covid-19 era: <i>Not all countries are equal</i>.",NA,"2021","07","13","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","Acute coronary syndromes; COVID-19; Myocardial infarction","Indolfi","Ciro","Division of Cardiology, Center fo Cardiovascular Research, University Magna Graecia, Catanzaro, Italy",NA
"935","34250515","10.1016/S2666-5247(21)00146-4","Blood transcriptional biomarkers of acute viral infection for detection of pre-symptomatic SARS-CoV-2 infection: a nested, case-control diagnostic accuracy study.","We hypothesised that host-response biomarkers of viral infections might contribute to early identification of individuals infected with SARS-CoV-2, which is critical to breaking the chains of transmission. We aimed to evaluate the diagnostic accuracy of existing candidate whole-blood transcriptomic signatures for viral infection to predict positivity of nasopharyngeal SARS-CoV-2 PCR testing. We did a nested case-control diagnostic accuracy study among a prospective cohort of health-care workers ","2021","07","21","Lancet Microbe","The Lancet. Microbe",NA,"Gupta","Rishi K","Institute of Global Health, University College London, London, UK",NA
"936","34250515","10.1016/S2666-5247(21)00146-4","Blood transcriptional biomarkers of acute viral infection for detection of pre-symptomatic SARS-CoV-2 infection: a nested, case-control diagnostic accuracy study.","We hypothesised that host-response biomarkers of viral infections might contribute to early identification of individuals infected with SARS-CoV-2, which is critical to breaking the chains of transmission. We aimed to evaluate the diagnostic accuracy of existing candidate whole-blood transcriptomic signatures for viral infection to predict positivity of nasopharyngeal SARS-CoV-2 PCR testing. We did a nested case-control diagnostic accuracy study among a prospective cohort of health-care workers ","2021","07","21","Lancet Microbe","The Lancet. Microbe",NA,"Rosenheim","Joshua","Division of Infection and Immunity, University College London, London, UK",NA
"937","34250515","10.1016/S2666-5247(21)00146-4","Blood transcriptional biomarkers of acute viral infection for detection of pre-symptomatic SARS-CoV-2 infection: a nested, case-control diagnostic accuracy study.","We hypothesised that host-response biomarkers of viral infections might contribute to early identification of individuals infected with SARS-CoV-2, which is critical to breaking the chains of transmission. We aimed to evaluate the diagnostic accuracy of existing candidate whole-blood transcriptomic signatures for viral infection to predict positivity of nasopharyngeal SARS-CoV-2 PCR testing. We did a nested case-control diagnostic accuracy study among a prospective cohort of health-care workers ","2021","07","21","Lancet Microbe","The Lancet. Microbe",NA,"Bell","Lucy C","Division of Infection and Immunity, University College London, London, UK",NA
"938","34250515","10.1016/S2666-5247(21)00146-4","Blood transcriptional biomarkers of acute viral infection for detection of pre-symptomatic SARS-CoV-2 infection: a nested, case-control diagnostic accuracy study.","We hypothesised that host-response biomarkers of viral infections might contribute to early identification of individuals infected with SARS-CoV-2, which is critical to breaking the chains of transmission. We aimed to evaluate the diagnostic accuracy of existing candidate whole-blood transcriptomic signatures for viral infection to predict positivity of nasopharyngeal SARS-CoV-2 PCR testing. We did a nested case-control diagnostic accuracy study among a prospective cohort of health-care workers ","2021","07","21","Lancet Microbe","The Lancet. Microbe",NA,"Chandran","Aneesh","Division of Infection and Immunity, University College London, London, UK",NA
"939","34250515","10.1016/S2666-5247(21)00146-4","Blood transcriptional biomarkers of acute viral infection for detection of pre-symptomatic SARS-CoV-2 infection: a nested, case-control diagnostic accuracy study.","We hypothesised that host-response biomarkers of viral infections might contribute to early identification of individuals infected with SARS-CoV-2, which is critical to breaking the chains of transmission. We aimed to evaluate the diagnostic accuracy of existing candidate whole-blood transcriptomic signatures for viral infection to predict positivity of nasopharyngeal SARS-CoV-2 PCR testing. We did a nested case-control diagnostic accuracy study among a prospective cohort of health-care workers ","2021","07","21","Lancet Microbe","The Lancet. Microbe",NA,"Guerra-Assuncao","Jose A","Division of Infection and Immunity, University College London, London, UK",NA
"940","34250515","10.1016/S2666-5247(21)00146-4","Blood transcriptional biomarkers of acute viral infection for detection of pre-symptomatic SARS-CoV-2 infection: a nested, case-control diagnostic accuracy study.","We hypothesised that host-response biomarkers of viral infections might contribute to early identification of individuals infected with SARS-CoV-2, which is critical to breaking the chains of transmission. We aimed to evaluate the diagnostic accuracy of existing candidate whole-blood transcriptomic signatures for viral infection to predict positivity of nasopharyngeal SARS-CoV-2 PCR testing. We did a nested case-control diagnostic accuracy study among a prospective cohort of health-care workers ","2021","07","21","Lancet Microbe","The Lancet. Microbe",NA,"Pollara","Gabriele","Division of Infection and Immunity, University College London, London, UK",NA
"941","34250515","10.1016/S2666-5247(21)00146-4","Blood transcriptional biomarkers of acute viral infection for detection of pre-symptomatic SARS-CoV-2 infection: a nested, case-control diagnostic accuracy study.","We hypothesised that host-response biomarkers of viral infections might contribute to early identification of individuals infected with SARS-CoV-2, which is critical to breaking the chains of transmission. We aimed to evaluate the diagnostic accuracy of existing candidate whole-blood transcriptomic signatures for viral infection to predict positivity of nasopharyngeal SARS-CoV-2 PCR testing. We did a nested case-control diagnostic accuracy study among a prospective cohort of health-care workers ","2021","07","21","Lancet Microbe","The Lancet. Microbe",NA,"Whelan","Matthew","Division of Infection and Immunity, University College London, London, UK",NA
"942","34250515","10.1016/S2666-5247(21)00146-4","Blood transcriptional biomarkers of acute viral infection for detection of pre-symptomatic SARS-CoV-2 infection: a nested, case-control diagnostic accuracy study.","We hypothesised that host-response biomarkers of viral infections might contribute to early identification of individuals infected with SARS-CoV-2, which is critical to breaking the chains of transmission. We aimed to evaluate the diagnostic accuracy of existing candidate whole-blood transcriptomic signatures for viral infection to predict positivity of nasopharyngeal SARS-CoV-2 PCR testing. We did a nested case-control diagnostic accuracy study among a prospective cohort of health-care workers ","2021","07","21","Lancet Microbe","The Lancet. Microbe",NA,"Artico","Jessica","Barts Heart Centre, St Bartholomew's Hospital, Barts Health NHS Trust, London, UK",NA
"943","34250515","10.1016/S2666-5247(21)00146-4","Blood transcriptional biomarkers of acute viral infection for detection of pre-symptomatic SARS-CoV-2 infection: a nested, case-control diagnostic accuracy study.","We hypothesised that host-response biomarkers of viral infections might contribute to early identification of individuals infected with SARS-CoV-2, which is critical to breaking the chains of transmission. We aimed to evaluate the diagnostic accuracy of existing candidate whole-blood transcriptomic signatures for viral infection to predict positivity of nasopharyngeal SARS-CoV-2 PCR testing. We did a nested case-control diagnostic accuracy study among a prospective cohort of health-care workers ","2021","07","21","Lancet Microbe","The Lancet. Microbe",NA,"Joy","George","Barts Heart Centre, St Bartholomew's Hospital, Barts Health NHS Trust, London, UK",NA
"944","34250515","10.1016/S2666-5247(21)00146-4","Blood transcriptional biomarkers of acute viral infection for detection of pre-symptomatic SARS-CoV-2 infection: a nested, case-control diagnostic accuracy study.","We hypothesised that host-response biomarkers of viral infections might contribute to early identification of individuals infected with SARS-CoV-2, which is critical to breaking the chains of transmission. We aimed to evaluate the diagnostic accuracy of existing candidate whole-blood transcriptomic signatures for viral infection to predict positivity of nasopharyngeal SARS-CoV-2 PCR testing. We did a nested case-control diagnostic accuracy study among a prospective cohort of health-care workers ","2021","07","21","Lancet Microbe","The Lancet. Microbe",NA,"Kurdi","Hibba","Barts Heart Centre, St Bartholomew's Hospital, Barts Health NHS Trust, London, UK",NA
"945","34250515","10.1016/S2666-5247(21)00146-4","Blood transcriptional biomarkers of acute viral infection for detection of pre-symptomatic SARS-CoV-2 infection: a nested, case-control diagnostic accuracy study.","We hypothesised that host-response biomarkers of viral infections might contribute to early identification of individuals infected with SARS-CoV-2, which is critical to breaking the chains of transmission. We aimed to evaluate the diagnostic accuracy of existing candidate whole-blood transcriptomic signatures for viral infection to predict positivity of nasopharyngeal SARS-CoV-2 PCR testing. We did a nested case-control diagnostic accuracy study among a prospective cohort of health-care workers ","2021","07","21","Lancet Microbe","The Lancet. Microbe",NA,"Altmann","Daniel M","Department of Immunology and Inflammation, Imperial College London, London, UK",NA
"946","34250515","10.1016/S2666-5247(21)00146-4","Blood transcriptional biomarkers of acute viral infection for detection of pre-symptomatic SARS-CoV-2 infection: a nested, case-control diagnostic accuracy study.","We hypothesised that host-response biomarkers of viral infections might contribute to early identification of individuals infected with SARS-CoV-2, which is critical to breaking the chains of transmission. We aimed to evaluate the diagnostic accuracy of existing candidate whole-blood transcriptomic signatures for viral infection to predict positivity of nasopharyngeal SARS-CoV-2 PCR testing. We did a nested case-control diagnostic accuracy study among a prospective cohort of health-care workers ","2021","07","21","Lancet Microbe","The Lancet. Microbe",NA,"Boyton","Rosemary J","Lung Division, Royal Brompton &amp",NA
"947","34250515","10.1016/S2666-5247(21)00146-4","Blood transcriptional biomarkers of acute viral infection for detection of pre-symptomatic SARS-CoV-2 infection: a nested, case-control diagnostic accuracy study.","We hypothesised that host-response biomarkers of viral infections might contribute to early identification of individuals infected with SARS-CoV-2, which is critical to breaking the chains of transmission. We aimed to evaluate the diagnostic accuracy of existing candidate whole-blood transcriptomic signatures for viral infection to predict positivity of nasopharyngeal SARS-CoV-2 PCR testing. We did a nested case-control diagnostic accuracy study among a prospective cohort of health-care workers ","2021","07","21","Lancet Microbe","The Lancet. Microbe",NA,"Maini","Mala K","Division of Infection and Immunity, University College London, London, UK",NA
"948","34250515","10.1016/S2666-5247(21)00146-4","Blood transcriptional biomarkers of acute viral infection for detection of pre-symptomatic SARS-CoV-2 infection: a nested, case-control diagnostic accuracy study.","We hypothesised that host-response biomarkers of viral infections might contribute to early identification of individuals infected with SARS-CoV-2, which is critical to breaking the chains of transmission. We aimed to evaluate the diagnostic accuracy of existing candidate whole-blood transcriptomic signatures for viral infection to predict positivity of nasopharyngeal SARS-CoV-2 PCR testing. We did a nested case-control diagnostic accuracy study among a prospective cohort of health-care workers ","2021","07","21","Lancet Microbe","The Lancet. Microbe",NA,"McKnight","Aine","Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK",NA
"949","34250515","10.1016/S2666-5247(21)00146-4","Blood transcriptional biomarkers of acute viral infection for detection of pre-symptomatic SARS-CoV-2 infection: a nested, case-control diagnostic accuracy study.","We hypothesised that host-response biomarkers of viral infections might contribute to early identification of individuals infected with SARS-CoV-2, which is critical to breaking the chains of transmission. We aimed to evaluate the diagnostic accuracy of existing candidate whole-blood transcriptomic signatures for viral infection to predict positivity of nasopharyngeal SARS-CoV-2 PCR testing. We did a nested case-control diagnostic accuracy study among a prospective cohort of health-care workers ","2021","07","21","Lancet Microbe","The Lancet. Microbe",NA,"Lambourne","Jonathan","Department of Infection, St Bartholomew's Hospital, Barts Health NHS Trust, London, UK",NA
"950","34250515","10.1016/S2666-5247(21)00146-4","Blood transcriptional biomarkers of acute viral infection for detection of pre-symptomatic SARS-CoV-2 infection: a nested, case-control diagnostic accuracy study.","We hypothesised that host-response biomarkers of viral infections might contribute to early identification of individuals infected with SARS-CoV-2, which is critical to breaking the chains of transmission. We aimed to evaluate the diagnostic accuracy of existing candidate whole-blood transcriptomic signatures for viral infection to predict positivity of nasopharyngeal SARS-CoV-2 PCR testing. We did a nested case-control diagnostic accuracy study among a prospective cohort of health-care workers ","2021","07","21","Lancet Microbe","The Lancet. Microbe",NA,"Cutino-Moguel","Teresa","Department of Virology, St Bartholomew's Hospital, Barts Health NHS Trust, London, UK",NA
"951","34250515","10.1016/S2666-5247(21)00146-4","Blood transcriptional biomarkers of acute viral infection for detection of pre-symptomatic SARS-CoV-2 infection: a nested, case-control diagnostic accuracy study.","We hypothesised that host-response biomarkers of viral infections might contribute to early identification of individuals infected with SARS-CoV-2, which is critical to breaking the chains of transmission. We aimed to evaluate the diagnostic accuracy of existing candidate whole-blood transcriptomic signatures for viral infection to predict positivity of nasopharyngeal SARS-CoV-2 PCR testing. We did a nested case-control diagnostic accuracy study among a prospective cohort of health-care workers ","2021","07","21","Lancet Microbe","The Lancet. Microbe",NA,"Manisty","Charlotte","Institute of Cardiovascular Sciences, University College London, London, UK",NA
"952","34250515","10.1016/S2666-5247(21)00146-4","Blood transcriptional biomarkers of acute viral infection for detection of pre-symptomatic SARS-CoV-2 infection: a nested, case-control diagnostic accuracy study.","We hypothesised that host-response biomarkers of viral infections might contribute to early identification of individuals infected with SARS-CoV-2, which is critical to breaking the chains of transmission. We aimed to evaluate the diagnostic accuracy of existing candidate whole-blood transcriptomic signatures for viral infection to predict positivity of nasopharyngeal SARS-CoV-2 PCR testing. We did a nested case-control diagnostic accuracy study among a prospective cohort of health-care workers ","2021","07","21","Lancet Microbe","The Lancet. Microbe",NA,"Treibel","Thomas A","Institute of Cardiovascular Sciences, University College London, London, UK",NA
"953","34250515","10.1016/S2666-5247(21)00146-4","Blood transcriptional biomarkers of acute viral infection for detection of pre-symptomatic SARS-CoV-2 infection: a nested, case-control diagnostic accuracy study.","We hypothesised that host-response biomarkers of viral infections might contribute to early identification of individuals infected with SARS-CoV-2, which is critical to breaking the chains of transmission. We aimed to evaluate the diagnostic accuracy of existing candidate whole-blood transcriptomic signatures for viral infection to predict positivity of nasopharyngeal SARS-CoV-2 PCR testing. We did a nested case-control diagnostic accuracy study among a prospective cohort of health-care workers ","2021","07","21","Lancet Microbe","The Lancet. Microbe",NA,"Moon","James C","Institute of Cardiovascular Sciences, University College London, London, UK",NA
"954","34250515","10.1016/S2666-5247(21)00146-4","Blood transcriptional biomarkers of acute viral infection for detection of pre-symptomatic SARS-CoV-2 infection: a nested, case-control diagnostic accuracy study.","We hypothesised that host-response biomarkers of viral infections might contribute to early identification of individuals infected with SARS-CoV-2, which is critical to breaking the chains of transmission. We aimed to evaluate the diagnostic accuracy of existing candidate whole-blood transcriptomic signatures for viral infection to predict positivity of nasopharyngeal SARS-CoV-2 PCR testing. We did a nested case-control diagnostic accuracy study among a prospective cohort of health-care workers ","2021","07","21","Lancet Microbe","The Lancet. Microbe",NA,"Chain","Benjamin M","Division of Infection and Immunity, University College London, London, UK",NA
"955","34250515","10.1016/S2666-5247(21)00146-4","Blood transcriptional biomarkers of acute viral infection for detection of pre-symptomatic SARS-CoV-2 infection: a nested, case-control diagnostic accuracy study.","We hypothesised that host-response biomarkers of viral infections might contribute to early identification of individuals infected with SARS-CoV-2, which is critical to breaking the chains of transmission. We aimed to evaluate the diagnostic accuracy of existing candidate whole-blood transcriptomic signatures for viral infection to predict positivity of nasopharyngeal SARS-CoV-2 PCR testing. We did a nested case-control diagnostic accuracy study among a prospective cohort of health-care workers ","2021","07","21","Lancet Microbe","The Lancet. Microbe",NA,"Noursadeghi","Mahdad","Division of Infection and Immunity, University College London, London, UK",NA
"956","34250514","10.1016/j.tige.2021.07.001","High rate of percutaneous gastrostomy placement in COVID-19 patients with low overall complications.",NA,"2021","07","13","Tech Innov Gastrointest Endosc","Techniques and innovations in gastrointestinal endoscopy","COVID-19; Coronavirus; PEG; PEG adverse events; percutaneous endoscopic gastrostomy","Lipcsey","Megan","Division of Gastroenterology, Hepatology and Nutrition, University of Pittsburgh Medical Center, Pittsburgh PA",NA
"957","34250514","10.1016/j.tige.2021.07.001","High rate of percutaneous gastrostomy placement in COVID-19 patients with low overall complications.",NA,"2021","07","13","Tech Innov Gastrointest Endosc","Techniques and innovations in gastrointestinal endoscopy","COVID-19; Coronavirus; PEG; PEG adverse events; percutaneous endoscopic gastrostomy","Stein","Daniel J","Division of Gastroenterology, Hepatology and Endoscopy, Brigham and Women's Hospital, Boston MA",NA
"958","34250514","10.1016/j.tige.2021.07.001","High rate of percutaneous gastrostomy placement in COVID-19 patients with low overall complications.",NA,"2021","07","13","Tech Innov Gastrointest Endosc","Techniques and innovations in gastrointestinal endoscopy","COVID-19; Coronavirus; PEG; PEG adverse events; percutaneous endoscopic gastrostomy","Yu","Rosa L","Department of Medicine, Beth Israel Deaconess Medical Center &amp",NA
"959","34250514","10.1016/j.tige.2021.07.001","High rate of percutaneous gastrostomy placement in COVID-19 patients with low overall complications.",NA,"2021","07","13","Tech Innov Gastrointest Endosc","Techniques and innovations in gastrointestinal endoscopy","COVID-19; Coronavirus; PEG; PEG adverse events; percutaneous endoscopic gastrostomy","Anand","Rajsavi","Department of Medicine, Beth Israel Deaconess Medical Center &amp",NA
"960","34250514","10.1016/j.tige.2021.07.001","High rate of percutaneous gastrostomy placement in COVID-19 patients with low overall complications.",NA,"2021","07","13","Tech Innov Gastrointest Endosc","Techniques and innovations in gastrointestinal endoscopy","COVID-19; Coronavirus; PEG; PEG adverse events; percutaneous endoscopic gastrostomy","Bilal","Mohammad","Department of Gastroenterology, University of Minnesota Minneapolis VA Medical Center, Minneapolis, MN",NA
"961","34250514","10.1016/j.tige.2021.07.001","High rate of percutaneous gastrostomy placement in COVID-19 patients with low overall complications.",NA,"2021","07","13","Tech Innov Gastrointest Endosc","Techniques and innovations in gastrointestinal endoscopy","COVID-19; Coronavirus; PEG; PEG adverse events; percutaneous endoscopic gastrostomy","Leibowitz","Akiva","Department of Anesthesiology, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center",NA
"962","34250514","10.1016/j.tige.2021.07.001","High rate of percutaneous gastrostomy placement in COVID-19 patients with low overall complications.",NA,"2021","07","13","Tech Innov Gastrointest Endosc","Techniques and innovations in gastrointestinal endoscopy","COVID-19; Coronavirus; PEG; PEG adverse events; percutaneous endoscopic gastrostomy","Sawhney","Mandeep","Division of Gastroenterology, Beth Israel Deaconess Medical Center &amp",NA
"963","34250514","10.1016/j.tige.2021.07.001","High rate of percutaneous gastrostomy placement in COVID-19 patients with low overall complications.",NA,"2021","07","13","Tech Innov Gastrointest Endosc","Techniques and innovations in gastrointestinal endoscopy","COVID-19; Coronavirus; PEG; PEG adverse events; percutaneous endoscopic gastrostomy","Feuerstein","Joseph D","Division of Gastroenterology, Beth Israel Deaconess Medical Center &amp",NA
"964","34250513","10.1016/j.crviro.2021.100008","Transmission of infectious viruses in the natural setting at human-animal interface.","Most viral pathogens causing epidemics and pandemics are zoonotic, emerging from wildlife reservoirs like SARS CoV2 causing the global Covid-19 pandemic, although animal origin of this virus remains a mystery. Cross-species transmission of pathogens from animals to humans is known as zoonosis. However, pathogens are also transmitted from humans to animals in regions where there is a close interaction between animals and humans by 'reverse transmission' (anthroponosis). Molecular evidence for the","2021","07","13","Curr Res Virol Sci","Current Research in Virological Science",NA,"Nandi","Jayashree S","National Institute of Virology, Pune, India",NA
"965","34250513","10.1016/j.crviro.2021.100008","Transmission of infectious viruses in the natural setting at human-animal interface.","Most viral pathogens causing epidemics and pandemics are zoonotic, emerging from wildlife reservoirs like SARS CoV2 causing the global Covid-19 pandemic, although animal origin of this virus remains a mystery. Cross-species transmission of pathogens from animals to humans is known as zoonosis. However, pathogens are also transmitted from humans to animals in regions where there is a close interaction between animals and humans by 'reverse transmission' (anthroponosis). Molecular evidence for the","2021","07","13","Curr Res Virol Sci","Current Research in Virological Science",NA,"Rathore","Shravan Singh","Senior Wildlife Veterinarian, Machiya Biological Park, Post Office Saran Nagar Jodhpur, 342015, India",NA
"966","34250513","10.1016/j.crviro.2021.100008","Transmission of infectious viruses in the natural setting at human-animal interface.","Most viral pathogens causing epidemics and pandemics are zoonotic, emerging from wildlife reservoirs like SARS CoV2 causing the global Covid-19 pandemic, although animal origin of this virus remains a mystery. Cross-species transmission of pathogens from animals to humans is known as zoonosis. However, pathogens are also transmitted from humans to animals in regions where there is a close interaction between animals and humans by 'reverse transmission' (anthroponosis). Molecular evidence for the","2021","07","13","Curr Res Virol Sci","Current Research in Virological Science",NA,"Mathur","Bajrang Raj","Veterinary Expert, Government Veterinary Services, 6, Kamla Nehru Nagar, 1B1, Jodhpur, 342001, Rajasthan, India",NA
"967","34250512","10.1016/j.xcrm.2021.100354","Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells.","Ending the COVID-19 pandemic will require long-lived immunity to SARS-CoV-2. Here, we evaluate 254 COVID-19 patients longitudinally up to 8 months and find durable broad-based immune responses. SARS-CoV-2 spike binding and neutralizing antibodies exhibit a bi-phasic decay with an extended half-life of &gt;200 days suggesting the generation of longer-lived plasma cells. SARS-CoV-2 infection also boosts antibody titers to SARS-CoV-1 and common betacoronaviruses. In addition, spike-specific IgG+ me","2021","07","22","Cell Rep Med","Cell reports. Medicine","B cells; CD4 T cells; CD8 T cells; COVID-19; SARS-CoV-2; binding antibody; coronaviruses; immune correlates; immune memory; neutralizing antibody","Cohen","Kristen W","Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, 98109, USA",NA
"968","34250512","10.1016/j.xcrm.2021.100354","Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells.","Ending the COVID-19 pandemic will require long-lived immunity to SARS-CoV-2. Here, we evaluate 254 COVID-19 patients longitudinally up to 8 months and find durable broad-based immune responses. SARS-CoV-2 spike binding and neutralizing antibodies exhibit a bi-phasic decay with an extended half-life of &gt;200 days suggesting the generation of longer-lived plasma cells. SARS-CoV-2 infection also boosts antibody titers to SARS-CoV-1 and common betacoronaviruses. In addition, spike-specific IgG+ me","2021","07","22","Cell Rep Med","Cell reports. Medicine","B cells; CD4 T cells; CD8 T cells; COVID-19; SARS-CoV-2; binding antibody; coronaviruses; immune correlates; immune memory; neutralizing antibody","Linderman","Susanne L","Emory Vaccine Center, Emory University, Atlanta, GA 30322, USA",NA
"969","34250512","10.1016/j.xcrm.2021.100354","Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells.","Ending the COVID-19 pandemic will require long-lived immunity to SARS-CoV-2. Here, we evaluate 254 COVID-19 patients longitudinally up to 8 months and find durable broad-based immune responses. SARS-CoV-2 spike binding and neutralizing antibodies exhibit a bi-phasic decay with an extended half-life of &gt;200 days suggesting the generation of longer-lived plasma cells. SARS-CoV-2 infection also boosts antibody titers to SARS-CoV-1 and common betacoronaviruses. In addition, spike-specific IgG+ me","2021","07","22","Cell Rep Med","Cell reports. Medicine","B cells; CD4 T cells; CD8 T cells; COVID-19; SARS-CoV-2; binding antibody; coronaviruses; immune correlates; immune memory; neutralizing antibody","Moodie","Zoe","Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, 98109, USA",NA
"970","34250512","10.1016/j.xcrm.2021.100354","Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells.","Ending the COVID-19 pandemic will require long-lived immunity to SARS-CoV-2. Here, we evaluate 254 COVID-19 patients longitudinally up to 8 months and find durable broad-based immune responses. SARS-CoV-2 spike binding and neutralizing antibodies exhibit a bi-phasic decay with an extended half-life of &gt;200 days suggesting the generation of longer-lived plasma cells. SARS-CoV-2 infection also boosts antibody titers to SARS-CoV-1 and common betacoronaviruses. In addition, spike-specific IgG+ me","2021","07","22","Cell Rep Med","Cell reports. Medicine","B cells; CD4 T cells; CD8 T cells; COVID-19; SARS-CoV-2; binding antibody; coronaviruses; immune correlates; immune memory; neutralizing antibody","Czartoski","Julie","Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, 98109, USA",NA
"971","34250512","10.1016/j.xcrm.2021.100354","Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells.","Ending the COVID-19 pandemic will require long-lived immunity to SARS-CoV-2. Here, we evaluate 254 COVID-19 patients longitudinally up to 8 months and find durable broad-based immune responses. SARS-CoV-2 spike binding and neutralizing antibodies exhibit a bi-phasic decay with an extended half-life of &gt;200 days suggesting the generation of longer-lived plasma cells. SARS-CoV-2 infection also boosts antibody titers to SARS-CoV-1 and common betacoronaviruses. In addition, spike-specific IgG+ me","2021","07","22","Cell Rep Med","Cell reports. Medicine","B cells; CD4 T cells; CD8 T cells; COVID-19; SARS-CoV-2; binding antibody; coronaviruses; immune correlates; immune memory; neutralizing antibody","Lai","Lilin","Emory Vaccine Center, Emory University, Atlanta, GA 30322, USA",NA
"972","34250512","10.1016/j.xcrm.2021.100354","Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells.","Ending the COVID-19 pandemic will require long-lived immunity to SARS-CoV-2. Here, we evaluate 254 COVID-19 patients longitudinally up to 8 months and find durable broad-based immune responses. SARS-CoV-2 spike binding and neutralizing antibodies exhibit a bi-phasic decay with an extended half-life of &gt;200 days suggesting the generation of longer-lived plasma cells. SARS-CoV-2 infection also boosts antibody titers to SARS-CoV-1 and common betacoronaviruses. In addition, spike-specific IgG+ me","2021","07","22","Cell Rep Med","Cell reports. Medicine","B cells; CD4 T cells; CD8 T cells; COVID-19; SARS-CoV-2; binding antibody; coronaviruses; immune correlates; immune memory; neutralizing antibody","Mantus","Grace","Emory Vaccine Center, Emory University, Atlanta, GA 30322, USA",NA
"973","34250512","10.1016/j.xcrm.2021.100354","Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells.","Ending the COVID-19 pandemic will require long-lived immunity to SARS-CoV-2. Here, we evaluate 254 COVID-19 patients longitudinally up to 8 months and find durable broad-based immune responses. SARS-CoV-2 spike binding and neutralizing antibodies exhibit a bi-phasic decay with an extended half-life of &gt;200 days suggesting the generation of longer-lived plasma cells. SARS-CoV-2 infection also boosts antibody titers to SARS-CoV-1 and common betacoronaviruses. In addition, spike-specific IgG+ me","2021","07","22","Cell Rep Med","Cell reports. Medicine","B cells; CD4 T cells; CD8 T cells; COVID-19; SARS-CoV-2; binding antibody; coronaviruses; immune correlates; immune memory; neutralizing antibody","Norwood","Carson","Emory Vaccine Center, Emory University, Atlanta, GA 30322, USA",NA
"974","34250512","10.1016/j.xcrm.2021.100354","Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells.","Ending the COVID-19 pandemic will require long-lived immunity to SARS-CoV-2. Here, we evaluate 254 COVID-19 patients longitudinally up to 8 months and find durable broad-based immune responses. SARS-CoV-2 spike binding and neutralizing antibodies exhibit a bi-phasic decay with an extended half-life of &gt;200 days suggesting the generation of longer-lived plasma cells. SARS-CoV-2 infection also boosts antibody titers to SARS-CoV-1 and common betacoronaviruses. In addition, spike-specific IgG+ me","2021","07","22","Cell Rep Med","Cell reports. Medicine","B cells; CD4 T cells; CD8 T cells; COVID-19; SARS-CoV-2; binding antibody; coronaviruses; immune correlates; immune memory; neutralizing antibody","Nyhoff","Lindsay E","Emory Vaccine Center, Emory University, Atlanta, GA 30322, USA",NA
"975","34250512","10.1016/j.xcrm.2021.100354","Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells.","Ending the COVID-19 pandemic will require long-lived immunity to SARS-CoV-2. Here, we evaluate 254 COVID-19 patients longitudinally up to 8 months and find durable broad-based immune responses. SARS-CoV-2 spike binding and neutralizing antibodies exhibit a bi-phasic decay with an extended half-life of &gt;200 days suggesting the generation of longer-lived plasma cells. SARS-CoV-2 infection also boosts antibody titers to SARS-CoV-1 and common betacoronaviruses. In addition, spike-specific IgG+ me","2021","07","22","Cell Rep Med","Cell reports. Medicine","B cells; CD4 T cells; CD8 T cells; COVID-19; SARS-CoV-2; binding antibody; coronaviruses; immune correlates; immune memory; neutralizing antibody","Edara","Venkata Viswanadh","Emory Vaccine Center, Emory University, Atlanta, GA 30322, USA",NA
"976","34250512","10.1016/j.xcrm.2021.100354","Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells.","Ending the COVID-19 pandemic will require long-lived immunity to SARS-CoV-2. Here, we evaluate 254 COVID-19 patients longitudinally up to 8 months and find durable broad-based immune responses. SARS-CoV-2 spike binding and neutralizing antibodies exhibit a bi-phasic decay with an extended half-life of &gt;200 days suggesting the generation of longer-lived plasma cells. SARS-CoV-2 infection also boosts antibody titers to SARS-CoV-1 and common betacoronaviruses. In addition, spike-specific IgG+ me","2021","07","22","Cell Rep Med","Cell reports. Medicine","B cells; CD4 T cells; CD8 T cells; COVID-19; SARS-CoV-2; binding antibody; coronaviruses; immune correlates; immune memory; neutralizing antibody","Floyd","Katharine","Emory Vaccine Center, Emory University, Atlanta, GA 30322, USA",NA
"977","34250512","10.1016/j.xcrm.2021.100354","Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells.","Ending the COVID-19 pandemic will require long-lived immunity to SARS-CoV-2. Here, we evaluate 254 COVID-19 patients longitudinally up to 8 months and find durable broad-based immune responses. SARS-CoV-2 spike binding and neutralizing antibodies exhibit a bi-phasic decay with an extended half-life of &gt;200 days suggesting the generation of longer-lived plasma cells. SARS-CoV-2 infection also boosts antibody titers to SARS-CoV-1 and common betacoronaviruses. In addition, spike-specific IgG+ me","2021","07","22","Cell Rep Med","Cell reports. Medicine","B cells; CD4 T cells; CD8 T cells; COVID-19; SARS-CoV-2; binding antibody; coronaviruses; immune correlates; immune memory; neutralizing antibody","De Rosa","Stephen C","Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, 98109, USA",NA
"978","34250512","10.1016/j.xcrm.2021.100354","Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells.","Ending the COVID-19 pandemic will require long-lived immunity to SARS-CoV-2. Here, we evaluate 254 COVID-19 patients longitudinally up to 8 months and find durable broad-based immune responses. SARS-CoV-2 spike binding and neutralizing antibodies exhibit a bi-phasic decay with an extended half-life of &gt;200 days suggesting the generation of longer-lived plasma cells. SARS-CoV-2 infection also boosts antibody titers to SARS-CoV-1 and common betacoronaviruses. In addition, spike-specific IgG+ me","2021","07","22","Cell Rep Med","Cell reports. Medicine","B cells; CD4 T cells; CD8 T cells; COVID-19; SARS-CoV-2; binding antibody; coronaviruses; immune correlates; immune memory; neutralizing antibody","Ahmed","Hasan","Department of Biology, Emory University, Atlanta, GA 30322, USA",NA
"979","34250512","10.1016/j.xcrm.2021.100354","Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells.","Ending the COVID-19 pandemic will require long-lived immunity to SARS-CoV-2. Here, we evaluate 254 COVID-19 patients longitudinally up to 8 months and find durable broad-based immune responses. SARS-CoV-2 spike binding and neutralizing antibodies exhibit a bi-phasic decay with an extended half-life of &gt;200 days suggesting the generation of longer-lived plasma cells. SARS-CoV-2 infection also boosts antibody titers to SARS-CoV-1 and common betacoronaviruses. In addition, spike-specific IgG+ me","2021","07","22","Cell Rep Med","Cell reports. Medicine","B cells; CD4 T cells; CD8 T cells; COVID-19; SARS-CoV-2; binding antibody; coronaviruses; immune correlates; immune memory; neutralizing antibody","Whaley","Rachael","Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, 98109, USA",NA
"980","34250512","10.1016/j.xcrm.2021.100354","Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells.","Ending the COVID-19 pandemic will require long-lived immunity to SARS-CoV-2. Here, we evaluate 254 COVID-19 patients longitudinally up to 8 months and find durable broad-based immune responses. SARS-CoV-2 spike binding and neutralizing antibodies exhibit a bi-phasic decay with an extended half-life of &gt;200 days suggesting the generation of longer-lived plasma cells. SARS-CoV-2 infection also boosts antibody titers to SARS-CoV-1 and common betacoronaviruses. In addition, spike-specific IgG+ me","2021","07","22","Cell Rep Med","Cell reports. Medicine","B cells; CD4 T cells; CD8 T cells; COVID-19; SARS-CoV-2; binding antibody; coronaviruses; immune correlates; immune memory; neutralizing antibody","Patel","Shivan N","Department of Medicine, Emory University School of Medicine, Atlanta, GA 30329, USA",NA
"981","34250512","10.1016/j.xcrm.2021.100354","Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells.","Ending the COVID-19 pandemic will require long-lived immunity to SARS-CoV-2. Here, we evaluate 254 COVID-19 patients longitudinally up to 8 months and find durable broad-based immune responses. SARS-CoV-2 spike binding and neutralizing antibodies exhibit a bi-phasic decay with an extended half-life of &gt;200 days suggesting the generation of longer-lived plasma cells. SARS-CoV-2 infection also boosts antibody titers to SARS-CoV-1 and common betacoronaviruses. In addition, spike-specific IgG+ me","2021","07","22","Cell Rep Med","Cell reports. Medicine","B cells; CD4 T cells; CD8 T cells; COVID-19; SARS-CoV-2; binding antibody; coronaviruses; immune correlates; immune memory; neutralizing antibody","Prigmore","Brittany","Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, 98109, USA",NA
"982","34250512","10.1016/j.xcrm.2021.100354","Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells.","Ending the COVID-19 pandemic will require long-lived immunity to SARS-CoV-2. Here, we evaluate 254 COVID-19 patients longitudinally up to 8 months and find durable broad-based immune responses. SARS-CoV-2 spike binding and neutralizing antibodies exhibit a bi-phasic decay with an extended half-life of &gt;200 days suggesting the generation of longer-lived plasma cells. SARS-CoV-2 infection also boosts antibody titers to SARS-CoV-1 and common betacoronaviruses. In addition, spike-specific IgG+ me","2021","07","22","Cell Rep Med","Cell reports. Medicine","B cells; CD4 T cells; CD8 T cells; COVID-19; SARS-CoV-2; binding antibody; coronaviruses; immune correlates; immune memory; neutralizing antibody","Lemos","Maria P","Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, 98109, USA",NA
"983","34250512","10.1016/j.xcrm.2021.100354","Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells.","Ending the COVID-19 pandemic will require long-lived immunity to SARS-CoV-2. Here, we evaluate 254 COVID-19 patients longitudinally up to 8 months and find durable broad-based immune responses. SARS-CoV-2 spike binding and neutralizing antibodies exhibit a bi-phasic decay with an extended half-life of &gt;200 days suggesting the generation of longer-lived plasma cells. SARS-CoV-2 infection also boosts antibody titers to SARS-CoV-1 and common betacoronaviruses. In addition, spike-specific IgG+ me","2021","07","22","Cell Rep Med","Cell reports. Medicine","B cells; CD4 T cells; CD8 T cells; COVID-19; SARS-CoV-2; binding antibody; coronaviruses; immune correlates; immune memory; neutralizing antibody","Davis","Carl W","Emory Vaccine Center, Emory University, Atlanta, GA 30322, USA",NA
"984","34250512","10.1016/j.xcrm.2021.100354","Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells.","Ending the COVID-19 pandemic will require long-lived immunity to SARS-CoV-2. Here, we evaluate 254 COVID-19 patients longitudinally up to 8 months and find durable broad-based immune responses. SARS-CoV-2 spike binding and neutralizing antibodies exhibit a bi-phasic decay with an extended half-life of &gt;200 days suggesting the generation of longer-lived plasma cells. SARS-CoV-2 infection also boosts antibody titers to SARS-CoV-1 and common betacoronaviruses. In addition, spike-specific IgG+ me","2021","07","22","Cell Rep Med","Cell reports. Medicine","B cells; CD4 T cells; CD8 T cells; COVID-19; SARS-CoV-2; binding antibody; coronaviruses; immune correlates; immune memory; neutralizing antibody","Furth","Sarah","Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, 98109, USA",NA
"985","34250512","10.1016/j.xcrm.2021.100354","Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells.","Ending the COVID-19 pandemic will require long-lived immunity to SARS-CoV-2. Here, we evaluate 254 COVID-19 patients longitudinally up to 8 months and find durable broad-based immune responses. SARS-CoV-2 spike binding and neutralizing antibodies exhibit a bi-phasic decay with an extended half-life of &gt;200 days suggesting the generation of longer-lived plasma cells. SARS-CoV-2 infection also boosts antibody titers to SARS-CoV-1 and common betacoronaviruses. In addition, spike-specific IgG+ me","2021","07","22","Cell Rep Med","Cell reports. Medicine","B cells; CD4 T cells; CD8 T cells; COVID-19; SARS-CoV-2; binding antibody; coronaviruses; immune correlates; immune memory; neutralizing antibody","O'Keefe","James B","Department of Medicine, Emory University School of Medicine, Atlanta, GA 30329, USA",NA
"986","34250512","10.1016/j.xcrm.2021.100354","Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells.","Ending the COVID-19 pandemic will require long-lived immunity to SARS-CoV-2. Here, we evaluate 254 COVID-19 patients longitudinally up to 8 months and find durable broad-based immune responses. SARS-CoV-2 spike binding and neutralizing antibodies exhibit a bi-phasic decay with an extended half-life of &gt;200 days suggesting the generation of longer-lived plasma cells. SARS-CoV-2 infection also boosts antibody titers to SARS-CoV-1 and common betacoronaviruses. In addition, spike-specific IgG+ me","2021","07","22","Cell Rep Med","Cell reports. Medicine","B cells; CD4 T cells; CD8 T cells; COVID-19; SARS-CoV-2; binding antibody; coronaviruses; immune correlates; immune memory; neutralizing antibody","Gharpure","Mohini P","Emory Vaccine Center, Emory University, Atlanta, GA 30322, USA",NA
"987","34250512","10.1016/j.xcrm.2021.100354","Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells.","Ending the COVID-19 pandemic will require long-lived immunity to SARS-CoV-2. Here, we evaluate 254 COVID-19 patients longitudinally up to 8 months and find durable broad-based immune responses. SARS-CoV-2 spike binding and neutralizing antibodies exhibit a bi-phasic decay with an extended half-life of &gt;200 days suggesting the generation of longer-lived plasma cells. SARS-CoV-2 infection also boosts antibody titers to SARS-CoV-1 and common betacoronaviruses. In addition, spike-specific IgG+ me","2021","07","22","Cell Rep Med","Cell reports. Medicine","B cells; CD4 T cells; CD8 T cells; COVID-19; SARS-CoV-2; binding antibody; coronaviruses; immune correlates; immune memory; neutralizing antibody","Gunisetty","Sivaram","Emory Vaccine Center, Emory University, Atlanta, GA 30322, USA",NA
"988","34250512","10.1016/j.xcrm.2021.100354","Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells.","Ending the COVID-19 pandemic will require long-lived immunity to SARS-CoV-2. Here, we evaluate 254 COVID-19 patients longitudinally up to 8 months and find durable broad-based immune responses. SARS-CoV-2 spike binding and neutralizing antibodies exhibit a bi-phasic decay with an extended half-life of &gt;200 days suggesting the generation of longer-lived plasma cells. SARS-CoV-2 infection also boosts antibody titers to SARS-CoV-1 and common betacoronaviruses. In addition, spike-specific IgG+ me","2021","07","22","Cell Rep Med","Cell reports. Medicine","B cells; CD4 T cells; CD8 T cells; COVID-19; SARS-CoV-2; binding antibody; coronaviruses; immune correlates; immune memory; neutralizing antibody","Stephens","Kathy","Center for Childhood Infections and Vaccines of Children's Healthcare of Atlanta, Emory University Department of Pediatrics Department of Medicine, Atlanta, GA 30322, USA",NA
"989","34250512","10.1016/j.xcrm.2021.100354","Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells.","Ending the COVID-19 pandemic will require long-lived immunity to SARS-CoV-2. Here, we evaluate 254 COVID-19 patients longitudinally up to 8 months and find durable broad-based immune responses. SARS-CoV-2 spike binding and neutralizing antibodies exhibit a bi-phasic decay with an extended half-life of &gt;200 days suggesting the generation of longer-lived plasma cells. SARS-CoV-2 infection also boosts antibody titers to SARS-CoV-1 and common betacoronaviruses. In addition, spike-specific IgG+ me","2021","07","22","Cell Rep Med","Cell reports. Medicine","B cells; CD4 T cells; CD8 T cells; COVID-19; SARS-CoV-2; binding antibody; coronaviruses; immune correlates; immune memory; neutralizing antibody","Antia","Rustom","Department of Biology, Emory University, Atlanta, GA 30322, USA",NA
"990","34250512","10.1016/j.xcrm.2021.100354","Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells.","Ending the COVID-19 pandemic will require long-lived immunity to SARS-CoV-2. Here, we evaluate 254 COVID-19 patients longitudinally up to 8 months and find durable broad-based immune responses. SARS-CoV-2 spike binding and neutralizing antibodies exhibit a bi-phasic decay with an extended half-life of &gt;200 days suggesting the generation of longer-lived plasma cells. SARS-CoV-2 infection also boosts antibody titers to SARS-CoV-1 and common betacoronaviruses. In addition, spike-specific IgG+ me","2021","07","22","Cell Rep Med","Cell reports. Medicine","B cells; CD4 T cells; CD8 T cells; COVID-19; SARS-CoV-2; binding antibody; coronaviruses; immune correlates; immune memory; neutralizing antibody","Zarnitsyna","Veronika I","Emory Vaccine Center, Emory University, Atlanta, GA 30322, USA",NA
"991","34250512","10.1016/j.xcrm.2021.100354","Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells.","Ending the COVID-19 pandemic will require long-lived immunity to SARS-CoV-2. Here, we evaluate 254 COVID-19 patients longitudinally up to 8 months and find durable broad-based immune responses. SARS-CoV-2 spike binding and neutralizing antibodies exhibit a bi-phasic decay with an extended half-life of &gt;200 days suggesting the generation of longer-lived plasma cells. SARS-CoV-2 infection also boosts antibody titers to SARS-CoV-1 and common betacoronaviruses. In addition, spike-specific IgG+ me","2021","07","22","Cell Rep Med","Cell reports. Medicine","B cells; CD4 T cells; CD8 T cells; COVID-19; SARS-CoV-2; binding antibody; coronaviruses; immune correlates; immune memory; neutralizing antibody","Stephens","David S","Department of Medicine, Emory University School of Medicine, Atlanta, GA 30329, USA",NA
"992","34250512","10.1016/j.xcrm.2021.100354","Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells.","Ending the COVID-19 pandemic will require long-lived immunity to SARS-CoV-2. Here, we evaluate 254 COVID-19 patients longitudinally up to 8 months and find durable broad-based immune responses. SARS-CoV-2 spike binding and neutralizing antibodies exhibit a bi-phasic decay with an extended half-life of &gt;200 days suggesting the generation of longer-lived plasma cells. SARS-CoV-2 infection also boosts antibody titers to SARS-CoV-1 and common betacoronaviruses. In addition, spike-specific IgG+ me","2021","07","22","Cell Rep Med","Cell reports. Medicine","B cells; CD4 T cells; CD8 T cells; COVID-19; SARS-CoV-2; binding antibody; coronaviruses; immune correlates; immune memory; neutralizing antibody","Edupuganti","Srilatha","Department of Medicine, Emory University School of Medicine, Atlanta, GA 30329, USA",NA
"993","34250512","10.1016/j.xcrm.2021.100354","Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells.","Ending the COVID-19 pandemic will require long-lived immunity to SARS-CoV-2. Here, we evaluate 254 COVID-19 patients longitudinally up to 8 months and find durable broad-based immune responses. SARS-CoV-2 spike binding and neutralizing antibodies exhibit a bi-phasic decay with an extended half-life of &gt;200 days suggesting the generation of longer-lived plasma cells. SARS-CoV-2 infection also boosts antibody titers to SARS-CoV-1 and common betacoronaviruses. In addition, spike-specific IgG+ me","2021","07","22","Cell Rep Med","Cell reports. Medicine","B cells; CD4 T cells; CD8 T cells; COVID-19; SARS-CoV-2; binding antibody; coronaviruses; immune correlates; immune memory; neutralizing antibody","Rouphael","Nadine","Department of Medicine, Emory University School of Medicine, Atlanta, GA 30329, USA",NA
"994","34250512","10.1016/j.xcrm.2021.100354","Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells.","Ending the COVID-19 pandemic will require long-lived immunity to SARS-CoV-2. Here, we evaluate 254 COVID-19 patients longitudinally up to 8 months and find durable broad-based immune responses. SARS-CoV-2 spike binding and neutralizing antibodies exhibit a bi-phasic decay with an extended half-life of &gt;200 days suggesting the generation of longer-lived plasma cells. SARS-CoV-2 infection also boosts antibody titers to SARS-CoV-1 and common betacoronaviruses. In addition, spike-specific IgG+ me","2021","07","22","Cell Rep Med","Cell reports. Medicine","B cells; CD4 T cells; CD8 T cells; COVID-19; SARS-CoV-2; binding antibody; coronaviruses; immune correlates; immune memory; neutralizing antibody","Anderson","Evan J","Center for Childhood Infections and Vaccines of Children's Healthcare of Atlanta, Emory University Department of Pediatrics Department of Medicine, Atlanta, GA 30322, USA",NA
"995","34250512","10.1016/j.xcrm.2021.100354","Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells.","Ending the COVID-19 pandemic will require long-lived immunity to SARS-CoV-2. Here, we evaluate 254 COVID-19 patients longitudinally up to 8 months and find durable broad-based immune responses. SARS-CoV-2 spike binding and neutralizing antibodies exhibit a bi-phasic decay with an extended half-life of &gt;200 days suggesting the generation of longer-lived plasma cells. SARS-CoV-2 infection also boosts antibody titers to SARS-CoV-1 and common betacoronaviruses. In addition, spike-specific IgG+ me","2021","07","22","Cell Rep Med","Cell reports. Medicine","B cells; CD4 T cells; CD8 T cells; COVID-19; SARS-CoV-2; binding antibody; coronaviruses; immune correlates; immune memory; neutralizing antibody","Mehta","Aneesh K","Department of Medicine, Emory University School of Medicine, Atlanta, GA 30329, USA",NA
"996","34250512","10.1016/j.xcrm.2021.100354","Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells.","Ending the COVID-19 pandemic will require long-lived immunity to SARS-CoV-2. Here, we evaluate 254 COVID-19 patients longitudinally up to 8 months and find durable broad-based immune responses. SARS-CoV-2 spike binding and neutralizing antibodies exhibit a bi-phasic decay with an extended half-life of &gt;200 days suggesting the generation of longer-lived plasma cells. SARS-CoV-2 infection also boosts antibody titers to SARS-CoV-1 and common betacoronaviruses. In addition, spike-specific IgG+ me","2021","07","22","Cell Rep Med","Cell reports. Medicine","B cells; CD4 T cells; CD8 T cells; COVID-19; SARS-CoV-2; binding antibody; coronaviruses; immune correlates; immune memory; neutralizing antibody","Wrammert","Jens","Emory Vaccine Center, Emory University, Atlanta, GA 30322, USA",NA
"997","34250512","10.1016/j.xcrm.2021.100354","Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells.","Ending the COVID-19 pandemic will require long-lived immunity to SARS-CoV-2. Here, we evaluate 254 COVID-19 patients longitudinally up to 8 months and find durable broad-based immune responses. SARS-CoV-2 spike binding and neutralizing antibodies exhibit a bi-phasic decay with an extended half-life of &gt;200 days suggesting the generation of longer-lived plasma cells. SARS-CoV-2 infection also boosts antibody titers to SARS-CoV-1 and common betacoronaviruses. In addition, spike-specific IgG+ me","2021","07","22","Cell Rep Med","Cell reports. Medicine","B cells; CD4 T cells; CD8 T cells; COVID-19; SARS-CoV-2; binding antibody; coronaviruses; immune correlates; immune memory; neutralizing antibody","Suthar","Mehul S","Emory Vaccine Center, Emory University, Atlanta, GA 30322, USA",NA
"998","34250512","10.1016/j.xcrm.2021.100354","Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells.","Ending the COVID-19 pandemic will require long-lived immunity to SARS-CoV-2. Here, we evaluate 254 COVID-19 patients longitudinally up to 8 months and find durable broad-based immune responses. SARS-CoV-2 spike binding and neutralizing antibodies exhibit a bi-phasic decay with an extended half-life of &gt;200 days suggesting the generation of longer-lived plasma cells. SARS-CoV-2 infection also boosts antibody titers to SARS-CoV-1 and common betacoronaviruses. In addition, spike-specific IgG+ me","2021","07","22","Cell Rep Med","Cell reports. Medicine","B cells; CD4 T cells; CD8 T cells; COVID-19; SARS-CoV-2; binding antibody; coronaviruses; immune correlates; immune memory; neutralizing antibody","Ahmed","Rafi","Emory Vaccine Center, Emory University, Atlanta, GA 30322, USA",NA
"999","34250512","10.1016/j.xcrm.2021.100354","Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells.","Ending the COVID-19 pandemic will require long-lived immunity to SARS-CoV-2. Here, we evaluate 254 COVID-19 patients longitudinally up to 8 months and find durable broad-based immune responses. SARS-CoV-2 spike binding and neutralizing antibodies exhibit a bi-phasic decay with an extended half-life of &gt;200 days suggesting the generation of longer-lived plasma cells. SARS-CoV-2 infection also boosts antibody titers to SARS-CoV-1 and common betacoronaviruses. In addition, spike-specific IgG+ me","2021","07","22","Cell Rep Med","Cell reports. Medicine","B cells; CD4 T cells; CD8 T cells; COVID-19; SARS-CoV-2; binding antibody; coronaviruses; immune correlates; immune memory; neutralizing antibody","McElrath","M Juliana","Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, 98109, USA",NA
"1000","34250510","10.1016/j.xpro.2021.100663","Immunohistochemistry for protein detection in PFA-fixed paraffin-embedded SARS-CoV-2-infected COPD airway epithelium.","Patients with chronic lung disease are vulnerable to getting severe diseases associated with SARS-CoV-2 infection. Here, we describe protocols for subculturing and differentiating primary normal human bronchial epithelial (NHBE) cells of patients with chronic obstructive lung disease. The differentiation of NHBE cells in air-liquid interface mimics an in vivo airway and provides an in vitro model for studying SARS-CoV-2 infection. We also describe a protocol for detecting proteins ","2021","07","18","STAR Protoc","STAR protocols","Antibody; Health Sciences; Immunology; Microbiology; Microscopy","Osan","Jaspreet Kaur","Department of Biomedical Sciences, University of North Dakota School of Medicine &amp",NA
"1001","34250510","10.1016/j.xpro.2021.100663","Immunohistochemistry for protein detection in PFA-fixed paraffin-embedded SARS-CoV-2-infected COPD airway epithelium.","Patients with chronic lung disease are vulnerable to getting severe diseases associated with SARS-CoV-2 infection. Here, we describe protocols for subculturing and differentiating primary normal human bronchial epithelial (NHBE) cells of patients with chronic obstructive lung disease. The differentiation of NHBE cells in air-liquid interface mimics an in vivo airway and provides an in vitro model for studying SARS-CoV-2 infection. We also describe a protocol for detecting proteins ","2021","07","18","STAR Protoc","STAR protocols","Antibody; Health Sciences; Immunology; Microbiology; Microscopy","DeMontigny","Beth Ann","Department of Biomedical Sciences, University of North Dakota School of Medicine &amp",NA
"1002","34250510","10.1016/j.xpro.2021.100663","Immunohistochemistry for protein detection in PFA-fixed paraffin-embedded SARS-CoV-2-infected COPD airway epithelium.","Patients with chronic lung disease are vulnerable to getting severe diseases associated with SARS-CoV-2 infection. Here, we describe protocols for subculturing and differentiating primary normal human bronchial epithelial (NHBE) cells of patients with chronic obstructive lung disease. The differentiation of NHBE cells in air-liquid interface mimics an in vivo airway and provides an in vitro model for studying SARS-CoV-2 infection. We also describe a protocol for detecting proteins ","2021","07","18","STAR Protoc","STAR protocols","Antibody; Health Sciences; Immunology; Microbiology; Microscopy","Mehedi","Masfique","Department of Biomedical Sciences, University of North Dakota School of Medicine &amp",NA
"1003","34250509","10.1016/S2665-9913(21)00211-3","Reactivation of IgA vasculitis after COVID-19 vaccination.",NA,"2021","07","13","Lancet Rheumatol","The Lancet. Rheumatology",NA,"Obeid","Michel","Centre Hospitalier Universitaire Vaudois, University Hospital of Lausanne, CH-1011 Lausanne, Switzerland",NA
"1004","34250509","10.1016/S2665-9913(21)00211-3","Reactivation of IgA vasculitis after COVID-19 vaccination.",NA,"2021","07","13","Lancet Rheumatol","The Lancet. Rheumatology",NA,"Fenwick","Craig","Centre Hospitalier Universitaire Vaudois, University Hospital of Lausanne, CH-1011 Lausanne, Switzerland",NA
"1005","34250509","10.1016/S2665-9913(21)00211-3","Reactivation of IgA vasculitis after COVID-19 vaccination.",NA,"2021","07","13","Lancet Rheumatol","The Lancet. Rheumatology",NA,"Pantaleo","Giuseppe","Centre Hospitalier Universitaire Vaudois, University Hospital of Lausanne, CH-1011 Lausanne, Switzerland",NA
"1006","34250465","10.3389/frai.2021.673527","Symptom Prediction and Mortality Risk Calculation for COVID-19 Using Machine Learning.","Background: Early prediction of symptoms and mortality risks for COVID-19 patients would improve healthcare outcomes, allow for the appropriate distribution of healthcare resources, reduce healthcare costs, aid in vaccine prioritization and self-isolation strategies, and thus reduce the prevalence of the disease. Such publicly accessible prediction models are lacking, however. Methods: Based on a comprehensive evaluation of existing machine learning (ML) methods, we created two mod","2021","07","13","Front Artif Intell","Frontiers in artificial intelligence","COVID-19; artificial intelligence; machine learning; mortality; symptom","Jamshidi","Elham","Functional Neurosurgery Research Center, Shohada Tajrish Comprehensive Neurosurgical Center of Excellence, Shahid Beheshti University of Medical Sciences, Tehran, Iran",NA
"1007","34250465","10.3389/frai.2021.673527","Symptom Prediction and Mortality Risk Calculation for COVID-19 Using Machine Learning.","Background: Early prediction of symptoms and mortality risks for COVID-19 patients would improve healthcare outcomes, allow for the appropriate distribution of healthcare resources, reduce healthcare costs, aid in vaccine prioritization and self-isolation strategies, and thus reduce the prevalence of the disease. Such publicly accessible prediction models are lacking, however. Methods: Based on a comprehensive evaluation of existing machine learning (ML) methods, we created two mod","2021","07","13","Front Artif Intell","Frontiers in artificial intelligence","COVID-19; artificial intelligence; machine learning; mortality; symptom","Asgary","Amirhossein","Department of Biotechnology, College of Sciences, University of Tehran, Tehran, Iran",NA
"1008","34250465","10.3389/frai.2021.673527","Symptom Prediction and Mortality Risk Calculation for COVID-19 Using Machine Learning.","Background: Early prediction of symptoms and mortality risks for COVID-19 patients would improve healthcare outcomes, allow for the appropriate distribution of healthcare resources, reduce healthcare costs, aid in vaccine prioritization and self-isolation strategies, and thus reduce the prevalence of the disease. Such publicly accessible prediction models are lacking, however. Methods: Based on a comprehensive evaluation of existing machine learning (ML) methods, we created two mod","2021","07","13","Front Artif Intell","Frontiers in artificial intelligence","COVID-19; artificial intelligence; machine learning; mortality; symptom","Tavakoli","Nader","Trauma and Injury Research Center, Iran University of Medical Sciences, Tehran, Iran",NA
"1009","34250465","10.3389/frai.2021.673527","Symptom Prediction and Mortality Risk Calculation for COVID-19 Using Machine Learning.","Background: Early prediction of symptoms and mortality risks for COVID-19 patients would improve healthcare outcomes, allow for the appropriate distribution of healthcare resources, reduce healthcare costs, aid in vaccine prioritization and self-isolation strategies, and thus reduce the prevalence of the disease. Such publicly accessible prediction models are lacking, however. Methods: Based on a comprehensive evaluation of existing machine learning (ML) methods, we created two mod","2021","07","13","Front Artif Intell","Frontiers in artificial intelligence","COVID-19; artificial intelligence; machine learning; mortality; symptom","Zali","Alireza","Functional Neurosurgery Research Center, Shohada Tajrish Comprehensive Neurosurgical Center of Excellence, Shahid Beheshti University of Medical Sciences, Tehran, Iran",NA
"1010","34250465","10.3389/frai.2021.673527","Symptom Prediction and Mortality Risk Calculation for COVID-19 Using Machine Learning.","Background: Early prediction of symptoms and mortality risks for COVID-19 patients would improve healthcare outcomes, allow for the appropriate distribution of healthcare resources, reduce healthcare costs, aid in vaccine prioritization and self-isolation strategies, and thus reduce the prevalence of the disease. Such publicly accessible prediction models are lacking, however. Methods: Based on a comprehensive evaluation of existing machine learning (ML) methods, we created two mod","2021","07","13","Front Artif Intell","Frontiers in artificial intelligence","COVID-19; artificial intelligence; machine learning; mortality; symptom","Dastan","Farzaneh","Department of Clinical Pharmacy, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran",NA
"1011","34250465","10.3389/frai.2021.673527","Symptom Prediction and Mortality Risk Calculation for COVID-19 Using Machine Learning.","Background: Early prediction of symptoms and mortality risks for COVID-19 patients would improve healthcare outcomes, allow for the appropriate distribution of healthcare resources, reduce healthcare costs, aid in vaccine prioritization and self-isolation strategies, and thus reduce the prevalence of the disease. Such publicly accessible prediction models are lacking, however. Methods: Based on a comprehensive evaluation of existing machine learning (ML) methods, we created two mod","2021","07","13","Front Artif Intell","Frontiers in artificial intelligence","COVID-19; artificial intelligence; machine learning; mortality; symptom","Daaee","Amir","School of Mechanical Engineering, Sharif University of Technology, Tehran, Iran",NA
"1012","34250465","10.3389/frai.2021.673527","Symptom Prediction and Mortality Risk Calculation for COVID-19 Using Machine Learning.","Background: Early prediction of symptoms and mortality risks for COVID-19 patients would improve healthcare outcomes, allow for the appropriate distribution of healthcare resources, reduce healthcare costs, aid in vaccine prioritization and self-isolation strategies, and thus reduce the prevalence of the disease. Such publicly accessible prediction models are lacking, however. Methods: Based on a comprehensive evaluation of existing machine learning (ML) methods, we created two mod","2021","07","13","Front Artif Intell","Frontiers in artificial intelligence","COVID-19; artificial intelligence; machine learning; mortality; symptom","Badakhshan","Mohammadtaghi","School of Electrical and Computer Engineering, Engineering Faculty, University of Tehran, Tehran, Iran",NA
"1013","34250465","10.3389/frai.2021.673527","Symptom Prediction and Mortality Risk Calculation for COVID-19 Using Machine Learning.","Background: Early prediction of symptoms and mortality risks for COVID-19 patients would improve healthcare outcomes, allow for the appropriate distribution of healthcare resources, reduce healthcare costs, aid in vaccine prioritization and self-isolation strategies, and thus reduce the prevalence of the disease. Such publicly accessible prediction models are lacking, however. Methods: Based on a comprehensive evaluation of existing machine learning (ML) methods, we created two mod","2021","07","13","Front Artif Intell","Frontiers in artificial intelligence","COVID-19; artificial intelligence; machine learning; mortality; symptom","Esmaily","Hadi","Department of Clinical Pharmacy, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran",NA
"1014","34250465","10.3389/frai.2021.673527","Symptom Prediction and Mortality Risk Calculation for COVID-19 Using Machine Learning.","Background: Early prediction of symptoms and mortality risks for COVID-19 patients would improve healthcare outcomes, allow for the appropriate distribution of healthcare resources, reduce healthcare costs, aid in vaccine prioritization and self-isolation strategies, and thus reduce the prevalence of the disease. Such publicly accessible prediction models are lacking, however. Methods: Based on a comprehensive evaluation of existing machine learning (ML) methods, we created two mod","2021","07","13","Front Artif Intell","Frontiers in artificial intelligence","COVID-19; artificial intelligence; machine learning; mortality; symptom","Jamaldini","Seyed Hamid","Department of Genetic, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran",NA
"1015","34250465","10.3389/frai.2021.673527","Symptom Prediction and Mortality Risk Calculation for COVID-19 Using Machine Learning.","Background: Early prediction of symptoms and mortality risks for COVID-19 patients would improve healthcare outcomes, allow for the appropriate distribution of healthcare resources, reduce healthcare costs, aid in vaccine prioritization and self-isolation strategies, and thus reduce the prevalence of the disease. Such publicly accessible prediction models are lacking, however. Methods: Based on a comprehensive evaluation of existing machine learning (ML) methods, we created two mod","2021","07","13","Front Artif Intell","Frontiers in artificial intelligence","COVID-19; artificial intelligence; machine learning; mortality; symptom","Safari","Saeid","Functional Neurosurgery Research Center, Shohada Tajrish Comprehensive Neurosurgical Center of Excellence, Shahid Beheshti University of Medical Sciences, Tehran, Iran",NA
"1016","34250465","10.3389/frai.2021.673527","Symptom Prediction and Mortality Risk Calculation for COVID-19 Using Machine Learning.","Background: Early prediction of symptoms and mortality risks for COVID-19 patients would improve healthcare outcomes, allow for the appropriate distribution of healthcare resources, reduce healthcare costs, aid in vaccine prioritization and self-isolation strategies, and thus reduce the prevalence of the disease. Such publicly accessible prediction models are lacking, however. Methods: Based on a comprehensive evaluation of existing machine learning (ML) methods, we created two mod","2021","07","13","Front Artif Intell","Frontiers in artificial intelligence","COVID-19; artificial intelligence; machine learning; mortality; symptom","Bastanhagh","Ehsan","Department of Anesthesiology, Tehran University of Medical Sciences, Tehran, Iran",NA
"1017","34250465","10.3389/frai.2021.673527","Symptom Prediction and Mortality Risk Calculation for COVID-19 Using Machine Learning.","Background: Early prediction of symptoms and mortality risks for COVID-19 patients would improve healthcare outcomes, allow for the appropriate distribution of healthcare resources, reduce healthcare costs, aid in vaccine prioritization and self-isolation strategies, and thus reduce the prevalence of the disease. Such publicly accessible prediction models are lacking, however. Methods: Based on a comprehensive evaluation of existing machine learning (ML) methods, we created two mod","2021","07","13","Front Artif Intell","Frontiers in artificial intelligence","COVID-19; artificial intelligence; machine learning; mortality; symptom","Maher","Ali","School of Management and Medical Education, Shahid Beheshti University of Medical Sciences, Tehran, Iran",NA
"1018","34250465","10.3389/frai.2021.673527","Symptom Prediction and Mortality Risk Calculation for COVID-19 Using Machine Learning.","Background: Early prediction of symptoms and mortality risks for COVID-19 patients would improve healthcare outcomes, allow for the appropriate distribution of healthcare resources, reduce healthcare costs, aid in vaccine prioritization and self-isolation strategies, and thus reduce the prevalence of the disease. Such publicly accessible prediction models are lacking, however. Methods: Based on a comprehensive evaluation of existing machine learning (ML) methods, we created two mod","2021","07","13","Front Artif Intell","Frontiers in artificial intelligence","COVID-19; artificial intelligence; machine learning; mortality; symptom","Babajani","Amirhesam","Department of Pharmacology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran",NA
"1019","34250465","10.3389/frai.2021.673527","Symptom Prediction and Mortality Risk Calculation for COVID-19 Using Machine Learning.","Background: Early prediction of symptoms and mortality risks for COVID-19 patients would improve healthcare outcomes, allow for the appropriate distribution of healthcare resources, reduce healthcare costs, aid in vaccine prioritization and self-isolation strategies, and thus reduce the prevalence of the disease. Such publicly accessible prediction models are lacking, however. Methods: Based on a comprehensive evaluation of existing machine learning (ML) methods, we created two mod","2021","07","13","Front Artif Intell","Frontiers in artificial intelligence","COVID-19; artificial intelligence; machine learning; mortality; symptom","Mehrazi","Maryam","Trauma and Injury Research Center, Iran University of Medical Sciences, Tehran, Iran",NA
"1020","34250465","10.3389/frai.2021.673527","Symptom Prediction and Mortality Risk Calculation for COVID-19 Using Machine Learning.","Background: Early prediction of symptoms and mortality risks for COVID-19 patients would improve healthcare outcomes, allow for the appropriate distribution of healthcare resources, reduce healthcare costs, aid in vaccine prioritization and self-isolation strategies, and thus reduce the prevalence of the disease. Such publicly accessible prediction models are lacking, however. Methods: Based on a comprehensive evaluation of existing machine learning (ML) methods, we created two mod","2021","07","13","Front Artif Intell","Frontiers in artificial intelligence","COVID-19; artificial intelligence; machine learning; mortality; symptom","Sendani Kashi","Mohammad Ali","Department of Business Management, Faculty of Management, University of Tehran, Tehran, Iran",NA
"1021","34250465","10.3389/frai.2021.673527","Symptom Prediction and Mortality Risk Calculation for COVID-19 Using Machine Learning.","Background: Early prediction of symptoms and mortality risks for COVID-19 patients would improve healthcare outcomes, allow for the appropriate distribution of healthcare resources, reduce healthcare costs, aid in vaccine prioritization and self-isolation strategies, and thus reduce the prevalence of the disease. Such publicly accessible prediction models are lacking, however. Methods: Based on a comprehensive evaluation of existing machine learning (ML) methods, we created two mod","2021","07","13","Front Artif Intell","Frontiers in artificial intelligence","COVID-19; artificial intelligence; machine learning; mortality; symptom","Jamshidi","Masoud","Department of Exercise Physiology, Tehran University, Tehran, Iran",NA
"1022","34250465","10.3389/frai.2021.673527","Symptom Prediction and Mortality Risk Calculation for COVID-19 Using Machine Learning.","Background: Early prediction of symptoms and mortality risks for COVID-19 patients would improve healthcare outcomes, allow for the appropriate distribution of healthcare resources, reduce healthcare costs, aid in vaccine prioritization and self-isolation strategies, and thus reduce the prevalence of the disease. Such publicly accessible prediction models are lacking, however. Methods: Based on a comprehensive evaluation of existing machine learning (ML) methods, we created two mod","2021","07","13","Front Artif Intell","Frontiers in artificial intelligence","COVID-19; artificial intelligence; machine learning; mortality; symptom","Sendani","Mohammad Hassan","Department of Computer Engineering, Sharif University of Technology, Tehran, Iran",NA
"1023","34250465","10.3389/frai.2021.673527","Symptom Prediction and Mortality Risk Calculation for COVID-19 Using Machine Learning.","Background: Early prediction of symptoms and mortality risks for COVID-19 patients would improve healthcare outcomes, allow for the appropriate distribution of healthcare resources, reduce healthcare costs, aid in vaccine prioritization and self-isolation strategies, and thus reduce the prevalence of the disease. Such publicly accessible prediction models are lacking, however. Methods: Based on a comprehensive evaluation of existing machine learning (ML) methods, we created two mod","2021","07","13","Front Artif Intell","Frontiers in artificial intelligence","COVID-19; artificial intelligence; machine learning; mortality; symptom","Rahi","Sahand Jamal","Laboratory of the Physics of Biological Systems, Institute of Physics, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland",NA
"1024","34250465","10.3389/frai.2021.673527","Symptom Prediction and Mortality Risk Calculation for COVID-19 Using Machine Learning.","Background: Early prediction of symptoms and mortality risks for COVID-19 patients would improve healthcare outcomes, allow for the appropriate distribution of healthcare resources, reduce healthcare costs, aid in vaccine prioritization and self-isolation strategies, and thus reduce the prevalence of the disease. Such publicly accessible prediction models are lacking, however. Methods: Based on a comprehensive evaluation of existing machine learning (ML) methods, we created two mod","2021","07","13","Front Artif Intell","Frontiers in artificial intelligence","COVID-19; artificial intelligence; machine learning; mortality; symptom","Mansouri","Nahal","Division of Pulmonary Medicine, Department of Medicine, Lausanne University Hospital (CHUV), University of Lausanne (UNIL), Lausanne, Switzerland",NA
"1025","34250462","10.1016/j.ssaho.2021.100187","Flipped classroom: How higher education institutions (HEIs) of Bangladesh could move forward during COVID-19 pandemic.","Due to COVID-19 pandemic, Bangladesh along with most of the developing countries is facing unexpected impediments towards functioning their regular activities. Most importantly, schools at all levels and Higher Educational Institutions (HEIs) have been completely shut down since March 26, 2020 that directly obliged stakeholders (Ministry of Education, institutes authorities, parents and other relevant bodies) to adopt online education. Due to having very less experience, in many cases no experie","2021","07","14","Soc Sci Humanit Open","Social sciences &amp; humanities open","COVID-19; Flipped classroom; Higher education; Online learning space; Pandemic","Khan","Md Shahadat Hossain","Department of Technical and Vocational Education (TVE), Islamic University of Technology (IUT), Room: 304, Academic Building 1, Board Bazar, Gazipur, 1704, Bangladesh",NA
"1026","34250462","10.1016/j.ssaho.2021.100187","Flipped classroom: How higher education institutions (HEIs) of Bangladesh could move forward during COVID-19 pandemic.","Due to COVID-19 pandemic, Bangladesh along with most of the developing countries is facing unexpected impediments towards functioning their regular activities. Most importantly, schools at all levels and Higher Educational Institutions (HEIs) have been completely shut down since March 26, 2020 that directly obliged stakeholders (Ministry of Education, institutes authorities, parents and other relevant bodies) to adopt online education. Due to having very less experience, in many cases no experie","2021","07","14","Soc Sci Humanit Open","Social sciences &amp; humanities open","COVID-19; Flipped classroom; Higher education; Online learning space; Pandemic","Abdou","Benadjih Oiriddine","Department of Technical and Vocational Education (TVE), Islamic University of Technology (IUT), Room: 301, Academic Building 1, Board Bazar, Gazipur, 1704, Bangladesh",NA
"1027","34250461","10.1016/j.ssaho.2021.100186","The psychological distress and mental health disorders from COVID-19 stigmatization in Ghana.","The emergence of the COVID-19 global pandemic in Ghana has resulted in various degrees of stigmatization. Previous studies have stressed the need for developing policies to curb the stigma towards COVID-19 survivors and healthcare workers. Some have investigated the knowledge and willingness of people to accept COVID-19 survivors. Others have also explored the experiences of health workers who have been victims of stigma from COVID-19. There is a need for further studies to understand COVID-19 r","2021","07","13","Soc Sci Humanit Open","Social sciences &amp; humanities open","Covid-19; Mental health disorders; Psychological distress; Psychotherapy; Stigmatization","Adom","Dickson","Educational Innovations in Science and Technology, Kwame Nkrumah University of Science and Technology, PMB, University Post Office, Ghana",NA
"1028","34250461","10.1016/j.ssaho.2021.100186","The psychological distress and mental health disorders from COVID-19 stigmatization in Ghana.","The emergence of the COVID-19 global pandemic in Ghana has resulted in various degrees of stigmatization. Previous studies have stressed the need for developing policies to curb the stigma towards COVID-19 survivors and healthcare workers. Some have investigated the knowledge and willingness of people to accept COVID-19 survivors. Others have also explored the experiences of health workers who have been victims of stigma from COVID-19. There is a need for further studies to understand COVID-19 r","2021","07","13","Soc Sci Humanit Open","Social sciences &amp; humanities open","Covid-19; Mental health disorders; Psychological distress; Psychotherapy; Stigmatization","Mensah","Jephthar Adu","Ghana Psychology Council, Ghana",NA
"1029","34250461","10.1016/j.ssaho.2021.100186","The psychological distress and mental health disorders from COVID-19 stigmatization in Ghana.","The emergence of the COVID-19 global pandemic in Ghana has resulted in various degrees of stigmatization. Previous studies have stressed the need for developing policies to curb the stigma towards COVID-19 survivors and healthcare workers. Some have investigated the knowledge and willingness of people to accept COVID-19 survivors. Others have also explored the experiences of health workers who have been victims of stigma from COVID-19. There is a need for further studies to understand COVID-19 r","2021","07","13","Soc Sci Humanit Open","Social sciences &amp; humanities open","Covid-19; Mental health disorders; Psychological distress; Psychotherapy; Stigmatization","Osei","Mavis","Educational Innovations in Science and Technology, Kwame Nkrumah University of Science and Technology, PMB, University Post Office, Ghana",NA
"1030","34250460","10.1016/j.clinpr.2021.100085","A study of staff mask contamination on a respiratory admissions ward managing COVID-19 patients reveals concern with infection prevention practice.",NA,"2021","07","21","Clin Infect Pract","Clinical infection in practice",NA,"Fouda","Ahmed","Respiratory Medicine, University Hospitals of Leicester NHS Trust, Leicester, UK",NA
"1031","34250460","10.1016/j.clinpr.2021.100085","A study of staff mask contamination on a respiratory admissions ward managing COVID-19 patients reveals concern with infection prevention practice.",NA,"2021","07","21","Clin Infect Pract","Clinical infection in practice",NA,"Abouzaid","Abdulrahman","Respiratory Medicine, University Hospitals of Leicester NHS Trust, Leicester, UK",NA
"1032","34250460","10.1016/j.clinpr.2021.100085","A study of staff mask contamination on a respiratory admissions ward managing COVID-19 patients reveals concern with infection prevention practice.",NA,"2021","07","21","Clin Infect Pract","Clinical infection in practice",NA,"Nicoara","Daniela C","Respiratory Medicine, University Hospitals of Leicester NHS Trust, Leicester, UK",NA
"1033","34250460","10.1016/j.clinpr.2021.100085","A study of staff mask contamination on a respiratory admissions ward managing COVID-19 patients reveals concern with infection prevention practice.",NA,"2021","07","21","Clin Infect Pract","Clinical infection in practice",NA,"Woltmann","Gerrit","Respiratory Medicine, University Hospitals of Leicester NHS Trust, Leicester, UK",NA
"1034","34250460","10.1016/j.clinpr.2021.100085","A study of staff mask contamination on a respiratory admissions ward managing COVID-19 patients reveals concern with infection prevention practice.",NA,"2021","07","21","Clin Infect Pract","Clinical infection in practice",NA,"David","Joicy","Clinical Microbiology, University Hospitals of Leicester NHS Trust, Leicester, UK",NA
"1035","34250460","10.1016/j.clinpr.2021.100085","A study of staff mask contamination on a respiratory admissions ward managing COVID-19 patients reveals concern with infection prevention practice.",NA,"2021","07","21","Clin Infect Pract","Clinical infection in practice",NA,"Holmes","Christopher W","Clinical Microbiology, University Hospitals of Leicester NHS Trust, Leicester, UK",NA
"1036","34250460","10.1016/j.clinpr.2021.100085","A study of staff mask contamination on a respiratory admissions ward managing COVID-19 patients reveals concern with infection prevention practice.",NA,"2021","07","21","Clin Infect Pract","Clinical infection in practice",NA,"Tang","Julian W","Clinical Microbiology, University Hospitals of Leicester NHS Trust, Leicester, UK",NA
"1037","34250459","10.1016/j.ebr.2021.100468","Alternating hemiparesis in the context of hemolytic uremic syndrome and COVID-19 positivity.","Hemiparesis has been reported in hemolytic uremic syndrome (HUS), however electrophysiological findings associated with this syndrome have not been well-characterized, and alternating hemiparesis presentations have not been reported. We present detailed electrophysiological and clinical findings in a case of alternating hemiparesis corresponding to alternating focal contralateral delta slowing on prolonged EEG monitoring in a case of HUS with COVID-19 positivity. A 24-year-old woman was admitted","2021","07","16","Epilepsy Behav Rep","Epilepsy &amp; behavior reports","COVID19; EEG; Hemiparesis; Hemiplegia; Hemolytic uremic syndrome","Simpson","Hugh D","Division of Epilepsy, Mayo Clinic, Rochester, MN, USA",NA
"1038","34250459","10.1016/j.ebr.2021.100468","Alternating hemiparesis in the context of hemolytic uremic syndrome and COVID-19 positivity.","Hemiparesis has been reported in hemolytic uremic syndrome (HUS), however electrophysiological findings associated with this syndrome have not been well-characterized, and alternating hemiparesis presentations have not been reported. We present detailed electrophysiological and clinical findings in a case of alternating hemiparesis corresponding to alternating focal contralateral delta slowing on prolonged EEG monitoring in a case of HUS with COVID-19 positivity. A 24-year-old woman was admitted","2021","07","16","Epilepsy Behav Rep","Epilepsy &amp; behavior reports","COVID19; EEG; Hemiparesis; Hemiplegia; Hemolytic uremic syndrome","Johnson","Erica","Division of Critical Care and Hospital Neurology, Department of Neurology, Mayo Clinic, Rochester, MN, USA",NA
"1039","34250459","10.1016/j.ebr.2021.100468","Alternating hemiparesis in the context of hemolytic uremic syndrome and COVID-19 positivity.","Hemiparesis has been reported in hemolytic uremic syndrome (HUS), however electrophysiological findings associated with this syndrome have not been well-characterized, and alternating hemiparesis presentations have not been reported. We present detailed electrophysiological and clinical findings in a case of alternating hemiparesis corresponding to alternating focal contralateral delta slowing on prolonged EEG monitoring in a case of HUS with COVID-19 positivity. A 24-year-old woman was admitted","2021","07","16","Epilepsy Behav Rep","Epilepsy &amp; behavior reports","COVID19; EEG; Hemiparesis; Hemiplegia; Hemolytic uremic syndrome","Britton","Jeffrey","Division of Epilepsy, Mayo Clinic, Rochester, MN, USA",NA
"1040","34250459","10.1016/j.ebr.2021.100468","Alternating hemiparesis in the context of hemolytic uremic syndrome and COVID-19 positivity.","Hemiparesis has been reported in hemolytic uremic syndrome (HUS), however electrophysiological findings associated with this syndrome have not been well-characterized, and alternating hemiparesis presentations have not been reported. We present detailed electrophysiological and clinical findings in a case of alternating hemiparesis corresponding to alternating focal contralateral delta slowing on prolonged EEG monitoring in a case of HUS with COVID-19 positivity. A 24-year-old woman was admitted","2021","07","16","Epilepsy Behav Rep","Epilepsy &amp; behavior reports","COVID19; EEG; Hemiparesis; Hemiplegia; Hemolytic uremic syndrome","Braksick","Sherri","Division of Critical Care and Hospital Neurology, Department of Neurology, Mayo Clinic, Rochester, MN, USA",NA
"1041","34250458","10.1016/j.metop.2021.100106","Vitamin D in infectious complications in critically ill patients with or without COVID-19.","25-hydroxyvitamin D [25(OH)D] is an important immunomodulator, whose deficiency may aggravate the incidence and outcome of infectious complications in patients admitted to the intensive care unit. The most recognized extra-skeletal action of vitamin D is the regulation of immune function. Host defense against intracellular pathogens depends upon both innate and adaptive immunity. It has been suggested that vitamin D regulates the pro-inflammatory endothelial response to lipopolysaccharide, rende","2021","07","22","Metabol Open","Metabolism open","COVID-19; Critical illness; Infections; Outcomes; Vitamin D","Vassiliou","Alice G","First Department of Critical Care Medicine &amp",NA
"1042","34250458","10.1016/j.metop.2021.100106","Vitamin D in infectious complications in critically ill patients with or without COVID-19.","25-hydroxyvitamin D [25(OH)D] is an important immunomodulator, whose deficiency may aggravate the incidence and outcome of infectious complications in patients admitted to the intensive care unit. The most recognized extra-skeletal action of vitamin D is the regulation of immune function. Host defense against intracellular pathogens depends upon both innate and adaptive immunity. It has been suggested that vitamin D regulates the pro-inflammatory endothelial response to lipopolysaccharide, rende","2021","07","22","Metabol Open","Metabolism open","COVID-19; Critical illness; Infections; Outcomes; Vitamin D","Jahaj","Edison","First Department of Critical Care Medicine &amp",NA
"1043","34250458","10.1016/j.metop.2021.100106","Vitamin D in infectious complications in critically ill patients with or without COVID-19.","25-hydroxyvitamin D [25(OH)D] is an important immunomodulator, whose deficiency may aggravate the incidence and outcome of infectious complications in patients admitted to the intensive care unit. The most recognized extra-skeletal action of vitamin D is the regulation of immune function. Host defense against intracellular pathogens depends upon both innate and adaptive immunity. It has been suggested that vitamin D regulates the pro-inflammatory endothelial response to lipopolysaccharide, rende","2021","07","22","Metabol Open","Metabolism open","COVID-19; Critical illness; Infections; Outcomes; Vitamin D","Orfanos","Stylianos E","First Department of Critical Care Medicine &amp",NA
"1044","34250458","10.1016/j.metop.2021.100106","Vitamin D in infectious complications in critically ill patients with or without COVID-19.","25-hydroxyvitamin D [25(OH)D] is an important immunomodulator, whose deficiency may aggravate the incidence and outcome of infectious complications in patients admitted to the intensive care unit. The most recognized extra-skeletal action of vitamin D is the regulation of immune function. Host defense against intracellular pathogens depends upon both innate and adaptive immunity. It has been suggested that vitamin D regulates the pro-inflammatory endothelial response to lipopolysaccharide, rende","2021","07","22","Metabol Open","Metabolism open","COVID-19; Critical illness; Infections; Outcomes; Vitamin D","Dimopoulou","Ioanna","First Department of Critical Care Medicine &amp",NA
"1045","34250458","10.1016/j.metop.2021.100106","Vitamin D in infectious complications in critically ill patients with or without COVID-19.","25-hydroxyvitamin D [25(OH)D] is an important immunomodulator, whose deficiency may aggravate the incidence and outcome of infectious complications in patients admitted to the intensive care unit. The most recognized extra-skeletal action of vitamin D is the regulation of immune function. Host defense against intracellular pathogens depends upon both innate and adaptive immunity. It has been suggested that vitamin D regulates the pro-inflammatory endothelial response to lipopolysaccharide, rende","2021","07","22","Metabol Open","Metabolism open","COVID-19; Critical illness; Infections; Outcomes; Vitamin D","Kotanidou","Anastasia","First Department of Critical Care Medicine &amp",NA
"1046","34250457","10.1016/j.eclinm.2021.101013","Investigating the impact of asymptomatic or mild SARS-CoV-2 infection on female fertility and <i>in vitro</i> fertilization outcomes: A retrospective cohort study.","Background: The current study aimed to investigate the impact of asymptomatic or mild severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection on female fertility and laboratory and clinical outcomes in assisted reproductive technology (ART) treatments. Methods: Patients undergoing ART treatments in the Reproductive Medicine Center, Tongji Hospital, Wuhan, from May 2020 to February 2021 were enrolled. Seventy of them were positive for serum SARS-CoV-2 antibodies (IgG ","2021","07","13","EClinicalMedicine","EClinicalMedicine","COVID 19; Fertility evaluation; IVF outcome; SARS CoV-2","Wang","Meng","Reproductive Medicine Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China",NA
"1047","34250457","10.1016/j.eclinm.2021.101013","Investigating the impact of asymptomatic or mild SARS-CoV-2 infection on female fertility and <i>in vitro</i> fertilization outcomes: A retrospective cohort study.","Background: The current study aimed to investigate the impact of asymptomatic or mild severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection on female fertility and laboratory and clinical outcomes in assisted reproductive technology (ART) treatments. Methods: Patients undergoing ART treatments in the Reproductive Medicine Center, Tongji Hospital, Wuhan, from May 2020 to February 2021 were enrolled. Seventy of them were positive for serum SARS-CoV-2 antibodies (IgG ","2021","07","13","EClinicalMedicine","EClinicalMedicine","COVID 19; Fertility evaluation; IVF outcome; SARS CoV-2","Yang","Qiyu","Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China",NA
"1048","34250457","10.1016/j.eclinm.2021.101013","Investigating the impact of asymptomatic or mild SARS-CoV-2 infection on female fertility and <i>in vitro</i> fertilization outcomes: A retrospective cohort study.","Background: The current study aimed to investigate the impact of asymptomatic or mild severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection on female fertility and laboratory and clinical outcomes in assisted reproductive technology (ART) treatments. Methods: Patients undergoing ART treatments in the Reproductive Medicine Center, Tongji Hospital, Wuhan, from May 2020 to February 2021 were enrolled. Seventy of them were positive for serum SARS-CoV-2 antibodies (IgG ","2021","07","13","EClinicalMedicine","EClinicalMedicine","COVID 19; Fertility evaluation; IVF outcome; SARS CoV-2","Ren","Xinling","Reproductive Medicine Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China",NA
"1049","34250457","10.1016/j.eclinm.2021.101013","Investigating the impact of asymptomatic or mild SARS-CoV-2 infection on female fertility and <i>in vitro</i> fertilization outcomes: A retrospective cohort study.","Background: The current study aimed to investigate the impact of asymptomatic or mild severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection on female fertility and laboratory and clinical outcomes in assisted reproductive technology (ART) treatments. Methods: Patients undergoing ART treatments in the Reproductive Medicine Center, Tongji Hospital, Wuhan, from May 2020 to February 2021 were enrolled. Seventy of them were positive for serum SARS-CoV-2 antibodies (IgG ","2021","07","13","EClinicalMedicine","EClinicalMedicine","COVID 19; Fertility evaluation; IVF outcome; SARS CoV-2","Hu","Juan","Reproductive Medicine Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China",NA
"1050","34250457","10.1016/j.eclinm.2021.101013","Investigating the impact of asymptomatic or mild SARS-CoV-2 infection on female fertility and <i>in vitro</i> fertilization outcomes: A retrospective cohort study.","Background: The current study aimed to investigate the impact of asymptomatic or mild severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection on female fertility and laboratory and clinical outcomes in assisted reproductive technology (ART) treatments. Methods: Patients undergoing ART treatments in the Reproductive Medicine Center, Tongji Hospital, Wuhan, from May 2020 to February 2021 were enrolled. Seventy of them were positive for serum SARS-CoV-2 antibodies (IgG ","2021","07","13","EClinicalMedicine","EClinicalMedicine","COVID 19; Fertility evaluation; IVF outcome; SARS CoV-2","Li","Zhou","Reproductive Medicine Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China",NA
"1051","34250457","10.1016/j.eclinm.2021.101013","Investigating the impact of asymptomatic or mild SARS-CoV-2 infection on female fertility and <i>in vitro</i> fertilization outcomes: A retrospective cohort study.","Background: The current study aimed to investigate the impact of asymptomatic or mild severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection on female fertility and laboratory and clinical outcomes in assisted reproductive technology (ART) treatments. Methods: Patients undergoing ART treatments in the Reproductive Medicine Center, Tongji Hospital, Wuhan, from May 2020 to February 2021 were enrolled. Seventy of them were positive for serum SARS-CoV-2 antibodies (IgG ","2021","07","13","EClinicalMedicine","EClinicalMedicine","COVID 19; Fertility evaluation; IVF outcome; SARS CoV-2","Long","Rui","Reproductive Medicine Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China",NA
"1052","34250457","10.1016/j.eclinm.2021.101013","Investigating the impact of asymptomatic or mild SARS-CoV-2 infection on female fertility and <i>in vitro</i> fertilization outcomes: A retrospective cohort study.","Background: The current study aimed to investigate the impact of asymptomatic or mild severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection on female fertility and laboratory and clinical outcomes in assisted reproductive technology (ART) treatments. Methods: Patients undergoing ART treatments in the Reproductive Medicine Center, Tongji Hospital, Wuhan, from May 2020 to February 2021 were enrolled. Seventy of them were positive for serum SARS-CoV-2 antibodies (IgG ","2021","07","13","EClinicalMedicine","EClinicalMedicine","COVID 19; Fertility evaluation; IVF outcome; SARS CoV-2","Xi","Qingsong","Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China",NA
"1053","34250457","10.1016/j.eclinm.2021.101013","Investigating the impact of asymptomatic or mild SARS-CoV-2 infection on female fertility and <i>in vitro</i> fertilization outcomes: A retrospective cohort study.","Background: The current study aimed to investigate the impact of asymptomatic or mild severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection on female fertility and laboratory and clinical outcomes in assisted reproductive technology (ART) treatments. Methods: Patients undergoing ART treatments in the Reproductive Medicine Center, Tongji Hospital, Wuhan, from May 2020 to February 2021 were enrolled. Seventy of them were positive for serum SARS-CoV-2 antibodies (IgG ","2021","07","13","EClinicalMedicine","EClinicalMedicine","COVID 19; Fertility evaluation; IVF outcome; SARS CoV-2","Zhu","Lixia","Reproductive Medicine Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China",NA
"1054","34250457","10.1016/j.eclinm.2021.101013","Investigating the impact of asymptomatic or mild SARS-CoV-2 infection on female fertility and <i>in vitro</i> fertilization outcomes: A retrospective cohort study.","Background: The current study aimed to investigate the impact of asymptomatic or mild severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection on female fertility and laboratory and clinical outcomes in assisted reproductive technology (ART) treatments. Methods: Patients undergoing ART treatments in the Reproductive Medicine Center, Tongji Hospital, Wuhan, from May 2020 to February 2021 were enrolled. Seventy of them were positive for serum SARS-CoV-2 antibodies (IgG ","2021","07","13","EClinicalMedicine","EClinicalMedicine","COVID 19; Fertility evaluation; IVF outcome; SARS CoV-2","Jin","Lei","Reproductive Medicine Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China",NA
"1055","34250456","10.1016/j.eclinm.2021.101010","Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18 years or older: A randomized, double-blind, placebo-controlled, phase 1/2 trial.","We aimed to assess the safety and immunogenicity of an inactivated vaccine against COVID-19 in Chinese adults aged =18 years. This is an ongoing randomized, double-blind, placebo-controlled, phase 1/2 clinical trial among healthy adults aged =18 years in Henan Province, China. Participants (n = 336 in 18-59 age group and n = 336 in =60 age group) were enrolled between April 12 and May 17 2020, and were equally randomized to receive vaccine or placebo (aluminum hydroxide adjuvant) in a three-dose","2021","07","13","EClinicalMedicine","EClinicalMedicine",NA,"Guo","Wanshen","Henan Province Centre for Disease Control and Prevention, Zhengzhou, Henan, China",NA
"1056","34250456","10.1016/j.eclinm.2021.101010","Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18 years or older: A randomized, double-blind, placebo-controlled, phase 1/2 trial.","We aimed to assess the safety and immunogenicity of an inactivated vaccine against COVID-19 in Chinese adults aged =18 years. This is an ongoing randomized, double-blind, placebo-controlled, phase 1/2 clinical trial among healthy adults aged =18 years in Henan Province, China. Participants (n = 336 in 18-59 age group and n = 336 in =60 age group) were enrolled between April 12 and May 17 2020, and were equally randomized to receive vaccine or placebo (aluminum hydroxide adjuvant) in a three-dose","2021","07","13","EClinicalMedicine","EClinicalMedicine",NA,"Duan","Kai","National Engineering Technology Research Centre for Combined Vaccines, Wuhan Institute of Biological Products Co. Ltd., Wuhan, Hubei, China",NA
"1057","34250456","10.1016/j.eclinm.2021.101010","Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18 years or older: A randomized, double-blind, placebo-controlled, phase 1/2 trial.","We aimed to assess the safety and immunogenicity of an inactivated vaccine against COVID-19 in Chinese adults aged =18 years. This is an ongoing randomized, double-blind, placebo-controlled, phase 1/2 clinical trial among healthy adults aged =18 years in Henan Province, China. Participants (n = 336 in 18-59 age group and n = 336 in =60 age group) were enrolled between April 12 and May 17 2020, and were equally randomized to receive vaccine or placebo (aluminum hydroxide adjuvant) in a three-dose","2021","07","13","EClinicalMedicine","EClinicalMedicine",NA,"Zhang","Yuntao","China National Biotec Group Company Limited, Beijing, China",NA
"1058","34250456","10.1016/j.eclinm.2021.101010","Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18 years or older: A randomized, double-blind, placebo-controlled, phase 1/2 trial.","We aimed to assess the safety and immunogenicity of an inactivated vaccine against COVID-19 in Chinese adults aged =18 years. This is an ongoing randomized, double-blind, placebo-controlled, phase 1/2 clinical trial among healthy adults aged =18 years in Henan Province, China. Participants (n = 336 in 18-59 age group and n = 336 in =60 age group) were enrolled between April 12 and May 17 2020, and were equally randomized to receive vaccine or placebo (aluminum hydroxide adjuvant) in a three-dose","2021","07","13","EClinicalMedicine","EClinicalMedicine",NA,"Yuan","Zhiming","Chinese Academy of Sciences Key Laboratory of Special Pathogens, Wuhan Institute of Virology, Centre for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, Hubei, China",NA
"1059","34250456","10.1016/j.eclinm.2021.101010","Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18 years or older: A randomized, double-blind, placebo-controlled, phase 1/2 trial.","We aimed to assess the safety and immunogenicity of an inactivated vaccine against COVID-19 in Chinese adults aged =18 years. This is an ongoing randomized, double-blind, placebo-controlled, phase 1/2 clinical trial among healthy adults aged =18 years in Henan Province, China. Participants (n = 336 in 18-59 age group and n = 336 in =60 age group) were enrolled between April 12 and May 17 2020, and were equally randomized to receive vaccine or placebo (aluminum hydroxide adjuvant) in a three-dose","2021","07","13","EClinicalMedicine","EClinicalMedicine",NA,"Zhang","Yan-Bo","Department of Epidemiology and Biostatistics, Ministry of Education Key Laboratory of Environment and Health and State Key Laboratory of Environmental Health (incubation), School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China",NA
"1060","34250456","10.1016/j.eclinm.2021.101010","Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18 years or older: A randomized, double-blind, placebo-controlled, phase 1/2 trial.","We aimed to assess the safety and immunogenicity of an inactivated vaccine against COVID-19 in Chinese adults aged =18 years. This is an ongoing randomized, double-blind, placebo-controlled, phase 1/2 clinical trial among healthy adults aged =18 years in Henan Province, China. Participants (n = 336 in 18-59 age group and n = 336 in =60 age group) were enrolled between April 12 and May 17 2020, and were equally randomized to receive vaccine or placebo (aluminum hydroxide adjuvant) in a three-dose","2021","07","13","EClinicalMedicine","EClinicalMedicine",NA,"Wang","Zejun","National Engineering Technology Research Centre for Combined Vaccines, Wuhan Institute of Biological Products Co. Ltd., Wuhan, Hubei, China",NA
"1061","34250456","10.1016/j.eclinm.2021.101010","Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18 years or older: A randomized, double-blind, placebo-controlled, phase 1/2 trial.","We aimed to assess the safety and immunogenicity of an inactivated vaccine against COVID-19 in Chinese adults aged =18 years. This is an ongoing randomized, double-blind, placebo-controlled, phase 1/2 clinical trial among healthy adults aged =18 years in Henan Province, China. Participants (n = 336 in 18-59 age group and n = 336 in =60 age group) were enrolled between April 12 and May 17 2020, and were equally randomized to receive vaccine or placebo (aluminum hydroxide adjuvant) in a three-dose","2021","07","13","EClinicalMedicine","EClinicalMedicine",NA,"Zhao","Dongyang","Henan Province Centre for Disease Control and Prevention, Zhengzhou, Henan, China",NA
"1062","34250456","10.1016/j.eclinm.2021.101010","Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18 years or older: A randomized, double-blind, placebo-controlled, phase 1/2 trial.","We aimed to assess the safety and immunogenicity of an inactivated vaccine against COVID-19 in Chinese adults aged =18 years. This is an ongoing randomized, double-blind, placebo-controlled, phase 1/2 clinical trial among healthy adults aged =18 years in Henan Province, China. Participants (n = 336 in 18-59 age group and n = 336 in =60 age group) were enrolled between April 12 and May 17 2020, and were equally randomized to receive vaccine or placebo (aluminum hydroxide adjuvant) in a three-dose","2021","07","13","EClinicalMedicine","EClinicalMedicine",NA,"Zhang","Huajun","Chinese Academy of Sciences Key Laboratory of Special Pathogens, Wuhan Institute of Virology, Centre for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, Hubei, China",NA
"1063","34250456","10.1016/j.eclinm.2021.101010","Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18 years or older: A randomized, double-blind, placebo-controlled, phase 1/2 trial.","We aimed to assess the safety and immunogenicity of an inactivated vaccine against COVID-19 in Chinese adults aged =18 years. This is an ongoing randomized, double-blind, placebo-controlled, phase 1/2 clinical trial among healthy adults aged =18 years in Henan Province, China. Participants (n = 336 in 18-59 age group and n = 336 in =60 age group) were enrolled between April 12 and May 17 2020, and were equally randomized to receive vaccine or placebo (aluminum hydroxide adjuvant) in a three-dose","2021","07","13","EClinicalMedicine","EClinicalMedicine",NA,"Xie","Zhiqiang","Henan Province Centre for Disease Control and Prevention, Zhengzhou, Henan, China",NA
"1064","34250456","10.1016/j.eclinm.2021.101010","Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18 years or older: A randomized, double-blind, placebo-controlled, phase 1/2 trial.","We aimed to assess the safety and immunogenicity of an inactivated vaccine against COVID-19 in Chinese adults aged =18 years. This is an ongoing randomized, double-blind, placebo-controlled, phase 1/2 clinical trial among healthy adults aged =18 years in Henan Province, China. Participants (n = 336 in 18-59 age group and n = 336 in =60 age group) were enrolled between April 12 and May 17 2020, and were equally randomized to receive vaccine or placebo (aluminum hydroxide adjuvant) in a three-dose","2021","07","13","EClinicalMedicine","EClinicalMedicine",NA,"Li","Xinguo","National Engineering Technology Research Centre for Combined Vaccines, Wuhan Institute of Biological Products Co. Ltd., Wuhan, Hubei, China",NA
"1065","34250456","10.1016/j.eclinm.2021.101010","Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18 years or older: A randomized, double-blind, placebo-controlled, phase 1/2 trial.","We aimed to assess the safety and immunogenicity of an inactivated vaccine against COVID-19 in Chinese adults aged =18 years. This is an ongoing randomized, double-blind, placebo-controlled, phase 1/2 clinical trial among healthy adults aged =18 years in Henan Province, China. Participants (n = 336 in 18-59 age group and n = 336 in =60 age group) were enrolled between April 12 and May 17 2020, and were equally randomized to receive vaccine or placebo (aluminum hydroxide adjuvant) in a three-dose","2021","07","13","EClinicalMedicine","EClinicalMedicine",NA,"Peng","Cheng","Chinese Academy of Sciences Key Laboratory of Special Pathogens, Wuhan Institute of Virology, Centre for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, Hubei, China",NA
"1066","34250456","10.1016/j.eclinm.2021.101010","Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18 years or older: A randomized, double-blind, placebo-controlled, phase 1/2 trial.","We aimed to assess the safety and immunogenicity of an inactivated vaccine against COVID-19 in Chinese adults aged =18 years. This is an ongoing randomized, double-blind, placebo-controlled, phase 1/2 clinical trial among healthy adults aged =18 years in Henan Province, China. Participants (n = 336 in 18-59 age group and n = 336 in =60 age group) were enrolled between April 12 and May 17 2020, and were equally randomized to receive vaccine or placebo (aluminum hydroxide adjuvant) in a three-dose","2021","07","13","EClinicalMedicine","EClinicalMedicine",NA,"Zhang","Wei","Henan Province Centre for Disease Control and Prevention, Zhengzhou, Henan, China",NA
"1067","34250456","10.1016/j.eclinm.2021.101010","Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18 years or older: A randomized, double-blind, placebo-controlled, phase 1/2 trial.","We aimed to assess the safety and immunogenicity of an inactivated vaccine against COVID-19 in Chinese adults aged =18 years. This is an ongoing randomized, double-blind, placebo-controlled, phase 1/2 clinical trial among healthy adults aged =18 years in Henan Province, China. Participants (n = 336 in 18-59 age group and n = 336 in =60 age group) were enrolled between April 12 and May 17 2020, and were equally randomized to receive vaccine or placebo (aluminum hydroxide adjuvant) in a three-dose","2021","07","13","EClinicalMedicine","EClinicalMedicine",NA,"Yang","Yunkai","China National Biotec Group Company Limited, Beijing, China",NA
"1068","34250456","10.1016/j.eclinm.2021.101010","Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18 years or older: A randomized, double-blind, placebo-controlled, phase 1/2 trial.","We aimed to assess the safety and immunogenicity of an inactivated vaccine against COVID-19 in Chinese adults aged =18 years. This is an ongoing randomized, double-blind, placebo-controlled, phase 1/2 clinical trial among healthy adults aged =18 years in Henan Province, China. Participants (n = 336 in 18-59 age group and n = 336 in =60 age group) were enrolled between April 12 and May 17 2020, and were equally randomized to receive vaccine or placebo (aluminum hydroxide adjuvant) in a three-dose","2021","07","13","EClinicalMedicine","EClinicalMedicine",NA,"Chen","Wei","National Engineering Technology Research Centre for Combined Vaccines, Wuhan Institute of Biological Products Co. Ltd., Wuhan, Hubei, China",NA
"1069","34250456","10.1016/j.eclinm.2021.101010","Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18 years or older: A randomized, double-blind, placebo-controlled, phase 1/2 trial.","We aimed to assess the safety and immunogenicity of an inactivated vaccine against COVID-19 in Chinese adults aged =18 years. This is an ongoing randomized, double-blind, placebo-controlled, phase 1/2 clinical trial among healthy adults aged =18 years in Henan Province, China. Participants (n = 336 in 18-59 age group and n = 336 in =60 age group) were enrolled between April 12 and May 17 2020, and were equally randomized to receive vaccine or placebo (aluminum hydroxide adjuvant) in a three-dose","2021","07","13","EClinicalMedicine","EClinicalMedicine",NA,"Gao","Xiaoxiao","Chinese Academy of Sciences Key Laboratory of Special Pathogens, Wuhan Institute of Virology, Centre for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, Hubei, China",NA
"1070","34250456","10.1016/j.eclinm.2021.101010","Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18 years or older: A randomized, double-blind, placebo-controlled, phase 1/2 trial.","We aimed to assess the safety and immunogenicity of an inactivated vaccine against COVID-19 in Chinese adults aged =18 years. This is an ongoing randomized, double-blind, placebo-controlled, phase 1/2 clinical trial among healthy adults aged =18 years in Henan Province, China. Participants (n = 336 in 18-59 age group and n = 336 in =60 age group) were enrolled between April 12 and May 17 2020, and were equally randomized to receive vaccine or placebo (aluminum hydroxide adjuvant) in a three-dose","2021","07","13","EClinicalMedicine","EClinicalMedicine",NA,"You","Wangyang","Henan Province Centre for Disease Control and Prevention, Zhengzhou, Henan, China",NA
"1071","34250456","10.1016/j.eclinm.2021.101010","Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18 years or older: A randomized, double-blind, placebo-controlled, phase 1/2 trial.","We aimed to assess the safety and immunogenicity of an inactivated vaccine against COVID-19 in Chinese adults aged =18 years. This is an ongoing randomized, double-blind, placebo-controlled, phase 1/2 clinical trial among healthy adults aged =18 years in Henan Province, China. Participants (n = 336 in 18-59 age group and n = 336 in =60 age group) were enrolled between April 12 and May 17 2020, and were equally randomized to receive vaccine or placebo (aluminum hydroxide adjuvant) in a three-dose","2021","07","13","EClinicalMedicine","EClinicalMedicine",NA,"Wang","Xue-Wei","China National Biotec Group Company Limited, Beijing, China",NA
"1072","34250456","10.1016/j.eclinm.2021.101010","Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18 years or older: A randomized, double-blind, placebo-controlled, phase 1/2 trial.","We aimed to assess the safety and immunogenicity of an inactivated vaccine against COVID-19 in Chinese adults aged =18 years. This is an ongoing randomized, double-blind, placebo-controlled, phase 1/2 clinical trial among healthy adults aged =18 years in Henan Province, China. Participants (n = 336 in 18-59 age group and n = 336 in =60 age group) were enrolled between April 12 and May 17 2020, and were equally randomized to receive vaccine or placebo (aluminum hydroxide adjuvant) in a three-dose","2021","07","13","EClinicalMedicine","EClinicalMedicine",NA,"Shi","Zhengli","Chinese Academy of Sciences Key Laboratory of Special Pathogens, Wuhan Institute of Virology, Centre for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, Hubei, China",NA
"1073","34250456","10.1016/j.eclinm.2021.101010","Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18 years or older: A randomized, double-blind, placebo-controlled, phase 1/2 trial.","We aimed to assess the safety and immunogenicity of an inactivated vaccine against COVID-19 in Chinese adults aged =18 years. This is an ongoing randomized, double-blind, placebo-controlled, phase 1/2 clinical trial among healthy adults aged =18 years in Henan Province, China. Participants (n = 336 in 18-59 age group and n = 336 in =60 age group) were enrolled between April 12 and May 17 2020, and were equally randomized to receive vaccine or placebo (aluminum hydroxide adjuvant) in a three-dose","2021","07","13","EClinicalMedicine","EClinicalMedicine",NA,"Wang","Yanxia","Henan Province Centre for Disease Control and Prevention, Zhengzhou, Henan, China",NA
"1074","34250456","10.1016/j.eclinm.2021.101010","Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18 years or older: A randomized, double-blind, placebo-controlled, phase 1/2 trial.","We aimed to assess the safety and immunogenicity of an inactivated vaccine against COVID-19 in Chinese adults aged =18 years. This is an ongoing randomized, double-blind, placebo-controlled, phase 1/2 clinical trial among healthy adults aged =18 years in Henan Province, China. Participants (n = 336 in 18-59 age group and n = 336 in =60 age group) were enrolled between April 12 and May 17 2020, and were equally randomized to receive vaccine or placebo (aluminum hydroxide adjuvant) in a three-dose","2021","07","13","EClinicalMedicine","EClinicalMedicine",NA,"Yang","Xu-Qin","China National Biotec Group Company Limited, Beijing, China",NA
"1075","34250456","10.1016/j.eclinm.2021.101010","Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18 years or older: A randomized, double-blind, placebo-controlled, phase 1/2 trial.","We aimed to assess the safety and immunogenicity of an inactivated vaccine against COVID-19 in Chinese adults aged =18 years. This is an ongoing randomized, double-blind, placebo-controlled, phase 1/2 clinical trial among healthy adults aged =18 years in Henan Province, China. Participants (n = 336 in 18-59 age group and n = 336 in =60 age group) were enrolled between April 12 and May 17 2020, and were equally randomized to receive vaccine or placebo (aluminum hydroxide adjuvant) in a three-dose","2021","07","13","EClinicalMedicine","EClinicalMedicine",NA,"Zhang","Lianghao","National Engineering Technology Research Centre for Combined Vaccines, Wuhan Institute of Biological Products Co. Ltd., Wuhan, Hubei, China",NA
"1076","34250456","10.1016/j.eclinm.2021.101010","Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18 years or older: A randomized, double-blind, placebo-controlled, phase 1/2 trial.","We aimed to assess the safety and immunogenicity of an inactivated vaccine against COVID-19 in Chinese adults aged =18 years. This is an ongoing randomized, double-blind, placebo-controlled, phase 1/2 clinical trial among healthy adults aged =18 years in Henan Province, China. Participants (n = 336 in 18-59 age group and n = 336 in =60 age group) were enrolled between April 12 and May 17 2020, and were equally randomized to receive vaccine or placebo (aluminum hydroxide adjuvant) in a three-dose","2021","07","13","EClinicalMedicine","EClinicalMedicine",NA,"Huang","Lili","Henan Province Centre for Disease Control and Prevention, Zhengzhou, Henan, China",NA
"1077","34250456","10.1016/j.eclinm.2021.101010","Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18 years or older: A randomized, double-blind, placebo-controlled, phase 1/2 trial.","We aimed to assess the safety and immunogenicity of an inactivated vaccine against COVID-19 in Chinese adults aged =18 years. This is an ongoing randomized, double-blind, placebo-controlled, phase 1/2 clinical trial among healthy adults aged =18 years in Henan Province, China. Participants (n = 336 in 18-59 age group and n = 336 in =60 age group) were enrolled between April 12 and May 17 2020, and were equally randomized to receive vaccine or placebo (aluminum hydroxide adjuvant) in a three-dose","2021","07","13","EClinicalMedicine","EClinicalMedicine",NA,"Wang","Qian","China National Biotec Group Company Limited, Beijing, China",NA
"1078","34250456","10.1016/j.eclinm.2021.101010","Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18 years or older: A randomized, double-blind, placebo-controlled, phase 1/2 trial.","We aimed to assess the safety and immunogenicity of an inactivated vaccine against COVID-19 in Chinese adults aged =18 years. This is an ongoing randomized, double-blind, placebo-controlled, phase 1/2 clinical trial among healthy adults aged =18 years in Henan Province, China. Participants (n = 336 in 18-59 age group and n = 336 in =60 age group) were enrolled between April 12 and May 17 2020, and were equally randomized to receive vaccine or placebo (aluminum hydroxide adjuvant) in a three-dose","2021","07","13","EClinicalMedicine","EClinicalMedicine",NA,"Lu","Jia","National Engineering Technology Research Centre for Combined Vaccines, Wuhan Institute of Biological Products Co. Ltd., Wuhan, Hubei, China",NA
"1079","34250456","10.1016/j.eclinm.2021.101010","Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18 years or older: A randomized, double-blind, placebo-controlled, phase 1/2 trial.","We aimed to assess the safety and immunogenicity of an inactivated vaccine against COVID-19 in Chinese adults aged =18 years. This is an ongoing randomized, double-blind, placebo-controlled, phase 1/2 clinical trial among healthy adults aged =18 years in Henan Province, China. Participants (n = 336 in 18-59 age group and n = 336 in =60 age group) were enrolled between April 12 and May 17 2020, and were equally randomized to receive vaccine or placebo (aluminum hydroxide adjuvant) in a three-dose","2021","07","13","EClinicalMedicine","EClinicalMedicine",NA,"Yang","Yong-Li","Department of Epidemiology and Biostatistics, College of Public Health, Zhengzhou University, Zhengzhou, Henan, China",NA
"1080","34250456","10.1016/j.eclinm.2021.101010","Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18 years or older: A randomized, double-blind, placebo-controlled, phase 1/2 trial.","We aimed to assess the safety and immunogenicity of an inactivated vaccine against COVID-19 in Chinese adults aged =18 years. This is an ongoing randomized, double-blind, placebo-controlled, phase 1/2 clinical trial among healthy adults aged =18 years in Henan Province, China. Participants (n = 336 in 18-59 age group and n = 336 in =60 age group) were enrolled between April 12 and May 17 2020, and were equally randomized to receive vaccine or placebo (aluminum hydroxide adjuvant) in a three-dose","2021","07","13","EClinicalMedicine","EClinicalMedicine",NA,"Guo","Jing","National Engineering Technology Research Centre for Combined Vaccines, Wuhan Institute of Biological Products Co. Ltd., Wuhan, Hubei, China",NA
"1081","34250456","10.1016/j.eclinm.2021.101010","Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18 years or older: A randomized, double-blind, placebo-controlled, phase 1/2 trial.","We aimed to assess the safety and immunogenicity of an inactivated vaccine against COVID-19 in Chinese adults aged =18 years. This is an ongoing randomized, double-blind, placebo-controlled, phase 1/2 clinical trial among healthy adults aged =18 years in Henan Province, China. Participants (n = 336 in 18-59 age group and n = 336 in =60 age group) were enrolled between April 12 and May 17 2020, and were equally randomized to receive vaccine or placebo (aluminum hydroxide adjuvant) in a three-dose","2021","07","13","EClinicalMedicine","EClinicalMedicine",NA,"Zhou","Wei","National Engineering Technology Research Centre for Combined Vaccines, Wuhan Institute of Biological Products Co. Ltd., Wuhan, Hubei, China",NA
"1082","34250456","10.1016/j.eclinm.2021.101010","Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18 years or older: A randomized, double-blind, placebo-controlled, phase 1/2 trial.","We aimed to assess the safety and immunogenicity of an inactivated vaccine against COVID-19 in Chinese adults aged =18 years. This is an ongoing randomized, double-blind, placebo-controlled, phase 1/2 clinical trial among healthy adults aged =18 years in Henan Province, China. Participants (n = 336 in 18-59 age group and n = 336 in =60 age group) were enrolled between April 12 and May 17 2020, and were equally randomized to receive vaccine or placebo (aluminum hydroxide adjuvant) in a three-dose","2021","07","13","EClinicalMedicine","EClinicalMedicine",NA,"Wan","Xin","National Engineering Technology Research Centre for Combined Vaccines, Wuhan Institute of Biological Products Co. Ltd., Wuhan, Hubei, China",NA
"1083","34250456","10.1016/j.eclinm.2021.101010","Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18 years or older: A randomized, double-blind, placebo-controlled, phase 1/2 trial.","We aimed to assess the safety and immunogenicity of an inactivated vaccine against COVID-19 in Chinese adults aged =18 years. This is an ongoing randomized, double-blind, placebo-controlled, phase 1/2 clinical trial among healthy adults aged =18 years in Henan Province, China. Participants (n = 336 in 18-59 age group and n = 336 in =60 age group) were enrolled between April 12 and May 17 2020, and were equally randomized to receive vaccine or placebo (aluminum hydroxide adjuvant) in a three-dose","2021","07","13","EClinicalMedicine","EClinicalMedicine",NA,"Wu","Cong","National Engineering Technology Research Centre for Combined Vaccines, Wuhan Institute of Biological Products Co. Ltd., Wuhan, Hubei, China",NA
"1084","34250456","10.1016/j.eclinm.2021.101010","Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18 years or older: A randomized, double-blind, placebo-controlled, phase 1/2 trial.","We aimed to assess the safety and immunogenicity of an inactivated vaccine against COVID-19 in Chinese adults aged =18 years. This is an ongoing randomized, double-blind, placebo-controlled, phase 1/2 clinical trial among healthy adults aged =18 years in Henan Province, China. Participants (n = 336 in 18-59 age group and n = 336 in =60 age group) were enrolled between April 12 and May 17 2020, and were equally randomized to receive vaccine or placebo (aluminum hydroxide adjuvant) in a three-dose","2021","07","13","EClinicalMedicine","EClinicalMedicine",NA,"Wang","Wenhui","National Engineering Technology Research Centre for Combined Vaccines, Wuhan Institute of Biological Products Co. Ltd., Wuhan, Hubei, China",NA
"1085","34250456","10.1016/j.eclinm.2021.101010","Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18 years or older: A randomized, double-blind, placebo-controlled, phase 1/2 trial.","We aimed to assess the safety and immunogenicity of an inactivated vaccine against COVID-19 in Chinese adults aged =18 years. This is an ongoing randomized, double-blind, placebo-controlled, phase 1/2 clinical trial among healthy adults aged =18 years in Henan Province, China. Participants (n = 336 in 18-59 age group and n = 336 in =60 age group) were enrolled between April 12 and May 17 2020, and were equally randomized to receive vaccine or placebo (aluminum hydroxide adjuvant) in a three-dose","2021","07","13","EClinicalMedicine","EClinicalMedicine",NA,"Du","Jianhui","National Engineering Technology Research Centre for Combined Vaccines, Wuhan Institute of Biological Products Co. Ltd., Wuhan, Hubei, China",NA
"1086","34250456","10.1016/j.eclinm.2021.101010","Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18 years or older: A randomized, double-blind, placebo-controlled, phase 1/2 trial.","We aimed to assess the safety and immunogenicity of an inactivated vaccine against COVID-19 in Chinese adults aged =18 years. This is an ongoing randomized, double-blind, placebo-controlled, phase 1/2 clinical trial among healthy adults aged =18 years in Henan Province, China. Participants (n = 336 in 18-59 age group and n = 336 in =60 age group) were enrolled between April 12 and May 17 2020, and were equally randomized to receive vaccine or placebo (aluminum hydroxide adjuvant) in a three-dose","2021","07","13","EClinicalMedicine","EClinicalMedicine",NA,"Nian","Xuanxuan","National Engineering Technology Research Centre for Combined Vaccines, Wuhan Institute of Biological Products Co. Ltd., Wuhan, Hubei, China",NA
"1087","34250456","10.1016/j.eclinm.2021.101010","Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18 years or older: A randomized, double-blind, placebo-controlled, phase 1/2 trial.","We aimed to assess the safety and immunogenicity of an inactivated vaccine against COVID-19 in Chinese adults aged =18 years. This is an ongoing randomized, double-blind, placebo-controlled, phase 1/2 clinical trial among healthy adults aged =18 years in Henan Province, China. Participants (n = 336 in 18-59 age group and n = 336 in =60 age group) were enrolled between April 12 and May 17 2020, and were equally randomized to receive vaccine or placebo (aluminum hydroxide adjuvant) in a three-dose","2021","07","13","EClinicalMedicine","EClinicalMedicine",NA,"Li","Xing-Hang","National Engineering Technology Research Centre for Combined Vaccines, Wuhan Institute of Biological Products Co. Ltd., Wuhan, Hubei, China",NA
"1088","34250456","10.1016/j.eclinm.2021.101010","Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18 years or older: A randomized, double-blind, placebo-controlled, phase 1/2 trial.","We aimed to assess the safety and immunogenicity of an inactivated vaccine against COVID-19 in Chinese adults aged =18 years. This is an ongoing randomized, double-blind, placebo-controlled, phase 1/2 clinical trial among healthy adults aged =18 years in Henan Province, China. Participants (n = 336 in 18-59 age group and n = 336 in =60 age group) were enrolled between April 12 and May 17 2020, and were equally randomized to receive vaccine or placebo (aluminum hydroxide adjuvant) in a three-dose","2021","07","13","EClinicalMedicine","EClinicalMedicine",NA,"Huang","Shihe","National Engineering Technology Research Centre for Combined Vaccines, Wuhan Institute of Biological Products Co. Ltd., Wuhan, Hubei, China",NA
"1089","34250456","10.1016/j.eclinm.2021.101010","Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18 years or older: A randomized, double-blind, placebo-controlled, phase 1/2 trial.","We aimed to assess the safety and immunogenicity of an inactivated vaccine against COVID-19 in Chinese adults aged =18 years. This is an ongoing randomized, double-blind, placebo-controlled, phase 1/2 clinical trial among healthy adults aged =18 years in Henan Province, China. Participants (n = 336 in 18-59 age group and n = 336 in =60 age group) were enrolled between April 12 and May 17 2020, and were equally randomized to receive vaccine or placebo (aluminum hydroxide adjuvant) in a three-dose","2021","07","13","EClinicalMedicine","EClinicalMedicine",NA,"Shen","Shuo","National Engineering Technology Research Centre for Combined Vaccines, Wuhan Institute of Biological Products Co. Ltd., Wuhan, Hubei, China",NA
"1090","34250456","10.1016/j.eclinm.2021.101010","Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18 years or older: A randomized, double-blind, placebo-controlled, phase 1/2 trial.","We aimed to assess the safety and immunogenicity of an inactivated vaccine against COVID-19 in Chinese adults aged =18 years. This is an ongoing randomized, double-blind, placebo-controlled, phase 1/2 clinical trial among healthy adults aged =18 years in Henan Province, China. Participants (n = 336 in 18-59 age group and n = 336 in =60 age group) were enrolled between April 12 and May 17 2020, and were equally randomized to receive vaccine or placebo (aluminum hydroxide adjuvant) in a three-dose","2021","07","13","EClinicalMedicine","EClinicalMedicine",NA,"Xia","Shengli","Henan Province Centre for Disease Control and Prevention, Zhengzhou, Henan, China",NA
"1091","34250456","10.1016/j.eclinm.2021.101010","Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18 years or older: A randomized, double-blind, placebo-controlled, phase 1/2 trial.","We aimed to assess the safety and immunogenicity of an inactivated vaccine against COVID-19 in Chinese adults aged =18 years. This is an ongoing randomized, double-blind, placebo-controlled, phase 1/2 clinical trial among healthy adults aged =18 years in Henan Province, China. Participants (n = 336 in 18-59 age group and n = 336 in =60 age group) were enrolled between April 12 and May 17 2020, and were equally randomized to receive vaccine or placebo (aluminum hydroxide adjuvant) in a three-dose","2021","07","13","EClinicalMedicine","EClinicalMedicine",NA,"Pan","An","Department of Epidemiology and Biostatistics, Ministry of Education Key Laboratory of Environment and Health and State Key Laboratory of Environmental Health (incubation), School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China",NA
"1092","34250456","10.1016/j.eclinm.2021.101010","Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18 years or older: A randomized, double-blind, placebo-controlled, phase 1/2 trial.","We aimed to assess the safety and immunogenicity of an inactivated vaccine against COVID-19 in Chinese adults aged =18 years. This is an ongoing randomized, double-blind, placebo-controlled, phase 1/2 clinical trial among healthy adults aged =18 years in Henan Province, China. Participants (n = 336 in 18-59 age group and n = 336 in =60 age group) were enrolled between April 12 and May 17 2020, and were equally randomized to receive vaccine or placebo (aluminum hydroxide adjuvant) in a three-dose","2021","07","13","EClinicalMedicine","EClinicalMedicine",NA,"Yang","Xiaoming","National Engineering Technology Research Centre for Combined Vaccines, Wuhan Institute of Biological Products Co. Ltd., Wuhan, Hubei, China",NA
"1093","34250455","10.1016/j.hest.2021.06.005","Intracerebral bleeding after janus-kinase inhibitor baricitinib for COVID-19.","Intracerebral hemorhaghe/bleeding (ICH) after an infection with SARS-CoV-2 (COVID-19) treated with the Janus-kinase inhibitor baricitinib has not been reported.Case presentation: a 86yo Caucasian female suddenly developed aphasia with a systolic blood pressure of 220 mmHg. Cerebral imaging revealed an ICH in the left temporal lobe without mass effect and no need for neurosurgical intervention. Her previous history was positive for arterial hypertension, hyperlipidemia, heart failure, renal insuf","2021","07","13","Brain Hemorrhages","Brain hemorrhages","COVID-19; Cerebral bleeding; Coagulation; Hypertension; Hypocoagulability; SARS-CoV-2; Thrombocytes","Finsterer","Josef","Klinik Landstrasse, Messerli Institute, Vienna, Austria",NA
"1094","34250455","10.1016/j.hest.2021.06.005","Intracerebral bleeding after janus-kinase inhibitor baricitinib for COVID-19.","Intracerebral hemorhaghe/bleeding (ICH) after an infection with SARS-CoV-2 (COVID-19) treated with the Janus-kinase inhibitor baricitinib has not been reported.Case presentation: a 86yo Caucasian female suddenly developed aphasia with a systolic blood pressure of 220 mmHg. Cerebral imaging revealed an ICH in the left temporal lobe without mass effect and no need for neurosurgical intervention. Her previous history was positive for arterial hypertension, hyperlipidemia, heart failure, renal insuf","2021","07","13","Brain Hemorrhages","Brain hemorrhages","COVID-19; Cerebral bleeding; Coagulation; Hypertension; Hypocoagulability; SARS-CoV-2; Thrombocytes","Scorza","Fulvio A","Disciplina de Neurociência., Universidade Federal de São Paulo/Escola Paulista de Medicina (UNIFESP/EPM), Rua Pedro de Toledo, 697 - Vila Clementino, São Paulo, SP, 04039-00, Brazil",NA
"1095","34250445","10.1007/s42399-021-01009-9","Comment on: Emerging Evidence on Multisystem Inflammatory Syndrome in Children Associated with SARS-CoV-2 Infection.",NA,"2021","07","13","SN Compr Clin Med","SN comprehensive clinical medicine","COVID-19; Multisystem inflammatory syndrome in children (MIS-C); SARS-CoV-2; Systematic review","Mantina","Namoonga M","Department of Health Promotion Sciences, Mel &amp",NA
"1096","34250445","10.1007/s42399-021-01009-9","Comment on: Emerging Evidence on Multisystem Inflammatory Syndrome in Children Associated with SARS-CoV-2 Infection.",NA,"2021","07","13","SN Compr Clin Med","SN comprehensive clinical medicine","COVID-19; Multisystem inflammatory syndrome in children (MIS-C); SARS-CoV-2; Systematic review","Madhivanan","Purnima","Department of Health Promotion Sciences, Mel &amp",NA
"1097","34250436","10.3389/frma.2021.712672","Editorial: Coronavirus Research Landscape: Resources, Utilities, and Analytic Studies.",NA,"2021","07","12","Front Res Metr Anal","Frontiers in research metrics and analytics","COVID-19; coronavirus research; literature reviews; resources of scholarly publications; studies of scholarly literature","Chen","Chaomei","College of Computing and Informatics, Drexel University, Philadelphia, PA, United States",NA
"1098","34250436","10.3389/frma.2021.712672","Editorial: Coronavirus Research Landscape: Resources, Utilities, and Analytic Studies.",NA,"2021","07","12","Front Res Metr Anal","Frontiers in research metrics and analytics","COVID-19; coronavirus research; literature reviews; resources of scholarly publications; studies of scholarly literature","Chavalarias","David","Centre d'Analyse et de Mathématique Sociales, École des Hautes Études en Sciences Sociales, Paris, France",NA
"1099","34250436","10.3389/frma.2021.712672","Editorial: Coronavirus Research Landscape: Resources, Utilities, and Analytic Studies.",NA,"2021","07","12","Front Res Metr Anal","Frontiers in research metrics and analytics","COVID-19; coronavirus research; literature reviews; resources of scholarly publications; studies of scholarly literature","Smalheiser","Neil R","Department of Psychiatry, University of Illinois at Chicago, Chicago, llinois, United States",NA
"1100","34250436","10.3389/frma.2021.712672","Editorial: Coronavirus Research Landscape: Resources, Utilities, and Analytic Studies.",NA,"2021","07","12","Front Res Metr Anal","Frontiers in research metrics and analytics","COVID-19; coronavirus research; literature reviews; resources of scholarly publications; studies of scholarly literature","Wolfram","Dietmar","School of Information Studies, University of Wisconsin-Milwaukee, Milwaukee, WI, United States",NA
"1101","34250348","10.1021/acsomega.1c01501","Anti-Covid-19 Drug Analogues: Synthesis of Novel Pyrimidine Thioglycosides as Antiviral Agents Against SARS-COV-2 and Avian Influenza H5N1 Viruses.","A class of pyrimidine thioglycoside analogs (6a-h) were synthesized from a reaction of 2-cyano-3,3-dimercapto-N-arylacrylamide (2a-d) and thiourea to produce the corresponding 4-amino-2-mercapto-N-arylpyrimidine-5-carboxamide derivatives (3a-d), and stirring of compounds (3a-d) with peracylated a-d-gluco- and galacto-pyranosyl bromides (4a,b) in DMF-sodium hydride gave the corresponding pyrimidine thioglycosides (5a-h). Deacet","2021","07","13","ACS Omega","ACS omega",NA,"Abu-Zaied","Mamdouh A","Green Chemistry Department, National Research Centre, 33 El Bohouth Street, Dokki, Giza 12622, Egypt",NA
"1102","34250348","10.1021/acsomega.1c01501","Anti-Covid-19 Drug Analogues: Synthesis of Novel Pyrimidine Thioglycosides as Antiviral Agents Against SARS-COV-2 and Avian Influenza H5N1 Viruses.","A class of pyrimidine thioglycoside analogs (6a-h) were synthesized from a reaction of 2-cyano-3,3-dimercapto-N-arylacrylamide (2a-d) and thiourea to produce the corresponding 4-amino-2-mercapto-N-arylpyrimidine-5-carboxamide derivatives (3a-d), and stirring of compounds (3a-d) with peracylated a-d-gluco- and galacto-pyranosyl bromides (4a,b) in DMF-sodium hydride gave the corresponding pyrimidine thioglycosides (5a-h). Deacet","2021","07","13","ACS Omega","ACS omega",NA,"Elgemeie","Galal H","Chemistry Department, Faculty of Science, Helwan University, Helwan, Cairo 11795, Egypt",NA
"1103","34250348","10.1021/acsomega.1c01501","Anti-Covid-19 Drug Analogues: Synthesis of Novel Pyrimidine Thioglycosides as Antiviral Agents Against SARS-COV-2 and Avian Influenza H5N1 Viruses.","A class of pyrimidine thioglycoside analogs (6a-h) were synthesized from a reaction of 2-cyano-3,3-dimercapto-N-arylacrylamide (2a-d) and thiourea to produce the corresponding 4-amino-2-mercapto-N-arylpyrimidine-5-carboxamide derivatives (3a-d), and stirring of compounds (3a-d) with peracylated a-d-gluco- and galacto-pyranosyl bromides (4a,b) in DMF-sodium hydride gave the corresponding pyrimidine thioglycosides (5a-h). Deacet","2021","07","13","ACS Omega","ACS omega",NA,"Mahmoud","Nashwa M","Chemistry Department, Faculty of Science, Suez University, Suez 43533, Egypt",NA
"1104","34250347","10.1021/acsomega.1c01489","CFD Simulation of the Airborne Transmission of COVID-19 Vectors Emitted during Respiratory Mechanisms: Revisiting the Concept of Safe Distance.","The airborne transmission of the COVID-19 virus has been suggested as a major mode of transmission in recent studies. In this context, we studied the spatial transmission of COVID-19 vectors in an indoor setting representative of a typical office room. Computational fluid dynamics (CFD) simulations were performed to study the airborne dispersion of particles ejected due to different respiratory mechanisms, i.e., coughing, sneezing, normal talking, and loud talking. Number concentration profiles ","2021","07","13","ACS Omega","ACS omega",NA,"Mariam","Radiological Physics and Advisory Division, Bhabha Atomic Research Centre, Mumbai 400085, India","CFDVR Institute, Dharamshala, Himachal Pradesh 176219, India","34250347"
"1105","34250347","10.1021/acsomega.1c01489","CFD Simulation of the Airborne Transmission of COVID-19 Vectors Emitted during Respiratory Mechanisms: Revisiting the Concept of Safe Distance.","The airborne transmission of the COVID-19 virus has been suggested as a major mode of transmission in recent studies. In this context, we studied the spatial transmission of COVID-19 vectors in an indoor setting representative of a typical office room. Computational fluid dynamics (CFD) simulations were performed to study the airborne dispersion of particles ejected due to different respiratory mechanisms, i.e., coughing, sneezing, normal talking, and loud talking. Number concentration profiles ","2021","07","13","ACS Omega","ACS omega",NA,"Magar","Ashish","CFDVR Institute, Dharamshala, Himachal Pradesh 176219, India",NA
"1106","34250347","10.1021/acsomega.1c01489","CFD Simulation of the Airborne Transmission of COVID-19 Vectors Emitted during Respiratory Mechanisms: Revisiting the Concept of Safe Distance.","The airborne transmission of the COVID-19 virus has been suggested as a major mode of transmission in recent studies. In this context, we studied the spatial transmission of COVID-19 vectors in an indoor setting representative of a typical office room. Computational fluid dynamics (CFD) simulations were performed to study the airborne dispersion of particles ejected due to different respiratory mechanisms, i.e., coughing, sneezing, normal talking, and loud talking. Number concentration profiles ","2021","07","13","ACS Omega","ACS omega",NA,"Joshi","Manish","Radiological Physics and Advisory Division, Bhabha Atomic Research Centre, Mumbai 400085, India",NA
"1107","34250347","10.1021/acsomega.1c01489","CFD Simulation of the Airborne Transmission of COVID-19 Vectors Emitted during Respiratory Mechanisms: Revisiting the Concept of Safe Distance.","The airborne transmission of the COVID-19 virus has been suggested as a major mode of transmission in recent studies. In this context, we studied the spatial transmission of COVID-19 vectors in an indoor setting representative of a typical office room. Computational fluid dynamics (CFD) simulations were performed to study the airborne dispersion of particles ejected due to different respiratory mechanisms, i.e., coughing, sneezing, normal talking, and loud talking. Number concentration profiles ","2021","07","13","ACS Omega","ACS omega",NA,"Rajagopal","Pachalla S","ACRi Infotech Pvt. Ltd., Bangalore 560037, India",NA
"1108","34250347","10.1021/acsomega.1c01489","CFD Simulation of the Airborne Transmission of COVID-19 Vectors Emitted during Respiratory Mechanisms: Revisiting the Concept of Safe Distance.","The airborne transmission of the COVID-19 virus has been suggested as a major mode of transmission in recent studies. In this context, we studied the spatial transmission of COVID-19 vectors in an indoor setting representative of a typical office room. Computational fluid dynamics (CFD) simulations were performed to study the airborne dispersion of particles ejected due to different respiratory mechanisms, i.e., coughing, sneezing, normal talking, and loud talking. Number concentration profiles ","2021","07","13","ACS Omega","ACS omega",NA,"Khan","Arshad","Radiological Physics and Advisory Division, Bhabha Atomic Research Centre, Mumbai 400085, India",NA
"1109","34250347","10.1021/acsomega.1c01489","CFD Simulation of the Airborne Transmission of COVID-19 Vectors Emitted during Respiratory Mechanisms: Revisiting the Concept of Safe Distance.","The airborne transmission of the COVID-19 virus has been suggested as a major mode of transmission in recent studies. In this context, we studied the spatial transmission of COVID-19 vectors in an indoor setting representative of a typical office room. Computational fluid dynamics (CFD) simulations were performed to study the airborne dispersion of particles ejected due to different respiratory mechanisms, i.e., coughing, sneezing, normal talking, and loud talking. Number concentration profiles ","2021","07","13","ACS Omega","ACS omega",NA,"Rao","Madhukar M","ACRi Infotech Pvt. Ltd., Bangalore 560037, India",NA
"1110","34250347","10.1021/acsomega.1c01489","CFD Simulation of the Airborne Transmission of COVID-19 Vectors Emitted during Respiratory Mechanisms: Revisiting the Concept of Safe Distance.","The airborne transmission of the COVID-19 virus has been suggested as a major mode of transmission in recent studies. In this context, we studied the spatial transmission of COVID-19 vectors in an indoor setting representative of a typical office room. Computational fluid dynamics (CFD) simulations were performed to study the airborne dispersion of particles ejected due to different respiratory mechanisms, i.e., coughing, sneezing, normal talking, and loud talking. Number concentration profiles ","2021","07","13","ACS Omega","ACS omega",NA,"Sapra","Balvinder K","Radiological Physics and Advisory Division, Bhabha Atomic Research Centre, Mumbai 400085, India",NA
"1111","34250342","10.1021/acsomega.1c01375","SOD1 is a Possible Predictor of COVID-19 Progression as Revealed by Plasma Proteomics.","The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a worldwide health emergency. Patients infected with SARS-CoV-2 present with diverse symptoms related to the severity of the disease. Determining the proteomic changes associated with these diverse symptoms and in different stages of infection is beneficial for clinical diagnosis and management. Here, we performed a tandem mass tag-labeling proteomic study on the pla","2021","07","13","ACS Omega","ACS omega",NA,"Xu","Benhong","Shenzhen Center for Disease Control and Prevention, Shenzhen 518055, China",NA
"1112","34250342","10.1021/acsomega.1c01375","SOD1 is a Possible Predictor of COVID-19 Progression as Revealed by Plasma Proteomics.","The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a worldwide health emergency. Patients infected with SARS-CoV-2 present with diverse symptoms related to the severity of the disease. Determining the proteomic changes associated with these diverse symptoms and in different stages of infection is beneficial for clinical diagnosis and management. Here, we performed a tandem mass tag-labeling proteomic study on the pla","2021","07","13","ACS Omega","ACS omega",NA,"Lei","Yuxuan","Shenzhen Center for Disease Control and Prevention, Shenzhen 518055, China",NA
"1113","34250342","10.1021/acsomega.1c01375","SOD1 is a Possible Predictor of COVID-19 Progression as Revealed by Plasma Proteomics.","The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a worldwide health emergency. Patients infected with SARS-CoV-2 present with diverse symptoms related to the severity of the disease. Determining the proteomic changes associated with these diverse symptoms and in different stages of infection is beneficial for clinical diagnosis and management. Here, we performed a tandem mass tag-labeling proteomic study on the pla","2021","07","13","ACS Omega","ACS omega",NA,"Ren","Xiaohu","Shenzhen Center for Disease Control and Prevention, Shenzhen 518055, China",NA
"1114","34250342","10.1021/acsomega.1c01375","SOD1 is a Possible Predictor of COVID-19 Progression as Revealed by Plasma Proteomics.","The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a worldwide health emergency. Patients infected with SARS-CoV-2 present with diverse symptoms related to the severity of the disease. Determining the proteomic changes associated with these diverse symptoms and in different stages of infection is beneficial for clinical diagnosis and management. Here, we performed a tandem mass tag-labeling proteomic study on the pla","2021","07","13","ACS Omega","ACS omega",NA,"Yin","Feng","State Key Laboratory of Chemical Oncogenomics, School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School, Shenzhen 518055, China",NA
"1115","34250342","10.1021/acsomega.1c01375","SOD1 is a Possible Predictor of COVID-19 Progression as Revealed by Plasma Proteomics.","The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a worldwide health emergency. Patients infected with SARS-CoV-2 present with diverse symptoms related to the severity of the disease. Determining the proteomic changes associated with these diverse symptoms and in different stages of infection is beneficial for clinical diagnosis and management. Here, we performed a tandem mass tag-labeling proteomic study on the pla","2021","07","13","ACS Omega","ACS omega",NA,"Wu","Weihua","Shenzhen Center for Disease Control and Prevention, Shenzhen 518055, China",NA
"1116","34250342","10.1021/acsomega.1c01375","SOD1 is a Possible Predictor of COVID-19 Progression as Revealed by Plasma Proteomics.","The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a worldwide health emergency. Patients infected with SARS-CoV-2 present with diverse symptoms related to the severity of the disease. Determining the proteomic changes associated with these diverse symptoms and in different stages of infection is beneficial for clinical diagnosis and management. Here, we performed a tandem mass tag-labeling proteomic study on the pla","2021","07","13","ACS Omega","ACS omega",NA,"Sun","Ying","Shenzhen Center for Disease Control and Prevention, Shenzhen 518055, China",NA
"1117","34250342","10.1021/acsomega.1c01375","SOD1 is a Possible Predictor of COVID-19 Progression as Revealed by Plasma Proteomics.","The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a worldwide health emergency. Patients infected with SARS-CoV-2 present with diverse symptoms related to the severity of the disease. Determining the proteomic changes associated with these diverse symptoms and in different stages of infection is beneficial for clinical diagnosis and management. Here, we performed a tandem mass tag-labeling proteomic study on the pla","2021","07","13","ACS Omega","ACS omega",NA,"Wang","Xiaohui","Shenzhen Center for Disease Control and Prevention, Shenzhen 518055, China",NA
"1118","34250342","10.1021/acsomega.1c01375","SOD1 is a Possible Predictor of COVID-19 Progression as Revealed by Plasma Proteomics.","The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a worldwide health emergency. Patients infected with SARS-CoV-2 present with diverse symptoms related to the severity of the disease. Determining the proteomic changes associated with these diverse symptoms and in different stages of infection is beneficial for clinical diagnosis and management. Here, we performed a tandem mass tag-labeling proteomic study on the pla","2021","07","13","ACS Omega","ACS omega",NA,"Sun","Qian","Shenzhen Center for Disease Control and Prevention, Shenzhen 518055, China",NA
"1119","34250342","10.1021/acsomega.1c01375","SOD1 is a Possible Predictor of COVID-19 Progression as Revealed by Plasma Proteomics.","The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a worldwide health emergency. Patients infected with SARS-CoV-2 present with diverse symptoms related to the severity of the disease. Determining the proteomic changes associated with these diverse symptoms and in different stages of infection is beneficial for clinical diagnosis and management. Here, we performed a tandem mass tag-labeling proteomic study on the pla","2021","07","13","ACS Omega","ACS omega",NA,"Yang","Xifei","Shenzhen Center for Disease Control and Prevention, Shenzhen 518055, China",NA
"1120","34250342","10.1021/acsomega.1c01375","SOD1 is a Possible Predictor of COVID-19 Progression as Revealed by Plasma Proteomics.","The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a worldwide health emergency. Patients infected with SARS-CoV-2 present with diverse symptoms related to the severity of the disease. Determining the proteomic changes associated with these diverse symptoms and in different stages of infection is beneficial for clinical diagnosis and management. Here, we performed a tandem mass tag-labeling proteomic study on the pla","2021","07","13","ACS Omega","ACS omega",NA,"Wang","Xin","Shenzhen Center for Disease Control and Prevention, Shenzhen 518055, China",NA
"1121","34250342","10.1021/acsomega.1c01375","SOD1 is a Possible Predictor of COVID-19 Progression as Revealed by Plasma Proteomics.","The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a worldwide health emergency. Patients infected with SARS-CoV-2 present with diverse symptoms related to the severity of the disease. Determining the proteomic changes associated with these diverse symptoms and in different stages of infection is beneficial for clinical diagnosis and management. Here, we performed a tandem mass tag-labeling proteomic study on the pla","2021","07","13","ACS Omega","ACS omega",NA,"Zhang","Renli","Shenzhen Center for Disease Control and Prevention, Shenzhen 518055, China",NA
"1122","34250342","10.1021/acsomega.1c01375","SOD1 is a Possible Predictor of COVID-19 Progression as Revealed by Plasma Proteomics.","The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a worldwide health emergency. Patients infected with SARS-CoV-2 present with diverse symptoms related to the severity of the disease. Determining the proteomic changes associated with these diverse symptoms and in different stages of infection is beneficial for clinical diagnosis and management. Here, we performed a tandem mass tag-labeling proteomic study on the pla","2021","07","13","ACS Omega","ACS omega",NA,"Li","Zigang","State Key Laboratory of Chemical Oncogenomics, School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School, Shenzhen 518055, China",NA
"1123","34250342","10.1021/acsomega.1c01375","SOD1 is a Possible Predictor of COVID-19 Progression as Revealed by Plasma Proteomics.","The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a worldwide health emergency. Patients infected with SARS-CoV-2 present with diverse symptoms related to the severity of the disease. Determining the proteomic changes associated with these diverse symptoms and in different stages of infection is beneficial for clinical diagnosis and management. Here, we performed a tandem mass tag-labeling proteomic study on the pla","2021","07","13","ACS Omega","ACS omega",NA,"Fang","Shisong","Shenzhen Center for Disease Control and Prevention, Shenzhen 518055, China",NA
"1124","34250342","10.1021/acsomega.1c01375","SOD1 is a Possible Predictor of COVID-19 Progression as Revealed by Plasma Proteomics.","The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a worldwide health emergency. Patients infected with SARS-CoV-2 present with diverse symptoms related to the severity of the disease. Determining the proteomic changes associated with these diverse symptoms and in different stages of infection is beneficial for clinical diagnosis and management. Here, we performed a tandem mass tag-labeling proteomic study on the pla","2021","07","13","ACS Omega","ACS omega",NA,"Liu","Jianjun","Shenzhen Center for Disease Control and Prevention, Shenzhen 518055, China",NA
"1125","34250324","10.1016/j.cophys.2021.06.010","Silent hypoxia in COVID-19: a gut microbiota connection.","Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection has triggered the COVID-19 pandemic. Several factors induce hypoxia in COVID-19. Despite being hypoxic, some SARS-CoV-2-infected individuals do not experience any respiratory distress, a phenomenon termed 'silent (or happy) hypoxia'. Prolonged undetected hypoxia could be dangerous, sometimes leading to death. A few studies attempted to unravel what causes silent hypoxia, however, the exact mechanisms are still elusive. Here, ","2021","07","23","Curr Opin Physiol","Current opinion in physiology",NA,"Gopal","Akshita B","School of Biological Sciences, National Institute of Science Education and Research (NISER) Bhubaneswar, HBNI, P.O. Bhimpur-Padanpur, Via Jatni, Dist. Khurda, 752050, Odisha, India",NA
"1126","34250324","10.1016/j.cophys.2021.06.010","Silent hypoxia in COVID-19: a gut microbiota connection.","Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection has triggered the COVID-19 pandemic. Several factors induce hypoxia in COVID-19. Despite being hypoxic, some SARS-CoV-2-infected individuals do not experience any respiratory distress, a phenomenon termed 'silent (or happy) hypoxia'. Prolonged undetected hypoxia could be dangerous, sometimes leading to death. A few studies attempted to unravel what causes silent hypoxia, however, the exact mechanisms are still elusive. Here, ","2021","07","23","Curr Opin Physiol","Current opinion in physiology",NA,"Chakraborty","Soumyadeep","School of Biological Sciences, National Institute of Science Education and Research (NISER) Bhubaneswar, HBNI, P.O. Bhimpur-Padanpur, Via Jatni, Dist. Khurda, 752050, Odisha, India",NA
"1127","34250324","10.1016/j.cophys.2021.06.010","Silent hypoxia in COVID-19: a gut microbiota connection.","Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection has triggered the COVID-19 pandemic. Several factors induce hypoxia in COVID-19. Despite being hypoxic, some SARS-CoV-2-infected individuals do not experience any respiratory distress, a phenomenon termed 'silent (or happy) hypoxia'. Prolonged undetected hypoxia could be dangerous, sometimes leading to death. A few studies attempted to unravel what causes silent hypoxia, however, the exact mechanisms are still elusive. Here, ","2021","07","23","Curr Opin Physiol","Current opinion in physiology",NA,"Padhan","Pratyush K","School of Biological Sciences, National Institute of Science Education and Research (NISER) Bhubaneswar, HBNI, P.O. Bhimpur-Padanpur, Via Jatni, Dist. Khurda, 752050, Odisha, India",NA
"1128","34250324","10.1016/j.cophys.2021.06.010","Silent hypoxia in COVID-19: a gut microbiota connection.","Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection has triggered the COVID-19 pandemic. Several factors induce hypoxia in COVID-19. Despite being hypoxic, some SARS-CoV-2-infected individuals do not experience any respiratory distress, a phenomenon termed 'silent (or happy) hypoxia'. Prolonged undetected hypoxia could be dangerous, sometimes leading to death. A few studies attempted to unravel what causes silent hypoxia, however, the exact mechanisms are still elusive. Here, ","2021","07","23","Curr Opin Physiol","Current opinion in physiology",NA,"Barik","Alok","School of Biological Sciences, National Institute of Science Education and Research (NISER) Bhubaneswar, HBNI, P.O. Bhimpur-Padanpur, Via Jatni, Dist. Khurda, 752050, Odisha, India",NA
"1129","34250324","10.1016/j.cophys.2021.06.010","Silent hypoxia in COVID-19: a gut microbiota connection.","Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection has triggered the COVID-19 pandemic. Several factors induce hypoxia in COVID-19. Despite being hypoxic, some SARS-CoV-2-infected individuals do not experience any respiratory distress, a phenomenon termed 'silent (or happy) hypoxia'. Prolonged undetected hypoxia could be dangerous, sometimes leading to death. A few studies attempted to unravel what causes silent hypoxia, however, the exact mechanisms are still elusive. Here, ","2021","07","23","Curr Opin Physiol","Current opinion in physiology",NA,"Dixit","Pragyesh","School of Biological Sciences, National Institute of Science Education and Research (NISER) Bhubaneswar, HBNI, P.O. Bhimpur-Padanpur, Via Jatni, Dist. Khurda, 752050, Odisha, India",NA
"1130","34250324","10.1016/j.cophys.2021.06.010","Silent hypoxia in COVID-19: a gut microbiota connection.","Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection has triggered the COVID-19 pandemic. Several factors induce hypoxia in COVID-19. Despite being hypoxic, some SARS-CoV-2-infected individuals do not experience any respiratory distress, a phenomenon termed 'silent (or happy) hypoxia'. Prolonged undetected hypoxia could be dangerous, sometimes leading to death. A few studies attempted to unravel what causes silent hypoxia, however, the exact mechanisms are still elusive. Here, ","2021","07","23","Curr Opin Physiol","Current opinion in physiology",NA,"Chakraborty","Debashish","School of Biological Sciences, National Institute of Science Education and Research (NISER) Bhubaneswar, HBNI, P.O. Bhimpur-Padanpur, Via Jatni, Dist. Khurda, 752050, Odisha, India",NA
"1131","34250324","10.1016/j.cophys.2021.06.010","Silent hypoxia in COVID-19: a gut microbiota connection.","Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection has triggered the COVID-19 pandemic. Several factors induce hypoxia in COVID-19. Despite being hypoxic, some SARS-CoV-2-infected individuals do not experience any respiratory distress, a phenomenon termed 'silent (or happy) hypoxia'. Prolonged undetected hypoxia could be dangerous, sometimes leading to death. A few studies attempted to unravel what causes silent hypoxia, however, the exact mechanisms are still elusive. Here, ","2021","07","23","Curr Opin Physiol","Current opinion in physiology",NA,"Poirah","Indrajit","School of Biological Sciences, National Institute of Science Education and Research (NISER) Bhubaneswar, HBNI, P.O. Bhimpur-Padanpur, Via Jatni, Dist. Khurda, 752050, Odisha, India",NA
"1132","34250324","10.1016/j.cophys.2021.06.010","Silent hypoxia in COVID-19: a gut microbiota connection.","Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection has triggered the COVID-19 pandemic. Several factors induce hypoxia in COVID-19. Despite being hypoxic, some SARS-CoV-2-infected individuals do not experience any respiratory distress, a phenomenon termed 'silent (or happy) hypoxia'. Prolonged undetected hypoxia could be dangerous, sometimes leading to death. A few studies attempted to unravel what causes silent hypoxia, however, the exact mechanisms are still elusive. Here, ","2021","07","23","Curr Opin Physiol","Current opinion in physiology",NA,"Samal","Supriya","School of Biological Sciences, National Institute of Science Education and Research (NISER) Bhubaneswar, HBNI, P.O. Bhimpur-Padanpur, Via Jatni, Dist. Khurda, 752050, Odisha, India",NA
"1133","34250324","10.1016/j.cophys.2021.06.010","Silent hypoxia in COVID-19: a gut microbiota connection.","Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection has triggered the COVID-19 pandemic. Several factors induce hypoxia in COVID-19. Despite being hypoxic, some SARS-CoV-2-infected individuals do not experience any respiratory distress, a phenomenon termed 'silent (or happy) hypoxia'. Prolonged undetected hypoxia could be dangerous, sometimes leading to death. A few studies attempted to unravel what causes silent hypoxia, however, the exact mechanisms are still elusive. Here, ","2021","07","23","Curr Opin Physiol","Current opinion in physiology",NA,"Sarkar","Arup","Trident Academy of Creative Technology, Bhubaneswar 751024, Odisha, India",NA
"1134","34250324","10.1016/j.cophys.2021.06.010","Silent hypoxia in COVID-19: a gut microbiota connection.","Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection has triggered the COVID-19 pandemic. Several factors induce hypoxia in COVID-19. Despite being hypoxic, some SARS-CoV-2-infected individuals do not experience any respiratory distress, a phenomenon termed 'silent (or happy) hypoxia'. Prolonged undetected hypoxia could be dangerous, sometimes leading to death. A few studies attempted to unravel what causes silent hypoxia, however, the exact mechanisms are still elusive. Here, ","2021","07","23","Curr Opin Physiol","Current opinion in physiology",NA,"Bhattacharyya","Asima","School of Biological Sciences, National Institute of Science Education and Research (NISER) Bhubaneswar, HBNI, P.O. Bhimpur-Padanpur, Via Jatni, Dist. Khurda, 752050, Odisha, India",NA
"1135","34250323","10.1016/j.coesh.2021.100290","Efficacy of frontline chemical biocides and disinfection approaches for inactivating SARS-CoV-2 variants of concern that cause coronavirus disease (COVID-19) with emergence of opportunities for green eco-solutions.","The emergence of severe acute respiratory disease (SARS-CoV-2) variants that causes coronavirus disease (COVID-19) is of global concern. SARS-Cov-2 variants of concern (VOC) exhibiting greater transmissibility, and potentially increased risk of hospitalization, severity and mortality, are attributed to molecular mutations in outer viral surface spike proteins. Thus, there is a reliance on using appropriate counter-disease measures including non-pharmaceutical interventions and vaccination. Best ","2021","07","13","Curr Opin Environ Sci Health","Current opinion in environmental science &amp; health","COVID-19; PPE; SAR-Cov-2 variants; biocides; disinfection; environment; healthcare","Rowan","Neil J","Centre for Disinfection and Sterilisation, Athlone Institute of Technology, Dublin Road, Athlone, Ireland",NA
"1136","34250323","10.1016/j.coesh.2021.100290","Efficacy of frontline chemical biocides and disinfection approaches for inactivating SARS-CoV-2 variants of concern that cause coronavirus disease (COVID-19) with emergence of opportunities for green eco-solutions.","The emergence of severe acute respiratory disease (SARS-CoV-2) variants that causes coronavirus disease (COVID-19) is of global concern. SARS-Cov-2 variants of concern (VOC) exhibiting greater transmissibility, and potentially increased risk of hospitalization, severity and mortality, are attributed to molecular mutations in outer viral surface spike proteins. Thus, there is a reliance on using appropriate counter-disease measures including non-pharmaceutical interventions and vaccination. Best ","2021","07","13","Curr Opin Environ Sci Health","Current opinion in environmental science &amp; health","COVID-19; PPE; SAR-Cov-2 variants; biocides; disinfection; environment; healthcare","Meade","Elaine","Department of Life Science, Institute of Technology, Sligo, Ash Lane, Sligo, Ireland",NA
"1137","34250323","10.1016/j.coesh.2021.100290","Efficacy of frontline chemical biocides and disinfection approaches for inactivating SARS-CoV-2 variants of concern that cause coronavirus disease (COVID-19) with emergence of opportunities for green eco-solutions.","The emergence of severe acute respiratory disease (SARS-CoV-2) variants that causes coronavirus disease (COVID-19) is of global concern. SARS-Cov-2 variants of concern (VOC) exhibiting greater transmissibility, and potentially increased risk of hospitalization, severity and mortality, are attributed to molecular mutations in outer viral surface spike proteins. Thus, there is a reliance on using appropriate counter-disease measures including non-pharmaceutical interventions and vaccination. Best ","2021","07","13","Curr Opin Environ Sci Health","Current opinion in environmental science &amp; health","COVID-19; PPE; SAR-Cov-2 variants; biocides; disinfection; environment; healthcare","Garvey","Mary","Department of Life Science, Institute of Technology, Sligo, Ash Lane, Sligo, Ireland",NA
"1138","34250321","10.1016/j.sciaf.2021.e00827","Spread of COVID-19 in Zambia: An assessment of environmental and socioeconomic factors using a classification tree approach.","The global pandemic emergent from SARS-COV-2 (COVID-19) has continued to cause both health and socio-economic challenges worldwide. However, there is limited information on the factors affecting the dynamics of COVID-19, especially in developing countries, including African countries. In this study, we have focused on understanding the association of COVID-19 cases with environmental and socioeconomic factors in Zambia - a sub-Saharan African country. We used Zambia's district-level COVID-19 dat","2021","07","16","Sci Afr","Scientific African","Africa; COVID-19; Classification Tree; GIS; HIV/AIDS; Zambia","Phiri","Darius","Department of Plant and Environmental Sciences, School of Natural Resources, Copperbelt University, Kitwe 10101, Zambia",NA
"1139","34250321","10.1016/j.sciaf.2021.e00827","Spread of COVID-19 in Zambia: An assessment of environmental and socioeconomic factors using a classification tree approach.","The global pandemic emergent from SARS-COV-2 (COVID-19) has continued to cause both health and socio-economic challenges worldwide. However, there is limited information on the factors affecting the dynamics of COVID-19, especially in developing countries, including African countries. In this study, we have focused on understanding the association of COVID-19 cases with environmental and socioeconomic factors in Zambia - a sub-Saharan African country. We used Zambia's district-level COVID-19 dat","2021","07","16","Sci Afr","Scientific African","Africa; COVID-19; Classification Tree; GIS; HIV/AIDS; Zambia","Salekin","Serajis","Scion, Titokorangi Drive (formerly Longmile Road), Private Bag 3020, Rotorua 3046, New Zealand",NA
"1140","34250321","10.1016/j.sciaf.2021.e00827","Spread of COVID-19 in Zambia: An assessment of environmental and socioeconomic factors using a classification tree approach.","The global pandemic emergent from SARS-COV-2 (COVID-19) has continued to cause both health and socio-economic challenges worldwide. However, there is limited information on the factors affecting the dynamics of COVID-19, especially in developing countries, including African countries. In this study, we have focused on understanding the association of COVID-19 cases with environmental and socioeconomic factors in Zambia - a sub-Saharan African country. We used Zambia's district-level COVID-19 dat","2021","07","16","Sci Afr","Scientific African","Africa; COVID-19; Classification Tree; GIS; HIV/AIDS; Zambia","Nyirenda","Vincent R","Department of Zoology and Aquatic Sciences, School of Natural Resources, Copperbelt University, P.O. Box 21692, Kitwe 10101, Zambia",NA
"1141","34250321","10.1016/j.sciaf.2021.e00827","Spread of COVID-19 in Zambia: An assessment of environmental and socioeconomic factors using a classification tree approach.","The global pandemic emergent from SARS-COV-2 (COVID-19) has continued to cause both health and socio-economic challenges worldwide. However, there is limited information on the factors affecting the dynamics of COVID-19, especially in developing countries, including African countries. In this study, we have focused on understanding the association of COVID-19 cases with environmental and socioeconomic factors in Zambia - a sub-Saharan African country. We used Zambia's district-level COVID-19 dat","2021","07","16","Sci Afr","Scientific African","Africa; COVID-19; Classification Tree; GIS; HIV/AIDS; Zambia","Simwanda","Matamyo","Department of Plant and Environmental Sciences, School of Natural Resources, Copperbelt University, Kitwe 10101, Zambia",NA
"1142","34250321","10.1016/j.sciaf.2021.e00827","Spread of COVID-19 in Zambia: An assessment of environmental and socioeconomic factors using a classification tree approach.","The global pandemic emergent from SARS-COV-2 (COVID-19) has continued to cause both health and socio-economic challenges worldwide. However, there is limited information on the factors affecting the dynamics of COVID-19, especially in developing countries, including African countries. In this study, we have focused on understanding the association of COVID-19 cases with environmental and socioeconomic factors in Zambia - a sub-Saharan African country. We used Zambia's district-level COVID-19 dat","2021","07","16","Sci Afr","Scientific African","Africa; COVID-19; Classification Tree; GIS; HIV/AIDS; Zambia","Ranagalage","Manjula","Department of Environmental Management, Faculty of Social Sciences and Humanities, Rajarata University of Sri Lanka, Mihintale 50300, Sri Lanka",NA
"1143","34250321","10.1016/j.sciaf.2021.e00827","Spread of COVID-19 in Zambia: An assessment of environmental and socioeconomic factors using a classification tree approach.","The global pandemic emergent from SARS-COV-2 (COVID-19) has continued to cause both health and socio-economic challenges worldwide. However, there is limited information on the factors affecting the dynamics of COVID-19, especially in developing countries, including African countries. In this study, we have focused on understanding the association of COVID-19 cases with environmental and socioeconomic factors in Zambia - a sub-Saharan African country. We used Zambia's district-level COVID-19 dat","2021","07","16","Sci Afr","Scientific African","Africa; COVID-19; Classification Tree; GIS; HIV/AIDS; Zambia","Murayama","Yuji","Faculty of Life and Environmental Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba City, Ibaraki 305-8572, Japan",NA
"1144","34250320","10.1016/j.idm.2021.06.004","Grappling with COVID-19 by imposing and lifting non-pharmaceutical interventions in Sri Lanka: A modeling perspective.","The imposition and lifting of non-pharmaceutical interventions (NPIs) to avert the COVID-19 pandemic have gained popularity worldwide and will continue to be enforced until herd immunity is achieved. We developed a linear regression model to ascertain the nexus between the time-varying reproduction number averaged over a time window of six days (Rts) and seven NPIs: contact tracing, quarantine efforts, social distancing and health checks, hand hygiene, wearing of facemasks, lockdown a","2021","07","14","Infect Dis Model","Infectious Disease Modelling","Contact tracing; Isolation; Lockdown; Modeling; Reproduction number","Jayaweera","Mahesh","Department of Civil Engineering, University of Moratuwa, Sri Lanka",NA
"1145","34250320","10.1016/j.idm.2021.06.004","Grappling with COVID-19 by imposing and lifting non-pharmaceutical interventions in Sri Lanka: A modeling perspective.","The imposition and lifting of non-pharmaceutical interventions (NPIs) to avert the COVID-19 pandemic have gained popularity worldwide and will continue to be enforced until herd immunity is achieved. We developed a linear regression model to ascertain the nexus between the time-varying reproduction number averaged over a time window of six days (Rts) and seven NPIs: contact tracing, quarantine efforts, social distancing and health checks, hand hygiene, wearing of facemasks, lockdown a","2021","07","14","Infect Dis Model","Infectious Disease Modelling","Contact tracing; Isolation; Lockdown; Modeling; Reproduction number","Dannangoda","Chamath","Department of Physics and Astronomy, University of Texas at Rio Grande Valley, Brownsville, TX, 78520, USA",NA
"1146","34250320","10.1016/j.idm.2021.06.004","Grappling with COVID-19 by imposing and lifting non-pharmaceutical interventions in Sri Lanka: A modeling perspective.","The imposition and lifting of non-pharmaceutical interventions (NPIs) to avert the COVID-19 pandemic have gained popularity worldwide and will continue to be enforced until herd immunity is achieved. We developed a linear regression model to ascertain the nexus between the time-varying reproduction number averaged over a time window of six days (Rts) and seven NPIs: contact tracing, quarantine efforts, social distancing and health checks, hand hygiene, wearing of facemasks, lockdown a","2021","07","14","Infect Dis Model","Infectious Disease Modelling","Contact tracing; Isolation; Lockdown; Modeling; Reproduction number","Dilshan","Dilum","Department of Civil Engineering, University of Moratuwa, Sri Lanka",NA
"1147","34250320","10.1016/j.idm.2021.06.004","Grappling with COVID-19 by imposing and lifting non-pharmaceutical interventions in Sri Lanka: A modeling perspective.","The imposition and lifting of non-pharmaceutical interventions (NPIs) to avert the COVID-19 pandemic have gained popularity worldwide and will continue to be enforced until herd immunity is achieved. We developed a linear regression model to ascertain the nexus between the time-varying reproduction number averaged over a time window of six days (Rts) and seven NPIs: contact tracing, quarantine efforts, social distancing and health checks, hand hygiene, wearing of facemasks, lockdown a","2021","07","14","Infect Dis Model","Infectious Disease Modelling","Contact tracing; Isolation; Lockdown; Modeling; Reproduction number","Dissanayake","Janith","Department of Civil &amp",NA
"1148","34250320","10.1016/j.idm.2021.06.004","Grappling with COVID-19 by imposing and lifting non-pharmaceutical interventions in Sri Lanka: A modeling perspective.","The imposition and lifting of non-pharmaceutical interventions (NPIs) to avert the COVID-19 pandemic have gained popularity worldwide and will continue to be enforced until herd immunity is achieved. We developed a linear regression model to ascertain the nexus between the time-varying reproduction number averaged over a time window of six days (Rts) and seven NPIs: contact tracing, quarantine efforts, social distancing and health checks, hand hygiene, wearing of facemasks, lockdown a","2021","07","14","Infect Dis Model","Infectious Disease Modelling","Contact tracing; Isolation; Lockdown; Modeling; Reproduction number","Perera","Hasini","Department of Forestry and Environmental Science, University of Sri Jayewardenepura, Sri Lanka",NA
"1149","34250320","10.1016/j.idm.2021.06.004","Grappling with COVID-19 by imposing and lifting non-pharmaceutical interventions in Sri Lanka: A modeling perspective.","The imposition and lifting of non-pharmaceutical interventions (NPIs) to avert the COVID-19 pandemic have gained popularity worldwide and will continue to be enforced until herd immunity is achieved. We developed a linear regression model to ascertain the nexus between the time-varying reproduction number averaged over a time window of six days (Rts) and seven NPIs: contact tracing, quarantine efforts, social distancing and health checks, hand hygiene, wearing of facemasks, lockdown a","2021","07","14","Infect Dis Model","Infectious Disease Modelling","Contact tracing; Isolation; Lockdown; Modeling; Reproduction number","Manatunge","Jagath","Department of Civil Engineering, University of Moratuwa, Sri Lanka",NA
"1150","34250320","10.1016/j.idm.2021.06.004","Grappling with COVID-19 by imposing and lifting non-pharmaceutical interventions in Sri Lanka: A modeling perspective.","The imposition and lifting of non-pharmaceutical interventions (NPIs) to avert the COVID-19 pandemic have gained popularity worldwide and will continue to be enforced until herd immunity is achieved. We developed a linear regression model to ascertain the nexus between the time-varying reproduction number averaged over a time window of six days (Rts) and seven NPIs: contact tracing, quarantine efforts, social distancing and health checks, hand hygiene, wearing of facemasks, lockdown a","2021","07","14","Infect Dis Model","Infectious Disease Modelling","Contact tracing; Isolation; Lockdown; Modeling; Reproduction number","Gunawardana","Buddhika","Department of Civil Engineering, University of Moratuwa, Sri Lanka",NA
"1151","34250319","10.1016/j.ekir.2021.06.027","Systematic Review of Early Immune Response to SARS-CoV-2 Vaccination Among Patients with Chronic Kidney Disease.","The effects of the coronavirus disease 19 (COVID-19) pandemic in particular affect those with chronic kidney disease (CKD), who commonly have defects in humoral and cellular immunity, and the efficacy of vaccinations against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is uncertain. To inform public health and clinical practice, we synthesized published studies and preprints evaluating surrogate measures of immunity after SARS-CoV-2 vaccination in patients with CKD including thos","2021","07","17","Kidney Int Rep","Kidney international reports","coronavirus; covid; covid-19; dialysis; kidney disease; transplant; vaccine","Carr","Edward J","The Francis Crick Institute, London, UK",NA
"1152","34250319","10.1016/j.ekir.2021.06.027","Systematic Review of Early Immune Response to SARS-CoV-2 Vaccination Among Patients with Chronic Kidney Disease.","The effects of the coronavirus disease 19 (COVID-19) pandemic in particular affect those with chronic kidney disease (CKD), who commonly have defects in humoral and cellular immunity, and the efficacy of vaccinations against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is uncertain. To inform public health and clinical practice, we synthesized published studies and preprints evaluating surrogate measures of immunity after SARS-CoV-2 vaccination in patients with CKD including thos","2021","07","17","Kidney Int Rep","Kidney international reports","coronavirus; covid; covid-19; dialysis; kidney disease; transplant; vaccine","Kronbichler","Andreas","Department of Medicine, University of Cambridge, Cambridge, UK",NA
"1153","34250319","10.1016/j.ekir.2021.06.027","Systematic Review of Early Immune Response to SARS-CoV-2 Vaccination Among Patients with Chronic Kidney Disease.","The effects of the coronavirus disease 19 (COVID-19) pandemic in particular affect those with chronic kidney disease (CKD), who commonly have defects in humoral and cellular immunity, and the efficacy of vaccinations against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is uncertain. To inform public health and clinical practice, we synthesized published studies and preprints evaluating surrogate measures of immunity after SARS-CoV-2 vaccination in patients with CKD including thos","2021","07","17","Kidney Int Rep","Kidney international reports","coronavirus; covid; covid-19; dialysis; kidney disease; transplant; vaccine","Graham-Brown","Matthew","Department of Cardiovascular Sciences, University of Leicester",NA
"1154","34250319","10.1016/j.ekir.2021.06.027","Systematic Review of Early Immune Response to SARS-CoV-2 Vaccination Among Patients with Chronic Kidney Disease.","The effects of the coronavirus disease 19 (COVID-19) pandemic in particular affect those with chronic kidney disease (CKD), who commonly have defects in humoral and cellular immunity, and the efficacy of vaccinations against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is uncertain. To inform public health and clinical practice, we synthesized published studies and preprints evaluating surrogate measures of immunity after SARS-CoV-2 vaccination in patients with CKD including thos","2021","07","17","Kidney Int Rep","Kidney international reports","coronavirus; covid; covid-19; dialysis; kidney disease; transplant; vaccine","Abra","Graham","Satellite Healthcare, San Jose CA USA, Division of Nephrology, Department of Medicine, Stanford University, Palo Alto CA USA",NA
"1155","34250319","10.1016/j.ekir.2021.06.027","Systematic Review of Early Immune Response to SARS-CoV-2 Vaccination Among Patients with Chronic Kidney Disease.","The effects of the coronavirus disease 19 (COVID-19) pandemic in particular affect those with chronic kidney disease (CKD), who commonly have defects in humoral and cellular immunity, and the efficacy of vaccinations against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is uncertain. To inform public health and clinical practice, we synthesized published studies and preprints evaluating surrogate measures of immunity after SARS-CoV-2 vaccination in patients with CKD including thos","2021","07","17","Kidney Int Rep","Kidney international reports","coronavirus; covid; covid-19; dialysis; kidney disease; transplant; vaccine","Argyropoulos","Christos","University of New Mexico School of Medicine, Department of Internal Medicine, Division of Nephrology, Albuquerque, NM USA",NA
"1156","34250319","10.1016/j.ekir.2021.06.027","Systematic Review of Early Immune Response to SARS-CoV-2 Vaccination Among Patients with Chronic Kidney Disease.","The effects of the coronavirus disease 19 (COVID-19) pandemic in particular affect those with chronic kidney disease (CKD), who commonly have defects in humoral and cellular immunity, and the efficacy of vaccinations against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is uncertain. To inform public health and clinical practice, we synthesized published studies and preprints evaluating surrogate measures of immunity after SARS-CoV-2 vaccination in patients with CKD including thos","2021","07","17","Kidney Int Rep","Kidney international reports","coronavirus; covid; covid-19; dialysis; kidney disease; transplant; vaccine","Harper","Lorraine","Institute of Applied Health Research, University of Birmingham, Birmingham UK",NA
"1157","34250319","10.1016/j.ekir.2021.06.027","Systematic Review of Early Immune Response to SARS-CoV-2 Vaccination Among Patients with Chronic Kidney Disease.","The effects of the coronavirus disease 19 (COVID-19) pandemic in particular affect those with chronic kidney disease (CKD), who commonly have defects in humoral and cellular immunity, and the efficacy of vaccinations against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is uncertain. To inform public health and clinical practice, we synthesized published studies and preprints evaluating surrogate measures of immunity after SARS-CoV-2 vaccination in patients with CKD including thos","2021","07","17","Kidney Int Rep","Kidney international reports","coronavirus; covid; covid-19; dialysis; kidney disease; transplant; vaccine","Lerma","Edgar V","Section of Nephrology, University of Illinois at Chicago/ Advocate Christ Medical Center, Oak Lawn, IL USA",NA
"1158","34250319","10.1016/j.ekir.2021.06.027","Systematic Review of Early Immune Response to SARS-CoV-2 Vaccination Among Patients with Chronic Kidney Disease.","The effects of the coronavirus disease 19 (COVID-19) pandemic in particular affect those with chronic kidney disease (CKD), who commonly have defects in humoral and cellular immunity, and the efficacy of vaccinations against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is uncertain. To inform public health and clinical practice, we synthesized published studies and preprints evaluating surrogate measures of immunity after SARS-CoV-2 vaccination in patients with CKD including thos","2021","07","17","Kidney Int Rep","Kidney international reports","coronavirus; covid; covid-19; dialysis; kidney disease; transplant; vaccine","Suri","Rita S","Research Institute of the McGill University Health Center, Department of Medicine, McGill University, Montreal, Québec, Canada",NA
"1159","34250319","10.1016/j.ekir.2021.06.027","Systematic Review of Early Immune Response to SARS-CoV-2 Vaccination Among Patients with Chronic Kidney Disease.","The effects of the coronavirus disease 19 (COVID-19) pandemic in particular affect those with chronic kidney disease (CKD), who commonly have defects in humoral and cellular immunity, and the efficacy of vaccinations against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is uncertain. To inform public health and clinical practice, we synthesized published studies and preprints evaluating surrogate measures of immunity after SARS-CoV-2 vaccination in patients with CKD including thos","2021","07","17","Kidney Int Rep","Kidney international reports","coronavirus; covid; covid-19; dialysis; kidney disease; transplant; vaccine","Topf","Joel","Department of Medicine, Oakland University William Beaumont School of Medicine, Detroit, MI, USA",NA
"1160","34250319","10.1016/j.ekir.2021.06.027","Systematic Review of Early Immune Response to SARS-CoV-2 Vaccination Among Patients with Chronic Kidney Disease.","The effects of the coronavirus disease 19 (COVID-19) pandemic in particular affect those with chronic kidney disease (CKD), who commonly have defects in humoral and cellular immunity, and the efficacy of vaccinations against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is uncertain. To inform public health and clinical practice, we synthesized published studies and preprints evaluating surrogate measures of immunity after SARS-CoV-2 vaccination in patients with CKD including thos","2021","07","17","Kidney Int Rep","Kidney international reports","coronavirus; covid; covid-19; dialysis; kidney disease; transplant; vaccine","Willicombe","Michelle","Department of Inflammation and Immunity, Imperial College, London",NA
"1161","34250319","10.1016/j.ekir.2021.06.027","Systematic Review of Early Immune Response to SARS-CoV-2 Vaccination Among Patients with Chronic Kidney Disease.","The effects of the coronavirus disease 19 (COVID-19) pandemic in particular affect those with chronic kidney disease (CKD), who commonly have defects in humoral and cellular immunity, and the efficacy of vaccinations against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is uncertain. To inform public health and clinical practice, we synthesized published studies and preprints evaluating surrogate measures of immunity after SARS-CoV-2 vaccination in patients with CKD including thos","2021","07","17","Kidney Int Rep","Kidney international reports","coronavirus; covid; covid-19; dialysis; kidney disease; transplant; vaccine","Hiremath","Swapnil","Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada",NA
"1162","34250318","10.1016/j.ekir.2021.06.024","Nephrotic syndrome following ChAdOx1 nCoV-19 vaccine against SARScoV-2.",NA,"2021","07","16","Kidney Int Rep","Kidney international reports",NA,"Anupama","Y J","Department of Nephrology, Nanjappa Hospital, Shivamogga, India",NA
"1163","34250318","10.1016/j.ekir.2021.06.024","Nephrotic syndrome following ChAdOx1 nCoV-19 vaccine against SARScoV-2.",NA,"2021","07","16","Kidney Int Rep","Kidney international reports",NA,"Patel","Ravi G N","Department of Nephrology, Nanjappa Hospital, Shivamogga, India",NA
"1164","34250318","10.1016/j.ekir.2021.06.024","Nephrotic syndrome following ChAdOx1 nCoV-19 vaccine against SARScoV-2.",NA,"2021","07","16","Kidney Int Rep","Kidney international reports",NA,"Vankalakunti","Mahesha","Department of Pathology, Manipal Hospital, Bengaluru, India",NA
"1165","34250317","10.1016/j.ekir.2021.06.023","Use and safety of remdesivir in kidney transplant recipients with COVID-19.","Remdesivir has demonstrated antiviral activity against coronavirus, shortening the time to recovery in adults hospitalized with moderate/severe COVID-19. Severe adverse events such as acute kidney injury (AKI) have been reported. There is little available data on the use and safety of remdesivir in kidney transplant (KT) recipients. We present a multicenter cohort study of 51 KT recipients with COVID-19 treated with remdesivir. Outcomes and safety were assessed. Mean age at diagnosis was 60 year","2021","07","22","Kidney Int Rep","Kidney international reports","SARS-CoV2; acute kidney injury; immunosuppression; kidney transplantation; remdesivir","Buxeda","Anna","Department of Nephrology, Hospital del Mar, <U+FEFF>Institute Mar for Medical Research (IMIM), REDinREN (RD16/0009/0013), Barcelona, Spain",NA
"1166","34250317","10.1016/j.ekir.2021.06.023","Use and safety of remdesivir in kidney transplant recipients with COVID-19.","Remdesivir has demonstrated antiviral activity against coronavirus, shortening the time to recovery in adults hospitalized with moderate/severe COVID-19. Severe adverse events such as acute kidney injury (AKI) have been reported. There is little available data on the use and safety of remdesivir in kidney transplant (KT) recipients. We present a multicenter cohort study of 51 KT recipients with COVID-19 treated with remdesivir. Outcomes and safety were assessed. Mean age at diagnosis was 60 year","2021","07","22","Kidney Int Rep","Kidney international reports","SARS-CoV2; acute kidney injury; immunosuppression; kidney transplantation; remdesivir","Arias-Cabrales","Carlos","Department of Nephrology, Hospital del Mar, <U+FEFF>Institute Mar for Medical Research (IMIM), REDinREN (RD16/0009/0013), Barcelona, Spain",NA
"1167","34250317","10.1016/j.ekir.2021.06.023","Use and safety of remdesivir in kidney transplant recipients with COVID-19.","Remdesivir has demonstrated antiviral activity against coronavirus, shortening the time to recovery in adults hospitalized with moderate/severe COVID-19. Severe adverse events such as acute kidney injury (AKI) have been reported. There is little available data on the use and safety of remdesivir in kidney transplant (KT) recipients. We present a multicenter cohort study of 51 KT recipients with COVID-19 treated with remdesivir. Outcomes and safety were assessed. Mean age at diagnosis was 60 year","2021","07","22","Kidney Int Rep","Kidney international reports","SARS-CoV2; acute kidney injury; immunosuppression; kidney transplantation; remdesivir","Pérez-Sáez","María José","Department of Nephrology, Hospital del Mar, <U+FEFF>Institute Mar for Medical Research (IMIM), REDinREN (RD16/0009/0013), Barcelona, Spain",NA
"1168","34250317","10.1016/j.ekir.2021.06.023","Use and safety of remdesivir in kidney transplant recipients with COVID-19.","Remdesivir has demonstrated antiviral activity against coronavirus, shortening the time to recovery in adults hospitalized with moderate/severe COVID-19. Severe adverse events such as acute kidney injury (AKI) have been reported. There is little available data on the use and safety of remdesivir in kidney transplant (KT) recipients. We present a multicenter cohort study of 51 KT recipients with COVID-19 treated with remdesivir. Outcomes and safety were assessed. Mean age at diagnosis was 60 year","2021","07","22","Kidney Int Rep","Kidney international reports","SARS-CoV2; acute kidney injury; immunosuppression; kidney transplantation; remdesivir","Cacho","Judit","Department of Nephrology, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain",NA
"1169","34250317","10.1016/j.ekir.2021.06.023","Use and safety of remdesivir in kidney transplant recipients with COVID-19.","Remdesivir has demonstrated antiviral activity against coronavirus, shortening the time to recovery in adults hospitalized with moderate/severe COVID-19. Severe adverse events such as acute kidney injury (AKI) have been reported. There is little available data on the use and safety of remdesivir in kidney transplant (KT) recipients. We present a multicenter cohort study of 51 KT recipients with COVID-19 treated with remdesivir. Outcomes and safety were assessed. Mean age at diagnosis was 60 year","2021","07","22","Kidney Int Rep","Kidney international reports","SARS-CoV2; acute kidney injury; immunosuppression; kidney transplantation; remdesivir","Pelegrin","Sheila Cabello","Department of Nephrology, Hospital Universitario Son Espases, Palma de Mallorca, Spain",NA
"1170","34250317","10.1016/j.ekir.2021.06.023","Use and safety of remdesivir in kidney transplant recipients with COVID-19.","Remdesivir has demonstrated antiviral activity against coronavirus, shortening the time to recovery in adults hospitalized with moderate/severe COVID-19. Severe adverse events such as acute kidney injury (AKI) have been reported. There is little available data on the use and safety of remdesivir in kidney transplant (KT) recipients. We present a multicenter cohort study of 51 KT recipients with COVID-19 treated with remdesivir. Outcomes and safety were assessed. Mean age at diagnosis was 60 year","2021","07","22","Kidney Int Rep","Kidney international reports","SARS-CoV2; acute kidney injury; immunosuppression; kidney transplantation; remdesivir","Melilli","Edoardo","Department of Nephrology, Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain",NA
"1171","34250317","10.1016/j.ekir.2021.06.023","Use and safety of remdesivir in kidney transplant recipients with COVID-19.","Remdesivir has demonstrated antiviral activity against coronavirus, shortening the time to recovery in adults hospitalized with moderate/severe COVID-19. Severe adverse events such as acute kidney injury (AKI) have been reported. There is little available data on the use and safety of remdesivir in kidney transplant (KT) recipients. We present a multicenter cohort study of 51 KT recipients with COVID-19 treated with remdesivir. Outcomes and safety were assessed. Mean age at diagnosis was 60 year","2021","07","22","Kidney Int Rep","Kidney international reports","SARS-CoV2; acute kidney injury; immunosuppression; kidney transplantation; remdesivir","Aladrén","María José","Department of Nephrology, Hospital Universitario Miguel Servet, Zaragoza, Spain",NA
"1172","34250317","10.1016/j.ekir.2021.06.023","Use and safety of remdesivir in kidney transplant recipients with COVID-19.","Remdesivir has demonstrated antiviral activity against coronavirus, shortening the time to recovery in adults hospitalized with moderate/severe COVID-19. Severe adverse events such as acute kidney injury (AKI) have been reported. There is little available data on the use and safety of remdesivir in kidney transplant (KT) recipients. We present a multicenter cohort study of 51 KT recipients with COVID-19 treated with remdesivir. Outcomes and safety were assessed. Mean age at diagnosis was 60 year","2021","07","22","Kidney Int Rep","Kidney international reports","SARS-CoV2; acute kidney injury; immunosuppression; kidney transplantation; remdesivir","Galeano","Cristina","Department of Nephrology, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain",NA
"1173","34250317","10.1016/j.ekir.2021.06.023","Use and safety of remdesivir in kidney transplant recipients with COVID-19.","Remdesivir has demonstrated antiviral activity against coronavirus, shortening the time to recovery in adults hospitalized with moderate/severe COVID-19. Severe adverse events such as acute kidney injury (AKI) have been reported. There is little available data on the use and safety of remdesivir in kidney transplant (KT) recipients. We present a multicenter cohort study of 51 KT recipients with COVID-19 treated with remdesivir. Outcomes and safety were assessed. Mean age at diagnosis was 60 year","2021","07","22","Kidney Int Rep","Kidney international reports","SARS-CoV2; acute kidney injury; immunosuppression; kidney transplantation; remdesivir","Lorenzo","Inmaculada","Department of Nephrology, Hospital General de Albacete, Albacete, Spain",NA
"1174","34250317","10.1016/j.ekir.2021.06.023","Use and safety of remdesivir in kidney transplant recipients with COVID-19.","Remdesivir has demonstrated antiviral activity against coronavirus, shortening the time to recovery in adults hospitalized with moderate/severe COVID-19. Severe adverse events such as acute kidney injury (AKI) have been reported. There is little available data on the use and safety of remdesivir in kidney transplant (KT) recipients. We present a multicenter cohort study of 51 KT recipients with COVID-19 treated with remdesivir. Outcomes and safety were assessed. Mean age at diagnosis was 60 year","2021","07","22","Kidney Int Rep","Kidney international reports","SARS-CoV2; acute kidney injury; immunosuppression; kidney transplantation; remdesivir","Mazuecos","Auxiliadora","Department of Nephrology, Hospital Universitario Puerta del Mar, Cádiz, Spain",NA
"1175","34250317","10.1016/j.ekir.2021.06.023","Use and safety of remdesivir in kidney transplant recipients with COVID-19.","Remdesivir has demonstrated antiviral activity against coronavirus, shortening the time to recovery in adults hospitalized with moderate/severe COVID-19. Severe adverse events such as acute kidney injury (AKI) have been reported. There is little available data on the use and safety of remdesivir in kidney transplant (KT) recipients. We present a multicenter cohort study of 51 KT recipients with COVID-19 treated with remdesivir. Outcomes and safety were assessed. Mean age at diagnosis was 60 year","2021","07","22","Kidney Int Rep","Kidney international reports","SARS-CoV2; acute kidney injury; immunosuppression; kidney transplantation; remdesivir","Saura","Isabel María","Department of Nephrology, Hospital Universitario Vírgen de la Arrixaca, El Palmar, Múrcia, Spain",NA
"1176","34250317","10.1016/j.ekir.2021.06.023","Use and safety of remdesivir in kidney transplant recipients with COVID-19.","Remdesivir has demonstrated antiviral activity against coronavirus, shortening the time to recovery in adults hospitalized with moderate/severe COVID-19. Severe adverse events such as acute kidney injury (AKI) have been reported. There is little available data on the use and safety of remdesivir in kidney transplant (KT) recipients. We present a multicenter cohort study of 51 KT recipients with COVID-19 treated with remdesivir. Outcomes and safety were assessed. Mean age at diagnosis was 60 year","2021","07","22","Kidney Int Rep","Kidney international reports","SARS-CoV2; acute kidney injury; immunosuppression; kidney transplantation; remdesivir","Franco","Antonio","Department of Nephrology, Hospital General Universitario de Alicante, Alicante, Spain",NA
"1177","34250317","10.1016/j.ekir.2021.06.023","Use and safety of remdesivir in kidney transplant recipients with COVID-19.","Remdesivir has demonstrated antiviral activity against coronavirus, shortening the time to recovery in adults hospitalized with moderate/severe COVID-19. Severe adverse events such as acute kidney injury (AKI) have been reported. There is little available data on the use and safety of remdesivir in kidney transplant (KT) recipients. We present a multicenter cohort study of 51 KT recipients with COVID-19 treated with remdesivir. Outcomes and safety were assessed. Mean age at diagnosis was 60 year","2021","07","22","Kidney Int Rep","Kidney international reports","SARS-CoV2; acute kidney injury; immunosuppression; kidney transplantation; remdesivir","Ruiz-Fuentes","María Del Carmen","Department of Nephrology, Hospital Universitario Virgen de las Nieves, Granada, Spain",NA
"1178","34250317","10.1016/j.ekir.2021.06.023","Use and safety of remdesivir in kidney transplant recipients with COVID-19.","Remdesivir has demonstrated antiviral activity against coronavirus, shortening the time to recovery in adults hospitalized with moderate/severe COVID-19. Severe adverse events such as acute kidney injury (AKI) have been reported. There is little available data on the use and safety of remdesivir in kidney transplant (KT) recipients. We present a multicenter cohort study of 51 KT recipients with COVID-19 treated with remdesivir. Outcomes and safety were assessed. Mean age at diagnosis was 60 year","2021","07","22","Kidney Int Rep","Kidney international reports","SARS-CoV2; acute kidney injury; immunosuppression; kidney transplantation; remdesivir","Sánchez-Cámara","Luis Alberto","Department of Nephrology, Hospital General Universitario Gregorio Marañón, Instituto de investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain",NA
"1179","34250317","10.1016/j.ekir.2021.06.023","Use and safety of remdesivir in kidney transplant recipients with COVID-19.","Remdesivir has demonstrated antiviral activity against coronavirus, shortening the time to recovery in adults hospitalized with moderate/severe COVID-19. Severe adverse events such as acute kidney injury (AKI) have been reported. There is little available data on the use and safety of remdesivir in kidney transplant (KT) recipients. We present a multicenter cohort study of 51 KT recipients with COVID-19 treated with remdesivir. Outcomes and safety were assessed. Mean age at diagnosis was 60 year","2021","07","22","Kidney Int Rep","Kidney international reports","SARS-CoV2; acute kidney injury; immunosuppression; kidney transplantation; remdesivir","Siverio","Orlando","Department of Nephrology, Hospital Universitario Nuestra Señora de la Candelaria, Tenerife, Spain",NA
"1180","34250317","10.1016/j.ekir.2021.06.023","Use and safety of remdesivir in kidney transplant recipients with COVID-19.","Remdesivir has demonstrated antiviral activity against coronavirus, shortening the time to recovery in adults hospitalized with moderate/severe COVID-19. Severe adverse events such as acute kidney injury (AKI) have been reported. There is little available data on the use and safety of remdesivir in kidney transplant (KT) recipients. We present a multicenter cohort study of 51 KT recipients with COVID-19 treated with remdesivir. Outcomes and safety were assessed. Mean age at diagnosis was 60 year","2021","07","22","Kidney Int Rep","Kidney international reports","SARS-CoV2; acute kidney injury; immunosuppression; kidney transplantation; remdesivir","Martin","María Luisa","Department of Nephrology, Hospital Universitari Arnau de Vilanova, Lleida, Spain",NA
"1181","34250317","10.1016/j.ekir.2021.06.023","Use and safety of remdesivir in kidney transplant recipients with COVID-19.","Remdesivir has demonstrated antiviral activity against coronavirus, shortening the time to recovery in adults hospitalized with moderate/severe COVID-19. Severe adverse events such as acute kidney injury (AKI) have been reported. There is little available data on the use and safety of remdesivir in kidney transplant (KT) recipients. We present a multicenter cohort study of 51 KT recipients with COVID-19 treated with remdesivir. Outcomes and safety were assessed. Mean age at diagnosis was 60 year","2021","07","22","Kidney Int Rep","Kidney international reports","SARS-CoV2; acute kidney injury; immunosuppression; kidney transplantation; remdesivir","González-García","Elena","Department of Nephrology, Hospital Universitario La Paz, Madrid, Spain",NA
"1182","34250317","10.1016/j.ekir.2021.06.023","Use and safety of remdesivir in kidney transplant recipients with COVID-19.","Remdesivir has demonstrated antiviral activity against coronavirus, shortening the time to recovery in adults hospitalized with moderate/severe COVID-19. Severe adverse events such as acute kidney injury (AKI) have been reported. There is little available data on the use and safety of remdesivir in kidney transplant (KT) recipients. We present a multicenter cohort study of 51 KT recipients with COVID-19 treated with remdesivir. Outcomes and safety were assessed. Mean age at diagnosis was 60 year","2021","07","22","Kidney Int Rep","Kidney international reports","SARS-CoV2; acute kidney injury; immunosuppression; kidney transplantation; remdesivir","López","Verónica","Department of Nephrology, Hospital Regional Universitario de Málaga and University of Málaga, IBIMA, REDinREN (RD16/0009/0006), Málaga, Spain",NA
"1183","34250317","10.1016/j.ekir.2021.06.023","Use and safety of remdesivir in kidney transplant recipients with COVID-19.","Remdesivir has demonstrated antiviral activity against coronavirus, shortening the time to recovery in adults hospitalized with moderate/severe COVID-19. Severe adverse events such as acute kidney injury (AKI) have been reported. There is little available data on the use and safety of remdesivir in kidney transplant (KT) recipients. We present a multicenter cohort study of 51 KT recipients with COVID-19 treated with remdesivir. Outcomes and safety were assessed. Mean age at diagnosis was 60 year","2021","07","22","Kidney Int Rep","Kidney international reports","SARS-CoV2; acute kidney injury; immunosuppression; kidney transplantation; remdesivir","Martin-Moreno","Paloma Leticia","Department of Nephrology, Clínica Universidad de Navarra, Navarra Institute for Health Research (IdiSNA), Pamplona, Spain",NA
"1184","34250317","10.1016/j.ekir.2021.06.023","Use and safety of remdesivir in kidney transplant recipients with COVID-19.","Remdesivir has demonstrated antiviral activity against coronavirus, shortening the time to recovery in adults hospitalized with moderate/severe COVID-19. Severe adverse events such as acute kidney injury (AKI) have been reported. There is little available data on the use and safety of remdesivir in kidney transplant (KT) recipients. We present a multicenter cohort study of 51 KT recipients with COVID-19 treated with remdesivir. Outcomes and safety were assessed. Mean age at diagnosis was 60 year","2021","07","22","Kidney Int Rep","Kidney international reports","SARS-CoV2; acute kidney injury; immunosuppression; kidney transplantation; remdesivir","Moina","Iñigo","Department of Nephrology, Hospital Universitario de Basurto, Bilbao, Spain",NA
"1185","34250317","10.1016/j.ekir.2021.06.023","Use and safety of remdesivir in kidney transplant recipients with COVID-19.","Remdesivir has demonstrated antiviral activity against coronavirus, shortening the time to recovery in adults hospitalized with moderate/severe COVID-19. Severe adverse events such as acute kidney injury (AKI) have been reported. There is little available data on the use and safety of remdesivir in kidney transplant (KT) recipients. We present a multicenter cohort study of 51 KT recipients with COVID-19 treated with remdesivir. Outcomes and safety were assessed. Mean age at diagnosis was 60 year","2021","07","22","Kidney Int Rep","Kidney international reports","SARS-CoV2; acute kidney injury; immunosuppression; kidney transplantation; remdesivir","Berrio","Esperanza Moral","Department of Nephrology, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain",NA
"1186","34250317","10.1016/j.ekir.2021.06.023","Use and safety of remdesivir in kidney transplant recipients with COVID-19.","Remdesivir has demonstrated antiviral activity against coronavirus, shortening the time to recovery in adults hospitalized with moderate/severe COVID-19. Severe adverse events such as acute kidney injury (AKI) have been reported. There is little available data on the use and safety of remdesivir in kidney transplant (KT) recipients. We present a multicenter cohort study of 51 KT recipients with COVID-19 treated with remdesivir. Outcomes and safety were assessed. Mean age at diagnosis was 60 year","2021","07","22","Kidney Int Rep","Kidney international reports","SARS-CoV2; acute kidney injury; immunosuppression; kidney transplantation; remdesivir","Moreso","Francesc","Department of Nephrology, Hospital Universitari Vall d'Hebrón, Barcelona, Spain",NA
"1187","34250317","10.1016/j.ekir.2021.06.023","Use and safety of remdesivir in kidney transplant recipients with COVID-19.","Remdesivir has demonstrated antiviral activity against coronavirus, shortening the time to recovery in adults hospitalized with moderate/severe COVID-19. Severe adverse events such as acute kidney injury (AKI) have been reported. There is little available data on the use and safety of remdesivir in kidney transplant (KT) recipients. We present a multicenter cohort study of 51 KT recipients with COVID-19 treated with remdesivir. Outcomes and safety were assessed. Mean age at diagnosis was 60 year","2021","07","22","Kidney Int Rep","Kidney international reports","SARS-CoV2; acute kidney injury; immunosuppression; kidney transplantation; remdesivir","Portolés","José María","Department of Nephrology, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain",NA
"1188","34250317","10.1016/j.ekir.2021.06.023","Use and safety of remdesivir in kidney transplant recipients with COVID-19.","Remdesivir has demonstrated antiviral activity against coronavirus, shortening the time to recovery in adults hospitalized with moderate/severe COVID-19. Severe adverse events such as acute kidney injury (AKI) have been reported. There is little available data on the use and safety of remdesivir in kidney transplant (KT) recipients. We present a multicenter cohort study of 51 KT recipients with COVID-19 treated with remdesivir. Outcomes and safety were assessed. Mean age at diagnosis was 60 year","2021","07","22","Kidney Int Rep","Kidney international reports","SARS-CoV2; acute kidney injury; immunosuppression; kidney transplantation; remdesivir","Santana-Estupiñán","Raquel","Department of Nephrology, Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, Spain",NA
"1189","34250317","10.1016/j.ekir.2021.06.023","Use and safety of remdesivir in kidney transplant recipients with COVID-19.","Remdesivir has demonstrated antiviral activity against coronavirus, shortening the time to recovery in adults hospitalized with moderate/severe COVID-19. Severe adverse events such as acute kidney injury (AKI) have been reported. There is little available data on the use and safety of remdesivir in kidney transplant (KT) recipients. We present a multicenter cohort study of 51 KT recipients with COVID-19 treated with remdesivir. Outcomes and safety were assessed. Mean age at diagnosis was 60 year","2021","07","22","Kidney Int Rep","Kidney international reports","SARS-CoV2; acute kidney injury; immunosuppression; kidney transplantation; remdesivir","Zárraga","Sofía","Department of Nephrology, Hospital Universitario de Cruces, Barakaldo, Bilbao, Spain",NA
"1190","34250317","10.1016/j.ekir.2021.06.023","Use and safety of remdesivir in kidney transplant recipients with COVID-19.","Remdesivir has demonstrated antiviral activity against coronavirus, shortening the time to recovery in adults hospitalized with moderate/severe COVID-19. Severe adverse events such as acute kidney injury (AKI) have been reported. There is little available data on the use and safety of remdesivir in kidney transplant (KT) recipients. We present a multicenter cohort study of 51 KT recipients with COVID-19 treated with remdesivir. Outcomes and safety were assessed. Mean age at diagnosis was 60 year","2021","07","22","Kidney Int Rep","Kidney international reports","SARS-CoV2; acute kidney injury; immunosuppression; kidney transplantation; remdesivir","Canal","Cristina","Department of Nephrology, Fundació Puigvert, Barcelona, Spain",NA
"1191","34250317","10.1016/j.ekir.2021.06.023","Use and safety of remdesivir in kidney transplant recipients with COVID-19.","Remdesivir has demonstrated antiviral activity against coronavirus, shortening the time to recovery in adults hospitalized with moderate/severe COVID-19. Severe adverse events such as acute kidney injury (AKI) have been reported. There is little available data on the use and safety of remdesivir in kidney transplant (KT) recipients. We present a multicenter cohort study of 51 KT recipients with COVID-19 treated with remdesivir. Outcomes and safety were assessed. Mean age at diagnosis was 60 year","2021","07","22","Kidney Int Rep","Kidney international reports","SARS-CoV2; acute kidney injury; immunosuppression; kidney transplantation; remdesivir","Sánchez-Álvarez","Emilio","Department of Nephrology, Hospital de Cabueñes, Gijón, Spain",NA
"1192","34250317","10.1016/j.ekir.2021.06.023","Use and safety of remdesivir in kidney transplant recipients with COVID-19.","Remdesivir has demonstrated antiviral activity against coronavirus, shortening the time to recovery in adults hospitalized with moderate/severe COVID-19. Severe adverse events such as acute kidney injury (AKI) have been reported. There is little available data on the use and safety of remdesivir in kidney transplant (KT) recipients. We present a multicenter cohort study of 51 KT recipients with COVID-19 treated with remdesivir. Outcomes and safety were assessed. Mean age at diagnosis was 60 year","2021","07","22","Kidney Int Rep","Kidney international reports","SARS-CoV2; acute kidney injury; immunosuppression; kidney transplantation; remdesivir","Pascual","Julio","Department of Nephrology, Hospital del Mar, <U+FEFF>Institute Mar for Medical Research (IMIM), REDinREN (RD16/0009/0013), Barcelona, Spain",NA
"1193","34250317","10.1016/j.ekir.2021.06.023","Use and safety of remdesivir in kidney transplant recipients with COVID-19.","Remdesivir has demonstrated antiviral activity against coronavirus, shortening the time to recovery in adults hospitalized with moderate/severe COVID-19. Severe adverse events such as acute kidney injury (AKI) have been reported. There is little available data on the use and safety of remdesivir in kidney transplant (KT) recipients. We present a multicenter cohort study of 51 KT recipients with COVID-19 treated with remdesivir. Outcomes and safety were assessed. Mean age at diagnosis was 60 year","2021","07","22","Kidney Int Rep","Kidney international reports","SARS-CoV2; acute kidney injury; immunosuppression; kidney transplantation; remdesivir","Crespo","Marta","Department of Nephrology, Hospital del Mar, <U+FEFF>Institute Mar for Medical Research (IMIM), REDinREN (RD16/0009/0013), Barcelona, Spain",NA
"1194","34250316","10.1016/j.ekir.2021.06.021","Brazil and the COVID-19 Pandemic.",NA,"2021","07","14","Kidney Int Rep","Kidney international reports",NA,"Soares Dos Santos","Augusto Cesar","Hospital das Clínicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil",NA
"1195","34250314","10.1016/j.genrep.2021.101270","Relevance of vitamin D<sub>3</sub> in COVID-19 infection.","SARS-CoV-2 virus, the main culprit for COVID-19 disaster, has triggered a gust of curiosity both in the mechanism of action of this infection as well as potential risk factors for disease generation and regimentation. The prime focus of the present review, which is basically a narrative one, is in utilizing the current concepts of vitamin D3 as an agent with myriad functions, one of them being immunocompetence and a promising weapon for both innate and adaptive immunity against COVID-","2021","07","13","Gene Rep","Gene reports","ARDS, acute respiratory distress syndrome; AhR, aryl hydrocarbon receptor; COVID-19; CYP27B1; GSH, glutathione; Glutathione; Hydroxyderivatives; LC, l-cysteine; MERS, Middle East respiratory syndrome; RCT, Randomised Controlled Trial; ROR, retinoid acid-related orphan receptors; ROS, reactive oxygen species; SARS-CoV-2 virus; VDR, vitamin D receptor; Vitamin D3; l-Cysteine","Ul Afshan","Falaque","Department of Biochemistry, University of Kashmir, Hazratbal, Srinagar, J&amp",NA
"1196","34250314","10.1016/j.genrep.2021.101270","Relevance of vitamin D<sub>3</sub> in COVID-19 infection.","SARS-CoV-2 virus, the main culprit for COVID-19 disaster, has triggered a gust of curiosity both in the mechanism of action of this infection as well as potential risk factors for disease generation and regimentation. The prime focus of the present review, which is basically a narrative one, is in utilizing the current concepts of vitamin D3 as an agent with myriad functions, one of them being immunocompetence and a promising weapon for both innate and adaptive immunity against COVID-","2021","07","13","Gene Rep","Gene reports","ARDS, acute respiratory distress syndrome; AhR, aryl hydrocarbon receptor; COVID-19; CYP27B1; GSH, glutathione; Glutathione; Hydroxyderivatives; LC, l-cysteine; MERS, Middle East respiratory syndrome; RCT, Randomised Controlled Trial; ROR, retinoid acid-related orphan receptors; ROS, reactive oxygen species; SARS-CoV-2 virus; VDR, vitamin D receptor; Vitamin D3; l-Cysteine","Nissar","Bushra","Department of Biochemistry, University of Kashmir, Hazratbal, Srinagar, J&amp",NA
"1197","34250314","10.1016/j.genrep.2021.101270","Relevance of vitamin D<sub>3</sub> in COVID-19 infection.","SARS-CoV-2 virus, the main culprit for COVID-19 disaster, has triggered a gust of curiosity both in the mechanism of action of this infection as well as potential risk factors for disease generation and regimentation. The prime focus of the present review, which is basically a narrative one, is in utilizing the current concepts of vitamin D3 as an agent with myriad functions, one of them being immunocompetence and a promising weapon for both innate and adaptive immunity against COVID-","2021","07","13","Gene Rep","Gene reports","ARDS, acute respiratory distress syndrome; AhR, aryl hydrocarbon receptor; COVID-19; CYP27B1; GSH, glutathione; Glutathione; Hydroxyderivatives; LC, l-cysteine; MERS, Middle East respiratory syndrome; RCT, Randomised Controlled Trial; ROR, retinoid acid-related orphan receptors; ROS, reactive oxygen species; SARS-CoV-2 virus; VDR, vitamin D receptor; Vitamin D3; l-Cysteine","Chowdri","Nisar Ahmad","Division of Colorectal Surgery, SKIMS, Soura, Srinagar, J&amp",NA
"1198","34250314","10.1016/j.genrep.2021.101270","Relevance of vitamin D<sub>3</sub> in COVID-19 infection.","SARS-CoV-2 virus, the main culprit for COVID-19 disaster, has triggered a gust of curiosity both in the mechanism of action of this infection as well as potential risk factors for disease generation and regimentation. The prime focus of the present review, which is basically a narrative one, is in utilizing the current concepts of vitamin D3 as an agent with myriad functions, one of them being immunocompetence and a promising weapon for both innate and adaptive immunity against COVID-","2021","07","13","Gene Rep","Gene reports","ARDS, acute respiratory distress syndrome; AhR, aryl hydrocarbon receptor; COVID-19; CYP27B1; GSH, glutathione; Glutathione; Hydroxyderivatives; LC, l-cysteine; MERS, Middle East respiratory syndrome; RCT, Randomised Controlled Trial; ROR, retinoid acid-related orphan receptors; ROS, reactive oxygen species; SARS-CoV-2 virus; VDR, vitamin D receptor; Vitamin D3; l-Cysteine","Ganai","Bashir Ahmad","Centre For Research and Development, University of Kashmir, Hazratbal, Srinagar, J&amp",NA
"1199","34250313","10.1016/j.coelec.2021.100794","Perspectives on electrochemical biosensing of COVID-19.","Rapid detection of human coronavirus 2019, termed as SARS-CoV-2 or COVID-19 infection is urgently needed for containment strategy due to its unprecedented spreading. Novel biosensors can be deployed in remote clinical settings without central facilities for infection screening. Electrochemical biosensors serve as analytical tools for rapid detection of viral structure proteins, mainly spike (S) and nucleocapsid (N) proteins, human immune responses, reactive oxygen species (ROS), viral ribonuclei","2021","07","23","Curr Opin Electrochem","Current opinion in electrochemistry","SARS-CoV-2; antibodies; biosensor; diagnosis; electrochemistry; point of care (POC); viral proteins","Luong","Albert D","Department of Surgery, Jacobs School of Medicine, University of Buffalo, Buffalo, NY 14215, USA",NA
"1200","34250313","10.1016/j.coelec.2021.100794","Perspectives on electrochemical biosensing of COVID-19.","Rapid detection of human coronavirus 2019, termed as SARS-CoV-2 or COVID-19 infection is urgently needed for containment strategy due to its unprecedented spreading. Novel biosensors can be deployed in remote clinical settings without central facilities for infection screening. Electrochemical biosensors serve as analytical tools for rapid detection of viral structure proteins, mainly spike (S) and nucleocapsid (N) proteins, human immune responses, reactive oxygen species (ROS), viral ribonuclei","2021","07","23","Curr Opin Electrochem","Current opinion in electrochemistry","SARS-CoV-2; antibodies; biosensor; diagnosis; electrochemistry; point of care (POC); viral proteins","Buzid","Alyah","Department of Chemistry, College of Science, King Faisal University, P.O. Box 380, Al-Ahsa, 31982, Saudi Arabia",NA
"1201","34250313","10.1016/j.coelec.2021.100794","Perspectives on electrochemical biosensing of COVID-19.","Rapid detection of human coronavirus 2019, termed as SARS-CoV-2 or COVID-19 infection is urgently needed for containment strategy due to its unprecedented spreading. Novel biosensors can be deployed in remote clinical settings without central facilities for infection screening. Electrochemical biosensors serve as analytical tools for rapid detection of viral structure proteins, mainly spike (S) and nucleocapsid (N) proteins, human immune responses, reactive oxygen species (ROS), viral ribonuclei","2021","07","23","Curr Opin Electrochem","Current opinion in electrochemistry","SARS-CoV-2; antibodies; biosensor; diagnosis; electrochemistry; point of care (POC); viral proteins","Vashist","Sandeep K","Pictor Pvt. Ltd., 24 Balfour Road Parnell, Auckland 1052, New Zealand",NA
"1202","34250313","10.1016/j.coelec.2021.100794","Perspectives on electrochemical biosensing of COVID-19.","Rapid detection of human coronavirus 2019, termed as SARS-CoV-2 or COVID-19 infection is urgently needed for containment strategy due to its unprecedented spreading. Novel biosensors can be deployed in remote clinical settings without central facilities for infection screening. Electrochemical biosensors serve as analytical tools for rapid detection of viral structure proteins, mainly spike (S) and nucleocapsid (N) proteins, human immune responses, reactive oxygen species (ROS), viral ribonuclei","2021","07","23","Curr Opin Electrochem","Current opinion in electrochemistry","SARS-CoV-2; antibodies; biosensor; diagnosis; electrochemistry; point of care (POC); viral proteins","Luong","John H T","Innovative Chromatography Group, Irish Separation Science Cluster (ISSC), School of Chemistry and Analytical &amp",NA
"1203","34250312","10.1016/j.obmed.2021.100358","Anthropometric analysis of body habitus and outcomes in critically ill COVID-19 patients.","This study aimed to determine whether anthropometric markers of thoracic skeletal muscle and abdominal visceral fat tissue correlate with outcome parameters in critically ill COVID-19 patients. We retrospectively analysed thoracic CT-scans of 67 patients in four ICUs at a university hospital. Thoracic skeletal muscle (total cross-sectional area (CSA); pectoralis muscle area (PMA)) and abdominal visceral fat tissue (VAT) were quantified using a semi-automated method. Point-biserial-correlation-co","2021","07","13","Obes Med","Obesity medicine","Adipose tissue; Anthropometry; COVID-19; Critical care; muscle(skeletal)","Poros","Balázs","Department of Anesthesiology, LMU Klinikum, University Hospital, Ludwig-Maximilians-University, Munich, Marchioninistr. 15, 81377, Munich, Germany",NA
"1204","34250312","10.1016/j.obmed.2021.100358","Anthropometric analysis of body habitus and outcomes in critically ill COVID-19 patients.","This study aimed to determine whether anthropometric markers of thoracic skeletal muscle and abdominal visceral fat tissue correlate with outcome parameters in critically ill COVID-19 patients. We retrospectively analysed thoracic CT-scans of 67 patients in four ICUs at a university hospital. Thoracic skeletal muscle (total cross-sectional area (CSA); pectoralis muscle area (PMA)) and abdominal visceral fat tissue (VAT) were quantified using a semi-automated method. Point-biserial-correlation-co","2021","07","13","Obes Med","Obesity medicine","Adipose tissue; Anthropometry; COVID-19; Critical care; muscle(skeletal)","Becker-Pennrich","Andrea Sabine","Department of Anesthesiology, LMU Klinikum, University Hospital, Ludwig-Maximilians-University, Munich, Marchioninistr. 15, 81377, Munich, Germany",NA
"1205","34250312","10.1016/j.obmed.2021.100358","Anthropometric analysis of body habitus and outcomes in critically ill COVID-19 patients.","This study aimed to determine whether anthropometric markers of thoracic skeletal muscle and abdominal visceral fat tissue correlate with outcome parameters in critically ill COVID-19 patients. We retrospectively analysed thoracic CT-scans of 67 patients in four ICUs at a university hospital. Thoracic skeletal muscle (total cross-sectional area (CSA); pectoralis muscle area (PMA)) and abdominal visceral fat tissue (VAT) were quantified using a semi-automated method. Point-biserial-correlation-co","2021","07","13","Obes Med","Obesity medicine","Adipose tissue; Anthropometry; COVID-19; Critical care; muscle(skeletal)","Sabel","Bastian","Department of Radiology, LMU Klinikum, University Hospital, Ludwig-Maximilians-University, Munich, Marchioninistr. 15, 81377, Munich, Germany",NA
"1206","34250312","10.1016/j.obmed.2021.100358","Anthropometric analysis of body habitus and outcomes in critically ill COVID-19 patients.","This study aimed to determine whether anthropometric markers of thoracic skeletal muscle and abdominal visceral fat tissue correlate with outcome parameters in critically ill COVID-19 patients. We retrospectively analysed thoracic CT-scans of 67 patients in four ICUs at a university hospital. Thoracic skeletal muscle (total cross-sectional area (CSA); pectoralis muscle area (PMA)) and abdominal visceral fat tissue (VAT) were quantified using a semi-automated method. Point-biserial-correlation-co","2021","07","13","Obes Med","Obesity medicine","Adipose tissue; Anthropometry; COVID-19; Critical care; muscle(skeletal)","Stemmler","Hans Joachim","Department of Medicine III, LMU Klinikum, University Hospital, Ludwig-Maximilians-University, Munich, Marchioninistr. 15, 81377, Munich, Germany",NA
"1207","34250312","10.1016/j.obmed.2021.100358","Anthropometric analysis of body habitus and outcomes in critically ill COVID-19 patients.","This study aimed to determine whether anthropometric markers of thoracic skeletal muscle and abdominal visceral fat tissue correlate with outcome parameters in critically ill COVID-19 patients. We retrospectively analysed thoracic CT-scans of 67 patients in four ICUs at a university hospital. Thoracic skeletal muscle (total cross-sectional area (CSA); pectoralis muscle area (PMA)) and abdominal visceral fat tissue (VAT) were quantified using a semi-automated method. Point-biserial-correlation-co","2021","07","13","Obes Med","Obesity medicine","Adipose tissue; Anthropometry; COVID-19; Critical care; muscle(skeletal)","Wassilowsky","Dietmar","Department of Anesthesiology, LMU Klinikum, University Hospital, Ludwig-Maximilians-University, Munich, Marchioninistr. 15, 81377, Munich, Germany",NA
"1208","34250312","10.1016/j.obmed.2021.100358","Anthropometric analysis of body habitus and outcomes in critically ill COVID-19 patients.","This study aimed to determine whether anthropometric markers of thoracic skeletal muscle and abdominal visceral fat tissue correlate with outcome parameters in critically ill COVID-19 patients. We retrospectively analysed thoracic CT-scans of 67 patients in four ICUs at a university hospital. Thoracic skeletal muscle (total cross-sectional area (CSA); pectoralis muscle area (PMA)) and abdominal visceral fat tissue (VAT) were quantified using a semi-automated method. Point-biserial-correlation-co","2021","07","13","Obes Med","Obesity medicine","Adipose tissue; Anthropometry; COVID-19; Critical care; muscle(skeletal)","Weig","Thomas","Department of Anesthesiology, LMU Klinikum, University Hospital, Ludwig-Maximilians-University, Munich, Marchioninistr. 15, 81377, Munich, Germany",NA
"1209","34250312","10.1016/j.obmed.2021.100358","Anthropometric analysis of body habitus and outcomes in critically ill COVID-19 patients.","This study aimed to determine whether anthropometric markers of thoracic skeletal muscle and abdominal visceral fat tissue correlate with outcome parameters in critically ill COVID-19 patients. We retrospectively analysed thoracic CT-scans of 67 patients in four ICUs at a university hospital. Thoracic skeletal muscle (total cross-sectional area (CSA); pectoralis muscle area (PMA)) and abdominal visceral fat tissue (VAT) were quantified using a semi-automated method. Point-biserial-correlation-co","2021","07","13","Obes Med","Obesity medicine","Adipose tissue; Anthropometry; COVID-19; Critical care; muscle(skeletal)","Hinske","Ludwig Christian","Department of Anesthesiology, LMU Klinikum, University Hospital, Ludwig-Maximilians-University, Munich, Marchioninistr. 15, 81377, Munich, Germany",NA
"1210","34250312","10.1016/j.obmed.2021.100358","Anthropometric analysis of body habitus and outcomes in critically ill COVID-19 patients.","This study aimed to determine whether anthropometric markers of thoracic skeletal muscle and abdominal visceral fat tissue correlate with outcome parameters in critically ill COVID-19 patients. We retrospectively analysed thoracic CT-scans of 67 patients in four ICUs at a university hospital. Thoracic skeletal muscle (total cross-sectional area (CSA); pectoralis muscle area (PMA)) and abdominal visceral fat tissue (VAT) were quantified using a semi-automated method. Point-biserial-correlation-co","2021","07","13","Obes Med","Obesity medicine","Adipose tissue; Anthropometry; COVID-19; Critical care; muscle(skeletal)","Zwissler","Bernhard","Department of Anesthesiology, LMU Klinikum, University Hospital, Ludwig-Maximilians-University, Munich, Marchioninistr. 15, 81377, Munich, Germany",NA
"1211","34250312","10.1016/j.obmed.2021.100358","Anthropometric analysis of body habitus and outcomes in critically ill COVID-19 patients.","This study aimed to determine whether anthropometric markers of thoracic skeletal muscle and abdominal visceral fat tissue correlate with outcome parameters in critically ill COVID-19 patients. We retrospectively analysed thoracic CT-scans of 67 patients in four ICUs at a university hospital. Thoracic skeletal muscle (total cross-sectional area (CSA); pectoralis muscle area (PMA)) and abdominal visceral fat tissue (VAT) were quantified using a semi-automated method. Point-biserial-correlation-co","2021","07","13","Obes Med","Obesity medicine","Adipose tissue; Anthropometry; COVID-19; Critical care; muscle(skeletal)","Ricke","Jens","Department of Radiology, LMU Klinikum, University Hospital, Ludwig-Maximilians-University, Munich, Marchioninistr. 15, 81377, Munich, Germany",NA
"1212","34250312","10.1016/j.obmed.2021.100358","Anthropometric analysis of body habitus and outcomes in critically ill COVID-19 patients.","This study aimed to determine whether anthropometric markers of thoracic skeletal muscle and abdominal visceral fat tissue correlate with outcome parameters in critically ill COVID-19 patients. We retrospectively analysed thoracic CT-scans of 67 patients in four ICUs at a university hospital. Thoracic skeletal muscle (total cross-sectional area (CSA); pectoralis muscle area (PMA)) and abdominal visceral fat tissue (VAT) were quantified using a semi-automated method. Point-biserial-correlation-co","2021","07","13","Obes Med","Obesity medicine","Adipose tissue; Anthropometry; COVID-19; Critical care; muscle(skeletal)","Hoechter","Dominik J","Department of Anesthesiology, LMU Klinikum, University Hospital, Ludwig-Maximilians-University, Munich, Marchioninistr. 15, 81377, Munich, Germany",NA
"1213","34250296","10.2478/jvetres-2021-0029","High-throughput Sequencing in Vaccine Research.","The world of vaccines has changed tremendously since the time of Louis Pasteur. In the present day, it is regarded as vaccinology, a discipline which includes not only the knowledge of vaccine production, strategies for its delivery and influence on the clinical course of disease and the response of the host immune system but also regulatory, ethical, economic and ecological aspects of their use. A hundred years after Pasteur created the first vaccine, there was another scientific breakthrough o","2021","07","13","J Vet Res","Journal of veterinary research","HTS; NGS; vaccine","Pasik","Katarzyna","Department of Veterinary Pharmacy, 24-100 Pulawy, Poland",NA
"1214","34250296","10.2478/jvetres-2021-0029","High-throughput Sequencing in Vaccine Research.","The world of vaccines has changed tremendously since the time of Louis Pasteur. In the present day, it is regarded as vaccinology, a discipline which includes not only the knowledge of vaccine production, strategies for its delivery and influence on the clinical course of disease and the response of the host immune system but also regulatory, ethical, economic and ecological aspects of their use. A hundred years after Pasteur created the first vaccine, there was another scientific breakthrough o","2021","07","13","J Vet Res","Journal of veterinary research","HTS; NGS; vaccine","Domanska-Blicharz","Katarzyna","Department of Poultry Diseases, National Veterinary Research Institute, 24-100 Pulawy, Poland",NA
"1215","34250295","10.35772/ghm.2021.01058","The profile of patients hospitalized with COVID-19 under the Quarantine Act in a designated hospital near an international airport in Japan.","The Japanese Government has implemented quarantine measures in response to the COVID-19 pandemic. Individuals testing positive at the airport's quarantine office were lodged either in a designated hotel or hospital under the Quarantine Act. The aim of this study is to describe the management of patients with COVID-19 admitted under the Quarantine Act and to evaluate its impact on medical resources. Data were retrospectively collected, including demographics, comorbidities, status at admission, c","2021","07","13","Glob Health Med","Global health &amp; medicine","COVID-19; Chiba Prefecture; international airport; quarantine office","Hase","Ryota","Department of Infectious Diseases, Japanese Red Cross Narita Hospital, Narita, Chiba, Japan",NA
"1216","34250295","10.35772/ghm.2021.01058","The profile of patients hospitalized with COVID-19 under the Quarantine Act in a designated hospital near an international airport in Japan.","The Japanese Government has implemented quarantine measures in response to the COVID-19 pandemic. Individuals testing positive at the airport's quarantine office were lodged either in a designated hotel or hospital under the Quarantine Act. The aim of this study is to describe the management of patients with COVID-19 admitted under the Quarantine Act and to evaluate its impact on medical resources. Data were retrospectively collected, including demographics, comorbidities, status at admission, c","2021","07","13","Glob Health Med","Global health &amp; medicine","COVID-19; Chiba Prefecture; international airport; quarantine office","Kubota","Yoshifumi","Department of Infectious Diseases, Japanese Red Cross Narita Hospital, Narita, Chiba, Japan",NA
"1217","34250295","10.35772/ghm.2021.01058","The profile of patients hospitalized with COVID-19 under the Quarantine Act in a designated hospital near an international airport in Japan.","The Japanese Government has implemented quarantine measures in response to the COVID-19 pandemic. Individuals testing positive at the airport's quarantine office were lodged either in a designated hotel or hospital under the Quarantine Act. The aim of this study is to describe the management of patients with COVID-19 admitted under the Quarantine Act and to evaluate its impact on medical resources. Data were retrospectively collected, including demographics, comorbidities, status at admission, c","2021","07","13","Glob Health Med","Global health &amp; medicine","COVID-19; Chiba Prefecture; international airport; quarantine office","Niiyama","Yu","Department of Infectious Diseases, Japanese Red Cross Narita Hospital, Narita, Chiba, Japan",NA
"1218","34250295","10.35772/ghm.2021.01058","The profile of patients hospitalized with COVID-19 under the Quarantine Act in a designated hospital near an international airport in Japan.","The Japanese Government has implemented quarantine measures in response to the COVID-19 pandemic. Individuals testing positive at the airport's quarantine office were lodged either in a designated hotel or hospital under the Quarantine Act. The aim of this study is to describe the management of patients with COVID-19 admitted under the Quarantine Act and to evaluate its impact on medical resources. Data were retrospectively collected, including demographics, comorbidities, status at admission, c","2021","07","13","Glob Health Med","Global health &amp; medicine","COVID-19; Chiba Prefecture; international airport; quarantine office","Ishida","Keiko","Department of Infectious Diseases, Japanese Red Cross Narita Hospital, Narita, Chiba, Japan",NA
"1219","34250295","10.35772/ghm.2021.01058","The profile of patients hospitalized with COVID-19 under the Quarantine Act in a designated hospital near an international airport in Japan.","The Japanese Government has implemented quarantine measures in response to the COVID-19 pandemic. Individuals testing positive at the airport's quarantine office were lodged either in a designated hotel or hospital under the Quarantine Act. The aim of this study is to describe the management of patients with COVID-19 admitted under the Quarantine Act and to evaluate its impact on medical resources. Data were retrospectively collected, including demographics, comorbidities, status at admission, c","2021","07","13","Glob Health Med","Global health &amp; medicine","COVID-19; Chiba Prefecture; international airport; quarantine office","Muranaka","Emiri","Department of Infectious Diseases, Japanese Red Cross Narita Hospital, Narita, Chiba, Japan",NA
"1220","34250295","10.35772/ghm.2021.01058","The profile of patients hospitalized with COVID-19 under the Quarantine Act in a designated hospital near an international airport in Japan.","The Japanese Government has implemented quarantine measures in response to the COVID-19 pandemic. Individuals testing positive at the airport's quarantine office were lodged either in a designated hotel or hospital under the Quarantine Act. The aim of this study is to describe the management of patients with COVID-19 admitted under the Quarantine Act and to evaluate its impact on medical resources. Data were retrospectively collected, including demographics, comorbidities, status at admission, c","2021","07","13","Glob Health Med","Global health &amp; medicine","COVID-19; Chiba Prefecture; international airport; quarantine office","Kikuchi","Koki","Department of Infectious Diseases, Japanese Red Cross Narita Hospital, Narita, Chiba, Japan",NA
"1221","34250295","10.35772/ghm.2021.01058","The profile of patients hospitalized with COVID-19 under the Quarantine Act in a designated hospital near an international airport in Japan.","The Japanese Government has implemented quarantine measures in response to the COVID-19 pandemic. Individuals testing positive at the airport's quarantine office were lodged either in a designated hotel or hospital under the Quarantine Act. The aim of this study is to describe the management of patients with COVID-19 admitted under the Quarantine Act and to evaluate its impact on medical resources. Data were retrospectively collected, including demographics, comorbidities, status at admission, c","2021","07","13","Glob Health Med","Global health &amp; medicine","COVID-19; Chiba Prefecture; international airport; quarantine office","Kurita","Takashi","Department of Infectious Diseases, Japanese Red Cross Narita Hospital, Narita, Chiba, Japan",NA
"1222","34250295","10.35772/ghm.2021.01058","The profile of patients hospitalized with COVID-19 under the Quarantine Act in a designated hospital near an international airport in Japan.","The Japanese Government has implemented quarantine measures in response to the COVID-19 pandemic. Individuals testing positive at the airport's quarantine office were lodged either in a designated hotel or hospital under the Quarantine Act. The aim of this study is to describe the management of patients with COVID-19 admitted under the Quarantine Act and to evaluate its impact on medical resources. Data were retrospectively collected, including demographics, comorbidities, status at admission, c","2021","07","13","Glob Health Med","Global health &amp; medicine","COVID-19; Chiba Prefecture; international airport; quarantine office","Mito","Haruki","Department of Infectious Diseases, Japanese Red Cross Narita Hospital, Narita, Chiba, Japan",NA
"1223","34250295","10.35772/ghm.2021.01058","The profile of patients hospitalized with COVID-19 under the Quarantine Act in a designated hospital near an international airport in Japan.","The Japanese Government has implemented quarantine measures in response to the COVID-19 pandemic. Individuals testing positive at the airport's quarantine office were lodged either in a designated hotel or hospital under the Quarantine Act. The aim of this study is to describe the management of patients with COVID-19 admitted under the Quarantine Act and to evaluate its impact on medical resources. Data were retrospectively collected, including demographics, comorbidities, status at admission, c","2021","07","13","Glob Health Med","Global health &amp; medicine","COVID-19; Chiba Prefecture; international airport; quarantine office","Sasazawa","Hiroki","Department of Infectious Diseases, Japanese Red Cross Narita Hospital, Narita, Chiba, Japan",NA
"1224","34250295","10.35772/ghm.2021.01058","The profile of patients hospitalized with COVID-19 under the Quarantine Act in a designated hospital near an international airport in Japan.","The Japanese Government has implemented quarantine measures in response to the COVID-19 pandemic. Individuals testing positive at the airport's quarantine office were lodged either in a designated hotel or hospital under the Quarantine Act. The aim of this study is to describe the management of patients with COVID-19 admitted under the Quarantine Act and to evaluate its impact on medical resources. Data were retrospectively collected, including demographics, comorbidities, status at admission, c","2021","07","13","Glob Health Med","Global health &amp; medicine","COVID-19; Chiba Prefecture; international airport; quarantine office","Yano","Yudai","Department of Infectious Diseases, Japanese Red Cross Narita Hospital, Narita, Chiba, Japan",NA
"1225","34250287","10.35772/ghm.2021.01076","Effects of COVID-19 vaccination on FDG-PET/CT imaging: A literature review.","COVID-19 vaccination using mRNA technology began at the end of 2020 in several countries, approximately 9 months after the WHO declared the new coronavirus a pandemic, and began in Japan at the end of February 2021. Several studies have reported FDG avidity in enlarged axillary lymph nodes as a specific feature of FDG-PET/CT imaging after COVID-19 vaccination. A major concern is that this finding could lead to a misdiagnosis in patients with various types of malignancy. We review the impact of C","2021","07","13","Glob Health Med","Global health &amp; medicine","COVID-19; FDG; PET/CT; vaccine","Minamimoto","Ryogo","Division of Nuclear Medicine, Department of Radiology, National Center for Global Health and Medicine, Tokyo, Japan",NA
"1226","34250287","10.35772/ghm.2021.01076","Effects of COVID-19 vaccination on FDG-PET/CT imaging: A literature review.","COVID-19 vaccination using mRNA technology began at the end of 2020 in several countries, approximately 9 months after the WHO declared the new coronavirus a pandemic, and began in Japan at the end of February 2021. Several studies have reported FDG avidity in enlarged axillary lymph nodes as a specific feature of FDG-PET/CT imaging after COVID-19 vaccination. A major concern is that this finding could lead to a misdiagnosis in patients with various types of malignancy. We review the impact of C","2021","07","13","Glob Health Med","Global health &amp; medicine","COVID-19; FDG; PET/CT; vaccine","Kiyomatsu","Tomomichi","Department of Surgery, National Center for Global Health and Medicine, Tokyo, Japan",NA
"1227","34250286","10.35772/ghm.2021.01066","Behavioral changes adopted to constrain COVID-19 in Japan: What are the implications for seasonal influenza prevention and control?","Respiratory disease deaths associated with seasonal influenza are estimated to be 290,000 to 650,000 per year globally. In Japan, seasonal influenza affects more than 10 million people per year, and especially children, the elderly, and patients with underlying medical conditions, and seasonal influenza can cause severe illness. As SARS-CoV-2 continues to spread, the combined risk of concurrent influenza epidemics and the COVID-19 pandemic are a concern. When the status of influenza virus infect","2021","07","13","Glob Health Med","Global health &amp; medicine","COVID-19; Japan; behavioral pattern; influenza; new normal","Sawakami","Tatsuo","Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan",NA
"1228","34250286","10.35772/ghm.2021.01066","Behavioral changes adopted to constrain COVID-19 in Japan: What are the implications for seasonal influenza prevention and control?","Respiratory disease deaths associated with seasonal influenza are estimated to be 290,000 to 650,000 per year globally. In Japan, seasonal influenza affects more than 10 million people per year, and especially children, the elderly, and patients with underlying medical conditions, and seasonal influenza can cause severe illness. As SARS-CoV-2 continues to spread, the combined risk of concurrent influenza epidemics and the COVID-19 pandemic are a concern. When the status of influenza virus infect","2021","07","13","Glob Health Med","Global health &amp; medicine","COVID-19; Japan; behavioral pattern; influenza; new normal","Karako","Kenji","Department of Human and Engineered Environmental Studies, Graduate School of Frontier Sciences, The University of Tokyo, Chiba, Japan",NA
"1229","34250286","10.35772/ghm.2021.01066","Behavioral changes adopted to constrain COVID-19 in Japan: What are the implications for seasonal influenza prevention and control?","Respiratory disease deaths associated with seasonal influenza are estimated to be 290,000 to 650,000 per year globally. In Japan, seasonal influenza affects more than 10 million people per year, and especially children, the elderly, and patients with underlying medical conditions, and seasonal influenza can cause severe illness. As SARS-CoV-2 continues to spread, the combined risk of concurrent influenza epidemics and the COVID-19 pandemic are a concern. When the status of influenza virus infect","2021","07","13","Glob Health Med","Global health &amp; medicine","COVID-19; Japan; behavioral pattern; influenza; new normal","Song","Peipei","Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan",NA
"1230","34250284","10.1253/circrep.CR-21-0055","Multimodal Findings of COVID-19-Related Rhabdomyolysis Complicated With Pericarditis Mimicking Fulminant Myocarditis.",NA,"2021","07","12","Circ Rep","Circulation reports",NA,"Arai","Riku","Division of Cardiology, Department of Medicine, Nihon University School of Medicine Tokyo Japan",NA
"1231","34250284","10.1253/circrep.CR-21-0055","Multimodal Findings of COVID-19-Related Rhabdomyolysis Complicated With Pericarditis Mimicking Fulminant Myocarditis.",NA,"2021","07","12","Circ Rep","Circulation reports",NA,"Murata","Nobuhiro","Division of Cardiology, Department of Medicine, Nihon University School of Medicine Tokyo Japan",NA
"1232","34250284","10.1253/circrep.CR-21-0055","Multimodal Findings of COVID-19-Related Rhabdomyolysis Complicated With Pericarditis Mimicking Fulminant Myocarditis.",NA,"2021","07","12","Circ Rep","Circulation reports",NA,"Yamada","Akimasa","Division of Cardiology, Department of Medicine, Nihon University School of Medicine Tokyo Japan",NA
"1233","34250284","10.1253/circrep.CR-21-0055","Multimodal Findings of COVID-19-Related Rhabdomyolysis Complicated With Pericarditis Mimicking Fulminant Myocarditis.",NA,"2021","07","12","Circ Rep","Circulation reports",NA,"Migita","Suguru","Division of Cardiology, Department of Medicine, Nihon University School of Medicine Tokyo Japan",NA
"1234","34250284","10.1253/circrep.CR-21-0055","Multimodal Findings of COVID-19-Related Rhabdomyolysis Complicated With Pericarditis Mimicking Fulminant Myocarditis.",NA,"2021","07","12","Circ Rep","Circulation reports",NA,"Koyama","Yutaka","Division of Cardiology, Department of Medicine, Nihon University School of Medicine Tokyo Japan",NA
"1235","34250284","10.1253/circrep.CR-21-0055","Multimodal Findings of COVID-19-Related Rhabdomyolysis Complicated With Pericarditis Mimicking Fulminant Myocarditis.",NA,"2021","07","12","Circ Rep","Circulation reports",NA,"Morikawa","Tomoyuki","Division of Cardiology, Department of Medicine, Nihon University School of Medicine Tokyo Japan",NA
"1236","34250284","10.1253/circrep.CR-21-0055","Multimodal Findings of COVID-19-Related Rhabdomyolysis Complicated With Pericarditis Mimicking Fulminant Myocarditis.",NA,"2021","07","12","Circ Rep","Circulation reports",NA,"Ihara","Shingo","Division of Emergency and Critical Care Medicine, Department of Acute Medicine, Nihon University School of Medicine Tokyo Japan",NA
"1237","34250284","10.1253/circrep.CR-21-0055","Multimodal Findings of COVID-19-Related Rhabdomyolysis Complicated With Pericarditis Mimicking Fulminant Myocarditis.",NA,"2021","07","12","Circ Rep","Circulation reports",NA,"Akutsu","Naotaka","Division of Cardiology, Department of Medicine, Nihon University School of Medicine Tokyo Japan",NA
"1238","34250284","10.1253/circrep.CR-21-0055","Multimodal Findings of COVID-19-Related Rhabdomyolysis Complicated With Pericarditis Mimicking Fulminant Myocarditis.",NA,"2021","07","12","Circ Rep","Circulation reports",NA,"Kuwana","Tsukasa","Division of Emergency and Critical Care Medicine, Department of Acute Medicine, Nihon University School of Medicine Tokyo Japan",NA
"1239","34250284","10.1253/circrep.CR-21-0055","Multimodal Findings of COVID-19-Related Rhabdomyolysis Complicated With Pericarditis Mimicking Fulminant Myocarditis.",NA,"2021","07","12","Circ Rep","Circulation reports",NA,"Fukamachi","Daisuke","Division of Cardiology, Department of Medicine, Nihon University School of Medicine Tokyo Japan",NA
"1240","34250284","10.1253/circrep.CR-21-0055","Multimodal Findings of COVID-19-Related Rhabdomyolysis Complicated With Pericarditis Mimicking Fulminant Myocarditis.",NA,"2021","07","12","Circ Rep","Circulation reports",NA,"Kinoshita","Kosaku","Division of Emergency and Critical Care Medicine, Department of Acute Medicine, Nihon University School of Medicine Tokyo Japan",NA
"1241","34250284","10.1253/circrep.CR-21-0055","Multimodal Findings of COVID-19-Related Rhabdomyolysis Complicated With Pericarditis Mimicking Fulminant Myocarditis.",NA,"2021","07","12","Circ Rep","Circulation reports",NA,"Okumura","Yasuo","Division of Cardiology, Department of Medicine, Nihon University School of Medicine Tokyo Japan",NA
"1242","34250284","10.1253/circrep.CR-21-0055","Multimodal Findings of COVID-19-Related Rhabdomyolysis Complicated With Pericarditis Mimicking Fulminant Myocarditis.",NA,"2021","07","12","Circ Rep","Circulation reports",NA,"Hao","Hiroyuki","Division of Human Pathology, Department of Pathology and Microbiology, Nihon University School of Medicine Tokyo Japan",NA
"1243","34250278","10.1253/circrep.CR-21-0066","Intensive Care Unit Admission for Moderate-to-Severe COVID-19 Patients With Known Cardiovascular Diseases or Their Risk Factors - Insights From a Nationwide Japanese Cohort Study.","Background: The COVID-19 pandemic has challenged healthcare systems, at times overwhelming intensive care units (ICUs). We aimed to describe the length and rate of ICU admission, and explore the clinical variables influencing ICU use, for COVID-19 patients with known cardiovascular diseases or their risk factors (CVDRF). Methods and Results: A post hoc analysis was performed of 693 Japanese COVID-19 patients with CVDRF enrolled in the nationwide CLAVIS-COVID registrat","2021","07","13","Circ Rep","Circulation reports","COVID-19; Cardiovascular diseases; ICU admission; ICU length of stay; Intensive care unit (ICU)","Yoshida","Naofumi","Division of Cardiovascular Medicine, Hyogo Prefectural Kakogawa Medical Center Kakogawa Japan",NA
"1244","34250278","10.1253/circrep.CR-21-0066","Intensive Care Unit Admission for Moderate-to-Severe COVID-19 Patients With Known Cardiovascular Diseases or Their Risk Factors - Insights From a Nationwide Japanese Cohort Study.","Background: The COVID-19 pandemic has challenged healthcare systems, at times overwhelming intensive care units (ICUs). We aimed to describe the length and rate of ICU admission, and explore the clinical variables influencing ICU use, for COVID-19 patients with known cardiovascular diseases or their risk factors (CVDRF). Methods and Results: A post hoc analysis was performed of 693 Japanese COVID-19 patients with CVDRF enrolled in the nationwide CLAVIS-COVID registrat","2021","07","13","Circ Rep","Circulation reports","COVID-19; Cardiovascular diseases; ICU admission; ICU length of stay; Intensive care unit (ICU)","Iwata","Sachiyo","Division of Cardiovascular Medicine, Hyogo Prefectural Kakogawa Medical Center Kakogawa Japan",NA
"1245","34250278","10.1253/circrep.CR-21-0066","Intensive Care Unit Admission for Moderate-to-Severe COVID-19 Patients With Known Cardiovascular Diseases or Their Risk Factors - Insights From a Nationwide Japanese Cohort Study.","Background: The COVID-19 pandemic has challenged healthcare systems, at times overwhelming intensive care units (ICUs). We aimed to describe the length and rate of ICU admission, and explore the clinical variables influencing ICU use, for COVID-19 patients with known cardiovascular diseases or their risk factors (CVDRF). Methods and Results: A post hoc analysis was performed of 693 Japanese COVID-19 patients with CVDRF enrolled in the nationwide CLAVIS-COVID registrat","2021","07","13","Circ Rep","Circulation reports","COVID-19; Cardiovascular diseases; ICU admission; ICU length of stay; Intensive care unit (ICU)","Ogawa","Masato","Division of Rehabilitation Medicine, Kobe University Hospital Kobe Japan",NA
"1246","34250278","10.1253/circrep.CR-21-0066","Intensive Care Unit Admission for Moderate-to-Severe COVID-19 Patients With Known Cardiovascular Diseases or Their Risk Factors - Insights From a Nationwide Japanese Cohort Study.","Background: The COVID-19 pandemic has challenged healthcare systems, at times overwhelming intensive care units (ICUs). We aimed to describe the length and rate of ICU admission, and explore the clinical variables influencing ICU use, for COVID-19 patients with known cardiovascular diseases or their risk factors (CVDRF). Methods and Results: A post hoc analysis was performed of 693 Japanese COVID-19 patients with CVDRF enrolled in the nationwide CLAVIS-COVID registrat","2021","07","13","Circ Rep","Circulation reports","COVID-19; Cardiovascular diseases; ICU admission; ICU length of stay; Intensive care unit (ICU)","Izawa","Kazuhiro P","Department of Public Health, Kobe University Graduate School of Health Sciences Kobe Japan",NA
"1247","34250278","10.1253/circrep.CR-21-0066","Intensive Care Unit Admission for Moderate-to-Severe COVID-19 Patients With Known Cardiovascular Diseases or Their Risk Factors - Insights From a Nationwide Japanese Cohort Study.","Background: The COVID-19 pandemic has challenged healthcare systems, at times overwhelming intensive care units (ICUs). We aimed to describe the length and rate of ICU admission, and explore the clinical variables influencing ICU use, for COVID-19 patients with known cardiovascular diseases or their risk factors (CVDRF). Methods and Results: A post hoc analysis was performed of 693 Japanese COVID-19 patients with CVDRF enrolled in the nationwide CLAVIS-COVID registrat","2021","07","13","Circ Rep","Circulation reports","COVID-19; Cardiovascular diseases; ICU admission; ICU length of stay; Intensive care unit (ICU)","Kuroda","Shunsuke","Department of Cardiology, Kameda Medical Center Chiba Japan",NA
"1248","34250278","10.1253/circrep.CR-21-0066","Intensive Care Unit Admission for Moderate-to-Severe COVID-19 Patients With Known Cardiovascular Diseases or Their Risk Factors - Insights From a Nationwide Japanese Cohort Study.","Background: The COVID-19 pandemic has challenged healthcare systems, at times overwhelming intensive care units (ICUs). We aimed to describe the length and rate of ICU admission, and explore the clinical variables influencing ICU use, for COVID-19 patients with known cardiovascular diseases or their risk factors (CVDRF). Methods and Results: A post hoc analysis was performed of 693 Japanese COVID-19 patients with CVDRF enrolled in the nationwide CLAVIS-COVID registrat","2021","07","13","Circ Rep","Circulation reports","COVID-19; Cardiovascular diseases; ICU admission; ICU length of stay; Intensive care unit (ICU)","Kohsaka","Shun","Department of Cardiology, Keio University School of Medicine Tokyo Japan",NA
"1249","34250278","10.1253/circrep.CR-21-0066","Intensive Care Unit Admission for Moderate-to-Severe COVID-19 Patients With Known Cardiovascular Diseases or Their Risk Factors - Insights From a Nationwide Japanese Cohort Study.","Background: The COVID-19 pandemic has challenged healthcare systems, at times overwhelming intensive care units (ICUs). We aimed to describe the length and rate of ICU admission, and explore the clinical variables influencing ICU use, for COVID-19 patients with known cardiovascular diseases or their risk factors (CVDRF). Methods and Results: A post hoc analysis was performed of 693 Japanese COVID-19 patients with CVDRF enrolled in the nationwide CLAVIS-COVID registrat","2021","07","13","Circ Rep","Circulation reports","COVID-19; Cardiovascular diseases; ICU admission; ICU length of stay; Intensive care unit (ICU)","Yonetsu","Taishi","Department of Cardiovascular Medicine, Tokyo Medical and Dental University Tokyo Japan",NA
"1250","34250278","10.1253/circrep.CR-21-0066","Intensive Care Unit Admission for Moderate-to-Severe COVID-19 Patients With Known Cardiovascular Diseases or Their Risk Factors - Insights From a Nationwide Japanese Cohort Study.","Background: The COVID-19 pandemic has challenged healthcare systems, at times overwhelming intensive care units (ICUs). We aimed to describe the length and rate of ICU admission, and explore the clinical variables influencing ICU use, for COVID-19 patients with known cardiovascular diseases or their risk factors (CVDRF). Methods and Results: A post hoc analysis was performed of 693 Japanese COVID-19 patients with CVDRF enrolled in the nationwide CLAVIS-COVID registrat","2021","07","13","Circ Rep","Circulation reports","COVID-19; Cardiovascular diseases; ICU admission; ICU length of stay; Intensive care unit (ICU)","Kitai","Takeshi","Department of Cardiovascular Medicine, Kobe City Medical Center General Hospital Kobe Japan",NA
"1251","34250278","10.1253/circrep.CR-21-0066","Intensive Care Unit Admission for Moderate-to-Severe COVID-19 Patients With Known Cardiovascular Diseases or Their Risk Factors - Insights From a Nationwide Japanese Cohort Study.","Background: The COVID-19 pandemic has challenged healthcare systems, at times overwhelming intensive care units (ICUs). We aimed to describe the length and rate of ICU admission, and explore the clinical variables influencing ICU use, for COVID-19 patients with known cardiovascular diseases or their risk factors (CVDRF). Methods and Results: A post hoc analysis was performed of 693 Japanese COVID-19 patients with CVDRF enrolled in the nationwide CLAVIS-COVID registrat","2021","07","13","Circ Rep","Circulation reports","COVID-19; Cardiovascular diseases; ICU admission; ICU length of stay; Intensive care unit (ICU)","Torii","Sho","Department of Cardiology, Tokai University School of Medicine Isehara Japan",NA
"1252","34250278","10.1253/circrep.CR-21-0066","Intensive Care Unit Admission for Moderate-to-Severe COVID-19 Patients With Known Cardiovascular Diseases or Their Risk Factors - Insights From a Nationwide Japanese Cohort Study.","Background: The COVID-19 pandemic has challenged healthcare systems, at times overwhelming intensive care units (ICUs). We aimed to describe the length and rate of ICU admission, and explore the clinical variables influencing ICU use, for COVID-19 patients with known cardiovascular diseases or their risk factors (CVDRF). Methods and Results: A post hoc analysis was performed of 693 Japanese COVID-19 patients with CVDRF enrolled in the nationwide CLAVIS-COVID registrat","2021","07","13","Circ Rep","Circulation reports","COVID-19; Cardiovascular diseases; ICU admission; ICU length of stay; Intensive care unit (ICU)","Sano","Takahide","Department of Cardiovascular Medicine, Department of Internal Medicine, Toho University Faculty of Medicine Tokyo Japan",NA
"1253","34250278","10.1253/circrep.CR-21-0066","Intensive Care Unit Admission for Moderate-to-Severe COVID-19 Patients With Known Cardiovascular Diseases or Their Risk Factors - Insights From a Nationwide Japanese Cohort Study.","Background: The COVID-19 pandemic has challenged healthcare systems, at times overwhelming intensive care units (ICUs). We aimed to describe the length and rate of ICU admission, and explore the clinical variables influencing ICU use, for COVID-19 patients with known cardiovascular diseases or their risk factors (CVDRF). Methods and Results: A post hoc analysis was performed of 693 Japanese COVID-19 patients with CVDRF enrolled in the nationwide CLAVIS-COVID registrat","2021","07","13","Circ Rep","Circulation reports","COVID-19; Cardiovascular diseases; ICU admission; ICU length of stay; Intensive care unit (ICU)","Sakai","Yoshitada","Division of Rehabilitation Medicine, Kobe University Hospital Kobe Japan",NA
"1254","34250278","10.1253/circrep.CR-21-0066","Intensive Care Unit Admission for Moderate-to-Severe COVID-19 Patients With Known Cardiovascular Diseases or Their Risk Factors - Insights From a Nationwide Japanese Cohort Study.","Background: The COVID-19 pandemic has challenged healthcare systems, at times overwhelming intensive care units (ICUs). We aimed to describe the length and rate of ICU admission, and explore the clinical variables influencing ICU use, for COVID-19 patients with known cardiovascular diseases or their risk factors (CVDRF). Methods and Results: A post hoc analysis was performed of 693 Japanese COVID-19 patients with CVDRF enrolled in the nationwide CLAVIS-COVID registrat","2021","07","13","Circ Rep","Circulation reports","COVID-19; Cardiovascular diseases; ICU admission; ICU length of stay; Intensive care unit (ICU)","Yamashita","Tomoya","Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine Kobe Japan",NA
"1255","34250278","10.1253/circrep.CR-21-0066","Intensive Care Unit Admission for Moderate-to-Severe COVID-19 Patients With Known Cardiovascular Diseases or Their Risk Factors - Insights From a Nationwide Japanese Cohort Study.","Background: The COVID-19 pandemic has challenged healthcare systems, at times overwhelming intensive care units (ICUs). We aimed to describe the length and rate of ICU admission, and explore the clinical variables influencing ICU use, for COVID-19 patients with known cardiovascular diseases or their risk factors (CVDRF). Methods and Results: A post hoc analysis was performed of 693 Japanese COVID-19 patients with CVDRF enrolled in the nationwide CLAVIS-COVID registrat","2021","07","13","Circ Rep","Circulation reports","COVID-19; Cardiovascular diseases; ICU admission; ICU length of stay; Intensive care unit (ICU)","Hirata","Ken-Ichi","Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine Kobe Japan",NA
"1256","34250278","10.1253/circrep.CR-21-0066","Intensive Care Unit Admission for Moderate-to-Severe COVID-19 Patients With Known Cardiovascular Diseases or Their Risk Factors - Insights From a Nationwide Japanese Cohort Study.","Background: The COVID-19 pandemic has challenged healthcare systems, at times overwhelming intensive care units (ICUs). We aimed to describe the length and rate of ICU admission, and explore the clinical variables influencing ICU use, for COVID-19 patients with known cardiovascular diseases or their risk factors (CVDRF). Methods and Results: A post hoc analysis was performed of 693 Japanese COVID-19 patients with CVDRF enrolled in the nationwide CLAVIS-COVID registrat","2021","07","13","Circ Rep","Circulation reports","COVID-19; Cardiovascular diseases; ICU admission; ICU length of stay; Intensive care unit (ICU)","Matsue","Yuya","Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine Tokyo Japan",NA
"1257","34250278","10.1253/circrep.CR-21-0066","Intensive Care Unit Admission for Moderate-to-Severe COVID-19 Patients With Known Cardiovascular Diseases or Their Risk Factors - Insights From a Nationwide Japanese Cohort Study.","Background: The COVID-19 pandemic has challenged healthcare systems, at times overwhelming intensive care units (ICUs). We aimed to describe the length and rate of ICU admission, and explore the clinical variables influencing ICU use, for COVID-19 patients with known cardiovascular diseases or their risk factors (CVDRF). Methods and Results: A post hoc analysis was performed of 693 Japanese COVID-19 patients with CVDRF enrolled in the nationwide CLAVIS-COVID registrat","2021","07","13","Circ Rep","Circulation reports","COVID-19; Cardiovascular diseases; ICU admission; ICU length of stay; Intensive care unit (ICU)","Matsumoto","Shingo","Department of Cardiovascular Medicine, Department of Internal Medicine, Toho University Faculty of Medicine Tokyo Japan",NA
"1258","34250278","10.1253/circrep.CR-21-0066","Intensive Care Unit Admission for Moderate-to-Severe COVID-19 Patients With Known Cardiovascular Diseases or Their Risk Factors - Insights From a Nationwide Japanese Cohort Study.","Background: The COVID-19 pandemic has challenged healthcare systems, at times overwhelming intensive care units (ICUs). We aimed to describe the length and rate of ICU admission, and explore the clinical variables influencing ICU use, for COVID-19 patients with known cardiovascular diseases or their risk factors (CVDRF). Methods and Results: A post hoc analysis was performed of 693 Japanese COVID-19 patients with CVDRF enrolled in the nationwide CLAVIS-COVID registrat","2021","07","13","Circ Rep","Circulation reports","COVID-19; Cardiovascular diseases; ICU admission; ICU length of stay; Intensive care unit (ICU)","Node","Koichi","Department of Cardiovascular Medicine, Saga University Saga Japan",NA
"1259","34250275","10.1016/j.bbrep.2021.101069","Peptide inhibitors against SARS-CoV-2 2'-O-methyltransferase involved in RNA capping: A computational approach.","The COVID-19 pandemic is still evolving and is caused by SARS-CoV-2. The 2'-O-methyltransferase (nsp16) enzyme is crucial for maintaining the stability of viral RNA for effective translation of viral proteins and its life cycle. Another protein, nsp10, is important for enzymatic activity of nsp16. Any disturbance in the interaction between nsp16 and nsp10 may affect viral replication fidelity. Here, five peptide inhibitors, derived from nsp16, were designed and assessed for their effectiveness i","2021","07","13","Biochem Biophys Rep","Biochemistry and biophysics reports","Molecular dynamics simulation; Nsp10; Nsp16; Peptide inhibitors; SARS-CoV-2; Therapeutics","Dutta","Mainak","Department of Biotechnology, BITS Pilani, Dubai Campus, Academic City, Dubai, United Arab Emirates",NA
"1260","34250275","10.1016/j.bbrep.2021.101069","Peptide inhibitors against SARS-CoV-2 2'-O-methyltransferase involved in RNA capping: A computational approach.","The COVID-19 pandemic is still evolving and is caused by SARS-CoV-2. The 2'-O-methyltransferase (nsp16) enzyme is crucial for maintaining the stability of viral RNA for effective translation of viral proteins and its life cycle. Another protein, nsp10, is important for enzymatic activity of nsp16. Any disturbance in the interaction between nsp16 and nsp10 may affect viral replication fidelity. Here, five peptide inhibitors, derived from nsp16, were designed and assessed for their effectiveness i","2021","07","13","Biochem Biophys Rep","Biochemistry and biophysics reports","Molecular dynamics simulation; Nsp10; Nsp16; Peptide inhibitors; SARS-CoV-2; Therapeutics","Iype","Eldhose","Department of Chemical Engineering, BITS Pilani, Dubai Campus, Academic City, Dubai, United Arab Emirates",NA
"1261","34250272","10.1002/hsr2.320","Effects of social prescribing pilot project for the elderly in rural area of South Korea during COVID-19 pandemic.","Older adults-classified as a high-risk group-are highly likely to experience increased loneliness due to the implementation of various policies designed to prevent the spread of COVID-19. Accordingly, this study aims to examine the effects of a pilot social prescribing project for elderly people in rural area of South Korea during the COVID-19 pandemic. Using the PRECEDE-PROCEED model, the effectiveness of the pilot project was verified through pre- and post-impact and outcome evaluation. Accord","2021","07","13","Health Sci Rep","Health science reports","COVID-19; depression; elderly; rural area; social prescribing","Kim","Ji Eon","Healthy City Research Center, Institute of Health and Welfare Yonsei University Wonju South Korea",NA
"1262","34250272","10.1002/hsr2.320","Effects of social prescribing pilot project for the elderly in rural area of South Korea during COVID-19 pandemic.","Older adults-classified as a high-risk group-are highly likely to experience increased loneliness due to the implementation of various policies designed to prevent the spread of COVID-19. Accordingly, this study aims to examine the effects of a pilot social prescribing project for elderly people in rural area of South Korea during the COVID-19 pandemic. Using the PRECEDE-PROCEED model, the effectiveness of the pilot project was verified through pre- and post-impact and outcome evaluation. Accord","2021","07","13","Health Sci Rep","Health science reports","COVID-19; depression; elderly; rural area; social prescribing","Lee","Yu Lim","Healthy City Research Center, Institute of Health and Welfare Yonsei University Wonju South Korea",NA
"1263","34250272","10.1002/hsr2.320","Effects of social prescribing pilot project for the elderly in rural area of South Korea during COVID-19 pandemic.","Older adults-classified as a high-risk group-are highly likely to experience increased loneliness due to the implementation of various policies designed to prevent the spread of COVID-19. Accordingly, this study aims to examine the effects of a pilot social prescribing project for elderly people in rural area of South Korea during the COVID-19 pandemic. Using the PRECEDE-PROCEED model, the effectiveness of the pilot project was verified through pre- and post-impact and outcome evaluation. Accord","2021","07","13","Health Sci Rep","Health science reports","COVID-19; depression; elderly; rural area; social prescribing","Chung","Min Ah","Healthy City Research Center, Institute of Health and Welfare Yonsei University Wonju South Korea",NA
"1264","34250272","10.1002/hsr2.320","Effects of social prescribing pilot project for the elderly in rural area of South Korea during COVID-19 pandemic.","Older adults-classified as a high-risk group-are highly likely to experience increased loneliness due to the implementation of various policies designed to prevent the spread of COVID-19. Accordingly, this study aims to examine the effects of a pilot social prescribing project for elderly people in rural area of South Korea during the COVID-19 pandemic. Using the PRECEDE-PROCEED model, the effectiveness of the pilot project was verified through pre- and post-impact and outcome evaluation. Accord","2021","07","13","Health Sci Rep","Health science reports","COVID-19; depression; elderly; rural area; social prescribing","Yoon","Hye Jin","Healthy City Research Center, Institute of Health and Welfare Yonsei University Wonju South Korea",NA
"1265","34250272","10.1002/hsr2.320","Effects of social prescribing pilot project for the elderly in rural area of South Korea during COVID-19 pandemic.","Older adults-classified as a high-risk group-are highly likely to experience increased loneliness due to the implementation of various policies designed to prevent the spread of COVID-19. Accordingly, this study aims to examine the effects of a pilot social prescribing project for elderly people in rural area of South Korea during the COVID-19 pandemic. Using the PRECEDE-PROCEED model, the effectiveness of the pilot project was verified through pre- and post-impact and outcome evaluation. Accord","2021","07","13","Health Sci Rep","Health science reports","COVID-19; depression; elderly; rural area; social prescribing","Shin","Dong Eun","Healthy City Research Center, Institute of Health and Welfare Yonsei University Wonju South Korea",NA
"1266","34250272","10.1002/hsr2.320","Effects of social prescribing pilot project for the elderly in rural area of South Korea during COVID-19 pandemic.","Older adults-classified as a high-risk group-are highly likely to experience increased loneliness due to the implementation of various policies designed to prevent the spread of COVID-19. Accordingly, this study aims to examine the effects of a pilot social prescribing project for elderly people in rural area of South Korea during the COVID-19 pandemic. Using the PRECEDE-PROCEED model, the effectiveness of the pilot project was verified through pre- and post-impact and outcome evaluation. Accord","2021","07","13","Health Sci Rep","Health science reports","COVID-19; depression; elderly; rural area; social prescribing","Choi","Jin Hee","Mirae Campus LINC+ Yonsei University Wonju South Korea",NA
"1267","34250272","10.1002/hsr2.320","Effects of social prescribing pilot project for the elderly in rural area of South Korea during COVID-19 pandemic.","Older adults-classified as a high-risk group-are highly likely to experience increased loneliness due to the implementation of various policies designed to prevent the spread of COVID-19. Accordingly, this study aims to examine the effects of a pilot social prescribing project for elderly people in rural area of South Korea during the COVID-19 pandemic. Using the PRECEDE-PROCEED model, the effectiveness of the pilot project was verified through pre- and post-impact and outcome evaluation. Accord","2021","07","13","Health Sci Rep","Health science reports","COVID-19; depression; elderly; rural area; social prescribing","Lee","Sangheon","Heungeop-myeon Sub-Health Center Wonju South Korea",NA
"1268","34250272","10.1002/hsr2.320","Effects of social prescribing pilot project for the elderly in rural area of South Korea during COVID-19 pandemic.","Older adults-classified as a high-risk group-are highly likely to experience increased loneliness due to the implementation of various policies designed to prevent the spread of COVID-19. Accordingly, this study aims to examine the effects of a pilot social prescribing project for elderly people in rural area of South Korea during the COVID-19 pandemic. Using the PRECEDE-PROCEED model, the effectiveness of the pilot project was verified through pre- and post-impact and outcome evaluation. Accord","2021","07","13","Health Sci Rep","Health science reports","COVID-19; depression; elderly; rural area; social prescribing","Kim","Hae Kyung","Healthy City Research Center, Institute of Health and Welfare Yonsei University Wonju South Korea",NA
"1269","34250272","10.1002/hsr2.320","Effects of social prescribing pilot project for the elderly in rural area of South Korea during COVID-19 pandemic.","Older adults-classified as a high-risk group-are highly likely to experience increased loneliness due to the implementation of various policies designed to prevent the spread of COVID-19. Accordingly, this study aims to examine the effects of a pilot social prescribing project for elderly people in rural area of South Korea during the COVID-19 pandemic. Using the PRECEDE-PROCEED model, the effectiveness of the pilot project was verified through pre- and post-impact and outcome evaluation. Accord","2021","07","13","Health Sci Rep","Health science reports","COVID-19; depression; elderly; rural area; social prescribing","Nam","Eun Woo","Healthy City Research Center, Institute of Health and Welfare Yonsei University Wonju South Korea",NA
"1270","34250245","10.1016/j.medcle.2021.07.002","Declaration of COVID-19 as an occupational disease in healthcare workers: challenges and reality.",NA,"2021","07","14","Med Clin (Engl Ed)","Medicina clinica (English ed.)","COVID-19; accidente de trabajo; enfermedad profesional; profesionales; sanitarios","Gil-Blanco","Laura","Grupo Consolidado de Investigación GIIS-063, Instituto de Investigación Sanitaria de Aragón (ISS-Aragón), Aragón, Spain",NA
"1271","34250245","10.1016/j.medcle.2021.07.002","Declaration of COVID-19 as an occupational disease in healthcare workers: challenges and reality.",NA,"2021","07","14","Med Clin (Engl Ed)","Medicina clinica (English ed.)","COVID-19; accidente de trabajo; enfermedad profesional; profesionales; sanitarios","Martínez-Jarreta","Begoña","Grupo Consolidado de Investigación GIIS-063, Instituto de Investigación Sanitaria de Aragón (ISS-Aragón), Aragón, Spain",NA
"1272","34250244","10.1016/j.medcle.2021.01.012","SARS-CoV-2 infection: A predisposing factor for acute coronary syndrome.","Several case series of ACS have been reported in COVID 19 patients. We aim to study its incidence, characteristics, and three-month prognosis. To put this incidence in perspective we compared it with the incidence of in-hospital ACS during the same period of 2019. Observational multicenter cohort study of 3.108 COVID-19 patients admitted to two hospitals in Madrid between March 1st and May 15th, 2020. Ten patients suffered an ACS while being hospitalized for COVID 19 and were followed for three ","2021","07","13","Med Clin (Engl Ed)","Medicina clinica (English ed.)","Acute coronary syndrome; Coronavirus; Myocardial ischemia; Thrombosis","de Cortina Camarero","Cristina","Servicio de Cardiología, Hospital Universitario Infanta Leonor, Madrid, Spain",NA
"1273","34250244","10.1016/j.medcle.2021.01.012","SARS-CoV-2 infection: A predisposing factor for acute coronary syndrome.","Several case series of ACS have been reported in COVID 19 patients. We aim to study its incidence, characteristics, and three-month prognosis. To put this incidence in perspective we compared it with the incidence of in-hospital ACS during the same period of 2019. Observational multicenter cohort study of 3.108 COVID-19 patients admitted to two hospitals in Madrid between March 1st and May 15th, 2020. Ten patients suffered an ACS while being hospitalized for COVID 19 and were followed for three ","2021","07","13","Med Clin (Engl Ed)","Medicina clinica (English ed.)","Acute coronary syndrome; Coronavirus; Myocardial ischemia; Thrombosis","Gómez Mariscal","Eloy","Servicio de Cardiología, Hospital Universitario Infanta Leonor, Madrid, Spain",NA
"1274","34250244","10.1016/j.medcle.2021.01.012","SARS-CoV-2 infection: A predisposing factor for acute coronary syndrome.","Several case series of ACS have been reported in COVID 19 patients. We aim to study its incidence, characteristics, and three-month prognosis. To put this incidence in perspective we compared it with the incidence of in-hospital ACS during the same period of 2019. Observational multicenter cohort study of 3.108 COVID-19 patients admitted to two hospitals in Madrid between March 1st and May 15th, 2020. Ten patients suffered an ACS while being hospitalized for COVID 19 and were followed for three ","2021","07","13","Med Clin (Engl Ed)","Medicina clinica (English ed.)","Acute coronary syndrome; Coronavirus; Myocardial ischemia; Thrombosis","Espejo Bares","Victoria","Servicio de Cardiología, Hospital Universitario Fundación Alcorcón, Madrid, Spain",NA
"1275","34250244","10.1016/j.medcle.2021.01.012","SARS-CoV-2 infection: A predisposing factor for acute coronary syndrome.","Several case series of ACS have been reported in COVID 19 patients. We aim to study its incidence, characteristics, and three-month prognosis. To put this incidence in perspective we compared it with the incidence of in-hospital ACS during the same period of 2019. Observational multicenter cohort study of 3.108 COVID-19 patients admitted to two hospitals in Madrid between March 1st and May 15th, 2020. Ten patients suffered an ACS while being hospitalized for COVID 19 and were followed for three ","2021","07","13","Med Clin (Engl Ed)","Medicina clinica (English ed.)","Acute coronary syndrome; Coronavirus; Myocardial ischemia; Thrombosis","Núñez Garcia","Alberto","Servicio de Cardiología, Hospital Universitario Fundación Alcorcón, Madrid, Spain",NA
"1276","34250244","10.1016/j.medcle.2021.01.012","SARS-CoV-2 infection: A predisposing factor for acute coronary syndrome.","Several case series of ACS have been reported in COVID 19 patients. We aim to study its incidence, characteristics, and three-month prognosis. To put this incidence in perspective we compared it with the incidence of in-hospital ACS during the same period of 2019. Observational multicenter cohort study of 3.108 COVID-19 patients admitted to two hospitals in Madrid between March 1st and May 15th, 2020. Ten patients suffered an ACS while being hospitalized for COVID 19 and were followed for three ","2021","07","13","Med Clin (Engl Ed)","Medicina clinica (English ed.)","Acute coronary syndrome; Coronavirus; Myocardial ischemia; Thrombosis","Muñoz Aguilera","Roberto","Servicio de Cardiología, Hospital Universitario Infanta Leonor, Madrid, Spain",NA
"1277","34250244","10.1016/j.medcle.2021.01.012","SARS-CoV-2 infection: A predisposing factor for acute coronary syndrome.","Several case series of ACS have been reported in COVID 19 patients. We aim to study its incidence, characteristics, and three-month prognosis. To put this incidence in perspective we compared it with the incidence of in-hospital ACS during the same period of 2019. Observational multicenter cohort study of 3.108 COVID-19 patients admitted to two hospitals in Madrid between March 1st and May 15th, 2020. Ten patients suffered an ACS while being hospitalized for COVID 19 and were followed for three ","2021","07","13","Med Clin (Engl Ed)","Medicina clinica (English ed.)","Acute coronary syndrome; Coronavirus; Myocardial ischemia; Thrombosis","Botas Rodriguez","Javier","Servicio de Cardiología, Hospital Universitario Fundación Alcorcón, Madrid, Spain",NA
"1278","34250243","10.1016/j.medcle.2021.07.001","Encephalitis as a neurological manifestation of COVID-19.","In the context of the global COVID-19 pandemic, the different clinical manifestations of this infection pose a challenge for healthcare professionals. Respiratory involvement, the main symptom of SARS-CoV-2 infection, means that other manifestations, such as neurological, take a back seat, with the consequent delay in diagnosis and treatment. All COVID-19 patients admitted with neurological symptoms or diagnosed with encephalitis since March 2020 in a tertiary hospital in Zaragoza, Spain. Two pa","2021","07","16","Med Clin (Engl Ed)","Medicina clinica (English ed.)","COVID-19; Encephalitis; Neurological manifestations; Neurology; SARS-CoV-2","Lozano Gómez","Herminia","Servicio de Medicina Intensiva, Hospital Clínico Universitario Lozano Blesa, Zargoza, Spain",NA
"1279","34250243","10.1016/j.medcle.2021.07.001","Encephalitis as a neurological manifestation of COVID-19.","In the context of the global COVID-19 pandemic, the different clinical manifestations of this infection pose a challenge for healthcare professionals. Respiratory involvement, the main symptom of SARS-CoV-2 infection, means that other manifestations, such as neurological, take a back seat, with the consequent delay in diagnosis and treatment. All COVID-19 patients admitted with neurological symptoms or diagnosed with encephalitis since March 2020 in a tertiary hospital in Zaragoza, Spain. Two pa","2021","07","16","Med Clin (Engl Ed)","Medicina clinica (English ed.)","COVID-19; Encephalitis; Neurological manifestations; Neurology; SARS-CoV-2","Pascual Bielsa","Ana","Servicio de Medicina Intensiva, Hospital Clínico Universitario Lozano Blesa, Zargoza, Spain",NA
"1280","34250243","10.1016/j.medcle.2021.07.001","Encephalitis as a neurological manifestation of COVID-19.","In the context of the global COVID-19 pandemic, the different clinical manifestations of this infection pose a challenge for healthcare professionals. Respiratory involvement, the main symptom of SARS-CoV-2 infection, means that other manifestations, such as neurological, take a back seat, with the consequent delay in diagnosis and treatment. All COVID-19 patients admitted with neurological symptoms or diagnosed with encephalitis since March 2020 in a tertiary hospital in Zaragoza, Spain. Two pa","2021","07","16","Med Clin (Engl Ed)","Medicina clinica (English ed.)","COVID-19; Encephalitis; Neurological manifestations; Neurology; SARS-CoV-2","Abansés Moreno","Paula","Servicio de Medicina Intensiva, Hospital Clínico Universitario Lozano Blesa, Zargoza, Spain",NA
"1281","34250243","10.1016/j.medcle.2021.07.001","Encephalitis as a neurological manifestation of COVID-19.","In the context of the global COVID-19 pandemic, the different clinical manifestations of this infection pose a challenge for healthcare professionals. Respiratory involvement, the main symptom of SARS-CoV-2 infection, means that other manifestations, such as neurological, take a back seat, with the consequent delay in diagnosis and treatment. All COVID-19 patients admitted with neurological symptoms or diagnosed with encephalitis since March 2020 in a tertiary hospital in Zaragoza, Spain. Two pa","2021","07","16","Med Clin (Engl Ed)","Medicina clinica (English ed.)","COVID-19; Encephalitis; Neurological manifestations; Neurology; SARS-CoV-2","Luque Gómez","María Pilar","Servicio de Medicina Intensiva, Hospital Clínico Universitario Lozano Blesa, Zargoza, Spain",NA
"1282","34250243","10.1016/j.medcle.2021.07.001","Encephalitis as a neurological manifestation of COVID-19.","In the context of the global COVID-19 pandemic, the different clinical manifestations of this infection pose a challenge for healthcare professionals. Respiratory involvement, the main symptom of SARS-CoV-2 infection, means that other manifestations, such as neurological, take a back seat, with the consequent delay in diagnosis and treatment. All COVID-19 patients admitted with neurological symptoms or diagnosed with encephalitis since March 2020 in a tertiary hospital in Zaragoza, Spain. Two pa","2021","07","16","Med Clin (Engl Ed)","Medicina clinica (English ed.)","COVID-19; Encephalitis; Neurological manifestations; Neurology; SARS-CoV-2","Matute Guerrero","Almudena","Servicio de Medicina Intensiva, Hospital Clínico Universitario Lozano Blesa, Zargoza, Spain",NA
"1283","34250243","10.1016/j.medcle.2021.07.001","Encephalitis as a neurological manifestation of COVID-19.","In the context of the global COVID-19 pandemic, the different clinical manifestations of this infection pose a challenge for healthcare professionals. Respiratory involvement, the main symptom of SARS-CoV-2 infection, means that other manifestations, such as neurological, take a back seat, with the consequent delay in diagnosis and treatment. All COVID-19 patients admitted with neurological symptoms or diagnosed with encephalitis since March 2020 in a tertiary hospital in Zaragoza, Spain. Two pa","2021","07","16","Med Clin (Engl Ed)","Medicina clinica (English ed.)","COVID-19; Encephalitis; Neurological manifestations; Neurology; SARS-CoV-2","Araiz Burdio","Juan José","Servicio de Medicina Intensiva, Hospital Clínico Universitario Lozano Blesa, Zargoza, Spain",NA
"1284","34250225","10.1016/j.aace.2021.06.011","REPLY TO: What is the effect of obesity on the natriuretic peptide pathway?","Thyroid storm is a severe exacerbation of thyrotoxicosis that can cause significant morbidity and mortality. The emergence of the novel coronavirus (SARS-CoV-2) that originated in Wuhan, China has become a worldwide pandemic. We present the first documented case of thyroid storm (as defined by the Burch-Wartofsky criteria) in a patient positive for COVID-19. Laboratory and diagnostic studies including thyroid function tests, thyroid antibody testing, SARS-CoV-2 nasopharyngeal PCR testing, and th","2021","07","13","AACE Clin Case Rep","AACE clinical case reports","AST/ALT, aspartate amino transferase/amino alanine transferase; BMI, body mass index; BMP, basic metabolic panel; CBC, complete blood count; CNS, central nervous system; COVID-19, coronavirus disease 2019; ECG, electrocardiogram; FT4, free thyroxine; RNA, ribonucleic acid; RT- PCR, reverse transcription polymerase chain reaction; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; T3, triiodothyronine; T4, thyroxine; TSH, thyroid-stimulating hormone; WBC, white blood cell; bpm, beats per minute","Rao","Angela N","Baylor College of Medicine, Department of Internal Medicine",NA
"1285","34250225","10.1016/j.aace.2021.06.011","REPLY TO: What is the effect of obesity on the natriuretic peptide pathway?","Thyroid storm is a severe exacerbation of thyrotoxicosis that can cause significant morbidity and mortality. The emergence of the novel coronavirus (SARS-CoV-2) that originated in Wuhan, China has become a worldwide pandemic. We present the first documented case of thyroid storm (as defined by the Burch-Wartofsky criteria) in a patient positive for COVID-19. Laboratory and diagnostic studies including thyroid function tests, thyroid antibody testing, SARS-CoV-2 nasopharyngeal PCR testing, and th","2021","07","13","AACE Clin Case Rep","AACE clinical case reports","AST/ALT, aspartate amino transferase/amino alanine transferase; BMI, body mass index; BMP, basic metabolic panel; CBC, complete blood count; CNS, central nervous system; COVID-19, coronavirus disease 2019; ECG, electrocardiogram; FT4, free thyroxine; RNA, ribonucleic acid; RT- PCR, reverse transcription polymerase chain reaction; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; T3, triiodothyronine; T4, thyroxine; TSH, thyroid-stimulating hormone; WBC, white blood cell; bpm, beats per minute","Al-Ward","Ruaa Y","Baylor College of Medicine, Department of Internal Medicine, Section of Endocrinology",NA
"1286","34250225","10.1016/j.aace.2021.06.011","REPLY TO: What is the effect of obesity on the natriuretic peptide pathway?","Thyroid storm is a severe exacerbation of thyrotoxicosis that can cause significant morbidity and mortality. The emergence of the novel coronavirus (SARS-CoV-2) that originated in Wuhan, China has become a worldwide pandemic. We present the first documented case of thyroid storm (as defined by the Burch-Wartofsky criteria) in a patient positive for COVID-19. Laboratory and diagnostic studies including thyroid function tests, thyroid antibody testing, SARS-CoV-2 nasopharyngeal PCR testing, and th","2021","07","13","AACE Clin Case Rep","AACE clinical case reports","AST/ALT, aspartate amino transferase/amino alanine transferase; BMI, body mass index; BMP, basic metabolic panel; CBC, complete blood count; CNS, central nervous system; COVID-19, coronavirus disease 2019; ECG, electrocardiogram; FT4, free thyroxine; RNA, ribonucleic acid; RT- PCR, reverse transcription polymerase chain reaction; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; T3, triiodothyronine; T4, thyroxine; TSH, thyroid-stimulating hormone; WBC, white blood cell; bpm, beats per minute","Gaba","Ruchi","Baylor College of Medicine, Department of Internal Medicine, Section of Endocrinology",NA
"1287","34250222","10.1007/s41207-021-00263-6","Current vaccine technology with an emphasis on recombinant measles virus as a new perspective for vaccination against SARS-CoV-2.","The novel coronavirus disease 2019 (COVID-19) that emerged in China has spread to more than 212 countries to date. COVID-19 can cause serious acute respiratory syndrome (SARS). Therefore, research advances on the associated SARS-coronavirus-2 (CoV-2) may enable the scientific community to establish effective vaccines to prevent SARS-CoV-2 infections by increasing understanding of viral pathogenesis. Measles virus (MV) expressing SARS-CoV-2 spike protein (S) represents a promising class of biothe","2021","07","13","EuroMediterr J Environ Integr","Euro-Mediterranean journal for environmental integration","Coronavirus disease 2019 (COVID-19); MVSchw2-SARS-S; MVSchw2-SARS-Ssol; Measles virus (MV); Recombinant viruses","Jbeli","Rim","Department of Biology Sicences, Faculty of Sciences of Bizerte, University of Carthage, 7021 Zarzouna, Bizerte, Tunisia",NA
"1288","34250222","10.1007/s41207-021-00263-6","Current vaccine technology with an emphasis on recombinant measles virus as a new perspective for vaccination against SARS-CoV-2.","The novel coronavirus disease 2019 (COVID-19) that emerged in China has spread to more than 212 countries to date. COVID-19 can cause serious acute respiratory syndrome (SARS). Therefore, research advances on the associated SARS-coronavirus-2 (CoV-2) may enable the scientific community to establish effective vaccines to prevent SARS-CoV-2 infections by increasing understanding of viral pathogenesis. Measles virus (MV) expressing SARS-CoV-2 spike protein (S) represents a promising class of biothe","2021","07","13","EuroMediterr J Environ Integr","Euro-Mediterranean journal for environmental integration","Coronavirus disease 2019 (COVID-19); MVSchw2-SARS-S; MVSchw2-SARS-Ssol; Measles virus (MV); Recombinant viruses","Jelassi","Awatef","Laboratory of Biochemistry, LR 99 ES 11, Faculty of Medicine, University Tunis Elmanar, Tunis, Tunisia",NA
"1289","34250219","10.1016/j.tcr.2021.100507","Blunt and penetrating chest trauma with concomitant COVID-19 infections: Two case reports.","We present two patients: one with a blunt and one with a penetrating chest trauma mechanism and both with concomitant COVID-19 infections. The first patient is a 23 year old previously healthy male who presented to a Level 1 trauma center following a motor vehicle collision with blunt chest trauma and respiratory failure. The second patient is a 30 year old previously healthy male who presented to a Level 1 trauma center for a stab wound to the anterior chest with a right ventricular injury. Bot","2021","07","16","Trauma Case Rep","Trauma case reports","COVID-19; Chest trauma; Coagulopathy; Coronavirus; Lung contusion","VanDruff","Rembrandt R","Department of Surgery, University of Illinois at Chicago, Chicago, IL, United States of America",NA
"1290","34250219","10.1016/j.tcr.2021.100507","Blunt and penetrating chest trauma with concomitant COVID-19 infections: Two case reports.","We present two patients: one with a blunt and one with a penetrating chest trauma mechanism and both with concomitant COVID-19 infections. The first patient is a 23 year old previously healthy male who presented to a Level 1 trauma center following a motor vehicle collision with blunt chest trauma and respiratory failure. The second patient is a 30 year old previously healthy male who presented to a Level 1 trauma center for a stab wound to the anterior chest with a right ventricular injury. Bot","2021","07","16","Trauma Case Rep","Trauma case reports","COVID-19; Chest trauma; Coagulopathy; Coronavirus; Lung contusion","Lee","J Kayle","Division of Trauma Surgery and Surgical Critical Care, Department of Surgery, Advocate Christ Medical Center, Oak Lawn, IL, United States of America",NA
"1291","34250218","10.1016/j.jpra.2021.06.002","Full title: Rapid implementation of virtual hand therapy clinics during COVID-19, opportunities for the future.",NA,"2021","07","13","JPRAS Open","JPRAS open",NA,"Timon","Dr Charles","Department of Plastics and Reconstructive Surgery, Galway University Hospitals, Galway, Ireland",NA
"1292","34250218","10.1016/j.jpra.2021.06.002","Full title: Rapid implementation of virtual hand therapy clinics during COVID-19, opportunities for the future.",NA,"2021","07","13","JPRAS Open","JPRAS open",NA,"O'Ceallaigh","Brian","Department of Plastics and Reconstructive Surgery, Galway University Hospitals, Galway, Ireland",NA
"1293","34250218","10.1016/j.jpra.2021.06.002","Full title: Rapid implementation of virtual hand therapy clinics during COVID-19, opportunities for the future.",NA,"2021","07","13","JPRAS Open","JPRAS open",NA,"Siney","Edel","Department of Plastics and Reconstructive Surgery, Galway University Hospitals, Galway, Ireland",NA
"1294","34250218","10.1016/j.jpra.2021.06.002","Full title: Rapid implementation of virtual hand therapy clinics during COVID-19, opportunities for the future.",NA,"2021","07","13","JPRAS Open","JPRAS open",NA,"McInerney","Mr Niall","Department of Plastics and Reconstructive Surgery, Galway University Hospitals, Galway, Ireland",NA
"1295","34250217","10.1016/j.eti.2021.101696","Defining the methodological approach for wastewater-based epidemiological studies-Surveillance of SARS-CoV-2.","Since COVID-19 outbreak, wastewater-based epidemiology (WBE) studies as surveillance system is becoming an emerging interest due to its functional advantage as a tool for early warning signal and to catalyze effective disease management strategies based on the community diagnosis. An attempt was made in this study to define and establish a methodological approach for conducting WBE studies in the framework of identifying/selection of surveillance sites, standardizing sampling policy, designing s","2021","07","13","Environ Technol Innov","Environmental technology &amp; innovation","Composite sample; Domestic sewage treatment plants (STP); Grab sample; Sampling protocol; Urban area","Kopperi","Harishankar","Bioengineering and Environmental Sciences Lab, Department of Energy and Environmental Engineering (DEEE), CSIR-Indian Institute of Chemical Technology (CSIR-IICT), Hyderabad 500007, India",NA
"1296","34250217","10.1016/j.eti.2021.101696","Defining the methodological approach for wastewater-based epidemiological studies-Surveillance of SARS-CoV-2.","Since COVID-19 outbreak, wastewater-based epidemiology (WBE) studies as surveillance system is becoming an emerging interest due to its functional advantage as a tool for early warning signal and to catalyze effective disease management strategies based on the community diagnosis. An attempt was made in this study to define and establish a methodological approach for conducting WBE studies in the framework of identifying/selection of surveillance sites, standardizing sampling policy, designing s","2021","07","13","Environ Technol Innov","Environmental technology &amp; innovation","Composite sample; Domestic sewage treatment plants (STP); Grab sample; Sampling protocol; Urban area","Tharak","Athmakuri","Bioengineering and Environmental Sciences Lab, Department of Energy and Environmental Engineering (DEEE), CSIR-Indian Institute of Chemical Technology (CSIR-IICT), Hyderabad 500007, India",NA
"1297","34250217","10.1016/j.eti.2021.101696","Defining the methodological approach for wastewater-based epidemiological studies-Surveillance of SARS-CoV-2.","Since COVID-19 outbreak, wastewater-based epidemiology (WBE) studies as surveillance system is becoming an emerging interest due to its functional advantage as a tool for early warning signal and to catalyze effective disease management strategies based on the community diagnosis. An attempt was made in this study to define and establish a methodological approach for conducting WBE studies in the framework of identifying/selection of surveillance sites, standardizing sampling policy, designing s","2021","07","13","Environ Technol Innov","Environmental technology &amp; innovation","Composite sample; Domestic sewage treatment plants (STP); Grab sample; Sampling protocol; Urban area","Hemalatha","Manupati","Bioengineering and Environmental Sciences Lab, Department of Energy and Environmental Engineering (DEEE), CSIR-Indian Institute of Chemical Technology (CSIR-IICT), Hyderabad 500007, India",NA
"1298","34250217","10.1016/j.eti.2021.101696","Defining the methodological approach for wastewater-based epidemiological studies-Surveillance of SARS-CoV-2.","Since COVID-19 outbreak, wastewater-based epidemiology (WBE) studies as surveillance system is becoming an emerging interest due to its functional advantage as a tool for early warning signal and to catalyze effective disease management strategies based on the community diagnosis. An attempt was made in this study to define and establish a methodological approach for conducting WBE studies in the framework of identifying/selection of surveillance sites, standardizing sampling policy, designing s","2021","07","13","Environ Technol Innov","Environmental technology &amp; innovation","Composite sample; Domestic sewage treatment plants (STP); Grab sample; Sampling protocol; Urban area","Kiran","Uday","CSIR-Centre for Cellular and Molecular Biology (CSIR-CCMB), Hyderabad 500007, India",NA
"1299","34250217","10.1016/j.eti.2021.101696","Defining the methodological approach for wastewater-based epidemiological studies-Surveillance of SARS-CoV-2.","Since COVID-19 outbreak, wastewater-based epidemiology (WBE) studies as surveillance system is becoming an emerging interest due to its functional advantage as a tool for early warning signal and to catalyze effective disease management strategies based on the community diagnosis. An attempt was made in this study to define and establish a methodological approach for conducting WBE studies in the framework of identifying/selection of surveillance sites, standardizing sampling policy, designing s","2021","07","13","Environ Technol Innov","Environmental technology &amp; innovation","Composite sample; Domestic sewage treatment plants (STP); Grab sample; Sampling protocol; Urban area","Gokulan","C G","CSIR-Centre for Cellular and Molecular Biology (CSIR-CCMB), Hyderabad 500007, India",NA
"1300","34250217","10.1016/j.eti.2021.101696","Defining the methodological approach for wastewater-based epidemiological studies-Surveillance of SARS-CoV-2.","Since COVID-19 outbreak, wastewater-based epidemiology (WBE) studies as surveillance system is becoming an emerging interest due to its functional advantage as a tool for early warning signal and to catalyze effective disease management strategies based on the community diagnosis. An attempt was made in this study to define and establish a methodological approach for conducting WBE studies in the framework of identifying/selection of surveillance sites, standardizing sampling policy, designing s","2021","07","13","Environ Technol Innov","Environmental technology &amp; innovation","Composite sample; Domestic sewage treatment plants (STP); Grab sample; Sampling protocol; Urban area","Mishra","Rakesh K","CSIR-Centre for Cellular and Molecular Biology (CSIR-CCMB), Hyderabad 500007, India",NA
"1301","34250217","10.1016/j.eti.2021.101696","Defining the methodological approach for wastewater-based epidemiological studies-Surveillance of SARS-CoV-2.","Since COVID-19 outbreak, wastewater-based epidemiology (WBE) studies as surveillance system is becoming an emerging interest due to its functional advantage as a tool for early warning signal and to catalyze effective disease management strategies based on the community diagnosis. An attempt was made in this study to define and establish a methodological approach for conducting WBE studies in the framework of identifying/selection of surveillance sites, standardizing sampling policy, designing s","2021","07","13","Environ Technol Innov","Environmental technology &amp; innovation","Composite sample; Domestic sewage treatment plants (STP); Grab sample; Sampling protocol; Urban area","Mohan","S Venkata","Bioengineering and Environmental Sciences Lab, Department of Energy and Environmental Engineering (DEEE), CSIR-Indian Institute of Chemical Technology (CSIR-IICT), Hyderabad 500007, India",NA
"1302","34250193","10.1093/ofid/ofab274","First Experience Addressing the Prognostic Utility of Novel Urinary Biomarkers in Patients With COVID-19.","Urine 11-dehydro-thromboxane B2 (u11-dh-TxB2), 8-hydroxy-2'-deoxyguanosine (8-OHdG), and liver-type fatty acid binding protein levels (L-FABP) at the time of hospitalization were higher in coronavirus disease 2019 (COVID-19) patients with adverse events vs without events. Higher u11-dh-TxB2 and L-FABP levels were associated with longer hospitalization, more thrombotic events, and greater mortality, providing evidence for potential utility as early prognostic biom","2021","07","13","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; liver-type fatty acid binding protein; urinary 11-dehydro- thromboxane B2; urinary 8-hydroxy-2-deoxyguanosine","Tantry","Udaya S","Sinai Center for Thrombosis Research and Drug Development, Sinai Hospital of Baltimore, Lifebridge Health, Baltimore, Maryland, USA",NA
"1303","34250193","10.1093/ofid/ofab274","First Experience Addressing the Prognostic Utility of Novel Urinary Biomarkers in Patients With COVID-19.","Urine 11-dehydro-thromboxane B2 (u11-dh-TxB2), 8-hydroxy-2'-deoxyguanosine (8-OHdG), and liver-type fatty acid binding protein levels (L-FABP) at the time of hospitalization were higher in coronavirus disease 2019 (COVID-19) patients with adverse events vs without events. Higher u11-dh-TxB2 and L-FABP levels were associated with longer hospitalization, more thrombotic events, and greater mortality, providing evidence for potential utility as early prognostic biom","2021","07","13","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; liver-type fatty acid binding protein; urinary 11-dehydro- thromboxane B2; urinary 8-hydroxy-2-deoxyguanosine","Bliden","Kevin P","Sinai Center for Thrombosis Research and Drug Development, Sinai Hospital of Baltimore, Lifebridge Health, Baltimore, Maryland, USA",NA
"1304","34250193","10.1093/ofid/ofab274","First Experience Addressing the Prognostic Utility of Novel Urinary Biomarkers in Patients With COVID-19.","Urine 11-dehydro-thromboxane B2 (u11-dh-TxB2), 8-hydroxy-2'-deoxyguanosine (8-OHdG), and liver-type fatty acid binding protein levels (L-FABP) at the time of hospitalization were higher in coronavirus disease 2019 (COVID-19) patients with adverse events vs without events. Higher u11-dh-TxB2 and L-FABP levels were associated with longer hospitalization, more thrombotic events, and greater mortality, providing evidence for potential utility as early prognostic biom","2021","07","13","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; liver-type fatty acid binding protein; urinary 11-dehydro- thromboxane B2; urinary 8-hydroxy-2-deoxyguanosine","Cho","Alastair","Sinai Center for Thrombosis Research and Drug Development, Sinai Hospital of Baltimore, Lifebridge Health, Baltimore, Maryland, USA",NA
"1305","34250193","10.1093/ofid/ofab274","First Experience Addressing the Prognostic Utility of Novel Urinary Biomarkers in Patients With COVID-19.","Urine 11-dehydro-thromboxane B2 (u11-dh-TxB2), 8-hydroxy-2'-deoxyguanosine (8-OHdG), and liver-type fatty acid binding protein levels (L-FABP) at the time of hospitalization were higher in coronavirus disease 2019 (COVID-19) patients with adverse events vs without events. Higher u11-dh-TxB2 and L-FABP levels were associated with longer hospitalization, more thrombotic events, and greater mortality, providing evidence for potential utility as early prognostic biom","2021","07","13","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; liver-type fatty acid binding protein; urinary 11-dehydro- thromboxane B2; urinary 8-hydroxy-2-deoxyguanosine","Walia","Naval","Sinai Center for Thrombosis Research and Drug Development, Sinai Hospital of Baltimore, Lifebridge Health, Baltimore, Maryland, USA",NA
"1306","34250193","10.1093/ofid/ofab274","First Experience Addressing the Prognostic Utility of Novel Urinary Biomarkers in Patients With COVID-19.","Urine 11-dehydro-thromboxane B2 (u11-dh-TxB2), 8-hydroxy-2'-deoxyguanosine (8-OHdG), and liver-type fatty acid binding protein levels (L-FABP) at the time of hospitalization were higher in coronavirus disease 2019 (COVID-19) patients with adverse events vs without events. Higher u11-dh-TxB2 and L-FABP levels were associated with longer hospitalization, more thrombotic events, and greater mortality, providing evidence for potential utility as early prognostic biom","2021","07","13","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; liver-type fatty acid binding protein; urinary 11-dehydro- thromboxane B2; urinary 8-hydroxy-2-deoxyguanosine","Dahlen","Jeffrey R","Hikari Dx, Inc, San Diego, California, USA",NA
"1307","34250193","10.1093/ofid/ofab274","First Experience Addressing the Prognostic Utility of Novel Urinary Biomarkers in Patients With COVID-19.","Urine 11-dehydro-thromboxane B2 (u11-dh-TxB2), 8-hydroxy-2'-deoxyguanosine (8-OHdG), and liver-type fatty acid binding protein levels (L-FABP) at the time of hospitalization were higher in coronavirus disease 2019 (COVID-19) patients with adverse events vs without events. Higher u11-dh-TxB2 and L-FABP levels were associated with longer hospitalization, more thrombotic events, and greater mortality, providing evidence for potential utility as early prognostic biom","2021","07","13","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; liver-type fatty acid binding protein; urinary 11-dehydro- thromboxane B2; urinary 8-hydroxy-2-deoxyguanosine","Ens","Gordon","Inflammatory Markers Laboratory, Wichita, Kansas, USA",NA
"1308","34250193","10.1093/ofid/ofab274","First Experience Addressing the Prognostic Utility of Novel Urinary Biomarkers in Patients With COVID-19.","Urine 11-dehydro-thromboxane B2 (u11-dh-TxB2), 8-hydroxy-2'-deoxyguanosine (8-OHdG), and liver-type fatty acid binding protein levels (L-FABP) at the time of hospitalization were higher in coronavirus disease 2019 (COVID-19) patients with adverse events vs without events. Higher u11-dh-TxB2 and L-FABP levels were associated with longer hospitalization, more thrombotic events, and greater mortality, providing evidence for potential utility as early prognostic biom","2021","07","13","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; liver-type fatty acid binding protein; urinary 11-dehydro- thromboxane B2; urinary 8-hydroxy-2-deoxyguanosine","Traianova","Malina","CEDx Laboratory, Nashua, New Hampshire, USA",NA
"1309","34250193","10.1093/ofid/ofab274","First Experience Addressing the Prognostic Utility of Novel Urinary Biomarkers in Patients With COVID-19.","Urine 11-dehydro-thromboxane B2 (u11-dh-TxB2), 8-hydroxy-2'-deoxyguanosine (8-OHdG), and liver-type fatty acid binding protein levels (L-FABP) at the time of hospitalization were higher in coronavirus disease 2019 (COVID-19) patients with adverse events vs without events. Higher u11-dh-TxB2 and L-FABP levels were associated with longer hospitalization, more thrombotic events, and greater mortality, providing evidence for potential utility as early prognostic biom","2021","07","13","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; liver-type fatty acid binding protein; urinary 11-dehydro- thromboxane B2; urinary 8-hydroxy-2-deoxyguanosine","Jerjian","Christophe","Sinai Center for Thrombosis Research and Drug Development, Sinai Hospital of Baltimore, Lifebridge Health, Baltimore, Maryland, USA",NA
"1310","34250193","10.1093/ofid/ofab274","First Experience Addressing the Prognostic Utility of Novel Urinary Biomarkers in Patients With COVID-19.","Urine 11-dehydro-thromboxane B2 (u11-dh-TxB2), 8-hydroxy-2'-deoxyguanosine (8-OHdG), and liver-type fatty acid binding protein levels (L-FABP) at the time of hospitalization were higher in coronavirus disease 2019 (COVID-19) patients with adverse events vs without events. Higher u11-dh-TxB2 and L-FABP levels were associated with longer hospitalization, more thrombotic events, and greater mortality, providing evidence for potential utility as early prognostic biom","2021","07","13","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; liver-type fatty acid binding protein; urinary 11-dehydro- thromboxane B2; urinary 8-hydroxy-2-deoxyguanosine","Usman","Abira","Sinai Center for Thrombosis Research and Drug Development, Sinai Hospital of Baltimore, Lifebridge Health, Baltimore, Maryland, USA",NA
"1311","34250193","10.1093/ofid/ofab274","First Experience Addressing the Prognostic Utility of Novel Urinary Biomarkers in Patients With COVID-19.","Urine 11-dehydro-thromboxane B2 (u11-dh-TxB2), 8-hydroxy-2'-deoxyguanosine (8-OHdG), and liver-type fatty acid binding protein levels (L-FABP) at the time of hospitalization were higher in coronavirus disease 2019 (COVID-19) patients with adverse events vs without events. Higher u11-dh-TxB2 and L-FABP levels were associated with longer hospitalization, more thrombotic events, and greater mortality, providing evidence for potential utility as early prognostic biom","2021","07","13","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; liver-type fatty acid binding protein; urinary 11-dehydro- thromboxane B2; urinary 8-hydroxy-2-deoxyguanosine","Gurbel","Paul A","Sinai Center for Thrombosis Research and Drug Development, Sinai Hospital of Baltimore, Lifebridge Health, Baltimore, Maryland, USA",NA
"1312","34250192","10.1093/ofid/ofab254","Impact of Bamlanivimab Monoclonal Antibody Treatment on Hospitalization and Mortality Among Nonhospitalized Adults With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.","Monoclonal antibody treatment may prevent complications of coronavirus disease 2019 (COVID-19). We sought to quantify the impact of bamlanivimab monoclonal antibody monotherapy on hospitalization and mortality among outpatients at high risk of COVID-19 complications. In this observational study we compared outpatients who received bamlanivimab monoclonal antibody from December 9, 2020 to March 3, 2021 to nontreated patients with a positive polymerase chain reaction or antigen test for severe acu","2021","07","13","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; bamlanivimab; monoclonal antibodies","Bariola","J Ryan","Division of Infectious Diseases, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA",NA
"1313","34250192","10.1093/ofid/ofab254","Impact of Bamlanivimab Monoclonal Antibody Treatment on Hospitalization and Mortality Among Nonhospitalized Adults With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.","Monoclonal antibody treatment may prevent complications of coronavirus disease 2019 (COVID-19). We sought to quantify the impact of bamlanivimab monoclonal antibody monotherapy on hospitalization and mortality among outpatients at high risk of COVID-19 complications. In this observational study we compared outpatients who received bamlanivimab monoclonal antibody from December 9, 2020 to March 3, 2021 to nontreated patients with a positive polymerase chain reaction or antigen test for severe acu","2021","07","13","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; bamlanivimab; monoclonal antibodies","McCreary","Erin K","Division of Infectious Diseases, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA",NA
"1314","34250192","10.1093/ofid/ofab254","Impact of Bamlanivimab Monoclonal Antibody Treatment on Hospitalization and Mortality Among Nonhospitalized Adults With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.","Monoclonal antibody treatment may prevent complications of coronavirus disease 2019 (COVID-19). We sought to quantify the impact of bamlanivimab monoclonal antibody monotherapy on hospitalization and mortality among outpatients at high risk of COVID-19 complications. In this observational study we compared outpatients who received bamlanivimab monoclonal antibody from December 9, 2020 to March 3, 2021 to nontreated patients with a positive polymerase chain reaction or antigen test for severe acu","2021","07","13","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; bamlanivimab; monoclonal antibodies","Wadas","Richard J","Department of Emergency Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA",NA
"1315","34250192","10.1093/ofid/ofab254","Impact of Bamlanivimab Monoclonal Antibody Treatment on Hospitalization and Mortality Among Nonhospitalized Adults With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.","Monoclonal antibody treatment may prevent complications of coronavirus disease 2019 (COVID-19). We sought to quantify the impact of bamlanivimab monoclonal antibody monotherapy on hospitalization and mortality among outpatients at high risk of COVID-19 complications. In this observational study we compared outpatients who received bamlanivimab monoclonal antibody from December 9, 2020 to March 3, 2021 to nontreated patients with a positive polymerase chain reaction or antigen test for severe acu","2021","07","13","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; bamlanivimab; monoclonal antibodies","Kip","Kevin E","Clinical Analytics, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA",NA
"1316","34250192","10.1093/ofid/ofab254","Impact of Bamlanivimab Monoclonal Antibody Treatment on Hospitalization and Mortality Among Nonhospitalized Adults With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.","Monoclonal antibody treatment may prevent complications of coronavirus disease 2019 (COVID-19). We sought to quantify the impact of bamlanivimab monoclonal antibody monotherapy on hospitalization and mortality among outpatients at high risk of COVID-19 complications. In this observational study we compared outpatients who received bamlanivimab monoclonal antibody from December 9, 2020 to March 3, 2021 to nontreated patients with a positive polymerase chain reaction or antigen test for severe acu","2021","07","13","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; bamlanivimab; monoclonal antibodies","Marroquin","Oscar C","Clinical Analytics, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA",NA
"1317","34250192","10.1093/ofid/ofab254","Impact of Bamlanivimab Monoclonal Antibody Treatment on Hospitalization and Mortality Among Nonhospitalized Adults With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.","Monoclonal antibody treatment may prevent complications of coronavirus disease 2019 (COVID-19). We sought to quantify the impact of bamlanivimab monoclonal antibody monotherapy on hospitalization and mortality among outpatients at high risk of COVID-19 complications. In this observational study we compared outpatients who received bamlanivimab monoclonal antibody from December 9, 2020 to March 3, 2021 to nontreated patients with a positive polymerase chain reaction or antigen test for severe acu","2021","07","13","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; bamlanivimab; monoclonal antibodies","Minnier","Tami","Wolff Center, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA",NA
"1318","34250192","10.1093/ofid/ofab254","Impact of Bamlanivimab Monoclonal Antibody Treatment on Hospitalization and Mortality Among Nonhospitalized Adults With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.","Monoclonal antibody treatment may prevent complications of coronavirus disease 2019 (COVID-19). We sought to quantify the impact of bamlanivimab monoclonal antibody monotherapy on hospitalization and mortality among outpatients at high risk of COVID-19 complications. In this observational study we compared outpatients who received bamlanivimab monoclonal antibody from December 9, 2020 to March 3, 2021 to nontreated patients with a positive polymerase chain reaction or antigen test for severe acu","2021","07","13","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; bamlanivimab; monoclonal antibodies","Koscumb","Stephen","Clinical Analytics, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA",NA
"1319","34250192","10.1093/ofid/ofab254","Impact of Bamlanivimab Monoclonal Antibody Treatment on Hospitalization and Mortality Among Nonhospitalized Adults With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.","Monoclonal antibody treatment may prevent complications of coronavirus disease 2019 (COVID-19). We sought to quantify the impact of bamlanivimab monoclonal antibody monotherapy on hospitalization and mortality among outpatients at high risk of COVID-19 complications. In this observational study we compared outpatients who received bamlanivimab monoclonal antibody from December 9, 2020 to March 3, 2021 to nontreated patients with a positive polymerase chain reaction or antigen test for severe acu","2021","07","13","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; bamlanivimab; monoclonal antibodies","Collins","Kevin","Clinical Analytics, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA",NA
"1320","34250192","10.1093/ofid/ofab254","Impact of Bamlanivimab Monoclonal Antibody Treatment on Hospitalization and Mortality Among Nonhospitalized Adults With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.","Monoclonal antibody treatment may prevent complications of coronavirus disease 2019 (COVID-19). We sought to quantify the impact of bamlanivimab monoclonal antibody monotherapy on hospitalization and mortality among outpatients at high risk of COVID-19 complications. In this observational study we compared outpatients who received bamlanivimab monoclonal antibody from December 9, 2020 to March 3, 2021 to nontreated patients with a positive polymerase chain reaction or antigen test for severe acu","2021","07","13","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; bamlanivimab; monoclonal antibodies","Schmidhofer","Mark","Division of Cardiology, Dept of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA",NA
"1321","34250192","10.1093/ofid/ofab254","Impact of Bamlanivimab Monoclonal Antibody Treatment on Hospitalization and Mortality Among Nonhospitalized Adults With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.","Monoclonal antibody treatment may prevent complications of coronavirus disease 2019 (COVID-19). We sought to quantify the impact of bamlanivimab monoclonal antibody monotherapy on hospitalization and mortality among outpatients at high risk of COVID-19 complications. In this observational study we compared outpatients who received bamlanivimab monoclonal antibody from December 9, 2020 to March 3, 2021 to nontreated patients with a positive polymerase chain reaction or antigen test for severe acu","2021","07","13","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; bamlanivimab; monoclonal antibodies","Shovel","Judith A","Wolff Center, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA",NA
"1322","34250192","10.1093/ofid/ofab254","Impact of Bamlanivimab Monoclonal Antibody Treatment on Hospitalization and Mortality Among Nonhospitalized Adults With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.","Monoclonal antibody treatment may prevent complications of coronavirus disease 2019 (COVID-19). We sought to quantify the impact of bamlanivimab monoclonal antibody monotherapy on hospitalization and mortality among outpatients at high risk of COVID-19 complications. In this observational study we compared outpatients who received bamlanivimab monoclonal antibody from December 9, 2020 to March 3, 2021 to nontreated patients with a positive polymerase chain reaction or antigen test for severe acu","2021","07","13","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; bamlanivimab; monoclonal antibodies","Wisniewski","Mary Kay","Wolff Center, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA",NA
"1323","34250192","10.1093/ofid/ofab254","Impact of Bamlanivimab Monoclonal Antibody Treatment on Hospitalization and Mortality Among Nonhospitalized Adults With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.","Monoclonal antibody treatment may prevent complications of coronavirus disease 2019 (COVID-19). We sought to quantify the impact of bamlanivimab monoclonal antibody monotherapy on hospitalization and mortality among outpatients at high risk of COVID-19 complications. In this observational study we compared outpatients who received bamlanivimab monoclonal antibody from December 9, 2020 to March 3, 2021 to nontreated patients with a positive polymerase chain reaction or antigen test for severe acu","2021","07","13","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; bamlanivimab; monoclonal antibodies","Sullivan","Colleen","UPMC Health System Office of Healthcare Innovation, Pittsburgh, Pennsylvania, USA",NA
"1324","34250192","10.1093/ofid/ofab254","Impact of Bamlanivimab Monoclonal Antibody Treatment on Hospitalization and Mortality Among Nonhospitalized Adults With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.","Monoclonal antibody treatment may prevent complications of coronavirus disease 2019 (COVID-19). We sought to quantify the impact of bamlanivimab monoclonal antibody monotherapy on hospitalization and mortality among outpatients at high risk of COVID-19 complications. In this observational study we compared outpatients who received bamlanivimab monoclonal antibody from December 9, 2020 to March 3, 2021 to nontreated patients with a positive polymerase chain reaction or antigen test for severe acu","2021","07","13","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; bamlanivimab; monoclonal antibodies","Yealy","Donald M","Department of Emergency Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA",NA
"1325","34250192","10.1093/ofid/ofab254","Impact of Bamlanivimab Monoclonal Antibody Treatment on Hospitalization and Mortality Among Nonhospitalized Adults With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.","Monoclonal antibody treatment may prevent complications of coronavirus disease 2019 (COVID-19). We sought to quantify the impact of bamlanivimab monoclonal antibody monotherapy on hospitalization and mortality among outpatients at high risk of COVID-19 complications. In this observational study we compared outpatients who received bamlanivimab monoclonal antibody from December 9, 2020 to March 3, 2021 to nontreated patients with a positive polymerase chain reaction or antigen test for severe acu","2021","07","13","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; bamlanivimab; monoclonal antibodies","Nace","David A","Division of Geriatric Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA",NA
"1326","34250192","10.1093/ofid/ofab254","Impact of Bamlanivimab Monoclonal Antibody Treatment on Hospitalization and Mortality Among Nonhospitalized Adults With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.","Monoclonal antibody treatment may prevent complications of coronavirus disease 2019 (COVID-19). We sought to quantify the impact of bamlanivimab monoclonal antibody monotherapy on hospitalization and mortality among outpatients at high risk of COVID-19 complications. In this observational study we compared outpatients who received bamlanivimab monoclonal antibody from December 9, 2020 to March 3, 2021 to nontreated patients with a positive polymerase chain reaction or antigen test for severe acu","2021","07","13","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; bamlanivimab; monoclonal antibodies","Huang","David T","Department of Emergency Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA",NA
"1327","34250192","10.1093/ofid/ofab254","Impact of Bamlanivimab Monoclonal Antibody Treatment on Hospitalization and Mortality Among Nonhospitalized Adults With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.","Monoclonal antibody treatment may prevent complications of coronavirus disease 2019 (COVID-19). We sought to quantify the impact of bamlanivimab monoclonal antibody monotherapy on hospitalization and mortality among outpatients at high risk of COVID-19 complications. In this observational study we compared outpatients who received bamlanivimab monoclonal antibody from December 9, 2020 to March 3, 2021 to nontreated patients with a positive polymerase chain reaction or antigen test for severe acu","2021","07","13","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; bamlanivimab; monoclonal antibodies","Haidar","Ghady","Division of Infectious Diseases, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA",NA
"1328","34250192","10.1093/ofid/ofab254","Impact of Bamlanivimab Monoclonal Antibody Treatment on Hospitalization and Mortality Among Nonhospitalized Adults With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.","Monoclonal antibody treatment may prevent complications of coronavirus disease 2019 (COVID-19). We sought to quantify the impact of bamlanivimab monoclonal antibody monotherapy on hospitalization and mortality among outpatients at high risk of COVID-19 complications. In this observational study we compared outpatients who received bamlanivimab monoclonal antibody from December 9, 2020 to March 3, 2021 to nontreated patients with a positive polymerase chain reaction or antigen test for severe acu","2021","07","13","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; bamlanivimab; monoclonal antibodies","Khadem","Tina","Division of Infectious Diseases, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA",NA
"1329","34250192","10.1093/ofid/ofab254","Impact of Bamlanivimab Monoclonal Antibody Treatment on Hospitalization and Mortality Among Nonhospitalized Adults With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.","Monoclonal antibody treatment may prevent complications of coronavirus disease 2019 (COVID-19). We sought to quantify the impact of bamlanivimab monoclonal antibody monotherapy on hospitalization and mortality among outpatients at high risk of COVID-19 complications. In this observational study we compared outpatients who received bamlanivimab monoclonal antibody from December 9, 2020 to March 3, 2021 to nontreated patients with a positive polymerase chain reaction or antigen test for severe acu","2021","07","13","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; bamlanivimab; monoclonal antibodies","Linstrum","Kelsey","UPMC Health System Office of Healthcare Innovation, Pittsburgh, Pennsylvania, USA",NA
"1330","34250192","10.1093/ofid/ofab254","Impact of Bamlanivimab Monoclonal Antibody Treatment on Hospitalization and Mortality Among Nonhospitalized Adults With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.","Monoclonal antibody treatment may prevent complications of coronavirus disease 2019 (COVID-19). We sought to quantify the impact of bamlanivimab monoclonal antibody monotherapy on hospitalization and mortality among outpatients at high risk of COVID-19 complications. In this observational study we compared outpatients who received bamlanivimab monoclonal antibody from December 9, 2020 to March 3, 2021 to nontreated patients with a positive polymerase chain reaction or antigen test for severe acu","2021","07","13","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; bamlanivimab; monoclonal antibodies","Seymour","Christopher W","Department of Emergency Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA",NA
"1331","34250192","10.1093/ofid/ofab254","Impact of Bamlanivimab Monoclonal Antibody Treatment on Hospitalization and Mortality Among Nonhospitalized Adults With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.","Monoclonal antibody treatment may prevent complications of coronavirus disease 2019 (COVID-19). We sought to quantify the impact of bamlanivimab monoclonal antibody monotherapy on hospitalization and mortality among outpatients at high risk of COVID-19 complications. In this observational study we compared outpatients who received bamlanivimab monoclonal antibody from December 9, 2020 to March 3, 2021 to nontreated patients with a positive polymerase chain reaction or antigen test for severe acu","2021","07","13","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; bamlanivimab; monoclonal antibodies","Montgomery","Stephanie K","UPMC Health System Office of Healthcare Innovation, Pittsburgh, Pennsylvania, USA",NA
"1332","34250192","10.1093/ofid/ofab254","Impact of Bamlanivimab Monoclonal Antibody Treatment on Hospitalization and Mortality Among Nonhospitalized Adults With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.","Monoclonal antibody treatment may prevent complications of coronavirus disease 2019 (COVID-19). We sought to quantify the impact of bamlanivimab monoclonal antibody monotherapy on hospitalization and mortality among outpatients at high risk of COVID-19 complications. In this observational study we compared outpatients who received bamlanivimab monoclonal antibody from December 9, 2020 to March 3, 2021 to nontreated patients with a positive polymerase chain reaction or antigen test for severe acu","2021","07","13","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; bamlanivimab; monoclonal antibodies","Angus","Derek C","UPMC Health System Office of Healthcare Innovation, Pittsburgh, Pennsylvania, USA",NA
"1333","34250192","10.1093/ofid/ofab254","Impact of Bamlanivimab Monoclonal Antibody Treatment on Hospitalization and Mortality Among Nonhospitalized Adults With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.","Monoclonal antibody treatment may prevent complications of coronavirus disease 2019 (COVID-19). We sought to quantify the impact of bamlanivimab monoclonal antibody monotherapy on hospitalization and mortality among outpatients at high risk of COVID-19 complications. In this observational study we compared outpatients who received bamlanivimab monoclonal antibody from December 9, 2020 to March 3, 2021 to nontreated patients with a positive polymerase chain reaction or antigen test for severe acu","2021","07","13","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; bamlanivimab; monoclonal antibodies","Snyder","Graham M","Division of Infectious Diseases, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA",NA
"1334","34250188","10.1093/ofid/ofab243","Performance and Operational Evaluation of the Access Bio CareStart Rapid Antigen Test in a High-Throughput Drive-Through Community Testing Site in Massachusetts.","To facilitate deployment of point-of-care testing for severe acute respiratory syndrome coronavirus 2, we evaluated the Access Bio CareStart COVID-19 Antigen test in a high-throughput, drive-through, free community testing site using anterior nasal (AN) swab reverse-transcription polymerase chain reaction (RT-PCR) for clinical testing. Consenting symptomatic and asymptomatic children (=18 years) and adults received dual AN swabs. CareStart testing was performed with temperature/humidity monitori","2021","07","13","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; antigen; diagnostic; point-of-care","Pollock","Nira R","Department of Laboratory Medicine, Boston Children's Hospital, Boston, Massachusetts, USA",NA
"1335","34250188","10.1093/ofid/ofab243","Performance and Operational Evaluation of the Access Bio CareStart Rapid Antigen Test in a High-Throughput Drive-Through Community Testing Site in Massachusetts.","To facilitate deployment of point-of-care testing for severe acute respiratory syndrome coronavirus 2, we evaluated the Access Bio CareStart COVID-19 Antigen test in a high-throughput, drive-through, free community testing site using anterior nasal (AN) swab reverse-transcription polymerase chain reaction (RT-PCR) for clinical testing. Consenting symptomatic and asymptomatic children (=18 years) and adults received dual AN swabs. CareStart testing was performed with temperature/humidity monitori","2021","07","13","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; antigen; diagnostic; point-of-care","Tran","Kristine","Massachusetts Department of Public Health, Jamaica Plain, Massachusetts, USA",NA
"1336","34250188","10.1093/ofid/ofab243","Performance and Operational Evaluation of the Access Bio CareStart Rapid Antigen Test in a High-Throughput Drive-Through Community Testing Site in Massachusetts.","To facilitate deployment of point-of-care testing for severe acute respiratory syndrome coronavirus 2, we evaluated the Access Bio CareStart COVID-19 Antigen test in a high-throughput, drive-through, free community testing site using anterior nasal (AN) swab reverse-transcription polymerase chain reaction (RT-PCR) for clinical testing. Consenting symptomatic and asymptomatic children (=18 years) and adults received dual AN swabs. CareStart testing was performed with temperature/humidity monitori","2021","07","13","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; antigen; diagnostic; point-of-care","Jacobs","Jesica R","Massachusetts Department of Public Health, Jamaica Plain, Massachusetts, USA",NA
"1337","34250188","10.1093/ofid/ofab243","Performance and Operational Evaluation of the Access Bio CareStart Rapid Antigen Test in a High-Throughput Drive-Through Community Testing Site in Massachusetts.","To facilitate deployment of point-of-care testing for severe acute respiratory syndrome coronavirus 2, we evaluated the Access Bio CareStart COVID-19 Antigen test in a high-throughput, drive-through, free community testing site using anterior nasal (AN) swab reverse-transcription polymerase chain reaction (RT-PCR) for clinical testing. Consenting symptomatic and asymptomatic children (=18 years) and adults received dual AN swabs. CareStart testing was performed with temperature/humidity monitori","2021","07","13","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; antigen; diagnostic; point-of-care","Cranston","Amber E","Massachusetts Department of Public Health, Jamaica Plain, Massachusetts, USA",NA
"1338","34250188","10.1093/ofid/ofab243","Performance and Operational Evaluation of the Access Bio CareStart Rapid Antigen Test in a High-Throughput Drive-Through Community Testing Site in Massachusetts.","To facilitate deployment of point-of-care testing for severe acute respiratory syndrome coronavirus 2, we evaluated the Access Bio CareStart COVID-19 Antigen test in a high-throughput, drive-through, free community testing site using anterior nasal (AN) swab reverse-transcription polymerase chain reaction (RT-PCR) for clinical testing. Consenting symptomatic and asymptomatic children (=18 years) and adults received dual AN swabs. CareStart testing was performed with temperature/humidity monitori","2021","07","13","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; antigen; diagnostic; point-of-care","Smith","Sita","Massachusetts Department of Public Health, Jamaica Plain, Massachusetts, USA",NA
"1339","34250188","10.1093/ofid/ofab243","Performance and Operational Evaluation of the Access Bio CareStart Rapid Antigen Test in a High-Throughput Drive-Through Community Testing Site in Massachusetts.","To facilitate deployment of point-of-care testing for severe acute respiratory syndrome coronavirus 2, we evaluated the Access Bio CareStart COVID-19 Antigen test in a high-throughput, drive-through, free community testing site using anterior nasal (AN) swab reverse-transcription polymerase chain reaction (RT-PCR) for clinical testing. Consenting symptomatic and asymptomatic children (=18 years) and adults received dual AN swabs. CareStart testing was performed with temperature/humidity monitori","2021","07","13","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; antigen; diagnostic; point-of-care","O'Kane","Claire Y","Massachusetts Department of Public Health, Jamaica Plain, Massachusetts, USA",NA
"1340","34250188","10.1093/ofid/ofab243","Performance and Operational Evaluation of the Access Bio CareStart Rapid Antigen Test in a High-Throughput Drive-Through Community Testing Site in Massachusetts.","To facilitate deployment of point-of-care testing for severe acute respiratory syndrome coronavirus 2, we evaluated the Access Bio CareStart COVID-19 Antigen test in a high-throughput, drive-through, free community testing site using anterior nasal (AN) swab reverse-transcription polymerase chain reaction (RT-PCR) for clinical testing. Consenting symptomatic and asymptomatic children (=18 years) and adults received dual AN swabs. CareStart testing was performed with temperature/humidity monitori","2021","07","13","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; antigen; diagnostic; point-of-care","Roady","Tyler J","Massachusetts Department of Public Health, Jamaica Plain, Massachusetts, USA",NA
"1341","34250188","10.1093/ofid/ofab243","Performance and Operational Evaluation of the Access Bio CareStart Rapid Antigen Test in a High-Throughput Drive-Through Community Testing Site in Massachusetts.","To facilitate deployment of point-of-care testing for severe acute respiratory syndrome coronavirus 2, we evaluated the Access Bio CareStart COVID-19 Antigen test in a high-throughput, drive-through, free community testing site using anterior nasal (AN) swab reverse-transcription polymerase chain reaction (RT-PCR) for clinical testing. Consenting symptomatic and asymptomatic children (=18 years) and adults received dual AN swabs. CareStart testing was performed with temperature/humidity monitori","2021","07","13","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; antigen; diagnostic; point-of-care","Moran","Anne","Lawrence General Hospital, Lawrence, Massachusetts, USA",NA
"1342","34250188","10.1093/ofid/ofab243","Performance and Operational Evaluation of the Access Bio CareStart Rapid Antigen Test in a High-Throughput Drive-Through Community Testing Site in Massachusetts.","To facilitate deployment of point-of-care testing for severe acute respiratory syndrome coronavirus 2, we evaluated the Access Bio CareStart COVID-19 Antigen test in a high-throughput, drive-through, free community testing site using anterior nasal (AN) swab reverse-transcription polymerase chain reaction (RT-PCR) for clinical testing. Consenting symptomatic and asymptomatic children (=18 years) and adults received dual AN swabs. CareStart testing was performed with temperature/humidity monitori","2021","07","13","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; antigen; diagnostic; point-of-care","Scarry","Alison","Lawrence General Hospital, Lawrence, Massachusetts, USA",NA
"1343","34250188","10.1093/ofid/ofab243","Performance and Operational Evaluation of the Access Bio CareStart Rapid Antigen Test in a High-Throughput Drive-Through Community Testing Site in Massachusetts.","To facilitate deployment of point-of-care testing for severe acute respiratory syndrome coronavirus 2, we evaluated the Access Bio CareStart COVID-19 Antigen test in a high-throughput, drive-through, free community testing site using anterior nasal (AN) swab reverse-transcription polymerase chain reaction (RT-PCR) for clinical testing. Consenting symptomatic and asymptomatic children (=18 years) and adults received dual AN swabs. CareStart testing was performed with temperature/humidity monitori","2021","07","13","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; antigen; diagnostic; point-of-care","Carroll","Melissa","Lawrence General Hospital, Lawrence, Massachusetts, USA",NA
"1344","34250188","10.1093/ofid/ofab243","Performance and Operational Evaluation of the Access Bio CareStart Rapid Antigen Test in a High-Throughput Drive-Through Community Testing Site in Massachusetts.","To facilitate deployment of point-of-care testing for severe acute respiratory syndrome coronavirus 2, we evaluated the Access Bio CareStart COVID-19 Antigen test in a high-throughput, drive-through, free community testing site using anterior nasal (AN) swab reverse-transcription polymerase chain reaction (RT-PCR) for clinical testing. Consenting symptomatic and asymptomatic children (=18 years) and adults received dual AN swabs. CareStart testing was performed with temperature/humidity monitori","2021","07","13","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; antigen; diagnostic; point-of-care","Volinsky","Leila","Lawrence General Hospital, Lawrence, Massachusetts, USA",NA
"1345","34250188","10.1093/ofid/ofab243","Performance and Operational Evaluation of the Access Bio CareStart Rapid Antigen Test in a High-Throughput Drive-Through Community Testing Site in Massachusetts.","To facilitate deployment of point-of-care testing for severe acute respiratory syndrome coronavirus 2, we evaluated the Access Bio CareStart COVID-19 Antigen test in a high-throughput, drive-through, free community testing site using anterior nasal (AN) swab reverse-transcription polymerase chain reaction (RT-PCR) for clinical testing. Consenting symptomatic and asymptomatic children (=18 years) and adults received dual AN swabs. CareStart testing was performed with temperature/humidity monitori","2021","07","13","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; antigen; diagnostic; point-of-care","Perez","Gloria","Lawrence General Hospital, Lawrence, Massachusetts, USA",NA
"1346","34250188","10.1093/ofid/ofab243","Performance and Operational Evaluation of the Access Bio CareStart Rapid Antigen Test in a High-Throughput Drive-Through Community Testing Site in Massachusetts.","To facilitate deployment of point-of-care testing for severe acute respiratory syndrome coronavirus 2, we evaluated the Access Bio CareStart COVID-19 Antigen test in a high-throughput, drive-through, free community testing site using anterior nasal (AN) swab reverse-transcription polymerase chain reaction (RT-PCR) for clinical testing. Consenting symptomatic and asymptomatic children (=18 years) and adults received dual AN swabs. CareStart testing was performed with temperature/humidity monitori","2021","07","13","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; antigen; diagnostic; point-of-care","Patel","Pinal","Massachusetts Department of Public Health, Jamaica Plain, Massachusetts, USA",NA
"1347","34250188","10.1093/ofid/ofab243","Performance and Operational Evaluation of the Access Bio CareStart Rapid Antigen Test in a High-Throughput Drive-Through Community Testing Site in Massachusetts.","To facilitate deployment of point-of-care testing for severe acute respiratory syndrome coronavirus 2, we evaluated the Access Bio CareStart COVID-19 Antigen test in a high-throughput, drive-through, free community testing site using anterior nasal (AN) swab reverse-transcription polymerase chain reaction (RT-PCR) for clinical testing. Consenting symptomatic and asymptomatic children (=18 years) and adults received dual AN swabs. CareStart testing was performed with temperature/humidity monitori","2021","07","13","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; antigen; diagnostic; point-of-care","Gabriel","Stacey","Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA",NA
"1348","34250188","10.1093/ofid/ofab243","Performance and Operational Evaluation of the Access Bio CareStart Rapid Antigen Test in a High-Throughput Drive-Through Community Testing Site in Massachusetts.","To facilitate deployment of point-of-care testing for severe acute respiratory syndrome coronavirus 2, we evaluated the Access Bio CareStart COVID-19 Antigen test in a high-throughput, drive-through, free community testing site using anterior nasal (AN) swab reverse-transcription polymerase chain reaction (RT-PCR) for clinical testing. Consenting symptomatic and asymptomatic children (=18 years) and adults received dual AN swabs. CareStart testing was performed with temperature/humidity monitori","2021","07","13","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; antigen; diagnostic; point-of-care","Lennon","Niall J","Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA",NA
"1349","34250188","10.1093/ofid/ofab243","Performance and Operational Evaluation of the Access Bio CareStart Rapid Antigen Test in a High-Throughput Drive-Through Community Testing Site in Massachusetts.","To facilitate deployment of point-of-care testing for severe acute respiratory syndrome coronavirus 2, we evaluated the Access Bio CareStart COVID-19 Antigen test in a high-throughput, drive-through, free community testing site using anterior nasal (AN) swab reverse-transcription polymerase chain reaction (RT-PCR) for clinical testing. Consenting symptomatic and asymptomatic children (=18 years) and adults received dual AN swabs. CareStart testing was performed with temperature/humidity monitori","2021","07","13","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; antigen; diagnostic; point-of-care","Madoff","Lawrence C","Massachusetts Department of Public Health, Jamaica Plain, Massachusetts, USA",NA
"1350","34250188","10.1093/ofid/ofab243","Performance and Operational Evaluation of the Access Bio CareStart Rapid Antigen Test in a High-Throughput Drive-Through Community Testing Site in Massachusetts.","To facilitate deployment of point-of-care testing for severe acute respiratory syndrome coronavirus 2, we evaluated the Access Bio CareStart COVID-19 Antigen test in a high-throughput, drive-through, free community testing site using anterior nasal (AN) swab reverse-transcription polymerase chain reaction (RT-PCR) for clinical testing. Consenting symptomatic and asymptomatic children (=18 years) and adults received dual AN swabs. CareStart testing was performed with temperature/humidity monitori","2021","07","13","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; antigen; diagnostic; point-of-care","Brown","Catherine","Massachusetts Department of Public Health, Jamaica Plain, Massachusetts, USA",NA
"1351","34250188","10.1093/ofid/ofab243","Performance and Operational Evaluation of the Access Bio CareStart Rapid Antigen Test in a High-Throughput Drive-Through Community Testing Site in Massachusetts.","To facilitate deployment of point-of-care testing for severe acute respiratory syndrome coronavirus 2, we evaluated the Access Bio CareStart COVID-19 Antigen test in a high-throughput, drive-through, free community testing site using anterior nasal (AN) swab reverse-transcription polymerase chain reaction (RT-PCR) for clinical testing. Consenting symptomatic and asymptomatic children (=18 years) and adults received dual AN swabs. CareStart testing was performed with temperature/humidity monitori","2021","07","13","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; antigen; diagnostic; point-of-care","Smole","Sandra C","Massachusetts Department of Public Health, Jamaica Plain, Massachusetts, USA",NA
"1352","34250136","10.4103/jehp.jehp_971_20","Study of clinical features of patients with COVID-19 hospitalized in an educational hospital in Iran.","The outbreak of new pathogens or the resurgence of pathogens that have already spread is a serious challenge to public health. Coronavirus is a pathogen that seems to invade the human respiratory system in the first place. Coronaviruses form a large family and are so called because of the presence of crown like cristae on their surface. This is a cross-sectional, descriptive study conducted to assess the status of patients with COVID-19 who were hospitalized in an educational hospital. For this ","2021","07","13","J Educ Health Promot","Journal of education and health promotion","COVID-19; Clinical features; coronavirus; hospital; inpatient","Homauni","Abbas","Department of Health Care Management, School of Public Health and Institute of Public Health Research, Tehran University Medical Sciences, Tehran, Iran",NA
"1353","34250136","10.4103/jehp.jehp_971_20","Study of clinical features of patients with COVID-19 hospitalized in an educational hospital in Iran.","The outbreak of new pathogens or the resurgence of pathogens that have already spread is a serious challenge to public health. Coronavirus is a pathogen that seems to invade the human respiratory system in the first place. Coronaviruses form a large family and are so called because of the presence of crown like cristae on their surface. This is a cross-sectional, descriptive study conducted to assess the status of patients with COVID-19 who were hospitalized in an educational hospital. For this ","2021","07","13","J Educ Health Promot","Journal of education and health promotion","COVID-19; Clinical features; coronavirus; hospital; inpatient","Ghadami","Ladan","Department of Health Care Management, Amiralam Hospital, Tehran University of Medical Sciences, Tehran, Iran",NA
"1354","34250136","10.4103/jehp.jehp_971_20","Study of clinical features of patients with COVID-19 hospitalized in an educational hospital in Iran.","The outbreak of new pathogens or the resurgence of pathogens that have already spread is a serious challenge to public health. Coronavirus is a pathogen that seems to invade the human respiratory system in the first place. Coronaviruses form a large family and are so called because of the presence of crown like cristae on their surface. This is a cross-sectional, descriptive study conducted to assess the status of patients with COVID-19 who were hospitalized in an educational hospital. For this ","2021","07","13","J Educ Health Promot","Journal of education and health promotion","COVID-19; Clinical features; coronavirus; hospital; inpatient","Abdollahi","Hamed","Department of Anesthesthia and Critical Care, Amiralam Hospital, Tehran University Medical Sciences, Tehran, Iran",NA
"1355","34250136","10.4103/jehp.jehp_971_20","Study of clinical features of patients with COVID-19 hospitalized in an educational hospital in Iran.","The outbreak of new pathogens or the resurgence of pathogens that have already spread is a serious challenge to public health. Coronavirus is a pathogen that seems to invade the human respiratory system in the first place. Coronaviruses form a large family and are so called because of the presence of crown like cristae on their surface. This is a cross-sectional, descriptive study conducted to assess the status of patients with COVID-19 who were hospitalized in an educational hospital. For this ","2021","07","13","J Educ Health Promot","Journal of education and health promotion","COVID-19; Clinical features; coronavirus; hospital; inpatient","Shabestari","Alireza Namazi","Department of Geriatric Medicine and Gerontology, School of Medicine, Tehran University Medical Sciences, Tehran, Iran",NA
"1356","34250136","10.4103/jehp.jehp_971_20","Study of clinical features of patients with COVID-19 hospitalized in an educational hospital in Iran.","The outbreak of new pathogens or the resurgence of pathogens that have already spread is a serious challenge to public health. Coronavirus is a pathogen that seems to invade the human respiratory system in the first place. Coronaviruses form a large family and are so called because of the presence of crown like cristae on their surface. This is a cross-sectional, descriptive study conducted to assess the status of patients with COVID-19 who were hospitalized in an educational hospital. For this ","2021","07","13","J Educ Health Promot","Journal of education and health promotion","COVID-19; Clinical features; coronavirus; hospital; inpatient","Asanjarani","Behzad","Department of Oncology, Tehran University Medical Sciences, Tehran, Iran",NA
"1357","34250134","10.4103/jehp.jehp_1032_20","Social media exposure and mental health problems during coronavirus disease 2019 pandemic in Indonesia.","Several preventive measures were used by governments around the world to suppress the transmission of SARS-CoV-2, including quarantine. During quarantine more people are at risk of developing mental health problems as social media exposure was increasing. The objective is to investigate the impact of social media exposure during coronavirus disease 2019 (COVID-19) pandemic on depression, anxiety, and stress. A cross-sectional study was conducted between April and May 2020 during the large scale ","2021","07","13","J Educ Health Promot","Journal of education and health promotion","Coronavirus disease 2019; mental health; social media","Lugito","Nata Pratama Hardjo","Department of Internal Medicine, Faculty of Medicine, Pelita Harapan University, Tangerang, Banten, Indonesia",NA
"1358","34250134","10.4103/jehp.jehp_1032_20","Social media exposure and mental health problems during coronavirus disease 2019 pandemic in Indonesia.","Several preventive measures were used by governments around the world to suppress the transmission of SARS-CoV-2, including quarantine. During quarantine more people are at risk of developing mental health problems as social media exposure was increasing. The objective is to investigate the impact of social media exposure during coronavirus disease 2019 (COVID-19) pandemic on depression, anxiety, and stress. A cross-sectional study was conducted between April and May 2020 during the large scale ","2021","07","13","J Educ Health Promot","Journal of education and health promotion","Coronavirus disease 2019; mental health; social media","Damay","Vika","Department of Medicine, Faculty of Medicine, Pelita Harapan University, Tangerang, Banten, Indonesia",NA
"1359","34250134","10.4103/jehp.jehp_1032_20","Social media exposure and mental health problems during coronavirus disease 2019 pandemic in Indonesia.","Several preventive measures were used by governments around the world to suppress the transmission of SARS-CoV-2, including quarantine. During quarantine more people are at risk of developing mental health problems as social media exposure was increasing. The objective is to investigate the impact of social media exposure during coronavirus disease 2019 (COVID-19) pandemic on depression, anxiety, and stress. A cross-sectional study was conducted between April and May 2020 during the large scale ","2021","07","13","J Educ Health Promot","Journal of education and health promotion","Coronavirus disease 2019; mental health; social media","Chyntya","Henny","Department of Medicine, Faculty of Medicine, Pelita Harapan University, Tangerang, Banten, Indonesia",NA
"1360","34250134","10.4103/jehp.jehp_1032_20","Social media exposure and mental health problems during coronavirus disease 2019 pandemic in Indonesia.","Several preventive measures were used by governments around the world to suppress the transmission of SARS-CoV-2, including quarantine. During quarantine more people are at risk of developing mental health problems as social media exposure was increasing. The objective is to investigate the impact of social media exposure during coronavirus disease 2019 (COVID-19) pandemic on depression, anxiety, and stress. A cross-sectional study was conducted between April and May 2020 during the large scale ","2021","07","13","J Educ Health Promot","Journal of education and health promotion","Coronavirus disease 2019; mental health; social media","Sugianto","Natasya","Department of Medicine, Faculty of Medicine, Pelita Harapan University, Tangerang, Banten, Indonesia",NA
"1361","34250128","10.4103/jehp.jehp_954_20","Coronavirus disease 2019 in pregnancy: Maternal and perinatal outcome.","Since the advent of coronavirus disease 2019 (COVID-19) infection, there is debate whether pregnancy outcome in COVID-19 is more severe as compared to general population. Pregnant population is particularly susceptible to viral infections due to altered immune response. H1N1 infection and Zika virus infection led to unfavorable maternal and fetal outcomes. SARS during pregnancy has been linked previously with high risk of spontaneous abortions, preterm births and intrauterine growth restriction.","2021","07","13","J Educ Health Promot","Journal of education and health promotion","Coronavirus disease 2019 in pregnancy; maternal and fetal outcomes; perinatal outcome; severe acute respiratory syndrome coronavirus 2; vertical transmission of coronavirus disease 2019","Agarwal","Neha","Department of Obstetrics and Gynecology, SN Medical College, Agra, Uttar Pradesh, India",NA
"1362","34250128","10.4103/jehp.jehp_954_20","Coronavirus disease 2019 in pregnancy: Maternal and perinatal outcome.","Since the advent of coronavirus disease 2019 (COVID-19) infection, there is debate whether pregnancy outcome in COVID-19 is more severe as compared to general population. Pregnant population is particularly susceptible to viral infections due to altered immune response. H1N1 infection and Zika virus infection led to unfavorable maternal and fetal outcomes. SARS during pregnancy has been linked previously with high risk of spontaneous abortions, preterm births and intrauterine growth restriction.","2021","07","13","J Educ Health Promot","Journal of education and health promotion","Coronavirus disease 2019 in pregnancy; maternal and fetal outcomes; perinatal outcome; severe acute respiratory syndrome coronavirus 2; vertical transmission of coronavirus disease 2019","Garg","Ruchika","Department of Obstetrics and Gynecology, SN Medical College, Agra, Uttar Pradesh, India",NA
"1363","34250128","10.4103/jehp.jehp_954_20","Coronavirus disease 2019 in pregnancy: Maternal and perinatal outcome.","Since the advent of coronavirus disease 2019 (COVID-19) infection, there is debate whether pregnancy outcome in COVID-19 is more severe as compared to general population. Pregnant population is particularly susceptible to viral infections due to altered immune response. H1N1 infection and Zika virus infection led to unfavorable maternal and fetal outcomes. SARS during pregnancy has been linked previously with high risk of spontaneous abortions, preterm births and intrauterine growth restriction.","2021","07","13","J Educ Health Promot","Journal of education and health promotion","Coronavirus disease 2019 in pregnancy; maternal and fetal outcomes; perinatal outcome; severe acute respiratory syndrome coronavirus 2; vertical transmission of coronavirus disease 2019","Singh","Saroj","Department of Obstetrics and Gynecology, SN Medical College, Agra, Uttar Pradesh, India",NA
"1364","34250128","10.4103/jehp.jehp_954_20","Coronavirus disease 2019 in pregnancy: Maternal and perinatal outcome.","Since the advent of coronavirus disease 2019 (COVID-19) infection, there is debate whether pregnancy outcome in COVID-19 is more severe as compared to general population. Pregnant population is particularly susceptible to viral infections due to altered immune response. H1N1 infection and Zika virus infection led to unfavorable maternal and fetal outcomes. SARS during pregnancy has been linked previously with high risk of spontaneous abortions, preterm births and intrauterine growth restriction.","2021","07","13","J Educ Health Promot","Journal of education and health promotion","Coronavirus disease 2019 in pregnancy; maternal and fetal outcomes; perinatal outcome; severe acute respiratory syndrome coronavirus 2; vertical transmission of coronavirus disease 2019","Agrawal","Arti","Department of Microbiology, SN Medical College, Agra, Uttar Pradesh, India",NA
"1365","34250118","10.4103/jehp.jehp_1102_20","Existential anxiety amid COVID-19 pandemic in Kashmir: A cross-sectional study.","Existential anxiety (EA) revolves around the question of ultimate concern related to life and death. It gets more prominent when there is an exposure to stressful experiences where the stress is profound and resources seem insufficient. The objective was to measure the prevalence and magnitude of EA in the study population from the Kashmir valley during the COVID-19 pandemic. In this cross-sectional study, data were collected through social media. All the participants belonging to the Kashmir va","2021","07","13","J Educ Health Promot","Journal of education and health promotion","Anxiety; death; existentialism; life; mental health","Ain","Syed Najmul","Department of Community Medicine GMC, Baramulla, Jammu and Kashmir, India",NA
"1366","34250118","10.4103/jehp.jehp_1102_20","Existential anxiety amid COVID-19 pandemic in Kashmir: A cross-sectional study.","Existential anxiety (EA) revolves around the question of ultimate concern related to life and death. It gets more prominent when there is an exposure to stressful experiences where the stress is profound and resources seem insufficient. The objective was to measure the prevalence and magnitude of EA in the study population from the Kashmir valley during the COVID-19 pandemic. In this cross-sectional study, data were collected through social media. All the participants belonging to the Kashmir va","2021","07","13","J Educ Health Promot","Journal of education and health promotion","Anxiety; death; existentialism; life; mental health","Gilani","Syed Nasir Ahmad","Department of Psychiatry GMC, Srinagar, Jammu and Kashmir, India",NA
"1367","34250117","10.4103/jehp.jehp_1009_20","Effectiveness of video modules in infection control trainings during COVID-19 pandemic: A quasi-experimental study in tertiary care institute.","Continuous pertinent trainings for infection prevention and control (IPC) measures are essential to ensure quality health-care services along with the safety of the health personnel. Amid the COVID-19 pandemic, the current study focusses on the utilization of explicated video modules training of all health-care personnel of the institute and assessment of the effectiveness of video training for IPC practices during COVID-19 pandemic. A quasi-experimental study, one group pre- and posttest design","2021","07","13","J Educ Health Promot","Journal of education and health promotion","COVID-19; infection control; training; video modules","Singh","Vanya","Department of Microbiology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India",NA
"1368","34250117","10.4103/jehp.jehp_1009_20","Effectiveness of video modules in infection control trainings during COVID-19 pandemic: A quasi-experimental study in tertiary care institute.","Continuous pertinent trainings for infection prevention and control (IPC) measures are essential to ensure quality health-care services along with the safety of the health personnel. Amid the COVID-19 pandemic, the current study focusses on the utilization of explicated video modules training of all health-care personnel of the institute and assessment of the effectiveness of video training for IPC practices during COVID-19 pandemic. A quasi-experimental study, one group pre- and posttest design","2021","07","13","J Educ Health Promot","Journal of education and health promotion","COVID-19; infection control; training; video modules","Supehia","Sakshi","Department of Community and Family Medicine, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India",NA
"1369","34250117","10.4103/jehp.jehp_1009_20","Effectiveness of video modules in infection control trainings during COVID-19 pandemic: A quasi-experimental study in tertiary care institute.","Continuous pertinent trainings for infection prevention and control (IPC) measures are essential to ensure quality health-care services along with the safety of the health personnel. Amid the COVID-19 pandemic, the current study focusses on the utilization of explicated video modules training of all health-care personnel of the institute and assessment of the effectiveness of video training for IPC practices during COVID-19 pandemic. A quasi-experimental study, one group pre- and posttest design","2021","07","13","J Educ Health Promot","Journal of education and health promotion","COVID-19; infection control; training; video modules","Gupta","Puneet Kumar","Department of Microbiology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India",NA
"1370","34250117","10.4103/jehp.jehp_1009_20","Effectiveness of video modules in infection control trainings during COVID-19 pandemic: A quasi-experimental study in tertiary care institute.","Continuous pertinent trainings for infection prevention and control (IPC) measures are essential to ensure quality health-care services along with the safety of the health personnel. Amid the COVID-19 pandemic, the current study focusses on the utilization of explicated video modules training of all health-care personnel of the institute and assessment of the effectiveness of video training for IPC practices during COVID-19 pandemic. A quasi-experimental study, one group pre- and posttest design","2021","07","13","J Educ Health Promot","Journal of education and health promotion","COVID-19; infection control; training; video modules","Narula","Himanshu","Department of Microbiology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India",NA
"1371","34250117","10.4103/jehp.jehp_1009_20","Effectiveness of video modules in infection control trainings during COVID-19 pandemic: A quasi-experimental study in tertiary care institute.","Continuous pertinent trainings for infection prevention and control (IPC) measures are essential to ensure quality health-care services along with the safety of the health personnel. Amid the COVID-19 pandemic, the current study focusses on the utilization of explicated video modules training of all health-care personnel of the institute and assessment of the effectiveness of video training for IPC practices during COVID-19 pandemic. A quasi-experimental study, one group pre- and posttest design","2021","07","13","J Educ Health Promot","Journal of education and health promotion","COVID-19; infection control; training; video modules","Sharma","Maneesh","Department of Medical Surgical Nursing, College of Nursing, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India",NA
"1372","34250117","10.4103/jehp.jehp_1009_20","Effectiveness of video modules in infection control trainings during COVID-19 pandemic: A quasi-experimental study in tertiary care institute.","Continuous pertinent trainings for infection prevention and control (IPC) measures are essential to ensure quality health-care services along with the safety of the health personnel. Amid the COVID-19 pandemic, the current study focusses on the utilization of explicated video modules training of all health-care personnel of the institute and assessment of the effectiveness of video training for IPC practices during COVID-19 pandemic. A quasi-experimental study, one group pre- and posttest design","2021","07","13","J Educ Health Promot","Journal of education and health promotion","COVID-19; infection control; training; video modules","Devi","Komal","Department of Microbiology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India",NA
"1373","34250117","10.4103/jehp.jehp_1009_20","Effectiveness of video modules in infection control trainings during COVID-19 pandemic: A quasi-experimental study in tertiary care institute.","Continuous pertinent trainings for infection prevention and control (IPC) measures are essential to ensure quality health-care services along with the safety of the health personnel. Amid the COVID-19 pandemic, the current study focusses on the utilization of explicated video modules training of all health-care personnel of the institute and assessment of the effectiveness of video training for IPC practices during COVID-19 pandemic. A quasi-experimental study, one group pre- and posttest design","2021","07","13","J Educ Health Promot","Journal of education and health promotion","COVID-19; infection control; training; video modules","Bhute","Ashish Ramesh","Department of Forensic Medicine, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India",NA
"1374","34250113","10.4103/jehp.jehp_1082_20","Notifiable diseases interoperable framework toward improving Iran public health surveillance system: Lessons learned from COVID-19 pandemic.","Direct transmission of notifiable disease information in a real-time and reliable way to public health decision-makers is imperative for early identification of epidemiological trends as well as proper response to potential pandemic like ongoing coronavirus disease 2019 crisis. Thus, this research aimed to develop of semantic-sharing and collaborative-modeling to meet the information exchange requirements of Iran's notifiable diseases surveillance system. First, the Iran's Notifiable diseases Mi","2021","07","13","J Educ Health Promot","Journal of education and health promotion","COVID-19; Coronavirus; health information exchange; notifiable disease; public health surveillance; semantic interoperability","Shanbehzadeh","Mostafa","Assistant Professor of Health Information Management, Department of Health Information Technology, School of Paramedical, Ilam University of Medical Sciences, Ilam, Iran",NA
"1375","34250113","10.4103/jehp.jehp_1082_20","Notifiable diseases interoperable framework toward improving Iran public health surveillance system: Lessons learned from COVID-19 pandemic.","Direct transmission of notifiable disease information in a real-time and reliable way to public health decision-makers is imperative for early identification of epidemiological trends as well as proper response to potential pandemic like ongoing coronavirus disease 2019 crisis. Thus, this research aimed to develop of semantic-sharing and collaborative-modeling to meet the information exchange requirements of Iran's notifiable diseases surveillance system. First, the Iran's Notifiable diseases Mi","2021","07","13","J Educ Health Promot","Journal of education and health promotion","COVID-19; Coronavirus; health information exchange; notifiable disease; public health surveillance; semantic interoperability","Kazemi-Arpanahi","Hadi","Assistant Professor of Health Information Management, Department of Health Information Technology, School of Paramedical, Ilam University of Medical Sciences, Ilam, Iran",NA
"1376","34250113","10.4103/jehp.jehp_1082_20","Notifiable diseases interoperable framework toward improving Iran public health surveillance system: Lessons learned from COVID-19 pandemic.","Direct transmission of notifiable disease information in a real-time and reliable way to public health decision-makers is imperative for early identification of epidemiological trends as well as proper response to potential pandemic like ongoing coronavirus disease 2019 crisis. Thus, this research aimed to develop of semantic-sharing and collaborative-modeling to meet the information exchange requirements of Iran's notifiable diseases surveillance system. First, the Iran's Notifiable diseases Mi","2021","07","13","J Educ Health Promot","Journal of education and health promotion","COVID-19; Coronavirus; health information exchange; notifiable disease; public health surveillance; semantic interoperability","Valipour","Ali Asghar","Assistant Professor of Health Information Management, Student Research Committee, Abadan Faculty of Medical Sciences, Abadan, Iran",NA
"1377","34250113","10.4103/jehp.jehp_1082_20","Notifiable diseases interoperable framework toward improving Iran public health surveillance system: Lessons learned from COVID-19 pandemic.","Direct transmission of notifiable disease information in a real-time and reliable way to public health decision-makers is imperative for early identification of epidemiological trends as well as proper response to potential pandemic like ongoing coronavirus disease 2019 crisis. Thus, this research aimed to develop of semantic-sharing and collaborative-modeling to meet the information exchange requirements of Iran's notifiable diseases surveillance system. First, the Iran's Notifiable diseases Mi","2021","07","13","J Educ Health Promot","Journal of education and health promotion","COVID-19; Coronavirus; health information exchange; notifiable disease; public health surveillance; semantic interoperability","Zahedi","Atefeh","Assistant Professor of Health Information Management, Student Research Committee, Abadan Faculty of Medical Sciences, Abadan, Iran",NA
"1378","34250107","10.4103/jehp.jehp_20_21","Evaluation of clinical outcomes of neonates born to mothers with coronavirus (COVID-19) in Shahid Beheshti Hospitals.","The coronavirus, which is caused by acute respiratory syndrome, appeared in Wuhan, China, in December 2019 and gradually spread around the world until almost all countries became infected with the coronavirus. In Iran, the outbreak of coronavirus began on February 21, 2020, with the report of infection of two people in the city of Qom. The aim of this study is to evaluate the clinical findings of neonates born to pregnant women with corona disease. During this case study (February 21 to November","2021","07","13","J Educ Health Promot","Journal of education and health promotion","COVID-19; Coronavirus; infant; pregnancy","Hosseini","Maryam Sadat","Preventative Gynecology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran",NA
"1379","34250107","10.4103/jehp.jehp_20_21","Evaluation of clinical outcomes of neonates born to mothers with coronavirus (COVID-19) in Shahid Beheshti Hospitals.","The coronavirus, which is caused by acute respiratory syndrome, appeared in Wuhan, China, in December 2019 and gradually spread around the world until almost all countries became infected with the coronavirus. In Iran, the outbreak of coronavirus began on February 21, 2020, with the report of infection of two people in the city of Qom. The aim of this study is to evaluate the clinical findings of neonates born to pregnant women with corona disease. During this case study (February 21 to November","2021","07","13","J Educ Health Promot","Journal of education and health promotion","COVID-19; Coronavirus; infant; pregnancy","Hosseini","Afsaneh","Preventative Gynecology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran",NA
"1380","34250107","10.4103/jehp.jehp_20_21","Evaluation of clinical outcomes of neonates born to mothers with coronavirus (COVID-19) in Shahid Beheshti Hospitals.","The coronavirus, which is caused by acute respiratory syndrome, appeared in Wuhan, China, in December 2019 and gradually spread around the world until almost all countries became infected with the coronavirus. In Iran, the outbreak of coronavirus began on February 21, 2020, with the report of infection of two people in the city of Qom. The aim of this study is to evaluate the clinical findings of neonates born to pregnant women with corona disease. During this case study (February 21 to November","2021","07","13","J Educ Health Promot","Journal of education and health promotion","COVID-19; Coronavirus; infant; pregnancy","Ghaffari","Elnaz","Preventative Gynecology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran",NA
"1381","34250107","10.4103/jehp.jehp_20_21","Evaluation of clinical outcomes of neonates born to mothers with coronavirus (COVID-19) in Shahid Beheshti Hospitals.","The coronavirus, which is caused by acute respiratory syndrome, appeared in Wuhan, China, in December 2019 and gradually spread around the world until almost all countries became infected with the coronavirus. In Iran, the outbreak of coronavirus began on February 21, 2020, with the report of infection of two people in the city of Qom. The aim of this study is to evaluate the clinical findings of neonates born to pregnant women with corona disease. During this case study (February 21 to November","2021","07","13","J Educ Health Promot","Journal of education and health promotion","COVID-19; Coronavirus; infant; pregnancy","Radfar","Mitra","Pediatric Infections Research Center, Research Institute for Children Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran",NA
"1382","34250107","10.4103/jehp.jehp_20_21","Evaluation of clinical outcomes of neonates born to mothers with coronavirus (COVID-19) in Shahid Beheshti Hospitals.","The coronavirus, which is caused by acute respiratory syndrome, appeared in Wuhan, China, in December 2019 and gradually spread around the world until almost all countries became infected with the coronavirus. In Iran, the outbreak of coronavirus began on February 21, 2020, with the report of infection of two people in the city of Qom. The aim of this study is to evaluate the clinical findings of neonates born to pregnant women with corona disease. During this case study (February 21 to November","2021","07","13","J Educ Health Promot","Journal of education and health promotion","COVID-19; Coronavirus; infant; pregnancy","Shirvani","Fariba","Pediatric Infections Research Center, Research Institute for Children Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran",NA
"1383","34250107","10.4103/jehp.jehp_20_21","Evaluation of clinical outcomes of neonates born to mothers with coronavirus (COVID-19) in Shahid Beheshti Hospitals.","The coronavirus, which is caused by acute respiratory syndrome, appeared in Wuhan, China, in December 2019 and gradually spread around the world until almost all countries became infected with the coronavirus. In Iran, the outbreak of coronavirus began on February 21, 2020, with the report of infection of two people in the city of Qom. The aim of this study is to evaluate the clinical findings of neonates born to pregnant women with corona disease. During this case study (February 21 to November","2021","07","13","J Educ Health Promot","Journal of education and health promotion","COVID-19; Coronavirus; infant; pregnancy","Tabatabai","Shahrzad","Department of Pediatric, Shahid Beheshti University of Medical Sciences, Tehran, Iran",NA
"1384","34250107","10.4103/jehp.jehp_20_21","Evaluation of clinical outcomes of neonates born to mothers with coronavirus (COVID-19) in Shahid Beheshti Hospitals.","The coronavirus, which is caused by acute respiratory syndrome, appeared in Wuhan, China, in December 2019 and gradually spread around the world until almost all countries became infected with the coronavirus. In Iran, the outbreak of coronavirus began on February 21, 2020, with the report of infection of two people in the city of Qom. The aim of this study is to evaluate the clinical findings of neonates born to pregnant women with corona disease. During this case study (February 21 to November","2021","07","13","J Educ Health Promot","Journal of education and health promotion","COVID-19; Coronavirus; infant; pregnancy","Abtahi","Dariush","Department of Anesthesiology, Imam Hossein General Hospital, Shahid Beheshti University of Medical Science, Tehran, Iran",NA
"1385","34250107","10.4103/jehp.jehp_20_21","Evaluation of clinical outcomes of neonates born to mothers with coronavirus (COVID-19) in Shahid Beheshti Hospitals.","The coronavirus, which is caused by acute respiratory syndrome, appeared in Wuhan, China, in December 2019 and gradually spread around the world until almost all countries became infected with the coronavirus. In Iran, the outbreak of coronavirus began on February 21, 2020, with the report of infection of two people in the city of Qom. The aim of this study is to evaluate the clinical findings of neonates born to pregnant women with corona disease. During this case study (February 21 to November","2021","07","13","J Educ Health Promot","Journal of education and health promotion","COVID-19; Coronavirus; infant; pregnancy","Mirhadi","Mahsa","Preventative Gynecology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran",NA
"1386","34250107","10.4103/jehp.jehp_20_21","Evaluation of clinical outcomes of neonates born to mothers with coronavirus (COVID-19) in Shahid Beheshti Hospitals.","The coronavirus, which is caused by acute respiratory syndrome, appeared in Wuhan, China, in December 2019 and gradually spread around the world until almost all countries became infected with the coronavirus. In Iran, the outbreak of coronavirus began on February 21, 2020, with the report of infection of two people in the city of Qom. The aim of this study is to evaluate the clinical findings of neonates born to pregnant women with corona disease. During this case study (February 21 to November","2021","07","13","J Educ Health Promot","Journal of education and health promotion","COVID-19; Coronavirus; infant; pregnancy","Mortazavi","Maziyar","Department of Pediatric, Sarem Hospital, Tehran, Iran",NA
"1387","34250107","10.4103/jehp.jehp_20_21","Evaluation of clinical outcomes of neonates born to mothers with coronavirus (COVID-19) in Shahid Beheshti Hospitals.","The coronavirus, which is caused by acute respiratory syndrome, appeared in Wuhan, China, in December 2019 and gradually spread around the world until almost all countries became infected with the coronavirus. In Iran, the outbreak of coronavirus began on February 21, 2020, with the report of infection of two people in the city of Qom. The aim of this study is to evaluate the clinical findings of neonates born to pregnant women with corona disease. During this case study (February 21 to November","2021","07","13","J Educ Health Promot","Journal of education and health promotion","COVID-19; Coronavirus; infant; pregnancy","Ariana","Shideh","Preventative Gynecology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran",NA
"1388","34250103","10.4103/jehp.jehp_946_20","Age-standardized mortality rate and predictors of mortality among COVID-19 patients in Iran.","To have a thorough understanding of epidemic surveillance, it is essential to broaden our knowledge of death tolls worldwide. This study aimed to determine the age-standardized mortality rate (ASMR) and predictors of mortality among coronavirus disease 2019 (COVID-19) patients. In this cross-sectional design, all COVID-19 patients with a positive polymerase chain reaction test in the population covered by Arak University of Medical Sciences (AUMS) were entered to the study. Data collection was c","2021","07","13","J Educ Health Promot","Journal of education and health promotion","Age-standardized; COVID-19; Iran; epidemiology; mortality","Moradzadeh","Rahmatollah","Department of Epidemiology, School of Health, Arak University of Medical Sciences, Arak, Iran",NA
"1389","34250103","10.4103/jehp.jehp_946_20","Age-standardized mortality rate and predictors of mortality among COVID-19 patients in Iran.","To have a thorough understanding of epidemic surveillance, it is essential to broaden our knowledge of death tolls worldwide. This study aimed to determine the age-standardized mortality rate (ASMR) and predictors of mortality among coronavirus disease 2019 (COVID-19) patients. In this cross-sectional design, all COVID-19 patients with a positive polymerase chain reaction test in the population covered by Arak University of Medical Sciences (AUMS) were entered to the study. Data collection was c","2021","07","13","J Educ Health Promot","Journal of education and health promotion","Age-standardized; COVID-19; Iran; epidemiology; mortality","Jamalian","Seyed Mohammad","Department of Forensic Medicine and Poisoning, Arak University of Medical Sciences, Arak, Iran",NA
"1390","34250103","10.4103/jehp.jehp_946_20","Age-standardized mortality rate and predictors of mortality among COVID-19 patients in Iran.","To have a thorough understanding of epidemic surveillance, it is essential to broaden our knowledge of death tolls worldwide. This study aimed to determine the age-standardized mortality rate (ASMR) and predictors of mortality among coronavirus disease 2019 (COVID-19) patients. In this cross-sectional design, all COVID-19 patients with a positive polymerase chain reaction test in the population covered by Arak University of Medical Sciences (AUMS) were entered to the study. Data collection was c","2021","07","13","J Educ Health Promot","Journal of education and health promotion","Age-standardized; COVID-19; Iran; epidemiology; mortality","Nazari","Javad","Department of Pediatrics, School of Medicine, Arak University of Medical Sciences, Arak, Iran",NA
"1391","34250103","10.4103/jehp.jehp_946_20","Age-standardized mortality rate and predictors of mortality among COVID-19 patients in Iran.","To have a thorough understanding of epidemic surveillance, it is essential to broaden our knowledge of death tolls worldwide. This study aimed to determine the age-standardized mortality rate (ASMR) and predictors of mortality among coronavirus disease 2019 (COVID-19) patients. In this cross-sectional design, all COVID-19 patients with a positive polymerase chain reaction test in the population covered by Arak University of Medical Sciences (AUMS) were entered to the study. Data collection was c","2021","07","13","J Educ Health Promot","Journal of education and health promotion","Age-standardized; COVID-19; Iran; epidemiology; mortality","Kamali","Alireza","Department of Anesthesiology and Critical Care, Arak University of Medical Sciences, Arak, Iran",NA
"1392","34250103","10.4103/jehp.jehp_946_20","Age-standardized mortality rate and predictors of mortality among COVID-19 patients in Iran.","To have a thorough understanding of epidemic surveillance, it is essential to broaden our knowledge of death tolls worldwide. This study aimed to determine the age-standardized mortality rate (ASMR) and predictors of mortality among coronavirus disease 2019 (COVID-19) patients. In this cross-sectional design, all COVID-19 patients with a positive polymerase chain reaction test in the population covered by Arak University of Medical Sciences (AUMS) were entered to the study. Data collection was c","2021","07","13","J Educ Health Promot","Journal of education and health promotion","Age-standardized; COVID-19; Iran; epidemiology; mortality","Sadeghi","Bahman","Department of Social Medicine, School of Medicine, Arak University of Medical Sciences, Arak, Iran",NA
"1393","34250103","10.4103/jehp.jehp_946_20","Age-standardized mortality rate and predictors of mortality among COVID-19 patients in Iran.","To have a thorough understanding of epidemic surveillance, it is essential to broaden our knowledge of death tolls worldwide. This study aimed to determine the age-standardized mortality rate (ASMR) and predictors of mortality among coronavirus disease 2019 (COVID-19) patients. In this cross-sectional design, all COVID-19 patients with a positive polymerase chain reaction test in the population covered by Arak University of Medical Sciences (AUMS) were entered to the study. Data collection was c","2021","07","13","J Educ Health Promot","Journal of education and health promotion","Age-standardized; COVID-19; Iran; epidemiology; mortality","Hosseinkhani","Zahra","Metabolic Diseases Research Center, Research Institute for Prevention of Non-Communicable Diseases, Qazvin University of Medical Sciences, Qazvin, Iran",NA
"1394","34250103","10.4103/jehp.jehp_946_20","Age-standardized mortality rate and predictors of mortality among COVID-19 patients in Iran.","To have a thorough understanding of epidemic surveillance, it is essential to broaden our knowledge of death tolls worldwide. This study aimed to determine the age-standardized mortality rate (ASMR) and predictors of mortality among coronavirus disease 2019 (COVID-19) patients. In this cross-sectional design, all COVID-19 patients with a positive polymerase chain reaction test in the population covered by Arak University of Medical Sciences (AUMS) were entered to the study. Data collection was c","2021","07","13","J Educ Health Promot","Journal of education and health promotion","Age-standardized; COVID-19; Iran; epidemiology; mortality","Sofian","Masoomeh","Infectious Disease Research Center, Arak University of Medical Sciences, Arak, Iran",NA
"1395","34250103","10.4103/jehp.jehp_946_20","Age-standardized mortality rate and predictors of mortality among COVID-19 patients in Iran.","To have a thorough understanding of epidemic surveillance, it is essential to broaden our knowledge of death tolls worldwide. This study aimed to determine the age-standardized mortality rate (ASMR) and predictors of mortality among coronavirus disease 2019 (COVID-19) patients. In this cross-sectional design, all COVID-19 patients with a positive polymerase chain reaction test in the population covered by Arak University of Medical Sciences (AUMS) were entered to the study. Data collection was c","2021","07","13","J Educ Health Promot","Journal of education and health promotion","Age-standardized; COVID-19; Iran; epidemiology; mortality","Zamanian","Maryam","Department of Epidemiology, School of Health, Arak University of Medical Sciences, Arak, Iran",NA
"1396","34250102","10.4103/jehp.jehp_609_20","Learning with lockdown: Utility of whatsApp status-based multiple-choice question discussion on COVID-19 among medical students and teaching faculty.","Following the COVID-19 pandemic, the Government of India announced lockdown from March 25, 2020, which included measures such as social distancing, canceling mass gatherings, and closure of schools and colleges. Since the present generation of students spends a lot of time on social media, especially WhatsApp, the utility of the same to discuss the various public health domains of COVID-19 through multiple-choice questions (MCQs) was explored. This longitudinal study was conducted among 154 part","2021","07","13","J Educ Health Promot","Journal of education and health promotion","COVID-19; WhatsApp; multiple-choice question; self-directed learning","Doddaiah","Sunil Kumar","Department of Community Medicine, JSS Medical College, JSS Academy of Higher Education and Research, Mysore, Karnataka, India",NA
"1397","34250102","10.4103/jehp.jehp_609_20","Learning with lockdown: Utility of whatsApp status-based multiple-choice question discussion on COVID-19 among medical students and teaching faculty.","Following the COVID-19 pandemic, the Government of India announced lockdown from March 25, 2020, which included measures such as social distancing, canceling mass gatherings, and closure of schools and colleges. Since the present generation of students spends a lot of time on social media, especially WhatsApp, the utility of the same to discuss the various public health domains of COVID-19 through multiple-choice questions (MCQs) was explored. This longitudinal study was conducted among 154 part","2021","07","13","J Educ Health Promot","Journal of education and health promotion","COVID-19; WhatsApp; multiple-choice question; self-directed learning","Kulkarni","Praveen","Department of Community Medicine, JSS Medical College, JSS Academy of Higher Education and Research, Mysore, Karnataka, India",NA
"1398","34250102","10.4103/jehp.jehp_609_20","Learning with lockdown: Utility of whatsApp status-based multiple-choice question discussion on COVID-19 among medical students and teaching faculty.","Following the COVID-19 pandemic, the Government of India announced lockdown from March 25, 2020, which included measures such as social distancing, canceling mass gatherings, and closure of schools and colleges. Since the present generation of students spends a lot of time on social media, especially WhatsApp, the utility of the same to discuss the various public health domains of COVID-19 through multiple-choice questions (MCQs) was explored. This longitudinal study was conducted among 154 part","2021","07","13","J Educ Health Promot","Journal of education and health promotion","COVID-19; WhatsApp; multiple-choice question; self-directed learning","Mohandas","Aparna","Department of Community Medicine, JSS Medical College, JSS Academy of Higher Education and Research, Mysore, Karnataka, India",NA
"1399","34250102","10.4103/jehp.jehp_609_20","Learning with lockdown: Utility of whatsApp status-based multiple-choice question discussion on COVID-19 among medical students and teaching faculty.","Following the COVID-19 pandemic, the Government of India announced lockdown from March 25, 2020, which included measures such as social distancing, canceling mass gatherings, and closure of schools and colleges. Since the present generation of students spends a lot of time on social media, especially WhatsApp, the utility of the same to discuss the various public health domains of COVID-19 through multiple-choice questions (MCQs) was explored. This longitudinal study was conducted among 154 part","2021","07","13","J Educ Health Promot","Journal of education and health promotion","COVID-19; WhatsApp; multiple-choice question; self-directed learning","Murthy","M R Narayana","Department of Community Medicine, JSS Medical College, JSS Academy of Higher Education and Research, Mysore, Karnataka, India",NA
"1400","34250095","10.1155/2021/9995073","Studying the Effect of Taking Statins before Infection in the Severity Reduction of COVID-19 with Machine Learning.","Statins can help COVID-19 patients' treatment because of their involvement in angiotensin-converting enzyme-2. The main objective of this study is to evaluate the impact of statins on COVID-19 severity for people who have been taking statins before COVID-19 infection. The examined research patients include people that had taken three types of statins consisting of Atorvastatin, Simvastatin, and Rosuvastatin. The case study includes 561 patients admitted to the Razi Hospital in Ghaemshahr, Iran, ","2021","07","16","Biomed Res Int","BioMed research international","Aged; Algorithms; Atorvastatin; COVID-19; Drug Prescriptions; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Iran; Machine Learning; Male; Middle Aged; Retrospective Studies; Rosuvastatin Calcium; Severity of Illness Index; Simvastatin","Davoudi","Alireza","Department of Infectious Diseases, Mazandaran University of Medical Sciences, P.O. Box: 48175-866, Sari, Iran",NA
"1401","34250095","10.1155/2021/9995073","Studying the Effect of Taking Statins before Infection in the Severity Reduction of COVID-19 with Machine Learning.","Statins can help COVID-19 patients' treatment because of their involvement in angiotensin-converting enzyme-2. The main objective of this study is to evaluate the impact of statins on COVID-19 severity for people who have been taking statins before COVID-19 infection. The examined research patients include people that had taken three types of statins consisting of Atorvastatin, Simvastatin, and Rosuvastatin. The case study includes 561 patients admitted to the Razi Hospital in Ghaemshahr, Iran, ","2021","07","16","Biomed Res Int","BioMed research international","Aged; Algorithms; Atorvastatin; COVID-19; Drug Prescriptions; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Iran; Machine Learning; Male; Middle Aged; Retrospective Studies; Rosuvastatin Calcium; Severity of Illness Index; Simvastatin","Ahmadi","Mohsen","Department of Industrial Engineering, Urmia University of Technology (UUT), P.O. Box: 57166-419, Urmia, Iran",NA
"1402","34250095","10.1155/2021/9995073","Studying the Effect of Taking Statins before Infection in the Severity Reduction of COVID-19 with Machine Learning.","Statins can help COVID-19 patients' treatment because of their involvement in angiotensin-converting enzyme-2. The main objective of this study is to evaluate the impact of statins on COVID-19 severity for people who have been taking statins before COVID-19 infection. The examined research patients include people that had taken three types of statins consisting of Atorvastatin, Simvastatin, and Rosuvastatin. The case study includes 561 patients admitted to the Razi Hospital in Ghaemshahr, Iran, ","2021","07","16","Biomed Res Int","BioMed research international","Aged; Algorithms; Atorvastatin; COVID-19; Drug Prescriptions; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Iran; Machine Learning; Male; Middle Aged; Retrospective Studies; Rosuvastatin Calcium; Severity of Illness Index; Simvastatin","Sharifi","Abbas","Department of Mechanical Engineering, Urmia University of Technology (UUT), P.O. Box: 57166-419, Urmia, Iran",NA
"1403","34250095","10.1155/2021/9995073","Studying the Effect of Taking Statins before Infection in the Severity Reduction of COVID-19 with Machine Learning.","Statins can help COVID-19 patients' treatment because of their involvement in angiotensin-converting enzyme-2. The main objective of this study is to evaluate the impact of statins on COVID-19 severity for people who have been taking statins before COVID-19 infection. The examined research patients include people that had taken three types of statins consisting of Atorvastatin, Simvastatin, and Rosuvastatin. The case study includes 561 patients admitted to the Razi Hospital in Ghaemshahr, Iran, ","2021","07","16","Biomed Res Int","BioMed research international","Aged; Algorithms; Atorvastatin; COVID-19; Drug Prescriptions; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Iran; Machine Learning; Male; Middle Aged; Retrospective Studies; Rosuvastatin Calcium; Severity of Illness Index; Simvastatin","Hassantabar","Roshina","Department of Infectious Diseases, Mazandaran University of Medical Sciences, P.O. Box: 48175-866, Sari, Iran",NA
"1404","34250095","10.1155/2021/9995073","Studying the Effect of Taking Statins before Infection in the Severity Reduction of COVID-19 with Machine Learning.","Statins can help COVID-19 patients' treatment because of their involvement in angiotensin-converting enzyme-2. The main objective of this study is to evaluate the impact of statins on COVID-19 severity for people who have been taking statins before COVID-19 infection. The examined research patients include people that had taken three types of statins consisting of Atorvastatin, Simvastatin, and Rosuvastatin. The case study includes 561 patients admitted to the Razi Hospital in Ghaemshahr, Iran, ","2021","07","16","Biomed Res Int","BioMed research international","Aged; Algorithms; Atorvastatin; COVID-19; Drug Prescriptions; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Iran; Machine Learning; Male; Middle Aged; Retrospective Studies; Rosuvastatin Calcium; Severity of Illness Index; Simvastatin","Najafi","Narges","Department of Infectious Diseases, Mazandaran University of Medical Sciences, P.O. Box: 48175-866, Sari, Iran",NA
"1405","34250095","10.1155/2021/9995073","Studying the Effect of Taking Statins before Infection in the Severity Reduction of COVID-19 with Machine Learning.","Statins can help COVID-19 patients' treatment because of their involvement in angiotensin-converting enzyme-2. The main objective of this study is to evaluate the impact of statins on COVID-19 severity for people who have been taking statins before COVID-19 infection. The examined research patients include people that had taken three types of statins consisting of Atorvastatin, Simvastatin, and Rosuvastatin. The case study includes 561 patients admitted to the Razi Hospital in Ghaemshahr, Iran, ","2021","07","16","Biomed Res Int","BioMed research international","Aged; Algorithms; Atorvastatin; COVID-19; Drug Prescriptions; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Iran; Machine Learning; Male; Middle Aged; Retrospective Studies; Rosuvastatin Calcium; Severity of Illness Index; Simvastatin","Tayebi","Atefeh","Department of Infectious Diseases, Mazandaran University of Medical Sciences, P.O. Box: 48175-866, Sari, Iran",NA
"1406","34250095","10.1155/2021/9995073","Studying the Effect of Taking Statins before Infection in the Severity Reduction of COVID-19 with Machine Learning.","Statins can help COVID-19 patients' treatment because of their involvement in angiotensin-converting enzyme-2. The main objective of this study is to evaluate the impact of statins on COVID-19 severity for people who have been taking statins before COVID-19 infection. The examined research patients include people that had taken three types of statins consisting of Atorvastatin, Simvastatin, and Rosuvastatin. The case study includes 561 patients admitted to the Razi Hospital in Ghaemshahr, Iran, ","2021","07","16","Biomed Res Int","BioMed research international","Aged; Algorithms; Atorvastatin; COVID-19; Drug Prescriptions; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Iran; Machine Learning; Male; Middle Aged; Retrospective Studies; Rosuvastatin Calcium; Severity of Illness Index; Simvastatin","Kasgari","Hamideh Abbaspour","Department of Clinical Pharmacy, Mazandaran University of Medical Science, P.O. Box: 48175-866, Sari, Iran",NA
"1407","34250095","10.1155/2021/9995073","Studying the Effect of Taking Statins before Infection in the Severity Reduction of COVID-19 with Machine Learning.","Statins can help COVID-19 patients' treatment because of their involvement in angiotensin-converting enzyme-2. The main objective of this study is to evaluate the impact of statins on COVID-19 severity for people who have been taking statins before COVID-19 infection. The examined research patients include people that had taken three types of statins consisting of Atorvastatin, Simvastatin, and Rosuvastatin. The case study includes 561 patients admitted to the Razi Hospital in Ghaemshahr, Iran, ","2021","07","16","Biomed Res Int","BioMed research international","Aged; Algorithms; Atorvastatin; COVID-19; Drug Prescriptions; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Iran; Machine Learning; Male; Middle Aged; Retrospective Studies; Rosuvastatin Calcium; Severity of Illness Index; Simvastatin","Ahmadi","Fatemeh","Department of Infectious Diseases, Mazandaran University of Medical Sciences, P.O. Box: 48175-866, Sari, Iran",NA
"1408","34250095","10.1155/2021/9995073","Studying the Effect of Taking Statins before Infection in the Severity Reduction of COVID-19 with Machine Learning.","Statins can help COVID-19 patients' treatment because of their involvement in angiotensin-converting enzyme-2. The main objective of this study is to evaluate the impact of statins on COVID-19 severity for people who have been taking statins before COVID-19 infection. The examined research patients include people that had taken three types of statins consisting of Atorvastatin, Simvastatin, and Rosuvastatin. The case study includes 561 patients admitted to the Razi Hospital in Ghaemshahr, Iran, ","2021","07","16","Biomed Res Int","BioMed research international","Aged; Algorithms; Atorvastatin; COVID-19; Drug Prescriptions; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Iran; Machine Learning; Male; Middle Aged; Retrospective Studies; Rosuvastatin Calcium; Severity of Illness Index; Simvastatin","Rabiee","Marzieh","Department of Infectious Diseases, Mazandaran University of Medical Sciences, P.O. Box: 48175-866, Sari, Iran",NA
"1409","34250060","10.3389/fvets.2021.667265","Message Delivery Strategy Influences Willingness to Comply With Biosecurity.","As the Covid-19 pandemic continues worldwide, it has become increasingly clear that effective communication of disease transmission risks associated with protective behaviors is essential, and that communication tactics are not ubiquitously and homogenously understood. Analogous to Covid-19, communicable diseases in the hog industry result in millions of animal deaths and in the United States costs hundreds of millions of dollars annually. Protective behaviors such as preventative biosecurity pr","2021","07","13","Front Vet Sci","Frontiers in veterinary science","compliance; experimental game; graphical message; linguistic message; message efficacy; numeric message; risk; uncertainty","Merrill","Scott C","Department of Plant and Soil Science, University of Vermont, Burlington, VT, United States",NA
"1410","34250060","10.3389/fvets.2021.667265","Message Delivery Strategy Influences Willingness to Comply With Biosecurity.","As the Covid-19 pandemic continues worldwide, it has become increasingly clear that effective communication of disease transmission risks associated with protective behaviors is essential, and that communication tactics are not ubiquitously and homogenously understood. Analogous to Covid-19, communicable diseases in the hog industry result in millions of animal deaths and in the United States costs hundreds of millions of dollars annually. Protective behaviors such as preventative biosecurity pr","2021","07","13","Front Vet Sci","Frontiers in veterinary science","compliance; experimental game; graphical message; linguistic message; message efficacy; numeric message; risk; uncertainty","Trinity","Luke","Department of Computer Science, University of Victoria, Victoria, BC, Canada",NA
"1411","34250060","10.3389/fvets.2021.667265","Message Delivery Strategy Influences Willingness to Comply With Biosecurity.","As the Covid-19 pandemic continues worldwide, it has become increasingly clear that effective communication of disease transmission risks associated with protective behaviors is essential, and that communication tactics are not ubiquitously and homogenously understood. Analogous to Covid-19, communicable diseases in the hog industry result in millions of animal deaths and in the United States costs hundreds of millions of dollars annually. Protective behaviors such as preventative biosecurity pr","2021","07","13","Front Vet Sci","Frontiers in veterinary science","compliance; experimental game; graphical message; linguistic message; message efficacy; numeric message; risk; uncertainty","Clark","Eric M","Department of Plant and Soil Science, University of Vermont, Burlington, VT, United States",NA
"1412","34250060","10.3389/fvets.2021.667265","Message Delivery Strategy Influences Willingness to Comply With Biosecurity.","As the Covid-19 pandemic continues worldwide, it has become increasingly clear that effective communication of disease transmission risks associated with protective behaviors is essential, and that communication tactics are not ubiquitously and homogenously understood. Analogous to Covid-19, communicable diseases in the hog industry result in millions of animal deaths and in the United States costs hundreds of millions of dollars annually. Protective behaviors such as preventative biosecurity pr","2021","07","13","Front Vet Sci","Frontiers in veterinary science","compliance; experimental game; graphical message; linguistic message; message efficacy; numeric message; risk; uncertainty","Shrum","Trisha R","Department of Community Development and Applied Economics, University of Vermont, Burlington, VT, United States",NA
"1413","34250060","10.3389/fvets.2021.667265","Message Delivery Strategy Influences Willingness to Comply With Biosecurity.","As the Covid-19 pandemic continues worldwide, it has become increasingly clear that effective communication of disease transmission risks associated with protective behaviors is essential, and that communication tactics are not ubiquitously and homogenously understood. Analogous to Covid-19, communicable diseases in the hog industry result in millions of animal deaths and in the United States costs hundreds of millions of dollars annually. Protective behaviors such as preventative biosecurity pr","2021","07","13","Front Vet Sci","Frontiers in veterinary science","compliance; experimental game; graphical message; linguistic message; message efficacy; numeric message; risk; uncertainty","Koliba","Christopher J","Gund Institute for Environment, University of Vermont, Burlington, VT, United States",NA
"1414","34250060","10.3389/fvets.2021.667265","Message Delivery Strategy Influences Willingness to Comply With Biosecurity.","As the Covid-19 pandemic continues worldwide, it has become increasingly clear that effective communication of disease transmission risks associated with protective behaviors is essential, and that communication tactics are not ubiquitously and homogenously understood. Analogous to Covid-19, communicable diseases in the hog industry result in millions of animal deaths and in the United States costs hundreds of millions of dollars annually. Protective behaviors such as preventative biosecurity pr","2021","07","13","Front Vet Sci","Frontiers in veterinary science","compliance; experimental game; graphical message; linguistic message; message efficacy; numeric message; risk; uncertainty","Zia","Asim","Gund Institute for Environment, University of Vermont, Burlington, VT, United States",NA
"1415","34250060","10.3389/fvets.2021.667265","Message Delivery Strategy Influences Willingness to Comply With Biosecurity.","As the Covid-19 pandemic continues worldwide, it has become increasingly clear that effective communication of disease transmission risks associated with protective behaviors is essential, and that communication tactics are not ubiquitously and homogenously understood. Analogous to Covid-19, communicable diseases in the hog industry result in millions of animal deaths and in the United States costs hundreds of millions of dollars annually. Protective behaviors such as preventative biosecurity pr","2021","07","13","Front Vet Sci","Frontiers in veterinary science","compliance; experimental game; graphical message; linguistic message; message efficacy; numeric message; risk; uncertainty","Bucini","Gabriela","Department of Plant and Soil Science, University of Vermont, Burlington, VT, United States",NA
"1416","34250060","10.3389/fvets.2021.667265","Message Delivery Strategy Influences Willingness to Comply With Biosecurity.","As the Covid-19 pandemic continues worldwide, it has become increasingly clear that effective communication of disease transmission risks associated with protective behaviors is essential, and that communication tactics are not ubiquitously and homogenously understood. Analogous to Covid-19, communicable diseases in the hog industry result in millions of animal deaths and in the United States costs hundreds of millions of dollars annually. Protective behaviors such as preventative biosecurity pr","2021","07","13","Front Vet Sci","Frontiers in veterinary science","compliance; experimental game; graphical message; linguistic message; message efficacy; numeric message; risk; uncertainty","Sellnow","Timothy L","Nicholson School of Communication, University of Central Florida, Orlando, FL, United States",NA
"1417","34250060","10.3389/fvets.2021.667265","Message Delivery Strategy Influences Willingness to Comply With Biosecurity.","As the Covid-19 pandemic continues worldwide, it has become increasingly clear that effective communication of disease transmission risks associated with protective behaviors is essential, and that communication tactics are not ubiquitously and homogenously understood. Analogous to Covid-19, communicable diseases in the hog industry result in millions of animal deaths and in the United States costs hundreds of millions of dollars annually. Protective behaviors such as preventative biosecurity pr","2021","07","13","Front Vet Sci","Frontiers in veterinary science","compliance; experimental game; graphical message; linguistic message; message efficacy; numeric message; risk; uncertainty","Sellnow","Deanna D","Nicholson School of Communication, University of Central Florida, Orlando, FL, United States",NA
"1418","34250060","10.3389/fvets.2021.667265","Message Delivery Strategy Influences Willingness to Comply With Biosecurity.","As the Covid-19 pandemic continues worldwide, it has become increasingly clear that effective communication of disease transmission risks associated with protective behaviors is essential, and that communication tactics are not ubiquitously and homogenously understood. Analogous to Covid-19, communicable diseases in the hog industry result in millions of animal deaths and in the United States costs hundreds of millions of dollars annually. Protective behaviors such as preventative biosecurity pr","2021","07","13","Front Vet Sci","Frontiers in veterinary science","compliance; experimental game; graphical message; linguistic message; message efficacy; numeric message; risk; uncertainty","Smith","Julia M","Department of Animal and Veterinary Sciences, University of Vermont, Burlington, VT, United States",NA
"1419","34250044","10.3389/fcvm.2021.690790","B-Type Natriuretic Peptide Concentrations, COVID-19 Severity, and Mortality: A Systematic Review and Meta-Analysis With Meta-Regression.","Alterations in cardiac biomarkers have been reported in patients with coronavirus disease 2019 (COVID-19) in relation to disease severity and mortality. We conducted a systematic review and meta-analysis with meta-regression of studies reporting B-type natriuretic peptide (BNP) or N-terminal proBNP (NT-proBNP) plasma concentrations in COVID-19. We searched PubMed, Web of Science, and Scopus, between January 2020 and 2021, for studies reporting BNP/NT-proBNP concentrations, measures of COVID-19 s","2021","07","13","Front Cardiovasc Med","Frontiers in cardiovascular medicine","B-type natriuretic peptide; COVID-19; biomarkers; disease severity; mortality","Zinellu","Angelo","Department of Biomedical Sciences, University of Sassari, Sassari, Italy",NA
"1420","34250044","10.3389/fcvm.2021.690790","B-Type Natriuretic Peptide Concentrations, COVID-19 Severity, and Mortality: A Systematic Review and Meta-Analysis With Meta-Regression.","Alterations in cardiac biomarkers have been reported in patients with coronavirus disease 2019 (COVID-19) in relation to disease severity and mortality. We conducted a systematic review and meta-analysis with meta-regression of studies reporting B-type natriuretic peptide (BNP) or N-terminal proBNP (NT-proBNP) plasma concentrations in COVID-19. We searched PubMed, Web of Science, and Scopus, between January 2020 and 2021, for studies reporting BNP/NT-proBNP concentrations, measures of COVID-19 s","2021","07","13","Front Cardiovasc Med","Frontiers in cardiovascular medicine","B-type natriuretic peptide; COVID-19; biomarkers; disease severity; mortality","Sotgia","Salvatore","Department of Biomedical Sciences, University of Sassari, Sassari, Italy",NA
"1421","34250044","10.3389/fcvm.2021.690790","B-Type Natriuretic Peptide Concentrations, COVID-19 Severity, and Mortality: A Systematic Review and Meta-Analysis With Meta-Regression.","Alterations in cardiac biomarkers have been reported in patients with coronavirus disease 2019 (COVID-19) in relation to disease severity and mortality. We conducted a systematic review and meta-analysis with meta-regression of studies reporting B-type natriuretic peptide (BNP) or N-terminal proBNP (NT-proBNP) plasma concentrations in COVID-19. We searched PubMed, Web of Science, and Scopus, between January 2020 and 2021, for studies reporting BNP/NT-proBNP concentrations, measures of COVID-19 s","2021","07","13","Front Cardiovasc Med","Frontiers in cardiovascular medicine","B-type natriuretic peptide; COVID-19; biomarkers; disease severity; mortality","Carru","Ciriaco","Department of Biomedical Sciences, University of Sassari, Sassari, Italy",NA
"1422","34250044","10.3389/fcvm.2021.690790","B-Type Natriuretic Peptide Concentrations, COVID-19 Severity, and Mortality: A Systematic Review and Meta-Analysis With Meta-Regression.","Alterations in cardiac biomarkers have been reported in patients with coronavirus disease 2019 (COVID-19) in relation to disease severity and mortality. We conducted a systematic review and meta-analysis with meta-regression of studies reporting B-type natriuretic peptide (BNP) or N-terminal proBNP (NT-proBNP) plasma concentrations in COVID-19. We searched PubMed, Web of Science, and Scopus, between January 2020 and 2021, for studies reporting BNP/NT-proBNP concentrations, measures of COVID-19 s","2021","07","13","Front Cardiovasc Med","Frontiers in cardiovascular medicine","B-type natriuretic peptide; COVID-19; biomarkers; disease severity; mortality","Mangoni","Arduino A","Discipline of Clinical Pharmacology, College of Medicine and Public Health, Flinders University, Adelaide, SA, Australia",NA
"1423","34250025","10.3389/frobt.2021.612964","Telerobotic Operation of Intensive Care Unit Ventilators.","Since the first reports of a novel coronavirus (SARS-CoV-2) in December 2019, over 33 million people have been infected worldwide and approximately 1 million people worldwide have died from the disease caused by this virus, COVID-19. In the United States alone, there have been approximately 7 million cases and over 200,000 deaths. This outbreak has placed an enormous strain on healthcare systems and workers. Severe cases require hospital care, and 8.5% of patients require mechanical ventilation ","2021","07","13","Front Robot AI","Frontiers in robotics and AI","coronavirus (2019-nCoV); intensive care unit; personal protective equipment; robotics; telerobotics and teleoperation; touch screen; ventilator; visual servoing","Vagvolgyi","Balazs P","Laboratory for Computational Sensing and Robotics, Whiting School of Engineering, Johns Hopkins University, Baltimore, MD, United States",NA
"1424","34250025","10.3389/frobt.2021.612964","Telerobotic Operation of Intensive Care Unit Ventilators.","Since the first reports of a novel coronavirus (SARS-CoV-2) in December 2019, over 33 million people have been infected worldwide and approximately 1 million people worldwide have died from the disease caused by this virus, COVID-19. In the United States alone, there have been approximately 7 million cases and over 200,000 deaths. This outbreak has placed an enormous strain on healthcare systems and workers. Severe cases require hospital care, and 8.5% of patients require mechanical ventilation ","2021","07","13","Front Robot AI","Frontiers in robotics and AI","coronavirus (2019-nCoV); intensive care unit; personal protective equipment; robotics; telerobotics and teleoperation; touch screen; ventilator; visual servoing","Khrenov","Mikhail","Department of Mechanical Engineering, A. James Clark School of Engineering, University of Maryland, College Park, MD, United States",NA
"1425","34250025","10.3389/frobt.2021.612964","Telerobotic Operation of Intensive Care Unit Ventilators.","Since the first reports of a novel coronavirus (SARS-CoV-2) in December 2019, over 33 million people have been infected worldwide and approximately 1 million people worldwide have died from the disease caused by this virus, COVID-19. In the United States alone, there have been approximately 7 million cases and over 200,000 deaths. This outbreak has placed an enormous strain on healthcare systems and workers. Severe cases require hospital care, and 8.5% of patients require mechanical ventilation ","2021","07","13","Front Robot AI","Frontiers in robotics and AI","coronavirus (2019-nCoV); intensive care unit; personal protective equipment; robotics; telerobotics and teleoperation; touch screen; ventilator; visual servoing","Cope","Jonathan","Anaesthesia and Critical Care Medicine, Johns Hopkins Hospital, Baltimore, MD, United States",NA
"1426","34250025","10.3389/frobt.2021.612964","Telerobotic Operation of Intensive Care Unit Ventilators.","Since the first reports of a novel coronavirus (SARS-CoV-2) in December 2019, over 33 million people have been infected worldwide and approximately 1 million people worldwide have died from the disease caused by this virus, COVID-19. In the United States alone, there have been approximately 7 million cases and over 200,000 deaths. This outbreak has placed an enormous strain on healthcare systems and workers. Severe cases require hospital care, and 8.5% of patients require mechanical ventilation ","2021","07","13","Front Robot AI","Frontiers in robotics and AI","coronavirus (2019-nCoV); intensive care unit; personal protective equipment; robotics; telerobotics and teleoperation; touch screen; ventilator; visual servoing","Deguet","Anton","Laboratory for Computational Sensing and Robotics, Whiting School of Engineering, Johns Hopkins University, Baltimore, MD, United States",NA
"1427","34250025","10.3389/frobt.2021.612964","Telerobotic Operation of Intensive Care Unit Ventilators.","Since the first reports of a novel coronavirus (SARS-CoV-2) in December 2019, over 33 million people have been infected worldwide and approximately 1 million people worldwide have died from the disease caused by this virus, COVID-19. In the United States alone, there have been approximately 7 million cases and over 200,000 deaths. This outbreak has placed an enormous strain on healthcare systems and workers. Severe cases require hospital care, and 8.5% of patients require mechanical ventilation ","2021","07","13","Front Robot AI","Frontiers in robotics and AI","coronavirus (2019-nCoV); intensive care unit; personal protective equipment; robotics; telerobotics and teleoperation; touch screen; ventilator; visual servoing","Kazanzides","Peter","Laboratory for Computational Sensing and Robotics, Whiting School of Engineering, Johns Hopkins University, Baltimore, MD, United States",NA
"1428","34250025","10.3389/frobt.2021.612964","Telerobotic Operation of Intensive Care Unit Ventilators.","Since the first reports of a novel coronavirus (SARS-CoV-2) in December 2019, over 33 million people have been infected worldwide and approximately 1 million people worldwide have died from the disease caused by this virus, COVID-19. In the United States alone, there have been approximately 7 million cases and over 200,000 deaths. This outbreak has placed an enormous strain on healthcare systems and workers. Severe cases require hospital care, and 8.5% of patients require mechanical ventilation ","2021","07","13","Front Robot AI","Frontiers in robotics and AI","coronavirus (2019-nCoV); intensive care unit; personal protective equipment; robotics; telerobotics and teleoperation; touch screen; ventilator; visual servoing","Manzoor","Sajid","Anaesthesia and Critical Care Medicine, Johns Hopkins Hospital, Baltimore, MD, United States",NA
"1429","34250025","10.3389/frobt.2021.612964","Telerobotic Operation of Intensive Care Unit Ventilators.","Since the first reports of a novel coronavirus (SARS-CoV-2) in December 2019, over 33 million people have been infected worldwide and approximately 1 million people worldwide have died from the disease caused by this virus, COVID-19. In the United States alone, there have been approximately 7 million cases and over 200,000 deaths. This outbreak has placed an enormous strain on healthcare systems and workers. Severe cases require hospital care, and 8.5% of patients require mechanical ventilation ","2021","07","13","Front Robot AI","Frontiers in robotics and AI","coronavirus (2019-nCoV); intensive care unit; personal protective equipment; robotics; telerobotics and teleoperation; touch screen; ventilator; visual servoing","Taylor","Russell H","Laboratory for Computational Sensing and Robotics, Whiting School of Engineering, Johns Hopkins University, Baltimore, MD, United States",NA
"1430","34250025","10.3389/frobt.2021.612964","Telerobotic Operation of Intensive Care Unit Ventilators.","Since the first reports of a novel coronavirus (SARS-CoV-2) in December 2019, over 33 million people have been infected worldwide and approximately 1 million people worldwide have died from the disease caused by this virus, COVID-19. In the United States alone, there have been approximately 7 million cases and over 200,000 deaths. This outbreak has placed an enormous strain on healthcare systems and workers. Severe cases require hospital care, and 8.5% of patients require mechanical ventilation ","2021","07","13","Front Robot AI","Frontiers in robotics and AI","coronavirus (2019-nCoV); intensive care unit; personal protective equipment; robotics; telerobotics and teleoperation; touch screen; ventilator; visual servoing","Krieger","Axel","Laboratory for Computational Sensing and Robotics, Whiting School of Engineering, Johns Hopkins University, Baltimore, MD, United States",NA
"1431","34250010","10.3389/fsurg.2021.695341","Standardization of Procedures to Contain Cost and Reduce Variability of Care After the Pandemic.","The coronavirus disease 2019 (COVID-19) pandemic has changed many aspects of our private and professional routine. In particular, the lockdowns have severely affected the entire healthcare system and hospital activities, forcing it to rethink the protocols in force. We suggest that this scenario, in spite of the new challenges involving so far complex healthcare providers, may lead to the unique opportunity to rethink pathways and management of patients. Indeed, having to resume institutional ac","2021","07","13","Front Surg","Frontiers in surgery","lean; lean six sigma; lobectomy (lung); pandemic (COVID-19); sigma six; thoracic surgery","Raveglia","Federico","Thoracic Surgery, San Gerardo Hospital, Azienda Socio Sanitaria Territoriale (ASST)-Monza, Monza, Italy",NA
"1432","34250010","10.3389/fsurg.2021.695341","Standardization of Procedures to Contain Cost and Reduce Variability of Care After the Pandemic.","The coronavirus disease 2019 (COVID-19) pandemic has changed many aspects of our private and professional routine. In particular, the lockdowns have severely affected the entire healthcare system and hospital activities, forcing it to rethink the protocols in force. We suggest that this scenario, in spite of the new challenges involving so far complex healthcare providers, may lead to the unique opportunity to rethink pathways and management of patients. Indeed, having to resume institutional ac","2021","07","13","Front Surg","Frontiers in surgery","lean; lean six sigma; lobectomy (lung); pandemic (COVID-19); sigma six; thoracic surgery","Orlandi","Riccardo","Thoracic Surgery, San Gerardo Hospital, Azienda Socio Sanitaria Territoriale (ASST)-Monza, Monza, Italy",NA
"1433","34250010","10.3389/fsurg.2021.695341","Standardization of Procedures to Contain Cost and Reduce Variability of Care After the Pandemic.","The coronavirus disease 2019 (COVID-19) pandemic has changed many aspects of our private and professional routine. In particular, the lockdowns have severely affected the entire healthcare system and hospital activities, forcing it to rethink the protocols in force. We suggest that this scenario, in spite of the new challenges involving so far complex healthcare providers, may lead to the unique opportunity to rethink pathways and management of patients. Indeed, having to resume institutional ac","2021","07","13","Front Surg","Frontiers in surgery","lean; lean six sigma; lobectomy (lung); pandemic (COVID-19); sigma six; thoracic surgery","Rimessi","Arianna","Thoracic Surgery, San Gerardo Hospital, Azienda Socio Sanitaria Territoriale (ASST)-Monza, Monza, Italy",NA
"1434","34250010","10.3389/fsurg.2021.695341","Standardization of Procedures to Contain Cost and Reduce Variability of Care After the Pandemic.","The coronavirus disease 2019 (COVID-19) pandemic has changed many aspects of our private and professional routine. In particular, the lockdowns have severely affected the entire healthcare system and hospital activities, forcing it to rethink the protocols in force. We suggest that this scenario, in spite of the new challenges involving so far complex healthcare providers, may lead to the unique opportunity to rethink pathways and management of patients. Indeed, having to resume institutional ac","2021","07","13","Front Surg","Frontiers in surgery","lean; lean six sigma; lobectomy (lung); pandemic (COVID-19); sigma six; thoracic surgery","Minervini","Fabrizio","Thoracic Surgery, Lucerne Cantonal Hospital, University of Lucerne, Lucerne, Switzerland",NA
"1435","34250010","10.3389/fsurg.2021.695341","Standardization of Procedures to Contain Cost and Reduce Variability of Care After the Pandemic.","The coronavirus disease 2019 (COVID-19) pandemic has changed many aspects of our private and professional routine. In particular, the lockdowns have severely affected the entire healthcare system and hospital activities, forcing it to rethink the protocols in force. We suggest that this scenario, in spite of the new challenges involving so far complex healthcare providers, may lead to the unique opportunity to rethink pathways and management of patients. Indeed, having to resume institutional ac","2021","07","13","Front Surg","Frontiers in surgery","lean; lean six sigma; lobectomy (lung); pandemic (COVID-19); sigma six; thoracic surgery","Cioffi","Ugo","Department of Surgery, University of Milan, Milan, Italy",NA
"1436","34250010","10.3389/fsurg.2021.695341","Standardization of Procedures to Contain Cost and Reduce Variability of Care After the Pandemic.","The coronavirus disease 2019 (COVID-19) pandemic has changed many aspects of our private and professional routine. In particular, the lockdowns have severely affected the entire healthcare system and hospital activities, forcing it to rethink the protocols in force. We suggest that this scenario, in spite of the new challenges involving so far complex healthcare providers, may lead to the unique opportunity to rethink pathways and management of patients. Indeed, having to resume institutional ac","2021","07","13","Front Surg","Frontiers in surgery","lean; lean six sigma; lobectomy (lung); pandemic (COVID-19); sigma six; thoracic surgery","De Simone","Matilde","Department of Surgery, University of Milan, Milan, Italy",NA
"1437","34250010","10.3389/fsurg.2021.695341","Standardization of Procedures to Contain Cost and Reduce Variability of Care After the Pandemic.","The coronavirus disease 2019 (COVID-19) pandemic has changed many aspects of our private and professional routine. In particular, the lockdowns have severely affected the entire healthcare system and hospital activities, forcing it to rethink the protocols in force. We suggest that this scenario, in spite of the new challenges involving so far complex healthcare providers, may lead to the unique opportunity to rethink pathways and management of patients. Indeed, having to resume institutional ac","2021","07","13","Front Surg","Frontiers in surgery","lean; lean six sigma; lobectomy (lung); pandemic (COVID-19); sigma six; thoracic surgery","Guttadauro","Angelo","Department of Surgery, Istituti Clinici Zucchi, University of Milan Bicocca, Monza, Italy",NA
"1438","34250010","10.3389/fsurg.2021.695341","Standardization of Procedures to Contain Cost and Reduce Variability of Care After the Pandemic.","The coronavirus disease 2019 (COVID-19) pandemic has changed many aspects of our private and professional routine. In particular, the lockdowns have severely affected the entire healthcare system and hospital activities, forcing it to rethink the protocols in force. We suggest that this scenario, in spite of the new challenges involving so far complex healthcare providers, may lead to the unique opportunity to rethink pathways and management of patients. Indeed, having to resume institutional ac","2021","07","13","Front Surg","Frontiers in surgery","lean; lean six sigma; lobectomy (lung); pandemic (COVID-19); sigma six; thoracic surgery","Scarci","Marco","Thoracic Surgery, San Gerardo Hospital, Azienda Socio Sanitaria Territoriale (ASST)-Monza, Monza, Italy",NA
"1439","34249999","10.3389/fnut.2021.697225","Promoting Sustainable and Healthy Diets to Mitigate Food Insecurity Amidst Economic and Health Crises in Lebanon.","Introduction: Lebanon, a middle-income Eastern Mediterranean country, continues to face detrimental economic, health and socio-political challenges that are further exacerbated by the COVID-19 pandemic. In parallel, the country has been experiencing a remarkable nutrition transition that has contributed to the burden of malnutrition and non-communicable diseases, all imposing serious repercussions on people's livelihoods, food security, and health. Such circumstances have prodded public d","2021","07","13","Front Nutr","Frontiers in nutrition","Lebanon; food consumption; food security; healthy diet; quadratic optimization; sustainable diet","Hwalla","Nahla","Nutrition and Food Sciences Department, Faculty of Agriculture and Food Sciences, American University of Beirut, Beirut, Lebanon",NA
"1440","34249999","10.3389/fnut.2021.697225","Promoting Sustainable and Healthy Diets to Mitigate Food Insecurity Amidst Economic and Health Crises in Lebanon.","Introduction: Lebanon, a middle-income Eastern Mediterranean country, continues to face detrimental economic, health and socio-political challenges that are further exacerbated by the COVID-19 pandemic. In parallel, the country has been experiencing a remarkable nutrition transition that has contributed to the burden of malnutrition and non-communicable diseases, all imposing serious repercussions on people's livelihoods, food security, and health. Such circumstances have prodded public d","2021","07","13","Front Nutr","Frontiers in nutrition","Lebanon; food consumption; food security; healthy diet; quadratic optimization; sustainable diet","Jomaa","Lamis","Nutrition and Food Sciences Department, Faculty of Agriculture and Food Sciences, American University of Beirut, Beirut, Lebanon",NA
"1441","34249999","10.3389/fnut.2021.697225","Promoting Sustainable and Healthy Diets to Mitigate Food Insecurity Amidst Economic and Health Crises in Lebanon.","Introduction: Lebanon, a middle-income Eastern Mediterranean country, continues to face detrimental economic, health and socio-political challenges that are further exacerbated by the COVID-19 pandemic. In parallel, the country has been experiencing a remarkable nutrition transition that has contributed to the burden of malnutrition and non-communicable diseases, all imposing serious repercussions on people's livelihoods, food security, and health. Such circumstances have prodded public d","2021","07","13","Front Nutr","Frontiers in nutrition","Lebanon; food consumption; food security; healthy diet; quadratic optimization; sustainable diet","Hachem","Fatima","Nutrition and Food Systems Division, Food and Agricultural Organization of the United Nations, Rome, Italy",NA
"1442","34249999","10.3389/fnut.2021.697225","Promoting Sustainable and Healthy Diets to Mitigate Food Insecurity Amidst Economic and Health Crises in Lebanon.","Introduction: Lebanon, a middle-income Eastern Mediterranean country, continues to face detrimental economic, health and socio-political challenges that are further exacerbated by the COVID-19 pandemic. In parallel, the country has been experiencing a remarkable nutrition transition that has contributed to the burden of malnutrition and non-communicable diseases, all imposing serious repercussions on people's livelihoods, food security, and health. Such circumstances have prodded public d","2021","07","13","Front Nutr","Frontiers in nutrition","Lebanon; food consumption; food security; healthy diet; quadratic optimization; sustainable diet","Kharroubi","Samer","Nutrition and Food Sciences Department, Faculty of Agriculture and Food Sciences, American University of Beirut, Beirut, Lebanon",NA
"1443","34249999","10.3389/fnut.2021.697225","Promoting Sustainable and Healthy Diets to Mitigate Food Insecurity Amidst Economic and Health Crises in Lebanon.","Introduction: Lebanon, a middle-income Eastern Mediterranean country, continues to face detrimental economic, health and socio-political challenges that are further exacerbated by the COVID-19 pandemic. In parallel, the country has been experiencing a remarkable nutrition transition that has contributed to the burden of malnutrition and non-communicable diseases, all imposing serious repercussions on people's livelihoods, food security, and health. Such circumstances have prodded public d","2021","07","13","Front Nutr","Frontiers in nutrition","Lebanon; food consumption; food security; healthy diet; quadratic optimization; sustainable diet","Hamadeh","Rena","Nutrition and Food Sciences Department, Faculty of Agriculture and Food Sciences, American University of Beirut, Beirut, Lebanon",NA
"1444","34249999","10.3389/fnut.2021.697225","Promoting Sustainable and Healthy Diets to Mitigate Food Insecurity Amidst Economic and Health Crises in Lebanon.","Introduction: Lebanon, a middle-income Eastern Mediterranean country, continues to face detrimental economic, health and socio-political challenges that are further exacerbated by the COVID-19 pandemic. In parallel, the country has been experiencing a remarkable nutrition transition that has contributed to the burden of malnutrition and non-communicable diseases, all imposing serious repercussions on people's livelihoods, food security, and health. Such circumstances have prodded public d","2021","07","13","Front Nutr","Frontiers in nutrition","Lebanon; food consumption; food security; healthy diet; quadratic optimization; sustainable diet","Nasreddine","Lara","Nutrition and Food Sciences Department, Faculty of Agriculture and Food Sciences, American University of Beirut, Beirut, Lebanon",NA
"1445","34249999","10.3389/fnut.2021.697225","Promoting Sustainable and Healthy Diets to Mitigate Food Insecurity Amidst Economic and Health Crises in Lebanon.","Introduction: Lebanon, a middle-income Eastern Mediterranean country, continues to face detrimental economic, health and socio-political challenges that are further exacerbated by the COVID-19 pandemic. In parallel, the country has been experiencing a remarkable nutrition transition that has contributed to the burden of malnutrition and non-communicable diseases, all imposing serious repercussions on people's livelihoods, food security, and health. Such circumstances have prodded public d","2021","07","13","Front Nutr","Frontiers in nutrition","Lebanon; food consumption; food security; healthy diet; quadratic optimization; sustainable diet","Naja","Farah","Department of Clinical Nutrition and Dietetics, College of Health Sciences, Research Institute of Medical &amp",NA
"1446","34249979","10.3389/fmed.2021.689994","Sero-Prevalence and Sero-Incidence of Antibodies to SARS-CoV-2 in Health Care Workers in Israel, Prior to Mass COVID-19 Vaccination.","Objectives: This study aims to examine the prevalence and risk factors of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sero-positivity in health care workers (HCWs), a main risk group, and assess the sero-incidence of SARS-CoV-2 infection between the first and second waves of coronavirus disease 2019 (COVID-19) in Israel. Methods: A longitudinal study was conducted among 874 HCWs from nine hospitals. Demographics, health information, and blood samples were obtained ","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","SARS-CoV-2; health care workers; longitudinal study; nucleocapsid antigen; occupational risk; risk factors; sero-epidemiology","Muhsen","Khitam","Department of Epidemiology and Preventive Medicine, School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel",NA
"1447","34249979","10.3389/fmed.2021.689994","Sero-Prevalence and Sero-Incidence of Antibodies to SARS-CoV-2 in Health Care Workers in Israel, Prior to Mass COVID-19 Vaccination.","Objectives: This study aims to examine the prevalence and risk factors of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sero-positivity in health care workers (HCWs), a main risk group, and assess the sero-incidence of SARS-CoV-2 infection between the first and second waves of coronavirus disease 2019 (COVID-19) in Israel. Methods: A longitudinal study was conducted among 874 HCWs from nine hospitals. Demographics, health information, and blood samples were obtained ","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","SARS-CoV-2; health care workers; longitudinal study; nucleocapsid antigen; occupational risk; risk factors; sero-epidemiology","Schwaber","Mitchell J","National Institute for Antibiotic Resistance and Infection Control, Israel Ministry of Health, Tel Aviv, Israel",NA
"1448","34249979","10.3389/fmed.2021.689994","Sero-Prevalence and Sero-Incidence of Antibodies to SARS-CoV-2 in Health Care Workers in Israel, Prior to Mass COVID-19 Vaccination.","Objectives: This study aims to examine the prevalence and risk factors of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sero-positivity in health care workers (HCWs), a main risk group, and assess the sero-incidence of SARS-CoV-2 infection between the first and second waves of coronavirus disease 2019 (COVID-19) in Israel. Methods: A longitudinal study was conducted among 874 HCWs from nine hospitals. Demographics, health information, and blood samples were obtained ","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","SARS-CoV-2; health care workers; longitudinal study; nucleocapsid antigen; occupational risk; risk factors; sero-epidemiology","Bishara","Jihad","Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel",NA
"1449","34249979","10.3389/fmed.2021.689994","Sero-Prevalence and Sero-Incidence of Antibodies to SARS-CoV-2 in Health Care Workers in Israel, Prior to Mass COVID-19 Vaccination.","Objectives: This study aims to examine the prevalence and risk factors of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sero-positivity in health care workers (HCWs), a main risk group, and assess the sero-incidence of SARS-CoV-2 infection between the first and second waves of coronavirus disease 2019 (COVID-19) in Israel. Methods: A longitudinal study was conducted among 874 HCWs from nine hospitals. Demographics, health information, and blood samples were obtained ","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","SARS-CoV-2; health care workers; longitudinal study; nucleocapsid antigen; occupational risk; risk factors; sero-epidemiology","Kassem","Eias","Department of Pediatrics, Hillel Yaffe Medical Centre, Hadera, Israel",NA
"1450","34249979","10.3389/fmed.2021.689994","Sero-Prevalence and Sero-Incidence of Antibodies to SARS-CoV-2 in Health Care Workers in Israel, Prior to Mass COVID-19 Vaccination.","Objectives: This study aims to examine the prevalence and risk factors of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sero-positivity in health care workers (HCWs), a main risk group, and assess the sero-incidence of SARS-CoV-2 infection between the first and second waves of coronavirus disease 2019 (COVID-19) in Israel. Methods: A longitudinal study was conducted among 874 HCWs from nine hospitals. Demographics, health information, and blood samples were obtained ","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","SARS-CoV-2; health care workers; longitudinal study; nucleocapsid antigen; occupational risk; risk factors; sero-epidemiology","Atamna","Alaa","Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel",NA
"1451","34249979","10.3389/fmed.2021.689994","Sero-Prevalence and Sero-Incidence of Antibodies to SARS-CoV-2 in Health Care Workers in Israel, Prior to Mass COVID-19 Vaccination.","Objectives: This study aims to examine the prevalence and risk factors of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sero-positivity in health care workers (HCWs), a main risk group, and assess the sero-incidence of SARS-CoV-2 infection between the first and second waves of coronavirus disease 2019 (COVID-19) in Israel. Methods: A longitudinal study was conducted among 874 HCWs from nine hospitals. Demographics, health information, and blood samples were obtained ","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","SARS-CoV-2; health care workers; longitudinal study; nucleocapsid antigen; occupational risk; risk factors; sero-epidemiology","Na'amnih","Wasef","Department of Epidemiology and Preventive Medicine, School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel",NA
"1452","34249979","10.3389/fmed.2021.689994","Sero-Prevalence and Sero-Incidence of Antibodies to SARS-CoV-2 in Health Care Workers in Israel, Prior to Mass COVID-19 Vaccination.","Objectives: This study aims to examine the prevalence and risk factors of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sero-positivity in health care workers (HCWs), a main risk group, and assess the sero-incidence of SARS-CoV-2 infection between the first and second waves of coronavirus disease 2019 (COVID-19) in Israel. Methods: A longitudinal study was conducted among 874 HCWs from nine hospitals. Demographics, health information, and blood samples were obtained ","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","SARS-CoV-2; health care workers; longitudinal study; nucleocapsid antigen; occupational risk; risk factors; sero-epidemiology","Goren","Sophy","Department of Epidemiology and Preventive Medicine, School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel",NA
"1453","34249979","10.3389/fmed.2021.689994","Sero-Prevalence and Sero-Incidence of Antibodies to SARS-CoV-2 in Health Care Workers in Israel, Prior to Mass COVID-19 Vaccination.","Objectives: This study aims to examine the prevalence and risk factors of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sero-positivity in health care workers (HCWs), a main risk group, and assess the sero-incidence of SARS-CoV-2 infection between the first and second waves of coronavirus disease 2019 (COVID-19) in Israel. Methods: A longitudinal study was conducted among 874 HCWs from nine hospitals. Demographics, health information, and blood samples were obtained ","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","SARS-CoV-2; health care workers; longitudinal study; nucleocapsid antigen; occupational risk; risk factors; sero-epidemiology","Bialik","Anya","Department of Epidemiology and Preventive Medicine, School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel",NA
"1454","34249979","10.3389/fmed.2021.689994","Sero-Prevalence and Sero-Incidence of Antibodies to SARS-CoV-2 in Health Care Workers in Israel, Prior to Mass COVID-19 Vaccination.","Objectives: This study aims to examine the prevalence and risk factors of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sero-positivity in health care workers (HCWs), a main risk group, and assess the sero-incidence of SARS-CoV-2 infection between the first and second waves of coronavirus disease 2019 (COVID-19) in Israel. Methods: A longitudinal study was conducted among 874 HCWs from nine hospitals. Demographics, health information, and blood samples were obtained ","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","SARS-CoV-2; health care workers; longitudinal study; nucleocapsid antigen; occupational risk; risk factors; sero-epidemiology","Mohsen","Jameel","Department of Cardiology, Hillel Yaffe Medical Centre, Hadera, Israel",NA
"1455","34249979","10.3389/fmed.2021.689994","Sero-Prevalence and Sero-Incidence of Antibodies to SARS-CoV-2 in Health Care Workers in Israel, Prior to Mass COVID-19 Vaccination.","Objectives: This study aims to examine the prevalence and risk factors of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sero-positivity in health care workers (HCWs), a main risk group, and assess the sero-incidence of SARS-CoV-2 infection between the first and second waves of coronavirus disease 2019 (COVID-19) in Israel. Methods: A longitudinal study was conducted among 874 HCWs from nine hospitals. Demographics, health information, and blood samples were obtained ","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","SARS-CoV-2; health care workers; longitudinal study; nucleocapsid antigen; occupational risk; risk factors; sero-epidemiology","Zaide","Yona","American Medical Laboratories, Herzlya, Israel",NA
"1456","34249979","10.3389/fmed.2021.689994","Sero-Prevalence and Sero-Incidence of Antibodies to SARS-CoV-2 in Health Care Workers in Israel, Prior to Mass COVID-19 Vaccination.","Objectives: This study aims to examine the prevalence and risk factors of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sero-positivity in health care workers (HCWs), a main risk group, and assess the sero-incidence of SARS-CoV-2 infection between the first and second waves of coronavirus disease 2019 (COVID-19) in Israel. Methods: A longitudinal study was conducted among 874 HCWs from nine hospitals. Demographics, health information, and blood samples were obtained ","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","SARS-CoV-2; health care workers; longitudinal study; nucleocapsid antigen; occupational risk; risk factors; sero-epidemiology","Hazan","Nimrod","American Medical Laboratories, Herzlya, Israel",NA
"1457","34249979","10.3389/fmed.2021.689994","Sero-Prevalence and Sero-Incidence of Antibodies to SARS-CoV-2 in Health Care Workers in Israel, Prior to Mass COVID-19 Vaccination.","Objectives: This study aims to examine the prevalence and risk factors of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sero-positivity in health care workers (HCWs), a main risk group, and assess the sero-incidence of SARS-CoV-2 infection between the first and second waves of coronavirus disease 2019 (COVID-19) in Israel. Methods: A longitudinal study was conducted among 874 HCWs from nine hospitals. Demographics, health information, and blood samples were obtained ","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","SARS-CoV-2; health care workers; longitudinal study; nucleocapsid antigen; occupational risk; risk factors; sero-epidemiology","Ariel-Cohen","Ortal","Department of Epidemiology and Preventive Medicine, School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel",NA
"1458","34249979","10.3389/fmed.2021.689994","Sero-Prevalence and Sero-Incidence of Antibodies to SARS-CoV-2 in Health Care Workers in Israel, Prior to Mass COVID-19 Vaccination.","Objectives: This study aims to examine the prevalence and risk factors of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sero-positivity in health care workers (HCWs), a main risk group, and assess the sero-incidence of SARS-CoV-2 infection between the first and second waves of coronavirus disease 2019 (COVID-19) in Israel. Methods: A longitudinal study was conducted among 874 HCWs from nine hospitals. Demographics, health information, and blood samples were obtained ","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","SARS-CoV-2; health care workers; longitudinal study; nucleocapsid antigen; occupational risk; risk factors; sero-epidemiology","Cohen","Regev","Infection Control Unit, Sanz Medical Centre, Netanya, Israel",NA
"1459","34249979","10.3389/fmed.2021.689994","Sero-Prevalence and Sero-Incidence of Antibodies to SARS-CoV-2 in Health Care Workers in Israel, Prior to Mass COVID-19 Vaccination.","Objectives: This study aims to examine the prevalence and risk factors of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sero-positivity in health care workers (HCWs), a main risk group, and assess the sero-incidence of SARS-CoV-2 infection between the first and second waves of coronavirus disease 2019 (COVID-19) in Israel. Methods: A longitudinal study was conducted among 874 HCWs from nine hospitals. Demographics, health information, and blood samples were obtained ","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","SARS-CoV-2; health care workers; longitudinal study; nucleocapsid antigen; occupational risk; risk factors; sero-epidemiology","Shitrit","Pnina","Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel",NA
"1460","34249979","10.3389/fmed.2021.689994","Sero-Prevalence and Sero-Incidence of Antibodies to SARS-CoV-2 in Health Care Workers in Israel, Prior to Mass COVID-19 Vaccination.","Objectives: This study aims to examine the prevalence and risk factors of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sero-positivity in health care workers (HCWs), a main risk group, and assess the sero-incidence of SARS-CoV-2 infection between the first and second waves of coronavirus disease 2019 (COVID-19) in Israel. Methods: A longitudinal study was conducted among 874 HCWs from nine hospitals. Demographics, health information, and blood samples were obtained ","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","SARS-CoV-2; health care workers; longitudinal study; nucleocapsid antigen; occupational risk; risk factors; sero-epidemiology","Marchaim","Dror","Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel",NA
"1461","34249979","10.3389/fmed.2021.689994","Sero-Prevalence and Sero-Incidence of Antibodies to SARS-CoV-2 in Health Care Workers in Israel, Prior to Mass COVID-19 Vaccination.","Objectives: This study aims to examine the prevalence and risk factors of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sero-positivity in health care workers (HCWs), a main risk group, and assess the sero-incidence of SARS-CoV-2 infection between the first and second waves of coronavirus disease 2019 (COVID-19) in Israel. Methods: A longitudinal study was conducted among 874 HCWs from nine hospitals. Demographics, health information, and blood samples were obtained ","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","SARS-CoV-2; health care workers; longitudinal study; nucleocapsid antigen; occupational risk; risk factors; sero-epidemiology","Benenson","Shmuel","Department of Clinical Microbiology and Infectious Diseases, Hadassah Hebrew University Medical Centre, Jerusalem, Israel",NA
"1462","34249979","10.3389/fmed.2021.689994","Sero-Prevalence and Sero-Incidence of Antibodies to SARS-CoV-2 in Health Care Workers in Israel, Prior to Mass COVID-19 Vaccination.","Objectives: This study aims to examine the prevalence and risk factors of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sero-positivity in health care workers (HCWs), a main risk group, and assess the sero-incidence of SARS-CoV-2 infection between the first and second waves of coronavirus disease 2019 (COVID-19) in Israel. Methods: A longitudinal study was conducted among 874 HCWs from nine hospitals. Demographics, health information, and blood samples were obtained ","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","SARS-CoV-2; health care workers; longitudinal study; nucleocapsid antigen; occupational risk; risk factors; sero-epidemiology","Ben-David","Debby","Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel",NA
"1463","34249979","10.3389/fmed.2021.689994","Sero-Prevalence and Sero-Incidence of Antibodies to SARS-CoV-2 in Health Care Workers in Israel, Prior to Mass COVID-19 Vaccination.","Objectives: This study aims to examine the prevalence and risk factors of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sero-positivity in health care workers (HCWs), a main risk group, and assess the sero-incidence of SARS-CoV-2 infection between the first and second waves of coronavirus disease 2019 (COVID-19) in Israel. Methods: A longitudinal study was conducted among 874 HCWs from nine hospitals. Demographics, health information, and blood samples were obtained ","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","SARS-CoV-2; health care workers; longitudinal study; nucleocapsid antigen; occupational risk; risk factors; sero-epidemiology","Rubinovitch","Bina","Infection Control Unit, Beilinson Hospital, Rabin Medical Centre, Petah-Tiqva, Israel",NA
"1464","34249979","10.3389/fmed.2021.689994","Sero-Prevalence and Sero-Incidence of Antibodies to SARS-CoV-2 in Health Care Workers in Israel, Prior to Mass COVID-19 Vaccination.","Objectives: This study aims to examine the prevalence and risk factors of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sero-positivity in health care workers (HCWs), a main risk group, and assess the sero-incidence of SARS-CoV-2 infection between the first and second waves of coronavirus disease 2019 (COVID-19) in Israel. Methods: A longitudinal study was conducted among 874 HCWs from nine hospitals. Demographics, health information, and blood samples were obtained ","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","SARS-CoV-2; health care workers; longitudinal study; nucleocapsid antigen; occupational risk; risk factors; sero-epidemiology","Gotessman","Tamar","Infectious Disease and Infection Control Service, Hasharon Hospital, Rabin Medical Centre, Petah-Tiqva, Israel",NA
"1465","34249979","10.3389/fmed.2021.689994","Sero-Prevalence and Sero-Incidence of Antibodies to SARS-CoV-2 in Health Care Workers in Israel, Prior to Mass COVID-19 Vaccination.","Objectives: This study aims to examine the prevalence and risk factors of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sero-positivity in health care workers (HCWs), a main risk group, and assess the sero-incidence of SARS-CoV-2 infection between the first and second waves of coronavirus disease 2019 (COVID-19) in Israel. Methods: A longitudinal study was conducted among 874 HCWs from nine hospitals. Demographics, health information, and blood samples were obtained ","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","SARS-CoV-2; health care workers; longitudinal study; nucleocapsid antigen; occupational risk; risk factors; sero-epidemiology","Nutman","Amir","National Institute for Antibiotic Resistance and Infection Control, Israel Ministry of Health, Tel Aviv, Israel",NA
"1466","34249979","10.3389/fmed.2021.689994","Sero-Prevalence and Sero-Incidence of Antibodies to SARS-CoV-2 in Health Care Workers in Israel, Prior to Mass COVID-19 Vaccination.","Objectives: This study aims to examine the prevalence and risk factors of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sero-positivity in health care workers (HCWs), a main risk group, and assess the sero-incidence of SARS-CoV-2 infection between the first and second waves of coronavirus disease 2019 (COVID-19) in Israel. Methods: A longitudinal study was conducted among 874 HCWs from nine hospitals. Demographics, health information, and blood samples were obtained ","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","SARS-CoV-2; health care workers; longitudinal study; nucleocapsid antigen; occupational risk; risk factors; sero-epidemiology","Wiener-Well","Yonit","Infectious Disease Unit, Shaare Zedek Medical Centre, Jerusalem, Israel",NA
"1467","34249979","10.3389/fmed.2021.689994","Sero-Prevalence and Sero-Incidence of Antibodies to SARS-CoV-2 in Health Care Workers in Israel, Prior to Mass COVID-19 Vaccination.","Objectives: This study aims to examine the prevalence and risk factors of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sero-positivity in health care workers (HCWs), a main risk group, and assess the sero-incidence of SARS-CoV-2 infection between the first and second waves of coronavirus disease 2019 (COVID-19) in Israel. Methods: A longitudinal study was conducted among 874 HCWs from nine hospitals. Demographics, health information, and blood samples were obtained ","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","SARS-CoV-2; health care workers; longitudinal study; nucleocapsid antigen; occupational risk; risk factors; sero-epidemiology","Maor","Yasmin","Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel",NA
"1468","34249979","10.3389/fmed.2021.689994","Sero-Prevalence and Sero-Incidence of Antibodies to SARS-CoV-2 in Health Care Workers in Israel, Prior to Mass COVID-19 Vaccination.","Objectives: This study aims to examine the prevalence and risk factors of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sero-positivity in health care workers (HCWs), a main risk group, and assess the sero-incidence of SARS-CoV-2 infection between the first and second waves of coronavirus disease 2019 (COVID-19) in Israel. Methods: A longitudinal study was conducted among 874 HCWs from nine hospitals. Demographics, health information, and blood samples were obtained ","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","SARS-CoV-2; health care workers; longitudinal study; nucleocapsid antigen; occupational risk; risk factors; sero-epidemiology","Carmeli","Yehuda","National Institute for Antibiotic Resistance and Infection Control, Israel Ministry of Health, Tel Aviv, Israel",NA
"1469","34249979","10.3389/fmed.2021.689994","Sero-Prevalence and Sero-Incidence of Antibodies to SARS-CoV-2 in Health Care Workers in Israel, Prior to Mass COVID-19 Vaccination.","Objectives: This study aims to examine the prevalence and risk factors of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sero-positivity in health care workers (HCWs), a main risk group, and assess the sero-incidence of SARS-CoV-2 infection between the first and second waves of coronavirus disease 2019 (COVID-19) in Israel. Methods: A longitudinal study was conducted among 874 HCWs from nine hospitals. Demographics, health information, and blood samples were obtained ","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","SARS-CoV-2; health care workers; longitudinal study; nucleocapsid antigen; occupational risk; risk factors; sero-epidemiology","Cohen","Dani","Department of Epidemiology and Preventive Medicine, School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel",NA
"1470","34249973","10.3389/fmed.2021.682087","Comparison of Residual Pulmonary Abnormalities 3 Months After Discharge in Patients Who Recovered From COVID-19 of Different Severity.","Background and Objectives: To investigate whether coronavirus disease 2019 (COVID-19) survivors who had different disease severities have different levels of pulmonary sequelae at 3 months post-discharge. Methods: COVID-19 patients discharged from four hospitals 3 months previously, recovered asymptomatic patients from an isolation hotel, and uninfected healthy controls (HCs) from the community were prospectively recruited. Participants were recruited at Wuhan Union Hospital and un","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","chest computerized tomography; health-related quality of life; laboratory findings; pulmonary function; recovered COVID-19 patients","Zhou","Mei","NHC Key Laboratory of Pulmonary Diseases, Department of Respiratory and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China",NA
"1471","34249973","10.3389/fmed.2021.682087","Comparison of Residual Pulmonary Abnormalities 3 Months After Discharge in Patients Who Recovered From COVID-19 of Different Severity.","Background and Objectives: To investigate whether coronavirus disease 2019 (COVID-19) survivors who had different disease severities have different levels of pulmonary sequelae at 3 months post-discharge. Methods: COVID-19 patients discharged from four hospitals 3 months previously, recovered asymptomatic patients from an isolation hotel, and uninfected healthy controls (HCs) from the community were prospectively recruited. Participants were recruited at Wuhan Union Hospital and un","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","chest computerized tomography; health-related quality of life; laboratory findings; pulmonary function; recovered COVID-19 patients","Xu","Juanjuan","NHC Key Laboratory of Pulmonary Diseases, Department of Respiratory and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China",NA
"1472","34249973","10.3389/fmed.2021.682087","Comparison of Residual Pulmonary Abnormalities 3 Months After Discharge in Patients Who Recovered From COVID-19 of Different Severity.","Background and Objectives: To investigate whether coronavirus disease 2019 (COVID-19) survivors who had different disease severities have different levels of pulmonary sequelae at 3 months post-discharge. Methods: COVID-19 patients discharged from four hospitals 3 months previously, recovered asymptomatic patients from an isolation hotel, and uninfected healthy controls (HCs) from the community were prospectively recruited. Participants were recruited at Wuhan Union Hospital and un","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","chest computerized tomography; health-related quality of life; laboratory findings; pulmonary function; recovered COVID-19 patients","Liao","Tingting","NHC Key Laboratory of Pulmonary Diseases, Department of Respiratory and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China",NA
"1473","34249973","10.3389/fmed.2021.682087","Comparison of Residual Pulmonary Abnormalities 3 Months After Discharge in Patients Who Recovered From COVID-19 of Different Severity.","Background and Objectives: To investigate whether coronavirus disease 2019 (COVID-19) survivors who had different disease severities have different levels of pulmonary sequelae at 3 months post-discharge. Methods: COVID-19 patients discharged from four hospitals 3 months previously, recovered asymptomatic patients from an isolation hotel, and uninfected healthy controls (HCs) from the community were prospectively recruited. Participants were recruited at Wuhan Union Hospital and un","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","chest computerized tomography; health-related quality of life; laboratory findings; pulmonary function; recovered COVID-19 patients","Yin","Zhengrong","NHC Key Laboratory of Pulmonary Diseases, Department of Respiratory and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China",NA
"1474","34249973","10.3389/fmed.2021.682087","Comparison of Residual Pulmonary Abnormalities 3 Months After Discharge in Patients Who Recovered From COVID-19 of Different Severity.","Background and Objectives: To investigate whether coronavirus disease 2019 (COVID-19) survivors who had different disease severities have different levels of pulmonary sequelae at 3 months post-discharge. Methods: COVID-19 patients discharged from four hospitals 3 months previously, recovered asymptomatic patients from an isolation hotel, and uninfected healthy controls (HCs) from the community were prospectively recruited. Participants were recruited at Wuhan Union Hospital and un","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","chest computerized tomography; health-related quality of life; laboratory findings; pulmonary function; recovered COVID-19 patients","Yang","Fan","Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China",NA
"1475","34249973","10.3389/fmed.2021.682087","Comparison of Residual Pulmonary Abnormalities 3 Months After Discharge in Patients Who Recovered From COVID-19 of Different Severity.","Background and Objectives: To investigate whether coronavirus disease 2019 (COVID-19) survivors who had different disease severities have different levels of pulmonary sequelae at 3 months post-discharge. Methods: COVID-19 patients discharged from four hospitals 3 months previously, recovered asymptomatic patients from an isolation hotel, and uninfected healthy controls (HCs) from the community were prospectively recruited. Participants were recruited at Wuhan Union Hospital and un","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","chest computerized tomography; health-related quality of life; laboratory findings; pulmonary function; recovered COVID-19 patients","Wang","Kai","Key Laboratory for Environmental and Health, Department of Epidemiology and Biostatistics, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China",NA
"1476","34249973","10.3389/fmed.2021.682087","Comparison of Residual Pulmonary Abnormalities 3 Months After Discharge in Patients Who Recovered From COVID-19 of Different Severity.","Background and Objectives: To investigate whether coronavirus disease 2019 (COVID-19) survivors who had different disease severities have different levels of pulmonary sequelae at 3 months post-discharge. Methods: COVID-19 patients discharged from four hospitals 3 months previously, recovered asymptomatic patients from an isolation hotel, and uninfected healthy controls (HCs) from the community were prospectively recruited. Participants were recruited at Wuhan Union Hospital and un","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","chest computerized tomography; health-related quality of life; laboratory findings; pulmonary function; recovered COVID-19 patients","Wang","Zhen","NHC Key Laboratory of Pulmonary Diseases, Department of Respiratory and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China",NA
"1477","34249973","10.3389/fmed.2021.682087","Comparison of Residual Pulmonary Abnormalities 3 Months After Discharge in Patients Who Recovered From COVID-19 of Different Severity.","Background and Objectives: To investigate whether coronavirus disease 2019 (COVID-19) survivors who had different disease severities have different levels of pulmonary sequelae at 3 months post-discharge. Methods: COVID-19 patients discharged from four hospitals 3 months previously, recovered asymptomatic patients from an isolation hotel, and uninfected healthy controls (HCs) from the community were prospectively recruited. Participants were recruited at Wuhan Union Hospital and un","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","chest computerized tomography; health-related quality of life; laboratory findings; pulmonary function; recovered COVID-19 patients","Yang","Dan","NHC Key Laboratory of Pulmonary Diseases, Department of Respiratory and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China",NA
"1478","34249973","10.3389/fmed.2021.682087","Comparison of Residual Pulmonary Abnormalities 3 Months After Discharge in Patients Who Recovered From COVID-19 of Different Severity.","Background and Objectives: To investigate whether coronavirus disease 2019 (COVID-19) survivors who had different disease severities have different levels of pulmonary sequelae at 3 months post-discharge. Methods: COVID-19 patients discharged from four hospitals 3 months previously, recovered asymptomatic patients from an isolation hotel, and uninfected healthy controls (HCs) from the community were prospectively recruited. Participants were recruited at Wuhan Union Hospital and un","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","chest computerized tomography; health-related quality of life; laboratory findings; pulmonary function; recovered COVID-19 patients","Wang","Sufei","NHC Key Laboratory of Pulmonary Diseases, Department of Respiratory and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China",NA
"1479","34249973","10.3389/fmed.2021.682087","Comparison of Residual Pulmonary Abnormalities 3 Months After Discharge in Patients Who Recovered From COVID-19 of Different Severity.","Background and Objectives: To investigate whether coronavirus disease 2019 (COVID-19) survivors who had different disease severities have different levels of pulmonary sequelae at 3 months post-discharge. Methods: COVID-19 patients discharged from four hospitals 3 months previously, recovered asymptomatic patients from an isolation hotel, and uninfected healthy controls (HCs) from the community were prospectively recruited. Participants were recruited at Wuhan Union Hospital and un","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","chest computerized tomography; health-related quality of life; laboratory findings; pulmonary function; recovered COVID-19 patients","Peng","Yi","NHC Key Laboratory of Pulmonary Diseases, Department of Respiratory and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China",NA
"1480","34249973","10.3389/fmed.2021.682087","Comparison of Residual Pulmonary Abnormalities 3 Months After Discharge in Patients Who Recovered From COVID-19 of Different Severity.","Background and Objectives: To investigate whether coronavirus disease 2019 (COVID-19) survivors who had different disease severities have different levels of pulmonary sequelae at 3 months post-discharge. Methods: COVID-19 patients discharged from four hospitals 3 months previously, recovered asymptomatic patients from an isolation hotel, and uninfected healthy controls (HCs) from the community were prospectively recruited. Participants were recruited at Wuhan Union Hospital and un","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","chest computerized tomography; health-related quality of life; laboratory findings; pulmonary function; recovered COVID-19 patients","Peng","Shuyi","Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China",NA
"1481","34249973","10.3389/fmed.2021.682087","Comparison of Residual Pulmonary Abnormalities 3 Months After Discharge in Patients Who Recovered From COVID-19 of Different Severity.","Background and Objectives: To investigate whether coronavirus disease 2019 (COVID-19) survivors who had different disease severities have different levels of pulmonary sequelae at 3 months post-discharge. Methods: COVID-19 patients discharged from four hospitals 3 months previously, recovered asymptomatic patients from an isolation hotel, and uninfected healthy controls (HCs) from the community were prospectively recruited. Participants were recruited at Wuhan Union Hospital and un","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","chest computerized tomography; health-related quality of life; laboratory findings; pulmonary function; recovered COVID-19 patients","Wu","Feihong","Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China",NA
"1482","34249973","10.3389/fmed.2021.682087","Comparison of Residual Pulmonary Abnormalities 3 Months After Discharge in Patients Who Recovered From COVID-19 of Different Severity.","Background and Objectives: To investigate whether coronavirus disease 2019 (COVID-19) survivors who had different disease severities have different levels of pulmonary sequelae at 3 months post-discharge. Methods: COVID-19 patients discharged from four hospitals 3 months previously, recovered asymptomatic patients from an isolation hotel, and uninfected healthy controls (HCs) from the community were prospectively recruited. Participants were recruited at Wuhan Union Hospital and un","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","chest computerized tomography; health-related quality of life; laboratory findings; pulmonary function; recovered COVID-19 patients","Chen","Leqing","Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China",NA
"1483","34249973","10.3389/fmed.2021.682087","Comparison of Residual Pulmonary Abnormalities 3 Months After Discharge in Patients Who Recovered From COVID-19 of Different Severity.","Background and Objectives: To investigate whether coronavirus disease 2019 (COVID-19) survivors who had different disease severities have different levels of pulmonary sequelae at 3 months post-discharge. Methods: COVID-19 patients discharged from four hospitals 3 months previously, recovered asymptomatic patients from an isolation hotel, and uninfected healthy controls (HCs) from the community were prospectively recruited. Participants were recruited at Wuhan Union Hospital and un","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","chest computerized tomography; health-related quality of life; laboratory findings; pulmonary function; recovered COVID-19 patients","Jin","Yang","NHC Key Laboratory of Pulmonary Diseases, Department of Respiratory and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China",NA
"1484","34249972","10.3389/fmed.2021.681942","Retinal Involvement in COVID-19: Results From a Prospective Retina Screening Program in the Acute and Convalescent Phase.","Objective: To detect retinal involvement in coronavirus disease 2019 (COVID-19) patients in acute and convalescent phase by their fundus screening. Methods: In a prospective, cross-sectional, observational study (July-November 2020), 235 patients (142 acute and 93 convalescent phase) underwent fundus screening in a tertiary care center in North India. For convalescent phase, ""hospitalized"" patients (73) were screened at least 2 weeks after hospital discharge, and ""home-isolated"" pa","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","SARS-CoV-2; acute; convalescent; coronavirus disease 2019; cotton wool spots; retina; retinopathy; screening","Bansal","Reema","Advanced Eye Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, India",NA
"1485","34249972","10.3389/fmed.2021.681942","Retinal Involvement in COVID-19: Results From a Prospective Retina Screening Program in the Acute and Convalescent Phase.","Objective: To detect retinal involvement in coronavirus disease 2019 (COVID-19) patients in acute and convalescent phase by their fundus screening. Methods: In a prospective, cross-sectional, observational study (July-November 2020), 235 patients (142 acute and 93 convalescent phase) underwent fundus screening in a tertiary care center in North India. For convalescent phase, ""hospitalized"" patients (73) were screened at least 2 weeks after hospital discharge, and ""home-isolated"" pa","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","SARS-CoV-2; acute; convalescent; coronavirus disease 2019; cotton wool spots; retina; retinopathy; screening","Markan","Ashish","Advanced Eye Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, India",NA
"1486","34249972","10.3389/fmed.2021.681942","Retinal Involvement in COVID-19: Results From a Prospective Retina Screening Program in the Acute and Convalescent Phase.","Objective: To detect retinal involvement in coronavirus disease 2019 (COVID-19) patients in acute and convalescent phase by their fundus screening. Methods: In a prospective, cross-sectional, observational study (July-November 2020), 235 patients (142 acute and 93 convalescent phase) underwent fundus screening in a tertiary care center in North India. For convalescent phase, ""hospitalized"" patients (73) were screened at least 2 weeks after hospital discharge, and ""home-isolated"" pa","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","SARS-CoV-2; acute; convalescent; coronavirus disease 2019; cotton wool spots; retina; retinopathy; screening","Gautam","Nitin","Advanced Eye Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, India",NA
"1487","34249972","10.3389/fmed.2021.681942","Retinal Involvement in COVID-19: Results From a Prospective Retina Screening Program in the Acute and Convalescent Phase.","Objective: To detect retinal involvement in coronavirus disease 2019 (COVID-19) patients in acute and convalescent phase by their fundus screening. Methods: In a prospective, cross-sectional, observational study (July-November 2020), 235 patients (142 acute and 93 convalescent phase) underwent fundus screening in a tertiary care center in North India. For convalescent phase, ""hospitalized"" patients (73) were screened at least 2 weeks after hospital discharge, and ""home-isolated"" pa","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","SARS-CoV-2; acute; convalescent; coronavirus disease 2019; cotton wool spots; retina; retinopathy; screening","Guru","Rashmi Ranjan","Department of Hospital Administration, Post Graduate Institute of Medical Education and Research, Chandigarh, India",NA
"1488","34249972","10.3389/fmed.2021.681942","Retinal Involvement in COVID-19: Results From a Prospective Retina Screening Program in the Acute and Convalescent Phase.","Objective: To detect retinal involvement in coronavirus disease 2019 (COVID-19) patients in acute and convalescent phase by their fundus screening. Methods: In a prospective, cross-sectional, observational study (July-November 2020), 235 patients (142 acute and 93 convalescent phase) underwent fundus screening in a tertiary care center in North India. For convalescent phase, ""hospitalized"" patients (73) were screened at least 2 weeks after hospital discharge, and ""home-isolated"" pa","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","SARS-CoV-2; acute; convalescent; coronavirus disease 2019; cotton wool spots; retina; retinopathy; screening","Lakshmi","P V M","Department of Community Medicine, School of Public Health, Post Graduate Institute of Medical Education and Research, Chandigarh, India",NA
"1489","34249972","10.3389/fmed.2021.681942","Retinal Involvement in COVID-19: Results From a Prospective Retina Screening Program in the Acute and Convalescent Phase.","Objective: To detect retinal involvement in coronavirus disease 2019 (COVID-19) patients in acute and convalescent phase by their fundus screening. Methods: In a prospective, cross-sectional, observational study (July-November 2020), 235 patients (142 acute and 93 convalescent phase) underwent fundus screening in a tertiary care center in North India. For convalescent phase, ""hospitalized"" patients (73) were screened at least 2 weeks after hospital discharge, and ""home-isolated"" pa","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","SARS-CoV-2; acute; convalescent; coronavirus disease 2019; cotton wool spots; retina; retinopathy; screening","Katoch","Deeksha","Advanced Eye Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, India",NA
"1490","34249972","10.3389/fmed.2021.681942","Retinal Involvement in COVID-19: Results From a Prospective Retina Screening Program in the Acute and Convalescent Phase.","Objective: To detect retinal involvement in coronavirus disease 2019 (COVID-19) patients in acute and convalescent phase by their fundus screening. Methods: In a prospective, cross-sectional, observational study (July-November 2020), 235 patients (142 acute and 93 convalescent phase) underwent fundus screening in a tertiary care center in North India. For convalescent phase, ""hospitalized"" patients (73) were screened at least 2 weeks after hospital discharge, and ""home-isolated"" pa","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","SARS-CoV-2; acute; convalescent; coronavirus disease 2019; cotton wool spots; retina; retinopathy; screening","Agarwal","Aniruddha","Advanced Eye Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, India",NA
"1491","34249972","10.3389/fmed.2021.681942","Retinal Involvement in COVID-19: Results From a Prospective Retina Screening Program in the Acute and Convalescent Phase.","Objective: To detect retinal involvement in coronavirus disease 2019 (COVID-19) patients in acute and convalescent phase by their fundus screening. Methods: In a prospective, cross-sectional, observational study (July-November 2020), 235 patients (142 acute and 93 convalescent phase) underwent fundus screening in a tertiary care center in North India. For convalescent phase, ""hospitalized"" patients (73) were screened at least 2 weeks after hospital discharge, and ""home-isolated"" pa","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","SARS-CoV-2; acute; convalescent; coronavirus disease 2019; cotton wool spots; retina; retinopathy; screening","Singh","Mini P","Department of Virology, Post Graduate Institute of Medical Education and Research, Chandigarh, India",NA
"1492","34249972","10.3389/fmed.2021.681942","Retinal Involvement in COVID-19: Results From a Prospective Retina Screening Program in the Acute and Convalescent Phase.","Objective: To detect retinal involvement in coronavirus disease 2019 (COVID-19) patients in acute and convalescent phase by their fundus screening. Methods: In a prospective, cross-sectional, observational study (July-November 2020), 235 patients (142 acute and 93 convalescent phase) underwent fundus screening in a tertiary care center in North India. For convalescent phase, ""hospitalized"" patients (73) were screened at least 2 weeks after hospital discharge, and ""home-isolated"" pa","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","SARS-CoV-2; acute; convalescent; coronavirus disease 2019; cotton wool spots; retina; retinopathy; screening","Suri","Vikas","Department of Internal Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India",NA
"1493","34249972","10.3389/fmed.2021.681942","Retinal Involvement in COVID-19: Results From a Prospective Retina Screening Program in the Acute and Convalescent Phase.","Objective: To detect retinal involvement in coronavirus disease 2019 (COVID-19) patients in acute and convalescent phase by their fundus screening. Methods: In a prospective, cross-sectional, observational study (July-November 2020), 235 patients (142 acute and 93 convalescent phase) underwent fundus screening in a tertiary care center in North India. For convalescent phase, ""hospitalized"" patients (73) were screened at least 2 weeks after hospital discharge, and ""home-isolated"" pa","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","SARS-CoV-2; acute; convalescent; coronavirus disease 2019; cotton wool spots; retina; retinopathy; screening","Mohindra","Ritin","Department of Internal Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India",NA
"1494","34249972","10.3389/fmed.2021.681942","Retinal Involvement in COVID-19: Results From a Prospective Retina Screening Program in the Acute and Convalescent Phase.","Objective: To detect retinal involvement in coronavirus disease 2019 (COVID-19) patients in acute and convalescent phase by their fundus screening. Methods: In a prospective, cross-sectional, observational study (July-November 2020), 235 patients (142 acute and 93 convalescent phase) underwent fundus screening in a tertiary care center in North India. For convalescent phase, ""hospitalized"" patients (73) were screened at least 2 weeks after hospital discharge, and ""home-isolated"" pa","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","SARS-CoV-2; acute; convalescent; coronavirus disease 2019; cotton wool spots; retina; retinopathy; screening","Sahni","Neeru","Department of Anesthesia and Intensive Care, Post Graduate Institute of Medical Education and Research, Chandigarh, India",NA
"1495","34249972","10.3389/fmed.2021.681942","Retinal Involvement in COVID-19: Results From a Prospective Retina Screening Program in the Acute and Convalescent Phase.","Objective: To detect retinal involvement in coronavirus disease 2019 (COVID-19) patients in acute and convalescent phase by their fundus screening. Methods: In a prospective, cross-sectional, observational study (July-November 2020), 235 patients (142 acute and 93 convalescent phase) underwent fundus screening in a tertiary care center in North India. For convalescent phase, ""hospitalized"" patients (73) were screened at least 2 weeks after hospital discharge, and ""home-isolated"" pa","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","SARS-CoV-2; acute; convalescent; coronavirus disease 2019; cotton wool spots; retina; retinopathy; screening","Bhalla","Ashish","Department of Internal Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India",NA
"1496","34249972","10.3389/fmed.2021.681942","Retinal Involvement in COVID-19: Results From a Prospective Retina Screening Program in the Acute and Convalescent Phase.","Objective: To detect retinal involvement in coronavirus disease 2019 (COVID-19) patients in acute and convalescent phase by their fundus screening. Methods: In a prospective, cross-sectional, observational study (July-November 2020), 235 patients (142 acute and 93 convalescent phase) underwent fundus screening in a tertiary care center in North India. For convalescent phase, ""hospitalized"" patients (73) were screened at least 2 weeks after hospital discharge, and ""home-isolated"" pa","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","SARS-CoV-2; acute; convalescent; coronavirus disease 2019; cotton wool spots; retina; retinopathy; screening","Malhotra","Pankaj","Department of Internal Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India",NA
"1497","34249972","10.3389/fmed.2021.681942","Retinal Involvement in COVID-19: Results From a Prospective Retina Screening Program in the Acute and Convalescent Phase.","Objective: To detect retinal involvement in coronavirus disease 2019 (COVID-19) patients in acute and convalescent phase by their fundus screening. Methods: In a prospective, cross-sectional, observational study (July-November 2020), 235 patients (142 acute and 93 convalescent phase) underwent fundus screening in a tertiary care center in North India. For convalescent phase, ""hospitalized"" patients (73) were screened at least 2 weeks after hospital discharge, and ""home-isolated"" pa","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","SARS-CoV-2; acute; convalescent; coronavirus disease 2019; cotton wool spots; retina; retinopathy; screening","Gupta","Vishali","Advanced Eye Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, India",NA
"1498","34249972","10.3389/fmed.2021.681942","Retinal Involvement in COVID-19: Results From a Prospective Retina Screening Program in the Acute and Convalescent Phase.","Objective: To detect retinal involvement in coronavirus disease 2019 (COVID-19) patients in acute and convalescent phase by their fundus screening. Methods: In a prospective, cross-sectional, observational study (July-November 2020), 235 patients (142 acute and 93 convalescent phase) underwent fundus screening in a tertiary care center in North India. For convalescent phase, ""hospitalized"" patients (73) were screened at least 2 weeks after hospital discharge, and ""home-isolated"" pa","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","SARS-CoV-2; acute; convalescent; coronavirus disease 2019; cotton wool spots; retina; retinopathy; screening","Puri","G D","Department of Anesthesia and Intensive Care, Post Graduate Institute of Medical Education and Research, Chandigarh, India",NA
"1499","34249971","10.3389/fmed.2021.681469","COVID-19 and Influenza Co-infection: A Systematic Review and Meta-Analysis.","Background and Aim: Co-infection of COVID-19 with other respiratory pathogens which may complicate the diagnosis, treatment, and prognosis of COVID-19 emerge new concern. The overlap of COVID-19 and influenza, as two epidemics at the same time can occur in the cold months of the year. The aim of current study was to evaluate the rate of such co-infection as a systematic review and meta-analysis. Methods: A systematic literature search was performed on September 28, 2019 for origina","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","COVID-19; co-infection; coronavirus; influenza virus; meta-analysis; systematic review","Dadashi","Masoud","Department of Microbiology, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran",NA
"1500","34249971","10.3389/fmed.2021.681469","COVID-19 and Influenza Co-infection: A Systematic Review and Meta-Analysis.","Background and Aim: Co-infection of COVID-19 with other respiratory pathogens which may complicate the diagnosis, treatment, and prognosis of COVID-19 emerge new concern. The overlap of COVID-19 and influenza, as two epidemics at the same time can occur in the cold months of the year. The aim of current study was to evaluate the rate of such co-infection as a systematic review and meta-analysis. Methods: A systematic literature search was performed on September 28, 2019 for origina","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","COVID-19; co-infection; coronavirus; influenza virus; meta-analysis; systematic review","Khaleghnejad","Saeedeh","Department of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran",NA
"1501","34249971","10.3389/fmed.2021.681469","COVID-19 and Influenza Co-infection: A Systematic Review and Meta-Analysis.","Background and Aim: Co-infection of COVID-19 with other respiratory pathogens which may complicate the diagnosis, treatment, and prognosis of COVID-19 emerge new concern. The overlap of COVID-19 and influenza, as two epidemics at the same time can occur in the cold months of the year. The aim of current study was to evaluate the rate of such co-infection as a systematic review and meta-analysis. Methods: A systematic literature search was performed on September 28, 2019 for origina","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","COVID-19; co-infection; coronavirus; influenza virus; meta-analysis; systematic review","Abedi Elkhichi","Parisa","Department of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran",NA
"1502","34249971","10.3389/fmed.2021.681469","COVID-19 and Influenza Co-infection: A Systematic Review and Meta-Analysis.","Background and Aim: Co-infection of COVID-19 with other respiratory pathogens which may complicate the diagnosis, treatment, and prognosis of COVID-19 emerge new concern. The overlap of COVID-19 and influenza, as two epidemics at the same time can occur in the cold months of the year. The aim of current study was to evaluate the rate of such co-infection as a systematic review and meta-analysis. Methods: A systematic literature search was performed on September 28, 2019 for origina","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","COVID-19; co-infection; coronavirus; influenza virus; meta-analysis; systematic review","Goudarzi","Mehdi","Department of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran",NA
"1503","34249971","10.3389/fmed.2021.681469","COVID-19 and Influenza Co-infection: A Systematic Review and Meta-Analysis.","Background and Aim: Co-infection of COVID-19 with other respiratory pathogens which may complicate the diagnosis, treatment, and prognosis of COVID-19 emerge new concern. The overlap of COVID-19 and influenza, as two epidemics at the same time can occur in the cold months of the year. The aim of current study was to evaluate the rate of such co-infection as a systematic review and meta-analysis. Methods: A systematic literature search was performed on September 28, 2019 for origina","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","COVID-19; co-infection; coronavirus; influenza virus; meta-analysis; systematic review","Goudarzi","Hossein","Department of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran",NA
"1504","34249971","10.3389/fmed.2021.681469","COVID-19 and Influenza Co-infection: A Systematic Review and Meta-Analysis.","Background and Aim: Co-infection of COVID-19 with other respiratory pathogens which may complicate the diagnosis, treatment, and prognosis of COVID-19 emerge new concern. The overlap of COVID-19 and influenza, as two epidemics at the same time can occur in the cold months of the year. The aim of current study was to evaluate the rate of such co-infection as a systematic review and meta-analysis. Methods: A systematic literature search was performed on September 28, 2019 for origina","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","COVID-19; co-infection; coronavirus; influenza virus; meta-analysis; systematic review","Taghavi","Afsoon","Department of Pathology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran",NA
"1505","34249971","10.3389/fmed.2021.681469","COVID-19 and Influenza Co-infection: A Systematic Review and Meta-Analysis.","Background and Aim: Co-infection of COVID-19 with other respiratory pathogens which may complicate the diagnosis, treatment, and prognosis of COVID-19 emerge new concern. The overlap of COVID-19 and influenza, as two epidemics at the same time can occur in the cold months of the year. The aim of current study was to evaluate the rate of such co-infection as a systematic review and meta-analysis. Methods: A systematic literature search was performed on September 28, 2019 for origina","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","COVID-19; co-infection; coronavirus; influenza virus; meta-analysis; systematic review","Vaezjalali","Maryam","Department of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran",NA
"1506","34249971","10.3389/fmed.2021.681469","COVID-19 and Influenza Co-infection: A Systematic Review and Meta-Analysis.","Background and Aim: Co-infection of COVID-19 with other respiratory pathogens which may complicate the diagnosis, treatment, and prognosis of COVID-19 emerge new concern. The overlap of COVID-19 and influenza, as two epidemics at the same time can occur in the cold months of the year. The aim of current study was to evaluate the rate of such co-infection as a systematic review and meta-analysis. Methods: A systematic literature search was performed on September 28, 2019 for origina","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","COVID-19; co-infection; coronavirus; influenza virus; meta-analysis; systematic review","Hajikhani","Bahareh","Department of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran",NA
"1507","34249969","10.3389/fmed.2021.670744","Association of Preexisting Asthma and Other Allergic Diseases With Mortality in COVID-19 Patients: A Systematic Review and Meta-Analysis.","Background: Respiratory viruses are known to contribute to asthma exacerbations. A meta-analysis of three studies reported no association between coronavirus disease 2019 (COVID-19) mortality and preexisting asthma. This study aimed to investigate the mortality of patients with COVID-19 in relation to preexisting asthma and other allergic diseases associated with changes in respiratory function. Methods: PubMed, Embase, and the Cochrane Library were queried for papers published up ","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","COVID-19; allergy; asthma; intensive care unit; meta-analysis; mortality","Wu","Xianbo","School of Sports Medicine and Health, Chengdu Sport University, Chengdu, China",NA
"1508","34249969","10.3389/fmed.2021.670744","Association of Preexisting Asthma and Other Allergic Diseases With Mortality in COVID-19 Patients: A Systematic Review and Meta-Analysis.","Background: Respiratory viruses are known to contribute to asthma exacerbations. A meta-analysis of three studies reported no association between coronavirus disease 2019 (COVID-19) mortality and preexisting asthma. This study aimed to investigate the mortality of patients with COVID-19 in relation to preexisting asthma and other allergic diseases associated with changes in respiratory function. Methods: PubMed, Embase, and the Cochrane Library were queried for papers published up ","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","COVID-19; allergy; asthma; intensive care unit; meta-analysis; mortality","Xu","Yihua","School of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine (TCM), Chengdu, China",NA
"1509","34249969","10.3389/fmed.2021.670744","Association of Preexisting Asthma and Other Allergic Diseases With Mortality in COVID-19 Patients: A Systematic Review and Meta-Analysis.","Background: Respiratory viruses are known to contribute to asthma exacerbations. A meta-analysis of three studies reported no association between coronavirus disease 2019 (COVID-19) mortality and preexisting asthma. This study aimed to investigate the mortality of patients with COVID-19 in relation to preexisting asthma and other allergic diseases associated with changes in respiratory function. Methods: PubMed, Embase, and the Cochrane Library were queried for papers published up ","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","COVID-19; allergy; asthma; intensive care unit; meta-analysis; mortality","Jin","Lina","Department of Respiratory, Yanbian Hospital of Traditional Chinese Medicine, Yanji City Hospital of Traditional Chinese Medicine, Jilin, China",NA
"1510","34249969","10.3389/fmed.2021.670744","Association of Preexisting Asthma and Other Allergic Diseases With Mortality in COVID-19 Patients: A Systematic Review and Meta-Analysis.","Background: Respiratory viruses are known to contribute to asthma exacerbations. A meta-analysis of three studies reported no association between coronavirus disease 2019 (COVID-19) mortality and preexisting asthma. This study aimed to investigate the mortality of patients with COVID-19 in relation to preexisting asthma and other allergic diseases associated with changes in respiratory function. Methods: PubMed, Embase, and the Cochrane Library were queried for papers published up ","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","COVID-19; allergy; asthma; intensive care unit; meta-analysis; mortality","Wang","Xiaoou","Department of Nephrology, Yanbian Hospital of Traditional Chinese Medicine, Yanji City Hospital of Traditional Chinese Medicine, Jilin, China",NA
"1511","34249969","10.3389/fmed.2021.670744","Association of Preexisting Asthma and Other Allergic Diseases With Mortality in COVID-19 Patients: A Systematic Review and Meta-Analysis.","Background: Respiratory viruses are known to contribute to asthma exacerbations. A meta-analysis of three studies reported no association between coronavirus disease 2019 (COVID-19) mortality and preexisting asthma. This study aimed to investigate the mortality of patients with COVID-19 in relation to preexisting asthma and other allergic diseases associated with changes in respiratory function. Methods: PubMed, Embase, and the Cochrane Library were queried for papers published up ","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","COVID-19; allergy; asthma; intensive care unit; meta-analysis; mortality","Zhu","Haiyan","Integrated Traditional Chinese Medicine (TCM) &amp",NA
"1512","34249969","10.3389/fmed.2021.670744","Association of Preexisting Asthma and Other Allergic Diseases With Mortality in COVID-19 Patients: A Systematic Review and Meta-Analysis.","Background: Respiratory viruses are known to contribute to asthma exacerbations. A meta-analysis of three studies reported no association between coronavirus disease 2019 (COVID-19) mortality and preexisting asthma. This study aimed to investigate the mortality of patients with COVID-19 in relation to preexisting asthma and other allergic diseases associated with changes in respiratory function. Methods: PubMed, Embase, and the Cochrane Library were queried for papers published up ","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","COVID-19; allergy; asthma; intensive care unit; meta-analysis; mortality","Xie","Yiqiang","Traditional Chinese Medicine (TCM) College, Hainan Medical University, Haikou, China",NA
"1513","34249965","10.3389/fmed.2021.664297","The Significance of Duration of Exposure and Circulation of Fresh Air in SARS-CoV-2 Transmission Among Healthcare Workers.","Background: The true risk of infection after exposure to SARS-CoV-2 of healthcare workers (HCWs) in the workplace has not yet been established. This descriptive study analyzes the exposure characteristics of HCWs to SARS-CoV-2. Methods: In March 2020, at the beginning of the pandemic, a total of 58 HCWs in a regional hospital in Greece were exposed to three patients with symptomatic SARS-CoV-2 infection. These three index cases had taken part in an 8-day religious tour, during whic","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","COVID-19; SARS-CoV-2 transmission; health care facilities; health care worker; safety measures","Vlacha","Vasiliki","Department of Early Years Learning and Care, University of Ioannina, Ioannina, Greece",NA
"1514","34249965","10.3389/fmed.2021.664297","The Significance of Duration of Exposure and Circulation of Fresh Air in SARS-CoV-2 Transmission Among Healthcare Workers.","Background: The true risk of infection after exposure to SARS-CoV-2 of healthcare workers (HCWs) in the workplace has not yet been established. This descriptive study analyzes the exposure characteristics of HCWs to SARS-CoV-2. Methods: In March 2020, at the beginning of the pandemic, a total of 58 HCWs in a regional hospital in Greece were exposed to three patients with symptomatic SARS-CoV-2 infection. These three index cases had taken part in an 8-day religious tour, during whic","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","COVID-19; SARS-CoV-2 transmission; health care facilities; health care worker; safety measures","Feketea","Gavriela","PhD School, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania",NA
"1515","34249965","10.3389/fmed.2021.664297","The Significance of Duration of Exposure and Circulation of Fresh Air in SARS-CoV-2 Transmission Among Healthcare Workers.","Background: The true risk of infection after exposure to SARS-CoV-2 of healthcare workers (HCWs) in the workplace has not yet been established. This descriptive study analyzes the exposure characteristics of HCWs to SARS-CoV-2. Methods: In March 2020, at the beginning of the pandemic, a total of 58 HCWs in a regional hospital in Greece were exposed to three patients with symptomatic SARS-CoV-2 infection. These three index cases had taken part in an 8-day religious tour, during whic","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","COVID-19; SARS-CoV-2 transmission; health care facilities; health care worker; safety measures","Petropoulou","Athanasia","Nursing Service, Amaliada Hospital Unit, General Hospital of Ilia, Amaliada, Greece",NA
"1516","34249965","10.3389/fmed.2021.664297","The Significance of Duration of Exposure and Circulation of Fresh Air in SARS-CoV-2 Transmission Among Healthcare Workers.","Background: The true risk of infection after exposure to SARS-CoV-2 of healthcare workers (HCWs) in the workplace has not yet been established. This descriptive study analyzes the exposure characteristics of HCWs to SARS-CoV-2. Methods: In March 2020, at the beginning of the pandemic, a total of 58 HCWs in a regional hospital in Greece were exposed to three patients with symptomatic SARS-CoV-2 infection. These three index cases had taken part in an 8-day religious tour, during whic","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","COVID-19; SARS-CoV-2 transmission; health care facilities; health care worker; safety measures","Trancá","Sebastian Daniel","Department of Anesthesia and Intensive Care II, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania",NA
"1517","34249953","10.3389/fmed.2021.591372","Estimating the Prevalence of Asymptomatic COVID-19 Cases and Their Contribution in Transmission - Using Henan Province, China, as an Example.","Background: Novel coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2), is now sweeping across the world. A substantial proportion of infections only lead to mild symptoms or are asymptomatic, but the proportion and infectivity of asymptomatic infections remains unknown. In this paper, we proposed a model to estimate the proportion and infectivity of asymptomatic cases, using COVID-19 in Henan Province, China, as an example. Me","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","COVID-19; asymptomatic cases; infectious dynamic model; prevention and control measures; the effective reproductive number","Li","Chunyu","Department of Biostatistics, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, China",NA
"1518","34249953","10.3389/fmed.2021.591372","Estimating the Prevalence of Asymptomatic COVID-19 Cases and Their Contribution in Transmission - Using Henan Province, China, as an Example.","Background: Novel coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2), is now sweeping across the world. A substantial proportion of infections only lead to mild symptoms or are asymptomatic, but the proportion and infectivity of asymptomatic infections remains unknown. In this paper, we proposed a model to estimate the proportion and infectivity of asymptomatic cases, using COVID-19 in Henan Province, China, as an example. Me","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","COVID-19; asymptomatic cases; infectious dynamic model; prevention and control measures; the effective reproductive number","Zhu","Yuchen","Department of Biostatistics, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, China",NA
"1519","34249953","10.3389/fmed.2021.591372","Estimating the Prevalence of Asymptomatic COVID-19 Cases and Their Contribution in Transmission - Using Henan Province, China, as an Example.","Background: Novel coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2), is now sweeping across the world. A substantial proportion of infections only lead to mild symptoms or are asymptomatic, but the proportion and infectivity of asymptomatic infections remains unknown. In this paper, we proposed a model to estimate the proportion and infectivity of asymptomatic cases, using COVID-19 in Henan Province, China, as an example. Me","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","COVID-19; asymptomatic cases; infectious dynamic model; prevention and control measures; the effective reproductive number","Qi","Chang","Department of Biostatistics, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, China",NA
"1520","34249953","10.3389/fmed.2021.591372","Estimating the Prevalence of Asymptomatic COVID-19 Cases and Their Contribution in Transmission - Using Henan Province, China, as an Example.","Background: Novel coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2), is now sweeping across the world. A substantial proportion of infections only lead to mild symptoms or are asymptomatic, but the proportion and infectivity of asymptomatic infections remains unknown. In this paper, we proposed a model to estimate the proportion and infectivity of asymptomatic cases, using COVID-19 in Henan Province, China, as an example. Me","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","COVID-19; asymptomatic cases; infectious dynamic model; prevention and control measures; the effective reproductive number","Liu","Lili","Department of Biostatistics, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, China",NA
"1521","34249953","10.3389/fmed.2021.591372","Estimating the Prevalence of Asymptomatic COVID-19 Cases and Their Contribution in Transmission - Using Henan Province, China, as an Example.","Background: Novel coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2), is now sweeping across the world. A substantial proportion of infections only lead to mild symptoms or are asymptomatic, but the proportion and infectivity of asymptomatic infections remains unknown. In this paper, we proposed a model to estimate the proportion and infectivity of asymptomatic cases, using COVID-19 in Henan Province, China, as an example. Me","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","COVID-19; asymptomatic cases; infectious dynamic model; prevention and control measures; the effective reproductive number","Zhang","Dandan","Department of Biostatistics, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, China",NA
"1522","34249953","10.3389/fmed.2021.591372","Estimating the Prevalence of Asymptomatic COVID-19 Cases and Their Contribution in Transmission - Using Henan Province, China, as an Example.","Background: Novel coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2), is now sweeping across the world. A substantial proportion of infections only lead to mild symptoms or are asymptomatic, but the proportion and infectivity of asymptomatic infections remains unknown. In this paper, we proposed a model to estimate the proportion and infectivity of asymptomatic cases, using COVID-19 in Henan Province, China, as an example. Me","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","COVID-19; asymptomatic cases; infectious dynamic model; prevention and control measures; the effective reproductive number","Wang","Xu","Department of Biostatistics, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, China",NA
"1523","34249953","10.3389/fmed.2021.591372","Estimating the Prevalence of Asymptomatic COVID-19 Cases and Their Contribution in Transmission - Using Henan Province, China, as an Example.","Background: Novel coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2), is now sweeping across the world. A substantial proportion of infections only lead to mild symptoms or are asymptomatic, but the proportion and infectivity of asymptomatic infections remains unknown. In this paper, we proposed a model to estimate the proportion and infectivity of asymptomatic cases, using COVID-19 in Henan Province, China, as an example. Me","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","COVID-19; asymptomatic cases; infectious dynamic model; prevention and control measures; the effective reproductive number","She","Kaili","Department of Biostatistics, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, China",NA
"1524","34249953","10.3389/fmed.2021.591372","Estimating the Prevalence of Asymptomatic COVID-19 Cases and Their Contribution in Transmission - Using Henan Province, China, as an Example.","Background: Novel coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2), is now sweeping across the world. A substantial proportion of infections only lead to mild symptoms or are asymptomatic, but the proportion and infectivity of asymptomatic infections remains unknown. In this paper, we proposed a model to estimate the proportion and infectivity of asymptomatic cases, using COVID-19 in Henan Province, China, as an example. Me","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","COVID-19; asymptomatic cases; infectious dynamic model; prevention and control measures; the effective reproductive number","Jia","Yan","Department of Biostatistics, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, China",NA
"1525","34249953","10.3389/fmed.2021.591372","Estimating the Prevalence of Asymptomatic COVID-19 Cases and Their Contribution in Transmission - Using Henan Province, China, as an Example.","Background: Novel coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2), is now sweeping across the world. A substantial proportion of infections only lead to mild symptoms or are asymptomatic, but the proportion and infectivity of asymptomatic infections remains unknown. In this paper, we proposed a model to estimate the proportion and infectivity of asymptomatic cases, using COVID-19 in Henan Province, China, as an example. Me","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","COVID-19; asymptomatic cases; infectious dynamic model; prevention and control measures; the effective reproductive number","Liu","Tingxuan","Department of Biostatistics, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, China",NA
"1526","34249953","10.3389/fmed.2021.591372","Estimating the Prevalence of Asymptomatic COVID-19 Cases and Their Contribution in Transmission - Using Henan Province, China, as an Example.","Background: Novel coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2), is now sweeping across the world. A substantial proportion of infections only lead to mild symptoms or are asymptomatic, but the proportion and infectivity of asymptomatic infections remains unknown. In this paper, we proposed a model to estimate the proportion and infectivity of asymptomatic cases, using COVID-19 in Henan Province, China, as an example. Me","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","COVID-19; asymptomatic cases; infectious dynamic model; prevention and control measures; the effective reproductive number","He","Daihai","Department of Applied Mathematics, Hong Kong Polytechnic University, Hong Kong, China",NA
"1527","34249953","10.3389/fmed.2021.591372","Estimating the Prevalence of Asymptomatic COVID-19 Cases and Their Contribution in Transmission - Using Henan Province, China, as an Example.","Background: Novel coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2), is now sweeping across the world. A substantial proportion of infections only lead to mild symptoms or are asymptomatic, but the proportion and infectivity of asymptomatic infections remains unknown. In this paper, we proposed a model to estimate the proportion and infectivity of asymptomatic cases, using COVID-19 in Henan Province, China, as an example. Me","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","COVID-19; asymptomatic cases; infectious dynamic model; prevention and control measures; the effective reproductive number","Xiong","Momiao","Department of Biostatistics and Data Science, School of Public Health, University of Texas Health Science Center at Houston, Houston, TX, United States",NA
"1528","34249953","10.3389/fmed.2021.591372","Estimating the Prevalence of Asymptomatic COVID-19 Cases and Their Contribution in Transmission - Using Henan Province, China, as an Example.","Background: Novel coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2), is now sweeping across the world. A substantial proportion of infections only lead to mild symptoms or are asymptomatic, but the proportion and infectivity of asymptomatic infections remains unknown. In this paper, we proposed a model to estimate the proportion and infectivity of asymptomatic cases, using COVID-19 in Henan Province, China, as an example. Me","2021","07","13","Front Med (Lausanne)","Frontiers in medicine","COVID-19; asymptomatic cases; infectious dynamic model; prevention and control measures; the effective reproductive number","Li","Xiujun","Department of Biostatistics, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, China",NA
"1529","34249938","10.3389/fcell.2021.684874","The Altered Anatomical Distribution of ACE2 in the Brain With Alzheimer's Disease Pathology.","The whole world is suffering from the coronavirus disease 2019 (COVID-19) pandemic, induced by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) through angiotensin-converting enzyme 2 (ACE2). Neurological manifestations in COVID-19 patients suggested the invasion of SARS-CoV-2 into the central nervous system. The present study mapped the expression level of ACE2 in 12 brain regions through immunohistochemistry and detected ACE2 in endothelial cells and non-vascular cells. The compari","2021","07","13","Front Cell Dev Biol","Frontiers in cell and developmental biology","ACE2; Alzheimers disease; COVID-19; anatomical distribution; brain regions","Cui","Huan","Department of Human Anatomy, Histology, and Embryology, Neuroscience Center, School of Basic Medicine, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China",NA
"1530","34249938","10.3389/fcell.2021.684874","The Altered Anatomical Distribution of ACE2 in the Brain With Alzheimer's Disease Pathology.","The whole world is suffering from the coronavirus disease 2019 (COVID-19) pandemic, induced by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) through angiotensin-converting enzyme 2 (ACE2). Neurological manifestations in COVID-19 patients suggested the invasion of SARS-CoV-2 into the central nervous system. The present study mapped the expression level of ACE2 in 12 brain regions through immunohistochemistry and detected ACE2 in endothelial cells and non-vascular cells. The compari","2021","07","13","Front Cell Dev Biol","Frontiers in cell and developmental biology","ACE2; Alzheimers disease; COVID-19; anatomical distribution; brain regions","Su","Si","Department of Human Anatomy, Histology, and Embryology, Neuroscience Center, School of Basic Medicine, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China",NA
"1531","34249938","10.3389/fcell.2021.684874","The Altered Anatomical Distribution of ACE2 in the Brain With Alzheimer's Disease Pathology.","The whole world is suffering from the coronavirus disease 2019 (COVID-19) pandemic, induced by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) through angiotensin-converting enzyme 2 (ACE2). Neurological manifestations in COVID-19 patients suggested the invasion of SARS-CoV-2 into the central nervous system. The present study mapped the expression level of ACE2 in 12 brain regions through immunohistochemistry and detected ACE2 in endothelial cells and non-vascular cells. The compari","2021","07","13","Front Cell Dev Biol","Frontiers in cell and developmental biology","ACE2; Alzheimers disease; COVID-19; anatomical distribution; brain regions","Cao","Yan","Department of Human Anatomy, Histology, and Embryology, Neuroscience Center, School of Basic Medicine, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China",NA
"1532","34249938","10.3389/fcell.2021.684874","The Altered Anatomical Distribution of ACE2 in the Brain With Alzheimer's Disease Pathology.","The whole world is suffering from the coronavirus disease 2019 (COVID-19) pandemic, induced by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) through angiotensin-converting enzyme 2 (ACE2). Neurological manifestations in COVID-19 patients suggested the invasion of SARS-CoV-2 into the central nervous system. The present study mapped the expression level of ACE2 in 12 brain regions through immunohistochemistry and detected ACE2 in endothelial cells and non-vascular cells. The compari","2021","07","13","Front Cell Dev Biol","Frontiers in cell and developmental biology","ACE2; Alzheimers disease; COVID-19; anatomical distribution; brain regions","Ma","Chao","Department of Human Anatomy, Histology, and Embryology, Neuroscience Center, School of Basic Medicine, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China",NA
"1533","34249938","10.3389/fcell.2021.684874","The Altered Anatomical Distribution of ACE2 in the Brain With Alzheimer's Disease Pathology.","The whole world is suffering from the coronavirus disease 2019 (COVID-19) pandemic, induced by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) through angiotensin-converting enzyme 2 (ACE2). Neurological manifestations in COVID-19 patients suggested the invasion of SARS-CoV-2 into the central nervous system. The present study mapped the expression level of ACE2 in 12 brain regions through immunohistochemistry and detected ACE2 in endothelial cells and non-vascular cells. The compari","2021","07","13","Front Cell Dev Biol","Frontiers in cell and developmental biology","ACE2; Alzheimers disease; COVID-19; anatomical distribution; brain regions","Qiu","Wenying","Department of Human Anatomy, Histology, and Embryology, Neuroscience Center, School of Basic Medicine, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China",NA
"1534","34249902","10.3389/fcell.2021.627914","PNPLA3 and TLL-1 Polymorphisms as Potential Predictors of Disease Severity in Patients With COVID-19.","Albeit the pathogenesis of COVID-19 remains unclear, host's genetic polymorphisms in genes involved in infection and reinfection, inflammation, or immune stimulation could play a role in determining the course and outcome. We studied in the early phase of pandemic consecutive patients (N = 383) with SARS-CoV-2 infection, whose subsequent clinical course was classified as mild or severe, the latter being characterized by admission to intensive therapy unit or death. Five host gene polymorp","2021","07","13","Front Cell Dev Biol","Frontiers in cell and developmental biology","COVID-19; PNPLA3 I148M; TLL-1; genetic polymorphism; severity of disease","Grimaudo","Stefania","Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties ""G. D'Alessandro"" - University of Palermo, Palermo, Italy",NA
"1535","34249902","10.3389/fcell.2021.627914","PNPLA3 and TLL-1 Polymorphisms as Potential Predictors of Disease Severity in Patients With COVID-19.","Albeit the pathogenesis of COVID-19 remains unclear, host's genetic polymorphisms in genes involved in infection and reinfection, inflammation, or immune stimulation could play a role in determining the course and outcome. We studied in the early phase of pandemic consecutive patients (N = 383) with SARS-CoV-2 infection, whose subsequent clinical course was classified as mild or severe, the latter being characterized by admission to intensive therapy unit or death. Five host gene polymorp","2021","07","13","Front Cell Dev Biol","Frontiers in cell and developmental biology","COVID-19; PNPLA3 I148M; TLL-1; genetic polymorphism; severity of disease","Amodio","Emanuele","Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties ""G. D'Alessandro"" - University of Palermo, Palermo, Italy",NA
"1536","34249902","10.3389/fcell.2021.627914","PNPLA3 and TLL-1 Polymorphisms as Potential Predictors of Disease Severity in Patients With COVID-19.","Albeit the pathogenesis of COVID-19 remains unclear, host's genetic polymorphisms in genes involved in infection and reinfection, inflammation, or immune stimulation could play a role in determining the course and outcome. We studied in the early phase of pandemic consecutive patients (N = 383) with SARS-CoV-2 infection, whose subsequent clinical course was classified as mild or severe, the latter being characterized by admission to intensive therapy unit or death. Five host gene polymorp","2021","07","13","Front Cell Dev Biol","Frontiers in cell and developmental biology","COVID-19; PNPLA3 I148M; TLL-1; genetic polymorphism; severity of disease","Pipitone","Rosaria Maria","Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties ""G. D'Alessandro"" - University of Palermo, Palermo, Italy",NA
"1537","34249902","10.3389/fcell.2021.627914","PNPLA3 and TLL-1 Polymorphisms as Potential Predictors of Disease Severity in Patients With COVID-19.","Albeit the pathogenesis of COVID-19 remains unclear, host's genetic polymorphisms in genes involved in infection and reinfection, inflammation, or immune stimulation could play a role in determining the course and outcome. We studied in the early phase of pandemic consecutive patients (N = 383) with SARS-CoV-2 infection, whose subsequent clinical course was classified as mild or severe, the latter being characterized by admission to intensive therapy unit or death. Five host gene polymorp","2021","07","13","Front Cell Dev Biol","Frontiers in cell and developmental biology","COVID-19; PNPLA3 I148M; TLL-1; genetic polymorphism; severity of disease","Maida","Carmelo Massimo","Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties ""G. D'Alessandro"" - University of Palermo, Palermo, Italy",NA
"1538","34249902","10.3389/fcell.2021.627914","PNPLA3 and TLL-1 Polymorphisms as Potential Predictors of Disease Severity in Patients With COVID-19.","Albeit the pathogenesis of COVID-19 remains unclear, host's genetic polymorphisms in genes involved in infection and reinfection, inflammation, or immune stimulation could play a role in determining the course and outcome. We studied in the early phase of pandemic consecutive patients (N = 383) with SARS-CoV-2 infection, whose subsequent clinical course was classified as mild or severe, the latter being characterized by admission to intensive therapy unit or death. Five host gene polymorp","2021","07","13","Front Cell Dev Biol","Frontiers in cell and developmental biology","COVID-19; PNPLA3 I148M; TLL-1; genetic polymorphism; severity of disease","Pizzo","Stefano","Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties ""G. D'Alessandro"" - University of Palermo, Palermo, Italy",NA
"1539","34249902","10.3389/fcell.2021.627914","PNPLA3 and TLL-1 Polymorphisms as Potential Predictors of Disease Severity in Patients With COVID-19.","Albeit the pathogenesis of COVID-19 remains unclear, host's genetic polymorphisms in genes involved in infection and reinfection, inflammation, or immune stimulation could play a role in determining the course and outcome. We studied in the early phase of pandemic consecutive patients (N = 383) with SARS-CoV-2 infection, whose subsequent clinical course was classified as mild or severe, the latter being characterized by admission to intensive therapy unit or death. Five host gene polymorp","2021","07","13","Front Cell Dev Biol","Frontiers in cell and developmental biology","COVID-19; PNPLA3 I148M; TLL-1; genetic polymorphism; severity of disease","Prestileo","Tullio","Infectious Diseases Unit and Centre for Migration and Health ARNAS, Ospedale Civico Benfratelli, Palermo, Italy",NA
"1540","34249902","10.3389/fcell.2021.627914","PNPLA3 and TLL-1 Polymorphisms as Potential Predictors of Disease Severity in Patients With COVID-19.","Albeit the pathogenesis of COVID-19 remains unclear, host's genetic polymorphisms in genes involved in infection and reinfection, inflammation, or immune stimulation could play a role in determining the course and outcome. We studied in the early phase of pandemic consecutive patients (N = 383) with SARS-CoV-2 infection, whose subsequent clinical course was classified as mild or severe, the latter being characterized by admission to intensive therapy unit or death. Five host gene polymorp","2021","07","13","Front Cell Dev Biol","Frontiers in cell and developmental biology","COVID-19; PNPLA3 I148M; TLL-1; genetic polymorphism; severity of disease","Tramuto","Fabio","Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties ""G. D'Alessandro"" - University of Palermo, Palermo, Italy",NA
"1541","34249902","10.3389/fcell.2021.627914","PNPLA3 and TLL-1 Polymorphisms as Potential Predictors of Disease Severity in Patients With COVID-19.","Albeit the pathogenesis of COVID-19 remains unclear, host's genetic polymorphisms in genes involved in infection and reinfection, inflammation, or immune stimulation could play a role in determining the course and outcome. We studied in the early phase of pandemic consecutive patients (N = 383) with SARS-CoV-2 infection, whose subsequent clinical course was classified as mild or severe, the latter being characterized by admission to intensive therapy unit or death. Five host gene polymorp","2021","07","13","Front Cell Dev Biol","Frontiers in cell and developmental biology","COVID-19; PNPLA3 I148M; TLL-1; genetic polymorphism; severity of disease","Sardina","Davide","Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties ""G. D'Alessandro"" - University of Palermo, Palermo, Italy",NA
"1542","34249902","10.3389/fcell.2021.627914","PNPLA3 and TLL-1 Polymorphisms as Potential Predictors of Disease Severity in Patients With COVID-19.","Albeit the pathogenesis of COVID-19 remains unclear, host's genetic polymorphisms in genes involved in infection and reinfection, inflammation, or immune stimulation could play a role in determining the course and outcome. We studied in the early phase of pandemic consecutive patients (N = 383) with SARS-CoV-2 infection, whose subsequent clinical course was classified as mild or severe, the latter being characterized by admission to intensive therapy unit or death. Five host gene polymorp","2021","07","13","Front Cell Dev Biol","Frontiers in cell and developmental biology","COVID-19; PNPLA3 I148M; TLL-1; genetic polymorphism; severity of disease","Vitale","Francesco","Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties ""G. D'Alessandro"" - University of Palermo, Palermo, Italy",NA
"1543","34249902","10.3389/fcell.2021.627914","PNPLA3 and TLL-1 Polymorphisms as Potential Predictors of Disease Severity in Patients With COVID-19.","Albeit the pathogenesis of COVID-19 remains unclear, host's genetic polymorphisms in genes involved in infection and reinfection, inflammation, or immune stimulation could play a role in determining the course and outcome. We studied in the early phase of pandemic consecutive patients (N = 383) with SARS-CoV-2 infection, whose subsequent clinical course was classified as mild or severe, the latter being characterized by admission to intensive therapy unit or death. Five host gene polymorp","2021","07","13","Front Cell Dev Biol","Frontiers in cell and developmental biology","COVID-19; PNPLA3 I148M; TLL-1; genetic polymorphism; severity of disease","Casuccio","Alessandra","Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties ""G. D'Alessandro"" - University of Palermo, Palermo, Italy",NA
"1544","34249902","10.3389/fcell.2021.627914","PNPLA3 and TLL-1 Polymorphisms as Potential Predictors of Disease Severity in Patients With COVID-19.","Albeit the pathogenesis of COVID-19 remains unclear, host's genetic polymorphisms in genes involved in infection and reinfection, inflammation, or immune stimulation could play a role in determining the course and outcome. We studied in the early phase of pandemic consecutive patients (N = 383) with SARS-CoV-2 infection, whose subsequent clinical course was classified as mild or severe, the latter being characterized by admission to intensive therapy unit or death. Five host gene polymorp","2021","07","13","Front Cell Dev Biol","Frontiers in cell and developmental biology","COVID-19; PNPLA3 I148M; TLL-1; genetic polymorphism; severity of disease","Craxì","Antonio","Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties ""G. D'Alessandro"" - University of Palermo, Palermo, Italy",NA
"1545","34249878","10.3389/fbioe.2021.646184","Oropharyngeal Probiotic ENT-K12 Prevents Respiratory Tract Infections Among Frontline Medical Staff Fighting Against COVID-19: A Pilot Study.","Healthcare workers at the frontline are facing a substantial risk of respiratory tract infection during the COVID-19 outbreak due to an extremely stressful work schedule and public health event. A well-established first-line defense on oropharyngeal microbiome could be a promising strategy to protect individuals from respiratory tract infections including COVID-19. The most thoroughly studied oropharyngeal probiotic product which creates a stable upper respiratory tract microbiota capable of pre","2021","07","13","Front Bioeng Biotechnol","Frontiers in bioengineering and biotechnology","COVID-19; group A ß-hemolytic streptococcus; healthcare workers; oropharyngeal probiotic ENT-K12; respiratory tract infections","Wang","Qiang","Institute of Infection, Immunology and Tumor Microenvironment, Hubei Province Key Laboratory of Occupational Hazard Identification and Control, Medical College, Wuhan University of Science and Technology, Wuhan, China",NA
"1546","34249878","10.3389/fbioe.2021.646184","Oropharyngeal Probiotic ENT-K12 Prevents Respiratory Tract Infections Among Frontline Medical Staff Fighting Against COVID-19: A Pilot Study.","Healthcare workers at the frontline are facing a substantial risk of respiratory tract infection during the COVID-19 outbreak due to an extremely stressful work schedule and public health event. A well-established first-line defense on oropharyngeal microbiome could be a promising strategy to protect individuals from respiratory tract infections including COVID-19. The most thoroughly studied oropharyngeal probiotic product which creates a stable upper respiratory tract microbiota capable of pre","2021","07","13","Front Bioeng Biotechnol","Frontiers in bioengineering and biotechnology","COVID-19; group A ß-hemolytic streptococcus; healthcare workers; oropharyngeal probiotic ENT-K12; respiratory tract infections","Lin","Xuan","Huarun WISCO General Hospital Affiliated to Wuhan University of Science and Technology, Wuhan, China",NA
"1547","34249878","10.3389/fbioe.2021.646184","Oropharyngeal Probiotic ENT-K12 Prevents Respiratory Tract Infections Among Frontline Medical Staff Fighting Against COVID-19: A Pilot Study.","Healthcare workers at the frontline are facing a substantial risk of respiratory tract infection during the COVID-19 outbreak due to an extremely stressful work schedule and public health event. A well-established first-line defense on oropharyngeal microbiome could be a promising strategy to protect individuals from respiratory tract infections including COVID-19. The most thoroughly studied oropharyngeal probiotic product which creates a stable upper respiratory tract microbiota capable of pre","2021","07","13","Front Bioeng Biotechnol","Frontiers in bioengineering and biotechnology","COVID-19; group A ß-hemolytic streptococcus; healthcare workers; oropharyngeal probiotic ENT-K12; respiratory tract infections","Xiang","Xiaochen","Institute of Infection, Immunology and Tumor Microenvironment, Hubei Province Key Laboratory of Occupational Hazard Identification and Control, Medical College, Wuhan University of Science and Technology, Wuhan, China",NA
"1548","34249878","10.3389/fbioe.2021.646184","Oropharyngeal Probiotic ENT-K12 Prevents Respiratory Tract Infections Among Frontline Medical Staff Fighting Against COVID-19: A Pilot Study.","Healthcare workers at the frontline are facing a substantial risk of respiratory tract infection during the COVID-19 outbreak due to an extremely stressful work schedule and public health event. A well-established first-line defense on oropharyngeal microbiome could be a promising strategy to protect individuals from respiratory tract infections including COVID-19. The most thoroughly studied oropharyngeal probiotic product which creates a stable upper respiratory tract microbiota capable of pre","2021","07","13","Front Bioeng Biotechnol","Frontiers in bioengineering and biotechnology","COVID-19; group A ß-hemolytic streptococcus; healthcare workers; oropharyngeal probiotic ENT-K12; respiratory tract infections","Liu","Wanxin","Institute of Infection, Immunology and Tumor Microenvironment, Hubei Province Key Laboratory of Occupational Hazard Identification and Control, Medical College, Wuhan University of Science and Technology, Wuhan, China",NA
"1549","34249878","10.3389/fbioe.2021.646184","Oropharyngeal Probiotic ENT-K12 Prevents Respiratory Tract Infections Among Frontline Medical Staff Fighting Against COVID-19: A Pilot Study.","Healthcare workers at the frontline are facing a substantial risk of respiratory tract infection during the COVID-19 outbreak due to an extremely stressful work schedule and public health event. A well-established first-line defense on oropharyngeal microbiome could be a promising strategy to protect individuals from respiratory tract infections including COVID-19. The most thoroughly studied oropharyngeal probiotic product which creates a stable upper respiratory tract microbiota capable of pre","2021","07","13","Front Bioeng Biotechnol","Frontiers in bioengineering and biotechnology","COVID-19; group A ß-hemolytic streptococcus; healthcare workers; oropharyngeal probiotic ENT-K12; respiratory tract infections","Fang","Ying","Huarun WISCO General Hospital Affiliated to Wuhan University of Science and Technology, Wuhan, China",NA
"1550","34249878","10.3389/fbioe.2021.646184","Oropharyngeal Probiotic ENT-K12 Prevents Respiratory Tract Infections Among Frontline Medical Staff Fighting Against COVID-19: A Pilot Study.","Healthcare workers at the frontline are facing a substantial risk of respiratory tract infection during the COVID-19 outbreak due to an extremely stressful work schedule and public health event. A well-established first-line defense on oropharyngeal microbiome could be a promising strategy to protect individuals from respiratory tract infections including COVID-19. The most thoroughly studied oropharyngeal probiotic product which creates a stable upper respiratory tract microbiota capable of pre","2021","07","13","Front Bioeng Biotechnol","Frontiers in bioengineering and biotechnology","COVID-19; group A ß-hemolytic streptococcus; healthcare workers; oropharyngeal probiotic ENT-K12; respiratory tract infections","Chen","Haiping","Huarun WISCO General Hospital Affiliated to Wuhan University of Science and Technology, Wuhan, China",NA
"1551","34249878","10.3389/fbioe.2021.646184","Oropharyngeal Probiotic ENT-K12 Prevents Respiratory Tract Infections Among Frontline Medical Staff Fighting Against COVID-19: A Pilot Study.","Healthcare workers at the frontline are facing a substantial risk of respiratory tract infection during the COVID-19 outbreak due to an extremely stressful work schedule and public health event. A well-established first-line defense on oropharyngeal microbiome could be a promising strategy to protect individuals from respiratory tract infections including COVID-19. The most thoroughly studied oropharyngeal probiotic product which creates a stable upper respiratory tract microbiota capable of pre","2021","07","13","Front Bioeng Biotechnol","Frontiers in bioengineering and biotechnology","COVID-19; group A ß-hemolytic streptococcus; healthcare workers; oropharyngeal probiotic ENT-K12; respiratory tract infections","Tang","Fang","Huarun WISCO General Hospital Affiliated to Wuhan University of Science and Technology, Wuhan, China",NA
"1552","34249878","10.3389/fbioe.2021.646184","Oropharyngeal Probiotic ENT-K12 Prevents Respiratory Tract Infections Among Frontline Medical Staff Fighting Against COVID-19: A Pilot Study.","Healthcare workers at the frontline are facing a substantial risk of respiratory tract infection during the COVID-19 outbreak due to an extremely stressful work schedule and public health event. A well-established first-line defense on oropharyngeal microbiome could be a promising strategy to protect individuals from respiratory tract infections including COVID-19. The most thoroughly studied oropharyngeal probiotic product which creates a stable upper respiratory tract microbiota capable of pre","2021","07","13","Front Bioeng Biotechnol","Frontiers in bioengineering and biotechnology","COVID-19; group A ß-hemolytic streptococcus; healthcare workers; oropharyngeal probiotic ENT-K12; respiratory tract infections","Guo","Hongyan","Huarun WISCO General Hospital Affiliated to Wuhan University of Science and Technology, Wuhan, China",NA
"1553","34249878","10.3389/fbioe.2021.646184","Oropharyngeal Probiotic ENT-K12 Prevents Respiratory Tract Infections Among Frontline Medical Staff Fighting Against COVID-19: A Pilot Study.","Healthcare workers at the frontline are facing a substantial risk of respiratory tract infection during the COVID-19 outbreak due to an extremely stressful work schedule and public health event. A well-established first-line defense on oropharyngeal microbiome could be a promising strategy to protect individuals from respiratory tract infections including COVID-19. The most thoroughly studied oropharyngeal probiotic product which creates a stable upper respiratory tract microbiota capable of pre","2021","07","13","Front Bioeng Biotechnol","Frontiers in bioengineering and biotechnology","COVID-19; group A ß-hemolytic streptococcus; healthcare workers; oropharyngeal probiotic ENT-K12; respiratory tract infections","Chen","Di","Huarun WISCO General Hospital Affiliated to Wuhan University of Science and Technology, Wuhan, China",NA
"1554","34249878","10.3389/fbioe.2021.646184","Oropharyngeal Probiotic ENT-K12 Prevents Respiratory Tract Infections Among Frontline Medical Staff Fighting Against COVID-19: A Pilot Study.","Healthcare workers at the frontline are facing a substantial risk of respiratory tract infection during the COVID-19 outbreak due to an extremely stressful work schedule and public health event. A well-established first-line defense on oropharyngeal microbiome could be a promising strategy to protect individuals from respiratory tract infections including COVID-19. The most thoroughly studied oropharyngeal probiotic product which creates a stable upper respiratory tract microbiota capable of pre","2021","07","13","Front Bioeng Biotechnol","Frontiers in bioengineering and biotechnology","COVID-19; group A ß-hemolytic streptococcus; healthcare workers; oropharyngeal probiotic ENT-K12; respiratory tract infections","Hu","Xiafen","Institute of Infection, Immunology and Tumor Microenvironment, Hubei Province Key Laboratory of Occupational Hazard Identification and Control, Medical College, Wuhan University of Science and Technology, Wuhan, China",NA
"1555","34249878","10.3389/fbioe.2021.646184","Oropharyngeal Probiotic ENT-K12 Prevents Respiratory Tract Infections Among Frontline Medical Staff Fighting Against COVID-19: A Pilot Study.","Healthcare workers at the frontline are facing a substantial risk of respiratory tract infection during the COVID-19 outbreak due to an extremely stressful work schedule and public health event. A well-established first-line defense on oropharyngeal microbiome could be a promising strategy to protect individuals from respiratory tract infections including COVID-19. The most thoroughly studied oropharyngeal probiotic product which creates a stable upper respiratory tract microbiota capable of pre","2021","07","13","Front Bioeng Biotechnol","Frontiers in bioengineering and biotechnology","COVID-19; group A ß-hemolytic streptococcus; healthcare workers; oropharyngeal probiotic ENT-K12; respiratory tract infections","Wu","Qingming","Institute of Infection, Immunology and Tumor Microenvironment, Hubei Province Key Laboratory of Occupational Hazard Identification and Control, Medical College, Wuhan University of Science and Technology, Wuhan, China",NA
"1556","34249878","10.3389/fbioe.2021.646184","Oropharyngeal Probiotic ENT-K12 Prevents Respiratory Tract Infections Among Frontline Medical Staff Fighting Against COVID-19: A Pilot Study.","Healthcare workers at the frontline are facing a substantial risk of respiratory tract infection during the COVID-19 outbreak due to an extremely stressful work schedule and public health event. A well-established first-line defense on oropharyngeal microbiome could be a promising strategy to protect individuals from respiratory tract infections including COVID-19. The most thoroughly studied oropharyngeal probiotic product which creates a stable upper respiratory tract microbiota capable of pre","2021","07","13","Front Bioeng Biotechnol","Frontiers in bioengineering and biotechnology","COVID-19; group A ß-hemolytic streptococcus; healthcare workers; oropharyngeal probiotic ENT-K12; respiratory tract infections","Zhu","Baoli","CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China",NA
"1557","34249878","10.3389/fbioe.2021.646184","Oropharyngeal Probiotic ENT-K12 Prevents Respiratory Tract Infections Among Frontline Medical Staff Fighting Against COVID-19: A Pilot Study.","Healthcare workers at the frontline are facing a substantial risk of respiratory tract infection during the COVID-19 outbreak due to an extremely stressful work schedule and public health event. A well-established first-line defense on oropharyngeal microbiome could be a promising strategy to protect individuals from respiratory tract infections including COVID-19. The most thoroughly studied oropharyngeal probiotic product which creates a stable upper respiratory tract microbiota capable of pre","2021","07","13","Front Bioeng Biotechnol","Frontiers in bioengineering and biotechnology","COVID-19; group A ß-hemolytic streptococcus; healthcare workers; oropharyngeal probiotic ENT-K12; respiratory tract infections","Xia","Junbo","Department of Pulmonary Medicine, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, China",NA
"1558","34249864","10.3389/fchem.2021.692168","Catalytic Dyad Residues His41 and Cys145 Impact the Catalytic Activity and Overall Conformational Fold of the Main SARS-CoV-2 Protease 3-Chymotrypsin-Like Protease.","Coronaviruses are responsible for multiple pandemics and millions of deaths globally, including the current pandemic of coronavirus disease 2019 (COVID-19). Development of antivirals against coronaviruses, including the severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) responsible for COVID-19, is essential for containing the current and future coronavirus outbreaks. SARS-CoV-2 proteases represent important targets for the development of antivirals because of their role in the process","2021","07","13","Front Chem","Frontiers in chemistry","3-chymotrypsin-like protease; 3CLpro; COVID-19; SARS-CoV-2; catalytic dyad; catalytic rate; thermodynamic stability","Ferreira","Juliana C","Science Division, New York University Abu Dhabi, Abu Dhabi, United Arab Emirates",NA
"1559","34249864","10.3389/fchem.2021.692168","Catalytic Dyad Residues His41 and Cys145 Impact the Catalytic Activity and Overall Conformational Fold of the Main SARS-CoV-2 Protease 3-Chymotrypsin-Like Protease.","Coronaviruses are responsible for multiple pandemics and millions of deaths globally, including the current pandemic of coronavirus disease 2019 (COVID-19). Development of antivirals against coronaviruses, including the severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) responsible for COVID-19, is essential for containing the current and future coronavirus outbreaks. SARS-CoV-2 proteases represent important targets for the development of antivirals because of their role in the process","2021","07","13","Front Chem","Frontiers in chemistry","3-chymotrypsin-like protease; 3CLpro; COVID-19; SARS-CoV-2; catalytic dyad; catalytic rate; thermodynamic stability","Fadl","Samar","Science Division, New York University Abu Dhabi, Abu Dhabi, United Arab Emirates",NA
"1560","34249864","10.3389/fchem.2021.692168","Catalytic Dyad Residues His41 and Cys145 Impact the Catalytic Activity and Overall Conformational Fold of the Main SARS-CoV-2 Protease 3-Chymotrypsin-Like Protease.","Coronaviruses are responsible for multiple pandemics and millions of deaths globally, including the current pandemic of coronavirus disease 2019 (COVID-19). Development of antivirals against coronaviruses, including the severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) responsible for COVID-19, is essential for containing the current and future coronavirus outbreaks. SARS-CoV-2 proteases represent important targets for the development of antivirals because of their role in the process","2021","07","13","Front Chem","Frontiers in chemistry","3-chymotrypsin-like protease; 3CLpro; COVID-19; SARS-CoV-2; catalytic dyad; catalytic rate; thermodynamic stability","Villanueva","Adrian J","Science Division, New York University Abu Dhabi, Abu Dhabi, United Arab Emirates",NA
"1561","34249864","10.3389/fchem.2021.692168","Catalytic Dyad Residues His41 and Cys145 Impact the Catalytic Activity and Overall Conformational Fold of the Main SARS-CoV-2 Protease 3-Chymotrypsin-Like Protease.","Coronaviruses are responsible for multiple pandemics and millions of deaths globally, including the current pandemic of coronavirus disease 2019 (COVID-19). Development of antivirals against coronaviruses, including the severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) responsible for COVID-19, is essential for containing the current and future coronavirus outbreaks. SARS-CoV-2 proteases represent important targets for the development of antivirals because of their role in the process","2021","07","13","Front Chem","Frontiers in chemistry","3-chymotrypsin-like protease; 3CLpro; COVID-19; SARS-CoV-2; catalytic dyad; catalytic rate; thermodynamic stability","Rabeh","Wael M","Science Division, New York University Abu Dhabi, Abu Dhabi, United Arab Emirates",NA
"1562","34249853","10.3389/fpubh.2021.702960","Ethical Considerations for Unblinding and Vaccinating COVID-19 Vaccine Trial Placebo Group Participants.",NA,"2021","07","14","Front Public Health","Frontiers in public health","COVID-19; clinical trials; placebo; vaccine; vaccine ethics; COVID-19; COVID-19 Vaccines; Double-Blind Method; Humans; SARS-CoV-2","Stoehr","Jenna Rose","Feinberg School of Medicine, Northwestern University, Chicago, IL, United States",NA
"1563","34249853","10.3389/fpubh.2021.702960","Ethical Considerations for Unblinding and Vaccinating COVID-19 Vaccine Trial Placebo Group Participants.",NA,"2021","07","14","Front Public Health","Frontiers in public health","COVID-19; clinical trials; placebo; vaccine; vaccine ethics; COVID-19; COVID-19 Vaccines; Double-Blind Method; Humans; SARS-CoV-2","Hamidian Jahromi","Alireza","Plastic and Reconstructive Surgery Department, Rush University Medical Center, Chicago, IL, United States",NA
"1564","34249853","10.3389/fpubh.2021.702960","Ethical Considerations for Unblinding and Vaccinating COVID-19 Vaccine Trial Placebo Group Participants.",NA,"2021","07","14","Front Public Health","Frontiers in public health","COVID-19; clinical trials; placebo; vaccine; vaccine ethics; COVID-19; COVID-19 Vaccines; Double-Blind Method; Humans; SARS-CoV-2","Thomason","Clayton","Department of Religion, Health and Human Values, Rush University Medical Center, Chicago, IL, United States",NA
"1565","34249851","10.3389/fpubh.2021.698106","Socio-Demographics Correlate of COVID-19 Vaccine Hesitancy During the Second Wave of COVID-19 Pandemic: A Cross-Sectional Web-Based Survey in Saudi Arabia.","Background: The Coronavirus disease 2019 (COVID-19) pandemic is considered a major global public health threat affecting across the life course and socioeconomic aspects of life. Global acceptance to an effective vaccine is the most anticipated resolution. This study aims to evaluate intent to be vaccinated among public in Saudi Arabia during the second wave of the COVID-19 pandemic. Methods: A cross-sectional web-based study was designed in Saudi Arabia. Study participants (N</","2021","07","14","Front Public Health","Frontiers in public health","Saudi Arabia; risk perception; second wave of COVID-19; trust; vaccine acceptance; vaccine hesitancy; COVID-19; COVID-19 Vaccines; Cross-Sectional Studies; Demography; Female; Humans; Internet; Pandemics; SARS-CoV-2; Saudi Arabia; Vaccines","Al-Mohaithef","Mohammed","Department of Public Health, College of Health Sciences, Saudi Electronic University, Riyadh, Saudi Arabia",NA
"1566","34249851","10.3389/fpubh.2021.698106","Socio-Demographics Correlate of COVID-19 Vaccine Hesitancy During the Second Wave of COVID-19 Pandemic: A Cross-Sectional Web-Based Survey in Saudi Arabia.","Background: The Coronavirus disease 2019 (COVID-19) pandemic is considered a major global public health threat affecting across the life course and socioeconomic aspects of life. Global acceptance to an effective vaccine is the most anticipated resolution. This study aims to evaluate intent to be vaccinated among public in Saudi Arabia during the second wave of the COVID-19 pandemic. Methods: A cross-sectional web-based study was designed in Saudi Arabia. Study participants (N</","2021","07","14","Front Public Health","Frontiers in public health","Saudi Arabia; risk perception; second wave of COVID-19; trust; vaccine acceptance; vaccine hesitancy; COVID-19; COVID-19 Vaccines; Cross-Sectional Studies; Demography; Female; Humans; Internet; Pandemics; SARS-CoV-2; Saudi Arabia; Vaccines","Padhi","Bijaya Kumar","Department of Community Medicine &amp",NA
"1567","34249851","10.3389/fpubh.2021.698106","Socio-Demographics Correlate of COVID-19 Vaccine Hesitancy During the Second Wave of COVID-19 Pandemic: A Cross-Sectional Web-Based Survey in Saudi Arabia.","Background: The Coronavirus disease 2019 (COVID-19) pandemic is considered a major global public health threat affecting across the life course and socioeconomic aspects of life. Global acceptance to an effective vaccine is the most anticipated resolution. This study aims to evaluate intent to be vaccinated among public in Saudi Arabia during the second wave of the COVID-19 pandemic. Methods: A cross-sectional web-based study was designed in Saudi Arabia. Study participants (N</","2021","07","14","Front Public Health","Frontiers in public health","Saudi Arabia; risk perception; second wave of COVID-19; trust; vaccine acceptance; vaccine hesitancy; COVID-19; COVID-19 Vaccines; Cross-Sectional Studies; Demography; Female; Humans; Internet; Pandemics; SARS-CoV-2; Saudi Arabia; Vaccines","Ennaceur","Soukaina","Department of Public Health, College of Health Sciences, Saudi Electronic University, Jeddah, Saudi Arabia",NA
"1568","34249847","10.3389/fpubh.2021.683683","Association Between Air Pollution and Acute Coronary Syndromes During Lockdown for COVID-19: Results From the Terni Hub Center.","Background: During the lockdown for COVID-19, a massive decrease in hospital admissions for acute coronary syndrome (ACS) and a drop in air pollution were both detected in Italy. Our aim was to investigate the possible association between these two events at the Province of Terni, one of the most polluted urban and industrial area in Central Italy. Methods: We analyzed data of daily 24-h urban air concentrations of particulate matter (PM)10 and PM2.5 from fixed station monitoring n","2021","07","14","Front Public Health","Frontiers in public health","COVID-19; acute coronary syndromes; air pollution; invasive procedures; lockdown; particulate matter; Acute Coronary Syndrome; Air Pollutants; Air Pollution; COVID-19; Cities; Communicable Disease Control; Environmental Monitoring; Humans; Italy; SARS-CoV-2","Arrivi","Alessio","Interventional Cardiology Unit, ""Santa Maria"" University Hospital, Terni, Italy",NA
"1569","34249847","10.3389/fpubh.2021.683683","Association Between Air Pollution and Acute Coronary Syndromes During Lockdown for COVID-19: Results From the Terni Hub Center.","Background: During the lockdown for COVID-19, a massive decrease in hospital admissions for acute coronary syndrome (ACS) and a drop in air pollution were both detected in Italy. Our aim was to investigate the possible association between these two events at the Province of Terni, one of the most polluted urban and industrial area in Central Italy. Methods: We analyzed data of daily 24-h urban air concentrations of particulate matter (PM)10 and PM2.5 from fixed station monitoring n","2021","07","14","Front Public Health","Frontiers in public health","COVID-19; acute coronary syndromes; air pollution; invasive procedures; lockdown; particulate matter; Acute Coronary Syndrome; Air Pollutants; Air Pollution; COVID-19; Cities; Communicable Disease Control; Environmental Monitoring; Humans; Italy; SARS-CoV-2","Dominici","Marcello","Interventional Cardiology Unit, ""Santa Maria"" University Hospital, Terni, Italy",NA
"1570","34249847","10.3389/fpubh.2021.683683","Association Between Air Pollution and Acute Coronary Syndromes During Lockdown for COVID-19: Results From the Terni Hub Center.","Background: During the lockdown for COVID-19, a massive decrease in hospital admissions for acute coronary syndrome (ACS) and a drop in air pollution were both detected in Italy. Our aim was to investigate the possible association between these two events at the Province of Terni, one of the most polluted urban and industrial area in Central Italy. Methods: We analyzed data of daily 24-h urban air concentrations of particulate matter (PM)10 and PM2.5 from fixed station monitoring n","2021","07","14","Front Public Health","Frontiers in public health","COVID-19; acute coronary syndromes; air pollution; invasive procedures; lockdown; particulate matter; Acute Coronary Syndrome; Air Pollutants; Air Pollution; COVID-19; Cities; Communicable Disease Control; Environmental Monitoring; Humans; Italy; SARS-CoV-2","Bier","Nicola","Interventional Cardiology Unit, ""Santa Maria"" University Hospital, Terni, Italy",NA
"1571","34249847","10.3389/fpubh.2021.683683","Association Between Air Pollution and Acute Coronary Syndromes During Lockdown for COVID-19: Results From the Terni Hub Center.","Background: During the lockdown for COVID-19, a massive decrease in hospital admissions for acute coronary syndrome (ACS) and a drop in air pollution were both detected in Italy. Our aim was to investigate the possible association between these two events at the Province of Terni, one of the most polluted urban and industrial area in Central Italy. Methods: We analyzed data of daily 24-h urban air concentrations of particulate matter (PM)10 and PM2.5 from fixed station monitoring n","2021","07","14","Front Public Health","Frontiers in public health","COVID-19; acute coronary syndromes; air pollution; invasive procedures; lockdown; particulate matter; Acute Coronary Syndrome; Air Pollutants; Air Pollution; COVID-19; Cities; Communicable Disease Control; Environmental Monitoring; Humans; Italy; SARS-CoV-2","Truglio","Mauro","Laboratory of Cutaneous Physiopathology, San Gallicano Dermatological Institute Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Rome, Italy",NA
"1572","34249847","10.3389/fpubh.2021.683683","Association Between Air Pollution and Acute Coronary Syndromes During Lockdown for COVID-19: Results From the Terni Hub Center.","Background: During the lockdown for COVID-19, a massive decrease in hospital admissions for acute coronary syndrome (ACS) and a drop in air pollution were both detected in Italy. Our aim was to investigate the possible association between these two events at the Province of Terni, one of the most polluted urban and industrial area in Central Italy. Methods: We analyzed data of daily 24-h urban air concentrations of particulate matter (PM)10 and PM2.5 from fixed station monitoring n","2021","07","14","Front Public Health","Frontiers in public health","COVID-19; acute coronary syndromes; air pollution; invasive procedures; lockdown; particulate matter; Acute Coronary Syndrome; Air Pollutants; Air Pollution; COVID-19; Cities; Communicable Disease Control; Environmental Monitoring; Humans; Italy; SARS-CoV-2","Vaudo","Gaetano","Department of Medicine and Surgery, University of Perugia, Perugia, Italy",NA
"1573","34249847","10.3389/fpubh.2021.683683","Association Between Air Pollution and Acute Coronary Syndromes During Lockdown for COVID-19: Results From the Terni Hub Center.","Background: During the lockdown for COVID-19, a massive decrease in hospital admissions for acute coronary syndrome (ACS) and a drop in air pollution were both detected in Italy. Our aim was to investigate the possible association between these two events at the Province of Terni, one of the most polluted urban and industrial area in Central Italy. Methods: We analyzed data of daily 24-h urban air concentrations of particulate matter (PM)10 and PM2.5 from fixed station monitoring n","2021","07","14","Front Public Health","Frontiers in public health","COVID-19; acute coronary syndromes; air pollution; invasive procedures; lockdown; particulate matter; Acute Coronary Syndrome; Air Pollutants; Air Pollution; COVID-19; Cities; Communicable Disease Control; Environmental Monitoring; Humans; Italy; SARS-CoV-2","Pucci","Giacomo","Department of Medicine and Surgery, University of Perugia, Perugia, Italy",NA
"1574","34249844","10.3389/fpubh.2021.680028","Psychological and Demographic Determinants of Substance Use and Mental Health During the COVID-19 Pandemic.","Background: Alcohol consumption and distress have increased among Canadians since the start of the COVID-19 pandemic. Methods: We examined whether sociodemographic and COVID-19-related worries are associated with various combinations of alcohol consumption and comorbid psychological distress variables among a Canadian sample of adults. Data were derived from a sample of Canadian adults (N = 1,005, 49.6% female) who participated in an online survey in May 2020. Four multivari","2021","07","14","Front Public Health","Frontiers in public health","COVID-19; alcohol use and alcohol problems; anxiety; binge drinking; concurrency; depression; Adult; COVID-19; Canada; Demography; Female; Humans; Male; Mental Health; Pandemics; SARS-CoV-2; Substance-Related Disorders","Mougharbel","Fatima","Interdisciplinary School of Health Sciences, University of Ottawa, Ottawa, ON, Canada",NA
"1575","34249844","10.3389/fpubh.2021.680028","Psychological and Demographic Determinants of Substance Use and Mental Health During the COVID-19 Pandemic.","Background: Alcohol consumption and distress have increased among Canadians since the start of the COVID-19 pandemic. Methods: We examined whether sociodemographic and COVID-19-related worries are associated with various combinations of alcohol consumption and comorbid psychological distress variables among a Canadian sample of adults. Data were derived from a sample of Canadian adults (N = 1,005, 49.6% female) who participated in an online survey in May 2020. Four multivari","2021","07","14","Front Public Health","Frontiers in public health","COVID-19; alcohol use and alcohol problems; anxiety; binge drinking; concurrency; depression; Adult; COVID-19; Canada; Demography; Female; Humans; Male; Mental Health; Pandemics; SARS-CoV-2; Substance-Related Disorders","Sampasa-Kanyinga","Hugues","Healthy Active Living and Obesity Research Group, Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada",NA
"1576","34249844","10.3389/fpubh.2021.680028","Psychological and Demographic Determinants of Substance Use and Mental Health During the COVID-19 Pandemic.","Background: Alcohol consumption and distress have increased among Canadians since the start of the COVID-19 pandemic. Methods: We examined whether sociodemographic and COVID-19-related worries are associated with various combinations of alcohol consumption and comorbid psychological distress variables among a Canadian sample of adults. Data were derived from a sample of Canadian adults (N = 1,005, 49.6% female) who participated in an online survey in May 2020. Four multivari","2021","07","14","Front Public Health","Frontiers in public health","COVID-19; alcohol use and alcohol problems; anxiety; binge drinking; concurrency; depression; Adult; COVID-19; Canada; Demography; Female; Humans; Male; Mental Health; Pandemics; SARS-CoV-2; Substance-Related Disorders","Heidinger","Brandon","Healthy Active Living and Obesity Research Group, Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada",NA
"1577","34249844","10.3389/fpubh.2021.680028","Psychological and Demographic Determinants of Substance Use and Mental Health During the COVID-19 Pandemic.","Background: Alcohol consumption and distress have increased among Canadians since the start of the COVID-19 pandemic. Methods: We examined whether sociodemographic and COVID-19-related worries are associated with various combinations of alcohol consumption and comorbid psychological distress variables among a Canadian sample of adults. Data were derived from a sample of Canadian adults (N = 1,005, 49.6% female) who participated in an online survey in May 2020. Four multivari","2021","07","14","Front Public Health","Frontiers in public health","COVID-19; alcohol use and alcohol problems; anxiety; binge drinking; concurrency; depression; Adult; COVID-19; Canada; Demography; Female; Humans; Male; Mental Health; Pandemics; SARS-CoV-2; Substance-Related Disorders","Corace","Kim","The Royal's Institute of Mental Health Research, Ottawa, ON, Canada",NA
"1578","34249844","10.3389/fpubh.2021.680028","Psychological and Demographic Determinants of Substance Use and Mental Health During the COVID-19 Pandemic.","Background: Alcohol consumption and distress have increased among Canadians since the start of the COVID-19 pandemic. Methods: We examined whether sociodemographic and COVID-19-related worries are associated with various combinations of alcohol consumption and comorbid psychological distress variables among a Canadian sample of adults. Data were derived from a sample of Canadian adults (N = 1,005, 49.6% female) who participated in an online survey in May 2020. Four multivari","2021","07","14","Front Public Health","Frontiers in public health","COVID-19; alcohol use and alcohol problems; anxiety; binge drinking; concurrency; depression; Adult; COVID-19; Canada; Demography; Female; Humans; Male; Mental Health; Pandemics; SARS-CoV-2; Substance-Related Disorders","Hamilton","Hayley A","Centre for Addiction and Mental Health, Institute for Mental Health Policy Research, Toronto, ON, Canada",NA
"1579","34249844","10.3389/fpubh.2021.680028","Psychological and Demographic Determinants of Substance Use and Mental Health During the COVID-19 Pandemic.","Background: Alcohol consumption and distress have increased among Canadians since the start of the COVID-19 pandemic. Methods: We examined whether sociodemographic and COVID-19-related worries are associated with various combinations of alcohol consumption and comorbid psychological distress variables among a Canadian sample of adults. Data were derived from a sample of Canadian adults (N = 1,005, 49.6% female) who participated in an online survey in May 2020. Four multivari","2021","07","14","Front Public Health","Frontiers in public health","COVID-19; alcohol use and alcohol problems; anxiety; binge drinking; concurrency; depression; Adult; COVID-19; Canada; Demography; Female; Humans; Male; Mental Health; Pandemics; SARS-CoV-2; Substance-Related Disorders","Goldfield","Gary S","Healthy Active Living and Obesity Research Group, Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada",NA
"1580","34249843","10.3389/fpubh.2021.676784","Declaring Racism a Public Health Crisis in the United States: Cure, Poison, or Both?","Declaring racism a public health crisis has the potential to shepherd meaningful anti-racism policy forward and bridge long standing divisions between policy-makers, community organizers, healers, and public health practitioners. At their best, the declarations are a first step to address long standing inaction in the face of need. At their worst, the declarations poison or sedate grassroots momentum toward anti-racism structural change by delivering politicians unearned publicity and slowing pr","2021","07","14","Front Public Health","Frontiers in public health","accountability; black lives matter; decolonial practice; health equity; pharmakon; public health crisis; social justice policy; structural racism; African Americans; Health Equity; Humans; Poisons; Public Health; Racism; United States","Paine","Lilliann","National Birth Equity Collaborative, Washington, DC, United States",NA
"1581","34249843","10.3389/fpubh.2021.676784","Declaring Racism a Public Health Crisis in the United States: Cure, Poison, or Both?","Declaring racism a public health crisis has the potential to shepherd meaningful anti-racism policy forward and bridge long standing divisions between policy-makers, community organizers, healers, and public health practitioners. At their best, the declarations are a first step to address long standing inaction in the face of need. At their worst, the declarations poison or sedate grassroots momentum toward anti-racism structural change by delivering politicians unearned publicity and slowing pr","2021","07","14","Front Public Health","Frontiers in public health","accountability; black lives matter; decolonial practice; health equity; pharmakon; public health crisis; social justice policy; structural racism; African Americans; Health Equity; Humans; Poisons; Public Health; Racism; United States","de la Rocha","Patanjali","EqualHealth's Global Campaign Against Racism, Brookline, MA, United States",NA
"1582","34249843","10.3389/fpubh.2021.676784","Declaring Racism a Public Health Crisis in the United States: Cure, Poison, or Both?","Declaring racism a public health crisis has the potential to shepherd meaningful anti-racism policy forward and bridge long standing divisions between policy-makers, community organizers, healers, and public health practitioners. At their best, the declarations are a first step to address long standing inaction in the face of need. At their worst, the declarations poison or sedate grassroots momentum toward anti-racism structural change by delivering politicians unearned publicity and slowing pr","2021","07","14","Front Public Health","Frontiers in public health","accountability; black lives matter; decolonial practice; health equity; pharmakon; public health crisis; social justice policy; structural racism; African Americans; Health Equity; Humans; Poisons; Public Health; Racism; United States","Eyssallenne","Antonia P","EqualHealth's Global Campaign Against Racism, Brookline, MA, United States",NA
"1583","34249843","10.3389/fpubh.2021.676784","Declaring Racism a Public Health Crisis in the United States: Cure, Poison, or Both?","Declaring racism a public health crisis has the potential to shepherd meaningful anti-racism policy forward and bridge long standing divisions between policy-makers, community organizers, healers, and public health practitioners. At their best, the declarations are a first step to address long standing inaction in the face of need. At their worst, the declarations poison or sedate grassroots momentum toward anti-racism structural change by delivering politicians unearned publicity and slowing pr","2021","07","14","Front Public Health","Frontiers in public health","accountability; black lives matter; decolonial practice; health equity; pharmakon; public health crisis; social justice policy; structural racism; African Americans; Health Equity; Humans; Poisons; Public Health; Racism; United States","Andrews","Courtni Alexis","EqualHealth's Global Campaign Against Racism, Brookline, MA, United States",NA
"1584","34249843","10.3389/fpubh.2021.676784","Declaring Racism a Public Health Crisis in the United States: Cure, Poison, or Both?","Declaring racism a public health crisis has the potential to shepherd meaningful anti-racism policy forward and bridge long standing divisions between policy-makers, community organizers, healers, and public health practitioners. At their best, the declarations are a first step to address long standing inaction in the face of need. At their worst, the declarations poison or sedate grassroots momentum toward anti-racism structural change by delivering politicians unearned publicity and slowing pr","2021","07","14","Front Public Health","Frontiers in public health","accountability; black lives matter; decolonial practice; health equity; pharmakon; public health crisis; social justice policy; structural racism; African Americans; Health Equity; Humans; Poisons; Public Health; Racism; United States","Loo","Leanne","EqualHealth's Global Campaign Against Racism, Brookline, MA, United States",NA
"1585","34249843","10.3389/fpubh.2021.676784","Declaring Racism a Public Health Crisis in the United States: Cure, Poison, or Both?","Declaring racism a public health crisis has the potential to shepherd meaningful anti-racism policy forward and bridge long standing divisions between policy-makers, community organizers, healers, and public health practitioners. At their best, the declarations are a first step to address long standing inaction in the face of need. At their worst, the declarations poison or sedate grassroots momentum toward anti-racism structural change by delivering politicians unearned publicity and slowing pr","2021","07","14","Front Public Health","Frontiers in public health","accountability; black lives matter; decolonial practice; health equity; pharmakon; public health crisis; social justice policy; structural racism; African Americans; Health Equity; Humans; Poisons; Public Health; Racism; United States","Jones","Camara Phyllis","EqualHealth's Global Campaign Against Racism, Brookline, MA, United States",NA
"1586","34249843","10.3389/fpubh.2021.676784","Declaring Racism a Public Health Crisis in the United States: Cure, Poison, or Both?","Declaring racism a public health crisis has the potential to shepherd meaningful anti-racism policy forward and bridge long standing divisions between policy-makers, community organizers, healers, and public health practitioners. At their best, the declarations are a first step to address long standing inaction in the face of need. At their worst, the declarations poison or sedate grassroots momentum toward anti-racism structural change by delivering politicians unearned publicity and slowing pr","2021","07","14","Front Public Health","Frontiers in public health","accountability; black lives matter; decolonial practice; health equity; pharmakon; public health crisis; social justice policy; structural racism; African Americans; Health Equity; Humans; Poisons; Public Health; Racism; United States","Collins","Anne Marie","EqualHealth's Global Campaign Against Racism, Brookline, MA, United States",NA
"1587","34249843","10.3389/fpubh.2021.676784","Declaring Racism a Public Health Crisis in the United States: Cure, Poison, or Both?","Declaring racism a public health crisis has the potential to shepherd meaningful anti-racism policy forward and bridge long standing divisions between policy-makers, community organizers, healers, and public health practitioners. At their best, the declarations are a first step to address long standing inaction in the face of need. At their worst, the declarations poison or sedate grassroots momentum toward anti-racism structural change by delivering politicians unearned publicity and slowing pr","2021","07","14","Front Public Health","Frontiers in public health","accountability; black lives matter; decolonial practice; health equity; pharmakon; public health crisis; social justice policy; structural racism; African Americans; Health Equity; Humans; Poisons; Public Health; Racism; United States","Morse","Michelle","EqualHealth's Global Campaign Against Racism, Brookline, MA, United States",NA
"1588","34249841","10.3389/fpubh.2021.674843","Development of an Asthma Home-Visit Training Program for Community Health Workers and Their Supervisors in Washington State.","The community health worker (CHW) asthma home-visiting model developed by Public Health-Seattle &amp; King County (PHSKC) is an evidence-based approach proven to improve health outcomes and quality of life. In addition, it has been shown to be an effective and culturally appropriate approach to helping people with asthma understand the environmental and behavioral causes of uncontrolled asthma, while acquiring the skills they need to control their asthma. This paper describes the development and","2021","07","14","Front Public Health","Frontiers in public health","asthma; community based participatory research; community health worker; environmental assessment; health disparities; home visit; implementation science; training; Aged; Asthma; COVID-19; Community Health Workers; House Calls; Humans; Medicare; Pandemics; Quality of Life; SARS-CoV-2; United States; Washington","Elkugia","Nuha","Chronic Disease and Injury Prevention Section, Public Health-Seattle and King County, Seattle, WA, United States",NA
"1589","34249841","10.3389/fpubh.2021.674843","Development of an Asthma Home-Visit Training Program for Community Health Workers and Their Supervisors in Washington State.","The community health worker (CHW) asthma home-visiting model developed by Public Health-Seattle &amp; King County (PHSKC) is an evidence-based approach proven to improve health outcomes and quality of life. In addition, it has been shown to be an effective and culturally appropriate approach to helping people with asthma understand the environmental and behavioral causes of uncontrolled asthma, while acquiring the skills they need to control their asthma. This paper describes the development and","2021","07","14","Front Public Health","Frontiers in public health","asthma; community based participatory research; community health worker; environmental assessment; health disparities; home visit; implementation science; training; Aged; Asthma; COVID-19; Community Health Workers; House Calls; Humans; Medicare; Pandemics; Quality of Life; SARS-CoV-2; United States; Washington","Crocker","Mary E","Division of Pulmonary and Sleep Medicine, Department of Pediatrics, University of Washington, Seattle, WA, United States",NA
"1590","34249841","10.3389/fpubh.2021.674843","Development of an Asthma Home-Visit Training Program for Community Health Workers and Their Supervisors in Washington State.","The community health worker (CHW) asthma home-visiting model developed by Public Health-Seattle &amp; King County (PHSKC) is an evidence-based approach proven to improve health outcomes and quality of life. In addition, it has been shown to be an effective and culturally appropriate approach to helping people with asthma understand the environmental and behavioral causes of uncontrolled asthma, while acquiring the skills they need to control their asthma. This paper describes the development and","2021","07","14","Front Public Health","Frontiers in public health","asthma; community based participatory research; community health worker; environmental assessment; health disparities; home visit; implementation science; training; Aged; Asthma; COVID-19; Community Health Workers; House Calls; Humans; Medicare; Pandemics; Quality of Life; SARS-CoV-2; United States; Washington","Stout","James W","Division of General Pediatrics, Department of Pediatrics, University of Washington, Seattle, WA, United States",NA
"1591","34249841","10.3389/fpubh.2021.674843","Development of an Asthma Home-Visit Training Program for Community Health Workers and Their Supervisors in Washington State.","The community health worker (CHW) asthma home-visiting model developed by Public Health-Seattle &amp; King County (PHSKC) is an evidence-based approach proven to improve health outcomes and quality of life. In addition, it has been shown to be an effective and culturally appropriate approach to helping people with asthma understand the environmental and behavioral causes of uncontrolled asthma, while acquiring the skills they need to control their asthma. This paper describes the development and","2021","07","14","Front Public Health","Frontiers in public health","asthma; community based participatory research; community health worker; environmental assessment; health disparities; home visit; implementation science; training; Aged; Asthma; COVID-19; Community Health Workers; House Calls; Humans; Medicare; Pandemics; Quality of Life; SARS-CoV-2; United States; Washington","Bolt","Kaylin","Assessment Policy Development and Evaluation Unit, Public Health-Seattle and King County, Seattle, WA, United States",NA
"1592","34249841","10.3389/fpubh.2021.674843","Development of an Asthma Home-Visit Training Program for Community Health Workers and Their Supervisors in Washington State.","The community health worker (CHW) asthma home-visiting model developed by Public Health-Seattle &amp; King County (PHSKC) is an evidence-based approach proven to improve health outcomes and quality of life. In addition, it has been shown to be an effective and culturally appropriate approach to helping people with asthma understand the environmental and behavioral causes of uncontrolled asthma, while acquiring the skills they need to control their asthma. This paper describes the development and","2021","07","14","Front Public Health","Frontiers in public health","asthma; community based participatory research; community health worker; environmental assessment; health disparities; home visit; implementation science; training; Aged; Asthma; COVID-19; Community Health Workers; House Calls; Humans; Medicare; Pandemics; Quality of Life; SARS-CoV-2; United States; Washington","Weiner","Bryan J","Department of Health Services, University of Washington, Seattle, WA, United States",NA
"1593","34249841","10.3389/fpubh.2021.674843","Development of an Asthma Home-Visit Training Program for Community Health Workers and Their Supervisors in Washington State.","The community health worker (CHW) asthma home-visiting model developed by Public Health-Seattle &amp; King County (PHSKC) is an evidence-based approach proven to improve health outcomes and quality of life. In addition, it has been shown to be an effective and culturally appropriate approach to helping people with asthma understand the environmental and behavioral causes of uncontrolled asthma, while acquiring the skills they need to control their asthma. This paper describes the development and","2021","07","14","Front Public Health","Frontiers in public health","asthma; community based participatory research; community health worker; environmental assessment; health disparities; home visit; implementation science; training; Aged; Asthma; COVID-19; Community Health Workers; House Calls; Humans; Medicare; Pandemics; Quality of Life; SARS-CoV-2; United States; Washington","Kramer","C Bradley","Chronic Disease and Injury Prevention Section, Public Health-Seattle and King County, Seattle, WA, United States",NA
"1594","34249839","10.3389/fpubh.2021.672344","Providing a Safe, In-Person, Residential College Experience During the COVID-19 Pandemic.","Due to the COVID-19 pandemic, higher education institutions were forced to make difficult decisions regarding the 2020-2021 academic year. Many institutions decided to have courses in an online remote format, others decided to attempt an in-person experience, while still others took a hybrid approach. Hope College (Holland, MI) decided that an in-person semester would be safer and more equitable for students. To achieve this at a residential college required broad collaboration across multiple s","2021","07","14","Front Public Health","Frontiers in public health","COVID-19 testing; SARS-CoV2 (COVID-19); public health; undergraduate college education; virology; wastewater; COVID-19; Education, Distance; Humans; Pandemics; SARS-CoV-2; Universities","Travis","Scott A","Hope College, Holland, MI, United States",NA
"1595","34249839","10.3389/fpubh.2021.672344","Providing a Safe, In-Person, Residential College Experience During the COVID-19 Pandemic.","Due to the COVID-19 pandemic, higher education institutions were forced to make difficult decisions regarding the 2020-2021 academic year. Many institutions decided to have courses in an online remote format, others decided to attempt an in-person experience, while still others took a hybrid approach. Hope College (Holland, MI) decided that an in-person semester would be safer and more equitable for students. To achieve this at a residential college required broad collaboration across multiple s","2021","07","14","Front Public Health","Frontiers in public health","COVID-19 testing; SARS-CoV2 (COVID-19); public health; undergraduate college education; virology; wastewater; COVID-19; Education, Distance; Humans; Pandemics; SARS-CoV-2; Universities","Best","Aaron A","Department of Biology, Hope College, Holland, MI, United States",NA
"1596","34249839","10.3389/fpubh.2021.672344","Providing a Safe, In-Person, Residential College Experience During the COVID-19 Pandemic.","Due to the COVID-19 pandemic, higher education institutions were forced to make difficult decisions regarding the 2020-2021 academic year. Many institutions decided to have courses in an online remote format, others decided to attempt an in-person experience, while still others took a hybrid approach. Hope College (Holland, MI) decided that an in-person semester would be safer and more equitable for students. To achieve this at a residential college required broad collaboration across multiple s","2021","07","14","Front Public Health","Frontiers in public health","COVID-19 testing; SARS-CoV2 (COVID-19); public health; undergraduate college education; virology; wastewater; COVID-19; Education, Distance; Humans; Pandemics; SARS-CoV-2; Universities","Bochniak","Kristyn S","Hope College, Holland, MI, United States",NA
"1597","34249839","10.3389/fpubh.2021.672344","Providing a Safe, In-Person, Residential College Experience During the COVID-19 Pandemic.","Due to the COVID-19 pandemic, higher education institutions were forced to make difficult decisions regarding the 2020-2021 academic year. Many institutions decided to have courses in an online remote format, others decided to attempt an in-person experience, while still others took a hybrid approach. Hope College (Holland, MI) decided that an in-person semester would be safer and more equitable for students. To achieve this at a residential college required broad collaboration across multiple s","2021","07","14","Front Public Health","Frontiers in public health","COVID-19 testing; SARS-CoV2 (COVID-19); public health; undergraduate college education; virology; wastewater; COVID-19; Education, Distance; Humans; Pandemics; SARS-CoV-2; Universities","Dunteman","Nicole D","Hope College, Holland, MI, United States",NA
"1598","34249839","10.3389/fpubh.2021.672344","Providing a Safe, In-Person, Residential College Experience During the COVID-19 Pandemic.","Due to the COVID-19 pandemic, higher education institutions were forced to make difficult decisions regarding the 2020-2021 academic year. Many institutions decided to have courses in an online remote format, others decided to attempt an in-person experience, while still others took a hybrid approach. Hope College (Holland, MI) decided that an in-person semester would be safer and more equitable for students. To achieve this at a residential college required broad collaboration across multiple s","2021","07","14","Front Public Health","Frontiers in public health","COVID-19 testing; SARS-CoV2 (COVID-19); public health; undergraduate college education; virology; wastewater; COVID-19; Education, Distance; Humans; Pandemics; SARS-CoV-2; Universities","Fellinger","Jennifer","Hope College, Holland, MI, United States",NA
"1599","34249839","10.3389/fpubh.2021.672344","Providing a Safe, In-Person, Residential College Experience During the COVID-19 Pandemic.","Due to the COVID-19 pandemic, higher education institutions were forced to make difficult decisions regarding the 2020-2021 academic year. Many institutions decided to have courses in an online remote format, others decided to attempt an in-person experience, while still others took a hybrid approach. Hope College (Holland, MI) decided that an in-person semester would be safer and more equitable for students. To achieve this at a residential college required broad collaboration across multiple s","2021","07","14","Front Public Health","Frontiers in public health","COVID-19 testing; SARS-CoV2 (COVID-19); public health; undergraduate college education; virology; wastewater; COVID-19; Education, Distance; Humans; Pandemics; SARS-CoV-2; Universities","Folkert","Peter D","Hope College, Holland, MI, United States",NA
"1600","34249839","10.3389/fpubh.2021.672344","Providing a Safe, In-Person, Residential College Experience During the COVID-19 Pandemic.","Due to the COVID-19 pandemic, higher education institutions were forced to make difficult decisions regarding the 2020-2021 academic year. Many institutions decided to have courses in an online remote format, others decided to attempt an in-person experience, while still others took a hybrid approach. Hope College (Holland, MI) decided that an in-person semester would be safer and more equitable for students. To achieve this at a residential college required broad collaboration across multiple s","2021","07","14","Front Public Health","Frontiers in public health","COVID-19 testing; SARS-CoV2 (COVID-19); public health; undergraduate college education; virology; wastewater; COVID-19; Education, Distance; Humans; Pandemics; SARS-CoV-2; Universities","Koberna","Timothy","Hope College, Holland, MI, United States",NA
"1601","34249839","10.3389/fpubh.2021.672344","Providing a Safe, In-Person, Residential College Experience During the COVID-19 Pandemic.","Due to the COVID-19 pandemic, higher education institutions were forced to make difficult decisions regarding the 2020-2021 academic year. Many institutions decided to have courses in an online remote format, others decided to attempt an in-person experience, while still others took a hybrid approach. Hope College (Holland, MI) decided that an in-person semester would be safer and more equitable for students. To achieve this at a residential college required broad collaboration across multiple s","2021","07","14","Front Public Health","Frontiers in public health","COVID-19 testing; SARS-CoV2 (COVID-19); public health; undergraduate college education; virology; wastewater; COVID-19; Education, Distance; Humans; Pandemics; SARS-CoV-2; Universities","Kopek","Benjamin G","Department of Biology, Hope College, Holland, MI, United States",NA
"1602","34249839","10.3389/fpubh.2021.672344","Providing a Safe, In-Person, Residential College Experience During the COVID-19 Pandemic.","Due to the COVID-19 pandemic, higher education institutions were forced to make difficult decisions regarding the 2020-2021 academic year. Many institutions decided to have courses in an online remote format, others decided to attempt an in-person experience, while still others took a hybrid approach. Hope College (Holland, MI) decided that an in-person semester would be safer and more equitable for students. To achieve this at a residential college required broad collaboration across multiple s","2021","07","14","Front Public Health","Frontiers in public health","COVID-19 testing; SARS-CoV2 (COVID-19); public health; undergraduate college education; virology; wastewater; COVID-19; Education, Distance; Humans; Pandemics; SARS-CoV-2; Universities","Krueger","Brent P","Department of Chemistry, Hope College, Holland, MI, United States",NA
"1603","34249839","10.3389/fpubh.2021.672344","Providing a Safe, In-Person, Residential College Experience During the COVID-19 Pandemic.","Due to the COVID-19 pandemic, higher education institutions were forced to make difficult decisions regarding the 2020-2021 academic year. Many institutions decided to have courses in an online remote format, others decided to attempt an in-person experience, while still others took a hybrid approach. Hope College (Holland, MI) decided that an in-person semester would be safer and more equitable for students. To achieve this at a residential college required broad collaboration across multiple s","2021","07","14","Front Public Health","Frontiers in public health","COVID-19 testing; SARS-CoV2 (COVID-19); public health; undergraduate college education; virology; wastewater; COVID-19; Education, Distance; Humans; Pandemics; SARS-CoV-2; Universities","Pestun","Jeff","Hope College, Holland, MI, United States",NA
"1604","34249839","10.3389/fpubh.2021.672344","Providing a Safe, In-Person, Residential College Experience During the COVID-19 Pandemic.","Due to the COVID-19 pandemic, higher education institutions were forced to make difficult decisions regarding the 2020-2021 academic year. Many institutions decided to have courses in an online remote format, others decided to attempt an in-person experience, while still others took a hybrid approach. Hope College (Holland, MI) decided that an in-person semester would be safer and more equitable for students. To achieve this at a residential college required broad collaboration across multiple s","2021","07","14","Front Public Health","Frontiers in public health","COVID-19 testing; SARS-CoV2 (COVID-19); public health; undergraduate college education; virology; wastewater; COVID-19; Education, Distance; Humans; Pandemics; SARS-CoV-2; Universities","Pikaart","Michael J","Department of Chemistry, Hope College, Holland, MI, United States",NA
"1605","34249839","10.3389/fpubh.2021.672344","Providing a Safe, In-Person, Residential College Experience During the COVID-19 Pandemic.","Due to the COVID-19 pandemic, higher education institutions were forced to make difficult decisions regarding the 2020-2021 academic year. Many institutions decided to have courses in an online remote format, others decided to attempt an in-person experience, while still others took a hybrid approach. Hope College (Holland, MI) decided that an in-person semester would be safer and more equitable for students. To achieve this at a residential college required broad collaboration across multiple s","2021","07","14","Front Public Health","Frontiers in public health","COVID-19 testing; SARS-CoV2 (COVID-19); public health; undergraduate college education; virology; wastewater; COVID-19; Education, Distance; Humans; Pandemics; SARS-CoV-2; Universities","Sabo","Cindy","Hope College, Holland, MI, United States",NA
"1606","34249839","10.3389/fpubh.2021.672344","Providing a Safe, In-Person, Residential College Experience During the COVID-19 Pandemic.","Due to the COVID-19 pandemic, higher education institutions were forced to make difficult decisions regarding the 2020-2021 academic year. Many institutions decided to have courses in an online remote format, others decided to attempt an in-person experience, while still others took a hybrid approach. Hope College (Holland, MI) decided that an in-person semester would be safer and more equitable for students. To achieve this at a residential college required broad collaboration across multiple s","2021","07","14","Front Public Health","Frontiers in public health","COVID-19 testing; SARS-CoV2 (COVID-19); public health; undergraduate college education; virology; wastewater; COVID-19; Education, Distance; Humans; Pandemics; SARS-CoV-2; Universities","Schuitema","Alex J","Hope College, Holland, MI, United States",NA
"1607","34249831","10.3389/fpubh.2021.649524","Rapid Point-Of-Care Serology and Clinical History Assessment Increase Protection Provided by RT-PCR Screening: A Pilot Study Involving Three Nursing Homes in Brescia, a Hotspot of Lombardy.","Background: COVID-19 outbursts have been registered worldwide within care homes with asymptomatic transmission combined with shortage/inaccuracy of diagnostic tests undermining the efforts at containment of the disease. Nursing facilities in Lombardy (Italy) were left with no, or limited, access to testing for 8 weeks after the outbreak of COVID-19. Methods: This study includes 246 residents and 286 workers of three different nursing homes in Brescia-Lombardy. Clinical questionnair","2021","07","14","Front Public Health","Frontiers in public health","COVID-19; COVID-19 symptoms; RT-PCR screening; SARSCoV-2; asymptomatic transmission; nursing home; on-site testing; rapid serological assays; Aged; COVID-19; Humans; Italy; Nursing Homes; Pilot Projects; Point-of-Care Systems; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2","Savio","Antonella","Histopathology Department, The Royal Marsden Hospital, London, United Kingdom",NA
"1608","34249831","10.3389/fpubh.2021.649524","Rapid Point-Of-Care Serology and Clinical History Assessment Increase Protection Provided by RT-PCR Screening: A Pilot Study Involving Three Nursing Homes in Brescia, a Hotspot of Lombardy.","Background: COVID-19 outbursts have been registered worldwide within care homes with asymptomatic transmission combined with shortage/inaccuracy of diagnostic tests undermining the efforts at containment of the disease. Nursing facilities in Lombardy (Italy) were left with no, or limited, access to testing for 8 weeks after the outbreak of COVID-19. Methods: This study includes 246 residents and 286 workers of three different nursing homes in Brescia-Lombardy. Clinical questionnair","2021","07","14","Front Public Health","Frontiers in public health","COVID-19; COVID-19 symptoms; RT-PCR screening; SARSCoV-2; asymptomatic transmission; nursing home; on-site testing; rapid serological assays; Aged; COVID-19; Humans; Italy; Nursing Homes; Pilot Projects; Point-of-Care Systems; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2","Calza","Stefano","Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy",NA
"1609","34249831","10.3389/fpubh.2021.649524","Rapid Point-Of-Care Serology and Clinical History Assessment Increase Protection Provided by RT-PCR Screening: A Pilot Study Involving Three Nursing Homes in Brescia, a Hotspot of Lombardy.","Background: COVID-19 outbursts have been registered worldwide within care homes with asymptomatic transmission combined with shortage/inaccuracy of diagnostic tests undermining the efforts at containment of the disease. Nursing facilities in Lombardy (Italy) were left with no, or limited, access to testing for 8 weeks after the outbreak of COVID-19. Methods: This study includes 246 residents and 286 workers of three different nursing homes in Brescia-Lombardy. Clinical questionnair","2021","07","14","Front Public Health","Frontiers in public health","COVID-19; COVID-19 symptoms; RT-PCR screening; SARSCoV-2; asymptomatic transmission; nursing home; on-site testing; rapid serological assays; Aged; COVID-19; Humans; Italy; Nursing Homes; Pilot Projects; Point-of-Care Systems; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2","Guerrini","Gianbattista","Nursing Homes Villa Elisa and Arici-Sega, Brescia, Italy",NA
"1610","34249831","10.3389/fpubh.2021.649524","Rapid Point-Of-Care Serology and Clinical History Assessment Increase Protection Provided by RT-PCR Screening: A Pilot Study Involving Three Nursing Homes in Brescia, a Hotspot of Lombardy.","Background: COVID-19 outbursts have been registered worldwide within care homes with asymptomatic transmission combined with shortage/inaccuracy of diagnostic tests undermining the efforts at containment of the disease. Nursing facilities in Lombardy (Italy) were left with no, or limited, access to testing for 8 weeks after the outbreak of COVID-19. Methods: This study includes 246 residents and 286 workers of three different nursing homes in Brescia-Lombardy. Clinical questionnair","2021","07","14","Front Public Health","Frontiers in public health","COVID-19; COVID-19 symptoms; RT-PCR screening; SARSCoV-2; asymptomatic transmission; nursing home; on-site testing; rapid serological assays; Aged; COVID-19; Humans; Italy; Nursing Homes; Pilot Projects; Point-of-Care Systems; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2","Romano","Valentina","Nursing Home Casa Industria, Brescia, Italy",NA
"1611","34249831","10.3389/fpubh.2021.649524","Rapid Point-Of-Care Serology and Clinical History Assessment Increase Protection Provided by RT-PCR Screening: A Pilot Study Involving Three Nursing Homes in Brescia, a Hotspot of Lombardy.","Background: COVID-19 outbursts have been registered worldwide within care homes with asymptomatic transmission combined with shortage/inaccuracy of diagnostic tests undermining the efforts at containment of the disease. Nursing facilities in Lombardy (Italy) were left with no, or limited, access to testing for 8 weeks after the outbreak of COVID-19. Methods: This study includes 246 residents and 286 workers of three different nursing homes in Brescia-Lombardy. Clinical questionnair","2021","07","14","Front Public Health","Frontiers in public health","COVID-19; COVID-19 symptoms; RT-PCR screening; SARSCoV-2; asymptomatic transmission; nursing home; on-site testing; rapid serological assays; Aged; COVID-19; Humans; Italy; Nursing Homes; Pilot Projects; Point-of-Care Systems; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2","Marchina","Eleonora","Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy",NA
"1612","34249830","10.3389/fpubh.2021.628098","Epidemiology of SARS-CoV-2 Infection Evaluated by Immunochromatographic Rapid Testing for the Determination of IgM and IgG Against SARS-CoV-2 in a Cohort of Mask Wearing Workers in the Metal-Mechanical Sector in an Area With a High Incidence of COVID-19.","Background: Although the diagnosis of new coronavirus 2019 (COVID-19) is made through the identification of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in respiratory secretions by means of molecular methods, a more accurate estimation of SARS-CoV-2 circulation can be obtained by seroprevalence studies. The main aim of this study was to evaluate the true epidemiology of SARS-CoV-2 infection among workers in the metal-mechanical sector who never stopped working during the ","2021","07","14","Front Public Health","Frontiers in public health","COVID-19; SARS-CoV-2; epidemiology; occupational medicine; public health; Antibodies, Viral; COVID-19; Communicable Disease Control; Humans; Immunoglobulin G; Immunoglobulin M; Incidence; Italy; SARS-CoV-2; Seroepidemiologic Studies","Esposito","Susanna","University of Parma, Parma, Italy",NA
"1613","34249830","10.3389/fpubh.2021.628098","Epidemiology of SARS-CoV-2 Infection Evaluated by Immunochromatographic Rapid Testing for the Determination of IgM and IgG Against SARS-CoV-2 in a Cohort of Mask Wearing Workers in the Metal-Mechanical Sector in an Area With a High Incidence of COVID-19.","Background: Although the diagnosis of new coronavirus 2019 (COVID-19) is made through the identification of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in respiratory secretions by means of molecular methods, a more accurate estimation of SARS-CoV-2 circulation can be obtained by seroprevalence studies. The main aim of this study was to evaluate the true epidemiology of SARS-CoV-2 infection among workers in the metal-mechanical sector who never stopped working during the ","2021","07","14","Front Public Health","Frontiers in public health","COVID-19; SARS-CoV-2; epidemiology; occupational medicine; public health; Antibodies, Viral; COVID-19; Communicable Disease Control; Humans; Immunoglobulin G; Immunoglobulin M; Incidence; Italy; SARS-CoV-2; Seroepidemiologic Studies","Neglia","Cosimo","University of Parma, Parma, Italy",NA
"1614","34249830","10.3389/fpubh.2021.628098","Epidemiology of SARS-CoV-2 Infection Evaluated by Immunochromatographic Rapid Testing for the Determination of IgM and IgG Against SARS-CoV-2 in a Cohort of Mask Wearing Workers in the Metal-Mechanical Sector in an Area With a High Incidence of COVID-19.","Background: Although the diagnosis of new coronavirus 2019 (COVID-19) is made through the identification of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in respiratory secretions by means of molecular methods, a more accurate estimation of SARS-CoV-2 circulation can be obtained by seroprevalence studies. The main aim of this study was to evaluate the true epidemiology of SARS-CoV-2 infection among workers in the metal-mechanical sector who never stopped working during the ","2021","07","14","Front Public Health","Frontiers in public health","COVID-19; SARS-CoV-2; epidemiology; occupational medicine; public health; Antibodies, Viral; COVID-19; Communicable Disease Control; Humans; Immunoglobulin G; Immunoglobulin M; Incidence; Italy; SARS-CoV-2; Seroepidemiologic Studies","Affanni","Paola","University of Parma, Parma, Italy",NA
"1615","34249830","10.3389/fpubh.2021.628098","Epidemiology of SARS-CoV-2 Infection Evaluated by Immunochromatographic Rapid Testing for the Determination of IgM and IgG Against SARS-CoV-2 in a Cohort of Mask Wearing Workers in the Metal-Mechanical Sector in an Area With a High Incidence of COVID-19.","Background: Although the diagnosis of new coronavirus 2019 (COVID-19) is made through the identification of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in respiratory secretions by means of molecular methods, a more accurate estimation of SARS-CoV-2 circulation can be obtained by seroprevalence studies. The main aim of this study was to evaluate the true epidemiology of SARS-CoV-2 infection among workers in the metal-mechanical sector who never stopped working during the ","2021","07","14","Front Public Health","Frontiers in public health","COVID-19; SARS-CoV-2; epidemiology; occupational medicine; public health; Antibodies, Viral; COVID-19; Communicable Disease Control; Humans; Immunoglobulin G; Immunoglobulin M; Incidence; Italy; SARS-CoV-2; Seroepidemiologic Studies","Colucci","Maria Eugenia","University of Parma, Parma, Italy",NA
"1616","34249830","10.3389/fpubh.2021.628098","Epidemiology of SARS-CoV-2 Infection Evaluated by Immunochromatographic Rapid Testing for the Determination of IgM and IgG Against SARS-CoV-2 in a Cohort of Mask Wearing Workers in the Metal-Mechanical Sector in an Area With a High Incidence of COVID-19.","Background: Although the diagnosis of new coronavirus 2019 (COVID-19) is made through the identification of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in respiratory secretions by means of molecular methods, a more accurate estimation of SARS-CoV-2 circulation can be obtained by seroprevalence studies. The main aim of this study was to evaluate the true epidemiology of SARS-CoV-2 infection among workers in the metal-mechanical sector who never stopped working during the ","2021","07","14","Front Public Health","Frontiers in public health","COVID-19; SARS-CoV-2; epidemiology; occupational medicine; public health; Antibodies, Viral; COVID-19; Communicable Disease Control; Humans; Immunoglobulin G; Immunoglobulin M; Incidence; Italy; SARS-CoV-2; Seroepidemiologic Studies","Argentiero","Alberto","University of Parma, Parma, Italy",NA
"1617","34249830","10.3389/fpubh.2021.628098","Epidemiology of SARS-CoV-2 Infection Evaluated by Immunochromatographic Rapid Testing for the Determination of IgM and IgG Against SARS-CoV-2 in a Cohort of Mask Wearing Workers in the Metal-Mechanical Sector in an Area With a High Incidence of COVID-19.","Background: Although the diagnosis of new coronavirus 2019 (COVID-19) is made through the identification of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in respiratory secretions by means of molecular methods, a more accurate estimation of SARS-CoV-2 circulation can be obtained by seroprevalence studies. The main aim of this study was to evaluate the true epidemiology of SARS-CoV-2 infection among workers in the metal-mechanical sector who never stopped working during the ","2021","07","14","Front Public Health","Frontiers in public health","COVID-19; SARS-CoV-2; epidemiology; occupational medicine; public health; Antibodies, Viral; COVID-19; Communicable Disease Control; Humans; Immunoglobulin G; Immunoglobulin M; Incidence; Italy; SARS-CoV-2; Seroepidemiologic Studies","Veronesi","Licia","University of Parma, Parma, Italy",NA
"1618","34249830","10.3389/fpubh.2021.628098","Epidemiology of SARS-CoV-2 Infection Evaluated by Immunochromatographic Rapid Testing for the Determination of IgM and IgG Against SARS-CoV-2 in a Cohort of Mask Wearing Workers in the Metal-Mechanical Sector in an Area With a High Incidence of COVID-19.","Background: Although the diagnosis of new coronavirus 2019 (COVID-19) is made through the identification of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in respiratory secretions by means of molecular methods, a more accurate estimation of SARS-CoV-2 circulation can be obtained by seroprevalence studies. The main aim of this study was to evaluate the true epidemiology of SARS-CoV-2 infection among workers in the metal-mechanical sector who never stopped working during the ","2021","07","14","Front Public Health","Frontiers in public health","COVID-19; SARS-CoV-2; epidemiology; occupational medicine; public health; Antibodies, Viral; COVID-19; Communicable Disease Control; Humans; Immunoglobulin G; Immunoglobulin M; Incidence; Italy; SARS-CoV-2; Seroepidemiologic Studies","Messina","Giulia","University of Parma, Parma, Italy",NA
"1619","34249830","10.3389/fpubh.2021.628098","Epidemiology of SARS-CoV-2 Infection Evaluated by Immunochromatographic Rapid Testing for the Determination of IgM and IgG Against SARS-CoV-2 in a Cohort of Mask Wearing Workers in the Metal-Mechanical Sector in an Area With a High Incidence of COVID-19.","Background: Although the diagnosis of new coronavirus 2019 (COVID-19) is made through the identification of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in respiratory secretions by means of molecular methods, a more accurate estimation of SARS-CoV-2 circulation can be obtained by seroprevalence studies. The main aim of this study was to evaluate the true epidemiology of SARS-CoV-2 infection among workers in the metal-mechanical sector who never stopped working during the ","2021","07","14","Front Public Health","Frontiers in public health","COVID-19; SARS-CoV-2; epidemiology; occupational medicine; public health; Antibodies, Viral; COVID-19; Communicable Disease Control; Humans; Immunoglobulin G; Immunoglobulin M; Incidence; Italy; SARS-CoV-2; Seroepidemiologic Studies","Deolmi","Michela","University of Parma, Parma, Italy",NA
"1620","34249830","10.3389/fpubh.2021.628098","Epidemiology of SARS-CoV-2 Infection Evaluated by Immunochromatographic Rapid Testing for the Determination of IgM and IgG Against SARS-CoV-2 in a Cohort of Mask Wearing Workers in the Metal-Mechanical Sector in an Area With a High Incidence of COVID-19.","Background: Although the diagnosis of new coronavirus 2019 (COVID-19) is made through the identification of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in respiratory secretions by means of molecular methods, a more accurate estimation of SARS-CoV-2 circulation can be obtained by seroprevalence studies. The main aim of this study was to evaluate the true epidemiology of SARS-CoV-2 infection among workers in the metal-mechanical sector who never stopped working during the ","2021","07","14","Front Public Health","Frontiers in public health","COVID-19; SARS-CoV-2; epidemiology; occupational medicine; public health; Antibodies, Viral; COVID-19; Communicable Disease Control; Humans; Immunoglobulin G; Immunoglobulin M; Incidence; Italy; SARS-CoV-2; Seroepidemiologic Studies","Principi","Nicola","University of Milan, Milan, Italy",NA
"1621","34249828","10.3389/fpubh.2021.620521","Latent Profiles and Influencing Factors of Posttraumatic Stress Symptoms Among Adults During the COVID-19 Pandemic.","The COVID-19 pandemic severely affected public health and the prevalence of posttraumatic stress symptoms among adults in Hubei Province, China. In this study, a total of 2,930 (662 males and 2,268 females) adults answered a questionnaire obtaining information on their demographics, posttraumatic stress symptoms (i.e., intrusion and avoidance), social media exposure, social media involvement, and self-efficacy. Results of the latent profile analysis identified four latent profiles of posttraumat","2021","07","14","Front Public Health","Frontiers in public health","COVID-19; latent profile; posttraumatic stress symptoms; self-efficacy; social media; Adult; COVID-19; China; Female; Humans; Male; Pandemics; SARS-CoV-2; Stress Disorders, Post-Traumatic","Duan","Wenjie","School of Social and Public Administration, East China University of Science and Technology, Shanghai, China",NA
"1622","34249828","10.3389/fpubh.2021.620521","Latent Profiles and Influencing Factors of Posttraumatic Stress Symptoms Among Adults During the COVID-19 Pandemic.","The COVID-19 pandemic severely affected public health and the prevalence of posttraumatic stress symptoms among adults in Hubei Province, China. In this study, a total of 2,930 (662 males and 2,268 females) adults answered a questionnaire obtaining information on their demographics, posttraumatic stress symptoms (i.e., intrusion and avoidance), social media exposure, social media involvement, and self-efficacy. Results of the latent profile analysis identified four latent profiles of posttraumat","2021","07","14","Front Public Health","Frontiers in public health","COVID-19; latent profile; posttraumatic stress symptoms; self-efficacy; social media; Adult; COVID-19; China; Female; Humans; Male; Pandemics; SARS-CoV-2; Stress Disorders, Post-Traumatic","Guan","Qiujie","School of Social Development and Public Policy, Fudan University, Shanghai, China",NA
"1623","34249828","10.3389/fpubh.2021.620521","Latent Profiles and Influencing Factors of Posttraumatic Stress Symptoms Among Adults During the COVID-19 Pandemic.","The COVID-19 pandemic severely affected public health and the prevalence of posttraumatic stress symptoms among adults in Hubei Province, China. In this study, a total of 2,930 (662 males and 2,268 females) adults answered a questionnaire obtaining information on their demographics, posttraumatic stress symptoms (i.e., intrusion and avoidance), social media exposure, social media involvement, and self-efficacy. Results of the latent profile analysis identified four latent profiles of posttraumat","2021","07","14","Front Public Health","Frontiers in public health","COVID-19; latent profile; posttraumatic stress symptoms; self-efficacy; social media; Adult; COVID-19; China; Female; Humans; Male; Pandemics; SARS-CoV-2; Stress Disorders, Post-Traumatic","Jin","Qiuping","School of Labor and Human Resources, Renmin University of China, Beijing, China",NA
"1624","34249827","10.3389/fpubh.2021.614321","Assessment of Knowledge and Practices Toward COVID-19 Prevention Among Healthcare Workers in Tigray, North Ethiopia.","Background: The incidence rate of coronavirus disease 2019 (COVID-19) is increasing in several countries despite that public health measures are put in place. Given that COVID-19 is a newly emerging disease, there is little knowledge about the disease. The present study aims to assess knowledge, perception, and preventive practices toward COVID-19 among health workers in Tigray, North Ethiopia. Materials and Methods: A health facility-based cross-sectional study was conducted among","2021","07","14","Front Public Health","Frontiers in public health","COVID-19; Ethiopia; Tigray; healthcare workers; knowledge; perception; practice; COVID-19; Cross-Sectional Studies; Ethiopia; Female; Health Personnel; Humans; SARS-CoV-2","Gebremeskel","Teferi G","Department of Reproductive Health, College of Health Sciences, Aksum University, Aksum, Ethiopia",NA
"1625","34249827","10.3389/fpubh.2021.614321","Assessment of Knowledge and Practices Toward COVID-19 Prevention Among Healthcare Workers in Tigray, North Ethiopia.","Background: The incidence rate of coronavirus disease 2019 (COVID-19) is increasing in several countries despite that public health measures are put in place. Given that COVID-19 is a newly emerging disease, there is little knowledge about the disease. The present study aims to assess knowledge, perception, and preventive practices toward COVID-19 among health workers in Tigray, North Ethiopia. Materials and Methods: A health facility-based cross-sectional study was conducted among","2021","07","14","Front Public Health","Frontiers in public health","COVID-19; Ethiopia; Tigray; healthcare workers; knowledge; perception; practice; COVID-19; Cross-Sectional Studies; Ethiopia; Female; Health Personnel; Humans; SARS-CoV-2","Kiros","Kalayu","School of Medicine, College of Medicine and Health Science, Aksum University, Aksum, Ethiopia",NA
"1626","34249827","10.3389/fpubh.2021.614321","Assessment of Knowledge and Practices Toward COVID-19 Prevention Among Healthcare Workers in Tigray, North Ethiopia.","Background: The incidence rate of coronavirus disease 2019 (COVID-19) is increasing in several countries despite that public health measures are put in place. Given that COVID-19 is a newly emerging disease, there is little knowledge about the disease. The present study aims to assess knowledge, perception, and preventive practices toward COVID-19 among health workers in Tigray, North Ethiopia. Materials and Methods: A health facility-based cross-sectional study was conducted among","2021","07","14","Front Public Health","Frontiers in public health","COVID-19; Ethiopia; Tigray; healthcare workers; knowledge; perception; practice; COVID-19; Cross-Sectional Studies; Ethiopia; Female; Health Personnel; Humans; SARS-CoV-2","Gesesew","Hailay A","Discipline of Public Health, Flinders University, Adelaide, SA, Australia",NA
"1627","34249827","10.3389/fpubh.2021.614321","Assessment of Knowledge and Practices Toward COVID-19 Prevention Among Healthcare Workers in Tigray, North Ethiopia.","Background: The incidence rate of coronavirus disease 2019 (COVID-19) is increasing in several countries despite that public health measures are put in place. Given that COVID-19 is a newly emerging disease, there is little knowledge about the disease. The present study aims to assess knowledge, perception, and preventive practices toward COVID-19 among health workers in Tigray, North Ethiopia. Materials and Methods: A health facility-based cross-sectional study was conducted among","2021","07","14","Front Public Health","Frontiers in public health","COVID-19; Ethiopia; Tigray; healthcare workers; knowledge; perception; practice; COVID-19; Cross-Sectional Studies; Ethiopia; Female; Health Personnel; Humans; SARS-CoV-2","Ward","Paul R","Discipline of Public Health, Flinders University, Adelaide, SA, Australia",NA
"1628","34249826","10.3389/fpubh.2021.606666","Knowledge, Attitude, and Practice of Healthcare Providers Toward Novel Coronavirus 19 During the First Months of the Pandemic: A Systematic Review.","Introduction: Coronavirus disease (COVID-19) is a highly contagious viral infection that has spread to every corner of the world. Lack of knowledge among healthcare providers (HCPs) about diseases such as COVID-19 may delay the diagnosis, disease spread, and produce poor infection control practices. Hence, this systematic review aimed to summarize the knowledge, attitudes, and practices (KAP) of HCPs toward COVID-19 during the first months of the pandemic. Methods: A systematic rev","2021","07","14","Front Public Health","Frontiers in public health","COVID-19; attitude; healthcare provider; knowledge; practice; Aged; COVID-19; Health Knowledge, Attitudes, Practice; Health Personnel; Humans; Pandemics; SARS-CoV-2","Tegegne","Gobezie T","Department of Pharmacology and Clinical Pharmacy, School of Pharmacy, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia",NA
"1629","34249826","10.3389/fpubh.2021.606666","Knowledge, Attitude, and Practice of Healthcare Providers Toward Novel Coronavirus 19 During the First Months of the Pandemic: A Systematic Review.","Introduction: Coronavirus disease (COVID-19) is a highly contagious viral infection that has spread to every corner of the world. Lack of knowledge among healthcare providers (HCPs) about diseases such as COVID-19 may delay the diagnosis, disease spread, and produce poor infection control practices. Hence, this systematic review aimed to summarize the knowledge, attitudes, and practices (KAP) of HCPs toward COVID-19 during the first months of the pandemic. Methods: A systematic rev","2021","07","14","Front Public Health","Frontiers in public health","COVID-19; attitude; healthcare provider; knowledge; practice; Aged; COVID-19; Health Knowledge, Attitudes, Practice; Health Personnel; Humans; Pandemics; SARS-CoV-2","Kefale","Belayneh","Clinical Pharmacy Unit and Research Team, Department of Pharmacy, College of Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia",NA
"1630","34249826","10.3389/fpubh.2021.606666","Knowledge, Attitude, and Practice of Healthcare Providers Toward Novel Coronavirus 19 During the First Months of the Pandemic: A Systematic Review.","Introduction: Coronavirus disease (COVID-19) is a highly contagious viral infection that has spread to every corner of the world. Lack of knowledge among healthcare providers (HCPs) about diseases such as COVID-19 may delay the diagnosis, disease spread, and produce poor infection control practices. Hence, this systematic review aimed to summarize the knowledge, attitudes, and practices (KAP) of HCPs toward COVID-19 during the first months of the pandemic. Methods: A systematic rev","2021","07","14","Front Public Health","Frontiers in public health","COVID-19; attitude; healthcare provider; knowledge; practice; Aged; COVID-19; Health Knowledge, Attitudes, Practice; Health Personnel; Humans; Pandemics; SARS-CoV-2","Engidaw","Melaku Tadege","Department of Social and Public Health, College of Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia",NA
"1631","34249826","10.3389/fpubh.2021.606666","Knowledge, Attitude, and Practice of Healthcare Providers Toward Novel Coronavirus 19 During the First Months of the Pandemic: A Systematic Review.","Introduction: Coronavirus disease (COVID-19) is a highly contagious viral infection that has spread to every corner of the world. Lack of knowledge among healthcare providers (HCPs) about diseases such as COVID-19 may delay the diagnosis, disease spread, and produce poor infection control practices. Hence, this systematic review aimed to summarize the knowledge, attitudes, and practices (KAP) of HCPs toward COVID-19 during the first months of the pandemic. Methods: A systematic rev","2021","07","14","Front Public Health","Frontiers in public health","COVID-19; attitude; healthcare provider; knowledge; practice; Aged; COVID-19; Health Knowledge, Attitudes, Practice; Health Personnel; Humans; Pandemics; SARS-CoV-2","Degu","Amsalu","Department of Pharmaceutics and Pharmacy Practice, School of Pharmacy and Health Sciences, United States International University-Africa, Nairobi, Kenya",NA
"1632","34249826","10.3389/fpubh.2021.606666","Knowledge, Attitude, and Practice of Healthcare Providers Toward Novel Coronavirus 19 During the First Months of the Pandemic: A Systematic Review.","Introduction: Coronavirus disease (COVID-19) is a highly contagious viral infection that has spread to every corner of the world. Lack of knowledge among healthcare providers (HCPs) about diseases such as COVID-19 may delay the diagnosis, disease spread, and produce poor infection control practices. Hence, this systematic review aimed to summarize the knowledge, attitudes, and practices (KAP) of HCPs toward COVID-19 during the first months of the pandemic. Methods: A systematic rev","2021","07","14","Front Public Health","Frontiers in public health","COVID-19; attitude; healthcare provider; knowledge; practice; Aged; COVID-19; Health Knowledge, Attitudes, Practice; Health Personnel; Humans; Pandemics; SARS-CoV-2","Tesfa","Desalegn","Department of Social and Public Health, College of Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia",NA
"1633","34249826","10.3389/fpubh.2021.606666","Knowledge, Attitude, and Practice of Healthcare Providers Toward Novel Coronavirus 19 During the First Months of the Pandemic: A Systematic Review.","Introduction: Coronavirus disease (COVID-19) is a highly contagious viral infection that has spread to every corner of the world. Lack of knowledge among healthcare providers (HCPs) about diseases such as COVID-19 may delay the diagnosis, disease spread, and produce poor infection control practices. Hence, this systematic review aimed to summarize the knowledge, attitudes, and practices (KAP) of HCPs toward COVID-19 during the first months of the pandemic. Methods: A systematic rev","2021","07","14","Front Public Health","Frontiers in public health","COVID-19; attitude; healthcare provider; knowledge; practice; Aged; COVID-19; Health Knowledge, Attitudes, Practice; Health Personnel; Humans; Pandemics; SARS-CoV-2","Ewunetei","Amien","Pharmacology Unit and Research Team, Department of Pharmacy, College of Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia",NA
"1634","34249826","10.3389/fpubh.2021.606666","Knowledge, Attitude, and Practice of Healthcare Providers Toward Novel Coronavirus 19 During the First Months of the Pandemic: A Systematic Review.","Introduction: Coronavirus disease (COVID-19) is a highly contagious viral infection that has spread to every corner of the world. Lack of knowledge among healthcare providers (HCPs) about diseases such as COVID-19 may delay the diagnosis, disease spread, and produce poor infection control practices. Hence, this systematic review aimed to summarize the knowledge, attitudes, and practices (KAP) of HCPs toward COVID-19 during the first months of the pandemic. Methods: A systematic rev","2021","07","14","Front Public Health","Frontiers in public health","COVID-19; attitude; healthcare provider; knowledge; practice; Aged; COVID-19; Health Knowledge, Attitudes, Practice; Health Personnel; Humans; Pandemics; SARS-CoV-2","Yazie","Taklo Simeneh","Pharmacology Unit and Research Team, Department of Pharmacy, College of Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia",NA
"1635","34249826","10.3389/fpubh.2021.606666","Knowledge, Attitude, and Practice of Healthcare Providers Toward Novel Coronavirus 19 During the First Months of the Pandemic: A Systematic Review.","Introduction: Coronavirus disease (COVID-19) is a highly contagious viral infection that has spread to every corner of the world. Lack of knowledge among healthcare providers (HCPs) about diseases such as COVID-19 may delay the diagnosis, disease spread, and produce poor infection control practices. Hence, this systematic review aimed to summarize the knowledge, attitudes, and practices (KAP) of HCPs toward COVID-19 during the first months of the pandemic. Methods: A systematic rev","2021","07","14","Front Public Health","Frontiers in public health","COVID-19; attitude; healthcare provider; knowledge; practice; Aged; COVID-19; Health Knowledge, Attitudes, Practice; Health Personnel; Humans; Pandemics; SARS-CoV-2","Molla","Mulugeta","Pharmacology Unit and Research Team, Department of Pharmacy, College of Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia",NA
"1636","34249824","10.3389/fpubh.2021.586465","The Psychological Effect of Forming WeChat Groups Between Medical Staff and Patients With COVID-19.","Background: This study was conducted in order to explore the effect of psychological intervention based on the use of WeChat with coronavirus disease 2019 (COVID-19) patients. Methods: A total of 65 patients with COVID-19, from two wards, were divided into an experimental group and a control group with the ward as the basic unit. Communication concerning routine treatment and nursing was established between the medical staff and patients in the experimental group via WeChat ","2021","07","14","Front Public Health","Frontiers in public health","2019-nCoV; WeChat group; disease response; health education; pneumonia; psychological care; satisfaction; COVID-19; Hospitalization; Humans; Medical Staff; SARS-CoV-2; Surveys and Questionnaires","Yuan","Li-Ping","Department of Intensive Care Unit, Yijishan Hospital of Wannan Medical College, Wuhu, China",NA
"1637","34249824","10.3389/fpubh.2021.586465","The Psychological Effect of Forming WeChat Groups Between Medical Staff and Patients With COVID-19.","Background: This study was conducted in order to explore the effect of psychological intervention based on the use of WeChat with coronavirus disease 2019 (COVID-19) patients. Methods: A total of 65 patients with COVID-19, from two wards, were divided into an experimental group and a control group with the ward as the basic unit. Communication concerning routine treatment and nursing was established between the medical staff and patients in the experimental group via WeChat ","2021","07","14","Front Public Health","Frontiers in public health","2019-nCoV; WeChat group; disease response; health education; pneumonia; psychological care; satisfaction; COVID-19; Hospitalization; Humans; Medical Staff; SARS-CoV-2; Surveys and Questionnaires","Yu","Zheng-Hao","Department of Intensive Care Unit, Yijishan Hospital of Wannan Medical College, Wuhu, China",NA
"1638","34249824","10.3389/fpubh.2021.586465","The Psychological Effect of Forming WeChat Groups Between Medical Staff and Patients With COVID-19.","Background: This study was conducted in order to explore the effect of psychological intervention based on the use of WeChat with coronavirus disease 2019 (COVID-19) patients. Methods: A total of 65 patients with COVID-19, from two wards, were divided into an experimental group and a control group with the ward as the basic unit. Communication concerning routine treatment and nursing was established between the medical staff and patients in the experimental group via WeChat ","2021","07","14","Front Public Health","Frontiers in public health","2019-nCoV; WeChat group; disease response; health education; pneumonia; psychological care; satisfaction; COVID-19; Hospitalization; Humans; Medical Staff; SARS-CoV-2; Surveys and Questionnaires","Zhang","Xian-Cui","Department of Intensive Care Unit, Yijishan Hospital of Wannan Medical College, Wuhu, China",NA
"1639","34249824","10.3389/fpubh.2021.586465","The Psychological Effect of Forming WeChat Groups Between Medical Staff and Patients With COVID-19.","Background: This study was conducted in order to explore the effect of psychological intervention based on the use of WeChat with coronavirus disease 2019 (COVID-19) patients. Methods: A total of 65 patients with COVID-19, from two wards, were divided into an experimental group and a control group with the ward as the basic unit. Communication concerning routine treatment and nursing was established between the medical staff and patients in the experimental group via WeChat ","2021","07","14","Front Public Health","Frontiers in public health","2019-nCoV; WeChat group; disease response; health education; pneumonia; psychological care; satisfaction; COVID-19; Hospitalization; Humans; Medical Staff; SARS-CoV-2; Surveys and Questionnaires","Zhang","Wei","Department of Intensive Care Unit, Yijishan Hospital of Wannan Medical College, Wuhu, China",NA
"1640","34249824","10.3389/fpubh.2021.586465","The Psychological Effect of Forming WeChat Groups Between Medical Staff and Patients With COVID-19.","Background: This study was conducted in order to explore the effect of psychological intervention based on the use of WeChat with coronavirus disease 2019 (COVID-19) patients. Methods: A total of 65 patients with COVID-19, from two wards, were divided into an experimental group and a control group with the ward as the basic unit. Communication concerning routine treatment and nursing was established between the medical staff and patients in the experimental group via WeChat ","2021","07","14","Front Public Health","Frontiers in public health","2019-nCoV; WeChat group; disease response; health education; pneumonia; psychological care; satisfaction; COVID-19; Hospitalization; Humans; Medical Staff; SARS-CoV-2; Surveys and Questionnaires","Jin","Ling-Li","Department of Intensive Care Unit, Yijishan Hospital of Wannan Medical College, Wuhu, China",NA
"1641","34249824","10.3389/fpubh.2021.586465","The Psychological Effect of Forming WeChat Groups Between Medical Staff and Patients With COVID-19.","Background: This study was conducted in order to explore the effect of psychological intervention based on the use of WeChat with coronavirus disease 2019 (COVID-19) patients. Methods: A total of 65 patients with COVID-19, from two wards, were divided into an experimental group and a control group with the ward as the basic unit. Communication concerning routine treatment and nursing was established between the medical staff and patients in the experimental group via WeChat ","2021","07","14","Front Public Health","Frontiers in public health","2019-nCoV; WeChat group; disease response; health education; pneumonia; psychological care; satisfaction; COVID-19; Hospitalization; Humans; Medical Staff; SARS-CoV-2; Surveys and Questionnaires","Wang","Zhen","Department of Intensive Care Unit, Yijishan Hospital of Wannan Medical College, Wuhu, China",NA
"1642","34249824","10.3389/fpubh.2021.586465","The Psychological Effect of Forming WeChat Groups Between Medical Staff and Patients With COVID-19.","Background: This study was conducted in order to explore the effect of psychological intervention based on the use of WeChat with coronavirus disease 2019 (COVID-19) patients. Methods: A total of 65 patients with COVID-19, from two wards, were divided into an experimental group and a control group with the ward as the basic unit. Communication concerning routine treatment and nursing was established between the medical staff and patients in the experimental group via WeChat ","2021","07","14","Front Public Health","Frontiers in public health","2019-nCoV; WeChat group; disease response; health education; pneumonia; psychological care; satisfaction; COVID-19; Hospitalization; Humans; Medical Staff; SARS-CoV-2; Surveys and Questionnaires","Yang","Jin-Sun","Department of Intensive Care Unit, Yijishan Hospital of Wannan Medical College, Wuhu, China",NA
"1643","34249824","10.3389/fpubh.2021.586465","The Psychological Effect of Forming WeChat Groups Between Medical Staff and Patients With COVID-19.","Background: This study was conducted in order to explore the effect of psychological intervention based on the use of WeChat with coronavirus disease 2019 (COVID-19) patients. Methods: A total of 65 patients with COVID-19, from two wards, were divided into an experimental group and a control group with the ward as the basic unit. Communication concerning routine treatment and nursing was established between the medical staff and patients in the experimental group via WeChat ","2021","07","14","Front Public Health","Frontiers in public health","2019-nCoV; WeChat group; disease response; health education; pneumonia; psychological care; satisfaction; COVID-19; Hospitalization; Humans; Medical Staff; SARS-CoV-2; Surveys and Questionnaires","Huang","Hou-Bao","Department of Intensive Care Unit, Yijishan Hospital of Wannan Medical College, Wuhu, China",NA
"1644","34249824","10.3389/fpubh.2021.586465","The Psychological Effect of Forming WeChat Groups Between Medical Staff and Patients With COVID-19.","Background: This study was conducted in order to explore the effect of psychological intervention based on the use of WeChat with coronavirus disease 2019 (COVID-19) patients. Methods: A total of 65 patients with COVID-19, from two wards, were divided into an experimental group and a control group with the ward as the basic unit. Communication concerning routine treatment and nursing was established between the medical staff and patients in the experimental group via WeChat ","2021","07","14","Front Public Health","Frontiers in public health","2019-nCoV; WeChat group; disease response; health education; pneumonia; psychological care; satisfaction; COVID-19; Hospitalization; Humans; Medical Staff; SARS-CoV-2; Surveys and Questionnaires","Zhang","Qu","Department of Intensive Care Unit, Yijishan Hospital of Wannan Medical College, Wuhu, China",NA
"1645","34249824","10.3389/fpubh.2021.586465","The Psychological Effect of Forming WeChat Groups Between Medical Staff and Patients With COVID-19.","Background: This study was conducted in order to explore the effect of psychological intervention based on the use of WeChat with coronavirus disease 2019 (COVID-19) patients. Methods: A total of 65 patients with COVID-19, from two wards, were divided into an experimental group and a control group with the ward as the basic unit. Communication concerning routine treatment and nursing was established between the medical staff and patients in the experimental group via WeChat ","2021","07","14","Front Public Health","Frontiers in public health","2019-nCoV; WeChat group; disease response; health education; pneumonia; psychological care; satisfaction; COVID-19; Hospitalization; Humans; Medical Staff; SARS-CoV-2; Surveys and Questionnaires","Tao","Xiu-Bin","Department of Intensive Care Unit, Yijishan Hospital of Wannan Medical College, Wuhu, China",NA
"1646","34249822","10.3389/fpubh.2021.584000","A Review and Clinical Practice Guideline for Health Professionals Working With Indigenous and Culturally and Linguistically Diverse (CALD) Populations During COVID-19.","Background: As the rates of infection and mortality from COVID-19 have been higher in minority groups, the communication of health information in a way that is understood and accepted is of particular importance. Aims: To provide health professionals with a clinical practice guideline for clear and culturally sensitive communication of health information about COVID-19 to people of Indigenous and culturally and linguistically diverse (CALD) backgrounds. Assessment of Guideline O","2021","07","14","Front Public Health","Frontiers in public health","clinical practice guideline; ethnicity; health communication; health professionals; indigenous; COVID-19; Cultural Diversity; Health Personnel; Humans; Minority Groups; SARS-CoV-2","Kayrouz","Rony","MindSpot Clinic, Macquarie University, Sydney, NSW, Australia",NA
"1647","34249822","10.3389/fpubh.2021.584000","A Review and Clinical Practice Guideline for Health Professionals Working With Indigenous and Culturally and Linguistically Diverse (CALD) Populations During COVID-19.","Background: As the rates of infection and mortality from COVID-19 have been higher in minority groups, the communication of health information in a way that is understood and accepted is of particular importance. Aims: To provide health professionals with a clinical practice guideline for clear and culturally sensitive communication of health information about COVID-19 to people of Indigenous and culturally and linguistically diverse (CALD) backgrounds. Assessment of Guideline O","2021","07","14","Front Public Health","Frontiers in public health","clinical practice guideline; ethnicity; health communication; health professionals; indigenous; COVID-19; Cultural Diversity; Health Personnel; Humans; Minority Groups; SARS-CoV-2","Schofield","Carlie","MindSpot Clinic, Macquarie University, Sydney, NSW, Australia",NA
"1648","34249822","10.3389/fpubh.2021.584000","A Review and Clinical Practice Guideline for Health Professionals Working With Indigenous and Culturally and Linguistically Diverse (CALD) Populations During COVID-19.","Background: As the rates of infection and mortality from COVID-19 have been higher in minority groups, the communication of health information in a way that is understood and accepted is of particular importance. Aims: To provide health professionals with a clinical practice guideline for clear and culturally sensitive communication of health information about COVID-19 to people of Indigenous and culturally and linguistically diverse (CALD) backgrounds. Assessment of Guideline O","2021","07","14","Front Public Health","Frontiers in public health","clinical practice guideline; ethnicity; health communication; health professionals; indigenous; COVID-19; Cultural Diversity; Health Personnel; Humans; Minority Groups; SARS-CoV-2","Nielssen","Olav","MindSpot Clinic, Macquarie University, Sydney, NSW, Australia",NA
"1649","34249822","10.3389/fpubh.2021.584000","A Review and Clinical Practice Guideline for Health Professionals Working With Indigenous and Culturally and Linguistically Diverse (CALD) Populations During COVID-19.","Background: As the rates of infection and mortality from COVID-19 have been higher in minority groups, the communication of health information in a way that is understood and accepted is of particular importance. Aims: To provide health professionals with a clinical practice guideline for clear and culturally sensitive communication of health information about COVID-19 to people of Indigenous and culturally and linguistically diverse (CALD) backgrounds. Assessment of Guideline O","2021","07","14","Front Public Health","Frontiers in public health","clinical practice guideline; ethnicity; health communication; health professionals; indigenous; COVID-19; Cultural Diversity; Health Personnel; Humans; Minority Groups; SARS-CoV-2","Karin","Eyal","MindSpot Clinic, Macquarie University, Sydney, NSW, Australia",NA
"1650","34249822","10.3389/fpubh.2021.584000","A Review and Clinical Practice Guideline for Health Professionals Working With Indigenous and Culturally and Linguistically Diverse (CALD) Populations During COVID-19.","Background: As the rates of infection and mortality from COVID-19 have been higher in minority groups, the communication of health information in a way that is understood and accepted is of particular importance. Aims: To provide health professionals with a clinical practice guideline for clear and culturally sensitive communication of health information about COVID-19 to people of Indigenous and culturally and linguistically diverse (CALD) backgrounds. Assessment of Guideline O","2021","07","14","Front Public Health","Frontiers in public health","clinical practice guideline; ethnicity; health communication; health professionals; indigenous; COVID-19; Cultural Diversity; Health Personnel; Humans; Minority Groups; SARS-CoV-2","Staples","Lauren","MindSpot Clinic, Macquarie University, Sydney, NSW, Australia",NA
"1651","34249822","10.3389/fpubh.2021.584000","A Review and Clinical Practice Guideline for Health Professionals Working With Indigenous and Culturally and Linguistically Diverse (CALD) Populations During COVID-19.","Background: As the rates of infection and mortality from COVID-19 have been higher in minority groups, the communication of health information in a way that is understood and accepted is of particular importance. Aims: To provide health professionals with a clinical practice guideline for clear and culturally sensitive communication of health information about COVID-19 to people of Indigenous and culturally and linguistically diverse (CALD) backgrounds. Assessment of Guideline O","2021","07","14","Front Public Health","Frontiers in public health","clinical practice guideline; ethnicity; health communication; health professionals; indigenous; COVID-19; Cultural Diversity; Health Personnel; Humans; Minority Groups; SARS-CoV-2","Titov","Nickolai","MindSpot Clinic, Macquarie University, Sydney, NSW, Australia",NA
"1652","34249814","10.3389/fped.2021.676718","Face Masks in Young Children During the COVID-19 Pandemic: Parents' and Pediatricians' Point of View.","Background: In countries with high SARS-CoV-2 circulation, the pandemic has presented many challenges on different fronts, affecting lives and livelihoods; efforts to keep schools open are among the most important. In France, to keep schools open, wearing a face mask has been mandatory for children from age 6 years since November 2020. Objective: To evaluate the acceptability and tolerance of this measure by children as well as both parents and pediatricians. Setting: Parent","2021","07","13","Front Pediatr","Frontiers in pediatrics","COVID-19; children; face mask; pandemic; parenthood","Assathiany","Rémy","Association Française de Pédiatrie Ambulatoire, Orléans, France",NA
"1653","34249814","10.3389/fped.2021.676718","Face Masks in Young Children During the COVID-19 Pandemic: Parents' and Pediatricians' Point of View.","Background: In countries with high SARS-CoV-2 circulation, the pandemic has presented many challenges on different fronts, affecting lives and livelihoods; efforts to keep schools open are among the most important. In France, to keep schools open, wearing a face mask has been mandatory for children from age 6 years since November 2020. Objective: To evaluate the acceptability and tolerance of this measure by children as well as both parents and pediatricians. Setting: Parent","2021","07","13","Front Pediatr","Frontiers in pediatrics","COVID-19; children; face mask; pandemic; parenthood","Salinier","Catherine","Association Française de Pédiatrie Ambulatoire, Orléans, France",NA
"1654","34249814","10.3389/fped.2021.676718","Face Masks in Young Children During the COVID-19 Pandemic: Parents' and Pediatricians' Point of View.","Background: In countries with high SARS-CoV-2 circulation, the pandemic has presented many challenges on different fronts, affecting lives and livelihoods; efforts to keep schools open are among the most important. In France, to keep schools open, wearing a face mask has been mandatory for children from age 6 years since November 2020. Objective: To evaluate the acceptability and tolerance of this measure by children as well as both parents and pediatricians. Setting: Parent","2021","07","13","Front Pediatr","Frontiers in pediatrics","COVID-19; children; face mask; pandemic; parenthood","Béchet","Stéphane","Association Clinique et Thérapeutique Infantile du Val de Marne, Créteil, France",NA
"1655","34249814","10.3389/fped.2021.676718","Face Masks in Young Children During the COVID-19 Pandemic: Parents' and Pediatricians' Point of View.","Background: In countries with high SARS-CoV-2 circulation, the pandemic has presented many challenges on different fronts, affecting lives and livelihoods; efforts to keep schools open are among the most important. In France, to keep schools open, wearing a face mask has been mandatory for children from age 6 years since November 2020. Objective: To evaluate the acceptability and tolerance of this measure by children as well as both parents and pediatricians. Setting: Parent","2021","07","13","Front Pediatr","Frontiers in pediatrics","COVID-19; children; face mask; pandemic; parenthood","Dolard","Claire","Doola, Bordeaux, France",NA
"1656","34249814","10.3389/fped.2021.676718","Face Masks in Young Children During the COVID-19 Pandemic: Parents' and Pediatricians' Point of View.","Background: In countries with high SARS-CoV-2 circulation, the pandemic has presented many challenges on different fronts, affecting lives and livelihoods; efforts to keep schools open are among the most important. In France, to keep schools open, wearing a face mask has been mandatory for children from age 6 years since November 2020. Objective: To evaluate the acceptability and tolerance of this measure by children as well as both parents and pediatricians. Setting: Parent","2021","07","13","Front Pediatr","Frontiers in pediatrics","COVID-19; children; face mask; pandemic; parenthood","Kochert","Fabienne","Association Française de Pédiatrie Ambulatoire, Orléans, France",NA
"1657","34249814","10.3389/fped.2021.676718","Face Masks in Young Children During the COVID-19 Pandemic: Parents' and Pediatricians' Point of View.","Background: In countries with high SARS-CoV-2 circulation, the pandemic has presented many challenges on different fronts, affecting lives and livelihoods; efforts to keep schools open are among the most important. In France, to keep schools open, wearing a face mask has been mandatory for children from age 6 years since November 2020. Objective: To evaluate the acceptability and tolerance of this measure by children as well as both parents and pediatricians. Setting: Parent","2021","07","13","Front Pediatr","Frontiers in pediatrics","COVID-19; children; face mask; pandemic; parenthood","Bocquet","Alain","Association Française de Pédiatrie Ambulatoire, Orléans, France",NA
"1658","34249814","10.3389/fped.2021.676718","Face Masks in Young Children During the COVID-19 Pandemic: Parents' and Pediatricians' Point of View.","Background: In countries with high SARS-CoV-2 circulation, the pandemic has presented many challenges on different fronts, affecting lives and livelihoods; efforts to keep schools open are among the most important. In France, to keep schools open, wearing a face mask has been mandatory for children from age 6 years since November 2020. Objective: To evaluate the acceptability and tolerance of this measure by children as well as both parents and pediatricians. Setting: Parent","2021","07","13","Front Pediatr","Frontiers in pediatrics","COVID-19; children; face mask; pandemic; parenthood","Levy","Corinne","Association Clinique et Thérapeutique Infantile du Val de Marne, Créteil, France",NA
"1659","34249813","10.3389/fped.2021.676611","Influenza vs. COVID-19: Comparison of Clinical Characteristics and Outcomes in Pediatric Patients in Mexico City.","Introduction: Respiratory viruses are among the leading causes of disease and death among children. Co-circulation of influenza and SARS-CoV2 can lead to diagnostic and management difficulties given the similarities in the clinical picture. Methods: This is a cohort of all children hospitalized with SARS-CoV2 infection from March to September 3rd 2020, and all children admitted with influenza throughout five flu-seasons (2013-2018) at a pediatric referral hospital. Patients with in","2021","07","13","Front Pediatr","Frontiers in pediatrics","COVID-19; SARS  CoV  2; children; clinical chracteristics; influenza; outcome","Laris-González","Almudena","Department of Infectious Diseases, Hospital Infantil de México Federico Gómez, Mexico City, Mexico",NA
"1660","34249813","10.3389/fped.2021.676611","Influenza vs. COVID-19: Comparison of Clinical Characteristics and Outcomes in Pediatric Patients in Mexico City.","Introduction: Respiratory viruses are among the leading causes of disease and death among children. Co-circulation of influenza and SARS-CoV2 can lead to diagnostic and management difficulties given the similarities in the clinical picture. Methods: This is a cohort of all children hospitalized with SARS-CoV2 infection from March to September 3rd 2020, and all children admitted with influenza throughout five flu-seasons (2013-2018) at a pediatric referral hospital. Patients with in","2021","07","13","Front Pediatr","Frontiers in pediatrics","COVID-19; SARS  CoV  2; children; clinical chracteristics; influenza; outcome","Avilés-Robles","Martha","Department of Infectious Diseases, Hospital Infantil de México Federico Gómez, Mexico City, Mexico",NA
"1661","34249813","10.3389/fped.2021.676611","Influenza vs. COVID-19: Comparison of Clinical Characteristics and Outcomes in Pediatric Patients in Mexico City.","Introduction: Respiratory viruses are among the leading causes of disease and death among children. Co-circulation of influenza and SARS-CoV2 can lead to diagnostic and management difficulties given the similarities in the clinical picture. Methods: This is a cohort of all children hospitalized with SARS-CoV2 infection from March to September 3rd 2020, and all children admitted with influenza throughout five flu-seasons (2013-2018) at a pediatric referral hospital. Patients with in","2021","07","13","Front Pediatr","Frontiers in pediatrics","COVID-19; SARS  CoV  2; children; clinical chracteristics; influenza; outcome","Domínguez-Barrera","Clemen","Department of Infectious Diseases, Hospital Infantil de México Federico Gómez, Mexico City, Mexico",NA
"1662","34249813","10.3389/fped.2021.676611","Influenza vs. COVID-19: Comparison of Clinical Characteristics and Outcomes in Pediatric Patients in Mexico City.","Introduction: Respiratory viruses are among the leading causes of disease and death among children. Co-circulation of influenza and SARS-CoV2 can lead to diagnostic and management difficulties given the similarities in the clinical picture. Methods: This is a cohort of all children hospitalized with SARS-CoV2 infection from March to September 3rd 2020, and all children admitted with influenza throughout five flu-seasons (2013-2018) at a pediatric referral hospital. Patients with in","2021","07","13","Front Pediatr","Frontiers in pediatrics","COVID-19; SARS  CoV  2; children; clinical chracteristics; influenza; outcome","Parra-Ortega","Israel","Department of Clinical Laboratory, Hospital Infantil de México Federico Gómez, Mexico City, Mexico",NA
"1663","34249813","10.3389/fped.2021.676611","Influenza vs. COVID-19: Comparison of Clinical Characteristics and Outcomes in Pediatric Patients in Mexico City.","Introduction: Respiratory viruses are among the leading causes of disease and death among children. Co-circulation of influenza and SARS-CoV2 can lead to diagnostic and management difficulties given the similarities in the clinical picture. Methods: This is a cohort of all children hospitalized with SARS-CoV2 infection from March to September 3rd 2020, and all children admitted with influenza throughout five flu-seasons (2013-2018) at a pediatric referral hospital. Patients with in","2021","07","13","Front Pediatr","Frontiers in pediatrics","COVID-19; SARS  CoV  2; children; clinical chracteristics; influenza; outcome","Sánchez-Huerta","José Luis","Department of Clinical Laboratory, Hospital Infantil de México Federico Gómez, Mexico City, Mexico",NA
"1664","34249813","10.3389/fped.2021.676611","Influenza vs. COVID-19: Comparison of Clinical Characteristics and Outcomes in Pediatric Patients in Mexico City.","Introduction: Respiratory viruses are among the leading causes of disease and death among children. Co-circulation of influenza and SARS-CoV2 can lead to diagnostic and management difficulties given the similarities in the clinical picture. Methods: This is a cohort of all children hospitalized with SARS-CoV2 infection from March to September 3rd 2020, and all children admitted with influenza throughout five flu-seasons (2013-2018) at a pediatric referral hospital. Patients with in","2021","07","13","Front Pediatr","Frontiers in pediatrics","COVID-19; SARS  CoV  2; children; clinical chracteristics; influenza; outcome","Ojeda-Diezbarroso","Karla","Department of Infectious Diseases, Hospital Infantil de México Federico Gómez, Mexico City, Mexico",NA
"1665","34249813","10.3389/fped.2021.676611","Influenza vs. COVID-19: Comparison of Clinical Characteristics and Outcomes in Pediatric Patients in Mexico City.","Introduction: Respiratory viruses are among the leading causes of disease and death among children. Co-circulation of influenza and SARS-CoV2 can lead to diagnostic and management difficulties given the similarities in the clinical picture. Methods: This is a cohort of all children hospitalized with SARS-CoV2 infection from March to September 3rd 2020, and all children admitted with influenza throughout five flu-seasons (2013-2018) at a pediatric referral hospital. Patients with in","2021","07","13","Front Pediatr","Frontiers in pediatrics","COVID-19; SARS  CoV  2; children; clinical chracteristics; influenza; outcome","Bonilla-Pellegrini","Sergio","Department of Infectious Diseases, Hospital Infantil de México Federico Gómez, Mexico City, Mexico",NA
"1666","34249813","10.3389/fped.2021.676611","Influenza vs. COVID-19: Comparison of Clinical Characteristics and Outcomes in Pediatric Patients in Mexico City.","Introduction: Respiratory viruses are among the leading causes of disease and death among children. Co-circulation of influenza and SARS-CoV2 can lead to diagnostic and management difficulties given the similarities in the clinical picture. Methods: This is a cohort of all children hospitalized with SARS-CoV2 infection from March to September 3rd 2020, and all children admitted with influenza throughout five flu-seasons (2013-2018) at a pediatric referral hospital. Patients with in","2021","07","13","Front Pediatr","Frontiers in pediatrics","COVID-19; SARS  CoV  2; children; clinical chracteristics; influenza; outcome","Olivar-López","Víctor","Department of Emergency Medicine, Hospital Infantil de México Federico Gómez, Mexico City, Mexico",NA
"1667","34249813","10.3389/fped.2021.676611","Influenza vs. COVID-19: Comparison of Clinical Characteristics and Outcomes in Pediatric Patients in Mexico City.","Introduction: Respiratory viruses are among the leading causes of disease and death among children. Co-circulation of influenza and SARS-CoV2 can lead to diagnostic and management difficulties given the similarities in the clinical picture. Methods: This is a cohort of all children hospitalized with SARS-CoV2 infection from March to September 3rd 2020, and all children admitted with influenza throughout five flu-seasons (2013-2018) at a pediatric referral hospital. Patients with in","2021","07","13","Front Pediatr","Frontiers in pediatrics","COVID-19; SARS  CoV  2; children; clinical chracteristics; influenza; outcome","Chávez-López","Adrián","Department of Pediatric Intensive Care, Hospital Infantil de México Federico Gómez, Mexico City, Mexico",NA
"1668","34249813","10.3389/fped.2021.676611","Influenza vs. COVID-19: Comparison of Clinical Characteristics and Outcomes in Pediatric Patients in Mexico City.","Introduction: Respiratory viruses are among the leading causes of disease and death among children. Co-circulation of influenza and SARS-CoV2 can lead to diagnostic and management difficulties given the similarities in the clinical picture. Methods: This is a cohort of all children hospitalized with SARS-CoV2 infection from March to September 3rd 2020, and all children admitted with influenza throughout five flu-seasons (2013-2018) at a pediatric referral hospital. Patients with in","2021","07","13","Front Pediatr","Frontiers in pediatrics","COVID-19; SARS  CoV  2; children; clinical chracteristics; influenza; outcome","Jiménez-Juárez","Rodolfo","Department of Infectious Diseases, Hospital Infantil de México Federico Gómez, Mexico City, Mexico",NA
"1669","34249807","10.3389/fped.2021.656720","Case Report: Acute Intracardiac Thrombosis in Children With Coronavirus Disease 2019 (COVID-19).","We herein describe a case series of children with SARS-CoV-2 infection (COVID-19) complicated with acute intracardiac thrombosis. The diagnosis of COVID-19 was confirmed through the reverse transcription-polymerase chain reaction (RT-PCR). Transthoracic echocardiography of patients revealed large intracardiac mobile masses resected successfully via cardiac surgery. The underlying mechanisms of this thrombus in the COVID-19 infection may be attributed to the hypercoagulation and inflammatory stat","2021","07","13","Front Pediatr","Frontiers in pediatrics","COVID-19; acute thrombosis; cardiac surgery; case series; children","Bigdelian","Hamid","Department of Cardiovascular Surgery, School of Medicine, Isfahan University of Medical Science, Isfahan, Iran",NA
"1670","34249807","10.3389/fped.2021.656720","Case Report: Acute Intracardiac Thrombosis in Children With Coronavirus Disease 2019 (COVID-19).","We herein describe a case series of children with SARS-CoV-2 infection (COVID-19) complicated with acute intracardiac thrombosis. The diagnosis of COVID-19 was confirmed through the reverse transcription-polymerase chain reaction (RT-PCR). Transthoracic echocardiography of patients revealed large intracardiac mobile masses resected successfully via cardiac surgery. The underlying mechanisms of this thrombus in the COVID-19 infection may be attributed to the hypercoagulation and inflammatory stat","2021","07","13","Front Pediatr","Frontiers in pediatrics","COVID-19; acute thrombosis; cardiac surgery; case series; children","Sedighi","Mohsen","Department of Anesthesiology and Pain Medicine, Pain Research Center, Iran University of Medical Sciences, Tehran, Iran",NA
"1671","34249807","10.3389/fped.2021.656720","Case Report: Acute Intracardiac Thrombosis in Children With Coronavirus Disease 2019 (COVID-19).","We herein describe a case series of children with SARS-CoV-2 infection (COVID-19) complicated with acute intracardiac thrombosis. The diagnosis of COVID-19 was confirmed through the reverse transcription-polymerase chain reaction (RT-PCR). Transthoracic echocardiography of patients revealed large intracardiac mobile masses resected successfully via cardiac surgery. The underlying mechanisms of this thrombus in the COVID-19 infection may be attributed to the hypercoagulation and inflammatory stat","2021","07","13","Front Pediatr","Frontiers in pediatrics","COVID-19; acute thrombosis; cardiac surgery; case series; children","Sabri","Mohammad Reza","Pediatric Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran",NA
"1672","34249807","10.3389/fped.2021.656720","Case Report: Acute Intracardiac Thrombosis in Children With Coronavirus Disease 2019 (COVID-19).","We herein describe a case series of children with SARS-CoV-2 infection (COVID-19) complicated with acute intracardiac thrombosis. The diagnosis of COVID-19 was confirmed through the reverse transcription-polymerase chain reaction (RT-PCR). Transthoracic echocardiography of patients revealed large intracardiac mobile masses resected successfully via cardiac surgery. The underlying mechanisms of this thrombus in the COVID-19 infection may be attributed to the hypercoagulation and inflammatory stat","2021","07","13","Front Pediatr","Frontiers in pediatrics","COVID-19; acute thrombosis; cardiac surgery; case series; children","Dehghan","Bahar","Pediatric Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran",NA
"1673","34249807","10.3389/fped.2021.656720","Case Report: Acute Intracardiac Thrombosis in Children With Coronavirus Disease 2019 (COVID-19).","We herein describe a case series of children with SARS-CoV-2 infection (COVID-19) complicated with acute intracardiac thrombosis. The diagnosis of COVID-19 was confirmed through the reverse transcription-polymerase chain reaction (RT-PCR). Transthoracic echocardiography of patients revealed large intracardiac mobile masses resected successfully via cardiac surgery. The underlying mechanisms of this thrombus in the COVID-19 infection may be attributed to the hypercoagulation and inflammatory stat","2021","07","13","Front Pediatr","Frontiers in pediatrics","COVID-19; acute thrombosis; cardiac surgery; case series; children","Mahdavi","Chehreh","Pediatric Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran",NA
"1674","34249807","10.3389/fped.2021.656720","Case Report: Acute Intracardiac Thrombosis in Children With Coronavirus Disease 2019 (COVID-19).","We herein describe a case series of children with SARS-CoV-2 infection (COVID-19) complicated with acute intracardiac thrombosis. The diagnosis of COVID-19 was confirmed through the reverse transcription-polymerase chain reaction (RT-PCR). Transthoracic echocardiography of patients revealed large intracardiac mobile masses resected successfully via cardiac surgery. The underlying mechanisms of this thrombus in the COVID-19 infection may be attributed to the hypercoagulation and inflammatory stat","2021","07","13","Front Pediatr","Frontiers in pediatrics","COVID-19; acute thrombosis; cardiac surgery; case series; children","Ahmadi","Alireza","Pediatric Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran",NA
"1675","34249807","10.3389/fped.2021.656720","Case Report: Acute Intracardiac Thrombosis in Children With Coronavirus Disease 2019 (COVID-19).","We herein describe a case series of children with SARS-CoV-2 infection (COVID-19) complicated with acute intracardiac thrombosis. The diagnosis of COVID-19 was confirmed through the reverse transcription-polymerase chain reaction (RT-PCR). Transthoracic echocardiography of patients revealed large intracardiac mobile masses resected successfully via cardiac surgery. The underlying mechanisms of this thrombus in the COVID-19 infection may be attributed to the hypercoagulation and inflammatory stat","2021","07","13","Front Pediatr","Frontiers in pediatrics","COVID-19; acute thrombosis; cardiac surgery; case series; children","Ghaderian","Mehdi","Pediatric Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran",NA
"1676","34249807","10.3389/fped.2021.656720","Case Report: Acute Intracardiac Thrombosis in Children With Coronavirus Disease 2019 (COVID-19).","We herein describe a case series of children with SARS-CoV-2 infection (COVID-19) complicated with acute intracardiac thrombosis. The diagnosis of COVID-19 was confirmed through the reverse transcription-polymerase chain reaction (RT-PCR). Transthoracic echocardiography of patients revealed large intracardiac mobile masses resected successfully via cardiac surgery. The underlying mechanisms of this thrombus in the COVID-19 infection may be attributed to the hypercoagulation and inflammatory stat","2021","07","13","Front Pediatr","Frontiers in pediatrics","COVID-19; acute thrombosis; cardiac surgery; case series; children","Rahimi","Hamid","Pediatric Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran",NA
"1677","34249807","10.3389/fped.2021.656720","Case Report: Acute Intracardiac Thrombosis in Children With Coronavirus Disease 2019 (COVID-19).","We herein describe a case series of children with SARS-CoV-2 infection (COVID-19) complicated with acute intracardiac thrombosis. The diagnosis of COVID-19 was confirmed through the reverse transcription-polymerase chain reaction (RT-PCR). Transthoracic echocardiography of patients revealed large intracardiac mobile masses resected successfully via cardiac surgery. The underlying mechanisms of this thrombus in the COVID-19 infection may be attributed to the hypercoagulation and inflammatory stat","2021","07","13","Front Pediatr","Frontiers in pediatrics","COVID-19; acute thrombosis; cardiac surgery; case series; children","Sadeghizadeh","Atefeh","Department of Pediatrics, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran",NA
"1678","34249807","10.3389/fped.2021.656720","Case Report: Acute Intracardiac Thrombosis in Children With Coronavirus Disease 2019 (COVID-19).","We herein describe a case series of children with SARS-CoV-2 infection (COVID-19) complicated with acute intracardiac thrombosis. The diagnosis of COVID-19 was confirmed through the reverse transcription-polymerase chain reaction (RT-PCR). Transthoracic echocardiography of patients revealed large intracardiac mobile masses resected successfully via cardiac surgery. The underlying mechanisms of this thrombus in the COVID-19 infection may be attributed to the hypercoagulation and inflammatory stat","2021","07","13","Front Pediatr","Frontiers in pediatrics","COVID-19; acute thrombosis; cardiac surgery; case series; children","Emadoleslami","Monirsadat","Department of Pediatrics, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran",NA
"1679","34249807","10.3389/fped.2021.656720","Case Report: Acute Intracardiac Thrombosis in Children With Coronavirus Disease 2019 (COVID-19).","We herein describe a case series of children with SARS-CoV-2 infection (COVID-19) complicated with acute intracardiac thrombosis. The diagnosis of COVID-19 was confirmed through the reverse transcription-polymerase chain reaction (RT-PCR). Transthoracic echocardiography of patients revealed large intracardiac mobile masses resected successfully via cardiac surgery. The underlying mechanisms of this thrombus in the COVID-19 infection may be attributed to the hypercoagulation and inflammatory stat","2021","07","13","Front Pediatr","Frontiers in pediatrics","COVID-19; acute thrombosis; cardiac surgery; case series; children","Mostafavi","Seyed Nasser","Department of Pediatrics, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran",NA
"1680","34249807","10.3389/fped.2021.656720","Case Report: Acute Intracardiac Thrombosis in Children With Coronavirus Disease 2019 (COVID-19).","We herein describe a case series of children with SARS-CoV-2 infection (COVID-19) complicated with acute intracardiac thrombosis. The diagnosis of COVID-19 was confirmed through the reverse transcription-polymerase chain reaction (RT-PCR). Transthoracic echocardiography of patients revealed large intracardiac mobile masses resected successfully via cardiac surgery. The underlying mechanisms of this thrombus in the COVID-19 infection may be attributed to the hypercoagulation and inflammatory stat","2021","07","13","Front Pediatr","Frontiers in pediatrics","COVID-19; acute thrombosis; cardiac surgery; case series; children","Saleh","Rana","Department of Pediatrics, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran",NA
"1681","34249807","10.3389/fped.2021.656720","Case Report: Acute Intracardiac Thrombosis in Children With Coronavirus Disease 2019 (COVID-19).","We herein describe a case series of children with SARS-CoV-2 infection (COVID-19) complicated with acute intracardiac thrombosis. The diagnosis of COVID-19 was confirmed through the reverse transcription-polymerase chain reaction (RT-PCR). Transthoracic echocardiography of patients revealed large intracardiac mobile masses resected successfully via cardiac surgery. The underlying mechanisms of this thrombus in the COVID-19 infection may be attributed to the hypercoagulation and inflammatory stat","2021","07","13","Front Pediatr","Frontiers in pediatrics","COVID-19; acute thrombosis; cardiac surgery; case series; children","Javadi","Niloofar","Student Research Committee, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran",NA
"1682","34249807","10.3389/fped.2021.656720","Case Report: Acute Intracardiac Thrombosis in Children With Coronavirus Disease 2019 (COVID-19).","We herein describe a case series of children with SARS-CoV-2 infection (COVID-19) complicated with acute intracardiac thrombosis. The diagnosis of COVID-19 was confirmed through the reverse transcription-polymerase chain reaction (RT-PCR). Transthoracic echocardiography of patients revealed large intracardiac mobile masses resected successfully via cardiac surgery. The underlying mechanisms of this thrombus in the COVID-19 infection may be attributed to the hypercoagulation and inflammatory stat","2021","07","13","Front Pediatr","Frontiers in pediatrics","COVID-19; acute thrombosis; cardiac surgery; case series; children","Derakhshan","Maryam","Department of Pathology, School of Medicine, Isfahan University of Medical Science, Isfahan, Iran",NA
"1683","34249807","10.3389/fped.2021.656720","Case Report: Acute Intracardiac Thrombosis in Children With Coronavirus Disease 2019 (COVID-19).","We herein describe a case series of children with SARS-CoV-2 infection (COVID-19) complicated with acute intracardiac thrombosis. The diagnosis of COVID-19 was confirmed through the reverse transcription-polymerase chain reaction (RT-PCR). Transthoracic echocardiography of patients revealed large intracardiac mobile masses resected successfully via cardiac surgery. The underlying mechanisms of this thrombus in the COVID-19 infection may be attributed to the hypercoagulation and inflammatory stat","2021","07","13","Front Pediatr","Frontiers in pediatrics","COVID-19; acute thrombosis; cardiac surgery; case series; children","Pourmoghaddas","Zahra","Department of Pediatrics, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran",NA
"1684","34249807","10.3389/fped.2021.656720","Case Report: Acute Intracardiac Thrombosis in Children With Coronavirus Disease 2019 (COVID-19).","We herein describe a case series of children with SARS-CoV-2 infection (COVID-19) complicated with acute intracardiac thrombosis. The diagnosis of COVID-19 was confirmed through the reverse transcription-polymerase chain reaction (RT-PCR). Transthoracic echocardiography of patients revealed large intracardiac mobile masses resected successfully via cardiac surgery. The underlying mechanisms of this thrombus in the COVID-19 infection may be attributed to the hypercoagulation and inflammatory stat","2021","07","13","Front Pediatr","Frontiers in pediatrics","COVID-19; acute thrombosis; cardiac surgery; case series; children","Sarfarazi Moghadam","Shima","Pediatric Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran",NA
"1685","34249804","10.3389/fped.2021.650302","The Yin and the Yang of Transformative Research During the COVID-19 Pandemic-A Perspective.","The COVID-19 pandemic has highlighted the necessity for scientists from diverse disciplines to collaboratively mitigate the singular calamity facing humanity this century. The ability of researchers to combine exponential advances in technology and scientific acumen has resulted in landmark discoveries in pediatric research and is surmounting the COVID-19 challenge. Several of these discoveries exist in a realm of research that is not classically ""basic"" or ""clinical."" Translational research cha","2021","07","13","Front Pediatr","Frontiers in pediatrics","COVID-19; basic and clinical sciences; broad scientific training; rare and complex disease; research; training &amp; development; transformative team science","Sampath","Venkatesh","Division of Neonatology, Children's Mercy Kansas City, Kansas City, MO, United States",NA
"1686","34249804","10.3389/fped.2021.650302","The Yin and the Yang of Transformative Research During the COVID-19 Pandemic-A Perspective.","The COVID-19 pandemic has highlighted the necessity for scientists from diverse disciplines to collaboratively mitigate the singular calamity facing humanity this century. The ability of researchers to combine exponential advances in technology and scientific acumen has resulted in landmark discoveries in pediatric research and is surmounting the COVID-19 challenge. Several of these discoveries exist in a realm of research that is not classically ""basic"" or ""clinical."" Translational research cha","2021","07","13","Front Pediatr","Frontiers in pediatrics","COVID-19; basic and clinical sciences; broad scientific training; rare and complex disease; research; training &amp; development; transformative team science","Ramchandran","Ramani","Department of Pediatrics, Division of Neonatology, Medical College of Wisconsin, Milwaukee, WI, United States",NA
"1687","34249790","10.4322/acr.2021.286","Utilizing electronic resources to promote your residency program.","As the COVID-19 pandemic spread to the United States, it was followed by unprecedented changes. These changes did not spare undergraduate and graduate medical students. Specifically, medical students applying for residency programs were faced with a novel challenge. In March 2020, as the pandemic became increasingly severe, the Association of American Medical Colleges (AAMC) recommended pulling medical students from in-person clinical rotations. By May 2020, the AAMC recommended that all residen","2021","07","13","Autops Case Rep","Autopsy &amp; case reports","Coronavirus Infections; Internship and Residency; Pandemics","Mabis","Colton","St. George's University, School of Medicine, Detroit, Mi, USA",NA
"1688","34249790","10.4322/acr.2021.286","Utilizing electronic resources to promote your residency program.","As the COVID-19 pandemic spread to the United States, it was followed by unprecedented changes. These changes did not spare undergraduate and graduate medical students. Specifically, medical students applying for residency programs were faced with a novel challenge. In March 2020, as the pandemic became increasingly severe, the Association of American Medical Colleges (AAMC) recommended pulling medical students from in-person clinical rotations. By May 2020, the AAMC recommended that all residen","2021","07","13","Autops Case Rep","Autopsy &amp; case reports","Coronavirus Infections; Internship and Residency; Pandemics","Chand","Momal Tara","Ascension St John Hospital, Department of Pathology, Detroit, Mi, USA",NA
"1689","34249790","10.4322/acr.2021.286","Utilizing electronic resources to promote your residency program.","As the COVID-19 pandemic spread to the United States, it was followed by unprecedented changes. These changes did not spare undergraduate and graduate medical students. Specifically, medical students applying for residency programs were faced with a novel challenge. In March 2020, as the pandemic became increasingly severe, the Association of American Medical Colleges (AAMC) recommended pulling medical students from in-person clinical rotations. By May 2020, the AAMC recommended that all residen","2021","07","13","Autops Case Rep","Autopsy &amp; case reports","Coronavirus Infections; Internship and Residency; Pandemics","Miller","Shelby","Ascension St John Hospital, Department of Research, Detroit, Mi, USA",NA
"1690","34249668","10.1007/s12070-021-02730-6","Post Viral Olfactory Dysfunction After SARS-CoV-2 Infection: Anticipated Post-pandemic Clinical Challenge.","Persistent olfactory dysfunction (OD) is the second most common symptom of post coronavirus disease-19 (COVID-19) now being termed long-COVID. Its prevalence after recovery from COVID-19 is estimated to be 12% after nearly 6 months of follow-up. It thus becomes imperative for the treating clinicians to update themselves with the pathophysiology of this post COVID disability as well as the tools for diagnosis and the available treatment options. A systematic literature search was performed as per","2021","07","13","Indian J Otolaryngol Head Neck Surg","Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India","Anosmia; COVID-19; Long-COVID; Olfaction disorders; PVOD; Post COVID; Post viral","Kapoor","Dhruv","Department of Otorhinolaryngology, University College of Medical Sciences, Delhi, India",NA
"1691","34249668","10.1007/s12070-021-02730-6","Post Viral Olfactory Dysfunction After SARS-CoV-2 Infection: Anticipated Post-pandemic Clinical Challenge.","Persistent olfactory dysfunction (OD) is the second most common symptom of post coronavirus disease-19 (COVID-19) now being termed long-COVID. Its prevalence after recovery from COVID-19 is estimated to be 12% after nearly 6 months of follow-up. It thus becomes imperative for the treating clinicians to update themselves with the pathophysiology of this post COVID disability as well as the tools for diagnosis and the available treatment options. A systematic literature search was performed as per","2021","07","13","Indian J Otolaryngol Head Neck Surg","Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India","Anosmia; COVID-19; Long-COVID; Olfaction disorders; PVOD; Post COVID; Post viral","Verma","Neha","Department of Otorhinolaryngology, University College of Medical Sciences, Delhi, India",NA
"1692","34249668","10.1007/s12070-021-02730-6","Post Viral Olfactory Dysfunction After SARS-CoV-2 Infection: Anticipated Post-pandemic Clinical Challenge.","Persistent olfactory dysfunction (OD) is the second most common symptom of post coronavirus disease-19 (COVID-19) now being termed long-COVID. Its prevalence after recovery from COVID-19 is estimated to be 12% after nearly 6 months of follow-up. It thus becomes imperative for the treating clinicians to update themselves with the pathophysiology of this post COVID disability as well as the tools for diagnosis and the available treatment options. A systematic literature search was performed as per","2021","07","13","Indian J Otolaryngol Head Neck Surg","Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India","Anosmia; COVID-19; Long-COVID; Olfaction disorders; PVOD; Post COVID; Post viral","Gupta","Neelima","Department of Otorhinolaryngology, University College of Medical Sciences, Delhi, India",NA
"1693","34249668","10.1007/s12070-021-02730-6","Post Viral Olfactory Dysfunction After SARS-CoV-2 Infection: Anticipated Post-pandemic Clinical Challenge.","Persistent olfactory dysfunction (OD) is the second most common symptom of post coronavirus disease-19 (COVID-19) now being termed long-COVID. Its prevalence after recovery from COVID-19 is estimated to be 12% after nearly 6 months of follow-up. It thus becomes imperative for the treating clinicians to update themselves with the pathophysiology of this post COVID disability as well as the tools for diagnosis and the available treatment options. A systematic literature search was performed as per","2021","07","13","Indian J Otolaryngol Head Neck Surg","Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India","Anosmia; COVID-19; Long-COVID; Olfaction disorders; PVOD; Post COVID; Post viral","Goyal","Arun","Department of Otorhinolaryngology, University College of Medical Sciences, Delhi, India",NA
"1694","34249667","10.1007/s12070-021-02717-3","The Efficacy of Tracheotomy for Covid-19 Pneumonia: Impacts on Survival and Prognostic Factors.","The role of tracheotomy during the pandemic remains to be determined for severe COVID-19 pneumonia. We evaluated the effect of tracheotomy on prognostic markers and assessed 4 weeks survival in terms of clinical and biochemical characteristics of patients and time and type (open or percutaneous) of the operation. We performed a retrospective study considering ICU patients with COVID-19 pneumonia and tracheotomy, between May 30 and December 31, 2020. Four weeks survival postoperatively and altera","2021","07","13","Indian J Otolaryngol Head Neck Surg","Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India","Biochemical markers; Covid-19; Prognostic markers; Survival; Tracheotomy","Tuna","Bilge","Department of Otorhinolaryngology, Bursa City Hospital, Doganköy Nilüfer, 16110 Bursa, Turkey",NA
"1695","34249667","10.1007/s12070-021-02717-3","The Efficacy of Tracheotomy for Covid-19 Pneumonia: Impacts on Survival and Prognostic Factors.","The role of tracheotomy during the pandemic remains to be determined for severe COVID-19 pneumonia. We evaluated the effect of tracheotomy on prognostic markers and assessed 4 weeks survival in terms of clinical and biochemical characteristics of patients and time and type (open or percutaneous) of the operation. We performed a retrospective study considering ICU patients with COVID-19 pneumonia and tracheotomy, between May 30 and December 31, 2020. Four weeks survival postoperatively and altera","2021","07","13","Indian J Otolaryngol Head Neck Surg","Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India","Biochemical markers; Covid-19; Prognostic markers; Survival; Tracheotomy","Birdane","Leman","Department of Otorhinolaryngology, Bursa City Hospital, Doganköy Nilüfer, 16110 Bursa, Turkey",NA
"1696","34249666","10.1007/s12070-021-02702-w","Prevalence of Olfactory and Gustatory Dysfunction in Coronavirus Disease (COVID-19): A Cross Sectional Study in Our Tertiary Care Hospital.","COVID-19 pandemic is affecting millions of people all across the globe. Along with other clinical features, anosmia and dysgeusia are important symptoms being seen. This study evaluates the prevalence of olfactory and gustatory dysfunction in patients with SARS CoV-2 infection in a tertiary care centre and the severity and duration of altered taste and smell sensation in COVID positive patients. A total number of 167 patients that had tested positive for COVID 19 KLES Dr. Prabhakar Kore hospital","2021","07","13","Indian J Otolaryngol Head Neck Surg","Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India","Anosmia; Corona virus; Dysgeusia; Parosmia; SARS-COV-2","Hajare","Priti S","Department of ENT, Head and Neck Surgery, J.N. Medical College, KLE Academy of Higher Education and Research, Belagavi, Karnataka India",NA
"1697","34249666","10.1007/s12070-021-02702-w","Prevalence of Olfactory and Gustatory Dysfunction in Coronavirus Disease (COVID-19): A Cross Sectional Study in Our Tertiary Care Hospital.","COVID-19 pandemic is affecting millions of people all across the globe. Along with other clinical features, anosmia and dysgeusia are important symptoms being seen. This study evaluates the prevalence of olfactory and gustatory dysfunction in patients with SARS CoV-2 infection in a tertiary care centre and the severity and duration of altered taste and smell sensation in COVID positive patients. A total number of 167 patients that had tested positive for COVID 19 KLES Dr. Prabhakar Kore hospital","2021","07","13","Indian J Otolaryngol Head Neck Surg","Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India","Anosmia; Corona virus; Dysgeusia; Parosmia; SARS-COV-2","Harugop","Anil S","Department of ENT, Head and Neck Surgery, J.N. Medical College, KLE Academy of Higher Education and Research, Belagavi, Karnataka India",NA
"1698","34249666","10.1007/s12070-021-02702-w","Prevalence of Olfactory and Gustatory Dysfunction in Coronavirus Disease (COVID-19): A Cross Sectional Study in Our Tertiary Care Hospital.","COVID-19 pandemic is affecting millions of people all across the globe. Along with other clinical features, anosmia and dysgeusia are important symptoms being seen. This study evaluates the prevalence of olfactory and gustatory dysfunction in patients with SARS CoV-2 infection in a tertiary care centre and the severity and duration of altered taste and smell sensation in COVID positive patients. A total number of 167 patients that had tested positive for COVID 19 KLES Dr. Prabhakar Kore hospital","2021","07","13","Indian J Otolaryngol Head Neck Surg","Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India","Anosmia; Corona virus; Dysgeusia; Parosmia; SARS-COV-2","Goswami","Lakshmi","Department of ENT, Head and Neck Surgery, J.N. Medical College, KLE Academy of Higher Education and Research, Belagavi, Karnataka India",NA
"1699","34249666","10.1007/s12070-021-02702-w","Prevalence of Olfactory and Gustatory Dysfunction in Coronavirus Disease (COVID-19): A Cross Sectional Study in Our Tertiary Care Hospital.","COVID-19 pandemic is affecting millions of people all across the globe. Along with other clinical features, anosmia and dysgeusia are important symptoms being seen. This study evaluates the prevalence of olfactory and gustatory dysfunction in patients with SARS CoV-2 infection in a tertiary care centre and the severity and duration of altered taste and smell sensation in COVID positive patients. A total number of 167 patients that had tested positive for COVID 19 KLES Dr. Prabhakar Kore hospital","2021","07","13","Indian J Otolaryngol Head Neck Surg","Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India","Anosmia; Corona virus; Dysgeusia; Parosmia; SARS-COV-2","Padmavathy","O","Department of ENT, Head and Neck Surgery, J.N. Medical College, KLE Academy of Higher Education and Research, Belagavi, Karnataka India",NA
"1700","34249666","10.1007/s12070-021-02702-w","Prevalence of Olfactory and Gustatory Dysfunction in Coronavirus Disease (COVID-19): A Cross Sectional Study in Our Tertiary Care Hospital.","COVID-19 pandemic is affecting millions of people all across the globe. Along with other clinical features, anosmia and dysgeusia are important symptoms being seen. This study evaluates the prevalence of olfactory and gustatory dysfunction in patients with SARS CoV-2 infection in a tertiary care centre and the severity and duration of altered taste and smell sensation in COVID positive patients. A total number of 167 patients that had tested positive for COVID 19 KLES Dr. Prabhakar Kore hospital","2021","07","13","Indian J Otolaryngol Head Neck Surg","Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India","Anosmia; Corona virus; Dysgeusia; Parosmia; SARS-COV-2","Aggarwal","Umang","Department of ENT, Head and Neck Surgery, J.N. Medical College, KLE Academy of Higher Education and Research, Belagavi, Karnataka India",NA
"1701","34249666","10.1007/s12070-021-02702-w","Prevalence of Olfactory and Gustatory Dysfunction in Coronavirus Disease (COVID-19): A Cross Sectional Study in Our Tertiary Care Hospital.","COVID-19 pandemic is affecting millions of people all across the globe. Along with other clinical features, anosmia and dysgeusia are important symptoms being seen. This study evaluates the prevalence of olfactory and gustatory dysfunction in patients with SARS CoV-2 infection in a tertiary care centre and the severity and duration of altered taste and smell sensation in COVID positive patients. A total number of 167 patients that had tested positive for COVID 19 KLES Dr. Prabhakar Kore hospital","2021","07","13","Indian J Otolaryngol Head Neck Surg","Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India","Anosmia; Corona virus; Dysgeusia; Parosmia; SARS-COV-2","Reddy","Yannamreddy Lavanya","Department of ENT, Head and Neck Surgery, J.N. Medical College, KLE Academy of Higher Education and Research, Belagavi, Karnataka India",NA
"1702","34249665","10.1007/s12070-021-02715-5","New Onset Vertigo After COVID-19 Infection. A Case Report.","In addition to the known pathophysiological sequelae of the SARS-COV-2 virus and its related respiratory symptoms, several studies have recently reported cardiovascular, gastrointestinal, and neurological symptoms of new-onset after a history of infection. Vertigo is a symptom indicating dysfunction of the vestibular system and this report of a 60-year-old female patient points out the possible association between new-onset vertigo and SARS-COV-2 infection. A 60-year-old diabetic and hypertensiv","2021","07","13","Indian J Otolaryngol Head Neck Surg","Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India","COVID-19; SARS-COV-2; Vertigo; Vestibular neuritis","Motawea","Karam R","Faculty of Medicine, Alexandria University, Alexandria, Egypt",NA
"1703","34249665","10.1007/s12070-021-02715-5","New Onset Vertigo After COVID-19 Infection. A Case Report.","In addition to the known pathophysiological sequelae of the SARS-COV-2 virus and its related respiratory symptoms, several studies have recently reported cardiovascular, gastrointestinal, and neurological symptoms of new-onset after a history of infection. Vertigo is a symptom indicating dysfunction of the vestibular system and this report of a 60-year-old female patient points out the possible association between new-onset vertigo and SARS-COV-2 infection. A 60-year-old diabetic and hypertensiv","2021","07","13","Indian J Otolaryngol Head Neck Surg","Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India","COVID-19; SARS-COV-2; Vertigo; Vestibular neuritis","Monib","Fatma A","Faculty of Medicine, Assiut University, Assiut, Egypt",NA
"1704","34249645","10.21037/qims-20-1176","Ultra-low-dose chest CT performance for the detection of viral pneumonia patterns during the COVID-19 outbreak period: a monocentric experience.","Ultra low dose chest computed tomography (CT) acquisitions have been used for selected emergency room patients with acute dyspnea or minor thoracic trauma. The purpose of this study was to evaluate the diagnostic performance of ultra-low-dose (ULD) chest CT for detecting viral pneumonia patterns compared to standard (STD) dose chest CT. All consecutive adult patients with two non-enhanced chest CT acquisitions, one STD and one ULD, for suspicion of viral pneumonia between March 5<sup>th</sup> an","2021","07","13","Quant Imaging Med Surg","Quantitative imaging in medicine and surgery","Multidetector computed tomography (multidetector CT); coronavirus infections; ultra-low-dose CT (ULD CT)","Greffier","Joël","Department of Medical Imaging, Nîmes University Hospital, University of Montpellier, Medical Imaging Group Nîmes, Nîmes, France",NA
"1705","34249645","10.21037/qims-20-1176","Ultra-low-dose chest CT performance for the detection of viral pneumonia patterns during the COVID-19 outbreak period: a monocentric experience.","Ultra low dose chest computed tomography (CT) acquisitions have been used for selected emergency room patients with acute dyspnea or minor thoracic trauma. The purpose of this study was to evaluate the diagnostic performance of ultra-low-dose (ULD) chest CT for detecting viral pneumonia patterns compared to standard (STD) dose chest CT. All consecutive adult patients with two non-enhanced chest CT acquisitions, one STD and one ULD, for suspicion of viral pneumonia between March 5<sup>th</sup> an","2021","07","13","Quant Imaging Med Surg","Quantitative imaging in medicine and surgery","Multidetector computed tomography (multidetector CT); coronavirus infections; ultra-low-dose CT (ULD CT)","Hoballah","Adel","Department of Medical Imaging, Nîmes University Hospital, University of Montpellier, Medical Imaging Group Nîmes, Nîmes, France",NA
"1706","34249645","10.21037/qims-20-1176","Ultra-low-dose chest CT performance for the detection of viral pneumonia patterns during the COVID-19 outbreak period: a monocentric experience.","Ultra low dose chest computed tomography (CT) acquisitions have been used for selected emergency room patients with acute dyspnea or minor thoracic trauma. The purpose of this study was to evaluate the diagnostic performance of ultra-low-dose (ULD) chest CT for detecting viral pneumonia patterns compared to standard (STD) dose chest CT. All consecutive adult patients with two non-enhanced chest CT acquisitions, one STD and one ULD, for suspicion of viral pneumonia between March 5<sup>th</sup> an","2021","07","13","Quant Imaging Med Surg","Quantitative imaging in medicine and surgery","Multidetector computed tomography (multidetector CT); coronavirus infections; ultra-low-dose CT (ULD CT)","Sadate","Alexandre","Department of Medical Imaging, Nîmes University Hospital, University of Montpellier, Medical Imaging Group Nîmes, Nîmes, France",NA
"1707","34249645","10.21037/qims-20-1176","Ultra-low-dose chest CT performance for the detection of viral pneumonia patterns during the COVID-19 outbreak period: a monocentric experience.","Ultra low dose chest computed tomography (CT) acquisitions have been used for selected emergency room patients with acute dyspnea or minor thoracic trauma. The purpose of this study was to evaluate the diagnostic performance of ultra-low-dose (ULD) chest CT for detecting viral pneumonia patterns compared to standard (STD) dose chest CT. All consecutive adult patients with two non-enhanced chest CT acquisitions, one STD and one ULD, for suspicion of viral pneumonia between March 5<sup>th</sup> an","2021","07","13","Quant Imaging Med Surg","Quantitative imaging in medicine and surgery","Multidetector computed tomography (multidetector CT); coronavirus infections; ultra-low-dose CT (ULD CT)","de Oliveira","Fabien","Department of Medical Imaging, Nîmes University Hospital, University of Montpellier, Medical Imaging Group Nîmes, Nîmes, France",NA
"1708","34249645","10.21037/qims-20-1176","Ultra-low-dose chest CT performance for the detection of viral pneumonia patterns during the COVID-19 outbreak period: a monocentric experience.","Ultra low dose chest computed tomography (CT) acquisitions have been used for selected emergency room patients with acute dyspnea or minor thoracic trauma. The purpose of this study was to evaluate the diagnostic performance of ultra-low-dose (ULD) chest CT for detecting viral pneumonia patterns compared to standard (STD) dose chest CT. All consecutive adult patients with two non-enhanced chest CT acquisitions, one STD and one ULD, for suspicion of viral pneumonia between March 5<sup>th</sup> an","2021","07","13","Quant Imaging Med Surg","Quantitative imaging in medicine and surgery","Multidetector computed tomography (multidetector CT); coronavirus infections; ultra-low-dose CT (ULD CT)","Claret","Pierre-Geraud","Department of Anesthesia Resuscitation Pain Emergencies, Nîmes University Hospital, University of Montpellier, Nîmes, France",NA
"1709","34249645","10.21037/qims-20-1176","Ultra-low-dose chest CT performance for the detection of viral pneumonia patterns during the COVID-19 outbreak period: a monocentric experience.","Ultra low dose chest computed tomography (CT) acquisitions have been used for selected emergency room patients with acute dyspnea or minor thoracic trauma. The purpose of this study was to evaluate the diagnostic performance of ultra-low-dose (ULD) chest CT for detecting viral pneumonia patterns compared to standard (STD) dose chest CT. All consecutive adult patients with two non-enhanced chest CT acquisitions, one STD and one ULD, for suspicion of viral pneumonia between March 5<sup>th</sup> an","2021","07","13","Quant Imaging Med Surg","Quantitative imaging in medicine and surgery","Multidetector computed tomography (multidetector CT); coronavirus infections; ultra-low-dose CT (ULD CT)","de Forges","Hélène","Department of Medical Imaging, Nîmes University Hospital, University of Montpellier, Medical Imaging Group Nîmes, Nîmes, France",NA
"1710","34249645","10.21037/qims-20-1176","Ultra-low-dose chest CT performance for the detection of viral pneumonia patterns during the COVID-19 outbreak period: a monocentric experience.","Ultra low dose chest computed tomography (CT) acquisitions have been used for selected emergency room patients with acute dyspnea or minor thoracic trauma. The purpose of this study was to evaluate the diagnostic performance of ultra-low-dose (ULD) chest CT for detecting viral pneumonia patterns compared to standard (STD) dose chest CT. All consecutive adult patients with two non-enhanced chest CT acquisitions, one STD and one ULD, for suspicion of viral pneumonia between March 5<sup>th</sup> an","2021","07","13","Quant Imaging Med Surg","Quantitative imaging in medicine and surgery","Multidetector computed tomography (multidetector CT); coronavirus infections; ultra-low-dose CT (ULD CT)","Loubet","Paul","VBMI, INSERM U1047, Department of Infectious and Tropical Disease, CHU Nîmes, Univ Montpellier, Nîmes, France",NA
"1711","34249645","10.21037/qims-20-1176","Ultra-low-dose chest CT performance for the detection of viral pneumonia patterns during the COVID-19 outbreak period: a monocentric experience.","Ultra low dose chest computed tomography (CT) acquisitions have been used for selected emergency room patients with acute dyspnea or minor thoracic trauma. The purpose of this study was to evaluate the diagnostic performance of ultra-low-dose (ULD) chest CT for detecting viral pneumonia patterns compared to standard (STD) dose chest CT. All consecutive adult patients with two non-enhanced chest CT acquisitions, one STD and one ULD, for suspicion of viral pneumonia between March 5<sup>th</sup> an","2021","07","13","Quant Imaging Med Surg","Quantitative imaging in medicine and surgery","Multidetector computed tomography (multidetector CT); coronavirus infections; ultra-low-dose CT (ULD CT)","Mauboussin","Jean-Marc","VBMI, INSERM U1047, Department of Infectious and Tropical Disease, CHU Nîmes, Univ Montpellier, Nîmes, France",NA
"1712","34249645","10.21037/qims-20-1176","Ultra-low-dose chest CT performance for the detection of viral pneumonia patterns during the COVID-19 outbreak period: a monocentric experience.","Ultra low dose chest computed tomography (CT) acquisitions have been used for selected emergency room patients with acute dyspnea or minor thoracic trauma. The purpose of this study was to evaluate the diagnostic performance of ultra-low-dose (ULD) chest CT for detecting viral pneumonia patterns compared to standard (STD) dose chest CT. All consecutive adult patients with two non-enhanced chest CT acquisitions, one STD and one ULD, for suspicion of viral pneumonia between March 5<sup>th</sup> an","2021","07","13","Quant Imaging Med Surg","Quantitative imaging in medicine and surgery","Multidetector computed tomography (multidetector CT); coronavirus infections; ultra-low-dose CT (ULD CT)","Hamard","Aymeric","Department of Medical Imaging, Nîmes University Hospital, University of Montpellier, Medical Imaging Group Nîmes, Nîmes, France",NA
"1713","34249645","10.21037/qims-20-1176","Ultra-low-dose chest CT performance for the detection of viral pneumonia patterns during the COVID-19 outbreak period: a monocentric experience.","Ultra low dose chest computed tomography (CT) acquisitions have been used for selected emergency room patients with acute dyspnea or minor thoracic trauma. The purpose of this study was to evaluate the diagnostic performance of ultra-low-dose (ULD) chest CT for detecting viral pneumonia patterns compared to standard (STD) dose chest CT. All consecutive adult patients with two non-enhanced chest CT acquisitions, one STD and one ULD, for suspicion of viral pneumonia between March 5<sup>th</sup> an","2021","07","13","Quant Imaging Med Surg","Quantitative imaging in medicine and surgery","Multidetector computed tomography (multidetector CT); coronavirus infections; ultra-low-dose CT (ULD CT)","Beregi","Jean-Paul","Department of Medical Imaging, Nîmes University Hospital, University of Montpellier, Medical Imaging Group Nîmes, Nîmes, France",NA
"1714","34249645","10.21037/qims-20-1176","Ultra-low-dose chest CT performance for the detection of viral pneumonia patterns during the COVID-19 outbreak period: a monocentric experience.","Ultra low dose chest computed tomography (CT) acquisitions have been used for selected emergency room patients with acute dyspnea or minor thoracic trauma. The purpose of this study was to evaluate the diagnostic performance of ultra-low-dose (ULD) chest CT for detecting viral pneumonia patterns compared to standard (STD) dose chest CT. All consecutive adult patients with two non-enhanced chest CT acquisitions, one STD and one ULD, for suspicion of viral pneumonia between March 5<sup>th</sup> an","2021","07","13","Quant Imaging Med Surg","Quantitative imaging in medicine and surgery","Multidetector computed tomography (multidetector CT); coronavirus infections; ultra-low-dose CT (ULD CT)","Frandon","Julien","Department of Medical Imaging, Nîmes University Hospital, University of Montpellier, Medical Imaging Group Nîmes, Nîmes, France",NA
"1715","34249619","10.5334/aogh.3330","Children and Adolescent Mental Health in a Time of COVID-19: A Forgotten Priority.","Globally, 10-20% of children and adolescents experience mental health conditions, but most of them do not receive the appropriate care when it is needed. The COVID-19 deaths and prevention measures, such as the lockdowns, economic downturns, and school closures, have affected many communities physically, mentally, and economically and significantly impacted the already-neglected children and adolescents' mental health. As a result, evidence has shown that many children and adolescents are experi","2021","07","20","Ann Glob Health","Annals of global health","Adolescent; COVID-19; Child; Communicable Disease Control; Community Mental Health Services; Early Medical Intervention; Education, Distance; Global Health; Health Services Needs and Demand; Humans; Intersectoral Collaboration; Mental Disorders; Mental Health; Psychosocial Deprivation; Quarantine; Rwanda; SARS-CoV-2","Binagwaho","Agnes","University of Global Health Equity, Kigali, Rwanda",NA
"1716","34249619","10.5334/aogh.3330","Children and Adolescent Mental Health in a Time of COVID-19: A Forgotten Priority.","Globally, 10-20% of children and adolescents experience mental health conditions, but most of them do not receive the appropriate care when it is needed. The COVID-19 deaths and prevention measures, such as the lockdowns, economic downturns, and school closures, have affected many communities physically, mentally, and economically and significantly impacted the already-neglected children and adolescents' mental health. As a result, evidence has shown that many children and adolescents are experi","2021","07","20","Ann Glob Health","Annals of global health","Adolescent; COVID-19; Child; Communicable Disease Control; Community Mental Health Services; Early Medical Intervention; Education, Distance; Global Health; Health Services Needs and Demand; Humans; Intersectoral Collaboration; Mental Disorders; Mental Health; Psychosocial Deprivation; Quarantine; Rwanda; SARS-CoV-2","Senga","Joyeuse","University of Global Health Equity, Kigali, Rwanda",NA
"1717","34249617","10.1016/j.matpr.2021.07.026","Effect of sanitizer on obliteration of SARS -CoV2/COVID 19: A mini review.","Corona virus is a respiratory virus which causes infectious Covid-19 (Corona Virus -2019) disease and globally the virus continues to pose major risks of mortality. It is lucid that close links are the key aspect for transitory of communicable Corona virus. Rapid research is in progress to identify prolific drugs and vaccine for Covid-19 however, it is a time consuming process. Social distancing and Sanitizers are helpful in combating virus and safeguarding the human health. Hand sanitizers are ","2021","07","16","Mater Today Proc","Materials today. Proceedings","Alcohol; COVID-19; SARS-CoV2; Sanitizers","Andal","V","Department of Chemistry, KCG College of Technology, Chennai 600 097, India",NA
"1718","34249617","10.1016/j.matpr.2021.07.026","Effect of sanitizer on obliteration of SARS -CoV2/COVID 19: A mini review.","Corona virus is a respiratory virus which causes infectious Covid-19 (Corona Virus -2019) disease and globally the virus continues to pose major risks of mortality. It is lucid that close links are the key aspect for transitory of communicable Corona virus. Rapid research is in progress to identify prolific drugs and vaccine for Covid-19 however, it is a time consuming process. Social distancing and Sanitizers are helpful in combating virus and safeguarding the human health. Hand sanitizers are ","2021","07","16","Mater Today Proc","Materials today. Proceedings","Alcohol; COVID-19; SARS-CoV2; Sanitizers","Lakshmipathy","R","Department of Chemistry, KCG College of Technology, Chennai 600 097, India",NA
"1719","34249617","10.1016/j.matpr.2021.07.026","Effect of sanitizer on obliteration of SARS -CoV2/COVID 19: A mini review.","Corona virus is a respiratory virus which causes infectious Covid-19 (Corona Virus -2019) disease and globally the virus continues to pose major risks of mortality. It is lucid that close links are the key aspect for transitory of communicable Corona virus. Rapid research is in progress to identify prolific drugs and vaccine for Covid-19 however, it is a time consuming process. Social distancing and Sanitizers are helpful in combating virus and safeguarding the human health. Hand sanitizers are ","2021","07","16","Mater Today Proc","Materials today. Proceedings","Alcohol; COVID-19; SARS-CoV2; Sanitizers","Jose","Deepa","Dept of Electronics and Communication Engineering, KCG College of Technology, Chennai 600 097, India",NA
"1720","34249615","10.1016/j.jbef.2021.100541","Stock price reaction to appointment of a chief health officer during COVID-19.","This study examines how appointing a chief health officer (CHO) at the corporate-board level during the COVID-19 outbreak affects the stock returns of US firms. As the COVID-19 progressed, the negative abnormal return (CAR) is -7.5%. In contrast, shares of firms that had appointed a CHO before or during the window surrounding the date of the first reported COVID-19 case (the WHO declaration) exhibited positive CAR of +6.29% (+0.136%). CARs surrounding the exact CHO appointment date once the COVI","2021","07","14","J Behav Exp Finance","Journal of behavioral and experimental finance","COVID-19; Chief health officer; Corporate board; Investor sentiment; Stock markets","Ichev","Riste","Faculty of Economics, University of Ljubljana, Kardeljeva plocad 17, 1000 Ljubljana, Slovenia",NA
"1721","34249614","10.1016/j.idcr.2021.e01219","Central catecholaminergic blockade with clonidine prevent SARS-CoV-2 complication: A case series.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a life-threating viral infection that is highly transmissible and be lethal. Although many patients with mild symptoms recover, an acute form of the infection is characterized by rapidly evolving respiratory failure, an acute inflammatory response, organ failure, and death. Herein, we describe the use of clonidine to modulate the acute inflammatory consequences of this infection in three cases. The patients were three men between 40","2021","07","13","IDCases","IDCases","Catecholamine; Clonidine; SAR-CoV-2; Sympathetic Nervous System","Hyoju","Sanjiv K","Bhomi Hospital and Institute of Medical Sciences, Banepa, Nepal",NA
"1722","34249614","10.1016/j.idcr.2021.e01219","Central catecholaminergic blockade with clonidine prevent SARS-CoV-2 complication: A case series.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a life-threating viral infection that is highly transmissible and be lethal. Although many patients with mild symptoms recover, an acute form of the infection is characterized by rapidly evolving respiratory failure, an acute inflammatory response, organ failure, and death. Herein, we describe the use of clonidine to modulate the acute inflammatory consequences of this infection in three cases. The patients were three men between 40","2021","07","13","IDCases","IDCases","Catecholamine; Clonidine; SAR-CoV-2; Sympathetic Nervous System","Baral","Bidur","Critical Care and Anesthesiology, Bir Hospital, Nepal",NA
"1723","34249614","10.1016/j.idcr.2021.e01219","Central catecholaminergic blockade with clonidine prevent SARS-CoV-2 complication: A case series.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a life-threating viral infection that is highly transmissible and be lethal. Although many patients with mild symptoms recover, an acute form of the infection is characterized by rapidly evolving respiratory failure, an acute inflammatory response, organ failure, and death. Herein, we describe the use of clonidine to modulate the acute inflammatory consequences of this infection in three cases. The patients were three men between 40","2021","07","13","IDCases","IDCases","Catecholamine; Clonidine; SAR-CoV-2; Sympathetic Nervous System","Jha","Prabin K","Anesthesiology Department, Koshi Zonal Hospital, Nepal",NA
"1724","34249608","10.1016/j.spasta.2021.100526","Spatial-temporal generalized additive model for modeling COVID-19 mortality risk in Toronto, Canada.","This article presents a spatial-temporal generalized additive model for modeling geo-referenced COVID-19 mortality data in Toronto, Canada. A range of factors and spatial-temporal terms are incorporated into the model. The non-linear and interactive effects of the neighborhood-level factors, i.e., population density and average of income, are modeled as a two-dimensional spline smoother. The change of spatial pattern over time is modeled as a three-dimensional tensor product smoother. By fitting","2021","07","13","Spat Stat","Spatial statistics","COVID-19 mortality; Generalized additive model; Spacetime interaction; Tensor product smooth; Thin plate spline","Feng","Cindy","Department of Community Health and Epidemiology, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada, B3H 1V7",NA
"1725","34249607","10.1016/j.apsb.2021.06.016","Recent advances in developing small-molecule inhibitors against SARS-CoV-2.","The COVID-19 pandemic caused by the novel SARS-CoV-2 virus has caused havoc across the entire world. Even though several COVID-19 vaccines are currently in distribution worldwide, with others in the pipeline, treatment modalities lag behind. Accordingly, researchers have been working hard to understand the nature of the virus, its mutant strains, and the pathogenesis of the disease in order to uncover possible drug targets and effective therapeutic agents. As the research continues, we now know ","2021","07","13","Acta Pharm Sin B","Acta pharmaceutica Sinica. B","COVID-19; Prophylactic; SARS-CoV-2; Small-molecule inhibitors; Therapeutic","Xiang","Rong","College of Life Sciences, Hebei Agricultural University, Baoding 071001, China",NA
"1726","34249607","10.1016/j.apsb.2021.06.016","Recent advances in developing small-molecule inhibitors against SARS-CoV-2.","The COVID-19 pandemic caused by the novel SARS-CoV-2 virus has caused havoc across the entire world. Even though several COVID-19 vaccines are currently in distribution worldwide, with others in the pipeline, treatment modalities lag behind. Accordingly, researchers have been working hard to understand the nature of the virus, its mutant strains, and the pathogenesis of the disease in order to uncover possible drug targets and effective therapeutic agents. As the research continues, we now know ","2021","07","13","Acta Pharm Sin B","Acta pharmaceutica Sinica. B","COVID-19; Prophylactic; SARS-CoV-2; Small-molecule inhibitors; Therapeutic","Yu","Zhengsen","College of Life Sciences, Hebei Agricultural University, Baoding 071001, China",NA
"1727","34249607","10.1016/j.apsb.2021.06.016","Recent advances in developing small-molecule inhibitors against SARS-CoV-2.","The COVID-19 pandemic caused by the novel SARS-CoV-2 virus has caused havoc across the entire world. Even though several COVID-19 vaccines are currently in distribution worldwide, with others in the pipeline, treatment modalities lag behind. Accordingly, researchers have been working hard to understand the nature of the virus, its mutant strains, and the pathogenesis of the disease in order to uncover possible drug targets and effective therapeutic agents. As the research continues, we now know ","2021","07","13","Acta Pharm Sin B","Acta pharmaceutica Sinica. B","COVID-19; Prophylactic; SARS-CoV-2; Small-molecule inhibitors; Therapeutic","Wang","Yang","College of Life Sciences, Hebei Agricultural University, Baoding 071001, China",NA
"1728","34249607","10.1016/j.apsb.2021.06.016","Recent advances in developing small-molecule inhibitors against SARS-CoV-2.","The COVID-19 pandemic caused by the novel SARS-CoV-2 virus has caused havoc across the entire world. Even though several COVID-19 vaccines are currently in distribution worldwide, with others in the pipeline, treatment modalities lag behind. Accordingly, researchers have been working hard to understand the nature of the virus, its mutant strains, and the pathogenesis of the disease in order to uncover possible drug targets and effective therapeutic agents. As the research continues, we now know ","2021","07","13","Acta Pharm Sin B","Acta pharmaceutica Sinica. B","COVID-19; Prophylactic; SARS-CoV-2; Small-molecule inhibitors; Therapeutic","Wang","Lili","Research Center of Chinese Jujube, Hebei Agricultural University, Baoding 071001, China",NA
"1729","34249607","10.1016/j.apsb.2021.06.016","Recent advances in developing small-molecule inhibitors against SARS-CoV-2.","The COVID-19 pandemic caused by the novel SARS-CoV-2 virus has caused havoc across the entire world. Even though several COVID-19 vaccines are currently in distribution worldwide, with others in the pipeline, treatment modalities lag behind. Accordingly, researchers have been working hard to understand the nature of the virus, its mutant strains, and the pathogenesis of the disease in order to uncover possible drug targets and effective therapeutic agents. As the research continues, we now know ","2021","07","13","Acta Pharm Sin B","Acta pharmaceutica Sinica. B","COVID-19; Prophylactic; SARS-CoV-2; Small-molecule inhibitors; Therapeutic","Huo","Shanshan","College of Life Sciences, Hebei Agricultural University, Baoding 071001, China",NA
"1730","34249607","10.1016/j.apsb.2021.06.016","Recent advances in developing small-molecule inhibitors against SARS-CoV-2.","The COVID-19 pandemic caused by the novel SARS-CoV-2 virus has caused havoc across the entire world. Even though several COVID-19 vaccines are currently in distribution worldwide, with others in the pipeline, treatment modalities lag behind. Accordingly, researchers have been working hard to understand the nature of the virus, its mutant strains, and the pathogenesis of the disease in order to uncover possible drug targets and effective therapeutic agents. As the research continues, we now know ","2021","07","13","Acta Pharm Sin B","Acta pharmaceutica Sinica. B","COVID-19; Prophylactic; SARS-CoV-2; Small-molecule inhibitors; Therapeutic","Li","Yanbai","College of Life Sciences, Hebei Agricultural University, Baoding 071001, China",NA
"1731","34249607","10.1016/j.apsb.2021.06.016","Recent advances in developing small-molecule inhibitors against SARS-CoV-2.","The COVID-19 pandemic caused by the novel SARS-CoV-2 virus has caused havoc across the entire world. Even though several COVID-19 vaccines are currently in distribution worldwide, with others in the pipeline, treatment modalities lag behind. Accordingly, researchers have been working hard to understand the nature of the virus, its mutant strains, and the pathogenesis of the disease in order to uncover possible drug targets and effective therapeutic agents. As the research continues, we now know ","2021","07","13","Acta Pharm Sin B","Acta pharmaceutica Sinica. B","COVID-19; Prophylactic; SARS-CoV-2; Small-molecule inhibitors; Therapeutic","Liang","Ruiying","College of Life Sciences, Hebei Agricultural University, Baoding 071001, China",NA
"1732","34249607","10.1016/j.apsb.2021.06.016","Recent advances in developing small-molecule inhibitors against SARS-CoV-2.","The COVID-19 pandemic caused by the novel SARS-CoV-2 virus has caused havoc across the entire world. Even though several COVID-19 vaccines are currently in distribution worldwide, with others in the pipeline, treatment modalities lag behind. Accordingly, researchers have been working hard to understand the nature of the virus, its mutant strains, and the pathogenesis of the disease in order to uncover possible drug targets and effective therapeutic agents. As the research continues, we now know ","2021","07","13","Acta Pharm Sin B","Acta pharmaceutica Sinica. B","COVID-19; Prophylactic; SARS-CoV-2; Small-molecule inhibitors; Therapeutic","Hao","Qinghong","College of Life Sciences, Hebei Agricultural University, Baoding 071001, China",NA
"1733","34249607","10.1016/j.apsb.2021.06.016","Recent advances in developing small-molecule inhibitors against SARS-CoV-2.","The COVID-19 pandemic caused by the novel SARS-CoV-2 virus has caused havoc across the entire world. Even though several COVID-19 vaccines are currently in distribution worldwide, with others in the pipeline, treatment modalities lag behind. Accordingly, researchers have been working hard to understand the nature of the virus, its mutant strains, and the pathogenesis of the disease in order to uncover possible drug targets and effective therapeutic agents. As the research continues, we now know ","2021","07","13","Acta Pharm Sin B","Acta pharmaceutica Sinica. B","COVID-19; Prophylactic; SARS-CoV-2; Small-molecule inhibitors; Therapeutic","Ying","Tianlei","Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, Shanghai Institute of Infectious Diseases and Biosecurity, Fudan University, Shanghai 200032, China",NA
"1734","34249607","10.1016/j.apsb.2021.06.016","Recent advances in developing small-molecule inhibitors against SARS-CoV-2.","The COVID-19 pandemic caused by the novel SARS-CoV-2 virus has caused havoc across the entire world. Even though several COVID-19 vaccines are currently in distribution worldwide, with others in the pipeline, treatment modalities lag behind. Accordingly, researchers have been working hard to understand the nature of the virus, its mutant strains, and the pathogenesis of the disease in order to uncover possible drug targets and effective therapeutic agents. As the research continues, we now know ","2021","07","13","Acta Pharm Sin B","Acta pharmaceutica Sinica. B","COVID-19; Prophylactic; SARS-CoV-2; Small-molecule inhibitors; Therapeutic","Gao","Yaning","Beijing Pharma and Biotech Center, Beijing 100176, China",NA
"1735","34249607","10.1016/j.apsb.2021.06.016","Recent advances in developing small-molecule inhibitors against SARS-CoV-2.","The COVID-19 pandemic caused by the novel SARS-CoV-2 virus has caused havoc across the entire world. Even though several COVID-19 vaccines are currently in distribution worldwide, with others in the pipeline, treatment modalities lag behind. Accordingly, researchers have been working hard to understand the nature of the virus, its mutant strains, and the pathogenesis of the disease in order to uncover possible drug targets and effective therapeutic agents. As the research continues, we now know ","2021","07","13","Acta Pharm Sin B","Acta pharmaceutica Sinica. B","COVID-19; Prophylactic; SARS-CoV-2; Small-molecule inhibitors; Therapeutic","Yu","Fei","College of Life Sciences, Hebei Agricultural University, Baoding 071001, China",NA
"1736","34249607","10.1016/j.apsb.2021.06.016","Recent advances in developing small-molecule inhibitors against SARS-CoV-2.","The COVID-19 pandemic caused by the novel SARS-CoV-2 virus has caused havoc across the entire world. Even though several COVID-19 vaccines are currently in distribution worldwide, with others in the pipeline, treatment modalities lag behind. Accordingly, researchers have been working hard to understand the nature of the virus, its mutant strains, and the pathogenesis of the disease in order to uncover possible drug targets and effective therapeutic agents. As the research continues, we now know ","2021","07","13","Acta Pharm Sin B","Acta pharmaceutica Sinica. B","COVID-19; Prophylactic; SARS-CoV-2; Small-molecule inhibitors; Therapeutic","Jiang","Shibo","Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, Shanghai Institute of Infectious Diseases and Biosecurity, Fudan University, Shanghai 200032, China",NA
"1737","34249606","10.1186/s40643-021-00413-2","Development and comparison of cell-free protein synthesis systems derived from typical bacterial chassis.","Cell-free protein synthesis (CFPS) systems have become an ideal choice for pathway prototyping, protein production, and biosensing, due to their high controllability, tolerance, stability, and ability to produce proteins in a short time. At present, the widely used CFPS systems are mainly based on Escherichia coli strain. Bacillus subtilis, Corynebacterium glutamate, and Vibrio natriegens are potential chassis cells for many biotechnological applications with their respective characteristics. Th","2021","07","13","Bioresour Bioprocess","Bioresources and bioprocessing","Bacillus subtilis; Cell-free protein synthesis system; Corynebacterium glutamate; Escherichia coli; SARS-CoV-2 RBD protein expression; Vibrio natriegens","Zhang","Liyuan","Department of Ecology, Shenyang Agricultural University, Shenyang, 110866 Liaoning Province China",NA
"1738","34249606","10.1186/s40643-021-00413-2","Development and comparison of cell-free protein synthesis systems derived from typical bacterial chassis.","Cell-free protein synthesis (CFPS) systems have become an ideal choice for pathway prototyping, protein production, and biosensing, due to their high controllability, tolerance, stability, and ability to produce proteins in a short time. At present, the widely used CFPS systems are mainly based on Escherichia coli strain. Bacillus subtilis, Corynebacterium glutamate, and Vibrio natriegens are potential chassis cells for many biotechnological applications with their respective characteristics. Th","2021","07","13","Bioresour Bioprocess","Bioresources and bioprocessing","Bacillus subtilis; Cell-free protein synthesis system; Corynebacterium glutamate; Escherichia coli; SARS-CoV-2 RBD protein expression; Vibrio natriegens","Lin","Xiaomei","Key Laboratory of Industrial Biocatalysis, Ministry of Education, Department of Chemical Engineering, Tsinghua University, Beijing, 100084 China",NA
"1739","34249606","10.1186/s40643-021-00413-2","Development and comparison of cell-free protein synthesis systems derived from typical bacterial chassis.","Cell-free protein synthesis (CFPS) systems have become an ideal choice for pathway prototyping, protein production, and biosensing, due to their high controllability, tolerance, stability, and ability to produce proteins in a short time. At present, the widely used CFPS systems are mainly based on Escherichia coli strain. Bacillus subtilis, Corynebacterium glutamate, and Vibrio natriegens are potential chassis cells for many biotechnological applications with their respective characteristics. Th","2021","07","13","Bioresour Bioprocess","Bioresources and bioprocessing","Bacillus subtilis; Cell-free protein synthesis system; Corynebacterium glutamate; Escherichia coli; SARS-CoV-2 RBD protein expression; Vibrio natriegens","Wang","Ting","Key Laboratory of Industrial Biocatalysis, Ministry of Education, Department of Chemical Engineering, Tsinghua University, Beijing, 100084 China",NA
"1740","34249606","10.1186/s40643-021-00413-2","Development and comparison of cell-free protein synthesis systems derived from typical bacterial chassis.","Cell-free protein synthesis (CFPS) systems have become an ideal choice for pathway prototyping, protein production, and biosensing, due to their high controllability, tolerance, stability, and ability to produce proteins in a short time. At present, the widely used CFPS systems are mainly based on Escherichia coli strain. Bacillus subtilis, Corynebacterium glutamate, and Vibrio natriegens are potential chassis cells for many biotechnological applications with their respective characteristics. Th","2021","07","13","Bioresour Bioprocess","Bioresources and bioprocessing","Bacillus subtilis; Cell-free protein synthesis system; Corynebacterium glutamate; Escherichia coli; SARS-CoV-2 RBD protein expression; Vibrio natriegens","Guo","Wei","Department of Ecology, Shenyang Agricultural University, Shenyang, 110866 Liaoning Province China",NA
"1741","34249606","10.1186/s40643-021-00413-2","Development and comparison of cell-free protein synthesis systems derived from typical bacterial chassis.","Cell-free protein synthesis (CFPS) systems have become an ideal choice for pathway prototyping, protein production, and biosensing, due to their high controllability, tolerance, stability, and ability to produce proteins in a short time. At present, the widely used CFPS systems are mainly based on Escherichia coli strain. Bacillus subtilis, Corynebacterium glutamate, and Vibrio natriegens are potential chassis cells for many biotechnological applications with their respective characteristics. Th","2021","07","13","Bioresour Bioprocess","Bioresources and bioprocessing","Bacillus subtilis; Cell-free protein synthesis system; Corynebacterium glutamate; Escherichia coli; SARS-CoV-2 RBD protein expression; Vibrio natriegens","Lu","Yuan","Key Laboratory of Industrial Biocatalysis, Ministry of Education, Department of Chemical Engineering, Tsinghua University, Beijing, 100084 China",NA
"1742","34249605","10.1007/s40588-021-00172-w","A Review on the Effectivity of the Current COVID-19 Drugs and Vaccines: Are They Really Working Against the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants?","In order to eradicate the COVID-19 pandemic, scientists around the world have been working very hard for a year or more with the motto of designing effective drugs and vaccines against the severe acute respiratory coronavirus 2 (SARS-CoV-2). Along with the positive results with the antiviral drugs and a few commercialized vaccines, the unresponsiveness as well as some side effects of such therapies have also been noticed, possibly due to the emergence of the SARS-CoV-2 variants. Therefore, curre","2021","07","13","Curr Clin Microbiol Rep","Current clinical microbiology reports","Antiviral drugs; COVID-19 pandemic; SARS-CoV-2; Vaccines","Noor","Rashed","Department of Life Sciences (DLS), School of Environment and Life Sciences (SELS), Independent University, Bangladesh (IUB), Plot 16, Block B, Aftabuddin Ahmed Road, Bashundhara, Dhaka, 1229 Bangladesh",NA
"1743","34249604","10.1007/s40588-021-00174-8","COVID-19 Pandemic and the Convalescent Plasma Therapy: Possible Benefits and Risks.","COVID-19 pandemic has been the major threat to the global public health for a year (last of 2019-till date); and unfortunately, there is still as no specific antiviral agent which can be effectively used against this disease curation. Present review focused on the application of the convalescent plasma (CP) therapy as a quick remediation of the disease severity. While several drugs have been repurposed based on a number of completed clinical trials together with a huge ongoing effort to develop ","2021","07","13","Curr Clin Microbiol Rep","Current clinical microbiology reports","COVID-19 pandemic; Convalescent plasma (CP) therapy; SARS-CoV-2","Noor","Rashed","Department of Life Sciences (DLS), School of Environment and Life Sciences (SELS), Independent University, Bangladesh (IUB), Plot 16, Block B, Aftabuddin Ahmed Road, Bashundhara, Dhaka, 1229 Bangladesh",NA
"1744","34249604","10.1007/s40588-021-00174-8","COVID-19 Pandemic and the Convalescent Plasma Therapy: Possible Benefits and Risks.","COVID-19 pandemic has been the major threat to the global public health for a year (last of 2019-till date); and unfortunately, there is still as no specific antiviral agent which can be effectively used against this disease curation. Present review focused on the application of the convalescent plasma (CP) therapy as a quick remediation of the disease severity. While several drugs have been repurposed based on a number of completed clinical trials together with a huge ongoing effort to develop ","2021","07","13","Curr Clin Microbiol Rep","Current clinical microbiology reports","COVID-19 pandemic; Convalescent plasma (CP) therapy; SARS-CoV-2","Tasnim","Nishat","Department of Life Sciences (DLS), School of Environment and Life Sciences (SELS), Independent University, Bangladesh (IUB), Plot 16, Block B, Aftabuddin Ahmed Road, Bashundhara, Dhaka, 1229 Bangladesh",NA
"1745","34249604","10.1007/s40588-021-00174-8","COVID-19 Pandemic and the Convalescent Plasma Therapy: Possible Benefits and Risks.","COVID-19 pandemic has been the major threat to the global public health for a year (last of 2019-till date); and unfortunately, there is still as no specific antiviral agent which can be effectively used against this disease curation. Present review focused on the application of the convalescent plasma (CP) therapy as a quick remediation of the disease severity. While several drugs have been repurposed based on a number of completed clinical trials together with a huge ongoing effort to develop ","2021","07","13","Curr Clin Microbiol Rep","Current clinical microbiology reports","COVID-19 pandemic; Convalescent plasma (CP) therapy; SARS-CoV-2","Saha","Chandrika","Department of Life Sciences (DLS), School of Environment and Life Sciences (SELS), Independent University, Bangladesh (IUB), Plot 16, Block B, Aftabuddin Ahmed Road, Bashundhara, Dhaka, 1229 Bangladesh",NA
"1746","34249603","10.1186/s40537-021-00491-1","The forecast of COVID-19 spread risk at the county level.","The early detection of the coronavirus disease 2019 (COVID-19) outbreak is important to save people's lives and restart the economy quickly and safely. People's social behavior, reflected in their mobility data, plays a major role in spreading the disease. Therefore, we used the daily mobility data aggregated at the county level beside COVID-19 statistics and demographic information for short-term forecasting of COVID-19 outbreaks in the United States. The daily data are fed to a deep learning m","2021","07","13","J Big Data","Journal of big data","COVID-19 Forecast; County demographics; Deep learning; Mobility","Hssayeni","Murtadha D","Department of Computer and Electrical Engineering and Computer Science, Florida Atlantic University, Boca Raton, FL 33431 USA",NA
"1747","34249603","10.1186/s40537-021-00491-1","The forecast of COVID-19 spread risk at the county level.","The early detection of the coronavirus disease 2019 (COVID-19) outbreak is important to save people's lives and restart the economy quickly and safely. People's social behavior, reflected in their mobility data, plays a major role in spreading the disease. Therefore, we used the daily mobility data aggregated at the county level beside COVID-19 statistics and demographic information for short-term forecasting of COVID-19 outbreaks in the United States. The daily data are fed to a deep learning m","2021","07","13","J Big Data","Journal of big data","COVID-19 Forecast; County demographics; Deep learning; Mobility","Chala","Arjuna","LexisNexis Risk Solution, Alpharetta, GA USA",NA
"1748","34249603","10.1186/s40537-021-00491-1","The forecast of COVID-19 spread risk at the county level.","The early detection of the coronavirus disease 2019 (COVID-19) outbreak is important to save people's lives and restart the economy quickly and safely. People's social behavior, reflected in their mobility data, plays a major role in spreading the disease. Therefore, we used the daily mobility data aggregated at the county level beside COVID-19 statistics and demographic information for short-term forecasting of COVID-19 outbreaks in the United States. The daily data are fed to a deep learning m","2021","07","13","J Big Data","Journal of big data","COVID-19 Forecast; County demographics; Deep learning; Mobility","Dev","Roger","LexisNexis Risk Solution, Alpharetta, GA USA",NA
"1749","34249603","10.1186/s40537-021-00491-1","The forecast of COVID-19 spread risk at the county level.","The early detection of the coronavirus disease 2019 (COVID-19) outbreak is important to save people's lives and restart the economy quickly and safely. People's social behavior, reflected in their mobility data, plays a major role in spreading the disease. Therefore, we used the daily mobility data aggregated at the county level beside COVID-19 statistics and demographic information for short-term forecasting of COVID-19 outbreaks in the United States. The daily data are fed to a deep learning m","2021","07","13","J Big Data","Journal of big data","COVID-19 Forecast; County demographics; Deep learning; Mobility","Xu","Lili","LexisNexis Risk Solution, Alpharetta, GA USA",NA
"1750","34249603","10.1186/s40537-021-00491-1","The forecast of COVID-19 spread risk at the county level.","The early detection of the coronavirus disease 2019 (COVID-19) outbreak is important to save people's lives and restart the economy quickly and safely. People's social behavior, reflected in their mobility data, plays a major role in spreading the disease. Therefore, we used the daily mobility data aggregated at the county level beside COVID-19 statistics and demographic information for short-term forecasting of COVID-19 outbreaks in the United States. The daily data are fed to a deep learning m","2021","07","13","J Big Data","Journal of big data","COVID-19 Forecast; County demographics; Deep learning; Mobility","Shaw","Jesse","LexisNexis Risk Solution, Alpharetta, GA USA",NA
"1751","34249603","10.1186/s40537-021-00491-1","The forecast of COVID-19 spread risk at the county level.","The early detection of the coronavirus disease 2019 (COVID-19) outbreak is important to save people's lives and restart the economy quickly and safely. People's social behavior, reflected in their mobility data, plays a major role in spreading the disease. Therefore, we used the daily mobility data aggregated at the county level beside COVID-19 statistics and demographic information for short-term forecasting of COVID-19 outbreaks in the United States. The daily data are fed to a deep learning m","2021","07","13","J Big Data","Journal of big data","COVID-19 Forecast; County demographics; Deep learning; Mobility","Furht","Borko","Department of Computer and Electrical Engineering and Computer Science, Florida Atlantic University, Boca Raton, FL 33431 USA",NA
"1752","34249603","10.1186/s40537-021-00491-1","The forecast of COVID-19 spread risk at the county level.","The early detection of the coronavirus disease 2019 (COVID-19) outbreak is important to save people's lives and restart the economy quickly and safely. People's social behavior, reflected in their mobility data, plays a major role in spreading the disease. Therefore, we used the daily mobility data aggregated at the county level beside COVID-19 statistics and demographic information for short-term forecasting of COVID-19 outbreaks in the United States. The daily data are fed to a deep learning m","2021","07","13","J Big Data","Journal of big data","COVID-19 Forecast; County demographics; Deep learning; Mobility","Ghoraani","Behnaz","Department of Computer and Electrical Engineering and Computer Science, Florida Atlantic University, Boca Raton, FL 33431 USA",NA
"1753","34249599","10.1140/epjds/s13688-021-00289-4","Flow of online misinformation during the peak of the COVID-19 pandemic in Italy.","The COVID-19 pandemic has impacted on every human activity and, because of the urgency of finding the proper responses to such an unprecedented emergency, it generated a diffused societal debate. The online version of this discussion was not exempted by the presence of misinformation campaigns, but, differently from what already witnessed in other debates, the COVID-19 -intentional or not- flow of false information put at severe risk the public health, possibly reducing the efficacy of governmen","2021","07","13","EPJ Data Sci","EPJ data science","COVID-19 Infodemic; Misinformation; Twitter","Caldarelli","Guido","Department of Molecular Sciences and Nanosystems, Ca'Foscari University of Venice, Ed. Alfa, Via Torino 155, 30170 Venezia Mestre, Italy",NA
"1754","34249599","10.1140/epjds/s13688-021-00289-4","Flow of online misinformation during the peak of the COVID-19 pandemic in Italy.","The COVID-19 pandemic has impacted on every human activity and, because of the urgency of finding the proper responses to such an unprecedented emergency, it generated a diffused societal debate. The online version of this discussion was not exempted by the presence of misinformation campaigns, but, differently from what already witnessed in other debates, the COVID-19 -intentional or not- flow of false information put at severe risk the public health, possibly reducing the efficacy of governmen","2021","07","13","EPJ Data Sci","EPJ data science","COVID-19 Infodemic; Misinformation; Twitter","De Nicola","Rocco","IMT School For Advanced Studies Lucca, Piazza San Francesco 19, 55100 Lucca, Italy",NA
"1755","34249599","10.1140/epjds/s13688-021-00289-4","Flow of online misinformation during the peak of the COVID-19 pandemic in Italy.","The COVID-19 pandemic has impacted on every human activity and, because of the urgency of finding the proper responses to such an unprecedented emergency, it generated a diffused societal debate. The online version of this discussion was not exempted by the presence of misinformation campaigns, but, differently from what already witnessed in other debates, the COVID-19 -intentional or not- flow of false information put at severe risk the public health, possibly reducing the efficacy of governmen","2021","07","13","EPJ Data Sci","EPJ data science","COVID-19 Infodemic; Misinformation; Twitter","Petrocchi","Marinella","Institute of Informatics and Telematics, National Research Council, via Moruzzi 1, 56124 Pisa, Italy",NA
"1756","34249599","10.1140/epjds/s13688-021-00289-4","Flow of online misinformation during the peak of the COVID-19 pandemic in Italy.","The COVID-19 pandemic has impacted on every human activity and, because of the urgency of finding the proper responses to such an unprecedented emergency, it generated a diffused societal debate. The online version of this discussion was not exempted by the presence of misinformation campaigns, but, differently from what already witnessed in other debates, the COVID-19 -intentional or not- flow of false information put at severe risk the public health, possibly reducing the efficacy of governmen","2021","07","13","EPJ Data Sci","EPJ data science","COVID-19 Infodemic; Misinformation; Twitter","Pratelli","Manuel","IMT School For Advanced Studies Lucca, Piazza San Francesco 19, 55100 Lucca, Italy",NA
"1757","34249599","10.1140/epjds/s13688-021-00289-4","Flow of online misinformation during the peak of the COVID-19 pandemic in Italy.","The COVID-19 pandemic has impacted on every human activity and, because of the urgency of finding the proper responses to such an unprecedented emergency, it generated a diffused societal debate. The online version of this discussion was not exempted by the presence of misinformation campaigns, but, differently from what already witnessed in other debates, the COVID-19 -intentional or not- flow of false information put at severe risk the public health, possibly reducing the efficacy of governmen","2021","07","13","EPJ Data Sci","EPJ data science","COVID-19 Infodemic; Misinformation; Twitter","Saracco","Fabio","IMT School For Advanced Studies Lucca, Piazza San Francesco 19, 55100 Lucca, Italy",NA
"1758","34249598","10.1007/s13721-021-00323-5","COVID-19 Community Temporal Visualizer: a new methodology for the network-based analysis and visualization of COVID-19 data.","Understanding the evolution of the spread of the COVID-19 pandemic requires the analysis of several data at the spatial and temporal levels. Here, we present a new network-based methodology to analyze COVID-19 data measures containing spatial and temporal features and its application on a real dataset. The goal of the methodology is to analyze sets of homogeneous datasets (i.e. COVID-19 data taken in different periods and in several regions) using a statistical test to find similar/dissimilar da","2021","07","13","Netw Model Anal Health Inform Bioinform","Network modeling and analysis in health informatics and bioinformatics","COVID-19; Community detection; Network analysis","Milano","Marianna","Department of Medical and Surgical Sciences, University of Catanzaro, Catanzaro, 88100 Italy",NA
"1759","34249598","10.1007/s13721-021-00323-5","COVID-19 Community Temporal Visualizer: a new methodology for the network-based analysis and visualization of COVID-19 data.","Understanding the evolution of the spread of the COVID-19 pandemic requires the analysis of several data at the spatial and temporal levels. Here, we present a new network-based methodology to analyze COVID-19 data measures containing spatial and temporal features and its application on a real dataset. The goal of the methodology is to analyze sets of homogeneous datasets (i.e. COVID-19 data taken in different periods and in several regions) using a statistical test to find similar/dissimilar da","2021","07","13","Netw Model Anal Health Inform Bioinform","Network modeling and analysis in health informatics and bioinformatics","COVID-19; Community detection; Network analysis","Zucco","Chiara","Department of Medical and Surgical Sciences, University of Catanzaro, Catanzaro, 88100 Italy",NA
"1760","34249598","10.1007/s13721-021-00323-5","COVID-19 Community Temporal Visualizer: a new methodology for the network-based analysis and visualization of COVID-19 data.","Understanding the evolution of the spread of the COVID-19 pandemic requires the analysis of several data at the spatial and temporal levels. Here, we present a new network-based methodology to analyze COVID-19 data measures containing spatial and temporal features and its application on a real dataset. The goal of the methodology is to analyze sets of homogeneous datasets (i.e. COVID-19 data taken in different periods and in several regions) using a statistical test to find similar/dissimilar da","2021","07","13","Netw Model Anal Health Inform Bioinform","Network modeling and analysis in health informatics and bioinformatics","COVID-19; Community detection; Network analysis","Cannataro","Mario","Department of Medical and Surgical Sciences, University of Catanzaro, Catanzaro, 88100 Italy",NA
"1761","34249592","10.1186/s12302-021-00517-8","Changes in handwashing and hygiene product usage patterns in Korea before and after the outbreak of COVID-19.","The World Health Organization declared COVID-19, the disease caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), a global pandemic on March 11, 2020. Non-pharmaceutical interventions such as social distancing, handwashing, using hand sanitizer, and wearing facial masks are recommended as the first line of protection against COVID-19. Encouraging hand hygiene may be one of the most cost-effective means of reducing the global burden of disease. This study uses a web-based quest","2021","07","13","Environ Sci Eur","Environmental sciences Europe","Bar soap; COVID-19; Hand hygiene; Hand sanitizer; Handwashing; Korea; Liquid hand soap","Choi","KeunOh","Department of Integrated Bioscience and Biotechnology, College of Life Science, Sejong University, Kwangjingu, Kunjadong, Seoul, 05006 Korea",NA
"1762","34249592","10.1186/s12302-021-00517-8","Changes in handwashing and hygiene product usage patterns in Korea before and after the outbreak of COVID-19.","The World Health Organization declared COVID-19, the disease caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), a global pandemic on March 11, 2020. Non-pharmaceutical interventions such as social distancing, handwashing, using hand sanitizer, and wearing facial masks are recommended as the first line of protection against COVID-19. Encouraging hand hygiene may be one of the most cost-effective means of reducing the global burden of disease. This study uses a web-based quest","2021","07","13","Environ Sci Eur","Environmental sciences Europe","Bar soap; COVID-19; Hand hygiene; Hand sanitizer; Handwashing; Korea; Liquid hand soap","Sim","Seunghye","Department of Integrated Bioscience and Biotechnology, College of Life Science, Sejong University, Kwangjingu, Kunjadong, Seoul, 05006 Korea",NA
"1763","34249592","10.1186/s12302-021-00517-8","Changes in handwashing and hygiene product usage patterns in Korea before and after the outbreak of COVID-19.","The World Health Organization declared COVID-19, the disease caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), a global pandemic on March 11, 2020. Non-pharmaceutical interventions such as social distancing, handwashing, using hand sanitizer, and wearing facial masks are recommended as the first line of protection against COVID-19. Encouraging hand hygiene may be one of the most cost-effective means of reducing the global burden of disease. This study uses a web-based quest","2021","07","13","Environ Sci Eur","Environmental sciences Europe","Bar soap; COVID-19; Hand hygiene; Hand sanitizer; Handwashing; Korea; Liquid hand soap","Choi","Junyeong","Department of Integrated Bioscience and Biotechnology, College of Life Science, Sejong University, Kwangjingu, Kunjadong, Seoul, 05006 Korea",NA
"1764","34249592","10.1186/s12302-021-00517-8","Changes in handwashing and hygiene product usage patterns in Korea before and after the outbreak of COVID-19.","The World Health Organization declared COVID-19, the disease caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), a global pandemic on March 11, 2020. Non-pharmaceutical interventions such as social distancing, handwashing, using hand sanitizer, and wearing facial masks are recommended as the first line of protection against COVID-19. Encouraging hand hygiene may be one of the most cost-effective means of reducing the global burden of disease. This study uses a web-based quest","2021","07","13","Environ Sci Eur","Environmental sciences Europe","Bar soap; COVID-19; Hand hygiene; Hand sanitizer; Handwashing; Korea; Liquid hand soap","Park","Choa","Department of Integrated Bioscience and Biotechnology, College of Life Science, Sejong University, Kwangjingu, Kunjadong, Seoul, 05006 Korea",NA
"1765","34249592","10.1186/s12302-021-00517-8","Changes in handwashing and hygiene product usage patterns in Korea before and after the outbreak of COVID-19.","The World Health Organization declared COVID-19, the disease caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), a global pandemic on March 11, 2020. Non-pharmaceutical interventions such as social distancing, handwashing, using hand sanitizer, and wearing facial masks are recommended as the first line of protection against COVID-19. Encouraging hand hygiene may be one of the most cost-effective means of reducing the global burden of disease. This study uses a web-based quest","2021","07","13","Environ Sci Eur","Environmental sciences Europe","Bar soap; COVID-19; Hand hygiene; Hand sanitizer; Handwashing; Korea; Liquid hand soap","Uhm","Yoonhee","Korea National Council of Consumer Organizations, SEOUL YWCA Bld. #701, 20, Myungdong11gil, Jung-Gu, Seoul, Korea",NA
"1766","34249592","10.1186/s12302-021-00517-8","Changes in handwashing and hygiene product usage patterns in Korea before and after the outbreak of COVID-19.","The World Health Organization declared COVID-19, the disease caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), a global pandemic on March 11, 2020. Non-pharmaceutical interventions such as social distancing, handwashing, using hand sanitizer, and wearing facial masks are recommended as the first line of protection against COVID-19. Encouraging hand hygiene may be one of the most cost-effective means of reducing the global burden of disease. This study uses a web-based quest","2021","07","13","Environ Sci Eur","Environmental sciences Europe","Bar soap; COVID-19; Hand hygiene; Hand sanitizer; Handwashing; Korea; Liquid hand soap","Lim","Eunkyung","Korea National Council of Consumer Organizations, SEOUL YWCA Bld. #701, 20, Myungdong11gil, Jung-Gu, Seoul, Korea",NA
"1767","34249592","10.1186/s12302-021-00517-8","Changes in handwashing and hygiene product usage patterns in Korea before and after the outbreak of COVID-19.","The World Health Organization declared COVID-19, the disease caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), a global pandemic on March 11, 2020. Non-pharmaceutical interventions such as social distancing, handwashing, using hand sanitizer, and wearing facial masks are recommended as the first line of protection against COVID-19. Encouraging hand hygiene may be one of the most cost-effective means of reducing the global burden of disease. This study uses a web-based quest","2021","07","13","Environ Sci Eur","Environmental sciences Europe","Bar soap; COVID-19; Hand hygiene; Hand sanitizer; Handwashing; Korea; Liquid hand soap","Kim","Augustine Yonghwi","Department of Food Science and Biotechnology, Sejong University, Kwangjingu, Kunjadong, Seoul, 05006 Korea",NA
"1768","34249592","10.1186/s12302-021-00517-8","Changes in handwashing and hygiene product usage patterns in Korea before and after the outbreak of COVID-19.","The World Health Organization declared COVID-19, the disease caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), a global pandemic on March 11, 2020. Non-pharmaceutical interventions such as social distancing, handwashing, using hand sanitizer, and wearing facial masks are recommended as the first line of protection against COVID-19. Encouraging hand hygiene may be one of the most cost-effective means of reducing the global burden of disease. This study uses a web-based quest","2021","07","13","Environ Sci Eur","Environmental sciences Europe","Bar soap; COVID-19; Hand hygiene; Hand sanitizer; Handwashing; Korea; Liquid hand soap","Yoo","Seong Joon","Department of Computer Science and Engineering, College of Software Convergence, Sejong University, Kwangjingu, Kunjadong, Seoul, 05006 Korea",NA
"1769","34249592","10.1186/s12302-021-00517-8","Changes in handwashing and hygiene product usage patterns in Korea before and after the outbreak of COVID-19.","The World Health Organization declared COVID-19, the disease caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), a global pandemic on March 11, 2020. Non-pharmaceutical interventions such as social distancing, handwashing, using hand sanitizer, and wearing facial masks are recommended as the first line of protection against COVID-19. Encouraging hand hygiene may be one of the most cost-effective means of reducing the global burden of disease. This study uses a web-based quest","2021","07","13","Environ Sci Eur","Environmental sciences Europe","Bar soap; COVID-19; Hand hygiene; Hand sanitizer; Handwashing; Korea; Liquid hand soap","Lee","YoungJoo","Department of Integrated Bioscience and Biotechnology, College of Life Science, Sejong University, Kwangjingu, Kunjadong, Seoul, 05006 Korea",NA
"1770","34249579","10.7759/cureus.15448","Asystole During Nasopharyngeal Swab: Is COVID-19 to Blame?","The use of nasopharyngeal (NP) swab sampling for the detection of various respiratory pathogens has been a standard procedure in medicine for many years. While this is a fairly common procedure, there has been a significant increase in utilization recently due to the SARS-CoV-2 pandemic. We describe a case of a 40-year-old SARS-CoV-2 positive patient with no prior cardiac history who developed asystole while an NP swab was being used to obtain a sample for a SARS-CoV-2 assay. Return of normal si","2021","07","13","Cureus","Cureus","arrhythmias; asystole; covid 19; nasopharyngeal swab; sars-cov-2; trigeminocardiac reflex; vagal response","Madanat","Luai","Internal Medicine, Beaumont Hospital, Royal Oak, USA",NA
"1771","34249579","10.7759/cureus.15448","Asystole During Nasopharyngeal Swab: Is COVID-19 to Blame?","The use of nasopharyngeal (NP) swab sampling for the detection of various respiratory pathogens has been a standard procedure in medicine for many years. While this is a fairly common procedure, there has been a significant increase in utilization recently due to the SARS-CoV-2 pandemic. We describe a case of a 40-year-old SARS-CoV-2 positive patient with no prior cardiac history who developed asystole while an NP swab was being used to obtain a sample for a SARS-CoV-2 assay. Return of normal si","2021","07","13","Cureus","Cureus","arrhythmias; asystole; covid 19; nasopharyngeal swab; sars-cov-2; trigeminocardiac reflex; vagal response","Khalife","Amal","Infectious Disease, Beaumont Hospital, Royal Oak, USA",NA
"1772","34249579","10.7759/cureus.15448","Asystole During Nasopharyngeal Swab: Is COVID-19 to Blame?","The use of nasopharyngeal (NP) swab sampling for the detection of various respiratory pathogens has been a standard procedure in medicine for many years. While this is a fairly common procedure, there has been a significant increase in utilization recently due to the SARS-CoV-2 pandemic. We describe a case of a 40-year-old SARS-CoV-2 positive patient with no prior cardiac history who developed asystole while an NP swab was being used to obtain a sample for a SARS-CoV-2 assay. Return of normal si","2021","07","13","Cureus","Cureus","arrhythmias; asystole; covid 19; nasopharyngeal swab; sars-cov-2; trigeminocardiac reflex; vagal response","Sims","Matthew","Infectious Disease, Beaumont Hospital, Royal Oak, USA",NA
"1773","34249563","10.7759/cureus.15416","You Only Find What You Look for: Anchor Bias During the COVID-19 Pandemic.","Hypersensitivity pneumonitis (HP) is an immune-mediated syndrome caused by allergen inhalation. High-resolution computed tomography (HRCT) of HP usually shows diffuse ground-glass opacities, but can show centrilobular ground-glass nodules, areas of air-trapping, or fibrotic changes. The clinical presentation of HP as well as the imaging findings can resemble coronavirus disease 2019 (COVID-19) pneumonia. This resemblance, in the absence of a high level of suspicion for other etiologies, led to a","2021","07","13","Cureus","Cureus","anchoring bias; cognitive bias; covid-19; hypersensitivity pneumonitis; missed diagnosis","Abu-Rumaileh","Mohammed A","Department of Internal Medicine, University of Jordan, Amman, JOR",NA
"1774","34249563","10.7759/cureus.15416","You Only Find What You Look for: Anchor Bias During the COVID-19 Pandemic.","Hypersensitivity pneumonitis (HP) is an immune-mediated syndrome caused by allergen inhalation. High-resolution computed tomography (HRCT) of HP usually shows diffuse ground-glass opacities, but can show centrilobular ground-glass nodules, areas of air-trapping, or fibrotic changes. The clinical presentation of HP as well as the imaging findings can resemble coronavirus disease 2019 (COVID-19) pneumonia. This resemblance, in the absence of a high level of suspicion for other etiologies, led to a","2021","07","13","Cureus","Cureus","anchoring bias; cognitive bias; covid-19; hypersensitivity pneumonitis; missed diagnosis","Alsharif","Nada M","Department of Internal Medicine, University of Jordan, Amman, JOR",NA
"1775","34249563","10.7759/cureus.15416","You Only Find What You Look for: Anchor Bias During the COVID-19 Pandemic.","Hypersensitivity pneumonitis (HP) is an immune-mediated syndrome caused by allergen inhalation. High-resolution computed tomography (HRCT) of HP usually shows diffuse ground-glass opacities, but can show centrilobular ground-glass nodules, areas of air-trapping, or fibrotic changes. The clinical presentation of HP as well as the imaging findings can resemble coronavirus disease 2019 (COVID-19) pneumonia. This resemblance, in the absence of a high level of suspicion for other etiologies, led to a","2021","07","13","Cureus","Cureus","anchoring bias; cognitive bias; covid-19; hypersensitivity pneumonitis; missed diagnosis","Abdulelah","Mohammad","Department of Internal Medicine, University of Jordan, Amman, JOR",NA
"1776","34249563","10.7759/cureus.15416","You Only Find What You Look for: Anchor Bias During the COVID-19 Pandemic.","Hypersensitivity pneumonitis (HP) is an immune-mediated syndrome caused by allergen inhalation. High-resolution computed tomography (HRCT) of HP usually shows diffuse ground-glass opacities, but can show centrilobular ground-glass nodules, areas of air-trapping, or fibrotic changes. The clinical presentation of HP as well as the imaging findings can resemble coronavirus disease 2019 (COVID-19) pneumonia. This resemblance, in the absence of a high level of suspicion for other etiologies, led to a","2021","07","13","Cureus","Cureus","anchoring bias; cognitive bias; covid-19; hypersensitivity pneumonitis; missed diagnosis","Mueting","Samuel","Department of Internal Medicine, University of New Mexico, Albuquerque, USA",NA
"1777","34249563","10.7759/cureus.15416","You Only Find What You Look for: Anchor Bias During the COVID-19 Pandemic.","Hypersensitivity pneumonitis (HP) is an immune-mediated syndrome caused by allergen inhalation. High-resolution computed tomography (HRCT) of HP usually shows diffuse ground-glass opacities, but can show centrilobular ground-glass nodules, areas of air-trapping, or fibrotic changes. The clinical presentation of HP as well as the imaging findings can resemble coronavirus disease 2019 (COVID-19) pneumonia. This resemblance, in the absence of a high level of suspicion for other etiologies, led to a","2021","07","13","Cureus","Cureus","anchoring bias; cognitive bias; covid-19; hypersensitivity pneumonitis; missed diagnosis","Bader","Husam","Department of Internal Medicine, Presbyterian Medical Center, Albuquerque, USA",NA
"1778","34249554","10.7759/cureus.15406","Assessing the Diagnostic Accuracy of Teledermatology Consultations at a Local Veterans Affairs Dermatology Clinic.","With the advances in health information technology and the need for increased access to specialized health care, the advent of telemedicine was designed to bring care to individuals at a distance. Telemedicine decreases barriers to health care and brings medical specialists to underserved areas and populations. We have seen a tremendous increase in the need and utilization of telemedicine during the COVID-19 pandemic due to the lockdowns and social distancing efforts. Virtual care continues to b","2021","07","13","Cureus","Cureus","dermatology diagnostic concordance; diagnostic concordance; online dermatology; teledermatology; telemedicine; virtual care","Gerhardt","Caroline A","Medicine, University of South Florida Morsani College of Medicine, Tampa, USA",NA
"1779","34249554","10.7759/cureus.15406","Assessing the Diagnostic Accuracy of Teledermatology Consultations at a Local Veterans Affairs Dermatology Clinic.","With the advances in health information technology and the need for increased access to specialized health care, the advent of telemedicine was designed to bring care to individuals at a distance. Telemedicine decreases barriers to health care and brings medical specialists to underserved areas and populations. We have seen a tremendous increase in the need and utilization of telemedicine during the COVID-19 pandemic due to the lockdowns and social distancing efforts. Virtual care continues to b","2021","07","13","Cureus","Cureus","dermatology diagnostic concordance; diagnostic concordance; online dermatology; teledermatology; telemedicine; virtual care","Foels","Rachel","Internal Medicine, Lehigh Valley Health Network, Allentown, USA",NA
"1780","34249554","10.7759/cureus.15406","Assessing the Diagnostic Accuracy of Teledermatology Consultations at a Local Veterans Affairs Dermatology Clinic.","With the advances in health information technology and the need for increased access to specialized health care, the advent of telemedicine was designed to bring care to individuals at a distance. Telemedicine decreases barriers to health care and brings medical specialists to underserved areas and populations. We have seen a tremendous increase in the need and utilization of telemedicine during the COVID-19 pandemic due to the lockdowns and social distancing efforts. Virtual care continues to b","2021","07","13","Cureus","Cureus","dermatology diagnostic concordance; diagnostic concordance; online dermatology; teledermatology; telemedicine; virtual care","Grewe","Stefanie","Pathology, University of South Florida Morsani College of Medicine, Tampa, USA",NA
"1781","34249554","10.7759/cureus.15406","Assessing the Diagnostic Accuracy of Teledermatology Consultations at a Local Veterans Affairs Dermatology Clinic.","With the advances in health information technology and the need for increased access to specialized health care, the advent of telemedicine was designed to bring care to individuals at a distance. Telemedicine decreases barriers to health care and brings medical specialists to underserved areas and populations. We have seen a tremendous increase in the need and utilization of telemedicine during the COVID-19 pandemic due to the lockdowns and social distancing efforts. Virtual care continues to b","2021","07","13","Cureus","Cureus","dermatology diagnostic concordance; diagnostic concordance; online dermatology; teledermatology; telemedicine; virtual care","Baldwin","Brooke T","Dermatology, James A. Haley Veterans' Hospital, Tampa, USA",NA
"1782","34249543","10.7759/cureus.15393","Impact of Nonpharmacological Public Health Interventions on Epidemiological Parameters of COVID-19 Pandemic in India.","Background Public health interventions are epidemiologically sound and cost-effective methods to control disease burden. Non-pharmacological public health interventions are the only mode to control diseases in the absence of medication. Objective To find the impact of public health interventions on the epidemiological indicators of disease progression. Methods This is a secondary data analysis done on COVID-19 data. The median doubling time and R0 were calculated for a rolling period of seven da","2021","07","13","Cureus","Cureus","covid-19; india; public health interventions","Kharya","Pradip","Department of Community Medicine &amp",NA
"1783","34249543","10.7759/cureus.15393","Impact of Nonpharmacological Public Health Interventions on Epidemiological Parameters of COVID-19 Pandemic in India.","Background Public health interventions are epidemiologically sound and cost-effective methods to control disease burden. Non-pharmacological public health interventions are the only mode to control diseases in the absence of medication. Objective To find the impact of public health interventions on the epidemiological indicators of disease progression. Methods This is a secondary data analysis done on COVID-19 data. The median doubling time and R0 were calculated for a rolling period of seven da","2021","07","13","Cureus","Cureus","covid-19; india; public health interventions","Koparkar","Anil R","Department of Community Medicine &amp",NA
"1784","34249543","10.7759/cureus.15393","Impact of Nonpharmacological Public Health Interventions on Epidemiological Parameters of COVID-19 Pandemic in India.","Background Public health interventions are epidemiologically sound and cost-effective methods to control disease burden. Non-pharmacological public health interventions are the only mode to control diseases in the absence of medication. Objective To find the impact of public health interventions on the epidemiological indicators of disease progression. Methods This is a secondary data analysis done on COVID-19 data. The median doubling time and R0 were calculated for a rolling period of seven da","2021","07","13","Cureus","Cureus","covid-19; india; public health interventions","Dixit","Anand M","Department of Community Medicine &amp",NA
"1785","34249543","10.7759/cureus.15393","Impact of Nonpharmacological Public Health Interventions on Epidemiological Parameters of COVID-19 Pandemic in India.","Background Public health interventions are epidemiologically sound and cost-effective methods to control disease burden. Non-pharmacological public health interventions are the only mode to control diseases in the absence of medication. Objective To find the impact of public health interventions on the epidemiological indicators of disease progression. Methods This is a secondary data analysis done on COVID-19 data. The median doubling time and R0 were calculated for a rolling period of seven da","2021","07","13","Cureus","Cureus","covid-19; india; public health interventions","Joshi","Hari S","Department of Community Medicine &amp",NA
"1786","34249543","10.7759/cureus.15393","Impact of Nonpharmacological Public Health Interventions on Epidemiological Parameters of COVID-19 Pandemic in India.","Background Public health interventions are epidemiologically sound and cost-effective methods to control disease burden. Non-pharmacological public health interventions are the only mode to control diseases in the absence of medication. Objective To find the impact of public health interventions on the epidemiological indicators of disease progression. Methods This is a secondary data analysis done on COVID-19 data. The median doubling time and R0 were calculated for a rolling period of seven da","2021","07","13","Cureus","Cureus","covid-19; india; public health interventions","Rath","Rama S","Department of Community Medicine &amp",NA
"1787","34249531","10.7759/cureus.15378","A Case Report on Extensive Arterial Thrombosis: A Rare Complication of COVID-19 Infection.","Coronavirus disease (COVID-19) is a global health crisis leading to increased morbidity and mortality worldwide. It is associated with increased activation of the clotting system leading to thrombotic complications increasing the risk of life-threatening complications. We report a case of a 70-years-old COVID-19 positive patient who presented with both lower extremities and forearm pain. On workup, she was found to have an extensive arterial clot. In patients with COVID-19, arterial clots may be","2021","07","13","Cureus","Cureus","arterial clot; arterial thrombosis; coagulopathy; coronavirus disease of 2019 (covid-19); left ventricle thrombus; venous clot","Mandal","Shobha","Internal Medicine, Guthrie Robert Packer Hospital, Sayre, USA",NA
"1788","34249531","10.7759/cureus.15378","A Case Report on Extensive Arterial Thrombosis: A Rare Complication of COVID-19 Infection.","Coronavirus disease (COVID-19) is a global health crisis leading to increased morbidity and mortality worldwide. It is associated with increased activation of the clotting system leading to thrombotic complications increasing the risk of life-threatening complications. We report a case of a 70-years-old COVID-19 positive patient who presented with both lower extremities and forearm pain. On workup, she was found to have an extensive arterial clot. In patients with COVID-19, arterial clots may be","2021","07","13","Cureus","Cureus","arterial clot; arterial thrombosis; coagulopathy; coronavirus disease of 2019 (covid-19); left ventricle thrombus; venous clot","Gami","Sumit","Medicine, Universal College of Medical Sciences, Bhairahawa, Bhairahawa, NPL",NA
"1789","34249531","10.7759/cureus.15378","A Case Report on Extensive Arterial Thrombosis: A Rare Complication of COVID-19 Infection.","Coronavirus disease (COVID-19) is a global health crisis leading to increased morbidity and mortality worldwide. It is associated with increased activation of the clotting system leading to thrombotic complications increasing the risk of life-threatening complications. We report a case of a 70-years-old COVID-19 positive patient who presented with both lower extremities and forearm pain. On workup, she was found to have an extensive arterial clot. In patients with COVID-19, arterial clots may be","2021","07","13","Cureus","Cureus","arterial clot; arterial thrombosis; coagulopathy; coronavirus disease of 2019 (covid-19); left ventricle thrombus; venous clot","Khadka","Sushmita","Internal Medicine, Guthrie Robert Packer Hospital, Sayre, USA",NA
"1790","34249531","10.7759/cureus.15378","A Case Report on Extensive Arterial Thrombosis: A Rare Complication of COVID-19 Infection.","Coronavirus disease (COVID-19) is a global health crisis leading to increased morbidity and mortality worldwide. It is associated with increased activation of the clotting system leading to thrombotic complications increasing the risk of life-threatening complications. We report a case of a 70-years-old COVID-19 positive patient who presented with both lower extremities and forearm pain. On workup, she was found to have an extensive arterial clot. In patients with COVID-19, arterial clots may be","2021","07","13","Cureus","Cureus","arterial clot; arterial thrombosis; coagulopathy; coronavirus disease of 2019 (covid-19); left ventricle thrombus; venous clot","Ray","Barun","Internal Medicine, Bishweshwar Prasad Koirala Institute of Health Sciences, Dharan, NPL",NA
"1791","34249531","10.7759/cureus.15378","A Case Report on Extensive Arterial Thrombosis: A Rare Complication of COVID-19 Infection.","Coronavirus disease (COVID-19) is a global health crisis leading to increased morbidity and mortality worldwide. It is associated with increased activation of the clotting system leading to thrombotic complications increasing the risk of life-threatening complications. We report a case of a 70-years-old COVID-19 positive patient who presented with both lower extremities and forearm pain. On workup, she was found to have an extensive arterial clot. In patients with COVID-19, arterial clots may be","2021","07","13","Cureus","Cureus","arterial clot; arterial thrombosis; coagulopathy; coronavirus disease of 2019 (covid-19); left ventricle thrombus; venous clot","Ghimire","Subash","Internal Medicine, Guthrie Robert Packer Hospital, Sayre, USA",NA
"1792","34249527","10.7759/cureus.15374","Coronavirus Disease 2019 Pneumonia and Acute Pancreatitis in a Young Girl.","Severe acute respiratory syndrome coronavirus 2 pneumonia and acute pancreatitis are rarely reported in patients with coronavirus disease 2019 (COVID-19). We present the case of a 13-year-old girl who presented with nausea, vomiting, and abdominal pain for the last two days, along with a cough for the last week. She had a fever and tachycardia. Lung examination revealed reduced breath sounds, and abdominal examination showed tenderness in the epigastrium. COVID-19 polymerase chain reaction was p","2021","07","13","Cureus","Cureus","acute pancreatitis; coronavirus disease 2019; covid-19; pneumonia; sars-cov-2","Ehsan","Paghunda","Medicine, Hayatabad Medical Complex Peshawar, Peshawar, PAK",NA
"1793","34249527","10.7759/cureus.15374","Coronavirus Disease 2019 Pneumonia and Acute Pancreatitis in a Young Girl.","Severe acute respiratory syndrome coronavirus 2 pneumonia and acute pancreatitis are rarely reported in patients with coronavirus disease 2019 (COVID-19). We present the case of a 13-year-old girl who presented with nausea, vomiting, and abdominal pain for the last two days, along with a cough for the last week. She had a fever and tachycardia. Lung examination revealed reduced breath sounds, and abdominal examination showed tenderness in the epigastrium. COVID-19 polymerase chain reaction was p","2021","07","13","Cureus","Cureus","acute pancreatitis; coronavirus disease 2019; covid-19; pneumonia; sars-cov-2","Haseeb","Muhammad","Internal Medicine, Jinnah Hospital Lahore, Lahore, PAK",NA
"1794","34249527","10.7759/cureus.15374","Coronavirus Disease 2019 Pneumonia and Acute Pancreatitis in a Young Girl.","Severe acute respiratory syndrome coronavirus 2 pneumonia and acute pancreatitis are rarely reported in patients with coronavirus disease 2019 (COVID-19). We present the case of a 13-year-old girl who presented with nausea, vomiting, and abdominal pain for the last two days, along with a cough for the last week. She had a fever and tachycardia. Lung examination revealed reduced breath sounds, and abdominal examination showed tenderness in the epigastrium. COVID-19 polymerase chain reaction was p","2021","07","13","Cureus","Cureus","acute pancreatitis; coronavirus disease 2019; covid-19; pneumonia; sars-cov-2","Khan","Zaraq","Internal Medicine, Hayatabad Medical Complex Peshawar, Peshawar, PAK",NA
"1795","34249527","10.7759/cureus.15374","Coronavirus Disease 2019 Pneumonia and Acute Pancreatitis in a Young Girl.","Severe acute respiratory syndrome coronavirus 2 pneumonia and acute pancreatitis are rarely reported in patients with coronavirus disease 2019 (COVID-19). We present the case of a 13-year-old girl who presented with nausea, vomiting, and abdominal pain for the last two days, along with a cough for the last week. She had a fever and tachycardia. Lung examination revealed reduced breath sounds, and abdominal examination showed tenderness in the epigastrium. COVID-19 polymerase chain reaction was p","2021","07","13","Cureus","Cureus","acute pancreatitis; coronavirus disease 2019; covid-19; pneumonia; sars-cov-2","Rehan","Aiman","Internal Medicine, Dow University of Health Sciences, Karachi, PAK",NA
"1796","34249527","10.7759/cureus.15374","Coronavirus Disease 2019 Pneumonia and Acute Pancreatitis in a Young Girl.","Severe acute respiratory syndrome coronavirus 2 pneumonia and acute pancreatitis are rarely reported in patients with coronavirus disease 2019 (COVID-19). We present the case of a 13-year-old girl who presented with nausea, vomiting, and abdominal pain for the last two days, along with a cough for the last week. She had a fever and tachycardia. Lung examination revealed reduced breath sounds, and abdominal examination showed tenderness in the epigastrium. COVID-19 polymerase chain reaction was p","2021","07","13","Cureus","Cureus","acute pancreatitis; coronavirus disease 2019; covid-19; pneumonia; sars-cov-2","Singh","Romil","Critical Care, Mayo Clinic, Rochester, USA",NA
"1797","34249513","10.7717/peerj.11686","A synthetic defective interfering SARS-CoV-2.","Viruses thrive by exploiting the cells they infect, but in order to replicate and infect other cells they must produce viral proteins. As a result, viruses are also susceptible to exploitation by defective versions of themselves that do not produce such proteins. A defective viral genome with deletions in protein-coding genes could still replicate in cells coinfected with full-length viruses. Such a defective genome could even replicate faster due to its shorter size, interfering with the replic","2021","07","13","PeerJ","PeerJ","Coronavirus; Covid-19; Defective Interfering Particle; SARS-CoV-2; Synthetic Biology","Yao","Shun","Department of Biology, Pennsylvania State University, University Park, United States of America",NA
"1798","34249513","10.7717/peerj.11686","A synthetic defective interfering SARS-CoV-2.","Viruses thrive by exploiting the cells they infect, but in order to replicate and infect other cells they must produce viral proteins. As a result, viruses are also susceptible to exploitation by defective versions of themselves that do not produce such proteins. A defective viral genome with deletions in protein-coding genes could still replicate in cells coinfected with full-length viruses. Such a defective genome could even replicate faster due to its shorter size, interfering with the replic","2021","07","13","PeerJ","PeerJ","Coronavirus; Covid-19; Defective Interfering Particle; SARS-CoV-2; Synthetic Biology","Narayanan","Anoop","Department of Biochemistry &amp",NA
"1799","34249513","10.7717/peerj.11686","A synthetic defective interfering SARS-CoV-2.","Viruses thrive by exploiting the cells they infect, but in order to replicate and infect other cells they must produce viral proteins. As a result, viruses are also susceptible to exploitation by defective versions of themselves that do not produce such proteins. A defective viral genome with deletions in protein-coding genes could still replicate in cells coinfected with full-length viruses. Such a defective genome could even replicate faster due to its shorter size, interfering with the replic","2021","07","13","PeerJ","PeerJ","Coronavirus; Covid-19; Defective Interfering Particle; SARS-CoV-2; Synthetic Biology","Majowicz","Sydney A","Department of Biochemistry &amp",NA
"1800","34249513","10.7717/peerj.11686","A synthetic defective interfering SARS-CoV-2.","Viruses thrive by exploiting the cells they infect, but in order to replicate and infect other cells they must produce viral proteins. As a result, viruses are also susceptible to exploitation by defective versions of themselves that do not produce such proteins. A defective viral genome with deletions in protein-coding genes could still replicate in cells coinfected with full-length viruses. Such a defective genome could even replicate faster due to its shorter size, interfering with the replic","2021","07","13","PeerJ","PeerJ","Coronavirus; Covid-19; Defective Interfering Particle; SARS-CoV-2; Synthetic Biology","Jose","Joyce","Department of Biochemistry &amp",NA
"1801","34249513","10.7717/peerj.11686","A synthetic defective interfering SARS-CoV-2.","Viruses thrive by exploiting the cells they infect, but in order to replicate and infect other cells they must produce viral proteins. As a result, viruses are also susceptible to exploitation by defective versions of themselves that do not produce such proteins. A defective viral genome with deletions in protein-coding genes could still replicate in cells coinfected with full-length viruses. Such a defective genome could even replicate faster due to its shorter size, interfering with the replic","2021","07","13","PeerJ","PeerJ","Coronavirus; Covid-19; Defective Interfering Particle; SARS-CoV-2; Synthetic Biology","Archetti","Marco","Department of Biology, Pennsylvania State University, University Park, United States of America",NA
"1802","34249495","10.7717/peerj.11603","Forecasting the COVID-19 transmission in Italy based on the minimum spanning tree of dynamic region network.","Italy surpassed 1.5 million confirmed Coronavirus Disease 2019 (COVID-19) infections on November 26, as its death toll rose rapidly in the second wave of COVID-19 outbreak which is a heavy burden on hospitals. Therefore, it is necessary to forecast and early warn the potential outbreak of COVID-19 in the future, which facilitates the timely implementation of appropriate control measures. However, real-time prediction of COVID-19 transmission and outbreaks is usually challenging because of its co","2021","07","13","PeerJ","PeerJ","Coronavirus Disease 2019 (COVID-19); Dynamic network marker (DNM); Early warning signals; Italy; Minimum spanning tree (MST); Region network","Dong","Min","School of Computer Science and Engineering, South China University of Technology, Guangzhou, China",NA
"1803","34249495","10.7717/peerj.11603","Forecasting the COVID-19 transmission in Italy based on the minimum spanning tree of dynamic region network.","Italy surpassed 1.5 million confirmed Coronavirus Disease 2019 (COVID-19) infections on November 26, as its death toll rose rapidly in the second wave of COVID-19 outbreak which is a heavy burden on hospitals. Therefore, it is necessary to forecast and early warn the potential outbreak of COVID-19 in the future, which facilitates the timely implementation of appropriate control measures. However, real-time prediction of COVID-19 transmission and outbreaks is usually challenging because of its co","2021","07","13","PeerJ","PeerJ","Coronavirus Disease 2019 (COVID-19); Dynamic network marker (DNM); Early warning signals; Italy; Minimum spanning tree (MST); Region network","Zhang","Xuhang","School of Computer Science and Engineering, South China University of Technology, Guangzhou, China",NA
"1804","34249495","10.7717/peerj.11603","Forecasting the COVID-19 transmission in Italy based on the minimum spanning tree of dynamic region network.","Italy surpassed 1.5 million confirmed Coronavirus Disease 2019 (COVID-19) infections on November 26, as its death toll rose rapidly in the second wave of COVID-19 outbreak which is a heavy burden on hospitals. Therefore, it is necessary to forecast and early warn the potential outbreak of COVID-19 in the future, which facilitates the timely implementation of appropriate control measures. However, real-time prediction of COVID-19 transmission and outbreaks is usually challenging because of its co","2021","07","13","PeerJ","PeerJ","Coronavirus Disease 2019 (COVID-19); Dynamic network marker (DNM); Early warning signals; Italy; Minimum spanning tree (MST); Region network","Yang","Kun","School of Computer Science and Engineering, South China University of Technology, Guangzhou, China",NA
"1805","34249495","10.7717/peerj.11603","Forecasting the COVID-19 transmission in Italy based on the minimum spanning tree of dynamic region network.","Italy surpassed 1.5 million confirmed Coronavirus Disease 2019 (COVID-19) infections on November 26, as its death toll rose rapidly in the second wave of COVID-19 outbreak which is a heavy burden on hospitals. Therefore, it is necessary to forecast and early warn the potential outbreak of COVID-19 in the future, which facilitates the timely implementation of appropriate control measures. However, real-time prediction of COVID-19 transmission and outbreaks is usually challenging because of its co","2021","07","13","PeerJ","PeerJ","Coronavirus Disease 2019 (COVID-19); Dynamic network marker (DNM); Early warning signals; Italy; Minimum spanning tree (MST); Region network","Liu","Rui","School of Mathematics, South China University of Technology, Guangzhou, China",NA
"1806","34249495","10.7717/peerj.11603","Forecasting the COVID-19 transmission in Italy based on the minimum spanning tree of dynamic region network.","Italy surpassed 1.5 million confirmed Coronavirus Disease 2019 (COVID-19) infections on November 26, as its death toll rose rapidly in the second wave of COVID-19 outbreak which is a heavy burden on hospitals. Therefore, it is necessary to forecast and early warn the potential outbreak of COVID-19 in the future, which facilitates the timely implementation of appropriate control measures. However, real-time prediction of COVID-19 transmission and outbreaks is usually challenging because of its co","2021","07","13","PeerJ","PeerJ","Coronavirus Disease 2019 (COVID-19); Dynamic network marker (DNM); Early warning signals; Italy; Minimum spanning tree (MST); Region network","Chen","Pei","School of Mathematics, South China University of Technology, Guangzhou, China",NA
"1807","34249404","10.1177/21526567211026271","Two Cases of Well Controlled Chronic Spontaneous Urticaria Triggered by the Moderna COVID-19 Vaccine.","Chronic spontaneous urticaria (CSU, chronic idiopathic urticaria) is a clinical diagnosis characterized by recurrent urticaria of unknown origin, with or without angioedema, that occurs for six weeks or longer. Management of CSU includes a second-generation H1 antihistamine and/or elimination of exacerbating factors. If initial treatment is unsuccessful, trials of first generation H1 antihistamine, H2 blocking antihistamine, leukotriene-receptor antagonist, anti-inflammatory or immunosuppressive","2021","07","13","Allergy Rhinol (Providence)","Allergy &amp; rhinology (Providence, R.I.)","COVID-19 vaccine; CSU; chronic spontaneous urticaria","Alflen","Cylie","Lake Erie College of Osteopathic Medicine, Erie, Pennsylvania",NA
"1808","34249404","10.1177/21526567211026271","Two Cases of Well Controlled Chronic Spontaneous Urticaria Triggered by the Moderna COVID-19 Vaccine.","Chronic spontaneous urticaria (CSU, chronic idiopathic urticaria) is a clinical diagnosis characterized by recurrent urticaria of unknown origin, with or without angioedema, that occurs for six weeks or longer. Management of CSU includes a second-generation H1 antihistamine and/or elimination of exacerbating factors. If initial treatment is unsuccessful, trials of first generation H1 antihistamine, H2 blocking antihistamine, leukotriene-receptor antagonist, anti-inflammatory or immunosuppressive","2021","07","13","Allergy Rhinol (Providence)","Allergy &amp; rhinology (Providence, R.I.)","COVID-19 vaccine; CSU; chronic spontaneous urticaria","Birch","Katheryn","Allergy/Immunology Associates Inc., Mayfield Heights, Ohio",NA
"1809","34249404","10.1177/21526567211026271","Two Cases of Well Controlled Chronic Spontaneous Urticaria Triggered by the Moderna COVID-19 Vaccine.","Chronic spontaneous urticaria (CSU, chronic idiopathic urticaria) is a clinical diagnosis characterized by recurrent urticaria of unknown origin, with or without angioedema, that occurs for six weeks or longer. Management of CSU includes a second-generation H1 antihistamine and/or elimination of exacerbating factors. If initial treatment is unsuccessful, trials of first generation H1 antihistamine, H2 blocking antihistamine, leukotriene-receptor antagonist, anti-inflammatory or immunosuppressive","2021","07","13","Allergy Rhinol (Providence)","Allergy &amp; rhinology (Providence, R.I.)","COVID-19 vaccine; CSU; chronic spontaneous urticaria","Shilian","Ryan","Allergy/Immunology Associates Inc., Mayfield Heights, Ohio",NA
"1810","34249404","10.1177/21526567211026271","Two Cases of Well Controlled Chronic Spontaneous Urticaria Triggered by the Moderna COVID-19 Vaccine.","Chronic spontaneous urticaria (CSU, chronic idiopathic urticaria) is a clinical diagnosis characterized by recurrent urticaria of unknown origin, with or without angioedema, that occurs for six weeks or longer. Management of CSU includes a second-generation H1 antihistamine and/or elimination of exacerbating factors. If initial treatment is unsuccessful, trials of first generation H1 antihistamine, H2 blocking antihistamine, leukotriene-receptor antagonist, anti-inflammatory or immunosuppressive","2021","07","13","Allergy Rhinol (Providence)","Allergy &amp; rhinology (Providence, R.I.)","COVID-19 vaccine; CSU; chronic spontaneous urticaria","Wu","Shan Shan","Allergy/Immunology Associates Inc., Mayfield Heights, Ohio",NA
"1811","34249404","10.1177/21526567211026271","Two Cases of Well Controlled Chronic Spontaneous Urticaria Triggered by the Moderna COVID-19 Vaccine.","Chronic spontaneous urticaria (CSU, chronic idiopathic urticaria) is a clinical diagnosis characterized by recurrent urticaria of unknown origin, with or without angioedema, that occurs for six weeks or longer. Management of CSU includes a second-generation H1 antihistamine and/or elimination of exacerbating factors. If initial treatment is unsuccessful, trials of first generation H1 antihistamine, H2 blocking antihistamine, leukotriene-receptor antagonist, anti-inflammatory or immunosuppressive","2021","07","13","Allergy Rhinol (Providence)","Allergy &amp; rhinology (Providence, R.I.)","COVID-19 vaccine; CSU; chronic spontaneous urticaria","Hostoffer","Robert","Allergy/Immunology Associates Inc., Mayfield Heights, Ohio",NA
"1812","34249372","10.1016/j.jve.2021.100049","Highlights from the <i>virtual</i> conference on retroviruses and opportunistic infections (CROI) 2021: SARS-CoV-2 pathogenesis, new data about antiretroviral treatments, HIV-associated comorbidities, pediatrics and pregnancy.",NA,"2021","07","13","J Virus Erad","Journal of virus eradication",NA,"Psomas","Christina K","European Hospital Marseille, France",NA
"1813","34249372","10.1016/j.jve.2021.100049","Highlights from the <i>virtual</i> conference on retroviruses and opportunistic infections (CROI) 2021: SARS-CoV-2 pathogenesis, new data about antiretroviral treatments, HIV-associated comorbidities, pediatrics and pregnancy.",NA,"2021","07","13","J Virus Erad","Journal of virus eradication",NA,"Waters","Laura J","Mortimer Market Center, Central and North West London NHS Foundation Trust, UK",NA
"1814","34249372","10.1016/j.jve.2021.100049","Highlights from the <i>virtual</i> conference on retroviruses and opportunistic infections (CROI) 2021: SARS-CoV-2 pathogenesis, new data about antiretroviral treatments, HIV-associated comorbidities, pediatrics and pregnancy.",NA,"2021","07","13","J Virus Erad","Journal of virus eradication",NA,"Barber","Tristan","Ian Charleson Day Centre, Royal Free London NHS Foundation Trust, London, UK",NA
"1815","34249370","10.5334/pb.1059","Parents' Perceived Impact of the Societal Lockdown of COVID-19 on Family Well-Being and on the Emotional and Behavioral State of Walloon Belgian Children Aged 4 to 13 Years: An Exploratory Study.","This exploratory study assessed parents' perceptions of the emotional and behavioral impacts of the COVID-19 lockdown on their children. The total sample included 749 children, aged 4 to 13 years old (353 girls, 396 boys); 524 parents took part. The emotional and behavioral changes observed during the societal lockdown, family coexistence, the impact of COVID-19 on family well-being, and the frequency of social contacts before and during this lockdown were investigated. Results show that the mos","2021","07","13","Psychol Belg","Psychologica Belgica","COVID-19; children; psychological impact; societal lockdown","Stassart","C","Inter University Health and Society Research Unit (URiSS), Health Psychology, Department of Psychology, University of Liege, Liege, Belgium",NA
"1816","34249370","10.5334/pb.1059","Parents' Perceived Impact of the Societal Lockdown of COVID-19 on Family Well-Being and on the Emotional and Behavioral State of Walloon Belgian Children Aged 4 to 13 Years: An Exploratory Study.","This exploratory study assessed parents' perceptions of the emotional and behavioral impacts of the COVID-19 lockdown on their children. The total sample included 749 children, aged 4 to 13 years old (353 girls, 396 boys); 524 parents took part. The emotional and behavioral changes observed during the societal lockdown, family coexistence, the impact of COVID-19 on family well-being, and the frequency of social contacts before and during this lockdown were investigated. Results show that the mos","2021","07","13","Psychol Belg","Psychologica Belgica","COVID-19; children; psychological impact; societal lockdown","Wagener","A","Inter University Health and Society Research Unit (URiSS), Health Psychology, Department of Psychology, University of Liege, Liege, Belgium",NA
"1817","34249370","10.5334/pb.1059","Parents' Perceived Impact of the Societal Lockdown of COVID-19 on Family Well-Being and on the Emotional and Behavioral State of Walloon Belgian Children Aged 4 to 13 Years: An Exploratory Study.","This exploratory study assessed parents' perceptions of the emotional and behavioral impacts of the COVID-19 lockdown on their children. The total sample included 749 children, aged 4 to 13 years old (353 girls, 396 boys); 524 parents took part. The emotional and behavioral changes observed during the societal lockdown, family coexistence, the impact of COVID-19 on family well-being, and the frequency of social contacts before and during this lockdown were investigated. Results show that the mos","2021","07","13","Psychol Belg","Psychologica Belgica","COVID-19; children; psychological impact; societal lockdown","Etienne","A-M","Inter University Health and Society Research Unit (URiSS), Health Psychology, Department of Psychology, University of Liege, Liege, Belgium",NA
"1818","34249367","10.1016/j.nmni.2021.100915","Early COVID-19 Therapy with azithromycin plus nitazoxanide, ivermectin or hydroxychloroquine in Outpatient Settings Significantly Improved COVID-19 outcomes compared to Known outcomes in untreated patients.","In a prospective observational study (pre-AndroCoV Trial), the use of nitazoxanide, ivermectin and hydroxychloroquine demonstrated unexpected improvements in COVID-19 outcomes, when compared to untreated patients. The apparent yet likely positive results raised ethical concerns on the employment of further full placebo84 controlled studies in early stage COVID-19. The present analysis aimed to elucidate whether full placebo-control randomized clinical trials (RCTs) on early-stage COVID-19 are st","2021","07","12","New Microbes New Infect","New microbes and new infections","COVID-19; SARS-CoV-2; antiandrogen; clinical equipoise; dutasteride; hydroxychloroquine; ivermectin; nitazoxanide; proxalutamide; spironolactone","Cadegiani","Flavio A","Corpometria Institute, Brasília, DF, Brazil",NA
"1819","34249367","10.1016/j.nmni.2021.100915","Early COVID-19 Therapy with azithromycin plus nitazoxanide, ivermectin or hydroxychloroquine in Outpatient Settings Significantly Improved COVID-19 outcomes compared to Known outcomes in untreated patients.","In a prospective observational study (pre-AndroCoV Trial), the use of nitazoxanide, ivermectin and hydroxychloroquine demonstrated unexpected improvements in COVID-19 outcomes, when compared to untreated patients. The apparent yet likely positive results raised ethical concerns on the employment of further full placebo84 controlled studies in early stage COVID-19. The present analysis aimed to elucidate whether full placebo-control randomized clinical trials (RCTs) on early-stage COVID-19 are st","2021","07","12","New Microbes New Infect","New microbes and new infections","COVID-19; SARS-CoV-2; antiandrogen; clinical equipoise; dutasteride; hydroxychloroquine; ivermectin; nitazoxanide; proxalutamide; spironolactone","Goren","Andy","Applied Biology, Inc. Irvine, CA, USA",NA
"1820","34249367","10.1016/j.nmni.2021.100915","Early COVID-19 Therapy with azithromycin plus nitazoxanide, ivermectin or hydroxychloroquine in Outpatient Settings Significantly Improved COVID-19 outcomes compared to Known outcomes in untreated patients.","In a prospective observational study (pre-AndroCoV Trial), the use of nitazoxanide, ivermectin and hydroxychloroquine demonstrated unexpected improvements in COVID-19 outcomes, when compared to untreated patients. The apparent yet likely positive results raised ethical concerns on the employment of further full placebo84 controlled studies in early stage COVID-19. The present analysis aimed to elucidate whether full placebo-control randomized clinical trials (RCTs) on early-stage COVID-19 are st","2021","07","12","New Microbes New Infect","New microbes and new infections","COVID-19; SARS-CoV-2; antiandrogen; clinical equipoise; dutasteride; hydroxychloroquine; ivermectin; nitazoxanide; proxalutamide; spironolactone","Wambier","Carlos G","Department of Dermatology, The Alpert Medical School of Brown University, RI, USA",NA
"1821","34249367","10.1016/j.nmni.2021.100915","Early COVID-19 Therapy with azithromycin plus nitazoxanide, ivermectin or hydroxychloroquine in Outpatient Settings Significantly Improved COVID-19 outcomes compared to Known outcomes in untreated patients.","In a prospective observational study (pre-AndroCoV Trial), the use of nitazoxanide, ivermectin and hydroxychloroquine demonstrated unexpected improvements in COVID-19 outcomes, when compared to untreated patients. The apparent yet likely positive results raised ethical concerns on the employment of further full placebo84 controlled studies in early stage COVID-19. The present analysis aimed to elucidate whether full placebo-control randomized clinical trials (RCTs) on early-stage COVID-19 are st","2021","07","12","New Microbes New Infect","New microbes and new infections","COVID-19; SARS-CoV-2; antiandrogen; clinical equipoise; dutasteride; hydroxychloroquine; ivermectin; nitazoxanide; proxalutamide; spironolactone","McCoy","John","Applied Biology, Inc. Irvine, CA, USA",NA
"1822","34249366","10.1016/j.nmni.2021.100914","Knowledge, Attitude and Associated Factors toward COVID-19 among Nurses Who Work in South Gondar Zone, Hospitals, Northwest Ethiopia 2020. A multi central Institutional based cross sectional study.","Coronavirus disease 2019 is an emerging respiratory disease that is caused by a novel coronavirus and was first detected in December 2019 in Wuhan, China. The world is affected by the Coronavirus Disease in 2019. In sub-Saharan Africa Including Ethiopia there is no study conducted level of Knowledge, Attitude and Associated Factors toward Coronavirus disease 2019 among Health care workers Specifically Nurses. This study aims to assess the level of Knowledge, Attitude and Associated Factors towar","2021","07","12","New Microbes New Infect","New microbes and new infections","Coronovirus-2019; Ethiopia; Knowledge; attitude; nurse","Feleke","Dejen Getaneh","Department of Pediatrics and Child Health Nursing, College of Health Sciences, Debre Tabor University, P.O.BOX 272, Debre Tabor, Ethiopia",NA
"1823","34249366","10.1016/j.nmni.2021.100914","Knowledge, Attitude and Associated Factors toward COVID-19 among Nurses Who Work in South Gondar Zone, Hospitals, Northwest Ethiopia 2020. A multi central Institutional based cross sectional study.","Coronavirus disease 2019 is an emerging respiratory disease that is caused by a novel coronavirus and was first detected in December 2019 in Wuhan, China. The world is affected by the Coronavirus Disease in 2019. In sub-Saharan Africa Including Ethiopia there is no study conducted level of Knowledge, Attitude and Associated Factors toward Coronavirus disease 2019 among Health care workers Specifically Nurses. This study aims to assess the level of Knowledge, Attitude and Associated Factors towar","2021","07","12","New Microbes New Infect","New microbes and new infections","Coronovirus-2019; Ethiopia; Knowledge; attitude; nurse","Chanie","Ermiase Sisay","Department of Pediatrics and Child Health Nursing, College of Health Sciences, Debre Tabor University, P.O.BOX 272, Debre Tabor, Ethiopia",NA
"1824","34249366","10.1016/j.nmni.2021.100914","Knowledge, Attitude and Associated Factors toward COVID-19 among Nurses Who Work in South Gondar Zone, Hospitals, Northwest Ethiopia 2020. A multi central Institutional based cross sectional study.","Coronavirus disease 2019 is an emerging respiratory disease that is caused by a novel coronavirus and was first detected in December 2019 in Wuhan, China. The world is affected by the Coronavirus Disease in 2019. In sub-Saharan Africa Including Ethiopia there is no study conducted level of Knowledge, Attitude and Associated Factors toward Coronavirus disease 2019 among Health care workers Specifically Nurses. This study aims to assess the level of Knowledge, Attitude and Associated Factors towar","2021","07","12","New Microbes New Infect","New microbes and new infections","Coronovirus-2019; Ethiopia; Knowledge; attitude; nurse","Tilaye","Birara Ayichew","Department of Pediatrics and Child Health Nursing, College of Health Sciences, Debre Tabor University, P.O.BOX 272, Debre Tabor, Ethiopia",NA
"1825","34249366","10.1016/j.nmni.2021.100914","Knowledge, Attitude and Associated Factors toward COVID-19 among Nurses Who Work in South Gondar Zone, Hospitals, Northwest Ethiopia 2020. A multi central Institutional based cross sectional study.","Coronavirus disease 2019 is an emerging respiratory disease that is caused by a novel coronavirus and was first detected in December 2019 in Wuhan, China. The world is affected by the Coronavirus Disease in 2019. In sub-Saharan Africa Including Ethiopia there is no study conducted level of Knowledge, Attitude and Associated Factors toward Coronavirus disease 2019 among Health care workers Specifically Nurses. This study aims to assess the level of Knowledge, Attitude and Associated Factors towar","2021","07","12","New Microbes New Infect","New microbes and new infections","Coronovirus-2019; Ethiopia; Knowledge; attitude; nurse","Mesfin","Demeke","Department of Pediatrics and Child Health Nursing, College of Health Sciences, Debre Tabor University, P.O.BOX 272, Debre Tabor, Ethiopia",NA
"1826","34249366","10.1016/j.nmni.2021.100914","Knowledge, Attitude and Associated Factors toward COVID-19 among Nurses Who Work in South Gondar Zone, Hospitals, Northwest Ethiopia 2020. A multi central Institutional based cross sectional study.","Coronavirus disease 2019 is an emerging respiratory disease that is caused by a novel coronavirus and was first detected in December 2019 in Wuhan, China. The world is affected by the Coronavirus Disease in 2019. In sub-Saharan Africa Including Ethiopia there is no study conducted level of Knowledge, Attitude and Associated Factors toward Coronavirus disease 2019 among Health care workers Specifically Nurses. This study aims to assess the level of Knowledge, Attitude and Associated Factors towar","2021","07","12","New Microbes New Infect","New microbes and new infections","Coronovirus-2019; Ethiopia; Knowledge; attitude; nurse","Bayih","Biniam Munye","Department of Maternity and Neonatal Nursing,College of Health Sciences, Debre Tabor University, P.O.BOX 272, Debre Tabor, Ethiopia",NA
"1827","34249366","10.1016/j.nmni.2021.100914","Knowledge, Attitude and Associated Factors toward COVID-19 among Nurses Who Work in South Gondar Zone, Hospitals, Northwest Ethiopia 2020. A multi central Institutional based cross sectional study.","Coronavirus disease 2019 is an emerging respiratory disease that is caused by a novel coronavirus and was first detected in December 2019 in Wuhan, China. The world is affected by the Coronavirus Disease in 2019. In sub-Saharan Africa Including Ethiopia there is no study conducted level of Knowledge, Attitude and Associated Factors toward Coronavirus disease 2019 among Health care workers Specifically Nurses. This study aims to assess the level of Knowledge, Attitude and Associated Factors towar","2021","07","12","New Microbes New Infect","New microbes and new infections","Coronovirus-2019; Ethiopia; Knowledge; attitude; nurse","Bayih","Wubet Alebachew","Department of Maternity and Neonatal Nursing,College of Health Sciences, Debre Tabor University, P.O.BOX 272, Debre Tabor, Ethiopia",NA
"1828","34249366","10.1016/j.nmni.2021.100914","Knowledge, Attitude and Associated Factors toward COVID-19 among Nurses Who Work in South Gondar Zone, Hospitals, Northwest Ethiopia 2020. A multi central Institutional based cross sectional study.","Coronavirus disease 2019 is an emerging respiratory disease that is caused by a novel coronavirus and was first detected in December 2019 in Wuhan, China. The world is affected by the Coronavirus Disease in 2019. In sub-Saharan Africa Including Ethiopia there is no study conducted level of Knowledge, Attitude and Associated Factors toward Coronavirus disease 2019 among Health care workers Specifically Nurses. This study aims to assess the level of Knowledge, Attitude and Associated Factors towar","2021","07","12","New Microbes New Infect","New microbes and new infections","Coronovirus-2019; Ethiopia; Knowledge; attitude; nurse","Tassew","Sheganew Fetene","Department of Emergency Medicine and Critical Care Nursing, College of Health Sciences, Debre Tabor University, P.O.BOX 272, Debre Tabor, Ethiopia",NA
"1829","34249366","10.1016/j.nmni.2021.100914","Knowledge, Attitude and Associated Factors toward COVID-19 among Nurses Who Work in South Gondar Zone, Hospitals, Northwest Ethiopia 2020. A multi central Institutional based cross sectional study.","Coronavirus disease 2019 is an emerging respiratory disease that is caused by a novel coronavirus and was first detected in December 2019 in Wuhan, China. The world is affected by the Coronavirus Disease in 2019. In sub-Saharan Africa Including Ethiopia there is no study conducted level of Knowledge, Attitude and Associated Factors toward Coronavirus disease 2019 among Health care workers Specifically Nurses. This study aims to assess the level of Knowledge, Attitude and Associated Factors towar","2021","07","12","New Microbes New Infect","New microbes and new infections","Coronovirus-2019; Ethiopia; Knowledge; attitude; nurse","Asnakew","Sentayehu","Department of Psychiatry, College of Health Sciences, Debre Tabor University, P.O.BOX 272, Debre Tabor, Ethiopia",NA
"1830","34249366","10.1016/j.nmni.2021.100914","Knowledge, Attitude and Associated Factors toward COVID-19 among Nurses Who Work in South Gondar Zone, Hospitals, Northwest Ethiopia 2020. A multi central Institutional based cross sectional study.","Coronavirus disease 2019 is an emerging respiratory disease that is caused by a novel coronavirus and was first detected in December 2019 in Wuhan, China. The world is affected by the Coronavirus Disease in 2019. In sub-Saharan Africa Including Ethiopia there is no study conducted level of Knowledge, Attitude and Associated Factors toward Coronavirus disease 2019 among Health care workers Specifically Nurses. This study aims to assess the level of Knowledge, Attitude and Associated Factors towar","2021","07","12","New Microbes New Infect","New microbes and new infections","Coronovirus-2019; Ethiopia; Knowledge; attitude; nurse","Berlie","Tekalign Amera","Department of Adult Health Nursing, College of Health Sciences, Debre Tabor University, P.O.BOX 272, Debre Tabor, Ethiopia",NA
"1831","34249366","10.1016/j.nmni.2021.100914","Knowledge, Attitude and Associated Factors toward COVID-19 among Nurses Who Work in South Gondar Zone, Hospitals, Northwest Ethiopia 2020. A multi central Institutional based cross sectional study.","Coronavirus disease 2019 is an emerging respiratory disease that is caused by a novel coronavirus and was first detected in December 2019 in Wuhan, China. The world is affected by the Coronavirus Disease in 2019. In sub-Saharan Africa Including Ethiopia there is no study conducted level of Knowledge, Attitude and Associated Factors toward Coronavirus disease 2019 among Health care workers Specifically Nurses. This study aims to assess the level of Knowledge, Attitude and Associated Factors towar","2021","07","12","New Microbes New Infect","New microbes and new infections","Coronovirus-2019; Ethiopia; Knowledge; attitude; nurse","Dires","Tadela","Department of Adult Health Nursing, College of Health Sciences, Debre Tabor University, P.O.BOX 272, Debre Tabor, Ethiopia",NA
"1832","34249366","10.1016/j.nmni.2021.100914","Knowledge, Attitude and Associated Factors toward COVID-19 among Nurses Who Work in South Gondar Zone, Hospitals, Northwest Ethiopia 2020. A multi central Institutional based cross sectional study.","Coronavirus disease 2019 is an emerging respiratory disease that is caused by a novel coronavirus and was first detected in December 2019 in Wuhan, China. The world is affected by the Coronavirus Disease in 2019. In sub-Saharan Africa Including Ethiopia there is no study conducted level of Knowledge, Attitude and Associated Factors toward Coronavirus disease 2019 among Health care workers Specifically Nurses. This study aims to assess the level of Knowledge, Attitude and Associated Factors towar","2021","07","12","New Microbes New Infect","New microbes and new infections","Coronovirus-2019; Ethiopia; Knowledge; attitude; nurse","Dagnaw","Enyew","Department of Midwifery, College of Health Sciences, Debre Tabor University, P.O.BOX 272, Debre Tabor, Ethiopia",NA
"1833","34249366","10.1016/j.nmni.2021.100914","Knowledge, Attitude and Associated Factors toward COVID-19 among Nurses Who Work in South Gondar Zone, Hospitals, Northwest Ethiopia 2020. A multi central Institutional based cross sectional study.","Coronavirus disease 2019 is an emerging respiratory disease that is caused by a novel coronavirus and was first detected in December 2019 in Wuhan, China. The world is affected by the Coronavirus Disease in 2019. In sub-Saharan Africa Including Ethiopia there is no study conducted level of Knowledge, Attitude and Associated Factors toward Coronavirus disease 2019 among Health care workers Specifically Nurses. This study aims to assess the level of Knowledge, Attitude and Associated Factors towar","2021","07","12","New Microbes New Infect","New microbes and new infections","Coronovirus-2019; Ethiopia; Knowledge; attitude; nurse","Tadesse","Tesfaye Yimer","Department of Pharmacy, College of Health Sciences, Debre Tabor University, P.O.BOX 272, Debre Tabor, Ethiopia",NA
"1834","34249362","10.1177/20503121211027462","COVID-19 and aging: Identifying measures of severity.","We aimed to compare clinical features of older age group and young and middle-aged patients with COVID-19 and analyze mortality predictors. Retrospective analysis of ongoing collection of prespecified data, on a single institution, including patients hospitalized consecutively due to COVID-19 infection, from March to June 2020. Of 195 patients, 56.9% were <U+2A7E>65 years (older age group). Older age group had multimorbidity (p &lt; 0.001). At admission Early Warning Score-2 (p &lt; 0.001), C-reactive ","2021","07","13","SAGE Open Med","SAGE open medicine","COVID-19; geriatric; mortality; older age; predictors; prognosis","Neves","Maria Teresa","Department of Medical Oncology Hospital São Francisco Xavier, Centro Hospitalar Lisboa Ocidental, Lisbon, Portugal",NA
"1835","34249362","10.1177/20503121211027462","COVID-19 and aging: Identifying measures of severity.","We aimed to compare clinical features of older age group and young and middle-aged patients with COVID-19 and analyze mortality predictors. Retrospective analysis of ongoing collection of prespecified data, on a single institution, including patients hospitalized consecutively due to COVID-19 infection, from March to June 2020. Of 195 patients, 56.9% were <U+2A7E>65 years (older age group). Older age group had multimorbidity (p &lt; 0.001). At admission Early Warning Score-2 (p &lt; 0.001), C-reactive ","2021","07","13","SAGE Open Med","SAGE open medicine","COVID-19; geriatric; mortality; older age; predictors; prognosis","de Matos","Leonor Vasconcelos","Department of Medical Oncology Hospital São Francisco Xavier, Centro Hospitalar Lisboa Ocidental, Lisbon, Portugal",NA
"1836","34249362","10.1177/20503121211027462","COVID-19 and aging: Identifying measures of severity.","We aimed to compare clinical features of older age group and young and middle-aged patients with COVID-19 and analyze mortality predictors. Retrospective analysis of ongoing collection of prespecified data, on a single institution, including patients hospitalized consecutively due to COVID-19 infection, from March to June 2020. Of 195 patients, 56.9% were <U+2A7E>65 years (older age group). Older age group had multimorbidity (p &lt; 0.001). At admission Early Warning Score-2 (p &lt; 0.001), C-reactive ","2021","07","13","SAGE Open Med","SAGE open medicine","COVID-19; geriatric; mortality; older age; predictors; prognosis","Vasques","Ana Carolina","Department of Medical Oncology Hospital São Francisco Xavier, Centro Hospitalar Lisboa Ocidental, Lisbon, Portugal",NA
"1837","34249362","10.1177/20503121211027462","COVID-19 and aging: Identifying measures of severity.","We aimed to compare clinical features of older age group and young and middle-aged patients with COVID-19 and analyze mortality predictors. Retrospective analysis of ongoing collection of prespecified data, on a single institution, including patients hospitalized consecutively due to COVID-19 infection, from March to June 2020. Of 195 patients, 56.9% were <U+2A7E>65 years (older age group). Older age group had multimorbidity (p &lt; 0.001). At admission Early Warning Score-2 (p &lt; 0.001), C-reactive ","2021","07","13","SAGE Open Med","SAGE open medicine","COVID-19; geriatric; mortality; older age; predictors; prognosis","Sousa","Inês Egídio","Department of Internal Medicine, Hospital São Francisco Xavier, Centro Hospitalar Lisboa Ocidental, Lisbon, Portugal",NA
"1838","34249362","10.1177/20503121211027462","COVID-19 and aging: Identifying measures of severity.","We aimed to compare clinical features of older age group and young and middle-aged patients with COVID-19 and analyze mortality predictors. Retrospective analysis of ongoing collection of prespecified data, on a single institution, including patients hospitalized consecutively due to COVID-19 infection, from March to June 2020. Of 195 patients, 56.9% were <U+2A7E>65 years (older age group). Older age group had multimorbidity (p &lt; 0.001). At admission Early Warning Score-2 (p &lt; 0.001), C-reactive ","2021","07","13","SAGE Open Med","SAGE open medicine","COVID-19; geriatric; mortality; older age; predictors; prognosis","Ferreira","Inês","Department of Internal Medicine, Hospital São Francisco Xavier, Centro Hospitalar Lisboa Ocidental, Lisbon, Portugal",NA
"1839","34249362","10.1177/20503121211027462","COVID-19 and aging: Identifying measures of severity.","We aimed to compare clinical features of older age group and young and middle-aged patients with COVID-19 and analyze mortality predictors. Retrospective analysis of ongoing collection of prespecified data, on a single institution, including patients hospitalized consecutively due to COVID-19 infection, from March to June 2020. Of 195 patients, 56.9% were <U+2A7E>65 years (older age group). Older age group had multimorbidity (p &lt; 0.001). At admission Early Warning Score-2 (p &lt; 0.001), C-reactive ","2021","07","13","SAGE Open Med","SAGE open medicine","COVID-19; geriatric; mortality; older age; predictors; prognosis","Peres","Susana","Department of Infectious Diseases, Hospital Egas Moniz, Centro Hospitalar Lisboa Ocidental, Lisbon, Portugal",NA
"1840","34249362","10.1177/20503121211027462","COVID-19 and aging: Identifying measures of severity.","We aimed to compare clinical features of older age group and young and middle-aged patients with COVID-19 and analyze mortality predictors. Retrospective analysis of ongoing collection of prespecified data, on a single institution, including patients hospitalized consecutively due to COVID-19 infection, from March to June 2020. Of 195 patients, 56.9% were <U+2A7E>65 years (older age group). Older age group had multimorbidity (p &lt; 0.001). At admission Early Warning Score-2 (p &lt; 0.001), C-reactive ","2021","07","13","SAGE Open Med","SAGE open medicine","COVID-19; geriatric; mortality; older age; predictors; prognosis","Jesus","Susana","Department of Internal Medicine, Hospital São Francisco Xavier, Centro Hospitalar Lisboa Ocidental, Lisbon, Portugal",NA
"1841","34249362","10.1177/20503121211027462","COVID-19 and aging: Identifying measures of severity.","We aimed to compare clinical features of older age group and young and middle-aged patients with COVID-19 and analyze mortality predictors. Retrospective analysis of ongoing collection of prespecified data, on a single institution, including patients hospitalized consecutively due to COVID-19 infection, from March to June 2020. Of 195 patients, 56.9% were <U+2A7E>65 years (older age group). Older age group had multimorbidity (p &lt; 0.001). At admission Early Warning Score-2 (p &lt; 0.001), C-reactive ","2021","07","13","SAGE Open Med","SAGE open medicine","COVID-19; geriatric; mortality; older age; predictors; prognosis","Fonseca","Cândida","Department of Internal Medicine, Hospital São Francisco Xavier, Centro Hospitalar Lisboa Ocidental, Lisbon, Portugal",NA
"1842","34249362","10.1177/20503121211027462","COVID-19 and aging: Identifying measures of severity.","We aimed to compare clinical features of older age group and young and middle-aged patients with COVID-19 and analyze mortality predictors. Retrospective analysis of ongoing collection of prespecified data, on a single institution, including patients hospitalized consecutively due to COVID-19 infection, from March to June 2020. Of 195 patients, 56.9% were <U+2A7E>65 years (older age group). Older age group had multimorbidity (p &lt; 0.001). At admission Early Warning Score-2 (p &lt; 0.001), C-reactive ","2021","07","13","SAGE Open Med","SAGE open medicine","COVID-19; geriatric; mortality; older age; predictors; prognosis","Mansinho","Kamal","Department of Infectious Diseases, Hospital Egas Moniz, Centro Hospitalar Lisboa Ocidental, Lisbon, Portugal",NA
"1843","34249357","10.1177/20499361211027390","Elevated glycohemoglobin is linked to critical illness in CoVID-19: a retrospective analysis.","Several studies have explored hospitalization risk factors with the novel coronavirus disease 2019 (COVID-19) infection. Our goal was to identify clinical characteristics outside of laboratory or radiologic data associated with intubation or death within 7 days of admission. The first 436 patients admitted to the University of Colorado Hospital (Denver metropolitan area) with confirmed COVID-19 were included. Demographics, comorbidities, and select medications were collected by chart abstraction","2021","07","13","Ther Adv Infect Dis","Therapeutic advances in infectious disease","COVID-19; diabetes; hemoglobin A1c; intensive care unit; mechanical ventilation","Windham","Samuel","Division of Infectious Disease, Department of Medicine, School of Medicine, University of Colorado, Aurora, CO, USA",NA
"1844","34249357","10.1177/20499361211027390","Elevated glycohemoglobin is linked to critical illness in CoVID-19: a retrospective analysis.","Several studies have explored hospitalization risk factors with the novel coronavirus disease 2019 (COVID-19) infection. Our goal was to identify clinical characteristics outside of laboratory or radiologic data associated with intubation or death within 7 days of admission. The first 436 patients admitted to the University of Colorado Hospital (Denver metropolitan area) with confirmed COVID-19 were included. Demographics, comorbidities, and select medications were collected by chart abstraction","2021","07","13","Ther Adv Infect Dis","Therapeutic advances in infectious disease","COVID-19; diabetes; hemoglobin A1c; intensive care unit; mechanical ventilation","Wilson","Melissa P","Department of Biostatistics and Informatics, Colorado School of Public Health, Aurora, CO, USA",NA
"1845","34249357","10.1177/20499361211027390","Elevated glycohemoglobin is linked to critical illness in CoVID-19: a retrospective analysis.","Several studies have explored hospitalization risk factors with the novel coronavirus disease 2019 (COVID-19) infection. Our goal was to identify clinical characteristics outside of laboratory or radiologic data associated with intubation or death within 7 days of admission. The first 436 patients admitted to the University of Colorado Hospital (Denver metropolitan area) with confirmed COVID-19 were included. Demographics, comorbidities, and select medications were collected by chart abstraction","2021","07","13","Ther Adv Infect Dis","Therapeutic advances in infectious disease","COVID-19; diabetes; hemoglobin A1c; intensive care unit; mechanical ventilation","Fling","Connor","University of Colorado School of Medicine, Aurora, CO, USA",NA
"1846","34249357","10.1177/20499361211027390","Elevated glycohemoglobin is linked to critical illness in CoVID-19: a retrospective analysis.","Several studies have explored hospitalization risk factors with the novel coronavirus disease 2019 (COVID-19) infection. Our goal was to identify clinical characteristics outside of laboratory or radiologic data associated with intubation or death within 7 days of admission. The first 436 patients admitted to the University of Colorado Hospital (Denver metropolitan area) with confirmed COVID-19 were included. Demographics, comorbidities, and select medications were collected by chart abstraction","2021","07","13","Ther Adv Infect Dis","Therapeutic advances in infectious disease","COVID-19; diabetes; hemoglobin A1c; intensive care unit; mechanical ventilation","Sheneman","David","University of Colorado School of Medicine, Aurora, CO, USA",NA
"1847","34249357","10.1177/20499361211027390","Elevated glycohemoglobin is linked to critical illness in CoVID-19: a retrospective analysis.","Several studies have explored hospitalization risk factors with the novel coronavirus disease 2019 (COVID-19) infection. Our goal was to identify clinical characteristics outside of laboratory or radiologic data associated with intubation or death within 7 days of admission. The first 436 patients admitted to the University of Colorado Hospital (Denver metropolitan area) with confirmed COVID-19 were included. Demographics, comorbidities, and select medications were collected by chart abstraction","2021","07","13","Ther Adv Infect Dis","Therapeutic advances in infectious disease","COVID-19; diabetes; hemoglobin A1c; intensive care unit; mechanical ventilation","Wand","Taylor","University of Colorado School of Medicine, Aurora, CO, USA",NA
"1848","34249357","10.1177/20499361211027390","Elevated glycohemoglobin is linked to critical illness in CoVID-19: a retrospective analysis.","Several studies have explored hospitalization risk factors with the novel coronavirus disease 2019 (COVID-19) infection. Our goal was to identify clinical characteristics outside of laboratory or radiologic data associated with intubation or death within 7 days of admission. The first 436 patients admitted to the University of Colorado Hospital (Denver metropolitan area) with confirmed COVID-19 were included. Demographics, comorbidities, and select medications were collected by chart abstraction","2021","07","13","Ther Adv Infect Dis","Therapeutic advances in infectious disease","COVID-19; diabetes; hemoglobin A1c; intensive care unit; mechanical ventilation","Babcock","Lyndsey","University of Colorado School of Medicine, Aurora, CO, USA",NA
"1849","34249357","10.1177/20499361211027390","Elevated glycohemoglobin is linked to critical illness in CoVID-19: a retrospective analysis.","Several studies have explored hospitalization risk factors with the novel coronavirus disease 2019 (COVID-19) infection. Our goal was to identify clinical characteristics outside of laboratory or radiologic data associated with intubation or death within 7 days of admission. The first 436 patients admitted to the University of Colorado Hospital (Denver metropolitan area) with confirmed COVID-19 were included. Demographics, comorbidities, and select medications were collected by chart abstraction","2021","07","13","Ther Adv Infect Dis","Therapeutic advances in infectious disease","COVID-19; diabetes; hemoglobin A1c; intensive care unit; mechanical ventilation","MaWhinney","Samantha","Department of Biostatistics and Informatics, Colorado School of Public Health, Aurora, CO, USA",NA
"1850","34249357","10.1177/20499361211027390","Elevated glycohemoglobin is linked to critical illness in CoVID-19: a retrospective analysis.","Several studies have explored hospitalization risk factors with the novel coronavirus disease 2019 (COVID-19) infection. Our goal was to identify clinical characteristics outside of laboratory or radiologic data associated with intubation or death within 7 days of admission. The first 436 patients admitted to the University of Colorado Hospital (Denver metropolitan area) with confirmed COVID-19 were included. Demographics, comorbidities, and select medications were collected by chart abstraction","2021","07","13","Ther Adv Infect Dis","Therapeutic advances in infectious disease","COVID-19; diabetes; hemoglobin A1c; intensive care unit; mechanical ventilation","Erlandson","Kristine M","Division of Infectious Disease, Department of Medicine, School of Medicine, University of Colorado, 12700 E. 19th Avenue, Mail Stop B168, Aurora, CO 80045, USA",NA
"1851","34249355","10.1016/j.amsu.2021.102543","The impact of mental health on COVID 19 disease progression: Case report.","It has been observed that mental disorder is associated with an aggravation of COVID 19 disease. A 44-year-old male patient, with no medical history, admitted to the emergency room for dyspnea, the exploration revealed SARS-COV-2 pneumonia. The patient was stable until he was aware of the death of his sister by COVID 19, he was admitted into the intensive care unit 24hours later in a serious condition after worsening of the inflammatory balance and pulmonary lesions. COVID 19 requires appropriat","2021","07","13","Ann Med Surg (Lond)","Annals of medicine and surgery (2012)","COVID 19; Case report; Mental health; Prognosis","Bouabdallaoui","Amine","Intensive Care Unit, Mohammed VI University Hospital Center, Oujda, Morocco",NA
"1852","34249355","10.1016/j.amsu.2021.102543","The impact of mental health on COVID 19 disease progression: Case report.","It has been observed that mental disorder is associated with an aggravation of COVID 19 disease. A 44-year-old male patient, with no medical history, admitted to the emergency room for dyspnea, the exploration revealed SARS-COV-2 pneumonia. The patient was stable until he was aware of the death of his sister by COVID 19, he was admitted into the intensive care unit 24hours later in a serious condition after worsening of the inflammatory balance and pulmonary lesions. COVID 19 requires appropriat","2021","07","13","Ann Med Surg (Lond)","Annals of medicine and surgery (2012)","COVID 19; Case report; Mental health; Prognosis","Taouihar","Salma","Intensive Care Unit, Mohammed VI University Hospital Center, Oujda, Morocco",NA
"1853","34249355","10.1016/j.amsu.2021.102543","The impact of mental health on COVID 19 disease progression: Case report.","It has been observed that mental disorder is associated with an aggravation of COVID 19 disease. A 44-year-old male patient, with no medical history, admitted to the emergency room for dyspnea, the exploration revealed SARS-COV-2 pneumonia. The patient was stable until he was aware of the death of his sister by COVID 19, he was admitted into the intensive care unit 24hours later in a serious condition after worsening of the inflammatory balance and pulmonary lesions. COVID 19 requires appropriat","2021","07","13","Ann Med Surg (Lond)","Annals of medicine and surgery (2012)","COVID 19; Case report; Mental health; Prognosis","El Aidouni","Ghizlane","Intensive Care Unit, Mohammed VI University Hospital Center, Oujda, Morocco",NA
"1854","34249355","10.1016/j.amsu.2021.102543","The impact of mental health on COVID 19 disease progression: Case report.","It has been observed that mental disorder is associated with an aggravation of COVID 19 disease. A 44-year-old male patient, with no medical history, admitted to the emergency room for dyspnea, the exploration revealed SARS-COV-2 pneumonia. The patient was stable until he was aware of the death of his sister by COVID 19, he was admitted into the intensive care unit 24hours later in a serious condition after worsening of the inflammatory balance and pulmonary lesions. COVID 19 requires appropriat","2021","07","13","Ann Med Surg (Lond)","Annals of medicine and surgery (2012)","COVID 19; Case report; Mental health; Prognosis","Aabdi","Mohamed","Intensive Care Unit, Mohammed VI University Hospital Center, Oujda, Morocco",NA
"1855","34249355","10.1016/j.amsu.2021.102543","The impact of mental health on COVID 19 disease progression: Case report.","It has been observed that mental disorder is associated with an aggravation of COVID 19 disease. A 44-year-old male patient, with no medical history, admitted to the emergency room for dyspnea, the exploration revealed SARS-COV-2 pneumonia. The patient was stable until he was aware of the death of his sister by COVID 19, he was admitted into the intensive care unit 24hours later in a serious condition after worsening of the inflammatory balance and pulmonary lesions. COVID 19 requires appropriat","2021","07","13","Ann Med Surg (Lond)","Annals of medicine and surgery (2012)","COVID 19; Case report; Mental health; Prognosis","Alkouh","Rajae","Intensive Care Unit, Mohammed VI University Hospital Center, Oujda, Morocco",NA
"1856","34249355","10.1016/j.amsu.2021.102543","The impact of mental health on COVID 19 disease progression: Case report.","It has been observed that mental disorder is associated with an aggravation of COVID 19 disease. A 44-year-old male patient, with no medical history, admitted to the emergency room for dyspnea, the exploration revealed SARS-COV-2 pneumonia. The patient was stable until he was aware of the death of his sister by COVID 19, he was admitted into the intensive care unit 24hours later in a serious condition after worsening of the inflammatory balance and pulmonary lesions. COVID 19 requires appropriat","2021","07","13","Ann Med Surg (Lond)","Annals of medicine and surgery (2012)","COVID 19; Case report; Mental health; Prognosis","Merbouh","Manal","Intensive Care Unit, Mohammed VI University Hospital Center, Oujda, Morocco",NA
"1857","34249355","10.1016/j.amsu.2021.102543","The impact of mental health on COVID 19 disease progression: Case report.","It has been observed that mental disorder is associated with an aggravation of COVID 19 disease. A 44-year-old male patient, with no medical history, admitted to the emergency room for dyspnea, the exploration revealed SARS-COV-2 pneumonia. The patient was stable until he was aware of the death of his sister by COVID 19, he was admitted into the intensive care unit 24hours later in a serious condition after worsening of the inflammatory balance and pulmonary lesions. COVID 19 requires appropriat","2021","07","13","Ann Med Surg (Lond)","Annals of medicine and surgery (2012)","COVID 19; Case report; Mental health; Prognosis","Bkiyar","Houssam","Intensive Care Unit, Mohammed VI University Hospital Center, Oujda, Morocco",NA
"1858","34249355","10.1016/j.amsu.2021.102543","The impact of mental health on COVID 19 disease progression: Case report.","It has been observed that mental disorder is associated with an aggravation of COVID 19 disease. A 44-year-old male patient, with no medical history, admitted to the emergency room for dyspnea, the exploration revealed SARS-COV-2 pneumonia. The patient was stable until he was aware of the death of his sister by COVID 19, he was admitted into the intensive care unit 24hours later in a serious condition after worsening of the inflammatory balance and pulmonary lesions. COVID 19 requires appropriat","2021","07","13","Ann Med Surg (Lond)","Annals of medicine and surgery (2012)","COVID 19; Case report; Mental health; Prognosis","Housni","Bahim","Intensive Care Unit, Mohammed VI University Hospital Center, Oujda, Morocco",NA
"1859","34249354","10.1016/j.amsu.2021.102541","Phlegmasia cerulea dolens during the SARS-COV-2 pandemic: What management ?",NA,"2021","07","13","Ann Med Surg (Lond)","Annals of medicine and surgery (2012)","COVID-19 pandemic; Compartment syndrome.; Phlegmasia Cerulea Dolens","Anane","Oussama","Mohammed First University, Faculty of Medicine and Pharmacy, Oujda, Morocco",NA
"1860","34249354","10.1016/j.amsu.2021.102541","Phlegmasia cerulea dolens during the SARS-COV-2 pandemic: What management ?",NA,"2021","07","13","Ann Med Surg (Lond)","Annals of medicine and surgery (2012)","COVID-19 pandemic; Compartment syndrome.; Phlegmasia Cerulea Dolens","Rezziki","Abdellah","Mohammed First University, Faculty of Medicine and Pharmacy, Oujda, Morocco",NA
"1861","34249354","10.1016/j.amsu.2021.102541","Phlegmasia cerulea dolens during the SARS-COV-2 pandemic: What management ?",NA,"2021","07","13","Ann Med Surg (Lond)","Annals of medicine and surgery (2012)","COVID-19 pandemic; Compartment syndrome.; Phlegmasia Cerulea Dolens","Benzirar","Adnane","Mohammed First University, Faculty of Medicine and Pharmacy, Oujda, Morocco",NA
"1862","34249354","10.1016/j.amsu.2021.102541","Phlegmasia cerulea dolens during the SARS-COV-2 pandemic: What management ?",NA,"2021","07","13","Ann Med Surg (Lond)","Annals of medicine and surgery (2012)","COVID-19 pandemic; Compartment syndrome.; Phlegmasia Cerulea Dolens","El Mahi","Omar","Mohammed First University, Faculty of Medicine and Pharmacy, Oujda, Morocco",NA
"1863","34249353","10.1016/j.amsu.2021.102540","Post-COVID-19 vaccine Guillain-Barré syndrome; first reported case from Qatar.","Guillain-Barré syndrome (GBS) is an immune-mediated peripheral neuropathy that was reported following meningococcus, polio, influenza and rabies vaccines. However, an association with the COVID-19 vaccine is yet to be established. We present the case of an elderly gentleman with no history of SARS-CoV-2 infection or any recent viral or bacterial illnesses who presented with GBS 20 days after the second dose of COVID-19 vaccination. The diagnosis was established based on physical examination, mag","2021","07","13","Ann Med Surg (Lond)","Annals of medicine and surgery (2012)","COVID-19 vaccine; Guillain-Barré syndrome; Molecular mimicry; Qatar","Razok","Almurtada","Department of Internal Medicine, Hamad Medical Corporation, P.O 3050, Doha, Qatar",NA
"1864","34249353","10.1016/j.amsu.2021.102540","Post-COVID-19 vaccine Guillain-Barré syndrome; first reported case from Qatar.","Guillain-Barré syndrome (GBS) is an immune-mediated peripheral neuropathy that was reported following meningococcus, polio, influenza and rabies vaccines. However, an association with the COVID-19 vaccine is yet to be established. We present the case of an elderly gentleman with no history of SARS-CoV-2 infection or any recent viral or bacterial illnesses who presented with GBS 20 days after the second dose of COVID-19 vaccination. The diagnosis was established based on physical examination, mag","2021","07","13","Ann Med Surg (Lond)","Annals of medicine and surgery (2012)","COVID-19 vaccine; Guillain-Barré syndrome; Molecular mimicry; Qatar","Shams","Abdullah","Department of Internal Medicine, Hamad Medical Corporation, P.O 3050, Doha, Qatar",NA
"1865","34249353","10.1016/j.amsu.2021.102540","Post-COVID-19 vaccine Guillain-Barré syndrome; first reported case from Qatar.","Guillain-Barré syndrome (GBS) is an immune-mediated peripheral neuropathy that was reported following meningococcus, polio, influenza and rabies vaccines. However, an association with the COVID-19 vaccine is yet to be established. We present the case of an elderly gentleman with no history of SARS-CoV-2 infection or any recent viral or bacterial illnesses who presented with GBS 20 days after the second dose of COVID-19 vaccination. The diagnosis was established based on physical examination, mag","2021","07","13","Ann Med Surg (Lond)","Annals of medicine and surgery (2012)","COVID-19 vaccine; Guillain-Barré syndrome; Molecular mimicry; Qatar","Almeer","Ahmed","Department of Internal Medicine, Hamad Medical Corporation, P.O 3050, Doha, Qatar",NA
"1866","34249353","10.1016/j.amsu.2021.102540","Post-COVID-19 vaccine Guillain-Barré syndrome; first reported case from Qatar.","Guillain-Barré syndrome (GBS) is an immune-mediated peripheral neuropathy that was reported following meningococcus, polio, influenza and rabies vaccines. However, an association with the COVID-19 vaccine is yet to be established. We present the case of an elderly gentleman with no history of SARS-CoV-2 infection or any recent viral or bacterial illnesses who presented with GBS 20 days after the second dose of COVID-19 vaccination. The diagnosis was established based on physical examination, mag","2021","07","13","Ann Med Surg (Lond)","Annals of medicine and surgery (2012)","COVID-19 vaccine; Guillain-Barré syndrome; Molecular mimicry; Qatar","Zahid","Muhammad","Department of Internal Medicine, Hamad Medical Corporation, P.O 3050, Doha, Qatar",NA
"1867","34249344","10.12688/f1000research.53904.1","Sleep quality among undergraduate students of a medical college in Nepal during COVID-19 pandemic: an online survey.","Background Good sleep quality is associated with a diverse range of positive outcomes such as better health, less daytime sleepiness, well-being, and proper psychological functioning. Sleep deprivation or poor sleep quality leads to many metabolic, endocrine, and immune changes. Many studies have shown changes in sleep schedule along with worsening of sleep quality during the COVID-19 pandemic. Methods This cross-sectional study was conducted among students of a medical college in Kathmandu, Nep","2021","07","14","F1000Res","F1000Research","COVID-19; Medical students; Nepal; Sleep; Sleep Deprivation; COVID-19; Cross-Sectional Studies; Female; Humans; Male; Nepal; Pandemics; Quality of Life; SARS-CoV-2; Sleep; Students; Surveys and Questionnaires","Shrestha","Dhan","Department of Emergency Medicine, Mangalbare Hospital, Urlabari, 1, 56600, Nepal",NA
"1868","34249344","10.12688/f1000research.53904.1","Sleep quality among undergraduate students of a medical college in Nepal during COVID-19 pandemic: an online survey.","Background Good sleep quality is associated with a diverse range of positive outcomes such as better health, less daytime sleepiness, well-being, and proper psychological functioning. Sleep deprivation or poor sleep quality leads to many metabolic, endocrine, and immune changes. Many studies have shown changes in sleep schedule along with worsening of sleep quality during the COVID-19 pandemic. Methods This cross-sectional study was conducted among students of a medical college in Kathmandu, Nep","2021","07","14","F1000Res","F1000Research","COVID-19; Medical students; Nepal; Sleep; Sleep Deprivation; COVID-19; Cross-Sectional Studies; Female; Humans; Male; Nepal; Pandemics; Quality of Life; SARS-CoV-2; Sleep; Students; Surveys and Questionnaires","Adhikari","Suman Prasad","Department of Neuro-psychiatry, Nepalese Army Institute of Health Sciences, Shree Birendra Hospital, Kathmandu, 3, 44600, Nepal",NA
"1869","34249344","10.12688/f1000research.53904.1","Sleep quality among undergraduate students of a medical college in Nepal during COVID-19 pandemic: an online survey.","Background Good sleep quality is associated with a diverse range of positive outcomes such as better health, less daytime sleepiness, well-being, and proper psychological functioning. Sleep deprivation or poor sleep quality leads to many metabolic, endocrine, and immune changes. Many studies have shown changes in sleep schedule along with worsening of sleep quality during the COVID-19 pandemic. Methods This cross-sectional study was conducted among students of a medical college in Kathmandu, Nep","2021","07","14","F1000Res","F1000Research","COVID-19; Medical students; Nepal; Sleep; Sleep Deprivation; COVID-19; Cross-Sectional Studies; Female; Humans; Male; Nepal; Pandemics; Quality of Life; SARS-CoV-2; Sleep; Students; Surveys and Questionnaires","Rawal","Namrata","Department of Neuro-psychiatry, Nepalese Army Institute of Health Sciences, Shree Birendra Hospital, Kathmandu, 3, 44600, Nepal",NA
"1870","34249344","10.12688/f1000research.53904.1","Sleep quality among undergraduate students of a medical college in Nepal during COVID-19 pandemic: an online survey.","Background Good sleep quality is associated with a diverse range of positive outcomes such as better health, less daytime sleepiness, well-being, and proper psychological functioning. Sleep deprivation or poor sleep quality leads to many metabolic, endocrine, and immune changes. Many studies have shown changes in sleep schedule along with worsening of sleep quality during the COVID-19 pandemic. Methods This cross-sectional study was conducted among students of a medical college in Kathmandu, Nep","2021","07","14","F1000Res","F1000Research","COVID-19; Medical students; Nepal; Sleep; Sleep Deprivation; COVID-19; Cross-Sectional Studies; Female; Humans; Male; Nepal; Pandemics; Quality of Life; SARS-CoV-2; Sleep; Students; Surveys and Questionnaires","Budhathoki","Pravash","Department of Emergency Medicine, Dr Iwamura Memorial Hospital, Bhaktapur, 3, 44800, Nepal",NA
"1871","34249344","10.12688/f1000research.53904.1","Sleep quality among undergraduate students of a medical college in Nepal during COVID-19 pandemic: an online survey.","Background Good sleep quality is associated with a diverse range of positive outcomes such as better health, less daytime sleepiness, well-being, and proper psychological functioning. Sleep deprivation or poor sleep quality leads to many metabolic, endocrine, and immune changes. Many studies have shown changes in sleep schedule along with worsening of sleep quality during the COVID-19 pandemic. Methods This cross-sectional study was conducted among students of a medical college in Kathmandu, Nep","2021","07","14","F1000Res","F1000Research","COVID-19; Medical students; Nepal; Sleep; Sleep Deprivation; COVID-19; Cross-Sectional Studies; Female; Humans; Male; Nepal; Pandemics; Quality of Life; SARS-CoV-2; Sleep; Students; Surveys and Questionnaires","Pokharel","Subashchandra","Medical student, Nepalese Army Institute of Health Sciences, Kathmandu, 3, 44600, Nepal",NA
"1872","34249344","10.12688/f1000research.53904.1","Sleep quality among undergraduate students of a medical college in Nepal during COVID-19 pandemic: an online survey.","Background Good sleep quality is associated with a diverse range of positive outcomes such as better health, less daytime sleepiness, well-being, and proper psychological functioning. Sleep deprivation or poor sleep quality leads to many metabolic, endocrine, and immune changes. Many studies have shown changes in sleep schedule along with worsening of sleep quality during the COVID-19 pandemic. Methods This cross-sectional study was conducted among students of a medical college in Kathmandu, Nep","2021","07","14","F1000Res","F1000Research","COVID-19; Medical students; Nepal; Sleep; Sleep Deprivation; COVID-19; Cross-Sectional Studies; Female; Humans; Male; Nepal; Pandemics; Quality of Life; SARS-CoV-2; Sleep; Students; Surveys and Questionnaires","Adhikari","Yuvraj","Medical student, Nepalese Army Institute of Health Sciences, Kathmandu, 3, 44600, Nepal",NA
"1873","34249344","10.12688/f1000research.53904.1","Sleep quality among undergraduate students of a medical college in Nepal during COVID-19 pandemic: an online survey.","Background Good sleep quality is associated with a diverse range of positive outcomes such as better health, less daytime sleepiness, well-being, and proper psychological functioning. Sleep deprivation or poor sleep quality leads to many metabolic, endocrine, and immune changes. Many studies have shown changes in sleep schedule along with worsening of sleep quality during the COVID-19 pandemic. Methods This cross-sectional study was conducted among students of a medical college in Kathmandu, Nep","2021","07","14","F1000Res","F1000Research","COVID-19; Medical students; Nepal; Sleep; Sleep Deprivation; COVID-19; Cross-Sectional Studies; Female; Humans; Male; Nepal; Pandemics; Quality of Life; SARS-CoV-2; Sleep; Students; Surveys and Questionnaires","Rokaya","Pooja","Medical student, Nepalese Army Institute of Health Sciences, Kathmandu, 3, 44600, Nepal",NA
"1874","34249344","10.12688/f1000research.53904.1","Sleep quality among undergraduate students of a medical college in Nepal during COVID-19 pandemic: an online survey.","Background Good sleep quality is associated with a diverse range of positive outcomes such as better health, less daytime sleepiness, well-being, and proper psychological functioning. Sleep deprivation or poor sleep quality leads to many metabolic, endocrine, and immune changes. Many studies have shown changes in sleep schedule along with worsening of sleep quality during the COVID-19 pandemic. Methods This cross-sectional study was conducted among students of a medical college in Kathmandu, Nep","2021","07","14","F1000Res","F1000Research","COVID-19; Medical students; Nepal; Sleep; Sleep Deprivation; COVID-19; Cross-Sectional Studies; Female; Humans; Male; Nepal; Pandemics; Quality of Life; SARS-CoV-2; Sleep; Students; Surveys and Questionnaires","Raut","Udit","Medical student, Nepalese Army Institute of Health Sciences, Kathmandu, 3, 44600, Nepal",NA
"1875","34249324","10.1136/flgastro-2020-101693","Severe alcohol-related liver disease admissions post-COVID-19 lockdown: canary in the coal mine?",NA,"2021","07","13","Frontline Gastroenterol","Frontline gastroenterology","alcohol; alcoholic liver disease; chronic liver disease","Cargill","Zillah","Institute of Liver Studies, King's College Hospital Liver Unit, London, London, UK",NA
"1876","34249324","10.1136/flgastro-2020-101693","Severe alcohol-related liver disease admissions post-COVID-19 lockdown: canary in the coal mine?",NA,"2021","07","13","Frontline Gastroenterol","Frontline gastroenterology","alcohol; alcoholic liver disease; chronic liver disease","Kattiparambil","Sajith","Institute of Liver Studies, King's College Hospital Liver Unit, London, London, UK",NA
"1877","34249324","10.1136/flgastro-2020-101693","Severe alcohol-related liver disease admissions post-COVID-19 lockdown: canary in the coal mine?",NA,"2021","07","13","Frontline Gastroenterol","Frontline gastroenterology","alcohol; alcoholic liver disease; chronic liver disease","Hansi","Navjyot","Institute of Liver Studies, King's College Hospital Liver Unit, London, London, UK",NA
"1878","34249324","10.1136/flgastro-2020-101693","Severe alcohol-related liver disease admissions post-COVID-19 lockdown: canary in the coal mine?",NA,"2021","07","13","Frontline Gastroenterol","Frontline gastroenterology","alcohol; alcoholic liver disease; chronic liver disease","Barnabas","Ashley","Institute of Liver Studies, King's College Hospital Liver Unit, London, London, UK",NA
"1879","34249324","10.1136/flgastro-2020-101693","Severe alcohol-related liver disease admissions post-COVID-19 lockdown: canary in the coal mine?",NA,"2021","07","13","Frontline Gastroenterol","Frontline gastroenterology","alcohol; alcoholic liver disease; chronic liver disease","Shawcross","Debbie L","Institute of Liver Studies, King's College Hospital Liver Unit, London, London, UK",NA
"1880","34249324","10.1136/flgastro-2020-101693","Severe alcohol-related liver disease admissions post-COVID-19 lockdown: canary in the coal mine?",NA,"2021","07","13","Frontline Gastroenterol","Frontline gastroenterology","alcohol; alcoholic liver disease; chronic liver disease","Williams","Roger","Foundation for Liver Research, The Institute of Hepatology London, London, UK",NA
"1881","34249324","10.1136/flgastro-2020-101693","Severe alcohol-related liver disease admissions post-COVID-19 lockdown: canary in the coal mine?",NA,"2021","07","13","Frontline Gastroenterol","Frontline gastroenterology","alcohol; alcoholic liver disease; chronic liver disease","Agarwal","Kosh","Institute of Liver Studies, King's College Hospital Liver Unit, London, London, UK",NA
"1882","34249323","10.1136/flgastro-2020-101598","Exit strategies from the COVID-19 lockdown for children and young people receiving home parenteral nutrition (HPN): lessons from the BSPGHAN Intestinal Failure Working Group experience.",NA,"2021","07","13","Frontline Gastroenterol","Frontline gastroenterology","intestinal failure; nutrition in paediatrics","Barclay","Andrew Robert","PGHN, Royal Hospital for Children, Glasgow, UK",NA
"1883","34249323","10.1136/flgastro-2020-101598","Exit strategies from the COVID-19 lockdown for children and young people receiving home parenteral nutrition (HPN): lessons from the BSPGHAN Intestinal Failure Working Group experience.",NA,"2021","07","13","Frontline Gastroenterol","Frontline gastroenterology","intestinal failure; nutrition in paediatrics","McGuckin","Christina","PGHN, Royal Hospital for Children, Glasgow, UK",NA
"1884","34249323","10.1136/flgastro-2020-101598","Exit strategies from the COVID-19 lockdown for children and young people receiving home parenteral nutrition (HPN): lessons from the BSPGHAN Intestinal Failure Working Group experience.",NA,"2021","07","13","Frontline Gastroenterol","Frontline gastroenterology","intestinal failure; nutrition in paediatrics","Hill","Susan","Great Ormond Street Hospital for Children, London, UK",NA
"1885","34249323","10.1136/flgastro-2020-101598","Exit strategies from the COVID-19 lockdown for children and young people receiving home parenteral nutrition (HPN): lessons from the BSPGHAN Intestinal Failure Working Group experience.",NA,"2021","07","13","Frontline Gastroenterol","Frontline gastroenterology","intestinal failure; nutrition in paediatrics","Protheroe","Sue","Birmingham Children's Hospital, Birmingham, UK",NA
"1886","34249323","10.1136/flgastro-2020-101598","Exit strategies from the COVID-19 lockdown for children and young people receiving home parenteral nutrition (HPN): lessons from the BSPGHAN Intestinal Failure Working Group experience.",NA,"2021","07","13","Frontline Gastroenterol","Frontline gastroenterology","intestinal failure; nutrition in paediatrics","Batra","Akshay","Paediatrics, University Hospital Southampton NHS Foundation Trust, Southampton, UK",NA
"1888","34249321","10.1136/flgastro-2020-101611","Challenges and opportunities of COVID-19 for gastroenterology and hepatology services.",NA,"2021","07","13","Frontline Gastroenterol","Frontline gastroenterology","clinical decision making; endoscopy; health service research; liver","Tham","Tony C","Immediate past Chair, British Society of Gastroenterology Clinical Services and Standards Committee, London, UK",NA
"1889","34249321","10.1136/flgastro-2020-101611","Challenges and opportunities of COVID-19 for gastroenterology and hepatology services.",NA,"2021","07","13","Frontline Gastroenterol","Frontline gastroenterology","clinical decision making; endoscopy; health service research; liver","Douds","Andrew C","Department of Gastroenterology, Norfolk and Norwich University Hospital NHS Trust, Norwich, Norfolk, UK",NA
"1890","34249321","10.1136/flgastro-2020-101611","Challenges and opportunities of COVID-19 for gastroenterology and hepatology services.",NA,"2021","07","13","Frontline Gastroenterol","Frontline gastroenterology","clinical decision making; endoscopy; health service research; liver","Ransford","Rupert","Department of Gastroenterology, Hereford County Hospital, Hereford, UK",NA
"1891","34249319","10.1136/flgastro-2020-101529","Gastrointestinal manifestations of COVID-19 in children: a systematic review and meta-analysis.","To summarise the published evidence on the gastrointestinal manifestations of COVID-19 in children and to determine the prevalence of gastrointestinal symptoms. In this systematic review and meta-analysis, we searched PubMed, Embase, CINAHL and the WHO's database of publications on novel coronavirus. We included English language studies that had described original demographic and clinical characteristics of children diagnosed with COVID-19 and reported on the presence or absence of gastrointesti","2021","07","13","Frontline Gastroenterol","Frontline gastroenterology","abdominal pain; diarrhoea; infectious disease","Akobeng","Anthony K","Division of Gastroenterology, Hepatology, and Nutrition, Sidra Medicine, Doha, Qatar",NA
"1892","34249319","10.1136/flgastro-2020-101529","Gastrointestinal manifestations of COVID-19 in children: a systematic review and meta-analysis.","To summarise the published evidence on the gastrointestinal manifestations of COVID-19 in children and to determine the prevalence of gastrointestinal symptoms. In this systematic review and meta-analysis, we searched PubMed, Embase, CINAHL and the WHO's database of publications on novel coronavirus. We included English language studies that had described original demographic and clinical characteristics of children diagnosed with COVID-19 and reported on the presence or absence of gastrointesti","2021","07","13","Frontline Gastroenterol","Frontline gastroenterology","abdominal pain; diarrhoea; infectious disease","Grafton-Clarke","Ciaran","University of Leicester, Leicester, Leicestershire, UK",NA
"1893","34249319","10.1136/flgastro-2020-101529","Gastrointestinal manifestations of COVID-19 in children: a systematic review and meta-analysis.","To summarise the published evidence on the gastrointestinal manifestations of COVID-19 in children and to determine the prevalence of gastrointestinal symptoms. In this systematic review and meta-analysis, we searched PubMed, Embase, CINAHL and the WHO's database of publications on novel coronavirus. We included English language studies that had described original demographic and clinical characteristics of children diagnosed with COVID-19 and reported on the presence or absence of gastrointesti","2021","07","13","Frontline Gastroenterol","Frontline gastroenterology","abdominal pain; diarrhoea; infectious disease","Abdelgadir","Ibtihal","Weill Cornell Medicine, Doha, Qatar",NA
"1894","34249319","10.1136/flgastro-2020-101529","Gastrointestinal manifestations of COVID-19 in children: a systematic review and meta-analysis.","To summarise the published evidence on the gastrointestinal manifestations of COVID-19 in children and to determine the prevalence of gastrointestinal symptoms. In this systematic review and meta-analysis, we searched PubMed, Embase, CINAHL and the WHO's database of publications on novel coronavirus. We included English language studies that had described original demographic and clinical characteristics of children diagnosed with COVID-19 and reported on the presence or absence of gastrointesti","2021","07","13","Frontline Gastroenterol","Frontline gastroenterology","abdominal pain; diarrhoea; infectious disease","Twum-Barimah","Erica","Paediatrics, Milton Keynes University Hospital, Milton Keynes, Milton Keynes, UK",NA
"1895","34249319","10.1136/flgastro-2020-101529","Gastrointestinal manifestations of COVID-19 in children: a systematic review and meta-analysis.","To summarise the published evidence on the gastrointestinal manifestations of COVID-19 in children and to determine the prevalence of gastrointestinal symptoms. In this systematic review and meta-analysis, we searched PubMed, Embase, CINAHL and the WHO's database of publications on novel coronavirus. We included English language studies that had described original demographic and clinical characteristics of children diagnosed with COVID-19 and reported on the presence or absence of gastrointesti","2021","07","13","Frontline Gastroenterol","Frontline gastroenterology","abdominal pain; diarrhoea; infectious disease","Gordon","Morris","University of Central Lancashire, Preston, Lancashire, UK",NA
"1896","34249317","10.1136/flgastro-2020-101531","Implications of recurrent SARS-CoV-2 outbreaks for IBD management.","The initial phases of the global SARS-CoV2 pandemic had significant implications for the management of patients with inflammatory bowel disease (IBD). This impact is likely to be sustained and far-reaching across all models of care. Initial questions about the risk of SARS-CoV2 infection, and COVID-19 complications, in patients taking maintenance anti-TNFs, JAK inhibitors and other immune modulators have preliminary data. Current models for SARS-CoV-2 transmission predict intermittent outbreaks ","2021","07","13","Frontline Gastroenterol","Frontline gastroenterology","IBD; epidemiology","Segal","Jonathan P","Gastroenterology and Hepatology, St Mary's Hospital, London, UK",NA
"1897","34249317","10.1136/flgastro-2020-101531","Implications of recurrent SARS-CoV-2 outbreaks for IBD management.","The initial phases of the global SARS-CoV2 pandemic had significant implications for the management of patients with inflammatory bowel disease (IBD). This impact is likely to be sustained and far-reaching across all models of care. Initial questions about the risk of SARS-CoV2 infection, and COVID-19 complications, in patients taking maintenance anti-TNFs, JAK inhibitors and other immune modulators have preliminary data. Current models for SARS-CoV-2 transmission predict intermittent outbreaks ","2021","07","13","Frontline Gastroenterol","Frontline gastroenterology","IBD; epidemiology","Moss","Alan C","Gastroenterology, BIDMC/Harvard Medical School, Boston, Massachusetts, USA",NA
"1898","34249315","10.1136/flgastro-2020-101704","COVID-19 and the challenges faced by gastroenterology trainees: time for capsule endoscopy training?",NA,"2021","07","13","Frontline Gastroenterol","Frontline gastroenterology","endoscopy; small bowel","Conley","Thomas Edward","Gastroenterology, Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, UK",NA
"1899","34249315","10.1136/flgastro-2020-101704","COVID-19 and the challenges faced by gastroenterology trainees: time for capsule endoscopy training?",NA,"2021","07","13","Frontline Gastroenterol","Frontline gastroenterology","endoscopy; small bowel","Fiske","Joseph","Gastroenterology, Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, UK",NA
"1900","34249315","10.1136/flgastro-2020-101704","COVID-19 and the challenges faced by gastroenterology trainees: time for capsule endoscopy training?",NA,"2021","07","13","Frontline Gastroenterol","Frontline gastroenterology","endoscopy; small bowel","Townsend","Tristan","Gastroenterology, Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, UK",NA
"1901","34249315","10.1136/flgastro-2020-101704","COVID-19 and the challenges faced by gastroenterology trainees: time for capsule endoscopy training?",NA,"2021","07","13","Frontline Gastroenterol","Frontline gastroenterology","endoscopy; small bowel","Collins","Paul","Gastroenterology, Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, UK",NA
"1902","34249315","10.1136/flgastro-2020-101704","COVID-19 and the challenges faced by gastroenterology trainees: time for capsule endoscopy training?",NA,"2021","07","13","Frontline Gastroenterol","Frontline gastroenterology","endoscopy; small bowel","Bond","Ashley","Gastroenterology, Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, UK",NA
"1903","34249314","10.1136/flgastro-2020-101689","Liver dysfunction in COVID-19: a useful prognostic marker of severe disease?","COVID-19 is a global pandemic caused by the novel coronavirus SARS-CoV-2. Risk factors and prognostic markers of severe disease remain to be fully determined, although some studies have suggested a correlation between abnormal liver function and adverse outcomes. Further studies are needed to investigate this further. This retrospective study enrolled patients with a confirmed diagnosis of COVID-19 who were admitted to Kingston Hospital in the UK. Data collected included age, sex, ethnicity, com","2021","07","13","Frontline Gastroenterol","Frontline gastroenterology","COVID-19; infectious disease; liver","Lok","James","Department of Gastroenterology, Kingston Hospital NHS Foundation Trust, Kingston upon Thames, UK",NA
"1904","34249314","10.1136/flgastro-2020-101689","Liver dysfunction in COVID-19: a useful prognostic marker of severe disease?","COVID-19 is a global pandemic caused by the novel coronavirus SARS-CoV-2. Risk factors and prognostic markers of severe disease remain to be fully determined, although some studies have suggested a correlation between abnormal liver function and adverse outcomes. Further studies are needed to investigate this further. This retrospective study enrolled patients with a confirmed diagnosis of COVID-19 who were admitted to Kingston Hospital in the UK. Data collected included age, sex, ethnicity, com","2021","07","13","Frontline Gastroenterol","Frontline gastroenterology","COVID-19; infectious disease; liver","Gess","Markus","Department of Gastroenterology, Kingston Hospital NHS Foundation Trust, Kingston upon Thames, UK",NA
"1905","34249313","10.1136/flgastro-2020-101701","Impact of COVID-19 pandemic on key performance indicators in pancreatobiliary endoscopy: prioritise, minimise risk, keep scoping and training.","The COVID-19 pandemic has profoundly affected endoscopy services including pancreatobiliary (PB) endoscopy across the UK. The British Society of Gastroenterology and Joint Advisory Group have issued guidance for managing endoscopy services safely throughout this period. There have been perceived concerns among the PB endoscopists that wearing full personal protective equipment might have an adverse impact on key performance indicators (KPIs) in endoscopic retrograde cholangiopancreatography (ERC","2021","07","13","Frontline Gastroenterol","Frontline gastroenterology","endoscopic retrograde pancreatography; endoscopic ultrasonography; pancreato-biliary disorders","Esmaily","Shiran","Gastroenterology, University Hospital of North Tees, Stockton-on-Tees, UK",NA
"1906","34249313","10.1136/flgastro-2020-101701","Impact of COVID-19 pandemic on key performance indicators in pancreatobiliary endoscopy: prioritise, minimise risk, keep scoping and training.","The COVID-19 pandemic has profoundly affected endoscopy services including pancreatobiliary (PB) endoscopy across the UK. The British Society of Gastroenterology and Joint Advisory Group have issued guidance for managing endoscopy services safely throughout this period. There have been perceived concerns among the PB endoscopists that wearing full personal protective equipment might have an adverse impact on key performance indicators (KPIs) in endoscopic retrograde cholangiopancreatography (ERC","2021","07","13","Frontline Gastroenterol","Frontline gastroenterology","endoscopic retrograde pancreatography; endoscopic ultrasonography; pancreato-biliary disorders","Yau","Chia Chuin","Gastroenterology, University Hospital of North Tees, Stockton-on-Tees, UK",NA
"1907","34249313","10.1136/flgastro-2020-101701","Impact of COVID-19 pandemic on key performance indicators in pancreatobiliary endoscopy: prioritise, minimise risk, keep scoping and training.","The COVID-19 pandemic has profoundly affected endoscopy services including pancreatobiliary (PB) endoscopy across the UK. The British Society of Gastroenterology and Joint Advisory Group have issued guidance for managing endoscopy services safely throughout this period. There have been perceived concerns among the PB endoscopists that wearing full personal protective equipment might have an adverse impact on key performance indicators (KPIs) in endoscopic retrograde cholangiopancreatography (ERC","2021","07","13","Frontline Gastroenterol","Frontline gastroenterology","endoscopic retrograde pancreatography; endoscopic ultrasonography; pancreato-biliary disorders","Dwarakanath","Deepak","Gastroenterology, University Hospital of North Tees, Stockton-on-Tees, UK",NA
"1908","34249313","10.1136/flgastro-2020-101701","Impact of COVID-19 pandemic on key performance indicators in pancreatobiliary endoscopy: prioritise, minimise risk, keep scoping and training.","The COVID-19 pandemic has profoundly affected endoscopy services including pancreatobiliary (PB) endoscopy across the UK. The British Society of Gastroenterology and Joint Advisory Group have issued guidance for managing endoscopy services safely throughout this period. There have been perceived concerns among the PB endoscopists that wearing full personal protective equipment might have an adverse impact on key performance indicators (KPIs) in endoscopic retrograde cholangiopancreatography (ERC","2021","07","13","Frontline Gastroenterol","Frontline gastroenterology","endoscopic retrograde pancreatography; endoscopic ultrasonography; pancreato-biliary disorders","Hancock","John","Gastroenterology, University Hospital of North Tees, Stockton-on-Tees, UK",NA
"1909","34249313","10.1136/flgastro-2020-101701","Impact of COVID-19 pandemic on key performance indicators in pancreatobiliary endoscopy: prioritise, minimise risk, keep scoping and training.","The COVID-19 pandemic has profoundly affected endoscopy services including pancreatobiliary (PB) endoscopy across the UK. The British Society of Gastroenterology and Joint Advisory Group have issued guidance for managing endoscopy services safely throughout this period. There have been perceived concerns among the PB endoscopists that wearing full personal protective equipment might have an adverse impact on key performance indicators (KPIs) in endoscopic retrograde cholangiopancreatography (ERC","2021","07","13","Frontline Gastroenterol","Frontline gastroenterology","endoscopic retrograde pancreatography; endoscopic ultrasonography; pancreato-biliary disorders","Mitra","Vikramjit","Gastroenterology, University Hospital of North Tees, Stockton-on-Tees, UK",NA
"1910","34249312","10.1136/flgastro-2020-101592","Reduced survival after upper gastrointestinal bleed endoscopy in the COVID-19 era is a secondary effect of the response to the global pandemic: a retrospective cohort study.","The COVID-19 pandemic has placed increased strain on healthcare systems worldwide with enormous reorganisation undertaken to support 'COVID-centric' services. Non-COVID-19 admissions reduced secondary to public health measures to halt viral transmission. We aimed to understand the impact of the response to COVID-19 on the outcomes of upper gastrointestinal (UGI) bleeds. A retrospective observational multicentre study comparing outcomes following endoscopy for UGI bleeds from 24 March 2020 to 20 ","2021","07","13","Frontline Gastroenterol","Frontline gastroenterology","endoscopy; gastrointestinal bleeding; oesophageal varices; therapeutic endoscopy","Tavabie","Oliver D","Institute of Liver Studies, King's College Hospital NHS Foundation Trust, London, UK",NA
"1911","34249312","10.1136/flgastro-2020-101592","Reduced survival after upper gastrointestinal bleed endoscopy in the COVID-19 era is a secondary effect of the response to the global pandemic: a retrospective cohort study.","The COVID-19 pandemic has placed increased strain on healthcare systems worldwide with enormous reorganisation undertaken to support 'COVID-centric' services. Non-COVID-19 admissions reduced secondary to public health measures to halt viral transmission. We aimed to understand the impact of the response to COVID-19 on the outcomes of upper gastrointestinal (UGI) bleeds. A retrospective observational multicentre study comparing outcomes following endoscopy for UGI bleeds from 24 March 2020 to 20 ","2021","07","13","Frontline Gastroenterol","Frontline gastroenterology","endoscopy; gastrointestinal bleeding; oesophageal varices; therapeutic endoscopy","Clough","Jennie N","Department of Gastroenterology, Guy's and Saint Thomas' NHS Foundation Trust, London, UK",NA
"1912","34249312","10.1136/flgastro-2020-101592","Reduced survival after upper gastrointestinal bleed endoscopy in the COVID-19 era is a secondary effect of the response to the global pandemic: a retrospective cohort study.","The COVID-19 pandemic has placed increased strain on healthcare systems worldwide with enormous reorganisation undertaken to support 'COVID-centric' services. Non-COVID-19 admissions reduced secondary to public health measures to halt viral transmission. We aimed to understand the impact of the response to COVID-19 on the outcomes of upper gastrointestinal (UGI) bleeds. A retrospective observational multicentre study comparing outcomes following endoscopy for UGI bleeds from 24 March 2020 to 20 ","2021","07","13","Frontline Gastroenterol","Frontline gastroenterology","endoscopy; gastrointestinal bleeding; oesophageal varices; therapeutic endoscopy","Blackwell","Jonathan","Department of Gastroenterology, St George's Hospitals NHS Foundation Trust, London, UK",NA
"1913","34249312","10.1136/flgastro-2020-101592","Reduced survival after upper gastrointestinal bleed endoscopy in the COVID-19 era is a secondary effect of the response to the global pandemic: a retrospective cohort study.","The COVID-19 pandemic has placed increased strain on healthcare systems worldwide with enormous reorganisation undertaken to support 'COVID-centric' services. Non-COVID-19 admissions reduced secondary to public health measures to halt viral transmission. We aimed to understand the impact of the response to COVID-19 on the outcomes of upper gastrointestinal (UGI) bleeds. A retrospective observational multicentre study comparing outcomes following endoscopy for UGI bleeds from 24 March 2020 to 20 ","2021","07","13","Frontline Gastroenterol","Frontline gastroenterology","endoscopy; gastrointestinal bleeding; oesophageal varices; therapeutic endoscopy","Bashyam","Maria","The Liver Unit, St Mary's Hospital, Imperial College Healthcare NHS Trust, London, London, UK",NA
"1914","34249312","10.1136/flgastro-2020-101592","Reduced survival after upper gastrointestinal bleed endoscopy in the COVID-19 era is a secondary effect of the response to the global pandemic: a retrospective cohort study.","The COVID-19 pandemic has placed increased strain on healthcare systems worldwide with enormous reorganisation undertaken to support 'COVID-centric' services. Non-COVID-19 admissions reduced secondary to public health measures to halt viral transmission. We aimed to understand the impact of the response to COVID-19 on the outcomes of upper gastrointestinal (UGI) bleeds. A retrospective observational multicentre study comparing outcomes following endoscopy for UGI bleeds from 24 March 2020 to 20 ","2021","07","13","Frontline Gastroenterol","Frontline gastroenterology","endoscopy; gastrointestinal bleeding; oesophageal varices; therapeutic endoscopy","Martin","Harry","Pancreaticobiliary Medicine Unit, UCLH, London, London, UK",NA
"1915","34249312","10.1136/flgastro-2020-101592","Reduced survival after upper gastrointestinal bleed endoscopy in the COVID-19 era is a secondary effect of the response to the global pandemic: a retrospective cohort study.","The COVID-19 pandemic has placed increased strain on healthcare systems worldwide with enormous reorganisation undertaken to support 'COVID-centric' services. Non-COVID-19 admissions reduced secondary to public health measures to halt viral transmission. We aimed to understand the impact of the response to COVID-19 on the outcomes of upper gastrointestinal (UGI) bleeds. A retrospective observational multicentre study comparing outcomes following endoscopy for UGI bleeds from 24 March 2020 to 20 ","2021","07","13","Frontline Gastroenterol","Frontline gastroenterology","endoscopy; gastrointestinal bleeding; oesophageal varices; therapeutic endoscopy","Soubieres","Anet","Department of Gastroenterology, Imperial College Healthcare NHS Trust, London, London, UK",NA
"1916","34249312","10.1136/flgastro-2020-101592","Reduced survival after upper gastrointestinal bleed endoscopy in the COVID-19 era is a secondary effect of the response to the global pandemic: a retrospective cohort study.","The COVID-19 pandemic has placed increased strain on healthcare systems worldwide with enormous reorganisation undertaken to support 'COVID-centric' services. Non-COVID-19 admissions reduced secondary to public health measures to halt viral transmission. We aimed to understand the impact of the response to COVID-19 on the outcomes of upper gastrointestinal (UGI) bleeds. A retrospective observational multicentre study comparing outcomes following endoscopy for UGI bleeds from 24 March 2020 to 20 ","2021","07","13","Frontline Gastroenterol","Frontline gastroenterology","endoscopy; gastrointestinal bleeding; oesophageal varices; therapeutic endoscopy","Direkze","Natalie","Department of Gastroenterology, Imperial College Healthcare NHS Trust, London, London, UK",NA
"1917","34249312","10.1136/flgastro-2020-101592","Reduced survival after upper gastrointestinal bleed endoscopy in the COVID-19 era is a secondary effect of the response to the global pandemic: a retrospective cohort study.","The COVID-19 pandemic has placed increased strain on healthcare systems worldwide with enormous reorganisation undertaken to support 'COVID-centric' services. Non-COVID-19 admissions reduced secondary to public health measures to halt viral transmission. We aimed to understand the impact of the response to COVID-19 on the outcomes of upper gastrointestinal (UGI) bleeds. A retrospective observational multicentre study comparing outcomes following endoscopy for UGI bleeds from 24 March 2020 to 20 ","2021","07","13","Frontline Gastroenterol","Frontline gastroenterology","endoscopy; gastrointestinal bleeding; oesophageal varices; therapeutic endoscopy","Graham","David","Department of Gastroenterology, UCLH, London, London, UK",NA
"1918","34249312","10.1136/flgastro-2020-101592","Reduced survival after upper gastrointestinal bleed endoscopy in the COVID-19 era is a secondary effect of the response to the global pandemic: a retrospective cohort study.","The COVID-19 pandemic has placed increased strain on healthcare systems worldwide with enormous reorganisation undertaken to support 'COVID-centric' services. Non-COVID-19 admissions reduced secondary to public health measures to halt viral transmission. We aimed to understand the impact of the response to COVID-19 on the outcomes of upper gastrointestinal (UGI) bleeds. A retrospective observational multicentre study comparing outcomes following endoscopy for UGI bleeds from 24 March 2020 to 20 ","2021","07","13","Frontline Gastroenterol","Frontline gastroenterology","endoscopy; gastrointestinal bleeding; oesophageal varices; therapeutic endoscopy","Groves","Christopher","Department of Gastroenterology, St George's Hospitals NHS Foundation Trust, London, UK",NA
"1919","34249312","10.1136/flgastro-2020-101592","Reduced survival after upper gastrointestinal bleed endoscopy in the COVID-19 era is a secondary effect of the response to the global pandemic: a retrospective cohort study.","The COVID-19 pandemic has placed increased strain on healthcare systems worldwide with enormous reorganisation undertaken to support 'COVID-centric' services. Non-COVID-19 admissions reduced secondary to public health measures to halt viral transmission. We aimed to understand the impact of the response to COVID-19 on the outcomes of upper gastrointestinal (UGI) bleeds. A retrospective observational multicentre study comparing outcomes following endoscopy for UGI bleeds from 24 March 2020 to 20 ","2021","07","13","Frontline Gastroenterol","Frontline gastroenterology","endoscopy; gastrointestinal bleeding; oesophageal varices; therapeutic endoscopy","Preston","Sean L","Department of Gastroenterology, Royal London Hospital, London, London, UK",NA
"1920","34249312","10.1136/flgastro-2020-101592","Reduced survival after upper gastrointestinal bleed endoscopy in the COVID-19 era is a secondary effect of the response to the global pandemic: a retrospective cohort study.","The COVID-19 pandemic has placed increased strain on healthcare systems worldwide with enormous reorganisation undertaken to support 'COVID-centric' services. Non-COVID-19 admissions reduced secondary to public health measures to halt viral transmission. We aimed to understand the impact of the response to COVID-19 on the outcomes of upper gastrointestinal (UGI) bleeds. A retrospective observational multicentre study comparing outcomes following endoscopy for UGI bleeds from 24 March 2020 to 20 ","2021","07","13","Frontline Gastroenterol","Frontline gastroenterology","endoscopy; gastrointestinal bleeding; oesophageal varices; therapeutic endoscopy","DeMartino","Sabina","Department of Gastroenterology, Guy's and Saint Thomas' NHS Foundation Trust, London, UK",NA
"1921","34249312","10.1136/flgastro-2020-101592","Reduced survival after upper gastrointestinal bleed endoscopy in the COVID-19 era is a secondary effect of the response to the global pandemic: a retrospective cohort study.","The COVID-19 pandemic has placed increased strain on healthcare systems worldwide with enormous reorganisation undertaken to support 'COVID-centric' services. Non-COVID-19 admissions reduced secondary to public health measures to halt viral transmission. We aimed to understand the impact of the response to COVID-19 on the outcomes of upper gastrointestinal (UGI) bleeds. A retrospective observational multicentre study comparing outcomes following endoscopy for UGI bleeds from 24 March 2020 to 20 ","2021","07","13","Frontline Gastroenterol","Frontline gastroenterology","endoscopy; gastrointestinal bleeding; oesophageal varices; therapeutic endoscopy","Gill","Upkar S","Department of Gastroenterology, Royal London Hospital, London, London, UK",NA
"1922","34249312","10.1136/flgastro-2020-101592","Reduced survival after upper gastrointestinal bleed endoscopy in the COVID-19 era is a secondary effect of the response to the global pandemic: a retrospective cohort study.","The COVID-19 pandemic has placed increased strain on healthcare systems worldwide with enormous reorganisation undertaken to support 'COVID-centric' services. Non-COVID-19 admissions reduced secondary to public health measures to halt viral transmission. We aimed to understand the impact of the response to COVID-19 on the outcomes of upper gastrointestinal (UGI) bleeds. A retrospective observational multicentre study comparing outcomes following endoscopy for UGI bleeds from 24 March 2020 to 20 ","2021","07","13","Frontline Gastroenterol","Frontline gastroenterology","endoscopy; gastrointestinal bleeding; oesophageal varices; therapeutic endoscopy","Hayee","Bu'Hussain","Department of Gastroenterology, King's College Hospital, London, UK",NA
"1923","34249312","10.1136/flgastro-2020-101592","Reduced survival after upper gastrointestinal bleed endoscopy in the COVID-19 era is a secondary effect of the response to the global pandemic: a retrospective cohort study.","The COVID-19 pandemic has placed increased strain on healthcare systems worldwide with enormous reorganisation undertaken to support 'COVID-centric' services. Non-COVID-19 admissions reduced secondary to public health measures to halt viral transmission. We aimed to understand the impact of the response to COVID-19 on the outcomes of upper gastrointestinal (UGI) bleeds. A retrospective observational multicentre study comparing outcomes following endoscopy for UGI bleeds from 24 March 2020 to 20 ","2021","07","13","Frontline Gastroenterol","Frontline gastroenterology","endoscopy; gastrointestinal bleeding; oesophageal varices; therapeutic endoscopy","Joshi","Deepak","Institute of Liver Studies, King's College Hospital NHS Foundation Trust, London, UK",NA
"1924","34249311","10.1136/flgastro-2020-101582","JAG/BSG national survey of UK endoscopy services: impact of the COVID-19 pandemic and early restoration of endoscopy services.","The COVID-19 pandemic has profoundly affected UK endoscopy workload. The Joint Advisory Group on GI endoscopy and British Society of Gastroenterology issued guidelines on endoscopy service delivery changes and restoration. We surveyed UK endoscopy clinical leads to gain insights into service restoration. A Google Forms-designed survey, assessing endoscopy provision, Covid minimisation and referral pathways was circulated to all UK endoscopy leads. The survey was open between 19 and 24 May 2020. ","2021","07","13","Frontline Gastroenterol","Frontline gastroenterology","colonoscopy; endoscopy; health service research","Catlow","Jamie","Gastroenterology, North Tees and Hartlepool NHS Foundation Trust, Stockton on Tees, UK",NA
"1925","34249311","10.1136/flgastro-2020-101582","JAG/BSG national survey of UK endoscopy services: impact of the COVID-19 pandemic and early restoration of endoscopy services.","The COVID-19 pandemic has profoundly affected UK endoscopy workload. The Joint Advisory Group on GI endoscopy and British Society of Gastroenterology issued guidelines on endoscopy service delivery changes and restoration. We surveyed UK endoscopy clinical leads to gain insights into service restoration. A Google Forms-designed survey, assessing endoscopy provision, Covid minimisation and referral pathways was circulated to all UK endoscopy leads. The survey was open between 19 and 24 May 2020. ","2021","07","13","Frontline Gastroenterol","Frontline gastroenterology","colonoscopy; endoscopy; health service research","Beaton","David","Gastroenterology, North Tees and Hartlepool NHS Foundation Trust, Stockton on Tees, UK",NA
"1926","34249311","10.1136/flgastro-2020-101582","JAG/BSG national survey of UK endoscopy services: impact of the COVID-19 pandemic and early restoration of endoscopy services.","The COVID-19 pandemic has profoundly affected UK endoscopy workload. The Joint Advisory Group on GI endoscopy and British Society of Gastroenterology issued guidelines on endoscopy service delivery changes and restoration. We surveyed UK endoscopy clinical leads to gain insights into service restoration. A Google Forms-designed survey, assessing endoscopy provision, Covid minimisation and referral pathways was circulated to all UK endoscopy leads. The survey was open between 19 and 24 May 2020. ","2021","07","13","Frontline Gastroenterol","Frontline gastroenterology","colonoscopy; endoscopy; health service research","Beintaris","Iosif","Gastroenterology, North Tees and Hartlepool NHS Foundation Trust, Stockton on Tees, UK",NA
"1927","34249311","10.1136/flgastro-2020-101582","JAG/BSG national survey of UK endoscopy services: impact of the COVID-19 pandemic and early restoration of endoscopy services.","The COVID-19 pandemic has profoundly affected UK endoscopy workload. The Joint Advisory Group on GI endoscopy and British Society of Gastroenterology issued guidelines on endoscopy service delivery changes and restoration. We surveyed UK endoscopy clinical leads to gain insights into service restoration. A Google Forms-designed survey, assessing endoscopy provision, Covid minimisation and referral pathways was circulated to all UK endoscopy leads. The survey was open between 19 and 24 May 2020. ","2021","07","13","Frontline Gastroenterol","Frontline gastroenterology","colonoscopy; endoscopy; health service research","Shaw","Tim","Joint Advisory Group on GI Endoscopy, Royal College of Physicians, London, London, UK",NA
"1928","34249311","10.1136/flgastro-2020-101582","JAG/BSG national survey of UK endoscopy services: impact of the COVID-19 pandemic and early restoration of endoscopy services.","The COVID-19 pandemic has profoundly affected UK endoscopy workload. The Joint Advisory Group on GI endoscopy and British Society of Gastroenterology issued guidelines on endoscopy service delivery changes and restoration. We surveyed UK endoscopy clinical leads to gain insights into service restoration. A Google Forms-designed survey, assessing endoscopy provision, Covid minimisation and referral pathways was circulated to all UK endoscopy leads. The survey was open between 19 and 24 May 2020. ","2021","07","13","Frontline Gastroenterol","Frontline gastroenterology","colonoscopy; endoscopy; health service research","Broughton","Raphael","Joint Advisory Group on GI Endoscopy, Royal College of Physicians, London, London, UK",NA
"1929","34249311","10.1136/flgastro-2020-101582","JAG/BSG national survey of UK endoscopy services: impact of the COVID-19 pandemic and early restoration of endoscopy services.","The COVID-19 pandemic has profoundly affected UK endoscopy workload. The Joint Advisory Group on GI endoscopy and British Society of Gastroenterology issued guidelines on endoscopy service delivery changes and restoration. We surveyed UK endoscopy clinical leads to gain insights into service restoration. A Google Forms-designed survey, assessing endoscopy provision, Covid minimisation and referral pathways was circulated to all UK endoscopy leads. The survey was open between 19 and 24 May 2020. ","2021","07","13","Frontline Gastroenterol","Frontline gastroenterology","colonoscopy; endoscopy; health service research","Healey","Chris","Gastroenterology and Hepatology Services, Airedale General Hospital, Keighley, West Yorkshire, UK",NA
"1930","34249311","10.1136/flgastro-2020-101582","JAG/BSG national survey of UK endoscopy services: impact of the COVID-19 pandemic and early restoration of endoscopy services.","The COVID-19 pandemic has profoundly affected UK endoscopy workload. The Joint Advisory Group on GI endoscopy and British Society of Gastroenterology issued guidelines on endoscopy service delivery changes and restoration. We surveyed UK endoscopy clinical leads to gain insights into service restoration. A Google Forms-designed survey, assessing endoscopy provision, Covid minimisation and referral pathways was circulated to all UK endoscopy leads. The survey was open between 19 and 24 May 2020. ","2021","07","13","Frontline Gastroenterol","Frontline gastroenterology","colonoscopy; endoscopy; health service research","Penman","Ian","Centre for Liver &amp",NA
"1931","34249311","10.1136/flgastro-2020-101582","JAG/BSG national survey of UK endoscopy services: impact of the COVID-19 pandemic and early restoration of endoscopy services.","The COVID-19 pandemic has profoundly affected UK endoscopy workload. The Joint Advisory Group on GI endoscopy and British Society of Gastroenterology issued guidelines on endoscopy service delivery changes and restoration. We surveyed UK endoscopy clinical leads to gain insights into service restoration. A Google Forms-designed survey, assessing endoscopy provision, Covid minimisation and referral pathways was circulated to all UK endoscopy leads. The survey was open between 19 and 24 May 2020. ","2021","07","13","Frontline Gastroenterol","Frontline gastroenterology","colonoscopy; endoscopy; health service research","Coleman","Mark","Colorectal Surgery, University Hospitals Plymouth NHS Trust, Plymouth, Plymouth, UK",NA
"1932","34249311","10.1136/flgastro-2020-101582","JAG/BSG national survey of UK endoscopy services: impact of the COVID-19 pandemic and early restoration of endoscopy services.","The COVID-19 pandemic has profoundly affected UK endoscopy workload. The Joint Advisory Group on GI endoscopy and British Society of Gastroenterology issued guidelines on endoscopy service delivery changes and restoration. We surveyed UK endoscopy clinical leads to gain insights into service restoration. A Google Forms-designed survey, assessing endoscopy provision, Covid minimisation and referral pathways was circulated to all UK endoscopy leads. The survey was open between 19 and 24 May 2020. ","2021","07","13","Frontline Gastroenterol","Frontline gastroenterology","colonoscopy; endoscopy; health service research","Rutter","Matt","Gastroenterology, North Tees and Hartlepool NHS Foundation Trust, Stockton on Tees, UK",NA
"1933","34249309","10.1136/flgastro-2021-101794","COVID-19: impetus to the adoption of capsule endoscopy as a primary diagnostic tool?",NA,"2021","07","13","Frontline Gastroenterol","Frontline gastroenterology","COVID-19; cancer; colonic adenomas; endoscopic procedures; endoscopy","McAlindon","Mark","Gastroenterology, Sheffield Teaching Hospitals NHS Trust, Sheffield, UK",NA
"1934","34249287","10.4103/ijpvm.IJPVM_469_20","Aspects of Epidemiology, Pathology, Virology, Immunology, Transmission, Prevention, Prognosis, Diagnosis, and Treatment of COVID-19 Pandemic: A Narrative Review.","Undoubtedly, COVID-19 pandemic is one of the largest pandemics and one of the biggest international challenges for health-care system of various countries in the world. This is a narrative review study based on the studies published related with different aspects of COVID-19. The highest numbers of active cases are in the USA, Brazil, India, Russia, South Africa, as well as Colombia and the disease surveillance system must operate more quickly, timely, effectively, and sensitively in these count","2021","07","13","Int J Prev Med","International journal of preventive medicine","COVID-19; epidemiology; infectious; narrative review; pandemics","Rahimi Pordanjani","Sajjad","Social Determinants of Health Research Center, Semnan University of Medical Sciences, Semnan, Iran",NA
"1935","34249287","10.4103/ijpvm.IJPVM_469_20","Aspects of Epidemiology, Pathology, Virology, Immunology, Transmission, Prevention, Prognosis, Diagnosis, and Treatment of COVID-19 Pandemic: A Narrative Review.","Undoubtedly, COVID-19 pandemic is one of the largest pandemics and one of the biggest international challenges for health-care system of various countries in the world. This is a narrative review study based on the studies published related with different aspects of COVID-19. The highest numbers of active cases are in the USA, Brazil, India, Russia, South Africa, as well as Colombia and the disease surveillance system must operate more quickly, timely, effectively, and sensitively in these count","2021","07","13","Int J Prev Med","International journal of preventive medicine","COVID-19; epidemiology; infectious; narrative review; pandemics","Hasanpour","Ali","Social Determinants of Health Research Center, School of Allied Medical Sciences, Shahrekord University of Medical Sciences, Shahrekord, Iran and Nickan Research Institute, Iran",NA
"1936","34249287","10.4103/ijpvm.IJPVM_469_20","Aspects of Epidemiology, Pathology, Virology, Immunology, Transmission, Prevention, Prognosis, Diagnosis, and Treatment of COVID-19 Pandemic: A Narrative Review.","Undoubtedly, COVID-19 pandemic is one of the largest pandemics and one of the biggest international challenges for health-care system of various countries in the world. This is a narrative review study based on the studies published related with different aspects of COVID-19. The highest numbers of active cases are in the USA, Brazil, India, Russia, South Africa, as well as Colombia and the disease surveillance system must operate more quickly, timely, effectively, and sensitively in these count","2021","07","13","Int J Prev Med","International journal of preventive medicine","COVID-19; epidemiology; infectious; narrative review; pandemics","Askarpour","Hasan","Department of Disease Management, Deputy of Health, Yasuj University of Medical Sciences, Yasuj, Iran",NA
"1937","34249287","10.4103/ijpvm.IJPVM_469_20","Aspects of Epidemiology, Pathology, Virology, Immunology, Transmission, Prevention, Prognosis, Diagnosis, and Treatment of COVID-19 Pandemic: A Narrative Review.","Undoubtedly, COVID-19 pandemic is one of the largest pandemics and one of the biggest international challenges for health-care system of various countries in the world. This is a narrative review study based on the studies published related with different aspects of COVID-19. The highest numbers of active cases are in the USA, Brazil, India, Russia, South Africa, as well as Colombia and the disease surveillance system must operate more quickly, timely, effectively, and sensitively in these count","2021","07","13","Int J Prev Med","International journal of preventive medicine","COVID-19; epidemiology; infectious; narrative review; pandemics","Bastam","Dariush","MSc of Epidemiology, Medical school, Yasuj University of Medical Sciences, Yasuj, Iran",NA
"1938","34249287","10.4103/ijpvm.IJPVM_469_20","Aspects of Epidemiology, Pathology, Virology, Immunology, Transmission, Prevention, Prognosis, Diagnosis, and Treatment of COVID-19 Pandemic: A Narrative Review.","Undoubtedly, COVID-19 pandemic is one of the largest pandemics and one of the biggest international challenges for health-care system of various countries in the world. This is a narrative review study based on the studies published related with different aspects of COVID-19. The highest numbers of active cases are in the USA, Brazil, India, Russia, South Africa, as well as Colombia and the disease surveillance system must operate more quickly, timely, effectively, and sensitively in these count","2021","07","13","Int J Prev Med","International journal of preventive medicine","COVID-19; epidemiology; infectious; narrative review; pandemics","Rafiee","Mohammad","Department of Medical Laboratory Sciences, School of Para medicine, Hamadan University of Medical Sciences, Hamadan, Iran",NA
"1939","34249287","10.4103/ijpvm.IJPVM_469_20","Aspects of Epidemiology, Pathology, Virology, Immunology, Transmission, Prevention, Prognosis, Diagnosis, and Treatment of COVID-19 Pandemic: A Narrative Review.","Undoubtedly, COVID-19 pandemic is one of the largest pandemics and one of the biggest international challenges for health-care system of various countries in the world. This is a narrative review study based on the studies published related with different aspects of COVID-19. The highest numbers of active cases are in the USA, Brazil, India, Russia, South Africa, as well as Colombia and the disease surveillance system must operate more quickly, timely, effectively, and sensitively in these count","2021","07","13","Int J Prev Med","International journal of preventive medicine","COVID-19; epidemiology; infectious; narrative review; pandemics","Khazaei","Zaher","Department of Public Health, Dezful University of Medical Sciences, Dezful, Iran",NA
"1940","34249287","10.4103/ijpvm.IJPVM_469_20","Aspects of Epidemiology, Pathology, Virology, Immunology, Transmission, Prevention, Prognosis, Diagnosis, and Treatment of COVID-19 Pandemic: A Narrative Review.","Undoubtedly, COVID-19 pandemic is one of the largest pandemics and one of the biggest international challenges for health-care system of various countries in the world. This is a narrative review study based on the studies published related with different aspects of COVID-19. The highest numbers of active cases are in the USA, Brazil, India, Russia, South Africa, as well as Colombia and the disease surveillance system must operate more quickly, timely, effectively, and sensitively in these count","2021","07","13","Int J Prev Med","International journal of preventive medicine","COVID-19; epidemiology; infectious; narrative review; pandemics","Mazaheri","Elaheh","Department of Medical Library and Information Sciences, Health Information Technology Research Center, Student Research Committee, School of Management and Medical Information Sciences, Isfahan University of Medical Sciences, Isfahan, Iran",NA
"1941","34249287","10.4103/ijpvm.IJPVM_469_20","Aspects of Epidemiology, Pathology, Virology, Immunology, Transmission, Prevention, Prognosis, Diagnosis, and Treatment of COVID-19 Pandemic: A Narrative Review.","Undoubtedly, COVID-19 pandemic is one of the largest pandemics and one of the biggest international challenges for health-care system of various countries in the world. This is a narrative review study based on the studies published related with different aspects of COVID-19. The highest numbers of active cases are in the USA, Brazil, India, Russia, South Africa, as well as Colombia and the disease surveillance system must operate more quickly, timely, effectively, and sensitively in these count","2021","07","13","Int J Prev Med","International journal of preventive medicine","COVID-19; epidemiology; infectious; narrative review; pandemics","Vaziri","Mohammad Hossein","Workplace Health Promotion Research Center (WHPRC), School of Public Health and Safety, Shahid Beheshti University of Medical Sciences, Tehran, Iran",NA
"1942","34249287","10.4103/ijpvm.IJPVM_469_20","Aspects of Epidemiology, Pathology, Virology, Immunology, Transmission, Prevention, Prognosis, Diagnosis, and Treatment of COVID-19 Pandemic: A Narrative Review.","Undoubtedly, COVID-19 pandemic is one of the largest pandemics and one of the biggest international challenges for health-care system of various countries in the world. This is a narrative review study based on the studies published related with different aspects of COVID-19. The highest numbers of active cases are in the USA, Brazil, India, Russia, South Africa, as well as Colombia and the disease surveillance system must operate more quickly, timely, effectively, and sensitively in these count","2021","07","13","Int J Prev Med","International journal of preventive medicine","COVID-19; epidemiology; infectious; narrative review; pandemics","Sabour","Siamak","Department of Clinical Epidemiology, School of Public Health and Safety, Shahid Beheshti University of Medical Sciences, Tehran, Iran",NA
"1943","34249284","10.4103/ijpvm.IJPVM_462_20","Pulmonary Covid Fibrosis a New Pharmaceutic Approach.","Patient's post-COVID may develop chronic irreversible respiratory failure with ""widespread signs of pulmonary fibrosis."" Our study analyzed the causes of this fibrosis to propose a therapeutic protocol. Identification of the biochemical causes of fibrosis in COVID-19 analysing the literature and chest CT. The CT imaging shows pulmonary fibrosis. The viral infection produces ""interleukin-6"", which binds to its receptor, in MUC1 of lung epithelial cells. The biochemical response of the cells promo","2021","07","13","Int J Prev Med","International journal of preventive medicine","COVID 19; fibrosis; lung","Menicagli","Roberto","Biochemistry, Senior Scientist, University Milan Consultant, Italy",NA
"1944","34249284","10.4103/ijpvm.IJPVM_462_20","Pulmonary Covid Fibrosis a New Pharmaceutic Approach.","Patient's post-COVID may develop chronic irreversible respiratory failure with ""widespread signs of pulmonary fibrosis."" Our study analyzed the causes of this fibrosis to propose a therapeutic protocol. Identification of the biochemical causes of fibrosis in COVID-19 analysing the literature and chest CT. The CT imaging shows pulmonary fibrosis. The viral infection produces ""interleukin-6"", which binds to its receptor, in MUC1 of lung epithelial cells. The biochemical response of the cells promo","2021","07","13","Int J Prev Med","International journal of preventive medicine","COVID 19; fibrosis; lung","Limodio","Mario","Researcher UOC, Infectious and Tropical Diseases, Spaziani Hospital Frosinone, Italy",NA
"1945","34249284","10.4103/ijpvm.IJPVM_462_20","Pulmonary Covid Fibrosis a New Pharmaceutic Approach.","Patient's post-COVID may develop chronic irreversible respiratory failure with ""widespread signs of pulmonary fibrosis."" Our study analyzed the causes of this fibrosis to propose a therapeutic protocol. Identification of the biochemical causes of fibrosis in COVID-19 analysing the literature and chest CT. The CT imaging shows pulmonary fibrosis. The viral infection produces ""interleukin-6"", which binds to its receptor, in MUC1 of lung epithelial cells. The biochemical response of the cells promo","2021","07","13","Int J Prev Med","International journal of preventive medicine","COVID 19; fibrosis; lung","Limodio","Marta","Pharmacological Researcher, ASST Frosinone, Italy",NA
"1946","34249284","10.4103/ijpvm.IJPVM_462_20","Pulmonary Covid Fibrosis a New Pharmaceutic Approach.","Patient's post-COVID may develop chronic irreversible respiratory failure with ""widespread signs of pulmonary fibrosis."" Our study analyzed the causes of this fibrosis to propose a therapeutic protocol. Identification of the biochemical causes of fibrosis in COVID-19 analysing the literature and chest CT. The CT imaging shows pulmonary fibrosis. The viral infection produces ""interleukin-6"", which binds to its receptor, in MUC1 of lung epithelial cells. The biochemical response of the cells promo","2021","07","13","Int J Prev Med","International journal of preventive medicine","COVID 19; fibrosis; lung","Casotti","Maria Teresa","Radiodiagnostic Department, Pisa University, Italy",NA
"1947","34249284","10.4103/ijpvm.IJPVM_462_20","Pulmonary Covid Fibrosis a New Pharmaceutic Approach.","Patient's post-COVID may develop chronic irreversible respiratory failure with ""widespread signs of pulmonary fibrosis."" Our study analyzed the causes of this fibrosis to propose a therapeutic protocol. Identification of the biochemical causes of fibrosis in COVID-19 analysing the literature and chest CT. The CT imaging shows pulmonary fibrosis. The viral infection produces ""interleukin-6"", which binds to its receptor, in MUC1 of lung epithelial cells. The biochemical response of the cells promo","2021","07","13","Int J Prev Med","International journal of preventive medicine","COVID 19; fibrosis; lung","Menicagli","Laura","Policliclinico San Donato Radiodiagnostic Department, Milan University, Italy",NA
"1948","34249275","10.4103/ijpvm.ijpvm_716_20","Prevention of SARS-CoV-2 Infection: A Liposomal Functional Food Approach.",NA,"2021","07","13","Int J Prev Med","International journal of preventive medicine",NA,"Hosseini","Fatemeh","Department of Vaccines and Immunotherapeutics, Bioluence Biopharmaceutical Company, Tehran, Iran",NA
"1949","34249275","10.4103/ijpvm.ijpvm_716_20","Prevention of SARS-CoV-2 Infection: A Liposomal Functional Food Approach.",NA,"2021","07","13","Int J Prev Med","International journal of preventive medicine",NA,"Bahramimeimandi","Bahar","Department of Medical Biotechnology, School of Allied Medicine, Iran University of Medical Sciences, Tehran, Iran",NA
"1950","34249275","10.4103/ijpvm.ijpvm_716_20","Prevention of SARS-CoV-2 Infection: A Liposomal Functional Food Approach.",NA,"2021","07","13","Int J Prev Med","International journal of preventive medicine",NA,"Raoufi","Ehsan","Department of Vaccines and Immunotherapeutics, Bioluence Biopharmaceutical Company, Tehran, Iran",NA
"1951","34249275","10.4103/ijpvm.ijpvm_716_20","Prevention of SARS-CoV-2 Infection: A Liposomal Functional Food Approach.",NA,"2021","07","13","Int J Prev Med","International journal of preventive medicine",NA,"Mozafari","M R","Australasian Nanoscience and Nanotechnology Initiative (ANNI), Monash University LPO, Clayton, Victoria, Australia",NA
"1952","34249243","10.1080/20008198.2021.1929029","COVID-19 related difficulties and perceived coping among university and college students: the moderating role of media-related exposure and stress.","Background: University and college students are not usually identified as a population at risk during the COVID-19 pandemic. Yet, there is growing evidence of their specific distress associated with facing multiple abrupt changes and the need for rapid adaptation to a variety of academic, social, and financial challenges. The extent of their exposure to COVID-19 media and the associated media-related stress may further impair students' perceived coping. Objective: This study assessed COVID-19-re","2021","07","13","Eur J Psychotraumatol","European journal of psychotraumatology","COVID-19; media exposure; perceived coping; stress; university students","Pat-Horenczyk","Ruth","Paul Baerwald School of Social Work and Social Welfare, Hebrew University of Jerusalem, Jerusalem, Israel",NA
"1953","34249243","10.1080/20008198.2021.1929029","COVID-19 related difficulties and perceived coping among university and college students: the moderating role of media-related exposure and stress.","Background: University and college students are not usually identified as a population at risk during the COVID-19 pandemic. Yet, there is growing evidence of their specific distress associated with facing multiple abrupt changes and the need for rapid adaptation to a variety of academic, social, and financial challenges. The extent of their exposure to COVID-19 media and the associated media-related stress may further impair students' perceived coping. Objective: This study assessed COVID-19-re","2021","07","13","Eur J Psychotraumatol","European journal of psychotraumatology","COVID-19; media exposure; perceived coping; stress; university students","Bergman","Yoav S","Faculty of Social Work, Ashkelon Academic College, Ashqelon, Israel",NA
"1954","34249243","10.1080/20008198.2021.1929029","COVID-19 related difficulties and perceived coping among university and college students: the moderating role of media-related exposure and stress.","Background: University and college students are not usually identified as a population at risk during the COVID-19 pandemic. Yet, there is growing evidence of their specific distress associated with facing multiple abrupt changes and the need for rapid adaptation to a variety of academic, social, and financial challenges. The extent of their exposure to COVID-19 media and the associated media-related stress may further impair students' perceived coping. Objective: This study assessed COVID-19-re","2021","07","13","Eur J Psychotraumatol","European journal of psychotraumatology","COVID-19; media exposure; perceived coping; stress; university students","Schiff","Miriam","Paul Baerwald School of Social Work and Social Welfare, Hebrew University of Jerusalem, Jerusalem, Israel",NA
"1955","34249243","10.1080/20008198.2021.1929029","COVID-19 related difficulties and perceived coping among university and college students: the moderating role of media-related exposure and stress.","Background: University and college students are not usually identified as a population at risk during the COVID-19 pandemic. Yet, there is growing evidence of their specific distress associated with facing multiple abrupt changes and the need for rapid adaptation to a variety of academic, social, and financial challenges. The extent of their exposure to COVID-19 media and the associated media-related stress may further impair students' perceived coping. Objective: This study assessed COVID-19-re","2021","07","13","Eur J Psychotraumatol","European journal of psychotraumatology","COVID-19; media exposure; perceived coping; stress; university students","Goldberg","Alon","Department of Education, Tel Hai Academic College, Kiryat Shmona, Israel",NA
"1956","34249243","10.1080/20008198.2021.1929029","COVID-19 related difficulties and perceived coping among university and college students: the moderating role of media-related exposure and stress.","Background: University and college students are not usually identified as a population at risk during the COVID-19 pandemic. Yet, there is growing evidence of their specific distress associated with facing multiple abrupt changes and the need for rapid adaptation to a variety of academic, social, and financial challenges. The extent of their exposure to COVID-19 media and the associated media-related stress may further impair students' perceived coping. Objective: This study assessed COVID-19-re","2021","07","13","Eur J Psychotraumatol","European journal of psychotraumatology","COVID-19; media exposure; perceived coping; stress; university students","Cohen","Ayala","School of Social Work, Tel Hai College, Kiryat Shmona, Israel",NA
"1957","34249243","10.1080/20008198.2021.1929029","COVID-19 related difficulties and perceived coping among university and college students: the moderating role of media-related exposure and stress.","Background: University and college students are not usually identified as a population at risk during the COVID-19 pandemic. Yet, there is growing evidence of their specific distress associated with facing multiple abrupt changes and the need for rapid adaptation to a variety of academic, social, and financial challenges. The extent of their exposure to COVID-19 media and the associated media-related stress may further impair students' perceived coping. Objective: This study assessed COVID-19-re","2021","07","13","Eur J Psychotraumatol","European journal of psychotraumatology","COVID-19; media exposure; perceived coping; stress; university students","Leshem","Becky","School of Education, Achva Academic College, Ashqelon, Israel",NA
"1958","34249243","10.1080/20008198.2021.1929029","COVID-19 related difficulties and perceived coping among university and college students: the moderating role of media-related exposure and stress.","Background: University and college students are not usually identified as a population at risk during the COVID-19 pandemic. Yet, there is growing evidence of their specific distress associated with facing multiple abrupt changes and the need for rapid adaptation to a variety of academic, social, and financial challenges. The extent of their exposure to COVID-19 media and the associated media-related stress may further impair students' perceived coping. Objective: This study assessed COVID-19-re","2021","07","13","Eur J Psychotraumatol","European journal of psychotraumatology","COVID-19; media exposure; perceived coping; stress; university students","Jubran","Hisham","Faculty of Education, Beit Berl Academic College, Kfar Saba, Israel",NA
"1959","34249243","10.1080/20008198.2021.1929029","COVID-19 related difficulties and perceived coping among university and college students: the moderating role of media-related exposure and stress.","Background: University and college students are not usually identified as a population at risk during the COVID-19 pandemic. Yet, there is growing evidence of their specific distress associated with facing multiple abrupt changes and the need for rapid adaptation to a variety of academic, social, and financial challenges. The extent of their exposure to COVID-19 media and the associated media-related stress may further impair students' perceived coping. Objective: This study assessed COVID-19-re","2021","07","13","Eur J Psychotraumatol","European journal of psychotraumatology","COVID-19; media exposure; perceived coping; stress; university students","Worku-Mengisto","Wovit","David Yellin Academic College of Education, Jerusalem, Israel",NA
"1960","34249243","10.1080/20008198.2021.1929029","COVID-19 related difficulties and perceived coping among university and college students: the moderating role of media-related exposure and stress.","Background: University and college students are not usually identified as a population at risk during the COVID-19 pandemic. Yet, there is growing evidence of their specific distress associated with facing multiple abrupt changes and the need for rapid adaptation to a variety of academic, social, and financial challenges. The extent of their exposure to COVID-19 media and the associated media-related stress may further impair students' perceived coping. Objective: This study assessed COVID-19-re","2021","07","13","Eur J Psychotraumatol","European journal of psychotraumatology","COVID-19; media exposure; perceived coping; stress; university students","Berkowitz","Ruth","School of Social Work, University of Haifa, Haifa, Israel",NA
"1961","34249243","10.1080/20008198.2021.1929029","COVID-19 related difficulties and perceived coping among university and college students: the moderating role of media-related exposure and stress.","Background: University and college students are not usually identified as a population at risk during the COVID-19 pandemic. Yet, there is growing evidence of their specific distress associated with facing multiple abrupt changes and the need for rapid adaptation to a variety of academic, social, and financial challenges. The extent of their exposure to COVID-19 media and the associated media-related stress may further impair students' perceived coping. Objective: This study assessed COVID-19-re","2021","07","13","Eur J Psychotraumatol","European journal of psychotraumatology","COVID-19; media exposure; perceived coping; stress; university students","Benbenishty","Rami","Paul Baerwald School of Social Work and Social Welfare, Hebrew University of Jerusalem, Jerusalem, Israel",NA
"1962","34249241","10.1080/20008198.2021.1924442","COVID-19 unmasked: preschool children's negative thoughts and worries during the COVID-19 pandemic in Australia.","Background: The COVID-19 pandemic and its consequences are stressful for many children and their families. Previous research with school-aged children has shown that negative thoughts and worries can predict mental health symptoms following stressful events. So far preschool children have been neglected in these investigations. Objective: The aim of this study was to explore negative thoughts and worries that preschool aged children are having during the COVID-19 pandemic. Method: As part of a l","2021","07","13","Eur J Psychotraumatol","European journal of psychotraumatology","COVID-19; Preschool; negative thoughts; qualitative; worries","Vasileva","Mira","Child and Community Wellbeing Unit, Centre for Health Equity, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Australia",NA
"1963","34249241","10.1080/20008198.2021.1924442","COVID-19 unmasked: preschool children's negative thoughts and worries during the COVID-19 pandemic in Australia.","Background: The COVID-19 pandemic and its consequences are stressful for many children and their families. Previous research with school-aged children has shown that negative thoughts and worries can predict mental health symptoms following stressful events. So far preschool children have been neglected in these investigations. Objective: The aim of this study was to explore negative thoughts and worries that preschool aged children are having during the COVID-19 pandemic. Method: As part of a l","2021","07","13","Eur J Psychotraumatol","European journal of psychotraumatology","COVID-19; Preschool; negative thoughts; qualitative; worries","Alisic","Eva","Child and Community Wellbeing Unit, Centre for Health Equity, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Australia",NA
"1964","34249241","10.1080/20008198.2021.1924442","COVID-19 unmasked: preschool children's negative thoughts and worries during the COVID-19 pandemic in Australia.","Background: The COVID-19 pandemic and its consequences are stressful for many children and their families. Previous research with school-aged children has shown that negative thoughts and worries can predict mental health symptoms following stressful events. So far preschool children have been neglected in these investigations. Objective: The aim of this study was to explore negative thoughts and worries that preschool aged children are having during the COVID-19 pandemic. Method: As part of a l","2021","07","13","Eur J Psychotraumatol","European journal of psychotraumatology","COVID-19; Preschool; negative thoughts; qualitative; worries","De Young","Alex","Queensland Centre for Perinatal &amp",NA
"1965","34249239","10.4329/wjr.v13.i6.192","Imaging in the COVID-19 era: Lessons learned during a pandemic.","The first year of the coronavirus disease 2019 (COVID-19) pandemic has been a year of unprecedented changes, scientific breakthroughs, and controversies. The radiology community has not been spared from the challenges imposed on global healthcare systems. Radiology has played a crucial part in tackling this pandemic, either by demonstrating the manifestations of the virus and guiding patient management, or by safely handling the patients and mitigating transmission within the hospital. Major mod","2021","07","13","World J Radiol","World journal of radiology","Artificial intelligence; COVID-19; Computed tomography; Diagnostic imaging; Infectious diseases; Radiography","Sideris","Georgios Antonios","Department of Radiology, University of Massachusetts Medical School, Baystate Medical Center, Springfield, MA 01199, United States",NA
"1966","34249239","10.4329/wjr.v13.i6.192","Imaging in the COVID-19 era: Lessons learned during a pandemic.","The first year of the coronavirus disease 2019 (COVID-19) pandemic has been a year of unprecedented changes, scientific breakthroughs, and controversies. The radiology community has not been spared from the challenges imposed on global healthcare systems. Radiology has played a crucial part in tackling this pandemic, either by demonstrating the manifestations of the virus and guiding patient management, or by safely handling the patients and mitigating transmission within the hospital. Major mod","2021","07","13","World J Radiol","World journal of radiology","Artificial intelligence; COVID-19; Computed tomography; Diagnostic imaging; Infectious diseases; Radiography","Nikolakea","Melina","Radiology Working Group, Society of Junior Doctors, Athens 11527, Greece",NA
"1967","34249239","10.4329/wjr.v13.i6.192","Imaging in the COVID-19 era: Lessons learned during a pandemic.","The first year of the coronavirus disease 2019 (COVID-19) pandemic has been a year of unprecedented changes, scientific breakthroughs, and controversies. The radiology community has not been spared from the challenges imposed on global healthcare systems. Radiology has played a crucial part in tackling this pandemic, either by demonstrating the manifestations of the virus and guiding patient management, or by safely handling the patients and mitigating transmission within the hospital. Major mod","2021","07","13","World J Radiol","World journal of radiology","Artificial intelligence; COVID-19; Computed tomography; Diagnostic imaging; Infectious diseases; Radiography","Karanikola","Aikaterini-Eleftheria","Radiology Working Group, Society of Junior Doctors, Athens 11527, Greece",NA
"1968","34249239","10.4329/wjr.v13.i6.192","Imaging in the COVID-19 era: Lessons learned during a pandemic.","The first year of the coronavirus disease 2019 (COVID-19) pandemic has been a year of unprecedented changes, scientific breakthroughs, and controversies. The radiology community has not been spared from the challenges imposed on global healthcare systems. Radiology has played a crucial part in tackling this pandemic, either by demonstrating the manifestations of the virus and guiding patient management, or by safely handling the patients and mitigating transmission within the hospital. Major mod","2021","07","13","World J Radiol","World journal of radiology","Artificial intelligence; COVID-19; Computed tomography; Diagnostic imaging; Infectious diseases; Radiography","Konstantinopoulou","Sofia","Division of Pulmonary Medicine, Department of Pediatrics, Sheikh Khalifa Medical City, Abu Dhabi W13-01, United Arab Emirates",NA
"1969","34249239","10.4329/wjr.v13.i6.192","Imaging in the COVID-19 era: Lessons learned during a pandemic.","The first year of the coronavirus disease 2019 (COVID-19) pandemic has been a year of unprecedented changes, scientific breakthroughs, and controversies. The radiology community has not been spared from the challenges imposed on global healthcare systems. Radiology has played a crucial part in tackling this pandemic, either by demonstrating the manifestations of the virus and guiding patient management, or by safely handling the patients and mitigating transmission within the hospital. Major mod","2021","07","13","World J Radiol","World journal of radiology","Artificial intelligence; COVID-19; Computed tomography; Diagnostic imaging; Infectious diseases; Radiography","Giannis","Dimitrios","Institute of Health Innovations and Outcomes Research, The Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY 11030, United States",NA
"1970","34249239","10.4329/wjr.v13.i6.192","Imaging in the COVID-19 era: Lessons learned during a pandemic.","The first year of the coronavirus disease 2019 (COVID-19) pandemic has been a year of unprecedented changes, scientific breakthroughs, and controversies. The radiology community has not been spared from the challenges imposed on global healthcare systems. Radiology has played a crucial part in tackling this pandemic, either by demonstrating the manifestations of the virus and guiding patient management, or by safely handling the patients and mitigating transmission within the hospital. Major mod","2021","07","13","World J Radiol","World journal of radiology","Artificial intelligence; COVID-19; Computed tomography; Diagnostic imaging; Infectious diseases; Radiography","Modahl","Lucy","Department of Radiology, University of Massachusetts Medical School, Baystate Medical Center, Springfield, MA 01199, United States",NA
"1971","34249238","10.4329/wjr.v13.i6.171","COVID-19 imaging: Diagnostic approaches, challenges, and evolving advances.","The role of radiology and the radiologist have evolved throughout the coronavirus disease-2019 (COVID-19) pandemic. Early on, chest computed tomography was used for screening and diagnosis of COVID-19; however, it is now indicated for high-risk patients, those with severe disease, or in areas where polymerase chain reaction testing is sparsely available. Chest radiography is now utilized mainly for monitoring disease progression in hospitalized patients showing signs of worsening clinical status","2021","07","13","World J Radiol","World journal of radiology","COVID-19; Computed tomography; Coronavirus; Diagnostic imaging; Future trends; Outcomes; Pandemic; Radiography","Pezzutti","Dante L","Department of Radiology, The Ohio State University Wexner Medical Center, Columbus, OH 43210, United States",NA
"1972","34249238","10.4329/wjr.v13.i6.171","COVID-19 imaging: Diagnostic approaches, challenges, and evolving advances.","The role of radiology and the radiologist have evolved throughout the coronavirus disease-2019 (COVID-19) pandemic. Early on, chest computed tomography was used for screening and diagnosis of COVID-19; however, it is now indicated for high-risk patients, those with severe disease, or in areas where polymerase chain reaction testing is sparsely available. Chest radiography is now utilized mainly for monitoring disease progression in hospitalized patients showing signs of worsening clinical status","2021","07","13","World J Radiol","World journal of radiology","COVID-19; Computed tomography; Coronavirus; Diagnostic imaging; Future trends; Outcomes; Pandemic; Radiography","Wadhwa","Vibhor","Department of Radiology, Weill Cornell Medical Center, New York City, NY 10065, United States",NA
"1973","34249238","10.4329/wjr.v13.i6.171","COVID-19 imaging: Diagnostic approaches, challenges, and evolving advances.","The role of radiology and the radiologist have evolved throughout the coronavirus disease-2019 (COVID-19) pandemic. Early on, chest computed tomography was used for screening and diagnosis of COVID-19; however, it is now indicated for high-risk patients, those with severe disease, or in areas where polymerase chain reaction testing is sparsely available. Chest radiography is now utilized mainly for monitoring disease progression in hospitalized patients showing signs of worsening clinical status","2021","07","13","World J Radiol","World journal of radiology","COVID-19; Computed tomography; Coronavirus; Diagnostic imaging; Future trends; Outcomes; Pandemic; Radiography","Makary","Mina S","Department of Radiology, The Ohio State University Wexner Medical Center, Columbus, OH 43210, United States. mina.makary@osumc","mina.makary@osumc.edu"
"1974","34249237","10.4329/wjr.v13.i6.157","Imaging spectrum of abdominal manifestations of COVID-19.","Coronavirus disease 2019 (COVID-19) has posed a serious threat to global public health with its rapid spread, high fatality, and severe burden on health care providers all over the world. Although COVID-19 has been established as a respiratory tract infection, it can manifest with gastrointestinal symptoms as a consequence of direct infection by the virus or due to inflammation-mediated cytotoxicity. It has been observed that COVID-19 patients presenting with gastrointestinal symptoms tend to pr","2021","07","13","World J Radiol","World journal of radiology","COVID-19; Gastrointestinal; Hepato-biliary; Imaging; Thrombosis; Vascular","Vaidya","Tanvi","Department of Radiology, Ruby Hall Clinic, Pune 411001, Maharashtra, India. tanvivaidya5@gmail","tanvivaidya5@gmail.com"
"1975","34249237","10.4329/wjr.v13.i6.157","Imaging spectrum of abdominal manifestations of COVID-19.","Coronavirus disease 2019 (COVID-19) has posed a serious threat to global public health with its rapid spread, high fatality, and severe burden on health care providers all over the world. Although COVID-19 has been established as a respiratory tract infection, it can manifest with gastrointestinal symptoms as a consequence of direct infection by the virus or due to inflammation-mediated cytotoxicity. It has been observed that COVID-19 patients presenting with gastrointestinal symptoms tend to pr","2021","07","13","World J Radiol","World journal of radiology","COVID-19; Gastrointestinal; Hepato-biliary; Imaging; Thrombosis; Vascular","Nanivadekar","Avinash","Department of Radiology, Ruby Hall Clinic, Pune 411001, Maharashtra, India",NA
"1976","34249237","10.4329/wjr.v13.i6.157","Imaging spectrum of abdominal manifestations of COVID-19.","Coronavirus disease 2019 (COVID-19) has posed a serious threat to global public health with its rapid spread, high fatality, and severe burden on health care providers all over the world. Although COVID-19 has been established as a respiratory tract infection, it can manifest with gastrointestinal symptoms as a consequence of direct infection by the virus or due to inflammation-mediated cytotoxicity. It has been observed that COVID-19 patients presenting with gastrointestinal symptoms tend to pr","2021","07","13","World J Radiol","World journal of radiology","COVID-19; Gastrointestinal; Hepato-biliary; Imaging; Thrombosis; Vascular","Patel","Rajan","Department of Radiology, Ruby Hall Clinic, Pune 411001, Maharashtra, India",NA
"1977","34249236","10.4329/wjr.v13.i6.149","Thoracic imaging outcomes in COVID-19 survivors.","The coronavirus disease 2019 (COVID-19) pandemic presents a significant global public health challenge. One in five individuals with COVID-19 presents with symptoms that last for weeks after hospital discharge, a condition termed ""long COVID"". Thus, efficient follow-up of patients is needed to assess the resolution of lung pathologies and systemic involvement. Thoracic imaging is multimodal and involves using different forms of waves to produce images of the organs within the thorax. In general,","2021","07","13","World J Radiol","World journal of radiology","COVID-19; Chest X-ray; Computed tomography; Long COVID; Lung ultrasound; SARS-CoV-2; Survivors; Thoracic imaging","Alqahtani","Jaber S","Department of Respiratory Care, Prince Sultan Military College of Health Sciences, Dammam 3431, Saudi Arabia",NA
"1978","34249236","10.4329/wjr.v13.i6.149","Thoracic imaging outcomes in COVID-19 survivors.","The coronavirus disease 2019 (COVID-19) pandemic presents a significant global public health challenge. One in five individuals with COVID-19 presents with symptoms that last for weeks after hospital discharge, a condition termed ""long COVID"". Thus, efficient follow-up of patients is needed to assess the resolution of lung pathologies and systemic involvement. Thoracic imaging is multimodal and involves using different forms of waves to produce images of the organs within the thorax. In general,","2021","07","13","World J Radiol","World journal of radiology","COVID-19; Chest X-ray; Computed tomography; Long COVID; Lung ultrasound; SARS-CoV-2; Survivors; Thoracic imaging","Alghamdi","Saeed M","Faculty of Applied Medical Sciences, Umm Al-Qura University, Makkah 21990, Saudi Arabia",NA
"1979","34249236","10.4329/wjr.v13.i6.149","Thoracic imaging outcomes in COVID-19 survivors.","The coronavirus disease 2019 (COVID-19) pandemic presents a significant global public health challenge. One in five individuals with COVID-19 presents with symptoms that last for weeks after hospital discharge, a condition termed ""long COVID"". Thus, efficient follow-up of patients is needed to assess the resolution of lung pathologies and systemic involvement. Thoracic imaging is multimodal and involves using different forms of waves to produce images of the organs within the thorax. In general,","2021","07","13","World J Radiol","World journal of radiology","COVID-19; Chest X-ray; Computed tomography; Long COVID; Lung ultrasound; SARS-CoV-2; Survivors; Thoracic imaging","Aldhahir","Abdulelah M","Respiratory Care Department, Faculty of Applied Medical Sciences, Jazan University, Jazan 4514, Saudi Arabia",NA
"1980","34249236","10.4329/wjr.v13.i6.149","Thoracic imaging outcomes in COVID-19 survivors.","The coronavirus disease 2019 (COVID-19) pandemic presents a significant global public health challenge. One in five individuals with COVID-19 presents with symptoms that last for weeks after hospital discharge, a condition termed ""long COVID"". Thus, efficient follow-up of patients is needed to assess the resolution of lung pathologies and systemic involvement. Thoracic imaging is multimodal and involves using different forms of waves to produce images of the organs within the thorax. In general,","2021","07","13","World J Radiol","World journal of radiology","COVID-19; Chest X-ray; Computed tomography; Long COVID; Lung ultrasound; SARS-CoV-2; Survivors; Thoracic imaging","Althobiani","Malik","Department of Respiratory Medicine, Division of Medicine, University College London, London NW3 2PF, United Kingdom",NA
"1981","34249236","10.4329/wjr.v13.i6.149","Thoracic imaging outcomes in COVID-19 survivors.","The coronavirus disease 2019 (COVID-19) pandemic presents a significant global public health challenge. One in five individuals with COVID-19 presents with symptoms that last for weeks after hospital discharge, a condition termed ""long COVID"". Thus, efficient follow-up of patients is needed to assess the resolution of lung pathologies and systemic involvement. Thoracic imaging is multimodal and involves using different forms of waves to produce images of the organs within the thorax. In general,","2021","07","13","World J Radiol","World journal of radiology","COVID-19; Chest X-ray; Computed tomography; Long COVID; Lung ultrasound; SARS-CoV-2; Survivors; Thoracic imaging","Raya","Reynie Purnama","Faculty of Science, Universitas 'Aisyiyah Bandung, Bandung 40264, Indonesia",NA
"1982","34249236","10.4329/wjr.v13.i6.149","Thoracic imaging outcomes in COVID-19 survivors.","The coronavirus disease 2019 (COVID-19) pandemic presents a significant global public health challenge. One in five individuals with COVID-19 presents with symptoms that last for weeks after hospital discharge, a condition termed ""long COVID"". Thus, efficient follow-up of patients is needed to assess the resolution of lung pathologies and systemic involvement. Thoracic imaging is multimodal and involves using different forms of waves to produce images of the organs within the thorax. In general,","2021","07","13","World J Radiol","World journal of radiology","COVID-19; Chest X-ray; Computed tomography; Long COVID; Lung ultrasound; SARS-CoV-2; Survivors; Thoracic imaging","Oyelade","Tope","Institute for Liver and Digestive Health, Division of Medicine, University College London, London NW3 2PF, United Kingdom",NA
"1983","34249228","10.4252/wjsc.v13.i6.568","Review of the potential of mesenchymal stem cells for the treatment of infectious diseases.","The therapeutic value of mesenchymal stem cells (MSCs) for the treatment of infectious diseases and the repair of disease-induced tissue damage has been explored extensively. MSCs inhibit inflammation, reduce pathogen load and tissue damage encountered during infectious diseases through the secretion of antimicrobial factors for pathogen clearance and they phagocytose certain bacteria themselves. MSCs dampen tissue damage during infection by downregulating the levels of pro-inflammatory cytokine","2021","07","13","World J Stem Cells","World journal of stem cells","Antimicrobial effect; COVID-19; Immunomodulation; Infectious diseases; Mesenchymal stem cells; Tissue repair","Sharma","Amit","Stem Cell and Cancer Biology Group, Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Guwahati 781039, India",NA
"1984","34249228","10.4252/wjsc.v13.i6.568","Review of the potential of mesenchymal stem cells for the treatment of infectious diseases.","The therapeutic value of mesenchymal stem cells (MSCs) for the treatment of infectious diseases and the repair of disease-induced tissue damage has been explored extensively. MSCs inhibit inflammation, reduce pathogen load and tissue damage encountered during infectious diseases through the secretion of antimicrobial factors for pathogen clearance and they phagocytose certain bacteria themselves. MSCs dampen tissue damage during infection by downregulating the levels of pro-inflammatory cytokine","2021","07","13","World J Stem Cells","World journal of stem cells","Antimicrobial effect; COVID-19; Immunomodulation; Infectious diseases; Mesenchymal stem cells; Tissue repair","Chakraborty","Anuja","Stem Cell and Cancer Biology Group, Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Guwahati 781039, India",NA
"1985","34249228","10.4252/wjsc.v13.i6.568","Review of the potential of mesenchymal stem cells for the treatment of infectious diseases.","The therapeutic value of mesenchymal stem cells (MSCs) for the treatment of infectious diseases and the repair of disease-induced tissue damage has been explored extensively. MSCs inhibit inflammation, reduce pathogen load and tissue damage encountered during infectious diseases through the secretion of antimicrobial factors for pathogen clearance and they phagocytose certain bacteria themselves. MSCs dampen tissue damage during infection by downregulating the levels of pro-inflammatory cytokine","2021","07","13","World J Stem Cells","World journal of stem cells","Antimicrobial effect; COVID-19; Immunomodulation; Infectious diseases; Mesenchymal stem cells; Tissue repair","Jaganathan","Bithiah Grace","Stem Cell and Cancer Biology Group, Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Guwahati 781039, India. bithiahgj@iitg.ac","bithiahgj@iitg.ac.in"
"1986","34249210","10.36834/cmej.71523","In the shadows: medical student clinical observerships and career exploration in the face of COVID-19.",NA,"2021","07","13","Can Med Educ J","Canadian medical education journal",NA,"Li","Ming K","MD Program, Temerty Faculty of Medicine, University of Toronto, Ontario, Canada",NA
"1987","34249210","10.36834/cmej.71523","In the shadows: medical student clinical observerships and career exploration in the face of COVID-19.",NA,"2021","07","13","Can Med Educ J","Canadian medical education journal",NA,"Pieris","Dilshan","MD Program, Temerty Faculty of Medicine, University of Toronto, Ontario, Canada",NA
"1988","34249210","10.36834/cmej.71523","In the shadows: medical student clinical observerships and career exploration in the face of COVID-19.",NA,"2021","07","13","Can Med Educ J","Canadian medical education journal",NA,"Xu","Grace","MD Program, Temerty Faculty of Medicine, University of Toronto, Ontario, Canada",NA
"1989","34249210","10.36834/cmej.71523","In the shadows: medical student clinical observerships and career exploration in the face of COVID-19.",NA,"2021","07","13","Can Med Educ J","Canadian medical education journal",NA,"Law","Marcus","MD Program, Temerty Faculty of Medicine, University of Toronto, Ontario, Canada",NA
"1990","34249208","10.36834/cmej.71155","Instagram as a virtual art display for medical students.","Implication Statement We require our medical students to create art as part of a core course. Projects have historically been displayed at our health sciences library. During a rapid adjustment to virtual teaching at the onset of the COVID-19 pandemic, using Instagram to hold a virtual art show was a quickly implemented alternative. With student consent, course directors posted different artwork every weekday for eight weeks to a course account. By capitalizing on the visual strengths and extens","2021","07","13","Can Med Educ J","Canadian medical education journal",NA,"Pippitt","Karly A","Department of Family and Preventive Medicine, School of Medicine, University of Utah, Utah, USA",NA
"1991","34249208","10.36834/cmej.71155","Instagram as a virtual art display for medical students.","Implication Statement We require our medical students to create art as part of a core course. Projects have historically been displayed at our health sciences library. During a rapid adjustment to virtual teaching at the onset of the COVID-19 pandemic, using Instagram to hold a virtual art show was a quickly implemented alternative. With student consent, course directors posted different artwork every weekday for eight weeks to a course account. By capitalizing on the visual strengths and extens","2021","07","13","Can Med Educ J","Canadian medical education journal",NA,"Chow","Candace J","Department of Internal Medicine, School of Medicine, University of Utah, Utah, USA",NA
"1992","34249208","10.36834/cmej.71155","Instagram as a virtual art display for medical students.","Implication Statement We require our medical students to create art as part of a core course. Projects have historically been displayed at our health sciences library. During a rapid adjustment to virtual teaching at the onset of the COVID-19 pandemic, using Instagram to hold a virtual art show was a quickly implemented alternative. With student consent, course directors posted different artwork every weekday for eight weeks to a course account. By capitalizing on the visual strengths and extens","2021","07","13","Can Med Educ J","Canadian medical education journal",NA,"Case","Gretchen A","Department of Internal Medicine, School of Medicine, University of Utah, Utah, USA",NA
"1993","34249205","10.36834/cmej.71172","Adapting clinical skills volunteer patient recruitment and retention during COVID-19.","Implication Statement Institutions have been faced with the unique challenge of continuing to deliver medical education to students in a COVID-19 environment.<sup>1</sup> <sup>,</sup> <sup>2</sup> Clinical skills teaching must be adapted to the pandemic environment, which begins with retaining Volunteer Patient (VP) engagement to facilitate the development of students' patient care aptitudes. The number of available VPs has been significantly reduced by the pandemic. We propose actionable soluti","2021","07","13","Can Med Educ J","Canadian medical education journal",NA,"Nazerali-Maitland","Alasdair","Division of Critical Care, Faculty of Medicine, University of British Columbia, British Columbia, Canada",NA
"1994","34249205","10.36834/cmej.71172","Adapting clinical skills volunteer patient recruitment and retention during COVID-19.","Implication Statement Institutions have been faced with the unique challenge of continuing to deliver medical education to students in a COVID-19 environment.<sup>1</sup> <sup>,</sup> <sup>2</sup> Clinical skills teaching must be adapted to the pandemic environment, which begins with retaining Volunteer Patient (VP) engagement to facilitate the development of students' patient care aptitudes. The number of available VPs has been significantly reduced by the pandemic. We propose actionable soluti","2021","07","13","Can Med Educ J","Canadian medical education journal",NA,"Holden","Reed","Faculty of Medicine, University of British Columbia, British Columbia, Canada",NA
"1995","34249205","10.36834/cmej.71172","Adapting clinical skills volunteer patient recruitment and retention during COVID-19.","Implication Statement Institutions have been faced with the unique challenge of continuing to deliver medical education to students in a COVID-19 environment.<sup>1</sup> <sup>,</sup> <sup>2</sup> Clinical skills teaching must be adapted to the pandemic environment, which begins with retaining Volunteer Patient (VP) engagement to facilitate the development of students' patient care aptitudes. The number of available VPs has been significantly reduced by the pandemic. We propose actionable soluti","2021","07","13","Can Med Educ J","Canadian medical education journal",NA,"Jones","Amanda","Vancouver Fraser Medical Program, Faculty of Medicine, University of British Columbia, British Columbia, Canada",NA
"1996","34249205","10.36834/cmej.71172","Adapting clinical skills volunteer patient recruitment and retention during COVID-19.","Implication Statement Institutions have been faced with the unique challenge of continuing to deliver medical education to students in a COVID-19 environment.<sup>1</sup> <sup>,</sup> <sup>2</sup> Clinical skills teaching must be adapted to the pandemic environment, which begins with retaining Volunteer Patient (VP) engagement to facilitate the development of students' patient care aptitudes. The number of available VPs has been significantly reduced by the pandemic. We propose actionable soluti","2021","07","13","Can Med Educ J","Canadian medical education journal",NA,"Cardoso","Jenni Uitto","Vancouver Fraser Medical Program, Faculty of Medicine, University of British Columbia, British Columbia, Canada",NA
"1997","34249205","10.36834/cmej.71172","Adapting clinical skills volunteer patient recruitment and retention during COVID-19.","Implication Statement Institutions have been faced with the unique challenge of continuing to deliver medical education to students in a COVID-19 environment.<sup>1</sup> <sup>,</sup> <sup>2</sup> Clinical skills teaching must be adapted to the pandemic environment, which begins with retaining Volunteer Patient (VP) engagement to facilitate the development of students' patient care aptitudes. The number of available VPs has been significantly reduced by the pandemic. We propose actionable soluti","2021","07","13","Can Med Educ J","Canadian medical education journal",NA,"Levido","Kelly","Vancouver Fraser Medical Program, Faculty of Medicine, University of British Columbia, British Columbia, Canada",NA
"1998","34249205","10.36834/cmej.71172","Adapting clinical skills volunteer patient recruitment and retention during COVID-19.","Implication Statement Institutions have been faced with the unique challenge of continuing to deliver medical education to students in a COVID-19 environment.<sup>1</sup> <sup>,</sup> <sup>2</sup> Clinical skills teaching must be adapted to the pandemic environment, which begins with retaining Volunteer Patient (VP) engagement to facilitate the development of students' patient care aptitudes. The number of available VPs has been significantly reduced by the pandemic. We propose actionable soluti","2021","07","13","Can Med Educ J","Canadian medical education journal",NA,"Douglas","Christina","Vancouver Fraser Medical Program, Faculty of Medicine, University of British Columbia, British Columbia, Canada",NA
"1999","34249194","10.36834/cmej.71261","The effect of COVID-19 on medical students' education and wellbeing: a cross-sectional survey.","Canadian medical school curriculums have undergone major restructuring during the COVID-19 pandemic. This study's goal was to assess the perceived impact of COVID-19 on medical students' education and wellbeing. An online survey was distributed to Canadian medical students. Descriptive analyses and ANOVAs were used to assess changes in mental health, health habits and quality of education during the pandemic. 248 medical students from 13 schools across Canada participated in this study. 74% repo","2021","07","13","Can Med Educ J","Canadian medical education journal",NA,"ElHawary","Hassan","Division of Plastic and Reconstructive Surgery, McGill University Health Centre, Quebec, Canada",NA
"2000","34249194","10.36834/cmej.71261","The effect of COVID-19 on medical students' education and wellbeing: a cross-sectional survey.","Canadian medical school curriculums have undergone major restructuring during the COVID-19 pandemic. This study's goal was to assess the perceived impact of COVID-19 on medical students' education and wellbeing. An online survey was distributed to Canadian medical students. Descriptive analyses and ANOVAs were used to assess changes in mental health, health habits and quality of education during the pandemic. 248 medical students from 13 schools across Canada participated in this study. 74% repo","2021","07","13","Can Med Educ J","Canadian medical education journal",NA,"Salimi","Ali","Department of Ophthalmology, Faculty of Medicine, McGill University, Quebec, Canada",NA
"2001","34249194","10.36834/cmej.71261","The effect of COVID-19 on medical students' education and wellbeing: a cross-sectional survey.","Canadian medical school curriculums have undergone major restructuring during the COVID-19 pandemic. This study's goal was to assess the perceived impact of COVID-19 on medical students' education and wellbeing. An online survey was distributed to Canadian medical students. Descriptive analyses and ANOVAs were used to assess changes in mental health, health habits and quality of education during the pandemic. 248 medical students from 13 schools across Canada participated in this study. 74% repo","2021","07","13","Can Med Educ J","Canadian medical education journal",NA,"Barone","Natasha","Faculty of Medicine, McGill University, Quebec, Canada",NA
"2002","34249194","10.36834/cmej.71261","The effect of COVID-19 on medical students' education and wellbeing: a cross-sectional survey.","Canadian medical school curriculums have undergone major restructuring during the COVID-19 pandemic. This study's goal was to assess the perceived impact of COVID-19 on medical students' education and wellbeing. An online survey was distributed to Canadian medical students. Descriptive analyses and ANOVAs were used to assess changes in mental health, health habits and quality of education during the pandemic. 248 medical students from 13 schools across Canada participated in this study. 74% repo","2021","07","13","Can Med Educ J","Canadian medical education journal",NA,"Alam","Peter","Division of Plastic and Reconstructive Surgery, McGill University Health Centre, Quebec, Canada",NA
"2003","34249194","10.36834/cmej.71261","The effect of COVID-19 on medical students' education and wellbeing: a cross-sectional survey.","Canadian medical school curriculums have undergone major restructuring during the COVID-19 pandemic. This study's goal was to assess the perceived impact of COVID-19 on medical students' education and wellbeing. An online survey was distributed to Canadian medical students. Descriptive analyses and ANOVAs were used to assess changes in mental health, health habits and quality of education during the pandemic. 248 medical students from 13 schools across Canada participated in this study. 74% repo","2021","07","13","Can Med Educ J","Canadian medical education journal",NA,"Thibaudeau","Stephanie","Division of Plastic and Reconstructive Surgery, McGill University Health Centre, Quebec, Canada",NA
"2004","34249191","10.36834/cmej.70995","Exploring the impact of the COVID-19 pandemic on medical learner wellness: a needs assessment for the development of learner wellness interventions.","On March 11, 2020 the World Health Organization declared the novel coronavirus SARS-CoV-2 disease (COVID-19) a global pandemic. We sought to understand impact of COVID-19 on learner wellness at a large tertiary care academic institution to inform the future development of learner wellness interventions during the COVID-19 pandemic. A cross-sectional, internet-based survey collected quantitative and qualitative data from learners April-June 2020. Descriptive statistics and univariate analyses wer","2021","07","13","Can Med Educ J","Canadian medical education journal",NA,"Cherak","Stephana J","Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Alberta, Canada",NA
"2005","34249191","10.36834/cmej.70995","Exploring the impact of the COVID-19 pandemic on medical learner wellness: a needs assessment for the development of learner wellness interventions.","On March 11, 2020 the World Health Organization declared the novel coronavirus SARS-CoV-2 disease (COVID-19) a global pandemic. We sought to understand impact of COVID-19 on learner wellness at a large tertiary care academic institution to inform the future development of learner wellness interventions during the COVID-19 pandemic. A cross-sectional, internet-based survey collected quantitative and qualitative data from learners April-June 2020. Descriptive statistics and univariate analyses wer","2021","07","13","Can Med Educ J","Canadian medical education journal",NA,"Brown","Allison","Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Alberta, Canada",NA
"2006","34249191","10.36834/cmej.70995","Exploring the impact of the COVID-19 pandemic on medical learner wellness: a needs assessment for the development of learner wellness interventions.","On March 11, 2020 the World Health Organization declared the novel coronavirus SARS-CoV-2 disease (COVID-19) a global pandemic. We sought to understand impact of COVID-19 on learner wellness at a large tertiary care academic institution to inform the future development of learner wellness interventions during the COVID-19 pandemic. A cross-sectional, internet-based survey collected quantitative and qualitative data from learners April-June 2020. Descriptive statistics and univariate analyses wer","2021","07","13","Can Med Educ J","Canadian medical education journal",NA,"Kachra","Rahim","Department of Medicine, Cumming School of Medicine, University of Calgary, Alberta, Canada",NA
"2007","34249191","10.36834/cmej.70995","Exploring the impact of the COVID-19 pandemic on medical learner wellness: a needs assessment for the development of learner wellness interventions.","On March 11, 2020 the World Health Organization declared the novel coronavirus SARS-CoV-2 disease (COVID-19) a global pandemic. We sought to understand impact of COVID-19 on learner wellness at a large tertiary care academic institution to inform the future development of learner wellness interventions during the COVID-19 pandemic. A cross-sectional, internet-based survey collected quantitative and qualitative data from learners April-June 2020. Descriptive statistics and univariate analyses wer","2021","07","13","Can Med Educ J","Canadian medical education journal",NA,"Makuk","Kira","Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Alberta, Canada",NA
"2008","34249191","10.36834/cmej.70995","Exploring the impact of the COVID-19 pandemic on medical learner wellness: a needs assessment for the development of learner wellness interventions.","On March 11, 2020 the World Health Organization declared the novel coronavirus SARS-CoV-2 disease (COVID-19) a global pandemic. We sought to understand impact of COVID-19 on learner wellness at a large tertiary care academic institution to inform the future development of learner wellness interventions during the COVID-19 pandemic. A cross-sectional, internet-based survey collected quantitative and qualitative data from learners April-June 2020. Descriptive statistics and univariate analyses wer","2021","07","13","Can Med Educ J","Canadian medical education journal",NA,"Sudershan","Sanjana","Department of Undergraduate Medical Education, Cumming School of Medicine, University of Calgary, Alberta, Canada",NA
"2009","34249191","10.36834/cmej.70995","Exploring the impact of the COVID-19 pandemic on medical learner wellness: a needs assessment for the development of learner wellness interventions.","On March 11, 2020 the World Health Organization declared the novel coronavirus SARS-CoV-2 disease (COVID-19) a global pandemic. We sought to understand impact of COVID-19 on learner wellness at a large tertiary care academic institution to inform the future development of learner wellness interventions during the COVID-19 pandemic. A cross-sectional, internet-based survey collected quantitative and qualitative data from learners April-June 2020. Descriptive statistics and univariate analyses wer","2021","07","13","Can Med Educ J","Canadian medical education journal",NA,"Paget","Mike","Department of Undergraduate Medical Education, Cumming School of Medicine, University of Calgary, Alberta, Canada",NA
"2010","34249191","10.36834/cmej.70995","Exploring the impact of the COVID-19 pandemic on medical learner wellness: a needs assessment for the development of learner wellness interventions.","On March 11, 2020 the World Health Organization declared the novel coronavirus SARS-CoV-2 disease (COVID-19) a global pandemic. We sought to understand impact of COVID-19 on learner wellness at a large tertiary care academic institution to inform the future development of learner wellness interventions during the COVID-19 pandemic. A cross-sectional, internet-based survey collected quantitative and qualitative data from learners April-June 2020. Descriptive statistics and univariate analyses wer","2021","07","13","Can Med Educ J","Canadian medical education journal",NA,"Kassam","Aliya","Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Alberta, Canada",NA
"2011","34249189","10.36834/cmej.71149","Exploring the global impact of the COVID-19 pandemic on medical education: an international cross-sectional study of medical learners.","The evidence surrounding the impact of COVID-19 on medical learners remains anecdotal and highly speculative despite the anticipated impact and potential consequences of the current pandemic on medical training. The purpose of this study was to explore the extent that COVID-19 initially impacted medical learners around the world and examine global trends and patterns across geographic regions and levels of training. A cross-sectional survey of medical learners was conducted between March 25-June","2021","07","13","Can Med Educ J","Canadian medical education journal",NA,"Brown","Allison","Cumming School of Medicine, University of Calgary, Alberta, Canada",NA
"2012","34249189","10.36834/cmej.71149","Exploring the global impact of the COVID-19 pandemic on medical education: an international cross-sectional study of medical learners.","The evidence surrounding the impact of COVID-19 on medical learners remains anecdotal and highly speculative despite the anticipated impact and potential consequences of the current pandemic on medical training. The purpose of this study was to explore the extent that COVID-19 initially impacted medical learners around the world and examine global trends and patterns across geographic regions and levels of training. A cross-sectional survey of medical learners was conducted between March 25-June","2021","07","13","Can Med Educ J","Canadian medical education journal",NA,"Kassam","Aliya","Cumming School of Medicine, University of Calgary, Alberta, Canada",NA
"2013","34249189","10.36834/cmej.71149","Exploring the global impact of the COVID-19 pandemic on medical education: an international cross-sectional study of medical learners.","The evidence surrounding the impact of COVID-19 on medical learners remains anecdotal and highly speculative despite the anticipated impact and potential consequences of the current pandemic on medical training. The purpose of this study was to explore the extent that COVID-19 initially impacted medical learners around the world and examine global trends and patterns across geographic regions and levels of training. A cross-sectional survey of medical learners was conducted between March 25-June","2021","07","13","Can Med Educ J","Canadian medical education journal",NA,"Paget","Mike","Cumming School of Medicine, University of Calgary, Alberta, Canada",NA
"2014","34249189","10.36834/cmej.71149","Exploring the global impact of the COVID-19 pandemic on medical education: an international cross-sectional study of medical learners.","The evidence surrounding the impact of COVID-19 on medical learners remains anecdotal and highly speculative despite the anticipated impact and potential consequences of the current pandemic on medical training. The purpose of this study was to explore the extent that COVID-19 initially impacted medical learners around the world and examine global trends and patterns across geographic regions and levels of training. A cross-sectional survey of medical learners was conducted between March 25-June","2021","07","13","Can Med Educ J","Canadian medical education journal",NA,"Blades","Kenneth","Cumming School of Medicine, University of Calgary, Alberta, Canada",NA
"2015","34249189","10.36834/cmej.71149","Exploring the global impact of the COVID-19 pandemic on medical education: an international cross-sectional study of medical learners.","The evidence surrounding the impact of COVID-19 on medical learners remains anecdotal and highly speculative despite the anticipated impact and potential consequences of the current pandemic on medical training. The purpose of this study was to explore the extent that COVID-19 initially impacted medical learners around the world and examine global trends and patterns across geographic regions and levels of training. A cross-sectional survey of medical learners was conducted between March 25-June","2021","07","13","Can Med Educ J","Canadian medical education journal",NA,"Mercia","Megan","Faculty of Science, University of Calgary, Alberta, Canada",NA
"2016","34249189","10.36834/cmej.71149","Exploring the global impact of the COVID-19 pandemic on medical education: an international cross-sectional study of medical learners.","The evidence surrounding the impact of COVID-19 on medical learners remains anecdotal and highly speculative despite the anticipated impact and potential consequences of the current pandemic on medical training. The purpose of this study was to explore the extent that COVID-19 initially impacted medical learners around the world and examine global trends and patterns across geographic regions and levels of training. A cross-sectional survey of medical learners was conducted between March 25-June","2021","07","13","Can Med Educ J","Canadian medical education journal",NA,"Kachra","Rahim","Cumming School of Medicine, University of Calgary, Alberta, Canada",NA
"2017","34249183","10.1016/j.ecns.2021.06.010","Nursing Students' Perceptions and Experiences of Using Virtual Simulation During the COVID-19 Pandemic.","This study aimed to understand pre-licensure nursing students' perceptions and experiences of using virtual simulation as an alternative to clinical practice during the coronavirus 2019 (COVID-19) pandemic in South Korea. A total of 20 students from a 4-year baccalaureate nursing program participated in this descriptive qualitative study. Six focus group interviews using Zoom video communications were conducted with three to four participants to understand their experiences. Data were analyzed u","2021","07","13","Clin Simul Nurs","Clinical simulation in nursing","Content Analysis; Experience; Nursing Students; Virtual Nursing Care; Virtual Simulation","Kim","Mi Jong","Department of Nursing, Hannam University, Daejeon, Korea, 70 Hannamro, Daedeok-Gu Daejeon 34430, Korea",NA
"2018","34249183","10.1016/j.ecns.2021.06.010","Nursing Students' Perceptions and Experiences of Using Virtual Simulation During the COVID-19 Pandemic.","This study aimed to understand pre-licensure nursing students' perceptions and experiences of using virtual simulation as an alternative to clinical practice during the coronavirus 2019 (COVID-19) pandemic in South Korea. A total of 20 students from a 4-year baccalaureate nursing program participated in this descriptive qualitative study. Six focus group interviews using Zoom video communications were conducted with three to four participants to understand their experiences. Data were analyzed u","2021","07","13","Clin Simul Nurs","Clinical simulation in nursing","Content Analysis; Experience; Nursing Students; Virtual Nursing Care; Virtual Simulation","Kang","Hee Sun","Red Cross College of Nursing, Chung-Ang University, Seoul, Korea, 84 Heukseok-ro, Dongjak-gu, 06974 Seoul, Korea",NA
"2019","34249183","10.1016/j.ecns.2021.06.010","Nursing Students' Perceptions and Experiences of Using Virtual Simulation During the COVID-19 Pandemic.","This study aimed to understand pre-licensure nursing students' perceptions and experiences of using virtual simulation as an alternative to clinical practice during the coronavirus 2019 (COVID-19) pandemic in South Korea. A total of 20 students from a 4-year baccalaureate nursing program participated in this descriptive qualitative study. Six focus group interviews using Zoom video communications were conducted with three to four participants to understand their experiences. Data were analyzed u","2021","07","13","Clin Simul Nurs","Clinical simulation in nursing","Content Analysis; Experience; Nursing Students; Virtual Nursing Care; Virtual Simulation","De Gagne","Jennie C","School of Nursing at Duke University, Durham, North Carolina, USA",NA
"2020","34249180","10.2174/1874306402115010028","Clinical Features of COVID-19 Patients in Jordan: A Study of 508 Patients.","The symptoms of COVID-19 have a wide range of severity ranging from no symptoms at all to mild symptoms, such as fever, cough, sore throat, general weakness. Moreover, in some situations, patients may develop severe complications as pneumonia, and sepsis, leading to death. This study aims to investigate the characteristic features of COVID-19 patients based on their medical condition prior to COVID-19 diagnosis. A retrospective cohort study took place between the 1st of April 2020 and the 31<sup","2021","07","13","Open Respir Med J","The open respiratory medicine journal","Asymptomatic patients; COVID-19; Hospitalization; Medical comorbidities; SARS-CoV-2; Symptomatic patients","Al-Balas","Mahmoud","Department of General and Special Surgery, Faculty of Medicine, Hashemite University, Zarqa, Jordan",NA
"2021","34249180","10.2174/1874306402115010028","Clinical Features of COVID-19 Patients in Jordan: A Study of 508 Patients.","The symptoms of COVID-19 have a wide range of severity ranging from no symptoms at all to mild symptoms, such as fever, cough, sore throat, general weakness. Moreover, in some situations, patients may develop severe complications as pneumonia, and sepsis, leading to death. This study aims to investigate the characteristic features of COVID-19 patients based on their medical condition prior to COVID-19 diagnosis. A retrospective cohort study took place between the 1st of April 2020 and the 31<sup","2021","07","13","Open Respir Med J","The open respiratory medicine journal","Asymptomatic patients; COVID-19; Hospitalization; Medical comorbidities; SARS-CoV-2; Symptomatic patients","Al-Balas","Hasan I","Faculty of Medicine, Yarmouk University, Irbid, Jordan",NA
"2022","34249180","10.2174/1874306402115010028","Clinical Features of COVID-19 Patients in Jordan: A Study of 508 Patients.","The symptoms of COVID-19 have a wide range of severity ranging from no symptoms at all to mild symptoms, such as fever, cough, sore throat, general weakness. Moreover, in some situations, patients may develop severe complications as pneumonia, and sepsis, leading to death. This study aims to investigate the characteristic features of COVID-19 patients based on their medical condition prior to COVID-19 diagnosis. A retrospective cohort study took place between the 1st of April 2020 and the 31<sup","2021","07","13","Open Respir Med J","The open respiratory medicine journal","Asymptomatic patients; COVID-19; Hospitalization; Medical comorbidities; SARS-CoV-2; Symptomatic patients","Alqassieh","Rami","Department of General and Special Surgery, Faculty of Medicine, Hashemite University, Zarqa, Jordan",NA
"2023","34249180","10.2174/1874306402115010028","Clinical Features of COVID-19 Patients in Jordan: A Study of 508 Patients.","The symptoms of COVID-19 have a wide range of severity ranging from no symptoms at all to mild symptoms, such as fever, cough, sore throat, general weakness. Moreover, in some situations, patients may develop severe complications as pneumonia, and sepsis, leading to death. This study aims to investigate the characteristic features of COVID-19 patients based on their medical condition prior to COVID-19 diagnosis. A retrospective cohort study took place between the 1st of April 2020 and the 31<sup","2021","07","13","Open Respir Med J","The open respiratory medicine journal","Asymptomatic patients; COVID-19; Hospitalization; Medical comorbidities; SARS-CoV-2; Symptomatic patients","Al-Balas","Hamzeh","Department of General and Special Surgery, Faculty of Medicine, Hashemite University, Zarqa, Jordan",NA
"2024","34249180","10.2174/1874306402115010028","Clinical Features of COVID-19 Patients in Jordan: A Study of 508 Patients.","The symptoms of COVID-19 have a wide range of severity ranging from no symptoms at all to mild symptoms, such as fever, cough, sore throat, general weakness. Moreover, in some situations, patients may develop severe complications as pneumonia, and sepsis, leading to death. This study aims to investigate the characteristic features of COVID-19 patients based on their medical condition prior to COVID-19 diagnosis. A retrospective cohort study took place between the 1st of April 2020 and the 31<sup","2021","07","13","Open Respir Med J","The open respiratory medicine journal","Asymptomatic patients; COVID-19; Hospitalization; Medical comorbidities; SARS-CoV-2; Symptomatic patients","Khamees","Almu'atasim","Faculty of Medicine, Yarmouk University, Irbid, Jordan",NA
"2025","34249180","10.2174/1874306402115010028","Clinical Features of COVID-19 Patients in Jordan: A Study of 508 Patients.","The symptoms of COVID-19 have a wide range of severity ranging from no symptoms at all to mild symptoms, such as fever, cough, sore throat, general weakness. Moreover, in some situations, patients may develop severe complications as pneumonia, and sepsis, leading to death. This study aims to investigate the characteristic features of COVID-19 patients based on their medical condition prior to COVID-19 diagnosis. A retrospective cohort study took place between the 1st of April 2020 and the 31<sup","2021","07","13","Open Respir Med J","The open respiratory medicine journal","Asymptomatic patients; COVID-19; Hospitalization; Medical comorbidities; SARS-CoV-2; Symptomatic patients","Al-Balas","Rahaf","Faculty of Medicine, Yarmouk University, Irbid, Jordan",NA
"2026","34249180","10.2174/1874306402115010028","Clinical Features of COVID-19 Patients in Jordan: A Study of 508 Patients.","The symptoms of COVID-19 have a wide range of severity ranging from no symptoms at all to mild symptoms, such as fever, cough, sore throat, general weakness. Moreover, in some situations, patients may develop severe complications as pneumonia, and sepsis, leading to death. This study aims to investigate the characteristic features of COVID-19 patients based on their medical condition prior to COVID-19 diagnosis. A retrospective cohort study took place between the 1st of April 2020 and the 31<sup","2021","07","13","Open Respir Med J","The open respiratory medicine journal","Asymptomatic patients; COVID-19; Hospitalization; Medical comorbidities; SARS-CoV-2; Symptomatic patients","Al-Balas","Samir","Department of Basic Sciences, Faculty of Medicine, Yarmouk University, Irbid, Jordan",NA
"2027","34249179","10.2174/1874306402115010023","Outcomes of Continuous Positive Airway Pressure in the Management of Patients with Coronavirus (COVID-19) Pneumonia who are not Suitable for Invasive Ventilation.","The optimum management of respiratory failure in patients with coronavirus (COVID-19) infections has been a challenge for physicians across the globe. Many scientific societies have suggested the use of CPAP (continuous positive airway pressure) in severe cases in an effort to reduce invasive ventilation. We investigated mortality outcomes in patients who needed CPAP but were not suitable for invasive ventilation. We retrospectively evaluated the mortality outcomes of all consecutive COVID-19 ca","2021","07","13","Open Respir Med J","The open respiratory medicine journal","COVID-19; CPAP; Critically ill; Non-invasive ventilation; Respiratory failure; Ventilation","Aung","Hnin","Department of Respiratory Medicine, Kettering General Hospital NHS Foundation Trust, Kettering, United Kingdom",NA
"2028","34249179","10.2174/1874306402115010023","Outcomes of Continuous Positive Airway Pressure in the Management of Patients with Coronavirus (COVID-19) Pneumonia who are not Suitable for Invasive Ventilation.","The optimum management of respiratory failure in patients with coronavirus (COVID-19) infections has been a challenge for physicians across the globe. Many scientific societies have suggested the use of CPAP (continuous positive airway pressure) in severe cases in an effort to reduce invasive ventilation. We investigated mortality outcomes in patients who needed CPAP but were not suitable for invasive ventilation. We retrospectively evaluated the mortality outcomes of all consecutive COVID-19 ca","2021","07","13","Open Respir Med J","The open respiratory medicine journal","COVID-19; CPAP; Critically ill; Non-invasive ventilation; Respiratory failure; Ventilation","Avraam","Eleni","Department of Respiratory Medicine, Kettering General Hospital NHS Foundation Trust, Kettering, United Kingdom",NA
"2029","34249179","10.2174/1874306402115010023","Outcomes of Continuous Positive Airway Pressure in the Management of Patients with Coronavirus (COVID-19) Pneumonia who are not Suitable for Invasive Ventilation.","The optimum management of respiratory failure in patients with coronavirus (COVID-19) infections has been a challenge for physicians across the globe. Many scientific societies have suggested the use of CPAP (continuous positive airway pressure) in severe cases in an effort to reduce invasive ventilation. We investigated mortality outcomes in patients who needed CPAP but were not suitable for invasive ventilation. We retrospectively evaluated the mortality outcomes of all consecutive COVID-19 ca","2021","07","13","Open Respir Med J","The open respiratory medicine journal","COVID-19; CPAP; Critically ill; Non-invasive ventilation; Respiratory failure; Ventilation","Ashraf","Muhammad","Department of Respiratory Medicine, Kettering General Hospital NHS Foundation Trust, Kettering, United Kingdom",NA
"2030","34249179","10.2174/1874306402115010023","Outcomes of Continuous Positive Airway Pressure in the Management of Patients with Coronavirus (COVID-19) Pneumonia who are not Suitable for Invasive Ventilation.","The optimum management of respiratory failure in patients with coronavirus (COVID-19) infections has been a challenge for physicians across the globe. Many scientific societies have suggested the use of CPAP (continuous positive airway pressure) in severe cases in an effort to reduce invasive ventilation. We investigated mortality outcomes in patients who needed CPAP but were not suitable for invasive ventilation. We retrospectively evaluated the mortality outcomes of all consecutive COVID-19 ca","2021","07","13","Open Respir Med J","The open respiratory medicine journal","COVID-19; CPAP; Critically ill; Non-invasive ventilation; Respiratory failure; Ventilation","Karim","Nawazish","Department of Respiratory Medicine, Kettering General Hospital NHS Foundation Trust, Kettering, United Kingdom",NA
"2031","34249179","10.2174/1874306402115010023","Outcomes of Continuous Positive Airway Pressure in the Management of Patients with Coronavirus (COVID-19) Pneumonia who are not Suitable for Invasive Ventilation.","The optimum management of respiratory failure in patients with coronavirus (COVID-19) infections has been a challenge for physicians across the globe. Many scientific societies have suggested the use of CPAP (continuous positive airway pressure) in severe cases in an effort to reduce invasive ventilation. We investigated mortality outcomes in patients who needed CPAP but were not suitable for invasive ventilation. We retrospectively evaluated the mortality outcomes of all consecutive COVID-19 ca","2021","07","13","Open Respir Med J","The open respiratory medicine journal","COVID-19; CPAP; Critically ill; Non-invasive ventilation; Respiratory failure; Ventilation","Kiran","Sidra","Department of Respiratory Medicine, Kettering General Hospital NHS Foundation Trust, Kettering, United Kingdom",NA
"2032","34249179","10.2174/1874306402115010023","Outcomes of Continuous Positive Airway Pressure in the Management of Patients with Coronavirus (COVID-19) Pneumonia who are not Suitable for Invasive Ventilation.","The optimum management of respiratory failure in patients with coronavirus (COVID-19) infections has been a challenge for physicians across the globe. Many scientific societies have suggested the use of CPAP (continuous positive airway pressure) in severe cases in an effort to reduce invasive ventilation. We investigated mortality outcomes in patients who needed CPAP but were not suitable for invasive ventilation. We retrospectively evaluated the mortality outcomes of all consecutive COVID-19 ca","2021","07","13","Open Respir Med J","The open respiratory medicine journal","COVID-19; CPAP; Critically ill; Non-invasive ventilation; Respiratory failure; Ventilation","Naeem","Muhammed","Department of Respiratory Medicine, Kettering General Hospital NHS Foundation Trust, Kettering, United Kingdom",NA
"2033","34249179","10.2174/1874306402115010023","Outcomes of Continuous Positive Airway Pressure in the Management of Patients with Coronavirus (COVID-19) Pneumonia who are not Suitable for Invasive Ventilation.","The optimum management of respiratory failure in patients with coronavirus (COVID-19) infections has been a challenge for physicians across the globe. Many scientific societies have suggested the use of CPAP (continuous positive airway pressure) in severe cases in an effort to reduce invasive ventilation. We investigated mortality outcomes in patients who needed CPAP but were not suitable for invasive ventilation. We retrospectively evaluated the mortality outcomes of all consecutive COVID-19 ca","2021","07","13","Open Respir Med J","The open respiratory medicine journal","COVID-19; CPAP; Critically ill; Non-invasive ventilation; Respiratory failure; Ventilation","Mallik","Srikumar","Department of Respiratory Medicine, Kettering General Hospital NHS Foundation Trust, Kettering, United Kingdom",NA
"2034","34249179","10.2174/1874306402115010023","Outcomes of Continuous Positive Airway Pressure in the Management of Patients with Coronavirus (COVID-19) Pneumonia who are not Suitable for Invasive Ventilation.","The optimum management of respiratory failure in patients with coronavirus (COVID-19) infections has been a challenge for physicians across the globe. Many scientific societies have suggested the use of CPAP (continuous positive airway pressure) in severe cases in an effort to reduce invasive ventilation. We investigated mortality outcomes in patients who needed CPAP but were not suitable for invasive ventilation. We retrospectively evaluated the mortality outcomes of all consecutive COVID-19 ca","2021","07","13","Open Respir Med J","The open respiratory medicine journal","COVID-19; CPAP; Critically ill; Non-invasive ventilation; Respiratory failure; Ventilation","Panchatsharam","Selva","Department of Intensive Care Medicine, Kettering General Hospital NHS Foundation Trust, Kettering, United Kingdom",NA
"2035","34249179","10.2174/1874306402115010023","Outcomes of Continuous Positive Airway Pressure in the Management of Patients with Coronavirus (COVID-19) Pneumonia who are not Suitable for Invasive Ventilation.","The optimum management of respiratory failure in patients with coronavirus (COVID-19) infections has been a challenge for physicians across the globe. Many scientific societies have suggested the use of CPAP (continuous positive airway pressure) in severe cases in an effort to reduce invasive ventilation. We investigated mortality outcomes in patients who needed CPAP but were not suitable for invasive ventilation. We retrospectively evaluated the mortality outcomes of all consecutive COVID-19 ca","2021","07","13","Open Respir Med J","The open respiratory medicine journal","COVID-19; CPAP; Critically ill; Non-invasive ventilation; Respiratory failure; Ventilation","Tsaknis","George","Department of Respiratory Medicine, Kettering General Hospital NHS Foundation Trust, Kettering, United Kingdom",NA
"2036","34249179","10.2174/1874306402115010023","Outcomes of Continuous Positive Airway Pressure in the Management of Patients with Coronavirus (COVID-19) Pneumonia who are not Suitable for Invasive Ventilation.","The optimum management of respiratory failure in patients with coronavirus (COVID-19) infections has been a challenge for physicians across the globe. Many scientific societies have suggested the use of CPAP (continuous positive airway pressure) in severe cases in an effort to reduce invasive ventilation. We investigated mortality outcomes in patients who needed CPAP but were not suitable for invasive ventilation. We retrospectively evaluated the mortality outcomes of all consecutive COVID-19 ca","2021","07","13","Open Respir Med J","The open respiratory medicine journal","COVID-19; CPAP; Critically ill; Non-invasive ventilation; Respiratory failure; Ventilation","Reddy","Raja","Department of Respiratory Medicine, Kettering General Hospital NHS Foundation Trust, Kettering, United Kingdom",NA
"2037","34249171","10.1007/s12308-021-00459-3","Blood cell morphology and COVID-19 clinical course, severity, and outcome.","COVID-19 infection affects different organs of the human body, and blood cells are not an exception. Peripheral blood smear (PBS) is a simple and available method to investigate blood cells' morphologic changes. In this study, we aimed to determine the morphologic changes and abnormalities of COVID-19 patients and their relation to the patients' clinical course. In this prospective cross-sectional study, we included 89 PCR-positive COVID-19 patients. A pathologist examined the PBS findings of th","2021","07","13","J Hematop","Journal of hematopathology","Blood cell; COVID-19; Morphology; Pathology","Pezeshki","Amirhossein","Pathology Department and Isfahan Medical Students Research Committee (ISRC), School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran",NA
"2038","34249171","10.1007/s12308-021-00459-3","Blood cell morphology and COVID-19 clinical course, severity, and outcome.","COVID-19 infection affects different organs of the human body, and blood cells are not an exception. Peripheral blood smear (PBS) is a simple and available method to investigate blood cells' morphologic changes. In this study, we aimed to determine the morphologic changes and abnormalities of COVID-19 patients and their relation to the patients' clinical course. In this prospective cross-sectional study, we included 89 PCR-positive COVID-19 patients. A pathologist examined the PBS findings of th","2021","07","13","J Hematop","Journal of hematopathology","Blood cell; COVID-19; Morphology; Pathology","Vaezi","Atefeh","Applied Physiology Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Science, Isfahan, Iran",NA
"2039","34249171","10.1007/s12308-021-00459-3","Blood cell morphology and COVID-19 clinical course, severity, and outcome.","COVID-19 infection affects different organs of the human body, and blood cells are not an exception. Peripheral blood smear (PBS) is a simple and available method to investigate blood cells' morphologic changes. In this study, we aimed to determine the morphologic changes and abnormalities of COVID-19 patients and their relation to the patients' clinical course. In this prospective cross-sectional study, we included 89 PCR-positive COVID-19 patients. A pathologist examined the PBS findings of th","2021","07","13","J Hematop","Journal of hematopathology","Blood cell; COVID-19; Morphology; Pathology","Nematollahi","Pardis","Pathology Department, Medical school, Isfahan University of Medical Sciences, Hezarjarib St, Isfahan, Iran",NA
"2040","34249167","10.1007/s12195-021-00686-9","Metal Organic Frameworks as Biosensing Materials for COVID-19.","The novel coronavirus disease (COVID-19) pandemic outbreak is the most startling public health crises with attendant global socio-economic burden ever experienced in the twenty-first century. The level of devastation by this outbreak is such that highly impacted countries will take years to recover. Studies have shown that timely detection based on accelerated sample testing and accurate diagnosis are crucial steps to reducing or preventing the spread of any pandemic outbreak. In this opinionate","2021","07","13","Cell Mol Bioeng","Cellular and molecular bioengineering","Biosensors; Covid-19; Infectious diseases testing and detection; Metal organic frameworks; Pandemic outbreak","Udourioh","Godwin A","Analytical/Material Chemistry Laboratory, Department of Pure and Applied Chemistry, Faculty of Natural and Applied Sciences, Veritas University, Abuja, P.O.Box 6523, Garki, Abuja Nigeria",NA
"2041","34249167","10.1007/s12195-021-00686-9","Metal Organic Frameworks as Biosensing Materials for COVID-19.","The novel coronavirus disease (COVID-19) pandemic outbreak is the most startling public health crises with attendant global socio-economic burden ever experienced in the twenty-first century. The level of devastation by this outbreak is such that highly impacted countries will take years to recover. Studies have shown that timely detection based on accelerated sample testing and accurate diagnosis are crucial steps to reducing or preventing the spread of any pandemic outbreak. In this opinionate","2021","07","13","Cell Mol Bioeng","Cellular and molecular bioengineering","Biosensors; Covid-19; Infectious diseases testing and detection; Metal organic frameworks; Pandemic outbreak","Solomon","Moses M","Department of Chemistry, College of Science and Technology, Covenant University, Canaanland, Km10, Idiroko Road, Ota, Ogun State Nigeria",NA
"2042","34249167","10.1007/s12195-021-00686-9","Metal Organic Frameworks as Biosensing Materials for COVID-19.","The novel coronavirus disease (COVID-19) pandemic outbreak is the most startling public health crises with attendant global socio-economic burden ever experienced in the twenty-first century. The level of devastation by this outbreak is such that highly impacted countries will take years to recover. Studies have shown that timely detection based on accelerated sample testing and accurate diagnosis are crucial steps to reducing or preventing the spread of any pandemic outbreak. In this opinionate","2021","07","13","Cell Mol Bioeng","Cellular and molecular bioengineering","Biosensors; Covid-19; Infectious diseases testing and detection; Metal organic frameworks; Pandemic outbreak","Epelle","Emmanuel I","Institute for Materials and Processes (IMP), School of Engineering, University of Edinburgh, The King's Buildings, Edinburgh, EH9 3FB UK",NA
"2043","34249149","10.1177/17588359211027825","Unexpected tumor reduction in metastatic colorectal cancer patients during SARS-Cov-2 infection: effect of ACE-2 expression on tumor cells or molecular mimicry phenomena? Two not mutually exclusive hypotheses.",NA,"2021","07","13","Ther Adv Med Oncol","Therapeutic advances in medical oncology","colorectal cancer; immunotherapy; metastasis; molecular oncology; prognostic biomarker","Cappello","Francesco","Department of Biomedicine, Neurosciences and Advanced Diagnostics (BIND), Institute of Human Anatomy and Histology, University of Palermo, Via del Vespro 129, Palermo 90141, Italy",NA
"2044","34249149","10.1177/17588359211027825","Unexpected tumor reduction in metastatic colorectal cancer patients during SARS-Cov-2 infection: effect of ACE-2 expression on tumor cells or molecular mimicry phenomena? Two not mutually exclusive hypotheses.",NA,"2021","07","13","Ther Adv Med Oncol","Therapeutic advances in medical oncology","colorectal cancer; immunotherapy; metastasis; molecular oncology; prognostic biomarker","Burgio","Stefano","Department of Biomedicine, Neurosciences and Advanced Diagnostics (BIND), Institute of Human Anatomy and Histology, University of Palermo, Palermo, Italy",NA
"2045","34249149","10.1177/17588359211027825","Unexpected tumor reduction in metastatic colorectal cancer patients during SARS-Cov-2 infection: effect of ACE-2 expression on tumor cells or molecular mimicry phenomena? Two not mutually exclusive hypotheses.",NA,"2021","07","13","Ther Adv Med Oncol","Therapeutic advances in medical oncology","colorectal cancer; immunotherapy; metastasis; molecular oncology; prognostic biomarker","Conway de Macario","Everly","Department of Microbiology and Immunology, School of Medicine, University of Maryland at Baltimore-Institute of Marine and Environmental Technology (IMET), Baltimore, MD, USA",NA
"2046","34249149","10.1177/17588359211027825","Unexpected tumor reduction in metastatic colorectal cancer patients during SARS-Cov-2 infection: effect of ACE-2 expression on tumor cells or molecular mimicry phenomena? Two not mutually exclusive hypotheses.",NA,"2021","07","13","Ther Adv Med Oncol","Therapeutic advances in medical oncology","colorectal cancer; immunotherapy; metastasis; molecular oncology; prognostic biomarker","Macario","Alberto J L","Department of Microbiology and Immunology, School of Medicine, University of Maryland at Baltimore-Institute of Marine and Environmental Technology (IMET), Baltimore, MD, USA",NA
"2047","34249143","10.1016/j.nantod.2021.101243","TiO<sub>2</sub> supported single Ag atoms nanozyme for elimination of SARS-CoV2.","The outbreak of SARS-coronavirus 2 (SARS-CoV2) has become a global health emergency. Although enormous efforts have been made, there is still no effective treatment against the new virus. Herein, a TiO2 supported single-atom nanozyme containing atomically dispersed Ag atoms (Ag-TiO2 SAN) is designed to serve as a highly efficient antiviral nanomaterial. Compared with traditional nano-TiO2 and Ag, Ag-TiO2 SAN exhibits higher adsorption (99.65%) of SARS-","2021","07","16","Nano Today","Nano today","Anti-SARS-CoV2; Neutralization; Peroxidase-like activity; Reactive oxygen species; Single-atom nanozyme","Wang","Daji","Shenzhen Key Laboratory of nanozymes and Translational Cancer Research, Department of Otolaryngology, and Institute of Translational Medicine, Shenzhen Second People's Hospital/the First Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen 518035, China",NA
"2048","34249143","10.1016/j.nantod.2021.101243","TiO<sub>2</sub> supported single Ag atoms nanozyme for elimination of SARS-CoV2.","The outbreak of SARS-coronavirus 2 (SARS-CoV2) has become a global health emergency. Although enormous efforts have been made, there is still no effective treatment against the new virus. Herein, a TiO2 supported single-atom nanozyme containing atomically dispersed Ag atoms (Ag-TiO2 SAN) is designed to serve as a highly efficient antiviral nanomaterial. Compared with traditional nano-TiO2 and Ag, Ag-TiO2 SAN exhibits higher adsorption (99.65%) of SARS-","2021","07","16","Nano Today","Nano today","Anti-SARS-CoV2; Neutralization; Peroxidase-like activity; Reactive oxygen species; Single-atom nanozyme","Zhang","Bin","Shenzhen Key Laboratory of nanozymes and Translational Cancer Research, Department of Otolaryngology, and Institute of Translational Medicine, Shenzhen Second People's Hospital/the First Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen 518035, China",NA
"2049","34249143","10.1016/j.nantod.2021.101243","TiO<sub>2</sub> supported single Ag atoms nanozyme for elimination of SARS-CoV2.","The outbreak of SARS-coronavirus 2 (SARS-CoV2) has become a global health emergency. Although enormous efforts have been made, there is still no effective treatment against the new virus. Herein, a TiO2 supported single-atom nanozyme containing atomically dispersed Ag atoms (Ag-TiO2 SAN) is designed to serve as a highly efficient antiviral nanomaterial. Compared with traditional nano-TiO2 and Ag, Ag-TiO2 SAN exhibits higher adsorption (99.65%) of SARS-","2021","07","16","Nano Today","Nano today","Anti-SARS-CoV2; Neutralization; Peroxidase-like activity; Reactive oxygen species; Single-atom nanozyme","Ding","Hui","Shenzhen Key Laboratory of nanozymes and Translational Cancer Research, Department of Otolaryngology, and Institute of Translational Medicine, Shenzhen Second People's Hospital/the First Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen 518035, China",NA
"2050","34249143","10.1016/j.nantod.2021.101243","TiO<sub>2</sub> supported single Ag atoms nanozyme for elimination of SARS-CoV2.","The outbreak of SARS-coronavirus 2 (SARS-CoV2) has become a global health emergency. Although enormous efforts have been made, there is still no effective treatment against the new virus. Herein, a TiO2 supported single-atom nanozyme containing atomically dispersed Ag atoms (Ag-TiO2 SAN) is designed to serve as a highly efficient antiviral nanomaterial. Compared with traditional nano-TiO2 and Ag, Ag-TiO2 SAN exhibits higher adsorption (99.65%) of SARS-","2021","07","16","Nano Today","Nano today","Anti-SARS-CoV2; Neutralization; Peroxidase-like activity; Reactive oxygen species; Single-atom nanozyme","Liu","Dan","CAS Engineering Laboratory for Nanozyme, Key Laboratory of Protein and Peptide Pharmaceuticals, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China",NA
"2051","34249143","10.1016/j.nantod.2021.101243","TiO<sub>2</sub> supported single Ag atoms nanozyme for elimination of SARS-CoV2.","The outbreak of SARS-coronavirus 2 (SARS-CoV2) has become a global health emergency. Although enormous efforts have been made, there is still no effective treatment against the new virus. Herein, a TiO2 supported single-atom nanozyme containing atomically dispersed Ag atoms (Ag-TiO2 SAN) is designed to serve as a highly efficient antiviral nanomaterial. Compared with traditional nano-TiO2 and Ag, Ag-TiO2 SAN exhibits higher adsorption (99.65%) of SARS-","2021","07","16","Nano Today","Nano today","Anti-SARS-CoV2; Neutralization; Peroxidase-like activity; Reactive oxygen species; Single-atom nanozyme","Xiang","Jianquan","School of Basic Medical Sciences, Southwest Medical University, Sichuan 646000, China",NA
"2052","34249143","10.1016/j.nantod.2021.101243","TiO<sub>2</sub> supported single Ag atoms nanozyme for elimination of SARS-CoV2.","The outbreak of SARS-coronavirus 2 (SARS-CoV2) has become a global health emergency. Although enormous efforts have been made, there is still no effective treatment against the new virus. Herein, a TiO2 supported single-atom nanozyme containing atomically dispersed Ag atoms (Ag-TiO2 SAN) is designed to serve as a highly efficient antiviral nanomaterial. Compared with traditional nano-TiO2 and Ag, Ag-TiO2 SAN exhibits higher adsorption (99.65%) of SARS-","2021","07","16","Nano Today","Nano today","Anti-SARS-CoV2; Neutralization; Peroxidase-like activity; Reactive oxygen species; Single-atom nanozyme","Gao","Xuejiao J","College of Chemistry and Chemical Engineering, Jiangxi Normal University, Nanchang 330022, China",NA
"2053","34249143","10.1016/j.nantod.2021.101243","TiO<sub>2</sub> supported single Ag atoms nanozyme for elimination of SARS-CoV2.","The outbreak of SARS-coronavirus 2 (SARS-CoV2) has become a global health emergency. Although enormous efforts have been made, there is still no effective treatment against the new virus. Herein, a TiO2 supported single-atom nanozyme containing atomically dispersed Ag atoms (Ag-TiO2 SAN) is designed to serve as a highly efficient antiviral nanomaterial. Compared with traditional nano-TiO2 and Ag, Ag-TiO2 SAN exhibits higher adsorption (99.65%) of SARS-","2021","07","16","Nano Today","Nano today","Anti-SARS-CoV2; Neutralization; Peroxidase-like activity; Reactive oxygen species; Single-atom nanozyme","Chen","Xuehui","CAS Engineering Laboratory for Nanozyme, Key Laboratory of Protein and Peptide Pharmaceuticals, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China",NA
"2054","34249143","10.1016/j.nantod.2021.101243","TiO<sub>2</sub> supported single Ag atoms nanozyme for elimination of SARS-CoV2.","The outbreak of SARS-coronavirus 2 (SARS-CoV2) has become a global health emergency. Although enormous efforts have been made, there is still no effective treatment against the new virus. Herein, a TiO2 supported single-atom nanozyme containing atomically dispersed Ag atoms (Ag-TiO2 SAN) is designed to serve as a highly efficient antiviral nanomaterial. Compared with traditional nano-TiO2 and Ag, Ag-TiO2 SAN exhibits higher adsorption (99.65%) of SARS-","2021","07","16","Nano Today","Nano today","Anti-SARS-CoV2; Neutralization; Peroxidase-like activity; Reactive oxygen species; Single-atom nanozyme","Li","Zhongjun","Shenzhen Key Laboratory of nanozymes and Translational Cancer Research, Department of Otolaryngology, and Institute of Translational Medicine, Shenzhen Second People's Hospital/the First Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen 518035, China",NA
"2055","34249143","10.1016/j.nantod.2021.101243","TiO<sub>2</sub> supported single Ag atoms nanozyme for elimination of SARS-CoV2.","The outbreak of SARS-coronavirus 2 (SARS-CoV2) has become a global health emergency. Although enormous efforts have been made, there is still no effective treatment against the new virus. Herein, a TiO2 supported single-atom nanozyme containing atomically dispersed Ag atoms (Ag-TiO2 SAN) is designed to serve as a highly efficient antiviral nanomaterial. Compared with traditional nano-TiO2 and Ag, Ag-TiO2 SAN exhibits higher adsorption (99.65%) of SARS-","2021","07","16","Nano Today","Nano today","Anti-SARS-CoV2; Neutralization; Peroxidase-like activity; Reactive oxygen species; Single-atom nanozyme","Yang","Lei","Shenzhen Key Laboratory of nanozymes and Translational Cancer Research, Department of Otolaryngology, and Institute of Translational Medicine, Shenzhen Second People's Hospital/the First Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen 518035, China",NA
"2056","34249143","10.1016/j.nantod.2021.101243","TiO<sub>2</sub> supported single Ag atoms nanozyme for elimination of SARS-CoV2.","The outbreak of SARS-coronavirus 2 (SARS-CoV2) has become a global health emergency. Although enormous efforts have been made, there is still no effective treatment against the new virus. Herein, a TiO2 supported single-atom nanozyme containing atomically dispersed Ag atoms (Ag-TiO2 SAN) is designed to serve as a highly efficient antiviral nanomaterial. Compared with traditional nano-TiO2 and Ag, Ag-TiO2 SAN exhibits higher adsorption (99.65%) of SARS-","2021","07","16","Nano Today","Nano today","Anti-SARS-CoV2; Neutralization; Peroxidase-like activity; Reactive oxygen species; Single-atom nanozyme","Duan","Hongxia","CAS Engineering Laboratory for Nanozyme, Key Laboratory of Protein and Peptide Pharmaceuticals, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China",NA
"2057","34249143","10.1016/j.nantod.2021.101243","TiO<sub>2</sub> supported single Ag atoms nanozyme for elimination of SARS-CoV2.","The outbreak of SARS-coronavirus 2 (SARS-CoV2) has become a global health emergency. Although enormous efforts have been made, there is still no effective treatment against the new virus. Herein, a TiO2 supported single-atom nanozyme containing atomically dispersed Ag atoms (Ag-TiO2 SAN) is designed to serve as a highly efficient antiviral nanomaterial. Compared with traditional nano-TiO2 and Ag, Ag-TiO2 SAN exhibits higher adsorption (99.65%) of SARS-","2021","07","16","Nano Today","Nano today","Anti-SARS-CoV2; Neutralization; Peroxidase-like activity; Reactive oxygen species; Single-atom nanozyme","Zheng","Jiyan","CAS Engineering Laboratory for Nanozyme, Key Laboratory of Protein and Peptide Pharmaceuticals, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China",NA
"2058","34249143","10.1016/j.nantod.2021.101243","TiO<sub>2</sub> supported single Ag atoms nanozyme for elimination of SARS-CoV2.","The outbreak of SARS-coronavirus 2 (SARS-CoV2) has become a global health emergency. Although enormous efforts have been made, there is still no effective treatment against the new virus. Herein, a TiO2 supported single-atom nanozyme containing atomically dispersed Ag atoms (Ag-TiO2 SAN) is designed to serve as a highly efficient antiviral nanomaterial. Compared with traditional nano-TiO2 and Ag, Ag-TiO2 SAN exhibits higher adsorption (99.65%) of SARS-","2021","07","16","Nano Today","Nano today","Anti-SARS-CoV2; Neutralization; Peroxidase-like activity; Reactive oxygen species; Single-atom nanozyme","Liu","Zheng","CAS Engineering Laboratory for Nanozyme, Key Laboratory of Protein and Peptide Pharmaceuticals, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China",NA
"2059","34249143","10.1016/j.nantod.2021.101243","TiO<sub>2</sub> supported single Ag atoms nanozyme for elimination of SARS-CoV2.","The outbreak of SARS-coronavirus 2 (SARS-CoV2) has become a global health emergency. Although enormous efforts have been made, there is still no effective treatment against the new virus. Herein, a TiO2 supported single-atom nanozyme containing atomically dispersed Ag atoms (Ag-TiO2 SAN) is designed to serve as a highly efficient antiviral nanomaterial. Compared with traditional nano-TiO2 and Ag, Ag-TiO2 SAN exhibits higher adsorption (99.65%) of SARS-","2021","07","16","Nano Today","Nano today","Anti-SARS-CoV2; Neutralization; Peroxidase-like activity; Reactive oxygen species; Single-atom nanozyme","Jiang","Bing","CAS Engineering Laboratory for Nanozyme, Key Laboratory of Protein and Peptide Pharmaceuticals, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China",NA
"2060","34249143","10.1016/j.nantod.2021.101243","TiO<sub>2</sub> supported single Ag atoms nanozyme for elimination of SARS-CoV2.","The outbreak of SARS-coronavirus 2 (SARS-CoV2) has become a global health emergency. Although enormous efforts have been made, there is still no effective treatment against the new virus. Herein, a TiO2 supported single-atom nanozyme containing atomically dispersed Ag atoms (Ag-TiO2 SAN) is designed to serve as a highly efficient antiviral nanomaterial. Compared with traditional nano-TiO2 and Ag, Ag-TiO2 SAN exhibits higher adsorption (99.65%) of SARS-","2021","07","16","Nano Today","Nano today","Anti-SARS-CoV2; Neutralization; Peroxidase-like activity; Reactive oxygen species; Single-atom nanozyme","Liu","Yang","Shenzhen Key Laboratory of nanozymes and Translational Cancer Research, Department of Otolaryngology, and Institute of Translational Medicine, Shenzhen Second People's Hospital/the First Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen 518035, China",NA
"2061","34249143","10.1016/j.nantod.2021.101243","TiO<sub>2</sub> supported single Ag atoms nanozyme for elimination of SARS-CoV2.","The outbreak of SARS-coronavirus 2 (SARS-CoV2) has become a global health emergency. Although enormous efforts have been made, there is still no effective treatment against the new virus. Herein, a TiO2 supported single-atom nanozyme containing atomically dispersed Ag atoms (Ag-TiO2 SAN) is designed to serve as a highly efficient antiviral nanomaterial. Compared with traditional nano-TiO2 and Ag, Ag-TiO2 SAN exhibits higher adsorption (99.65%) of SARS-","2021","07","16","Nano Today","Nano today","Anti-SARS-CoV2; Neutralization; Peroxidase-like activity; Reactive oxygen species; Single-atom nanozyme","Xie","Ni","Shenzhen Key Laboratory of nanozymes and Translational Cancer Research, Department of Otolaryngology, and Institute of Translational Medicine, Shenzhen Second People's Hospital/the First Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen 518035, China",NA
"2062","34249143","10.1016/j.nantod.2021.101243","TiO<sub>2</sub> supported single Ag atoms nanozyme for elimination of SARS-CoV2.","The outbreak of SARS-coronavirus 2 (SARS-CoV2) has become a global health emergency. Although enormous efforts have been made, there is still no effective treatment against the new virus. Herein, a TiO2 supported single-atom nanozyme containing atomically dispersed Ag atoms (Ag-TiO2 SAN) is designed to serve as a highly efficient antiviral nanomaterial. Compared with traditional nano-TiO2 and Ag, Ag-TiO2 SAN exhibits higher adsorption (99.65%) of SARS-","2021","07","16","Nano Today","Nano today","Anti-SARS-CoV2; Neutralization; Peroxidase-like activity; Reactive oxygen species; Single-atom nanozyme","Zhang","Han","SZU-NUS Collaborative Innovation Center for Optoelectronic Science &amp",NA
"2063","34249143","10.1016/j.nantod.2021.101243","TiO<sub>2</sub> supported single Ag atoms nanozyme for elimination of SARS-CoV2.","The outbreak of SARS-coronavirus 2 (SARS-CoV2) has become a global health emergency. Although enormous efforts have been made, there is still no effective treatment against the new virus. Herein, a TiO2 supported single-atom nanozyme containing atomically dispersed Ag atoms (Ag-TiO2 SAN) is designed to serve as a highly efficient antiviral nanomaterial. Compared with traditional nano-TiO2 and Ag, Ag-TiO2 SAN exhibits higher adsorption (99.65%) of SARS-","2021","07","16","Nano Today","Nano today","Anti-SARS-CoV2; Neutralization; Peroxidase-like activity; Reactive oxygen species; Single-atom nanozyme","Yan","Xiyun","Shenzhen Key Laboratory of nanozymes and Translational Cancer Research, Department of Otolaryngology, and Institute of Translational Medicine, Shenzhen Second People's Hospital/the First Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen 518035, China",NA
"2064","34249143","10.1016/j.nantod.2021.101243","TiO<sub>2</sub> supported single Ag atoms nanozyme for elimination of SARS-CoV2.","The outbreak of SARS-coronavirus 2 (SARS-CoV2) has become a global health emergency. Although enormous efforts have been made, there is still no effective treatment against the new virus. Herein, a TiO2 supported single-atom nanozyme containing atomically dispersed Ag atoms (Ag-TiO2 SAN) is designed to serve as a highly efficient antiviral nanomaterial. Compared with traditional nano-TiO2 and Ag, Ag-TiO2 SAN exhibits higher adsorption (99.65%) of SARS-","2021","07","16","Nano Today","Nano today","Anti-SARS-CoV2; Neutralization; Peroxidase-like activity; Reactive oxygen species; Single-atom nanozyme","Fan","Kelong","CAS Engineering Laboratory for Nanozyme, Key Laboratory of Protein and Peptide Pharmaceuticals, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China",NA
"2065","34249143","10.1016/j.nantod.2021.101243","TiO<sub>2</sub> supported single Ag atoms nanozyme for elimination of SARS-CoV2.","The outbreak of SARS-coronavirus 2 (SARS-CoV2) has become a global health emergency. Although enormous efforts have been made, there is still no effective treatment against the new virus. Herein, a TiO2 supported single-atom nanozyme containing atomically dispersed Ag atoms (Ag-TiO2 SAN) is designed to serve as a highly efficient antiviral nanomaterial. Compared with traditional nano-TiO2 and Ag, Ag-TiO2 SAN exhibits higher adsorption (99.65%) of SARS-","2021","07","16","Nano Today","Nano today","Anti-SARS-CoV2; Neutralization; Peroxidase-like activity; Reactive oxygen species; Single-atom nanozyme","Nie","Guohui","Shenzhen Key Laboratory of nanozymes and Translational Cancer Research, Department of Otolaryngology, and Institute of Translational Medicine, Shenzhen Second People's Hospital/the First Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen 518035, China",NA
"2066","34249142","10.1016/j.bspc.2021.102960","A cognitive IoT-based framework for effective diagnosis of COVID-19 using multimodal data.","The COVID-19 emerged at the end of 2019 and has become a global pandemic. There are many methods for COVID-19 prediction using a single modality. However, none of them predicts with 100% accuracy, as each individual exhibits varied symptoms for the disease. To decrease the rate of misdiagnosis, multiple modalities can be used for prediction. Besides, there is also a need for a self-diagnosis system to narrow down the risk of virus spread in testing centres. Therefore, we propose a robust IoT and","2021","07","12","Biomed Signal Process Control","Biomedical signal processing and control","Audio; Deep learning; Image; Multimodal fusion; Reduced network complexity; Self-diagnosis","Jayachitra","V P","Department of Computer Technology, MIT campus, Anna University, Chennai",NA
"2067","34249142","10.1016/j.bspc.2021.102960","A cognitive IoT-based framework for effective diagnosis of COVID-19 using multimodal data.","The COVID-19 emerged at the end of 2019 and has become a global pandemic. There are many methods for COVID-19 prediction using a single modality. However, none of them predicts with 100% accuracy, as each individual exhibits varied symptoms for the disease. To decrease the rate of misdiagnosis, multiple modalities can be used for prediction. Besides, there is also a need for a self-diagnosis system to narrow down the risk of virus spread in testing centres. Therefore, we propose a robust IoT and","2021","07","12","Biomed Signal Process Control","Biomedical signal processing and control","Audio; Deep learning; Image; Multimodal fusion; Reduced network complexity; Self-diagnosis","Nivetha","S","Department of Computer Technology, MIT campus, Anna University, Chennai",NA
"2068","34249142","10.1016/j.bspc.2021.102960","A cognitive IoT-based framework for effective diagnosis of COVID-19 using multimodal data.","The COVID-19 emerged at the end of 2019 and has become a global pandemic. There are many methods for COVID-19 prediction using a single modality. However, none of them predicts with 100% accuracy, as each individual exhibits varied symptoms for the disease. To decrease the rate of misdiagnosis, multiple modalities can be used for prediction. Besides, there is also a need for a self-diagnosis system to narrow down the risk of virus spread in testing centres. Therefore, we propose a robust IoT and","2021","07","12","Biomed Signal Process Control","Biomedical signal processing and control","Audio; Deep learning; Image; Multimodal fusion; Reduced network complexity; Self-diagnosis","Nivetha","R","Department of Computer Technology, MIT campus, Anna University, Chennai",NA
"2069","34249142","10.1016/j.bspc.2021.102960","A cognitive IoT-based framework for effective diagnosis of COVID-19 using multimodal data.","The COVID-19 emerged at the end of 2019 and has become a global pandemic. There are many methods for COVID-19 prediction using a single modality. However, none of them predicts with 100% accuracy, as each individual exhibits varied symptoms for the disease. To decrease the rate of misdiagnosis, multiple modalities can be used for prediction. Besides, there is also a need for a self-diagnosis system to narrow down the risk of virus spread in testing centres. Therefore, we propose a robust IoT and","2021","07","12","Biomed Signal Process Control","Biomedical signal processing and control","Audio; Deep learning; Image; Multimodal fusion; Reduced network complexity; Self-diagnosis","Harini","R","Department of Computer Technology, MIT campus, Anna University, Chennai",NA
"2070","34249141","10.2217/fvl-2021-0072","Safety, efficacy and acceptability of SARS-CoV-2 vaccines in patients with cancer.",NA,"2021","07","13","Future Virol","Future virology","COVID-19; SARS-CoV-2; cancer; immunogenicity; vaccines","Chebel","Roy","Department of Hematology-Oncology, Hotel-Dieu de France University Hospital, Saint Joseph University, Beirut, Lebanon",NA
"2071","34249141","10.2217/fvl-2021-0072","Safety, efficacy and acceptability of SARS-CoV-2 vaccines in patients with cancer.",NA,"2021","07","13","Future Virol","Future virology","COVID-19; SARS-CoV-2; cancer; immunogenicity; vaccines","Labaki","Chris","Department of Hematology-Oncology, Hotel-Dieu de France University Hospital, Saint Joseph University, Beirut, Lebanon",NA
"2072","34249141","10.2217/fvl-2021-0072","Safety, efficacy and acceptability of SARS-CoV-2 vaccines in patients with cancer.",NA,"2021","07","13","Future Virol","Future virology","COVID-19; SARS-CoV-2; cancer; immunogenicity; vaccines","Farhat","Maria","Department of Hematology-Oncology, Hotel-Dieu de France University Hospital, Saint Joseph University, Beirut, Lebanon",NA
"2073","34249141","10.2217/fvl-2021-0072","Safety, efficacy and acceptability of SARS-CoV-2 vaccines in patients with cancer.",NA,"2021","07","13","Future Virol","Future virology","COVID-19; SARS-CoV-2; cancer; immunogenicity; vaccines","Kattan","Joseph","Department of Hematology-Oncology, Hotel-Dieu de France University Hospital, Saint Joseph University, Beirut, Lebanon",NA
"2074","34249124","10.1186/s13662-021-03470-1","Complex mathematical SIR model for spreading of COVID-19 virus with Mittag-Leffler kernel.","This paper investigates a new model on coronavirus-19 disease (COVID-19), that is complex fractional SIR epidemic model with a nonstandard nonlinear incidence rate and a recovery, where derivative operator with Mittag-Leffler kernel in the Caputo sense (ABC). The model has two equilibrium points when the basic reproduction number <mml:math xmlns:mml=""http://www.w3.org/1998/Math/MathML""><mml:msub><mml:mi>R</mml:mi> <mml:mn>0</mml:mn></mml:msub> <mml:mo>&gt;</mml:mo> <mml:mn>1</mml:mn></mml:math> ","2021","07","13","Adv Differ Equ","Advances in difference equations","AtanganaBeleanuCaputo (ABC) derivatives; Complex fractional SIR model; Coronavirus-19 disease; Fixed-point method; Stability","Akyildiz","F Talay","Department of Mathematics and Statistics, Faculty of Science, Imam Mohammad ibn Saud Islamic University (IMSIU), Riyadh, Saudi Arabia",NA
"2075","34249124","10.1186/s13662-021-03470-1","Complex mathematical SIR model for spreading of COVID-19 virus with Mittag-Leffler kernel.","This paper investigates a new model on coronavirus-19 disease (COVID-19), that is complex fractional SIR epidemic model with a nonstandard nonlinear incidence rate and a recovery, where derivative operator with Mittag-Leffler kernel in the Caputo sense (ABC). The model has two equilibrium points when the basic reproduction number <mml:math xmlns:mml=""http://www.w3.org/1998/Math/MathML""><mml:msub><mml:mi>R</mml:mi> <mml:mn>0</mml:mn></mml:msub> <mml:mo>&gt;</mml:mo> <mml:mn>1</mml:mn></mml:math> ","2021","07","13","Adv Differ Equ","Advances in difference equations","AtanganaBeleanuCaputo (ABC) derivatives; Complex fractional SIR model; Coronavirus-19 disease; Fixed-point method; Stability","Alshammari","Fehaid Salem","Department of Mathematics and Statistics, Faculty of Science, Imam Mohammad ibn Saud Islamic University (IMSIU), Riyadh, Saudi Arabia",NA
"2076","34249121","10.26633/RPSP.2021.45","Dealing with perceptions related to thrombosis and COVID-19 vaccines.",NA,"2021","07","13","Rev Panam Salud Publica","Revista panamericana de salud publica = Pan American journal of public health",NA,"Ramírez","Céleo","Hospital del Valle San Pedro Sula Honduras Hospital del Valle, San Pedro Sula, Honduras",NA
"2077","34249121","10.26633/RPSP.2021.45","Dealing with perceptions related to thrombosis and COVID-19 vaccines.",NA,"2021","07","13","Rev Panam Salud Publica","Revista panamericana de salud publica = Pan American journal of public health",NA,"Herrera Paz","Edwin F","Universidad Católica de Honduras San Pedro Sula Honduras Universidad Católica de Honduras, San Pedro Sula, Honduras",NA
"2078","34249121","10.26633/RPSP.2021.45","Dealing with perceptions related to thrombosis and COVID-19 vaccines.",NA,"2021","07","13","Rev Panam Salud Publica","Revista panamericana de salud publica = Pan American journal of public health",NA,"Gómez Ventura","Sandra","Consorcio de Investigadores COVID Honduras Honduras Consorcio de Investigadores COVID Honduras, Honduras",NA
"2079","34249121","10.26633/RPSP.2021.45","Dealing with perceptions related to thrombosis and COVID-19 vaccines.",NA,"2021","07","13","Rev Panam Salud Publica","Revista panamericana de salud publica = Pan American journal of public health",NA,"Rodríguez","Gaspar","Consorcio de Investigadores COVID Honduras Honduras Consorcio de Investigadores COVID Honduras, Honduras",NA
"2080","34249121","10.26633/RPSP.2021.45","Dealing with perceptions related to thrombosis and COVID-19 vaccines.",NA,"2021","07","13","Rev Panam Salud Publica","Revista panamericana de salud publica = Pan American journal of public health",NA,"Linarez","Nery","Hospital General del Sur Choluteca Honduras Hospital General del Sur, Choluteca, Honduras",NA
"2081","34249121","10.26633/RPSP.2021.45","Dealing with perceptions related to thrombosis and COVID-19 vaccines.",NA,"2021","07","13","Rev Panam Salud Publica","Revista panamericana de salud publica = Pan American journal of public health",NA,"Durón","Reyna M","Observatorio de COVID-19, Universidad Tecnológica Centroamericana, UNITEC Tegucigalpa Honduras Observatorio de COVID-19, Universidad Tecnológica Centroamericana, UNITEC Tegucigalpa, Honduras",NA
"2082","34249118","10.1590/1677-5449.210021","Impact of the COVID-19 pandemic on drug treatment of patients with peripheral arterial disease: an observational cross-sectional study.","The Coronavirus 2019 (COVID-19) pandemic has had a negative impact on the population's behavior. In this context, the effect of the COVID-19 pandemic on drug treatment of patients with peripheral arterial disease (PAD) and intermittent claudication (IC) remains unclear. To analyze the impact of the COVID-19 pandemic on drug treatment of patients with PAD and IC. In this cross-sectional, observational study, 136 patients with PAD and IC were recruited from our database and answered a questionnair","2021","07","13","J Vasc Bras","Jornal vascular brasileiro","COVID-19; SARS-CoV-2; drug treatment; health; intermittent claudication; social isolation","Braghieri","Heloisa Amaral","Universidade Nove de Julho - UNINOVE, São Paulo, SP, Brasil",NA
"2083","34249118","10.1590/1677-5449.210021","Impact of the COVID-19 pandemic on drug treatment of patients with peripheral arterial disease: an observational cross-sectional study.","The Coronavirus 2019 (COVID-19) pandemic has had a negative impact on the population's behavior. In this context, the effect of the COVID-19 pandemic on drug treatment of patients with peripheral arterial disease (PAD) and intermittent claudication (IC) remains unclear. To analyze the impact of the COVID-19 pandemic on drug treatment of patients with PAD and IC. In this cross-sectional, observational study, 136 patients with PAD and IC were recruited from our database and answered a questionnair","2021","07","13","J Vasc Bras","Jornal vascular brasileiro","COVID-19; SARS-CoV-2; drug treatment; health; intermittent claudication; social isolation","Correia","Marília de Almeida","Universidade Nove de Julho - UNINOVE, São Paulo, SP, Brasil",NA
"2084","34249118","10.1590/1677-5449.210021","Impact of the COVID-19 pandemic on drug treatment of patients with peripheral arterial disease: an observational cross-sectional study.","The Coronavirus 2019 (COVID-19) pandemic has had a negative impact on the population's behavior. In this context, the effect of the COVID-19 pandemic on drug treatment of patients with peripheral arterial disease (PAD) and intermittent claudication (IC) remains unclear. To analyze the impact of the COVID-19 pandemic on drug treatment of patients with PAD and IC. In this cross-sectional, observational study, 136 patients with PAD and IC were recruited from our database and answered a questionnair","2021","07","13","J Vasc Bras","Jornal vascular brasileiro","COVID-19; SARS-CoV-2; drug treatment; health; intermittent claudication; social isolation","de Carvalho","Juliana Ferreira","Hospital Israelita Albert Einstein - EINSTEIN, São Paulo, SP, Brasil",NA
"2085","34249118","10.1590/1677-5449.210021","Impact of the COVID-19 pandemic on drug treatment of patients with peripheral arterial disease: an observational cross-sectional study.","The Coronavirus 2019 (COVID-19) pandemic has had a negative impact on the population's behavior. In this context, the effect of the COVID-19 pandemic on drug treatment of patients with peripheral arterial disease (PAD) and intermittent claudication (IC) remains unclear. To analyze the impact of the COVID-19 pandemic on drug treatment of patients with PAD and IC. In this cross-sectional, observational study, 136 patients with PAD and IC were recruited from our database and answered a questionnair","2021","07","13","J Vasc Bras","Jornal vascular brasileiro","COVID-19; SARS-CoV-2; drug treatment; health; intermittent claudication; social isolation","Longano","Paulo","Universidade Nove de Julho - UNINOVE, São Paulo, SP, Brasil",NA
"2086","34249118","10.1590/1677-5449.210021","Impact of the COVID-19 pandemic on drug treatment of patients with peripheral arterial disease: an observational cross-sectional study.","The Coronavirus 2019 (COVID-19) pandemic has had a negative impact on the population's behavior. In this context, the effect of the COVID-19 pandemic on drug treatment of patients with peripheral arterial disease (PAD) and intermittent claudication (IC) remains unclear. To analyze the impact of the COVID-19 pandemic on drug treatment of patients with PAD and IC. In this cross-sectional, observational study, 136 patients with PAD and IC were recruited from our database and answered a questionnair","2021","07","13","J Vasc Bras","Jornal vascular brasileiro","COVID-19; SARS-CoV-2; drug treatment; health; intermittent claudication; social isolation","Wolosker","Nelson","Hospital Israelita Albert Einstein - EINSTEIN, São Paulo, SP, Brasil",NA
"2087","34249118","10.1590/1677-5449.210021","Impact of the COVID-19 pandemic on drug treatment of patients with peripheral arterial disease: an observational cross-sectional study.","The Coronavirus 2019 (COVID-19) pandemic has had a negative impact on the population's behavior. In this context, the effect of the COVID-19 pandemic on drug treatment of patients with peripheral arterial disease (PAD) and intermittent claudication (IC) remains unclear. To analyze the impact of the COVID-19 pandemic on drug treatment of patients with PAD and IC. In this cross-sectional, observational study, 136 patients with PAD and IC were recruited from our database and answered a questionnair","2021","07","13","J Vasc Bras","Jornal vascular brasileiro","COVID-19; SARS-CoV-2; drug treatment; health; intermittent claudication; social isolation","Cucato","Gabriel Grizzo","Northumbria University, Newcastle upon Tyne, United Kingdom",NA
"2088","34249118","10.1590/1677-5449.210021","Impact of the COVID-19 pandemic on drug treatment of patients with peripheral arterial disease: an observational cross-sectional study.","The Coronavirus 2019 (COVID-19) pandemic has had a negative impact on the population's behavior. In this context, the effect of the COVID-19 pandemic on drug treatment of patients with peripheral arterial disease (PAD) and intermittent claudication (IC) remains unclear. To analyze the impact of the COVID-19 pandemic on drug treatment of patients with PAD and IC. In this cross-sectional, observational study, 136 patients with PAD and IC were recruited from our database and answered a questionnair","2021","07","13","J Vasc Bras","Jornal vascular brasileiro","COVID-19; SARS-CoV-2; drug treatment; health; intermittent claudication; social isolation","Ritti-Dias","Raphael Mendes","Universidade Nove de Julho - UNINOVE, São Paulo, SP, Brasil",NA
"2089","34249118","10.1590/1677-5449.210021","Impact of the COVID-19 pandemic on drug treatment of patients with peripheral arterial disease: an observational cross-sectional study.","The Coronavirus 2019 (COVID-19) pandemic has had a negative impact on the population's behavior. In this context, the effect of the COVID-19 pandemic on drug treatment of patients with peripheral arterial disease (PAD) and intermittent claudication (IC) remains unclear. To analyze the impact of the COVID-19 pandemic on drug treatment of patients with PAD and IC. In this cross-sectional, observational study, 136 patients with PAD and IC were recruited from our database and answered a questionnair","2021","07","13","J Vasc Bras","Jornal vascular brasileiro","COVID-19; SARS-CoV-2; drug treatment; health; intermittent claudication; social isolation","Kanegusuku","Hélcio","Hospital Israelita Albert Einstein - EINSTEIN, São Paulo, SP, Brasil",NA
"2090","34249101","10.3389/fgene.2021.684152","A Peptide Vaccine Candidate Tailored to Individuals' Genetics Mimics the Multi-Targeted T Cell Immunity of COVID-19 Convalescent Subjects.","Long-term immunity to coronaviruses likely stems from T cell activity. We present here a novel approach for the selection of immunoprevalent SARS-CoV-2-derived T cell epitopes using an in silico cohort of HLA-genotyped individuals with different ethnicities. Nine 30-mer peptides derived from the four major structural proteins of SARS-CoV-2 were selected and included in a peptide vaccine candidate to recapitulate the broad virus-specific T cell responses observed in natural infection. Poly","2021","07","13","Front Genet","Frontiers in genetics","HLA-genotype; SARS-CoV-2 immunity; ethnic diversity; global vaccine; in silico clinical trial","Somogyi","Eszter","Treos Bio Ltd., London, United Kingdom",NA
"2091","34249101","10.3389/fgene.2021.684152","A Peptide Vaccine Candidate Tailored to Individuals' Genetics Mimics the Multi-Targeted T Cell Immunity of COVID-19 Convalescent Subjects.","Long-term immunity to coronaviruses likely stems from T cell activity. We present here a novel approach for the selection of immunoprevalent SARS-CoV-2-derived T cell epitopes using an in silico cohort of HLA-genotyped individuals with different ethnicities. Nine 30-mer peptides derived from the four major structural proteins of SARS-CoV-2 were selected and included in a peptide vaccine candidate to recapitulate the broad virus-specific T cell responses observed in natural infection. Poly","2021","07","13","Front Genet","Frontiers in genetics","HLA-genotype; SARS-CoV-2 immunity; ethnic diversity; global vaccine; in silico clinical trial","Csiszovszki","Zsolt","Treos Bio Ltd., London, United Kingdom",NA
"2092","34249101","10.3389/fgene.2021.684152","A Peptide Vaccine Candidate Tailored to Individuals' Genetics Mimics the Multi-Targeted T Cell Immunity of COVID-19 Convalescent Subjects.","Long-term immunity to coronaviruses likely stems from T cell activity. We present here a novel approach for the selection of immunoprevalent SARS-CoV-2-derived T cell epitopes using an in silico cohort of HLA-genotyped individuals with different ethnicities. Nine 30-mer peptides derived from the four major structural proteins of SARS-CoV-2 were selected and included in a peptide vaccine candidate to recapitulate the broad virus-specific T cell responses observed in natural infection. Poly","2021","07","13","Front Genet","Frontiers in genetics","HLA-genotype; SARS-CoV-2 immunity; ethnic diversity; global vaccine; in silico clinical trial","Molnár","Levente","Treos Bio Ltd., London, United Kingdom",NA
"2093","34249101","10.3389/fgene.2021.684152","A Peptide Vaccine Candidate Tailored to Individuals' Genetics Mimics the Multi-Targeted T Cell Immunity of COVID-19 Convalescent Subjects.","Long-term immunity to coronaviruses likely stems from T cell activity. We present here a novel approach for the selection of immunoprevalent SARS-CoV-2-derived T cell epitopes using an in silico cohort of HLA-genotyped individuals with different ethnicities. Nine 30-mer peptides derived from the four major structural proteins of SARS-CoV-2 were selected and included in a peptide vaccine candidate to recapitulate the broad virus-specific T cell responses observed in natural infection. Poly","2021","07","13","Front Genet","Frontiers in genetics","HLA-genotype; SARS-CoV-2 immunity; ethnic diversity; global vaccine; in silico clinical trial","Lorincz","Orsolya","Treos Bio Ltd., London, United Kingdom",NA
"2094","34249101","10.3389/fgene.2021.684152","A Peptide Vaccine Candidate Tailored to Individuals' Genetics Mimics the Multi-Targeted T Cell Immunity of COVID-19 Convalescent Subjects.","Long-term immunity to coronaviruses likely stems from T cell activity. We present here a novel approach for the selection of immunoprevalent SARS-CoV-2-derived T cell epitopes using an in silico cohort of HLA-genotyped individuals with different ethnicities. Nine 30-mer peptides derived from the four major structural proteins of SARS-CoV-2 were selected and included in a peptide vaccine candidate to recapitulate the broad virus-specific T cell responses observed in natural infection. Poly","2021","07","13","Front Genet","Frontiers in genetics","HLA-genotype; SARS-CoV-2 immunity; ethnic diversity; global vaccine; in silico clinical trial","Tóth","József","Treos Bio Ltd., London, United Kingdom",NA
"2095","34249101","10.3389/fgene.2021.684152","A Peptide Vaccine Candidate Tailored to Individuals' Genetics Mimics the Multi-Targeted T Cell Immunity of COVID-19 Convalescent Subjects.","Long-term immunity to coronaviruses likely stems from T cell activity. We present here a novel approach for the selection of immunoprevalent SARS-CoV-2-derived T cell epitopes using an in silico cohort of HLA-genotyped individuals with different ethnicities. Nine 30-mer peptides derived from the four major structural proteins of SARS-CoV-2 were selected and included in a peptide vaccine candidate to recapitulate the broad virus-specific T cell responses observed in natural infection. Poly","2021","07","13","Front Genet","Frontiers in genetics","HLA-genotype; SARS-CoV-2 immunity; ethnic diversity; global vaccine; in silico clinical trial","Pattijn","Sofie","ImmunXperts Société Anonyme, A Nexelis Group Company, Gosselies, Belgium",NA
"2096","34249101","10.3389/fgene.2021.684152","A Peptide Vaccine Candidate Tailored to Individuals' Genetics Mimics the Multi-Targeted T Cell Immunity of COVID-19 Convalescent Subjects.","Long-term immunity to coronaviruses likely stems from T cell activity. We present here a novel approach for the selection of immunoprevalent SARS-CoV-2-derived T cell epitopes using an in silico cohort of HLA-genotyped individuals with different ethnicities. Nine 30-mer peptides derived from the four major structural proteins of SARS-CoV-2 were selected and included in a peptide vaccine candidate to recapitulate the broad virus-specific T cell responses observed in natural infection. Poly","2021","07","13","Front Genet","Frontiers in genetics","HLA-genotype; SARS-CoV-2 immunity; ethnic diversity; global vaccine; in silico clinical trial","Schockaert","Jana","ImmunXperts Société Anonyme, A Nexelis Group Company, Gosselies, Belgium",NA
"2097","34249101","10.3389/fgene.2021.684152","A Peptide Vaccine Candidate Tailored to Individuals' Genetics Mimics the Multi-Targeted T Cell Immunity of COVID-19 Convalescent Subjects.","Long-term immunity to coronaviruses likely stems from T cell activity. We present here a novel approach for the selection of immunoprevalent SARS-CoV-2-derived T cell epitopes using an in silico cohort of HLA-genotyped individuals with different ethnicities. Nine 30-mer peptides derived from the four major structural proteins of SARS-CoV-2 were selected and included in a peptide vaccine candidate to recapitulate the broad virus-specific T cell responses observed in natural infection. Poly","2021","07","13","Front Genet","Frontiers in genetics","HLA-genotype; SARS-CoV-2 immunity; ethnic diversity; global vaccine; in silico clinical trial","Mazy","Aurélie","ImmunXperts Société Anonyme, A Nexelis Group Company, Gosselies, Belgium",NA
"2098","34249101","10.3389/fgene.2021.684152","A Peptide Vaccine Candidate Tailored to Individuals' Genetics Mimics the Multi-Targeted T Cell Immunity of COVID-19 Convalescent Subjects.","Long-term immunity to coronaviruses likely stems from T cell activity. We present here a novel approach for the selection of immunoprevalent SARS-CoV-2-derived T cell epitopes using an in silico cohort of HLA-genotyped individuals with different ethnicities. Nine 30-mer peptides derived from the four major structural proteins of SARS-CoV-2 were selected and included in a peptide vaccine candidate to recapitulate the broad virus-specific T cell responses observed in natural infection. Poly","2021","07","13","Front Genet","Frontiers in genetics","HLA-genotype; SARS-CoV-2 immunity; ethnic diversity; global vaccine; in silico clinical trial","Miklós","István","Treos Bio Ltd., London, United Kingdom",NA
"2099","34249101","10.3389/fgene.2021.684152","A Peptide Vaccine Candidate Tailored to Individuals' Genetics Mimics the Multi-Targeted T Cell Immunity of COVID-19 Convalescent Subjects.","Long-term immunity to coronaviruses likely stems from T cell activity. We present here a novel approach for the selection of immunoprevalent SARS-CoV-2-derived T cell epitopes using an in silico cohort of HLA-genotyped individuals with different ethnicities. Nine 30-mer peptides derived from the four major structural proteins of SARS-CoV-2 were selected and included in a peptide vaccine candidate to recapitulate the broad virus-specific T cell responses observed in natural infection. Poly","2021","07","13","Front Genet","Frontiers in genetics","HLA-genotype; SARS-CoV-2 immunity; ethnic diversity; global vaccine; in silico clinical trial","Pántya","Katalin","Treos Bio Ltd., London, United Kingdom",NA
"2100","34249101","10.3389/fgene.2021.684152","A Peptide Vaccine Candidate Tailored to Individuals' Genetics Mimics the Multi-Targeted T Cell Immunity of COVID-19 Convalescent Subjects.","Long-term immunity to coronaviruses likely stems from T cell activity. We present here a novel approach for the selection of immunoprevalent SARS-CoV-2-derived T cell epitopes using an in silico cohort of HLA-genotyped individuals with different ethnicities. Nine 30-mer peptides derived from the four major structural proteins of SARS-CoV-2 were selected and included in a peptide vaccine candidate to recapitulate the broad virus-specific T cell responses observed in natural infection. Poly","2021","07","13","Front Genet","Frontiers in genetics","HLA-genotype; SARS-CoV-2 immunity; ethnic diversity; global vaccine; in silico clinical trial","Páles","Péter","Treos Bio Ltd., London, United Kingdom",NA
"2101","34249101","10.3389/fgene.2021.684152","A Peptide Vaccine Candidate Tailored to Individuals' Genetics Mimics the Multi-Targeted T Cell Immunity of COVID-19 Convalescent Subjects.","Long-term immunity to coronaviruses likely stems from T cell activity. We present here a novel approach for the selection of immunoprevalent SARS-CoV-2-derived T cell epitopes using an in silico cohort of HLA-genotyped individuals with different ethnicities. Nine 30-mer peptides derived from the four major structural proteins of SARS-CoV-2 were selected and included in a peptide vaccine candidate to recapitulate the broad virus-specific T cell responses observed in natural infection. Poly","2021","07","13","Front Genet","Frontiers in genetics","HLA-genotype; SARS-CoV-2 immunity; ethnic diversity; global vaccine; in silico clinical trial","Toke","Eniko R","Treos Bio Ltd., London, United Kingdom",NA
"2102","34249017","10.3389/fimmu.2021.708820","Case Report: Sars-CoV-2 Infection in a Vaccinated Individual: Evaluation of the Immunological Profile and Virus Transmission Risk.","During the COVID19 pandemic, a range of vaccines displayed high efficacy in preventing disease, severe outcomes of infection, and mortality. However, the immunological correlates of protection, the duration of immune response, the transmission risk over time from vaccinated individuals are currently under active investigation. In this brief report, we describe the case of a vaccinated Healthcare Professional infected with a variant of Sars-CoV-2, who has been extensively investigated in order to","2021","07","13","Front Immunol","Frontiers in immunology","COVID19; Sars-CoV-2 infection; immune response; immunology; vaccination","Strafella","Claudia","Genomic Medicine Laboratory UILDM, IRCCS Santa Lucia Foundation, Rome, Italy",NA
"2103","34249017","10.3389/fimmu.2021.708820","Case Report: Sars-CoV-2 Infection in a Vaccinated Individual: Evaluation of the Immunological Profile and Virus Transmission Risk.","During the COVID19 pandemic, a range of vaccines displayed high efficacy in preventing disease, severe outcomes of infection, and mortality. However, the immunological correlates of protection, the duration of immune response, the transmission risk over time from vaccinated individuals are currently under active investigation. In this brief report, we describe the case of a vaccinated Healthcare Professional infected with a variant of Sars-CoV-2, who has been extensively investigated in order to","2021","07","13","Front Immunol","Frontiers in immunology","COVID19; Sars-CoV-2 infection; immune response; immunology; vaccination","Caputo","Valerio","Genomic Medicine Laboratory UILDM, IRCCS Santa Lucia Foundation, Rome, Italy",NA
"2104","34249017","10.3389/fimmu.2021.708820","Case Report: Sars-CoV-2 Infection in a Vaccinated Individual: Evaluation of the Immunological Profile and Virus Transmission Risk.","During the COVID19 pandemic, a range of vaccines displayed high efficacy in preventing disease, severe outcomes of infection, and mortality. However, the immunological correlates of protection, the duration of immune response, the transmission risk over time from vaccinated individuals are currently under active investigation. In this brief report, we describe the case of a vaccinated Healthcare Professional infected with a variant of Sars-CoV-2, who has been extensively investigated in order to","2021","07","13","Front Immunol","Frontiers in immunology","COVID19; Sars-CoV-2 infection; immune response; immunology; vaccination","Guerrera","Gisella","Neuroimmunology Unit, IRCCS Santa Lucia Foundation, Rome, Italy",NA
"2105","34249017","10.3389/fimmu.2021.708820","Case Report: Sars-CoV-2 Infection in a Vaccinated Individual: Evaluation of the Immunological Profile and Virus Transmission Risk.","During the COVID19 pandemic, a range of vaccines displayed high efficacy in preventing disease, severe outcomes of infection, and mortality. However, the immunological correlates of protection, the duration of immune response, the transmission risk over time from vaccinated individuals are currently under active investigation. In this brief report, we describe the case of a vaccinated Healthcare Professional infected with a variant of Sars-CoV-2, who has been extensively investigated in order to","2021","07","13","Front Immunol","Frontiers in immunology","COVID19; Sars-CoV-2 infection; immune response; immunology; vaccination","Termine","Andrea","Genomic Medicine Laboratory UILDM, IRCCS Santa Lucia Foundation, Rome, Italy",NA
"2106","34249017","10.3389/fimmu.2021.708820","Case Report: Sars-CoV-2 Infection in a Vaccinated Individual: Evaluation of the Immunological Profile and Virus Transmission Risk.","During the COVID19 pandemic, a range of vaccines displayed high efficacy in preventing disease, severe outcomes of infection, and mortality. However, the immunological correlates of protection, the duration of immune response, the transmission risk over time from vaccinated individuals are currently under active investigation. In this brief report, we describe the case of a vaccinated Healthcare Professional infected with a variant of Sars-CoV-2, who has been extensively investigated in order to","2021","07","13","Front Immunol","Frontiers in immunology","COVID19; Sars-CoV-2 infection; immune response; immunology; vaccination","Fabrizio","Carlo","Genomic Medicine Laboratory UILDM, IRCCS Santa Lucia Foundation, Rome, Italy",NA
"2107","34249017","10.3389/fimmu.2021.708820","Case Report: Sars-CoV-2 Infection in a Vaccinated Individual: Evaluation of the Immunological Profile and Virus Transmission Risk.","During the COVID19 pandemic, a range of vaccines displayed high efficacy in preventing disease, severe outcomes of infection, and mortality. However, the immunological correlates of protection, the duration of immune response, the transmission risk over time from vaccinated individuals are currently under active investigation. In this brief report, we describe the case of a vaccinated Healthcare Professional infected with a variant of Sars-CoV-2, who has been extensively investigated in order to","2021","07","13","Front Immunol","Frontiers in immunology","COVID19; Sars-CoV-2 infection; immune response; immunology; vaccination","Cascella","Raffaella","Genomic Medicine Laboratory UILDM, IRCCS Santa Lucia Foundation, Rome, Italy",NA
"2108","34249017","10.3389/fimmu.2021.708820","Case Report: Sars-CoV-2 Infection in a Vaccinated Individual: Evaluation of the Immunological Profile and Virus Transmission Risk.","During the COVID19 pandemic, a range of vaccines displayed high efficacy in preventing disease, severe outcomes of infection, and mortality. However, the immunological correlates of protection, the duration of immune response, the transmission risk over time from vaccinated individuals are currently under active investigation. In this brief report, we describe the case of a vaccinated Healthcare Professional infected with a variant of Sars-CoV-2, who has been extensively investigated in order to","2021","07","13","Front Immunol","Frontiers in immunology","COVID19; Sars-CoV-2 infection; immune response; immunology; vaccination","Picozza","Mario","Neuroimmunology Unit, IRCCS Santa Lucia Foundation, Rome, Italy",NA
"2109","34249017","10.3389/fimmu.2021.708820","Case Report: Sars-CoV-2 Infection in a Vaccinated Individual: Evaluation of the Immunological Profile and Virus Transmission Risk.","During the COVID19 pandemic, a range of vaccines displayed high efficacy in preventing disease, severe outcomes of infection, and mortality. However, the immunological correlates of protection, the duration of immune response, the transmission risk over time from vaccinated individuals are currently under active investigation. In this brief report, we describe the case of a vaccinated Healthcare Professional infected with a variant of Sars-CoV-2, who has been extensively investigated in order to","2021","07","13","Front Immunol","Frontiers in immunology","COVID19; Sars-CoV-2 infection; immune response; immunology; vaccination","Caltagirone","Carlo","Department of Clinical and Behavioral Neurology, IRCCS Santa Lucia Foundation, Rome, Italy",NA
"2110","34249017","10.3389/fimmu.2021.708820","Case Report: Sars-CoV-2 Infection in a Vaccinated Individual: Evaluation of the Immunological Profile and Virus Transmission Risk.","During the COVID19 pandemic, a range of vaccines displayed high efficacy in preventing disease, severe outcomes of infection, and mortality. However, the immunological correlates of protection, the duration of immune response, the transmission risk over time from vaccinated individuals are currently under active investigation. In this brief report, we describe the case of a vaccinated Healthcare Professional infected with a variant of Sars-CoV-2, who has been extensively investigated in order to","2021","07","13","Front Immunol","Frontiers in immunology","COVID19; Sars-CoV-2 infection; immune response; immunology; vaccination","Rossini","Angelo","Medical Services, IRCCS Santa Lucia Foundation, Rome, Italy",NA
"2111","34249017","10.3389/fimmu.2021.708820","Case Report: Sars-CoV-2 Infection in a Vaccinated Individual: Evaluation of the Immunological Profile and Virus Transmission Risk.","During the COVID19 pandemic, a range of vaccines displayed high efficacy in preventing disease, severe outcomes of infection, and mortality. However, the immunological correlates of protection, the duration of immune response, the transmission risk over time from vaccinated individuals are currently under active investigation. In this brief report, we describe the case of a vaccinated Healthcare Professional infected with a variant of Sars-CoV-2, who has been extensively investigated in order to","2021","07","13","Front Immunol","Frontiers in immunology","COVID19; Sars-CoV-2 infection; immune response; immunology; vaccination","Balice","Maria Pia","Clinical Microbiology Laboratory, IRCCS Santa Lucia Foundation, Rome, Italy",NA
"2112","34249017","10.3389/fimmu.2021.708820","Case Report: Sars-CoV-2 Infection in a Vaccinated Individual: Evaluation of the Immunological Profile and Virus Transmission Risk.","During the COVID19 pandemic, a range of vaccines displayed high efficacy in preventing disease, severe outcomes of infection, and mortality. However, the immunological correlates of protection, the duration of immune response, the transmission risk over time from vaccinated individuals are currently under active investigation. In this brief report, we describe the case of a vaccinated Healthcare Professional infected with a variant of Sars-CoV-2, who has been extensively investigated in order to","2021","07","13","Front Immunol","Frontiers in immunology","COVID19; Sars-CoV-2 infection; immune response; immunology; vaccination","Salvia","Antonino","Medical Services, IRCCS Santa Lucia Foundation, Rome, Italy",NA
"2113","34249017","10.3389/fimmu.2021.708820","Case Report: Sars-CoV-2 Infection in a Vaccinated Individual: Evaluation of the Immunological Profile and Virus Transmission Risk.","During the COVID19 pandemic, a range of vaccines displayed high efficacy in preventing disease, severe outcomes of infection, and mortality. However, the immunological correlates of protection, the duration of immune response, the transmission risk over time from vaccinated individuals are currently under active investigation. In this brief report, we describe the case of a vaccinated Healthcare Professional infected with a variant of Sars-CoV-2, who has been extensively investigated in order to","2021","07","13","Front Immunol","Frontiers in immunology","COVID19; Sars-CoV-2 infection; immune response; immunology; vaccination","Battistini","Luca","Neuroimmunology Unit, IRCCS Santa Lucia Foundation, Rome, Italy",NA
"2114","34249017","10.3389/fimmu.2021.708820","Case Report: Sars-CoV-2 Infection in a Vaccinated Individual: Evaluation of the Immunological Profile and Virus Transmission Risk.","During the COVID19 pandemic, a range of vaccines displayed high efficacy in preventing disease, severe outcomes of infection, and mortality. However, the immunological correlates of protection, the duration of immune response, the transmission risk over time from vaccinated individuals are currently under active investigation. In this brief report, we describe the case of a vaccinated Healthcare Professional infected with a variant of Sars-CoV-2, who has been extensively investigated in order to","2021","07","13","Front Immunol","Frontiers in immunology","COVID19; Sars-CoV-2 infection; immune response; immunology; vaccination","Borsellino","Giovanna","Neuroimmunology Unit, IRCCS Santa Lucia Foundation, Rome, Italy",NA
"2115","34249017","10.3389/fimmu.2021.708820","Case Report: Sars-CoV-2 Infection in a Vaccinated Individual: Evaluation of the Immunological Profile and Virus Transmission Risk.","During the COVID19 pandemic, a range of vaccines displayed high efficacy in preventing disease, severe outcomes of infection, and mortality. However, the immunological correlates of protection, the duration of immune response, the transmission risk over time from vaccinated individuals are currently under active investigation. In this brief report, we describe the case of a vaccinated Healthcare Professional infected with a variant of Sars-CoV-2, who has been extensively investigated in order to","2021","07","13","Front Immunol","Frontiers in immunology","COVID19; Sars-CoV-2 infection; immune response; immunology; vaccination","Giardina","Emiliano","Genomic Medicine Laboratory UILDM, IRCCS Santa Lucia Foundation, Rome, Italy",NA
"2116","34249006","10.3389/fimmu.2021.700926","RIG-I-Like Receptor-Mediated Recognition of Viral Genomic RNA of Severe Acute Respiratory Syndrome Coronavirus-2 and Viral Escape From the Host Innate Immune Responses.","RIG-I-like receptors (RLR), RIG-I and MDA5, are cytoplasmic viral RNA sensors that recognize viral double-stranded RNAs and trigger signals to induce antiviral responses, including type I interferon production. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) caused the coronavirus disease 2019 pandemic. However, the RLR role in innate immune response to SARS-CoV-2 has not been fully elucidated. Here, we studied the roles of RLR in cytokine expression responding to SARS-CoV-2 and fou","2021","07","13","Front Immunol","Frontiers in immunology","Innate immunity; MDA5; RIG-I; SARS-CoV-2; Type I interferon; coronavirus ","Kouwaki","Takahisa","Department of Immunology, Graduate School of Medical Sciences, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan",NA
"2117","34249006","10.3389/fimmu.2021.700926","RIG-I-Like Receptor-Mediated Recognition of Viral Genomic RNA of Severe Acute Respiratory Syndrome Coronavirus-2 and Viral Escape From the Host Innate Immune Responses.","RIG-I-like receptors (RLR), RIG-I and MDA5, are cytoplasmic viral RNA sensors that recognize viral double-stranded RNAs and trigger signals to induce antiviral responses, including type I interferon production. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) caused the coronavirus disease 2019 pandemic. However, the RLR role in innate immune response to SARS-CoV-2 has not been fully elucidated. Here, we studied the roles of RLR in cytokine expression responding to SARS-CoV-2 and fou","2021","07","13","Front Immunol","Frontiers in immunology","Innate immunity; MDA5; RIG-I; SARS-CoV-2; Type I interferon; coronavirus ","Nishimura","Tasuku","Department of Immunology, Graduate School of Medical Sciences, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan",NA
"2118","34249006","10.3389/fimmu.2021.700926","RIG-I-Like Receptor-Mediated Recognition of Viral Genomic RNA of Severe Acute Respiratory Syndrome Coronavirus-2 and Viral Escape From the Host Innate Immune Responses.","RIG-I-like receptors (RLR), RIG-I and MDA5, are cytoplasmic viral RNA sensors that recognize viral double-stranded RNAs and trigger signals to induce antiviral responses, including type I interferon production. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) caused the coronavirus disease 2019 pandemic. However, the RLR role in innate immune response to SARS-CoV-2 has not been fully elucidated. Here, we studied the roles of RLR in cytokine expression responding to SARS-CoV-2 and fou","2021","07","13","Front Immunol","Frontiers in immunology","Innate immunity; MDA5; RIG-I; SARS-CoV-2; Type I interferon; coronavirus ","Wang","Guanming","Department of Immunology, Graduate School of Medical Sciences, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan",NA
"2119","34249006","10.3389/fimmu.2021.700926","RIG-I-Like Receptor-Mediated Recognition of Viral Genomic RNA of Severe Acute Respiratory Syndrome Coronavirus-2 and Viral Escape From the Host Innate Immune Responses.","RIG-I-like receptors (RLR), RIG-I and MDA5, are cytoplasmic viral RNA sensors that recognize viral double-stranded RNAs and trigger signals to induce antiviral responses, including type I interferon production. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) caused the coronavirus disease 2019 pandemic. However, the RLR role in innate immune response to SARS-CoV-2 has not been fully elucidated. Here, we studied the roles of RLR in cytokine expression responding to SARS-CoV-2 and fou","2021","07","13","Front Immunol","Frontiers in immunology","Innate immunity; MDA5; RIG-I; SARS-CoV-2; Type I interferon; coronavirus ","Oshiumi","Hiroyuki","Department of Immunology, Graduate School of Medical Sciences, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan",NA
"2120","34248993","10.3389/fimmu.2021.694857","Live Virus Neutralisation of the 501Y.V1 and 501Y.V2 SARS-CoV-2 Variants following INO-4800 Vaccination of Ferrets.","The ongoing COVID-19 pandemic has resulted in significant global morbidity and mortality on a scale similar to the influenza pandemic of 1918. Over the course of the last few months, a number of SARS-CoV-2 variants have been identified against which vaccine-induced immune responses may be less effective. These ""variants-of-concern"" have garnered significant attention in the media, with discussion around their impact on the future of the pandemic and the ability of leading COVID-19 vaccines to pr","2021","07","13","Front Immunol","Frontiers in immunology","COVID-19; DNA vaccine; SARS-CoV-2 antibodies; biomolecular modelling; neutralisation; variants","Riddell","Shane","Commonwealth Scientific and Industrial Research Organisation, Australian Centre for Disease Preparedness, Geelong, VIC, Australia",NA
"2121","34248993","10.3389/fimmu.2021.694857","Live Virus Neutralisation of the 501Y.V1 and 501Y.V2 SARS-CoV-2 Variants following INO-4800 Vaccination of Ferrets.","The ongoing COVID-19 pandemic has resulted in significant global morbidity and mortality on a scale similar to the influenza pandemic of 1918. Over the course of the last few months, a number of SARS-CoV-2 variants have been identified against which vaccine-induced immune responses may be less effective. These ""variants-of-concern"" have garnered significant attention in the media, with discussion around their impact on the future of the pandemic and the ability of leading COVID-19 vaccines to pr","2021","07","13","Front Immunol","Frontiers in immunology","COVID-19; DNA vaccine; SARS-CoV-2 antibodies; biomolecular modelling; neutralisation; variants","Goldie","Sarah","Commonwealth Scientific and Industrial Research Organisation, Australian Centre for Disease Preparedness, Geelong, VIC, Australia",NA
"2122","34248993","10.3389/fimmu.2021.694857","Live Virus Neutralisation of the 501Y.V1 and 501Y.V2 SARS-CoV-2 Variants following INO-4800 Vaccination of Ferrets.","The ongoing COVID-19 pandemic has resulted in significant global morbidity and mortality on a scale similar to the influenza pandemic of 1918. Over the course of the last few months, a number of SARS-CoV-2 variants have been identified against which vaccine-induced immune responses may be less effective. These ""variants-of-concern"" have garnered significant attention in the media, with discussion around their impact on the future of the pandemic and the ability of leading COVID-19 vaccines to pr","2021","07","13","Front Immunol","Frontiers in immunology","COVID-19; DNA vaccine; SARS-CoV-2 antibodies; biomolecular modelling; neutralisation; variants","McAuley","Alexander J","Commonwealth Scientific and Industrial Research Organisation, Australian Centre for Disease Preparedness, Geelong, VIC, Australia",NA
"2123","34248993","10.3389/fimmu.2021.694857","Live Virus Neutralisation of the 501Y.V1 and 501Y.V2 SARS-CoV-2 Variants following INO-4800 Vaccination of Ferrets.","The ongoing COVID-19 pandemic has resulted in significant global morbidity and mortality on a scale similar to the influenza pandemic of 1918. Over the course of the last few months, a number of SARS-CoV-2 variants have been identified against which vaccine-induced immune responses may be less effective. These ""variants-of-concern"" have garnered significant attention in the media, with discussion around their impact on the future of the pandemic and the ability of leading COVID-19 vaccines to pr","2021","07","13","Front Immunol","Frontiers in immunology","COVID-19; DNA vaccine; SARS-CoV-2 antibodies; biomolecular modelling; neutralisation; variants","Kuiper","Michael J","Commonwealth Scientific and Industrial Research Organisation, Data61, Docklands, VIC, Australia",NA
"2124","34248993","10.3389/fimmu.2021.694857","Live Virus Neutralisation of the 501Y.V1 and 501Y.V2 SARS-CoV-2 Variants following INO-4800 Vaccination of Ferrets.","The ongoing COVID-19 pandemic has resulted in significant global morbidity and mortality on a scale similar to the influenza pandemic of 1918. Over the course of the last few months, a number of SARS-CoV-2 variants have been identified against which vaccine-induced immune responses may be less effective. These ""variants-of-concern"" have garnered significant attention in the media, with discussion around their impact on the future of the pandemic and the ability of leading COVID-19 vaccines to pr","2021","07","13","Front Immunol","Frontiers in immunology","COVID-19; DNA vaccine; SARS-CoV-2 antibodies; biomolecular modelling; neutralisation; variants","Durr","Peter A","Commonwealth Scientific and Industrial Research Organisation, Australian Centre for Disease Preparedness, Geelong, VIC, Australia",NA
"2125","34248993","10.3389/fimmu.2021.694857","Live Virus Neutralisation of the 501Y.V1 and 501Y.V2 SARS-CoV-2 Variants following INO-4800 Vaccination of Ferrets.","The ongoing COVID-19 pandemic has resulted in significant global morbidity and mortality on a scale similar to the influenza pandemic of 1918. Over the course of the last few months, a number of SARS-CoV-2 variants have been identified against which vaccine-induced immune responses may be less effective. These ""variants-of-concern"" have garnered significant attention in the media, with discussion around their impact on the future of the pandemic and the ability of leading COVID-19 vaccines to pr","2021","07","13","Front Immunol","Frontiers in immunology","COVID-19; DNA vaccine; SARS-CoV-2 antibodies; biomolecular modelling; neutralisation; variants","Blasdell","Kim R","Commonwealth Scientific and Industrial Research Organisation, Australian Centre for Disease Preparedness, Geelong, VIC, Australia",NA
"2126","34248993","10.3389/fimmu.2021.694857","Live Virus Neutralisation of the 501Y.V1 and 501Y.V2 SARS-CoV-2 Variants following INO-4800 Vaccination of Ferrets.","The ongoing COVID-19 pandemic has resulted in significant global morbidity and mortality on a scale similar to the influenza pandemic of 1918. Over the course of the last few months, a number of SARS-CoV-2 variants have been identified against which vaccine-induced immune responses may be less effective. These ""variants-of-concern"" have garnered significant attention in the media, with discussion around their impact on the future of the pandemic and the ability of leading COVID-19 vaccines to pr","2021","07","13","Front Immunol","Frontiers in immunology","COVID-19; DNA vaccine; SARS-CoV-2 antibodies; biomolecular modelling; neutralisation; variants","Tachedjian","Mary","Commonwealth Scientific and Industrial Research Organisation, Australian Centre for Disease Preparedness, Geelong, VIC, Australia",NA
"2127","34248993","10.3389/fimmu.2021.694857","Live Virus Neutralisation of the 501Y.V1 and 501Y.V2 SARS-CoV-2 Variants following INO-4800 Vaccination of Ferrets.","The ongoing COVID-19 pandemic has resulted in significant global morbidity and mortality on a scale similar to the influenza pandemic of 1918. Over the course of the last few months, a number of SARS-CoV-2 variants have been identified against which vaccine-induced immune responses may be less effective. These ""variants-of-concern"" have garnered significant attention in the media, with discussion around their impact on the future of the pandemic and the ability of leading COVID-19 vaccines to pr","2021","07","13","Front Immunol","Frontiers in immunology","COVID-19; DNA vaccine; SARS-CoV-2 antibodies; biomolecular modelling; neutralisation; variants","Druce","Julian D","Victorian Infectious Diseases Reference Laboratory, The Royal Melbourne Hospital and The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia",NA
"2128","34248993","10.3389/fimmu.2021.694857","Live Virus Neutralisation of the 501Y.V1 and 501Y.V2 SARS-CoV-2 Variants following INO-4800 Vaccination of Ferrets.","The ongoing COVID-19 pandemic has resulted in significant global morbidity and mortality on a scale similar to the influenza pandemic of 1918. Over the course of the last few months, a number of SARS-CoV-2 variants have been identified against which vaccine-induced immune responses may be less effective. These ""variants-of-concern"" have garnered significant attention in the media, with discussion around their impact on the future of the pandemic and the ability of leading COVID-19 vaccines to pr","2021","07","13","Front Immunol","Frontiers in immunology","COVID-19; DNA vaccine; SARS-CoV-2 antibodies; biomolecular modelling; neutralisation; variants","Smith","Trevor R F","Research &amp",NA
"2129","34248993","10.3389/fimmu.2021.694857","Live Virus Neutralisation of the 501Y.V1 and 501Y.V2 SARS-CoV-2 Variants following INO-4800 Vaccination of Ferrets.","The ongoing COVID-19 pandemic has resulted in significant global morbidity and mortality on a scale similar to the influenza pandemic of 1918. Over the course of the last few months, a number of SARS-CoV-2 variants have been identified against which vaccine-induced immune responses may be less effective. These ""variants-of-concern"" have garnered significant attention in the media, with discussion around their impact on the future of the pandemic and the ability of leading COVID-19 vaccines to pr","2021","07","13","Front Immunol","Frontiers in immunology","COVID-19; DNA vaccine; SARS-CoV-2 antibodies; biomolecular modelling; neutralisation; variants","Broderick","Kate E","Research &amp",NA
"2130","34248993","10.3389/fimmu.2021.694857","Live Virus Neutralisation of the 501Y.V1 and 501Y.V2 SARS-CoV-2 Variants following INO-4800 Vaccination of Ferrets.","The ongoing COVID-19 pandemic has resulted in significant global morbidity and mortality on a scale similar to the influenza pandemic of 1918. Over the course of the last few months, a number of SARS-CoV-2 variants have been identified against which vaccine-induced immune responses may be less effective. These ""variants-of-concern"" have garnered significant attention in the media, with discussion around their impact on the future of the pandemic and the ability of leading COVID-19 vaccines to pr","2021","07","13","Front Immunol","Frontiers in immunology","COVID-19; DNA vaccine; SARS-CoV-2 antibodies; biomolecular modelling; neutralisation; variants","Vasan","Seshadri S","Commonwealth Scientific and Industrial Research Organisation, Australian Centre for Disease Preparedness, Geelong, VIC, Australia",NA
"2131","34248990","10.3389/fimmu.2021.693085","Interleukin-1- Receptor Kinase 4 Inhibition: Achieving Immunomodulatory Synergy to Mitigate the Impact of COVID-19.",NA,"2021","07","13","Front Immunol","Frontiers in immunology","COVID-19; Cytokine release syndrome (CRS); cytokine; immunomodulator; irak4","Gupta","Akash","Department of Internal Medicine, Yale School of Medicine, New Haven, CT, United States",NA
"2132","34248990","10.3389/fimmu.2021.693085","Interleukin-1- Receptor Kinase 4 Inhibition: Achieving Immunomodulatory Synergy to Mitigate the Impact of COVID-19.",NA,"2021","07","13","Front Immunol","Frontiers in immunology","COVID-19; Cytokine release syndrome (CRS); cytokine; immunomodulator; irak4","Chun","Hyung J","Yale Cardiovascular Research Center, Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, United States",NA
"2133","34248984","10.3389/fimmu.2021.691725","Severe COVID-19 Recovery Is Associated with Timely Acquisition of a Myeloid Cell Immune-Regulatory Phenotype.","After more than one year since the COVID-19 outbreak, patients with severe disease still constitute the bottleneck of the pandemic management. Aberrant inflammatory responses, ranging from cytokine storm to immune-suppression, were described in COVID-19 and no treatment was demonstrated to change the prognosis significantly. Therefore, there is an urgent need for understanding the underlying pathogenic mechanisms to guide therapeutic interventions. This study was designed to assess myeloid cell ","2021","07","13","Front Immunol","Frontiers in immunology","COVID-19; M2-like differentiation; SARS-CoV-2; immune-regulation; innate immunity","Trombetta","Amelia C","Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal",NA
"2134","34248984","10.3389/fimmu.2021.691725","Severe COVID-19 Recovery Is Associated with Timely Acquisition of a Myeloid Cell Immune-Regulatory Phenotype.","After more than one year since the COVID-19 outbreak, patients with severe disease still constitute the bottleneck of the pandemic management. Aberrant inflammatory responses, ranging from cytokine storm to immune-suppression, were described in COVID-19 and no treatment was demonstrated to change the prognosis significantly. Therefore, there is an urgent need for understanding the underlying pathogenic mechanisms to guide therapeutic interventions. This study was designed to assess myeloid cell ","2021","07","13","Front Immunol","Frontiers in immunology","COVID-19; M2-like differentiation; SARS-CoV-2; immune-regulation; innate immunity","Farias","Guilherme B","Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal",NA
"2135","34248984","10.3389/fimmu.2021.691725","Severe COVID-19 Recovery Is Associated with Timely Acquisition of a Myeloid Cell Immune-Regulatory Phenotype.","After more than one year since the COVID-19 outbreak, patients with severe disease still constitute the bottleneck of the pandemic management. Aberrant inflammatory responses, ranging from cytokine storm to immune-suppression, were described in COVID-19 and no treatment was demonstrated to change the prognosis significantly. Therefore, there is an urgent need for understanding the underlying pathogenic mechanisms to guide therapeutic interventions. This study was designed to assess myeloid cell ","2021","07","13","Front Immunol","Frontiers in immunology","COVID-19; M2-like differentiation; SARS-CoV-2; immune-regulation; innate immunity","Gomes","André M C","Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal",NA
"2136","34248984","10.3389/fimmu.2021.691725","Severe COVID-19 Recovery Is Associated with Timely Acquisition of a Myeloid Cell Immune-Regulatory Phenotype.","After more than one year since the COVID-19 outbreak, patients with severe disease still constitute the bottleneck of the pandemic management. Aberrant inflammatory responses, ranging from cytokine storm to immune-suppression, were described in COVID-19 and no treatment was demonstrated to change the prognosis significantly. Therefore, there is an urgent need for understanding the underlying pathogenic mechanisms to guide therapeutic interventions. This study was designed to assess myeloid cell ","2021","07","13","Front Immunol","Frontiers in immunology","COVID-19; M2-like differentiation; SARS-CoV-2; immune-regulation; innate immunity","Godinho-Santos","Ana","Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal",NA
"2137","34248984","10.3389/fimmu.2021.691725","Severe COVID-19 Recovery Is Associated with Timely Acquisition of a Myeloid Cell Immune-Regulatory Phenotype.","After more than one year since the COVID-19 outbreak, patients with severe disease still constitute the bottleneck of the pandemic management. Aberrant inflammatory responses, ranging from cytokine storm to immune-suppression, were described in COVID-19 and no treatment was demonstrated to change the prognosis significantly. Therefore, there is an urgent need for understanding the underlying pathogenic mechanisms to guide therapeutic interventions. This study was designed to assess myeloid cell ","2021","07","13","Front Immunol","Frontiers in immunology","COVID-19; M2-like differentiation; SARS-CoV-2; immune-regulation; innate immunity","Rosmaninho","Pedro","Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal",NA
"2138","34248984","10.3389/fimmu.2021.691725","Severe COVID-19 Recovery Is Associated with Timely Acquisition of a Myeloid Cell Immune-Regulatory Phenotype.","After more than one year since the COVID-19 outbreak, patients with severe disease still constitute the bottleneck of the pandemic management. Aberrant inflammatory responses, ranging from cytokine storm to immune-suppression, were described in COVID-19 and no treatment was demonstrated to change the prognosis significantly. Therefore, there is an urgent need for understanding the underlying pathogenic mechanisms to guide therapeutic interventions. This study was designed to assess myeloid cell ","2021","07","13","Front Immunol","Frontiers in immunology","COVID-19; M2-like differentiation; SARS-CoV-2; immune-regulation; innate immunity","Conceição","Carolina M","Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal",NA
"2139","34248984","10.3389/fimmu.2021.691725","Severe COVID-19 Recovery Is Associated with Timely Acquisition of a Myeloid Cell Immune-Regulatory Phenotype.","After more than one year since the COVID-19 outbreak, patients with severe disease still constitute the bottleneck of the pandemic management. Aberrant inflammatory responses, ranging from cytokine storm to immune-suppression, were described in COVID-19 and no treatment was demonstrated to change the prognosis significantly. Therefore, there is an urgent need for understanding the underlying pathogenic mechanisms to guide therapeutic interventions. This study was designed to assess myeloid cell ","2021","07","13","Front Immunol","Frontiers in immunology","COVID-19; M2-like differentiation; SARS-CoV-2; immune-regulation; innate immunity","Laia","Joel","Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal",NA
"2140","34248984","10.3389/fimmu.2021.691725","Severe COVID-19 Recovery Is Associated with Timely Acquisition of a Myeloid Cell Immune-Regulatory Phenotype.","After more than one year since the COVID-19 outbreak, patients with severe disease still constitute the bottleneck of the pandemic management. Aberrant inflammatory responses, ranging from cytokine storm to immune-suppression, were described in COVID-19 and no treatment was demonstrated to change the prognosis significantly. Therefore, there is an urgent need for understanding the underlying pathogenic mechanisms to guide therapeutic interventions. This study was designed to assess myeloid cell ","2021","07","13","Front Immunol","Frontiers in immunology","COVID-19; M2-like differentiation; SARS-CoV-2; immune-regulation; innate immunity","Santos","Diana F","Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal",NA
"2141","34248984","10.3389/fimmu.2021.691725","Severe COVID-19 Recovery Is Associated with Timely Acquisition of a Myeloid Cell Immune-Regulatory Phenotype.","After more than one year since the COVID-19 outbreak, patients with severe disease still constitute the bottleneck of the pandemic management. Aberrant inflammatory responses, ranging from cytokine storm to immune-suppression, were described in COVID-19 and no treatment was demonstrated to change the prognosis significantly. Therefore, there is an urgent need for understanding the underlying pathogenic mechanisms to guide therapeutic interventions. This study was designed to assess myeloid cell ","2021","07","13","Front Immunol","Frontiers in immunology","COVID-19; M2-like differentiation; SARS-CoV-2; immune-regulation; innate immunity","Almeida","Afonso R M","Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal",NA
"2142","34248984","10.3389/fimmu.2021.691725","Severe COVID-19 Recovery Is Associated with Timely Acquisition of a Myeloid Cell Immune-Regulatory Phenotype.","After more than one year since the COVID-19 outbreak, patients with severe disease still constitute the bottleneck of the pandemic management. Aberrant inflammatory responses, ranging from cytokine storm to immune-suppression, were described in COVID-19 and no treatment was demonstrated to change the prognosis significantly. Therefore, there is an urgent need for understanding the underlying pathogenic mechanisms to guide therapeutic interventions. This study was designed to assess myeloid cell ","2021","07","13","Front Immunol","Frontiers in immunology","COVID-19; M2-like differentiation; SARS-CoV-2; immune-regulation; innate immunity","Mota","Catarina","Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal",NA
"2143","34248984","10.3389/fimmu.2021.691725","Severe COVID-19 Recovery Is Associated with Timely Acquisition of a Myeloid Cell Immune-Regulatory Phenotype.","After more than one year since the COVID-19 outbreak, patients with severe disease still constitute the bottleneck of the pandemic management. Aberrant inflammatory responses, ranging from cytokine storm to immune-suppression, were described in COVID-19 and no treatment was demonstrated to change the prognosis significantly. Therefore, there is an urgent need for understanding the underlying pathogenic mechanisms to guide therapeutic interventions. This study was designed to assess myeloid cell ","2021","07","13","Front Immunol","Frontiers in immunology","COVID-19; M2-like differentiation; SARS-CoV-2; immune-regulation; innate immunity","Gomes","Andreia","Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal",NA
"2144","34248984","10.3389/fimmu.2021.691725","Severe COVID-19 Recovery Is Associated with Timely Acquisition of a Myeloid Cell Immune-Regulatory Phenotype.","After more than one year since the COVID-19 outbreak, patients with severe disease still constitute the bottleneck of the pandemic management. Aberrant inflammatory responses, ranging from cytokine storm to immune-suppression, were described in COVID-19 and no treatment was demonstrated to change the prognosis significantly. Therefore, there is an urgent need for understanding the underlying pathogenic mechanisms to guide therapeutic interventions. This study was designed to assess myeloid cell ","2021","07","13","Front Immunol","Frontiers in immunology","COVID-19; M2-like differentiation; SARS-CoV-2; immune-regulation; innate immunity","Serrano","Marta","Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal",NA
"2145","34248984","10.3389/fimmu.2021.691725","Severe COVID-19 Recovery Is Associated with Timely Acquisition of a Myeloid Cell Immune-Regulatory Phenotype.","After more than one year since the COVID-19 outbreak, patients with severe disease still constitute the bottleneck of the pandemic management. Aberrant inflammatory responses, ranging from cytokine storm to immune-suppression, were described in COVID-19 and no treatment was demonstrated to change the prognosis significantly. Therefore, there is an urgent need for understanding the underlying pathogenic mechanisms to guide therapeutic interventions. This study was designed to assess myeloid cell ","2021","07","13","Front Immunol","Frontiers in immunology","COVID-19; M2-like differentiation; SARS-CoV-2; immune-regulation; innate immunity","Veldhoen","Marc","Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal",NA
"2146","34248984","10.3389/fimmu.2021.691725","Severe COVID-19 Recovery Is Associated with Timely Acquisition of a Myeloid Cell Immune-Regulatory Phenotype.","After more than one year since the COVID-19 outbreak, patients with severe disease still constitute the bottleneck of the pandemic management. Aberrant inflammatory responses, ranging from cytokine storm to immune-suppression, were described in COVID-19 and no treatment was demonstrated to change the prognosis significantly. Therefore, there is an urgent need for understanding the underlying pathogenic mechanisms to guide therapeutic interventions. This study was designed to assess myeloid cell ","2021","07","13","Front Immunol","Frontiers in immunology","COVID-19; M2-like differentiation; SARS-CoV-2; immune-regulation; innate immunity","Sousa","Ana E","Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal",NA
"2147","34248984","10.3389/fimmu.2021.691725","Severe COVID-19 Recovery Is Associated with Timely Acquisition of a Myeloid Cell Immune-Regulatory Phenotype.","After more than one year since the COVID-19 outbreak, patients with severe disease still constitute the bottleneck of the pandemic management. Aberrant inflammatory responses, ranging from cytokine storm to immune-suppression, were described in COVID-19 and no treatment was demonstrated to change the prognosis significantly. Therefore, there is an urgent need for understanding the underlying pathogenic mechanisms to guide therapeutic interventions. This study was designed to assess myeloid cell ","2021","07","13","Front Immunol","Frontiers in immunology","COVID-19; M2-like differentiation; SARS-CoV-2; immune-regulation; innate immunity","Fernandes","Susana M","Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal",NA
"2148","34248968","10.3389/fimmu.2021.683800","SARS-CoV-2/ACE2 Interaction Suppresses IRAK-M Expression and Promotes Pro-Inflammatory Cytokine Production in Macrophages.","The major cause of death in SARS-CoV-2 infected patients is due to de-regulation of the innate immune system and development of cytokine storm. SARS-CoV-2 infects multiple cell types in the lung, including macrophages, by engagement of its spike (S) protein on angiotensin converting enzyme 2 (ACE2) receptor. ACE2 receptor initiates signals in macrophages that modulate their activation, including production of cytokines and chemokines. IL-1R-associated kinase (IRAK)-M is a central regulator of in","2021","07","13","Front Immunol","Frontiers in immunology","ACE2; COVID-19; IL-6; IRAK-M; SARS-CoV-2; cytokines; inflammation; macrophages","Pantazi","Ioanna","Laboratory of Clinical Chemistry, Medical School, University of Crete, Heraklion, Greece",NA
"2149","34248968","10.3389/fimmu.2021.683800","SARS-CoV-2/ACE2 Interaction Suppresses IRAK-M Expression and Promotes Pro-Inflammatory Cytokine Production in Macrophages.","The major cause of death in SARS-CoV-2 infected patients is due to de-regulation of the innate immune system and development of cytokine storm. SARS-CoV-2 infects multiple cell types in the lung, including macrophages, by engagement of its spike (S) protein on angiotensin converting enzyme 2 (ACE2) receptor. ACE2 receptor initiates signals in macrophages that modulate their activation, including production of cytokines and chemokines. IL-1R-associated kinase (IRAK)-M is a central regulator of in","2021","07","13","Front Immunol","Frontiers in immunology","ACE2; COVID-19; IL-6; IRAK-M; SARS-CoV-2; cytokines; inflammation; macrophages","Al-Qahtani","Ahmed A","Department of Infection and Immunity, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia",NA
"2150","34248968","10.3389/fimmu.2021.683800","SARS-CoV-2/ACE2 Interaction Suppresses IRAK-M Expression and Promotes Pro-Inflammatory Cytokine Production in Macrophages.","The major cause of death in SARS-CoV-2 infected patients is due to de-regulation of the innate immune system and development of cytokine storm. SARS-CoV-2 infects multiple cell types in the lung, including macrophages, by engagement of its spike (S) protein on angiotensin converting enzyme 2 (ACE2) receptor. ACE2 receptor initiates signals in macrophages that modulate their activation, including production of cytokines and chemokines. IL-1R-associated kinase (IRAK)-M is a central regulator of in","2021","07","13","Front Immunol","Frontiers in immunology","ACE2; COVID-19; IL-6; IRAK-M; SARS-CoV-2; cytokines; inflammation; macrophages","Alhamlan","Fatimah S","Department of Infection and Immunity, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia",NA
"2151","34248968","10.3389/fimmu.2021.683800","SARS-CoV-2/ACE2 Interaction Suppresses IRAK-M Expression and Promotes Pro-Inflammatory Cytokine Production in Macrophages.","The major cause of death in SARS-CoV-2 infected patients is due to de-regulation of the innate immune system and development of cytokine storm. SARS-CoV-2 infects multiple cell types in the lung, including macrophages, by engagement of its spike (S) protein on angiotensin converting enzyme 2 (ACE2) receptor. ACE2 receptor initiates signals in macrophages that modulate their activation, including production of cytokines and chemokines. IL-1R-associated kinase (IRAK)-M is a central regulator of in","2021","07","13","Front Immunol","Frontiers in immunology","ACE2; COVID-19; IL-6; IRAK-M; SARS-CoV-2; cytokines; inflammation; macrophages","Alothaid","Hani","Department of Basic Sciences, Faculty of Applied Medical Sciences, Al-Baha University, Al-Baha, Saudi Arabia",NA
"2152","34248968","10.3389/fimmu.2021.683800","SARS-CoV-2/ACE2 Interaction Suppresses IRAK-M Expression and Promotes Pro-Inflammatory Cytokine Production in Macrophages.","The major cause of death in SARS-CoV-2 infected patients is due to de-regulation of the innate immune system and development of cytokine storm. SARS-CoV-2 infects multiple cell types in the lung, including macrophages, by engagement of its spike (S) protein on angiotensin converting enzyme 2 (ACE2) receptor. ACE2 receptor initiates signals in macrophages that modulate their activation, including production of cytokines and chemokines. IL-1R-associated kinase (IRAK)-M is a central regulator of in","2021","07","13","Front Immunol","Frontiers in immunology","ACE2; COVID-19; IL-6; IRAK-M; SARS-CoV-2; cytokines; inflammation; macrophages","Matou-Nasri","Sabine","Cell and Gene Therapy Group, Medical Genomics Research Department, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia",NA
"2153","34248968","10.3389/fimmu.2021.683800","SARS-CoV-2/ACE2 Interaction Suppresses IRAK-M Expression and Promotes Pro-Inflammatory Cytokine Production in Macrophages.","The major cause of death in SARS-CoV-2 infected patients is due to de-regulation of the innate immune system and development of cytokine storm. SARS-CoV-2 infects multiple cell types in the lung, including macrophages, by engagement of its spike (S) protein on angiotensin converting enzyme 2 (ACE2) receptor. ACE2 receptor initiates signals in macrophages that modulate their activation, including production of cytokines and chemokines. IL-1R-associated kinase (IRAK)-M is a central regulator of in","2021","07","13","Front Immunol","Frontiers in immunology","ACE2; COVID-19; IL-6; IRAK-M; SARS-CoV-2; cytokines; inflammation; macrophages","Sourvinos","George","Laboratory of Virology, Medical School, University of Crete, Heraklion, Greece",NA
"2154","34248968","10.3389/fimmu.2021.683800","SARS-CoV-2/ACE2 Interaction Suppresses IRAK-M Expression and Promotes Pro-Inflammatory Cytokine Production in Macrophages.","The major cause of death in SARS-CoV-2 infected patients is due to de-regulation of the innate immune system and development of cytokine storm. SARS-CoV-2 infects multiple cell types in the lung, including macrophages, by engagement of its spike (S) protein on angiotensin converting enzyme 2 (ACE2) receptor. ACE2 receptor initiates signals in macrophages that modulate their activation, including production of cytokines and chemokines. IL-1R-associated kinase (IRAK)-M is a central regulator of in","2021","07","13","Front Immunol","Frontiers in immunology","ACE2; COVID-19; IL-6; IRAK-M; SARS-CoV-2; cytokines; inflammation; macrophages","Vergadi","Eleni","Department of Pediatrics, Medical School, University of Crete, Heraklion, Greece",NA
"2155","34248968","10.3389/fimmu.2021.683800","SARS-CoV-2/ACE2 Interaction Suppresses IRAK-M Expression and Promotes Pro-Inflammatory Cytokine Production in Macrophages.","The major cause of death in SARS-CoV-2 infected patients is due to de-regulation of the innate immune system and development of cytokine storm. SARS-CoV-2 infects multiple cell types in the lung, including macrophages, by engagement of its spike (S) protein on angiotensin converting enzyme 2 (ACE2) receptor. ACE2 receptor initiates signals in macrophages that modulate their activation, including production of cytokines and chemokines. IL-1R-associated kinase (IRAK)-M is a central regulator of in","2021","07","13","Front Immunol","Frontiers in immunology","ACE2; COVID-19; IL-6; IRAK-M; SARS-CoV-2; cytokines; inflammation; macrophages","Tsatsanis","Christos","Laboratory of Clinical Chemistry, Medical School, University of Crete, Heraklion, Greece",NA
"2156","34248962","10.3389/fimmu.2021.680567","Case Report: Adult Post-COVID-19 Multisystem Inflammatory Syndrome and Thrombotic Microangiopathy.","The coronavirus disease 2019 (COVID-19) pandemic has affected millions of people worldwide. A clinical series of Kawasaki-like multisystem inflammatory syndrome (MIS), occurring after SARS-CoV-2 infection, have been described in children (MIS-C) and adults (MIS-A), but the pathophysiology remains unknown. We describe a case of post-COVID-19 MIS-A in a 46-year-old man with biopsy-proven renal thrombotic microangiopathy (TMA). Specific complement inhibition with eculizumab was initiated promptly a","2021","07","13","Front Immunol","Frontiers in immunology","COVID-19; case report; complement system; eculizumab; multisystem inflammatory syndrome; thrombotic microangiopathy","Boudhabhay","Idris","Groupe Hospitalier Sud Ile de France, Service de Réanimation, Melun, France",NA
"2157","34248962","10.3389/fimmu.2021.680567","Case Report: Adult Post-COVID-19 Multisystem Inflammatory Syndrome and Thrombotic Microangiopathy.","The coronavirus disease 2019 (COVID-19) pandemic has affected millions of people worldwide. A clinical series of Kawasaki-like multisystem inflammatory syndrome (MIS), occurring after SARS-CoV-2 infection, have been described in children (MIS-C) and adults (MIS-A), but the pathophysiology remains unknown. We describe a case of post-COVID-19 MIS-A in a 46-year-old man with biopsy-proven renal thrombotic microangiopathy (TMA). Specific complement inhibition with eculizumab was initiated promptly a","2021","07","13","Front Immunol","Frontiers in immunology","COVID-19; case report; complement system; eculizumab; multisystem inflammatory syndrome; thrombotic microangiopathy","Rabant","Marion","Centre Hospitalo-Universitaire Necker, Service d'Anatomie Pathologique, Paris, France",NA
"2158","34248962","10.3389/fimmu.2021.680567","Case Report: Adult Post-COVID-19 Multisystem Inflammatory Syndrome and Thrombotic Microangiopathy.","The coronavirus disease 2019 (COVID-19) pandemic has affected millions of people worldwide. A clinical series of Kawasaki-like multisystem inflammatory syndrome (MIS), occurring after SARS-CoV-2 infection, have been described in children (MIS-C) and adults (MIS-A), but the pathophysiology remains unknown. We describe a case of post-COVID-19 MIS-A in a 46-year-old man with biopsy-proven renal thrombotic microangiopathy (TMA). Specific complement inhibition with eculizumab was initiated promptly a","2021","07","13","Front Immunol","Frontiers in immunology","COVID-19; case report; complement system; eculizumab; multisystem inflammatory syndrome; thrombotic microangiopathy","Roumenina","Lubka T","Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université de Paris, Paris, France",NA
"2159","34248962","10.3389/fimmu.2021.680567","Case Report: Adult Post-COVID-19 Multisystem Inflammatory Syndrome and Thrombotic Microangiopathy.","The coronavirus disease 2019 (COVID-19) pandemic has affected millions of people worldwide. A clinical series of Kawasaki-like multisystem inflammatory syndrome (MIS), occurring after SARS-CoV-2 infection, have been described in children (MIS-C) and adults (MIS-A), but the pathophysiology remains unknown. We describe a case of post-COVID-19 MIS-A in a 46-year-old man with biopsy-proven renal thrombotic microangiopathy (TMA). Specific complement inhibition with eculizumab was initiated promptly a","2021","07","13","Front Immunol","Frontiers in immunology","COVID-19; case report; complement system; eculizumab; multisystem inflammatory syndrome; thrombotic microangiopathy","Coupry","Louis-Marie","Groupe Hospitalier Sud Ile de France, Service de Réanimation, Melun, France",NA
"2160","34248962","10.3389/fimmu.2021.680567","Case Report: Adult Post-COVID-19 Multisystem Inflammatory Syndrome and Thrombotic Microangiopathy.","The coronavirus disease 2019 (COVID-19) pandemic has affected millions of people worldwide. A clinical series of Kawasaki-like multisystem inflammatory syndrome (MIS), occurring after SARS-CoV-2 infection, have been described in children (MIS-C) and adults (MIS-A), but the pathophysiology remains unknown. We describe a case of post-COVID-19 MIS-A in a 46-year-old man with biopsy-proven renal thrombotic microangiopathy (TMA). Specific complement inhibition with eculizumab was initiated promptly a","2021","07","13","Front Immunol","Frontiers in immunology","COVID-19; case report; complement system; eculizumab; multisystem inflammatory syndrome; thrombotic microangiopathy","Poillerat","Victoria","Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université de Paris, Paris, France",NA
"2161","34248962","10.3389/fimmu.2021.680567","Case Report: Adult Post-COVID-19 Multisystem Inflammatory Syndrome and Thrombotic Microangiopathy.","The coronavirus disease 2019 (COVID-19) pandemic has affected millions of people worldwide. A clinical series of Kawasaki-like multisystem inflammatory syndrome (MIS), occurring after SARS-CoV-2 infection, have been described in children (MIS-C) and adults (MIS-A), but the pathophysiology remains unknown. We describe a case of post-COVID-19 MIS-A in a 46-year-old man with biopsy-proven renal thrombotic microangiopathy (TMA). Specific complement inhibition with eculizumab was initiated promptly a","2021","07","13","Front Immunol","Frontiers in immunology","COVID-19; case report; complement system; eculizumab; multisystem inflammatory syndrome; thrombotic microangiopathy","Marchal","Armance","Hôpital Européen Georges Pompidou, Laboratoire d'Immunologie Biologique, Paris, France",NA
"2162","34248962","10.3389/fimmu.2021.680567","Case Report: Adult Post-COVID-19 Multisystem Inflammatory Syndrome and Thrombotic Microangiopathy.","The coronavirus disease 2019 (COVID-19) pandemic has affected millions of people worldwide. A clinical series of Kawasaki-like multisystem inflammatory syndrome (MIS), occurring after SARS-CoV-2 infection, have been described in children (MIS-C) and adults (MIS-A), but the pathophysiology remains unknown. We describe a case of post-COVID-19 MIS-A in a 46-year-old man with biopsy-proven renal thrombotic microangiopathy (TMA). Specific complement inhibition with eculizumab was initiated promptly a","2021","07","13","Front Immunol","Frontiers in immunology","COVID-19; case report; complement system; eculizumab; multisystem inflammatory syndrome; thrombotic microangiopathy","Frémeaux-Bacchi","Véronique","Hôpital Européen Georges Pompidou, Laboratoire d'Immunologie Biologique, Paris, France",NA
"2163","34248962","10.3389/fimmu.2021.680567","Case Report: Adult Post-COVID-19 Multisystem Inflammatory Syndrome and Thrombotic Microangiopathy.","The coronavirus disease 2019 (COVID-19) pandemic has affected millions of people worldwide. A clinical series of Kawasaki-like multisystem inflammatory syndrome (MIS), occurring after SARS-CoV-2 infection, have been described in children (MIS-C) and adults (MIS-A), but the pathophysiology remains unknown. We describe a case of post-COVID-19 MIS-A in a 46-year-old man with biopsy-proven renal thrombotic microangiopathy (TMA). Specific complement inhibition with eculizumab was initiated promptly a","2021","07","13","Front Immunol","Frontiers in immunology","COVID-19; case report; complement system; eculizumab; multisystem inflammatory syndrome; thrombotic microangiopathy","El Karoui","Khalil","Centre Hospitalo-Universitaire Henri Mondor, Service de Néphrologie et Transplantation, Créteil, France",NA
"2164","34248962","10.3389/fimmu.2021.680567","Case Report: Adult Post-COVID-19 Multisystem Inflammatory Syndrome and Thrombotic Microangiopathy.","The coronavirus disease 2019 (COVID-19) pandemic has affected millions of people worldwide. A clinical series of Kawasaki-like multisystem inflammatory syndrome (MIS), occurring after SARS-CoV-2 infection, have been described in children (MIS-C) and adults (MIS-A), but the pathophysiology remains unknown. We describe a case of post-COVID-19 MIS-A in a 46-year-old man with biopsy-proven renal thrombotic microangiopathy (TMA). Specific complement inhibition with eculizumab was initiated promptly a","2021","07","13","Front Immunol","Frontiers in immunology","COVID-19; case report; complement system; eculizumab; multisystem inflammatory syndrome; thrombotic microangiopathy","Monchi","Mehran","Groupe Hospitalier Sud Ile de France, Service de Réanimation, Melun, France",NA
"2165","34248962","10.3389/fimmu.2021.680567","Case Report: Adult Post-COVID-19 Multisystem Inflammatory Syndrome and Thrombotic Microangiopathy.","The coronavirus disease 2019 (COVID-19) pandemic has affected millions of people worldwide. A clinical series of Kawasaki-like multisystem inflammatory syndrome (MIS), occurring after SARS-CoV-2 infection, have been described in children (MIS-C) and adults (MIS-A), but the pathophysiology remains unknown. We describe a case of post-COVID-19 MIS-A in a 46-year-old man with biopsy-proven renal thrombotic microangiopathy (TMA). Specific complement inhibition with eculizumab was initiated promptly a","2021","07","13","Front Immunol","Frontiers in immunology","COVID-19; case report; complement system; eculizumab; multisystem inflammatory syndrome; thrombotic microangiopathy","Pourcine","Franck","Groupe Hospitalier Sud Ile de France, Service de Réanimation, Melun, France",NA
"2166","34248955","10.3389/fimmu.2021.674079","Kinetics of Neutrophil Subsets in Acute, Subacute, and Chronic Inflammation.","At homeostasis the vast majority of neutrophils in the circulation expresses CD16 and CD62L within a narrow expression range, but this quickly changes in disease. Little is known regarding the changes in kinetics of neutrophils phenotypes in inflammatory conditions. During acute inflammation more heterogeneity was found, characterized by an increase in CD16<sup>dim</sup> banded neutrophils. These cells were probably released from the bone marrow (left shift). Acute inflammation induced by human ","2021","07","13","Front Immunol","Frontiers in immunology","CD16; CD62L; acute inflammation; chronic inflammation; morphology; neutrophil subsets; neutrophils; subacute inflammation","Bongers","Suzanne H","Center for Translational Immunology (CTI), University Medical Center Utrecht, Utrecht, Netherlands",NA
"2167","34248955","10.3389/fimmu.2021.674079","Kinetics of Neutrophil Subsets in Acute, Subacute, and Chronic Inflammation.","At homeostasis the vast majority of neutrophils in the circulation expresses CD16 and CD62L within a narrow expression range, but this quickly changes in disease. Little is known regarding the changes in kinetics of neutrophils phenotypes in inflammatory conditions. During acute inflammation more heterogeneity was found, characterized by an increase in CD16<sup>dim</sup> banded neutrophils. These cells were probably released from the bone marrow (left shift). Acute inflammation induced by human ","2021","07","13","Front Immunol","Frontiers in immunology","CD16; CD62L; acute inflammation; chronic inflammation; morphology; neutrophil subsets; neutrophils; subacute inflammation","Chen","Na","Center for Translational Immunology (CTI), University Medical Center Utrecht, Utrecht, Netherlands",NA
"2168","34248955","10.3389/fimmu.2021.674079","Kinetics of Neutrophil Subsets in Acute, Subacute, and Chronic Inflammation.","At homeostasis the vast majority of neutrophils in the circulation expresses CD16 and CD62L within a narrow expression range, but this quickly changes in disease. Little is known regarding the changes in kinetics of neutrophils phenotypes in inflammatory conditions. During acute inflammation more heterogeneity was found, characterized by an increase in CD16<sup>dim</sup> banded neutrophils. These cells were probably released from the bone marrow (left shift). Acute inflammation induced by human ","2021","07","13","Front Immunol","Frontiers in immunology","CD16; CD62L; acute inflammation; chronic inflammation; morphology; neutrophil subsets; neutrophils; subacute inflammation","van Grinsven","Erinke","Center for Translational Immunology (CTI), University Medical Center Utrecht, Utrecht, Netherlands",NA
"2169","34248955","10.3389/fimmu.2021.674079","Kinetics of Neutrophil Subsets in Acute, Subacute, and Chronic Inflammation.","At homeostasis the vast majority of neutrophils in the circulation expresses CD16 and CD62L within a narrow expression range, but this quickly changes in disease. Little is known regarding the changes in kinetics of neutrophils phenotypes in inflammatory conditions. During acute inflammation more heterogeneity was found, characterized by an increase in CD16<sup>dim</sup> banded neutrophils. These cells were probably released from the bone marrow (left shift). Acute inflammation induced by human ","2021","07","13","Front Immunol","Frontiers in immunology","CD16; CD62L; acute inflammation; chronic inflammation; morphology; neutrophil subsets; neutrophils; subacute inflammation","van Staveren","Selma","Center for Translational Immunology (CTI), University Medical Center Utrecht, Utrecht, Netherlands",NA
"2170","34248955","10.3389/fimmu.2021.674079","Kinetics of Neutrophil Subsets in Acute, Subacute, and Chronic Inflammation.","At homeostasis the vast majority of neutrophils in the circulation expresses CD16 and CD62L within a narrow expression range, but this quickly changes in disease. Little is known regarding the changes in kinetics of neutrophils phenotypes in inflammatory conditions. During acute inflammation more heterogeneity was found, characterized by an increase in CD16<sup>dim</sup> banded neutrophils. These cells were probably released from the bone marrow (left shift). Acute inflammation induced by human ","2021","07","13","Front Immunol","Frontiers in immunology","CD16; CD62L; acute inflammation; chronic inflammation; morphology; neutrophil subsets; neutrophils; subacute inflammation","Hassani","Marwan","Center for Translational Immunology (CTI), University Medical Center Utrecht, Utrecht, Netherlands",NA
"2171","34248955","10.3389/fimmu.2021.674079","Kinetics of Neutrophil Subsets in Acute, Subacute, and Chronic Inflammation.","At homeostasis the vast majority of neutrophils in the circulation expresses CD16 and CD62L within a narrow expression range, but this quickly changes in disease. Little is known regarding the changes in kinetics of neutrophils phenotypes in inflammatory conditions. During acute inflammation more heterogeneity was found, characterized by an increase in CD16<sup>dim</sup> banded neutrophils. These cells were probably released from the bone marrow (left shift). Acute inflammation induced by human ","2021","07","13","Front Immunol","Frontiers in immunology","CD16; CD62L; acute inflammation; chronic inflammation; morphology; neutrophil subsets; neutrophils; subacute inflammation","Spijkerman","Roy","Center for Translational Immunology (CTI), University Medical Center Utrecht, Utrecht, Netherlands",NA
"2172","34248955","10.3389/fimmu.2021.674079","Kinetics of Neutrophil Subsets in Acute, Subacute, and Chronic Inflammation.","At homeostasis the vast majority of neutrophils in the circulation expresses CD16 and CD62L within a narrow expression range, but this quickly changes in disease. Little is known regarding the changes in kinetics of neutrophils phenotypes in inflammatory conditions. During acute inflammation more heterogeneity was found, characterized by an increase in CD16<sup>dim</sup> banded neutrophils. These cells were probably released from the bone marrow (left shift). Acute inflammation induced by human ","2021","07","13","Front Immunol","Frontiers in immunology","CD16; CD62L; acute inflammation; chronic inflammation; morphology; neutrophil subsets; neutrophils; subacute inflammation","Hesselink","Lilian","Center for Translational Immunology (CTI), University Medical Center Utrecht, Utrecht, Netherlands",NA
"2173","34248955","10.3389/fimmu.2021.674079","Kinetics of Neutrophil Subsets in Acute, Subacute, and Chronic Inflammation.","At homeostasis the vast majority of neutrophils in the circulation expresses CD16 and CD62L within a narrow expression range, but this quickly changes in disease. Little is known regarding the changes in kinetics of neutrophils phenotypes in inflammatory conditions. During acute inflammation more heterogeneity was found, characterized by an increase in CD16<sup>dim</sup> banded neutrophils. These cells were probably released from the bone marrow (left shift). Acute inflammation induced by human ","2021","07","13","Front Immunol","Frontiers in immunology","CD16; CD62L; acute inflammation; chronic inflammation; morphology; neutrophil subsets; neutrophils; subacute inflammation","Lo Tam Loi","Adèle T","Department of Respiratory Medicine, University Medical Center Utrecht, Utrecht, Netherlands",NA
"2174","34248955","10.3389/fimmu.2021.674079","Kinetics of Neutrophil Subsets in Acute, Subacute, and Chronic Inflammation.","At homeostasis the vast majority of neutrophils in the circulation expresses CD16 and CD62L within a narrow expression range, but this quickly changes in disease. Little is known regarding the changes in kinetics of neutrophils phenotypes in inflammatory conditions. During acute inflammation more heterogeneity was found, characterized by an increase in CD16<sup>dim</sup> banded neutrophils. These cells were probably released from the bone marrow (left shift). Acute inflammation induced by human ","2021","07","13","Front Immunol","Frontiers in immunology","CD16; CD62L; acute inflammation; chronic inflammation; morphology; neutrophil subsets; neutrophils; subacute inflammation","van Aalst","Corneli","Center for Translational Immunology (CTI), University Medical Center Utrecht, Utrecht, Netherlands",NA
"2175","34248955","10.3389/fimmu.2021.674079","Kinetics of Neutrophil Subsets in Acute, Subacute, and Chronic Inflammation.","At homeostasis the vast majority of neutrophils in the circulation expresses CD16 and CD62L within a narrow expression range, but this quickly changes in disease. Little is known regarding the changes in kinetics of neutrophils phenotypes in inflammatory conditions. During acute inflammation more heterogeneity was found, characterized by an increase in CD16<sup>dim</sup> banded neutrophils. These cells were probably released from the bone marrow (left shift). Acute inflammation induced by human ","2021","07","13","Front Immunol","Frontiers in immunology","CD16; CD62L; acute inflammation; chronic inflammation; morphology; neutrophil subsets; neutrophils; subacute inflammation","Leijte","Guus P","Department of Intensive Care, Radboud University Medical Center, Nijmegen, Netherlands",NA
"2176","34248955","10.3389/fimmu.2021.674079","Kinetics of Neutrophil Subsets in Acute, Subacute, and Chronic Inflammation.","At homeostasis the vast majority of neutrophils in the circulation expresses CD16 and CD62L within a narrow expression range, but this quickly changes in disease. Little is known regarding the changes in kinetics of neutrophils phenotypes in inflammatory conditions. During acute inflammation more heterogeneity was found, characterized by an increase in CD16<sup>dim</sup> banded neutrophils. These cells were probably released from the bone marrow (left shift). Acute inflammation induced by human ","2021","07","13","Front Immunol","Frontiers in immunology","CD16; CD62L; acute inflammation; chronic inflammation; morphology; neutrophil subsets; neutrophils; subacute inflammation","Kox","Matthijs","Department of Intensive Care, Radboud University Medical Center, Nijmegen, Netherlands",NA
"2177","34248955","10.3389/fimmu.2021.674079","Kinetics of Neutrophil Subsets in Acute, Subacute, and Chronic Inflammation.","At homeostasis the vast majority of neutrophils in the circulation expresses CD16 and CD62L within a narrow expression range, but this quickly changes in disease. Little is known regarding the changes in kinetics of neutrophils phenotypes in inflammatory conditions. During acute inflammation more heterogeneity was found, characterized by an increase in CD16<sup>dim</sup> banded neutrophils. These cells were probably released from the bone marrow (left shift). Acute inflammation induced by human ","2021","07","13","Front Immunol","Frontiers in immunology","CD16; CD62L; acute inflammation; chronic inflammation; morphology; neutrophil subsets; neutrophils; subacute inflammation","Pickkers","Peter","Department of Intensive Care, Radboud University Medical Center, Nijmegen, Netherlands",NA
"2178","34248955","10.3389/fimmu.2021.674079","Kinetics of Neutrophil Subsets in Acute, Subacute, and Chronic Inflammation.","At homeostasis the vast majority of neutrophils in the circulation expresses CD16 and CD62L within a narrow expression range, but this quickly changes in disease. Little is known regarding the changes in kinetics of neutrophils phenotypes in inflammatory conditions. During acute inflammation more heterogeneity was found, characterized by an increase in CD16<sup>dim</sup> banded neutrophils. These cells were probably released from the bone marrow (left shift). Acute inflammation induced by human ","2021","07","13","Front Immunol","Frontiers in immunology","CD16; CD62L; acute inflammation; chronic inflammation; morphology; neutrophil subsets; neutrophils; subacute inflammation","Hietbrink","Falco","Center for Translational Immunology (CTI), University Medical Center Utrecht, Utrecht, Netherlands",NA
"2179","34248955","10.3389/fimmu.2021.674079","Kinetics of Neutrophil Subsets in Acute, Subacute, and Chronic Inflammation.","At homeostasis the vast majority of neutrophils in the circulation expresses CD16 and CD62L within a narrow expression range, but this quickly changes in disease. Little is known regarding the changes in kinetics of neutrophils phenotypes in inflammatory conditions. During acute inflammation more heterogeneity was found, characterized by an increase in CD16<sup>dim</sup> banded neutrophils. These cells were probably released from the bone marrow (left shift). Acute inflammation induced by human ","2021","07","13","Front Immunol","Frontiers in immunology","CD16; CD62L; acute inflammation; chronic inflammation; morphology; neutrophil subsets; neutrophils; subacute inflammation","Leenen","Luke P H","Center for Translational Immunology (CTI), University Medical Center Utrecht, Utrecht, Netherlands",NA
"2180","34248955","10.3389/fimmu.2021.674079","Kinetics of Neutrophil Subsets in Acute, Subacute, and Chronic Inflammation.","At homeostasis the vast majority of neutrophils in the circulation expresses CD16 and CD62L within a narrow expression range, but this quickly changes in disease. Little is known regarding the changes in kinetics of neutrophils phenotypes in inflammatory conditions. During acute inflammation more heterogeneity was found, characterized by an increase in CD16<sup>dim</sup> banded neutrophils. These cells were probably released from the bone marrow (left shift). Acute inflammation induced by human ","2021","07","13","Front Immunol","Frontiers in immunology","CD16; CD62L; acute inflammation; chronic inflammation; morphology; neutrophil subsets; neutrophils; subacute inflammation","Koenderman","Leo","Center for Translational Immunology (CTI), University Medical Center Utrecht, Utrecht, Netherlands",NA
"2181","34248955","10.3389/fimmu.2021.674079","Kinetics of Neutrophil Subsets in Acute, Subacute, and Chronic Inflammation.","At homeostasis the vast majority of neutrophils in the circulation expresses CD16 and CD62L within a narrow expression range, but this quickly changes in disease. Little is known regarding the changes in kinetics of neutrophils phenotypes in inflammatory conditions. During acute inflammation more heterogeneity was found, characterized by an increase in CD16<sup>dim</sup> banded neutrophils. These cells were probably released from the bone marrow (left shift). Acute inflammation induced by human ","2021","07","13","Front Immunol","Frontiers in immunology","CD16; CD62L; acute inflammation; chronic inflammation; morphology; neutrophil subsets; neutrophils; subacute inflammation","Vrisekoop","Nienke","Center for Translational Immunology (CTI), University Medical Center Utrecht, Utrecht, Netherlands",NA
"2182","34248940","10.3389/fimmu.2021.653110","Endothelial Immunity Trained by Coronavirus Infections, DAMP Stimulations and Regulated by Anti-Oxidant NRF2 May Contribute to Inflammations, Myelopoiesis, COVID-19 Cytokine Storms and Thromboembolism.","To characterize transcriptomic changes in endothelial cells (ECs) infected by coronaviruses, and stimulated by DAMPs, the expressions of 1311 innate immune regulatomic genes (IGs) were examined in 28 EC microarray datasets with 7 monocyte datasets as controls. We made the following findings: The majority of IGs are upregulated in the first 12 hours post-infection (PI), and maintained until 48 hours PI in human microvascular EC infected by middle east respiratory syndrome-coronavirus (MERS-CoV) (","2021","07","13","Front Immunol","Frontiers in immunology","DAMP; coronavirus infection; endothelial cell; oxidative phosphorylation; trained immunity","Shao","Ying","Centers of Cardiovascular Research, Inflammation, Translational &amp",NA
"2183","34248940","10.3389/fimmu.2021.653110","Endothelial Immunity Trained by Coronavirus Infections, DAMP Stimulations and Regulated by Anti-Oxidant NRF2 May Contribute to Inflammations, Myelopoiesis, COVID-19 Cytokine Storms and Thromboembolism.","To characterize transcriptomic changes in endothelial cells (ECs) infected by coronaviruses, and stimulated by DAMPs, the expressions of 1311 innate immune regulatomic genes (IGs) were examined in 28 EC microarray datasets with 7 monocyte datasets as controls. We made the following findings: The majority of IGs are upregulated in the first 12 hours post-infection (PI), and maintained until 48 hours PI in human microvascular EC infected by middle east respiratory syndrome-coronavirus (MERS-CoV) (","2021","07","13","Front Immunol","Frontiers in immunology","DAMP; coronavirus infection; endothelial cell; oxidative phosphorylation; trained immunity","Saredy","Jason","Metabolic Disease Research, Thrombosis Research, Departments of Pharmacology, Microbiology and Immunology, Temple University Lewis Katz School of Medicine, Philadelphia, PA, United States",NA
"2184","34248940","10.3389/fimmu.2021.653110","Endothelial Immunity Trained by Coronavirus Infections, DAMP Stimulations and Regulated by Anti-Oxidant NRF2 May Contribute to Inflammations, Myelopoiesis, COVID-19 Cytokine Storms and Thromboembolism.","To characterize transcriptomic changes in endothelial cells (ECs) infected by coronaviruses, and stimulated by DAMPs, the expressions of 1311 innate immune regulatomic genes (IGs) were examined in 28 EC microarray datasets with 7 monocyte datasets as controls. We made the following findings: The majority of IGs are upregulated in the first 12 hours post-infection (PI), and maintained until 48 hours PI in human microvascular EC infected by middle east respiratory syndrome-coronavirus (MERS-CoV) (","2021","07","13","Front Immunol","Frontiers in immunology","DAMP; coronavirus infection; endothelial cell; oxidative phosphorylation; trained immunity","Xu","Keman","Centers of Cardiovascular Research, Inflammation, Translational &amp",NA
"2185","34248940","10.3389/fimmu.2021.653110","Endothelial Immunity Trained by Coronavirus Infections, DAMP Stimulations and Regulated by Anti-Oxidant NRF2 May Contribute to Inflammations, Myelopoiesis, COVID-19 Cytokine Storms and Thromboembolism.","To characterize transcriptomic changes in endothelial cells (ECs) infected by coronaviruses, and stimulated by DAMPs, the expressions of 1311 innate immune regulatomic genes (IGs) were examined in 28 EC microarray datasets with 7 monocyte datasets as controls. We made the following findings: The majority of IGs are upregulated in the first 12 hours post-infection (PI), and maintained until 48 hours PI in human microvascular EC infected by middle east respiratory syndrome-coronavirus (MERS-CoV) (","2021","07","13","Front Immunol","Frontiers in immunology","DAMP; coronavirus infection; endothelial cell; oxidative phosphorylation; trained immunity","Sun","Yu","Centers of Cardiovascular Research, Inflammation, Translational &amp",NA
"2186","34248940","10.3389/fimmu.2021.653110","Endothelial Immunity Trained by Coronavirus Infections, DAMP Stimulations and Regulated by Anti-Oxidant NRF2 May Contribute to Inflammations, Myelopoiesis, COVID-19 Cytokine Storms and Thromboembolism.","To characterize transcriptomic changes in endothelial cells (ECs) infected by coronaviruses, and stimulated by DAMPs, the expressions of 1311 innate immune regulatomic genes (IGs) were examined in 28 EC microarray datasets with 7 monocyte datasets as controls. We made the following findings: The majority of IGs are upregulated in the first 12 hours post-infection (PI), and maintained until 48 hours PI in human microvascular EC infected by middle east respiratory syndrome-coronavirus (MERS-CoV) (","2021","07","13","Front Immunol","Frontiers in immunology","DAMP; coronavirus infection; endothelial cell; oxidative phosphorylation; trained immunity","Saaoud","Fatma","Centers of Cardiovascular Research, Inflammation, Translational &amp",NA
"2187","34248940","10.3389/fimmu.2021.653110","Endothelial Immunity Trained by Coronavirus Infections, DAMP Stimulations and Regulated by Anti-Oxidant NRF2 May Contribute to Inflammations, Myelopoiesis, COVID-19 Cytokine Storms and Thromboembolism.","To characterize transcriptomic changes in endothelial cells (ECs) infected by coronaviruses, and stimulated by DAMPs, the expressions of 1311 innate immune regulatomic genes (IGs) were examined in 28 EC microarray datasets with 7 monocyte datasets as controls. We made the following findings: The majority of IGs are upregulated in the first 12 hours post-infection (PI), and maintained until 48 hours PI in human microvascular EC infected by middle east respiratory syndrome-coronavirus (MERS-CoV) (","2021","07","13","Front Immunol","Frontiers in immunology","DAMP; coronavirus infection; endothelial cell; oxidative phosphorylation; trained immunity","Drummer","Charles","Centers of Cardiovascular Research, Inflammation, Translational &amp",NA
"2188","34248940","10.3389/fimmu.2021.653110","Endothelial Immunity Trained by Coronavirus Infections, DAMP Stimulations and Regulated by Anti-Oxidant NRF2 May Contribute to Inflammations, Myelopoiesis, COVID-19 Cytokine Storms and Thromboembolism.","To characterize transcriptomic changes in endothelial cells (ECs) infected by coronaviruses, and stimulated by DAMPs, the expressions of 1311 innate immune regulatomic genes (IGs) were examined in 28 EC microarray datasets with 7 monocyte datasets as controls. We made the following findings: The majority of IGs are upregulated in the first 12 hours post-infection (PI), and maintained until 48 hours PI in human microvascular EC infected by middle east respiratory syndrome-coronavirus (MERS-CoV) (","2021","07","13","Front Immunol","Frontiers in immunology","DAMP; coronavirus infection; endothelial cell; oxidative phosphorylation; trained immunity","Lu","Yifan","Centers of Cardiovascular Research, Inflammation, Translational &amp",NA
"2189","34248940","10.3389/fimmu.2021.653110","Endothelial Immunity Trained by Coronavirus Infections, DAMP Stimulations and Regulated by Anti-Oxidant NRF2 May Contribute to Inflammations, Myelopoiesis, COVID-19 Cytokine Storms and Thromboembolism.","To characterize transcriptomic changes in endothelial cells (ECs) infected by coronaviruses, and stimulated by DAMPs, the expressions of 1311 innate immune regulatomic genes (IGs) were examined in 28 EC microarray datasets with 7 monocyte datasets as controls. We made the following findings: The majority of IGs are upregulated in the first 12 hours post-infection (PI), and maintained until 48 hours PI in human microvascular EC infected by middle east respiratory syndrome-coronavirus (MERS-CoV) (","2021","07","13","Front Immunol","Frontiers in immunology","DAMP; coronavirus infection; endothelial cell; oxidative phosphorylation; trained immunity","Luo","Jin J","Neurology, Temple University Lewis Katz School of Medicine, Philadelphia, PA, United States",NA
"2190","34248940","10.3389/fimmu.2021.653110","Endothelial Immunity Trained by Coronavirus Infections, DAMP Stimulations and Regulated by Anti-Oxidant NRF2 May Contribute to Inflammations, Myelopoiesis, COVID-19 Cytokine Storms and Thromboembolism.","To characterize transcriptomic changes in endothelial cells (ECs) infected by coronaviruses, and stimulated by DAMPs, the expressions of 1311 innate immune regulatomic genes (IGs) were examined in 28 EC microarray datasets with 7 monocyte datasets as controls. We made the following findings: The majority of IGs are upregulated in the first 12 hours post-infection (PI), and maintained until 48 hours PI in human microvascular EC infected by middle east respiratory syndrome-coronavirus (MERS-CoV) (","2021","07","13","Front Immunol","Frontiers in immunology","DAMP; coronavirus infection; endothelial cell; oxidative phosphorylation; trained immunity","Lopez-Pastrana","Jahaira","Psychiatry and Behavioral Science, Temple University Lewis Katz School of Medicine, Philadelphia, PA, United States",NA
"2191","34248940","10.3389/fimmu.2021.653110","Endothelial Immunity Trained by Coronavirus Infections, DAMP Stimulations and Regulated by Anti-Oxidant NRF2 May Contribute to Inflammations, Myelopoiesis, COVID-19 Cytokine Storms and Thromboembolism.","To characterize transcriptomic changes in endothelial cells (ECs) infected by coronaviruses, and stimulated by DAMPs, the expressions of 1311 innate immune regulatomic genes (IGs) were examined in 28 EC microarray datasets with 7 monocyte datasets as controls. We made the following findings: The majority of IGs are upregulated in the first 12 hours post-infection (PI), and maintained until 48 hours PI in human microvascular EC infected by middle east respiratory syndrome-coronavirus (MERS-CoV) (","2021","07","13","Front Immunol","Frontiers in immunology","DAMP; coronavirus infection; endothelial cell; oxidative phosphorylation; trained immunity","Choi","Eric T","Surgery, Temple University Lewis Katz School of Medicine, Philadelphia, PA, United States",NA
"2192","34248940","10.3389/fimmu.2021.653110","Endothelial Immunity Trained by Coronavirus Infections, DAMP Stimulations and Regulated by Anti-Oxidant NRF2 May Contribute to Inflammations, Myelopoiesis, COVID-19 Cytokine Storms and Thromboembolism.","To characterize transcriptomic changes in endothelial cells (ECs) infected by coronaviruses, and stimulated by DAMPs, the expressions of 1311 innate immune regulatomic genes (IGs) were examined in 28 EC microarray datasets with 7 monocyte datasets as controls. We made the following findings: The majority of IGs are upregulated in the first 12 hours post-infection (PI), and maintained until 48 hours PI in human microvascular EC infected by middle east respiratory syndrome-coronavirus (MERS-CoV) (","2021","07","13","Front Immunol","Frontiers in immunology","DAMP; coronavirus infection; endothelial cell; oxidative phosphorylation; trained immunity","Jiang","Xiaohua","Centers of Cardiovascular Research, Inflammation, Translational &amp",NA
"2193","34248940","10.3389/fimmu.2021.653110","Endothelial Immunity Trained by Coronavirus Infections, DAMP Stimulations and Regulated by Anti-Oxidant NRF2 May Contribute to Inflammations, Myelopoiesis, COVID-19 Cytokine Storms and Thromboembolism.","To characterize transcriptomic changes in endothelial cells (ECs) infected by coronaviruses, and stimulated by DAMPs, the expressions of 1311 innate immune regulatomic genes (IGs) were examined in 28 EC microarray datasets with 7 monocyte datasets as controls. We made the following findings: The majority of IGs are upregulated in the first 12 hours post-infection (PI), and maintained until 48 hours PI in human microvascular EC infected by middle east respiratory syndrome-coronavirus (MERS-CoV) (","2021","07","13","Front Immunol","Frontiers in immunology","DAMP; coronavirus infection; endothelial cell; oxidative phosphorylation; trained immunity","Wang","Hong","Metabolic Disease Research, Thrombosis Research, Departments of Pharmacology, Microbiology and Immunology, Temple University Lewis Katz School of Medicine, Philadelphia, PA, United States",NA
"2194","34248940","10.3389/fimmu.2021.653110","Endothelial Immunity Trained by Coronavirus Infections, DAMP Stimulations and Regulated by Anti-Oxidant NRF2 May Contribute to Inflammations, Myelopoiesis, COVID-19 Cytokine Storms and Thromboembolism.","To characterize transcriptomic changes in endothelial cells (ECs) infected by coronaviruses, and stimulated by DAMPs, the expressions of 1311 innate immune regulatomic genes (IGs) were examined in 28 EC microarray datasets with 7 monocyte datasets as controls. We made the following findings: The majority of IGs are upregulated in the first 12 hours post-infection (PI), and maintained until 48 hours PI in human microvascular EC infected by middle east respiratory syndrome-coronavirus (MERS-CoV) (","2021","07","13","Front Immunol","Frontiers in immunology","DAMP; coronavirus infection; endothelial cell; oxidative phosphorylation; trained immunity","Yang","Xiaofeng","Centers of Cardiovascular Research, Inflammation, Translational &amp",NA
"2195","34248936","10.3389/fimmu.2021.648250","A Computational Approach Identified Andrographolide as a Potential Drug for Suppressing COVID-19-Induced Cytokine Storm.","The newly identified betacoronavirus SARS-CoV-2 is the causative pathogen of the coronavirus disease of 2019 (COVID-19) that killed more than 3.5 million people till now. The cytokine storm induced in severe COVID-19 patients causes hyper-inflammation, is the primary reason for respiratory and multi-organ failure and fatality. This work uses a rational computational strategy to identify the existing drug molecules to target host pathways to reduce the cytokine storm. We used a ""host response sig","2021","07","13","Front Immunol","Frontiers in immunology","COVID-19; SARS-CoV-2; TNF signaling pathway; andrographolide; cytokine storm; drug-repurposing; molecular docking; systems bioinformatics","Rehan","Mohd","King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia",NA
"2196","34248936","10.3389/fimmu.2021.648250","A Computational Approach Identified Andrographolide as a Potential Drug for Suppressing COVID-19-Induced Cytokine Storm.","The newly identified betacoronavirus SARS-CoV-2 is the causative pathogen of the coronavirus disease of 2019 (COVID-19) that killed more than 3.5 million people till now. The cytokine storm induced in severe COVID-19 patients causes hyper-inflammation, is the primary reason for respiratory and multi-organ failure and fatality. This work uses a rational computational strategy to identify the existing drug molecules to target host pathways to reduce the cytokine storm. We used a ""host response sig","2021","07","13","Front Immunol","Frontiers in immunology","COVID-19; SARS-CoV-2; TNF signaling pathway; andrographolide; cytokine storm; drug-repurposing; molecular docking; systems bioinformatics","Ahmed","Firoz","Department of Biochemistry, College of Science, University of Jeddah, Jeddah, Saudi Arabia",NA
"2197","34248936","10.3389/fimmu.2021.648250","A Computational Approach Identified Andrographolide as a Potential Drug for Suppressing COVID-19-Induced Cytokine Storm.","The newly identified betacoronavirus SARS-CoV-2 is the causative pathogen of the coronavirus disease of 2019 (COVID-19) that killed more than 3.5 million people till now. The cytokine storm induced in severe COVID-19 patients causes hyper-inflammation, is the primary reason for respiratory and multi-organ failure and fatality. This work uses a rational computational strategy to identify the existing drug molecules to target host pathways to reduce the cytokine storm. We used a ""host response sig","2021","07","13","Front Immunol","Frontiers in immunology","COVID-19; SARS-CoV-2; TNF signaling pathway; andrographolide; cytokine storm; drug-repurposing; molecular docking; systems bioinformatics","Howladar","Saad M","Department of Biology, College of Science, University of Jeddah, Jeddah, Saudi Arabia",NA
"2198","34248936","10.3389/fimmu.2021.648250","A Computational Approach Identified Andrographolide as a Potential Drug for Suppressing COVID-19-Induced Cytokine Storm.","The newly identified betacoronavirus SARS-CoV-2 is the causative pathogen of the coronavirus disease of 2019 (COVID-19) that killed more than 3.5 million people till now. The cytokine storm induced in severe COVID-19 patients causes hyper-inflammation, is the primary reason for respiratory and multi-organ failure and fatality. This work uses a rational computational strategy to identify the existing drug molecules to target host pathways to reduce the cytokine storm. We used a ""host response sig","2021","07","13","Front Immunol","Frontiers in immunology","COVID-19; SARS-CoV-2; TNF signaling pathway; andrographolide; cytokine storm; drug-repurposing; molecular docking; systems bioinformatics","Refai","Mohammed Y","Department of Biochemistry, College of Science, University of Jeddah, Jeddah, Saudi Arabia",NA
"2199","34248936","10.3389/fimmu.2021.648250","A Computational Approach Identified Andrographolide as a Potential Drug for Suppressing COVID-19-Induced Cytokine Storm.","The newly identified betacoronavirus SARS-CoV-2 is the causative pathogen of the coronavirus disease of 2019 (COVID-19) that killed more than 3.5 million people till now. The cytokine storm induced in severe COVID-19 patients causes hyper-inflammation, is the primary reason for respiratory and multi-organ failure and fatality. This work uses a rational computational strategy to identify the existing drug molecules to target host pathways to reduce the cytokine storm. We used a ""host response sig","2021","07","13","Front Immunol","Frontiers in immunology","COVID-19; SARS-CoV-2; TNF signaling pathway; andrographolide; cytokine storm; drug-repurposing; molecular docking; systems bioinformatics","Baeissa","Hanadi M","Department of Biochemistry, College of Science, University of Jeddah, Jeddah, Saudi Arabia",NA
"2200","34248936","10.3389/fimmu.2021.648250","A Computational Approach Identified Andrographolide as a Potential Drug for Suppressing COVID-19-Induced Cytokine Storm.","The newly identified betacoronavirus SARS-CoV-2 is the causative pathogen of the coronavirus disease of 2019 (COVID-19) that killed more than 3.5 million people till now. The cytokine storm induced in severe COVID-19 patients causes hyper-inflammation, is the primary reason for respiratory and multi-organ failure and fatality. This work uses a rational computational strategy to identify the existing drug molecules to target host pathways to reduce the cytokine storm. We used a ""host response sig","2021","07","13","Front Immunol","Frontiers in immunology","COVID-19; SARS-CoV-2; TNF signaling pathway; andrographolide; cytokine storm; drug-repurposing; molecular docking; systems bioinformatics","Zughaibi","Torki A","King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia",NA
"2201","34248936","10.3389/fimmu.2021.648250","A Computational Approach Identified Andrographolide as a Potential Drug for Suppressing COVID-19-Induced Cytokine Storm.","The newly identified betacoronavirus SARS-CoV-2 is the causative pathogen of the coronavirus disease of 2019 (COVID-19) that killed more than 3.5 million people till now. The cytokine storm induced in severe COVID-19 patients causes hyper-inflammation, is the primary reason for respiratory and multi-organ failure and fatality. This work uses a rational computational strategy to identify the existing drug molecules to target host pathways to reduce the cytokine storm. We used a ""host response sig","2021","07","13","Front Immunol","Frontiers in immunology","COVID-19; SARS-CoV-2; TNF signaling pathway; andrographolide; cytokine storm; drug-repurposing; molecular docking; systems bioinformatics","Kedwa","Khalid Mohammed","Hematology Department, Regional Lab Makkah, Haddah, Saudi Arabia",NA
"2202","34248936","10.3389/fimmu.2021.648250","A Computational Approach Identified Andrographolide as a Potential Drug for Suppressing COVID-19-Induced Cytokine Storm.","The newly identified betacoronavirus SARS-CoV-2 is the causative pathogen of the coronavirus disease of 2019 (COVID-19) that killed more than 3.5 million people till now. The cytokine storm induced in severe COVID-19 patients causes hyper-inflammation, is the primary reason for respiratory and multi-organ failure and fatality. This work uses a rational computational strategy to identify the existing drug molecules to target host pathways to reduce the cytokine storm. We used a ""host response sig","2021","07","13","Front Immunol","Frontiers in immunology","COVID-19; SARS-CoV-2; TNF signaling pathway; andrographolide; cytokine storm; drug-repurposing; molecular docking; systems bioinformatics","Jamal","Mohammad Sarwar","Integrative Biosciences Center, Wayne State University, Detroit, MI, United States",NA
"2203","34248931","10.3389/fimmu.2021.634416","EASIX for Prediction of Outcome in Hospitalized SARS-CoV-2 Infected Patients.","The coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and has evoked a pandemic that challenges public health-care systems worldwide. Endothelial cell dysfunction plays a key role in pathophysiology, and simple prognosticators may help to optimize allocation of limited resources. Endothelial activation and stress index (EASIX) is a validated predictor of endothelial complications and outcome after allogeneic stem cell transplantation. A","2021","07","13","Front Immunol","Frontiers in immunology","EASIX; SARS-CoV2 (COVID- 19); angiopoietin-2 (Ang-2); endothelial activation and stress index; prediction of outcome; soluble thrombomodulin; suppressor of tumorigenicity 2 (ST2)","Luft","Thomas","Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany",NA
"2204","34248931","10.3389/fimmu.2021.634416","EASIX for Prediction of Outcome in Hospitalized SARS-CoV-2 Infected Patients.","The coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and has evoked a pandemic that challenges public health-care systems worldwide. Endothelial cell dysfunction plays a key role in pathophysiology, and simple prognosticators may help to optimize allocation of limited resources. Endothelial activation and stress index (EASIX) is a validated predictor of endothelial complications and outcome after allogeneic stem cell transplantation. A","2021","07","13","Front Immunol","Frontiers in immunology","EASIX; SARS-CoV2 (COVID- 19); angiopoietin-2 (Ang-2); endothelial activation and stress index; prediction of outcome; soluble thrombomodulin; suppressor of tumorigenicity 2 (ST2)","Wendtner","Clemens-Martin","Munich Clinic Schwabing, Academic Teaching Hospital, Ludwig-Maximilians University (LMU), Munich, Germany",NA
"2205","34248931","10.3389/fimmu.2021.634416","EASIX for Prediction of Outcome in Hospitalized SARS-CoV-2 Infected Patients.","The coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and has evoked a pandemic that challenges public health-care systems worldwide. Endothelial cell dysfunction plays a key role in pathophysiology, and simple prognosticators may help to optimize allocation of limited resources. Endothelial activation and stress index (EASIX) is a validated predictor of endothelial complications and outcome after allogeneic stem cell transplantation. A","2021","07","13","Front Immunol","Frontiers in immunology","EASIX; SARS-CoV2 (COVID- 19); angiopoietin-2 (Ang-2); endothelial activation and stress index; prediction of outcome; soluble thrombomodulin; suppressor of tumorigenicity 2 (ST2)","Kosely","Florentina","Medical Department B, Hospital Ludwigshafen, Ludwigshafen, Germany",NA
"2206","34248931","10.3389/fimmu.2021.634416","EASIX for Prediction of Outcome in Hospitalized SARS-CoV-2 Infected Patients.","The coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and has evoked a pandemic that challenges public health-care systems worldwide. Endothelial cell dysfunction plays a key role in pathophysiology, and simple prognosticators may help to optimize allocation of limited resources. Endothelial activation and stress index (EASIX) is a validated predictor of endothelial complications and outcome after allogeneic stem cell transplantation. A","2021","07","13","Front Immunol","Frontiers in immunology","EASIX; SARS-CoV2 (COVID- 19); angiopoietin-2 (Ang-2); endothelial activation and stress index; prediction of outcome; soluble thrombomodulin; suppressor of tumorigenicity 2 (ST2)","Radujkovic","Aleksandar","Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany",NA
"2207","34248931","10.3389/fimmu.2021.634416","EASIX for Prediction of Outcome in Hospitalized SARS-CoV-2 Infected Patients.","The coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and has evoked a pandemic that challenges public health-care systems worldwide. Endothelial cell dysfunction plays a key role in pathophysiology, and simple prognosticators may help to optimize allocation of limited resources. Endothelial activation and stress index (EASIX) is a validated predictor of endothelial complications and outcome after allogeneic stem cell transplantation. A","2021","07","13","Front Immunol","Frontiers in immunology","EASIX; SARS-CoV2 (COVID- 19); angiopoietin-2 (Ang-2); endothelial activation and stress index; prediction of outcome; soluble thrombomodulin; suppressor of tumorigenicity 2 (ST2)","Benner","Axel","Division of Biostatistics, German Cancer Research Center, Heidelberg, Germany",NA
"2208","34248931","10.3389/fimmu.2021.634416","EASIX for Prediction of Outcome in Hospitalized SARS-CoV-2 Infected Patients.","The coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and has evoked a pandemic that challenges public health-care systems worldwide. Endothelial cell dysfunction plays a key role in pathophysiology, and simple prognosticators may help to optimize allocation of limited resources. Endothelial activation and stress index (EASIX) is a validated predictor of endothelial complications and outcome after allogeneic stem cell transplantation. A","2021","07","13","Front Immunol","Frontiers in immunology","EASIX; SARS-CoV2 (COVID- 19); angiopoietin-2 (Ang-2); endothelial activation and stress index; prediction of outcome; soluble thrombomodulin; suppressor of tumorigenicity 2 (ST2)","Korell","Felix","Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany",NA
"2209","34248931","10.3389/fimmu.2021.634416","EASIX for Prediction of Outcome in Hospitalized SARS-CoV-2 Infected Patients.","The coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and has evoked a pandemic that challenges public health-care systems worldwide. Endothelial cell dysfunction plays a key role in pathophysiology, and simple prognosticators may help to optimize allocation of limited resources. Endothelial activation and stress index (EASIX) is a validated predictor of endothelial complications and outcome after allogeneic stem cell transplantation. A","2021","07","13","Front Immunol","Frontiers in immunology","EASIX; SARS-CoV2 (COVID- 19); angiopoietin-2 (Ang-2); endothelial activation and stress index; prediction of outcome; soluble thrombomodulin; suppressor of tumorigenicity 2 (ST2)","Kihm","Lars","Department of Internal Medicine I, University of Heidelberg, Heidelberg, Germany",NA
"2210","34248931","10.3389/fimmu.2021.634416","EASIX for Prediction of Outcome in Hospitalized SARS-CoV-2 Infected Patients.","The coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and has evoked a pandemic that challenges public health-care systems worldwide. Endothelial cell dysfunction plays a key role in pathophysiology, and simple prognosticators may help to optimize allocation of limited resources. Endothelial activation and stress index (EASIX) is a validated predictor of endothelial complications and outcome after allogeneic stem cell transplantation. A","2021","07","13","Front Immunol","Frontiers in immunology","EASIX; SARS-CoV2 (COVID- 19); angiopoietin-2 (Ang-2); endothelial activation and stress index; prediction of outcome; soluble thrombomodulin; suppressor of tumorigenicity 2 (ST2)","Bauer","Matthias F","Institute of Laboratory Diagnostics, Hygiene and Transfusion Medicine, Hospital Ludwigshafen, Ludwigshafen, Germany",NA
"2211","34248931","10.3389/fimmu.2021.634416","EASIX for Prediction of Outcome in Hospitalized SARS-CoV-2 Infected Patients.","The coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and has evoked a pandemic that challenges public health-care systems worldwide. Endothelial cell dysfunction plays a key role in pathophysiology, and simple prognosticators may help to optimize allocation of limited resources. Endothelial activation and stress index (EASIX) is a validated predictor of endothelial complications and outcome after allogeneic stem cell transplantation. A","2021","07","13","Front Immunol","Frontiers in immunology","EASIX; SARS-CoV2 (COVID- 19); angiopoietin-2 (Ang-2); endothelial activation and stress index; prediction of outcome; soluble thrombomodulin; suppressor of tumorigenicity 2 (ST2)","Dreger","Peter","Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany",NA
"2212","34248931","10.3389/fimmu.2021.634416","EASIX for Prediction of Outcome in Hospitalized SARS-CoV-2 Infected Patients.","The coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and has evoked a pandemic that challenges public health-care systems worldwide. Endothelial cell dysfunction plays a key role in pathophysiology, and simple prognosticators may help to optimize allocation of limited resources. Endothelial activation and stress index (EASIX) is a validated predictor of endothelial complications and outcome after allogeneic stem cell transplantation. A","2021","07","13","Front Immunol","Frontiers in immunology","EASIX; SARS-CoV2 (COVID- 19); angiopoietin-2 (Ang-2); endothelial activation and stress index; prediction of outcome; soluble thrombomodulin; suppressor of tumorigenicity 2 (ST2)","Merle","Uta","Department of Internal Medicine IV, University of Heidelberg, Heidelberg, Germany",NA
"2213","34248930","10.3389/fimmu.2021.621440","Immune Dysregulation and the Increased Risk of Complications and Mortality Following Respiratory Tract Infections in Adults With Down Syndrome.","The risk of severe outcomes following respiratory tract infections is significantly increased in individuals over 60 years, especially in those with chronic medical conditions, i.e., hypertension, diabetes, cardiovascular disease, dementia, chronic respiratory disease, and cancer. Down Syndrome (DS), the most prevalent intellectual disability, is caused by trisomy-21 in ~1:750 live births worldwide. Over the past few decades, a substantial body of evidence has accumulated, pointing at the occurr","2021","07","13","Front Immunol","Frontiers in immunology","COVID-19; Down syndrome; hospitalization; immune dysregulation; interferon; respiratory tract infections","Illouz","Tomer","The Leslie and Susan Gonda Multidisciplinary Brain Research Center, Bar-Ilan University, Ramat Gan, Israel",NA
"2214","34248930","10.3389/fimmu.2021.621440","Immune Dysregulation and the Increased Risk of Complications and Mortality Following Respiratory Tract Infections in Adults With Down Syndrome.","The risk of severe outcomes following respiratory tract infections is significantly increased in individuals over 60 years, especially in those with chronic medical conditions, i.e., hypertension, diabetes, cardiovascular disease, dementia, chronic respiratory disease, and cancer. Down Syndrome (DS), the most prevalent intellectual disability, is caused by trisomy-21 in ~1:750 live births worldwide. Over the past few decades, a substantial body of evidence has accumulated, pointing at the occurr","2021","07","13","Front Immunol","Frontiers in immunology","COVID-19; Down syndrome; hospitalization; immune dysregulation; interferon; respiratory tract infections","Biragyn","Arya","Laboratory of Molecular Biology and Immunology, National Institute on Aging, National Institute of Health, Baltimore, MD, United States",NA
"2215","34248930","10.3389/fimmu.2021.621440","Immune Dysregulation and the Increased Risk of Complications and Mortality Following Respiratory Tract Infections in Adults With Down Syndrome.","The risk of severe outcomes following respiratory tract infections is significantly increased in individuals over 60 years, especially in those with chronic medical conditions, i.e., hypertension, diabetes, cardiovascular disease, dementia, chronic respiratory disease, and cancer. Down Syndrome (DS), the most prevalent intellectual disability, is caused by trisomy-21 in ~1:750 live births worldwide. Over the past few decades, a substantial body of evidence has accumulated, pointing at the occurr","2021","07","13","Front Immunol","Frontiers in immunology","COVID-19; Down syndrome; hospitalization; immune dysregulation; interferon; respiratory tract infections","Iulita","Maria Florencia","Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain",NA
"2216","34248930","10.3389/fimmu.2021.621440","Immune Dysregulation and the Increased Risk of Complications and Mortality Following Respiratory Tract Infections in Adults With Down Syndrome.","The risk of severe outcomes following respiratory tract infections is significantly increased in individuals over 60 years, especially in those with chronic medical conditions, i.e., hypertension, diabetes, cardiovascular disease, dementia, chronic respiratory disease, and cancer. Down Syndrome (DS), the most prevalent intellectual disability, is caused by trisomy-21 in ~1:750 live births worldwide. Over the past few decades, a substantial body of evidence has accumulated, pointing at the occurr","2021","07","13","Front Immunol","Frontiers in immunology","COVID-19; Down syndrome; hospitalization; immune dysregulation; interferon; respiratory tract infections","Flores-Aguilar","Lisi","Department of Anatomy and Cell Biology, McGill University, Montreal, QC, Canada",NA
"2217","34248930","10.3389/fimmu.2021.621440","Immune Dysregulation and the Increased Risk of Complications and Mortality Following Respiratory Tract Infections in Adults With Down Syndrome.","The risk of severe outcomes following respiratory tract infections is significantly increased in individuals over 60 years, especially in those with chronic medical conditions, i.e., hypertension, diabetes, cardiovascular disease, dementia, chronic respiratory disease, and cancer. Down Syndrome (DS), the most prevalent intellectual disability, is caused by trisomy-21 in ~1:750 live births worldwide. Over the past few decades, a substantial body of evidence has accumulated, pointing at the occurr","2021","07","13","Front Immunol","Frontiers in immunology","COVID-19; Down syndrome; hospitalization; immune dysregulation; interferon; respiratory tract infections","Dierssen","Mara","Center for Genomic Regulation, The Barcelona Institute for Science and Technology, Barcelona, Spain",NA
"2218","34248930","10.3389/fimmu.2021.621440","Immune Dysregulation and the Increased Risk of Complications and Mortality Following Respiratory Tract Infections in Adults With Down Syndrome.","The risk of severe outcomes following respiratory tract infections is significantly increased in individuals over 60 years, especially in those with chronic medical conditions, i.e., hypertension, diabetes, cardiovascular disease, dementia, chronic respiratory disease, and cancer. Down Syndrome (DS), the most prevalent intellectual disability, is caused by trisomy-21 in ~1:750 live births worldwide. Over the past few decades, a substantial body of evidence has accumulated, pointing at the occurr","2021","07","13","Front Immunol","Frontiers in immunology","COVID-19; Down syndrome; hospitalization; immune dysregulation; interferon; respiratory tract infections","De Toma","Ilario","Center for Genomic Regulation, The Barcelona Institute for Science and Technology, Barcelona, Spain",NA
"2219","34248930","10.3389/fimmu.2021.621440","Immune Dysregulation and the Increased Risk of Complications and Mortality Following Respiratory Tract Infections in Adults With Down Syndrome.","The risk of severe outcomes following respiratory tract infections is significantly increased in individuals over 60 years, especially in those with chronic medical conditions, i.e., hypertension, diabetes, cardiovascular disease, dementia, chronic respiratory disease, and cancer. Down Syndrome (DS), the most prevalent intellectual disability, is caused by trisomy-21 in ~1:750 live births worldwide. Over the past few decades, a substantial body of evidence has accumulated, pointing at the occurr","2021","07","13","Front Immunol","Frontiers in immunology","COVID-19; Down syndrome; hospitalization; immune dysregulation; interferon; respiratory tract infections","Antonarakis","Stylianos E","Department of Genetic Medicine and Development, University of Geneva, Geneva, Switzerland",NA
"2220","34248930","10.3389/fimmu.2021.621440","Immune Dysregulation and the Increased Risk of Complications and Mortality Following Respiratory Tract Infections in Adults With Down Syndrome.","The risk of severe outcomes following respiratory tract infections is significantly increased in individuals over 60 years, especially in those with chronic medical conditions, i.e., hypertension, diabetes, cardiovascular disease, dementia, chronic respiratory disease, and cancer. Down Syndrome (DS), the most prevalent intellectual disability, is caused by trisomy-21 in ~1:750 live births worldwide. Over the past few decades, a substantial body of evidence has accumulated, pointing at the occurr","2021","07","13","Front Immunol","Frontiers in immunology","COVID-19; Down syndrome; hospitalization; immune dysregulation; interferon; respiratory tract infections","Yu","Eugene","The Children's Guild Foundation Down Syndrome Research Program, Genetics and Genomics Program and Department of Cancer Genetics and Genomics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, United States",NA
"2221","34248930","10.3389/fimmu.2021.621440","Immune Dysregulation and the Increased Risk of Complications and Mortality Following Respiratory Tract Infections in Adults With Down Syndrome.","The risk of severe outcomes following respiratory tract infections is significantly increased in individuals over 60 years, especially in those with chronic medical conditions, i.e., hypertension, diabetes, cardiovascular disease, dementia, chronic respiratory disease, and cancer. Down Syndrome (DS), the most prevalent intellectual disability, is caused by trisomy-21 in ~1:750 live births worldwide. Over the past few decades, a substantial body of evidence has accumulated, pointing at the occurr","2021","07","13","Front Immunol","Frontiers in immunology","COVID-19; Down syndrome; hospitalization; immune dysregulation; interferon; respiratory tract infections","Herault","Yann","Université de Strasbourg, CNRS, INSERM, Institut de Génétique Biologie Moléculaire et Cellulaire, IGBMC - UMR 7104 - Inserm U1258, Illkirch, France",NA
"2222","34248930","10.3389/fimmu.2021.621440","Immune Dysregulation and the Increased Risk of Complications and Mortality Following Respiratory Tract Infections in Adults With Down Syndrome.","The risk of severe outcomes following respiratory tract infections is significantly increased in individuals over 60 years, especially in those with chronic medical conditions, i.e., hypertension, diabetes, cardiovascular disease, dementia, chronic respiratory disease, and cancer. Down Syndrome (DS), the most prevalent intellectual disability, is caused by trisomy-21 in ~1:750 live births worldwide. Over the past few decades, a substantial body of evidence has accumulated, pointing at the occurr","2021","07","13","Front Immunol","Frontiers in immunology","COVID-19; Down syndrome; hospitalization; immune dysregulation; interferon; respiratory tract infections","Potier","Marie-Claude","Paris Brain Institute (ICM), CNRS UMR7225, INSERM U1127, Sorbonne Université, Hôpital de la Pitié-Salpêtrière, Paris, France",NA
"2223","34248930","10.3389/fimmu.2021.621440","Immune Dysregulation and the Increased Risk of Complications and Mortality Following Respiratory Tract Infections in Adults With Down Syndrome.","The risk of severe outcomes following respiratory tract infections is significantly increased in individuals over 60 years, especially in those with chronic medical conditions, i.e., hypertension, diabetes, cardiovascular disease, dementia, chronic respiratory disease, and cancer. Down Syndrome (DS), the most prevalent intellectual disability, is caused by trisomy-21 in ~1:750 live births worldwide. Over the past few decades, a substantial body of evidence has accumulated, pointing at the occurr","2021","07","13","Front Immunol","Frontiers in immunology","COVID-19; Down syndrome; hospitalization; immune dysregulation; interferon; respiratory tract infections","Botté","Alexandra","Paris Brain Institute (ICM), CNRS UMR7225, INSERM U1127, Sorbonne Université, Hôpital de la Pitié-Salpêtrière, Paris, France",NA
"2224","34248930","10.3389/fimmu.2021.621440","Immune Dysregulation and the Increased Risk of Complications and Mortality Following Respiratory Tract Infections in Adults With Down Syndrome.","The risk of severe outcomes following respiratory tract infections is significantly increased in individuals over 60 years, especially in those with chronic medical conditions, i.e., hypertension, diabetes, cardiovascular disease, dementia, chronic respiratory disease, and cancer. Down Syndrome (DS), the most prevalent intellectual disability, is caused by trisomy-21 in ~1:750 live births worldwide. Over the past few decades, a substantial body of evidence has accumulated, pointing at the occurr","2021","07","13","Front Immunol","Frontiers in immunology","COVID-19; Down syndrome; hospitalization; immune dysregulation; interferon; respiratory tract infections","Roper","Randall","Department of Biology, Indiana University-Purdue University Indianapolis, Indianapolis, IN, United States",NA
"2225","34248930","10.3389/fimmu.2021.621440","Immune Dysregulation and the Increased Risk of Complications and Mortality Following Respiratory Tract Infections in Adults With Down Syndrome.","The risk of severe outcomes following respiratory tract infections is significantly increased in individuals over 60 years, especially in those with chronic medical conditions, i.e., hypertension, diabetes, cardiovascular disease, dementia, chronic respiratory disease, and cancer. Down Syndrome (DS), the most prevalent intellectual disability, is caused by trisomy-21 in ~1:750 live births worldwide. Over the past few decades, a substantial body of evidence has accumulated, pointing at the occurr","2021","07","13","Front Immunol","Frontiers in immunology","COVID-19; Down syndrome; hospitalization; immune dysregulation; interferon; respiratory tract infections","Sredni","Benjamin","The Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat Gan, Israel",NA
"2226","34248930","10.3389/fimmu.2021.621440","Immune Dysregulation and the Increased Risk of Complications and Mortality Following Respiratory Tract Infections in Adults With Down Syndrome.","The risk of severe outcomes following respiratory tract infections is significantly increased in individuals over 60 years, especially in those with chronic medical conditions, i.e., hypertension, diabetes, cardiovascular disease, dementia, chronic respiratory disease, and cancer. Down Syndrome (DS), the most prevalent intellectual disability, is caused by trisomy-21 in ~1:750 live births worldwide. Over the past few decades, a substantial body of evidence has accumulated, pointing at the occurr","2021","07","13","Front Immunol","Frontiers in immunology","COVID-19; Down syndrome; hospitalization; immune dysregulation; interferon; respiratory tract infections","London","Jacqueline","Université de Paris, BFA, UMR 8251, CNRS, Paris, France",NA
"2227","34248930","10.3389/fimmu.2021.621440","Immune Dysregulation and the Increased Risk of Complications and Mortality Following Respiratory Tract Infections in Adults With Down Syndrome.","The risk of severe outcomes following respiratory tract infections is significantly increased in individuals over 60 years, especially in those with chronic medical conditions, i.e., hypertension, diabetes, cardiovascular disease, dementia, chronic respiratory disease, and cancer. Down Syndrome (DS), the most prevalent intellectual disability, is caused by trisomy-21 in ~1:750 live births worldwide. Over the past few decades, a substantial body of evidence has accumulated, pointing at the occurr","2021","07","13","Front Immunol","Frontiers in immunology","COVID-19; Down syndrome; hospitalization; immune dysregulation; interferon; respiratory tract infections","Mobley","William","Department of Neurosciences, University of California, San Diego, San Diego, CA, United States",NA
"2228","34248930","10.3389/fimmu.2021.621440","Immune Dysregulation and the Increased Risk of Complications and Mortality Following Respiratory Tract Infections in Adults With Down Syndrome.","The risk of severe outcomes following respiratory tract infections is significantly increased in individuals over 60 years, especially in those with chronic medical conditions, i.e., hypertension, diabetes, cardiovascular disease, dementia, chronic respiratory disease, and cancer. Down Syndrome (DS), the most prevalent intellectual disability, is caused by trisomy-21 in ~1:750 live births worldwide. Over the past few decades, a substantial body of evidence has accumulated, pointing at the occurr","2021","07","13","Front Immunol","Frontiers in immunology","COVID-19; Down syndrome; hospitalization; immune dysregulation; interferon; respiratory tract infections","Strydom","Andre","Department of Forensic and Neurodevelopmental Sciences, Institute of Psychiatry Psychology and Neuroscience, King's College London, London, United Kingdom",NA
"2229","34248930","10.3389/fimmu.2021.621440","Immune Dysregulation and the Increased Risk of Complications and Mortality Following Respiratory Tract Infections in Adults With Down Syndrome.","The risk of severe outcomes following respiratory tract infections is significantly increased in individuals over 60 years, especially in those with chronic medical conditions, i.e., hypertension, diabetes, cardiovascular disease, dementia, chronic respiratory disease, and cancer. Down Syndrome (DS), the most prevalent intellectual disability, is caused by trisomy-21 in ~1:750 live births worldwide. Over the past few decades, a substantial body of evidence has accumulated, pointing at the occurr","2021","07","13","Front Immunol","Frontiers in immunology","COVID-19; Down syndrome; hospitalization; immune dysregulation; interferon; respiratory tract infections","Okun","Eitan","The Leslie and Susan Gonda Multidisciplinary Brain Research Center, Bar-Ilan University, Ramat Gan, Israel",NA
"2230","34248925","10.3389/fimmu.2021.594356","Vitamin D and Exercise Are Major Determinants of Natural Killer Cell Activity, Which Is Age- and Gender-Specific.","The coronavirus-19 disease (COVID-19) pandemic reminds us of the importance of immune function, even in immunologically normal individuals. Multiple lifestyle factors are known to influence the immune function. The aim was to investigate the association between NK cell activity (NKA) and multiple factors including vitamin D, physical exercise, age, and gender. This was a cross-sectional association study using health check-up and NKA data of 2,095 subjects collected from 2016 to 2018 in a health","2021","07","13","Front Immunol","Frontiers in immunology","NK cell activity; exercise; immunity; immunosenescence; vitamin D","Oh","Sooyeon","Chaum Life Center, CHA University School of Medicine, Seoul, South Korea",NA
"2231","34248925","10.3389/fimmu.2021.594356","Vitamin D and Exercise Are Major Determinants of Natural Killer Cell Activity, Which Is Age- and Gender-Specific.","The coronavirus-19 disease (COVID-19) pandemic reminds us of the importance of immune function, even in immunologically normal individuals. Multiple lifestyle factors are known to influence the immune function. The aim was to investigate the association between NK cell activity (NKA) and multiple factors including vitamin D, physical exercise, age, and gender. This was a cross-sectional association study using health check-up and NKA data of 2,095 subjects collected from 2016 to 2018 in a health","2021","07","13","Front Immunol","Frontiers in immunology","NK cell activity; exercise; immunity; immunosenescence; vitamin D","Chun","Sukyung","Chaum Life Center, CHA University School of Medicine, Seoul, South Korea",NA
"2232","34248925","10.3389/fimmu.2021.594356","Vitamin D and Exercise Are Major Determinants of Natural Killer Cell Activity, Which Is Age- and Gender-Specific.","The coronavirus-19 disease (COVID-19) pandemic reminds us of the importance of immune function, even in immunologically normal individuals. Multiple lifestyle factors are known to influence the immune function. The aim was to investigate the association between NK cell activity (NKA) and multiple factors including vitamin D, physical exercise, age, and gender. This was a cross-sectional association study using health check-up and NKA data of 2,095 subjects collected from 2016 to 2018 in a health","2021","07","13","Front Immunol","Frontiers in immunology","NK cell activity; exercise; immunity; immunosenescence; vitamin D","Hwang","Sena","Chaum Life Center, CHA University School of Medicine, Seoul, South Korea",NA
"2233","34248925","10.3389/fimmu.2021.594356","Vitamin D and Exercise Are Major Determinants of Natural Killer Cell Activity, Which Is Age- and Gender-Specific.","The coronavirus-19 disease (COVID-19) pandemic reminds us of the importance of immune function, even in immunologically normal individuals. Multiple lifestyle factors are known to influence the immune function. The aim was to investigate the association between NK cell activity (NKA) and multiple factors including vitamin D, physical exercise, age, and gender. This was a cross-sectional association study using health check-up and NKA data of 2,095 subjects collected from 2016 to 2018 in a health","2021","07","13","Front Immunol","Frontiers in immunology","NK cell activity; exercise; immunity; immunosenescence; vitamin D","Kim","Jongseok","Chaum Life Center, CHA University School of Medicine, Seoul, South Korea",NA
"2234","34248925","10.3389/fimmu.2021.594356","Vitamin D and Exercise Are Major Determinants of Natural Killer Cell Activity, Which Is Age- and Gender-Specific.","The coronavirus-19 disease (COVID-19) pandemic reminds us of the importance of immune function, even in immunologically normal individuals. Multiple lifestyle factors are known to influence the immune function. The aim was to investigate the association between NK cell activity (NKA) and multiple factors including vitamin D, physical exercise, age, and gender. This was a cross-sectional association study using health check-up and NKA data of 2,095 subjects collected from 2016 to 2018 in a health","2021","07","13","Front Immunol","Frontiers in immunology","NK cell activity; exercise; immunity; immunosenescence; vitamin D","Cho","Yuri","Center for Liver and Pancreatobiliary Cancer, National Cancer Center, Goyang, South Korea",NA
"2235","34248925","10.3389/fimmu.2021.594356","Vitamin D and Exercise Are Major Determinants of Natural Killer Cell Activity, Which Is Age- and Gender-Specific.","The coronavirus-19 disease (COVID-19) pandemic reminds us of the importance of immune function, even in immunologically normal individuals. Multiple lifestyle factors are known to influence the immune function. The aim was to investigate the association between NK cell activity (NKA) and multiple factors including vitamin D, physical exercise, age, and gender. This was a cross-sectional association study using health check-up and NKA data of 2,095 subjects collected from 2016 to 2018 in a health","2021","07","13","Front Immunol","Frontiers in immunology","NK cell activity; exercise; immunity; immunosenescence; vitamin D","Lee","Jooho","Department of Gastroenterology and Hepatology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, South Korea",NA
"2236","34248925","10.3389/fimmu.2021.594356","Vitamin D and Exercise Are Major Determinants of Natural Killer Cell Activity, Which Is Age- and Gender-Specific.","The coronavirus-19 disease (COVID-19) pandemic reminds us of the importance of immune function, even in immunologically normal individuals. Multiple lifestyle factors are known to influence the immune function. The aim was to investigate the association between NK cell activity (NKA) and multiple factors including vitamin D, physical exercise, age, and gender. This was a cross-sectional association study using health check-up and NKA data of 2,095 subjects collected from 2016 to 2018 in a health","2021","07","13","Front Immunol","Frontiers in immunology","NK cell activity; exercise; immunity; immunosenescence; vitamin D","Kwack","KyuBum","Department of Biomedical Science, College of Life Science, CHA University, Seongnam, South Korea",NA
"2237","34248925","10.3389/fimmu.2021.594356","Vitamin D and Exercise Are Major Determinants of Natural Killer Cell Activity, Which Is Age- and Gender-Specific.","The coronavirus-19 disease (COVID-19) pandemic reminds us of the importance of immune function, even in immunologically normal individuals. Multiple lifestyle factors are known to influence the immune function. The aim was to investigate the association between NK cell activity (NKA) and multiple factors including vitamin D, physical exercise, age, and gender. This was a cross-sectional association study using health check-up and NKA data of 2,095 subjects collected from 2016 to 2018 in a health","2021","07","13","Front Immunol","Frontiers in immunology","NK cell activity; exercise; immunity; immunosenescence; vitamin D","Choi","Sang-Woon","Chaum Life Center, CHA University School of Medicine, Seoul, South Korea",NA
"2238","34248922","10.3389/fmicb.2021.698944","<i>In vitro</i> Characterization of Fitness and Convalescent Antibody Neutralization of SARS-CoV-2 Cluster 5 Variant Emerging in Mink at Danish Farms.","In addition to humans, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can transmit to animals that include hamsters, cats, dogs, mink, ferrets, tigers, lions, cynomolgus macaques, rhesus macaques, and treeshrew. Among these, mink are particularly susceptible. Indeed, 10 countries in Europe and North America reported SARS-CoV-2 infection among mink on fur farms. In Denmark, SARS-CoV-2 spread rapidly among mink farms and spilled-over back into humans, acquiring mutations/deletions wi","2021","07","13","Front Microbiol","Frontiers in microbiology","COVID-19; SARS-CoV-2; coronavirus; mink; virus neutralization","Lassaunière","Ria","Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark",NA
"2239","34248922","10.3389/fmicb.2021.698944","<i>In vitro</i> Characterization of Fitness and Convalescent Antibody Neutralization of SARS-CoV-2 Cluster 5 Variant Emerging in Mink at Danish Farms.","In addition to humans, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can transmit to animals that include hamsters, cats, dogs, mink, ferrets, tigers, lions, cynomolgus macaques, rhesus macaques, and treeshrew. Among these, mink are particularly susceptible. Indeed, 10 countries in Europe and North America reported SARS-CoV-2 infection among mink on fur farms. In Denmark, SARS-CoV-2 spread rapidly among mink farms and spilled-over back into humans, acquiring mutations/deletions wi","2021","07","13","Front Microbiol","Frontiers in microbiology","COVID-19; SARS-CoV-2; coronavirus; mink; virus neutralization","Fonager","Jannik","Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark",NA
"2240","34248922","10.3389/fmicb.2021.698944","<i>In vitro</i> Characterization of Fitness and Convalescent Antibody Neutralization of SARS-CoV-2 Cluster 5 Variant Emerging in Mink at Danish Farms.","In addition to humans, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can transmit to animals that include hamsters, cats, dogs, mink, ferrets, tigers, lions, cynomolgus macaques, rhesus macaques, and treeshrew. Among these, mink are particularly susceptible. Indeed, 10 countries in Europe and North America reported SARS-CoV-2 infection among mink on fur farms. In Denmark, SARS-CoV-2 spread rapidly among mink farms and spilled-over back into humans, acquiring mutations/deletions wi","2021","07","13","Front Microbiol","Frontiers in microbiology","COVID-19; SARS-CoV-2; coronavirus; mink; virus neutralization","Rasmussen","Morten","Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark",NA
"2241","34248922","10.3389/fmicb.2021.698944","<i>In vitro</i> Characterization of Fitness and Convalescent Antibody Neutralization of SARS-CoV-2 Cluster 5 Variant Emerging in Mink at Danish Farms.","In addition to humans, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can transmit to animals that include hamsters, cats, dogs, mink, ferrets, tigers, lions, cynomolgus macaques, rhesus macaques, and treeshrew. Among these, mink are particularly susceptible. Indeed, 10 countries in Europe and North America reported SARS-CoV-2 infection among mink on fur farms. In Denmark, SARS-CoV-2 spread rapidly among mink farms and spilled-over back into humans, acquiring mutations/deletions wi","2021","07","13","Front Microbiol","Frontiers in microbiology","COVID-19; SARS-CoV-2; coronavirus; mink; virus neutralization","Frische","Anders","Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark",NA
"2242","34248922","10.3389/fmicb.2021.698944","<i>In vitro</i> Characterization of Fitness and Convalescent Antibody Neutralization of SARS-CoV-2 Cluster 5 Variant Emerging in Mink at Danish Farms.","In addition to humans, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can transmit to animals that include hamsters, cats, dogs, mink, ferrets, tigers, lions, cynomolgus macaques, rhesus macaques, and treeshrew. Among these, mink are particularly susceptible. Indeed, 10 countries in Europe and North America reported SARS-CoV-2 infection among mink on fur farms. In Denmark, SARS-CoV-2 spread rapidly among mink farms and spilled-over back into humans, acquiring mutations/deletions wi","2021","07","13","Front Microbiol","Frontiers in microbiology","COVID-19; SARS-CoV-2; coronavirus; mink; virus neutralization","Polacek","Charlotta","Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark",NA
"2243","34248922","10.3389/fmicb.2021.698944","<i>In vitro</i> Characterization of Fitness and Convalescent Antibody Neutralization of SARS-CoV-2 Cluster 5 Variant Emerging in Mink at Danish Farms.","In addition to humans, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can transmit to animals that include hamsters, cats, dogs, mink, ferrets, tigers, lions, cynomolgus macaques, rhesus macaques, and treeshrew. Among these, mink are particularly susceptible. Indeed, 10 countries in Europe and North America reported SARS-CoV-2 infection among mink on fur farms. In Denmark, SARS-CoV-2 spread rapidly among mink farms and spilled-over back into humans, acquiring mutations/deletions wi","2021","07","13","Front Microbiol","Frontiers in microbiology","COVID-19; SARS-CoV-2; coronavirus; mink; virus neutralization","Rasmussen","Thomas Bruun","Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark",NA
"2244","34248922","10.3389/fmicb.2021.698944","<i>In vitro</i> Characterization of Fitness and Convalescent Antibody Neutralization of SARS-CoV-2 Cluster 5 Variant Emerging in Mink at Danish Farms.","In addition to humans, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can transmit to animals that include hamsters, cats, dogs, mink, ferrets, tigers, lions, cynomolgus macaques, rhesus macaques, and treeshrew. Among these, mink are particularly susceptible. Indeed, 10 countries in Europe and North America reported SARS-CoV-2 infection among mink on fur farms. In Denmark, SARS-CoV-2 spread rapidly among mink farms and spilled-over back into humans, acquiring mutations/deletions wi","2021","07","13","Front Microbiol","Frontiers in microbiology","COVID-19; SARS-CoV-2; coronavirus; mink; virus neutralization","Lohse","Louise","Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark",NA
"2245","34248922","10.3389/fmicb.2021.698944","<i>In vitro</i> Characterization of Fitness and Convalescent Antibody Neutralization of SARS-CoV-2 Cluster 5 Variant Emerging in Mink at Danish Farms.","In addition to humans, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can transmit to animals that include hamsters, cats, dogs, mink, ferrets, tigers, lions, cynomolgus macaques, rhesus macaques, and treeshrew. Among these, mink are particularly susceptible. Indeed, 10 countries in Europe and North America reported SARS-CoV-2 infection among mink on fur farms. In Denmark, SARS-CoV-2 spread rapidly among mink farms and spilled-over back into humans, acquiring mutations/deletions wi","2021","07","13","Front Microbiol","Frontiers in microbiology","COVID-19; SARS-CoV-2; coronavirus; mink; virus neutralization","Belsham","Graham J","Department of Veterinary and Animal Sciences, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark",NA
"2246","34248922","10.3389/fmicb.2021.698944","<i>In vitro</i> Characterization of Fitness and Convalescent Antibody Neutralization of SARS-CoV-2 Cluster 5 Variant Emerging in Mink at Danish Farms.","In addition to humans, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can transmit to animals that include hamsters, cats, dogs, mink, ferrets, tigers, lions, cynomolgus macaques, rhesus macaques, and treeshrew. Among these, mink are particularly susceptible. Indeed, 10 countries in Europe and North America reported SARS-CoV-2 infection among mink on fur farms. In Denmark, SARS-CoV-2 spread rapidly among mink farms and spilled-over back into humans, acquiring mutations/deletions wi","2021","07","13","Front Microbiol","Frontiers in microbiology","COVID-19; SARS-CoV-2; coronavirus; mink; virus neutralization","Underwood","Alexander","Copenhagen Hepatitis C Program (CO-HEP), Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark",NA
"2247","34248922","10.3389/fmicb.2021.698944","<i>In vitro</i> Characterization of Fitness and Convalescent Antibody Neutralization of SARS-CoV-2 Cluster 5 Variant Emerging in Mink at Danish Farms.","In addition to humans, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can transmit to animals that include hamsters, cats, dogs, mink, ferrets, tigers, lions, cynomolgus macaques, rhesus macaques, and treeshrew. Among these, mink are particularly susceptible. Indeed, 10 countries in Europe and North America reported SARS-CoV-2 infection among mink on fur farms. In Denmark, SARS-CoV-2 spread rapidly among mink farms and spilled-over back into humans, acquiring mutations/deletions wi","2021","07","13","Front Microbiol","Frontiers in microbiology","COVID-19; SARS-CoV-2; coronavirus; mink; virus neutralization","Winckelmann","Anni Assing","Copenhagen Hepatitis C Program (CO-HEP), Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark",NA
"2248","34248922","10.3389/fmicb.2021.698944","<i>In vitro</i> Characterization of Fitness and Convalescent Antibody Neutralization of SARS-CoV-2 Cluster 5 Variant Emerging in Mink at Danish Farms.","In addition to humans, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can transmit to animals that include hamsters, cats, dogs, mink, ferrets, tigers, lions, cynomolgus macaques, rhesus macaques, and treeshrew. Among these, mink are particularly susceptible. Indeed, 10 countries in Europe and North America reported SARS-CoV-2 infection among mink on fur farms. In Denmark, SARS-CoV-2 spread rapidly among mink farms and spilled-over back into humans, acquiring mutations/deletions wi","2021","07","13","Front Microbiol","Frontiers in microbiology","COVID-19; SARS-CoV-2; coronavirus; mink; virus neutralization","Bollerup","Signe","Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre, Copenhagen, Denmark",NA
"2249","34248922","10.3389/fmicb.2021.698944","<i>In vitro</i> Characterization of Fitness and Convalescent Antibody Neutralization of SARS-CoV-2 Cluster 5 Variant Emerging in Mink at Danish Farms.","In addition to humans, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can transmit to animals that include hamsters, cats, dogs, mink, ferrets, tigers, lions, cynomolgus macaques, rhesus macaques, and treeshrew. Among these, mink are particularly susceptible. Indeed, 10 countries in Europe and North America reported SARS-CoV-2 infection among mink on fur farms. In Denmark, SARS-CoV-2 spread rapidly among mink farms and spilled-over back into humans, acquiring mutations/deletions wi","2021","07","13","Front Microbiol","Frontiers in microbiology","COVID-19; SARS-CoV-2; coronavirus; mink; virus neutralization","Bukh","Jens","Copenhagen Hepatitis C Program (CO-HEP), Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark",NA
"2250","34248922","10.3389/fmicb.2021.698944","<i>In vitro</i> Characterization of Fitness and Convalescent Antibody Neutralization of SARS-CoV-2 Cluster 5 Variant Emerging in Mink at Danish Farms.","In addition to humans, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can transmit to animals that include hamsters, cats, dogs, mink, ferrets, tigers, lions, cynomolgus macaques, rhesus macaques, and treeshrew. Among these, mink are particularly susceptible. Indeed, 10 countries in Europe and North America reported SARS-CoV-2 infection among mink on fur farms. In Denmark, SARS-CoV-2 spread rapidly among mink farms and spilled-over back into humans, acquiring mutations/deletions wi","2021","07","13","Front Microbiol","Frontiers in microbiology","COVID-19; SARS-CoV-2; coronavirus; mink; virus neutralization","Weis","Nina","Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre, Copenhagen, Denmark",NA
"2251","34248922","10.3389/fmicb.2021.698944","<i>In vitro</i> Characterization of Fitness and Convalescent Antibody Neutralization of SARS-CoV-2 Cluster 5 Variant Emerging in Mink at Danish Farms.","In addition to humans, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can transmit to animals that include hamsters, cats, dogs, mink, ferrets, tigers, lions, cynomolgus macaques, rhesus macaques, and treeshrew. Among these, mink are particularly susceptible. Indeed, 10 countries in Europe and North America reported SARS-CoV-2 infection among mink on fur farms. In Denmark, SARS-CoV-2 spread rapidly among mink farms and spilled-over back into humans, acquiring mutations/deletions wi","2021","07","13","Front Microbiol","Frontiers in microbiology","COVID-19; SARS-CoV-2; coronavirus; mink; virus neutralization","Sækmose","Susanne Gjørup","Department of Clinical Immunology, Zealand University Hospital, Naestved, Denmark",NA
"2252","34248922","10.3389/fmicb.2021.698944","<i>In vitro</i> Characterization of Fitness and Convalescent Antibody Neutralization of SARS-CoV-2 Cluster 5 Variant Emerging in Mink at Danish Farms.","In addition to humans, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can transmit to animals that include hamsters, cats, dogs, mink, ferrets, tigers, lions, cynomolgus macaques, rhesus macaques, and treeshrew. Among these, mink are particularly susceptible. Indeed, 10 countries in Europe and North America reported SARS-CoV-2 infection among mink on fur farms. In Denmark, SARS-CoV-2 spread rapidly among mink farms and spilled-over back into humans, acquiring mutations/deletions wi","2021","07","13","Front Microbiol","Frontiers in microbiology","COVID-19; SARS-CoV-2; coronavirus; mink; virus neutralization","Aagaard","Bitten","Department of Clinical Immunology, Aalborg University Hospital, Aalborg, Denmark",NA
"2253","34248922","10.3389/fmicb.2021.698944","<i>In vitro</i> Characterization of Fitness and Convalescent Antibody Neutralization of SARS-CoV-2 Cluster 5 Variant Emerging in Mink at Danish Farms.","In addition to humans, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can transmit to animals that include hamsters, cats, dogs, mink, ferrets, tigers, lions, cynomolgus macaques, rhesus macaques, and treeshrew. Among these, mink are particularly susceptible. Indeed, 10 countries in Europe and North America reported SARS-CoV-2 infection among mink on fur farms. In Denmark, SARS-CoV-2 spread rapidly among mink farms and spilled-over back into humans, acquiring mutations/deletions wi","2021","07","13","Front Microbiol","Frontiers in microbiology","COVID-19; SARS-CoV-2; coronavirus; mink; virus neutralization","Alfaro-Núñez","Alonzo","Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark",NA
"2254","34248922","10.3389/fmicb.2021.698944","<i>In vitro</i> Characterization of Fitness and Convalescent Antibody Neutralization of SARS-CoV-2 Cluster 5 Variant Emerging in Mink at Danish Farms.","In addition to humans, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can transmit to animals that include hamsters, cats, dogs, mink, ferrets, tigers, lions, cynomolgus macaques, rhesus macaques, and treeshrew. Among these, mink are particularly susceptible. Indeed, 10 countries in Europe and North America reported SARS-CoV-2 infection among mink on fur farms. In Denmark, SARS-CoV-2 spread rapidly among mink farms and spilled-over back into humans, acquiring mutations/deletions wi","2021","07","13","Front Microbiol","Frontiers in microbiology","COVID-19; SARS-CoV-2; coronavirus; mink; virus neutralization","Mølbak","Kåre","Department of Veterinary and Animal Sciences, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark",NA
"2255","34248922","10.3389/fmicb.2021.698944","<i>In vitro</i> Characterization of Fitness and Convalescent Antibody Neutralization of SARS-CoV-2 Cluster 5 Variant Emerging in Mink at Danish Farms.","In addition to humans, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can transmit to animals that include hamsters, cats, dogs, mink, ferrets, tigers, lions, cynomolgus macaques, rhesus macaques, and treeshrew. Among these, mink are particularly susceptible. Indeed, 10 countries in Europe and North America reported SARS-CoV-2 infection among mink on fur farms. In Denmark, SARS-CoV-2 spread rapidly among mink farms and spilled-over back into humans, acquiring mutations/deletions wi","2021","07","13","Front Microbiol","Frontiers in microbiology","COVID-19; SARS-CoV-2; coronavirus; mink; virus neutralization","Bøtner","Anette","Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark",NA
"2256","34248922","10.3389/fmicb.2021.698944","<i>In vitro</i> Characterization of Fitness and Convalescent Antibody Neutralization of SARS-CoV-2 Cluster 5 Variant Emerging in Mink at Danish Farms.","In addition to humans, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can transmit to animals that include hamsters, cats, dogs, mink, ferrets, tigers, lions, cynomolgus macaques, rhesus macaques, and treeshrew. Among these, mink are particularly susceptible. Indeed, 10 countries in Europe and North America reported SARS-CoV-2 infection among mink on fur farms. In Denmark, SARS-CoV-2 spread rapidly among mink farms and spilled-over back into humans, acquiring mutations/deletions wi","2021","07","13","Front Microbiol","Frontiers in microbiology","COVID-19; SARS-CoV-2; coronavirus; mink; virus neutralization","Fomsgaard","Anders","Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark",NA
"2257","34248921","10.3389/fmicb.2021.698169","Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms.","The novel virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a pandemic of coronavirus disease 2019 (COVID-19). Across the globe, a subset of patients who sustain an acute SARS-CoV-2 infection are developing a wide range of persistent symptoms that do not resolve over the course of many months. These patients are being given the diagnosis Long COVID or Post-acute sequelae of COVID-19 (PASC). It is likely that individual patients with a PASC diagnosis have different und","2021","07","13","Front Microbiol","Frontiers in microbiology","COVID-19; SARS-CoV-2; brainstem; infection; long COVID; microbiome; vagus; virus","Proal","Amy D","PolyBio Research Foundation, Kenmore, WA, United States",NA
"2258","34248921","10.3389/fmicb.2021.698169","Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms.","The novel virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a pandemic of coronavirus disease 2019 (COVID-19). Across the globe, a subset of patients who sustain an acute SARS-CoV-2 infection are developing a wide range of persistent symptoms that do not resolve over the course of many months. These patients are being given the diagnosis Long COVID or Post-acute sequelae of COVID-19 (PASC). It is likely that individual patients with a PASC diagnosis have different und","2021","07","13","Front Microbiol","Frontiers in microbiology","COVID-19; SARS-CoV-2; brainstem; infection; long COVID; microbiome; vagus; virus","VanElzakker","Michael B","PolyBio Research Foundation, Kenmore, WA, United States",NA
"2259","34248910","10.3389/fmicb.2021.687513","Oral Microbiome Dysbiosis Is Associated With Symptoms Severity and Local Immune/Inflammatory Response in COVID-19 Patients: A Cross-Sectional Study.","The human oral microbiome (HOM) is the second largest microbial community after the gut and can impact the onset and progression of several localized and systemic diseases, including those of viral origin, especially for viruses entering the body via the oropharynx. However, this important aspect has not been clarified for the new pandemic human coronavirus SARS-CoV-2, causing COVID-19 disease, despite it being one of the many respiratory viruses having the oropharynx as the primary site of repl","2021","07","13","Front Microbiol","Frontiers in microbiology","COVID-19; inflammatory cytokines; oral microbiome; secretory IgA; symptom severity","Soffritti","Irene","Section of Microbiology, CIAS Research Center and LTTA, Department of Chemical and Pharmaceutical Sciences, University of Ferrara, Ferrara, Italy",NA
"2260","34248910","10.3389/fmicb.2021.687513","Oral Microbiome Dysbiosis Is Associated With Symptoms Severity and Local Immune/Inflammatory Response in COVID-19 Patients: A Cross-Sectional Study.","The human oral microbiome (HOM) is the second largest microbial community after the gut and can impact the onset and progression of several localized and systemic diseases, including those of viral origin, especially for viruses entering the body via the oropharynx. However, this important aspect has not been clarified for the new pandemic human coronavirus SARS-CoV-2, causing COVID-19 disease, despite it being one of the many respiratory viruses having the oropharynx as the primary site of repl","2021","07","13","Front Microbiol","Frontiers in microbiology","COVID-19; inflammatory cytokines; oral microbiome; secretory IgA; symptom severity","D'Accolti","Maria","Section of Microbiology, CIAS Research Center and LTTA, Department of Chemical and Pharmaceutical Sciences, University of Ferrara, Ferrara, Italy",NA
"2261","34248910","10.3389/fmicb.2021.687513","Oral Microbiome Dysbiosis Is Associated With Symptoms Severity and Local Immune/Inflammatory Response in COVID-19 Patients: A Cross-Sectional Study.","The human oral microbiome (HOM) is the second largest microbial community after the gut and can impact the onset and progression of several localized and systemic diseases, including those of viral origin, especially for viruses entering the body via the oropharynx. However, this important aspect has not been clarified for the new pandemic human coronavirus SARS-CoV-2, causing COVID-19 disease, despite it being one of the many respiratory viruses having the oropharynx as the primary site of repl","2021","07","13","Front Microbiol","Frontiers in microbiology","COVID-19; inflammatory cytokines; oral microbiome; secretory IgA; symptom severity","Fabbri","Chiara","Section of Dentistry, Department of Biomedical and Specialty Surgical Sciences, University of Ferrara, Ferrara, Italy",NA
"2262","34248910","10.3389/fmicb.2021.687513","Oral Microbiome Dysbiosis Is Associated With Symptoms Severity and Local Immune/Inflammatory Response in COVID-19 Patients: A Cross-Sectional Study.","The human oral microbiome (HOM) is the second largest microbial community after the gut and can impact the onset and progression of several localized and systemic diseases, including those of viral origin, especially for viruses entering the body via the oropharynx. However, this important aspect has not been clarified for the new pandemic human coronavirus SARS-CoV-2, causing COVID-19 disease, despite it being one of the many respiratory viruses having the oropharynx as the primary site of repl","2021","07","13","Front Microbiol","Frontiers in microbiology","COVID-19; inflammatory cytokines; oral microbiome; secretory IgA; symptom severity","Passaro","Angela","Unit of Internal Medicine, Department of Translational Medicine, University of Ferrara, Ferrara, Italy",NA
"2263","34248910","10.3389/fmicb.2021.687513","Oral Microbiome Dysbiosis Is Associated With Symptoms Severity and Local Immune/Inflammatory Response in COVID-19 Patients: A Cross-Sectional Study.","The human oral microbiome (HOM) is the second largest microbial community after the gut and can impact the onset and progression of several localized and systemic diseases, including those of viral origin, especially for viruses entering the body via the oropharynx. However, this important aspect has not been clarified for the new pandemic human coronavirus SARS-CoV-2, causing COVID-19 disease, despite it being one of the many respiratory viruses having the oropharynx as the primary site of repl","2021","07","13","Front Microbiol","Frontiers in microbiology","COVID-19; inflammatory cytokines; oral microbiome; secretory IgA; symptom severity","Manfredini","Roberto","Medical Clinic Unit, Department of Medical Sciences, University of Ferrara, Ferrara, Italy",NA
"2264","34248910","10.3389/fmicb.2021.687513","Oral Microbiome Dysbiosis Is Associated With Symptoms Severity and Local Immune/Inflammatory Response in COVID-19 Patients: A Cross-Sectional Study.","The human oral microbiome (HOM) is the second largest microbial community after the gut and can impact the onset and progression of several localized and systemic diseases, including those of viral origin, especially for viruses entering the body via the oropharynx. However, this important aspect has not been clarified for the new pandemic human coronavirus SARS-CoV-2, causing COVID-19 disease, despite it being one of the many respiratory viruses having the oropharynx as the primary site of repl","2021","07","13","Front Microbiol","Frontiers in microbiology","COVID-19; inflammatory cytokines; oral microbiome; secretory IgA; symptom severity","Zuliani","Giovanni","Unit of Internal Medicine, Department of Translational Medicine, University of Ferrara, Ferrara, Italy",NA
"2265","34248910","10.3389/fmicb.2021.687513","Oral Microbiome Dysbiosis Is Associated With Symptoms Severity and Local Immune/Inflammatory Response in COVID-19 Patients: A Cross-Sectional Study.","The human oral microbiome (HOM) is the second largest microbial community after the gut and can impact the onset and progression of several localized and systemic diseases, including those of viral origin, especially for viruses entering the body via the oropharynx. However, this important aspect has not been clarified for the new pandemic human coronavirus SARS-CoV-2, causing COVID-19 disease, despite it being one of the many respiratory viruses having the oropharynx as the primary site of repl","2021","07","13","Front Microbiol","Frontiers in microbiology","COVID-19; inflammatory cytokines; oral microbiome; secretory IgA; symptom severity","Libanore","Marco","Unit of Infectious Diseases, University Hospital of Ferrara, Ferrara, Italy",NA
"2266","34248910","10.3389/fmicb.2021.687513","Oral Microbiome Dysbiosis Is Associated With Symptoms Severity and Local Immune/Inflammatory Response in COVID-19 Patients: A Cross-Sectional Study.","The human oral microbiome (HOM) is the second largest microbial community after the gut and can impact the onset and progression of several localized and systemic diseases, including those of viral origin, especially for viruses entering the body via the oropharynx. However, this important aspect has not been clarified for the new pandemic human coronavirus SARS-CoV-2, causing COVID-19 disease, despite it being one of the many respiratory viruses having the oropharynx as the primary site of repl","2021","07","13","Front Microbiol","Frontiers in microbiology","COVID-19; inflammatory cytokines; oral microbiome; secretory IgA; symptom severity","Franchi","Maurizio","Section of Dentistry, Department of Biomedical and Specialty Surgical Sciences, University of Ferrara, Ferrara, Italy",NA
"2267","34248910","10.3389/fmicb.2021.687513","Oral Microbiome Dysbiosis Is Associated With Symptoms Severity and Local Immune/Inflammatory Response in COVID-19 Patients: A Cross-Sectional Study.","The human oral microbiome (HOM) is the second largest microbial community after the gut and can impact the onset and progression of several localized and systemic diseases, including those of viral origin, especially for viruses entering the body via the oropharynx. However, this important aspect has not been clarified for the new pandemic human coronavirus SARS-CoV-2, causing COVID-19 disease, despite it being one of the many respiratory viruses having the oropharynx as the primary site of repl","2021","07","13","Front Microbiol","Frontiers in microbiology","COVID-19; inflammatory cytokines; oral microbiome; secretory IgA; symptom severity","Contini","Carlo","Section of Infectious Diseases and Dermatology, Department of Medical Sciences, University of Ferrara, Ferrara, Italy",NA
"2268","34248910","10.3389/fmicb.2021.687513","Oral Microbiome Dysbiosis Is Associated With Symptoms Severity and Local Immune/Inflammatory Response in COVID-19 Patients: A Cross-Sectional Study.","The human oral microbiome (HOM) is the second largest microbial community after the gut and can impact the onset and progression of several localized and systemic diseases, including those of viral origin, especially for viruses entering the body via the oropharynx. However, this important aspect has not been clarified for the new pandemic human coronavirus SARS-CoV-2, causing COVID-19 disease, despite it being one of the many respiratory viruses having the oropharynx as the primary site of repl","2021","07","13","Front Microbiol","Frontiers in microbiology","COVID-19; inflammatory cytokines; oral microbiome; secretory IgA; symptom severity","Caselli","Elisabetta","Section of Microbiology, CIAS Research Center and LTTA, Department of Chemical and Pharmaceutical Sciences, University of Ferrara, Ferrara, Italy",NA
"2269","34248858","10.3389/fmicb.2021.551602","The MERS-CoV N Protein Regulates Host Cytokinesis and Protein Translation via Interaction With EF1A.","Middle East respiratory syndrome coronavirus (MERS-CoV), a pathogen causing severe respiratory disease in humans that emerged in June 2012, is a novel beta coronavirus similar to severe acute respiratory syndrome coronavirus (SARS-CoV). In this study, immunoprecipitation and proximity ligation assays revealed that the nucleocapsid (N) protein of MERS-CoV interacted with human translation elongation factor 1A (EF1A), an essential component of the translation system with important roles in protein","2021","07","13","Front Microbiol","Frontiers in microbiology","EF1A; F-actin; MERS-CoV; cytokinesis; multiple nuclei; nucleocapsid protein","Zhu","Lin","Beijing Institute of Biotechnology, Army Institute of Military Medical Sciences, Academy of Military Sciences, Beijing, China",NA
"2270","34248858","10.3389/fmicb.2021.551602","The MERS-CoV N Protein Regulates Host Cytokinesis and Protein Translation via Interaction With EF1A.","Middle East respiratory syndrome coronavirus (MERS-CoV), a pathogen causing severe respiratory disease in humans that emerged in June 2012, is a novel beta coronavirus similar to severe acute respiratory syndrome coronavirus (SARS-CoV). In this study, immunoprecipitation and proximity ligation assays revealed that the nucleocapsid (N) protein of MERS-CoV interacted with human translation elongation factor 1A (EF1A), an essential component of the translation system with important roles in protein","2021","07","13","Front Microbiol","Frontiers in microbiology","EF1A; F-actin; MERS-CoV; cytokinesis; multiple nuclei; nucleocapsid protein","Gao","Ting","Beijing Institute of Biotechnology, Army Institute of Military Medical Sciences, Academy of Military Sciences, Beijing, China",NA
"2271","34248858","10.3389/fmicb.2021.551602","The MERS-CoV N Protein Regulates Host Cytokinesis and Protein Translation via Interaction With EF1A.","Middle East respiratory syndrome coronavirus (MERS-CoV), a pathogen causing severe respiratory disease in humans that emerged in June 2012, is a novel beta coronavirus similar to severe acute respiratory syndrome coronavirus (SARS-CoV). In this study, immunoprecipitation and proximity ligation assays revealed that the nucleocapsid (N) protein of MERS-CoV interacted with human translation elongation factor 1A (EF1A), an essential component of the translation system with important roles in protein","2021","07","13","Front Microbiol","Frontiers in microbiology","EF1A; F-actin; MERS-CoV; cytokinesis; multiple nuclei; nucleocapsid protein","Fu","Yangbo","Beijing Institute of Biotechnology, Army Institute of Military Medical Sciences, Academy of Military Sciences, Beijing, China",NA
"2272","34248858","10.3389/fmicb.2021.551602","The MERS-CoV N Protein Regulates Host Cytokinesis and Protein Translation via Interaction With EF1A.","Middle East respiratory syndrome coronavirus (MERS-CoV), a pathogen causing severe respiratory disease in humans that emerged in June 2012, is a novel beta coronavirus similar to severe acute respiratory syndrome coronavirus (SARS-CoV). In this study, immunoprecipitation and proximity ligation assays revealed that the nucleocapsid (N) protein of MERS-CoV interacted with human translation elongation factor 1A (EF1A), an essential component of the translation system with important roles in protein","2021","07","13","Front Microbiol","Frontiers in microbiology","EF1A; F-actin; MERS-CoV; cytokinesis; multiple nuclei; nucleocapsid protein","Han","Xiujing","Department of Clinical Laboratory, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China",NA
"2273","34248858","10.3389/fmicb.2021.551602","The MERS-CoV N Protein Regulates Host Cytokinesis and Protein Translation via Interaction With EF1A.","Middle East respiratory syndrome coronavirus (MERS-CoV), a pathogen causing severe respiratory disease in humans that emerged in June 2012, is a novel beta coronavirus similar to severe acute respiratory syndrome coronavirus (SARS-CoV). In this study, immunoprecipitation and proximity ligation assays revealed that the nucleocapsid (N) protein of MERS-CoV interacted with human translation elongation factor 1A (EF1A), an essential component of the translation system with important roles in protein","2021","07","13","Front Microbiol","Frontiers in microbiology","EF1A; F-actin; MERS-CoV; cytokinesis; multiple nuclei; nucleocapsid protein","Yue","Junjie","Beijing Institute of Biotechnology, Army Institute of Military Medical Sciences, Academy of Military Sciences, Beijing, China",NA
"2274","34248858","10.3389/fmicb.2021.551602","The MERS-CoV N Protein Regulates Host Cytokinesis and Protein Translation via Interaction With EF1A.","Middle East respiratory syndrome coronavirus (MERS-CoV), a pathogen causing severe respiratory disease in humans that emerged in June 2012, is a novel beta coronavirus similar to severe acute respiratory syndrome coronavirus (SARS-CoV). In this study, immunoprecipitation and proximity ligation assays revealed that the nucleocapsid (N) protein of MERS-CoV interacted with human translation elongation factor 1A (EF1A), an essential component of the translation system with important roles in protein","2021","07","13","Front Microbiol","Frontiers in microbiology","EF1A; F-actin; MERS-CoV; cytokinesis; multiple nuclei; nucleocapsid protein","Liu","Yaoning","Institute of Physical Science and Information Technology, Anhui University, Hefei, China",NA
"2275","34248858","10.3389/fmicb.2021.551602","The MERS-CoV N Protein Regulates Host Cytokinesis and Protein Translation via Interaction With EF1A.","Middle East respiratory syndrome coronavirus (MERS-CoV), a pathogen causing severe respiratory disease in humans that emerged in June 2012, is a novel beta coronavirus similar to severe acute respiratory syndrome coronavirus (SARS-CoV). In this study, immunoprecipitation and proximity ligation assays revealed that the nucleocapsid (N) protein of MERS-CoV interacted with human translation elongation factor 1A (EF1A), an essential component of the translation system with important roles in protein","2021","07","13","Front Microbiol","Frontiers in microbiology","EF1A; F-actin; MERS-CoV; cytokinesis; multiple nuclei; nucleocapsid protein","Liu","Hainan","Beijing Institute of Biotechnology, Army Institute of Military Medical Sciences, Academy of Military Sciences, Beijing, China",NA
"2276","34248858","10.3389/fmicb.2021.551602","The MERS-CoV N Protein Regulates Host Cytokinesis and Protein Translation via Interaction With EF1A.","Middle East respiratory syndrome coronavirus (MERS-CoV), a pathogen causing severe respiratory disease in humans that emerged in June 2012, is a novel beta coronavirus similar to severe acute respiratory syndrome coronavirus (SARS-CoV). In this study, immunoprecipitation and proximity ligation assays revealed that the nucleocapsid (N) protein of MERS-CoV interacted with human translation elongation factor 1A (EF1A), an essential component of the translation system with important roles in protein","2021","07","13","Front Microbiol","Frontiers in microbiology","EF1A; F-actin; MERS-CoV; cytokinesis; multiple nuclei; nucleocapsid protein","Dong","Qincai","Beijing Institute of Biotechnology, Army Institute of Military Medical Sciences, Academy of Military Sciences, Beijing, China",NA
"2277","34248858","10.3389/fmicb.2021.551602","The MERS-CoV N Protein Regulates Host Cytokinesis and Protein Translation via Interaction With EF1A.","Middle East respiratory syndrome coronavirus (MERS-CoV), a pathogen causing severe respiratory disease in humans that emerged in June 2012, is a novel beta coronavirus similar to severe acute respiratory syndrome coronavirus (SARS-CoV). In this study, immunoprecipitation and proximity ligation assays revealed that the nucleocapsid (N) protein of MERS-CoV interacted with human translation elongation factor 1A (EF1A), an essential component of the translation system with important roles in protein","2021","07","13","Front Microbiol","Frontiers in microbiology","EF1A; F-actin; MERS-CoV; cytokinesis; multiple nuclei; nucleocapsid protein","Yang","Weihong","Institute of Physical Science and Information Technology, Anhui University, Hefei, China",NA
"2278","34248858","10.3389/fmicb.2021.551602","The MERS-CoV N Protein Regulates Host Cytokinesis and Protein Translation via Interaction With EF1A.","Middle East respiratory syndrome coronavirus (MERS-CoV), a pathogen causing severe respiratory disease in humans that emerged in June 2012, is a novel beta coronavirus similar to severe acute respiratory syndrome coronavirus (SARS-CoV). In this study, immunoprecipitation and proximity ligation assays revealed that the nucleocapsid (N) protein of MERS-CoV interacted with human translation elongation factor 1A (EF1A), an essential component of the translation system with important roles in protein","2021","07","13","Front Microbiol","Frontiers in microbiology","EF1A; F-actin; MERS-CoV; cytokinesis; multiple nuclei; nucleocapsid protein","Hu","Yong","Beijing Institute of Biotechnology, Army Institute of Military Medical Sciences, Academy of Military Sciences, Beijing, China",NA
"2279","34248858","10.3389/fmicb.2021.551602","The MERS-CoV N Protein Regulates Host Cytokinesis and Protein Translation via Interaction With EF1A.","Middle East respiratory syndrome coronavirus (MERS-CoV), a pathogen causing severe respiratory disease in humans that emerged in June 2012, is a novel beta coronavirus similar to severe acute respiratory syndrome coronavirus (SARS-CoV). In this study, immunoprecipitation and proximity ligation assays revealed that the nucleocapsid (N) protein of MERS-CoV interacted with human translation elongation factor 1A (EF1A), an essential component of the translation system with important roles in protein","2021","07","13","Front Microbiol","Frontiers in microbiology","EF1A; F-actin; MERS-CoV; cytokinesis; multiple nuclei; nucleocapsid protein","Jin","Yanwen","Beijing Institute of Biotechnology, Army Institute of Military Medical Sciences, Academy of Military Sciences, Beijing, China",NA
"2280","34248858","10.3389/fmicb.2021.551602","The MERS-CoV N Protein Regulates Host Cytokinesis and Protein Translation via Interaction With EF1A.","Middle East respiratory syndrome coronavirus (MERS-CoV), a pathogen causing severe respiratory disease in humans that emerged in June 2012, is a novel beta coronavirus similar to severe acute respiratory syndrome coronavirus (SARS-CoV). In this study, immunoprecipitation and proximity ligation assays revealed that the nucleocapsid (N) protein of MERS-CoV interacted with human translation elongation factor 1A (EF1A), an essential component of the translation system with important roles in protein","2021","07","13","Front Microbiol","Frontiers in microbiology","EF1A; F-actin; MERS-CoV; cytokinesis; multiple nuclei; nucleocapsid protein","Li","Ping","Beijing Institute of Biotechnology, Army Institute of Military Medical Sciences, Academy of Military Sciences, Beijing, China",NA
"2281","34248858","10.3389/fmicb.2021.551602","The MERS-CoV N Protein Regulates Host Cytokinesis and Protein Translation via Interaction With EF1A.","Middle East respiratory syndrome coronavirus (MERS-CoV), a pathogen causing severe respiratory disease in humans that emerged in June 2012, is a novel beta coronavirus similar to severe acute respiratory syndrome coronavirus (SARS-CoV). In this study, immunoprecipitation and proximity ligation assays revealed that the nucleocapsid (N) protein of MERS-CoV interacted with human translation elongation factor 1A (EF1A), an essential component of the translation system with important roles in protein","2021","07","13","Front Microbiol","Frontiers in microbiology","EF1A; F-actin; MERS-CoV; cytokinesis; multiple nuclei; nucleocapsid protein","Liu","Xuan","Beijing Institute of Biotechnology, Army Institute of Military Medical Sciences, Academy of Military Sciences, Beijing, China",NA
"2282","34248858","10.3389/fmicb.2021.551602","The MERS-CoV N Protein Regulates Host Cytokinesis and Protein Translation via Interaction With EF1A.","Middle East respiratory syndrome coronavirus (MERS-CoV), a pathogen causing severe respiratory disease in humans that emerged in June 2012, is a novel beta coronavirus similar to severe acute respiratory syndrome coronavirus (SARS-CoV). In this study, immunoprecipitation and proximity ligation assays revealed that the nucleocapsid (N) protein of MERS-CoV interacted with human translation elongation factor 1A (EF1A), an essential component of the translation system with important roles in protein","2021","07","13","Front Microbiol","Frontiers in microbiology","EF1A; F-actin; MERS-CoV; cytokinesis; multiple nuclei; nucleocapsid protein","Cao","Cheng","Beijing Institute of Biotechnology, Army Institute of Military Medical Sciences, Academy of Military Sciences, Beijing, China",NA
"2283","34248841","10.3389/fendo.2021.665134","Soluble Neuropilin-1 Response to Hypoglycemia in Type 2 Diabetes: Increased Risk or Protection in SARS-CoV-2 Infection?","Neuropilin-1(NRP1) is a cofactor that enhances SARS-CoV-2 coronavirus cell infectivity when co-expressed with angiotensin-converting enzyme 2(ACE2). The Renin-Angiotensin System (RAS) is activated in type 2 diabetes (T2D); therefore, the aim of this study was to determine if hypoglycaemia-induced stress in T2D would potentiate serum NRP1(sNRP1) levels, reflecting an increased risk for SARS-CoV-2 infection. A case-control study of aged-matched T2D (n = 23) and control (n = 23) subjects who underw","2021","07","16","Front Endocrinol (Lausanne)","Frontiers in endocrinology","ACE inhibitors; ADAM9; COVID-19; Neuropilin-1; SARS-CoV-2; type 2 diabetes; ADAM Proteins; Aged; Angiotensin-Converting Enzyme 2; Angiotensins; COVID-19; Diabetes Mellitus, Type 2; Female; Glucose Clamp Technique; Humans; Hypoglycemia; Male; Membrane Proteins; Middle Aged; Neuropilin-1; Protective Factors; Renin; Risk Factors; SARS-CoV-2; Semaphorin-3A; Vascular Endothelial Growth Factor A","Moin","Abu Saleh Md","Diabetes Research Center (DRC), Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), Doha, Qatar",NA
"2284","34248841","10.3389/fendo.2021.665134","Soluble Neuropilin-1 Response to Hypoglycemia in Type 2 Diabetes: Increased Risk or Protection in SARS-CoV-2 Infection?","Neuropilin-1(NRP1) is a cofactor that enhances SARS-CoV-2 coronavirus cell infectivity when co-expressed with angiotensin-converting enzyme 2(ACE2). The Renin-Angiotensin System (RAS) is activated in type 2 diabetes (T2D); therefore, the aim of this study was to determine if hypoglycaemia-induced stress in T2D would potentiate serum NRP1(sNRP1) levels, reflecting an increased risk for SARS-CoV-2 infection. A case-control study of aged-matched T2D (n = 23) and control (n = 23) subjects who underw","2021","07","16","Front Endocrinol (Lausanne)","Frontiers in endocrinology","ACE inhibitors; ADAM9; COVID-19; Neuropilin-1; SARS-CoV-2; type 2 diabetes; ADAM Proteins; Aged; Angiotensin-Converting Enzyme 2; Angiotensins; COVID-19; Diabetes Mellitus, Type 2; Female; Glucose Clamp Technique; Humans; Hypoglycemia; Male; Membrane Proteins; Middle Aged; Neuropilin-1; Protective Factors; Renin; Risk Factors; SARS-CoV-2; Semaphorin-3A; Vascular Endothelial Growth Factor A","Al-Qaissi","Ahmed","Academic Endocrinology, Diabetes and Metabolism, Hull York Medical School, Hull, United Kingdom",NA
"2285","34248841","10.3389/fendo.2021.665134","Soluble Neuropilin-1 Response to Hypoglycemia in Type 2 Diabetes: Increased Risk or Protection in SARS-CoV-2 Infection?","Neuropilin-1(NRP1) is a cofactor that enhances SARS-CoV-2 coronavirus cell infectivity when co-expressed with angiotensin-converting enzyme 2(ACE2). The Renin-Angiotensin System (RAS) is activated in type 2 diabetes (T2D); therefore, the aim of this study was to determine if hypoglycaemia-induced stress in T2D would potentiate serum NRP1(sNRP1) levels, reflecting an increased risk for SARS-CoV-2 infection. A case-control study of aged-matched T2D (n = 23) and control (n = 23) subjects who underw","2021","07","16","Front Endocrinol (Lausanne)","Frontiers in endocrinology","ACE inhibitors; ADAM9; COVID-19; Neuropilin-1; SARS-CoV-2; type 2 diabetes; ADAM Proteins; Aged; Angiotensin-Converting Enzyme 2; Angiotensins; COVID-19; Diabetes Mellitus, Type 2; Female; Glucose Clamp Technique; Humans; Hypoglycemia; Male; Membrane Proteins; Middle Aged; Neuropilin-1; Protective Factors; Renin; Risk Factors; SARS-CoV-2; Semaphorin-3A; Vascular Endothelial Growth Factor A","Sathyapalan","Thozhukat","Academic Endocrinology, Diabetes and Metabolism, Hull York Medical School, Hull, United Kingdom",NA
"2286","34248841","10.3389/fendo.2021.665134","Soluble Neuropilin-1 Response to Hypoglycemia in Type 2 Diabetes: Increased Risk or Protection in SARS-CoV-2 Infection?","Neuropilin-1(NRP1) is a cofactor that enhances SARS-CoV-2 coronavirus cell infectivity when co-expressed with angiotensin-converting enzyme 2(ACE2). The Renin-Angiotensin System (RAS) is activated in type 2 diabetes (T2D); therefore, the aim of this study was to determine if hypoglycaemia-induced stress in T2D would potentiate serum NRP1(sNRP1) levels, reflecting an increased risk for SARS-CoV-2 infection. A case-control study of aged-matched T2D (n = 23) and control (n = 23) subjects who underw","2021","07","16","Front Endocrinol (Lausanne)","Frontiers in endocrinology","ACE inhibitors; ADAM9; COVID-19; Neuropilin-1; SARS-CoV-2; type 2 diabetes; ADAM Proteins; Aged; Angiotensin-Converting Enzyme 2; Angiotensins; COVID-19; Diabetes Mellitus, Type 2; Female; Glucose Clamp Technique; Humans; Hypoglycemia; Male; Membrane Proteins; Middle Aged; Neuropilin-1; Protective Factors; Renin; Risk Factors; SARS-CoV-2; Semaphorin-3A; Vascular Endothelial Growth Factor A","Atkin","Stephen L","Department of Research, Royal College of Surgeons in Ireland Bahrain, Adliya, Bahrain",NA
"2287","34248841","10.3389/fendo.2021.665134","Soluble Neuropilin-1 Response to Hypoglycemia in Type 2 Diabetes: Increased Risk or Protection in SARS-CoV-2 Infection?","Neuropilin-1(NRP1) is a cofactor that enhances SARS-CoV-2 coronavirus cell infectivity when co-expressed with angiotensin-converting enzyme 2(ACE2). The Renin-Angiotensin System (RAS) is activated in type 2 diabetes (T2D); therefore, the aim of this study was to determine if hypoglycaemia-induced stress in T2D would potentiate serum NRP1(sNRP1) levels, reflecting an increased risk for SARS-CoV-2 infection. A case-control study of aged-matched T2D (n = 23) and control (n = 23) subjects who underw","2021","07","16","Front Endocrinol (Lausanne)","Frontiers in endocrinology","ACE inhibitors; ADAM9; COVID-19; Neuropilin-1; SARS-CoV-2; type 2 diabetes; ADAM Proteins; Aged; Angiotensin-Converting Enzyme 2; Angiotensins; COVID-19; Diabetes Mellitus, Type 2; Female; Glucose Clamp Technique; Humans; Hypoglycemia; Male; Membrane Proteins; Middle Aged; Neuropilin-1; Protective Factors; Renin; Risk Factors; SARS-CoV-2; Semaphorin-3A; Vascular Endothelial Growth Factor A","Butler","Alexandra E","Diabetes Research Center (DRC), Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), Doha, Qatar",NA
"2288","34248840","10.3389/fendo.2021.658304","Type 2 Diabetes Coagulopathy Proteins May Conflict With Biomarkers Reflective of COVID-19 Severity.","Detailed proteomic analysis in a cohort of patients with differing severity of COVID-19 disease identified biomarkers within the complement and coagulation cascades as biomarkers for disease severity has been reported; however, it is unclear if these proteins differ sufficiently from other conditions to be considered as biomarkers. A prospective, parallel study in T2D (n = 23) and controls (n = 23). A hyperinsulinemic clamp was performed and normoglycemia induced in T2D [4.5 ± 0.07 mmol/L (81 ± ","2021","07","16","Front Endocrinol (Lausanne)","Frontiers in endocrinology","COVID-19; biomarkers; hypoglycemia; proteomics; type 2 diabetes; Aged; Biomarkers; Blood Coagulation; Blood Coagulation Factors; COVID-19; Case-Control Studies; Complement Activation; Diabetes Mellitus, Type 2; Factor IX; Female; Glucose Clamp Technique; Heparin Cofactor II; Humans; Hypoglycemia; Kininogens; Male; Middle Aged; Peptides; Platelet Activation; Platelet Factor 4; Prospective Studies; Protein C; Proteomics; SARS-CoV-2; Severity of Illness Index; Thrombospondin 1; beta-Thromboglobulin","Moin","Abu Saleh Md","Diabetes Research Center (DRC), Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), Doha, Qatar",NA
"2289","34248840","10.3389/fendo.2021.658304","Type 2 Diabetes Coagulopathy Proteins May Conflict With Biomarkers Reflective of COVID-19 Severity.","Detailed proteomic analysis in a cohort of patients with differing severity of COVID-19 disease identified biomarkers within the complement and coagulation cascades as biomarkers for disease severity has been reported; however, it is unclear if these proteins differ sufficiently from other conditions to be considered as biomarkers. A prospective, parallel study in T2D (n = 23) and controls (n = 23). A hyperinsulinemic clamp was performed and normoglycemia induced in T2D [4.5 ± 0.07 mmol/L (81 ± ","2021","07","16","Front Endocrinol (Lausanne)","Frontiers in endocrinology","COVID-19; biomarkers; hypoglycemia; proteomics; type 2 diabetes; Aged; Biomarkers; Blood Coagulation; Blood Coagulation Factors; COVID-19; Case-Control Studies; Complement Activation; Diabetes Mellitus, Type 2; Factor IX; Female; Glucose Clamp Technique; Heparin Cofactor II; Humans; Hypoglycemia; Kininogens; Male; Middle Aged; Peptides; Platelet Activation; Platelet Factor 4; Prospective Studies; Protein C; Proteomics; SARS-CoV-2; Severity of Illness Index; Thrombospondin 1; beta-Thromboglobulin","Al-Qaissi","Ahmed","Academic Endocrinology, Diabetes and Metabolism, Hull York Medical School, Hull, United Kingdom",NA
"2290","34248840","10.3389/fendo.2021.658304","Type 2 Diabetes Coagulopathy Proteins May Conflict With Biomarkers Reflective of COVID-19 Severity.","Detailed proteomic analysis in a cohort of patients with differing severity of COVID-19 disease identified biomarkers within the complement and coagulation cascades as biomarkers for disease severity has been reported; however, it is unclear if these proteins differ sufficiently from other conditions to be considered as biomarkers. A prospective, parallel study in T2D (n = 23) and controls (n = 23). A hyperinsulinemic clamp was performed and normoglycemia induced in T2D [4.5 ± 0.07 mmol/L (81 ± ","2021","07","16","Front Endocrinol (Lausanne)","Frontiers in endocrinology","COVID-19; biomarkers; hypoglycemia; proteomics; type 2 diabetes; Aged; Biomarkers; Blood Coagulation; Blood Coagulation Factors; COVID-19; Case-Control Studies; Complement Activation; Diabetes Mellitus, Type 2; Factor IX; Female; Glucose Clamp Technique; Heparin Cofactor II; Humans; Hypoglycemia; Kininogens; Male; Middle Aged; Peptides; Platelet Activation; Platelet Factor 4; Prospective Studies; Protein C; Proteomics; SARS-CoV-2; Severity of Illness Index; Thrombospondin 1; beta-Thromboglobulin","Sathyapalan","Thozhukat","Academic Endocrinology, Diabetes and Metabolism, Hull York Medical School, Hull, United Kingdom",NA
"2291","34248840","10.3389/fendo.2021.658304","Type 2 Diabetes Coagulopathy Proteins May Conflict With Biomarkers Reflective of COVID-19 Severity.","Detailed proteomic analysis in a cohort of patients with differing severity of COVID-19 disease identified biomarkers within the complement and coagulation cascades as biomarkers for disease severity has been reported; however, it is unclear if these proteins differ sufficiently from other conditions to be considered as biomarkers. A prospective, parallel study in T2D (n = 23) and controls (n = 23). A hyperinsulinemic clamp was performed and normoglycemia induced in T2D [4.5 ± 0.07 mmol/L (81 ± ","2021","07","16","Front Endocrinol (Lausanne)","Frontiers in endocrinology","COVID-19; biomarkers; hypoglycemia; proteomics; type 2 diabetes; Aged; Biomarkers; Blood Coagulation; Blood Coagulation Factors; COVID-19; Case-Control Studies; Complement Activation; Diabetes Mellitus, Type 2; Factor IX; Female; Glucose Clamp Technique; Heparin Cofactor II; Humans; Hypoglycemia; Kininogens; Male; Middle Aged; Peptides; Platelet Activation; Platelet Factor 4; Prospective Studies; Protein C; Proteomics; SARS-CoV-2; Severity of Illness Index; Thrombospondin 1; beta-Thromboglobulin","Atkin","Stephen L","Research Department, Royal College of Surgeons in Ireland Bahrain, Adliya, Bahrain",NA
"2292","34248840","10.3389/fendo.2021.658304","Type 2 Diabetes Coagulopathy Proteins May Conflict With Biomarkers Reflective of COVID-19 Severity.","Detailed proteomic analysis in a cohort of patients with differing severity of COVID-19 disease identified biomarkers within the complement and coagulation cascades as biomarkers for disease severity has been reported; however, it is unclear if these proteins differ sufficiently from other conditions to be considered as biomarkers. A prospective, parallel study in T2D (n = 23) and controls (n = 23). A hyperinsulinemic clamp was performed and normoglycemia induced in T2D [4.5 ± 0.07 mmol/L (81 ± ","2021","07","16","Front Endocrinol (Lausanne)","Frontiers in endocrinology","COVID-19; biomarkers; hypoglycemia; proteomics; type 2 diabetes; Aged; Biomarkers; Blood Coagulation; Blood Coagulation Factors; COVID-19; Case-Control Studies; Complement Activation; Diabetes Mellitus, Type 2; Factor IX; Female; Glucose Clamp Technique; Heparin Cofactor II; Humans; Hypoglycemia; Kininogens; Male; Middle Aged; Peptides; Platelet Activation; Platelet Factor 4; Prospective Studies; Protein C; Proteomics; SARS-CoV-2; Severity of Illness Index; Thrombospondin 1; beta-Thromboglobulin","Butler","Alexandra E","Diabetes Research Center (DRC), Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), Doha, Qatar",NA
"2293","34248834","10.3389/fendo.2021.611526","Dyslipidemia Is Related to Mortality in Critical Patients With Coronavirus Disease 2019: A Retrospective Study.","It has been reported that dyslipidemia is related to coronavirus-related diseases. Critical patients with coronavirus disease 2019 (COVID-19) who suffered from multiple organ dysfunctions were treated in the intensive care unit (ICU) in Wuhan, China. Whether the lipids profile was associated with the prognosis of COVID-19 in critical patients remained unclear. A retrospective study was performed in critical patients (N=48) with coronavirus disease 2019 in Leishenshan hospital between February an","2021","07","16","Front Endocrinol (Lausanne)","Frontiers in endocrinology","coronavirus disease 2019 (COVID-19); critical patients; lipid metabolism; mortality; risk factor; Aged; Aged, 80 and over; Apolipoproteins A; Apolipoproteins B; COVID-19; China; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Critical Illness; Dyslipidemias; Female; Hospital Mortality; Humans; Male; Middle Aged; Multiple Organ Failure; Retrospective Studies; Risk Factors; SARS-CoV-2; Severity of Illness Index","Yue","Jiang","Department of Endocrinology and Metabolism, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China",NA
"2294","34248834","10.3389/fendo.2021.611526","Dyslipidemia Is Related to Mortality in Critical Patients With Coronavirus Disease 2019: A Retrospective Study.","It has been reported that dyslipidemia is related to coronavirus-related diseases. Critical patients with coronavirus disease 2019 (COVID-19) who suffered from multiple organ dysfunctions were treated in the intensive care unit (ICU) in Wuhan, China. Whether the lipids profile was associated with the prognosis of COVID-19 in critical patients remained unclear. A retrospective study was performed in critical patients (N=48) with coronavirus disease 2019 in Leishenshan hospital between February an","2021","07","16","Front Endocrinol (Lausanne)","Frontiers in endocrinology","coronavirus disease 2019 (COVID-19); critical patients; lipid metabolism; mortality; risk factor; Aged; Aged, 80 and over; Apolipoproteins A; Apolipoproteins B; COVID-19; China; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Critical Illness; Dyslipidemias; Female; Hospital Mortality; Humans; Male; Middle Aged; Multiple Organ Failure; Retrospective Studies; Risk Factors; SARS-CoV-2; Severity of Illness Index","Xu","Hua","Department of Endocrinology and Metabolism, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China",NA
"2295","34248834","10.3389/fendo.2021.611526","Dyslipidemia Is Related to Mortality in Critical Patients With Coronavirus Disease 2019: A Retrospective Study.","It has been reported that dyslipidemia is related to coronavirus-related diseases. Critical patients with coronavirus disease 2019 (COVID-19) who suffered from multiple organ dysfunctions were treated in the intensive care unit (ICU) in Wuhan, China. Whether the lipids profile was associated with the prognosis of COVID-19 in critical patients remained unclear. A retrospective study was performed in critical patients (N=48) with coronavirus disease 2019 in Leishenshan hospital between February an","2021","07","16","Front Endocrinol (Lausanne)","Frontiers in endocrinology","coronavirus disease 2019 (COVID-19); critical patients; lipid metabolism; mortality; risk factor; Aged; Aged, 80 and over; Apolipoproteins A; Apolipoproteins B; COVID-19; China; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Critical Illness; Dyslipidemias; Female; Hospital Mortality; Humans; Male; Middle Aged; Multiple Organ Failure; Retrospective Studies; Risk Factors; SARS-CoV-2; Severity of Illness Index","Zhou","Yong","Department of Cardiology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China",NA
"2296","34248834","10.3389/fendo.2021.611526","Dyslipidemia Is Related to Mortality in Critical Patients With Coronavirus Disease 2019: A Retrospective Study.","It has been reported that dyslipidemia is related to coronavirus-related diseases. Critical patients with coronavirus disease 2019 (COVID-19) who suffered from multiple organ dysfunctions were treated in the intensive care unit (ICU) in Wuhan, China. Whether the lipids profile was associated with the prognosis of COVID-19 in critical patients remained unclear. A retrospective study was performed in critical patients (N=48) with coronavirus disease 2019 in Leishenshan hospital between February an","2021","07","16","Front Endocrinol (Lausanne)","Frontiers in endocrinology","coronavirus disease 2019 (COVID-19); critical patients; lipid metabolism; mortality; risk factor; Aged; Aged, 80 and over; Apolipoproteins A; Apolipoproteins B; COVID-19; China; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Critical Illness; Dyslipidemias; Female; Hospital Mortality; Humans; Male; Middle Aged; Multiple Organ Failure; Retrospective Studies; Risk Factors; SARS-CoV-2; Severity of Illness Index","Liu","Wen","Department of Endocrinology and Metabolism, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China",NA
"2297","34248834","10.3389/fendo.2021.611526","Dyslipidemia Is Related to Mortality in Critical Patients With Coronavirus Disease 2019: A Retrospective Study.","It has been reported that dyslipidemia is related to coronavirus-related diseases. Critical patients with coronavirus disease 2019 (COVID-19) who suffered from multiple organ dysfunctions were treated in the intensive care unit (ICU) in Wuhan, China. Whether the lipids profile was associated with the prognosis of COVID-19 in critical patients remained unclear. A retrospective study was performed in critical patients (N=48) with coronavirus disease 2019 in Leishenshan hospital between February an","2021","07","16","Front Endocrinol (Lausanne)","Frontiers in endocrinology","coronavirus disease 2019 (COVID-19); critical patients; lipid metabolism; mortality; risk factor; Aged; Aged, 80 and over; Apolipoproteins A; Apolipoproteins B; COVID-19; China; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Critical Illness; Dyslipidemias; Female; Hospital Mortality; Humans; Male; Middle Aged; Multiple Organ Failure; Retrospective Studies; Risk Factors; SARS-CoV-2; Severity of Illness Index","Han","Xiaofeng","Department of Hematology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China",NA
"2298","34248834","10.3389/fendo.2021.611526","Dyslipidemia Is Related to Mortality in Critical Patients With Coronavirus Disease 2019: A Retrospective Study.","It has been reported that dyslipidemia is related to coronavirus-related diseases. Critical patients with coronavirus disease 2019 (COVID-19) who suffered from multiple organ dysfunctions were treated in the intensive care unit (ICU) in Wuhan, China. Whether the lipids profile was associated with the prognosis of COVID-19 in critical patients remained unclear. A retrospective study was performed in critical patients (N=48) with coronavirus disease 2019 in Leishenshan hospital between February an","2021","07","16","Front Endocrinol (Lausanne)","Frontiers in endocrinology","coronavirus disease 2019 (COVID-19); critical patients; lipid metabolism; mortality; risk factor; Aged; Aged, 80 and over; Apolipoproteins A; Apolipoproteins B; COVID-19; China; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Critical Illness; Dyslipidemias; Female; Hospital Mortality; Humans; Male; Middle Aged; Multiple Organ Failure; Retrospective Studies; Risk Factors; SARS-CoV-2; Severity of Illness Index","Mao","Qing","Department of Neurosurgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China",NA
"2299","34248834","10.3389/fendo.2021.611526","Dyslipidemia Is Related to Mortality in Critical Patients With Coronavirus Disease 2019: A Retrospective Study.","It has been reported that dyslipidemia is related to coronavirus-related diseases. Critical patients with coronavirus disease 2019 (COVID-19) who suffered from multiple organ dysfunctions were treated in the intensive care unit (ICU) in Wuhan, China. Whether the lipids profile was associated with the prognosis of COVID-19 in critical patients remained unclear. A retrospective study was performed in critical patients (N=48) with coronavirus disease 2019 in Leishenshan hospital between February an","2021","07","16","Front Endocrinol (Lausanne)","Frontiers in endocrinology","coronavirus disease 2019 (COVID-19); critical patients; lipid metabolism; mortality; risk factor; Aged; Aged, 80 and over; Apolipoproteins A; Apolipoproteins B; COVID-19; China; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Critical Illness; Dyslipidemias; Female; Hospital Mortality; Humans; Male; Middle Aged; Multiple Organ Failure; Retrospective Studies; Risk Factors; SARS-CoV-2; Severity of Illness Index","Li","Shengxian","Department of Endocrinology and Metabolism, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China",NA
"2300","34248834","10.3389/fendo.2021.611526","Dyslipidemia Is Related to Mortality in Critical Patients With Coronavirus Disease 2019: A Retrospective Study.","It has been reported that dyslipidemia is related to coronavirus-related diseases. Critical patients with coronavirus disease 2019 (COVID-19) who suffered from multiple organ dysfunctions were treated in the intensive care unit (ICU) in Wuhan, China. Whether the lipids profile was associated with the prognosis of COVID-19 in critical patients remained unclear. A retrospective study was performed in critical patients (N=48) with coronavirus disease 2019 in Leishenshan hospital between February an","2021","07","16","Front Endocrinol (Lausanne)","Frontiers in endocrinology","coronavirus disease 2019 (COVID-19); critical patients; lipid metabolism; mortality; risk factor; Aged; Aged, 80 and over; Apolipoproteins A; Apolipoproteins B; COVID-19; China; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Critical Illness; Dyslipidemias; Female; Hospital Mortality; Humans; Male; Middle Aged; Multiple Organ Failure; Retrospective Studies; Risk Factors; SARS-CoV-2; Severity of Illness Index","Tam","Lai-Shan","Department of Medicine and Therapeutics, The Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, Hong Kong",NA
"2301","34248834","10.3389/fendo.2021.611526","Dyslipidemia Is Related to Mortality in Critical Patients With Coronavirus Disease 2019: A Retrospective Study.","It has been reported that dyslipidemia is related to coronavirus-related diseases. Critical patients with coronavirus disease 2019 (COVID-19) who suffered from multiple organ dysfunctions were treated in the intensive care unit (ICU) in Wuhan, China. Whether the lipids profile was associated with the prognosis of COVID-19 in critical patients remained unclear. A retrospective study was performed in critical patients (N=48) with coronavirus disease 2019 in Leishenshan hospital between February an","2021","07","16","Front Endocrinol (Lausanne)","Frontiers in endocrinology","coronavirus disease 2019 (COVID-19); critical patients; lipid metabolism; mortality; risk factor; Aged; Aged, 80 and over; Apolipoproteins A; Apolipoproteins B; COVID-19; China; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Critical Illness; Dyslipidemias; Female; Hospital Mortality; Humans; Male; Middle Aged; Multiple Organ Failure; Retrospective Studies; Risk Factors; SARS-CoV-2; Severity of Illness Index","Ma","Jing","Department of Endocrinology and Metabolism, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China",NA
"2302","34248834","10.3389/fendo.2021.611526","Dyslipidemia Is Related to Mortality in Critical Patients With Coronavirus Disease 2019: A Retrospective Study.","It has been reported that dyslipidemia is related to coronavirus-related diseases. Critical patients with coronavirus disease 2019 (COVID-19) who suffered from multiple organ dysfunctions were treated in the intensive care unit (ICU) in Wuhan, China. Whether the lipids profile was associated with the prognosis of COVID-19 in critical patients remained unclear. A retrospective study was performed in critical patients (N=48) with coronavirus disease 2019 in Leishenshan hospital between February an","2021","07","16","Front Endocrinol (Lausanne)","Frontiers in endocrinology","coronavirus disease 2019 (COVID-19); critical patients; lipid metabolism; mortality; risk factor; Aged; Aged, 80 and over; Apolipoproteins A; Apolipoproteins B; COVID-19; China; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Critical Illness; Dyslipidemias; Female; Hospital Mortality; Humans; Male; Middle Aged; Multiple Organ Failure; Retrospective Studies; Risk Factors; SARS-CoV-2; Severity of Illness Index","Liu","Wei","Department of Endocrinology and Metabolism, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China",NA
"2303","34248793","10.3389/fpsyg.2021.687400","Uses of Digital Mediation in the School-Families Relationship During the COVID-19 Pandemic.","The COVID-19 pandemic has sharpened the inequalities in our societies. In Spain, we observed that the impact on schooling varied according to socioeconomic, gender and sociocultural variables. In this article, we present a case analysis illustrating the impact of the COVID-19 pandemic on schooling in early educational grades (ages 3-6), which leads us to focus on school-family relationship. First, we present some studies that show the inequalities in education during the lockdown period, the dig","2021","07","13","Front Psychol","Frontiers in psychology","digital interaction; funds of knowledge; mobile app uses; school-families interaction; schools on pandemics","León-Nabal","Blanca","Department of General, Developmental and Educational Psychology, Autonomous University of Barcelona, Bellaterra, Spain",NA
"2304","34248793","10.3389/fpsyg.2021.687400","Uses of Digital Mediation in the School-Families Relationship During the COVID-19 Pandemic.","The COVID-19 pandemic has sharpened the inequalities in our societies. In Spain, we observed that the impact on schooling varied according to socioeconomic, gender and sociocultural variables. In this article, we present a case analysis illustrating the impact of the COVID-19 pandemic on schooling in early educational grades (ages 3-6), which leads us to focus on school-family relationship. First, we present some studies that show the inequalities in education during the lockdown period, the dig","2021","07","13","Front Psychol","Frontiers in psychology","digital interaction; funds of knowledge; mobile app uses; school-families interaction; schools on pandemics","Zhang-Yu","Cristina","Department of Psychology, Institute of Educational Research, University of Girona, Girona, Spain",NA
"2305","34248793","10.3389/fpsyg.2021.687400","Uses of Digital Mediation in the School-Families Relationship During the COVID-19 Pandemic.","The COVID-19 pandemic has sharpened the inequalities in our societies. In Spain, we observed that the impact on schooling varied according to socioeconomic, gender and sociocultural variables. In this article, we present a case analysis illustrating the impact of the COVID-19 pandemic on schooling in early educational grades (ages 3-6), which leads us to focus on school-family relationship. First, we present some studies that show the inequalities in education during the lockdown period, the dig","2021","07","13","Front Psychol","Frontiers in psychology","digital interaction; funds of knowledge; mobile app uses; school-families interaction; schools on pandemics","Lalueza","José Luis","Department of General, Developmental and Educational Psychology, Autonomous University of Barcelona, Bellaterra, Spain",NA
"2306","34248789","10.3389/fpsyg.2021.685275","Teleworking in Times of COVID-19: Effects on the Acquisition of Personal Resources.","The COVID-19 pandemic has forced many employees to introduce different degrees of teleworking, leading to a transformation of the psychosocial work environment. In this study, we analyzed whether the relationship between a labor resource, social support, and a personal resource, vigor at work, is affected by the work modality (face-to-face, hybrid that includes face-to-face work and telework time, and telework caused by the current pandemic situation). Five hundred and forty-three employees answ","2021","07","13","Front Psychol","Frontiers in psychology","COVID-19; labor resources; social support; telework; vigor; well-being at work","Pulido-Martos","Manuel","Departamento de Psicología, Psicología Social, Universidad de Jaén, Jaén, Spain",NA
"2307","34248789","10.3389/fpsyg.2021.685275","Teleworking in Times of COVID-19: Effects on the Acquisition of Personal Resources.","The COVID-19 pandemic has forced many employees to introduce different degrees of teleworking, leading to a transformation of the psychosocial work environment. In this study, we analyzed whether the relationship between a labor resource, social support, and a personal resource, vigor at work, is affected by the work modality (face-to-face, hybrid that includes face-to-face work and telework time, and telework caused by the current pandemic situation). Five hundred and forty-three employees answ","2021","07","13","Front Psychol","Frontiers in psychology","COVID-19; labor resources; social support; telework; vigor; well-being at work","Cortés-Denia","Daniel","Departamento de Psicología, Psicología Social, Universidad de Jaén, Jaén, Spain",NA
"2308","34248789","10.3389/fpsyg.2021.685275","Teleworking in Times of COVID-19: Effects on the Acquisition of Personal Resources.","The COVID-19 pandemic has forced many employees to introduce different degrees of teleworking, leading to a transformation of the psychosocial work environment. In this study, we analyzed whether the relationship between a labor resource, social support, and a personal resource, vigor at work, is affected by the work modality (face-to-face, hybrid that includes face-to-face work and telework time, and telework caused by the current pandemic situation). Five hundred and forty-three employees answ","2021","07","13","Front Psychol","Frontiers in psychology","COVID-19; labor resources; social support; telework; vigor; well-being at work","Lopez-Zafra","Esther","Departamento de Psicología, Psicología Social, Universidad de Jaén, Jaén, Spain",NA
"2309","34248788","10.3389/fpsyg.2021.684354","The Impact of General Self-Efficacy on Psychological Resilience During the COVID-19 Pandemic: The Mediating Role of Posttraumatic Growth and the Moderating Role of Deliberate Rumination.","Purpose: This study used a moderated mediation model to explore the relationship between general self-efficacy (GSE) and psychological resilience (PR) and the associated mechanisms, the mediating role of posttraumatic growth (PTG), and the moderating role of deliberate rumination (DR) during the coronavirus disease 2019 (COVID-19) pandemic. Knowledge of the relationship between these four variables examined further understanding of the PR improvement mechanism of college students and even","2021","07","13","Front Psychol","Frontiers in psychology","COVID-19; deliberate rumination; general self-efficacy; moderated mediation; post-traumatic growth; psychological resilience","Zeng","Wei","School of Geography, South China Normal University, Guangzhou, China",NA
"2310","34248788","10.3389/fpsyg.2021.684354","The Impact of General Self-Efficacy on Psychological Resilience During the COVID-19 Pandemic: The Mediating Role of Posttraumatic Growth and the Moderating Role of Deliberate Rumination.","Purpose: This study used a moderated mediation model to explore the relationship between general self-efficacy (GSE) and psychological resilience (PR) and the associated mechanisms, the mediating role of posttraumatic growth (PTG), and the moderating role of deliberate rumination (DR) during the coronavirus disease 2019 (COVID-19) pandemic. Knowledge of the relationship between these four variables examined further understanding of the PR improvement mechanism of college students and even","2021","07","13","Front Psychol","Frontiers in psychology","COVID-19; deliberate rumination; general self-efficacy; moderated mediation; post-traumatic growth; psychological resilience","Wu","Xingrou","School of Geography, South China Normal University, Guangzhou, China",NA
"2311","34248788","10.3389/fpsyg.2021.684354","The Impact of General Self-Efficacy on Psychological Resilience During the COVID-19 Pandemic: The Mediating Role of Posttraumatic Growth and the Moderating Role of Deliberate Rumination.","Purpose: This study used a moderated mediation model to explore the relationship between general self-efficacy (GSE) and psychological resilience (PR) and the associated mechanisms, the mediating role of posttraumatic growth (PTG), and the moderating role of deliberate rumination (DR) during the coronavirus disease 2019 (COVID-19) pandemic. Knowledge of the relationship between these four variables examined further understanding of the PR improvement mechanism of college students and even","2021","07","13","Front Psychol","Frontiers in psychology","COVID-19; deliberate rumination; general self-efficacy; moderated mediation; post-traumatic growth; psychological resilience","Xu","Yanhua","College of Resource Environment and Tourism, Capital Normal University, Beijing, China",NA
"2312","34248788","10.3389/fpsyg.2021.684354","The Impact of General Self-Efficacy on Psychological Resilience During the COVID-19 Pandemic: The Mediating Role of Posttraumatic Growth and the Moderating Role of Deliberate Rumination.","Purpose: This study used a moderated mediation model to explore the relationship between general self-efficacy (GSE) and psychological resilience (PR) and the associated mechanisms, the mediating role of posttraumatic growth (PTG), and the moderating role of deliberate rumination (DR) during the coronavirus disease 2019 (COVID-19) pandemic. Knowledge of the relationship between these four variables examined further understanding of the PR improvement mechanism of college students and even","2021","07","13","Front Psychol","Frontiers in psychology","COVID-19; deliberate rumination; general self-efficacy; moderated mediation; post-traumatic growth; psychological resilience","Wu","Jiamin","School of Geography, South China Normal University, Guangzhou, China",NA
"2313","34248788","10.3389/fpsyg.2021.684354","The Impact of General Self-Efficacy on Psychological Resilience During the COVID-19 Pandemic: The Mediating Role of Posttraumatic Growth and the Moderating Role of Deliberate Rumination.","Purpose: This study used a moderated mediation model to explore the relationship between general self-efficacy (GSE) and psychological resilience (PR) and the associated mechanisms, the mediating role of posttraumatic growth (PTG), and the moderating role of deliberate rumination (DR) during the coronavirus disease 2019 (COVID-19) pandemic. Knowledge of the relationship between these four variables examined further understanding of the PR improvement mechanism of college students and even","2021","07","13","Front Psychol","Frontiers in psychology","COVID-19; deliberate rumination; general self-efficacy; moderated mediation; post-traumatic growth; psychological resilience","Zeng","Yuqing","School of Geography, South China Normal University, Guangzhou, China",NA
"2314","34248788","10.3389/fpsyg.2021.684354","The Impact of General Self-Efficacy on Psychological Resilience During the COVID-19 Pandemic: The Mediating Role of Posttraumatic Growth and the Moderating Role of Deliberate Rumination.","Purpose: This study used a moderated mediation model to explore the relationship between general self-efficacy (GSE) and psychological resilience (PR) and the associated mechanisms, the mediating role of posttraumatic growth (PTG), and the moderating role of deliberate rumination (DR) during the coronavirus disease 2019 (COVID-19) pandemic. Knowledge of the relationship between these four variables examined further understanding of the PR improvement mechanism of college students and even","2021","07","13","Front Psychol","Frontiers in psychology","COVID-19; deliberate rumination; general self-efficacy; moderated mediation; post-traumatic growth; psychological resilience","Shao","Jinlian","School of Geography, South China Normal University, Guangzhou, China",NA
"2315","34248788","10.3389/fpsyg.2021.684354","The Impact of General Self-Efficacy on Psychological Resilience During the COVID-19 Pandemic: The Mediating Role of Posttraumatic Growth and the Moderating Role of Deliberate Rumination.","Purpose: This study used a moderated mediation model to explore the relationship between general self-efficacy (GSE) and psychological resilience (PR) and the associated mechanisms, the mediating role of posttraumatic growth (PTG), and the moderating role of deliberate rumination (DR) during the coronavirus disease 2019 (COVID-19) pandemic. Knowledge of the relationship between these four variables examined further understanding of the PR improvement mechanism of college students and even","2021","07","13","Front Psychol","Frontiers in psychology","COVID-19; deliberate rumination; general self-efficacy; moderated mediation; post-traumatic growth; psychological resilience","Huang","Dongtao","School of Geography, South China Normal University, Guangzhou, China",NA
"2316","34248788","10.3389/fpsyg.2021.684354","The Impact of General Self-Efficacy on Psychological Resilience During the COVID-19 Pandemic: The Mediating Role of Posttraumatic Growth and the Moderating Role of Deliberate Rumination.","Purpose: This study used a moderated mediation model to explore the relationship between general self-efficacy (GSE) and psychological resilience (PR) and the associated mechanisms, the mediating role of posttraumatic growth (PTG), and the moderating role of deliberate rumination (DR) during the coronavirus disease 2019 (COVID-19) pandemic. Knowledge of the relationship between these four variables examined further understanding of the PR improvement mechanism of college students and even","2021","07","13","Front Psychol","Frontiers in psychology","COVID-19; deliberate rumination; general self-efficacy; moderated mediation; post-traumatic growth; psychological resilience","Zhu","Ziqi","Office of International Cooperation and Exchange, Dongguan University of Technology, Dongguan, China",NA
"2317","34248787","10.3389/fpsyg.2021.684083","A Crowd-Sourced Database of Coronamusic: Documenting Online Making and Sharing of Music During the COVID-19 Pandemic.",NA,"2021","07","13","Front Psychol","Frontiers in psychology","COVID-19; YouTube; corpus; crowdsourcing; emotion; music; social media; video","Hansen","Niels Chr","Aarhus Institute of Advanced Studies, Aarhus University, Aarhus, Denmark",NA
"2318","34248787","10.3389/fpsyg.2021.684083","A Crowd-Sourced Database of Coronamusic: Documenting Online Making and Sharing of Music During the COVID-19 Pandemic.",NA,"2021","07","13","Front Psychol","Frontiers in psychology","COVID-19; YouTube; corpus; crowdsourcing; emotion; music; social media; video","Treider","John Melvin G","Department of Musicology &amp",NA
"2319","34248787","10.3389/fpsyg.2021.684083","A Crowd-Sourced Database of Coronamusic: Documenting Online Making and Sharing of Music During the COVID-19 Pandemic.",NA,"2021","07","13","Front Psychol","Frontiers in psychology","COVID-19; YouTube; corpus; crowdsourcing; emotion; music; social media; video","Swarbrick","Dana","Department of Musicology &amp",NA
"2320","34248787","10.3389/fpsyg.2021.684083","A Crowd-Sourced Database of Coronamusic: Documenting Online Making and Sharing of Music During the COVID-19 Pandemic.",NA,"2021","07","13","Front Psychol","Frontiers in psychology","COVID-19; YouTube; corpus; crowdsourcing; emotion; music; social media; video","Bamford","Joshua S","Social Body Lab, Institute of Cognitive and Evolutionary Anthropology, School of Anthropology &amp",NA
"2321","34248787","10.3389/fpsyg.2021.684083","A Crowd-Sourced Database of Coronamusic: Documenting Online Making and Sharing of Music During the COVID-19 Pandemic.",NA,"2021","07","13","Front Psychol","Frontiers in psychology","COVID-19; YouTube; corpus; crowdsourcing; emotion; music; social media; video","Wilson","Johanna","Department of Music, Arts and Culture Studies, Centre for Interdisciplinary Music Research, University of Jyväskylä, Jyväskylä, Finland",NA
"2322","34248787","10.3389/fpsyg.2021.684083","A Crowd-Sourced Database of Coronamusic: Documenting Online Making and Sharing of Music During the COVID-19 Pandemic.",NA,"2021","07","13","Front Psychol","Frontiers in psychology","COVID-19; YouTube; corpus; crowdsourcing; emotion; music; social media; video","Vuoskoski","Jonna Katariina","Department of Musicology &amp",NA
"2323","34248786","10.3389/fpsyg.2021.683987","Protect ya Grandma! The Effects of Students' Epistemic Beliefs and Prosocial Values on COVID-19 Vaccination Intentions.","The present study investigates epistemic beliefs (beliefs about the nature of knowledge and knowing) and prosocial values as predictors of COVID-19 vaccination intentions. As a first hypothesis, we posit that beliefs in justification by authority will positively relate to vaccination intentions. Second, we expect a positive relationship between prosocial values and vaccination intentions. Third, we hypothesize that beliefs in justification by authority moderate the relationship between prosocial","2021","07","13","Front Psychol","Frontiers in psychology","COVID-19; epistemic beliefs; justification by authority; prosocial values; vaccination intentions","Rosman","Tom","Leibniz Institute for Psychology (ZPID), Research Literacy Unit, Trier, Germany",NA
"2324","34248786","10.3389/fpsyg.2021.683987","Protect ya Grandma! The Effects of Students' Epistemic Beliefs and Prosocial Values on COVID-19 Vaccination Intentions.","The present study investigates epistemic beliefs (beliefs about the nature of knowledge and knowing) and prosocial values as predictors of COVID-19 vaccination intentions. As a first hypothesis, we posit that beliefs in justification by authority will positively relate to vaccination intentions. Second, we expect a positive relationship between prosocial values and vaccination intentions. Third, we hypothesize that beliefs in justification by authority moderate the relationship between prosocial","2021","07","13","Front Psychol","Frontiers in psychology","COVID-19; epistemic beliefs; justification by authority; prosocial values; vaccination intentions","Adler","Kathrin","University of Trier, Psychology Department, Trier, Germany",NA
"2325","34248786","10.3389/fpsyg.2021.683987","Protect ya Grandma! The Effects of Students' Epistemic Beliefs and Prosocial Values on COVID-19 Vaccination Intentions.","The present study investigates epistemic beliefs (beliefs about the nature of knowledge and knowing) and prosocial values as predictors of COVID-19 vaccination intentions. As a first hypothesis, we posit that beliefs in justification by authority will positively relate to vaccination intentions. Second, we expect a positive relationship between prosocial values and vaccination intentions. Third, we hypothesize that beliefs in justification by authority moderate the relationship between prosocial","2021","07","13","Front Psychol","Frontiers in psychology","COVID-19; epistemic beliefs; justification by authority; prosocial values; vaccination intentions","Barbian","Luisa","University of Trier, Psychology Department, Trier, Germany",NA
"2326","34248786","10.3389/fpsyg.2021.683987","Protect ya Grandma! The Effects of Students' Epistemic Beliefs and Prosocial Values on COVID-19 Vaccination Intentions.","The present study investigates epistemic beliefs (beliefs about the nature of knowledge and knowing) and prosocial values as predictors of COVID-19 vaccination intentions. As a first hypothesis, we posit that beliefs in justification by authority will positively relate to vaccination intentions. Second, we expect a positive relationship between prosocial values and vaccination intentions. Third, we hypothesize that beliefs in justification by authority moderate the relationship between prosocial","2021","07","13","Front Psychol","Frontiers in psychology","COVID-19; epistemic beliefs; justification by authority; prosocial values; vaccination intentions","Blume","Vanessa","University of Trier, Psychology Department, Trier, Germany",NA
"2327","34248786","10.3389/fpsyg.2021.683987","Protect ya Grandma! The Effects of Students' Epistemic Beliefs and Prosocial Values on COVID-19 Vaccination Intentions.","The present study investigates epistemic beliefs (beliefs about the nature of knowledge and knowing) and prosocial values as predictors of COVID-19 vaccination intentions. As a first hypothesis, we posit that beliefs in justification by authority will positively relate to vaccination intentions. Second, we expect a positive relationship between prosocial values and vaccination intentions. Third, we hypothesize that beliefs in justification by authority moderate the relationship between prosocial","2021","07","13","Front Psychol","Frontiers in psychology","COVID-19; epistemic beliefs; justification by authority; prosocial values; vaccination intentions","Burczeck","Benno","University of Trier, Psychology Department, Trier, Germany",NA
"2328","34248786","10.3389/fpsyg.2021.683987","Protect ya Grandma! The Effects of Students' Epistemic Beliefs and Prosocial Values on COVID-19 Vaccination Intentions.","The present study investigates epistemic beliefs (beliefs about the nature of knowledge and knowing) and prosocial values as predictors of COVID-19 vaccination intentions. As a first hypothesis, we posit that beliefs in justification by authority will positively relate to vaccination intentions. Second, we expect a positive relationship between prosocial values and vaccination intentions. Third, we hypothesize that beliefs in justification by authority moderate the relationship between prosocial","2021","07","13","Front Psychol","Frontiers in psychology","COVID-19; epistemic beliefs; justification by authority; prosocial values; vaccination intentions","Cordes","Vivien","University of Trier, Psychology Department, Trier, Germany",NA
"2329","34248786","10.3389/fpsyg.2021.683987","Protect ya Grandma! The Effects of Students' Epistemic Beliefs and Prosocial Values on COVID-19 Vaccination Intentions.","The present study investigates epistemic beliefs (beliefs about the nature of knowledge and knowing) and prosocial values as predictors of COVID-19 vaccination intentions. As a first hypothesis, we posit that beliefs in justification by authority will positively relate to vaccination intentions. Second, we expect a positive relationship between prosocial values and vaccination intentions. Third, we hypothesize that beliefs in justification by authority moderate the relationship between prosocial","2021","07","13","Front Psychol","Frontiers in psychology","COVID-19; epistemic beliefs; justification by authority; prosocial values; vaccination intentions","Derman","Dilara","University of Trier, Psychology Department, Trier, Germany",NA
"2330","34248786","10.3389/fpsyg.2021.683987","Protect ya Grandma! The Effects of Students' Epistemic Beliefs and Prosocial Values on COVID-19 Vaccination Intentions.","The present study investigates epistemic beliefs (beliefs about the nature of knowledge and knowing) and prosocial values as predictors of COVID-19 vaccination intentions. As a first hypothesis, we posit that beliefs in justification by authority will positively relate to vaccination intentions. Second, we expect a positive relationship between prosocial values and vaccination intentions. Third, we hypothesize that beliefs in justification by authority moderate the relationship between prosocial","2021","07","13","Front Psychol","Frontiers in psychology","COVID-19; epistemic beliefs; justification by authority; prosocial values; vaccination intentions","Dertli","Susanne","University of Trier, Psychology Department, Trier, Germany",NA
"2331","34248786","10.3389/fpsyg.2021.683987","Protect ya Grandma! The Effects of Students' Epistemic Beliefs and Prosocial Values on COVID-19 Vaccination Intentions.","The present study investigates epistemic beliefs (beliefs about the nature of knowledge and knowing) and prosocial values as predictors of COVID-19 vaccination intentions. As a first hypothesis, we posit that beliefs in justification by authority will positively relate to vaccination intentions. Second, we expect a positive relationship between prosocial values and vaccination intentions. Third, we hypothesize that beliefs in justification by authority moderate the relationship between prosocial","2021","07","13","Front Psychol","Frontiers in psychology","COVID-19; epistemic beliefs; justification by authority; prosocial values; vaccination intentions","Glas","Hannah","University of Trier, Psychology Department, Trier, Germany",NA
"2332","34248786","10.3389/fpsyg.2021.683987","Protect ya Grandma! The Effects of Students' Epistemic Beliefs and Prosocial Values on COVID-19 Vaccination Intentions.","The present study investigates epistemic beliefs (beliefs about the nature of knowledge and knowing) and prosocial values as predictors of COVID-19 vaccination intentions. As a first hypothesis, we posit that beliefs in justification by authority will positively relate to vaccination intentions. Second, we expect a positive relationship between prosocial values and vaccination intentions. Third, we hypothesize that beliefs in justification by authority moderate the relationship between prosocial","2021","07","13","Front Psychol","Frontiers in psychology","COVID-19; epistemic beliefs; justification by authority; prosocial values; vaccination intentions","Heinen","Virginia","University of Trier, Psychology Department, Trier, Germany",NA
"2333","34248786","10.3389/fpsyg.2021.683987","Protect ya Grandma! The Effects of Students' Epistemic Beliefs and Prosocial Values on COVID-19 Vaccination Intentions.","The present study investigates epistemic beliefs (beliefs about the nature of knowledge and knowing) and prosocial values as predictors of COVID-19 vaccination intentions. As a first hypothesis, we posit that beliefs in justification by authority will positively relate to vaccination intentions. Second, we expect a positive relationship between prosocial values and vaccination intentions. Third, we hypothesize that beliefs in justification by authority moderate the relationship between prosocial","2021","07","13","Front Psychol","Frontiers in psychology","COVID-19; epistemic beliefs; justification by authority; prosocial values; vaccination intentions","Kenst","Stefan","University of Trier, Psychology Department, Trier, Germany",NA
"2334","34248786","10.3389/fpsyg.2021.683987","Protect ya Grandma! The Effects of Students' Epistemic Beliefs and Prosocial Values on COVID-19 Vaccination Intentions.","The present study investigates epistemic beliefs (beliefs about the nature of knowledge and knowing) and prosocial values as predictors of COVID-19 vaccination intentions. As a first hypothesis, we posit that beliefs in justification by authority will positively relate to vaccination intentions. Second, we expect a positive relationship between prosocial values and vaccination intentions. Third, we hypothesize that beliefs in justification by authority moderate the relationship between prosocial","2021","07","13","Front Psychol","Frontiers in psychology","COVID-19; epistemic beliefs; justification by authority; prosocial values; vaccination intentions","Khosroschahli","Marie","University of Trier, Psychology Department, Trier, Germany",NA
"2335","34248786","10.3389/fpsyg.2021.683987","Protect ya Grandma! The Effects of Students' Epistemic Beliefs and Prosocial Values on COVID-19 Vaccination Intentions.","The present study investigates epistemic beliefs (beliefs about the nature of knowledge and knowing) and prosocial values as predictors of COVID-19 vaccination intentions. As a first hypothesis, we posit that beliefs in justification by authority will positively relate to vaccination intentions. Second, we expect a positive relationship between prosocial values and vaccination intentions. Third, we hypothesize that beliefs in justification by authority moderate the relationship between prosocial","2021","07","13","Front Psychol","Frontiers in psychology","COVID-19; epistemic beliefs; justification by authority; prosocial values; vaccination intentions","Kittel","Laura","University of Trier, Psychology Department, Trier, Germany",NA
"2336","34248786","10.3389/fpsyg.2021.683987","Protect ya Grandma! The Effects of Students' Epistemic Beliefs and Prosocial Values on COVID-19 Vaccination Intentions.","The present study investigates epistemic beliefs (beliefs about the nature of knowledge and knowing) and prosocial values as predictors of COVID-19 vaccination intentions. As a first hypothesis, we posit that beliefs in justification by authority will positively relate to vaccination intentions. Second, we expect a positive relationship between prosocial values and vaccination intentions. Third, we hypothesize that beliefs in justification by authority moderate the relationship between prosocial","2021","07","13","Front Psychol","Frontiers in psychology","COVID-19; epistemic beliefs; justification by authority; prosocial values; vaccination intentions","Kraus","Corinna","University of Trier, Psychology Department, Trier, Germany",NA
"2337","34248786","10.3389/fpsyg.2021.683987","Protect ya Grandma! The Effects of Students' Epistemic Beliefs and Prosocial Values on COVID-19 Vaccination Intentions.","The present study investigates epistemic beliefs (beliefs about the nature of knowledge and knowing) and prosocial values as predictors of COVID-19 vaccination intentions. As a first hypothesis, we posit that beliefs in justification by authority will positively relate to vaccination intentions. Second, we expect a positive relationship between prosocial values and vaccination intentions. Third, we hypothesize that beliefs in justification by authority moderate the relationship between prosocial","2021","07","13","Front Psychol","Frontiers in psychology","COVID-19; epistemic beliefs; justification by authority; prosocial values; vaccination intentions","Linden","Alica","University of Trier, Psychology Department, Trier, Germany",NA
"2338","34248786","10.3389/fpsyg.2021.683987","Protect ya Grandma! The Effects of Students' Epistemic Beliefs and Prosocial Values on COVID-19 Vaccination Intentions.","The present study investigates epistemic beliefs (beliefs about the nature of knowledge and knowing) and prosocial values as predictors of COVID-19 vaccination intentions. As a first hypothesis, we posit that beliefs in justification by authority will positively relate to vaccination intentions. Second, we expect a positive relationship between prosocial values and vaccination intentions. Third, we hypothesize that beliefs in justification by authority moderate the relationship between prosocial","2021","07","13","Front Psychol","Frontiers in psychology","COVID-19; epistemic beliefs; justification by authority; prosocial values; vaccination intentions","Mironova","Anastasia","University of Trier, Psychology Department, Trier, Germany",NA
"2339","34248786","10.3389/fpsyg.2021.683987","Protect ya Grandma! The Effects of Students' Epistemic Beliefs and Prosocial Values on COVID-19 Vaccination Intentions.","The present study investigates epistemic beliefs (beliefs about the nature of knowledge and knowing) and prosocial values as predictors of COVID-19 vaccination intentions. As a first hypothesis, we posit that beliefs in justification by authority will positively relate to vaccination intentions. Second, we expect a positive relationship between prosocial values and vaccination intentions. Third, we hypothesize that beliefs in justification by authority moderate the relationship between prosocial","2021","07","13","Front Psychol","Frontiers in psychology","COVID-19; epistemic beliefs; justification by authority; prosocial values; vaccination intentions","Olinger","Lena","University of Trier, Psychology Department, Trier, Germany",NA
"2340","34248786","10.3389/fpsyg.2021.683987","Protect ya Grandma! The Effects of Students' Epistemic Beliefs and Prosocial Values on COVID-19 Vaccination Intentions.","The present study investigates epistemic beliefs (beliefs about the nature of knowledge and knowing) and prosocial values as predictors of COVID-19 vaccination intentions. As a first hypothesis, we posit that beliefs in justification by authority will positively relate to vaccination intentions. Second, we expect a positive relationship between prosocial values and vaccination intentions. Third, we hypothesize that beliefs in justification by authority moderate the relationship between prosocial","2021","07","13","Front Psychol","Frontiers in psychology","COVID-19; epistemic beliefs; justification by authority; prosocial values; vaccination intentions","Rastelica","Fatbardh","University of Trier, Psychology Department, Trier, Germany",NA
"2341","34248786","10.3389/fpsyg.2021.683987","Protect ya Grandma! The Effects of Students' Epistemic Beliefs and Prosocial Values on COVID-19 Vaccination Intentions.","The present study investigates epistemic beliefs (beliefs about the nature of knowledge and knowing) and prosocial values as predictors of COVID-19 vaccination intentions. As a first hypothesis, we posit that beliefs in justification by authority will positively relate to vaccination intentions. Second, we expect a positive relationship between prosocial values and vaccination intentions. Third, we hypothesize that beliefs in justification by authority moderate the relationship between prosocial","2021","07","13","Front Psychol","Frontiers in psychology","COVID-19; epistemic beliefs; justification by authority; prosocial values; vaccination intentions","Sauter","Theresia","University of Trier, Psychology Department, Trier, Germany",NA
"2342","34248786","10.3389/fpsyg.2021.683987","Protect ya Grandma! The Effects of Students' Epistemic Beliefs and Prosocial Values on COVID-19 Vaccination Intentions.","The present study investigates epistemic beliefs (beliefs about the nature of knowledge and knowing) and prosocial values as predictors of COVID-19 vaccination intentions. As a first hypothesis, we posit that beliefs in justification by authority will positively relate to vaccination intentions. Second, we expect a positive relationship between prosocial values and vaccination intentions. Third, we hypothesize that beliefs in justification by authority moderate the relationship between prosocial","2021","07","13","Front Psychol","Frontiers in psychology","COVID-19; epistemic beliefs; justification by authority; prosocial values; vaccination intentions","Schnurr","Vera","University of Trier, Psychology Department, Trier, Germany",NA
"2343","34248786","10.3389/fpsyg.2021.683987","Protect ya Grandma! The Effects of Students' Epistemic Beliefs and Prosocial Values on COVID-19 Vaccination Intentions.","The present study investigates epistemic beliefs (beliefs about the nature of knowledge and knowing) and prosocial values as predictors of COVID-19 vaccination intentions. As a first hypothesis, we posit that beliefs in justification by authority will positively relate to vaccination intentions. Second, we expect a positive relationship between prosocial values and vaccination intentions. Third, we hypothesize that beliefs in justification by authority moderate the relationship between prosocial","2021","07","13","Front Psychol","Frontiers in psychology","COVID-19; epistemic beliefs; justification by authority; prosocial values; vaccination intentions","Schwab","Elisabeth","University of Trier, Psychology Department, Trier, Germany",NA
"2344","34248786","10.3389/fpsyg.2021.683987","Protect ya Grandma! The Effects of Students' Epistemic Beliefs and Prosocial Values on COVID-19 Vaccination Intentions.","The present study investigates epistemic beliefs (beliefs about the nature of knowledge and knowing) and prosocial values as predictors of COVID-19 vaccination intentions. As a first hypothesis, we posit that beliefs in justification by authority will positively relate to vaccination intentions. Second, we expect a positive relationship between prosocial values and vaccination intentions. Third, we hypothesize that beliefs in justification by authority moderate the relationship between prosocial","2021","07","13","Front Psychol","Frontiers in psychology","COVID-19; epistemic beliefs; justification by authority; prosocial values; vaccination intentions","Vieyra","Yves","University of Trier, Psychology Department, Trier, Germany",NA
"2345","34248786","10.3389/fpsyg.2021.683987","Protect ya Grandma! The Effects of Students' Epistemic Beliefs and Prosocial Values on COVID-19 Vaccination Intentions.","The present study investigates epistemic beliefs (beliefs about the nature of knowledge and knowing) and prosocial values as predictors of COVID-19 vaccination intentions. As a first hypothesis, we posit that beliefs in justification by authority will positively relate to vaccination intentions. Second, we expect a positive relationship between prosocial values and vaccination intentions. Third, we hypothesize that beliefs in justification by authority moderate the relationship between prosocial","2021","07","13","Front Psychol","Frontiers in psychology","COVID-19; epistemic beliefs; justification by authority; prosocial values; vaccination intentions","Zidak","Andreas","University of Trier, Psychology Department, Trier, Germany",NA
"2346","34248786","10.3389/fpsyg.2021.683987","Protect ya Grandma! The Effects of Students' Epistemic Beliefs and Prosocial Values on COVID-19 Vaccination Intentions.","The present study investigates epistemic beliefs (beliefs about the nature of knowledge and knowing) and prosocial values as predictors of COVID-19 vaccination intentions. As a first hypothesis, we posit that beliefs in justification by authority will positively relate to vaccination intentions. Second, we expect a positive relationship between prosocial values and vaccination intentions. Third, we hypothesize that beliefs in justification by authority moderate the relationship between prosocial","2021","07","13","Front Psychol","Frontiers in psychology","COVID-19; epistemic beliefs; justification by authority; prosocial values; vaccination intentions","Zidarova","Ivana","University of Trier, Psychology Department, Trier, Germany",NA
"2347","34248784","10.3389/fpsyg.2021.682860","Gender Differences in Psychological Impact of the Confinement During the COVID-19 Outbreak in Spain: A Longitudinal Study.","The rapid spread of the coronavirus disease 2019 (COVID-19) has led the authorities to establish compulsory confinement for most of the Spanish population from March to May 2020. Severe isolation combined with the uncertainty and fear associated with the public health crisis can have a psychological impact on the general population. The aim of the current study was to compare possible gender differences in mental health and psychological measures throughout the confinement. One hundred and sixty","2021","07","13","Front Psychol","Frontiers in psychology","COVID-19; coronavirusCOVID-19; gender differences; longitudinal study; psychological impact","Fenollar-Cortés","Javier","Department of Psychology, Universidad Loyola Andalucía, Dos Hermanas, Spain",NA
"2348","34248784","10.3389/fpsyg.2021.682860","Gender Differences in Psychological Impact of the Confinement During the COVID-19 Outbreak in Spain: A Longitudinal Study.","The rapid spread of the coronavirus disease 2019 (COVID-19) has led the authorities to establish compulsory confinement for most of the Spanish population from March to May 2020. Severe isolation combined with the uncertainty and fear associated with the public health crisis can have a psychological impact on the general population. The aim of the current study was to compare possible gender differences in mental health and psychological measures throughout the confinement. One hundred and sixty","2021","07","13","Front Psychol","Frontiers in psychology","COVID-19; coronavirusCOVID-19; gender differences; longitudinal study; psychological impact","Jiménez","Óliver","Department of Personality, Assessment and Psychological Treatment, Universidad de Málaga, Málaga, Spain",NA
"2349","34248784","10.3389/fpsyg.2021.682860","Gender Differences in Psychological Impact of the Confinement During the COVID-19 Outbreak in Spain: A Longitudinal Study.","The rapid spread of the coronavirus disease 2019 (COVID-19) has led the authorities to establish compulsory confinement for most of the Spanish population from March to May 2020. Severe isolation combined with the uncertainty and fear associated with the public health crisis can have a psychological impact on the general population. The aim of the current study was to compare possible gender differences in mental health and psychological measures throughout the confinement. One hundred and sixty","2021","07","13","Front Psychol","Frontiers in psychology","COVID-19; coronavirusCOVID-19; gender differences; longitudinal study; psychological impact","Ruiz-García","Antonio","Department of Psychology, Universidad de Córdoba, Córdoba, Spain",NA
"2350","34248784","10.3389/fpsyg.2021.682860","Gender Differences in Psychological Impact of the Confinement During the COVID-19 Outbreak in Spain: A Longitudinal Study.","The rapid spread of the coronavirus disease 2019 (COVID-19) has led the authorities to establish compulsory confinement for most of the Spanish population from March to May 2020. Severe isolation combined with the uncertainty and fear associated with the public health crisis can have a psychological impact on the general population. The aim of the current study was to compare possible gender differences in mental health and psychological measures throughout the confinement. One hundred and sixty","2021","07","13","Front Psychol","Frontiers in psychology","COVID-19; coronavirusCOVID-19; gender differences; longitudinal study; psychological impact","Resurrección","Davinia M","Department of Psychology, Universidad Loyola Andalucía, Dos Hermanas, Spain",NA
"2351","34248783","10.3389/fpsyg.2021.682824","State Anhedonia in Young Healthy Adults: Psychometric Properties of the German Dimensional Anhedonia Rating Scale (DARS) and Effects of the COVID-19 Pandemic.","Healthy reward processing is a complex interplay of several components. Recent self-report measures of anhedonia, the decrease or loss of hedonic capacity, take this complexity into account. The Dimensional Anhedonia Rating Scale (DARS) measures interest, motivation, effort and consummatory pleasure across four domains: hobbies, food/drink, social activities and sensory experiences. In the present cross-sectional survey study, we validated the German version of the DARS in a sample of 557 young ","2021","07","13","Front Psychol","Frontiers in psychology","COVID-19; anhedonia; confirmatory factor analysis; depression; mental health; pleasure; reliability; validity","Wellan","Sarah A","Research Division of Mind and Brain, Department of Psychiatry and Psychotherapy Campus Charité Mitte, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany",NA
"2352","34248783","10.3389/fpsyg.2021.682824","State Anhedonia in Young Healthy Adults: Psychometric Properties of the German Dimensional Anhedonia Rating Scale (DARS) and Effects of the COVID-19 Pandemic.","Healthy reward processing is a complex interplay of several components. Recent self-report measures of anhedonia, the decrease or loss of hedonic capacity, take this complexity into account. The Dimensional Anhedonia Rating Scale (DARS) measures interest, motivation, effort and consummatory pleasure across four domains: hobbies, food/drink, social activities and sensory experiences. In the present cross-sectional survey study, we validated the German version of the DARS in a sample of 557 young ","2021","07","13","Front Psychol","Frontiers in psychology","COVID-19; anhedonia; confirmatory factor analysis; depression; mental health; pleasure; reliability; validity","Daniels","Anna","Research Division of Mind and Brain, Department of Psychiatry and Psychotherapy Campus Charité Mitte, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany",NA
"2353","34248783","10.3389/fpsyg.2021.682824","State Anhedonia in Young Healthy Adults: Psychometric Properties of the German Dimensional Anhedonia Rating Scale (DARS) and Effects of the COVID-19 Pandemic.","Healthy reward processing is a complex interplay of several components. Recent self-report measures of anhedonia, the decrease or loss of hedonic capacity, take this complexity into account. The Dimensional Anhedonia Rating Scale (DARS) measures interest, motivation, effort and consummatory pleasure across four domains: hobbies, food/drink, social activities and sensory experiences. In the present cross-sectional survey study, we validated the German version of the DARS in a sample of 557 young ","2021","07","13","Front Psychol","Frontiers in psychology","COVID-19; anhedonia; confirmatory factor analysis; depression; mental health; pleasure; reliability; validity","Walter","Henrik","Research Division of Mind and Brain, Department of Psychiatry and Psychotherapy Campus Charité Mitte, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany",NA
"2354","34248774","10.3389/fpsyg.2021.676238","Social and Cognitive Interactions Through an Interactive School Service for RTT Patients at the COVID-19 Time.","Background: The closure of all educational institutions and most rehabilitation centres represents a precautionary measure to face the COVID-19 pandemic, but the isolation and social distancing may be particularly challenging for children with special needs and disabilities (SEND), such as Rett Syndrome (RTT). The main aim of this study was to promote cognitive and social interactions among children with RTT through an interactive school program. Methods: The Interactive School pal","2021","07","13","Front Psychol","Frontiers in psychology","COVID-19; Rett Syndrome; attention; tele-health; telerehabilitation","Dovigo","Lucia","Airett Innovation and Research Center, Verona, Italy",NA
"2355","34248774","10.3389/fpsyg.2021.676238","Social and Cognitive Interactions Through an Interactive School Service for RTT Patients at the COVID-19 Time.","Background: The closure of all educational institutions and most rehabilitation centres represents a precautionary measure to face the COVID-19 pandemic, but the isolation and social distancing may be particularly challenging for children with special needs and disabilities (SEND), such as Rett Syndrome (RTT). The main aim of this study was to promote cognitive and social interactions among children with RTT through an interactive school program. Methods: The Interactive School pal","2021","07","13","Front Psychol","Frontiers in psychology","COVID-19; Rett Syndrome; attention; tele-health; telerehabilitation","Caprì","Tindara","Airett Innovation and Research Center, Verona, Italy",NA
"2356","34248774","10.3389/fpsyg.2021.676238","Social and Cognitive Interactions Through an Interactive School Service for RTT Patients at the COVID-19 Time.","Background: The closure of all educational institutions and most rehabilitation centres represents a precautionary measure to face the COVID-19 pandemic, but the isolation and social distancing may be particularly challenging for children with special needs and disabilities (SEND), such as Rett Syndrome (RTT). The main aim of this study was to promote cognitive and social interactions among children with RTT through an interactive school program. Methods: The Interactive School pal","2021","07","13","Front Psychol","Frontiers in psychology","COVID-19; Rett Syndrome; attention; tele-health; telerehabilitation","Iannizzotto","Giancarlo","Airett Innovation and Research Center, Verona, Italy",NA
"2357","34248774","10.3389/fpsyg.2021.676238","Social and Cognitive Interactions Through an Interactive School Service for RTT Patients at the COVID-19 Time.","Background: The closure of all educational institutions and most rehabilitation centres represents a precautionary measure to face the COVID-19 pandemic, but the isolation and social distancing may be particularly challenging for children with special needs and disabilities (SEND), such as Rett Syndrome (RTT). The main aim of this study was to promote cognitive and social interactions among children with RTT through an interactive school program. Methods: The Interactive School pal","2021","07","13","Front Psychol","Frontiers in psychology","COVID-19; Rett Syndrome; attention; tele-health; telerehabilitation","Nucita","Andrea","Airett Innovation and Research Center, Verona, Italy",NA
"2358","34248774","10.3389/fpsyg.2021.676238","Social and Cognitive Interactions Through an Interactive School Service for RTT Patients at the COVID-19 Time.","Background: The closure of all educational institutions and most rehabilitation centres represents a precautionary measure to face the COVID-19 pandemic, but the isolation and social distancing may be particularly challenging for children with special needs and disabilities (SEND), such as Rett Syndrome (RTT). The main aim of this study was to promote cognitive and social interactions among children with RTT through an interactive school program. Methods: The Interactive School pal","2021","07","13","Front Psychol","Frontiers in psychology","COVID-19; Rett Syndrome; attention; tele-health; telerehabilitation","Semino","Martina","Airett Innovation and Research Center, Verona, Italy",NA
"2359","34248774","10.3389/fpsyg.2021.676238","Social and Cognitive Interactions Through an Interactive School Service for RTT Patients at the COVID-19 Time.","Background: The closure of all educational institutions and most rehabilitation centres represents a precautionary measure to face the COVID-19 pandemic, but the isolation and social distancing may be particularly challenging for children with special needs and disabilities (SEND), such as Rett Syndrome (RTT). The main aim of this study was to promote cognitive and social interactions among children with RTT through an interactive school program. Methods: The Interactive School pal","2021","07","13","Front Psychol","Frontiers in psychology","COVID-19; Rett Syndrome; attention; tele-health; telerehabilitation","Giannatiempo","Samantha","Airett Innovation and Research Center, Verona, Italy",NA
"2360","34248774","10.3389/fpsyg.2021.676238","Social and Cognitive Interactions Through an Interactive School Service for RTT Patients at the COVID-19 Time.","Background: The closure of all educational institutions and most rehabilitation centres represents a precautionary measure to face the COVID-19 pandemic, but the isolation and social distancing may be particularly challenging for children with special needs and disabilities (SEND), such as Rett Syndrome (RTT). The main aim of this study was to promote cognitive and social interactions among children with RTT through an interactive school program. Methods: The Interactive School pal","2021","07","13","Front Psychol","Frontiers in psychology","COVID-19; Rett Syndrome; attention; tele-health; telerehabilitation","Zocca","Lia","Airett Innovation and Research Center, Verona, Italy",NA
"2361","34248774","10.3389/fpsyg.2021.676238","Social and Cognitive Interactions Through an Interactive School Service for RTT Patients at the COVID-19 Time.","Background: The closure of all educational institutions and most rehabilitation centres represents a precautionary measure to face the COVID-19 pandemic, but the isolation and social distancing may be particularly challenging for children with special needs and disabilities (SEND), such as Rett Syndrome (RTT). The main aim of this study was to promote cognitive and social interactions among children with RTT through an interactive school program. Methods: The Interactive School pal","2021","07","13","Front Psychol","Frontiers in psychology","COVID-19; Rett Syndrome; attention; tele-health; telerehabilitation","Fabio","Rosa Angela","Airett Innovation and Research Center, Verona, Italy",NA
"2362","34248770","10.3389/fpsyg.2021.673945","Explanatory Model of Perceived Stress in the General Population: A Cross-Sectional Study in Peru During the COVID-19 Context.","The COVID-19 pandemic had negatively impact mental health worldwide. High prevalence of stress had been previously reported in populations during this context. Many theoretical frameworks had been proposed for explaining the stress process, we aim to proposed and explanatory model for the genesis of perceived stress in Peruvian general population. We conducted an online survey in Peruvian general population assessing sociodemographic variables and evaluating mental health conditions by using The","2021","07","13","Front Psychol","Frontiers in psychology","COVID-19; Peru; general population; perceived stress; structural equation modeling","Boluarte-Carbajal","Alicia","Facultad de Ciencias de la Salud, Universidad César Vallejo - Lima Norte, Lima, Peru",NA
"2363","34248770","10.3389/fpsyg.2021.673945","Explanatory Model of Perceived Stress in the General Population: A Cross-Sectional Study in Peru During the COVID-19 Context.","The COVID-19 pandemic had negatively impact mental health worldwide. High prevalence of stress had been previously reported in populations during this context. Many theoretical frameworks had been proposed for explaining the stress process, we aim to proposed and explanatory model for the genesis of perceived stress in Peruvian general population. We conducted an online survey in Peruvian general population assessing sociodemographic variables and evaluating mental health conditions by using The","2021","07","13","Front Psychol","Frontiers in psychology","COVID-19; Peru; general population; perceived stress; structural equation modeling","Navarro-Flores","Alba","Instituto Peruano de Orientación Psicológica, Lima, Peru",NA
"2364","34248770","10.3389/fpsyg.2021.673945","Explanatory Model of Perceived Stress in the General Population: A Cross-Sectional Study in Peru During the COVID-19 Context.","The COVID-19 pandemic had negatively impact mental health worldwide. High prevalence of stress had been previously reported in populations during this context. Many theoretical frameworks had been proposed for explaining the stress process, we aim to proposed and explanatory model for the genesis of perceived stress in Peruvian general population. We conducted an online survey in Peruvian general population assessing sociodemographic variables and evaluating mental health conditions by using The","2021","07","13","Front Psychol","Frontiers in psychology","COVID-19; Peru; general population; perceived stress; structural equation modeling","Villarreal-Zegarra","David","Instituto Peruano de Orientación Psicológica, Lima, Peru",NA
"2365","34248745","10.3389/fpsyg.2021.647984","Dealing With the Pandemic of COVID-19 in Portugal: On the Important Role of Positivity, Experiential Avoidance, and Coping Strategies.","The global COVID-19 pandemic crisis has caused an unprecedented impact on most areas of people's lives. Thus, framed within the scope of Existential Positive Psychology (PP2.0), this study aimed at assessing the psychological distress of adults living in Portugal during the first national lockdown, how they are coping with stress, as well to contribute to a deeper understanding about the role that positivity, experiential avoidance, and coping strategies have in psychological distress and well-b","2021","07","13","Front Psychol","Frontiers in psychology","COVID-19 pandemic; acceptance; coping; existential positive psychology; experiential avoidance; positivity; psychological distress; well-being","Ferreira","Maria José","HEI-Lab: Digital Human-Environment Interaction Lab, Faculty of Psychology, Education and Sports, Lusófona University, Porto, Portugal",NA
"2366","34248745","10.3389/fpsyg.2021.647984","Dealing With the Pandemic of COVID-19 in Portugal: On the Important Role of Positivity, Experiential Avoidance, and Coping Strategies.","The global COVID-19 pandemic crisis has caused an unprecedented impact on most areas of people's lives. Thus, framed within the scope of Existential Positive Psychology (PP2.0), this study aimed at assessing the psychological distress of adults living in Portugal during the first national lockdown, how they are coping with stress, as well to contribute to a deeper understanding about the role that positivity, experiential avoidance, and coping strategies have in psychological distress and well-b","2021","07","13","Front Psychol","Frontiers in psychology","COVID-19 pandemic; acceptance; coping; existential positive psychology; experiential avoidance; positivity; psychological distress; well-being","Sofia","Rui","Center of Research, Education, Innovation and Intervention in Sport, Faculty of Sport, University of Porto, Porto, Portugal",NA
"2367","34248745","10.3389/fpsyg.2021.647984","Dealing With the Pandemic of COVID-19 in Portugal: On the Important Role of Positivity, Experiential Avoidance, and Coping Strategies.","The global COVID-19 pandemic crisis has caused an unprecedented impact on most areas of people's lives. Thus, framed within the scope of Existential Positive Psychology (PP2.0), this study aimed at assessing the psychological distress of adults living in Portugal during the first national lockdown, how they are coping with stress, as well to contribute to a deeper understanding about the role that positivity, experiential avoidance, and coping strategies have in psychological distress and well-b","2021","07","13","Front Psychol","Frontiers in psychology","COVID-19 pandemic; acceptance; coping; existential positive psychology; experiential avoidance; positivity; psychological distress; well-being","Carreno","David F","Department of Psychology, University of Almería, Almería, Spain",NA
"2368","34248745","10.3389/fpsyg.2021.647984","Dealing With the Pandemic of COVID-19 in Portugal: On the Important Role of Positivity, Experiential Avoidance, and Coping Strategies.","The global COVID-19 pandemic crisis has caused an unprecedented impact on most areas of people's lives. Thus, framed within the scope of Existential Positive Psychology (PP2.0), this study aimed at assessing the psychological distress of adults living in Portugal during the first national lockdown, how they are coping with stress, as well to contribute to a deeper understanding about the role that positivity, experiential avoidance, and coping strategies have in psychological distress and well-b","2021","07","13","Front Psychol","Frontiers in psychology","COVID-19 pandemic; acceptance; coping; existential positive psychology; experiential avoidance; positivity; psychological distress; well-being","Eisenbeck","Nikolett","Department of Personality, Evaluation and Psychological Treatment, University of Seville, Seville, Spain",NA
"2369","34248745","10.3389/fpsyg.2021.647984","Dealing With the Pandemic of COVID-19 in Portugal: On the Important Role of Positivity, Experiential Avoidance, and Coping Strategies.","The global COVID-19 pandemic crisis has caused an unprecedented impact on most areas of people's lives. Thus, framed within the scope of Existential Positive Psychology (PP2.0), this study aimed at assessing the psychological distress of adults living in Portugal during the first national lockdown, how they are coping with stress, as well to contribute to a deeper understanding about the role that positivity, experiential avoidance, and coping strategies have in psychological distress and well-b","2021","07","13","Front Psychol","Frontiers in psychology","COVID-19 pandemic; acceptance; coping; existential positive psychology; experiential avoidance; positivity; psychological distress; well-being","Jongenelen","Inês","HEI-Lab: Digital Human-Environment Interaction Lab, Faculty of Psychology, Education and Sports, Lusófona University, Porto, Portugal",NA
"2370","34248745","10.3389/fpsyg.2021.647984","Dealing With the Pandemic of COVID-19 in Portugal: On the Important Role of Positivity, Experiential Avoidance, and Coping Strategies.","The global COVID-19 pandemic crisis has caused an unprecedented impact on most areas of people's lives. Thus, framed within the scope of Existential Positive Psychology (PP2.0), this study aimed at assessing the psychological distress of adults living in Portugal during the first national lockdown, how they are coping with stress, as well to contribute to a deeper understanding about the role that positivity, experiential avoidance, and coping strategies have in psychological distress and well-b","2021","07","13","Front Psychol","Frontiers in psychology","COVID-19 pandemic; acceptance; coping; existential positive psychology; experiential avoidance; positivity; psychological distress; well-being","Cruz","José Fernando A","CiPsi - Psychology Research Center, University of Minho, Braga, Portugal",NA
"2371","34248741","10.3389/fpsyg.2021.638319","Home Information and Communication Technology Use and Student Academic Performance: Encouraging Results for Uncertain Times.","This study set out to examine the associations of certain information communication technology (ICT) factors in the home environment with academic performance. We employed existing data sets collated by Pearson Clinical Assessment in 2016 which included the WIAT-III A&amp;NZ (Wechsler Individual Achievement Test - Australian and New Zealand Standardised, Third Edition) completed by 714 students aged between 4 and 18 years old, and the home environment questionnaire (HEQ) completed by the parents","2021","07","13","Front Psychol","Frontiers in psychology","academic performance; home education; home learning; information technology; technology access","Skvarc","David Robert","Deakin University, Geelong, VIC, Australia",NA
"2372","34248741","10.3389/fpsyg.2021.638319","Home Information and Communication Technology Use and Student Academic Performance: Encouraging Results for Uncertain Times.","This study set out to examine the associations of certain information communication technology (ICT) factors in the home environment with academic performance. We employed existing data sets collated by Pearson Clinical Assessment in 2016 which included the WIAT-III A&amp;NZ (Wechsler Individual Achievement Test - Australian and New Zealand Standardised, Third Edition) completed by 714 students aged between 4 and 18 years old, and the home environment questionnaire (HEQ) completed by the parents","2021","07","13","Front Psychol","Frontiers in psychology","academic performance; home education; home learning; information technology; technology access","Talbot","Matthew","Deakin University, Geelong, VIC, Australia",NA
"2373","34248741","10.3389/fpsyg.2021.638319","Home Information and Communication Technology Use and Student Academic Performance: Encouraging Results for Uncertain Times.","This study set out to examine the associations of certain information communication technology (ICT) factors in the home environment with academic performance. We employed existing data sets collated by Pearson Clinical Assessment in 2016 which included the WIAT-III A&amp;NZ (Wechsler Individual Achievement Test - Australian and New Zealand Standardised, Third Edition) completed by 714 students aged between 4 and 18 years old, and the home environment questionnaire (HEQ) completed by the parents","2021","07","13","Front Psychol","Frontiers in psychology","academic performance; home education; home learning; information technology; technology access","Harries","Travis","Deakin University, Geelong, VIC, Australia",NA
"2374","34248741","10.3389/fpsyg.2021.638319","Home Information and Communication Technology Use and Student Academic Performance: Encouraging Results for Uncertain Times.","This study set out to examine the associations of certain information communication technology (ICT) factors in the home environment with academic performance. We employed existing data sets collated by Pearson Clinical Assessment in 2016 which included the WIAT-III A&amp;NZ (Wechsler Individual Achievement Test - Australian and New Zealand Standardised, Third Edition) completed by 714 students aged between 4 and 18 years old, and the home environment questionnaire (HEQ) completed by the parents","2021","07","13","Front Psychol","Frontiers in psychology","academic performance; home education; home learning; information technology; technology access","Wilson","Christopher J","Pearson Clinical Assessment, Melbourne, VIC, Australia",NA
"2375","34248741","10.3389/fpsyg.2021.638319","Home Information and Communication Technology Use and Student Academic Performance: Encouraging Results for Uncertain Times.","This study set out to examine the associations of certain information communication technology (ICT) factors in the home environment with academic performance. We employed existing data sets collated by Pearson Clinical Assessment in 2016 which included the WIAT-III A&amp;NZ (Wechsler Individual Achievement Test - Australian and New Zealand Standardised, Third Edition) completed by 714 students aged between 4 and 18 years old, and the home environment questionnaire (HEQ) completed by the parents","2021","07","13","Front Psychol","Frontiers in psychology","academic performance; home education; home learning; information technology; technology access","Joshua","Nicki","Pearson Clinical Assessment, Melbourne, VIC, Australia",NA
"2376","34248741","10.3389/fpsyg.2021.638319","Home Information and Communication Technology Use and Student Academic Performance: Encouraging Results for Uncertain Times.","This study set out to examine the associations of certain information communication technology (ICT) factors in the home environment with academic performance. We employed existing data sets collated by Pearson Clinical Assessment in 2016 which included the WIAT-III A&amp;NZ (Wechsler Individual Achievement Test - Australian and New Zealand Standardised, Third Edition) completed by 714 students aged between 4 and 18 years old, and the home environment questionnaire (HEQ) completed by the parents","2021","07","13","Front Psychol","Frontiers in psychology","academic performance; home education; home learning; information technology; technology access","Byrne","Linda K","Deakin University, Geelong, VIC, Australia",NA
"2377","34248740","10.3389/fpsyg.2021.632585","Trust Buffers Against Reduced Life Satisfaction When Faced With Financial Crisis.","Background: In light of the coronavirus disease 2019 (COVID-19) pandemic and its large economic consequences, we used a three-layer nested structural model (individual, community, and country), each with a corresponding measure of income, trust, and satisfaction, to assess change in their interrelationships following a global crisis; which, in this study, is the 2008/2009 financial crisis. Methods: With multilevel techniques, we analyzed data from two waves (2006 and 2012) of the E","2021","07","13","Front Psychol","Frontiers in psychology","Europe; financial crisis; income; satisfaction; trust; well-being","Clench-Aas","Jocelyne","Division of Mental and Physical Health, Department of Public Health Science, Norwegian Institute of Public Health, Oslo, Norway",NA
"2378","34248740","10.3389/fpsyg.2021.632585","Trust Buffers Against Reduced Life Satisfaction When Faced With Financial Crisis.","Background: In light of the coronavirus disease 2019 (COVID-19) pandemic and its large economic consequences, we used a three-layer nested structural model (individual, community, and country), each with a corresponding measure of income, trust, and satisfaction, to assess change in their interrelationships following a global crisis; which, in this study, is the 2008/2009 financial crisis. Methods: With multilevel techniques, we analyzed data from two waves (2006 and 2012) of the E","2021","07","13","Front Psychol","Frontiers in psychology","Europe; financial crisis; income; satisfaction; trust; well-being","Bergande","Ingrid","Faculty of Landscape and Society, Norwegian University of Life Sciences, Ås, Norway",NA
"2379","34248740","10.3389/fpsyg.2021.632585","Trust Buffers Against Reduced Life Satisfaction When Faced With Financial Crisis.","Background: In light of the coronavirus disease 2019 (COVID-19) pandemic and its large economic consequences, we used a three-layer nested structural model (individual, community, and country), each with a corresponding measure of income, trust, and satisfaction, to assess change in their interrelationships following a global crisis; which, in this study, is the 2008/2009 financial crisis. Methods: With multilevel techniques, we analyzed data from two waves (2006 and 2012) of the E","2021","07","13","Front Psychol","Frontiers in psychology","Europe; financial crisis; income; satisfaction; trust; well-being","Nes","Ragnhild Bang","Division of Mental and Physical Health, Department of Public Health Science, Norwegian Institute of Public Health, Oslo, Norway",NA
"2380","34248740","10.3389/fpsyg.2021.632585","Trust Buffers Against Reduced Life Satisfaction When Faced With Financial Crisis.","Background: In light of the coronavirus disease 2019 (COVID-19) pandemic and its large economic consequences, we used a three-layer nested structural model (individual, community, and country), each with a corresponding measure of income, trust, and satisfaction, to assess change in their interrelationships following a global crisis; which, in this study, is the 2008/2009 financial crisis. Methods: With multilevel techniques, we analyzed data from two waves (2006 and 2012) of the E","2021","07","13","Front Psychol","Frontiers in psychology","Europe; financial crisis; income; satisfaction; trust; well-being","Holte","Arne","Division of Mental and Physical Health, Department of Public Health Science, Norwegian Institute of Public Health, Oslo, Norway",NA
"2381","34248730","10.3389/fpsyg.2021.596582","Teacher Online Informal Learning as a Means to Innovative Teaching During Home Quarantine in the COVID-19 Pandemic.","The home quarantine in the COVID-19 pandemic has created challenges for teaching across the world and called for innovative teaching, as well as teachers' learning. Given the rapid development of teachers' online learning and teaching, identifying effective ways to facilitate innovative teaching under such challenging conditions is a critical issue. Although researchers have realized that workplace informal learning (IL) increasingly reveals its potential value to individual development, the rel","2021","07","13","Front Psychol","Frontiers in psychology","ICT efficacy; faculty; general teaching efficacy; informal learning; innovative teaching; online teaching and learning; personal teaching efficacy","Yu","Haiqin","School of Education, Huazhong University of Science &amp",NA
"2382","34248730","10.3389/fpsyg.2021.596582","Teacher Online Informal Learning as a Means to Innovative Teaching During Home Quarantine in the COVID-19 Pandemic.","The home quarantine in the COVID-19 pandemic has created challenges for teaching across the world and called for innovative teaching, as well as teachers' learning. Given the rapid development of teachers' online learning and teaching, identifying effective ways to facilitate innovative teaching under such challenging conditions is a critical issue. Although researchers have realized that workplace informal learning (IL) increasingly reveals its potential value to individual development, the rel","2021","07","13","Front Psychol","Frontiers in psychology","ICT efficacy; faculty; general teaching efficacy; informal learning; innovative teaching; online teaching and learning; personal teaching efficacy","Liu","Ping","School of Education, Huazhong University of Science &amp",NA
"2383","34248730","10.3389/fpsyg.2021.596582","Teacher Online Informal Learning as a Means to Innovative Teaching During Home Quarantine in the COVID-19 Pandemic.","The home quarantine in the COVID-19 pandemic has created challenges for teaching across the world and called for innovative teaching, as well as teachers' learning. Given the rapid development of teachers' online learning and teaching, identifying effective ways to facilitate innovative teaching under such challenging conditions is a critical issue. Although researchers have realized that workplace informal learning (IL) increasingly reveals its potential value to individual development, the rel","2021","07","13","Front Psychol","Frontiers in psychology","ICT efficacy; faculty; general teaching efficacy; informal learning; innovative teaching; online teaching and learning; personal teaching efficacy","Huang","Xiaoqing","School of Education, Huazhong University of Science &amp",NA
"2384","34248730","10.3389/fpsyg.2021.596582","Teacher Online Informal Learning as a Means to Innovative Teaching During Home Quarantine in the COVID-19 Pandemic.","The home quarantine in the COVID-19 pandemic has created challenges for teaching across the world and called for innovative teaching, as well as teachers' learning. Given the rapid development of teachers' online learning and teaching, identifying effective ways to facilitate innovative teaching under such challenging conditions is a critical issue. Although researchers have realized that workplace informal learning (IL) increasingly reveals its potential value to individual development, the rel","2021","07","13","Front Psychol","Frontiers in psychology","ICT efficacy; faculty; general teaching efficacy; informal learning; innovative teaching; online teaching and learning; personal teaching efficacy","Cao","Yuxi","School of Education, Huazhong University of Science &amp",NA
"2385","34248728","10.3389/fpsyg.2021.588478","What Should I Trust? Individual Differences in Attitudes to Conflicting Information and Misinformation on COVID-19.","The COVID-19 pandemic constitutes a novel threat and traditional and new media provide people with an abundance of information and misinformation on the topic. In the current study, we investigated who tends to trust what type of mis/information. The data were collected in Norway from a sample of 405 participants during the first wave of COVID-19 in April 2020. We focused on three kinds of belief: the belief that the threat is overrated (COVID-threat skepticism), the belief that the threat is un","2021","07","13","Front Psychol","Frontiers in psychology","COVID-19; evaluation of information; motivated reasoning; precautionary behavior; selective exposure; selective perception; trust in authorities; trust in misinformation","Filkuková","Petra","Simula Research Laboratory, Oslo, Norway",NA
"2386","34248728","10.3389/fpsyg.2021.588478","What Should I Trust? Individual Differences in Attitudes to Conflicting Information and Misinformation on COVID-19.","The COVID-19 pandemic constitutes a novel threat and traditional and new media provide people with an abundance of information and misinformation on the topic. In the current study, we investigated who tends to trust what type of mis/information. The data were collected in Norway from a sample of 405 participants during the first wave of COVID-19 in April 2020. We focused on three kinds of belief: the belief that the threat is overrated (COVID-threat skepticism), the belief that the threat is un","2021","07","13","Front Psychol","Frontiers in psychology","COVID-19; evaluation of information; motivated reasoning; precautionary behavior; selective exposure; selective perception; trust in authorities; trust in misinformation","Ayton","Peter","Centre for Decision Research, University of Leeds, Leeds, United Kingdom",NA
"2387","34248728","10.3389/fpsyg.2021.588478","What Should I Trust? Individual Differences in Attitudes to Conflicting Information and Misinformation on COVID-19.","The COVID-19 pandemic constitutes a novel threat and traditional and new media provide people with an abundance of information and misinformation on the topic. In the current study, we investigated who tends to trust what type of mis/information. The data were collected in Norway from a sample of 405 participants during the first wave of COVID-19 in April 2020. We focused on three kinds of belief: the belief that the threat is overrated (COVID-threat skepticism), the belief that the threat is un","2021","07","13","Front Psychol","Frontiers in psychology","COVID-19; evaluation of information; motivated reasoning; precautionary behavior; selective exposure; selective perception; trust in authorities; trust in misinformation","Rand","Kim","Health Services Research Centre, Akershus University Hospital, Akershus, Norway",NA
"2388","34248728","10.3389/fpsyg.2021.588478","What Should I Trust? Individual Differences in Attitudes to Conflicting Information and Misinformation on COVID-19.","The COVID-19 pandemic constitutes a novel threat and traditional and new media provide people with an abundance of information and misinformation on the topic. In the current study, we investigated who tends to trust what type of mis/information. The data were collected in Norway from a sample of 405 participants during the first wave of COVID-19 in April 2020. We focused on three kinds of belief: the belief that the threat is overrated (COVID-threat skepticism), the belief that the threat is un","2021","07","13","Front Psychol","Frontiers in psychology","COVID-19; evaluation of information; motivated reasoning; precautionary behavior; selective exposure; selective perception; trust in authorities; trust in misinformation","Langguth","Johannes","Simula Research Laboratory, Oslo, Norway",NA
"2389","34248726","10.3389/fpsyg.2021.566778","Mindfully Reframing the Psychological Impact of the COVID-19 Outbreak Through a Social Media Community for Students: A Pragmatic Study.","The COVID-19 outbreak and the restrictions that have been enforced by the health authorities are having a profound psychological impact on the population. Many people, including the students, faced forced modifications to their daily lives and this prompted the need for scalable strategies to promote resilience. We designed an online community intervention for psychology students and recent alumni aimed to promote functional coping strategies through openness and cognitive flexibility. This psyc","2021","07","13","Front Psychol","Frontiers in psychology","COVID-19; cognitive flexibility; coping; coronavirus; online community; openness; psychological intervention; stress","Pagnini","Francesco","Department of Psychology, Università Cattolica del Sacro Cuore, Milan, Italy",NA
"2390","34248726","10.3389/fpsyg.2021.566778","Mindfully Reframing the Psychological Impact of the COVID-19 Outbreak Through a Social Media Community for Students: A Pragmatic Study.","The COVID-19 outbreak and the restrictions that have been enforced by the health authorities are having a profound psychological impact on the population. Many people, including the students, faced forced modifications to their daily lives and this prompted the need for scalable strategies to promote resilience. We designed an online community intervention for psychology students and recent alumni aimed to promote functional coping strategies through openness and cognitive flexibility. This psyc","2021","07","13","Front Psychol","Frontiers in psychology","COVID-19; cognitive flexibility; coping; coronavirus; online community; openness; psychological intervention; stress","Bonalda","Elisa","Department of Psychology, Università Cattolica del Sacro Cuore, Milan, Italy",NA
"2391","34248726","10.3389/fpsyg.2021.566778","Mindfully Reframing the Psychological Impact of the COVID-19 Outbreak Through a Social Media Community for Students: A Pragmatic Study.","The COVID-19 outbreak and the restrictions that have been enforced by the health authorities are having a profound psychological impact on the population. Many people, including the students, faced forced modifications to their daily lives and this prompted the need for scalable strategies to promote resilience. We designed an online community intervention for psychology students and recent alumni aimed to promote functional coping strategies through openness and cognitive flexibility. This psyc","2021","07","13","Front Psychol","Frontiers in psychology","COVID-19; cognitive flexibility; coping; coronavirus; online community; openness; psychological intervention; stress","Montrasi","Eleonora","Department of Psychology, Università Cattolica del Sacro Cuore, Milan, Italy",NA
"2392","34248726","10.3389/fpsyg.2021.566778","Mindfully Reframing the Psychological Impact of the COVID-19 Outbreak Through a Social Media Community for Students: A Pragmatic Study.","The COVID-19 outbreak and the restrictions that have been enforced by the health authorities are having a profound psychological impact on the population. Many people, including the students, faced forced modifications to their daily lives and this prompted the need for scalable strategies to promote resilience. We designed an online community intervention for psychology students and recent alumni aimed to promote functional coping strategies through openness and cognitive flexibility. This psyc","2021","07","13","Front Psychol","Frontiers in psychology","COVID-19; cognitive flexibility; coping; coronavirus; online community; openness; psychological intervention; stress","Toselli","Elena","Department of Psychology, Università Cattolica del Sacro Cuore, Milan, Italy",NA
"2393","34248726","10.3389/fpsyg.2021.566778","Mindfully Reframing the Psychological Impact of the COVID-19 Outbreak Through a Social Media Community for Students: A Pragmatic Study.","The COVID-19 outbreak and the restrictions that have been enforced by the health authorities are having a profound psychological impact on the population. Many people, including the students, faced forced modifications to their daily lives and this prompted the need for scalable strategies to promote resilience. We designed an online community intervention for psychology students and recent alumni aimed to promote functional coping strategies through openness and cognitive flexibility. This psyc","2021","07","13","Front Psychol","Frontiers in psychology","COVID-19; cognitive flexibility; coping; coronavirus; online community; openness; psychological intervention; stress","Antonietti","Alessandro","Department of Psychology, Università Cattolica del Sacro Cuore, Milan, Italy",NA
"2394","34248725","10.3389/fpsyg.2021.559125","How Should Athletes Coping With COVID-19: Focus on Severity and Psychological Support.","Objective: Athletes are suffering from many uncertainties and hope to achieve the best possible position under the current circumstances of this global coronavirus disease (COVID-19) pandemic. In this study, we aimed to address the severity and psychological support for athletes with COVID-19. Methods: We extracted public data and news reports of the up-to-date first seven cases of elite athletes with COVID-19 confirmed in China and made psychological recommendations based on scien","2021","07","13","Front Psychol","Frontiers in psychology","COVID-19; athletes; mortality; psychology; severity","Han","Qi","Sport Science College, Beijing Sport University, Beijing, China",NA
"2395","34248725","10.3389/fpsyg.2021.559125","How Should Athletes Coping With COVID-19: Focus on Severity and Psychological Support.","Objective: Athletes are suffering from many uncertainties and hope to achieve the best possible position under the current circumstances of this global coronavirus disease (COVID-19) pandemic. In this study, we aimed to address the severity and psychological support for athletes with COVID-19. Methods: We extracted public data and news reports of the up-to-date first seven cases of elite athletes with COVID-19 confirmed in China and made psychological recommendations based on scien","2021","07","13","Front Psychol","Frontiers in psychology","COVID-19; athletes; mortality; psychology; severity","Li","Xueyang","Sport Science College, Beijing Sport University, Beijing, China",NA
"2396","34248725","10.3389/fpsyg.2021.559125","How Should Athletes Coping With COVID-19: Focus on Severity and Psychological Support.","Objective: Athletes are suffering from many uncertainties and hope to achieve the best possible position under the current circumstances of this global coronavirus disease (COVID-19) pandemic. In this study, we aimed to address the severity and psychological support for athletes with COVID-19. Methods: We extracted public data and news reports of the up-to-date first seven cases of elite athletes with COVID-19 confirmed in China and made psychological recommendations based on scien","2021","07","13","Front Psychol","Frontiers in psychology","COVID-19; athletes; mortality; psychology; severity","Wang","Zhenghanxiao","Department of Psychology, University of Limerick, Limerick, Ireland",NA
"2397","34248720","10.3389/fpsyt.2021.699869","High Prevalence of Post-stroke Anxiety in Elderly Patients Following COVID-19 Outbreak.","Objective: Post-stroke anxiety (PSA) is a common affective disorder in patients with ischemic stroke. The elderly are more susceptible to mental health issues, however, few studies have so far focused on PSA in elderly patients, especially in the context of the COVID-19, causing psychological issues in the general population. The aim of the present study was to assess the prevalence and risk factors of PSA in elderly patients following COVID-19 outbreak. Methods: We retrospectively","2021","07","13","Front Psychiatry","Frontiers in psychiatry","COVID-19; acute ischemic stroke; elderly patients; post-stroke anxiety; risk factors","Yao","Meiling","Department of Neurology, The First Affiliated Hospital, Sun Yat-Sen University, Guangdong Provincial Key Laboratory of Diagnosis and Treatment of Major Neurological Diseases, National Key Clinical Department and Key Discipline of Neurology, Guangzhou, China",NA
"2398","34248720","10.3389/fpsyt.2021.699869","High Prevalence of Post-stroke Anxiety in Elderly Patients Following COVID-19 Outbreak.","Objective: Post-stroke anxiety (PSA) is a common affective disorder in patients with ischemic stroke. The elderly are more susceptible to mental health issues, however, few studies have so far focused on PSA in elderly patients, especially in the context of the COVID-19, causing psychological issues in the general population. The aim of the present study was to assess the prevalence and risk factors of PSA in elderly patients following COVID-19 outbreak. Methods: We retrospectively","2021","07","13","Front Psychiatry","Frontiers in psychiatry","COVID-19; acute ischemic stroke; elderly patients; post-stroke anxiety; risk factors","Li","Hongjie","Department of Neurology, The First Affiliated Hospital, Sun Yat-Sen University, Guangdong Provincial Key Laboratory of Diagnosis and Treatment of Major Neurological Diseases, National Key Clinical Department and Key Discipline of Neurology, Guangzhou, China",NA
"2399","34248720","10.3389/fpsyt.2021.699869","High Prevalence of Post-stroke Anxiety in Elderly Patients Following COVID-19 Outbreak.","Objective: Post-stroke anxiety (PSA) is a common affective disorder in patients with ischemic stroke. The elderly are more susceptible to mental health issues, however, few studies have so far focused on PSA in elderly patients, especially in the context of the COVID-19, causing psychological issues in the general population. The aim of the present study was to assess the prevalence and risk factors of PSA in elderly patients following COVID-19 outbreak. Methods: We retrospectively","2021","07","13","Front Psychiatry","Frontiers in psychiatry","COVID-19; acute ischemic stroke; elderly patients; post-stroke anxiety; risk factors","Luo","Ying","Department of Neurology, The First Affiliated Hospital, Sun Yat-Sen University, Guangdong Provincial Key Laboratory of Diagnosis and Treatment of Major Neurological Diseases, National Key Clinical Department and Key Discipline of Neurology, Guangzhou, China",NA
"2400","34248720","10.3389/fpsyt.2021.699869","High Prevalence of Post-stroke Anxiety in Elderly Patients Following COVID-19 Outbreak.","Objective: Post-stroke anxiety (PSA) is a common affective disorder in patients with ischemic stroke. The elderly are more susceptible to mental health issues, however, few studies have so far focused on PSA in elderly patients, especially in the context of the COVID-19, causing psychological issues in the general population. The aim of the present study was to assess the prevalence and risk factors of PSA in elderly patients following COVID-19 outbreak. Methods: We retrospectively","2021","07","13","Front Psychiatry","Frontiers in psychiatry","COVID-19; acute ischemic stroke; elderly patients; post-stroke anxiety; risk factors","Li","Ling","Department of Neurology, The First Affiliated Hospital, Sun Yat-Sen University, Guangdong Provincial Key Laboratory of Diagnosis and Treatment of Major Neurological Diseases, National Key Clinical Department and Key Discipline of Neurology, Guangzhou, China",NA
"2401","34248720","10.3389/fpsyt.2021.699869","High Prevalence of Post-stroke Anxiety in Elderly Patients Following COVID-19 Outbreak.","Objective: Post-stroke anxiety (PSA) is a common affective disorder in patients with ischemic stroke. The elderly are more susceptible to mental health issues, however, few studies have so far focused on PSA in elderly patients, especially in the context of the COVID-19, causing psychological issues in the general population. The aim of the present study was to assess the prevalence and risk factors of PSA in elderly patients following COVID-19 outbreak. Methods: We retrospectively","2021","07","13","Front Psychiatry","Frontiers in psychiatry","COVID-19; acute ischemic stroke; elderly patients; post-stroke anxiety; risk factors","Yu","Jian","Department of Neurology, The First Affiliated Hospital, Sun Yat-Sen University, Guangdong Provincial Key Laboratory of Diagnosis and Treatment of Major Neurological Diseases, National Key Clinical Department and Key Discipline of Neurology, Guangzhou, China",NA
"2402","34248719","10.3389/fpsyt.2021.690295","Psychological Distress and Its Association With Quality of Life in Organ Transplant Recipients During COVID-19 Pandemic.","Objectives: The coronavirus disease 2019 (COVID-19) pandemic may have an impact on the psychological distress of organ transplant recipients. We aimed to assess the status of psychological distress and its association with quality of life (QoL) in organ transplant recipients during the COVID-19 pandemic. Materials and Methods: A cross-sectional survey was carried out with 305 organ transplant recipients during March 30 and April 2, 2020, in Wuhan. Psychological distress comprised d","2021","07","13","Front Psychiatry","Frontiers in psychiatry","coronavirus disease; cross-sectional study; organ transport; psychological distress; quality of life","Cai","Zhongxiang","Nursing Office, Renmin Hospital of Wuhan University, Wuhan, China",NA
"2403","34248719","10.3389/fpsyt.2021.690295","Psychological Distress and Its Association With Quality of Life in Organ Transplant Recipients During COVID-19 Pandemic.","Objectives: The coronavirus disease 2019 (COVID-19) pandemic may have an impact on the psychological distress of organ transplant recipients. We aimed to assess the status of psychological distress and its association with quality of life (QoL) in organ transplant recipients during the COVID-19 pandemic. Materials and Methods: A cross-sectional survey was carried out with 305 organ transplant recipients during March 30 and April 2, 2020, in Wuhan. Psychological distress comprised d","2021","07","13","Front Psychiatry","Frontiers in psychiatry","coronavirus disease; cross-sectional study; organ transport; psychological distress; quality of life","Cai","Xin","Department of Cardiovascular Surgery, Renmin Hospital of Wuhan University, Wuhan, China",NA
"2404","34248719","10.3389/fpsyt.2021.690295","Psychological Distress and Its Association With Quality of Life in Organ Transplant Recipients During COVID-19 Pandemic.","Objectives: The coronavirus disease 2019 (COVID-19) pandemic may have an impact on the psychological distress of organ transplant recipients. We aimed to assess the status of psychological distress and its association with quality of life (QoL) in organ transplant recipients during the COVID-19 pandemic. Materials and Methods: A cross-sectional survey was carried out with 305 organ transplant recipients during March 30 and April 2, 2020, in Wuhan. Psychological distress comprised d","2021","07","13","Front Psychiatry","Frontiers in psychiatry","coronavirus disease; cross-sectional study; organ transport; psychological distress; quality of life","Song","Yujuan","Department of Cardiovascular Surgery, Renmin Hospital of Wuhan University, Wuhan, China",NA
"2405","34248719","10.3389/fpsyt.2021.690295","Psychological Distress and Its Association With Quality of Life in Organ Transplant Recipients During COVID-19 Pandemic.","Objectives: The coronavirus disease 2019 (COVID-19) pandemic may have an impact on the psychological distress of organ transplant recipients. We aimed to assess the status of psychological distress and its association with quality of life (QoL) in organ transplant recipients during the COVID-19 pandemic. Materials and Methods: A cross-sectional survey was carried out with 305 organ transplant recipients during March 30 and April 2, 2020, in Wuhan. Psychological distress comprised d","2021","07","13","Front Psychiatry","Frontiers in psychiatry","coronavirus disease; cross-sectional study; organ transport; psychological distress; quality of life","Wang","Dianzhen","The Nephrology Division and Dialysis Transplant Center, Renmin Hospital of Wuhan University, Wuhan, China",NA
"2406","34248719","10.3389/fpsyt.2021.690295","Psychological Distress and Its Association With Quality of Life in Organ Transplant Recipients During COVID-19 Pandemic.","Objectives: The coronavirus disease 2019 (COVID-19) pandemic may have an impact on the psychological distress of organ transplant recipients. We aimed to assess the status of psychological distress and its association with quality of life (QoL) in organ transplant recipients during the COVID-19 pandemic. Materials and Methods: A cross-sectional survey was carried out with 305 organ transplant recipients during March 30 and April 2, 2020, in Wuhan. Psychological distress comprised d","2021","07","13","Front Psychiatry","Frontiers in psychiatry","coronavirus disease; cross-sectional study; organ transport; psychological distress; quality of life","Zhang","Yanbing","Department of Hepatobiliary Surgery, Renmin Hospital of Wuhan University, Wuhan, China",NA
"2407","34248719","10.3389/fpsyt.2021.690295","Psychological Distress and Its Association With Quality of Life in Organ Transplant Recipients During COVID-19 Pandemic.","Objectives: The coronavirus disease 2019 (COVID-19) pandemic may have an impact on the psychological distress of organ transplant recipients. We aimed to assess the status of psychological distress and its association with quality of life (QoL) in organ transplant recipients during the COVID-19 pandemic. Materials and Methods: A cross-sectional survey was carried out with 305 organ transplant recipients during March 30 and April 2, 2020, in Wuhan. Psychological distress comprised d","2021","07","13","Front Psychiatry","Frontiers in psychiatry","coronavirus disease; cross-sectional study; organ transport; psychological distress; quality of life","Ma","Simeng","Department of Psychiatry, Renmin Hospital of Wuhan University, Wuhan, China",NA
"2408","34248719","10.3389/fpsyt.2021.690295","Psychological Distress and Its Association With Quality of Life in Organ Transplant Recipients During COVID-19 Pandemic.","Objectives: The coronavirus disease 2019 (COVID-19) pandemic may have an impact on the psychological distress of organ transplant recipients. We aimed to assess the status of psychological distress and its association with quality of life (QoL) in organ transplant recipients during the COVID-19 pandemic. Materials and Methods: A cross-sectional survey was carried out with 305 organ transplant recipients during March 30 and April 2, 2020, in Wuhan. Psychological distress comprised d","2021","07","13","Front Psychiatry","Frontiers in psychiatry","coronavirus disease; cross-sectional study; organ transport; psychological distress; quality of life","Tang","Shiming","Department of Psychiatry, Renmin Hospital of Wuhan University, Wuhan, China",NA
"2409","34248719","10.3389/fpsyt.2021.690295","Psychological Distress and Its Association With Quality of Life in Organ Transplant Recipients During COVID-19 Pandemic.","Objectives: The coronavirus disease 2019 (COVID-19) pandemic may have an impact on the psychological distress of organ transplant recipients. We aimed to assess the status of psychological distress and its association with quality of life (QoL) in organ transplant recipients during the COVID-19 pandemic. Materials and Methods: A cross-sectional survey was carried out with 305 organ transplant recipients during March 30 and April 2, 2020, in Wuhan. Psychological distress comprised d","2021","07","13","Front Psychiatry","Frontiers in psychiatry","coronavirus disease; cross-sectional study; organ transport; psychological distress; quality of life","Bai","Hanping","Department of Psychiatry, Renmin Hospital of Wuhan University, Wuhan, China",NA
"2410","34248719","10.3389/fpsyt.2021.690295","Psychological Distress and Its Association With Quality of Life in Organ Transplant Recipients During COVID-19 Pandemic.","Objectives: The coronavirus disease 2019 (COVID-19) pandemic may have an impact on the psychological distress of organ transplant recipients. We aimed to assess the status of psychological distress and its association with quality of life (QoL) in organ transplant recipients during the COVID-19 pandemic. Materials and Methods: A cross-sectional survey was carried out with 305 organ transplant recipients during March 30 and April 2, 2020, in Wuhan. Psychological distress comprised d","2021","07","13","Front Psychiatry","Frontiers in psychiatry","coronavirus disease; cross-sectional study; organ transport; psychological distress; quality of life","Tan","Huawei","Department of Psychiatry, Renmin Hospital of Wuhan University, Wuhan, China",NA
"2411","34248719","10.3389/fpsyt.2021.690295","Psychological Distress and Its Association With Quality of Life in Organ Transplant Recipients During COVID-19 Pandemic.","Objectives: The coronavirus disease 2019 (COVID-19) pandemic may have an impact on the psychological distress of organ transplant recipients. We aimed to assess the status of psychological distress and its association with quality of life (QoL) in organ transplant recipients during the COVID-19 pandemic. Materials and Methods: A cross-sectional survey was carried out with 305 organ transplant recipients during March 30 and April 2, 2020, in Wuhan. Psychological distress comprised d","2021","07","13","Front Psychiatry","Frontiers in psychiatry","coronavirus disease; cross-sectional study; organ transport; psychological distress; quality of life","Li","Ruiting","Department of Psychiatry, Renmin Hospital of Wuhan University, Wuhan, China",NA
"2412","34248719","10.3389/fpsyt.2021.690295","Psychological Distress and Its Association With Quality of Life in Organ Transplant Recipients During COVID-19 Pandemic.","Objectives: The coronavirus disease 2019 (COVID-19) pandemic may have an impact on the psychological distress of organ transplant recipients. We aimed to assess the status of psychological distress and its association with quality of life (QoL) in organ transplant recipients during the COVID-19 pandemic. Materials and Methods: A cross-sectional survey was carried out with 305 organ transplant recipients during March 30 and April 2, 2020, in Wuhan. Psychological distress comprised d","2021","07","13","Front Psychiatry","Frontiers in psychiatry","coronavirus disease; cross-sectional study; organ transport; psychological distress; quality of life","Yao","Lihua","Department of Psychiatry, Renmin Hospital of Wuhan University, Wuhan, China",NA
"2413","34248719","10.3389/fpsyt.2021.690295","Psychological Distress and Its Association With Quality of Life in Organ Transplant Recipients During COVID-19 Pandemic.","Objectives: The coronavirus disease 2019 (COVID-19) pandemic may have an impact on the psychological distress of organ transplant recipients. We aimed to assess the status of psychological distress and its association with quality of life (QoL) in organ transplant recipients during the COVID-19 pandemic. Materials and Methods: A cross-sectional survey was carried out with 305 organ transplant recipients during March 30 and April 2, 2020, in Wuhan. Psychological distress comprised d","2021","07","13","Front Psychiatry","Frontiers in psychiatry","coronavirus disease; cross-sectional study; organ transport; psychological distress; quality of life","Liu","Zhongchun","Department of Psychiatry, Renmin Hospital of Wuhan University, Wuhan, China",NA
"2414","34248719","10.3389/fpsyt.2021.690295","Psychological Distress and Its Association With Quality of Life in Organ Transplant Recipients During COVID-19 Pandemic.","Objectives: The coronavirus disease 2019 (COVID-19) pandemic may have an impact on the psychological distress of organ transplant recipients. We aimed to assess the status of psychological distress and its association with quality of life (QoL) in organ transplant recipients during the COVID-19 pandemic. Materials and Methods: A cross-sectional survey was carried out with 305 organ transplant recipients during March 30 and April 2, 2020, in Wuhan. Psychological distress comprised d","2021","07","13","Front Psychiatry","Frontiers in psychiatry","coronavirus disease; cross-sectional study; organ transport; psychological distress; quality of life","Wang","Gaohua","Department of Psychiatry, Renmin Hospital of Wuhan University, Wuhan, China",NA
"2415","34248719","10.3389/fpsyt.2021.690295","Psychological Distress and Its Association With Quality of Life in Organ Transplant Recipients During COVID-19 Pandemic.","Objectives: The coronavirus disease 2019 (COVID-19) pandemic may have an impact on the psychological distress of organ transplant recipients. We aimed to assess the status of psychological distress and its association with quality of life (QoL) in organ transplant recipients during the COVID-19 pandemic. Materials and Methods: A cross-sectional survey was carried out with 305 organ transplant recipients during March 30 and April 2, 2020, in Wuhan. Psychological distress comprised d","2021","07","13","Front Psychiatry","Frontiers in psychiatry","coronavirus disease; cross-sectional study; organ transport; psychological distress; quality of life","Wang","Ying","Department of Psychiatry, Renmin Hospital of Wuhan University, Wuhan, China",NA
"2416","34248710","10.3389/fpsyt.2021.674194","One Year Into the Pandemic: A Systematic Review of Perinatal Mental Health Outcomes During COVID-19.","Obstetric guidelines have rapidly evolved to incorporate new data and research on the novel coronavirus disease (COVID-19), with data on perinatal mental health building over the last year. Our aim in the present manuscript is to provide a systematic review of mental health outcomes in pregnant and postpartum women during the COVID-19 pandemic in the context of neonatal and obstetric guidelines addressing symptoms and complications of COVID-19 during pregnancy, mother-to-neonate transmission, Ce","2021","07","13","Front Psychiatry","Frontiers in psychiatry","COVID-19; maternal; mental health; perinatal; postpartum; pregnancy","Iyengar","Udita","Department of Child and Adolescent Psychiatry, King's College London, Institute of Psychiatry, Psychology, and Neuroscience (IoPPN), London, United Kingdom",NA
"2417","34248710","10.3389/fpsyt.2021.674194","One Year Into the Pandemic: A Systematic Review of Perinatal Mental Health Outcomes During COVID-19.","Obstetric guidelines have rapidly evolved to incorporate new data and research on the novel coronavirus disease (COVID-19), with data on perinatal mental health building over the last year. Our aim in the present manuscript is to provide a systematic review of mental health outcomes in pregnant and postpartum women during the COVID-19 pandemic in the context of neonatal and obstetric guidelines addressing symptoms and complications of COVID-19 during pregnancy, mother-to-neonate transmission, Ce","2021","07","13","Front Psychiatry","Frontiers in psychiatry","COVID-19; maternal; mental health; perinatal; postpartum; pregnancy","Jaiprakash","Bhavisha","Department of Child and Adolescent Psychiatry, King's College London, Institute of Psychiatry, Psychology, and Neuroscience (IoPPN), London, United Kingdom",NA
"2418","34248710","10.3389/fpsyt.2021.674194","One Year Into the Pandemic: A Systematic Review of Perinatal Mental Health Outcomes During COVID-19.","Obstetric guidelines have rapidly evolved to incorporate new data and research on the novel coronavirus disease (COVID-19), with data on perinatal mental health building over the last year. Our aim in the present manuscript is to provide a systematic review of mental health outcomes in pregnant and postpartum women during the COVID-19 pandemic in the context of neonatal and obstetric guidelines addressing symptoms and complications of COVID-19 during pregnancy, mother-to-neonate transmission, Ce","2021","07","13","Front Psychiatry","Frontiers in psychiatry","COVID-19; maternal; mental health; perinatal; postpartum; pregnancy","Haitsuka","Hanako","Yale Child Study Center, Yale University, New Haven, CT, United States",NA
"2419","34248710","10.3389/fpsyt.2021.674194","One Year Into the Pandemic: A Systematic Review of Perinatal Mental Health Outcomes During COVID-19.","Obstetric guidelines have rapidly evolved to incorporate new data and research on the novel coronavirus disease (COVID-19), with data on perinatal mental health building over the last year. Our aim in the present manuscript is to provide a systematic review of mental health outcomes in pregnant and postpartum women during the COVID-19 pandemic in the context of neonatal and obstetric guidelines addressing symptoms and complications of COVID-19 during pregnancy, mother-to-neonate transmission, Ce","2021","07","13","Front Psychiatry","Frontiers in psychiatry","COVID-19; maternal; mental health; perinatal; postpartum; pregnancy","Kim","Sohye","Eunice Kennedy Shriver Center, University of Massachusetts Medical School, Worcester, MA, United States",NA
"2420","34248708","10.3389/fpsyt.2021.671442","INteractive Virtual Expert-Led Skills Training: A Multi-Modal Curriculum for Medical Trainees.","Background: Internationally, pediatric depression and suicide are significant issues. Additionally, in the context of the COVID-19 pandemic, pediatric mental health needs are rising astronomically. In light of Child &amp; Adolescent Psychiatrist (CAP) subspecialist shortages in the United States (US), there is an increasing call for primary care physicians in Family Medicine and Pediatrics to address an increasingly broad variety of patient needs. Here we report on the development and pre","2021","07","13","Front Psychiatry","Frontiers in psychiatry","adolescent; depression; medical education; primary care; suicidality; underserved","Curtin","Michelle","Division of Child Development, Department of Pediatrics, Riley Child Development Center, Indiana University School of Medicine, Indianapolis, IN, United States",NA
"2421","34248708","10.3389/fpsyt.2021.671442","INteractive Virtual Expert-Led Skills Training: A Multi-Modal Curriculum for Medical Trainees.","Background: Internationally, pediatric depression and suicide are significant issues. Additionally, in the context of the COVID-19 pandemic, pediatric mental health needs are rising astronomically. In light of Child &amp; Adolescent Psychiatrist (CAP) subspecialist shortages in the United States (US), there is an increasing call for primary care physicians in Family Medicine and Pediatrics to address an increasingly broad variety of patient needs. Here we report on the development and pre","2021","07","13","Front Psychiatry","Frontiers in psychiatry","adolescent; depression; medical education; primary care; suicidality; underserved","Downs","Jennifer","Division of Child Development, Department of Pediatrics, Riley Child Development Center, Indiana University School of Medicine, Indianapolis, IN, United States",NA
"2422","34248708","10.3389/fpsyt.2021.671442","INteractive Virtual Expert-Led Skills Training: A Multi-Modal Curriculum for Medical Trainees.","Background: Internationally, pediatric depression and suicide are significant issues. Additionally, in the context of the COVID-19 pandemic, pediatric mental health needs are rising astronomically. In light of Child &amp; Adolescent Psychiatrist (CAP) subspecialist shortages in the United States (US), there is an increasing call for primary care physicians in Family Medicine and Pediatrics to address an increasingly broad variety of patient needs. Here we report on the development and pre","2021","07","13","Front Psychiatry","Frontiers in psychiatry","adolescent; depression; medical education; primary care; suicidality; underserved","Hunt","Amber","Division of Child and Adolescent Psychiatry, Department of Psychiatry, Indiana University School of Medicine, Indianapolis, IN, United States",NA
"2423","34248708","10.3389/fpsyt.2021.671442","INteractive Virtual Expert-Led Skills Training: A Multi-Modal Curriculum for Medical Trainees.","Background: Internationally, pediatric depression and suicide are significant issues. Additionally, in the context of the COVID-19 pandemic, pediatric mental health needs are rising astronomically. In light of Child &amp; Adolescent Psychiatrist (CAP) subspecialist shortages in the United States (US), there is an increasing call for primary care physicians in Family Medicine and Pediatrics to address an increasingly broad variety of patient needs. Here we report on the development and pre","2021","07","13","Front Psychiatry","Frontiers in psychiatry","adolescent; depression; medical education; primary care; suicidality; underserved","Coleman","Emily R","Indiana University School of Medicine, Indianapolis, IN, United States",NA
"2424","34248708","10.3389/fpsyt.2021.671442","INteractive Virtual Expert-Led Skills Training: A Multi-Modal Curriculum for Medical Trainees.","Background: Internationally, pediatric depression and suicide are significant issues. Additionally, in the context of the COVID-19 pandemic, pediatric mental health needs are rising astronomically. In light of Child &amp; Adolescent Psychiatrist (CAP) subspecialist shortages in the United States (US), there is an increasing call for primary care physicians in Family Medicine and Pediatrics to address an increasingly broad variety of patient needs. Here we report on the development and pre","2021","07","13","Front Psychiatry","Frontiers in psychiatry","adolescent; depression; medical education; primary care; suicidality; underserved","Enneking","Brett A","Division of Child Development, Department of Pediatrics, Riley Child Development Center, Indiana University School of Medicine, Indianapolis, IN, United States",NA
"2425","34248708","10.3389/fpsyt.2021.671442","INteractive Virtual Expert-Led Skills Training: A Multi-Modal Curriculum for Medical Trainees.","Background: Internationally, pediatric depression and suicide are significant issues. Additionally, in the context of the COVID-19 pandemic, pediatric mental health needs are rising astronomically. In light of Child &amp; Adolescent Psychiatrist (CAP) subspecialist shortages in the United States (US), there is an increasing call for primary care physicians in Family Medicine and Pediatrics to address an increasingly broad variety of patient needs. Here we report on the development and pre","2021","07","13","Front Psychiatry","Frontiers in psychiatry","adolescent; depression; medical education; primary care; suicidality; underserved","McNally Keehn","Rebecca","Division of Child Development, Department of Pediatrics, Riley Child Development Center, Indiana University School of Medicine, Indianapolis, IN, United States",NA
"2426","34248706","10.3389/fpsyt.2021.668647","Impact of SARS-CoV-2-Pandemic on Mental Disorders and Quality of Life in Patients With Pulmonary Arterial Hypertension.","Background/Objective: Covid-19 pandemic may affect mental health and quality of life (QoL) in patients with pulmonary arterial hypertension (PAH). We assessed changes in anxiety and depression, quality of life (QoL) and self-described impact of Covid-19 in patients with PAH during the Covid-19 pandemic. Methods: This study included 152 patients with PAH from two German referral centers. Anxiety and depression were assessed using the Hospital Anxiety and Depression Scale (HADS-A and","2021","07","13","Front Psychiatry","Frontiers in psychiatry","Covid-19 pandemic; anxiety; depression; mental disorder; pulmonary arterial hypertension","Park","Da Hee","Department of Respiratory Medicine, Hannover Medical School, Hannover, Germany",NA
"2427","34248706","10.3389/fpsyt.2021.668647","Impact of SARS-CoV-2-Pandemic on Mental Disorders and Quality of Life in Patients With Pulmonary Arterial Hypertension.","Background/Objective: Covid-19 pandemic may affect mental health and quality of life (QoL) in patients with pulmonary arterial hypertension (PAH). We assessed changes in anxiety and depression, quality of life (QoL) and self-described impact of Covid-19 in patients with PAH during the Covid-19 pandemic. Methods: This study included 152 patients with PAH from two German referral centers. Anxiety and depression were assessed using the Hospital Anxiety and Depression Scale (HADS-A and","2021","07","13","Front Psychiatry","Frontiers in psychiatry","Covid-19 pandemic; anxiety; depression; mental disorder; pulmonary arterial hypertension","Fuge","Jan","Department of Respiratory Medicine, Hannover Medical School, Hannover, Germany",NA
"2428","34248706","10.3389/fpsyt.2021.668647","Impact of SARS-CoV-2-Pandemic on Mental Disorders and Quality of Life in Patients With Pulmonary Arterial Hypertension.","Background/Objective: Covid-19 pandemic may affect mental health and quality of life (QoL) in patients with pulmonary arterial hypertension (PAH). We assessed changes in anxiety and depression, quality of life (QoL) and self-described impact of Covid-19 in patients with PAH during the Covid-19 pandemic. Methods: This study included 152 patients with PAH from two German referral centers. Anxiety and depression were assessed using the Hospital Anxiety and Depression Scale (HADS-A and","2021","07","13","Front Psychiatry","Frontiers in psychiatry","Covid-19 pandemic; anxiety; depression; mental disorder; pulmonary arterial hypertension","Meltendorf","Tanja","Department of Psychiatry, Social Psychiatry, and Psychotherapy, Hannover Medical School, Hannover, Germany",NA
"2429","34248706","10.3389/fpsyt.2021.668647","Impact of SARS-CoV-2-Pandemic on Mental Disorders and Quality of Life in Patients With Pulmonary Arterial Hypertension.","Background/Objective: Covid-19 pandemic may affect mental health and quality of life (QoL) in patients with pulmonary arterial hypertension (PAH). We assessed changes in anxiety and depression, quality of life (QoL) and self-described impact of Covid-19 in patients with PAH during the Covid-19 pandemic. Methods: This study included 152 patients with PAH from two German referral centers. Anxiety and depression were assessed using the Hospital Anxiety and Depression Scale (HADS-A and","2021","07","13","Front Psychiatry","Frontiers in psychiatry","Covid-19 pandemic; anxiety; depression; mental disorder; pulmonary arterial hypertension","Kahl","Kai G","Department of Psychiatry, Social Psychiatry, and Psychotherapy, Hannover Medical School, Hannover, Germany",NA
"2430","34248706","10.3389/fpsyt.2021.668647","Impact of SARS-CoV-2-Pandemic on Mental Disorders and Quality of Life in Patients With Pulmonary Arterial Hypertension.","Background/Objective: Covid-19 pandemic may affect mental health and quality of life (QoL) in patients with pulmonary arterial hypertension (PAH). We assessed changes in anxiety and depression, quality of life (QoL) and self-described impact of Covid-19 in patients with PAH during the Covid-19 pandemic. Methods: This study included 152 patients with PAH from two German referral centers. Anxiety and depression were assessed using the Hospital Anxiety and Depression Scale (HADS-A and","2021","07","13","Front Psychiatry","Frontiers in psychiatry","Covid-19 pandemic; anxiety; depression; mental disorder; pulmonary arterial hypertension","Richter","Manuel J","Department of Internal Medicine, Justus Liebig University Giessen, Universities of Giessen and Marburg Lung Center, Giessen, Germany",NA
"2431","34248706","10.3389/fpsyt.2021.668647","Impact of SARS-CoV-2-Pandemic on Mental Disorders and Quality of Life in Patients With Pulmonary Arterial Hypertension.","Background/Objective: Covid-19 pandemic may affect mental health and quality of life (QoL) in patients with pulmonary arterial hypertension (PAH). We assessed changes in anxiety and depression, quality of life (QoL) and self-described impact of Covid-19 in patients with PAH during the Covid-19 pandemic. Methods: This study included 152 patients with PAH from two German referral centers. Anxiety and depression were assessed using the Hospital Anxiety and Depression Scale (HADS-A and","2021","07","13","Front Psychiatry","Frontiers in psychiatry","Covid-19 pandemic; anxiety; depression; mental disorder; pulmonary arterial hypertension","Gall","Henning","Department of Internal Medicine, Justus Liebig University Giessen, Universities of Giessen and Marburg Lung Center, Giessen, Germany",NA
"2432","34248706","10.3389/fpsyt.2021.668647","Impact of SARS-CoV-2-Pandemic on Mental Disorders and Quality of Life in Patients With Pulmonary Arterial Hypertension.","Background/Objective: Covid-19 pandemic may affect mental health and quality of life (QoL) in patients with pulmonary arterial hypertension (PAH). We assessed changes in anxiety and depression, quality of life (QoL) and self-described impact of Covid-19 in patients with PAH during the Covid-19 pandemic. Methods: This study included 152 patients with PAH from two German referral centers. Anxiety and depression were assessed using the Hospital Anxiety and Depression Scale (HADS-A and","2021","07","13","Front Psychiatry","Frontiers in psychiatry","Covid-19 pandemic; anxiety; depression; mental disorder; pulmonary arterial hypertension","Ghofrani","Hossein A","Department of Internal Medicine, Justus Liebig University Giessen, Universities of Giessen and Marburg Lung Center, Giessen, Germany",NA
"2433","34248706","10.3389/fpsyt.2021.668647","Impact of SARS-CoV-2-Pandemic on Mental Disorders and Quality of Life in Patients With Pulmonary Arterial Hypertension.","Background/Objective: Covid-19 pandemic may affect mental health and quality of life (QoL) in patients with pulmonary arterial hypertension (PAH). We assessed changes in anxiety and depression, quality of life (QoL) and self-described impact of Covid-19 in patients with PAH during the Covid-19 pandemic. Methods: This study included 152 patients with PAH from two German referral centers. Anxiety and depression were assessed using the Hospital Anxiety and Depression Scale (HADS-A and","2021","07","13","Front Psychiatry","Frontiers in psychiatry","Covid-19 pandemic; anxiety; depression; mental disorder; pulmonary arterial hypertension","Kamp","Jan C","Department of Respiratory Medicine, Hannover Medical School, Hannover, Germany",NA
"2434","34248706","10.3389/fpsyt.2021.668647","Impact of SARS-CoV-2-Pandemic on Mental Disorders and Quality of Life in Patients With Pulmonary Arterial Hypertension.","Background/Objective: Covid-19 pandemic may affect mental health and quality of life (QoL) in patients with pulmonary arterial hypertension (PAH). We assessed changes in anxiety and depression, quality of life (QoL) and self-described impact of Covid-19 in patients with PAH during the Covid-19 pandemic. Methods: This study included 152 patients with PAH from two German referral centers. Anxiety and depression were assessed using the Hospital Anxiety and Depression Scale (HADS-A and","2021","07","13","Front Psychiatry","Frontiers in psychiatry","Covid-19 pandemic; anxiety; depression; mental disorder; pulmonary arterial hypertension","Hoeper","Marius M","Department of Respiratory Medicine, Hannover Medical School, Hannover, Germany",NA
"2435","34248706","10.3389/fpsyt.2021.668647","Impact of SARS-CoV-2-Pandemic on Mental Disorders and Quality of Life in Patients With Pulmonary Arterial Hypertension.","Background/Objective: Covid-19 pandemic may affect mental health and quality of life (QoL) in patients with pulmonary arterial hypertension (PAH). We assessed changes in anxiety and depression, quality of life (QoL) and self-described impact of Covid-19 in patients with PAH during the Covid-19 pandemic. Methods: This study included 152 patients with PAH from two German referral centers. Anxiety and depression were assessed using the Hospital Anxiety and Depression Scale (HADS-A and","2021","07","13","Front Psychiatry","Frontiers in psychiatry","Covid-19 pandemic; anxiety; depression; mental disorder; pulmonary arterial hypertension","Olsson","Karen M","Department of Respiratory Medicine, Hannover Medical School, Hannover, Germany",NA
"2436","34248699","10.3389/fpsyt.2021.650671","A Possible Next Covid-19 Pandemic: The Violence Against Women and Its Psychiatric Consequences.",NA,"2021","07","13","Front Psychiatry","Frontiers in psychiatry","COVID-19; maltreatment; psychiatric disorders; violence; women","De Berardis","Domenico","National Health Service, Department of Mental Health, Psychiatric Service for Diagnosis and Treatment, Hospital ""G. Mazzini, "" Azienda Sanitaria Locale 4, Teramo, Italy",NA
"2437","34248699","10.3389/fpsyt.2021.650671","A Possible Next Covid-19 Pandemic: The Violence Against Women and Its Psychiatric Consequences.",NA,"2021","07","13","Front Psychiatry","Frontiers in psychiatry","COVID-19; maltreatment; psychiatric disorders; violence; women","Gianfelice","Giulia","National Health Service, Department of Mental Health, Psychiatric Service for Diagnosis and Treatment, Hospital ""G. Mazzini, "" Azienda Sanitaria Locale 4, Teramo, Italy",NA
"2438","34248699","10.3389/fpsyt.2021.650671","A Possible Next Covid-19 Pandemic: The Violence Against Women and Its Psychiatric Consequences.",NA,"2021","07","13","Front Psychiatry","Frontiers in psychiatry","COVID-19; maltreatment; psychiatric disorders; violence; women","Fornaro","Michele","Department of Neurosciences and Imaging, Chair of Psychiatry, University ""G. D'Annunzio"" Chieti, Chieti, Italy",NA
"2439","34248699","10.3389/fpsyt.2021.650671","A Possible Next Covid-19 Pandemic: The Violence Against Women and Its Psychiatric Consequences.",NA,"2021","07","13","Front Psychiatry","Frontiers in psychiatry","COVID-19; maltreatment; psychiatric disorders; violence; women","Vellante","Federica","Department of Psychiatry, Federico II University, Naples, Italy",NA
"2440","34248699","10.3389/fpsyt.2021.650671","A Possible Next Covid-19 Pandemic: The Violence Against Women and Its Psychiatric Consequences.",NA,"2021","07","13","Front Psychiatry","Frontiers in psychiatry","COVID-19; maltreatment; psychiatric disorders; violence; women","Ventriglio","Antonio","Department of Psychiatry, University of Foggia, Foggia, Italy",NA
"2441","34248699","10.3389/fpsyt.2021.650671","A Possible Next Covid-19 Pandemic: The Violence Against Women and Its Psychiatric Consequences.",NA,"2021","07","13","Front Psychiatry","Frontiers in psychiatry","COVID-19; maltreatment; psychiatric disorders; violence; women","Marini","Gabriella","ANAAO Assomed Syndicate, Women Section, Hospice and Palliative Therapy Unit, ASL Teramo, Teramo, Italy",NA
"2442","34248699","10.3389/fpsyt.2021.650671","A Possible Next Covid-19 Pandemic: The Violence Against Women and Its Psychiatric Consequences.",NA,"2021","07","13","Front Psychiatry","Frontiers in psychiatry","COVID-19; maltreatment; psychiatric disorders; violence; women","Pettorruso","Mauro","Department of Neurosciences and Imaging, Chair of Psychiatry, University ""G. D'Annunzio"" Chieti, Chieti, Italy",NA
"2443","34248699","10.3389/fpsyt.2021.650671","A Possible Next Covid-19 Pandemic: The Violence Against Women and Its Psychiatric Consequences.",NA,"2021","07","13","Front Psychiatry","Frontiers in psychiatry","COVID-19; maltreatment; psychiatric disorders; violence; women","Martinotti","Giovanni","Department of Neurosciences and Imaging, Chair of Psychiatry, University ""G. D'Annunzio"" Chieti, Chieti, Italy",NA
"2444","34248699","10.3389/fpsyt.2021.650671","A Possible Next Covid-19 Pandemic: The Violence Against Women and Its Psychiatric Consequences.",NA,"2021","07","13","Front Psychiatry","Frontiers in psychiatry","COVID-19; maltreatment; psychiatric disorders; violence; women","Fraticelli","Silvia","Department of Neurosciences and Imaging, Chair of Psychiatry, University ""G. D'Annunzio"" Chieti, Chieti, Italy",NA
"2445","34248699","10.3389/fpsyt.2021.650671","A Possible Next Covid-19 Pandemic: The Violence Against Women and Its Psychiatric Consequences.",NA,"2021","07","13","Front Psychiatry","Frontiers in psychiatry","COVID-19; maltreatment; psychiatric disorders; violence; women","Di Giannantonio","Massimo","Department of Neurosciences and Imaging, Chair of Psychiatry, University ""G. D'Annunzio"" Chieti, Chieti, Italy",NA
"2446","34248689","10.3389/fpsyt.2021.574671","Psychological Distress Among Health Care Workers in Health Facilities of Mettu Town During COVID-19 Outbreak, South West Ethiopia, 2020.","Background: During any of the infectious disease outbreak, health care workers were at increased risk of being infected, and psychological distress was a common phenomenon. Therefore, the study aimed to assess the psychological distress related to COVID-19 among healthcare workers in Mettu town. Methods: A cross sectional study was conducted from May 1-15, 2020 using convenient sampling techniques among 127 health care providers during COVID-19 pandemic in the Mettu town. Self-admi","2021","07","13","Front Psychiatry","Frontiers in psychiatry","2020; Ethiopia; Mettu; coronavirus; health care provider","Hajure","Mohammedamin","Department of Psychiatry, College of Health Sciences, Mettu University, Mettu, Ethiopia",NA
"2447","34248689","10.3389/fpsyt.2021.574671","Psychological Distress Among Health Care Workers in Health Facilities of Mettu Town During COVID-19 Outbreak, South West Ethiopia, 2020.","Background: During any of the infectious disease outbreak, health care workers were at increased risk of being infected, and psychological distress was a common phenomenon. Therefore, the study aimed to assess the psychological distress related to COVID-19 among healthcare workers in Mettu town. Methods: A cross sectional study was conducted from May 1-15, 2020 using convenient sampling techniques among 127 health care providers during COVID-19 pandemic in the Mettu town. Self-admi","2021","07","13","Front Psychiatry","Frontiers in psychiatry","2020; Ethiopia; Mettu; coronavirus; health care provider","Dibaba","Bekem","Department of Midwifery, College of Health Sciences, Mettu University, Mettu, Ethiopia",NA
"2448","34248689","10.3389/fpsyt.2021.574671","Psychological Distress Among Health Care Workers in Health Facilities of Mettu Town During COVID-19 Outbreak, South West Ethiopia, 2020.","Background: During any of the infectious disease outbreak, health care workers were at increased risk of being infected, and psychological distress was a common phenomenon. Therefore, the study aimed to assess the psychological distress related to COVID-19 among healthcare workers in Mettu town. Methods: A cross sectional study was conducted from May 1-15, 2020 using convenient sampling techniques among 127 health care providers during COVID-19 pandemic in the Mettu town. Self-admi","2021","07","13","Front Psychiatry","Frontiers in psychiatry","2020; Ethiopia; Mettu; coronavirus; health care provider","Shemsu","Shuayib","Department of Public Health, College of Health Sciences, Mettu University, Mettu, Ethiopia",NA
"2449","34248689","10.3389/fpsyt.2021.574671","Psychological Distress Among Health Care Workers in Health Facilities of Mettu Town During COVID-19 Outbreak, South West Ethiopia, 2020.","Background: During any of the infectious disease outbreak, health care workers were at increased risk of being infected, and psychological distress was a common phenomenon. Therefore, the study aimed to assess the psychological distress related to COVID-19 among healthcare workers in Mettu town. Methods: A cross sectional study was conducted from May 1-15, 2020 using convenient sampling techniques among 127 health care providers during COVID-19 pandemic in the Mettu town. Self-admi","2021","07","13","Front Psychiatry","Frontiers in psychiatry","2020; Ethiopia; Mettu; coronavirus; health care provider","Desalegn","Defaru","Department of Psychiatry, College of Health Sciences, Mettu University, Mettu, Ethiopia",NA
"2450","34248689","10.3389/fpsyt.2021.574671","Psychological Distress Among Health Care Workers in Health Facilities of Mettu Town During COVID-19 Outbreak, South West Ethiopia, 2020.","Background: During any of the infectious disease outbreak, health care workers were at increased risk of being infected, and psychological distress was a common phenomenon. Therefore, the study aimed to assess the psychological distress related to COVID-19 among healthcare workers in Mettu town. Methods: A cross sectional study was conducted from May 1-15, 2020 using convenient sampling techniques among 127 health care providers during COVID-19 pandemic in the Mettu town. Self-admi","2021","07","13","Front Psychiatry","Frontiers in psychiatry","2020; Ethiopia; Mettu; coronavirus; health care provider","Reshad","Mohammed","Department of Public Health, College of Health Sciences, Mettu University, Mettu, Ethiopia",NA
"2451","34248689","10.3389/fpsyt.2021.574671","Psychological Distress Among Health Care Workers in Health Facilities of Mettu Town During COVID-19 Outbreak, South West Ethiopia, 2020.","Background: During any of the infectious disease outbreak, health care workers were at increased risk of being infected, and psychological distress was a common phenomenon. Therefore, the study aimed to assess the psychological distress related to COVID-19 among healthcare workers in Mettu town. Methods: A cross sectional study was conducted from May 1-15, 2020 using convenient sampling techniques among 127 health care providers during COVID-19 pandemic in the Mettu town. Self-admi","2021","07","13","Front Psychiatry","Frontiers in psychiatry","2020; Ethiopia; Mettu; coronavirus; health care provider","Mohammedhussein","Mustefa","Department of Psychiatry, College of Health Sciences, Mettu University, Mettu, Ethiopia",NA
"2452","34248686","10.3389/fpsyt.2021.563533","Inverse Correlation Between Distress and Performance in the Medical Rescuers Against COVID-19 in Wuhan.","Background: During the COVID-19 pandemic, the Chinese government had transferred many medical rescuers to Wuhan, which provided effective support in disease control. The high-intensity working and mental stress during rescue could induce distress and negatively impact the performance of rescuer afterward. Materials and Methods: To identify the characteristics of stress load and its possible effects on performance, the study surveyed 90 medical rescuers in Wuhan using a mobile phone","2021","07","13","Front Psychiatry","Frontiers in psychiatry","COVID-19; medical rescuer; performanc; social support; stress load","Xie","Fang","Department of Stress Medicine, Institute of Basic Medical Sciences, Academy of Military Medical Sciences, Beijing, China",NA
"2453","34248686","10.3389/fpsyt.2021.563533","Inverse Correlation Between Distress and Performance in the Medical Rescuers Against COVID-19 in Wuhan.","Background: During the COVID-19 pandemic, the Chinese government had transferred many medical rescuers to Wuhan, which provided effective support in disease control. The high-intensity working and mental stress during rescue could induce distress and negatively impact the performance of rescuer afterward. Materials and Methods: To identify the characteristics of stress load and its possible effects on performance, the study surveyed 90 medical rescuers in Wuhan using a mobile phone","2021","07","13","Front Psychiatry","Frontiers in psychiatry","COVID-19; medical rescuer; performanc; social support; stress load","Wang","Xue","Department of Stress Medicine, Institute of Basic Medical Sciences, Academy of Military Medical Sciences, Beijing, China",NA
"2454","34248686","10.3389/fpsyt.2021.563533","Inverse Correlation Between Distress and Performance in the Medical Rescuers Against COVID-19 in Wuhan.","Background: During the COVID-19 pandemic, the Chinese government had transferred many medical rescuers to Wuhan, which provided effective support in disease control. The high-intensity working and mental stress during rescue could induce distress and negatively impact the performance of rescuer afterward. Materials and Methods: To identify the characteristics of stress load and its possible effects on performance, the study surveyed 90 medical rescuers in Wuhan using a mobile phone","2021","07","13","Front Psychiatry","Frontiers in psychiatry","COVID-19; medical rescuer; performanc; social support; stress load","Zhao","Yun","Department of Stress Medicine, Institute of Basic Medical Sciences, Academy of Military Medical Sciences, Beijing, China",NA
"2455","34248686","10.3389/fpsyt.2021.563533","Inverse Correlation Between Distress and Performance in the Medical Rescuers Against COVID-19 in Wuhan.","Background: During the COVID-19 pandemic, the Chinese government had transferred many medical rescuers to Wuhan, which provided effective support in disease control. The high-intensity working and mental stress during rescue could induce distress and negatively impact the performance of rescuer afterward. Materials and Methods: To identify the characteristics of stress load and its possible effects on performance, the study surveyed 90 medical rescuers in Wuhan using a mobile phone","2021","07","13","Front Psychiatry","Frontiers in psychiatry","COVID-19; medical rescuer; performanc; social support; stress load","Wang","Shi Da","Department of Stress Medicine, Institute of Basic Medical Sciences, Academy of Military Medical Sciences, Beijing, China",NA
"2456","34248686","10.3389/fpsyt.2021.563533","Inverse Correlation Between Distress and Performance in the Medical Rescuers Against COVID-19 in Wuhan.","Background: During the COVID-19 pandemic, the Chinese government had transferred many medical rescuers to Wuhan, which provided effective support in disease control. The high-intensity working and mental stress during rescue could induce distress and negatively impact the performance of rescuer afterward. Materials and Methods: To identify the characteristics of stress load and its possible effects on performance, the study surveyed 90 medical rescuers in Wuhan using a mobile phone","2021","07","13","Front Psychiatry","Frontiers in psychiatry","COVID-19; medical rescuer; performanc; social support; stress load","Xue","Cong","Department of Stress Medicine, Institute of Basic Medical Sciences, Academy of Military Medical Sciences, Beijing, China",NA
"2457","34248686","10.3389/fpsyt.2021.563533","Inverse Correlation Between Distress and Performance in the Medical Rescuers Against COVID-19 in Wuhan.","Background: During the COVID-19 pandemic, the Chinese government had transferred many medical rescuers to Wuhan, which provided effective support in disease control. The high-intensity working and mental stress during rescue could induce distress and negatively impact the performance of rescuer afterward. Materials and Methods: To identify the characteristics of stress load and its possible effects on performance, the study surveyed 90 medical rescuers in Wuhan using a mobile phone","2021","07","13","Front Psychiatry","Frontiers in psychiatry","COVID-19; medical rescuer; performanc; social support; stress load","Wang","Xiao Tian","Department of Stress Medicine, Institute of Basic Medical Sciences, Academy of Military Medical Sciences, Beijing, China",NA
"2458","34248686","10.3389/fpsyt.2021.563533","Inverse Correlation Between Distress and Performance in the Medical Rescuers Against COVID-19 in Wuhan.","Background: During the COVID-19 pandemic, the Chinese government had transferred many medical rescuers to Wuhan, which provided effective support in disease control. The high-intensity working and mental stress during rescue could induce distress and negatively impact the performance of rescuer afterward. Materials and Methods: To identify the characteristics of stress load and its possible effects on performance, the study surveyed 90 medical rescuers in Wuhan using a mobile phone","2021","07","13","Front Psychiatry","Frontiers in psychiatry","COVID-19; medical rescuer; performanc; social support; stress load","Chen","Yu Xin","Department of Stress Medicine, Institute of Basic Medical Sciences, Academy of Military Medical Sciences, Beijing, China",NA
"2459","34248686","10.3389/fpsyt.2021.563533","Inverse Correlation Between Distress and Performance in the Medical Rescuers Against COVID-19 in Wuhan.","Background: During the COVID-19 pandemic, the Chinese government had transferred many medical rescuers to Wuhan, which provided effective support in disease control. The high-intensity working and mental stress during rescue could induce distress and negatively impact the performance of rescuer afterward. Materials and Methods: To identify the characteristics of stress load and its possible effects on performance, the study surveyed 90 medical rescuers in Wuhan using a mobile phone","2021","07","13","Front Psychiatry","Frontiers in psychiatry","COVID-19; medical rescuer; performanc; social support; stress load","Qian","Ling Jia","Department of Stress Medicine, Institute of Basic Medical Sciences, Academy of Military Medical Sciences, Beijing, China",NA
"2460","34248665","10.3389/fphys.2021.678540","Application of Machine Learning in Pulmonary Function Assessment Where Are We Now and Where Are We Going?","Analysis of pulmonary function tests (PFTs) is an area where machine learning (ML) may benefit clinicians, researchers, and the patients. PFT measures spirometry, lung volumes, and carbon monoxide diffusion capacity of the lung (DLCO). The results are usually interpreted by the clinicians using discrete numeric data according to published guidelines. PFT interpretations by clinicians, however, are known to have inter-rater variability and the inaccuracy can impact patient care. This variability ","2021","07","13","Front Physiol","Frontiers in physiology","DLCO; artificial intelligence; flow-volume loop; lung volumes; machine learning; pulmonary function test; spirometry","Giri","Paresh C","Division of Pulmonary and Critical Care Medicine, Loma Linda University Medical Center, Loma Linda, CA, United States",NA
"2461","34248665","10.3389/fphys.2021.678540","Application of Machine Learning in Pulmonary Function Assessment Where Are We Now and Where Are We Going?","Analysis of pulmonary function tests (PFTs) is an area where machine learning (ML) may benefit clinicians, researchers, and the patients. PFT measures spirometry, lung volumes, and carbon monoxide diffusion capacity of the lung (DLCO). The results are usually interpreted by the clinicians using discrete numeric data according to published guidelines. PFT interpretations by clinicians, however, are known to have inter-rater variability and the inaccuracy can impact patient care. This variability ","2021","07","13","Front Physiol","Frontiers in physiology","DLCO; artificial intelligence; flow-volume loop; lung volumes; machine learning; pulmonary function test; spirometry","Chowdhury","Anand M","Division of Pulmonary, Allergy and Critical Care Medicine, Duke University Medical Center, Durham, NC, United States",NA
"2462","34248665","10.3389/fphys.2021.678540","Application of Machine Learning in Pulmonary Function Assessment Where Are We Now and Where Are We Going?","Analysis of pulmonary function tests (PFTs) is an area where machine learning (ML) may benefit clinicians, researchers, and the patients. PFT measures spirometry, lung volumes, and carbon monoxide diffusion capacity of the lung (DLCO). The results are usually interpreted by the clinicians using discrete numeric data according to published guidelines. PFT interpretations by clinicians, however, are known to have inter-rater variability and the inaccuracy can impact patient care. This variability ","2021","07","13","Front Physiol","Frontiers in physiology","DLCO; artificial intelligence; flow-volume loop; lung volumes; machine learning; pulmonary function test; spirometry","Bedoya","Armando","Division of Pulmonary, Allergy and Critical Care Medicine, Duke University Medical Center, Durham, NC, United States",NA
"2463","34248665","10.3389/fphys.2021.678540","Application of Machine Learning in Pulmonary Function Assessment Where Are We Now and Where Are We Going?","Analysis of pulmonary function tests (PFTs) is an area where machine learning (ML) may benefit clinicians, researchers, and the patients. PFT measures spirometry, lung volumes, and carbon monoxide diffusion capacity of the lung (DLCO). The results are usually interpreted by the clinicians using discrete numeric data according to published guidelines. PFT interpretations by clinicians, however, are known to have inter-rater variability and the inaccuracy can impact patient care. This variability ","2021","07","13","Front Physiol","Frontiers in physiology","DLCO; artificial intelligence; flow-volume loop; lung volumes; machine learning; pulmonary function test; spirometry","Chen","Hengji","Department of Mechanical Engineering and Materials Science, Pratt School of Engineering, Duke University Medical Center, Durham, NC, United States",NA
"2464","34248665","10.3389/fphys.2021.678540","Application of Machine Learning in Pulmonary Function Assessment Where Are We Now and Where Are We Going?","Analysis of pulmonary function tests (PFTs) is an area where machine learning (ML) may benefit clinicians, researchers, and the patients. PFT measures spirometry, lung volumes, and carbon monoxide diffusion capacity of the lung (DLCO). The results are usually interpreted by the clinicians using discrete numeric data according to published guidelines. PFT interpretations by clinicians, however, are known to have inter-rater variability and the inaccuracy can impact patient care. This variability ","2021","07","13","Front Physiol","Frontiers in physiology","DLCO; artificial intelligence; flow-volume loop; lung volumes; machine learning; pulmonary function test; spirometry","Lee","Hyun Suk","Hartford HealthCare, Hartford, CT, United States",NA
"2465","34248665","10.3389/fphys.2021.678540","Application of Machine Learning in Pulmonary Function Assessment Where Are We Now and Where Are We Going?","Analysis of pulmonary function tests (PFTs) is an area where machine learning (ML) may benefit clinicians, researchers, and the patients. PFT measures spirometry, lung volumes, and carbon monoxide diffusion capacity of the lung (DLCO). The results are usually interpreted by the clinicians using discrete numeric data according to published guidelines. PFT interpretations by clinicians, however, are known to have inter-rater variability and the inaccuracy can impact patient care. This variability ","2021","07","13","Front Physiol","Frontiers in physiology","DLCO; artificial intelligence; flow-volume loop; lung volumes; machine learning; pulmonary function test; spirometry","Lee","Patty","Division of Pulmonary, Allergy and Critical Care Medicine, Duke University Medical Center, Durham, NC, United States",NA
"2466","34248665","10.3389/fphys.2021.678540","Application of Machine Learning in Pulmonary Function Assessment Where Are We Now and Where Are We Going?","Analysis of pulmonary function tests (PFTs) is an area where machine learning (ML) may benefit clinicians, researchers, and the patients. PFT measures spirometry, lung volumes, and carbon monoxide diffusion capacity of the lung (DLCO). The results are usually interpreted by the clinicians using discrete numeric data according to published guidelines. PFT interpretations by clinicians, however, are known to have inter-rater variability and the inaccuracy can impact patient care. This variability ","2021","07","13","Front Physiol","Frontiers in physiology","DLCO; artificial intelligence; flow-volume loop; lung volumes; machine learning; pulmonary function test; spirometry","Henriquez","Craig","Department of Mechanical Engineering and Materials Science, Pratt School of Engineering, Duke University Medical Center, Durham, NC, United States",NA
"2467","34248665","10.3389/fphys.2021.678540","Application of Machine Learning in Pulmonary Function Assessment Where Are We Now and Where Are We Going?","Analysis of pulmonary function tests (PFTs) is an area where machine learning (ML) may benefit clinicians, researchers, and the patients. PFT measures spirometry, lung volumes, and carbon monoxide diffusion capacity of the lung (DLCO). The results are usually interpreted by the clinicians using discrete numeric data according to published guidelines. PFT interpretations by clinicians, however, are known to have inter-rater variability and the inaccuracy can impact patient care. This variability ","2021","07","13","Front Physiol","Frontiers in physiology","DLCO; artificial intelligence; flow-volume loop; lung volumes; machine learning; pulmonary function test; spirometry","MacIntyre","Neil R","Division of Pulmonary, Allergy and Critical Care Medicine, Duke University Medical Center, Durham, NC, United States",NA
"2468","34248665","10.3389/fphys.2021.678540","Application of Machine Learning in Pulmonary Function Assessment Where Are We Now and Where Are We Going?","Analysis of pulmonary function tests (PFTs) is an area where machine learning (ML) may benefit clinicians, researchers, and the patients. PFT measures spirometry, lung volumes, and carbon monoxide diffusion capacity of the lung (DLCO). The results are usually interpreted by the clinicians using discrete numeric data according to published guidelines. PFT interpretations by clinicians, however, are known to have inter-rater variability and the inaccuracy can impact patient care. This variability ","2021","07","13","Front Physiol","Frontiers in physiology","DLCO; artificial intelligence; flow-volume loop; lung volumes; machine learning; pulmonary function test; spirometry","Huang","Yuh-Chin T","Division of Pulmonary, Allergy and Critical Care Medicine, Duke University Medical Center, Durham, NC, United States",NA
"2469","34248658","10.3389/fphys.2021.655955","Maintenance of Muscle Mass and Cardiorespiratory Fitness to Cancer Patients During COVID-19 Era and After SARS-CoV-2 Vaccine.","There is emerging evidence that decreased muscle mass and cardiorespiratory fitness (CRF) are associated with increased risk of cancer-related mortality. This paper aimed to present recommendations to prescribe effective and safe exercise protocols to minimize losses, maintain or even improve muscle mass, strength, and CRF of the cancer patients who are undergoing or beyond treatment during the COVID-19 era. Overall, we recommend performing exercises with bodyweight, elastic bands, or suspension","2021","07","13","Front Physiol","Frontiers in physiology","COVID-19; cancer; exercise; physical distance; physical training","Conceição","Miguel S","School of Physical Education and Sport, University of São Paulo, São Paulo, Brazil",NA
"2470","34248658","10.3389/fphys.2021.655955","Maintenance of Muscle Mass and Cardiorespiratory Fitness to Cancer Patients During COVID-19 Era and After SARS-CoV-2 Vaccine.","There is emerging evidence that decreased muscle mass and cardiorespiratory fitness (CRF) are associated with increased risk of cancer-related mortality. This paper aimed to present recommendations to prescribe effective and safe exercise protocols to minimize losses, maintain or even improve muscle mass, strength, and CRF of the cancer patients who are undergoing or beyond treatment during the COVID-19 era. Overall, we recommend performing exercises with bodyweight, elastic bands, or suspension","2021","07","13","Front Physiol","Frontiers in physiology","COVID-19; cancer; exercise; physical distance; physical training","Derchain","Sophie","Department of Obstetrics and Gynecology, Faculty of Medical Sciences, University of Campinas, Campinas, Brazil",NA
"2471","34248658","10.3389/fphys.2021.655955","Maintenance of Muscle Mass and Cardiorespiratory Fitness to Cancer Patients During COVID-19 Era and After SARS-CoV-2 Vaccine.","There is emerging evidence that decreased muscle mass and cardiorespiratory fitness (CRF) are associated with increased risk of cancer-related mortality. This paper aimed to present recommendations to prescribe effective and safe exercise protocols to minimize losses, maintain or even improve muscle mass, strength, and CRF of the cancer patients who are undergoing or beyond treatment during the COVID-19 era. Overall, we recommend performing exercises with bodyweight, elastic bands, or suspension","2021","07","13","Front Physiol","Frontiers in physiology","COVID-19; cancer; exercise; physical distance; physical training","Vechin","Felipe Cassaro","School of Physical Education and Sport, University of São Paulo, São Paulo, Brazil",NA
"2472","34248658","10.3389/fphys.2021.655955","Maintenance of Muscle Mass and Cardiorespiratory Fitness to Cancer Patients During COVID-19 Era and After SARS-CoV-2 Vaccine.","There is emerging evidence that decreased muscle mass and cardiorespiratory fitness (CRF) are associated with increased risk of cancer-related mortality. This paper aimed to present recommendations to prescribe effective and safe exercise protocols to minimize losses, maintain or even improve muscle mass, strength, and CRF of the cancer patients who are undergoing or beyond treatment during the COVID-19 era. Overall, we recommend performing exercises with bodyweight, elastic bands, or suspension","2021","07","13","Front Physiol","Frontiers in physiology","COVID-19; cancer; exercise; physical distance; physical training","Telles","Guilherme","School of Physical Education and Sport, University of São Paulo, São Paulo, Brazil",NA
"2473","34248658","10.3389/fphys.2021.655955","Maintenance of Muscle Mass and Cardiorespiratory Fitness to Cancer Patients During COVID-19 Era and After SARS-CoV-2 Vaccine.","There is emerging evidence that decreased muscle mass and cardiorespiratory fitness (CRF) are associated with increased risk of cancer-related mortality. This paper aimed to present recommendations to prescribe effective and safe exercise protocols to minimize losses, maintain or even improve muscle mass, strength, and CRF of the cancer patients who are undergoing or beyond treatment during the COVID-19 era. Overall, we recommend performing exercises with bodyweight, elastic bands, or suspension","2021","07","13","Front Physiol","Frontiers in physiology","COVID-19; cancer; exercise; physical distance; physical training","Maginador","Guilherme Fiori","Department of Obstetrics and Gynecology, Faculty of Medical Sciences, University of Campinas, Campinas, Brazil",NA
"2474","34248658","10.3389/fphys.2021.655955","Maintenance of Muscle Mass and Cardiorespiratory Fitness to Cancer Patients During COVID-19 Era and After SARS-CoV-2 Vaccine.","There is emerging evidence that decreased muscle mass and cardiorespiratory fitness (CRF) are associated with increased risk of cancer-related mortality. This paper aimed to present recommendations to prescribe effective and safe exercise protocols to minimize losses, maintain or even improve muscle mass, strength, and CRF of the cancer patients who are undergoing or beyond treatment during the COVID-19 era. Overall, we recommend performing exercises with bodyweight, elastic bands, or suspension","2021","07","13","Front Physiol","Frontiers in physiology","COVID-19; cancer; exercise; physical distance; physical training","Sarian","Luís Otávio","Department of Obstetrics and Gynecology, Faculty of Medical Sciences, University of Campinas, Campinas, Brazil",NA
"2475","34248658","10.3389/fphys.2021.655955","Maintenance of Muscle Mass and Cardiorespiratory Fitness to Cancer Patients During COVID-19 Era and After SARS-CoV-2 Vaccine.","There is emerging evidence that decreased muscle mass and cardiorespiratory fitness (CRF) are associated with increased risk of cancer-related mortality. This paper aimed to present recommendations to prescribe effective and safe exercise protocols to minimize losses, maintain or even improve muscle mass, strength, and CRF of the cancer patients who are undergoing or beyond treatment during the COVID-19 era. Overall, we recommend performing exercises with bodyweight, elastic bands, or suspension","2021","07","13","Front Physiol","Frontiers in physiology","COVID-19; cancer; exercise; physical distance; physical training","Libardi","Cleiton Augusto","MUSCULAB-Laboratory of Neuromuscular Adaptations to Resistance Training, Department of Physical Education, Federal University of São Carlos, São Carlos, Brazil",NA
"2476","34248658","10.3389/fphys.2021.655955","Maintenance of Muscle Mass and Cardiorespiratory Fitness to Cancer Patients During COVID-19 Era and After SARS-CoV-2 Vaccine.","There is emerging evidence that decreased muscle mass and cardiorespiratory fitness (CRF) are associated with increased risk of cancer-related mortality. This paper aimed to present recommendations to prescribe effective and safe exercise protocols to minimize losses, maintain or even improve muscle mass, strength, and CRF of the cancer patients who are undergoing or beyond treatment during the COVID-19 era. Overall, we recommend performing exercises with bodyweight, elastic bands, or suspension","2021","07","13","Front Physiol","Frontiers in physiology","COVID-19; cancer; exercise; physical distance; physical training","Ugrinowitsch","Carlos","School of Physical Education and Sport, University of São Paulo, São Paulo, Brazil",NA
"2477","34248655","10.3389/fphys.2021.644149","Modeling NO Biotransport in Brain Using a Space-Fractional Reaction-Diffusion Equation.","Nitric oxide (NO) is a small gaseous molecule that is involved in some critical biochemical processes in the body such as the regulation of cerebral blood flow and pressure. Infection and inflammatory processes such as those caused by COVID-19 produce a disequilibrium in the NO bioavailability and/or a delay in the interactions of NO with other molecules contributing to the onset and evolution of cardiocerebrovascular diseases. A link between the SARS-CoV-2 virus and NO is introduced. Recent exp","2021","07","13","Front Physiol","Frontiers in physiology","Maxwell viscoelastic model; anomalous diffusion; fractional calculus; mechanotransduction; nitric oxide","Tamis","Andrew","Department of Engineering Science and Mechanics, Pennsylvania State University, University Park, PA, United States",NA
"2478","34248655","10.3389/fphys.2021.644149","Modeling NO Biotransport in Brain Using a Space-Fractional Reaction-Diffusion Equation.","Nitric oxide (NO) is a small gaseous molecule that is involved in some critical biochemical processes in the body such as the regulation of cerebral blood flow and pressure. Infection and inflammatory processes such as those caused by COVID-19 produce a disequilibrium in the NO bioavailability and/or a delay in the interactions of NO with other molecules contributing to the onset and evolution of cardiocerebrovascular diseases. A link between the SARS-CoV-2 virus and NO is introduced. Recent exp","2021","07","13","Front Physiol","Frontiers in physiology","Maxwell viscoelastic model; anomalous diffusion; fractional calculus; mechanotransduction; nitric oxide","Drapaca","Corina S","Department of Engineering Science and Mechanics, Pennsylvania State University, University Park, PA, United States",NA
"2479","34248620","10.3389/fphar.2021.656246","Prevention and Recovery of COVID-19 Patients With Kampo Medicine: Review of Case Reports and Ongoing Clinical Trials.","Coronavirus disease 2019 (COVID-19) spread to Japan in 2020, where the number of infected patients exceeded 250,000 and COVID-related deaths exceeded 3,500 in one year. Basic guidelines for infection control were implemented in Japan, and research and development of effective drugs and vaccines were promoted. This included considering Kampo medicine, which has a long history of treating recurring emerging viral infections. Considering the characteristics of the disease (inflammation of the upper","2021","07","13","Front Pharmacol","Frontiers in pharmacology","COVID-19; Japan society for oriental medicine; Kampo; SARS-CoV-2; prevention; recovery; treatment","Takayama","Shin","Department of Kampo Medicine, Tohoku University Hospital, Sendai, Japan",NA
"2480","34248620","10.3389/fphar.2021.656246","Prevention and Recovery of COVID-19 Patients With Kampo Medicine: Review of Case Reports and Ongoing Clinical Trials.","Coronavirus disease 2019 (COVID-19) spread to Japan in 2020, where the number of infected patients exceeded 250,000 and COVID-related deaths exceeded 3,500 in one year. Basic guidelines for infection control were implemented in Japan, and research and development of effective drugs and vaccines were promoted. This included considering Kampo medicine, which has a long history of treating recurring emerging viral infections. Considering the characteristics of the disease (inflammation of the upper","2021","07","13","Front Pharmacol","Frontiers in pharmacology","COVID-19; Japan society for oriental medicine; Kampo; SARS-CoV-2; prevention; recovery; treatment","Namiki","Takao","Department of Japanese-Oriental (Kampo) Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan",NA
"2481","34248620","10.3389/fphar.2021.656246","Prevention and Recovery of COVID-19 Patients With Kampo Medicine: Review of Case Reports and Ongoing Clinical Trials.","Coronavirus disease 2019 (COVID-19) spread to Japan in 2020, where the number of infected patients exceeded 250,000 and COVID-related deaths exceeded 3,500 in one year. Basic guidelines for infection control were implemented in Japan, and research and development of effective drugs and vaccines were promoted. This included considering Kampo medicine, which has a long history of treating recurring emerging viral infections. Considering the characteristics of the disease (inflammation of the upper","2021","07","13","Front Pharmacol","Frontiers in pharmacology","COVID-19; Japan society for oriental medicine; Kampo; SARS-CoV-2; prevention; recovery; treatment","Odaguchi","Hiroshi","Oriental Medicine Research Center, Kitasato University, Minato-ku, Japan",NA
"2482","34248620","10.3389/fphar.2021.656246","Prevention and Recovery of COVID-19 Patients With Kampo Medicine: Review of Case Reports and Ongoing Clinical Trials.","Coronavirus disease 2019 (COVID-19) spread to Japan in 2020, where the number of infected patients exceeded 250,000 and COVID-related deaths exceeded 3,500 in one year. Basic guidelines for infection control were implemented in Japan, and research and development of effective drugs and vaccines were promoted. This included considering Kampo medicine, which has a long history of treating recurring emerging viral infections. Considering the characteristics of the disease (inflammation of the upper","2021","07","13","Front Pharmacol","Frontiers in pharmacology","COVID-19; Japan society for oriental medicine; Kampo; SARS-CoV-2; prevention; recovery; treatment","Arita","Ryutaro","Department of Kampo Medicine, Tohoku University Hospital, Sendai, Japan",NA
"2483","34248620","10.3389/fphar.2021.656246","Prevention and Recovery of COVID-19 Patients With Kampo Medicine: Review of Case Reports and Ongoing Clinical Trials.","Coronavirus disease 2019 (COVID-19) spread to Japan in 2020, where the number of infected patients exceeded 250,000 and COVID-related deaths exceeded 3,500 in one year. Basic guidelines for infection control were implemented in Japan, and research and development of effective drugs and vaccines were promoted. This included considering Kampo medicine, which has a long history of treating recurring emerging viral infections. Considering the characteristics of the disease (inflammation of the upper","2021","07","13","Front Pharmacol","Frontiers in pharmacology","COVID-19; Japan society for oriental medicine; Kampo; SARS-CoV-2; prevention; recovery; treatment","Hisanaga","Akito","Hospital Bando, Ibaraki, Japan",NA
"2484","34248620","10.3389/fphar.2021.656246","Prevention and Recovery of COVID-19 Patients With Kampo Medicine: Review of Case Reports and Ongoing Clinical Trials.","Coronavirus disease 2019 (COVID-19) spread to Japan in 2020, where the number of infected patients exceeded 250,000 and COVID-related deaths exceeded 3,500 in one year. Basic guidelines for infection control were implemented in Japan, and research and development of effective drugs and vaccines were promoted. This included considering Kampo medicine, which has a long history of treating recurring emerging viral infections. Considering the characteristics of the disease (inflammation of the upper","2021","07","13","Front Pharmacol","Frontiers in pharmacology","COVID-19; Japan society for oriental medicine; Kampo; SARS-CoV-2; prevention; recovery; treatment","Mitani","Kazuo","Department of Yamato Kampo Medicine and Pharmacy Center, Nara Medical University, Kashihara, Japan",NA
"2485","34248620","10.3389/fphar.2021.656246","Prevention and Recovery of COVID-19 Patients With Kampo Medicine: Review of Case Reports and Ongoing Clinical Trials.","Coronavirus disease 2019 (COVID-19) spread to Japan in 2020, where the number of infected patients exceeded 250,000 and COVID-related deaths exceeded 3,500 in one year. Basic guidelines for infection control were implemented in Japan, and research and development of effective drugs and vaccines were promoted. This included considering Kampo medicine, which has a long history of treating recurring emerging viral infections. Considering the characteristics of the disease (inflammation of the upper","2021","07","13","Front Pharmacol","Frontiers in pharmacology","COVID-19; Japan society for oriental medicine; Kampo; SARS-CoV-2; prevention; recovery; treatment","Ito","Takashi","Akashi Clinic Kanda, Chiyoda-ku, Japan",NA
"2486","34248612","10.3389/fphar.2021.603997","Serratiopeptidase, A Serine Protease Anti-Inflammatory, Fibrinolytic, and Mucolytic Drug, Can Be a Useful Adjuvant for Management in COVID-19.",NA,"2021","07","13","Front Pharmacol","Frontiers in pharmacology","COVID-19; drug repurposing; immunomodulators; infection; inflammation; serratiopeptidase","Sharma","Charu","Department of Internal Medicine, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates",NA
"2487","34248612","10.3389/fphar.2021.603997","Serratiopeptidase, A Serine Protease Anti-Inflammatory, Fibrinolytic, and Mucolytic Drug, Can Be a Useful Adjuvant for Management in COVID-19.",NA,"2021","07","13","Front Pharmacol","Frontiers in pharmacology","COVID-19; drug repurposing; immunomodulators; infection; inflammation; serratiopeptidase","Jha","Niraj Kumar","Department of Biotechnology, School of Engineering and Technology (SET), Sharda University, Greater Noida, India",NA
"2488","34248612","10.3389/fphar.2021.603997","Serratiopeptidase, A Serine Protease Anti-Inflammatory, Fibrinolytic, and Mucolytic Drug, Can Be a Useful Adjuvant for Management in COVID-19.",NA,"2021","07","13","Front Pharmacol","Frontiers in pharmacology","COVID-19; drug repurposing; immunomodulators; infection; inflammation; serratiopeptidase","Meeran","M F Nagoor","Department of Pharmacology and Therapeutics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates",NA
"2489","34248612","10.3389/fphar.2021.603997","Serratiopeptidase, A Serine Protease Anti-Inflammatory, Fibrinolytic, and Mucolytic Drug, Can Be a Useful Adjuvant for Management in COVID-19.",NA,"2021","07","13","Front Pharmacol","Frontiers in pharmacology","COVID-19; drug repurposing; immunomodulators; infection; inflammation; serratiopeptidase","Patil","Chandragouda R","Department of Pharmacology, Delhi Pharmaceutical Sciences and Research University, New Delhi, India",NA
"2490","34248612","10.3389/fphar.2021.603997","Serratiopeptidase, A Serine Protease Anti-Inflammatory, Fibrinolytic, and Mucolytic Drug, Can Be a Useful Adjuvant for Management in COVID-19.",NA,"2021","07","13","Front Pharmacol","Frontiers in pharmacology","COVID-19; drug repurposing; immunomodulators; infection; inflammation; serratiopeptidase","Goyal","Sameer N","Shri Vile Parle Kelavani Mandal's Institute of Pharmacy, Dhule, India",NA
"2491","34248612","10.3389/fphar.2021.603997","Serratiopeptidase, A Serine Protease Anti-Inflammatory, Fibrinolytic, and Mucolytic Drug, Can Be a Useful Adjuvant for Management in COVID-19.",NA,"2021","07","13","Front Pharmacol","Frontiers in pharmacology","COVID-19; drug repurposing; immunomodulators; infection; inflammation; serratiopeptidase","Ojha","Shreesh","Department of Pharmacology and Therapeutics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates",NA
"2492","34248577","10.1159/000513977","Fatal Case of COVID-19 Pneumonia Associated with Acute Myelopathy.","In December 2019, a novel coronavirus outbreak with multiple system involvement started initially in Wuhan City, Hubei Province of China. Coronavirus disease 2019 (COVID-19) infection is a systemic disorder typically presenting with fever, fatigue, and upper and lower respiratory symptoms, although neurological manifestations are increasingly reported, but pathological mechanisms have yet to be established. The symptoms of infection with COVID-19 are dependent on the patient's age and underlying","2021","07","13","Case Rep Neurol","Case reports in neurology","COVID-19; Myelitis; Neurological manifestations; SARS virus","Hassoun","Hayder K","Faculty of Medicine, Kufa University, Middle Euphrates Neurosciences Center, Al-Najaf Al-Ashraf, Iraq",NA
"2493","34248577","10.1159/000513977","Fatal Case of COVID-19 Pneumonia Associated with Acute Myelopathy.","In December 2019, a novel coronavirus outbreak with multiple system involvement started initially in Wuhan City, Hubei Province of China. Coronavirus disease 2019 (COVID-19) infection is a systemic disorder typically presenting with fever, fatigue, and upper and lower respiratory symptoms, although neurological manifestations are increasingly reported, but pathological mechanisms have yet to be established. The symptoms of infection with COVID-19 are dependent on the patient's age and underlying","2021","07","13","Case Rep Neurol","Case reports in neurology","COVID-19; Myelitis; Neurological manifestations; SARS virus","Radeef","Mohammed R","Faculty of Medicine, Kufa University, Middle Euphrates Neurosciences Center, Al-Najaf Al-Ashraf, Iraq",NA
"2494","34248577","10.1159/000513977","Fatal Case of COVID-19 Pneumonia Associated with Acute Myelopathy.","In December 2019, a novel coronavirus outbreak with multiple system involvement started initially in Wuhan City, Hubei Province of China. Coronavirus disease 2019 (COVID-19) infection is a systemic disorder typically presenting with fever, fatigue, and upper and lower respiratory symptoms, although neurological manifestations are increasingly reported, but pathological mechanisms have yet to be established. The symptoms of infection with COVID-19 are dependent on the patient's age and underlying","2021","07","13","Case Rep Neurol","Case reports in neurology","COVID-19; Myelitis; Neurological manifestations; SARS virus","Aljid","Zahra","Faculty of Medicine, Kufa University, Middle Euphrates Neurosciences Center, Al-Najaf Al-Ashraf, Iraq",NA
"2495","34248577","10.1159/000513977","Fatal Case of COVID-19 Pneumonia Associated with Acute Myelopathy.","In December 2019, a novel coronavirus outbreak with multiple system involvement started initially in Wuhan City, Hubei Province of China. Coronavirus disease 2019 (COVID-19) infection is a systemic disorder typically presenting with fever, fatigue, and upper and lower respiratory symptoms, although neurological manifestations are increasingly reported, but pathological mechanisms have yet to be established. The symptoms of infection with COVID-19 are dependent on the patient's age and underlying","2021","07","13","Case Rep Neurol","Case reports in neurology","COVID-19; Myelitis; Neurological manifestations; SARS virus","Allebban","Zuhair","Middle Euphrates Unit for Cancer Research, Faculty of Medicine, University of Kufa, Al-Najaf Al-Ashraf, Iraq",NA
"2496","34248566","10.1159/000515457","Ischemic Stroke in a 29-Year-Old Patient with COVID-19: A Case Report.","Increasing evidence reports a greater incidence of stroke among patients with Coronavirus disease 2019 (COVID-19) than the non-COVID-19 population and suggests that SARS-CoV-2 infection represents a risk factor for thromboembolic and acute ischemic stroke. Elderly people have higher risk factors associated with acute ischemic stroke or embolization vascular events, and advanced age is strongly associated with severe COVID-19 and death. We reported, instead, a case of an ischemic stroke in a youn","2021","07","13","Case Rep Neurol","Case reports in neurology","Cerebral infarction; Coronavirus disease 2019; Hypercoagulability; SARS-CoV-2; Stroke","Avvantaggiato","Christian","Spasticity and Movement Disorders ""ReSTaRt"" Unit, Physical Medicine and Rehabilitation Section, OORR Hospital, University of Foggia, Foggia, Italy",NA
"2497","34248566","10.1159/000515457","Ischemic Stroke in a 29-Year-Old Patient with COVID-19: A Case Report.","Increasing evidence reports a greater incidence of stroke among patients with Coronavirus disease 2019 (COVID-19) than the non-COVID-19 population and suggests that SARS-CoV-2 infection represents a risk factor for thromboembolic and acute ischemic stroke. Elderly people have higher risk factors associated with acute ischemic stroke or embolization vascular events, and advanced age is strongly associated with severe COVID-19 and death. We reported, instead, a case of an ischemic stroke in a youn","2021","07","13","Case Rep Neurol","Case reports in neurology","Cerebral infarction; Coronavirus disease 2019; Hypercoagulability; SARS-CoV-2; Stroke","Amoruso","Loredana","Spasticity and Movement Disorders ""ReSTaRt"" Unit, Physical Medicine and Rehabilitation Section, OORR Hospital, University of Foggia, Foggia, Italy",NA
"2498","34248566","10.1159/000515457","Ischemic Stroke in a 29-Year-Old Patient with COVID-19: A Case Report.","Increasing evidence reports a greater incidence of stroke among patients with Coronavirus disease 2019 (COVID-19) than the non-COVID-19 population and suggests that SARS-CoV-2 infection represents a risk factor for thromboembolic and acute ischemic stroke. Elderly people have higher risk factors associated with acute ischemic stroke or embolization vascular events, and advanced age is strongly associated with severe COVID-19 and death. We reported, instead, a case of an ischemic stroke in a youn","2021","07","13","Case Rep Neurol","Case reports in neurology","Cerebral infarction; Coronavirus disease 2019; Hypercoagulability; SARS-CoV-2; Stroke","Lo Muzio","Maria Pia","Spasticity and Movement Disorders ""ReSTaRt"" Unit, Physical Medicine and Rehabilitation Section, OORR Hospital, University of Foggia, Foggia, Italy",NA
"2499","34248566","10.1159/000515457","Ischemic Stroke in a 29-Year-Old Patient with COVID-19: A Case Report.","Increasing evidence reports a greater incidence of stroke among patients with Coronavirus disease 2019 (COVID-19) than the non-COVID-19 population and suggests that SARS-CoV-2 infection represents a risk factor for thromboembolic and acute ischemic stroke. Elderly people have higher risk factors associated with acute ischemic stroke or embolization vascular events, and advanced age is strongly associated with severe COVID-19 and death. We reported, instead, a case of an ischemic stroke in a youn","2021","07","13","Case Rep Neurol","Case reports in neurology","Cerebral infarction; Coronavirus disease 2019; Hypercoagulability; SARS-CoV-2; Stroke","Mimmo","Maria Assunta","Spasticity and Movement Disorders ""ReSTaRt"" Unit, Physical Medicine and Rehabilitation Section, OORR Hospital, University of Foggia, Foggia, Italy",NA
"2500","34248566","10.1159/000515457","Ischemic Stroke in a 29-Year-Old Patient with COVID-19: A Case Report.","Increasing evidence reports a greater incidence of stroke among patients with Coronavirus disease 2019 (COVID-19) than the non-COVID-19 population and suggests that SARS-CoV-2 infection represents a risk factor for thromboembolic and acute ischemic stroke. Elderly people have higher risk factors associated with acute ischemic stroke or embolization vascular events, and advanced age is strongly associated with severe COVID-19 and death. We reported, instead, a case of an ischemic stroke in a youn","2021","07","13","Case Rep Neurol","Case reports in neurology","Cerebral infarction; Coronavirus disease 2019; Hypercoagulability; SARS-CoV-2; Stroke","Delli Bergoli","Michelina","Spasticity and Movement Disorders ""ReSTaRt"" Unit, Physical Medicine and Rehabilitation Section, OORR Hospital, University of Foggia, Foggia, Italy",NA
"2501","34248566","10.1159/000515457","Ischemic Stroke in a 29-Year-Old Patient with COVID-19: A Case Report.","Increasing evidence reports a greater incidence of stroke among patients with Coronavirus disease 2019 (COVID-19) than the non-COVID-19 population and suggests that SARS-CoV-2 infection represents a risk factor for thromboembolic and acute ischemic stroke. Elderly people have higher risk factors associated with acute ischemic stroke or embolization vascular events, and advanced age is strongly associated with severe COVID-19 and death. We reported, instead, a case of an ischemic stroke in a youn","2021","07","13","Case Rep Neurol","Case reports in neurology","Cerebral infarction; Coronavirus disease 2019; Hypercoagulability; SARS-CoV-2; Stroke","Cinone","Nicoletta","Spasticity and Movement Disorders ""ReSTaRt"" Unit, Physical Medicine and Rehabilitation Section, OORR Hospital, University of Foggia, Foggia, Italy",NA
"2502","34248566","10.1159/000515457","Ischemic Stroke in a 29-Year-Old Patient with COVID-19: A Case Report.","Increasing evidence reports a greater incidence of stroke among patients with Coronavirus disease 2019 (COVID-19) than the non-COVID-19 population and suggests that SARS-CoV-2 infection represents a risk factor for thromboembolic and acute ischemic stroke. Elderly people have higher risk factors associated with acute ischemic stroke or embolization vascular events, and advanced age is strongly associated with severe COVID-19 and death. We reported, instead, a case of an ischemic stroke in a youn","2021","07","13","Case Rep Neurol","Case reports in neurology","Cerebral infarction; Coronavirus disease 2019; Hypercoagulability; SARS-CoV-2; Stroke","Santoro","Luigi","Spasticity and Movement Disorders ""ReSTaRt"" Unit, Physical Medicine and Rehabilitation Section, OORR Hospital, University of Foggia, Foggia, Italy",NA
"2503","34248566","10.1159/000515457","Ischemic Stroke in a 29-Year-Old Patient with COVID-19: A Case Report.","Increasing evidence reports a greater incidence of stroke among patients with Coronavirus disease 2019 (COVID-19) than the non-COVID-19 population and suggests that SARS-CoV-2 infection represents a risk factor for thromboembolic and acute ischemic stroke. Elderly people have higher risk factors associated with acute ischemic stroke or embolization vascular events, and advanced age is strongly associated with severe COVID-19 and death. We reported, instead, a case of an ischemic stroke in a youn","2021","07","13","Case Rep Neurol","Case reports in neurology","Cerebral infarction; Coronavirus disease 2019; Hypercoagulability; SARS-CoV-2; Stroke","Stuppiello","Lucia","Spasticity and Movement Disorders ""ReSTaRt"" Unit, Physical Medicine and Rehabilitation Section, OORR Hospital, University of Foggia, Foggia, Italy",NA
"2504","34248566","10.1159/000515457","Ischemic Stroke in a 29-Year-Old Patient with COVID-19: A Case Report.","Increasing evidence reports a greater incidence of stroke among patients with Coronavirus disease 2019 (COVID-19) than the non-COVID-19 population and suggests that SARS-CoV-2 infection represents a risk factor for thromboembolic and acute ischemic stroke. Elderly people have higher risk factors associated with acute ischemic stroke or embolization vascular events, and advanced age is strongly associated with severe COVID-19 and death. We reported, instead, a case of an ischemic stroke in a youn","2021","07","13","Case Rep Neurol","Case reports in neurology","Cerebral infarction; Coronavirus disease 2019; Hypercoagulability; SARS-CoV-2; Stroke","Turitto","Antonio","Spasticity and Movement Disorders ""ReSTaRt"" Unit, Physical Medicine and Rehabilitation Section, OORR Hospital, University of Foggia, Foggia, Italy",NA
"2505","34248566","10.1159/000515457","Ischemic Stroke in a 29-Year-Old Patient with COVID-19: A Case Report.","Increasing evidence reports a greater incidence of stroke among patients with Coronavirus disease 2019 (COVID-19) than the non-COVID-19 population and suggests that SARS-CoV-2 infection represents a risk factor for thromboembolic and acute ischemic stroke. Elderly people have higher risk factors associated with acute ischemic stroke or embolization vascular events, and advanced age is strongly associated with severe COVID-19 and death. We reported, instead, a case of an ischemic stroke in a youn","2021","07","13","Case Rep Neurol","Case reports in neurology","Cerebral infarction; Coronavirus disease 2019; Hypercoagulability; SARS-CoV-2; Stroke","Ciritella","Chiara","Spasticity and Movement Disorders ""ReSTaRt"" Unit, Physical Medicine and Rehabilitation Section, OORR Hospital, University of Foggia, Foggia, Italy",NA
"2506","34248566","10.1159/000515457","Ischemic Stroke in a 29-Year-Old Patient with COVID-19: A Case Report.","Increasing evidence reports a greater incidence of stroke among patients with Coronavirus disease 2019 (COVID-19) than the non-COVID-19 population and suggests that SARS-CoV-2 infection represents a risk factor for thromboembolic and acute ischemic stroke. Elderly people have higher risk factors associated with acute ischemic stroke or embolization vascular events, and advanced age is strongly associated with severe COVID-19 and death. We reported, instead, a case of an ischemic stroke in a youn","2021","07","13","Case Rep Neurol","Case reports in neurology","Cerebral infarction; Coronavirus disease 2019; Hypercoagulability; SARS-CoV-2; Stroke","Fiore","Pietro","Istituti Clinici Scientifici Maugeri, IRCCS Institute of Bari, Bari, Italy",NA
"2507","34248566","10.1159/000515457","Ischemic Stroke in a 29-Year-Old Patient with COVID-19: A Case Report.","Increasing evidence reports a greater incidence of stroke among patients with Coronavirus disease 2019 (COVID-19) than the non-COVID-19 population and suggests that SARS-CoV-2 infection represents a risk factor for thromboembolic and acute ischemic stroke. Elderly people have higher risk factors associated with acute ischemic stroke or embolization vascular events, and advanced age is strongly associated with severe COVID-19 and death. We reported, instead, a case of an ischemic stroke in a youn","2021","07","13","Case Rep Neurol","Case reports in neurology","Cerebral infarction; Coronavirus disease 2019; Hypercoagulability; SARS-CoV-2; Stroke","Santamato","Andrea","Spasticity and Movement Disorders ""ReSTaRt"" Unit, Physical Medicine and Rehabilitation Section, OORR Hospital, University of Foggia, Foggia, Italy",NA
"2508","34248564","10.1159/000515815","Cerebral Vasculitis in a COVID-19 Confirmed Postpartum Patient: A Case Report.","COVID-19 has primarily been reported as a respiratory illness, but involvement of other organ systems has been reported. We describe a case of a postpartum with COVID-19 who had cerebral vasculitis. The patient presented with headache, blurring of vision, right-sided body weakness, and incoordination. Cranial magnetic resonance imaging (MRI) and angiography (MRA) showed a small acute hemorrhage on the left occipital lobe with associated acute subarachnoid hemorrhage along the parietal and occipi","2021","07","13","Case Rep Neurol","Case reports in neurology","COVID-19; Cerebral vasculitis; Inflammatory vasculitis; Postpartum","Chua","Audrey Marie U","Section of Neurology, Department of Internal Medicine, Cardinal Santos Medical Center, San Juan City, Philippines",NA
"2509","34248564","10.1159/000515815","Cerebral Vasculitis in a COVID-19 Confirmed Postpartum Patient: A Case Report.","COVID-19 has primarily been reported as a respiratory illness, but involvement of other organ systems has been reported. We describe a case of a postpartum with COVID-19 who had cerebral vasculitis. The patient presented with headache, blurring of vision, right-sided body weakness, and incoordination. Cranial magnetic resonance imaging (MRI) and angiography (MRA) showed a small acute hemorrhage on the left occipital lobe with associated acute subarachnoid hemorrhage along the parietal and occipi","2021","07","13","Case Rep Neurol","Case reports in neurology","COVID-19; Cerebral vasculitis; Inflammatory vasculitis; Postpartum","Jamora","Roland Dominic G","Section of Neurology, Department of Internal Medicine, Cardinal Santos Medical Center, San Juan City, Philippines",NA
"2510","34248564","10.1159/000515815","Cerebral Vasculitis in a COVID-19 Confirmed Postpartum Patient: A Case Report.","COVID-19 has primarily been reported as a respiratory illness, but involvement of other organ systems has been reported. We describe a case of a postpartum with COVID-19 who had cerebral vasculitis. The patient presented with headache, blurring of vision, right-sided body weakness, and incoordination. Cranial magnetic resonance imaging (MRI) and angiography (MRA) showed a small acute hemorrhage on the left occipital lobe with associated acute subarachnoid hemorrhage along the parietal and occipi","2021","07","13","Case Rep Neurol","Case reports in neurology","COVID-19; Cerebral vasculitis; Inflammatory vasculitis; Postpartum","Jose","Arianne Crizielle E","Department of Internal Medicine, Cardinal Santos Medical Center, San Juan City, Philippines",NA
"2511","34248564","10.1159/000515815","Cerebral Vasculitis in a COVID-19 Confirmed Postpartum Patient: A Case Report.","COVID-19 has primarily been reported as a respiratory illness, but involvement of other organ systems has been reported. We describe a case of a postpartum with COVID-19 who had cerebral vasculitis. The patient presented with headache, blurring of vision, right-sided body weakness, and incoordination. Cranial magnetic resonance imaging (MRI) and angiography (MRA) showed a small acute hemorrhage on the left occipital lobe with associated acute subarachnoid hemorrhage along the parietal and occipi","2021","07","13","Case Rep Neurol","Case reports in neurology","COVID-19; Cerebral vasculitis; Inflammatory vasculitis; Postpartum","Anlacan","Veeda Michelle M","Section of Neurology, Department of Internal Medicine, Cardinal Santos Medical Center, San Juan City, Philippines",NA
"2512","34248543","10.1159/000515261","Carcinoembryonic Antigen Elevation in a Patient with SARS-CoV-2 and a History of Colon Cancer.","The severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) pandemic continues to affect millions of people and impact health-care delivery worldwide. New data and insights into the diagnosis and treatment of SARS-CoV-2 are emerging rapidly. Several prognostic biomarkers have been studied in patients with SARS-CoV-2. Among those biomarkers is the carcinoembryonic antigen (CEA). We report the case of a 46-year-old male with a history of colon cancer who was found to have an elevated CEA leve","2021","07","13","Case Rep Oncol","Case reports in oncology","Carcinoembryonic antigen; Colon cancer; SARS-CoV-2","Alrifai","Taha","Section of Medical Oncology, Division of Hematology/Oncology/Cell Therapy, Department of Internal Medicine, Rush University Medical Center, Chicago, Illinois, USA",NA
"2513","34248543","10.1159/000515261","Carcinoembryonic Antigen Elevation in a Patient with SARS-CoV-2 and a History of Colon Cancer.","The severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) pandemic continues to affect millions of people and impact health-care delivery worldwide. New data and insights into the diagnosis and treatment of SARS-CoV-2 are emerging rapidly. Several prognostic biomarkers have been studied in patients with SARS-CoV-2. Among those biomarkers is the carcinoembryonic antigen (CEA). We report the case of a 46-year-old male with a history of colon cancer who was found to have an elevated CEA leve","2021","07","13","Case Rep Oncol","Case reports in oncology","Carcinoembryonic antigen; Colon cancer; SARS-CoV-2","Sharko","Anita","Section of Medical Oncology, Division of Hematology/Oncology/Cell Therapy, Department of Internal Medicine, Rush University Medical Center, Chicago, Illinois, USA",NA
"2514","34248543","10.1159/000515261","Carcinoembryonic Antigen Elevation in a Patient with SARS-CoV-2 and a History of Colon Cancer.","The severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) pandemic continues to affect millions of people and impact health-care delivery worldwide. New data and insights into the diagnosis and treatment of SARS-CoV-2 are emerging rapidly. Several prognostic biomarkers have been studied in patients with SARS-CoV-2. Among those biomarkers is the carcinoembryonic antigen (CEA). We report the case of a 46-year-old male with a history of colon cancer who was found to have an elevated CEA leve","2021","07","13","Case Rep Oncol","Case reports in oncology","Carcinoembryonic antigen; Colon cancer; SARS-CoV-2","Leslie","William T","Section of Medical Oncology, Division of Hematology/Oncology/Cell Therapy, Department of Internal Medicine, Rush University Medical Center, Chicago, Illinois, USA",NA
"2515","34248502","10.3389/fncel.2021.673217","Endothelial Senescence and Chronic Fatigue Syndrome, a COVID-19 Based Hypothesis.","Myalgic encephalomyelitis/chronic fatigue syndrome is a serious illness of unknown etiology, characterized by debilitating exhaustion, memory impairment, pain and sleep abnormalities. Viral infections are believed to initiate the pathogenesis of this syndrome although the definite proof remains elusive. With the unfolding of COVID-19 pandemic, the interest in this condition has resurfaced as excessive tiredness, a major complaint of patients infected with the SARS-CoV-2 virus, often lingers for ","2021","07","13","Front Cell Neurosci","Frontiers in cellular neuroscience","cellular senescence; endothelial cells; endotoxin tolerance; gut microbial community; microbial translocation","Sfera","Adonis","Patton State Hospital, San Bernardino, CA, United States",NA
"2516","34248502","10.3389/fncel.2021.673217","Endothelial Senescence and Chronic Fatigue Syndrome, a COVID-19 Based Hypothesis.","Myalgic encephalomyelitis/chronic fatigue syndrome is a serious illness of unknown etiology, characterized by debilitating exhaustion, memory impairment, pain and sleep abnormalities. Viral infections are believed to initiate the pathogenesis of this syndrome although the definite proof remains elusive. With the unfolding of COVID-19 pandemic, the interest in this condition has resurfaced as excessive tiredness, a major complaint of patients infected with the SARS-CoV-2 virus, often lingers for ","2021","07","13","Front Cell Neurosci","Frontiers in cellular neuroscience","cellular senescence; endothelial cells; endotoxin tolerance; gut microbial community; microbial translocation","Osorio","Carolina","Loma Linda University, Loma Linda, CA, United States",NA
"2517","34248502","10.3389/fncel.2021.673217","Endothelial Senescence and Chronic Fatigue Syndrome, a COVID-19 Based Hypothesis.","Myalgic encephalomyelitis/chronic fatigue syndrome is a serious illness of unknown etiology, characterized by debilitating exhaustion, memory impairment, pain and sleep abnormalities. Viral infections are believed to initiate the pathogenesis of this syndrome although the definite proof remains elusive. With the unfolding of COVID-19 pandemic, the interest in this condition has resurfaced as excessive tiredness, a major complaint of patients infected with the SARS-CoV-2 virus, often lingers for ","2021","07","13","Front Cell Neurosci","Frontiers in cellular neuroscience","cellular senescence; endothelial cells; endotoxin tolerance; gut microbial community; microbial translocation","Zapata Martín Del Campo","Carlos M","Psychiatry Service, Outpatient Consultation Department, National Institute of Cardiology Ignacio Chavez, Mexico, Mexico",NA
"2518","34248502","10.3389/fncel.2021.673217","Endothelial Senescence and Chronic Fatigue Syndrome, a COVID-19 Based Hypothesis.","Myalgic encephalomyelitis/chronic fatigue syndrome is a serious illness of unknown etiology, characterized by debilitating exhaustion, memory impairment, pain and sleep abnormalities. Viral infections are believed to initiate the pathogenesis of this syndrome although the definite proof remains elusive. With the unfolding of COVID-19 pandemic, the interest in this condition has resurfaced as excessive tiredness, a major complaint of patients infected with the SARS-CoV-2 virus, often lingers for ","2021","07","13","Front Cell Neurosci","Frontiers in cellular neuroscience","cellular senescence; endothelial cells; endotoxin tolerance; gut microbial community; microbial translocation","Pereida","Shaniah","Loma Linda University, Loma Linda, CA, United States",NA
"2519","34248502","10.3389/fncel.2021.673217","Endothelial Senescence and Chronic Fatigue Syndrome, a COVID-19 Based Hypothesis.","Myalgic encephalomyelitis/chronic fatigue syndrome is a serious illness of unknown etiology, characterized by debilitating exhaustion, memory impairment, pain and sleep abnormalities. Viral infections are believed to initiate the pathogenesis of this syndrome although the definite proof remains elusive. With the unfolding of COVID-19 pandemic, the interest in this condition has resurfaced as excessive tiredness, a major complaint of patients infected with the SARS-CoV-2 virus, often lingers for ","2021","07","13","Front Cell Neurosci","Frontiers in cellular neuroscience","cellular senescence; endothelial cells; endotoxin tolerance; gut microbial community; microbial translocation","Maurer","Steve","Patton State Hospital, San Bernardino, CA, United States",NA
"2520","34248502","10.3389/fncel.2021.673217","Endothelial Senescence and Chronic Fatigue Syndrome, a COVID-19 Based Hypothesis.","Myalgic encephalomyelitis/chronic fatigue syndrome is a serious illness of unknown etiology, characterized by debilitating exhaustion, memory impairment, pain and sleep abnormalities. Viral infections are believed to initiate the pathogenesis of this syndrome although the definite proof remains elusive. With the unfolding of COVID-19 pandemic, the interest in this condition has resurfaced as excessive tiredness, a major complaint of patients infected with the SARS-CoV-2 virus, often lingers for ","2021","07","13","Front Cell Neurosci","Frontiers in cellular neuroscience","cellular senescence; endothelial cells; endotoxin tolerance; gut microbial community; microbial translocation","Maldonado","Jose Campo","Department of Internal Medicine, The University of Texas Rio Grande Valley, Edinburg, TX, United States",NA
"2521","34248502","10.3389/fncel.2021.673217","Endothelial Senescence and Chronic Fatigue Syndrome, a COVID-19 Based Hypothesis.","Myalgic encephalomyelitis/chronic fatigue syndrome is a serious illness of unknown etiology, characterized by debilitating exhaustion, memory impairment, pain and sleep abnormalities. Viral infections are believed to initiate the pathogenesis of this syndrome although the definite proof remains elusive. With the unfolding of COVID-19 pandemic, the interest in this condition has resurfaced as excessive tiredness, a major complaint of patients infected with the SARS-CoV-2 virus, often lingers for ","2021","07","13","Front Cell Neurosci","Frontiers in cellular neuroscience","cellular senescence; endothelial cells; endotoxin tolerance; gut microbial community; microbial translocation","Kozlakidis","Zisis","International Agency for Research on Cancer (IARC), Lyon, France",NA
"2522","34248455","10.1007/s10433-021-00636-4","Time patterns of precautionary health behaviours during an easing phase of the COVID-19 pandemic in Europe.","Using data from the COVID-19 questionnaire of the Survey of Health, Ageing and Retirement in Europe (SHARE), we investigate the time patterns of precautionary health behaviours of individuals aged 50 years and above during the summer of 2020, an easing phase of the COVID-19 pandemic in Europe. We also examine how these health behaviours differ by the presence of chronic conditions such as hypertension, high cholesterol level, heart disease, diabetes or chronic bronchitis, which can be considered","2021","07","13","Eur J Ageing","European journal of ageing","COVID-19; Health risk; Precautionary behaviours; SHARE data","Bíró","Anikó","Centre for Economic and Regional Studies, Budapest, Hungary",NA
"2523","34248455","10.1007/s10433-021-00636-4","Time patterns of precautionary health behaviours during an easing phase of the COVID-19 pandemic in Europe.","Using data from the COVID-19 questionnaire of the Survey of Health, Ageing and Retirement in Europe (SHARE), we investigate the time patterns of precautionary health behaviours of individuals aged 50 years and above during the summer of 2020, an easing phase of the COVID-19 pandemic in Europe. We also examine how these health behaviours differ by the presence of chronic conditions such as hypertension, high cholesterol level, heart disease, diabetes or chronic bronchitis, which can be considered","2021","07","13","Eur J Ageing","European journal of ageing","COVID-19; Health risk; Precautionary behaviours; SHARE data","Branyiczki","Réka","Central European University and TÁRKI, Budapest, Hungary",NA
"2524","34248455","10.1007/s10433-021-00636-4","Time patterns of precautionary health behaviours during an easing phase of the COVID-19 pandemic in Europe.","Using data from the COVID-19 questionnaire of the Survey of Health, Ageing and Retirement in Europe (SHARE), we investigate the time patterns of precautionary health behaviours of individuals aged 50 years and above during the summer of 2020, an easing phase of the COVID-19 pandemic in Europe. We also examine how these health behaviours differ by the presence of chronic conditions such as hypertension, high cholesterol level, heart disease, diabetes or chronic bronchitis, which can be considered","2021","07","13","Eur J Ageing","European journal of ageing","COVID-19; Health risk; Precautionary behaviours; SHARE data","Elek","Péter","Centre for Economic and Regional Studies and Corvinus University of Budapest, Budapest, Hungary",NA
"2525","34248453","10.1007/s10340-021-01405-z","Social distancing measures differentially affected rats in North America and Tokyo.","Because rats are commensal organisms that depend on human activities for food, shifts in human behavior will have pronounced effects on local rat populations. In the spring of 2020, social distancing measures were implemented globally to curtail the spread of SARS-CoV-2. This presented a unique opportunity to obtain information regarding the immediate effects of shifts in human behavior on rat populations in a variety of countries. In response to increased sightings of rats in the USA that were ","2021","07","13","J Pest Sci (2004)","Journal of pest science","Brown rats; COVID-19; Questionnaires; Rat infestation; Roof rats","Kiyokawa","Yasushi","Laboratory of Veterinary Ethology, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo, 113-8657 Japan",NA
"2526","34248453","10.1007/s10340-021-01405-z","Social distancing measures differentially affected rats in North America and Tokyo.","Because rats are commensal organisms that depend on human activities for food, shifts in human behavior will have pronounced effects on local rat populations. In the spring of 2020, social distancing measures were implemented globally to curtail the spread of SARS-CoV-2. This presented a unique opportunity to obtain information regarding the immediate effects of shifts in human behavior on rat populations in a variety of countries. In response to increased sightings of rats in the USA that were ","2021","07","13","J Pest Sci (2004)","Journal of pest science","Brown rats; COVID-19; Questionnaires; Rat infestation; Roof rats","Tanikawa","Tsutomu","Tokyo Pest Control Association, 2-9-8 Kajicho, Chiyoda-ku, Tokyo, 101-0044 Japan",NA
"2527","34248453","10.1007/s10340-021-01405-z","Social distancing measures differentially affected rats in North America and Tokyo.","Because rats are commensal organisms that depend on human activities for food, shifts in human behavior will have pronounced effects on local rat populations. In the spring of 2020, social distancing measures were implemented globally to curtail the spread of SARS-CoV-2. This presented a unique opportunity to obtain information regarding the immediate effects of shifts in human behavior on rat populations in a variety of countries. In response to increased sightings of rats in the USA that were ","2021","07","13","J Pest Sci (2004)","Journal of pest science","Brown rats; COVID-19; Questionnaires; Rat infestation; Roof rats","Ootaki","Masato","Laboratory of Veterinary Ethology, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo, 113-8657 Japan",NA
"2528","34248453","10.1007/s10340-021-01405-z","Social distancing measures differentially affected rats in North America and Tokyo.","Because rats are commensal organisms that depend on human activities for food, shifts in human behavior will have pronounced effects on local rat populations. In the spring of 2020, social distancing measures were implemented globally to curtail the spread of SARS-CoV-2. This presented a unique opportunity to obtain information regarding the immediate effects of shifts in human behavior on rat populations in a variety of countries. In response to increased sightings of rats in the USA that were ","2021","07","13","J Pest Sci (2004)","Journal of pest science","Brown rats; COVID-19; Questionnaires; Rat infestation; Roof rats","Parsons","Michael H","Department of Biological Sciences, Fordham University, 441 East Fordham Road, Bronx, NY 10458 USA",NA
"2529","34248448","10.1016/j.asoc.2021.107683","Transmission trend of the COVID-19 pandemic predicted by dendritic neural regression.","In 2020, a novel coronavirus disease became a global problem. The disease was called COVID-19, as the first patient was diagnosed in December 2019. The disease spread around the world quickly due to its powerful viral ability. To date, the spread of COVID-19 has been relatively mild in China due to timely control measures. However, in other countries, the pandemic remains severe, and COVID-19 protection and control policies are urgently needed, which has motivated this research. Since the outbre","2021","07","14","Appl Soft Comput","Applied soft computing","COVID-19; Neural network; Optimization; Prediction; Regression","Dong","Minhui","College of Computer Science and Software Engineering, Shenzhen University, Shenzhen, 518060, China",NA
"2530","34248448","10.1016/j.asoc.2021.107683","Transmission trend of the COVID-19 pandemic predicted by dendritic neural regression.","In 2020, a novel coronavirus disease became a global problem. The disease was called COVID-19, as the first patient was diagnosed in December 2019. The disease spread around the world quickly due to its powerful viral ability. To date, the spread of COVID-19 has been relatively mild in China due to timely control measures. However, in other countries, the pandemic remains severe, and COVID-19 protection and control policies are urgently needed, which has motivated this research. Since the outbre","2021","07","14","Appl Soft Comput","Applied soft computing","COVID-19; Neural network; Optimization; Prediction; Regression","Tang","Cheng","Faculty of Engineering, University of Toyama, Toyama-shi, 930-8555, Japan",NA
"2531","34248448","10.1016/j.asoc.2021.107683","Transmission trend of the COVID-19 pandemic predicted by dendritic neural regression.","In 2020, a novel coronavirus disease became a global problem. The disease was called COVID-19, as the first patient was diagnosed in December 2019. The disease spread around the world quickly due to its powerful viral ability. To date, the spread of COVID-19 has been relatively mild in China due to timely control measures. However, in other countries, the pandemic remains severe, and COVID-19 protection and control policies are urgently needed, which has motivated this research. Since the outbre","2021","07","14","Appl Soft Comput","Applied soft computing","COVID-19; Neural network; Optimization; Prediction; Regression","Ji","Junkai","College of Computer Science and Software Engineering, Shenzhen University, Shenzhen, 518060, China",NA
"2532","34248448","10.1016/j.asoc.2021.107683","Transmission trend of the COVID-19 pandemic predicted by dendritic neural regression.","In 2020, a novel coronavirus disease became a global problem. The disease was called COVID-19, as the first patient was diagnosed in December 2019. The disease spread around the world quickly due to its powerful viral ability. To date, the spread of COVID-19 has been relatively mild in China due to timely control measures. However, in other countries, the pandemic remains severe, and COVID-19 protection and control policies are urgently needed, which has motivated this research. Since the outbre","2021","07","14","Appl Soft Comput","Applied soft computing","COVID-19; Neural network; Optimization; Prediction; Regression","Lin","Qiuzhen","College of Computer Science and Software Engineering, Shenzhen University, Shenzhen, 518060, China",NA
"2533","34248448","10.1016/j.asoc.2021.107683","Transmission trend of the COVID-19 pandemic predicted by dendritic neural regression.","In 2020, a novel coronavirus disease became a global problem. The disease was called COVID-19, as the first patient was diagnosed in December 2019. The disease spread around the world quickly due to its powerful viral ability. To date, the spread of COVID-19 has been relatively mild in China due to timely control measures. However, in other countries, the pandemic remains severe, and COVID-19 protection and control policies are urgently needed, which has motivated this research. Since the outbre","2021","07","14","Appl Soft Comput","Applied soft computing","COVID-19; Neural network; Optimization; Prediction; Regression","Wong","Ka-Chun","Department of Computer Science, City University of Hong Kong, Hong Kong, China",NA
"2534","34248447","10.1016/j.asoc.2021.107669","A new composite approach for COVID-19 detection in X-ray images using deep features.","The new type of coronavirus, COVID 19, appeared in China at the end of 2019. It has become a pandemic that is spreading all over the world in a very short time. The detection of this disease, which has serious health and socio-economic damages, is of vital importance. COVID-19 detection is performed by applying PCR and serological tests. Additionally, COVID detection is possible using X-ray and computed tomography images. Disease detection has an important position in scientific researches that ","2021","07","13","Appl Soft Comput","Applied soft computing","COVID-19 detection in X-ray images; Data processing; Deep features; Feature extraction; Feature fusion; Pre-trained models","Ozcan","Tayyip","Department of Computer Engineering, Erciyes University, 38039, Melikgazi, Kayseri, Turkey",NA
"2535","34248446","10.1007/s10993-021-09589-x","#workfromhome: how multi-level marketers enact and subvert federal language policy for profit.","This paper analyzes how multi-level marketing companies (MLMs), via direct selling through electronic commerce (e-commerce) and social media, enact and evade federal language policy to maximize profits. Here we describe the federal language policies that govern this type of e-commerce, and in particular, the language policies of the Federal Trade Commission, which dictate what can and cannot be communicated by MLM companies and their contractors. We then illustrate how these federal language pol","2021","07","13","Lang Policy","Language policy","#workfromhome; COVID-19; Direct sales; E-commerce; Hashtags; Instagram; Pandemic; Social media; Workplace","Fluegel","Sabrina","University of Minnesota, Minneapolis, USA",NA
"2536","34248446","10.1007/s10993-021-09589-x","#workfromhome: how multi-level marketers enact and subvert federal language policy for profit.","This paper analyzes how multi-level marketing companies (MLMs), via direct selling through electronic commerce (e-commerce) and social media, enact and evade federal language policy to maximize profits. Here we describe the federal language policies that govern this type of e-commerce, and in particular, the language policies of the Federal Trade Commission, which dictate what can and cannot be communicated by MLM companies and their contractors. We then illustrate how these federal language pol","2021","07","13","Lang Policy","Language policy","#workfromhome; COVID-19; Direct sales; E-commerce; Hashtags; Instagram; Pandemic; Social media; Workplace","King","Kendall","University of Minnesota, Minneapolis, USA",NA
"2537","34248442","10.1007/s11469-021-00577-0","The Impact of COVID-19 Traumatic Stressors on Mental Health: Is COVID-19 a New Trauma Type.","COVID-19 is a new type of trauma that has never been conceptually or empirically analyzed in our discipline. This study aimed to investigate the impact of COVID-19 as traumatic stress on mental health after controlling for individuals' previous stressors and traumas. We utilized a sample of (N = 1374) adults from seven Arab countries. We used an anonymous online questionnaire that included measures for COVID-19 traumatic stress, posttraumatic stress disorder, anxiety, depression, and cumulative ","2021","07","13","Int J Ment Health Addict","International journal of mental health and addiction","COVID-19; Continuous traumatic stress; Depression; PTSD; Type III trauma","Kira","Ibrahim A","Center for Cumulative Trauma Studies, Stone Mountain, GA, &amp",NA
"2538","34248442","10.1007/s11469-021-00577-0","The Impact of COVID-19 Traumatic Stressors on Mental Health: Is COVID-19 a New Trauma Type.","COVID-19 is a new type of trauma that has never been conceptually or empirically analyzed in our discipline. This study aimed to investigate the impact of COVID-19 as traumatic stress on mental health after controlling for individuals' previous stressors and traumas. We utilized a sample of (N = 1374) adults from seven Arab countries. We used an anonymous online questionnaire that included measures for COVID-19 traumatic stress, posttraumatic stress disorder, anxiety, depression, and cumulative ","2021","07","13","Int J Ment Health Addict","International journal of mental health and addiction","COVID-19; Continuous traumatic stress; Depression; PTSD; Type III trauma","Shuwiekh","Hanaa A M","Fayoum University, Fayoum, Egypt",NA
"2539","34248442","10.1007/s11469-021-00577-0","The Impact of COVID-19 Traumatic Stressors on Mental Health: Is COVID-19 a New Trauma Type.","COVID-19 is a new type of trauma that has never been conceptually or empirically analyzed in our discipline. This study aimed to investigate the impact of COVID-19 as traumatic stress on mental health after controlling for individuals' previous stressors and traumas. We utilized a sample of (N = 1374) adults from seven Arab countries. We used an anonymous online questionnaire that included measures for COVID-19 traumatic stress, posttraumatic stress disorder, anxiety, depression, and cumulative ","2021","07","13","Int J Ment Health Addict","International journal of mental health and addiction","COVID-19; Continuous traumatic stress; Depression; PTSD; Type III trauma","Ashby","Jeffrey S","Center for Stress, Trauma and Resiliency, Georgia State University, Atlanta, GA USA",NA
"2540","34248442","10.1007/s11469-021-00577-0","The Impact of COVID-19 Traumatic Stressors on Mental Health: Is COVID-19 a New Trauma Type.","COVID-19 is a new type of trauma that has never been conceptually or empirically analyzed in our discipline. This study aimed to investigate the impact of COVID-19 as traumatic stress on mental health after controlling for individuals' previous stressors and traumas. We utilized a sample of (N = 1374) adults from seven Arab countries. We used an anonymous online questionnaire that included measures for COVID-19 traumatic stress, posttraumatic stress disorder, anxiety, depression, and cumulative ","2021","07","13","Int J Ment Health Addict","International journal of mental health and addiction","COVID-19; Continuous traumatic stress; Depression; PTSD; Type III trauma","Elwakeel","Sayed Ahmed","Fayoum University, Fayoum, Egypt",NA
"2541","34248442","10.1007/s11469-021-00577-0","The Impact of COVID-19 Traumatic Stressors on Mental Health: Is COVID-19 a New Trauma Type.","COVID-19 is a new type of trauma that has never been conceptually or empirically analyzed in our discipline. This study aimed to investigate the impact of COVID-19 as traumatic stress on mental health after controlling for individuals' previous stressors and traumas. We utilized a sample of (N = 1374) adults from seven Arab countries. We used an anonymous online questionnaire that included measures for COVID-19 traumatic stress, posttraumatic stress disorder, anxiety, depression, and cumulative ","2021","07","13","Int J Ment Health Addict","International journal of mental health and addiction","COVID-19; Continuous traumatic stress; Depression; PTSD; Type III trauma","Alhuwailah","Amthal","Kuwait University, Kuwait, Kuwait",NA
"2542","34248442","10.1007/s11469-021-00577-0","The Impact of COVID-19 Traumatic Stressors on Mental Health: Is COVID-19 a New Trauma Type.","COVID-19 is a new type of trauma that has never been conceptually or empirically analyzed in our discipline. This study aimed to investigate the impact of COVID-19 as traumatic stress on mental health after controlling for individuals' previous stressors and traumas. We utilized a sample of (N = 1374) adults from seven Arab countries. We used an anonymous online questionnaire that included measures for COVID-19 traumatic stress, posttraumatic stress disorder, anxiety, depression, and cumulative ","2021","07","13","Int J Ment Health Addict","International journal of mental health and addiction","COVID-19; Continuous traumatic stress; Depression; PTSD; Type III trauma","Sous","Mariam Sous Fahmy","South Valley University, Qena, Egypt",NA
"2543","34248442","10.1007/s11469-021-00577-0","The Impact of COVID-19 Traumatic Stressors on Mental Health: Is COVID-19 a New Trauma Type.","COVID-19 is a new type of trauma that has never been conceptually or empirically analyzed in our discipline. This study aimed to investigate the impact of COVID-19 as traumatic stress on mental health after controlling for individuals' previous stressors and traumas. We utilized a sample of (N = 1374) adults from seven Arab countries. We used an anonymous online questionnaire that included measures for COVID-19 traumatic stress, posttraumatic stress disorder, anxiety, depression, and cumulative ","2021","07","13","Int J Ment Health Addict","International journal of mental health and addiction","COVID-19; Continuous traumatic stress; Depression; PTSD; Type III trauma","Baali","Shadia Bint Ali","Psychological Compatibility Center for Psychological Counseling, Riad, Saudi Arabia",NA
"2544","34248442","10.1007/s11469-021-00577-0","The Impact of COVID-19 Traumatic Stressors on Mental Health: Is COVID-19 a New Trauma Type.","COVID-19 is a new type of trauma that has never been conceptually or empirically analyzed in our discipline. This study aimed to investigate the impact of COVID-19 as traumatic stress on mental health after controlling for individuals' previous stressors and traumas. We utilized a sample of (N = 1374) adults from seven Arab countries. We used an anonymous online questionnaire that included measures for COVID-19 traumatic stress, posttraumatic stress disorder, anxiety, depression, and cumulative ","2021","07","13","Int J Ment Health Addict","International journal of mental health and addiction","COVID-19; Continuous traumatic stress; Depression; PTSD; Type III trauma","Azdaou","Chafika","University of Algiers, Algiers, Algeria",NA
"2545","34248442","10.1007/s11469-021-00577-0","The Impact of COVID-19 Traumatic Stressors on Mental Health: Is COVID-19 a New Trauma Type.","COVID-19 is a new type of trauma that has never been conceptually or empirically analyzed in our discipline. This study aimed to investigate the impact of COVID-19 as traumatic stress on mental health after controlling for individuals' previous stressors and traumas. We utilized a sample of (N = 1374) adults from seven Arab countries. We used an anonymous online questionnaire that included measures for COVID-19 traumatic stress, posttraumatic stress disorder, anxiety, depression, and cumulative ","2021","07","13","Int J Ment Health Addict","International journal of mental health and addiction","COVID-19; Continuous traumatic stress; Depression; PTSD; Type III trauma","Oliemat","Enas M","Hashemite University, Zarqa, Jordan",NA
"2546","34248442","10.1007/s11469-021-00577-0","The Impact of COVID-19 Traumatic Stressors on Mental Health: Is COVID-19 a New Trauma Type.","COVID-19 is a new type of trauma that has never been conceptually or empirically analyzed in our discipline. This study aimed to investigate the impact of COVID-19 as traumatic stress on mental health after controlling for individuals' previous stressors and traumas. We utilized a sample of (N = 1374) adults from seven Arab countries. We used an anonymous online questionnaire that included measures for COVID-19 traumatic stress, posttraumatic stress disorder, anxiety, depression, and cumulative ","2021","07","13","Int J Ment Health Addict","International journal of mental health and addiction","COVID-19; Continuous traumatic stress; Depression; PTSD; Type III trauma","Jamil","Hikmet J","Department of Family Medicine, Michigan State University, Lansing, MI USA",NA
"2547","34248441","10.1016/j.nurpra.2021.05.008","Multisystem Inflammatory Syndrome in Children.","Multisystem inflammatory syndrome in children (MIS-C), which was first documented in the United Kingdom and later recognized in other countries, is a postinfectious immune response to coronavirus disease 2019 (COVID-19). Its clinical manifestation resembles that of other inflammatory processes. Differentiation can be accomplished through epidemiology, a positive temporal relationship to COVID-19, and multiorgan involvement. Health care providers should maintain a high level of suspicion for MIS-","2021","07","13","J Nurse Pract","The journal for nurse practitioners : JNP","MIS-C; children; immune response; inflammatory","Holstein","Barbara",NA,NA
"2548","34248426","10.1007/s11930-021-00309-4","Women's Sexual Health During the Pandemic of COVID-19: Declines in Sexual Function and Sexual Pleasure.","The World Health Association declared COVID-19 a pandemic more than 1 year ago. We conducted a systematic review of the literature on the topic of women's sexual health during the pandemic, with a focus on sexual function and sexual pleasure. Our aim is to describe current findings and to discuss implications for women's sexual health during this period. Thirty-four articles, from 18 countries, were identified. These studies addressed topics ranging from individual aspects, such as cognitive, em","2021","07","13","Curr Sex Health Rep","Current sexual health reports","COVID-19; Gender inequality; Sexual function; Sexual health; Sexual pleasure; Women","de Oliveira","Leonor","Center for Psychology at University of Porto, Faculty of Psychology and Educational Sciences, University of Porto, R. Alfredo Allen, 4200-135 Porto, Portugal",NA
"2549","34248426","10.1007/s11930-021-00309-4","Women's Sexual Health During the Pandemic of COVID-19: Declines in Sexual Function and Sexual Pleasure.","The World Health Association declared COVID-19 a pandemic more than 1 year ago. We conducted a systematic review of the literature on the topic of women's sexual health during the pandemic, with a focus on sexual function and sexual pleasure. Our aim is to describe current findings and to discuss implications for women's sexual health during this period. Thirty-four articles, from 18 countries, were identified. These studies addressed topics ranging from individual aspects, such as cognitive, em","2021","07","13","Curr Sex Health Rep","Current sexual health reports","COVID-19; Gender inequality; Sexual function; Sexual health; Sexual pleasure; Women","Carvalho","Joana","Center for Psychology at University of Porto, Faculty of Psychology and Educational Sciences, University of Porto, R. Alfredo Allen, 4200-135 Porto, Portugal",NA
"2550","34248402","10.1590/1413-785220212902242330","ECONOMIC IMPACT OF COVID-19 ON BRAZILIAN ORTHOPEDISTS.","The aim of this study is to assess the economic impact of the new coronavirus (COVID-19) on Brazilian Orthopaedic Surgeons. The questionnaire was applied to orthopedists and it questions how long they have worked in this area; their monthly financial impact during the pandemic; what sector was impacted the most; if they had or didn't have any financial reserves and how long they would last; if they had any other source of fixed income; and how much time off they had taken from work. It was entir","2021","07","13","Acta Ortop Bras","Acta ortopedica brasileira","Coronavirus; Covid-19; Financial Reserve; Monetary Impact","Stirma","Guilherme Augusto","Universidade Federal de São Paulo, Paulista School of Medicine, São Paulo, SP, Brazil",NA
"2551","34248402","10.1590/1413-785220212902242330","ECONOMIC IMPACT OF COVID-19 ON BRAZILIAN ORTHOPEDISTS.","The aim of this study is to assess the economic impact of the new coronavirus (COVID-19) on Brazilian Orthopaedic Surgeons. The questionnaire was applied to orthopedists and it questions how long they have worked in this area; their monthly financial impact during the pandemic; what sector was impacted the most; if they had or didn't have any financial reserves and how long they would last; if they had any other source of fixed income; and how much time off they had taken from work. It was entir","2021","07","13","Acta Ortop Bras","Acta ortopedica brasileira","Coronavirus; Covid-19; Financial Reserve; Monetary Impact","Belangero","Paulo Santoro","Universidade Federal de São Paulo, Paulista School of Medicine, São Paulo, SP, Brazil",NA
"2552","34248402","10.1590/1413-785220212902242330","ECONOMIC IMPACT OF COVID-19 ON BRAZILIAN ORTHOPEDISTS.","The aim of this study is to assess the economic impact of the new coronavirus (COVID-19) on Brazilian Orthopaedic Surgeons. The questionnaire was applied to orthopedists and it questions how long they have worked in this area; their monthly financial impact during the pandemic; what sector was impacted the most; if they had or didn't have any financial reserves and how long they would last; if they had any other source of fixed income; and how much time off they had taken from work. It was entir","2021","07","13","Acta Ortop Bras","Acta ortopedica brasileira","Coronavirus; Covid-19; Financial Reserve; Monetary Impact","Pochini","Alberto DE Castro","Universidade Federal de São Paulo, Paulista School of Medicine, São Paulo, SP, Brazil",NA
"2553","34248402","10.1590/1413-785220212902242330","ECONOMIC IMPACT OF COVID-19 ON BRAZILIAN ORTHOPEDISTS.","The aim of this study is to assess the economic impact of the new coronavirus (COVID-19) on Brazilian Orthopaedic Surgeons. The questionnaire was applied to orthopedists and it questions how long they have worked in this area; their monthly financial impact during the pandemic; what sector was impacted the most; if they had or didn't have any financial reserves and how long they would last; if they had any other source of fixed income; and how much time off they had taken from work. It was entir","2021","07","13","Acta Ortop Bras","Acta ortopedica brasileira","Coronavirus; Covid-19; Financial Reserve; Monetary Impact","Andreoli","Carlos Vicente","Universidade Federal de São Paulo, Paulista School of Medicine, São Paulo, SP, Brazil",NA
"2554","34248402","10.1590/1413-785220212902242330","ECONOMIC IMPACT OF COVID-19 ON BRAZILIAN ORTHOPEDISTS.","The aim of this study is to assess the economic impact of the new coronavirus (COVID-19) on Brazilian Orthopaedic Surgeons. The questionnaire was applied to orthopedists and it questions how long they have worked in this area; their monthly financial impact during the pandemic; what sector was impacted the most; if they had or didn't have any financial reserves and how long they would last; if they had any other source of fixed income; and how much time off they had taken from work. It was entir","2021","07","13","Acta Ortop Bras","Acta ortopedica brasileira","Coronavirus; Covid-19; Financial Reserve; Monetary Impact","Ejnisman","Benno","Universidade Federal de São Paulo, Paulista School of Medicine, São Paulo, SP, Brazil",NA
"2555","34248400","10.1007/s10984-021-09376-9","Preservice teachers' perceptions of learning environments before and after pandemic-related course disruption.","When the 2020 semester began in the USA in January, it was unimaginable that the near-total closure of educational system across the globe would become the new normal. To mitigate the spread of the COVID-19 virus, teaching faculty hastily converted to an online learning environment in order for instruction to continue. This mixed-methods study used the What Is Happening In this Class? (WIHIC) questionnaire and analysis of student course evaluations to explore changes in student perceptions of le","2021","07","13","Learn Environ Res","Learning environments research","COVID-19 disruption; Higher education; Online learning environments; What Is Happening In this Class? (WIHIC)","Long","Christopher S","Department of Teacher Education and Administration, University of North Texas, Denton, USA",NA
"2556","34248400","10.1007/s10984-021-09376-9","Preservice teachers' perceptions of learning environments before and after pandemic-related course disruption.","When the 2020 semester began in the USA in January, it was unimaginable that the near-total closure of educational system across the globe would become the new normal. To mitigate the spread of the COVID-19 virus, teaching faculty hastily converted to an online learning environment in order for instruction to continue. This mixed-methods study used the What Is Happening In this Class? (WIHIC) questionnaire and analysis of student course evaluations to explore changes in student perceptions of le","2021","07","13","Learn Environ Res","Learning environments research","COVID-19 disruption; Higher education; Online learning environments; What Is Happening In this Class? (WIHIC)","Sinclair","Becky Barton","Department of Curriculum and Instruction, Texas A&amp",NA
"2557","34248400","10.1007/s10984-021-09376-9","Preservice teachers' perceptions of learning environments before and after pandemic-related course disruption.","When the 2020 semester began in the USA in January, it was unimaginable that the near-total closure of educational system across the globe would become the new normal. To mitigate the spread of the COVID-19 virus, teaching faculty hastily converted to an online learning environment in order for instruction to continue. This mixed-methods study used the What Is Happening In this Class? (WIHIC) questionnaire and analysis of student course evaluations to explore changes in student perceptions of le","2021","07","13","Learn Environ Res","Learning environments research","COVID-19 disruption; Higher education; Online learning environments; What Is Happening In this Class? (WIHIC)","Fraser","Barry J","School of Education, Curtin University, Perth, Australia",NA
"2558","34248400","10.1007/s10984-021-09376-9","Preservice teachers' perceptions of learning environments before and after pandemic-related course disruption.","When the 2020 semester began in the USA in January, it was unimaginable that the near-total closure of educational system across the globe would become the new normal. To mitigate the spread of the COVID-19 virus, teaching faculty hastily converted to an online learning environment in order for instruction to continue. This mixed-methods study used the What Is Happening In this Class? (WIHIC) questionnaire and analysis of student course evaluations to explore changes in student perceptions of le","2021","07","13","Learn Environ Res","Learning environments research","COVID-19 disruption; Higher education; Online learning environments; What Is Happening In this Class? (WIHIC)","Larson","Tiffany R","Department of Teacher Education and Administration, University of North Texas, Denton, USA",NA
"2559","34248400","10.1007/s10984-021-09376-9","Preservice teachers' perceptions of learning environments before and after pandemic-related course disruption.","When the 2020 semester began in the USA in January, it was unimaginable that the near-total closure of educational system across the globe would become the new normal. To mitigate the spread of the COVID-19 virus, teaching faculty hastily converted to an online learning environment in order for instruction to continue. This mixed-methods study used the What Is Happening In this Class? (WIHIC) questionnaire and analysis of student course evaluations to explore changes in student perceptions of le","2021","07","13","Learn Environ Res","Learning environments research","COVID-19 disruption; Higher education; Online learning environments; What Is Happening In this Class? (WIHIC)","Harrell","Pamela E","Department of Teacher Education and Administration, University of North Texas, Denton, USA",NA
"2560","34248394","10.1007/s11042-021-11100-x","Intrusion detection by machine learning for multimedia platform.","The multimedia service company, Netflix, increased the number of new subscribers during the Coronavirus pandemic age. Intrusion detection systems for multimedia platforms can prevent the platform from network attacks. An intelligent intrusion detection system is proposed for the security IP Multimedia Subsystem (IMS) based on machine learning technology. For increasing the accuracy of the classifiers, it is vital to select the critical features to construct the intrusion detection system. Two-cl","2021","07","13","Multimed Tools Appl","Multimedia tools and applications","Coronavirus pandemic; Decision tree; Intrusion detection; Machine learning; Naive Bayesian classifier; Streaming service; Support vector machine","Hsu","Chih-Yu","Fujian Provincial Key Laboratory of Big Data Mining and Applications, School of Computer Science and Mathematics, Fujian University of Technology, Fuzhou, 350118 China",NA
"2561","34248394","10.1007/s11042-021-11100-x","Intrusion detection by machine learning for multimedia platform.","The multimedia service company, Netflix, increased the number of new subscribers during the Coronavirus pandemic age. Intrusion detection systems for multimedia platforms can prevent the platform from network attacks. An intelligent intrusion detection system is proposed for the security IP Multimedia Subsystem (IMS) based on machine learning technology. For increasing the accuracy of the classifiers, it is vital to select the critical features to construct the intrusion detection system. Two-cl","2021","07","13","Multimed Tools Appl","Multimedia tools and applications","Coronavirus pandemic; Decision tree; Intrusion detection; Machine learning; Naive Bayesian classifier; Streaming service; Support vector machine","Wang","Shuai","School of Computer Science and Mathematics, Fujian University of Technology, Fuzhou, 350118 China",NA
"2562","34248394","10.1007/s11042-021-11100-x","Intrusion detection by machine learning for multimedia platform.","The multimedia service company, Netflix, increased the number of new subscribers during the Coronavirus pandemic age. Intrusion detection systems for multimedia platforms can prevent the platform from network attacks. An intelligent intrusion detection system is proposed for the security IP Multimedia Subsystem (IMS) based on machine learning technology. For increasing the accuracy of the classifiers, it is vital to select the critical features to construct the intrusion detection system. Two-cl","2021","07","13","Multimed Tools Appl","Multimedia tools and applications","Coronavirus pandemic; Decision tree; Intrusion detection; Machine learning; Naive Bayesian classifier; Streaming service; Support vector machine","Qiao","Yu","STEM, University of South Austrilia, Mawson Lakes, SA 5095 Australia",NA
"2563","34248390","10.1016/j.rser.2021.111400","COVID-19 pandemics Stage II - Energy and environmental impacts of vaccination.","The COVID-19 pandemic developed the severest public health event in recent history. The first stage for defence has already been documented. This paper moves forward to contribute to the second stage for offensive by assessing the energy and environmental impacts related to vaccination. The vaccination campaign is a multidisciplinary topic incorporating policies, population behaviour, planning, manufacturing, materials supporting, cold-chain logistics and waste treatment. The vaccination for pan","2021","07","12","Renew Sustain Energy Rev","Renewable &amp; sustainable energy reviews","COVID-19 vaccination campaigns; Cold supply chain; Energy and emissions; Environmental impact; Interdisciplinary analysis; Sustainability","Kleme","Jirí Jaromír","Sustainable Process Integration Laboratory - SPIL, NETME Centre, Faculty of Mechanical Engineering, Brno University of Technology- VUT Brno, Technická 2896/2, 616 69, Brno, Czech Republic",NA
"2564","34248390","10.1016/j.rser.2021.111400","COVID-19 pandemics Stage II - Energy and environmental impacts of vaccination.","The COVID-19 pandemic developed the severest public health event in recent history. The first stage for defence has already been documented. This paper moves forward to contribute to the second stage for offensive by assessing the energy and environmental impacts related to vaccination. The vaccination campaign is a multidisciplinary topic incorporating policies, population behaviour, planning, manufacturing, materials supporting, cold-chain logistics and waste treatment. The vaccination for pan","2021","07","12","Renew Sustain Energy Rev","Renewable &amp; sustainable energy reviews","COVID-19 vaccination campaigns; Cold supply chain; Energy and emissions; Environmental impact; Interdisciplinary analysis; Sustainability","Jiang","Peng","Department of Industrial Engineering and Engineering Management, Business School, Sichuan University, Chengdu, 610064, PR China",NA
"2565","34248390","10.1016/j.rser.2021.111400","COVID-19 pandemics Stage II - Energy and environmental impacts of vaccination.","The COVID-19 pandemic developed the severest public health event in recent history. The first stage for defence has already been documented. This paper moves forward to contribute to the second stage for offensive by assessing the energy and environmental impacts related to vaccination. The vaccination campaign is a multidisciplinary topic incorporating policies, population behaviour, planning, manufacturing, materials supporting, cold-chain logistics and waste treatment. The vaccination for pan","2021","07","12","Renew Sustain Energy Rev","Renewable &amp; sustainable energy reviews","COVID-19 vaccination campaigns; Cold supply chain; Energy and emissions; Environmental impact; Interdisciplinary analysis; Sustainability","Fan","Yee Van","Sustainable Process Integration Laboratory - SPIL, NETME Centre, Faculty of Mechanical Engineering, Brno University of Technology- VUT Brno, Technická 2896/2, 616 69, Brno, Czech Republic",NA
"2566","34248390","10.1016/j.rser.2021.111400","COVID-19 pandemics Stage II - Energy and environmental impacts of vaccination.","The COVID-19 pandemic developed the severest public health event in recent history. The first stage for defence has already been documented. This paper moves forward to contribute to the second stage for offensive by assessing the energy and environmental impacts related to vaccination. The vaccination campaign is a multidisciplinary topic incorporating policies, population behaviour, planning, manufacturing, materials supporting, cold-chain logistics and waste treatment. The vaccination for pan","2021","07","12","Renew Sustain Energy Rev","Renewable &amp; sustainable energy reviews","COVID-19 vaccination campaigns; Cold supply chain; Energy and emissions; Environmental impact; Interdisciplinary analysis; Sustainability","Bokhari","Awais","Sustainable Process Integration Laboratory - SPIL, NETME Centre, Faculty of Mechanical Engineering, Brno University of Technology- VUT Brno, Technická 2896/2, 616 69, Brno, Czech Republic",NA
"2567","34248390","10.1016/j.rser.2021.111400","COVID-19 pandemics Stage II - Energy and environmental impacts of vaccination.","The COVID-19 pandemic developed the severest public health event in recent history. The first stage for defence has already been documented. This paper moves forward to contribute to the second stage for offensive by assessing the energy and environmental impacts related to vaccination. The vaccination campaign is a multidisciplinary topic incorporating policies, population behaviour, planning, manufacturing, materials supporting, cold-chain logistics and waste treatment. The vaccination for pan","2021","07","12","Renew Sustain Energy Rev","Renewable &amp; sustainable energy reviews","COVID-19 vaccination campaigns; Cold supply chain; Energy and emissions; Environmental impact; Interdisciplinary analysis; Sustainability","Wang","Xue-Chao","State Key Laboratory of Earth Surface Processes and Resource Ecology, Faculty of Geographical Science, Beijing Normal University, Beijing, 100875, PR China",NA
"2568","34248388","10.1007/s10639-021-10652-7","""Working from home is one major disaster"": An analysis of student feedback at a South African university during the Covid-19 lockdown.","The Covid-19 global pandemic has resulted in many countries moving teaching and learning online. South Africa is a country with major inequalities in terms of access to electricity, internet and information technologies, which have created considerable problems for online learning at institutions of higher learning in the country. In this paper, we analyse student feedback from two large undergraduate English courses at a school of Education of a major South African university. We specifically f","2021","07","13","Educ Inf Technol (Dordr)","Education and information technologies","Challenges; Covid-19; Critical digital pedagogy; Decolonisation; Online learning","Fouche","Ilse","Division of Languages, Literacies and Literatures, University of the Witwatersrand, Johannesburg, South Africa",NA
"2569","34248388","10.1007/s10639-021-10652-7","""Working from home is one major disaster"": An analysis of student feedback at a South African university during the Covid-19 lockdown.","The Covid-19 global pandemic has resulted in many countries moving teaching and learning online. South Africa is a country with major inequalities in terms of access to electricity, internet and information technologies, which have created considerable problems for online learning at institutions of higher learning in the country. In this paper, we analyse student feedback from two large undergraduate English courses at a school of Education of a major South African university. We specifically f","2021","07","13","Educ Inf Technol (Dordr)","Education and information technologies","Challenges; Covid-19; Critical digital pedagogy; Decolonisation; Online learning","Andrews","Grant","Division of Languages, Literacies and Literatures, University of the Witwatersrand, Johannesburg, South Africa",NA
"2570","34248387","10.1007/s10639-021-10638-5","Digital transformation shaping structural pillars for academic entrepreneurship: A framework proposal and research agenda.","Digital technology always accelerates change, altering organisations culturally, socially and technically. These modifications are known as ""digital transformation"" (DT). On a much greater scale than DT, the world was changed in 2020 by the COVID-19 pandemic, which re-organised society in the way of thinking, acting, producing, consuming and creating new business. Higher Education Institutions (HEIs) were no different, since these institutions had to make changes to the student-lecturer interact","2021","07","13","Educ Inf Technol (Dordr)","Education and information technologies","Academic entrepreneurship; Covid19 pandemic; Digital transformation; SLR","Garcez","Ana","University of Beira Interior, Estrada do Sineiro, 6200-209 Covilhã, Portugal",NA
"2571","34248387","10.1007/s10639-021-10638-5","Digital transformation shaping structural pillars for academic entrepreneurship: A framework proposal and research agenda.","Digital technology always accelerates change, altering organisations culturally, socially and technically. These modifications are known as ""digital transformation"" (DT). On a much greater scale than DT, the world was changed in 2020 by the COVID-19 pandemic, which re-organised society in the way of thinking, acting, producing, consuming and creating new business. Higher Education Institutions (HEIs) were no different, since these institutions had to make changes to the student-lecturer interact","2021","07","13","Educ Inf Technol (Dordr)","Education and information technologies","Academic entrepreneurship; Covid19 pandemic; Digital transformation; SLR","Silva","Ricardo","Universidade Federal da Paraíba, Cidade Universitária, João Pessoa, 58051-900 Brazil",NA
"2572","34248387","10.1007/s10639-021-10638-5","Digital transformation shaping structural pillars for academic entrepreneurship: A framework proposal and research agenda.","Digital technology always accelerates change, altering organisations culturally, socially and technically. These modifications are known as ""digital transformation"" (DT). On a much greater scale than DT, the world was changed in 2020 by the COVID-19 pandemic, which re-organised society in the way of thinking, acting, producing, consuming and creating new business. Higher Education Institutions (HEIs) were no different, since these institutions had to make changes to the student-lecturer interact","2021","07","13","Educ Inf Technol (Dordr)","Education and information technologies","Academic entrepreneurship; Covid19 pandemic; Digital transformation; SLR","Franco","Mário","Department of Management and Economics, CEFAGE-UBI Research Center, University of Beira Interior, Estrada do Sineiro, 6200-209 Covilhã, Portugal",NA
"2573","34248386","10.1007/s10639-021-10629-6","NOTA: a novel online teaching and assessment scheme using Blockchain for emergency cases.","Technology advancements promote a redefinition of traditional instructional methodologies, as well as the roles of teachers and learners towards an efficient e-learning ecosystem. To date, all existing solutions are combined with the conventional face-to-face learning process. However, the latter can be unexpectedly hindered in some emergency cases, like the Coronavirus (COVID-19) pandemic. To handle such unexpected scenarios, this paper presents NOTA, a novel online teaching and assessment sche","2021","07","12","Educ Inf Technol (Dordr)","Education and information technologies","Blockchain technology; COVID-19 and education; Distance learning; Education during pandemics; Educational technology","Cheriguene","Anissa","Department of English Language and Literature, University of Ouargla, Ouargla, Algeria",NA
"2574","34248386","10.1007/s10639-021-10629-6","NOTA: a novel online teaching and assessment scheme using Blockchain for emergency cases.","Technology advancements promote a redefinition of traditional instructional methodologies, as well as the roles of teachers and learners towards an efficient e-learning ecosystem. To date, all existing solutions are combined with the conventional face-to-face learning process. However, the latter can be unexpectedly hindered in some emergency cases, like the Coronavirus (COVID-19) pandemic. To handle such unexpected scenarios, this paper presents NOTA, a novel online teaching and assessment sche","2021","07","12","Educ Inf Technol (Dordr)","Education and information technologies","Blockchain technology; COVID-19 and education; Distance learning; Education during pandemics; Educational technology","Kabache","Taieb","Department of English, ENS of Laghouat, Laghouat, Algeria",NA
"2575","34248386","10.1007/s10639-021-10629-6","NOTA: a novel online teaching and assessment scheme using Blockchain for emergency cases.","Technology advancements promote a redefinition of traditional instructional methodologies, as well as the roles of teachers and learners towards an efficient e-learning ecosystem. To date, all existing solutions are combined with the conventional face-to-face learning process. However, the latter can be unexpectedly hindered in some emergency cases, like the Coronavirus (COVID-19) pandemic. To handle such unexpected scenarios, this paper presents NOTA, a novel online teaching and assessment sche","2021","07","12","Educ Inf Technol (Dordr)","Education and information technologies","Blockchain technology; COVID-19 and education; Distance learning; Education during pandemics; Educational technology","Kerrache","Chaker Abdelaziz","Laboratoire d'Informatique et de Mathématique, Université Amar Telidji de Laghouat, Po Box 7022, Oasis-Nord, Laghouat, Algeria",NA
"2576","34248386","10.1007/s10639-021-10629-6","NOTA: a novel online teaching and assessment scheme using Blockchain for emergency cases.","Technology advancements promote a redefinition of traditional instructional methodologies, as well as the roles of teachers and learners towards an efficient e-learning ecosystem. To date, all existing solutions are combined with the conventional face-to-face learning process. However, the latter can be unexpectedly hindered in some emergency cases, like the Coronavirus (COVID-19) pandemic. To handle such unexpected scenarios, this paper presents NOTA, a novel online teaching and assessment sche","2021","07","12","Educ Inf Technol (Dordr)","Education and information technologies","Blockchain technology; COVID-19 and education; Distance learning; Education during pandemics; Educational technology","Calafate","Carlos T","Department of Computer Engineering, Universitat Politècnica de València, Camino de Vera, S/N, Valencia, Spain",NA
"2577","34248386","10.1007/s10639-021-10629-6","NOTA: a novel online teaching and assessment scheme using Blockchain for emergency cases.","Technology advancements promote a redefinition of traditional instructional methodologies, as well as the roles of teachers and learners towards an efficient e-learning ecosystem. To date, all existing solutions are combined with the conventional face-to-face learning process. However, the latter can be unexpectedly hindered in some emergency cases, like the Coronavirus (COVID-19) pandemic. To handle such unexpected scenarios, this paper presents NOTA, a novel online teaching and assessment sche","2021","07","12","Educ Inf Technol (Dordr)","Education and information technologies","Blockchain technology; COVID-19 and education; Distance learning; Education during pandemics; Educational technology","Cano","Juan Carlos","Department of Computer Engineering, Universitat Politècnica de València, Camino de Vera, S/N, Valencia, Spain",NA
"2578","34248384","10.1007/s42973-021-00078-8","Measuring business-level expectations and uncertainty: survey evidence and the COVID-19 pandemic.","Utilizing a unique firm-level survey in Japan that contains five-bin forecasts for sales, we document three findings. First, firm-level subjective uncertainty is highly and positively related to volatility of past firm growth. Second, there are substantial variations in subjective uncertainty across firms, with a long right tail with extremely high subjective uncertainty. In addition, firms that have exposure to international businesses either through international trade or foreign direct invest","2021","07","12","Jpn Econ Rev (Oxf)","Japanese economic review (Oxford, England)","COVID-19; Firm expectations; Subjective uncertainty","Chen","Cheng","Clemson University, Clemson, USA",NA
"2579","34248384","10.1007/s42973-021-00078-8","Measuring business-level expectations and uncertainty: survey evidence and the COVID-19 pandemic.","Utilizing a unique firm-level survey in Japan that contains five-bin forecasts for sales, we document three findings. First, firm-level subjective uncertainty is highly and positively related to volatility of past firm growth. Second, there are substantial variations in subjective uncertainty across firms, with a long right tail with extremely high subjective uncertainty. In addition, firms that have exposure to international businesses either through international trade or foreign direct invest","2021","07","12","Jpn Econ Rev (Oxf)","Japanese economic review (Oxford, England)","COVID-19; Firm expectations; Subjective uncertainty","Senga","Tatsuro","Keio University, Tokyo, Japan",NA
"2580","34248384","10.1007/s42973-021-00078-8","Measuring business-level expectations and uncertainty: survey evidence and the COVID-19 pandemic.","Utilizing a unique firm-level survey in Japan that contains five-bin forecasts for sales, we document three findings. First, firm-level subjective uncertainty is highly and positively related to volatility of past firm growth. Second, there are substantial variations in subjective uncertainty across firms, with a long right tail with extremely high subjective uncertainty. In addition, firms that have exposure to international businesses either through international trade or foreign direct invest","2021","07","12","Jpn Econ Rev (Oxf)","Japanese economic review (Oxford, England)","COVID-19; Firm expectations; Subjective uncertainty","Zhang","Hongyong","RIETI, Tokyo, Japan",NA
"2581","34248355","10.1177/11779322211027403","<i>In Silico</i> Exploration of Phytoconstituents From <i>Phyllanthus emblica</i> and <i>Aegle marmelos</i> as Potential Therapeutics Against SARS-CoV-2 RdRp.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) worldwide has increased the importance of computational tools to design a drug or vaccine in reduced time with minimum risk. Earlier studies have emphasized the important role of RNA-dependent RNA polymerase (RdRp) in SARS-CoV-2 replication as a potential drug target. In our study, comprehensive computational approaches were applied to identify potential compounds targeting RdRp of SARS-CoV-2. To study the binding affinity and stabilit","2021","07","13","Bioinform Biol Insights","Bioinformatics and biology insights","Aegle marmelos SARS-CoV-2 RdRp; MD simulation; Phyllanthus emblica; drug repurposing; molecular docking","Pandey","Khushboo","Bioinformatics Research Laboratory, Dr. D. Y. Patil Biotechnology &amp",NA
"2582","34248355","10.1177/11779322211027403","<i>In Silico</i> Exploration of Phytoconstituents From <i>Phyllanthus emblica</i> and <i>Aegle marmelos</i> as Potential Therapeutics Against SARS-CoV-2 RdRp.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) worldwide has increased the importance of computational tools to design a drug or vaccine in reduced time with minimum risk. Earlier studies have emphasized the important role of RNA-dependent RNA polymerase (RdRp) in SARS-CoV-2 replication as a potential drug target. In our study, comprehensive computational approaches were applied to identify potential compounds targeting RdRp of SARS-CoV-2. To study the binding affinity and stabilit","2021","07","13","Bioinform Biol Insights","Bioinformatics and biology insights","Aegle marmelos SARS-CoV-2 RdRp; MD simulation; Phyllanthus emblica; drug repurposing; molecular docking","Lokhande","Kiran Bharat","Bioinformatics Research Laboratory, Dr. D. Y. Patil Biotechnology &amp",NA
"2583","34248355","10.1177/11779322211027403","<i>In Silico</i> Exploration of Phytoconstituents From <i>Phyllanthus emblica</i> and <i>Aegle marmelos</i> as Potential Therapeutics Against SARS-CoV-2 RdRp.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) worldwide has increased the importance of computational tools to design a drug or vaccine in reduced time with minimum risk. Earlier studies have emphasized the important role of RNA-dependent RNA polymerase (RdRp) in SARS-CoV-2 replication as a potential drug target. In our study, comprehensive computational approaches were applied to identify potential compounds targeting RdRp of SARS-CoV-2. To study the binding affinity and stabilit","2021","07","13","Bioinform Biol Insights","Bioinformatics and biology insights","Aegle marmelos SARS-CoV-2 RdRp; MD simulation; Phyllanthus emblica; drug repurposing; molecular docking","Swamy","K Venkateswara","Bioinformatics Research Laboratory, Dr. D. Y. Patil Biotechnology &amp",NA
"2584","34248355","10.1177/11779322211027403","<i>In Silico</i> Exploration of Phytoconstituents From <i>Phyllanthus emblica</i> and <i>Aegle marmelos</i> as Potential Therapeutics Against SARS-CoV-2 RdRp.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) worldwide has increased the importance of computational tools to design a drug or vaccine in reduced time with minimum risk. Earlier studies have emphasized the important role of RNA-dependent RNA polymerase (RdRp) in SARS-CoV-2 replication as a potential drug target. In our study, comprehensive computational approaches were applied to identify potential compounds targeting RdRp of SARS-CoV-2. To study the binding affinity and stabilit","2021","07","13","Bioinform Biol Insights","Bioinformatics and biology insights","Aegle marmelos SARS-CoV-2 RdRp; MD simulation; Phyllanthus emblica; drug repurposing; molecular docking","Nagar","Shuchi","Bioinformatics Research Laboratory, Dr. D. Y. Patil Biotechnology &amp",NA
"2585","34248355","10.1177/11779322211027403","<i>In Silico</i> Exploration of Phytoconstituents From <i>Phyllanthus emblica</i> and <i>Aegle marmelos</i> as Potential Therapeutics Against SARS-CoV-2 RdRp.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) worldwide has increased the importance of computational tools to design a drug or vaccine in reduced time with minimum risk. Earlier studies have emphasized the important role of RNA-dependent RNA polymerase (RdRp) in SARS-CoV-2 replication as a potential drug target. In our study, comprehensive computational approaches were applied to identify potential compounds targeting RdRp of SARS-CoV-2. To study the binding affinity and stabilit","2021","07","13","Bioinform Biol Insights","Bioinformatics and biology insights","Aegle marmelos SARS-CoV-2 RdRp; MD simulation; Phyllanthus emblica; drug repurposing; molecular docking","Dake","Manjusha","Protein Biochemistry Laboratory, Dr. D. Y. Patil Biotechnology &amp",NA
"2586","34248354","10.1177/11772719211027022","Prognostic Value of Inflammatory Biomarkers in Patients with Severe COVID-19: A Single-Center Retrospective Study.","The current knowledge about novel coronavirus-2019 (COVID-19) indicates that the immune system and inflammatory response play a crucial role in the severity and prognosis of the disease. In this study, we aimed to investigate prognostic value of systemic inflammatory biomarkers including C-reactive protein/albumin ratio (CAR), prognostic nutritional index (PNI), neutrophil-to-lymphocyte ratio (NLR), lymphocyte-to-monocyte ratio (LMR), and platelet-to-lymphocyte ratio (PLR) in patients with sever","2021","07","13","Biomark Insights","Biomarker insights","Biomarkers; coronavirus; mortality; predictive value of tests","Açiksari","Gönül","Department of Cardiology, Istanbul Medeniyet University, Göztepe Prof. Dr. Süleyman Yalçin City Hospital, Istanbul, Turkey",NA
"2587","34248354","10.1177/11772719211027022","Prognostic Value of Inflammatory Biomarkers in Patients with Severe COVID-19: A Single-Center Retrospective Study.","The current knowledge about novel coronavirus-2019 (COVID-19) indicates that the immune system and inflammatory response play a crucial role in the severity and prognosis of the disease. In this study, we aimed to investigate prognostic value of systemic inflammatory biomarkers including C-reactive protein/albumin ratio (CAR), prognostic nutritional index (PNI), neutrophil-to-lymphocyte ratio (NLR), lymphocyte-to-monocyte ratio (LMR), and platelet-to-lymphocyte ratio (PLR) in patients with sever","2021","07","13","Biomark Insights","Biomarker insights","Biomarkers; coronavirus; mortality; predictive value of tests","Koçak","Mehmet","Department of Emergency Medicine, Fatih Sultan Mehmet Training and Research Hospital, Istanbul, Turkey",NA
"2588","34248354","10.1177/11772719211027022","Prognostic Value of Inflammatory Biomarkers in Patients with Severe COVID-19: A Single-Center Retrospective Study.","The current knowledge about novel coronavirus-2019 (COVID-19) indicates that the immune system and inflammatory response play a crucial role in the severity and prognosis of the disease. In this study, we aimed to investigate prognostic value of systemic inflammatory biomarkers including C-reactive protein/albumin ratio (CAR), prognostic nutritional index (PNI), neutrophil-to-lymphocyte ratio (NLR), lymphocyte-to-monocyte ratio (LMR), and platelet-to-lymphocyte ratio (PLR) in patients with sever","2021","07","13","Biomark Insights","Biomarker insights","Biomarkers; coronavirus; mortality; predictive value of tests","Çag","Yasemin","Department of Infectious Diseases and Clinical Microbiology, Istanbul Medeniyet University, Göztepe Prof. Dr. Süleyman Yalçin City Hospital, Istanbul, Turkey",NA
"2589","34248354","10.1177/11772719211027022","Prognostic Value of Inflammatory Biomarkers in Patients with Severe COVID-19: A Single-Center Retrospective Study.","The current knowledge about novel coronavirus-2019 (COVID-19) indicates that the immune system and inflammatory response play a crucial role in the severity and prognosis of the disease. In this study, we aimed to investigate prognostic value of systemic inflammatory biomarkers including C-reactive protein/albumin ratio (CAR), prognostic nutritional index (PNI), neutrophil-to-lymphocyte ratio (NLR), lymphocyte-to-monocyte ratio (LMR), and platelet-to-lymphocyte ratio (PLR) in patients with sever","2021","07","13","Biomark Insights","Biomarker insights","Biomarkers; coronavirus; mortality; predictive value of tests","Altunal","Lütfiye Nilsun","Department of Infectious Diseases and Clinical Microbiology, Umraniye Training and Research Hospital, Istanbul, Turkey",NA
"2590","34248354","10.1177/11772719211027022","Prognostic Value of Inflammatory Biomarkers in Patients with Severe COVID-19: A Single-Center Retrospective Study.","The current knowledge about novel coronavirus-2019 (COVID-19) indicates that the immune system and inflammatory response play a crucial role in the severity and prognosis of the disease. In this study, we aimed to investigate prognostic value of systemic inflammatory biomarkers including C-reactive protein/albumin ratio (CAR), prognostic nutritional index (PNI), neutrophil-to-lymphocyte ratio (NLR), lymphocyte-to-monocyte ratio (LMR), and platelet-to-lymphocyte ratio (PLR) in patients with sever","2021","07","13","Biomark Insights","Biomarker insights","Biomarkers; coronavirus; mortality; predictive value of tests","Atici","Adem","Department of Cardiology, Istanbul Medeniyet University, Göztepe Prof. Dr. Süleyman Yalçin City Hospital, Istanbul, Turkey",NA
"2591","34248354","10.1177/11772719211027022","Prognostic Value of Inflammatory Biomarkers in Patients with Severe COVID-19: A Single-Center Retrospective Study.","The current knowledge about novel coronavirus-2019 (COVID-19) indicates that the immune system and inflammatory response play a crucial role in the severity and prognosis of the disease. In this study, we aimed to investigate prognostic value of systemic inflammatory biomarkers including C-reactive protein/albumin ratio (CAR), prognostic nutritional index (PNI), neutrophil-to-lymphocyte ratio (NLR), lymphocyte-to-monocyte ratio (LMR), and platelet-to-lymphocyte ratio (PLR) in patients with sever","2021","07","13","Biomark Insights","Biomarker insights","Biomarkers; coronavirus; mortality; predictive value of tests","Çelik","Fatma Betül","Department of Cardiology, Istanbul Medeniyet University, Göztepe Prof. Dr. Süleyman Yalçin City Hospital, Istanbul, Turkey",NA
"2592","34248354","10.1177/11772719211027022","Prognostic Value of Inflammatory Biomarkers in Patients with Severe COVID-19: A Single-Center Retrospective Study.","The current knowledge about novel coronavirus-2019 (COVID-19) indicates that the immune system and inflammatory response play a crucial role in the severity and prognosis of the disease. In this study, we aimed to investigate prognostic value of systemic inflammatory biomarkers including C-reactive protein/albumin ratio (CAR), prognostic nutritional index (PNI), neutrophil-to-lymphocyte ratio (NLR), lymphocyte-to-monocyte ratio (LMR), and platelet-to-lymphocyte ratio (PLR) in patients with sever","2021","07","13","Biomark Insights","Biomarker insights","Biomarkers; coronavirus; mortality; predictive value of tests","Bölen","Furkan","Department of Cardiology, Istanbul Medeniyet University, Göztepe Prof. Dr. Süleyman Yalçin City Hospital, Istanbul, Turkey",NA
"2593","34248354","10.1177/11772719211027022","Prognostic Value of Inflammatory Biomarkers in Patients with Severe COVID-19: A Single-Center Retrospective Study.","The current knowledge about novel coronavirus-2019 (COVID-19) indicates that the immune system and inflammatory response play a crucial role in the severity and prognosis of the disease. In this study, we aimed to investigate prognostic value of systemic inflammatory biomarkers including C-reactive protein/albumin ratio (CAR), prognostic nutritional index (PNI), neutrophil-to-lymphocyte ratio (NLR), lymphocyte-to-monocyte ratio (LMR), and platelet-to-lymphocyte ratio (PLR) in patients with sever","2021","07","13","Biomark Insights","Biomarker insights","Biomarkers; coronavirus; mortality; predictive value of tests","Açiksari","Kurtulus","Department of Emergency Medicine, Istanbul Medeniyet University, Göztepe Prof. Dr. Süleyman Yalçin City Hospital, Istanbul, Turkey",NA
"2594","34248354","10.1177/11772719211027022","Prognostic Value of Inflammatory Biomarkers in Patients with Severe COVID-19: A Single-Center Retrospective Study.","The current knowledge about novel coronavirus-2019 (COVID-19) indicates that the immune system and inflammatory response play a crucial role in the severity and prognosis of the disease. In this study, we aimed to investigate prognostic value of systemic inflammatory biomarkers including C-reactive protein/albumin ratio (CAR), prognostic nutritional index (PNI), neutrophil-to-lymphocyte ratio (NLR), lymphocyte-to-monocyte ratio (LMR), and platelet-to-lymphocyte ratio (PLR) in patients with sever","2021","07","13","Biomark Insights","Biomarker insights","Biomarkers; coronavirus; mortality; predictive value of tests","Çaliskan","Mustafa","Department of Cardiology, Istanbul Medeniyet University, Göztepe Prof. Dr. Süleyman Yalçin City Hospital, Istanbul, Turkey",NA
"2595","34248351","10.1186/s12301-021-00200-7","Penile Mondor's in a Covid-19 patient on prophylactic anti-thrombosis with rivaroxaban: a case report.","Penile Mondor's disease (PMD) is thrombophlebitis of the superficial dorsal vein of the penis. Following the occurrence of thrombotic events in the affected veins, the lumen often becomes occluded with fibrin and inflammatory cells. A hyper-coagulative state is one of the underlying causes although most cases of PMD are idiopathic. Coronavirus disease-2019 infection (COVID-19) is associated with frequent thrombotic events. Inflammation and thrombosis play a central role in the course and outcome","2021","07","13","Afr J Urol","African journal of urology : the official journal of the Pan African Urological Surgeons' Association (PAUSA)","COVID-19; Drugs and medicines; Venous thromboembolism","Eren","Murat Tugrul","Department of Urology, Acibadem Healthcare Group, Acibadem Kozyatagi Hospital, 19 Mayis, Kozyatagi Kavsagi No:24, 34734 Kadiköy/Istanbul, Turkey",NA
"2596","34248351","10.1186/s12301-021-00200-7","Penile Mondor's in a Covid-19 patient on prophylactic anti-thrombosis with rivaroxaban: a case report.","Penile Mondor's disease (PMD) is thrombophlebitis of the superficial dorsal vein of the penis. Following the occurrence of thrombotic events in the affected veins, the lumen often becomes occluded with fibrin and inflammatory cells. A hyper-coagulative state is one of the underlying causes although most cases of PMD are idiopathic. Coronavirus disease-2019 infection (COVID-19) is associated with frequent thrombotic events. Inflammation and thrombosis play a central role in the course and outcome","2021","07","13","Afr J Urol","African journal of urology : the official journal of the Pan African Urological Surgeons' Association (PAUSA)","COVID-19; Drugs and medicines; Venous thromboembolism","Özveri","Hakan","Department of Urology, Acibadem Healthcare Group, Acibadem Kozyatagi Hospital, 19 Mayis, Kozyatagi Kavsagi No:24, 34734 Kadiköy/Istanbul, Turkey",NA
"2597","34248351","10.1186/s12301-021-00200-7","Penile Mondor's in a Covid-19 patient on prophylactic anti-thrombosis with rivaroxaban: a case report.","Penile Mondor's disease (PMD) is thrombophlebitis of the superficial dorsal vein of the penis. Following the occurrence of thrombotic events in the affected veins, the lumen often becomes occluded with fibrin and inflammatory cells. A hyper-coagulative state is one of the underlying causes although most cases of PMD are idiopathic. Coronavirus disease-2019 infection (COVID-19) is associated with frequent thrombotic events. Inflammation and thrombosis play a central role in the course and outcome","2021","07","13","Afr J Urol","African journal of urology : the official journal of the Pan African Urological Surgeons' Association (PAUSA)","COVID-19; Drugs and medicines; Venous thromboembolism","Kurtoglu","Hilal","Department of Cardiology, Acibadem Healthcare Group, Acibadem Hospital, Tekin Sk. No:8, 34718 Kadiköy/Istanbul, Turkey",NA
"2598","34248350","10.1186/s12301-021-00196-0","Impact of COVID-19 pandemic on non-COVID patient's management in urology: a public hospital experience in Mumbai.","To evaluate the impact of COVID-19 lockdown on non-COVID urological patient's management in tertiary care urology centres. This is an observational study in which data of patients visiting the urology department of all the MCGM run tertiary care hospitals were recorded for the duration of 1 April 2020 to 31 July 2020 and were compared to data of pre-COVID-19 period of similar duration. There was a decrease of 93.86% in indoor admissions of urology patients during the COVID-19 lockdown. Indoor ad","2021","07","13","Afr J Urol","African journal of urology : the official journal of the Pan African Urological Surgeons' Association (PAUSA)","COVID-19; MCGM; Mumbai; Pandemic; Urology","Jibhakate","Nikhilesh A","Department of Urology, Seth GS Medical College and KEM Hospital, Parel, Mumbai, Maharashtra 400012 India",NA
"2599","34248350","10.1186/s12301-021-00196-0","Impact of COVID-19 pandemic on non-COVID patient's management in urology: a public hospital experience in Mumbai.","To evaluate the impact of COVID-19 lockdown on non-COVID urological patient's management in tertiary care urology centres. This is an observational study in which data of patients visiting the urology department of all the MCGM run tertiary care hospitals were recorded for the duration of 1 April 2020 to 31 July 2020 and were compared to data of pre-COVID-19 period of similar duration. There was a decrease of 93.86% in indoor admissions of urology patients during the COVID-19 lockdown. Indoor ad","2021","07","13","Afr J Urol","African journal of urology : the official journal of the Pan African Urological Surgeons' Association (PAUSA)","COVID-19; MCGM; Mumbai; Pandemic; Urology","Patwardhan","Sujata K","Department of Urology, Seth GS Medical College and KEM Hospital, Parel, Mumbai, Maharashtra 400012 India",NA
"2600","34248350","10.1186/s12301-021-00196-0","Impact of COVID-19 pandemic on non-COVID patient's management in urology: a public hospital experience in Mumbai.","To evaluate the impact of COVID-19 lockdown on non-COVID urological patient's management in tertiary care urology centres. This is an observational study in which data of patients visiting the urology department of all the MCGM run tertiary care hospitals were recorded for the duration of 1 April 2020 to 31 July 2020 and were compared to data of pre-COVID-19 period of similar duration. There was a decrease of 93.86% in indoor admissions of urology patients during the COVID-19 lockdown. Indoor ad","2021","07","13","Afr J Urol","African journal of urology : the official journal of the Pan African Urological Surgeons' Association (PAUSA)","COVID-19; MCGM; Mumbai; Pandemic; Urology","Sawant","Ajit S","Department of Urology, Lokmanya Tilak Medical College and General Hospital, Mumbai, Maharashtra India",NA
"2601","34248350","10.1186/s12301-021-00196-0","Impact of COVID-19 pandemic on non-COVID patient's management in urology: a public hospital experience in Mumbai.","To evaluate the impact of COVID-19 lockdown on non-COVID urological patient's management in tertiary care urology centres. This is an observational study in which data of patients visiting the urology department of all the MCGM run tertiary care hospitals were recorded for the duration of 1 April 2020 to 31 July 2020 and were compared to data of pre-COVID-19 period of similar duration. There was a decrease of 93.86% in indoor admissions of urology patients during the COVID-19 lockdown. Indoor ad","2021","07","13","Afr J Urol","African journal of urology : the official journal of the Pan African Urological Surgeons' Association (PAUSA)","COVID-19; MCGM; Mumbai; Pandemic; Urology","Pathak","Hemant R","Department of Urology, TNMC and BYL Nair Ch. Hospital, Mumbai, Maharashtra India",NA
"2602","34248350","10.1186/s12301-021-00196-0","Impact of COVID-19 pandemic on non-COVID patient's management in urology: a public hospital experience in Mumbai.","To evaluate the impact of COVID-19 lockdown on non-COVID urological patient's management in tertiary care urology centres. This is an observational study in which data of patients visiting the urology department of all the MCGM run tertiary care hospitals were recorded for the duration of 1 April 2020 to 31 July 2020 and were compared to data of pre-COVID-19 period of similar duration. There was a decrease of 93.86% in indoor admissions of urology patients during the COVID-19 lockdown. Indoor ad","2021","07","13","Afr J Urol","African journal of urology : the official journal of the Pan African Urological Surgeons' Association (PAUSA)","COVID-19; MCGM; Mumbai; Pandemic; Urology","Patil","Bhushan P","Department of Urology, Seth GS Medical College and KEM Hospital, Parel, Mumbai, Maharashtra 400012 India",NA
"2603","34248350","10.1186/s12301-021-00196-0","Impact of COVID-19 pandemic on non-COVID patient's management in urology: a public hospital experience in Mumbai.","To evaluate the impact of COVID-19 lockdown on non-COVID urological patient's management in tertiary care urology centres. This is an observational study in which data of patients visiting the urology department of all the MCGM run tertiary care hospitals were recorded for the duration of 1 April 2020 to 31 July 2020 and were compared to data of pre-COVID-19 period of similar duration. There was a decrease of 93.86% in indoor admissions of urology patients during the COVID-19 lockdown. Indoor ad","2021","07","13","Afr J Urol","African journal of urology : the official journal of the Pan African Urological Surgeons' Association (PAUSA)","COVID-19; MCGM; Mumbai; Pandemic; Urology","Kamal","Hitesh","Department of Urology, Seth GS Medical College and KEM Hospital, Parel, Mumbai, Maharashtra 400012 India",NA
"2604","34248349","10.1186/s41983-021-00344-x","Is SARS-CoV-2 responsible for relapses of Parkinson's disease?",NA,"2021","07","13","Egypt J Neurol Psychiatr Neurosurg","The Egyptian journal of neurology, psychiatry and neurosurgery","COVID-19; Complications; Movement disorder; Parkinsons disease; SARS-CoV-2","Scorza","Fulvio A","Disciplina de Neurociencia, Universidade Federal de Sao Paulo/Escola Paulista de Medicina (UNIFESP/EPM), Rua Pedro de Toledo, 697-Vila Clementino, Sao Paulo, 04039-00 Brazil",NA
"2605","34248349","10.1186/s41983-021-00344-x","Is SARS-CoV-2 responsible for relapses of Parkinson's disease?",NA,"2021","07","13","Egypt J Neurol Psychiatr Neurosurg","The Egyptian journal of neurology, psychiatry and neurosurgery","COVID-19; Complications; Movement disorder; Parkinsons disease; SARS-CoV-2","Finsterer","Josef","Klinik Landstrasse, Messerli Institute, Postfach 20, 1180 Vienna, Austria",NA
"2606","34248349","10.1186/s41983-021-00344-x","Is SARS-CoV-2 responsible for relapses of Parkinson's disease?",NA,"2021","07","13","Egypt J Neurol Psychiatr Neurosurg","The Egyptian journal of neurology, psychiatry and neurosurgery","COVID-19; Complications; Movement disorder; Parkinsons disease; SARS-CoV-2","Fiorini","Ana C","Programa de Estudos Pos-Graduado em Fonoaudiologia, Pontifícia Universidade Catolica de Sao Paulo (PUC-SP), Sao Paulo, Brazil",NA
"2607","34248347","10.1007/s11213-021-09575-8","An Action Research Investigation of the Impact of Using Online Feedback Videos to Promote Self-Reflection on the Microteaching of Preservice EFL Teachers.","A growing number of researchers have investigated the potential of using video recordings to foster greater self-reflection in pre-service teacher preparation programs. However, at present, few investigations have explored secondary-level pre-service teachers' perceptions of in-the-moment video recorded feedback on their teaching. Thus, pre-service teachers taught video recorded microteaching lessons and were given video recorded feedback from their course instructor. The lessons were conducted ","2021","07","12","Syst Pract Action Res","Systemic practice and action research","English language teaching; Microteaching; Online feedback videos; Preservice teachers; Reflective practice","Murphy Odo","Dennis","Pusan National University, Busan, South Korea",NA
"2608","34248337","10.4293/JSLS.2021.00006","Operating-Room Procedures Do Not Increase Risk of COVID-19 Infection.","Operating-room procedures canceled due to the COVID-19 pandemic depleted hospital revenue and potentially worsened patient outcomes through disease progression. Despite safeguards to resume elective procedures, patients remain apprehensive of contracting COVID-19 during hospitalization and recovery. We investigated symptomatic COVID-19 infection in patients undergoing operating-room procedures during the spring 2020 outbreak in Fairfield County, CT, a heavily affected New York Metropolitan area.","2021","07","21","JSLS","JSLS : Journal of the Society of Laparoendoscopic Surgeons","COVID-19; Elective surgical procedures; Operating rooms; Aged; Aged, 80 and over; COVID-19; Connecticut; Cross Infection; Disease Transmission, Infectious; Elective Surgical Procedures; Female; Humans; Male; Middle Aged; New York City; Operating Rooms; Patient Discharge; Postoperative Complications; Retrospective Studies; SARS-CoV-2","Manuia","Emi P","Department of General Surgery, Nuvance Health, Danbury Hospital, Danbury, CT",NA
"2609","34248337","10.4293/JSLS.2021.00006","Operating-Room Procedures Do Not Increase Risk of COVID-19 Infection.","Operating-room procedures canceled due to the COVID-19 pandemic depleted hospital revenue and potentially worsened patient outcomes through disease progression. Despite safeguards to resume elective procedures, patients remain apprehensive of contracting COVID-19 during hospitalization and recovery. We investigated symptomatic COVID-19 infection in patients undergoing operating-room procedures during the spring 2020 outbreak in Fairfield County, CT, a heavily affected New York Metropolitan area.","2021","07","21","JSLS","JSLS : Journal of the Society of Laparoendoscopic Surgeons","COVID-19; Elective surgical procedures; Operating rooms; Aged; Aged, 80 and over; COVID-19; Connecticut; Cross Infection; Disease Transmission, Infectious; Elective Surgical Procedures; Female; Humans; Male; Middle Aged; New York City; Operating Rooms; Patient Discharge; Postoperative Complications; Retrospective Studies; SARS-CoV-2","Ostapenko","Alexander","Department of General Surgery, Nuvance Health, Danbury Hospital, Danbury, CT",NA
"2610","34248337","10.4293/JSLS.2021.00006","Operating-Room Procedures Do Not Increase Risk of COVID-19 Infection.","Operating-room procedures canceled due to the COVID-19 pandemic depleted hospital revenue and potentially worsened patient outcomes through disease progression. Despite safeguards to resume elective procedures, patients remain apprehensive of contracting COVID-19 during hospitalization and recovery. We investigated symptomatic COVID-19 infection in patients undergoing operating-room procedures during the spring 2020 outbreak in Fairfield County, CT, a heavily affected New York Metropolitan area.","2021","07","21","JSLS","JSLS : Journal of the Society of Laparoendoscopic Surgeons","COVID-19; Elective surgical procedures; Operating rooms; Aged; Aged, 80 and over; COVID-19; Connecticut; Cross Infection; Disease Transmission, Infectious; Elective Surgical Procedures; Female; Humans; Male; Middle Aged; New York City; Operating Rooms; Patient Discharge; Postoperative Complications; Retrospective Studies; SARS-CoV-2","Liechty","Shawn T","Department of General Surgery, Nuvance Health, Danbury Hospital, Danbury, CT",NA
"2611","34248337","10.4293/JSLS.2021.00006","Operating-Room Procedures Do Not Increase Risk of COVID-19 Infection.","Operating-room procedures canceled due to the COVID-19 pandemic depleted hospital revenue and potentially worsened patient outcomes through disease progression. Despite safeguards to resume elective procedures, patients remain apprehensive of contracting COVID-19 during hospitalization and recovery. We investigated symptomatic COVID-19 infection in patients undergoing operating-room procedures during the spring 2020 outbreak in Fairfield County, CT, a heavily affected New York Metropolitan area.","2021","07","21","JSLS","JSLS : Journal of the Society of Laparoendoscopic Surgeons","COVID-19; Elective surgical procedures; Operating rooms; Aged; Aged, 80 and over; COVID-19; Connecticut; Cross Infection; Disease Transmission, Infectious; Elective Surgical Procedures; Female; Humans; Male; Middle Aged; New York City; Operating Rooms; Patient Discharge; Postoperative Complications; Retrospective Studies; SARS-CoV-2","Kleiner","Daniel E","Department of Surgery, Waterbury Hospital, Waterbury, CT",NA
"2612","34248326","10.1007/s10643-021-01232-y","Occupational Commitment of Chinese Kindergarten Teachers During the COVID-19 Pandemic: Predictions of Anti-Epidemic Action, Income Reduction, and Career Confidence.","This study highlights a survey on 5783 kindergarten teachers' occupational commitment and its influencing factors in the socioeconomic context of China during the COVID-19 pandemic. Data were collected through the WenJuanXing public online platform. Quantitative analysis results showed that kindergarten teachers' occupational commitment was optimistic on the whole during this period, among which the affective commitment and the normative commitment were satisfactory, but the continuing commitmen","2021","07","13","Early Child Educ J","Early childhood education journal","COVID-19; Kindergarten teachers; Occupational commitment","Wei","Yonggang","Chongqing Early Childhood Education Quality Monitoring and Evaluation Research Center, Chongqing Normal University, No. 37 Middle Road, University Town, Gaoxin District, Chongqing, 401331 China",NA
"2613","34248326","10.1007/s10643-021-01232-y","Occupational Commitment of Chinese Kindergarten Teachers During the COVID-19 Pandemic: Predictions of Anti-Epidemic Action, Income Reduction, and Career Confidence.","This study highlights a survey on 5783 kindergarten teachers' occupational commitment and its influencing factors in the socioeconomic context of China during the COVID-19 pandemic. Data were collected through the WenJuanXing public online platform. Quantitative analysis results showed that kindergarten teachers' occupational commitment was optimistic on the whole during this period, among which the affective commitment and the normative commitment were satisfactory, but the continuing commitmen","2021","07","13","Early Child Educ J","Early childhood education journal","COVID-19; Kindergarten teachers; Occupational commitment","Wang","Lu","Chongqing Early Childhood Education Quality Monitoring and Evaluation Research Center, Chongqing Normal University, No. 37 Middle Road, University Town, Gaoxin District, Chongqing, 401331 China",NA
"2614","34248326","10.1007/s10643-021-01232-y","Occupational Commitment of Chinese Kindergarten Teachers During the COVID-19 Pandemic: Predictions of Anti-Epidemic Action, Income Reduction, and Career Confidence.","This study highlights a survey on 5783 kindergarten teachers' occupational commitment and its influencing factors in the socioeconomic context of China during the COVID-19 pandemic. Data were collected through the WenJuanXing public online platform. Quantitative analysis results showed that kindergarten teachers' occupational commitment was optimistic on the whole during this period, among which the affective commitment and the normative commitment were satisfactory, but the continuing commitmen","2021","07","13","Early Child Educ J","Early childhood education journal","COVID-19; Kindergarten teachers; Occupational commitment","Tan","Li","Chongqing Early Childhood Education Quality Monitoring and Evaluation Research Center, Chongqing Normal University, No. 37 Middle Road, University Town, Gaoxin District, Chongqing, 401331 China",NA
"2615","34248326","10.1007/s10643-021-01232-y","Occupational Commitment of Chinese Kindergarten Teachers During the COVID-19 Pandemic: Predictions of Anti-Epidemic Action, Income Reduction, and Career Confidence.","This study highlights a survey on 5783 kindergarten teachers' occupational commitment and its influencing factors in the socioeconomic context of China during the COVID-19 pandemic. Data were collected through the WenJuanXing public online platform. Quantitative analysis results showed that kindergarten teachers' occupational commitment was optimistic on the whole during this period, among which the affective commitment and the normative commitment were satisfactory, but the continuing commitmen","2021","07","13","Early Child Educ J","Early childhood education journal","COVID-19; Kindergarten teachers; Occupational commitment","Li","Qinglong","Chongqing Early Childhood Education Quality Monitoring and Evaluation Research Center, Chongqing Normal University, No. 37 Middle Road, University Town, Gaoxin District, Chongqing, 401331 China",NA
"2616","34248326","10.1007/s10643-021-01232-y","Occupational Commitment of Chinese Kindergarten Teachers During the COVID-19 Pandemic: Predictions of Anti-Epidemic Action, Income Reduction, and Career Confidence.","This study highlights a survey on 5783 kindergarten teachers' occupational commitment and its influencing factors in the socioeconomic context of China during the COVID-19 pandemic. Data were collected through the WenJuanXing public online platform. Quantitative analysis results showed that kindergarten teachers' occupational commitment was optimistic on the whole during this period, among which the affective commitment and the normative commitment were satisfactory, but the continuing commitmen","2021","07","13","Early Child Educ J","Early childhood education journal","COVID-19; Kindergarten teachers; Occupational commitment","Zhou","Dongmei","Chongqing Early Childhood Education Quality Monitoring and Evaluation Research Center, Chongqing Normal University, No. 37 Middle Road, University Town, Gaoxin District, Chongqing, 401331 China",NA
"2617","34248325","10.1063/5.0054110","Droplet fate, efficacy of face mask, and transmission of virus-laden droplets inside a conference room.","The second and third waves of coronavirus disease-2019 (COVID-19) pandemic have hit the world. Even after more than a year, the economy is yet to return to a semblance of normality. The conference/meeting room is one of the critical sections of offices that might be difficult not to use. This study analyzes the distribution of the virus-laden droplets expelled by coughing inside a conference room, the effect of ventilation rates, and their positioning. The efficacy of masks is studied to get qua","2021","07","13","Phys Fluids (1994)","Physics of fluids (Woodbury, N.Y. : 1994)",NA,"Mirikar","Dnyanesh","Applied Fluids Group, School of Mechanical Sciences, Indian Institute of Technology Bhubaneswar, Bhubaneswar 752050, India",NA
"2618","34248325","10.1063/5.0054110","Droplet fate, efficacy of face mask, and transmission of virus-laden droplets inside a conference room.","The second and third waves of coronavirus disease-2019 (COVID-19) pandemic have hit the world. Even after more than a year, the economy is yet to return to a semblance of normality. The conference/meeting room is one of the critical sections of offices that might be difficult not to use. This study analyzes the distribution of the virus-laden droplets expelled by coughing inside a conference room, the effect of ventilation rates, and their positioning. The efficacy of masks is studied to get qua","2021","07","13","Phys Fluids (1994)","Physics of fluids (Woodbury, N.Y. : 1994)",NA,"Palanivel","Silambarasan","Applied Fluids Group, School of Mechanical Sciences, Indian Institute of Technology Bhubaneswar, Bhubaneswar 752050, India",NA
"2619","34248325","10.1063/5.0054110","Droplet fate, efficacy of face mask, and transmission of virus-laden droplets inside a conference room.","The second and third waves of coronavirus disease-2019 (COVID-19) pandemic have hit the world. Even after more than a year, the economy is yet to return to a semblance of normality. The conference/meeting room is one of the critical sections of offices that might be difficult not to use. This study analyzes the distribution of the virus-laden droplets expelled by coughing inside a conference room, the effect of ventilation rates, and their positioning. The efficacy of masks is studied to get qua","2021","07","13","Phys Fluids (1994)","Physics of fluids (Woodbury, N.Y. : 1994)",NA,"Arumuru","Venugopal","Applied Fluids Group, School of Mechanical Sciences, Indian Institute of Technology Bhubaneswar, Bhubaneswar 752050, India",NA
"2620","34248322","10.1007/s12103-021-09625-w","Moving Beyond Narcan: A Police, Social Service, and Researcher Collaborative Response to the Opioid Crisis.","The opioid crisis is the most persistent, long-term public health emergency facing the United States, and available evidence suggests the crisis has worsened during the COVID-19 global pandemic. Naloxone is an effective overdose response that saves lives, but the drug does not address problematic drug use, addiction, or the underlying conditions that lead to overdoses. The opioid crisis is at its core a multidisciplinary, multisystem problem, and an effective response to the crisis requires coll","2021","07","13","Am J Crim Justice","American journal of criminal justice : AJCJ","Collaborative response; Naloxone; Opioid crisis; Police","White","Michael D","Center for Violence Prevention and Community Safety, Arizona State University, 411 N Central Ave, Phoenix, AZ 85004 USA",NA
"2621","34248322","10.1007/s12103-021-09625-w","Moving Beyond Narcan: A Police, Social Service, and Researcher Collaborative Response to the Opioid Crisis.","The opioid crisis is the most persistent, long-term public health emergency facing the United States, and available evidence suggests the crisis has worsened during the COVID-19 global pandemic. Naloxone is an effective overdose response that saves lives, but the drug does not address problematic drug use, addiction, or the underlying conditions that lead to overdoses. The opioid crisis is at its core a multidisciplinary, multisystem problem, and an effective response to the crisis requires coll","2021","07","13","Am J Crim Justice","American journal of criminal justice : AJCJ","Collaborative response; Naloxone; Opioid crisis; Police","Perrone","Dina","School of Criminology, Criminal Justice, and Emergency Management, California State University Long Beach, 1250 Bellflower Boulevard, Long Beach, CA 90840 USA",NA
"2622","34248322","10.1007/s12103-021-09625-w","Moving Beyond Narcan: A Police, Social Service, and Researcher Collaborative Response to the Opioid Crisis.","The opioid crisis is the most persistent, long-term public health emergency facing the United States, and available evidence suggests the crisis has worsened during the COVID-19 global pandemic. Naloxone is an effective overdose response that saves lives, but the drug does not address problematic drug use, addiction, or the underlying conditions that lead to overdoses. The opioid crisis is at its core a multidisciplinary, multisystem problem, and an effective response to the crisis requires coll","2021","07","13","Am J Crim Justice","American journal of criminal justice : AJCJ","Collaborative response; Naloxone; Opioid crisis; Police","Watts","Seth","Center for Violence Prevention and Community Safety, Arizona State University, 411 N Central Ave, Phoenix, AZ 85004 USA",NA
"2623","34248322","10.1007/s12103-021-09625-w","Moving Beyond Narcan: A Police, Social Service, and Researcher Collaborative Response to the Opioid Crisis.","The opioid crisis is the most persistent, long-term public health emergency facing the United States, and available evidence suggests the crisis has worsened during the COVID-19 global pandemic. Naloxone is an effective overdose response that saves lives, but the drug does not address problematic drug use, addiction, or the underlying conditions that lead to overdoses. The opioid crisis is at its core a multidisciplinary, multisystem problem, and an effective response to the crisis requires coll","2021","07","13","Am J Crim Justice","American journal of criminal justice : AJCJ","Collaborative response; Naloxone; Opioid crisis; Police","Malm","Aili","School of Criminology, Criminal Justice, and Emergency Management, California State University Long Beach, 1250 Bellflower Boulevard, Long Beach, CA 90840 USA",NA
"2624","34248316","10.1007/s11837-021-04782-z","The COVID-19 Pandemic and Materials Science and Engineering Education.",NA,"2021","07","12","JOM (1989)","JOM (Warrendale, Pa. : 1989)",NA,NA,NA,NA,NA
"2625","34248314","10.1007/s12144-021-02031-9","Risk and protective factors for psychological distress during COVID-19 in Israel.","The purpose of the present study was to identify the protective and risk factors related to psychological distress during COVID-19 in an Israeli sample. An online survey was administered from April 19 to May 2, 2020, while a strict lockdown was in place. Participants were recruited by snowball sampling. Psychological distress was evaluated using the Generalized Anxiety Disorder questionnaire (GAD-7) and the Patient Health Questionnaire-9 (PHQ-9). Risk and protective factors for psychological dis","2021","07","13","Curr Psychol","Current psychology (New Brunswick, N.J.)","Anxiety; COVID-19; Coping strategies; Depression; Life orientation; Protective factor; Psychological distress; Risk factor; Social support","Oryan","Zohar","Behavioral Sciences, Academic College of Tel Aviv-Yafo, P.O.B 8401, 61083 Tel Aviv, Jaffa Israel",NA
"2626","34248314","10.1007/s12144-021-02031-9","Risk and protective factors for psychological distress during COVID-19 in Israel.","The purpose of the present study was to identify the protective and risk factors related to psychological distress during COVID-19 in an Israeli sample. An online survey was administered from April 19 to May 2, 2020, while a strict lockdown was in place. Participants were recruited by snowball sampling. Psychological distress was evaluated using the Generalized Anxiety Disorder questionnaire (GAD-7) and the Patient Health Questionnaire-9 (PHQ-9). Risk and protective factors for psychological dis","2021","07","13","Curr Psychol","Current psychology (New Brunswick, N.J.)","Anxiety; COVID-19; Coping strategies; Depression; Life orientation; Protective factor; Psychological distress; Risk factor; Social support","Avinir","Asia","Behavioral Sciences, Academic College of Tel Aviv-Yafo, P.O.B 8401, 61083 Tel Aviv, Jaffa Israel",NA
"2627","34248314","10.1007/s12144-021-02031-9","Risk and protective factors for psychological distress during COVID-19 in Israel.","The purpose of the present study was to identify the protective and risk factors related to psychological distress during COVID-19 in an Israeli sample. An online survey was administered from April 19 to May 2, 2020, while a strict lockdown was in place. Participants were recruited by snowball sampling. Psychological distress was evaluated using the Generalized Anxiety Disorder questionnaire (GAD-7) and the Patient Health Questionnaire-9 (PHQ-9). Risk and protective factors for psychological dis","2021","07","13","Curr Psychol","Current psychology (New Brunswick, N.J.)","Anxiety; COVID-19; Coping strategies; Depression; Life orientation; Protective factor; Psychological distress; Risk factor; Social support","Levy","Sigal","Behavioral Sciences, Academic College of Tel Aviv-Yafo, P.O.B 8401, 61083 Tel Aviv, Jaffa Israel",NA
"2628","34248314","10.1007/s12144-021-02031-9","Risk and protective factors for psychological distress during COVID-19 in Israel.","The purpose of the present study was to identify the protective and risk factors related to psychological distress during COVID-19 in an Israeli sample. An online survey was administered from April 19 to May 2, 2020, while a strict lockdown was in place. Participants were recruited by snowball sampling. Psychological distress was evaluated using the Generalized Anxiety Disorder questionnaire (GAD-7) and the Patient Health Questionnaire-9 (PHQ-9). Risk and protective factors for psychological dis","2021","07","13","Curr Psychol","Current psychology (New Brunswick, N.J.)","Anxiety; COVID-19; Coping strategies; Depression; Life orientation; Protective factor; Psychological distress; Risk factor; Social support","Kodesh","Einat","Physical Therapy Department, University of Haifa, Haifa, Israel",NA
"2629","34248314","10.1007/s12144-021-02031-9","Risk and protective factors for psychological distress during COVID-19 in Israel.","The purpose of the present study was to identify the protective and risk factors related to psychological distress during COVID-19 in an Israeli sample. An online survey was administered from April 19 to May 2, 2020, while a strict lockdown was in place. Participants were recruited by snowball sampling. Psychological distress was evaluated using the Generalized Anxiety Disorder questionnaire (GAD-7) and the Patient Health Questionnaire-9 (PHQ-9). Risk and protective factors for psychological dis","2021","07","13","Curr Psychol","Current psychology (New Brunswick, N.J.)","Anxiety; COVID-19; Coping strategies; Depression; Life orientation; Protective factor; Psychological distress; Risk factor; Social support","Elkana","Odelia","Behavioral Sciences, Academic College of Tel Aviv-Yafo, P.O.B 8401, 61083 Tel Aviv, Jaffa Israel",NA
"2630","34248311","10.1134/S1022795421050057","Genetic Control of Human Infection with SARS-CoV-2.","In 2019, the SARS-CoV-2 beta-coronavirus, which caused a pandemic of severe acute respiratory viral infection COVID-19 (from COronaVIrus Disease 2019), was first detected. The susceptibility to SARS-CoV-2 and the nature of the course of the COVID-19 clinical picture are determined by many factors, including genetic characteristics of both the pathogen and the human. The SARS-CoV-2 genome has a similarity to the genomes of other coronaviruses, which are pathogenic for humans and cause a severe co","2021","07","13","Russ J Genet","Russian journal of genetics","COVID-19; DNA methylation; SARS-CoV-2 genome; SNV; candidate genes for susceptibility to SARS-CoV-2; eQTL; expression","Kucher","A N","Research Institute of Medical Genetics, Tomsk National Research Medical Center, Russian Academy of Sciences, 634050 Tomsk, Russia",NA
"2631","34248311","10.1134/S1022795421050057","Genetic Control of Human Infection with SARS-CoV-2.","In 2019, the SARS-CoV-2 beta-coronavirus, which caused a pandemic of severe acute respiratory viral infection COVID-19 (from COronaVIrus Disease 2019), was first detected. The susceptibility to SARS-CoV-2 and the nature of the course of the COVID-19 clinical picture are determined by many factors, including genetic characteristics of both the pathogen and the human. The SARS-CoV-2 genome has a similarity to the genomes of other coronaviruses, which are pathogenic for humans and cause a severe co","2021","07","13","Russ J Genet","Russian journal of genetics","COVID-19; DNA methylation; SARS-CoV-2 genome; SNV; candidate genes for susceptibility to SARS-CoV-2; eQTL; expression","Babushkina","N P","Research Institute of Medical Genetics, Tomsk National Research Medical Center, Russian Academy of Sciences, 634050 Tomsk, Russia",NA
"2632","34248311","10.1134/S1022795421050057","Genetic Control of Human Infection with SARS-CoV-2.","In 2019, the SARS-CoV-2 beta-coronavirus, which caused a pandemic of severe acute respiratory viral infection COVID-19 (from COronaVIrus Disease 2019), was first detected. The susceptibility to SARS-CoV-2 and the nature of the course of the COVID-19 clinical picture are determined by many factors, including genetic characteristics of both the pathogen and the human. The SARS-CoV-2 genome has a similarity to the genomes of other coronaviruses, which are pathogenic for humans and cause a severe co","2021","07","13","Russ J Genet","Russian journal of genetics","COVID-19; DNA methylation; SARS-CoV-2 genome; SNV; candidate genes for susceptibility to SARS-CoV-2; eQTL; expression","Sleptcov","A A","Research Institute of Medical Genetics, Tomsk National Research Medical Center, Russian Academy of Sciences, 634050 Tomsk, Russia",NA
"2633","34248311","10.1134/S1022795421050057","Genetic Control of Human Infection with SARS-CoV-2.","In 2019, the SARS-CoV-2 beta-coronavirus, which caused a pandemic of severe acute respiratory viral infection COVID-19 (from COronaVIrus Disease 2019), was first detected. The susceptibility to SARS-CoV-2 and the nature of the course of the COVID-19 clinical picture are determined by many factors, including genetic characteristics of both the pathogen and the human. The SARS-CoV-2 genome has a similarity to the genomes of other coronaviruses, which are pathogenic for humans and cause a severe co","2021","07","13","Russ J Genet","Russian journal of genetics","COVID-19; DNA methylation; SARS-CoV-2 genome; SNV; candidate genes for susceptibility to SARS-CoV-2; eQTL; expression","Nazarenko","M S","Research Institute of Medical Genetics, Tomsk National Research Medical Center, Russian Academy of Sciences, 634050 Tomsk, Russia",NA
"2634","34248309","10.1007/s13171-021-00249-0","Scalable Estimation of Epidemic Thresholds via Node Sampling.","Infectious or contagious diseases can be transmitted from one person to another through social contact networks. In today's interconnected global society, such contagion processes can cause global public health hazards, as exemplified by the ongoing Covid-19 pandemic. It is therefore of great practical relevance to investigate the network transmission of contagious diseases from the perspective of statistical inference. An important and widely studied boundary condition for contagion processes o","2021","07","13","Sankhya Ser A","Sankhya. Series A. (2008)","Configuration model; Epidemic threshold; Epidemiology.; Networks; Random walk; Sampling","Dasgupta","Anirban","Computer Science and Engineering, Indian Institute of Technology, Gandhinagar, Gandhinagar, India",NA
"2635","34248309","10.1007/s13171-021-00249-0","Scalable Estimation of Epidemic Thresholds via Node Sampling.","Infectious or contagious diseases can be transmitted from one person to another through social contact networks. In today's interconnected global society, such contagion processes can cause global public health hazards, as exemplified by the ongoing Covid-19 pandemic. It is therefore of great practical relevance to investigate the network transmission of contagious diseases from the perspective of statistical inference. An important and widely studied boundary condition for contagion processes o","2021","07","13","Sankhya Ser A","Sankhya. Series A. (2008)","Configuration model; Epidemic threshold; Epidemiology.; Networks; Random walk; Sampling","Sengupta","Srijan","Statistics, North Carolina State University, Raleigh, NC USA",NA
"2636","34248308","10.1007/s12262-021-03016-5","How to Implement a Simulation-Based Education Programme: Lessons from the UK Urology Simulation Boot Camp.","The operative and non-technical skills exposure of urology trainees has reduced due to a number of factors, including the European Working Time Directive, and the COVID-19 pandemic. Simulation-based education (SBE) is an innovative addition to clinical experience which can begin to address the skills-based learning deficiency in order to help trainees meet their curriculum requirements and optimise the exposure required for a trainee to become a competent general urology consultant. Surgical sim","2021","07","13","Indian J Surg","The Indian journal of surgery","Education; Implementation science; Simulation; Surgical skills; Teaching; Training; Urology","Please","Helen","Department of Urology, Saint James' Hospital, Leeds Teaching Hospitals NHS Trust, Leeds, UK",NA
"2637","34248308","10.1007/s12262-021-03016-5","How to Implement a Simulation-Based Education Programme: Lessons from the UK Urology Simulation Boot Camp.","The operative and non-technical skills exposure of urology trainees has reduced due to a number of factors, including the European Working Time Directive, and the COVID-19 pandemic. Simulation-based education (SBE) is an innovative addition to clinical experience which can begin to address the skills-based learning deficiency in order to help trainees meet their curriculum requirements and optimise the exposure required for a trainee to become a competent general urology consultant. Surgical sim","2021","07","13","Indian J Surg","The Indian journal of surgery","Education; Implementation science; Simulation; Surgical skills; Teaching; Training; Urology","Biyani","Chandra Shekhar","Department of Urology, Saint James' Hospital, Leeds Teaching Hospitals NHS Trust, Leeds, UK",NA
"2638","34248307","10.1007/s12355-021-01007-0","Sugar Beet Cultivation in India: Prospects for Bio-Ethanol Production and Value-Added Co-Products.","Sugar beet is an important crop in the advent of COVID 19 as it has a high potential for ethanol production in less growth span. The life cycle of this crop is of five to six months with a root yield of 60-80 t ha<sup>-1</sup> and sugar content of 15-17%. Sugar beet is known as a temperate crop of short duration grown in the month of September to October and harvested in April and May, but successful efforts have been made in establishing this crop for Indian agro-climatic conditions. India stan","2021","07","13","Sugar Tech","Sugar tech : an international journal of sugar crops &amp; related industries","Ethanol; Fodder; Sugar; Sugar beet; Value addition","Mall","Ashutosh Kumar","Division of Crop Improvement, ICAR-Indian Institute of Sugarcane Research, Lucknow, 226 002 U.P. India",NA
"2639","34248307","10.1007/s12355-021-01007-0","Sugar Beet Cultivation in India: Prospects for Bio-Ethanol Production and Value-Added Co-Products.","Sugar beet is an important crop in the advent of COVID 19 as it has a high potential for ethanol production in less growth span. The life cycle of this crop is of five to six months with a root yield of 60-80 t ha<sup>-1</sup> and sugar content of 15-17%. Sugar beet is known as a temperate crop of short duration grown in the month of September to October and harvested in April and May, but successful efforts have been made in establishing this crop for Indian agro-climatic conditions. India stan","2021","07","13","Sugar Tech","Sugar tech : an international journal of sugar crops &amp; related industries","Ethanol; Fodder; Sugar; Sugar beet; Value addition","Misra","Varucha","Division of Crop Improvement, ICAR-Indian Institute of Sugarcane Research, Lucknow, 226 002 U.P. India",NA
"2640","34248307","10.1007/s12355-021-01007-0","Sugar Beet Cultivation in India: Prospects for Bio-Ethanol Production and Value-Added Co-Products.","Sugar beet is an important crop in the advent of COVID 19 as it has a high potential for ethanol production in less growth span. The life cycle of this crop is of five to six months with a root yield of 60-80 t ha<sup>-1</sup> and sugar content of 15-17%. Sugar beet is known as a temperate crop of short duration grown in the month of September to October and harvested in April and May, but successful efforts have been made in establishing this crop for Indian agro-climatic conditions. India stan","2021","07","13","Sugar Tech","Sugar tech : an international journal of sugar crops &amp; related industries","Ethanol; Fodder; Sugar; Sugar beet; Value addition","Santeshwari","Division of Crop Improvement, ICAR-Indian Institute of Sugarcane Research, Lucknow, 226 002 U.P. India","Division of Crop Improvement, ICAR-Indian Institute of Sugarcane Research, Lucknow, 226 002 U.P. India","34248307"
"2641","34248307","10.1007/s12355-021-01007-0","Sugar Beet Cultivation in India: Prospects for Bio-Ethanol Production and Value-Added Co-Products.","Sugar beet is an important crop in the advent of COVID 19 as it has a high potential for ethanol production in less growth span. The life cycle of this crop is of five to six months with a root yield of 60-80 t ha<sup>-1</sup> and sugar content of 15-17%. Sugar beet is known as a temperate crop of short duration grown in the month of September to October and harvested in April and May, but successful efforts have been made in establishing this crop for Indian agro-climatic conditions. India stan","2021","07","13","Sugar Tech","Sugar tech : an international journal of sugar crops &amp; related industries","Ethanol; Fodder; Sugar; Sugar beet; Value addition","Pathak","A D","Division of Crop Improvement, ICAR-Indian Institute of Sugarcane Research, Lucknow, 226 002 U.P. India",NA
"2642","34248307","10.1007/s12355-021-01007-0","Sugar Beet Cultivation in India: Prospects for Bio-Ethanol Production and Value-Added Co-Products.","Sugar beet is an important crop in the advent of COVID 19 as it has a high potential for ethanol production in less growth span. The life cycle of this crop is of five to six months with a root yield of 60-80 t ha<sup>-1</sup> and sugar content of 15-17%. Sugar beet is known as a temperate crop of short duration grown in the month of September to October and harvested in April and May, but successful efforts have been made in establishing this crop for Indian agro-climatic conditions. India stan","2021","07","13","Sugar Tech","Sugar tech : an international journal of sugar crops &amp; related industries","Ethanol; Fodder; Sugar; Sugar beet; Value addition","Srivastava","Sangeeta","Division of Crop Improvement, ICAR-Indian Institute of Sugarcane Research, Lucknow, 226 002 U.P. India",NA
"2643","34248292","10.1007/s00530-021-00826-1","Deep learning-based meta-classifier approach for COVID-19 classification using CT scan and chest X-ray images.","Literature survey shows that convolutional neural network (CNN)-based pretrained models have been largely used for CoronaVirus Disease 2019 (COVID-19) classification using chest X-ray (CXR) and computed tomography (CT) datasets. However, most of the methods have used a smaller number of data samples for both CT and CXR datasets for training, validation, and testing. As a result, the model might have shown good performance during testing, but this type of model will not be more effective on unsee","2021","07","13","Multimed Syst","Multimedia systems","COVID-19; CT scan; Chest X-rays; Computer-aided diagnosis; Deep learning; Feature fusion; Meta-classifier; Stacked classifier; Transfer learning","Ravi","Vinayakumar","Center for Artificial Intelligence, Prince Mohammad Bin Fahd University, Khobar, Saudi Arabia",NA
"2644","34248292","10.1007/s00530-021-00826-1","Deep learning-based meta-classifier approach for COVID-19 classification using CT scan and chest X-ray images.","Literature survey shows that convolutional neural network (CNN)-based pretrained models have been largely used for CoronaVirus Disease 2019 (COVID-19) classification using chest X-ray (CXR) and computed tomography (CT) datasets. However, most of the methods have used a smaller number of data samples for both CT and CXR datasets for training, validation, and testing. As a result, the model might have shown good performance during testing, but this type of model will not be more effective on unsee","2021","07","13","Multimed Syst","Multimedia systems","COVID-19; CT scan; Chest X-rays; Computer-aided diagnosis; Deep learning; Feature fusion; Meta-classifier; Stacked classifier; Transfer learning","Narasimhan","Harini","Smart Materials Structures and Systems Lab, Indian Institute of Technology, Kanpur, India",NA
"2645","34248292","10.1007/s00530-021-00826-1","Deep learning-based meta-classifier approach for COVID-19 classification using CT scan and chest X-ray images.","Literature survey shows that convolutional neural network (CNN)-based pretrained models have been largely used for CoronaVirus Disease 2019 (COVID-19) classification using chest X-ray (CXR) and computed tomography (CT) datasets. However, most of the methods have used a smaller number of data samples for both CT and CXR datasets for training, validation, and testing. As a result, the model might have shown good performance during testing, but this type of model will not be more effective on unsee","2021","07","13","Multimed Syst","Multimedia systems","COVID-19; CT scan; Chest X-rays; Computer-aided diagnosis; Deep learning; Feature fusion; Meta-classifier; Stacked classifier; Transfer learning","Chakraborty","Chinmay","Department of Electronics and Communication Engineering, Birla Institute of Technology, Ranchi, Jharkhand India",NA
"2646","34248292","10.1007/s00530-021-00826-1","Deep learning-based meta-classifier approach for COVID-19 classification using CT scan and chest X-ray images.","Literature survey shows that convolutional neural network (CNN)-based pretrained models have been largely used for CoronaVirus Disease 2019 (COVID-19) classification using chest X-ray (CXR) and computed tomography (CT) datasets. However, most of the methods have used a smaller number of data samples for both CT and CXR datasets for training, validation, and testing. As a result, the model might have shown good performance during testing, but this type of model will not be more effective on unsee","2021","07","13","Multimed Syst","Multimedia systems","COVID-19; CT scan; Chest X-rays; Computer-aided diagnosis; Deep learning; Feature fusion; Meta-classifier; Stacked classifier; Transfer learning","Pham","Tuan D","Center for Artificial Intelligence, Prince Mohammad Bin Fahd University, Khobar, Saudi Arabia",NA
"2647","34248291","10.1007/s00521-021-06273-3","Improved manta ray foraging optimization for multi-level thresholding using COVID-19 CT images.","Coronavirus disease 2019 (COVID-19) is pervasive worldwide, posing a high risk to people's safety and health. Many algorithms were developed to identify COVID-19. One way of identifying COVID-19 is by computed tomography (CT) images. Some segmentation methods are proposed to extract regions of interest from COVID-19 CT images to improve the classification. In this paper, an efficient version of the recent manta ray foraging optimization (MRFO) algorithm is proposed based on the oppositionbased l","2021","07","13","Neural Comput Appl","Neural computing &amp; applications","COVID-19 CT images; Manta ray foraging optimization; Meta-heuristics algorithms; Multilevel thresholding image segmentation; Otsus method","Houssein","Essam H","Faculty of Computers and Information, Minia University, Minia, Egypt",NA
"2648","34248291","10.1007/s00521-021-06273-3","Improved manta ray foraging optimization for multi-level thresholding using COVID-19 CT images.","Coronavirus disease 2019 (COVID-19) is pervasive worldwide, posing a high risk to people's safety and health. Many algorithms were developed to identify COVID-19. One way of identifying COVID-19 is by computed tomography (CT) images. Some segmentation methods are proposed to extract regions of interest from COVID-19 CT images to improve the classification. In this paper, an efficient version of the recent manta ray foraging optimization (MRFO) algorithm is proposed based on the oppositionbased l","2021","07","13","Neural Comput Appl","Neural computing &amp; applications","COVID-19 CT images; Manta ray foraging optimization; Meta-heuristics algorithms; Multilevel thresholding image segmentation; Otsus method","Emam","Marwa M","Faculty of Computers and Information, Minia University, Minia, Egypt",NA
"2649","34248291","10.1007/s00521-021-06273-3","Improved manta ray foraging optimization for multi-level thresholding using COVID-19 CT images.","Coronavirus disease 2019 (COVID-19) is pervasive worldwide, posing a high risk to people's safety and health. Many algorithms were developed to identify COVID-19. One way of identifying COVID-19 is by computed tomography (CT) images. Some segmentation methods are proposed to extract regions of interest from COVID-19 CT images to improve the classification. In this paper, an efficient version of the recent manta ray foraging optimization (MRFO) algorithm is proposed based on the oppositionbased l","2021","07","13","Neural Comput Appl","Neural computing &amp; applications","COVID-19 CT images; Manta ray foraging optimization; Meta-heuristics algorithms; Multilevel thresholding image segmentation; Otsus method","Ali","Abdelmgeid A","Faculty of Computers and Information, Minia University, Minia, Egypt",NA
"2650","34248290","10.1007/s00521-021-06286-y","Linguistic methods in healthcare application and COVID-19 variants classification.","One of the most important goals of modern medicine is prevention against pandemic and civilization diseases. For such tasks, advanced IT infrastructures and intelligent AI systems are used, which allow supporting patients' diagnosis and treatment. In our research, we also try to define efficient tools for coronavirus classification, especially using mathematical linguistic methods. This paper presents the ways of application of linguistics techniques in supporting effective management of medical","2021","07","13","Neural Comput Appl","Neural computing &amp; applications","Formal grammars; Healthcare application; Mathematical linguistics; Pandemic prevention","Ogiela","Marek R","Cryptography and Cognitive Informatics Laboratory, AGH University of Science and Technology, 30 Mickiewicza Ave, 30-059 Kraków, Poland",NA
"2651","34248290","10.1007/s00521-021-06286-y","Linguistic methods in healthcare application and COVID-19 variants classification.","One of the most important goals of modern medicine is prevention against pandemic and civilization diseases. For such tasks, advanced IT infrastructures and intelligent AI systems are used, which allow supporting patients' diagnosis and treatment. In our research, we also try to define efficient tools for coronavirus classification, especially using mathematical linguistic methods. This paper presents the ways of application of linguistics techniques in supporting effective management of medical","2021","07","13","Neural Comput Appl","Neural computing &amp; applications","Formal grammars; Healthcare application; Mathematical linguistics; Pandemic prevention","Ogiela","Urszula","Pedagogical University of Krakow, Podchorazych 2 St, 30-084 Kraków, Poland",NA
"2652","34248288","10.1007/s00521-021-06219-9","Toward real-time and efficient cardiovascular monitoring for COVID-19 patients by 5G-enabled wearable medical devices: a deep learning approach.","Patients with deaths from COVID-19 often have co-morbid cardiovascular disease. Real-time cardiovascular disease monitoring based on wearable medical devices may effectively reduce COVID-19 mortality rates. However, due to technical limitations, there are three main issues. First, the traditional wireless communication technology for wearable medical devices is difficult to satisfy the real-time requirements fully. Second, current monitoring platforms lack efficient streaming data processing mec","2021","07","13","Neural Comput Appl","Neural computing &amp; applications","5G; CNN; Cardiovascular monitoring; Deep learning; Flink; LSTM","Tan","Liang","College of Computer Science, Sichuan Normal University, Chengdu, 610101 China",NA
"2653","34248288","10.1007/s00521-021-06219-9","Toward real-time and efficient cardiovascular monitoring for COVID-19 patients by 5G-enabled wearable medical devices: a deep learning approach.","Patients with deaths from COVID-19 often have co-morbid cardiovascular disease. Real-time cardiovascular disease monitoring based on wearable medical devices may effectively reduce COVID-19 mortality rates. However, due to technical limitations, there are three main issues. First, the traditional wireless communication technology for wearable medical devices is difficult to satisfy the real-time requirements fully. Second, current monitoring platforms lack efficient streaming data processing mec","2021","07","13","Neural Comput Appl","Neural computing &amp; applications","5G; CNN; Cardiovascular monitoring; Deep learning; Flink; LSTM","Yu","Keping","Global Information and Telecommunication Institute, Waseda University, Tokyo, Japan",NA
"2654","34248288","10.1007/s00521-021-06219-9","Toward real-time and efficient cardiovascular monitoring for COVID-19 patients by 5G-enabled wearable medical devices: a deep learning approach.","Patients with deaths from COVID-19 often have co-morbid cardiovascular disease. Real-time cardiovascular disease monitoring based on wearable medical devices may effectively reduce COVID-19 mortality rates. However, due to technical limitations, there are three main issues. First, the traditional wireless communication technology for wearable medical devices is difficult to satisfy the real-time requirements fully. Second, current monitoring platforms lack efficient streaming data processing mec","2021","07","13","Neural Comput Appl","Neural computing &amp; applications","5G; CNN; Cardiovascular monitoring; Deep learning; Flink; LSTM","Bashir","Ali Kashif","Department of Computing and Mathematics, Manchester Metropolitan University, Manchester, UK",NA
"2655","34248288","10.1007/s00521-021-06219-9","Toward real-time and efficient cardiovascular monitoring for COVID-19 patients by 5G-enabled wearable medical devices: a deep learning approach.","Patients with deaths from COVID-19 often have co-morbid cardiovascular disease. Real-time cardiovascular disease monitoring based on wearable medical devices may effectively reduce COVID-19 mortality rates. However, due to technical limitations, there are three main issues. First, the traditional wireless communication technology for wearable medical devices is difficult to satisfy the real-time requirements fully. Second, current monitoring platforms lack efficient streaming data processing mec","2021","07","13","Neural Comput Appl","Neural computing &amp; applications","5G; CNN; Cardiovascular monitoring; Deep learning; Flink; LSTM","Cheng","Xiaofan","College of Computer Science, Sichuan Normal University, Chengdu, 610101 China",NA
"2656","34248288","10.1007/s00521-021-06219-9","Toward real-time and efficient cardiovascular monitoring for COVID-19 patients by 5G-enabled wearable medical devices: a deep learning approach.","Patients with deaths from COVID-19 often have co-morbid cardiovascular disease. Real-time cardiovascular disease monitoring based on wearable medical devices may effectively reduce COVID-19 mortality rates. However, due to technical limitations, there are three main issues. First, the traditional wireless communication technology for wearable medical devices is difficult to satisfy the real-time requirements fully. Second, current monitoring platforms lack efficient streaming data processing mec","2021","07","13","Neural Comput Appl","Neural computing &amp; applications","5G; CNN; Cardiovascular monitoring; Deep learning; Flink; LSTM","Ming","Fangpeng","College of Computer Science, Sichuan Normal University, Chengdu, 610101 China",NA
"2657","34248288","10.1007/s00521-021-06219-9","Toward real-time and efficient cardiovascular monitoring for COVID-19 patients by 5G-enabled wearable medical devices: a deep learning approach.","Patients with deaths from COVID-19 often have co-morbid cardiovascular disease. Real-time cardiovascular disease monitoring based on wearable medical devices may effectively reduce COVID-19 mortality rates. However, due to technical limitations, there are three main issues. First, the traditional wireless communication technology for wearable medical devices is difficult to satisfy the real-time requirements fully. Second, current monitoring platforms lack efficient streaming data processing mec","2021","07","13","Neural Comput Appl","Neural computing &amp; applications","5G; CNN; Cardiovascular monitoring; Deep learning; Flink; LSTM","Zhao","Liang","School of Computer Science, Shenyang Aerospace University, Shenyang, 110136 China",NA
"2658","34248288","10.1007/s00521-021-06219-9","Toward real-time and efficient cardiovascular monitoring for COVID-19 patients by 5G-enabled wearable medical devices: a deep learning approach.","Patients with deaths from COVID-19 often have co-morbid cardiovascular disease. Real-time cardiovascular disease monitoring based on wearable medical devices may effectively reduce COVID-19 mortality rates. However, due to technical limitations, there are three main issues. First, the traditional wireless communication technology for wearable medical devices is difficult to satisfy the real-time requirements fully. Second, current monitoring platforms lack efficient streaming data processing mec","2021","07","13","Neural Comput Appl","Neural computing &amp; applications","5G; CNN; Cardiovascular monitoring; Deep learning; Flink; LSTM","Zhou","Xiaokang","Faculty of Data Science, Shiga University, Hikone, and RIKEN Center for Advanced Intelligence Project, Tokyo, Japan",NA
"2659","34248286","10.1007/s00278-021-00519-0","[Online psychotherapy in times of coronavirus disease 2019].","As a reaction to the coronavirus diseases 2019 (COVID-19) pandemic, in individual settings psychotherapy could be conducted online to an unlimited extent in Germany. The attitudes and experiences of psychotherapists with respect to online therapy (OT) have so far been generally poorly studied and particularly with a view to the situation during the pandemic. The aim of the study was to examine 1) the frequency of utilization of OT during the first lockdown, 2) the satisfaction with OT versus fac","2021","07","13","Psychotherapeut (Berl)","Psychotherapeut","Face-to-face therapy; Pandemics; Personal satisfaction; Technology acceptance; Telecommunications","Beck-Hiestermann","Franziska Marie Lea","Fachbereich Psychosomatik und Psychotherapie, Psychologische Hochschule Berlin, Am Köllnischen Park 2, 10179 Berlin, Deutschland",NA
"2660","34248286","10.1007/s00278-021-00519-0","[Online psychotherapy in times of coronavirus disease 2019].","As a reaction to the coronavirus diseases 2019 (COVID-19) pandemic, in individual settings psychotherapy could be conducted online to an unlimited extent in Germany. The attitudes and experiences of psychotherapists with respect to online therapy (OT) have so far been generally poorly studied and particularly with a view to the situation during the pandemic. The aim of the study was to examine 1) the frequency of utilization of OT during the first lockdown, 2) the satisfaction with OT versus fac","2021","07","13","Psychotherapeut (Berl)","Psychotherapeut","Face-to-face therapy; Pandemics; Personal satisfaction; Technology acceptance; Telecommunications","Kästner","Denise","Fachbereich Psychosomatik und Psychotherapie, Psychologische Hochschule Berlin, Am Köllnischen Park 2, 10179 Berlin, Deutschland",NA
"2661","34248286","10.1007/s00278-021-00519-0","[Online psychotherapy in times of coronavirus disease 2019].","As a reaction to the coronavirus diseases 2019 (COVID-19) pandemic, in individual settings psychotherapy could be conducted online to an unlimited extent in Germany. The attitudes and experiences of psychotherapists with respect to online therapy (OT) have so far been generally poorly studied and particularly with a view to the situation during the pandemic. The aim of the study was to examine 1) the frequency of utilization of OT during the first lockdown, 2) the satisfaction with OT versus fac","2021","07","13","Psychotherapeut (Berl)","Psychotherapeut","Face-to-face therapy; Pandemics; Personal satisfaction; Technology acceptance; Telecommunications","Gumz","Antje","Fachbereich Psychosomatik und Psychotherapie, Psychologische Hochschule Berlin, Am Köllnischen Park 2, 10179 Berlin, Deutschland",NA
"2662","34248284","10.1016/j.snb.2021.130411","Sensitive and rapid on-site detection of SARS-CoV-2 using a gold nanoparticle-based high-throughput platform coupled with CRISPR/Cas12-assisted RT-LAMP.","The outbreak of corona virus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to a global pandemic. The high infectivity of SARS-CoV-2 highlights the need for sensitive, rapid and on-site diagnostic assays of SARS-CoV-2 with high-throughput testing capability for large-scale population screening. The current detection methods in clinical application need to operate in centralized labs. Though some on-site detection methods have been developed","2021","07","14","Sens Actuators B Chem","Sensors and actuators. B, Chemical","AuNP, gold nanoparticle; COVID-19, Corona Virus Disease 2019; CRISPR, clustered regularly interspaced short palindromic repeats; CRISPR/Cas; Coronavirus disease; DMEM, Dulbeccos modified Eagles medium; FDA, American Food and Drug Administration; Gold nanoparticle; HCRs, hybridization chain reactions; High-throughput on-site detection; LAMP, loop-mediated isothermal amplification; Loop-mediated isothermal amplification; NMPA, the Chinese National Medical Products Administration; POCT, point of care testing; RPA, recombinase polymerase amplification; RT-qPCR, reverse transcription-real time quantitative PCR; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; TCEP, Tris(2-carboxyethyl) phosphine; TEM, transmission electron microscopy","Zhang","Yaqin","School of Life Sciences, Jilin University, Changchun, 130012, China",NA
"2663","34248284","10.1016/j.snb.2021.130411","Sensitive and rapid on-site detection of SARS-CoV-2 using a gold nanoparticle-based high-throughput platform coupled with CRISPR/Cas12-assisted RT-LAMP.","The outbreak of corona virus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to a global pandemic. The high infectivity of SARS-CoV-2 highlights the need for sensitive, rapid and on-site diagnostic assays of SARS-CoV-2 with high-throughput testing capability for large-scale population screening. The current detection methods in clinical application need to operate in centralized labs. Though some on-site detection methods have been developed","2021","07","14","Sens Actuators B Chem","Sensors and actuators. B, Chemical","AuNP, gold nanoparticle; COVID-19, Corona Virus Disease 2019; CRISPR, clustered regularly interspaced short palindromic repeats; CRISPR/Cas; Coronavirus disease; DMEM, Dulbeccos modified Eagles medium; FDA, American Food and Drug Administration; Gold nanoparticle; HCRs, hybridization chain reactions; High-throughput on-site detection; LAMP, loop-mediated isothermal amplification; Loop-mediated isothermal amplification; NMPA, the Chinese National Medical Products Administration; POCT, point of care testing; RPA, recombinase polymerase amplification; RT-qPCR, reverse transcription-real time quantitative PCR; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; TCEP, Tris(2-carboxyethyl) phosphine; TEM, transmission electron microscopy","Chen","Minyan","Engineering Research Center of Chinese Ministry of Education for Edible and Medicinal Fungi, Jilin Agricultural University, Changchun, 130118, China",NA
"2664","34248284","10.1016/j.snb.2021.130411","Sensitive and rapid on-site detection of SARS-CoV-2 using a gold nanoparticle-based high-throughput platform coupled with CRISPR/Cas12-assisted RT-LAMP.","The outbreak of corona virus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to a global pandemic. The high infectivity of SARS-CoV-2 highlights the need for sensitive, rapid and on-site diagnostic assays of SARS-CoV-2 with high-throughput testing capability for large-scale population screening. The current detection methods in clinical application need to operate in centralized labs. Though some on-site detection methods have been developed","2021","07","14","Sens Actuators B Chem","Sensors and actuators. B, Chemical","AuNP, gold nanoparticle; COVID-19, Corona Virus Disease 2019; CRISPR, clustered regularly interspaced short palindromic repeats; CRISPR/Cas; Coronavirus disease; DMEM, Dulbeccos modified Eagles medium; FDA, American Food and Drug Administration; Gold nanoparticle; HCRs, hybridization chain reactions; High-throughput on-site detection; LAMP, loop-mediated isothermal amplification; Loop-mediated isothermal amplification; NMPA, the Chinese National Medical Products Administration; POCT, point of care testing; RPA, recombinase polymerase amplification; RT-qPCR, reverse transcription-real time quantitative PCR; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; TCEP, Tris(2-carboxyethyl) phosphine; TEM, transmission electron microscopy","Liu","Chengrong","Shanghai Institute of Immunology, Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai, China",NA
"2665","34248284","10.1016/j.snb.2021.130411","Sensitive and rapid on-site detection of SARS-CoV-2 using a gold nanoparticle-based high-throughput platform coupled with CRISPR/Cas12-assisted RT-LAMP.","The outbreak of corona virus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to a global pandemic. The high infectivity of SARS-CoV-2 highlights the need for sensitive, rapid and on-site diagnostic assays of SARS-CoV-2 with high-throughput testing capability for large-scale population screening. The current detection methods in clinical application need to operate in centralized labs. Though some on-site detection methods have been developed","2021","07","14","Sens Actuators B Chem","Sensors and actuators. B, Chemical","AuNP, gold nanoparticle; COVID-19, Corona Virus Disease 2019; CRISPR, clustered regularly interspaced short palindromic repeats; CRISPR/Cas; Coronavirus disease; DMEM, Dulbeccos modified Eagles medium; FDA, American Food and Drug Administration; Gold nanoparticle; HCRs, hybridization chain reactions; High-throughput on-site detection; LAMP, loop-mediated isothermal amplification; Loop-mediated isothermal amplification; NMPA, the Chinese National Medical Products Administration; POCT, point of care testing; RPA, recombinase polymerase amplification; RT-qPCR, reverse transcription-real time quantitative PCR; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; TCEP, Tris(2-carboxyethyl) phosphine; TEM, transmission electron microscopy","Chen","Jiaqi","Engineering Research Center of Chinese Ministry of Education for Edible and Medicinal Fungi, Jilin Agricultural University, Changchun, 130118, China",NA
"2666","34248284","10.1016/j.snb.2021.130411","Sensitive and rapid on-site detection of SARS-CoV-2 using a gold nanoparticle-based high-throughput platform coupled with CRISPR/Cas12-assisted RT-LAMP.","The outbreak of corona virus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to a global pandemic. The high infectivity of SARS-CoV-2 highlights the need for sensitive, rapid and on-site diagnostic assays of SARS-CoV-2 with high-throughput testing capability for large-scale population screening. The current detection methods in clinical application need to operate in centralized labs. Though some on-site detection methods have been developed","2021","07","14","Sens Actuators B Chem","Sensors and actuators. B, Chemical","AuNP, gold nanoparticle; COVID-19, Corona Virus Disease 2019; CRISPR, clustered regularly interspaced short palindromic repeats; CRISPR/Cas; Coronavirus disease; DMEM, Dulbeccos modified Eagles medium; FDA, American Food and Drug Administration; Gold nanoparticle; HCRs, hybridization chain reactions; High-throughput on-site detection; LAMP, loop-mediated isothermal amplification; Loop-mediated isothermal amplification; NMPA, the Chinese National Medical Products Administration; POCT, point of care testing; RPA, recombinase polymerase amplification; RT-qPCR, reverse transcription-real time quantitative PCR; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; TCEP, Tris(2-carboxyethyl) phosphine; TEM, transmission electron microscopy","Luo","Xinyi","School of Biomedical Engineering, Sun Yat-sen University, Shenzhen, 518107, China",NA
"2667","34248284","10.1016/j.snb.2021.130411","Sensitive and rapid on-site detection of SARS-CoV-2 using a gold nanoparticle-based high-throughput platform coupled with CRISPR/Cas12-assisted RT-LAMP.","The outbreak of corona virus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to a global pandemic. The high infectivity of SARS-CoV-2 highlights the need for sensitive, rapid and on-site diagnostic assays of SARS-CoV-2 with high-throughput testing capability for large-scale population screening. The current detection methods in clinical application need to operate in centralized labs. Though some on-site detection methods have been developed","2021","07","14","Sens Actuators B Chem","Sensors and actuators. B, Chemical","AuNP, gold nanoparticle; COVID-19, Corona Virus Disease 2019; CRISPR, clustered regularly interspaced short palindromic repeats; CRISPR/Cas; Coronavirus disease; DMEM, Dulbeccos modified Eagles medium; FDA, American Food and Drug Administration; Gold nanoparticle; HCRs, hybridization chain reactions; High-throughput on-site detection; LAMP, loop-mediated isothermal amplification; Loop-mediated isothermal amplification; NMPA, the Chinese National Medical Products Administration; POCT, point of care testing; RPA, recombinase polymerase amplification; RT-qPCR, reverse transcription-real time quantitative PCR; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; TCEP, Tris(2-carboxyethyl) phosphine; TEM, transmission electron microscopy","Xue","Yingying","School of Biomedical Engineering, Sun Yat-sen University, Shenzhen, 518107, China",NA
"2668","34248284","10.1016/j.snb.2021.130411","Sensitive and rapid on-site detection of SARS-CoV-2 using a gold nanoparticle-based high-throughput platform coupled with CRISPR/Cas12-assisted RT-LAMP.","The outbreak of corona virus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to a global pandemic. The high infectivity of SARS-CoV-2 highlights the need for sensitive, rapid and on-site diagnostic assays of SARS-CoV-2 with high-throughput testing capability for large-scale population screening. The current detection methods in clinical application need to operate in centralized labs. Though some on-site detection methods have been developed","2021","07","14","Sens Actuators B Chem","Sensors and actuators. B, Chemical","AuNP, gold nanoparticle; COVID-19, Corona Virus Disease 2019; CRISPR, clustered regularly interspaced short palindromic repeats; CRISPR/Cas; Coronavirus disease; DMEM, Dulbeccos modified Eagles medium; FDA, American Food and Drug Administration; Gold nanoparticle; HCRs, hybridization chain reactions; High-throughput on-site detection; LAMP, loop-mediated isothermal amplification; Loop-mediated isothermal amplification; NMPA, the Chinese National Medical Products Administration; POCT, point of care testing; RPA, recombinase polymerase amplification; RT-qPCR, reverse transcription-real time quantitative PCR; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; TCEP, Tris(2-carboxyethyl) phosphine; TEM, transmission electron microscopy","Liang","Qiming","Shanghai Institute of Immunology, Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai, China",NA
"2669","34248284","10.1016/j.snb.2021.130411","Sensitive and rapid on-site detection of SARS-CoV-2 using a gold nanoparticle-based high-throughput platform coupled with CRISPR/Cas12-assisted RT-LAMP.","The outbreak of corona virus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to a global pandemic. The high infectivity of SARS-CoV-2 highlights the need for sensitive, rapid and on-site diagnostic assays of SARS-CoV-2 with high-throughput testing capability for large-scale population screening. The current detection methods in clinical application need to operate in centralized labs. Though some on-site detection methods have been developed","2021","07","14","Sens Actuators B Chem","Sensors and actuators. B, Chemical","AuNP, gold nanoparticle; COVID-19, Corona Virus Disease 2019; CRISPR, clustered regularly interspaced short palindromic repeats; CRISPR/Cas; Coronavirus disease; DMEM, Dulbeccos modified Eagles medium; FDA, American Food and Drug Administration; Gold nanoparticle; HCRs, hybridization chain reactions; High-throughput on-site detection; LAMP, loop-mediated isothermal amplification; Loop-mediated isothermal amplification; NMPA, the Chinese National Medical Products Administration; POCT, point of care testing; RPA, recombinase polymerase amplification; RT-qPCR, reverse transcription-real time quantitative PCR; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; TCEP, Tris(2-carboxyethyl) phosphine; TEM, transmission electron microscopy","Zhou","Li","Institute of Environmental Research at Greater Bay Area, Key Laboratory for Water Quality and Conservation of the Pearl River Delta, Ministry of Education, Guangzhou University, Guangzhou, 510006, China",NA
"2670","34248284","10.1016/j.snb.2021.130411","Sensitive and rapid on-site detection of SARS-CoV-2 using a gold nanoparticle-based high-throughput platform coupled with CRISPR/Cas12-assisted RT-LAMP.","The outbreak of corona virus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to a global pandemic. The high infectivity of SARS-CoV-2 highlights the need for sensitive, rapid and on-site diagnostic assays of SARS-CoV-2 with high-throughput testing capability for large-scale population screening. The current detection methods in clinical application need to operate in centralized labs. Though some on-site detection methods have been developed","2021","07","14","Sens Actuators B Chem","Sensors and actuators. B, Chemical","AuNP, gold nanoparticle; COVID-19, Corona Virus Disease 2019; CRISPR, clustered regularly interspaced short palindromic repeats; CRISPR/Cas; Coronavirus disease; DMEM, Dulbeccos modified Eagles medium; FDA, American Food and Drug Administration; Gold nanoparticle; HCRs, hybridization chain reactions; High-throughput on-site detection; LAMP, loop-mediated isothermal amplification; Loop-mediated isothermal amplification; NMPA, the Chinese National Medical Products Administration; POCT, point of care testing; RPA, recombinase polymerase amplification; RT-qPCR, reverse transcription-real time quantitative PCR; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; TCEP, Tris(2-carboxyethyl) phosphine; TEM, transmission electron microscopy","Tao","Yu","Laboratory of Biomaterials and Translational Medicine, Center for Nanomedicine, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510630, China",NA
"2671","34248284","10.1016/j.snb.2021.130411","Sensitive and rapid on-site detection of SARS-CoV-2 using a gold nanoparticle-based high-throughput platform coupled with CRISPR/Cas12-assisted RT-LAMP.","The outbreak of corona virus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to a global pandemic. The high infectivity of SARS-CoV-2 highlights the need for sensitive, rapid and on-site diagnostic assays of SARS-CoV-2 with high-throughput testing capability for large-scale population screening. The current detection methods in clinical application need to operate in centralized labs. Though some on-site detection methods have been developed","2021","07","14","Sens Actuators B Chem","Sensors and actuators. B, Chemical","AuNP, gold nanoparticle; COVID-19, Corona Virus Disease 2019; CRISPR, clustered regularly interspaced short palindromic repeats; CRISPR/Cas; Coronavirus disease; DMEM, Dulbeccos modified Eagles medium; FDA, American Food and Drug Administration; Gold nanoparticle; HCRs, hybridization chain reactions; High-throughput on-site detection; LAMP, loop-mediated isothermal amplification; Loop-mediated isothermal amplification; NMPA, the Chinese National Medical Products Administration; POCT, point of care testing; RPA, recombinase polymerase amplification; RT-qPCR, reverse transcription-real time quantitative PCR; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; TCEP, Tris(2-carboxyethyl) phosphine; TEM, transmission electron microscopy","Li","Mingqiang","Laboratory of Biomaterials and Translational Medicine, Center for Nanomedicine, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510630, China",NA
"2672","34248284","10.1016/j.snb.2021.130411","Sensitive and rapid on-site detection of SARS-CoV-2 using a gold nanoparticle-based high-throughput platform coupled with CRISPR/Cas12-assisted RT-LAMP.","The outbreak of corona virus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to a global pandemic. The high infectivity of SARS-CoV-2 highlights the need for sensitive, rapid and on-site diagnostic assays of SARS-CoV-2 with high-throughput testing capability for large-scale population screening. The current detection methods in clinical application need to operate in centralized labs. Though some on-site detection methods have been developed","2021","07","14","Sens Actuators B Chem","Sensors and actuators. B, Chemical","AuNP, gold nanoparticle; COVID-19, Corona Virus Disease 2019; CRISPR, clustered regularly interspaced short palindromic repeats; CRISPR/Cas; Coronavirus disease; DMEM, Dulbeccos modified Eagles medium; FDA, American Food and Drug Administration; Gold nanoparticle; HCRs, hybridization chain reactions; High-throughput on-site detection; LAMP, loop-mediated isothermal amplification; Loop-mediated isothermal amplification; NMPA, the Chinese National Medical Products Administration; POCT, point of care testing; RPA, recombinase polymerase amplification; RT-qPCR, reverse transcription-real time quantitative PCR; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; TCEP, Tris(2-carboxyethyl) phosphine; TEM, transmission electron microscopy","Wang","Di","School of Life Sciences, Jilin University, Changchun, 130012, China",NA
"2673","34248284","10.1016/j.snb.2021.130411","Sensitive and rapid on-site detection of SARS-CoV-2 using a gold nanoparticle-based high-throughput platform coupled with CRISPR/Cas12-assisted RT-LAMP.","The outbreak of corona virus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to a global pandemic. The high infectivity of SARS-CoV-2 highlights the need for sensitive, rapid and on-site diagnostic assays of SARS-CoV-2 with high-throughput testing capability for large-scale population screening. The current detection methods in clinical application need to operate in centralized labs. Though some on-site detection methods have been developed","2021","07","14","Sens Actuators B Chem","Sensors and actuators. B, Chemical","AuNP, gold nanoparticle; COVID-19, Corona Virus Disease 2019; CRISPR, clustered regularly interspaced short palindromic repeats; CRISPR/Cas; Coronavirus disease; DMEM, Dulbeccos modified Eagles medium; FDA, American Food and Drug Administration; Gold nanoparticle; HCRs, hybridization chain reactions; High-throughput on-site detection; LAMP, loop-mediated isothermal amplification; Loop-mediated isothermal amplification; NMPA, the Chinese National Medical Products Administration; POCT, point of care testing; RPA, recombinase polymerase amplification; RT-qPCR, reverse transcription-real time quantitative PCR; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; TCEP, Tris(2-carboxyethyl) phosphine; TEM, transmission electron microscopy","Zhou","Jianhua","School of Biomedical Engineering, Sun Yat-sen University, Shenzhen, 518107, China",NA
"2674","34248284","10.1016/j.snb.2021.130411","Sensitive and rapid on-site detection of SARS-CoV-2 using a gold nanoparticle-based high-throughput platform coupled with CRISPR/Cas12-assisted RT-LAMP.","The outbreak of corona virus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to a global pandemic. The high infectivity of SARS-CoV-2 highlights the need for sensitive, rapid and on-site diagnostic assays of SARS-CoV-2 with high-throughput testing capability for large-scale population screening. The current detection methods in clinical application need to operate in centralized labs. Though some on-site detection methods have been developed","2021","07","14","Sens Actuators B Chem","Sensors and actuators. B, Chemical","AuNP, gold nanoparticle; COVID-19, Corona Virus Disease 2019; CRISPR, clustered regularly interspaced short palindromic repeats; CRISPR/Cas; Coronavirus disease; DMEM, Dulbeccos modified Eagles medium; FDA, American Food and Drug Administration; Gold nanoparticle; HCRs, hybridization chain reactions; High-throughput on-site detection; LAMP, loop-mediated isothermal amplification; Loop-mediated isothermal amplification; NMPA, the Chinese National Medical Products Administration; POCT, point of care testing; RPA, recombinase polymerase amplification; RT-qPCR, reverse transcription-real time quantitative PCR; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; TCEP, Tris(2-carboxyethyl) phosphine; TEM, transmission electron microscopy","Wang","Jiasi","School of Biomedical Engineering, Sun Yat-sen University, Shenzhen, 518107, China",NA
"2675","34248283","10.1016/j.snb.2021.130394","Developing an Optical Interferometric Detection Method based biosensor for detecting specific SARS-CoV-2 immunoglobulins in Serum and Saliva, and their corresponding ELISA correlation.","The standard rapid approach for the diagnosis of coronavirus disease 2019 (COVID-19) is the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA. The detection of specific anti-SARS-CoV-2 immunoglobulins is crucial for screening people who have been exposed to the virus, whether or not they presented symptoms. Recent publications report different methods for the detection of specific IgGs, IgMs, and IgAs against SARS-CoV-2; these methods mainly detect immunoglobulins in ","2021","07","13","Sens Actuators B Chem","Sensors and actuators. B, Chemical","Biosensing; Immunoglobulins; Interferometric optical detection method; SARS-CoV-2; Saliva; Serum","Murillo","A M M","Center for Biomedical Technology (CTB), Universidad Politécnica de Madrid, Parque Científico y Tecnológico de la UPM, Campus de Montegancedo, 28223, Pozuelo de Alarcón, Madrid, Spain",NA
"2676","34248283","10.1016/j.snb.2021.130394","Developing an Optical Interferometric Detection Method based biosensor for detecting specific SARS-CoV-2 immunoglobulins in Serum and Saliva, and their corresponding ELISA correlation.","The standard rapid approach for the diagnosis of coronavirus disease 2019 (COVID-19) is the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA. The detection of specific anti-SARS-CoV-2 immunoglobulins is crucial for screening people who have been exposed to the virus, whether or not they presented symptoms. Recent publications report different methods for the detection of specific IgGs, IgMs, and IgAs against SARS-CoV-2; these methods mainly detect immunoglobulins in ","2021","07","13","Sens Actuators B Chem","Sensors and actuators. B, Chemical","Biosensing; Immunoglobulins; Interferometric optical detection method; SARS-CoV-2; Saliva; Serum","Tomé-Amat","J","Center for Plant Biotechnology and Genomics (CBGP), Universidad Politécnica de Madrid, Parque Científico y Tecnológico de la UPM. Campus de Montegancedo. 28223, Pozuelo de Alarcón, Madrid, Spain",NA
"2677","34248283","10.1016/j.snb.2021.130394","Developing an Optical Interferometric Detection Method based biosensor for detecting specific SARS-CoV-2 immunoglobulins in Serum and Saliva, and their corresponding ELISA correlation.","The standard rapid approach for the diagnosis of coronavirus disease 2019 (COVID-19) is the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA. The detection of specific anti-SARS-CoV-2 immunoglobulins is crucial for screening people who have been exposed to the virus, whether or not they presented symptoms. Recent publications report different methods for the detection of specific IgGs, IgMs, and IgAs against SARS-CoV-2; these methods mainly detect immunoglobulins in ","2021","07","13","Sens Actuators B Chem","Sensors and actuators. B, Chemical","Biosensing; Immunoglobulins; Interferometric optical detection method; SARS-CoV-2; Saliva; Serum","Ramírez","Y","Center for Biomedical Technology (CTB), Universidad Politécnica de Madrid, Parque Científico y Tecnológico de la UPM, Campus de Montegancedo, 28223, Pozuelo de Alarcón, Madrid, Spain",NA
"2678","34248283","10.1016/j.snb.2021.130394","Developing an Optical Interferometric Detection Method based biosensor for detecting specific SARS-CoV-2 immunoglobulins in Serum and Saliva, and their corresponding ELISA correlation.","The standard rapid approach for the diagnosis of coronavirus disease 2019 (COVID-19) is the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA. The detection of specific anti-SARS-CoV-2 immunoglobulins is crucial for screening people who have been exposed to the virus, whether or not they presented symptoms. Recent publications report different methods for the detection of specific IgGs, IgMs, and IgAs against SARS-CoV-2; these methods mainly detect immunoglobulins in ","2021","07","13","Sens Actuators B Chem","Sensors and actuators. B, Chemical","Biosensing; Immunoglobulins; Interferometric optical detection method; SARS-CoV-2; Saliva; Serum","Garrido-Arandia","M","Center for Plant Biotechnology and Genomics (CBGP), Universidad Politécnica de Madrid, Parque Científico y Tecnológico de la UPM. Campus de Montegancedo. 28223, Pozuelo de Alarcón, Madrid, Spain",NA
"2679","34248283","10.1016/j.snb.2021.130394","Developing an Optical Interferometric Detection Method based biosensor for detecting specific SARS-CoV-2 immunoglobulins in Serum and Saliva, and their corresponding ELISA correlation.","The standard rapid approach for the diagnosis of coronavirus disease 2019 (COVID-19) is the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA. The detection of specific anti-SARS-CoV-2 immunoglobulins is crucial for screening people who have been exposed to the virus, whether or not they presented symptoms. Recent publications report different methods for the detection of specific IgGs, IgMs, and IgAs against SARS-CoV-2; these methods mainly detect immunoglobulins in ","2021","07","13","Sens Actuators B Chem","Sensors and actuators. B, Chemical","Biosensing; Immunoglobulins; Interferometric optical detection method; SARS-CoV-2; Saliva; Serum","Valle","L G","Center for Biomedical Technology (CTB), Universidad Politécnica de Madrid, Parque Científico y Tecnológico de la UPM, Campus de Montegancedo, 28223, Pozuelo de Alarcón, Madrid, Spain",NA
"2680","34248283","10.1016/j.snb.2021.130394","Developing an Optical Interferometric Detection Method based biosensor for detecting specific SARS-CoV-2 immunoglobulins in Serum and Saliva, and their corresponding ELISA correlation.","The standard rapid approach for the diagnosis of coronavirus disease 2019 (COVID-19) is the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA. The detection of specific anti-SARS-CoV-2 immunoglobulins is crucial for screening people who have been exposed to the virus, whether or not they presented symptoms. Recent publications report different methods for the detection of specific IgGs, IgMs, and IgAs against SARS-CoV-2; these methods mainly detect immunoglobulins in ","2021","07","13","Sens Actuators B Chem","Sensors and actuators. B, Chemical","Biosensing; Immunoglobulins; Interferometric optical detection method; SARS-CoV-2; Saliva; Serum","Hernández-Ramírez","G","Center for Plant Biotechnology and Genomics (CBGP), Universidad Politécnica de Madrid, Parque Científico y Tecnológico de la UPM. Campus de Montegancedo. 28223, Pozuelo de Alarcón, Madrid, Spain",NA
"2681","34248283","10.1016/j.snb.2021.130394","Developing an Optical Interferometric Detection Method based biosensor for detecting specific SARS-CoV-2 immunoglobulins in Serum and Saliva, and their corresponding ELISA correlation.","The standard rapid approach for the diagnosis of coronavirus disease 2019 (COVID-19) is the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA. The detection of specific anti-SARS-CoV-2 immunoglobulins is crucial for screening people who have been exposed to the virus, whether or not they presented symptoms. Recent publications report different methods for the detection of specific IgGs, IgMs, and IgAs against SARS-CoV-2; these methods mainly detect immunoglobulins in ","2021","07","13","Sens Actuators B Chem","Sensors and actuators. B, Chemical","Biosensing; Immunoglobulins; Interferometric optical detection method; SARS-CoV-2; Saliva; Serum","Tramarin","L","Center for Biomedical Technology (CTB), Universidad Politécnica de Madrid, Parque Científico y Tecnológico de la UPM, Campus de Montegancedo, 28223, Pozuelo de Alarcón, Madrid, Spain",NA
"2682","34248283","10.1016/j.snb.2021.130394","Developing an Optical Interferometric Detection Method based biosensor for detecting specific SARS-CoV-2 immunoglobulins in Serum and Saliva, and their corresponding ELISA correlation.","The standard rapid approach for the diagnosis of coronavirus disease 2019 (COVID-19) is the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA. The detection of specific anti-SARS-CoV-2 immunoglobulins is crucial for screening people who have been exposed to the virus, whether or not they presented symptoms. Recent publications report different methods for the detection of specific IgGs, IgMs, and IgAs against SARS-CoV-2; these methods mainly detect immunoglobulins in ","2021","07","13","Sens Actuators B Chem","Sensors and actuators. B, Chemical","Biosensing; Immunoglobulins; Interferometric optical detection method; SARS-CoV-2; Saliva; Serum","Herreros","P","Center for Biomedical Technology (CTB), Universidad Politécnica de Madrid, Parque Científico y Tecnológico de la UPM, Campus de Montegancedo, 28223, Pozuelo de Alarcón, Madrid, Spain",NA
"2683","34248283","10.1016/j.snb.2021.130394","Developing an Optical Interferometric Detection Method based biosensor for detecting specific SARS-CoV-2 immunoglobulins in Serum and Saliva, and their corresponding ELISA correlation.","The standard rapid approach for the diagnosis of coronavirus disease 2019 (COVID-19) is the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA. The detection of specific anti-SARS-CoV-2 immunoglobulins is crucial for screening people who have been exposed to the virus, whether or not they presented symptoms. Recent publications report different methods for the detection of specific IgGs, IgMs, and IgAs against SARS-CoV-2; these methods mainly detect immunoglobulins in ","2021","07","13","Sens Actuators B Chem","Sensors and actuators. B, Chemical","Biosensing; Immunoglobulins; Interferometric optical detection method; SARS-CoV-2; Saliva; Serum","Santamaría","B","Center for Biomedical Technology (CTB), Universidad Politécnica de Madrid, Parque Científico y Tecnológico de la UPM, Campus de Montegancedo, 28223, Pozuelo de Alarcón, Madrid, Spain",NA
"2684","34248283","10.1016/j.snb.2021.130394","Developing an Optical Interferometric Detection Method based biosensor for detecting specific SARS-CoV-2 immunoglobulins in Serum and Saliva, and their corresponding ELISA correlation.","The standard rapid approach for the diagnosis of coronavirus disease 2019 (COVID-19) is the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA. The detection of specific anti-SARS-CoV-2 immunoglobulins is crucial for screening people who have been exposed to the virus, whether or not they presented symptoms. Recent publications report different methods for the detection of specific IgGs, IgMs, and IgAs against SARS-CoV-2; these methods mainly detect immunoglobulins in ","2021","07","13","Sens Actuators B Chem","Sensors and actuators. B, Chemical","Biosensing; Immunoglobulins; Interferometric optical detection method; SARS-CoV-2; Saliva; Serum","Díaz-Perales","A","Center for Plant Biotechnology and Genomics (CBGP), Universidad Politécnica de Madrid, Parque Científico y Tecnológico de la UPM. Campus de Montegancedo. 28223, Pozuelo de Alarcón, Madrid, Spain",NA
"2685","34248283","10.1016/j.snb.2021.130394","Developing an Optical Interferometric Detection Method based biosensor for detecting specific SARS-CoV-2 immunoglobulins in Serum and Saliva, and their corresponding ELISA correlation.","The standard rapid approach for the diagnosis of coronavirus disease 2019 (COVID-19) is the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA. The detection of specific anti-SARS-CoV-2 immunoglobulins is crucial for screening people who have been exposed to the virus, whether or not they presented symptoms. Recent publications report different methods for the detection of specific IgGs, IgMs, and IgAs against SARS-CoV-2; these methods mainly detect immunoglobulins in ","2021","07","13","Sens Actuators B Chem","Sensors and actuators. B, Chemical","Biosensing; Immunoglobulins; Interferometric optical detection method; SARS-CoV-2; Saliva; Serum","Holgado","M","Center for Biomedical Technology (CTB), Universidad Politécnica de Madrid, Parque Científico y Tecnológico de la UPM, Campus de Montegancedo, 28223, Pozuelo de Alarcón, Madrid, Spain",NA
"2686","34248281","10.1007/s11071-021-06680-0","Mathematical modelling of the second wave of COVID-19 infections using deterministic and stochastic SIDR models.","Recently, various countries from across the globe have been facing the second wave of COVID-19 infections. In order to understand the dynamics of the spread of the disease, much effort has been made in terms of mathematical modeling. In this scenario, compartmental models are widely used to simulate epidemics under various conditions. In general, there are uncertainties associated with the reported data, which must be considered when estimating the parameters of the model. In this work, we propo","2021","07","13","Nonlinear Dyn","Nonlinear dynamics","Inverse problem; Mathematical modeling of COVID-19; Second wave; Stochastic model; Uncertainty quantification","Lobato","Fran Sérgio","Chemical Engineering Faculty, Federal University of Uberlândia, Uberlândia, Brazil",NA
"2687","34248281","10.1007/s11071-021-06680-0","Mathematical modelling of the second wave of COVID-19 infections using deterministic and stochastic SIDR models.","Recently, various countries from across the globe have been facing the second wave of COVID-19 infections. In order to understand the dynamics of the spread of the disease, much effort has been made in terms of mathematical modeling. In this scenario, compartmental models are widely used to simulate epidemics under various conditions. In general, there are uncertainties associated with the reported data, which must be considered when estimating the parameters of the model. In this work, we propo","2021","07","13","Nonlinear Dyn","Nonlinear dynamics","Inverse problem; Mathematical modeling of COVID-19; Second wave; Stochastic model; Uncertainty quantification","Libotte","Gustavo Barbosa","National Laboratory for Scientific Computing, Petrópolis, Brazil",NA
"2688","34248281","10.1007/s11071-021-06680-0","Mathematical modelling of the second wave of COVID-19 infections using deterministic and stochastic SIDR models.","Recently, various countries from across the globe have been facing the second wave of COVID-19 infections. In order to understand the dynamics of the spread of the disease, much effort has been made in terms of mathematical modeling. In this scenario, compartmental models are widely used to simulate epidemics under various conditions. In general, there are uncertainties associated with the reported data, which must be considered when estimating the parameters of the model. In this work, we propo","2021","07","13","Nonlinear Dyn","Nonlinear dynamics","Inverse problem; Mathematical modeling of COVID-19; Second wave; Stochastic model; Uncertainty quantification","Platt","Gustavo Mendes","Graduate Program in Agroindustrial Systems and Processes, School of Chemistry and Food, Federal University of Rio Grande, Santo Antônio da Patrulha, Brazil",NA
"2689","34248280","10.1007/s11071-021-06631-9","A stochastic SEIHR model for COVID-19 data fluctuations.","Although deterministic compartmental models are useful for predicting the general trend of a disease's spread, they are unable to describe the random daily fluctuations in the number of new infections and hospitalizations, which is crucial in determining the necessary healthcare capacity for a specified level of risk. In this paper, we propose a stochastic SEIHR (sSEIHR) model to describe such random fluctuations and provide sufficient conditions for stochastic stability of the disease-free equi","2021","07","13","Nonlinear Dyn","Nonlinear dynamics","COVID-19; Data fluctuation; SEIHR model; Stochastic differential equation; Stochastic stability","Niu","Ruiwu","College of Mathematics and Statistics, Shenzhen University, Shenzhen, 518060 People's Republic of China",NA
"2690","34248280","10.1007/s11071-021-06631-9","A stochastic SEIHR model for COVID-19 data fluctuations.","Although deterministic compartmental models are useful for predicting the general trend of a disease's spread, they are unable to describe the random daily fluctuations in the number of new infections and hospitalizations, which is crucial in determining the necessary healthcare capacity for a specified level of risk. In this paper, we propose a stochastic SEIHR (sSEIHR) model to describe such random fluctuations and provide sufficient conditions for stochastic stability of the disease-free equi","2021","07","13","Nonlinear Dyn","Nonlinear dynamics","COVID-19; Data fluctuation; SEIHR model; Stochastic differential equation; Stochastic stability","Chan","Yin-Chi","Department of Electrical Engineering, City University of Hong Kong, 83 Tat Chee Ave., Kowloon Tong, Hong Kong",NA
"2691","34248280","10.1007/s11071-021-06631-9","A stochastic SEIHR model for COVID-19 data fluctuations.","Although deterministic compartmental models are useful for predicting the general trend of a disease's spread, they are unable to describe the random daily fluctuations in the number of new infections and hospitalizations, which is crucial in determining the necessary healthcare capacity for a specified level of risk. In this paper, we propose a stochastic SEIHR (sSEIHR) model to describe such random fluctuations and provide sufficient conditions for stochastic stability of the disease-free equi","2021","07","13","Nonlinear Dyn","Nonlinear dynamics","COVID-19; Data fluctuation; SEIHR model; Stochastic differential equation; Stochastic stability","Wong","Eric W M","Department of Electrical Engineering, City University of Hong Kong, 83 Tat Chee Ave., Kowloon Tong, Hong Kong",NA
"2692","34248280","10.1007/s11071-021-06631-9","A stochastic SEIHR model for COVID-19 data fluctuations.","Although deterministic compartmental models are useful for predicting the general trend of a disease's spread, they are unable to describe the random daily fluctuations in the number of new infections and hospitalizations, which is crucial in determining the necessary healthcare capacity for a specified level of risk. In this paper, we propose a stochastic SEIHR (sSEIHR) model to describe such random fluctuations and provide sufficient conditions for stochastic stability of the disease-free equi","2021","07","13","Nonlinear Dyn","Nonlinear dynamics","COVID-19; Data fluctuation; SEIHR model; Stochastic differential equation; Stochastic stability","van Wyk","Michaël Antonie","School of Electrical and Information Engineering, University of the Witwatersrand, Johannesburg, 2000 South Africa",NA
"2693","34248280","10.1007/s11071-021-06631-9","A stochastic SEIHR model for COVID-19 data fluctuations.","Although deterministic compartmental models are useful for predicting the general trend of a disease's spread, they are unable to describe the random daily fluctuations in the number of new infections and hospitalizations, which is crucial in determining the necessary healthcare capacity for a specified level of risk. In this paper, we propose a stochastic SEIHR (sSEIHR) model to describe such random fluctuations and provide sufficient conditions for stochastic stability of the disease-free equi","2021","07","13","Nonlinear Dyn","Nonlinear dynamics","COVID-19; Data fluctuation; SEIHR model; Stochastic differential equation; Stochastic stability","Chen","Guanrong","Department of Electrical Engineering, City University of Hong Kong, 83 Tat Chee Ave., Kowloon Tong, Hong Kong",NA
"2694","34248278","10.1007/s11069-021-04908-1","Dynamic analysis of emergency inter-organizational communication network under public health emergency: a case study of COVID-19 in Hubei Province of China.","Public health emergencies, especially major infectious diseases, may cause global crises. Timely and effective communication is essential for response to such incidents. However, the emergency response to such incidents usually lasts longer and break out repeatedly, and the existing static emergency communication network (ECN) analysis cannot fully reflect the dynamic information interaction between organizations during the emergency process. Therefore, this article takes the recent COVID-19 epi","2021","07","13","Nat Hazards (Dordr)","Natural hazards (Dordrecht, Netherlands)","COVID-19 emergency; Dynamic evolution; Emergency communication network; Network analysis; Public health emergencies","Lu","Yunmeng","School of Management and Economics, Beijing Institute of Technology, No. 5, South Street, Zhongguancun, Haidian District, Beijing, China",NA
"2695","34248278","10.1007/s11069-021-04908-1","Dynamic analysis of emergency inter-organizational communication network under public health emergency: a case study of COVID-19 in Hubei Province of China.","Public health emergencies, especially major infectious diseases, may cause global crises. Timely and effective communication is essential for response to such incidents. However, the emergency response to such incidents usually lasts longer and break out repeatedly, and the existing static emergency communication network (ECN) analysis cannot fully reflect the dynamic information interaction between organizations during the emergency process. Therefore, this article takes the recent COVID-19 epi","2021","07","13","Nat Hazards (Dordr)","Natural hazards (Dordrecht, Netherlands)","COVID-19 emergency; Dynamic evolution; Emergency communication network; Network analysis; Public health emergencies","Liu","Tiezhong","School of Management and Economics, Beijing Institute of Technology, No. 5, South Street, Zhongguancun, Haidian District, Beijing, China",NA
"2696","34248278","10.1007/s11069-021-04908-1","Dynamic analysis of emergency inter-organizational communication network under public health emergency: a case study of COVID-19 in Hubei Province of China.","Public health emergencies, especially major infectious diseases, may cause global crises. Timely and effective communication is essential for response to such incidents. However, the emergency response to such incidents usually lasts longer and break out repeatedly, and the existing static emergency communication network (ECN) analysis cannot fully reflect the dynamic information interaction between organizations during the emergency process. Therefore, this article takes the recent COVID-19 epi","2021","07","13","Nat Hazards (Dordr)","Natural hazards (Dordrecht, Netherlands)","COVID-19 emergency; Dynamic evolution; Emergency communication network; Network analysis; Public health emergencies","Wang","Tiantian","School of Management and Economics, Beijing Institute of Technology, No. 5, South Street, Zhongguancun, Haidian District, Beijing, China",NA
"2697","34248253","10.1177/0301574220988409","Level of Knowledge, Understanding, and Impact of the COVID-19 Pandemic on Continuing Fixed Orthodontic Treatment in Adults: A Questionnaire Study.","To evaluate the level of knowledge, understanding, and impact of the coronavirus disease 2019 (COVID-19) pandemic on adult patients regarding their ongoing fixed orthodontic treatment. A cross-sectional and descriptive survey was conducted on 108 adult patients undergoing fixed orthodontic treatment at GSL Dental College (GSLDC), India. All the candidates were aged 18 years and above, who were in lockdown due to the COVID-19 pandemic and devoid of treatment. Among the patients 43.5% were male an","2021","07","13","J Indian Orthod Soc","The Journal of Indian Orthodontic Society","COVID-19 pandemic; adult patients; lockdown; ongoing fixed orthodontic treatment","Ram","Rsvm Raghu","Department of Orthodontics and Dentofacial Orthopedics, GSL Dental College and Hospital, Rajahmundry, Andhra Pradesh, India",NA
"2698","34248253","10.1177/0301574220988409","Level of Knowledge, Understanding, and Impact of the COVID-19 Pandemic on Continuing Fixed Orthodontic Treatment in Adults: A Questionnaire Study.","To evaluate the level of knowledge, understanding, and impact of the coronavirus disease 2019 (COVID-19) pandemic on adult patients regarding their ongoing fixed orthodontic treatment. A cross-sectional and descriptive survey was conducted on 108 adult patients undergoing fixed orthodontic treatment at GSL Dental College (GSLDC), India. All the candidates were aged 18 years and above, who were in lockdown due to the COVID-19 pandemic and devoid of treatment. Among the patients 43.5% were male an","2021","07","13","J Indian Orthod Soc","The Journal of Indian Orthodontic Society","COVID-19 pandemic; adult patients; lockdown; ongoing fixed orthodontic treatment","Ranganayakulu","I","Department of Orthodontics and Dentofacial Orthopedics, GSL Dental College and Hospital, Rajahmundry, Andhra Pradesh, India",NA
"2699","34248253","10.1177/0301574220988409","Level of Knowledge, Understanding, and Impact of the COVID-19 Pandemic on Continuing Fixed Orthodontic Treatment in Adults: A Questionnaire Study.","To evaluate the level of knowledge, understanding, and impact of the coronavirus disease 2019 (COVID-19) pandemic on adult patients regarding their ongoing fixed orthodontic treatment. A cross-sectional and descriptive survey was conducted on 108 adult patients undergoing fixed orthodontic treatment at GSL Dental College (GSLDC), India. All the candidates were aged 18 years and above, who were in lockdown due to the COVID-19 pandemic and devoid of treatment. Among the patients 43.5% were male an","2021","07","13","J Indian Orthod Soc","The Journal of Indian Orthodontic Society","COVID-19 pandemic; adult patients; lockdown; ongoing fixed orthodontic treatment","Viswanadh","K Anand","Department of Orthodontics and Dentofacial Orthopedics, GSL Dental College and Hospital, Rajahmundry, Andhra Pradesh, India",NA
"2700","34248253","10.1177/0301574220988409","Level of Knowledge, Understanding, and Impact of the COVID-19 Pandemic on Continuing Fixed Orthodontic Treatment in Adults: A Questionnaire Study.","To evaluate the level of knowledge, understanding, and impact of the coronavirus disease 2019 (COVID-19) pandemic on adult patients regarding their ongoing fixed orthodontic treatment. A cross-sectional and descriptive survey was conducted on 108 adult patients undergoing fixed orthodontic treatment at GSL Dental College (GSLDC), India. All the candidates were aged 18 years and above, who were in lockdown due to the COVID-19 pandemic and devoid of treatment. Among the patients 43.5% were male an","2021","07","13","J Indian Orthod Soc","The Journal of Indian Orthodontic Society","COVID-19 pandemic; adult patients; lockdown; ongoing fixed orthodontic treatment","Kumar","Tss Manikanta","Department of Periodontics, GSL Dental College and Hospital, Rajahmundry, Andhra Pradesh, India",NA
"2701","34248253","10.1177/0301574220988409","Level of Knowledge, Understanding, and Impact of the COVID-19 Pandemic on Continuing Fixed Orthodontic Treatment in Adults: A Questionnaire Study.","To evaluate the level of knowledge, understanding, and impact of the coronavirus disease 2019 (COVID-19) pandemic on adult patients regarding their ongoing fixed orthodontic treatment. A cross-sectional and descriptive survey was conducted on 108 adult patients undergoing fixed orthodontic treatment at GSL Dental College (GSLDC), India. All the candidates were aged 18 years and above, who were in lockdown due to the COVID-19 pandemic and devoid of treatment. Among the patients 43.5% were male an","2021","07","13","J Indian Orthod Soc","The Journal of Indian Orthodontic Society","COVID-19 pandemic; adult patients; lockdown; ongoing fixed orthodontic treatment","Chaitanya","C Viswa","Department of Public Health Dentistry, Sibar Institute of Dental Sciences, Guntur, Andhra Pradesh, India",NA
"2702","34248253","10.1177/0301574220988409","Level of Knowledge, Understanding, and Impact of the COVID-19 Pandemic on Continuing Fixed Orthodontic Treatment in Adults: A Questionnaire Study.","To evaluate the level of knowledge, understanding, and impact of the coronavirus disease 2019 (COVID-19) pandemic on adult patients regarding their ongoing fixed orthodontic treatment. A cross-sectional and descriptive survey was conducted on 108 adult patients undergoing fixed orthodontic treatment at GSL Dental College (GSLDC), India. All the candidates were aged 18 years and above, who were in lockdown due to the COVID-19 pandemic and devoid of treatment. Among the patients 43.5% were male an","2021","07","13","J Indian Orthod Soc","The Journal of Indian Orthodontic Society","COVID-19 pandemic; adult patients; lockdown; ongoing fixed orthodontic treatment","Sunil","G","Department of Orthodontics and Dentofacial Orthopedics, GSL Dental College and Hospital, Rajahmundry, Andhra Pradesh, India",NA
"2703","34248246","10.1016/j.ribaf.2021.101491","Risk contagion of COVID-19 in Japanese firms: A network approach.","The novel coronavirus disease (COVID-19) is one of the worst pandemics in human history. Our research objective is to assess the contagion effect on Japanese firms and to evaluate the Japanese government's COVID-19 measures during the period from April 7, 2020, to May 25, 2020. We propose a susceptible-infected-recovered-dead model for COVID-19 and derive COVID-19 parameters for Japan. Subsequently, we analyze the effect of COVID-19 on Japanese firms through correlation-based network and credit ","2021","07","16","Res Int Bus Finance","Research in international business and finance","COVID-19; Correlation-based network; Net cash; Risk contagion; Stock market; Susceptible-infected-recovered-dead (SIRD) model","Kanno","Masayasu","College of Commerce, Nihon University, 5-2-1, Kinuta, Setagaya, Tokyo 157-8570, Japan",NA
"2704","34248243","10.1016/S0262-4079(21)01121-0","Delta to dominate world.","This surging variant of the coronavirus is on course to outcompete all the other versions of the virus globally, reports Adam Vaughan.","2021","07","12","New Sci","New scientist (1971)",NA,"Vaughan","Adam",NA,NA
"2705","34248242","10.1007/s10479-021-04154-5","Depth-wise dense neural network for automatic COVID19 infection detection and diagnosis.","Coronavirus (COVID-19) and its new strain resulted in massive damage to society and brought panic worldwide. Automated medical image analysis such as X-rays, CT, and MRI offers excellent early diagnosis potential to augment the traditional healthcare strategy to fight against COVID-19. However, the identification of COVID infected lungs X-rays is challenging due to the high variation in infection characteristics and low-intensity contrast between normal tissues and infections. To identify the in","2021","07","13","Ann Oper Res","Annals of operations research","COVID19; Deep learning; Diagnosis; Management","Qayyum","Abdul","Universite de Bourgogne, Dijon, France",NA
"2706","34248242","10.1007/s10479-021-04154-5","Depth-wise dense neural network for automatic COVID19 infection detection and diagnosis.","Coronavirus (COVID-19) and its new strain resulted in massive damage to society and brought panic worldwide. Automated medical image analysis such as X-rays, CT, and MRI offers excellent early diagnosis potential to augment the traditional healthcare strategy to fight against COVID-19. However, the identification of COVID infected lungs X-rays is challenging due to the high variation in infection characteristics and low-intensity contrast between normal tissues and infections. To identify the in","2021","07","13","Ann Oper Res","Annals of operations research","COVID19; Deep learning; Diagnosis; Management","Razzak","Imran","Deakin University, Geelong, Australia",NA
"2707","34248242","10.1007/s10479-021-04154-5","Depth-wise dense neural network for automatic COVID19 infection detection and diagnosis.","Coronavirus (COVID-19) and its new strain resulted in massive damage to society and brought panic worldwide. Automated medical image analysis such as X-rays, CT, and MRI offers excellent early diagnosis potential to augment the traditional healthcare strategy to fight against COVID-19. However, the identification of COVID infected lungs X-rays is challenging due to the high variation in infection characteristics and low-intensity contrast between normal tissues and infections. To identify the in","2021","07","13","Ann Oper Res","Annals of operations research","COVID19; Deep learning; Diagnosis; Management","Tanveer","M","IIT, Indore, India",NA
"2708","34248242","10.1007/s10479-021-04154-5","Depth-wise dense neural network for automatic COVID19 infection detection and diagnosis.","Coronavirus (COVID-19) and its new strain resulted in massive damage to society and brought panic worldwide. Automated medical image analysis such as X-rays, CT, and MRI offers excellent early diagnosis potential to augment the traditional healthcare strategy to fight against COVID-19. However, the identification of COVID infected lungs X-rays is challenging due to the high variation in infection characteristics and low-intensity contrast between normal tissues and infections. To identify the in","2021","07","13","Ann Oper Res","Annals of operations research","COVID19; Deep learning; Diagnosis; Management","Kumar","Ajay","EMLYON Business School, Écully, France",NA
"2709","34248237","10.1016/j.childyouth.2021.106137","Mental health difficulties in students with suspected COVID-19 symptoms and students without suspected COVID-19 symptoms: A cross-sectional comparative study during the COVID-19 pandemic.","Mental health problems are taking a heavy toll on students during the COVID-19 pandemic. The purpose of this study was to compare the level of anxiety symptoms, depressive symptoms, post-traumatic stress symptoms (PTSS), and fear of COVID-19 between students with suspected COVID-19 symptoms and students without any suspected symptoms during the pandemic in Bangladesh. This cross-sectional comparative study was conducted online among Bangladeshi students from May to July 2020. Anxiety symptoms, d","2021","07","20","Child Youth Serv Rev","Children and youth services review","Anxiety; Bangladesh; COVID-19 symptoms; Depression; Fear of COVID-19; Mental health; PTSS","Sultana","Mst Sadia","Department of Public Health and Informatics, Jahangirnagar University, Savar, Dhaka, Bangladesh",NA
"2710","34248237","10.1016/j.childyouth.2021.106137","Mental health difficulties in students with suspected COVID-19 symptoms and students without suspected COVID-19 symptoms: A cross-sectional comparative study during the COVID-19 pandemic.","Mental health problems are taking a heavy toll on students during the COVID-19 pandemic. The purpose of this study was to compare the level of anxiety symptoms, depressive symptoms, post-traumatic stress symptoms (PTSS), and fear of COVID-19 between students with suspected COVID-19 symptoms and students without any suspected symptoms during the pandemic in Bangladesh. This cross-sectional comparative study was conducted online among Bangladeshi students from May to July 2020. Anxiety symptoms, d","2021","07","20","Child Youth Serv Rev","Children and youth services review","Anxiety; Bangladesh; COVID-19 symptoms; Depression; Fear of COVID-19; Mental health; PTSS","Khan","Abid Hasan","Department of Public Health and Informatics, Jahangirnagar University, Savar, Dhaka, Bangladesh",NA
"2711","34248237","10.1016/j.childyouth.2021.106137","Mental health difficulties in students with suspected COVID-19 symptoms and students without suspected COVID-19 symptoms: A cross-sectional comparative study during the COVID-19 pandemic.","Mental health problems are taking a heavy toll on students during the COVID-19 pandemic. The purpose of this study was to compare the level of anxiety symptoms, depressive symptoms, post-traumatic stress symptoms (PTSS), and fear of COVID-19 between students with suspected COVID-19 symptoms and students without any suspected symptoms during the pandemic in Bangladesh. This cross-sectional comparative study was conducted online among Bangladeshi students from May to July 2020. Anxiety symptoms, d","2021","07","20","Child Youth Serv Rev","Children and youth services review","Anxiety; Bangladesh; COVID-19 symptoms; Depression; Fear of COVID-19; Mental health; PTSS","Hossain","Sahadat","Department of Public Health and Informatics, Jahangirnagar University, Savar, Dhaka, Bangladesh",NA
"2712","34248237","10.1016/j.childyouth.2021.106137","Mental health difficulties in students with suspected COVID-19 symptoms and students without suspected COVID-19 symptoms: A cross-sectional comparative study during the COVID-19 pandemic.","Mental health problems are taking a heavy toll on students during the COVID-19 pandemic. The purpose of this study was to compare the level of anxiety symptoms, depressive symptoms, post-traumatic stress symptoms (PTSS), and fear of COVID-19 between students with suspected COVID-19 symptoms and students without any suspected symptoms during the pandemic in Bangladesh. This cross-sectional comparative study was conducted online among Bangladeshi students from May to July 2020. Anxiety symptoms, d","2021","07","20","Child Youth Serv Rev","Children and youth services review","Anxiety; Bangladesh; COVID-19 symptoms; Depression; Fear of COVID-19; Mental health; PTSS","Hasan","M Tasdik","Public Health Foundation, Bangladesh",NA
"2713","34248236","10.1007/s11083-021-09571-6","Critical Relations of Crowns in Critical Times of Coronavirus Depression.","The critical relations are the building blocks of the relational clone of a relational structure with respect to the relational operations intersection and direct product. In this paper we describe the critical relations of crowns. As a consequence, we obtain that the subpower membership problem for any crown is polynomial-time solvable.","2021","07","12","Order (Dordr)","Order (Dordrecht, Netherlands)","Clone; Critical relation; Crown; Finitely generated; Obstruction; Poset; Subpower membership problem","Kunos","Ádám","Bolyai Institute, University of Szeged, Szeged, Hungary",NA
"2714","34248236","10.1007/s11083-021-09571-6","Critical Relations of Crowns in Critical Times of Coronavirus Depression.","The critical relations are the building blocks of the relational clone of a relational structure with respect to the relational operations intersection and direct product. In this paper we describe the critical relations of crowns. As a consequence, we obtain that the subpower membership problem for any crown is polynomial-time solvable.","2021","07","12","Order (Dordr)","Order (Dordrecht, Netherlands)","Clone; Critical relation; Crown; Finitely generated; Obstruction; Poset; Subpower membership problem","Maróti","Miklós","Bolyai Institute, University of Szeged, Szeged, Hungary",NA
"2715","34248236","10.1007/s11083-021-09571-6","Critical Relations of Crowns in Critical Times of Coronavirus Depression.","The critical relations are the building blocks of the relational clone of a relational structure with respect to the relational operations intersection and direct product. In this paper we describe the critical relations of crowns. As a consequence, we obtain that the subpower membership problem for any crown is polynomial-time solvable.","2021","07","12","Order (Dordr)","Order (Dordrecht, Netherlands)","Clone; Critical relation; Crown; Finitely generated; Obstruction; Poset; Subpower membership problem","Zádori","László","Bolyai Institute, University of Szeged, Szeged, Hungary",NA
"2716","34248235","10.1007/s10584-021-03143-8","Investigating similarities and differences in individual reactions to the COVID-19 pandemic and the climate crisis.","How can individuals' responses to the coronavirus disease-19 (COVID-19) pandemic be used to inform constructive responses for climate action? We present an exploratory, mixed-methods investigation (N = 1784 US adults) into similarities and differences in individuals' reactions to COVID-19 and climate change in June 2020. Participants identified many similarities between the issues, indicating that both are harmful to public health, politically polarizing, have global impacts, and have solutions.","2021","07","13","Clim Change","Climatic change","Behavior; COVID-19; Climate change; Cognitions; Emotions; Norms","Geiger","Nathaniel","The Media School, Indiana University Bloomington, Franklin Hall, 601 E Kirkwood Ave, Bloomington, IN 47405 USA",NA
"2717","34248235","10.1007/s10584-021-03143-8","Investigating similarities and differences in individual reactions to the COVID-19 pandemic and the climate crisis.","How can individuals' responses to the coronavirus disease-19 (COVID-19) pandemic be used to inform constructive responses for climate action? We present an exploratory, mixed-methods investigation (N = 1784 US adults) into similarities and differences in individuals' reactions to COVID-19 and climate change in June 2020. Participants identified many similarities between the issues, indicating that both are harmful to public health, politically polarizing, have global impacts, and have solutions.","2021","07","13","Clim Change","Climatic change","Behavior; COVID-19; Climate change; Cognitions; Emotions; Norms","Gore","Anagha","O'Neill School of Public and Environmental Affairs, Indiana University Bloomington, 1315 East Tenth Street, Bloomington, IN 47405 USA",NA
"2718","34248235","10.1007/s10584-021-03143-8","Investigating similarities and differences in individual reactions to the COVID-19 pandemic and the climate crisis.","How can individuals' responses to the coronavirus disease-19 (COVID-19) pandemic be used to inform constructive responses for climate action? We present an exploratory, mixed-methods investigation (N = 1784 US adults) into similarities and differences in individuals' reactions to COVID-19 and climate change in June 2020. Participants identified many similarities between the issues, indicating that both are harmful to public health, politically polarizing, have global impacts, and have solutions.","2021","07","13","Clim Change","Climatic change","Behavior; COVID-19; Climate change; Cognitions; Emotions; Norms","Squire","Claire V","O'Neill School of Public and Environmental Affairs, Indiana University Bloomington, 1315 East Tenth Street, Bloomington, IN 47405 USA",NA
"2719","34248235","10.1007/s10584-021-03143-8","Investigating similarities and differences in individual reactions to the COVID-19 pandemic and the climate crisis.","How can individuals' responses to the coronavirus disease-19 (COVID-19) pandemic be used to inform constructive responses for climate action? We present an exploratory, mixed-methods investigation (N = 1784 US adults) into similarities and differences in individuals' reactions to COVID-19 and climate change in June 2020. Participants identified many similarities between the issues, indicating that both are harmful to public health, politically polarizing, have global impacts, and have solutions.","2021","07","13","Clim Change","Climatic change","Behavior; COVID-19; Climate change; Cognitions; Emotions; Norms","Attari","Shahzeen Z","O'Neill School of Public and Environmental Affairs, Indiana University Bloomington, 1315 East Tenth Street, Bloomington, IN 47405 USA",NA
"2720","34248229","10.1016/j.cma.2021.114020","Bayesian inference of heterogeneous epidemic models: Application to COVID-19 spread accounting for long-term care facilities.","We propose a high dimensional Bayesian inference framework for learning heterogeneous dynamics of a COVID-19 model, with a specific application to the dynamics and severity of COVID-19 inside and outside long-term care (LTC) facilities. We develop a heterogeneous compartmental model that accounts for the heterogeneity of the time-varying spread and severity of COVID-19 inside and outside LTC facilities, which is characterized by time-dependent stochastic processes and time-independent parameters","2021","07","16","Comput Methods Appl Mech Eng","Computer methods in applied mechanics and engineering","Bayesian inference; COVID-19; Compartmental model; Epidemics; Forecast under uncertainty; Long-term care facility","Chen","Peng","Oden Institute for Computational Engineering &amp",NA
"2721","34248229","10.1016/j.cma.2021.114020","Bayesian inference of heterogeneous epidemic models: Application to COVID-19 spread accounting for long-term care facilities.","We propose a high dimensional Bayesian inference framework for learning heterogeneous dynamics of a COVID-19 model, with a specific application to the dynamics and severity of COVID-19 inside and outside long-term care (LTC) facilities. We develop a heterogeneous compartmental model that accounts for the heterogeneity of the time-varying spread and severity of COVID-19 inside and outside LTC facilities, which is characterized by time-dependent stochastic processes and time-independent parameters","2021","07","16","Comput Methods Appl Mech Eng","Computer methods in applied mechanics and engineering","Bayesian inference; COVID-19; Compartmental model; Epidemics; Forecast under uncertainty; Long-term care facility","Wu","Keyi","Department of Mathematics, The University of Texas at Austin, Austin, TX, United States of America",NA
"2722","34248229","10.1016/j.cma.2021.114020","Bayesian inference of heterogeneous epidemic models: Application to COVID-19 spread accounting for long-term care facilities.","We propose a high dimensional Bayesian inference framework for learning heterogeneous dynamics of a COVID-19 model, with a specific application to the dynamics and severity of COVID-19 inside and outside long-term care (LTC) facilities. We develop a heterogeneous compartmental model that accounts for the heterogeneity of the time-varying spread and severity of COVID-19 inside and outside LTC facilities, which is characterized by time-dependent stochastic processes and time-independent parameters","2021","07","16","Comput Methods Appl Mech Eng","Computer methods in applied mechanics and engineering","Bayesian inference; COVID-19; Compartmental model; Epidemics; Forecast under uncertainty; Long-term care facility","Ghattas","Omar","Oden Institute for Computational Engineering &amp",NA
"2723","34248225","10.2471/BLT.20.267757","Public health challenges and opportunities after COVID-19.","With hindsight, the main weakness behind the ineffective response to the coronavirus disease 2019 (COVID-19) pandemic in some countries has been the failure to understand, and take account of, the multilayered systemic interdependencies that spread the effects of the pandemic across social, technological, economic and health-care dimensions. For example, to respond to the COVID-19 pandemic, all people were required to rapidly adjust to social distancing and travel restrictions. Such a complex be","2021","07","21","Bull World Health Organ","Bulletin of the World Health Organization","COVID-19; Cost-Benefit Analysis; Health Policy; Humans; Pandemics; Public Health; Risk Assessment","Sacco","Pier Luigi","Department of Humanities, IULM University, Via Carlo Bo, 1, 20143 Milan, Italy",NA
"2724","34248225","10.2471/BLT.20.267757","Public health challenges and opportunities after COVID-19.","With hindsight, the main weakness behind the ineffective response to the coronavirus disease 2019 (COVID-19) pandemic in some countries has been the failure to understand, and take account of, the multilayered systemic interdependencies that spread the effects of the pandemic across social, technological, economic and health-care dimensions. For example, to respond to the COVID-19 pandemic, all people were required to rapidly adjust to social distancing and travel restrictions. Such a complex be","2021","07","21","Bull World Health Organ","Bulletin of the World Health Organization","COVID-19; Cost-Benefit Analysis; Health Policy; Humans; Pandemics; Public Health; Risk Assessment","De Domenico","Manlio","CoMuNe Lab, Fondazione Bruno Kessler, Povo, Italy",NA
"2725","34248221","10.2471/BLT.20.255752","Viral transmission and evolution dynamics of SARS-CoV-2 in shipboard quarantine.","To examine transmission and evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in shipboard quarantine of the Diamond Princess cruise ship. We obtained the full SARS-CoV-2 genome sequences of 28 samples from the Global Initiative on Sharing All Influenza Data database. The samples were collected between 10 and 25 February 2020 and came for individuals who had been tested for SARS-CoV-2 during the quarantine on the cruise ship. These samples were later sequenced in either J","2021","07","21","Bull World Health Organ","Bulletin of the World Health Organization","COVID-19; Databases, Nucleic Acid; Disease Outbreaks; Hong Kong; Humans; Mutation; Phylogeny; Quarantine; RNA; SARS-CoV-2; Ships","Yeh","Ting-Yu","Auxergen Inc., Columbus Center, 701 East Pratt Street, Baltimore, MD 21202, United States of America",NA
"2726","34248221","10.2471/BLT.20.255752","Viral transmission and evolution dynamics of SARS-CoV-2 in shipboard quarantine.","To examine transmission and evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in shipboard quarantine of the Diamond Princess cruise ship. We obtained the full SARS-CoV-2 genome sequences of 28 samples from the Global Initiative on Sharing All Influenza Data database. The samples were collected between 10 and 25 February 2020 and came for individuals who had been tested for SARS-CoV-2 during the quarantine on the cruise ship. These samples were later sequenced in either J","2021","07","21","Bull World Health Organ","Bulletin of the World Health Organization","COVID-19; Databases, Nucleic Acid; Disease Outbreaks; Hong Kong; Humans; Mutation; Phylogeny; Quarantine; RNA; SARS-CoV-2; Ships","Contreras","Gregory P","Auxergen Inc., Columbus Center, 701 East Pratt Street, Baltimore, MD 21202, United States of America",NA
"2727","34248219","10.2471/BLT.21.020721","Accelerating vaccine trials.","The unprecedented speed with which COVID-19 vaccines have been developed and approved reflects increasingly nimble trial procedures, but opportunities exist for greater collaboration. Gary Humphreys and Lynn Eaton report.","2021","07","21","Bull World Health Organ","Bulletin of the World Health Organization","COVID-19; COVID-19 Vaccines; Drug Development; Humans; Patient Acceptance of Health Care; Risk Assessment; Safety",NA,NA,NA,NA
"2728","34248216","10.2471/BLT.20.283028","COVID-19 outbreaks among isolated Amazonian indigenous people, Ecuador.",NA,"2021","07","21","Bull World Health Organ","Bulletin of the World Health Organization","COVID-19; Disease Outbreaks; Ecuador; Humans; Indigenous Peoples; SARS-CoV-2","Henriquez-Trujillo","Aquiles R","One Health Research Group, Universidad de Las Américas, Via a Nayón S/N.170125, Quito, Ecuador",NA
"2729","34248216","10.2471/BLT.20.283028","COVID-19 outbreaks among isolated Amazonian indigenous people, Ecuador.",NA,"2021","07","21","Bull World Health Organ","Bulletin of the World Health Organization","COVID-19; Disease Outbreaks; Ecuador; Humans; Indigenous Peoples; SARS-CoV-2","Ortiz-Prado","Esteban","One Health Research Group, Universidad de Las Américas, Via a Nayón S/N.170125, Quito, Ecuador",NA
"2730","34248216","10.2471/BLT.20.283028","COVID-19 outbreaks among isolated Amazonian indigenous people, Ecuador.",NA,"2021","07","21","Bull World Health Organ","Bulletin of the World Health Organization","COVID-19; Disease Outbreaks; Ecuador; Humans; Indigenous Peoples; SARS-CoV-2","Rivera-Olivero","Ismar A","One Health Research Group, Universidad de Las Américas, Via a Nayón S/N.170125, Quito, Ecuador",NA
"2731","34248216","10.2471/BLT.20.283028","COVID-19 outbreaks among isolated Amazonian indigenous people, Ecuador.",NA,"2021","07","21","Bull World Health Organ","Bulletin of the World Health Organization","COVID-19; Disease Outbreaks; Ecuador; Humans; Indigenous Peoples; SARS-CoV-2","Nenquimo","Nemonte","Organización Waorani de Pastaza, Shell, Ecuador",NA
"2732","34248216","10.2471/BLT.20.283028","COVID-19 outbreaks among isolated Amazonian indigenous people, Ecuador.",NA,"2021","07","21","Bull World Health Organ","Bulletin of the World Health Organization","COVID-19; Disease Outbreaks; Ecuador; Humans; Indigenous Peoples; SARS-CoV-2","Tapia","Andrés","Nacionalidad Kichwa de Pastaza and Confederation of Indigenous Nationalities of the Ecuadorian Amazon, Puyo, Ecuador",NA
"2733","34248216","10.2471/BLT.20.283028","COVID-19 outbreaks among isolated Amazonian indigenous people, Ecuador.",NA,"2021","07","21","Bull World Health Organ","Bulletin of the World Health Organization","COVID-19; Disease Outbreaks; Ecuador; Humans; Indigenous Peoples; SARS-CoV-2","Anderson","Mitchell","Amazon Frontlines, San Francisco, United States of America",NA
"2734","34248216","10.2471/BLT.20.283028","COVID-19 outbreaks among isolated Amazonian indigenous people, Ecuador.",NA,"2021","07","21","Bull World Health Organ","Bulletin of the World Health Organization","COVID-19; Disease Outbreaks; Ecuador; Humans; Indigenous Peoples; SARS-CoV-2","Lozada","Tannya","One Health Research Group, Universidad de Las Américas, Via a Nayón S/N.170125, Quito, Ecuador",NA
"2735","34248216","10.2471/BLT.20.283028","COVID-19 outbreaks among isolated Amazonian indigenous people, Ecuador.",NA,"2021","07","21","Bull World Health Organ","Bulletin of the World Health Organization","COVID-19; Disease Outbreaks; Ecuador; Humans; Indigenous Peoples; SARS-CoV-2","Garcia-Bereguiain","Miguel Angel","One Health Research Group, Universidad de Las Américas, Via a Nayón S/N.170125, Quito, Ecuador",NA
"2736","34248212","10.1016/j.seps.2021.101120","One year of COVID-19 in Italy: are containment policies enough to shape the pandemic pattern?","A successful fight against COVID-19 greatly depends on citizens' adherence to the restrictive measures, which may not suffice alone. Making use of a containment index, data on sanctions, and Google's movement trends across Italian provinces, complemented by other sources, we investigate the extent to which compliance with the mobility limitations has affected the number of infections and deaths over time, for the period running from February 24, 2020 to February 23, 2021. We find proof of a dete","2021","07","14","Socioecon Plann Sci","Socio-economic planning sciences","COVID-19 lockdown stringency; First and second wave; Google community mobility reports; Italian provinces and regions; Reopening of schools; Social distancing compliance","Panarello","Demetrio","University of Bologna, Department of Statistical Sciences ""Paolo Fortunati"", Via delle Belle Arti 41, 40126, Bologna, Italy",NA
"2737","34248212","10.1016/j.seps.2021.101120","One year of COVID-19 in Italy: are containment policies enough to shape the pandemic pattern?","A successful fight against COVID-19 greatly depends on citizens' adherence to the restrictive measures, which may not suffice alone. Making use of a containment index, data on sanctions, and Google's movement trends across Italian provinces, complemented by other sources, we investigate the extent to which compliance with the mobility limitations has affected the number of infections and deaths over time, for the period running from February 24, 2020 to February 23, 2021. We find proof of a dete","2021","07","14","Socioecon Plann Sci","Socio-economic planning sciences","COVID-19 lockdown stringency; First and second wave; Google community mobility reports; Italian provinces and regions; Reopening of schools; Social distancing compliance","Tassinari","Giorgio","University of Bologna, Department of Statistical Sciences ""Paolo Fortunati"", Via delle Belle Arti 41, 40126, Bologna, Italy",NA
"2738","34248209","10.1016/j.ijleo.2021.167572","An optimized KELM approach for the diagnosis of <i>COVID-19</i> from 2D-SSA reconstructed CXR Images.","The COVID-19 is proved to be the most infectious disease of the current century with a high mortality rate world-wide. The current RT-PCR test standard for the diagnosis of COVID-19 is an invasive and time-consuming procedure, whereas the chest X-ray (CXR) images provide a non-invasive and time/cost-effective method for COVID-19 diagnosis. The current existing deep learning methods for the detection and diagnosis of CXR images provide biased results for the small size datase","2021","07","13","Optik (Stuttg)","Optik","2-D SSA; COVID-19; CXR; GLCM; KELM","Mohanty","Figlu","School of Engineering &amp",NA
"2739","34248209","10.1016/j.ijleo.2021.167572","An optimized KELM approach for the diagnosis of <i>COVID-19</i> from 2D-SSA reconstructed CXR Images.","The COVID-19 is proved to be the most infectious disease of the current century with a high mortality rate world-wide. The current RT-PCR test standard for the diagnosis of COVID-19 is an invasive and time-consuming procedure, whereas the chest X-ray (CXR) images provide a non-invasive and time/cost-effective method for COVID-19 diagnosis. The current existing deep learning methods for the detection and diagnosis of CXR images provide biased results for the small size datase","2021","07","13","Optik (Stuttg)","Optik","2-D SSA; COVID-19; CXR; GLCM; KELM","Dora","Chinmayee","School of Engineering &amp",NA
"2740","34248208","10.1007/s13237-021-00361-4","Is it possible to ensure COVID19 vaccine supply by using plants?","Any disease that spreads quickly and crossed the geographical barrier is termed as pandemic. After the initial occurrence of Covid-19 from China, World Health Organization had declared novel corona viral outbreak as pandemic on March, 2020. Since then, COVID-19 continued to devastate people all around the world. Human civilization has witnessed one of its greatest crises by facing 180 million of confirmed cases with 38.9 lakh deaths across the world till end of June 2021. India alone contributes","2021","07","13","Nucleus (Calcutta)","The Nucleus : an international journal of cytology and allied topics","Covid 19; Pandemic; Plant derived vaccine; Therapeutics; Viral like particles","Bhar","Anirban","Department of Botany, Ramakrishna Mission Vivekananda Centenary College, Rahara, Kolkata, 700118 India",NA
"2741","34248207","10.1007/s00112-021-01233-6","[Mobile applications (apps) for diagnosis and treatment control in pediatric and adolescent medicine].","Digitalization is finding its way into medicine in many different forms. Whether patient-centered, networking, supporting medical personnel or in (clinical) research: digital technologies have become an integral part of everyday medical life not only since the pandemic triggered by the SARS-CoV-2 virus. For example, mobile smartphone applications are among the most frequent developments; however, the multitude of available products and the lack of time in medical practice often make a reliable a","2021","07","13","Monatsschr Kinderheilkd","Monatsschrift Kinderheilkunde : Organ der Deutschen Gesellschaft fur Kinderheilkunde","Digital health; Innovation; Mobile health; Risk; Safety","Dramburg","Stephanie","Klinik für Pädiatrie mit Schwerpunkt Pneumologie, Immunologie und Intensivmedizin, Charité - Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Deutschland",NA
"2742","34248207","10.1007/s00112-021-01233-6","[Mobile applications (apps) for diagnosis and treatment control in pediatric and adolescent medicine].","Digitalization is finding its way into medicine in many different forms. Whether patient-centered, networking, supporting medical personnel or in (clinical) research: digital technologies have become an integral part of everyday medical life not only since the pandemic triggered by the SARS-CoV-2 virus. For example, mobile smartphone applications are among the most frequent developments; however, the multitude of available products and the lack of time in medical practice often make a reliable a","2021","07","13","Monatsschr Kinderheilkd","Monatsschrift Kinderheilkunde : Organ der Deutschen Gesellschaft fur Kinderheilkunde","Digital health; Innovation; Mobile health; Risk; Safety","Braune","Katarina","Klinik für Pädiatrie mit Schwerpunkt Endokrinologie und Diabetologie, Charité - Universitätsmedizin Berlin, Berlin, Deutschland",NA
"2743","34248207","10.1007/s00112-021-01233-6","[Mobile applications (apps) for diagnosis and treatment control in pediatric and adolescent medicine].","Digitalization is finding its way into medicine in many different forms. Whether patient-centered, networking, supporting medical personnel or in (clinical) research: digital technologies have become an integral part of everyday medical life not only since the pandemic triggered by the SARS-CoV-2 virus. For example, mobile smartphone applications are among the most frequent developments; however, the multitude of available products and the lack of time in medical practice often make a reliable a","2021","07","13","Monatsschr Kinderheilkd","Monatsschrift Kinderheilkunde : Organ der Deutschen Gesellschaft fur Kinderheilkunde","Digital health; Innovation; Mobile health; Risk; Safety","Schröder","Lisa","Perinatalzentrum, Klinik für Kinder- und Jugendmedizin, Vivantes Klinikum im Friedrichshain, Berlin, Deutschland",NA
"2744","34248207","10.1007/s00112-021-01233-6","[Mobile applications (apps) for diagnosis and treatment control in pediatric and adolescent medicine].","Digitalization is finding its way into medicine in many different forms. Whether patient-centered, networking, supporting medical personnel or in (clinical) research: digital technologies have become an integral part of everyday medical life not only since the pandemic triggered by the SARS-CoV-2 virus. For example, mobile smartphone applications are among the most frequent developments; however, the multitude of available products and the lack of time in medical practice often make a reliable a","2021","07","13","Monatsschr Kinderheilkd","Monatsschrift Kinderheilkunde : Organ der Deutschen Gesellschaft fur Kinderheilkunde","Digital health; Innovation; Mobile health; Risk; Safety","Schneider","Welfhard","Perinatalzentrum, Klinik für Kinder- und Jugendmedizin, Vivantes Klinikum im Friedrichshain, Berlin, Deutschland",NA
"2745","34248207","10.1007/s00112-021-01233-6","[Mobile applications (apps) for diagnosis and treatment control in pediatric and adolescent medicine].","Digitalization is finding its way into medicine in many different forms. Whether patient-centered, networking, supporting medical personnel or in (clinical) research: digital technologies have become an integral part of everyday medical life not only since the pandemic triggered by the SARS-CoV-2 virus. For example, mobile smartphone applications are among the most frequent developments; however, the multitude of available products and the lack of time in medical practice often make a reliable a","2021","07","13","Monatsschr Kinderheilkd","Monatsschrift Kinderheilkunde : Organ der Deutschen Gesellschaft fur Kinderheilkunde","Digital health; Innovation; Mobile health; Risk; Safety","Schunck","Karl-Ulrich","Perinatalzentrum, Klinik für Kinder- und Jugendmedizin, Vivantes Klinikum im Friedrichshain, Berlin, Deutschland",NA
"2746","34248207","10.1007/s00112-021-01233-6","[Mobile applications (apps) for diagnosis and treatment control in pediatric and adolescent medicine].","Digitalization is finding its way into medicine in many different forms. Whether patient-centered, networking, supporting medical personnel or in (clinical) research: digital technologies have become an integral part of everyday medical life not only since the pandemic triggered by the SARS-CoV-2 virus. For example, mobile smartphone applications are among the most frequent developments; however, the multitude of available products and the lack of time in medical practice often make a reliable a","2021","07","13","Monatsschr Kinderheilkd","Monatsschrift Kinderheilkunde : Organ der Deutschen Gesellschaft fur Kinderheilkunde","Digital health; Innovation; Mobile health; Risk; Safety","Stephan","Volker","Klinik für Kinder- und Jugendmedizin, Sana Klinikum Lichtenberg, Berlin, Deutschland",NA
"2747","34248201","10.1016/j.molstruc.2021.131020","Novel piperazine based compounds as potential inhibitors for SARS-CoV-2 Protease Enzyme: Synthesis and molecular docking study.","Structurally diverse piperazine-based compounds hybrid with thiadiazole, isatin or with sulfur/nitrogen, functionalities were synthesized. The structures of the new compounds were established based on their spectral data and elemental analysis. The physicochemical, bioactivity scores and pharmacokinetic behavior of all the prepared ligands were evaluated using in silico computational tools. The new piperazine ligands have been screened for their inhibition activity against SARS-CoV-2 prot","2021","07","14","J Mol Struct","Journal of molecular structure","COVID-19; Mannich reaction; Piperazine; Protease enzyme inhibitors; SARS-CoV-2","Omar","Alaa Z","Chemistry Department, Faculty of Science, Alexandria University, P.O. 426 Ibrahemia, Alexandria 21321, Egypt",NA
"2748","34248201","10.1016/j.molstruc.2021.131020","Novel piperazine based compounds as potential inhibitors for SARS-CoV-2 Protease Enzyme: Synthesis and molecular docking study.","Structurally diverse piperazine-based compounds hybrid with thiadiazole, isatin or with sulfur/nitrogen, functionalities were synthesized. The structures of the new compounds were established based on their spectral data and elemental analysis. The physicochemical, bioactivity scores and pharmacokinetic behavior of all the prepared ligands were evaluated using in silico computational tools. The new piperazine ligands have been screened for their inhibition activity against SARS-CoV-2 prot","2021","07","14","J Mol Struct","Journal of molecular structure","COVID-19; Mannich reaction; Piperazine; Protease enzyme inhibitors; SARS-CoV-2","Mosa","Tawfik M","Chemistry Department, Faculty of Science, Alexandria University, P.O. 426 Ibrahemia, Alexandria 21321, Egypt",NA
"2749","34248201","10.1016/j.molstruc.2021.131020","Novel piperazine based compounds as potential inhibitors for SARS-CoV-2 Protease Enzyme: Synthesis and molecular docking study.","Structurally diverse piperazine-based compounds hybrid with thiadiazole, isatin or with sulfur/nitrogen, functionalities were synthesized. The structures of the new compounds were established based on their spectral data and elemental analysis. The physicochemical, bioactivity scores and pharmacokinetic behavior of all the prepared ligands were evaluated using in silico computational tools. The new piperazine ligands have been screened for their inhibition activity against SARS-CoV-2 prot","2021","07","14","J Mol Struct","Journal of molecular structure","COVID-19; Mannich reaction; Piperazine; Protease enzyme inhibitors; SARS-CoV-2","El-Sadany","Samer K","Chemistry Department, Faculty of Science, Alexandria University, P.O. 426 Ibrahemia, Alexandria 21321, Egypt",NA
"2750","34248201","10.1016/j.molstruc.2021.131020","Novel piperazine based compounds as potential inhibitors for SARS-CoV-2 Protease Enzyme: Synthesis and molecular docking study.","Structurally diverse piperazine-based compounds hybrid with thiadiazole, isatin or with sulfur/nitrogen, functionalities were synthesized. The structures of the new compounds were established based on their spectral data and elemental analysis. The physicochemical, bioactivity scores and pharmacokinetic behavior of all the prepared ligands were evaluated using in silico computational tools. The new piperazine ligands have been screened for their inhibition activity against SARS-CoV-2 prot","2021","07","14","J Mol Struct","Journal of molecular structure","COVID-19; Mannich reaction; Piperazine; Protease enzyme inhibitors; SARS-CoV-2","Hamed","Ezzat A","Chemistry Department, Faculty of Science, Alexandria University, P.O. 426 Ibrahemia, Alexandria 21321, Egypt",NA
"2751","34248201","10.1016/j.molstruc.2021.131020","Novel piperazine based compounds as potential inhibitors for SARS-CoV-2 Protease Enzyme: Synthesis and molecular docking study.","Structurally diverse piperazine-based compounds hybrid with thiadiazole, isatin or with sulfur/nitrogen, functionalities were synthesized. The structures of the new compounds were established based on their spectral data and elemental analysis. The physicochemical, bioactivity scores and pharmacokinetic behavior of all the prepared ligands were evaluated using in silico computational tools. The new piperazine ligands have been screened for their inhibition activity against SARS-CoV-2 prot","2021","07","14","J Mol Struct","Journal of molecular structure","COVID-19; Mannich reaction; Piperazine; Protease enzyme inhibitors; SARS-CoV-2","El-Atawy","Mohamed","Chemistry Department, Faculty of Science, Alexandria University, P.O. 426 Ibrahemia, Alexandria 21321, Egypt",NA
"2752","34248195","10.4103/ija.IJA_1538_20","Severe haemolytic anaemia in COVID 19- A rare manifestation.",NA,"2021","07","13","Indian J Anaesth","Indian journal of anaesthesia",NA,"Renganathan","Vyshnavi","Department of Anaesthesiology and Critical Care, ESIC Medical College and Superspeciality Hospital, Sanath Nagar, Hyderabad, Telangana, India",NA
"2753","34248195","10.4103/ija.IJA_1538_20","Severe haemolytic anaemia in COVID 19- A rare manifestation.",NA,"2021","07","13","Indian J Anaesth","Indian journal of anaesthesia",NA,"Dhanalakshmi","Kalyani Surya","Department of Anaesthesiology and Critical Care, ESIC Medical College and Superspeciality Hospital, Sanath Nagar, Hyderabad, Telangana, India",NA
"2754","34248195","10.4103/ija.IJA_1538_20","Severe haemolytic anaemia in COVID 19- A rare manifestation.",NA,"2021","07","13","Indian J Anaesth","Indian journal of anaesthesia",NA,"Nanda","Ananya","Department of Anaesthesiology and Critical Care, ESIC Medical College and Superspeciality Hospital, Sanath Nagar, Hyderabad, Telangana, India",NA
"2755","34248195","10.4103/ija.IJA_1538_20","Severe haemolytic anaemia in COVID 19- A rare manifestation.",NA,"2021","07","13","Indian J Anaesth","Indian journal of anaesthesia",NA,"Gopinath","Ramachandran","Department of Anaesthesiology and Critical Care, ESIC Medical College and Superspeciality Hospital, Sanath Nagar, Hyderabad, Telangana, India",NA
